-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 T21/KP7Rw6zmR5b0u4XJGO/byKpbKoxQCumBESIy68b/nClW6KEYfTWJLExpEYL4
 jABiYI28IVu245982OPGcQ==

<SEC-DOCUMENT>0001019687-08-005240.txt : 20081125
<SEC-HEADER>0001019687-08-005240.hdr.sgml : 20081125
<ACCEPTANCE-DATETIME>20081125171800
ACCESSION NUMBER:		0001019687-08-005240
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		21
FILED AS OF DATE:		20081125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vivakor, Inc.
		CENTRAL INDEX KEY:			0001450704
		IRS NUMBER:				262178141
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-155686
		FILM NUMBER:		081214690

	BUSINESS ADDRESS:	
		STREET 1:		2590 HOLIDAY ROAD
		STREET 2:		SUITE 100
		CITY:			CORALVILLE
		STATE:			IA
		ZIP:			52241
		BUSINESS PHONE:		(319) 625-2172

	MAIL ADDRESS:	
		STREET 1:		2590 HOLIDAY ROAD
		STREET 2:		SUITE 100
		CITY:			CORALVILLE
		STATE:			IA
		ZIP:			52241
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>vivakor_s1.htm
<DESCRIPTION>FORM S-1 REGISTRATION STATEMENT
<TEXT>
<html>
  <head>
    <title>vivakor_s1.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As filed
with the Securities and Exchange Commission on November __, 2008</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 396pt"></font>Registration No.
333-</font>&#160;<font style="TEXT-DECORATION: underline">&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNITED
STATES</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE
COMMISSION</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">WASHINGTON, D.C.
20549</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FORM
S-1</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Exact
name of registrant as specified in its charter)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="29%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nevada</font></div>
            </td>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="29%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8731</font></div>
            </td>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="29%">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26-2178141</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="29%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(State
      or other jurisdiction of</font></div>
            </td>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="29%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Primary
      standard industrial</font></div>
            </td>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="29%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(IRS
      employer</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="29%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">incorporation
      or organization)</font></div>
            </td>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="29%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">classification
      code number)</font></div>
            </td>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="29%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">identification
      number)</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2590
Holiday Road, Suite 100</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Coralville,
IA&#160;&#160;52241</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(319)
625-2172</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s
principal executive offices)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Registered
Agent Solutions, Inc.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4625 West
Nevso Drive, Suite 2</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Las
Vegas, NV&#160;&#160;89103</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(888)
705-7274</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Name,
address, including zip code, and telephone number, including area code, of agent
for service)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Copies
to:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Christopher
A. Wilson, Esq.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Wilson,
Haglund &amp; Paulsen, P.C.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9110
Irvine Center Drive</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Irvine,
CA&#160;&#160;92618</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Telephone
No. (949) 752-1100</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Facsimile
No. (949)752-1144</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">cwilson@whp-law.com</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approximate
date of commencement of proposed sale to the public: As soon as practicable
after this Registration Statement is declared effective.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If any of
the securities being registered on this Form are to be offered on a delayed or
continuous basis pursuant to Rule 415 under the Securities Act, check the
following box. <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If this
form is filed to register additional securities for an offering pursuant to Rule
462(b) under the Securities Act, please check the following box and list the
Securities Act registration statement number of the earlier effective
registration statement for the same offering. <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If this
form is a post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same
offering. <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If this
form is a post-effective amendment filed pursuant to Rule 462(d) under the
Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same
offering. <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller
reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="top" width="21%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Large
      accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div>
              </td>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="21%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accelerated
      filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div>
              </td>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="21%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-accelerated
      filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div>
              </td>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="21%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Smaller
      reporting company <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="21%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Do
      not check if a smaller reporting company)</font></div>
              </td>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CALCULATION
OF REGISTRATION FEE</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">
        <div align="center">
          <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td valign="bottom" width="20%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-WEIGHT: bold">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title
      of Each Class of</font> </font></font>

                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities
      to be</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Registered</font></div>
                </td>
                <td valign="bottom" width="20%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-WEIGHT: bold">A<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">mount</font>
      </font></font>

                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">to
      be</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Registered</font></div>
                </td>
                <td valign="bottom" width="20%" style="TEXT-ALIGN: center">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proposed
      Maximum</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offering
      Price Per Share</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2)</font></div>
                </td>
                <td valign="bottom" width="20%" style="TEXT-ALIGN: center">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proposed
      Maximum</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offering
      Price (3)</font></div>
                </td>
                <td valign="bottom" width="20%" style="TEXT-ALIGN: center">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount
      of Registration</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fee
      (4)</font></div>
                </td>
              </tr>
              <tr>
                <td width="20%">
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common
      stock, par value $.001 per share</font></div>
                </td>
                <td width="20%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,133,000</font></font></td>
                <td width="20%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;$0.50</font></td>
                <td width="20%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;$10,066,500</font></td>
                <td width="20%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;$396</font></td>
              </tr>
          </table>
        </div>
        <div>&#160;</div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160;&#160;
Registration fee has been paid via Fedwire.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)&#160;&#160;
This is the initial public offering and no current trading market exists for our
stock.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)&#160;&#160;
Estimated solely for the purpose of calculating the registration fee pursuant to
Rule 457(c).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)&#160;&#160;
Estimated solely for the purpose of computing the amount of the registration fee
pursuant to Rule 457(o) under the Securities Act.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
offering price has been estimated solely for the purpose of computing the amount
of the registration fee in accordance with Rule 457(o). Our common stock is not
traded on any national exchange and in accordance with Rule 457; the offering
price was determined by the price 133,000 shares were sold to our shareholders
in a private placement. Until our common stock is quoted on the OTC Electronic
Bulletin Board there is no market price for the shares.&#160;&#160;Once listed
on the OTCBB the shares may be sold at prevailing market prices or privately
negotiated prices. There can be no assurance that a market maker will agree to
file the necessary documents with the Financial Industry Regulatory Authority,
which operates the OTC Electronic Bulletin Board, nor can there be any assurance
that such an application for quotation will be approved.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
registrant hereby amends this registration statement on such date or dates as
may be necessary to delay its effective date until the registrant shall file a
further amendment which specifically states that this registration statement
shall thereafter become effective in accordance with Section 8(a) of the
Securities Act of 1933 or until this registration statement shall become
effective on such date as the Securities and Exchange Commission, acting
pursuant to said Section 8(a), may determine.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; COLOR: red; FONT-FAMILY: times new roman">SUBJECT
TO COMPLETION, DATED ____________ __, 2008.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; COLOR: red">The information in this
prospectus is not complete and may be changed. We may not sell these securities
until the registration statement filed with the Securities and Exchange
Commission is effective. This prospectus is not an offer to sell these
securities and we are not soliciting offers to buy these securities in any state
where the offer or sale is not permitted.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROSPECTUS</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">20,133,000
Shares of Common stock</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
prospectus relates to the sale of up to 5,133,000 shares of our common stock by
persons who have purchased shares of our common stock in a private placement or
who acquired shares in exchange for their shares of common stock of
HealthAmerica, Inc. The aforementioned persons are sometimes referred to in this
prospectus as the selling stockholders.&#160;&#160;&#160;The shares offered
under this prospectus by the selling stockholders may be sold on the public
market, in negotiated transactions with a broker-dealer or market maker as
principal or agent, or in privately negotiated transactions not involving a
broker dealer. The prices at which the selling stockholder may sell the shares
may be determined by the prevailing market price of the shares at the time of
sale, may be different than such prevailing market prices or may be determined
through negotiated transactions with third parties.&#160;&#160;We will not
receive proceeds from the sale of our shares by the selling
stockholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
selling stockholder may be considered an &#8220;underwriter&#8221; within the meaning of the
Securities Act of 1933, as amended.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
prospectus will also allow us to issue up to 15,000,000 shares of our common
stock, from time to time in one or more offerings.&#160;&#160;These shares of
common stock may be offered and sold separately or together in one or more
series of issuances. We will provide specific terms of the securities in
supplements to this prospectus.&#160;&#160;The proceeds from the sale of these
shares will be available for use by the company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
common stock is not listed or trading on any exchange or automated quotation
system.&#160;&#160;We intend, upon effectiveness of the registration of which
this prospectus is part, to engage a market maker to apply for quotation on the
OTC Electronic Bulletin Board.&#160;&#160;There can be no assurance that a
market maker will agree to file the necessary documents with the Financial
Industry Regulatory Authority, which operates the OTC Electronic Bulletin Board,
nor can there be any assurance that such an application for quotation will be
approved.</font><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">The securities offered in this
prospectus involve a high degree of risk. You should consider the risk factors
beginning on page 4 before purchasing our common stock.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of
these securities or passed upon the adequacy or accuracy of this prospectus. Any
representation to the contrary is a criminal offense.</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The date
of this prospectus is November __, 2008.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
          </div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Table of Contents</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prospectus
      Summary&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Risk
      Factors&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cautionary
      Note Regarding Forward-Looking Statements</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Use
      of Proceeds</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Capitalization</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dilution&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Market
      for Common Equity and Related Stockholder Matters</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Description
      of Business and Property</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Management&#8217;s
      Discussion and Analysis of Financial Condition and Results of
      Operations</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Our
      Management&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Security
      Ownership of Certain Beneficial Owners and
Management&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Certain
      Relationships and Related Party Transactions&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Description
      of Capital Stock</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Selling
      Stockholders</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Plan
      of Distribution</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Disclosure
      of Commission Position on Indemnification for Securities Act
      Liabilities</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Legal
      Opinion</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Experts&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interests
      of Named Experts an Counsel&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Additional
      Information&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Index
      to Financial
      Statements&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
              </td>
              <td align="right" valign="top" width="4%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-1</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Unless otherwise specified, the
information in this prospectus is set forth as of November __, 2008, and we
anticipate that changes in our affairs will occur after such date. We have not
authorized any person to give any information or to make any representations,
other than as contained in this prospectus, in connection with the offer
contained in this prospectus. If any person gives you any information or makes
representations in connection with this offer, do not rely on it as information
we have authorized. This prospectus is not an offer to sell our common stock in
any state or other jurisdiction to any person to whom it is unlawful to make
such offer.</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1101">PROSPECTUS SUMMARY</a></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
following summary highlights selected information from this prospectus and may
not contain all the information that is important to you. To understand our
business and this offering fully, you should read this entire prospectus
carefully, including the financial statements and the related notes beginning on
page F-1. When we refer in this prospectus to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and
&#8220;our,&#8221; we mean Vivakor, Inc., a Nevada corporation, together with our
subsidiary, HealthAmerica, Inc. This prospectus contains forward-looking
statements and information relating to Vivakor, Inc.&#160;&#160;See Cautionary
Note Regarding Forward Looking Statements on page 9.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
Company</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Vivakor,
Inc. (&#8220;Vivakor,&#8221; the &#8220;Company,&#8221; or &#8220;we&#8221;) is a transdisciplinary research company
that develops products in the fields of molecular medicine, electro-optics,
biological handling and natural and formulary compounds.&#160;&#160;We also
provide contract research services for third parties.&#160;&#160;We have
developed numerous products and have filed for 15 provisional patents with the
United States Patent and Trademark Office (USPTO).&#160;&#160;We intend to
commercialize such products, after completion of any required regulatory
approvals, through one of three methods:&#160;&#160;a sale of the technology,
licensing of the product to a manufacturer or distributor or, in some cases, by
manufacturing, marketing and directly selling the products
ourselves.&#160;&#160;We were originally formed as a Nevada limited liability
company on November 1, 2006 and subsequently converted to a Nevada corporation
on April 30, 2008. Our executive offices are located at 2590 Holiday Road, Suite
100, Coralville, Iowa 52241. Our telephone number is (319)
625-2172.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Offering</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
prospectus covers (i) shares being offered for resale by the selling
stockholders which shares were issued by us in two separate transactions, a
private placement of 133,000 shares of common stock in September and October
2008, and 5,000,000 shares issued as partial payment of the purchase price for
the acquisition of a majority of the outstanding shares of common stock of
Health America, Inc. on October 20, 2008; and (ii) up to 15,000,000 shares to
be&#160;&#160;issued and sold by us.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Between
May and October 2008, we offered and sold 133,000 shares of common stock to five
accredited investors for an aggregate gross purchase price of
$66,500.&#160;&#160;We agreed to file a registration statement with the United
States Securities and Exchange Commission (SEC) providing for the resale of such
shares of common stock.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
October 20, 2008, we acquired 25,000,000 shares of common stock of
HealthAmerica, Inc., a Nevada corporation (HealthAmerica), representing
approximately 84% of the outstanding shares of capital stock of HealthAmerica,
in exchange for the issuance of 5,000,000 shares of our common stock and a
promissory note in the principal amount of $1,500,000.&#160;&#160;We agreed with
the shareholders of HealthAmerica who received our stock in the acquisition that
we would include such shares in the registration statement. See Certain
Relationship and Related Party Transactions.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
addition, this prospectus covers up to 15,000,000 shares of common stock to be
sold by the company in one or more transactions.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">ABOUT THIS
OFFERING</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td align="left" valign="top" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Securities Being
      Offered</font></font></div>
              </td>
              <td align="left" valign="top" width="70%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Up
      to 5,133,000 shares of common stock in VivaKor, Inc. to be sold by selling
      stockholders.</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="70%">
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Up
      to 15,000,000 shares of common stock of VivaKor, Inc. to be sold by the
      company.</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="70%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Initial Offering
      Price</font></font></div>
              </td>
              <td align="left" valign="top" width="70%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      selling stockholders will sell up to 5,133,000 shares at prices
      established on the OTC Electronic Bulletin Board during the term of this
      offering, at prices different than prevailing market prices or at
      privately negotiated prices.</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      company will sell up to 15,000,000 shares from time to time in one or more
      offerings as prices to be determined in the future.</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="70%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Terms of the
      Offering</font></font></div>
              </td>
              <td align="left" valign="top" width="70%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      selling stockholders will determine the terms relative to the sale of the
      common stock offered and sold by them and the company will determine the
      terms relative to the shares sold by it.</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="70%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Termination of the
      Offering</font></font></div>
              </td>
              <td align="left" valign="top" width="70%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      offering will conclude when all of the 20,133,000 shares of common stock
      have been sold or at a time when the company, in its sole discretion,
      decides to terminate the registration of the shares.</font></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="30%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="70%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td align="left" valign="top" width="30%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Risk
    Factors</font></font></div>
              </td>
              <td valign="top" width="70%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">An
      investment in our common stock is highly speculative and involves a high
      degree of risk. See Risk Factors beginning on page
  4.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1102">RISK FACTORS</a></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">An
investment in our common stock is highly speculative, involves a high degree of
risk, and should be made only by investors who can afford a complete loss. You
should carefully consider the following risk factors, together with the other
information in this prospectus, including our financial statements and the
related notes, before you decide to buy our common stock. Our most significant
risks and uncertainties are described below; however, they are not the only
risks we face. If any of the following risks actually occur, our business,
financial condition, or results of operations could be materially adversely
affected, the trading of our common stock could decline, and you may lose all or
part of your investment therein.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Risks
Relating to the Early Stage of our Company</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
are at a very early operational stage and our success is subject to the
substantial risks inherent in the establishment of a new business
venture.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
implementation of our business strategy is in a very early stage. We are in the
process of developing numerous product candidates but none have proven to be
commercially successful. Our business and operations should be considered to be
in a very early stage and subject to all of the risks inherent in the
establishment of a new business venture. Accordingly, our intended business and
operations may not prove to be successful in the near future, if at all. Any
future success that we might enjoy will depend upon many factors, several of
which may be beyond our control, or which cannot be predicted at this time, and
which could have a material adverse effect upon our financial condition,
business prospects and operations and the value of an investment in our
company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
have a very limited operating history and our business plan is unproven and may
not be successful.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
company was formed in November 2006 but we began operations in earnest in March
2008 when one of our officers and some of our key employees commenced
employment.&#160;&#160;Since March 2008, our primary activities have been
research and development, the identification of collaborative partners,
intellectual property protection such as patent applications and capital raising
activities.&#160;&#160;We have not licensed or sold any substantial amount of
products commercially and do not have any definitive agreements to do
so.&#160;&#160;We have not proven that our business model will allow us to
identify and develop commercially feasible products.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">We have suffered operating losses
since inception and we may not be able to achieve
profitability.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We had an
accumulated deficit of $313,113 and have an overall deficit in stockholders&#8217;
equity as of September 30, 2008.&#160;&#160;We expect to continue to incur
significant research and development expenses in the foreseeable future related
to the completion of development and commercialization of our products. As a
result, we are sustaining substantial operating and net losses, and it is
possible that we will never be able to sustain or develop the revenue levels
necessary to attain profitability.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">We may have difficulty raising
additional capital, which could deprive us of necessary
resources.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expect
to continue to devote significant capital resources to fund research and
development. In order to support the initiatives envisioned in our business
plan, we will need to raise additional funds through the sale of assets, public
or private debt or equity financing, collaborative relationships or other
arrangements. Our ability to raise additional financing depends on many factors
beyond our control, including the state of capital markets, the market price of
our common stock and the development or prospects for development of competitive
technology by others. Because our common stock is not listed on a major stock
market, many investors may not be willing or allowed to purchase it or may
demand steep discounts. Sufficient additional financing may not be available to
us or may be available only on terms that would result in further dilution to
the current owners of our common stock.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expect
to raise additional capital during 2009 but we do not have any firm commitments
for additional funding.&#160;&#160;If we are unsuccessful in raising additional
capital, or the terms of raising such capital are unacceptable, we may have to
modify our business plan and/or significantly curtail our planned activities and
other operations.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Failure
to effectively manage our growth could place strains on our managerial,
operational and financial resources and could adversely affect our business and
operating results.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
growth has placed, and is expected to continue to place, a strain on our
managerial, operational and financial resources. Further, if our subsidiary&#8217;s
business grows, we will be required to manage multiple relationships. Any
further growth by us or our subsidiary, or an increase in the number of our
strategic relationships will increase this strain on our managerial, operational
and financial resources. This strain may inhibit our ability to achieve the
rapid execution necessary to implement our business plan, and could have a
material adverse effect upon our financial condition, business prospects and
operations and the value of an investment in our company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Risks
Relating to Our Research and Development Business</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">There
are substantial inherent risks in attempting to commercialize new technological
applications, and, as a result, we may not be able to successfully develop
products or technology for commercial use.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
company conducts research and development of products in numerous technological
and medical fields. Our research scientists are working on developing technology
in various stages. However, commercial feasibility and acceptance of such
product candidates are unknown. Scientific research and development requires
significant amounts of capital and takes an extremely long time to reach
commercial viability, if at all. To date, our research and development projects
have not produced commercially viable applications, and may never do so. During
the research and development process, we may experience technological barriers
that we may be unable to overcome. Because of these uncertainties, it is
possible that none of our product candidates will be successfully developed. If
we are unable to successfully develop products or technology for commercial use,
we will be unable to generate revenue or build a sustainable or profitable
business.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
will need to achieve commercial acceptance of our applications to generate
revenues and achieve profitability.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Even if
our research and development yields technologically feasible applications, we
may not successfully develop commercial products, and even if we do, we may not
do so on a timely basis. If our research efforts are successful on the
technology side, it could take at least several years before this technology
will be commercially viable. During this period, superior competitive
technologies may be introduced or customer needs may change, which will diminish
or extinguish the commercial uses for our applications. We cannot predict when
significant commercial market acceptance for our products will develop, if at
all, and we cannot reliably estimate the projected size of any such potential
market. If markets fail to accept our products, we may not be able to generate
revenues from the commercial application of our technologies. Our revenue growth
and achievement of profitability will depend substantially on our ability to
introduce new accepted by customers. If we are unable to cost-effectively
achieve acceptance of our technology by customers, or if the associated products
do not achieve wide market acceptance, our business will be materially and
adversely affected.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
will need to establish additional relationships with collaborative and
development partners to fully develop and market our products.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We do not
possess all of the resources necessary to develop and commercialize products on
a mass scale that may result from our technologies. Unless we expand our product
development capacity and enhance our internal marketing, we will need to make
appropriate arrangements with collaborative partners to develop and
commercialize current and future products.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Collaborations
may allow us to:</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 1.25;">
                <td style="WIDTH: 36pt">
                </td>
                <td align="right" style="WIDTH: 27pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                </td>
                <td align="left">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">generate
      cash flow and revenue;</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 1.25;">
                <td style="WIDTH: 36pt">
                </td>
                <td align="right" style="WIDTH: 27pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                </td>
                <td align="left">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">offset
      some of the costs associated with our internal research and development,
      preclinical testing, clinical trials and
  manufacturing;</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 1.25;">
                <td style="WIDTH: 36pt">
                </td>
                <td align="right" style="WIDTH: 27pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                </td>
                <td align="left">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">seek
      and obtain regulatory approvals faster than we could on our own;
      and</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 1.25;">
                <td style="WIDTH: 36pt">
                </td>
                <td align="right" style="WIDTH: 27pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                </td>
                <td align="left">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">successfully
      commercialize product
candidates.</font></div>
                </td>
              </tr>
          </table>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If we do
not find appropriate partners, our ability to develop and commercialize products
could be adversely affected. Even if we are able to find collaborative partners,
the overall success of the development and commercialization of product
candidates in those programs will depend largely on the efforts of other parties
and is beyond our control. In addition, in the event we pursue our
commercialization strategy through collaboration, there are a variety of
attendant technical, business and legal risks, including:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div align="left">&#160;</div>
      <div align="left">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
      development partner would likely gain access to our proprietary
      information, potentially enabling the partner to develop products without
      us or design around our intellectual
property;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">we
      may not be able to control the amount and timing of resources that our
      collaborators may be willing or able to devote to the development or
      commercialization of our product candidates or to their marketing and
      distribution; and</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">disputes may arise
      between us and our collaborators that result in the delay or termination
      of the research, development or commercialization of our product
      candidates or that result in costly litigation or arbitration that diverts
      our management&#8217;s
resources.</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
occurrence of any of the above risks could impair our ability to generate
revenues and harm our business and financial condition.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Clinical trials for our certain
product candidates may be lengthy and expensive and their outcome is
uncertain.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain
of our product candidates will be subject to regulatory approval from the United
States Food and Drug Administration (&#8220;FDA&#8221;) or other governmental regulatory
agencies. Before obtaining regulatory approval for the commercial sale of such
product candidates, we must demonstrate through preclinical testing and clinical
trials that such product candidates are safe and effective for use in humans.
Conducting clinical trials is a time consuming, expensive and uncertain process
and may take years to complete. Historically, the results from preclinical
testing and early clinical trials have often not been predictive of results
obtained in later clinical trials. Frequently, drugs or products that have shown
promising results in preclinical or early clinical trials subsequently fail to
establish sufficient safety and efficacy data necessary to obtain regulatory
approval. At any time during the clinical trials, we, the participating
institutions or FDA might delay or halt any clinical trials for our product
candidates for various reasons, including:</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div align="left">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 1.25;">
                <td style="WIDTH: 36pt">
                </td>
                <td align="right" style="WIDTH: 27pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                </td>
                <td align="left">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ineffectiveness
      of the product candidate;</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 1.25;">
                <td style="WIDTH: 36pt">
                </td>
                <td align="right" style="WIDTH: 27pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></font></div>
                </td>
                <td align="left">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">discovery
      of unacceptable toxicities or side
effects;</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 1.25;">
                <td style="WIDTH: 36pt">
                </td>
                <td align="right" style="WIDTH: 27pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></font></div>
                </td>
                <td align="left">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">development
      of disease resistance or other physiological
  factors;</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 1.25;">
                <td style="WIDTH: 36pt">
                </td>
                <td align="right" style="WIDTH: 27pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></font></div>
                </td>
                <td align="left">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">delays
      in patient enrollment; or</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
              <tr valign="top" style="LINE-HEIGHT: 1.25;">
                <td style="WIDTH: 36pt">
                </td>
                <td align="right" style="WIDTH: 27pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></font></div>
                </td>
                <td align="left">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">other
      reasons that are internal to the businesses of our potential collaborative
      partners, which reasons they may not share with
  us.</font></div>
                </td>
              </tr>
          </table>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
results of the clinical trials may fail to demonstrate the safety or
effectiveness of our product candidates to the extent necessary to obtain
regulatory approval or such that commercialization of our product candidates is
worthwhile. Any failure or substantial delay in successfully completing clinical
trials and obtaining regulatory approval for our product candidates could
severely harm our business.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">We expect to rely on third parties
to manufacture our product candidates and our business will suffer if they do
not perform.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We do not
expect to manufacture many of our products and will engage third party
contractors to provide manufacturing services.&#160;&#160;If our contractors do
not operate in accordance with regulatory requirements and quality standards,
our business will suffer. We expect to use or rely on components and services
that are provided by sole source suppliers. The qualification of additional or
replacement vendors is time consuming and costly. If a sole source supplier has
significant problems supplying our products, our sales and revenues will be hurt
until we find a new source of supply.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">We expect to rely on third parties
for the worldwide marketing and distribution of our product candidates, who may
not be successful in selling our products.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
currently do not have adequate resources to market and distribute any products
worldwide and expect to engage third party marketing and distribution companies
to perform these tasks. While we believe that distribution partners will be
available, we cannot assure you that the distribution partners, if any, will
succeed in marketing our products on a global basis. We may not be able to
maintain satisfactory arrangements with our marketing and distribution partners,
who may not devote adequate resources to selling our products. If this happens,
we may not be able to successfully market our products, which would decrease or
eliminate our ability to generate revenues.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We
may not be successful at marketing and selling HealthAmerica&#8217;s technology or
products.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
effectively acquired the assets of our subsidiary, HealthAmerica, on October 20,
2008. HealthAmerica owns patents and technology related to medical record bar
coding and magnetic resonance imaging (MRI) and systems employing its technology
have been previously commercially sold and operated.&#160;&#160;HealthAmerica&#8217;s
technology was developed years ago and no significant operations and no
commercial sales have occurred within the last four years.&#160;&#160;As a
result, the HealthAmerica technology may be outdated by recent technology
developments.&#160;&#160;As of the date of this prospectus we have not devoted
any substantial effort or resources to the development of HealthAmerica&#8217;s
products or technology.&#160;&#160;&#160;We may not be able to market and sell
the HealthAmerica technology or products and any financial or research efforts
we exert to develop, commercialize or promote such products may not result in
revenue or earnings.&#160;&#160;On an annual basis we will evaluate whether
there is any impairment of the acquired HealthAmerica assets and, if so, future
impairment charges may need to be recorded.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">We may lose out to larger and
better-established competitors.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
medical device and biotechnology industries are intensely competitive. Most of
our competitors have significantly greater financial, technical, manufacturing,
marketing and distribution resources as well as greater experience in the
medical device industry than we have. The particular medical conditions,
illnesses or diseases our product lines are intended to address can also be
addressed by other medical devices, procedures or drugs. Many of these
alternatives are widely accepted by physicians and have a long history of use.
Physicians may use our competitors&#8217; products and/or our products may not be
competitive with other technologies. If these things happen, our sales and
revenues will decline. In addition, our current and potential competitors may
establish cooperative relationships with large medical equipment companies to
gain access to greater research and development or marketing resources.
Competition may result in price reductions, reduced gross margins and loss of
market share.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Our products may be displaced by
newer technology.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
medical device and biotechnology industries are undergoing rapid and significant
technological change. Third parties may succeed in developing or marketing
technologies and products that are more effective than those developed or
marketed by us, or that would make our technology and products obsolete or
non-competitive. Additionally, researchers could develop new surgical procedures
and medications that replace or reduce the importance of the procedures that use
our products. Accordingly, our success will depend, in part, on our ability to
respond quickly to medical and technological changes through the development and
introduction of new products. We may not have the resources to do this. If our
product candidates become obsolete and our efforts to develop new products do
not result in any commercially successful products, our sales and revenues will
decline.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">We may not have sufficient legal
protection against infringement or loss of our intellectual property, and we may
lose rights to our licensed intellectual property if diligence requirements are
not met.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
success depends, in part, on our ability to secure and maintain patent
protection, to preserve our trade secrets, and to operate without infringing on
the patents of third parties. While we intend to protect our proprietary
positions by filing United States and foreign patent applications for our
important inventions and improvements, domestic and foreign patent offices may
not issue these patents.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To date
we have filed only provisional patents with respect to our product
candidates.&#160;&#160;Provisional patents are not reviewed by the USPTO and
will not result in the issuance of a patent, unless a regular patent application
is filed within one year after the filing of the provisional patent
application.&#160;&#160;Generally, our provisional patent applications do not
contain all of the detailed design and other information required by a regular
patent application.&#160;&#160;As a result, it may be uncertain whether the
description of the invention in a provisional patent meets the &#8220;best mode and
enablement&#8221; requirements for issuance of a patent. Failure to adequately
describe the invention may result in the loss of certain
claims.&#160;&#160;Although we intend to file regular patent applications with
respect to each of our product candidates, such filings require substantial
expenditures of management time and legal fees.&#160;&#160;If we do not have the
funds or resources to prepare, file and maintain patent applications, we could
lose proprietary rights to our technology.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Even if
we file patent applications and patents are issued, third parties may challenge,
invalidate, or circumvent our patents or patent applications in the future.
Competitors, many of which have significantly more resources than we have and
have made substantial investments in competing technologies, may apply for and
obtain patents that will prevent, limit, or interfere with our ability to make,
use, or sell our products either in the United States or abroad.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the
United States, patent applications are secret until patents are issued, and in
foreign countries, patent applications are secret for a time after filing.
Publications of discoveries tend to significantly lag the actual discoveries and
the filing of related patent applications. Third parties may have already filed
applications for patents for products or processes that will make our products
obsolete or will limit our patents or invalidate our patent
applications.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
typically require our employees, consultants, advisers and suppliers to execute
confidentiality and assignment of invention agreements in connection with their
employment, consulting, advisory, or supply relationships with us. They may
breach these agreements and we may not obtain an adequate remedy for breach.
Further, third parties may gain access to our trade secrets or independently
develop or acquire the same or equivalent information.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">We could be
damaged by product liability claims</font><font style="DISPLAY: inline; FONT-STYLE: italic">.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
products are intended to be used in various clinical or surgical procedures. If
one of our products malfunctions or a physician or patient misuses it and injury
results to a patient or operator, the injured party could assert a product
liability claim against our company. We currently do not have product liability
insurance and may not be able to obtain such insurance at a rate that is
acceptable to us or at all. Furthermore, even if we can obtain insurance,
insurance may not be sufficient to cover all of the liabilities resulting from a
product liability claim, and we might not have sufficient funds available to pay
any claims over the limits of our insurance. Because personal injury claims
based on product liability in a medical setting may be very large, an
underinsured or an uninsured claim could financially damage our
company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Risks
Relating to our Stock</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">The sale of the shares of common
stock acquired in private placements could cause the price of our common stock
to decline.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
2008, we completed financings in which we issued common stock to certain private
investors. The terms of these transactions require that we file registration
statements with the Securities and Exchange Commission under which the investors
may resell to the public common stock acquired in these
transactions.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
selling stockholders under these registration statements may sell none, some or
all of the shares of common stock acquired from us. We have no way of knowing
whether or when the selling stockholders will sell the shares covered by these
registration statements. Depending upon market liquidity at the time, a sale of
shares covered by these registration statements at any given time could cause
the trading price of our common stock to decline. The sale of a substantial
number of shares of our common stock under these registration statements, or
anticipation of such sales, could make it more difficult for us to sell equity
or equity-related securities in the future at a time and at a price that we
might otherwise wish to effect sales.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our
common stock is not listed or trading on any exchange and shareholders may not
be able to resell their shares.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Currently
our shares of common stock are not listed on any exchange or automated quotation
system.&#160;&#160;A public market for our shares may never
develop.&#160;&#160;There can be no assurance that purchaser of our shares will
be able to resell their shares at their original purchase price, if at
all.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Our common stock is expected to be
traded over the counter, which may deprive stockholders of the full value of
their shares.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
anticipate that our common stock will be quoted via the OTC Electronic Bulletin
Board. If successfully listed on the OTC Electronic Bulletin, our common stock
is expected to have fewer market makers, lower trading volumes and larger
spreads between bid and asked prices than securities listed on an exchange such
as the New York Stock Exchange or the NASDAQ Stock Market. These factors may
result in higher price volatility and less market liquidity for the common
stock.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">A low market price would severely
limit the potential market for our common stock.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
common stock is expected to trade at a price substantially below $5.00 per
share, subjecting trading in the stock to certain SEC rules requiring additional
disclosures by broker-dealers. These rules generally apply to any non-NASDAQ
equity security that has a market price share of less than $5.00 per share,
subject to certain exceptions (a &#8220;penny stock&#8221;). Such rules require the
delivery, prior to any penny stock transaction, of a disclosure schedule
explaining the penny stock market and the risks associated therewith and impose
various sales practice requirements on broker-dealers who sell penny stocks to
persons other than established customers and institutional or wealthy investors.
For these types of transactions, the broker-dealer must make a special
suitability determination for the purchaser and have received the purchaser&#8217;s
written consent to the transaction prior to the sale. The broker-dealer also
must disclose the commissions payable to the broker-dealer, current bid and
offer quotations for the penny stock and, if the broker-dealer is the sole
market maker, the broker-dealer must disclose this fact and the broker-dealer&#8217;s
presumed control over the market. Such information must be provided to the
customer orally or in writing before or with the written confirmation of trade
sent to the customer. Monthly statements must be sent disclosing recent price
information for the penny stock held in the account and information on the
limited market in penny stocks. The additional burdens imposed upon
broker-dealers by such requirements could discourage broker-dealers from
effecting transactions in our common stock.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">FINRA sales
practice requirements may also limit a stockholders ability to buy and sell our
stock.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;In
addition to the penny stock rules promulgated by the SEC, which are discussed in
the immediately preceding risk factor, FINRA rules require that in recommending
an investment to a customer, a broker-dealer must have reasonable grounds for
believing that the investment is suitable for that customer. Prior to
recommending speculative low priced securities to their non-institutional
customers, broker-dealers must make reasonable efforts to obtain information
about the customer&#8217;s financial status, tax status, investment objectives and
other information. Under interpretations of these rules, FINRA believes that
there is a high probability that speculative low priced securities will not be
suitable for at least some customers. FINRA requirements make it more difficult
for broker-dealers to recommend that their customers buy our common stock, which
may limit the ability to buy and sell our stock and have an adverse effect on
the market value for our shares.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">An investor&#8217;s ability to trade our
common stock may be limited by trading volume.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A
consistently active trading market for our common stock may not occur on the
OTCBB. A limited trading volume may prevent our shareholders from selling shares
at such times or in such amounts as they may otherwise desire.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our
company has a concentration of stock ownership and control, which may have the
effect of delaying, preventing, or deterring a change of control.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
common stock ownership is highly concentrated. Through its ownership of shares
of our common stock, two shareholders, Tannin J. Fuja, our President, and NFG,
Inc., beneficially own 81.5% of our total outstanding shares of common stock
before this offering. As a result of the concentrated ownership of the stock,
these two stockholders, acting together, will be able to control all matters
requiring stockholder approval, including the election of directors and approval
of mergers and other significant corporate transactions. This concentration of
ownership may have the effect of delaying, preventing or deterring a change in
control of our company. It could also deprive our stockholders of an opportunity
to receive a premium for their shares as part of a sale of our company and it
may affect the market price of our common stock.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">We have not
voluntarily implemented various corporate governance measures, in the absence of
which, shareholders may have more limited protections against interested
director transactions, conflicts of interest and similar matters</font><font style="DISPLAY: inline; FONT-STYLE: italic">.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;Recent
federal legislation, including the Sarbanes-Oxley Act of 2002, has resulted in
the adoption of various corporate governance measures designed to promote the
integrity of the corporate management and the securities markets. Some of these
measures have been adopted in response to legal requirements. Others have been
adopted by companies in response to the requirements of national securities
exchanges, such as the NYSE or The NASDAQ Stock Market, on which their
securities are listed. Among the corporate governance measures that are required
under the rules of national securities exchanges and NASDAQ are those that
address board of directors&#8217; independence, audit committee oversight and the
adoption of a code of ethics. While our Board of Directors has adopted a Code of
Ethics and Business Conduct, we have not yet adopted any of these corporate
governance measures and, since our securities are not listed on a national
securities exchange or NASDAQ, we are not required to do so. It is possible that
if we were to adopt some or all of these corporate governance measures,
shareholders would benefit from somewhat greater assurances that internal
corporate decisions were being made by disinterested directors and that policies
had been implemented to define responsible conduct. For example, in the absence
of audit, nominating and compensation committees comprised of at least a
majority of independent directors, decisions concerning matters such as
compensation packages to our senior officers and recommendations for director
nominees may be made by a majority of directors who have an interest in the
outcome of the matters being decided. Prospective investors should bear in mind
our current lack of corporate governance measures in formulating their
investment decisions.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our
board of directors has the authority to issue shares of &#8220;blank check&#8221; preferred
stock, which may make an acquisition of our company by another company more
difficult.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have
adopted and may in the future adopt certain measures that may have the effect of
delaying, deferring or preventing a takeover or other change in control of our
company that a holder of our common stock might consider in its best interest.
Specifically, our board of directors, without further action by our
stockholders, currently has the authority to issue up to 10,000,000 shares of
preferred stock and to fix the rights (including voting rights), preferences and
privileges of these shares (&#8220;blank check&#8221; preferred). Such preferred stock may
have rights, including economic rights, senior to our common stock. As a result,
the issuance of the preferred stock could have a material adverse effect on the
price of our common stock and could make it more difficult for a third party to
acquire a majority of our outstanding common stock.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Because we will not pay dividends in
the foreseeable future, stockholders will only benefit from owning common stock
if it appreciates.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have
never paid dividends on our common stock and we do not intend to do so in the
foreseeable future. We intend to retain any future earnings to finance our
growth. Accordingly, any potential investor who anticipates the need for current
dividends from his investment should not purchase our common stock.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">There
are doubts about our ability to continue as a going concern and if we are unable
to continue our business, our shares may have little or no value.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
discussed in Note 2 to the accompanying financial statements as of December 31,
2007 and 2006 and the periods then ended, the company&#8217;s ability to become a
profitable operating company is dependent upon obtaining financing adequate to
fulfill its research and market introduction activities, and achieving a level
of revenues adequate to support our cost structure has raised doubts about our
ability to continue as a going concern.&#160;&#160;We plan to attempt to raise
approximately $5 million in additional equity capital by selling shares in this
offering and, if necessary through one or more private placement or public
offerings.&#160;&#160;However, the doubts raised relating to our ability to
continue as a going concern may make our shares an unattractive investment for
potential investors.&#160;&#160;These factors, among others, may make it
difficult to raise the necessary amount of capital.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">CAUTIONARY NOTE REGARDING
FORWARD-LOOKING STATEMENTS</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
prospectus contains forward-looking statements within the meaning of Section 27A
of the Securities Act and Section 21E of the Exchange Act. We have based these
forward-looking statements largely on our current expectations and projections
about future events and financial trends affecting the financial condition of
our business. These forward-looking statements are subject to a number of risks,
uncertainties and assumptions, including, among other things:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Factors
that might cause these differences include the following:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      integration of multiple technologies and
  programs;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      ability to successfully complete development and commercialization of
      products and our company&#8217;s expectations regarding market
      growth;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      cost, timing, scope and results of ongoing research and development
      efforts;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      ability to successfully complete product research and further
      development;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      volume and profitability of product sales of future
    products;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">changes in existing
      and potential relationships with collaborative
  partners;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      availability, cost, delivery and quality of materials supplied by contract
      manufacturers;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      timing, cost and uncertainty of obtaining regulatory approvals of our
      products;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      ability to obtain substantial additional
  funding;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      ability to develop and commercialize products before competitors that are
      superior to the alternatives developed by
  competitors;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      ability to retain certain members of
management;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">our
      expectations regarding research and development expenses and general and
      administrative expenses;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">our
      expectations regarding cash balances, capital requirements, anticipated
      revenue and expenses, including infrastructure
  expenses;</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">our
      belief regarding the validity of our patents and potential litigation;
      and</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">other factors
      detailed from time to time in filings with the
  SEC.</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    </div>
    <div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
addition, in this prospectus, we use words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221;
&#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;future,&#8221; &#8220;intend,&#8221; and similar expressions to identify
forward-looking statements.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
undertake no obligation to update publicly or revise any forward-looking
statements, whether as a result of new information, future events or otherwise
after the date of this prospectus. In light of these risks and uncertainties,
the forward-looking events and circumstances discussed in this prospectus may
not occur and actual results could differ materially from those anticipated or
implied in the forward-looking statements.</font><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1104"><font style="DISPLAY: inline; FONT-WEIGHT: bold">USE OF
PROCEEDS</font></a></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">With
respect to shares of our common stock that may be offered and sold from time to
time by the selling stockholder, we will receive no proceeds from the sale of
shares of common stock in this offering.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">With
respect to up to 15,000,000 shares of common stock to be sold by us, unless we
provide otherwise in a supplement to this prospectus, we intend to use the net
proceeds from the sale of our securities for general corporate purposes, which
may include one or more of the following:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div align="left">
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">working
      capital;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">research
      and development activities;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">repayment
      of debt incurred in connection with the acquisition of HealthAmerica;
      and</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">capital
      expenditures.</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
management will have broad discretion in the allocation of the net proceeds of
any offering. Pending such uses, we intend to invest the net proceeds in
short-term, investment grade, interest-bearing securities.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1105">CAPITALIZATION</a></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
following table sets forth our capitalization as of September 30, 2008, and as
adjusted to give pro forma effect to (i) the&#160;&#160;issuance of $1,500,000
in debt and 5,000,000 common shares, at an assumed value of $0.50 per share, in
connection with the effective asset acquisition of HealthAmerica, Inc. in
October 2008 and (ii) the issuance in October 2008 of 22,000 common shares at
$0.50 per share, for net proceeds of $8,250 after issuance costs, and as
adjusted to give effect to the issuance of 15,000,000 shares offered hereby at
an assumed purchase price of $0.50 per share.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div align="left">
          <table cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September
      30,</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;2008</font></div>
                </td>
                <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September
      30, 2008</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(pro
      forma)</font></div>
                </td>
                <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September
      30, 2008</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(as
      adjusted)</font></div>
                </td>
                <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="bottom" width="64%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current
      liabilities</font></div>
                </td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">404,094</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">404,094</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">404,094</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="64%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long-term
      liabilities</font></div>
                </td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,500,000</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,500,000</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="bottom" width="64%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Minority
      interest</font></div>
                </td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">572,892</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">572,892</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="64%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stockholders&#8217;
      deficit:</font></div>
                </td>
                <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="bottom" width="64%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Preferred
      stock</font></div>
                </td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="64%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common
      stock</font></div>
                </td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45,204</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,226</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">65,226</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="bottom" width="64%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Additional
      paid-in capital</font></div>
                </td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23,336</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,526,564</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,982,145</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated
      deficit</font></div>
                </td>
                <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(313,113</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,305,431</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,305,431</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      stockholders&#8217; (deficit) equity</font></div>
                </td>
                <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(244,573</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,271,359</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,741,940</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      capitalization</font></div>
                </td>
                <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">159,521</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,748,345</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,218,926</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
          </table>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">DILUTION</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
negative net tangible book value of our company as of September 30, 2008 was
($244,573) or&#160;&#160;($0.005) per share of common stock. Net tangible book
value per share is determined by dividing the tangible book value of the company
(total tangible assets less total liabilities) by the number of outstanding
shares of our common stock on September 30, 2008.&#160;&#160;After adjusting for
the effects of (i) the 5,000,000 common shares issued in October 2008 in
connection with the HealthAmerica effective asset&#160;&#160;acquisition at an
assumed value of $0.50 per share and (ii) the issuance in October 2008 of 22,000
common shares at $0.50 per share, for net proceeds of $8,250 after issuance
costs, the pro forma net tangible book value as of September 30, 2008 was
$(2,309,215) or ($0.046) per share of common stock, which is a $0.041 decrease
in net tangible book value per share.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None of
the proceeds from the sale of 5,133,000 shares offered by the selling
stockholders will be paid to our company,&#160;&#160;Therefore, our net tangible
book value will be unaffected by such sales.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our net
tangible book value and our net tangible book value per share, however, will be
impacted by the 15,000,000 shares of common stock which may be sold by our
company. The amount of dilution will depend on the offering price and number of
shares sold by our company. The following example shows the dilution to new
investors at an assumed offering price of $0.50 per share.&#160;&#160;The
proforma amounts are based on an estimated per share value of $0.50 and
estimated values of the acquired HealthAmerica assets.&#160;&#160;The final
actual recording of the transactions may be different than reflected herein once
all valuation procedures are completed.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are
registering 15,000,000 shares of common stock for sale by our
company.&#160;&#160;If we assume that such shares will be sold at an assumed
offering price of $0.50 per share, less an underwriting discount or commissions
equal to ten percent (10%), underwriter expenses of two percent (2%), and
offering expenses of $129,419, our net tangible book value as of September 30,
2008 would have been $4,161,366 or approximately $0.064 per share. Such an
offering would represent an immediate increase in net tangible book value to
existing stockholders of $0.110 per share and an immediate dilution to new
stockholders of $0.436 per share. The following table illustrates the per share
dilution:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div align="left">
          <table cellpadding="0" cellspacing="0" width="100%">
              <tr bgcolor="#eeeeee">
                <td align="left" valign="bottom">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">Assumed</font>
      public offering price per share</font></div>
                </td>
                <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.50</font></td>
                <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="76%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      tangible book value per share before this offering</font></div>
                </td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.005</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="bottom" width="76%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Decrease
      attributable to shares issued in HealthAmerica acquisition and shares
      issued for cash in October 2008</font></div>
                </td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.041</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Increase
      attributable to new investors</font></div>
                </td>
                <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.110</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      tangible book value per share after this offering</font></div>
                </td>
                <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.064</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dilution
      per share to new stockholders</font></div>
                </td>
                <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.436</font></td>
                <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              </tr>
          </table>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1106">MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS</a></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
common stock is not currently listed or traded on any exchange or quotation
system.&#160;&#160;Upon effectiveness of the registration statement of which
this prospectus forms a part, we will apply for listing on the OTC Electronic
Bulletin Board. We cannot assure that our shares of common stock will be
accepted for listing on the OTC Electronic Bulletin Board or that any market for
the shares will develop or be sustained.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have
not paid any dividends on our common stock and do not anticipate paying cash
dividends in the foreseeable future. We intend to retain any earnings to finance
the growth of our business. We cannot assure you that we will ever pay cash
dividends. Whether we pay cash dividends in the future will be at the discretion
of our Board of Directors and will depend upon our financial condition, results
of operations, capital requirements and any other factors that the Board of
Directors decides are relevant. See Management&#8217;s Discussion and Analysis of
Financial Condition and Results of Operations.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Securities Authorized for Issuance
Under Equity Compensation Plans</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We did
not have any equity compensation plans in effect as of the end of our most
recent fiscal year ended December 31, 2007. However, on October 23, 2008, our
Board of Directors unanimously approved our 2008 Stock Incentive Plan (the &#8220;2008
Plan&#8221;). The purpose of the 2008 Plan is to retain current, and attract new,
employees, directors, consultants and advisors that have experience and ability,
along with encouraging a sense of proprietorship and interest in our company&#8217;s
development and financial success. The Board of Directors believes that option
grants and other forms of equity participation are an increasingly important
means of retaining and compensating employees, directors, advisors and
consultants. The 2008 Plan authorizes us to issue up to 7,500,000 shares of our
common stock which represented slightly less than 15% of our outstanding shares
at the time the 2008 Plan was adopted. The 2008 Plan allows us to grant
tax-qualified incentive stock options, non-qualified stock options and
restrictive stock awards to employees, directors and consultants of our
company.</font><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1107">DESCRIPTION OF BUSINESS AND PROPERTY</a></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">General</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Vivakor,
Inc. (&#8220;Vivakor,&#8221; the &#8220;Company,&#8221; or &#8220;we&#8221;) is a transdisciplinary research company
that develops products in the fields of molecular medicine, electro-optics,
biological handling and natural and formulary compounds.&#160;&#160;Additional
services include providing contract research services for third
parties.&#160;&#160;Numerous products and technologies have been developed and
to date we have filed for 15 USPTO Provisional Patents with the United States
Patent and Trademark Office (USPTO) over the past year.&#160;&#160;We intend to
commercialize such products, after completion of any required regulatory
approvals, through one of three methods:&#160;&#160;a sale of the technology,
licensing of the product to a manufacturer or distributor or, in some cases, by
manufacturing, marketing and directly selling the products ourselves or through
subsidiaries formed around specific technologies or products.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
business model is to be a research hub focused on areas that have both an
identified scientific need and a substantial market opportunity.&#160;&#160;This
approach is intended to provide the necessary environment of transdisciplinary
collaboration and cross-pollination to advance research. Our company mission is
to advance distinct ideas to improve the quality of life for individual
patients, researchers, clinicians and consumers.&#160;&#160;We believe that the
development of substantive technologies and cures for complex human conditions,
illnesses and diseases require a sophisticated approach with contribution from
many areas of scientific expertise typically requiring a lengthier trajectory to
market.&#160;&#160;&#160;&#160;Our research is anchored by our relationship with
collaborative partners and product-specific commercialization
strategies.&#160;&#160;From the commencement of product conception through
development, we target specific commercialization strategies and expect to have
collaborative partners or licensing arrangements in place for each of our
products before completion.&#160;&#160;We expect this model to provide several
advantages to our shareholders, including a more efficient research and
development process and a quicker time to market after completion of
development.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Product
Research Divisions</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Our research efforts have been divided
into four primary areas of medical and biotechnological
development.&#160;&#160;These are:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">1.&#160;&#160;Molecular
Medicine.</font> This division centers on the development of biologically
relevant molecules, tests and methods and their application in the practice of
medicine.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Vivakor
is translating systems biology (genomics, proteomics, metabalomics, etc.)
insights of the molecular and cellular basis of disease into commercializable
theranostic (diagnostic/therapeutic) products. Vivakor scientists are
participants in the discovery and development of new drugs and the early
diagnosis of disease states. For example, Vivakor is investigating SNPs (single
nucleotide polymorphisms or single point mutations) that give rise to differing
response to drugs and supplements or that are linked to human disease
conditions. Vivakor is especially focused on conditions and reactions affecting
human skin.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
division is developing the following types of products:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div align="left">
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                      </div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">laser
      poration (a unique method of gene
delivery);</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                      </div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">microtine
      dermprint allergy testing;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                      </div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SNP
      detection (customer-specific genetic markers);
  and</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></div>
                      </div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">synthetic
      peptide therapies and synthetic&#160;cellular
    immortalization.</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
central aim of the molecular medicine division is cancer detection and wound
healing, which we anticipate will lead to the development of customized
treatments.&#160;&#160;Our research in stem cell biology and nuclear
reprogramming is a critical element in this research.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">2</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Electro-Optics</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.</font>&#160;&#160;&#160;&#160;This
division focuses on the development of biomedical and related consumer products
that that incorporate optical and electronic engineering.&#160;&#160;We are
actively designing, building and testing several new electro-optic devices to
reach previously un-served or underserved areas of the biomedical device
market.&#160;&#160;Products being developed in this area include:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div align="left">
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                    <tr valign="top">
                      <td style="WIDTH: 36pt">
                      </td>
                      <td align="right" style="WIDTH: 27pt">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                      </td>
                      <td align="left">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VivaSight
      (USPTO Provisional Patent #61050505) a digital photorefractor that is
      intended to modernize child vision
screening</font></div>
                      </td>
                    </tr>
                </table>
              </div>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                  <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                      <tr valign="top">
                        <td style="WIDTH: 36pt">
                        </td>
                        <td align="right" style="WIDTH: 27pt">
                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                        </td>
                        <td align="left">
                          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
      label free multiplexed clinical biomolecular sensor (CBS) (USPTO
      Provisional Patent #61044472) for the detection and diagnosis of complex
      human conditions (cancer, infectious diseases, cardiovascular disease,
      metabolic disorders, auto immune and inflammatory
  diseases)</font></div>
                        </td>
                      </tr>
                  </table>
                </div>
              </div>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 63pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                    <tr valign="top">
                      <td style="WIDTH: 36pt">
                      </td>
                      <td align="right" style="WIDTH: 27pt">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                      </td>
                      <td align="left">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">multi-spectral
      imaging devices to examine burn degree and cutaneous melanoma
      and</font></div>
                      </td>
                    </tr>
                </table>
              </div>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
                <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                    <tr valign="top">
                      <td style="WIDTH: 36pt">
                      </td>
                      <td align="right" style="WIDTH: 27pt">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                      </td>
                      <td align="left">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">spectroscopic
      devices to track wound healing and ear
  infection.</font></div>
                      </td>
                    </tr>
                </table>
              </div>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">With the
recent acquisition of HealthAmerica&#8217;s SLICES&#8482; technology, we are adapting and
upgrading this technology to produce enhanced MRI images which we expect will
improve MRI resolution while providing additional data such as blood flow
velocity in imaged tissues. See Products and Development Status
below.&#160;&#160;Approval has been granted from Western Institutional Review
Board (20080731) to conduct human validation studies of our VivaSight technology
on children.&#160;&#160;This study is currently being conducted at The
University of Iowa Hospitals and Clinics.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">3.</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Biological
Handling</font>. Vivakor is developing commercial products for cryogengenic
preservation, storage and shipping of biological materials.&#160;&#160;We are
exploring new techniques to improve methods and products employed for cryogenic
preservation, storage and handling.&#160;&#160;Our research in this area is
leading to the development of products such as:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div align="left">
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">improved
      cryovials (USPTO Provisional Patent # 61087705; 61044997;
      61046706);</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">cryogenic
      devices for temperature maintenance and sample transport (USPTO
      Provisional Patent # 61050656;
61050670);</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
      cryogenic biopsy device
(Cryopsy);</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
      improved modular cryogenic freezer
designs.</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">4.</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Natural and
Formulary Products.&#160;&#160;</font>&#160;&#160;&#160;&#160;This division is
particularly focused on the investigation, validation and adaptation of medical
herbalism or botanical medicine.&#160;&#160;We are investigating the healing
properties of botanicals and developing supplements and pharmaceutical (both
over-the-counter and prescription) products that harness the power of these
natural sources.&#160;&#160;For example, our scientists are researching certain
botanical extracts for their properties in ameliorating the symptoms of the
common cold.&#160;&#160;This division has conducted a human participant study
approved by Western Institutional Review Board 20071809. Products currently
being developed in this area include:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div align="left">
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">fruit
      and vegetable extract for the protection of digestive
    system</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">fresh
      fruit and vegetable extract for antioxidant supplements (USPTO Provisional
      Patent #61093311)</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Symbol, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></font></font></font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">jam
      and jelly formula to contain both antioxidant supplements as well as bone
      &amp; cartilage supplements for healthy joints (USPTO Provisional Patent
      #61093311)</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ContractResearch
Services</font></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also
perform contract research and development in molecular biology and devices
engineering. This includes contracts to perform several studies to investigate
and validate topical product claims.&#160;&#160;For example, we have developed a
novel TO<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">2</font>PICAL
permeability test that measures breathability of topical
products.&#160;&#160;This test is used to assess cosmetic and cosmaceutical
claims of breathability or oxygen permeability.&#160;&#160;Contract services in
the areas of mechanical engineering, electrical engineering, optical layout, and
programming for instrument control and digital image analysis are also
offered.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Development
Phases and Milestones</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
pathway for development of products follows one of two routes to
commercialization.&#160;&#160;First is a short-term path in which products for
which an expedited regulatory oversight is available are rapidly pushed to the
prototype and alpha testing phase.&#160;&#160;These projects represent rapidly
commercializable technologies and products that will have the potential to
generate revenue quickly.&#160;&#160;Second is a long-term path in which more
involved and complex projects are developed.&#160;&#160;These products typically
require substantial regulatory oversight or approval.&#160;&#160;We anticipate
that cash flow generated by the short-term projects will help to fund the
long-term projects.&#160;&#160;These longer incubating projects
characteristically represent breakthrough technologies with more risk but higher
revenue potential.&#160;&#160;See Risk Factors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
following table outlines the general phases of development and milestones for
each of our product candidates.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">VIVAKOR
R&amp;D Product Pipeline Steps &amp; Phases</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">
          <div>
            <hr style="COLOR: black" align="center" noshade size="1" width="100%">
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      </div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr bgcolor="white">
              <td rowspan="21" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: gray 1px solid; PADDING-BOTTOM: 2px; BORDER-LEFT: gray 1px solid">
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">L</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">I</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">C</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">E</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">S</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">I</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">G</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">P</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">A</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">R</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">T</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">E</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">R</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">S</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">C</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">H</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">O</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">S</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">E</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N</font></div>
              </td>
              <td align="left" rowspan="3" valign="top" width="10%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: gray 1px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      0</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: gray 1px solid; PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      1</font></div>
              </td>
              <td align="left" valign="middle" width="58%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: gray 1px solid; PADDING-BOTTOM: 2px; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Targeted
      Brainstorming/Idea Generation</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      2</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Analysis
      &amp; Protection of Intellectual Property</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      3</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Idea
      Selection</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" rowspan="5" valign="top" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      I</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      4</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Apply
      for Public Monies and Grants</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      5</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">IP
      Protection Review</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      6</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Technology
      Proof-of-concept</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      7</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prototype
      Design &amp; Build</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      8</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Laboratory
      (in vitro) Prototype Testing</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" rowspan="6" valign="top" width="4%" style="BORDER-RIGHT: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      II</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: black 1px solid; PADDING-BOTTOM: 2px; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      9</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; PADDING-BOTTOM: 2px; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">IP
      Protection Review</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      10</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Regulatory
      Documentation and Filing (IRB, IDE, 510K, FDA)</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      11</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trial
      Product Validation using <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font>
      Model</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      12</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Small
      Scale Trial Product Validation using Human Cohort</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      13</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statistical
      Review &amp; Consumer Feedback on Trial Product</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      14</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Small
      Scale Alpha-Test &amp; Evaluation of Test Product</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" rowspan="7" valign="top" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      III</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      15</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; PADDING-BOTTOM: 2px; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Field
      Beta-Test &amp; Evaluation of Test Product</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      16</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">IP
      Protection Review</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      17</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Design
      for Production &amp; Manufacture</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      18</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pre-Manufacturing
      Model Product</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      19</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-TOP: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Manufacture
      Tooling &amp; Assembly</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      20</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Manufactured
      Product Specification Verification</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td valign="middle" width="4%" style="BORDER-RIGHT: black 1px solid; BORDER-BOTTOM: gray 1px solid; TEXT-ALIGN: left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Step
      21</font></div>
              </td>
              <td align="left" valign="middle" width="10%" style="BORDER-RIGHT: gray 1px solid; BORDER-BOTTOM: gray 1px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product
      for Sale</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Products</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Clinical
Biomolecular Sensor (CBS) Technology</font>.&#160;&#160;Our CBS technology
design is based on the ability to enable clinicians and scientists to detect
many biological molecules (DNA, RNA, protein) simultaneously and in parallel.
Important applications of this technology are found in the research, diagnosis,
and treatment of numerous molecular conditions (cancer, infectious disease,
autoimmune disorders, heart disease, etc.).&#160;&#160;Common applications in
cancer related fields include the identification of biomarkers that may be
indicative of a particular cancer diagnosis or prognosis.&#160;&#160;Biomarkers
identified by antibody (Ab) arrays can also be used as surrogate markers of drug
response. There is much knowledge to be gained using Ab arrays for the molecular
profiling of tumors as a diagnostic tool. The use of complex molecular profiling
in the clinic may lead to more comprehensive, accurate and contextualized
results than tests based on the assay of a single protein. Our CBS are expected
to be fast, convenient, and sensitive enough for clinical use at the bedside or
within the immediate clinical point-of-care. CBS results are generated in
seconds, rather than after hours of processing in the laboratory. Sensor chips
can be designed to be disposable and reusable options will also be
explored.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">We are
currently establishing joint-development partnerships to continue the evolution
of this technology which is in Phase I of the development
process.</font></font><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">SLICES&#8482;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.&#160;&#160;</font>Our acquisition
of HealthAmerica&#8217;s SLICES&#8482; technology will provide a technology platform for
optimization and adaptation by our scientists.&#160;&#160;This patented
technology&#160;&#160;has received FDA 510(k) clearance&#160;&#160;and it is
intended that this technology will enhance the resolution of images resulting
from MRI.&#160;&#160;The underlying algorithm may be useful in the determination
of blood flow velocity measures in imaged tissues.&#160;&#160;Such information
would be valuable in accessing areas of blood flow constriction from plaques or
other hematologic deposits.&#160;&#160;This information could help physicians
better diagnose, predict and assess stroke and related diseases involving blood
flow obstruction.&#160;&#160;Our scientists are attempting to streamline and
adapt this algorithm and accompanying software to meet current MRI standards and
practices.&#160;&#160;See Risk Factors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivaSight
(Digital PhotoRefractor or DPR)</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>We have developed a device
that will modernize screening of pre-verbal and pre-literate children for ocular
disorders.&#160;&#160;This type of screening is increasingly required by state
governments prior to enrollment in the public school system.&#160;&#160;Our
scientists are collaborating with physicians and clinicians at University of
Iowa Hospitals &amp; Clinics Department of Ophthalmology &amp; Visual Sciences
to develop a clinic-ready device.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Data from
the National Eye Institute (NEI) states that 2.3 million children have
undiagnosed eye disorders that can lead to blindness if left
untreated.&#160;&#160;Amblyopia, commonly known as &#8220;lazy eye&#8221;, is the leading
cause of monocular vision loss in the 20 to 70+ age range.&#160;&#160;It causes
more vision loss than diabetic retinopathy, glaucoma, macular degeneration, and
cataracts. Amblyopia occurs when the optical powers of the two eyes are
different and the brain favors the visual signal from one eye, functionally
ignoring the vision in the amblyopic eye. According to the NEI, an estimated
300,000 to 750,000 children between the ages of three to five suffer from
amblyopia.&#160;&#160;Visual acuity develops principally during the pre-school
years, from birth to about five years old, as a child&#8217;s visual experience molds
its genetic blueprint into its adult visual sensory system. If treatment is not
initiated during the visual maturation period, the prognosis for normal visual
development is poor.&#160;&#160;Amblyopia can be reversed and cured if it is
detected and treated during the critical visual development period.
Unfortunately, less than 21% of preschool children receive some form of vision
screening each year. Even those who are screened are often improperly screened
by a general health practitioner, pediatrician or screening volunteer due to
inadequate experience and lack of equipment or techniques for an assiduous exam.
Some children receive proper eye exams once they start school; unfortunately by
then it may be too late to effectively treat amblyopia.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our DPR
has been designed with ongoing end-user input to produce a device that will
readily penetrate and gain wide acceptance in the vision screening
market.&#160;&#160;Most importantly our DPR offers all screening programs a low
cost device with a high sensitivity and specificity. This device will streamline
the screening process by the following: 1) Eliminate recurring cost of Polaroid
film, 2) Instantaneously image a subject across two meridians of strabismus and
refractive error,&#160;&#160;3) Detect improper subject fixation, 4) Digitize
and automate the interpretation process, 5) Quantify the image interpretation
and adjust the referral criteria based upon screening demographics to achieve
predetermined levels of sensitivity and specificity, and 6) Give an instant
refer/do not refer response to the screener.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This device is currently in clinical
testing and is in Phase II of the development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivaThermic
CryoVial Technology</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.</font> We are actively developing
the technologies required for the cryopreservation of diverse biological samples
with improved recovery of viable cells post-cryopreservation. Emphasis has been
placed on strategies to eliminate the variations and time delays experienced in
the current biopsy and tissue preservation procedure by integrating a cryogenic
freezing capacity into the biopsy device.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Critical
advancements in biological sample preservation are evolving. We have developed
specialized cryovials that accommodate an improved method of cryopreservation of
cells, blood, and other bio-materials. When cryopreserving biological materials,
the rate of cooling is the main factor affecting the cell viability. Material
choice and design features of cryovials are critical parameters affecting the
cooling rate. Existing cryovials do not allow for rapid freezing. They are
usually manufactured from conventional polypropylene which is a poor thermally
conductive material. In addition, they offer no special design features to
enhance heat transfer.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
cryovials benefit from better designs and improved use of materials resulting in
better performance during the freezing and thawing process. Our cryovials
include a unique self-sealing cap feature (USPTO Provisional Patent # 61046706)
to prevent leakage, contamination, and explosion. The target markets for our
cryovials include clinical laboratories, hospitals, fertility clinics,
veterinarians, agribusiness, animal breeding and research
laboratories.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold"> This
product is in Phase III of the development process and first sales are
anticipated in December 2008.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Cryopsy
Device</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.</font>&#160;&#160;&#160;Our Cryopsy
will freeze the tissue specimens to cryogenic temperature below minus 132&#176;C
immediately after tumor excision and then transfer the tissue specimens directly
to the specimen holder embedded in the freezing chamber. As such, the tissue
specimens will be frozen to minus 132&#176; C or below within 1 min after excision.
Cryopsy will ensure very minimal time delays so that no significant biochemical
alternation occurs in tissues. By freezing the specimens to minus132&#176;C or below,
Cryopsy will also stop not only any enzymatic reaction but also all signaling
degradation. In this way, Cryopsy will preserve proteins, RNA, and DNA in tissue
specimens and provide accurate and repeatable information about signal
transduction pathways, molecular drug targets and biomarkers. Moreover, the
practice of biopsy will be standardized. Variations in sample size, cooling
rate, temperature and time intervals will be minimized and all of the parameters
will be held constant over time. Furthermore, Cryopsy will be a user-friendly
and hand-held device such that the collection, handling and storage of tissue
samples can be done by the physician in the clinic.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This product is in Phase I of the
development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivaBlend
</font>(USPTO Provisional Patent#61093311). Our proprietary balanced blend of
more than 18 different sources of&#160;&#160;phytochemical extracts from
antioxidant rich bioactive fruits and vegetables tested by the USDA that can be
added to many consumer foods, drinks and nutraceuticals as a convenient daily
source of important antioxidants and other critical bioactive
phytochemicals.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This
product is in Phase II of the development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">RejuviCeuticals</font>
(USPTO Provisional Patent #61093311). These are a family of nutraceutical
products containing our VivaBlend in combination with other supplements and
vitamins for use by people with specific conditions or disease
states.&#160;&#160;The delivery method of these RejuviCeuticals include foods
such as: jams, drinks, chips, etc.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This product is in Phase II of the
development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivaGastroProtect.&#160;&#160;</font>This
is a proprietary brand of dietary supplements to be used for the protection of
the digestive system as well as for the prevention of infection and associated
gastric ulcers.&#160;&#160;This natural extract derived from fruits and
vegetables will be delivered in a convenient way to take the
supplement.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This
product is in Phase I of the development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">CryoKeeper/Carrier</font>
(USPTO Provisional Patent# 61050670). A device designed for the storage and
transport of specimens maintaining temperatures at or below -130&#176;C for up to one
hour in a room temperature environment.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This product is in Phase II of the
development process</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivaPlate</font>
(USPTO Provisional Patent# 61048939). Composite multi-well microplate for rapid
temperature response.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This product is in Phase I of the
development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivaCycler</font>
(USPTO Provisional Patent# 61044997). Individually controlled high throughput
heating and cooling device.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This product is in Phase I of the
development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivAuris</font>
(USPTO Provisional Patent #61052204).&#160;&#160;This is a stand-alone device
able to detect possible ear infection and transmit results of an improving or
diminishing condition.&#160;&#160;This unit is a hand-held unit, easy to use and
affordable.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This
product is in Phase II of the development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivaGlobin</font>
(USPTO Provisional Patent #61052422). It is known that the degree of skin
redness can be indicative of several skin conditions.&#160;&#160;This device
enables a researcher or clinician to measure and track skin redness for anemia
and cutaneous hemoglobin detection.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This product is in Phase II of the
development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">MyDerm
</font>(USPTO Provisional Patent# 61051347). My-Derm is a cosmetics color
customization system for formulating and dispensing color specific
cosmetics.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This
product is in Phase II of the development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivaCrop</font>
(USPTO Provisional Patent#61053667). Vivakor is currently developing a
vegetation health monitor.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This product is in Phase I of the
development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">VivaSwab
</font>(USPTO Provisional Patent #61046447&amp; 61046445). Buccal swabs are
routinely used to collect DNA or cellular material from the inner
cheek.&#160;&#160;Vivakor is developing a proprietary swab concept that is
biodegradable and biomimetic.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">This product is in Phase II of the
development process.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Suppliers</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expect
to buy materials for our products from a multitude of suppliers, and do not
expect to be dependent on any one supplier or group of suppliers. The raw
materials used in our products will generally include chemicals, plastics,
vitamins, fruits/vegetables, electronic and optical components and biologics,
and packaging. We expect that these raw materials will be generally readily
available at competitive, stable prices from a number of suppliers. Certain raw
materials will be produced under our specifications.&#160;&#160;These materials
may be limited by supply and may be subject to delays in production and delivery
which could delay or interfere with our ability to produce and deliver
products.&#160;&#160;We intend to closely monitor these materials to maintain
adequate supplies.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Seasonality</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We do not
expect our business to experience seasonality in sales or revenue. However, our
products or contract research services may be sold primarily to, or our revenue
derived from, researchers, universities, government laboratories and private
foundations whose funding is dependent upon grants from government agencies. To
the extent that our customers experience increases, decreases or delays in
funding arrangements, and to the extent that any of our customers&#8217; activities
are slowed, such as during vacation periods or due to delays in the approval of
governmental budgets, we may experience fluctuations in sales volumes throughout
the year or delays from one period to the next in the recognition of
sales.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Competition</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We face
competition from medical product and biotechnology companies, as well as from
universities and non-profit research organizations.&#160;&#160;&#160;Many
emerging medical and biotechnology product companies have corporate partnership
arrangements with large, established companies to support the research,
development, and commercialization of products that may be competitive with our
products. Many of our existing or potential competitors have substantially
greater financial, research and development, regulatory, marketing, and
production resources than we have. Other companies may develop and introduce
products and processes competitive with or superior to those of ours. See Risk
Factors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For our
products, an important factor in competition is the timing of market
introduction of our products or those of our competitors&#8217; products. Accordingly,
the relative speed with which we can develop products, complete the regulatory
clearance processes and supply commercial quantities of the products to the
market is an important competitive factor. We expect that competition among
products cleared for marketing will be based on, among other things, product
efficacy, safety, reliability, availability, price, and patent
position.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Patents and Proprietary
Rights</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We regard
the establishment of a strong intellectual property position in our technology
as an integral part of the development process. We will attempt to protect our
proprietary technologies through patents and intellectual property positions in
the United States as well as major foreign markets. We have not yet been granted
any patents, and have filed to date 15 provisional
patents.&#160;&#160;Provisional patents are not reviewed by the USPTO and do not
result in the issuance of patents.&#160;&#160;We must file regular patent
applications in order to obtain any long-term proprietary rights in our
inventions and technology.&#160;&#160;We cannot guarantee that we will have
sufficient resources to file patent applications on all of our proprietary
inventions, or that if filed, such patent applications will actually result in
the issuance of patents.&#160;&#160;See Risk Factors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Even if
we were awarded patents, the patent position of biotechnology and medical device
firms, including our company, generally is highly uncertain and may involve
complex legal and factual questions. Potential competitors may have filed
applications, or may have been issued patents, or may obtain additional patents
and proprietary rights relating to products or processes in the same area of
technology as that used by our company. The scope and validity of these patents
and applications, the extent to which we may be required to obtain licenses
thereunder or under other proprietary rights, and the cost and availability of
licenses are uncertain. We cannot assure you that our patent applications will
result in additional patents being issued or that any of our patents will afford
protection against competitors with similar technology; nor can we assure you
that any of our patents will not be designed around by others or that others
will not obtain patents that we would need to license or design
around.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also
rely upon unpatented trade secrets. We cannot assure you that others will not
independently develop substantially equivalent proprietary information and
techniques, or otherwise gain access to our trade secrets, or disclose such
technology, or that we can meaningfully protect our rights to our unpatented
trade secrets.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
require our employees, consultants, advisers, and suppliers to execute a
confidentiality agreement upon the commencement of an employment, consulting or
manufacturing relationship with us. The agreement provides that all confidential
information developed by or made known to the individual during the course of
the relationship will be kept confidential and not disclosed to third parties
except in specified circumstances. In the case of employees, the agreements
provide that all inventions conceived by the individual will be the exclusive
property of our company. We cannot assure you, however, that these agreements
will provide meaningful protection for our trade secrets in the event of an
unauthorized use or disclosure of such information. See Risk
Factors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Government
Regulation</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Most
aspects of our business and product candidates are subject to some degree of
government regulation. As a developer of medical and biotechnology products, we
are subject to extensive regulation by, among other governmental entities the
FDA.&#160;&#160;In addition prior to any sales of our product candidates we will
be required to comply with the rules and regulations of state, local and foreign
regulatory bodies in jurisdictions in which we desire to sell our products.
These regulations govern the introduction of new products, the observance of
certain standards with respect to the manufacture, safety, efficacy and labeling
of such products, the maintenance of certain records, the tracking of such
products and other matters.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Failure
to comply with applicable federal, state, local or foreign laws or regulations
could subject us to enforcement action, including product seizures, recalls,
withdrawal of marketing clearances, and civil and criminal penalties, any one or
more of which could have a material adverse effect on our business. We believe
that we are in substantial compliance with such governmental regulations.
However, federal, state, local and foreign laws and regulations regarding the
manufacture and sale of medical devices are subject to future changes. We cannot
assure you that such changes will not have a material adverse effect on our
company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For some
of our product candidates, and in some countries, government regulation is
significant and, in general, there is a trend toward more stringent regulation.
In recent years, the FDA and certain foreign regulatory bodies have pursued a
more rigorous enforcement program to ensure that regulated businesses like ours
comply with applicable laws and regulations. We devote significant time, effort
and expense addressing the extensive governmental regulatory requirements
applicable to our business. To date, we have not received any notifications or
warning letters from the FDA or any other regulatory bodies of alleged
deficiencies in our compliance with the relevant requirements, nor have we
recalled or issued safety alerts on any of our products. However, we cannot
assure you that a warning letter, recall or safety alert, if it occurred, would
not have a material adverse effect on our company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Research and
Development</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We spent
zero and $197,669 on research and development activities in the fiscal year
ended December 31, 2007 and for the nine months ended September 30, 2008,
respectively.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Employees</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of
November 1, 2008, we had seven employees. We consider our relations with our
employees to be good.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1108"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Description of
Property</font></a></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
currently lease approximately 2,960 square feet of office space at 2590 Holiday
Road, Suite 100, Coralville, Iowa, as our principal offices. The current lease
term is from August 1, 2008 and ending on July 31, 2010, at a monthly base rent
of approximately $3,700 throughout the term. We believe these facilities are in
good condition, but that we may need to expand our leased space as our research
and development efforts increase or if we decide to manufacture and market any
of our product candidates.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1109">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS</a></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;The following discussion of
our financial condition and results of operations should be read in conjunction
with (i) our audited financial statements as of December 31, 2007 and 2006 and
for the fiscal year ended December 31, 2007 and period from November 1, 2006
(inception) through December 31, 2006 and (ii) the unaudited financial
statements for the periods ended September 30, 2008 and 2007 that appear
elsewhere in this registration statement. This registration statement contains
certain forward-looking statements and our future operating results could differ
materially from those discussed herein. Certain statements contained in this
discussion, including, without limitation, statements containing the words
"believes", "anticipates," "expects" and the like, constitute "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the
Exchange Act). However, as we will issue &#8220;penny stock,&#8221; as such term is defined
in Rule 3a51-1 promulgated under the Exchange Act, we are ineligible to rely on
these safe harbor provisions. Such forward-looking statements involve known and
unknown risks, uncertainties and other factors which may cause our actual
results, performance or achievements to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. Given these uncertainties, readers are cautioned not
to place undue reliance on such forward-looking statements. We disclaim any
obligation to update any such factors or to announce publicly the results of any
revisions of the forward-looking statements contained herein to reflect future
events or developments.&#160;&#160;For information regarding risk factors that
could have a material adverse effect on our business, refer to the Risk Factors
section of this prospectus beginning on page 4.</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Plan
of Operation</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Company plans on becoming a significant transdisciplinary
biomedical/biotechnology company involved in the discovery, development and
commercialization of a broad range of medical devices and pharmaceuticals to
improve human health.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We intend
to develop, manufacture and sell directly or indirectly through collaborative
partners, the following types of products:</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div>&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div>&#160;</div>
      <div>
        <div align="left">
          <table cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td align="left" valign="top" width="15%" style="BORDER-TOP: medium none; BORDER-LEFT: medium none; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">PRODUCT</font></div>
                </td>
                <td align="left" valign="top" width="15%" style="BORDER-TOP: medium none; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">R&amp;D
      PHASE</font></div>
                </td>
                <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">DESCRIPTION</font></div>
                </td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaThermic
      Vials</font></div>
                </td>
                <td align="left" valign="top" width="15%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      III</font></div>
                </td>
                <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Centrifugable
      and autoclavable vials for cryopreservation</font></div>
                </td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">CryoKeeper/Carrier</font></div>
                </td>
                <td align="left" valign="top" width="15%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      II</font></div>
                </td>
                <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Device
      for the storage &amp; transport of specimens at cryogenic
      temperatures</font></div>
                </td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivaplate</font></div>
                </td>
                <td align="left" valign="top" width="15%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      I</font></div>
                </td>
                <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Composite
      multi-well microplate for rapid temperature response</font></div>
                </td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaCycler</font></div>
                </td>
                <td align="left" valign="top" width="15%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      I</font></div>
                </td>
                <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Individually
      controlled high throughput heating and cooling
  device</font></div>
                </td>
              </tr>
          </table>
        </div>
      </div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaSight</font></div>
              </td>
              <td align="left" valign="top" width="15%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      II</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Digital
      PhotoRefractor for children's vision screening</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivAuris</font></div>
              </td>
              <td align="left" valign="top" width="15%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      II</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Device
      for middle ear redness detection</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaGlobin</font></div>
              </td>
              <td align="left" valign="top" width="15%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      II</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Device
      for anemia and Cutaneous hemoglobin detection</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaBlend</font></div>
              </td>
              <td align="left" valign="top" width="15%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      II</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fresh
      fruits &amp; vegetables extract for antioxidant
  supplements</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">RejuviJam</font></div>
              </td>
              <td align="left" valign="top" width="15%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      II</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jam
      &amp; Jelly with antioxidants and bone &amp; cartilage
      supplements</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaGastroProtect</font></div>
              </td>
              <td align="left" valign="top" width="15%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      I</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fruits
      and vegetables extract for the protection of digestive
    system</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">MyDerm</font></div>
              </td>
              <td align="left" valign="top" width="15%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      II</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">System
      &amp; Method for formulating/dispensing color-specific
      cosmetics</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaSwab</font></div>
              </td>
              <td align="left" valign="top" width="15%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      II</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Biodegradable
      swab for sample collection</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaCrop</font></div>
              </td>
              <td align="left" valign="top" width="15%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      I</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vegetation
      health monitor</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="15%" style="BORDER-LEFT: medium none; BORDER-BOTTOM: 4px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Clinical
      Biomolecular Sensor</font></div>
              </td>
              <td align="left" valign="top" width="15%" style="BORDER-BOTTOM: 4px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Phase
      I</font></div>
              </td>
              <td align="left" valign="top" width="70%" style="BORDER-RIGHT: medium none; BORDER-BOTTOM: 4px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">In
      vitro diagnostic device used at the point of
  care</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sales of
our cryovials are expected to commence in the first quarter of
2009.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also
plan to provide contract research and development services in molecular biology,
device engineering and other areas.&#160;&#160;We commenced providing contract
research and development services in the first quarter of 2008.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Liquidity
and Capital Resources</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
December 31, 2007 we had zero current assets. &#160;Current liabilities at
December 31, 2007 totaled $20,500 and consisted of accounts payable in the
amount of $2,000 and consulting fees and reimbursements payable to the founding
member/stockholder.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
September 30, 2008, we have $6,400 in cash and $28,700 in
deposits.&#160;&#160;Our current liabilities at September 30, 2008 consist of
accounts payable in the amount of $12,638, accrued wages and related expenses of
$184,793, advances payable to an officer of $19,461&#160;&#160;and advances
and&#160;&#160;note payable to a member/stockholder totaling $96,630 and
$90,572, respectively.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have
no material commitments for the next twelve months other than the monthly rental
payments of $3,700 on the facilities lease. &#160;We will require additional
capital to meet our liquidity needs. &#160;As a result, our independent auditors
have expressed substantial doubt about our ability to continue as a going
concern.&#160;&#160;We anticipate that we will receive sufficient proceeds from
investors to continue operations for at least the next twelve months; however,
there is no assurance that such proceeds will be received and there are no
agreements or understandings currently effect from any potential investors. We
may sell common stock, take loans or advances from officers, directors or
shareholders or enter into debt financing agreements.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Results
of Operations</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We did
not generate any revenue from November 1, 2006 (inception) to December 31, 2007.
&#160;For the year ended December 31, 2007 our expenses were $20,500.
&#160;Expenses consisted of consulting fees and reimbursements payable to the
founding member/stockholder and administrative expenses. &#160;&#160;As a
result, we have reported a net loss of $20,500 for the year ended December 31,
2007, which was also our total net loss from inception on November 1, 2006
through December 31, 2007.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
the period from January 1, 2008 through September 30, 2008, our company
commenced providing research and development services and internal research and
development activities.&#160; Research revenues totaled $194,700 during this
period.&#160;&#160;For the nine months ended September 30, 2008, the cost of
research services provided totaled $122,321 and research and development
expenses, which consisted primarily of payroll and related expenses and lab
supplies, totaled $197,669.&#160;&#160;General and administrative expenses
during this period totaled $164,201 and consisted primarily of payroll, and
office expenses.&#160;&#160;Interest expense totaled $3,122 during the nine
months ended September 30, 2008.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Going
Concern</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
future of our company is dependent upon its ability to obtain financing and upon
future profitable operations from the sale of its products and
services.&#160;&#160;Management has plans to seek additional capital through a
private placement and public offering of its common stock. These conditions
raise substantial doubt about our company's ability to continue as a going
concern.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Off-Balance
Sheet Arrangements</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We do not
have any off-balance sheet arrangements that have or are reasonably likely to
have a current or future effect on our financial condition, changes in financial
condition, revenues or expenses, results of operations, liquidity, capital
expenditures or capital resources that are material to investors.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Critical
Accounting Policies</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
financial statements and accompanying notes have been prepared in accordance
with United States generally accepted accounting principles applied on a
consistent basis. The preparation of financial statements in conformity with
U.S. generally accepted accounting principles requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities, the disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting periods.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
regularly evaluate the accounting policies and estimates that we use to prepare
our financial statements. In general, management's estimates are based on
historical experience, on information from third party professionals, and on
various other assumptions that are believed to be reasonable under the facts and
circumstances. Actual results could differ from those estimates made by
management.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Cash and Cash
Equivalents.&#160;&#160;</font>The Company considers all highly liquid
short-term investments with maturities of less than three months when acquired
to be cash equivalents.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Equipment,
Furniture and Leasehold Improvements.&#160;&#160;</font>Equipment, furniture and
leasehold improvements are recorded at cost and depreciated on a straight-line
basis over the lesser of their estimated useful lives, ranging from three to
seven years, or the life of the lease, as appropriate.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Impairment of
Long-Lived Assets</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic">&#160;</font>Long-lived
assets are reviewed for impairment whenever events or changes in circumstances
indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the
carrying amount of the assets to the future net cash flows expected to be
generated by such assets. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the carrying
amount of the assets exceeds the discounted expected future net cash flows from
the assets.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Revenue
Recognition.&#160;&#160;</font>The Company recognizes revenue when all four of
the following criteria are met: (i)&#160;persuasive evidence that an arrangement
exists; (ii)&#160;delivery of the products and/or services has occurred;
(iii)&#160;the fees earned can be readily determined; and
(iv)&#160;collectibility of the fees is reasonably assured. The Company
recognizes revenue from research contracts as services are performed under the
agreements.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Research and
Development and Patent Costs.&#160;&#160;</font>All research and development
costs, including all related salaries, clinical trial expenses, regulatory
expenses and facility costs are charged to expense when incurred. Expenditures
related to obtaining and protecting patents are also charged to expense when
incurred, and are included in research and development expense.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Loss Per Common
Share.&#160;&#160;</font>Basic net loss per share is calculated by dividing the
net loss by the weighted-average number of common shares outstanding for the
period, without consideration for common stock equivalents.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Recent Accounting
Developments</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In June
2006, the FASB issued Interpretation No. 48, or FIN 48, <font style="DISPLAY: inline; FONT-STYLE: italic">Accounting for Uncertainty in Income
Taxes &#8212; an Interpretation of FAS&#160;109</font>. FIN&#160;48 provides
clarification for the financial statement measurement and recognition of tax
positions that are taken or expected to be taken in a tax return. The Company
adopted FIN 48 effective January 1, 2007. The adoption had no impact on the
financial statements for the year ended December 31, 2007.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
September 2006, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued SFAS
No.&#160;157, <font style="DISPLAY: inline; FONT-STYLE: italic">Fair Value
Measurements</font>. SFAS&#160;No.&#160;157 establishes a framework for
measuring fair value in generally accepted accounting principles (&#8220;GAAP&#8221;), and
expands disclosures about fair value measurements. This Statement is effective
for financial statements for fiscal years beginning after November&#160;15,
2007, and interim periods within those fiscal years. We adopted SFAS No. 157 on
January 1, 2008 and it had an immaterial impact on the financial
statements.</font></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
December 2007, the FASB issued SFAS No. 141 (revised 2007), <font style="DISPLAY: inline; FONT-STYLE: italic">Business</font>&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">Combinations</font> (&#8220;FAS 141R),
which replaces FASB Statement No. 141. FAS 141R establishes principles and
requirements for how an acquirer recognizes and measures in its financial
statements the identifiable assets acquired, the liabilities assumed, any
noncontrolling interest in the acquiree and the goodwill acquired. The statement
also establishes disclosure requirements which will enable users to evaluate the
nature and financial effects of the business combination. FAS 141R is effective
as of the beginning of an entity&#8217;s fiscal year that begins after December 15,
2008, which will be our company&#8217;s year beginning January 1, 2009. The Company is
currently evaluating the potential impact, if any, of the adoption of FAS 141R
on our company&#8217;s financial statements.</font></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
December 2007, the FASB issued SFAS No. 160, <font style="DISPLAY: inline; FONT-STYLE: italic">Noncontrolling Interests in
Consolidated Financial Statements &#8211; amendments of ARB No. 51</font> (&#8220;FAS 160&#8221;).
FAS 160 states that accounting and reporting for minority interests will be
recharacterized as noncontrolling interests and classified as a component of
equity. The Statement also establishes reporting requirements that provide
sufficient disclosures that clearly identify and distinguish between the
interests of the parent and the interests of the noncontrolling owners. FAS 160
applies to all entities that prepare consolidated financial statements, except
for not-for-profit organizations, but will affect only those entities that have
an outstanding noncontrolling interest in one or more subsidiaries or that
deconsolidate a subsidiary. This statement is effective as of the beginning of
an entity&#8217;s first fiscal year beginning after December 15, 2008, which
corresponds to our company&#8217;s year beginning January 1, 2009. The company does
not expect the adoption of SFAS No. 160 to have a material effect on its
financial statements.</font></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other
recent accounting pronouncements issued by the FASB (including its Emerging
Issues Task Force) and the AICPA do not or are not believed by management to
have a material impact on our company's present or future financial
statements.</font></div>
    </div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OUR
MANAGEMENT</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Directors, Executive Officers,
Promoters and Control Persons</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Directors</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Matthew Nicosia</font>, age 34, has
served as a director of our Company since November, 2006. &#160;From&#160;2000
to 2007, prior to joining the Company as Executive Chairman of the Board, Mr.
Nicosia was the founder and Chief Executive Officer and currently serves as a
director of Dermacia, Inc. While founding Dermacia, Inc., in 2002, Mr. Nicosia,
co-founded Quantum Sphere, Inc. and&#160;served as a director until 2004.&#160;
Mr. Nicosia also currently sits on the Board of Directors and is a principal of
Integrity, Equity, and is a director of several private companies. Mr. Nicosia
received his Bachelor of Arts degree from Brigham Young University and an MBA
degree from Pepperdine University.&#160;&#160;Mr. Nicosia has been and currently
is an executive officer and director of Dermacia, Inc., a private medical
cosmetic company.&#160;&#160;In 2008 Dermacia became insolvent and was subject
to foreclosure proceedings by its principal creditor.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Dr. Tannin Fuja</font>, <font style="DISPLAY: inline; FONT-WEIGHT: bold">PhD</font>, age 32, has served as a
director and as Chief Executive Officer of our Company since March, 2008. Prior
to joining our company, from 2004 to 2006, Dr. Fuja headed the Molecular and
Cell Biology Research Group at the National Center for Voice and Speech, and was
a Member of the Scientific Advisory Board for Dermacia, Inc. and served as an
adjunct assistant professor in the Department of Speech Pathology and Audiology
at the University of Iowa. From 2004 through the present, Dr. Fuja is a Member
of the University of Iowa Center on Aging.&#160;&#160;From 2005, through the
present, Dr. Fuja serves as a Member of the Holden Comprehensive Cancer
Center.&#160;&#160;From 2006 through the present, Dr. Fuja serves as an Adjunct
Professor in the Department of Anatomy and Cell Biology at Carver College of
Medicine, University of Iowa. Dr. Fuja received his Bachelors of Science degree
from Brigham Young University, a certificate in Human Subject Research Ethics
from the University of Washington (Seattle) and his Doctorate in Biological
Sciences in the Department of Developmental and Cell Biology from the University
of California, Irvine.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Executive
Officers</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div align="left">
          <table cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td align="left" valign="top" width="29%" style="BORDER-TOP: medium none; BORDER-LEFT: medium none; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name</font></div>
                </td>
                <td align="left" valign="top" width="1%" style="BORDER-TOP: medium none; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="10%" style="BORDER-TOP: medium none; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Age</font></div>
                </td>
                <td align="left" valign="top" width="1%" style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="59%" style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; BORDER-BOTTOM: black 2px solid">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Position</font></div>
                </td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="top" width="29%" style="BORDER-LEFT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Matthew
      Nicosia</font></div>
                </td>
                <td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="10%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34</font></div>
                </td>
                <td align="left" valign="top" width="1%" style="BORDER-RIGHT: medium none"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="59%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive
      Chairman of the Board</font></div>
                </td>
              </tr>
              <tr bgcolor="white">
                <td align="left" valign="top" width="29%" style="BORDER-LEFT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.
      Tannin Fuja, PhD</font></div>
                </td>
                <td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="10%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32</font></div>
                </td>
                <td align="left" valign="top" width="1%" style="BORDER-RIGHT: medium none"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="59%" style="BORDER-RIGHT: medium none">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief
      Executive Officer, President, Chief Scientist</font></div>
                </td>
              </tr>
              <tr bgcolor="#eeeeee">
                <td align="left" valign="top" width="29%" style="BORDER-LEFT: medium none; BORDER-BOTTOM: 4px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ed
      Corrente</font></div>
                </td>
                <td align="left" valign="top" width="1%" style="BORDER-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="10%" style="BORDER-BOTTOM: 4px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">47</font></div>
                </td>
                <td align="left" valign="top" width="1%" style="BORDER-RIGHT: medium none; BORDER-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                <td align="left" valign="top" width="59%" style="BORDER-RIGHT: medium none; BORDER-BOTTOM: 4px">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief
      Financial Officer</font></div>
                </td>
              </tr>
          </table>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Ed Corrente</font>, age 47, is a
Certified Public Accountant and has been a consultant to our Company, acting as
CFO&#160;since March 2008 and became an employee of
our&#160;company,&#160;serving as the Chief Financial Officer since September,
2008.&#160; Prior to joining our company, Mr. Corrente was employed as the Chief
Financial Officer of Dermacia, Inc. from&#160;October, 2007&#160;to
September&#160;2008. From&#160;October 2006 to September 2007 he was a
consultant to Dermacia acting as an interim CFO.&#160;&#160;Between December
2000 and&#160;April 2007,&#160;Mr. Corrente was the Chief Financial Officer and
Vice President of Finance for Thuris Corporation and Accenx Technologies,
Inc.&#160; He was previously&#160;with&#160;Ernst and Young for approximately 16
years, working in its Toronto, Canada and Orange County, California
offices.&#160;&#160;Mr. Corrente is a member of the American Institute of
Certified Public Accountants and the California Society of CPA&#8217;s.&#160;&#160;Mr.
Corrente obtained his&#160;Bachelors degree at the University of Toronto,
Canada.&#160;&#160;Prior to joining our company, Mr. Corrente was the chief
financial officer of Dermacia, Inc., a private medical cosmetic
company.&#160;&#160;In 2008 Dermacia became insolvent and was subject to
foreclosure proceedings by its principal creditor.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Key
Employees</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Dr. YingYing Zhou, PhD</font>, has
served as our Cryobiology Program Manager since April, 2008.&#160;&#160;Prior to
that time, from 2001 to 2007, Dr. Zhou worked for HNI Corporation, where she
served as Senior Scientist. From 1996 to 2110 Dr. Zhou was a Graduat Student
Researcher for the University of California, Berkley.&#160;&#160;Dr. Zhou has
over ten years of research experience, five of which have been in research and
development, product testing, protocol, and manufacturing process
design.&#160;&#160;Dr. Zhou received her Bachelor&#8217;s and Master&#8217;s Degree in
Mechanical engineering from Tsinghua University in China and received her
Doctorate in Mechanical engineering from the University of California,
Berkley.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Dr. M. D. Mostaqul Huq, PhD</font>,
has serves as our Molecular Program Manager since May, 2008.&#160;&#160;Prior to
that time, from 2007 to 2008, Dr. Huq served as Research Associate at the Howard
Hughes Medical Institute, University of Michigan, Ann Arbor.&#160;&#160;From
2007 through 2008, Dr. Huq served as an Intern Pharmacist at Stadium Pharmacy in
Ann Arbor, Michigan.&#160;&#160;From 2003 through 2007, Dr. Huq was a
Post-Doctoral Fellow at the University of Minnesota School of
Medicine.&#160;&#160;Dr. Huq received his Bachelor&#8217;s of Science Degree and his
Master&#8217;s of Science Degree in Pharmacy and Pharmaceutical Technology from the
University of Dhaka, Dhaka, Bangladesh.&#160;&#160;Dr. Huq received his PhD for
Osaka University Graduate School of Pharmaceutical Sciences in Osaka, Japan and
completed his post Doctoral training at the University of Minnesota Medical
School in Minneapolis, Minnesota.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Family
Relationships.&#160;&#160;</font>There are no family relationships among the
directors and executive officers of the company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Code of Conduct
and Ethics</font>.&#160;&#160;We have adopted a code of business conduct and
ethics that applies to our directors, officers and all employees. The code of
business conduct and ethics is posted on our website at www.vivakor.com. The
code of business conduct and ethics may be also obtained free of charge by
writing to Vivakor, Inc., Attn: Chief Financial Officer, 2590 Holiday Road,
Suite 100, Coralville, Iowa 52241.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Executive
Compensation</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Summary
Compensation Table</font>.&#160;&#160;The following table sets forth certain
information concerning the annual and long-term compensation of our Chief
Executive Officer and our other two highest paid executive officers during the
last fiscal year (the Named Executives) for the last two fiscal
years.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font></div>
              </td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(b)</font></div>
                </div>
              </td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(c)</font></div>
              </td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name
      and Principal Position</font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Year</font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Salary</font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bonus</font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Option
      </font></div>
                  <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Awards</font></div>
                </div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All
      Other </font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Compensation</font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      </font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Compensation</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="bottom" width="28%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.
      Tannin Fuja, PhD</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="28%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief
      Executive Officer</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 24pt"></font>0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 28.2pt"></font>0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 22.2pt"></font>0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="bottom" width="28%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President,
      Chief Scientist</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="white">
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="bottom" width="28%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Matt
      Nicosia</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="28%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chairman
      of the Board</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 19.8pt"></font>0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 28.2pt"></font>0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="bottom" width="28%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ed
      Corrente</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
              </td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td align="left" valign="bottom" width="28%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief
      Financial Officer</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 18.6pt"></font>0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="white">
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Compensation of
Other Named Executives</font>.&#160;&#160;&#160;None of our Named Executive
Officers are currently employed under employment agreements</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Outstanding
Equity Awards at Fiscal Year End</font>.&#160;&#160;There were no outstanding
equity awards as of December 31, 2007.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">&#160;2008 Stock
Incentive Plan.&#160;&#160;</font>On October 23, 2008, our Board of Directors
unanimously approved our 2008 Stock Incentive Plan (the &#8220;2008 Plan&#8221;). The
purpose of the 2008 Plan is to retain current, and attract new, employees,
directors, consultants and advisors that have experience and ability, along with
encouraging a sense of proprietorship and interest in the Company&#8217;s development
and financial success. The Board of Directors believes that option grants and
other forms of equity participation are an increasingly important means of
retaining and compensating employees, directors, advisors and consultants. The
2008 Plan authorizes us to issue up to 7,500,000 shares of our common stock
which represented slightly less than 15% of our outstanding shares at the time
the 2008 Plan was adopted. The 2008 Plan allows us to grant tax-qualified
incentive stock options, non-qualified stock options and restrictive stock
awards to employees, directors and consultants of our
company.&#160;&#160;&#160;As of November 1, 2008, no options or awards had been
granted under the 2008 Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Compensation of
Non-Employee Directors</font> .&#160;&#160;We currently have no non-employee
directors and no compensation was paid to non-employee directors in the fiscal
year ended December 31, 2007.&#160;&#160;We intend during 2009 to identify
qualified candidates to serve on the Board of Directors and to develop a
compensation package to offer to members of the Board of Directors and its
Committees.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Audit, Compensation and Nominating
Committees</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As noted
above, we intend to apply for listing our common stock on the OTC Electronic
Bulletin Board, which does not require companies to maintain audit, compensation
or nominating committees. Considering the fact that we are an early stage
company, we do not maintain standing audit, compensation or nominating
committees. The functions typically associated with these committees are
performed by the entire Board of Directors which currently consists of three
members, none of whom is considered independent.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1111">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT</a></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Security
Ownership of Principal Stockholders, Directors, Nominees and Executive Officers
and Related Stockholder Matters</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
following table sets forth, as of November 1, 2008, certain information with
respect to the beneficial ownership of shares of our common stock by: (i) each
person known to us to be the beneficial owner of more than 5 percent of our
outstanding shares of common stock, (ii) each director or nominee for director
of our Company, (iii) each of the Named Executives (see &#8220;Executive Compensation
&#8211; Summary Compensation Table&#8221;), and (iv) our directors and executive officers as
a group.&#160;&#160;&#160;Unless otherwise indicated, the address of each
shareholder is c/o our company at 2590 Holiday Road, Suite 100, Coralville, Iowa
52241.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="7" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number
      of Shares</font></div>
              </td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percent
      of</font></div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficial
      Owner</font></div>
              </td>
              <td valign="bottom" style="PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Address</font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="7" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficially
      Owned (*)</font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Class
      (**)</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td valign="bottom" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">NFG
      Inc.</font></div>
              </td>
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 4.35pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23,980,219</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">47.74</font></div>
              </td>
              <td valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td valign="bottom" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr.
      Tannin Fuja, PhD</font></div>
              </td>
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 4.35pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,975,000</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33.80</font></div>
              </td>
              <td valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td valign="bottom" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Matt
      Nicosia</font></div>
              </td>
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 4.35pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">785,000</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(b)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.56</font></div>
              </td>
              <td valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td valign="bottom" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ed
      Corrente</font></div>
              </td>
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 4.35pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">785,000</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(c)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.56</font></div>
              </td>
              <td valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td valign="bottom" width="36%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="white">
              <td valign="bottom" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All
      directors and officers as a group</font></div>
              </td>
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 4.35pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,545,000</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36.92</font></div>
              </td>
              <td valign="top" width="1%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div>
              </td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td valign="bottom" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3
      persons)</font></div>
              </td>
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="white">
              <td valign="bottom" width="36%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr bgcolor="white">
              <td valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(*)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficial
      ownership is determined in accordance with the rules of the SEC which
      generally attribute beneficial ownership of securities to persons who
      possess sole or shared voting power and/or investment power with respect
      to those securities. Unless otherwise indicated, voting and investment
      power are exercised solely by the person named above or shared with
      members of such person&#8217;s household.</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="white">
              <td valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(**)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percent
      of class is calculated on the basis of the number of shares outstanding on
      November 1, 2008 (50,225,875), plus the number of shares the person has
      the right to acquire within 60 days of November 1,
2008.</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="white">
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All
      of NFG&#8217;s outstanding shares are held by an individual who is neither a
      director, officer nor employee of our company.</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td align="left" valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr bgcolor="white">
              <td valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(b)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All
      785,000 of such shares are issued in the name of Nicosia Family Trust, of
      which Mr. Nicosia is a Trustee, but of which he disclaims beneficial
      ownership.</font></div>
              </td>
            </tr>
            <tr bgcolor="white">
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="white">
              <td valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(c)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="73%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">This
      amount includes 300,000 shares in the name of Corrente Family Trust, of
      which Mr. Corrente is a Trustee, but of which he disclaims beneficial
      ownership.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">It
is our practice and policy to comply with all applicable laws, rules and
regulations regarding related-person transactions, including the Sarbanes-Oxley
Act of 2002. A related person is an executive officer, director or more than 5%
stockholder of Vivakor, including any immediate family members, and any entity
owned or controlled by such persons. Our Board of Directors (excluding any
interested director) is charged with reviewing and approving all related-person
transactions, and a special committee of our Board of Directors is established
to negotiate the terms of such transactions. In considering related-person
transactions, our Board of Directors takes into account all relevant available
facts and circumstances.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Loans
and Advances from Affiliates</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Through
September 30, 2008, a shareholder personally paid Company expenditures
(primarily including lab and office equipment and supplies) aggregating
$19,461.&#160;&#160;The amount payable to the shareholder at September 30, 2008
is noninterest bearing.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On June
30, 2008, our company purchased office and lab furniture and equipment from NFG,
Inc., a shareholder, at a total cost of $87,450. NFG financed the equipment with
a promissory note that that is secured by the assets purchased. The note bears
interest at 14% per annum and is due on December 31, 2008. In the event our
company is unable to repay the note when it matures, NFG has the option to
convert the note into shares of our common stock with piggyback registration
rights. The number of shares to be issued would be equal to the outstanding
principal plus accrued and unpaid interest divided by 80% of the average stock
price during the 30 days prior to maturity.&#160;&#160;Our Board of Directors
believes that the loan was on terms that are fair and reasonable to our company
and no less favorable than those that would be available from an unaffiliated
third party in an arms&#8217;-length transaction.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Through
September 30, 2008, NFG advanced or paid Company expenditures (primarily
including payroll, legal fees, lab and office equipment and supplies)
aggregating $96,630. This amount payable to NFG at September 30, 2008 is
noninterest bearing.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Acquisition
of HealthAmerica</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
October 20, 2008, we effectively acquired the assets (patents and technology
related to medical record bar coding and magnetic resonance imaging (MRI)
systems) of HealthAmerica, Inc., a company that has had no significant
operations, within the last four years, by acquiring 25,000,000 shares of its
common stock in exchange for (i) a promissory note in the principal amount of
$1,500,000 bearing interest at 4% per annum and (ii) 5,000,000 shares of our
common stock.&#160;&#160;Certain officers, directors and affiliates of our
company, directly or indirectly, were shareholders of HealthAmerica and received
shares of our common stock in exchange for their HealthAmerica
shares.&#160;&#160;Affiliates of our company owned or controlled, directly or
indirectly1,085,000 shares of HealthAmerica common stock, representing
approximately 21.7% of HealthAmerica&#8217;s outstanding shares prior to
acquisition.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Director
Independence</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our Board
of Directors has adopted the definition of &#8220;independence&#8221; as described under the
Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley) Section 301, Rule 10A-3 under the
Securities Exchange Act of 1934 (the Exchange Act) and NASDAQ Rules 4200 and
4350. Our Board of Directors has determined that none of its members meet the
independence requirements.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1113">DESCRIPTION OF CAPITAL STOCK</a></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div align="left">
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="bottom">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Authorized
      and Issued Stock</font></div>
              </td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="10" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="top"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Number of Shares at November 1,
      2008</font></font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td valign="bottom" style="PADDING-BOTTOM: 2px">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Title
      of Class</font></font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Authorized</font></font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Outstanding</font></font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Reserved</font></font></div>
              </td>
              <td valign="top" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td valign="bottom" width="64%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common
      stock, $0.001 par value per share</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">242,500,000</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,225,875</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,500,000*</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="white">
              <td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr bgcolor="#eeeeee">
              <td valign="bottom" width="64%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Preferred
      Stock, $0.001 par value per share</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000,000</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="right" valign="top" width="9%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;___________________</font></div>
      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">*</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Reserved
for issuances and awards under the 2008 Stock Incentive Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Common stock</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Dividends</font>.&#160;&#160;Each
share of common stock is entitled to receive an equal dividend, if one is
declared, which is unlikely. We have never paid dividends on our common stock
and do not intend to do so in the foreseeable future. We intend to retain any
future earnings to finance our growth. See Risk Factors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Liquidation</font>.&#160;&#160;If
our company is liquidated, any assets that remain after the creditors are paid,
and the owners of preferred stock receive any liquidation preferences, will be
distributed to the owners of our common stock pro-rata.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Voting
Rights</font>.&#160;&#160;Each share of our common stock entitles the owner to
one vote. There is no cumulative voting. A simple majority can elect all of the
directors at a given meeting and the minority would not be able to elect any
directors at that meeting.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Preemptive
Rights</font>.&#160;&#160;Owners of our common stock have no preemptive rights.
We may sell shares of our common stock to third parties without first offering
it to current stockholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Redemption
Rights.&#160;&#160;</font>We do not have the right to buy back shares of our
common stock except in extraordinary transactions such as mergers and court
approved bankruptcy reorganizations. Owners of our common stock do not
ordinarily have the right to require us to buy their common stock. We do not
have a sinking fund to provide assets for any buy back.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Conversion
Rights</font>.&#160;&#160;Shares of our common stock cannot be converted into
any other kind of stock except in extraordinary transactions, such as mergers
and court approved bankruptcy reorganizations.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Preferred Stock</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
articles of incorporation authorize our board of directors to issue &#8220;blank
check&#8221; preferred stock. The board of directors may divide this stock into series
and set their rights. The board of directors may, without prior stockholder
approval, issue any of the 10,000,000 shares of preferred stock with dividend,
liquidation, conversion, voting or other rights which could adversely affect the
relative voting power or other rights of the common stock. Preferred stock could
be used as a method of discouraging, delaying, or preventing a take-over of our
company. If we do issue preferred stock in the future, it could have a dilutive
effect upon the common stock. See Risk Factors.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Nevada Anti-Takeover
Laws</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Some
features of the Nevada Revised Statutes (NRS), which are further described
below, may have the effect of deterring third parties from making takeover bids
for control of our company or may be used to hinder or delay a takeover bid.
This would decrease the chance that our stockholders would realize a premium
over market price for their shares of common stock as a result of a takeover
bid.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Acquisition of
Controlling Interest</font>.&#160;&#160;The Nevada Revised Statutes contain a
provision governing Acquisition of Controlling Interest. This law provides
generally that any person or entity that acquires 20% or more of the outstanding
voting shares of a publicly-held Nevada corporation in the secondary public or
private market may be denied voting rights with respect to the acquired shares,
unless a majority of the disinterested stockholders of the corporation elects to
restore such voting rights in whole or in part. The control share acquisition
act provides that a person or entity acquires control shares whenever it
acquires shares that, but for the operation of the control share acquisition
act, would bring its voting power within any of the following three
ranges:</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20
      to 33 1/3%,</font></div>
              </td>
            </tr>
            <tr>
              <td colspan="4" valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(b)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33
      1/3 to 50%, or</font></div>
              </td>
            </tr>
            <tr>
              <td colspan="4" valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(c)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">more
      than 50%.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A control
share acquisition is generally defined as the direct or indirect acquisition of
either ownership or voting power associated with issued and outstanding control
shares. The stockholders or board of directors of a corporation may elect to
exempt the stock of the corporation from the provisions of the control share
acquisition act through adoption of a provision to that effect in the articles
of incorporation or bylaws of the corporation. Our articles of incorporation and
bylaws do not exempt our common stock from the control share acquisition
act.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
control share acquisition act is applicable only to shares of &#8220;Issuing
Corporations&#8221; as defined by the act.&#160;&#160;An &#8220;Issuing Corporation&#8221; is a
Nevada corporation, which:</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">has
      200 or more stockholders, with at least 100 of such stockholders being
      both stockholders of record and residents of Nevada;
and</font></div>
              </td>
            </tr>
            <tr>
              <td colspan="4" valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(b)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">does
      business in Nevada directly or through an affiliated
      corporation.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At this
time, we do not have 100 stockholders of record resident of Nevada nor do we do
business in Nevada directly or through an affiliated corporation. Therefore, the
provisions of the control share acquisition act do not apply to acquisitions of
our shares and will not until such time as these requirements have been met. At
such time as they may apply to us, the provisions of the control share
acquisition act may discourage companies or persons interested in acquiring a
significant interest in or control of our company, regardless of whether such
acquisition may be in the interest of our stockholders.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Combination with
Interested Stockholder.&#160;&#160;</font>The Nevada Combination with Interested
Stockholders Statute may also have an effect of delaying or making it more
difficult to effect a change in control of our company. This statute prevents an
interested stockholder and a resident domestic Nevada corporation from entering
into a combination, unless certain conditions are met. The statute defines
combination to include any merger or consolidation with an interested
stockholder, or any sale, lease, exchange, mortgage, pledge, transfer or other
disposition, in one transaction or a series of transactions with an interested
stockholder having:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">an
      aggregate market value equal to 5 percent or more of the aggregate market
      value of the assets of the corporation;</font></div>
              </td>
            </tr>
            <tr>
              <td colspan="4" valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(b)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">an
      aggregate market value equal to 5 percent or more of the aggregate market
      value of all outstanding shares of the corporation; or</font></div>
              </td>
            </tr>
            <tr>
              <td colspan="4" valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(c)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">representing
      10 percent or more of the earning power or net income of the
      corporation.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">An
interested stockholder means the beneficial owner of 10 percent or more of the
voting shares of a resident domestic corporation, or an affiliate or associate
thereof. A corporation affected by the statute may not engage in a combination
within three years after the interested stockholder acquires its shares unless
the combination or purchase is approved by the board of directors before the
interested stockholder acquired such shares. If approval is not obtained, then
after the expiration of the three-year period, the business combination may be
consummated with the approval of the board of directors or a majority of the
voting power held by disinterested stockholders, or if the consideration to be
paid by the interested stockholder is at least equal to the highest
of:</font><br></div>
      <div>&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">the
      highest price per share paid by the interested stockholder within the
      three years immediately preceding the date of the announcement of the
      combination or in the transaction in which he became an interested
      stockholder, whichever is higher;</font></div>
              </td>
            </tr>
            <tr>
              <td colspan="4" valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(b)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">the
      market value per common share on the date of announcement of the
      combination or the date the interested stockholder acquired the shares,
      whichever is higher; or</font></div>
              </td>
            </tr>
            <tr>
              <td colspan="4" valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            </tr>
            <tr>
              <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="3%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(c)</font></div>
              </td>
              <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
              <td align="left" valign="top" width="71%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">if
      higher for the holders of preferred stock, the highest liquidation value
      of the preferred stock.</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Limitations on Stockholder
Actions</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chapter
78 of the Nevada Revised Statutes ("NRS") provides that a corporation may
indemnify any person who was or is a party or is threatened to be made a party
to any threatened, pending or completed action, suit or proceeding whether
civil, criminal, administrative or investigative (other than an action by or in
the right of the corporation) by reason of the fact that he is or was a
director, officer, employee or agent of the corporation, or is or was serving at
the request of the corporation as a director, officer, employee or agent of
another corporation, partnership, joint venture, trust or other enterprise,
against expenses (including attorneys' fees), judgments, fines and amounts paid
in settlement actually and reasonably incurred by him in connection with such
action, suit or proceeding if he is not liable pursuant to NRS Section 78.138 or
acted in good faith and in a manner he reasonably believed to be in or not
opposed to the best interests of the corporation, and, with respect to any
criminal action or proceeding, had no reasonable cause to believe his conduct
was unlawful. NRS Chapter 78 further provides that a corporation similarly may
indemnify any such person serving in any such capacity who was or is a party or
is threatened to be made a party to any threatened, pending or completed action
or suit by or in the right of the corporation to procure a judgment in its favor
by reason of the fact that he is or was a director, officer, employee or agent
of the corporation or is or was serving at the request of the corporation as a
director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise, against expenses (including attorneys' fees)
actually and reasonably incurred in connection with the defense or settlement of
such action or suit if he is not liable pursuant to NRS Section 78.138 or acted
in good faith and in a manner he reasonably believed to be in or not opposed to
the best interests of the corporation and except that no indemnification shall
be made in respect of any claim, issue or matter as to which such person shall
have been adjudged to be liable to the corporation unless and only to the extent
that the court or other court of competent jurisdiction in which such action or
suit was brought shall determine upon application that, despite the adjudication
of liability but in view of all of the circumstances of the case, such person is
fairly and reasonably entitled to indemnity for such expenses which the court or
other court of competent jurisdiction shall deem proper.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our
bylaws provide that it may indemnify its officers, directors, agents and any
other persons to the fullest extent permitted by the NRS.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SELLING
STOCKHOLDERS</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1115">The following table presents information regarding the selling
stockholders and the shares that may be sold by them pursuant to this
prospectus. See also Security Ownership of Certain Beneficial Owners and
Management.</a></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
          <div align="left">
            <table cellpadding="0" cellspacing="0" width="100%">
                <tr>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name</font></div>
                  </td>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number
      of</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares
      of Common stock</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficially</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Owned</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prior
      to</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offering(1)</font></div>
                  </td>
                  <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number
      of</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares
      of</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock
      Being</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offered</font></div>
                  </td>
                  <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares
      of</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficially</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Owned</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">After
      the</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offering(1)</font></div>
                  </td>
                  <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficially</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Owned</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">After
      the</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offering</font></div>
                  </td>
                  <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">IME
      Capital LLC</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,000,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,000,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">William
      James &amp; Associates Inc.</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">935,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">935,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nicosia
      Family Trust</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">785,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">785,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Juris
      Equity Holdings, LLC</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">715,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">715,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Richard
      A. Taulli</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">715,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">715,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corrente
      Family Trust</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">785,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">300,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">485,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">*</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Charles
      Richard Maxfield</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Neal
      Bhatia</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">116,625</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">56,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">60,625</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">*</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Craig
      Geers</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">85,625</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">60,625</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">*</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David
      Wayne Strader</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Kyle
      H. Swenson</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Darin
      Glauner</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Charmel
      Buhl</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Angie
      Gautschi</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Michael
      Gross</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">NS
      Printing Inc.</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,500</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,500</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Triad
      Holdings Group LLC</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,500</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,500</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jim
      Cox</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Awesome
      Nancy LLC</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Lewis
      R. Bowman</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Centurion
      Marketing Group LLC</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cort
      Christie</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">D
      Bar M Stables Inc.</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Excelsior
      Management LLC</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="1">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
          <div align="left">
            <table cellpadding="0" cellspacing="0" width="100%">
                <tr>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name</font></div>
                  </td>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number
      of</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares
      of Common stock</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficially</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Owned</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prior
      to</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offering(1)</font></div>
                  </td>
                  <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number
      of</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares
      of</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock
      Being</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offered</font></div>
                  </td>
                  <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares
      of</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficially</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Owned</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">After
      the</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offering(1)</font></div>
                  </td>
                  <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Percentage</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficially</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Owned</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">After
      the</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offering</font></div>
                  </td>
                  <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">James
      M. Friend</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Donna
      Ganow</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Robert
      Garcia</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Casey
      Keen</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jaimie
      McKinnis</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mindmosaic
      LLC</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deborah
      L. Murphy</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">NS
      Enterprises Inc.</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David
      W. Paredes</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Rico
      Italia Investments Inc.</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Russell
      Rogers</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">George
      Patrick Shook</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pasquale
      J. Amendolia</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nick
      Yocca</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Larry
      Zimmerman</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="white">
                  <td align="left" valign="bottom" width="52%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mitch
      Parker</font></div>
                  </td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
                </tr>
                <tr bgcolor="#eeeeee">
                  <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,739,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,133,000</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">606,250</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">*</font></td>
                  <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*Less
than one percent.</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div>
          <table cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td valign="top" width="3%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1)</font></div>
                </td>
                <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                <td align="left" colspan="3" valign="top" width="73%">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      number of shares listed in these columns include all shares beneficially
      owned and all options or warrants to purchase shares held, whether or not
      deemed to be beneficially owned, by the selling stockholder. The ownership
      percentages listed in these columns include only shares beneficially owned
      by the listed selling stockholder. Beneficial ownership is determined in
      accordance with the rules of the SEC. In computing the percentage of
      shares beneficially owned by a selling stockholder, shares of common stock
      subject to options or warrants, or debt convertible into common stock held
      by that selling stockholder that was exercisable on or within 60 days
      after November 1, 2008, were deemed outstanding for the purpose of
      computing the percentage ownership of that selling stockholder. The
      ownership percentages are calculated assuming that 50,225,875 shares of
      common stock were outstanding on November 1,
  2008.</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="1">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1116">PLAN OF DISTRIBUTION</a></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By
Selling Stockholders</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
selling stockholders and any of its pledgees, donees, transferees, assignees and
successors-in-interest may, from time to time, sell any or all of its shares of
common stock on any stock exchange, market or trading facility on which the
shares are traded or in private transactions. These sales may be at fixed or
negotiated prices. The selling stockholder may use any one or more of the
following methods when selling shares:</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div align="left">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ordinary
      brokerage transactions and transactions in which the broker-dealer
      solicits investors;</font></div>
                  </td>
                </tr>
            </table>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">block
      trades in which the broker-dealer will attempt to sell the shares as agent
      but may position and resell a portion of the block as principal to
      facilitate the transaction;</font></div>
                  </td>
                </tr>
            </table>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">purchases
      by a broker-dealer as principal and resale by the broker-dealer for its
      account;</font></div>
                  </td>
                </tr>
            </table>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">an
      exchange distribution in accordance with the rules of the applicable
      exchange;</font></div>
                  </td>
                </tr>
            </table>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">privately
      negotiated transactions;</font></div>
                  </td>
                </tr>
            </table>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to
      cover short sales made after the date that this Registration Statement is
      declared effective by the
Commission;</font></div>
                  </td>
                </tr>
            </table>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">broker-dealers
      may agree with the selling stockholder to sell a specified number of such
      shares at a stipulated price per
share;</font></div>
                  </td>
                </tr>
            </table>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
      combination of any such methods of sale;
and</font></div>
                  </td>
                </tr>
            </table>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
            <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                <tr valign="top" style="LINE-HEIGHT: 1.25;">
                  <td style="WIDTH: 36pt">
                  </td>
                  <td align="right" style="WIDTH: 27pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></font></font></div>
                    </div>
                  </td>
                  <td align="left">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
      other method permitted pursuant to applicable
  law.</font></div>
                  </td>
                </tr>
            </table>
          </div>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
selling stockholder may also sell shares under Rule 144 promulgated under the
Securities Act, or another exemption from the registration requirements under
the Securities Act, if available, rather than under this
prospectus.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Broker-dealers
engaged by the selling stockholders may arrange for other brokers-dealers to
participate in sales. Broker-dealers may receive commissions or discounts from
the selling stockholder (or, if any broker-dealer acts as agent for the
purchaser of shares, from the purchaser) in amounts to be
negotiated.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
selling stockholders may from time to time pledge or grant a security interest
in some or all of the Shares owned by it and, if it defaults in the performance
of their secured obligations, the pledgees or secured parties may offer and sell
shares of common stock from time to time under this prospectus, or under an
amendment to this prospectus under Rule 424(b)(3) or other applicable provision
of the Securities Act of 1933 amending the list of selling stockholders to
include the pledgee, transferee or other successors in interest as selling
stockholders under this prospectus.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon the
company being notified in writing by a selling stockholder that any material
arrangement has been entered into with a broker-dealer for the sale of common
stock through a block trade, special offering, exchange distribution or
secondary distribution or a purchase by a broker or dealer, a supplement to this
prospectus will be filed, if required, pursuant to Rule 424(b) under the
Securities Act, disclosing (i) the name of each such selling stockholder and of
the participating broker-dealer(s), (ii) the number of shares involved, (iii)
the price at which such the shares of common stock were sold, (iv) the
commissions paid or discounts or concessions allowed to such broker-dealer(s),
where applicable, (v) that such broker-dealer(s) did not conduct any
investigation to verify the information set out or incorporated by reference in
this prospectus, and (vi) other facts material to the transaction. In addition,
upon the company being notified in writing by a selling stockholder that a donee
or pledgee intends to sell more than 500 shares of common stock, a supplement to
this prospectus will be filed if then required in accordance with applicable
securities law.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="1">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
selling stockholder also may transfer the shares of common stock in other
circumstances, in which case the transferees, pledgees or other successors in
interest will be the selling beneficial owners for purposes of this
prospectus.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
selling stockholders and any broker-dealers or agents that are involved in
selling the shares may be deemed to be &#8220;underwriters&#8221; within the meaning of the
Securities Act in connection with such sales. In such event, any commissions
received by such broker-dealers or agents and any profit on the resale of the
shares purchased by them may be deemed to be underwriting commissions or
discounts under the Securities Act. Because the selling stockholder may be
deemed to be an underwriter within the meaning of the Securities Act, they will
be subject to the prospectus delivery requirements of the Securities Act.
Discounts, concessions, commissions and similar selling expenses, if any, that
can be attributed to the sale of Securities will be paid by the selling
stockholder and/or the purchasers. The selling stockholder has represented and
warranted to the company that it acquired the securities subject to this
registration statement in the ordinary course of the selling stockholder&#8217;s
business and, at the time of its purchase of such securities the selling
stockholder had no agreements or understandings, directly or indirectly, with
any person to distribute any such securities.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
company has advised the selling stockholders that it may not use shares
registered on this Registration Statement to cover short sales of common stock
made prior to the date on which this Registration Statement shall have been
declared effective by the Commission. If the selling stockholder uses this
prospectus for any sale of the common stock, it will be subject to the
prospectus delivery requirements of the Securities Act. The selling stockholder
will be responsible to comply with the applicable provisions of the Securities
Act and Exchange Act, and the rules and regulations thereunder promulgated,
including, without limitation, Regulation M, as applicable to such selling
stockholder in connection with resales of their respective shares under this
Registration Statement.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
company is required to pay all fees and expenses incident to the registration of
the shares, but the company will not receive any proceeds from the sale of the
common stock by selling stockholders. The company has agreed to indemnify the
selling stockholder against certain losses, claims, damages and liabilities,
including liabilities under the Securities Act.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">By
Our Company</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We may
sell the shares of our common stock subject to this prospectus from time to time
in any manner permitted by the Securities Act, including any one or more of the
following ways:</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div align="left">
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">directly
      to investors;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to
      investors through agents;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to
      dealers; and/or</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">through
      one or more
underwriters.</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
underwritten offering may be on a best efforts or a firm commitment basis. We
may also make direct sales through subscription rights distributed to our
stockholders on a pro rata basis, which may or may not be transferable. In any
distribution of subscription rights to stockholders, if all of the underlying
securities are not subscribed for, we may then sell the unsubscribed securities
directly to third parties or may engage the services of one or more
underwriters, dealers or agents, including standby underwriters, to sell the
unsubscribed securities to third parties. Under agreements into which we may
enter, underwriters, dealers and agents who participate in the distribution of
the shares of common stock may be entitled to indemnification by us against some
liabilities, including liabilities under the Securities Act, or contribution
from us to payments which the underwriters, dealers or agents may be required to
make. Underwriters, dealers and agents may engage in transactions with us or
perform services for us from time to time in the ordinary course of
business.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="1">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
distribution of the shares of common stock may be effected from time to time in
one or more transactions:</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div align="left">
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">at
      a fixed price or prices, which may be
changed;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">at
      market prices prevailing at the time of
sale;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;at
      prices related to such prevailing market prices;
  or</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">at
      negotiated prices.</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any of
the prices may represent a discount from prevailing market prices.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shares of
common stock sold pursuant to the registration statement of which this
prospectus is a part may not be listed or traded on any exchange or automated
quotations system, but may be listed on the OTC Electronic Bulletin
Board.&#160;&#160;In the sale of the shares, underwriters or agents may receive
compensation from us or from purchasers of the shares, for whom they may act as
agents, in the form of discounts, concessions or commissions. Underwriters may
sell the shares to or through dealers, and such dealers may receive compensation
in the form of discounts, concessions or commissions from the underwriters
and/or commissions from the purchasers for whom they may act as agents.
Underwriters, dealers and agents that participate in the distribution of the
securities may be deemed to be underwriters under the Securities Act of 1933,
and any discounts or commissions they receive from us and any profit on the
resale of securities they realize may be deemed to be underwriting discounts and
commissions under the Securities Act.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each time
we sell shares, we will describe the method of distribution of the shares in the
prospectus supplement relating to such transaction. The applicable prospectus
supplement will, where applicable:</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div align="left">
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">identify
      any such underwriter or agent;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">describe
      any compensation in the form of discounts, concessions, commissions or
      otherwise received from us by each such underwriter or agent and in the
      aggregate to all underwriters and
agents;</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">identify
      the amounts underwritten; and</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
              <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
                  <tr valign="top" style="LINE-HEIGHT: 1.25;">
                    <td style="WIDTH: 36pt">
                    </td>
                    <td align="right" style="WIDTH: 27pt">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-FAMILY: Times New Roman">&#9679;</font></font></div>
                    </td>
                    <td align="left">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">identify
      the nature of the underwriter&#8217;s obligation to take the
    shares.</font></div>
                    </td>
                  </tr>
              </table>
            </div>
          </div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
underwriters are utilized in the sale of the securities, the shares may be
acquired by the underwriters for their own account and may be resold from time
to time in one or more transactions, including negotiated transactions, at fixed
public offering prices or at varying prices determined by the underwriters at
the time of the sale. We may offer the shares to the public either through
underwriting syndicates represented by managing underwriters or directly by the
managing underwriters. If any underwriters are utilized in the sale of the
securities, unless otherwise stated in the applicable prospectus supplement, the
underwriting agreement will provide that the obligations of the underwriters are
subject to specified conditions precedent and that the underwriters with respect
to a sale of the shares will be obligated to purchase all of the shares offered
if any are purchased.</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">38</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="1">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Until the
distribution of the securities is completed, rules of the SEC may limit the
ability of any underwriters and selling group members to bid for and purchase
the securities. As an exception to these rules, underwriters are permitted to
engage in some transactions that stabilize the price of the securities, such as
over allotment, stabilizing transactions, short covering transactions and
penalty bids in accordance with Regulation&#160;M under the Securities Exchange
Act of 1934. Over allotment involves sales in excess of the offering size which
create a short position. Stabilizing transactions consist of bids or purchases
for the purpose of pegging, fixing or maintaining the price of the securities.
Short covering transactions involve purchases of the securities in the open
market after the distribution is completed to cover short positions. The
underwriters may also impose a penalty bid, under which selling concessions
allowed to syndicate members or other broker-dealers for securities sold in the
offering for their account may be reclaimed by the syndicate if the securities
are repurchased by the syndicate in stabilizing or covering transactions. In
general, purchases of a security for the purpose of stabilization or to reduce a
short position could cause the price of the security to be higher than it might
be in the absence of such purchases. The imposition of a penalty bid might also
have an effect on the price of a security to the extent that it were to
discourage resales of the security before the distribution is
completed.</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We do not
make any representation or prediction as to the direction or magnitude of any
effect that the transactions described above might have on the price of the
securities. In addition, we do not make any representation that underwriters
will engage in such transactions or that such transactions, once commenced, will
not be discontinued without notice.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Underwriters,
dealers and agents may engage in transactions with us or perform services for us
in the ordinary course of business.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
indicated in the applicable prospectus supplement, we will authorize
underwriters or other persons acting as our agents to solicit offers by
particular institutions to purchase shares from us at the public offering price
set forth in such prospectus supplement pursuant to delayed delivery contracts
providing for payment and delivery on the date or dates stated in such
prospectus supplement. Each delayed delivery contract will be for an amount no
less than, and the aggregate principal amounts of securities sold under delayed
delivery contracts shall be not less nor more than, the respective amounts
stated in the applicable prospectus supplement. Institutions with which such
contracts, when authorized, may include commercial and savings banks, insurance
companies, pension funds, investment companies, educational and charitable
institutions and others, but will in all cases be subject to our approval. The
obligations of any purchaser under any such contract will be subject to the
conditions that (a)&#160;the purchase of the shares shall not at the time of
delivery be prohibited under the laws of any jurisdiction in the United States
to which the purchaser is subject, and (b)&#160;if the shares are being sold to
underwriters, we shall have sold to the underwriters the total principal amount
of the shares less the principal amount thereof covered by the contracts. The
underwriters and such other agents will not have any responsibility in respect
of the validity or performance of such contracts.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To comply
with applicable state securities laws, the shares offered by this prospectus
will be sold, if necessary, in such jurisdictions only through registered or
licensed brokers or dealers. In addition, shares may not be sold in some states
unless they have been registered or qualified for sale in the applicable state
or an exemption from the registration or qualification requirement is available
and is complied with.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1117"><font style="DISPLAY: inline; FONT-WEIGHT: bold">OTC Electronic
Bulletin Board Considerations</font></a></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The OTC
Electronic Bulletin Board is separate and distinct from the NASDAQ stock market
and other stock exchanges. NASDAQ has no business relationship with issuers of
securities quoted on the OTC Electronic Bulletin Board. The SEC&#8217;s order handling
rules, which apply to NASDAQ-listed securities, do not apply to securities
quoted on the OTC Electronic Bulletin Board.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Although
the NASDAQ stock market has rigorous listing standards to ensure the high
quality of its issuers, and can delist issuers for not meeting those standards,
the OTC Electronic Bulletin Board has no listing standards. Rather, it is the
market maker who chooses to quote a security on the system, files the
application, and is obligated to comply with keeping information about the
issuer in its files. The FINRA cannot deny an application by a market maker to
quote the stock of a company. The only requirement for inclusion in the OTC
Electronic Bulletin Board is that the issuer be current in its reporting
requirements with the SEC.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investors
must contact a broker-dealer to trade OTC Electronic Bulletin Board securities.
Investors do not have direct access to the bulletin board service. For bulletin
board securities, there only has to be one market maker.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="1">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bulletin
board transactions are conducted almost entirely manually. Because there are no
automated systems for negotiating trades on the bulletin board, they are
conducted via telephone. In times of heavy market volume, the limitations of
this process may result in a significant increase in the time it takes to
execute investor orders. Therefore, when investors place market orders &#8212; an
order to buy or sell a specific number of shares at the current market price &#8212;
it is possible for the price of a stock to go up or down significantly during
the lapse of time between placing a market order and getting
execution.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Because
bulletin board stocks are usually not followed by analysts, there may be lower
trading volume than for NASDAQ-listed securities.</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT
LIABILITIES</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
78.138 of the NRS (&#8220;Section 78.138&#8221;) provides that directors and officers of
Nevada corporations may, under certain circumstances, be indemnified against
expenses (including attorneys&#8217; fees) and other liabilities actually and
reasonably incurred by them as a result of any suit brought against them in
their capacity as a director or officer, if they acted in good faith and in a
manner they reasonably believed to be in or not opposed to the best interests of
the corporation, and, with respect to any criminal action or proceeding, if they
had no reasonable cause to believe their conduct was unlawful. Section 78.138
also provides that directors and officers may also be indemnified against
expenses (including attorneys&#8217; fees) incurred by them in connection with a
derivative suit if they acted in good faith and in a manner they reasonably
believed to be in or not opposed to the best interests of the corporation,
except that no indemnification may be made without court approval if such person
was adjudged liable to the corporation.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article
XI, Section 43 of our bylaws contains provisions which require that our company
indemnify its officers, directors, employees and agents, in substantially the
same language as Section 78.7502.</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may
be permitted to the directors, officers, and controlling persons of the
registrant pursuant to the foregoing provisions, or otherwise, the registrant
has been advised that in the opinion of the Commission such indemnification is
against public policy as expressed in the Securities Act and is, therefore,
unenforceable.</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the
event that a claim for indemnification against such liabilities (other than the
payment by the small business issuer of expenses incurred or paid by a
directors, officers or controlling person of the small business issuer in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer, or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of counsel the matter has
been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1118">LEGAL OPINION</a></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
validity of the shares offered hereby has been passed upon for us by Wilson,
Haglund &amp; Paulsen, P.C.&#160;&#160;<a name="S1119" /></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXPERTS</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
consolidated financial statements included in this prospectus for the year ended
December 31, 2007 and period from November 1, 2006 (inception) to December 31,
2006 have been audited by McGladrey &amp; Pullen, LLP, an independent registered
public accounting firm, to the extent and for the periods set forth in their
report appearing elsewhere herein and are included in reliance upon such report
given upon the authority of said firm as experts in auditing and
accounting.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INERESTS
OF NAMED EXPERTS AND COUNSEL</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Christopher A. Wilson, Esq., a partner
in the law firm of Wilson, Haglund &amp; Paulsen, P.C., indirectly owns 715,000
shares of our common stock, received in exchange for his shares of HealthAmerica
common stock.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="1">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="S1120">ADDITIONAL INFORMATION</a></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We will
be subject to the reporting requirements of the Securities Exchange Act of 1934,
as amended, and will file reports, proxy statements and other information with
the SEC. These reports, proxy statements and other information may be inspected
and copied at the public reference facilities maintained by the SEC at 100 F
Street, N.E., Washington, D.C. 20549 and at the SEC&#8217;s regional offices located
at the Northwestern Atrium Center, 500 West Madison Street, Suite 1400, Chicago,
Illinois 60661 and 233 Broadway, New York, New York 10279. You can obtain copies
of these materials from the Public Reference Section of the SEC upon payment of
fees prescribed by the SEC. You may obtain information on the operation of the
Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC&#8217;s Web site
contains reports, proxy and information statements and other information
regarding registrants that file electronically with the SEC. The address of that
site is http://www.sec.gov.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have
filed a Registration Statement on Form S-1 with the SEC under the Securities Act
of 1933, as amended, with respect to the securities offered in this prospectus.
This prospectus, which is filed as part of a Registration Statement, does not
contain all of the information set forth in the Registration Statement, some
portions of which have been omitted in accordance with the SEC&#8217;s rules and
regulations. Statements made in this prospectus as to the contents of any
contract, agreement or other document referred to in this prospectus are not
necessarily complete and are qualified in their entirety by reference to each
such contract, agreement or other document which is filed as an exhibit to the
Registration Statement. The Registration Statement may be inspected without
charge at the public reference facilities maintained by the SEC, and copies of
such materials can be obtained from the Public Reference Section of the SEC at
prescribed rates. You may also obtain additional information regarding the
company on our website, located at http://www.vivakor.com.</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41</font></div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="1">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
          <div>
            <div style="MARGIN: 0in 0in 10pt; TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-pagination: none; mso-layout-grid-align: none" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold">VIVAKOR,
INC.</font></div>
            <div>&#160;</div>
            <div style="MARGIN: 6pt 0in 10pt; TEXT-ALIGN: center; mso-pagination: none; mso-layout-grid-align: none" align="center"><a name="S1121" /><a name="S1120"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Index to Financial
Statements</font></a></div>
            <div>&#160;</div>
            <div>
              <table cellpadding="0" cellspacing="0" width="100%">
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Financial
      Statements of Vivakor, Inc.</font></div>
                    </td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Report
      of Independent Registered Public Accounting Firm</font></div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-2</font></div>
                    </td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: none">Balance
      Sheets as of December 31, 2007 and December 31, 2006</font></div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-3</font></div>
                    </td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Operations for the Year Ended December 31, 2007 and Period from
      November 1, 2006 (Inception) through December 31, 2006</font></div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-4</font></div>
                    </td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Member&#8217;s Deficit for the Period from November 1, 2006 (Inception)
      through December&#160;31, 2007</font></div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-4</font></div>
                    </td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Cash Flows for the Year Ended December 31, 2007 and Period from
      November 1, 2006 (Inception) through December 31, 2006</font></div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-5</font></div>
                    </td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notes
      to the Financial Statements</font></div>
                      </div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-6</font></div>
                    </td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Unaudited
      Interim Financial Statements of Vivakor, Inc. for the nine months ended
      September 30, 2008 and 2007</font></div>
                    </td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance
      Sheets</font></div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-10</font></div>
                    </td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Operations</font></div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-11</font></div>
                    </td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Cash Flows</font></div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-12</font></div>
                    </td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="top" width="68%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="top" width="68%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notes
      to Financial Statements</font></div>
                    </td>
                    <td align="left" valign="top" width="4%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-13</font></div>
                    </td>
                  </tr>
              </table>
            </div>
            <div align="center">&#160;</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-1</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div align="center">&#160;</div>
            <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold">REPORT OF
INDEPENDENT REGISTERED </font></div>
            <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold">PUBLIC ACCOUNTING
FIRM</font></div>
          </div>
          <div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">To
the Board of Directors<br>Vivakor, Inc. (f/k/a NGI Holdings, LLC)<br>Coralville,
Iowa</div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">We
have audited the accompanying balance sheets of Vivakor, Inc. (f/k/a NGI
Holdings, LLC) as of December 31, 2007 and 2006, and the related statements of
operations, statement of member&#8217;s equity (deficit) and cash flows for the year
ending December 31, 2007 and the period from November 1, 2006 (date of
inception) to December 31, 2006. These financial statements are the
responsibility of the Company&#8217;s management. Our responsibility is to express an
opinion on these financial statements based on our audits.</div>
            <div style="MARGIN: 0in 0in 10pt">We conducted our audits in accordance with the
standards of the Public Company Accounting Oversight Board (United States).
Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.</div>
            <div style="MARGIN: 0in 0in 10pt">The accompanying financial statements have
been prepared assuming that the Company will continue as a going concern. As
discussed in Note 2 to the financial statements, the Company&#8217;s ability to become
a profitable operating company is dependent upon obtaining financing adequate to
fulfill its research and market introduction activities, and achieving a level
of revenues adequate to support the Company&#8217;s cost structure. This raises
substantial doubt about the Company's ability to continue as a going concern.
Management's plans in regard to these matters are also described in Note 2 to
the financial statements. The financial statements do not include any
adjustments that might result from the outcome of this uncertainty.</div>
            <div style="MARGIN: 0in 0in 10pt">In our opinion, the financial statements
referred to above present fairly, in all material respects, the financial
position of Vivakor, Inc. (f/k/a NGI Holdings, LLC) as of December 31, 2007 and
2006, and the results of its operations and its cash flows for the year ending
December 31, 2007 and the period from November 1, 2006 (date of inception) to
December 31, 2006, in conformity U.S. generally accepted accounting principles.
</div>
            <div>&#160;</div>
            <div>/s/ McGladrey &amp; Pullen, LLP</div>
            <div>&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">Cedar
Rapids, Iowa</div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">November
24, 2008 </div>
            <div>&#160;</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-2</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <div>&#160;</div>
            <div align="left">
              <table cellpadding="0" cellspacing="0" width="100%">
                  <tr>
                    <td colspan="8" valign="bottom">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc.</font></div>
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance
      Sheets</font></div>
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December
      31, 2007 and 2006</font></div>
                    </td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr>
                    <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Assets</font></div>
                    </td>
                    <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
                    </td>
                    <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>
                    </td>
                    <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current
      assets</font></div>
                    </td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      current assets</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      assets</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Liabilities
      and Member's&#160;&#160;Equity (Deficit)</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current
      liabilities</font></div>
                    </td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount
      payable to member</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,500</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts
      payable</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,000</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Total
      current liabilities</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,500</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Member's
      equity (deficit):</font></div>
                    </td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated
      deficit</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,500</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      member's&#160;&#160;equity (deficit)</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,500</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      liabilities and member's equity (deficit)</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
              </table>
            </div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">See
Notes to Financial Statements.</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-3</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <div>&#160;</div>
            <div align="left">
              <table cellpadding="0" cellspacing="0" width="100%">
                  <tr>
                    <td colspan="8" valign="bottom">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc.</font></div>
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Operations</font></div>
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Year
      ended December 31, 2007 and period from November 1, 2006
      (inception)</font></div>
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">through
      December 31, 2006</font></div>
                    </td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr>
                    <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
                    </td>
                    <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>
                    </td>
                    <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating
      Expenses</font></div>
                    </td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">General
      and administrative</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,500</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating
      loss and loss before income tax</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,500</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      (loss)</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,500</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
              </table>
            </div>
            <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">See Notes
to Financial Statements.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
              <div align="left">
                <table cellpadding="0" cellspacing="0" width="100%">
                    <tr>
                      <td colspan="4" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc.</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Member's Deficit</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Period
      from November 1, 2006 (inception) through December 31,
2007</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="88%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance,
      November 1, 2006 (inception)</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Activity
      in 2006</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="88%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance,
      December 31, 2006</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      loss</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,500</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance,
      December 31, 2007</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,500</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                    </tr>
                </table>
              </div>
            </div>
            <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">See Notes
to Financial Statements.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-4</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>&#160;

            <div align="left">
              <table cellpadding="0" cellspacing="0" width="100%">
                  <tr>
                    <td colspan="8" valign="bottom">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc.</font></div>
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Cash Flows</font></div>
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Year
      ended December 31, 2007 and period from November 1, 2006
      (inception)</font></div>
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">through
      December 31, 2006</font></div>
                    </td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr>
                    <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
                    </td>
                    <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2006</font></div>
                    </td>
                    <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating
      Activities</font></div>
                    </td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      loss</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,500</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Adjustments
      to reconcile net loss to net cash provided</font></div>
                    </td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">by
      operating activities:</font></div>
                    </td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Changes
      in operating assets and liabilities:</font></div>
                    </td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount
      payable to member</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,500</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts
      payable</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,000</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      cash provided by operating activities</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      change in cash</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="white">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash,
      beginning of period</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
                  <tr bgcolor="#eeeeee">
                    <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash,
      end of period</font></div>
                    </td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                    <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                    <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  </tr>
              </table>
            </div>
          </div>
          <div>
            <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">See
Notes to Financial Statements.</font></div>
            <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">&#160;</div>
              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                <div id="FTR">
                  <div id="GLFTR" style="WIDTH: 100%" align="left">
                  </div>
                </div>
                <div id="PN" style="PAGE-BREAK-AFTER: always">
                  <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-5</font></div>
                  <div style="WIDTH: 100%; TEXT-ALIGN: center">
                    <hr style="COLOR: black" noshade size="1">
                  </div>
                </div>
                <div id="HDR">
                  <div id="GLHDR" style="WIDTH: 100%" align="right">
                  </div>
                </div>
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div>
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES
TO FINANCIAL STATEMENTS</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">December
31, 2007 and 2006</font></div>
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div>
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Organization
and Business</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Vivakor,
Inc. (the &#8220;Company&#8221;) is a Nevada corporation based in Coralville, Iowa and is a
transdisciplinary biomedical company involved in the discovery, development and
commercialization of a broad range of medical devices and pharmaceuticals to
improve human health. The Company also performs contract research and
development in molecular biology and devices engineering. The Company was
originally organized as Genecular Holdings LLC, a Nevada limited liability
company on November 1, 2006. On November 3, 2006, the Company changed the name
to NGI Holdings, LLC.&#160;&#160;On April 30, 2008, the limited liability
company was converted into a Nevada corporation and changed its name to Vivakor,
Inc.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of the
second quarter 2008, the Company reached operating stage. Therefore, these
financial statements have been prepared as an operating stage company rather
than a development stage company.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Summary
of Significant Accounting Policies</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Basis
of Presentation and Management&#8217;s Plan</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
accompanying financial statements have been prepared assuming that the Company
will continue as a going concern. This basis of accounting contemplates the
recovery of the Company&#8217;s assets and the satisfaction of its liabilities in the
normal course of business. Since inception, the Company has been engaged in
organizational activities, including recruiting personnel and establishing
office facilities; research and development; and obtaining financing. The
Company&#8217;s ability to become a profitable operating company is dependent upon
obtaining financing adequate to fulfill its research and market introduction
activities, and achieving a level of revenues adequate to support the Company&#8217;s
cost structure. Management intends to finance research and market introduction
primarily from future equity financings and proceeds from research and
development services provided to others. However, there can be no assurance that
the Company will be able to obtain such financing, which may impact the
Company&#8217;s ability to continue as a going concern. The accompanying financial
statements do on included any adjustments to reflect the possible future effects
on the recoverability and classification of assets or the amounts and
classification of liabilities that may result from the possible inability of the
Company to continue as a going concern.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Use
of Estimates</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the amounts reported in the consolidated
financial statements and accompanying notes. Actual results could differ from
those estimates.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Member&#8217;s
Equity (Deficit)</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Vivakor,
Inc. is a perpetual limited liability company. The Company has one member with
100% ownership and no units issued.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                  <div id="FTR">
                    <div id="GLFTR" style="WIDTH: 100%" align="left">
                    </div>
                  </div>
                  <div id="PN" style="PAGE-BREAK-AFTER: always">
                    <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-6</font></div>
                    <div style="WIDTH: 100%; TEXT-ALIGN: center">
                      <hr style="COLOR: black" noshade size="1">
                    </div>
                  </div>
                  <div id="HDR">
                    <div id="GLHDR" style="WIDTH: 100%" align="right">
                    </div>
                  </div>
                </div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">
                  <div>
                    <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES
TO FINANCIAL STATEMENTS</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">December
31, 2007 and 2006</font></div>
                    <div>
                      <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                    </div>
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">&#160;</div>
                </div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Summary
of Significant Accounting Policies (Continued)</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Cash
and Cash Equivalents</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Company considers all highly liquid investments with an original maturity of
less than three months when purchased to be cash equivalents.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Income
Taxes</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a
limited liability company, the Company&#8217;s taxable loss is allocated to the
members in accordance with their respective percentage ownership interests.
Therefore, no credit or tax asset related to income tax matters has been
included in the financial statements.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Recently
Issued Accounting Standards</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In June
2006, the FASB issued Interpretation No. 48, of FIN 48, <font style="DISPLAY: inline; FONT-STYLE: italic">Accounting for Uncertainty in Income
Taxes &#8211; an Interpretation of FAS 109. </font>FIN 48 provides clarification for
the financial statement measurement and recognition of tax positions that are
taken or expected to be taken in a tax return. The Company adopted FIN 48
effective January&#160;1, 2007. The adoption had no impact on the financial
statements for the year ended December 31, 2007.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
September 2006, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued SFAS
No. 157, <font style="DISPLAY: inline; FONT-STYLE: italic">Fair Value
Measurements.</font> SFAS No. 157 establishes a framework for measuring fair
value in generally accepted accounting principles (&#8220;GAAP&#8221;), and expands
disclosures about fair value measurements. This Statement is effective for
financial statements for fiscal years beginning after November 15, 2007, and
interim periods within those fiscal years. Management does not expect the
adoption of SFAS No. 157 to have a material impact on its financial
statements.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
December 2007, the FASB issued SFAS No. 141 (revised 2007), <font style="DISPLAY: inline; FONT-STYLE: italic">Business Combinations </font>(&#8220;FAS
141R&#8221;), which replaces FASB Statement No. 141. FAS 141R establishes principles
and requirements for how an acquirer recognizes and measures in its financial
statements the identifiable assets acquired, the liabilities assumed, any
noncontrolling interest in the acquiree and the goodwill acquired. The statement
also establishes disclosure requirements which will enable users to evaluate the
nature and financial effects of the business combination. FAS 141R is effective
as of the beginning of an entity&#8217;s fiscal year that begins after December 15,
2008, which will be the Company&#8217;s year beginning January 1, 2009. The Company is
currently evaluating the potential impact, if any, of the adoption of FAS 141R
on its financial statements.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
December 2007, the FASB issued SFAS No. 160, <font style="DISPLAY: inline; FONT-STYLE: italic">Noncontrolling Interests in
Consolidated Financial Statements &#8211; amendments of ARB No. 51 (&#8220;FAS 160&#8221;).
</font>FAS 160 states that accounting and reporting for minority interests will
be recharacterized as noncontrolling interests and classified as a component of
equity. The Statement also establishes reporting requirements that provide
sufficient disclosures that clearly identify and distinguish between the
interests of the parent and the interests of the noncontrolling owners. FAS 160
applies to all entities that prepare consolidated financial statements, except
for not-for-profit organizations, but will affect only those entities that have
an outstanding noncontrolling interest in one or more subsidiaries or that
deconsolidate a subsidiary. This statement is effective as of the beginning of
an entity&#8217;s first fiscal year beginning after December 15, 2008, which
corresponds to the Company&#8217;s year beginning January 1, 2009. The Company does
not expect the adoption of SFAS No. 160 to have a material effect on its
financial statements.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                  <div id="FTR">
                    <div id="GLFTR" style="WIDTH: 100%" align="left">
                    </div>
                  </div>
                  <div id="PN" style="PAGE-BREAK-AFTER: always">
                    <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-7</font></div>
                    <div style="WIDTH: 100%; TEXT-ALIGN: center">
                      <hr style="COLOR: black" noshade size="1">
                    </div>
                  </div>
                  <div id="HDR">
                    <div id="GLHDR" style="WIDTH: 100%" align="right">
                    </div>
                  </div>
                </div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
                  <div>
                    <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES
TO FINANCIAL STATEMENTS</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">December
31, 2007 and 2006</font></div>
                    <div>
                      <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                    </div>
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">&#160;</div>
                </div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other
recent accounting pronouncements issued by the FASB (including its Emerging
Issues Task Force) and the AICPA do not or are not believed by management to
have a material impact on the Company&#8217;s present or future financial
statements.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related
Party Transactions</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
2007, the founding member incurred certain costs on behalf of the Company and
provided certain consulting and advisory services all aggregating
$18,500.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent
Events</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In March
2008, the Company hired 6 employees; a number of which were granted membership
interests aggregating less than 1%. The membership interests were valued at
$120, which was recorded as compensation expense.&#160;&#160;As noted below,
these interests were converted into 120,000 common shares (291,000 post-split)
upon the Company&#8217;s conversion from an LLC to a corporation</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
connection with the Company&#8217;s conversion from a limited liability company to a
corporation on April 30, 2008, the Company issued 44,862,500 (post-split) shares
of common stock to the founding member and the founding member forgave the
$18,500 liability it was owed at December 31, 2007. The Company also issued
291,000 (post-split) shares to certain employees, based on their respective
percentage interests prior to conversion. Upon the conversion, the Company had
authorized 100,000,000 common shares and 10,000,000 preferred shares. Effective
September 5, 2008, the Company increased its authorized common shares to
242,500,000 shares and effectuated a stock split such that 2.425 common shares
were issued in exchange for each common share outstanding.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Company adopted a defined contribution 401(k) plan (the &#8220;Plan&#8221;) covering
substantially all employees that meet certain age and service requirements.
Employees may contribute up to 80% of their compensation per year (subject to a
maximum limit by federal law). The Plan allows for employer matching; however,
no employer matching or other contributions have been made.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On June
30, 2008, the Company purchased office and lab furniture and equipment from a
stockholder at a total cost of $87,450. The stockholder financed the equipment
with a note agreement that that is secured by the assets purchased. The note
bears interest at 14% per annum and is due on December 31, 2008. In the event
the Company is unable to repay the note when it matures, the note holder has the
option to be repaid with common stock with piggyback registration rights. The
number of shares to be issued would be equal to the outstanding principal plus
accrued and unpaid interest divided by 80% of the average stock price 30 days
prior to maturity.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On July
10, 2008, the Company entered into a lease for approximately 3,000 square feet
of office and lab space. The lease commences on the later of August 1, 2008 or
completion of specified tenant improvements and requires the Company make a
$2,500 payment for tenant improvements upon move in, and monthly lease payments
of $3,700 through July 10, 2010.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Between
April 30, 2008 and October 21, 2008, the Company issued 133,000 shares of common
stock at $0.50 per share for aggregate gross proceeds of $66,500.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                  <div id="FTR">
                    <div id="GLFTR" style="WIDTH: 100%" align="left">
                    </div>
                  </div>
                  <div id="PN" style="PAGE-BREAK-AFTER: always">
                    <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-8</font></div>
                    <div style="WIDTH: 100%; TEXT-ALIGN: center">
                      <hr style="COLOR: black" noshade size="1">
                    </div>
                  </div>
                  <div id="HDR">
                    <div id="GLHDR" style="WIDTH: 100%" align="right">
                    </div>
                  </div>
                </div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">
                  <div>
                    <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES
TO FINANCIAL STATEMENTS</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">December
31, 2007 and 2006</font></div>
                    <div>
                      <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                    </div>
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">&#160;</div>
                </div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;&#160;&#160;&#160;&#160;Subsequent
Events (Continued)</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
September 2008, the Board of Directors authorized management to sell up to
$5,000,000 in the Company&#8217;s capital stock. Management subsequently commenced
activities to sell the stock, including signing agreements with various parties
to assist in fund raising efforts. The agreements require the Company to pay
these parties certain referral or other success fees based on the funds
raised.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
October 1, 2008, the Company received notice from the Iowa Department of
Economic Development that it has been awarded a $150,000 Demonstration Fund
Grant to assist in the development and commercialization of its CryoVial,
CryoKeeper and CryoCarrier products. Under the terms of the grant, the Company
will receive $2 in grant funds for every $1 in specified expenditures made by
the Company. In the event certain events occur, the Company would be required to
repay the grant proceeds received plus interest at 6%.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
October 20, 2008 the Company effectively acquired the assets of HealthAmerica,
Inc. (&#8220;HealthAmerica&#8221;), a corporation organized under the laws of the state of
Nevada. HealthAmerica has a patented and FDA approved MRI technology as well as
a patented medical Bar-coding technology that the Company plans to develop and
commercialize. The asset price consisted of 5,000,000 common shares of Vivakor
plus a nonrecourse promissory note in the amount of $1,500,000; currently
Vivakor owns approximately 84% of the share capital of HealthAmerica. The note,
secured by the acquired HealthAmerica stock and all of HealthAmerica&#8217;s assets,
bears interest at 4% per annum and requires the Company to make monthly payments
of $25,000. In addition, every 90 days, the Company is required to make
additional note payments equal to 10% of the gross proceeds received from any
sales of equity or debt securities, or any sale or licensing of products or
technology until all outstanding principal and interest are repaid. As of
November 19, 2008, the Company was $75,000 in arrears in monthly payments under
the note. Certain officers and directors of the Company had beneficial interests
in HealthAmerica&#8217;s common stock prior to the acquisition. On an annual basis,
the Company will evaluate whether there is any impairment of the acquired
HealthAmerica assets and, if so, future impairment charges may need to be
recorded.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">&#160;</div>
            </div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-9</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div style="MARGIN: 0in 0in 10pt">&#160;</div>
            <div>
              <div align="left">
                <table cellpadding="0" cellspacing="0" width="100%">
                    <tr>
                      <td colspan="8" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc.</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance
      Sheets</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September
      30, 2008 and December 31, 2007</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September
      30,</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December
      31,</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Unaudited)</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Assets</font></div>
                      </td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current
      assets</font></div>
                      </td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash
      and cash equivalents</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,400</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deposits</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28,700</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      current assets</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35,100</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equipment,
      furniture and leasehold improvements, net</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">119,421</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deferred
      offering costs</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,000</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      assets</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">159,521</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Liabilities
      and Stockholders' Equity</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current
      liabilities</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts
      payable</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12,638</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,000</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accrued
      wages and related expenses</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">184,793</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Advances
      payable to officer</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,461</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount
      payable to stockholder/member</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">96,630</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,500</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Note
      payable to stockholder</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">90,572</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      current liabilities</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">404,094</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,500</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Commitments
      (Note 3)</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stockholders'
      / member's&#160;&#160;equity (deficit):</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Preferred
      stock, $.001 par value; 10,000,000 shares</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">in
      2008 and none in 2007 authorized ; none issued and
    outstanding</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common
      stock, $.001 par value; 242,500,000 shares</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;in
      2008 and none in 2007 authorized; 45,203,875 shares in
2008</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">and
      none in 2007, issued and outstanding</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45,204</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Additional
      paid-in capital</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23,336</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Retained
      deficit</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(313,113</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,500</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      stockholders'/member's equity (deficit)</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(244,573</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20,500</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      liabilities and stockholders'/member's equity (deficit)</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">159,521</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                </table>
              </div>
            </div>
            <div>&#160;</div>
            <div>See Notes to Financial Statements.</div>
            <div>&#160;</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-10</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div>&#160;</div>
            <div>
              <div align="left">
                <table cellpadding="0" cellspacing="0" width="100%">
                    <tr>
                      <td colspan="8" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc.</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Operations</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For
      the Nine Months Ended September 30, 2008 and 2007</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td colspan="8" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="6" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nine
      Months</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="6" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ended
      September 30,</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(unaudited)</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research
      Revenue</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">194,700</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating
      Expenses</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost
      of services</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">122,321</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research
      and development</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">197,669</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">General
      and administrative</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">164,201</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total
      operating expenses</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">484,191</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss
      from operations</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(289,491</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest
      expense</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,122</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating
      loss and loss before income tax</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(292,613</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income
      taxes</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      loss</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(292,613</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss
      per share:</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic
      and diluted</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.006</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">n/a</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted
      average shares - Basic and diluted</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45,066,903</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">n/a</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                </table>
              </div>
            </div>
            <div>
              <div>&#160;</div>
              <div>See Notes to Financial Statements.</div>
              <div>&#160;</div>
              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                <div id="FTR">
                  <div id="GLFTR" style="WIDTH: 100%" align="left">
                  </div>
                </div>
                <div id="PN" style="PAGE-BREAK-AFTER: always">
                  <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-11</font></div>
                  <div style="WIDTH: 100%; TEXT-ALIGN: center">
                    <hr style="COLOR: black" noshade size="1">
                  </div>
                </div>
                <div id="HDR">
                  <div id="GLHDR" style="WIDTH: 100%" align="right">
                  </div>
                </div>
              </div>
              <div>&#160;</div>
            </div>
            <div>
              <div align="left">
                <table cellpadding="0" cellspacing="0" width="100%">
                    <tr>
                      <td colspan="8" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc.</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statements
      of Cash Flows</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For
      the Nine Months ended September 30, 2008 and 2007</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td colspan="8" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="6" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nine
      Months</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="6" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ended
      September 30,</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2007</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(unaudited)</font></div>
                      </td>
                      <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating
      Activities</font></div>
                      </td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      loss</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(292,613</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Depreciation
      and amortization</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,760</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock
      compensation expense</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">95</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest
      added to note payable to stockholder</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,122</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Adjustments
      to reconcile net loss to net cash used</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">in
      operating activities:</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Changes
      in operating assets and liabilities:</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Deposits</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(28,700</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accounts
      payable</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,638</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accrued
      wages and related expenses</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">184,793</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Advances
      payable to officer</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,461</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amount
      payable to stockholder</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">96,630</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      cash provided by operating activities</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,186</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Investing&#160;&#160;activities</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchases
      of fixed assets</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(127,181</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      cash (used in) investing activities</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(127,181</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financing
      activities</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Payment
      of deferred offering costs</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5,000</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds
      from note payable to stockholder</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">87,450</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      proceeds from sale of common stock</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">49,945</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      cash provided by operating activities</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">132,395</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net
      increase in cash and cash equivalents</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,400</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beginning
      of period</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">End
      of period</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,400</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td align="left" valign="bottom" width="76%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Noncash
      transactions:</font></div>
                      </td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issuance
      of shares to founder as payment of amount due</font></div>
                      </td>
                      <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,500</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                </table>
              </div>
            </div>
            <div style="MARGIN: 0in 0in 10pt; mso-pagination: none; mso-layout-grid-align: none">
            </div>
            <div>
              <div>
                <div>See Notes to Financial Statements.</div>
                <div>&#160;</div>
                <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                  <div id="FTR">
                    <div id="GLFTR" style="WIDTH: 100%" align="left">
                    </div>
                  </div>
                  <div id="PN" style="PAGE-BREAK-AFTER: always">
                    <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-12</font></div>
                    <div style="WIDTH: 100%; TEXT-ALIGN: center">
                      <hr style="COLOR: black" noshade size="1">
                    </div>
                  </div>
                  <div id="HDR">
                    <div id="GLHDR" style="WIDTH: 100%" align="right">
                    </div>
                  </div>
                </div>
              </div>
            </div>
            <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

              <div>
                <hr style="COLOR: black" align="left" noshade size="1" width="100%">
              </div>
            </div>
            <div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
              </div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES
TO FINANCIAL STATEMENTS</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Nine
Months ended September 30, 2008 and 2007</font></div>
              </div>
              <div>
                <hr style="COLOR: black" align="center" noshade size="1" width="100%">
              </div>
            </div>
            <div>&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in"><font style="DISPLAY: inline; FONT-WEIGHT: bold">1.&#160;&#160;&#160;&#160;
Organization and Business</font></div>
            <div style="MARGIN: 0in 0in 10pt">Vivakor, Inc. (the &#8220;Company&#8221;) is a Nevada
corporation based in Coralville, Iowa and is a trans-disciplinary biomedical
company involved in the discovery, development and commercialization of a broad
range of medical devices and pharmaceuticals to improve human health. The
Company also performs contract research and development in molecular biology and
devices engineering. The Company was originally organized as Genecular Holdings
LLC, a Nevada limited liability company on November 1, 2006. On November 2,
2006, the Company changed its name to NGI Holdings, LLC. On April 30, 2008, the
limited liability company was converted into a Nevada corporation and changed
its name to Vivakor, Inc.</div>
            <div style="MARGIN: 0in 0in 10pt">As of the second quarter 2008, the Company
reached operating stage. Therefore, these financial statements have been
prepared as an operating stage company rather than a development stage
company.</div>
            <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in"><font style="DISPLAY: inline; FONT-WEIGHT: bold">2.&#160;&#160;&#160;&#160; Summary of
Significant Accounting Policies</font></div>
            <div style="MARGIN: 0in 0in 10pt"><font style="DISPLAY: inline; FONT-STYLE: italic"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Basis of Presentation and
Management&#8217;s Plan</font></font></div>
            <div style="MARGIN: 0in 0in 10pt">The accompanying unaudited interim condensed
financial statements have been prepared in accordance with accounting principles
generally accepted in the United States for interim financial information and
the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by accounting
principles generally accepted in the United States for complete financial
statements. In the opinion of management, all adjustments (consisting only of
normal recurring accruals) considered necessary for a fair presentation have
been included. Operating results for the nine-month period ended
September&#160;30, 2008 are not necessarily indicative of the results that may
be expected for the full fiscal year. For further information, refer to the
Company&#8217;s financial statements and notes thereto for the fiscal year ended
December&#160;31, 2007.</div>
            <div style="MARGIN: 0in 0in 10pt">The accompanying financial statements have
been prepared assuming that the Company will continue as a going concern. This
basis of accounting contemplates the recovery of the Company&#8217;s assets and the
satisfaction of its liabilities in the normal course of business. Since<font style="DISPLAY: inline; FONT-WEIGHT: bold"> </font>inception, the Company has
been engaged in organizational activities, including recruiting personnel and
establishing office facilities; research and development; and obtaining
financing. The Company&#8217;s ability to become a profitable operating company is
dependent upon obtaining financing adequate to fulfill its research and market
introduction activities, and achieving a level of revenues adequate to support
the Company&#8217;s cost structure. Management intends to finance research and market
introduction primarily from future equity financings and proceeds from research
and development services provided to others. However, there can be no assurance
that the Company will be able to obtain such financing, which may affect the
Company&#8217;s ability<font style="DISPLAY: inline; FONT-WEIGHT: bold"> </font>to
continue as a going concern. The accompanying financial statements do not
include any adjustments to reflect the possible future effects on the
recoverability and classification of assets or the amounts and classification of
liabilities that may result from the possible inability of the Company to
continue as a going concern.</div>
            <div style="MARGIN: 0in 0in 10pt"><font style="DISPLAY: inline; FONT-STYLE: italic"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Cash and Cash Equivalents
</font></font></div>
            <div style="MARGIN: 0in 0in 10pt">The Company considers all highly liquid
short-term investments with maturities of less than three months when acquired
to be cash equivalents.</div>
            <div style="MARGIN: 0in 0in 10pt"><font style="DISPLAY: inline; FONT-STYLE: italic"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Equipment, Furniture and Leasehold
Improvements</font></font></div>
            <div style="MARGIN: 0in 0in 10pt">Equipment, furniture and leasehold
improvements are recorded at cost and depreciated on a straight-line basis over
the lesser of their estimated useful lives, ranging from three to seven years,
or the life of the lease, as appropriate.</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-13</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div>
              <div>
                <hr style="COLOR: black" align="left" noshade size="1" width="100%">
              </div>
              <div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
                </div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES
TO FINANCIAL STATEMENTS</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Nine
Months ended September 30, 2008 and 2007</font></div>
                </div>
                <div>
                  <hr style="COLOR: black" align="center" noshade size="1" width="100%">
                </div>
              </div>
              <div>&#160;</div>
            </div>
            <div>
              <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in"><font style="DISPLAY: inline; FONT-WEIGHT: bold">2.&#160;&#160;&#160;&#160; Summary of
Significant Accounting Policies (Continued)</font></div>
              <div style="MARGIN: 0in 0in 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-STYLE: italic">Impairment of Long-Lived Assets
</font></font></div>
              <div>&#160;</div>
              <div style="BACKGROUND: white; MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal">Long-lived
assets are reviewed for impairment whenever events or changes in circumstances
indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the
carrying amount of the assets to the future net cash flows expected to be
generated by such assets. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the carrying
amount of the assets exceeds the discounted expected future net cash flows from
the assets. </div>
              <div>&#160;</div>
              <div style="MARGIN: 0in 0in 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-STYLE: italic">Revenue
Recognition</font></font></div>
              <div>&#160;</div>
              <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal">The Company recognizes
revenue when all four of the following criteria are met: (i)&#160;persuasive
evidence that an arrangement exists; (ii)&#160;delivery of the products and/or
services has occurred; (iii)&#160;the fees earned can be readily determined; and
(iv)&#160;collectibility of the fees is reasonably assured. The Company
recognizes revenue from research contracts as services are performed under the
agreements.</div>
              <div>&#160;</div>
              <div style="MARGIN: 0in 0in 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-STYLE: italic">Research and Development and Patent
Costs </font></font></div>
              <div>&#160;</div>
              <div style="BACKGROUND: white; MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal">All
research and development costs, including all related salaries, clinical trial
expenses, regulatory expenses and facility costs are charged to expense when
incurred. Expenditures related to obtaining and protecting patents are also
charged to expense when incurred, and are included in research and development
expense. </div>
              <div>&#160;</div>
              <div style="MARGIN: 0in 0in 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-STYLE: italic">Loss Per Common
Share</font></font></div>
              <div style="MARGIN: 0in 0in 0pt">&#160;</div>
              <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal">Basic net loss per share
is calculated by dividing the net loss by the weighted-average number of common
shares outstanding for the period, without consideration for common stock
equivalents. Diluted net loss per common share is computed by dividing the net
loss by the weighted-average number of common share equivalents outstanding for
the period determined using the treasury-stock method if their effect is
dilutive. </div>
              <div>&#160;</div>
              <div style="BACKGROUND: white; MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-STYLE: italic">Income Taxes</font></font></div>
              <div>&#160;</div>
              <div style="BACKGROUND: white; MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal">The
Company uses the liability method of accounting for income taxes as
requir&lt;?xml:namespace prefix = st1 ns =
"urn:schemas-microsoft-com:office:smarttags" /&gt;ed by SFAS&#160;No.&#160;109,
<font style="DISPLAY: inline; FONT-STYLE: italic">Accounting for Income
Taxes.</font> Under this method, deferred tax assets and liabilities are
determined based on the difference between the financial reporting and the tax
reporting basis of assets and liabilities and are measured using the enacted tax
rates and laws that are expected to be in effect when the differences are
expected to reverse. The Company provides a valuation allowance against net
deferred tax assets unless, based upon the available evidence, it is more likely
than not that the deferred tax assets will be realized. </div>
              <div>&#160;</div>
              <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; tab-stops: .25in"><font style="DISPLAY: inline; FONT-WEIGHT: bold">3.&#160;&#160;&#160;&#160;
Commitments</font></div>
              <div>&#160;</div>
              <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal">On July 10, 2008, the
Company entered into a lease for approximately 3,000 square feet of office and
lab space. The lease commenced on August 1, 2008 and required the Company make a
$2,500 payment for tenant improvements and monthly lease payments of $3,700
through July 10, 2010.</div>
              <div>&#160;</div>
              <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in"><font style="DISPLAY: inline; FONT-WEIGHT: bold">4.&#160;&#160;&#160;&#160; Equity
Transactions</font></div>
              <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in">The Board of Directors
authorized a 2.425 for 1 stock split for shareholders of record on September 5,
2008. All references in the financial statements and notes to financial
statements to number of shares and per share amounts have been restated to
reflect the increased number of shares outstanding.</div>
              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                <div id="FTR">
                  <div id="GLFTR" style="WIDTH: 100%" align="left">
                  </div>
                </div>
                <div id="PN" style="PAGE-BREAK-AFTER: always">
                  <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-14</font></div>
                  <div style="WIDTH: 100%; TEXT-ALIGN: center">
                    <hr style="COLOR: black" noshade size="1">
                  </div>
                </div>
                <div id="HDR">
                  <div id="GLHDR" style="WIDTH: 100%" align="right">
                  </div>
                </div>
              </div>
              <div style="MARGIN: 0in 0in 10pt">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div>
                <div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES
TO FINANCIAL STATEMENTS</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Nine
Months ended September 30, 2008 and 2007</font></div>
                  </div>
                  <div>
                    <hr style="COLOR: black" align="center" noshade size="1" width="100%">
                  </div>
                </div>
                <div>&#160;</div>
                <div>In March 2008 the Company hired six employees, a number of which were
granted membership interests aggregating less than 1%. The aggregate of these
membership interests was valued at $120, which was recorded as compensation
expense in March 2008. </div>
              </div>
              <div style="MARGIN: 0in 0in 10pt">In connection with the Company&#8217;s conversion
from a limited liability Company to a corporation on April 30, 2008, the Company
issued 44,862,500 shares of common stock to the founding member and issued
291,000 shares to certain employees, based on their respective percentage
interests prior to conversion. </div>
              <div style="MARGIN: 0in 0in 10pt">Between April 30, 2008 and September 30, 2008,
the Company issued 111,000 shares of common stock at $0.50 per share for
aggregate gross proceeds of $55,500. </div>
              <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in"><font style="DISPLAY: inline; FONT-WEIGHT: bold">5.&#160;&#160;&#160;&#160; Benefit
Plan</font></div>
              <div style="MARGIN: 0in 0in 10pt">The Company adopted a defined contribution
401(k) plan (the &#8220;Plan&#8221;) covering substantially all employees that meet certain
age and service requirements. Employees may contribute up to 80% of their
compensation per year (subject to a maximum limit by federal law). The Plan
allows for employer matching; however, no employer matching or other
contributions have been made.</div>
              <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in"><font style="DISPLAY: inline; FONT-WEIGHT: bold">6.&#160;&#160;&#160;&#160; Related
Party Transaction</font></div>
              <div style="MARGIN: 0in 0in 10pt">On June 30, 2008, the Company purchased office
and lab furniture and equipment from a stockholder at a total cost of $87,450.
The stockholder financed the equipment with a note agreement that that is
secured by the assets purchased. The note bears interest at 14% per annum and is
due on December 31, 2008. In the event the Company is unable to repay the note
when it matures, the note holder has the option to be repaid with common stock
with piggyback registration rights. The number of shares to be issued would be
equal to the outstanding principal plus accrued and unpaid interest divided by
80% of the average stock price 30 days prior to maturity. Interest expense
during the three and nine months ended September 30, 2008, each totaled $3,122
and was added to the note balance.</div>
              <div style="MARGIN: 0in 0in 10pt">The amount payable to officer at September 30,
2008 is noninterest bearing and represents Company expenditures (primarily
including lab and office equipment and supplies) that were paid for directly by
the officer on behalf of the Company for which the officer has not been
reimbursed.</div>
              <div style="MARGIN: 0in 0in 10pt">The amount payable to stockholder at September
30, 2008 is noninterest bearing and represents Company expenditures (primarily
including payroll, legal fees, lab and office equipment and supplies) that were
paid for directly by the stockholder on behalf of the Company for which the
stockholder has not been reimbursed.</div>
              <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in"><font style="DISPLAY: inline; FONT-WEIGHT: bold">7.&#160;&#160;&#160;&#160; Income
Taxes</font></div>
              <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in">The Company uses the
liability method of accounting for income taxes as set forth in Statement of
Financial Accounting Standards No.&#160;109, &#8220;Accounting for Income Taxes&#8221;
(&#8220;SFAS 109&#8221;). Under the liability method, deferred taxes are determined based on
differences between the financial statement and tax bases of assets and
liabilities using enacted tax rates. As of September&#160;30, 2008, the Company
had deferred tax assets of approximately $116,000, resulting primarily from net
operating loss carryforwards A valuation allowance of $116,000 has been
established against the Company&#8217;s deferred tax assets as realization of such
assets is uncertain due to continuing net operating losses.</div>
              <div style="MARGIN: 0in 0in 10pt; tab-stops: .25in"><font style="DISPLAY: inline; FONT-WEIGHT: bold">8.&#160;&#160;&#160;&#160; Subsequent
Events</font></div>
              <div style="MARGIN: 0in 0in 10pt">In September 2008, the Board of Directors
authorized management to sell up to $5,000,000 in the Company&#8217;s capital stock.
Management subsequently commenced activities to sell the stock, including
signing agreements with various parties to assist in fund raising efforts. The
agreements require the Company to pay these parties certain referral or other
success fees based on the funds raised.</div>
              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                <div id="FTR">
                  <div id="GLFTR" style="WIDTH: 100%" align="left">
                  </div>
                </div>
                <div id="PN" style="PAGE-BREAK-AFTER: always">
                  <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-15</font></div>
                  <div style="WIDTH: 100%; TEXT-ALIGN: center">
                    <hr style="COLOR: black" noshade size="1">
                  </div>
                </div>
                <div id="HDR">
                  <div id="GLHDR" style="WIDTH: 100%" align="right">
                  </div>
                </div>
              </div>
              <div style="MARGIN: 0in 0in 10pt">
                <div>
                  <hr style="COLOR: black" align="left" noshade size="1" width="100%">
                </div>
                <div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
                  </div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES
TO FINANCIAL STATEMENTS</font></div>
                  <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Nine
Months ended September 30, 2008 and 2007</font></div>
                  </div>
                  <div>
                    <hr style="COLOR: black" align="center" noshade size="1" width="100%">
                  </div>
                </div>
                <div>&#160;</div>
                <div>Subsequent to September 30, 2008, the Company issued 22,000 shares of
common stock at $0.50 per share for aggregate gross proceeds of $11,000.
</div>
              </div>
              <div style="MARGIN: 0in 0in 10pt">On October 1, 2008, the Company received
notice from the Iowa Department of Economic Development that it has been awarded
a $150,000 Demonstration Fund Grant to assist in the development and
commercialization of its CryoVial, CryoKeeper and CryoCarrier products. Under
the terms of the grant, the Company will receive $2 in grant funds for every $1
in specified expenditures made by the Company. In the event certain events
occur, the Company would be required to repay the grant proceeds received plus
interest at 6%.</div>
              <div style="MARGIN: 0in 0in 10pt">On October 20, 2008 the Company effectively
acquired the assets of HealthAmerica, Inc. (&#8220;HealthAmerica&#8221;), a corporation
organized under the laws of the state of Nevada. HealthAmerica has a patented
and FDA approved MRI technology as well as a patented medical Bar-coding
technology that the Company plans to develop and commercialize. The asset price
consisted of 5,000,000 common shares of Vivakor plus a nonrecourse promissory
note in the amount of $1,500,000; currently Vivakor owns approximately 84% of
the share capital of HealthAmerica. The note, secured by the acquired
HealthAmerica stock and all of HealthAmerica&#8217;s assets, bears interest at 4% per
annum and requires the Company to make monthly payments of $25,000. In addition,
every 90 days, the Company is required to make additional note payments equal to
10% of the gross proceeds received from any sales of equity or debt securities,
or any sale or licensing of products or technology until all outstanding
principal and interest are repaid. As of November 19, 2008, the Company was
$75,000 in arrears in monthly payments under the note. Certain officers and
directors of the Company had beneficial interests in HealthAmerica&#8217;s common
stock prior to the acquisition. On an annual basis, the Company will evaluate
whether there is any impairment of the acquired HealthAmerica assets and, if so,
future impairment charges may need to be recorded. </div>
              <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                <div id="FTR">
                  <div id="GLFTR" style="WIDTH: 100%" align="left">
                  </div>
                </div>
                <div id="PN" style="PAGE-BREAK-AFTER: always">
                  <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-16</font></div>
                  <div style="WIDTH: 100%; TEXT-ALIGN: center">
                    <hr style="COLOR: black" noshade size="1">
                  </div>
                </div>
                <div id="HDR">
                  <div id="GLHDR" style="WIDTH: 100%" align="right">
                  </div>
                </div>
              </div>
            </div>
            <div>&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-pagination: none; mso-layout-grid-align: none">
              <div>
                <hr style="COLOR: black" align="left" noshade size="1" width="100%">
              </div>
            </div>
            <div style="MARGIN: 0in 0in 10pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-pagination: none; mso-layout-grid-align: none"><font style="DISPLAY: inline; FONT-WEIGHT: bold">PART II &#8212; INFORMATION NOT REQUIRED IN
PROSPECTUS</font></div>
            <div style="MARGIN: 0in 0in 10pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-pagination: none; mso-layout-grid-align: none"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Item 13. Other Expenses of Issuance
and Distribution.</font></div>
            <div>The following table sets forth the expenses expected to be incurred in
connection with the issuance and distribution of the securities being
registered. </div>
            <div>&#160;</div>
            <div>
              <div align="left">
                <table cellpadding="0" cellspacing="0" width="100%">
                    <tr bgcolor="#eeeeee">
                      <td valign="bottom" width="88%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SEC
      Registration</font></div>
                      </td>
                      <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">396</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="88%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Legal
      Fees and Expenses*</font></div>
                      </td>
                      <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">60,000</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="bottom" width="88%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounting
      Fees*</font></div>
                      </td>
                      <td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></td>
                      <td align="left" nowrap valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Miscellaneous*</font></div>
                      </td>
                      <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">10,000</font></font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
                      </td>
                      <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
                      <td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">120,396</font></font></td>
                      <td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                </table>
              </div>
            </div>
            <div>&#160;</div>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none">*
Estimated.</div>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <div><font style="DISPLAY: inline; FONT-WEIGHT: bold">Item 14. Indemnification
of Directors and Officers.</font></div>
            <div>&#160;</div>
            <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt">Article XI,
Section 43 of our bylaws contains provisions which require that the company
indemnify its officers, directors, employees and agents, in substantially the
same language as Section 78.7502 of the Nevada Revised Statutes. &#160;&#160;The
Company&#8217;s Articles of Incorporation currently do not contain any provisions
relating to indemnification.&#160; </div>
            <div style="MARGIN: 12pt 0in 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Item 15. Recent Sales of Unregistered
Securities</font></div>
            <div style="MARGIN: 12pt 0in 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none">During
2008, we sold a total of 133,000 shares to five accredited investors resulting
for a gross price of $66,500. The issuances of the shares to the investors were
exempt from registration under Sections 4(2) and 4(6) of the Securities Act and
Regulation D. </div>
            <div style="MARGIN: 12pt 0in 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none">On
October 20, 2008, we issued 5,000,000 shares of our common stock as partial
consideration for the purchase of 25,000,000 shares of HealthAmerica, Inc.
common stock.&#160; Such shares were issued pro rata to the 33 shareholders of
HealthAmerica, Inc.&#160; The issuance of the shares to the HealthAmerica
shareholders was exempt from registration under Sections 4(2) and 4(6) of the
Securities Act and Regulation D.</div>
            <div>&#160;</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">II-1</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div>&#160;</div>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Item 16. Exhibits.</font></div>
            <div>&#160;</div>
            <div>
              <div align="left">
                <table cellpadding="0" cellspacing="0" width="100%">
                    <tr>
                      <td valign="top" width="20%" style="BORDER-BOTTOM: black 2px solid">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exhibit</font></div>
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number</font></div>
                      </td>
                      <td align="left" valign="bottom" width="2%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" valign="bottom" width="78%" style="BORDER-BOTTOM: black 2px solid">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exhibit
      Description</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.1</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Articles
      of Incorporation of Vivakor, Inc. dated April 30,
2008.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.1.1</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment
      to Articles of Incorporation of Vivakor, Inc. dated September 5,
      2008.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.1.2</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Articles
      of Conversion from limited liability company to corporation dated April
      30, 2008.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.1.3</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Limited
      liability company Articles of Organization of Genecular Holdings, LLC
      dated November 1, 2006.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.2</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bylaws
      dated April 30, 2008.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.1</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Opinion
      of Wilson, Haglund &amp; Paulsen, P.C.**</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.1</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2008
      Incentive Plan.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.2</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form
      of Stock Option Agreement under the Vivakor, Inc. 2008 Incentive
      Plan.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.3</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form
      of Restricted Stock Award and Agreement under the Vivakor, Inc. 2008
      Incentive Plan.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.4</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Acquisition
      Agreement and Plan of Acquisition, dated as of September 8,
      2008.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.5</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Secured
      Nonrecourse Promissory Note, dated September 18, 2008.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.6</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pledge
      and Security Agreement, dated as of September 30,
2008.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.1</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc. Code of Ethics.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21.1</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Subsidiaries
      of the registrant.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23.1</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consent
      of McGladrey &amp; Pullen, LLP.*</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23.2</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consent
      of Wilson, Haglund &amp; Paulsen, P.C. (included in Exhibit 5.1
      herein).**</font></div>
                      </td>
                    </tr>
                    <tr bgcolor="white">
                      <td valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr bgcolor="#eeeeee">
                      <td valign="top" width="20%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24.1</font></div>
                      </td>
                      <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="78%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Power
      of Attorney (included on signature
page).*</font></div>
                      </td>
                    </tr>
                </table>
              </div>
            </div>
            <div>&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-pagination: none; mso-layout-grid-align: none"><font style="DISPLAY: inline; FONT-WEIGHT: bold">*&#160;&#160; Filed
herewith.</font></div>
            <div style="MARGIN: 0in 0in 10pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-pagination: none; mso-layout-grid-align: none"><font style="DISPLAY: inline; FONT-WEIGHT: bold">** To be filed by amendment.<br clear="all"></font></div>
            <div>&#160;</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">II-2</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div style="MARGIN: 6pt 0in 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Item 17. Undertakings.</font></div>
            <div style="MARGIN: 6pt 0in 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The undersigned hereby
undertakes: </font></div>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none">
            </div>
            <div>&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-padding-alt: 0in 0in 0in 0in">
                <tr style="MSO-YFTI-LASTROW: yes; MSO-YFTI-IROW: 0; MSO-YFTI-FIRSTROW: yes;">
                  <td valign="top" width="25" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 18.9pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1)</font></div>
                  </td>
                  <td valign="top" width="8" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 6.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="707" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 530.1pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">to file, during any
      period in which offers or sales are being made, a post-effective amendment
      to this Registration Statement to:</font></div>
                  </td>
                </tr>
            </table>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-padding-alt: 0in 0in 0in 0in">
                <tr style="MSO-YFTI-IROW: 0; MSO-YFTI-FIRSTROW: yes;">
                  <td valign="top" width="22" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 16.7pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="42" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 31.55pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(i)</font></div>
                  </td>
                  <td valign="top" width="8" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 6.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="668" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 500.75pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">include any
      prospectus required by section 10(a)(3) of the Securities Act of
      1933;</font></div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-IROW: 1;">
                  <td colspan="4" valign="top" width="740" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 555.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-IROW: 2;">
                  <td valign="top" width="22" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 16.7pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="42" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 31.55pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(ii)</font></div>
                    <div>&#160;</div>
                  </td>
                  <td valign="top" width="8" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 6.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="668" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 500.75pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">reflect in the
      prospectus any facts or events which, individually or together, represent
      a fundamental change in the information in the registration statement.
      Notwithstanding the foregoing, any increase or decrease in volume of
      securities offered (if the total dollar value of securities offered would
      not exceed that which was registered) and any deviation from the low or
      high end of the estimated maximum offering range may be reflected in the
      form of prospectus filed with the Commission pursuant to Rule 424(b) if,
      in the aggregate, the changes in volume and price represent no more than a
      20% change in the maximum aggregate offering price set forth in the
      &#8220;Calculation of Registration Fee&#8221; table in the effective registration
      statement; and</font></div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-IROW: 3;">
                  <td colspan="4" valign="top" width="740" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 555.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-LASTROW: yes; MSO-YFTI-IROW: 4;">
                  <td valign="top" width="22" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 16.7pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="42" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 31.55pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(iii)</font></div>
                  </td>
                  <td valign="top" width="8" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 6.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="668" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 500.75pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">include any
      additional or changed material information on the plan of
      distribution.</font></div>
                  </td>
                </tr>
            </table>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-padding-alt: 0in 0in 0in 0in">
                <tr style="MSO-YFTI-LASTROW: yes; MSO-YFTI-IROW: 0; MSO-YFTI-FIRSTROW: yes;">
                  <td valign="top" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 25px; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2)</font></div>
                    <div>&#160;</div>
                  </td>
                  <td valign="top" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 8px; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 707px; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">that for determining
      liability under the Securities Act, to treat each post-effective amendment
      as a new registration statement of the securities offered, and the
      offering of the securities at that time to be the initial bona fide
      offering.</font></div>
                  </td>
                </tr>
            </table>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-padding-alt: 0in 0in 0in 0in">
                <tr style="MSO-YFTI-LASTROW: yes; MSO-YFTI-IROW: 0; MSO-YFTI-FIRSTROW: yes;">
                  <td valign="top" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 25px; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3)</font></div>
                  </td>
                  <td valign="top" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 8px; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 707px; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">to file a
      post-effective amendment to remove from registration any of the securities
      that remain unsold at the end of the
offering.</font></div>
                  </td>
                </tr>
            </table>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-padding-alt: 0in 0in 0in 0in">
                <tr style="MSO-YFTI-LASTROW: yes; MSO-YFTI-IROW: 0; MSO-YFTI-FIRSTROW: yes;">
                  <td valign="top" width="25" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 18.9pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(4)</font></div>
                    <div>&#160;</div>
                  </td>
                  <td valign="top" width="8" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 6.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                    <div>&#160;</div>
                  </td>
                  <td valign="top" width="707" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 530.1pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">that for determining
      liability of the undersigned small business issuer under the Securities
      Act to any purchaser in the initial distribution of the securities, the
      undersigned small business issuer undertakes that in a primary offering of
      securities of the undersigned small business issuer pursuant to this
      registration statement, regardless of the underwriting method used to sell
      the securities to the purchaser, if the securities are offered or sold to
      such purchaser by means of any of the following communications, the
      undersigned small business issuer will be a seller to the purchaser and
      will be considered to offer or sell such securities to such
      purchaser:</font></div>
                  </td>
                </tr>
            </table>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-padding-alt: 0in 0in 0in 0in">
                <tr style="MSO-YFTI-IROW: 0; MSO-YFTI-FIRSTROW: yes;">
                  <td valign="top" width="22" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 16.65pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="34" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 0.35in; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(i)</font></div>
                    <div>&#160;</div>
                  </td>
                  <td valign="top" width="8" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 6.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="676" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 507.15pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Any preliminary
      prospectus or prospectus of the undersigned small business issuer relating
      to the offering required to be filed pursuant to Rule
  424;</font></div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-IROW: 1;">
                  <td colspan="4" valign="top" width="740" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 555.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-IROW: 2;">
                  <td valign="top" width="22" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 16.65pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="34" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 0.35in; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(ii)</font></div>
                    <div>&#160;</div>
                  </td>
                  <td valign="top" width="8" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 6.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="676" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 507.15pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Any free writing
      prospectus relating to the offering prepared by or on behalf of the
      undersigned small business issuer or used or referred to by the
      undersigned small business issuer;</font></div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-IROW: 3;">
                  <td colspan="4" valign="top" width="740" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 555.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-IROW: 4;">
                  <td valign="top" width="22" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 16.65pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="34" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 0.35in; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(iii)</font></div>
                    <div>&#160;</div>
                  </td>
                  <td valign="top" width="8" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 6.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="676" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 507.15pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The portion of any
      other free writing prospectus relating to the offering containing material
      information about the undersigned small business issuer or its securities
      provided by or on behalf of the undersigned small business issuer;
      and</font></div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-IROW: 5;">
                  <td colspan="4" valign="top" width="740" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 555.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                </tr>
                <tr style="MSO-YFTI-LASTROW: yes; MSO-YFTI-IROW: 6;">
                  <td valign="top" width="22" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 16.65pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="34" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 0.35in; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(iv)</font></div>
                  </td>
                  <td valign="top" width="8" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 6.3pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
                  </td>
                  <td valign="top" width="676" bgcolor="transparent" style="BORDER-RIGHT: #e1e0d2; PADDING-RIGHT: 0in; BORDER-TOP: #e1e0d2; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: #e1e0d2; WIDTH: 507.15pt; PADDING-TOP: 0in; BORDER-BOTTOM: #e1e0d2">
                    <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Any other
      communication that is an offer in the offering made by the undersigned
      small business issuer to the purchaser</font></div>
                  </td>
                </tr>
            </table>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <div style="MARGIN: 6pt 0in 0pt; TEXT-INDENT: 0.5in; LINE-HEIGHT: normal; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Insofar as indemnification
for liabilities arising under the Securities Act of 1933 may be permitted to the
directors, officers, and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been advised that in the
opinion of the Commission such indemnification is against public policy as
expressed in the Securities Act and is, therefore, unenforceable. </font></div>
            <div>&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; TEXT-INDENT: 0.5in; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-pagination: none; mso-layout-grid-align: none"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the event that a claim
for indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a directors, officers or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer, or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue. </font></div>
            <div>&#160;</div>
            <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
              <div id="FTR">
                <div id="GLFTR" style="WIDTH: 100%" align="left">
                </div>
              </div>
              <div id="PN" style="PAGE-BREAK-AFTER: always">
                <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">II-3</font></div>
                <div style="WIDTH: 100%; TEXT-ALIGN: center">
                  <hr style="COLOR: black" noshade size="1">
                </div>
              </div>
              <div id="HDR">
                <div id="GLHDR" style="WIDTH: 100%" align="right">
                </div>
              </div>
            </div>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none">&#160;</div>
            <div style="MARGIN: 0in 0in 10pt; LINE-HEIGHT: normal; TEXT-ALIGN: center; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-pagination: none; mso-layout-grid-align: none" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SIGNATURES</font></div>
            <div style="MARGIN: 6pt 0in 0pt; TEXT-INDENT: 0.5in; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant
has duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized in the City of Coralville, Iowa, on
November 25, 2008. </div>
            <div>&#160;</div>
            <div>
              <div>
                <table border="0" cellpadding="0" cellspacing="0" width="100%">
                    <tr>
                      <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td colspan="2" valign="top" width="38%"><font size="3" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Vivakor,
      Inc.</font></font></td>
                      <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" width="50%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
                      </td>
                      <td valign="top" width="3%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:
      </font></div>
                      </td>
                      <td align="left" nowrap valign="top" width="35%"><font size="3" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="TEXT-DECORATION: underline">/s/ Tannin Fuja&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font>
      </font></td>
                      <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tannin
      Fuja</font></td>
                      <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="35%"><font size="3" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President and Chief Executive Officer</font></td>
                      <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                      <td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                    </tr>
                </table>
              </div>
            </div>
            <div style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: justify; mso-pagination: none; mso-layout-grid-align: none">
            </div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Power
of Attorney</font></font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">KNOW ALL
MEN BY THESE PRESENTS, that each director and officer whose signature appears
below constitutes and appoints Tannin J. Fuja, as such person's true and lawful
attorney-in-fact and agent, with full powers of substitution and
re-substitution, for such person in name, place and stead, to sign in any and
all amendments (including post-effective amendments) to this Registration
Statement on Form S-1, in any and all capacities, and to file the same, with all
exhibits thereto and all other documents in connection therewith, with the
Securities and Exchange Commission, granting unto such attorney-in-fact and
agents, and every act and thing requisite and necessary to be done, as fully to
all intents and purposes as he might or could do in person, hereby ratifying and
confirming all that such attorneys-in-fact and agents, or any of them, may
lawfully do or cause to be done by virtue hereof.</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
accordance with the requirements of the Securities Act of 1933, this
registration statement was signed by the following persons in the capacities and
on the dates indicated:</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
              <div align="left">
                <table cellpadding="0" cellspacing="0" width="100%">
                    <tr>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Signature</font></div>
                      </td>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title</font></div>
                      </td>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td colspan="3" valign="top" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">/s/
      Tannin Fuja<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font></div>
                      </td>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President
      and Chief Executive</font></div>
                      </td>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">November
      25, 2008</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;Tannin
      Fuja</font></div>
                      </td>
                      <td valign="top" width="24%">
                        <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Officer
      and Director</font></div>
                        <div><font size="2">(Printipal Executive Officer</font></div>
                      </td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">/s/
      Matt Nicosia<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font></div>
                      </td>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chairman
      of the Board</font></div>
                      </td>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">November
      25, 2008</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;Matt
      Nicosia</font></div>
                      </td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                    <tr>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">/s/
      Ed Corrente<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font></div>
                      </td>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief
      Financial Officer</font></div>
                      </td>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">November
      25, 2008</font></div>
                      </td>
                    </tr>
                    <tr>
                      <td valign="top" width="24%">
                        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160;&#160;Ed
      Corrente</font></div>
                      </td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Principal
      Financial Officer and<br>Principal Accounting Officer</font></td>
                      <td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
                    </tr>
                </table>
              </div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
              <div>
              </div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
            </div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div>&#160;</div>
            <div style="TEXT-ALIGN: center">II-4

              <div>
                <hr style="COLOR: black" align="left" noshade size="1" width="100%">
              </div>
            </div>
          </div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      </div>
    </div>
  </body>
</html>




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>vivakor_s1-ex301.htm
<DESCRIPTION>ARTICLES OF INCORPORATION
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex301.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div>&#160;</div>
    <div>&#160;</div>
    <div>Exhibit 3.1</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div>
    </div>
    <div>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%">
              <div style="TEXT-ALIGN: center"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">STATE
      OF NEVADA</font></div>
            </td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%">
              <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ROSS
      MILLER</font></div>
              <div style="TEXT-ALIGN: center"><font size="2">Secretary of
      State</font></div>
            </td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%">
              <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SCOTT W.
      ANDERSON</font></div>
              <div style="TEXT-ALIGN: center"><font size="2">Deputy Secretary</font></div>
              <div style="TEXT-ALIGN: center"><font size="2">for Commercial
      Recordings</font></div>
            </td>
          </tr>
          <tr>
            <td width="33%">&#160;</td>
            <td valign="top" width="33%">
              <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">OFFICE OF
      THE</font></div>
              <div style="TEXT-ALIGN: center"><font size="2">SECRETARY OF
      STATE</font></div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center"><font size="2" style="FONT-WEIGHT: bold">Filing Acknowledgement</font></div>
            </td>
            <td valign="bottom" width="33%">
              <div>&#160;</div>
              <div>&#160;</div>
              <div>&#160;</div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center"><font size="2">April 30,
  2008</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center">&#160;</div>
    <div style="TEXT-ALIGN: left">
    </div>
    <div>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Job
      Number</font></td>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporation
      Number</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">C20080430-1452</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">E0799472006-9</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Filing
      Description</font></td>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Document
      Filing Number</font></td>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date/Time
      of Filing</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Articles of
      Incorporation</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20080297796-60</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 30, 2008
      09:16:44AM</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%">
              <div><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporation
      Name</font></div>
              <div><font size="2" style="FONT-WEIGHT: bold">VIVAKOR, INC.</font></div>
            </td>
            <td valign="bottom" width="33%">
              <div style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">, Resident
      Agent</font></div>
            </td>
            <td valign="bottom" width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">The attached document(s) were filed with the
Nevada Secretary of State, Commercial Recordings Division.&#160; The filing date
and time have been affzed to each document, indicating the date and time of
filing.&#160; A filing number is also affixed and can be used to reference this
document in the future.</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">
    </div>
    <div>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="50%">
              <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Respectfully,</font></div>
              <div style="TEXT-ALIGN: left">&#160;</div>
              <div style="TEXT-ALIGN: left">&#160;</div>
              <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Ross
      Miller</font></div>
              <div style="TEXT-ALIGN: left">&#160;</div>
              <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ROSS
      MILLER</font></div>
              <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Secretary of
      State</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: center">Commercial Recording Division</div>
    <div style="TEXT-ALIGN: center">202 N. Carson Street</div>
    <div style="TEXT-ALIGN: center">Carson City, Nevada&#160; 89701-4069</div>
    <div style="TEXT-ALIGN: center">Telephone&#160; (775) 684-5708</div>
    <div style="TEXT-ALIGN: center">Fax (775) 68407138</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center"><img src="vivakorex301image1.jpg" alt=""></div>
    <div style="TEXT-ALIGN: center">&#160;</div>
    <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

      <div>
        <hr style="COLOR: black" align="left" noshade size="1" width="100%">
      </div>
    </div>
  </body>
</html>





</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1.1
<SEQUENCE>3
<FILENAME>vivakor_s1-ex311.htm
<DESCRIPTION>AMENDMENT TO ARTICLES OF INCORPORATION
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex311.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div>&#160;</div>
    <div>Exhibit 3.1.1</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div>
    </div>
    <div>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%">
              <div style="TEXT-ALIGN: center"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">STATE
      OF NEVADA</font></div>
            </td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%">
              <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ROSS
      MILLER</font></div>
              <div style="TEXT-ALIGN: center"><font size="2">Secretary of
      State</font></div>
            </td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%">
              <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SCOTT W.
      ANDERSON</font></div>
              <div style="TEXT-ALIGN: center"><font size="2">Deputy Secretary</font></div>
              <div style="TEXT-ALIGN: center"><font size="2">for Commercial
      Recordings</font></div>
            </td>
          </tr>
          <tr>
            <td width="33%">&#160;</td>
            <td valign="top" width="33%">
              <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">OFFICE OF
      THE</font></div>
              <div style="TEXT-ALIGN: center"><font size="2">SECRETARY OF
      STATE</font></div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center"><font size="2" style="FONT-WEIGHT: bold">Filing Acknowledgement</font></div>
            </td>
            <td valign="bottom" width="33%">
              <div>&#160;</div>
              <div>&#160;</div>
              <div>&#160;</div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center">&#160;</div>
              <div style="TEXT-ALIGN: center"><font size="2">September 5,
    2008</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center">&#160;</div>
    <div style="TEXT-ALIGN: left">
    </div>
    <div>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Job
      Number</font></td>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporation
      Number</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">C20080908-0044</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">E0799472006-9</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Filing
      Description</font></td>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Document
      Filing Number</font></td>
            <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date/Time
      of Filing</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock
Split</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20080595982-48</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 5, 2008
      04:45:22AM</font></td>
          </tr>
          <tr>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="33%">
              <div><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporation
      Name</font></div>
              <div><font size="2" style="FONT-WEIGHT: bold">VIVAKOR, INC.</font></div>
            </td>
            <td valign="bottom" width="33%">
              <div style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">REGISTERED AGENT
      SOLUTIONS, INC, Resident Agent</font></div>
            </td>
            <td valign="bottom" width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">The attached document(s) were filed with the
Nevada Secretary of State, Commercial Recordings Division.&#160; The filing date
and time have been affzed to each document, indicating the date and time of
filing.&#160; A filing number is also affixed and can be used to reference this
document in the future.</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">
    </div>
    <div>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="50%">
              <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Respectfully,</font></div>
              <div style="TEXT-ALIGN: left">&#160;</div>
              <div style="TEXT-ALIGN: left">&#160;</div>
              <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Ross
      Miller</font></div>
              <div style="TEXT-ALIGN: left">&#160;</div>
              <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ROSS
      MILLER</font></div>
              <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Secretary of
      State</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: center">Commercial Recording Division</div>
    <div style="TEXT-ALIGN: center">202 N. Carson Street</div>
    <div style="TEXT-ALIGN: center">Carson City, Nevada&#160; 89701-4069</div>
    <div style="TEXT-ALIGN: center">Telephone&#160; (775) 684-5708</div>
    <div style="TEXT-ALIGN: center">Fax (775) 68407138</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center"><img src="vivakorex311image1.jpg" alt=""></div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

      <div>
        <hr style="COLOR: black" align="left" noshade size="1" width="100%">
      </div>
    </div>
    <div style="TEXT-ALIGN: center">&#160;</div>
  </body>
</html>





</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1.2
<SEQUENCE>4
<FILENAME>vivakor_s1-ex312.htm
<DESCRIPTION>ARTICLES OF CONVERSION
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex312.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div>Exhibit 3.1.2</div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center">SECRETARY OF STATE</div>
    <div style="TEXT-ALIGN: center">STATE OF NEVADA</div>
    <div style="TEXT-ALIGN: center">&#160;</div>
    <div style="TEXT-ALIGN: center">CORPORATE CHARTER</div>
    <div style="TEXT-ALIGN: center">(CONVERSION)</div>
    <div style="TEXT-ALIGN: center">&#160;</div>
    <div style="TEXT-ALIGN: left">
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">I, ROSS
MILLER, the duly elected and qualified Nevada Secretary of State, do hereby
certify that VIVAKOR, INC. did on April 30, 2008 file in this office the Convert
In and Articles of Incorporation; that said Articles are now on file and of
record in the office of the Secretary of State of the State of Nevada, and
further, that said Articles contain all the provisions required by the law of
said State of Nevada.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">

        <div>&#160;</div>
        <div align="center">
          <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
              <tr>
                <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></td>
                <td width="50%">
                  <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">IN
      WITNESS WHEREOF, I have hereunto set my hand and affixed the Great Seal of
      State, at my office, on April 30, 2008.</font></div>
                  <div>&#160;</div>
                  <div>&#160;</div>
                  <div><font size="2">/s/ ROSS MILLER</font></div>
                  <div><font size="2">ROSS MILLER</font></div>
                  <div><font size="2">Secretary of State</font></div>
                  <div>&#160;</div>
                  <div><font size="2">By:&#160; Certification
Clerk</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div>&#160;</div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    </div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div>
      <div align="center">
        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%">
                <div style="TEXT-ALIGN: center"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">STATE
      OF NEVADA</font></div>
              </td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%">
                <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ROSS
      MILLER</font></div>
                <div style="TEXT-ALIGN: center"><font size="2">Secretary of
      State</font></div>
              </td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%">
                <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SCOTT W.
      ANDERSON</font></div>
                <div style="TEXT-ALIGN: center"><font size="2">Deputy Secretary</font></div>
                <div style="TEXT-ALIGN: center"><font size="2">for Commercial
      Recordings</font></div>
              </td>
            </tr>
            <tr>
              <td width="33%">&#160;</td>
              <td valign="top" width="33%">
                <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">OFFICE OF
      THE</font></div>
                <div style="TEXT-ALIGN: center"><font size="2">SECRETARY OF
      STATE</font></div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center"><font size="2" style="FONT-WEIGHT: bold">Filing Acknowledgement</font></div>
              </td>
              <td valign="bottom" width="33%">
                <div>&#160;</div>
                <div>&#160;</div>
                <div>&#160;</div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center"><font size="2">April 30,
  2008</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div>&#160;</div>
      <div style="TEXT-ALIGN: center">&#160;</div>
      <div style="TEXT-ALIGN: left">
      </div>
      <div>&#160;</div>
      <div align="center">
        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Job
      Number</font></td>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporation
      Number</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">C20080430-1452</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">E0799472006-9</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Filing
      Description</font></td>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Document
      Filing Number</font></td>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date/Time
      of Filing</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Convert In</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20080297794-48</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 30, 2008
      09:16:44AM</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%">
                <div><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporation
      Name</font></div>
                <div><font size="2" style="FONT-WEIGHT: bold">VIVAKOR, INC.</font></div>
              </td>
              <td valign="bottom" width="33%">
                <div style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">, Resident
      Agent</font></div>
              </td>
              <td valign="bottom" width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
        </table>
      </div>
      <div>&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">The attached document(s) were filed with the
Nevada Secretary of State, Commercial Recordings Division.&#160; The filing date
and time have been affzed to each document, indicating the date and time of
filing.&#160; A filing number is also affixed and can be used to reference this
document in the future.</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">
      </div>
      <div>&#160;</div>
      <div align="center">
        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="50%">
                <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Respectfully,</font></div>
                <div style="TEXT-ALIGN: left">&#160;</div>
                <div style="TEXT-ALIGN: left">&#160;</div>
                <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Ross
      Miller</font></div>
                <div style="TEXT-ALIGN: left">&#160;</div>
                <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ROSS
      MILLER</font></div>
                <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Secretary of
      State</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div>&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: center">Commercial Recording Division</div>
      <div style="TEXT-ALIGN: center">202 N. Carson Street</div>
      <div style="TEXT-ALIGN: center">Carson City, Nevada&#160; 89701-4069</div>
      <div style="TEXT-ALIGN: center">Telephone&#160; (775) 684-5708</div>
      <div style="TEXT-ALIGN: center">Fax (775) 68407138</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center"><img src="vivakorex312image1.jpg" alt=""></div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center"><img src="vivakorex312image2.jpg" alt=""></div>
    <div style="TEXT-ALIGN: left">\</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: left">
      <div>&#160;</div>
      <div align="center">
        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%">
                <div style="TEXT-ALIGN: center"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">STATE
      OF NEVADA</font></div>
              </td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%">
                <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ROSS
      MILLER</font></div>
                <div style="TEXT-ALIGN: center"><font size="2">Secretary of
      State</font></div>
              </td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%">
                <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SCOTT W.
      ANDERSON</font></div>
                <div style="TEXT-ALIGN: center"><font size="2">Deputy Secretary</font></div>
                <div style="TEXT-ALIGN: center"><font size="2">for Commercial
      Recordings</font></div>
              </td>
            </tr>
            <tr>
              <td width="33%">&#160;</td>
              <td valign="top" width="33%">
                <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">OFFICE OF
      THE</font></div>
                <div style="TEXT-ALIGN: center"><font size="2">SECRETARY OF
      STATE</font></div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center"><font size="2" style="FONT-WEIGHT: bold">Filing Acknowledgement</font></div>
              </td>
              <td valign="bottom" width="33%">
                <div>&#160;</div>
                <div>&#160;</div>
                <div>&#160;</div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center">&#160;</div>
                <div style="TEXT-ALIGN: center"><font size="2">April 30,
  2008</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div>&#160;</div>
      <div style="TEXT-ALIGN: center">&#160;</div>
      <div style="TEXT-ALIGN: left">
      </div>
      <div>&#160;</div>
      <div align="center">
        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Job
      Number</font></td>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporation
      Number</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">C20080430-1452</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">E0799472006-9</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Filing
      Description</font></td>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Document
      Filing Number</font></td>
              <td width="33%"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date/Time
      of Filing</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Articles of
      Incorporation</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20080297796-60</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 30, 2008
      09:16:44AM</font></td>
            </tr>
            <tr>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
            <tr>
              <td width="33%">
                <div><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporation
      Name</font></div>
                <div><font size="2" style="FONT-WEIGHT: bold">VIVAKOR, INC.</font></div>
              </td>
              <td valign="bottom" width="33%">
                <div style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">, Resident
      Agent</font></div>
              </td>
              <td valign="bottom" width="33%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            </tr>
        </table>
      </div>
      <div>&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">The attached document(s) were filed with the
Nevada Secretary of State, Commercial Recordings Division.&#160; The filing date
and time have been affzed to each document, indicating the date and time of
filing.&#160; A filing number is also affixed and can be used to reference this
document in the future.</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">
      </div>
      <div>&#160;</div>
      <div align="center">
        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="50%">
                <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Respectfully,</font></div>
                <div style="TEXT-ALIGN: left">&#160;</div>
                <div style="TEXT-ALIGN: left">&#160;</div>
                <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Ross
      Miller</font></div>
                <div style="TEXT-ALIGN: left">&#160;</div>
                <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ROSS
      MILLER</font></div>
                <div style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Secretary of
      State</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div>&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: center">Commercial Recording Division</div>
      <div style="TEXT-ALIGN: center">202 N. Carson Street</div>
      <div style="TEXT-ALIGN: center">Carson City, Nevada&#160; 89701-4069</div>
      <div style="TEXT-ALIGN: center">Telephone&#160; (775) 684-5708</div>
      <div style="TEXT-ALIGN: center">Fax (775) 68407138</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div style="TEXT-ALIGN: left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center"><img src="vivakorex312image3.jpg" alt=""></div>
    <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

      <div>
        <hr style="COLOR: black" align="left" noshade size="1" width="100%">
      </div>
    </div>
  </body>
</html>





</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1.3
<SEQUENCE>5
<FILENAME>vivakor_s1-ex313.htm
<DESCRIPTION>LIMITED LIABILITY COMPANY ARTICLES OF ORGANIZATION
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex313.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div>Exhibit 3.1.3</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center">Amendment to Articles of Organization</div>
    <div style="TEXT-ALIGN: center">&#160;</div>
    <div style="TEXT-ALIGN: center">Certificate of Amendment to Articles of
Organization</div>
    <div style="TEXT-ALIGN: center">For a Nevada Limited-Liability Company Before
Issuance of Members Interest</div>
    <div style="TEXT-ALIGN: center">(Pursuant to NRS 76.216)</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">1.&#160; Name of limited-liability company</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">Genecular Holdings, LLC</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">2.&#160; The articles have been amended as follows
(provide articles numbers, if available);*</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">Article I.</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">The name of the Limited Liability Company shall be
NGI Holdings, LLC</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">3.&#160; The effective date of this certificate,
if other than filing date is:&#160; 11-1-06.</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">4.&#160; As of the date of this certificate, no
member's interest in the limited-liability company has been issued.</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">5.&#160; Signatures represent at least 2/3 of the
(check one:):&#160; **&#160; [x] irgabuzers [ ] managers</div>
    <div style="TEXT-ALIGN: left">&#160;</div>
    <div style="TEXT-ALIGN: left">
    </div>
    <div>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td width="50%">
              <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">/s/
      Cathleen D. Wushel</font></div>
              <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Signature<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;</font>&#160;</font></div>
            </td>
            <td width="50%">
              <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="TEXT-DECORATION: underline">----&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      </font></font></div>
              <div><font size="2">Signature</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div>
      <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top">
            <td align="right" style="WIDTH: 9pt">
              <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*&#160;</font></div>
            </td>
            <td align="left">
              <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1)&#160;
      If amending company name, if must contain the words "Limited-Liability
      Company," "Limited Company" or "Limited" or the abbreviations "Ltd.,"
      "L.L.C.," or L.C.," "LLC" or "LC,"&#160; The word "Company" may be
      abbreviated and "Cp."</font></div>
              <div>&#160;</div>
              <div><font size="2">2)&#160; If adding managers, provide names and
      addresses."</font></div>
            </td>
          </tr>
          <tr valign="top">
            <td align="right" style="WIDTH: 9pt">&#160;</td>
            <td align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr valign="top">
            <td align="right" style="WIDTH: 9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">**&#160;</font></td>
            <td align="left">
              <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">If more
      than two signatures, attach 8 1/2 x 11 plain sheet with the additional
      signatures.</font></div>
              <div>&#160;</div>
              <div><font size="2">FILING FEE:&#160; $175.00</font></div>
              <div><font size="2">IMPORTANT:&#160; Failure to incude any of the above
      information and submit the proper fees may cause this filing to be
      refected.</font></div>
              <div><font size="2">This form must be accompanied by appropriate
      fees.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div>
      <div style="TEXT-ALIGN: center">SECRETARY OF STATE</div>
      <div style="TEXT-ALIGN: center">STATE OF NEVADA</div>
      <div style="TEXT-ALIGN: center">&#160;</div>
      <div style="TEXT-ALIGN: center">Limited Liability Company Charter</div>
      <div style="TEXT-ALIGN: center">&#160;</div>
      <div style="TEXT-ALIGN: left">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
          <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">I, DEAN
HELLER, the Nevada Secretary of State, do hereby certify that GENECULAR
HOLDINGS, LLC did on November 1, 2006, file in this office the Articles of
Organization for a Limited Liability Company, that said Articles of Organization
are now on file and of record in the office of the Nevada Secretary of State,
and further, that said Articles contain all the provisions required by the laws
governing Limited Liability Companies in the State of Nevada.</font></div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div>&#160;</div>
          <div align="center">
            <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
                <tr>
                  <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
                  <td width="50%">
                    <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">IN
      WITNESS WHEREOF, I have hereunto set my hand and affixed the Great Seal of
      State, at my office, on April 30, 2008.</font></div>
                    <div>&#160;</div>
                    <div>&#160;</div>
                    <div><font size="2">/s/ DEAN HELLER</font></div>
                    <div><font size="2">DEAN HELLER</font></div>
                    <div><font size="2">Secretary of State</font></div>
                    <div>&#160;</div>
                    <div><font size="2">By:&#160; Certification
Clerk</font></div>
                  </td>
                </tr>
            </table>
          </div>
          <div>&#160;</div>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
          <div id="FTR">
            <div id="GLFTR" style="WIDTH: 100%" align="left">
            </div>
          </div>
          <div id="PN" style="PAGE-BREAK-AFTER: always">
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
            </div>
            <div style="WIDTH: 100%; TEXT-ALIGN: center">
              <hr style="COLOR: black" noshade size="1">
            </div>
          </div>
          <div id="HDR">
            <div id="GLHDR" style="WIDTH: 100%" align="right">
            </div>
          </div>
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center"><img src="vivakorex313image1.jpg" alt=""></div>
    <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

      <div>
        <hr style="COLOR: black" align="left" noshade size="1" width="100%">
      </div>
    </div>
  </body>
</html>





</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>6
<FILENAME>vivakor_s1-ex302.htm
<DESCRIPTION>BYLAWS
<TEXT>
<html>
  <head>
    <title>Unassociated Document</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="FONT-WEIGHT: bold">EXHIBIT 3.2</font><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 24pt; FONT-FAMILY: Times New Roman">BYLAWS</font><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 24pt; FONT-FAMILY: Times New Roman">OF</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br>&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 24pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(A NEVADA
CORPORATION)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BYLAWS</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OF</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a Nevada
corporation</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br>&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
I</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OFFICES</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 1. Registered Office</font>.
The registered office of the corporation in the State of Nevada shall be at such
place as the board shall resolve.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 2. Other Offices</font>. The
corporation shall also have and maintain an office or principal place of
business at such place as may be fixed by the Board of Directors, and may also
have offices at such other places, both within and without the State of Nevada
as the Board of Directors may from time to time determine or the business of the
corporation may require.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
II</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CORPORATE
SEAL</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 3. Corporate Seal</font>. The
corporate seal shall consist of a stamp or die bearing the name of the
corporation and the date and state of incorporation.&#160;&#160;Said seal may be
used by causing it or a facsimile thereof to be impressed or affixed or
reproduced or otherwise.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
III</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">STOCKHOLDERS'
MEETINGS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 4. Place of Meetings</font>.
Meetings of the stockholders of the corporation shall be held at such place,
either within or without the State of Nevada, as may be designated from time to
time by the Board of Directors, or, if not so designated, then at the office of
the corporation required to be maintained pursuant to Section 2
hereof.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 5. Annual
Meeting</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) The
annual meeting of the stockholders of the corporation, for the purpose of
election of directors and for such other business as may lawfully come before
it, shall be held on such date and at such time as may be designated from time
to time by the Board of Directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) At an
annual meeting of the stockholders, only such business shall be conducted as
shall have been properly brought before the meeting. To be properly brought
before an annual meeting, business must be: (A) specified in the notice of
meeting (or any supplement thereto) given by or at the direction of the Board of
Directors, (B) otherwise properly brought before the meeting by or at the
direction of the Board of Directors, or (C) otherwise properly brought before
tile meeting by a stockholder. For business to be properly brought before an
annual meeting by a stockholder, the stockholder must have given timely notice
thereof in writing to the Secretary of the corporation. To be timely, a
stockholder's notice must be delivered to or mailed and received at the
principal executive offices of the corporation not later than the close of
business on the sixtieth (60th) day nor earlier than the close of business on
the ninetieth (90th) day prior to the first anniversary of the preceding year's
annual meeting; provided, however, that in the event that no annual meeting was
held in the previous year or the date of the annual meeting has been changed by
more than thirty (30) days from the date contemplated at the time of the
previous year's proxy statement, notice by the stockholder to be timely must be
so received not earlier than the close of business on the ninetieth (90th) day
prior to such annual meeting and not later than the close of business on the
later of the sixtieth (60th) day prior to such annual meeting or, in the event
public announcement of the date of such annual meeting is first made by the
corporation fewer than seventy (70) days prior to the date of such annual
meeting, the close of business on the tenth (10th) day following the day on
which public announcement of the date of such meeting is first made by the
corporation. A stockholder's notice to the Secretary shall set forth as to each
matter the stockholder proposes to bring before the annual meeting: (i) a brief
description of the business desired to be brought before the annual meeting and
the reasons for conducting such business at the annual meeting, (ii) the name
and address, as they appear on the corporation's books, of the stockholder
proposing such business, (iii) the class and number of shares of the corporation
which are beneficially owned by the stockholder, (iv) any material interest of
the stockholder in such business and (v) any other information that is required
to be provided by the stockholder pursuant to Regulation 14A under the
Securities Exchange Act of 1934, as amended (the "1934 Act"), in his capacity as
a proponent to a stockholder proposal.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
the foregoing, in order to include information with respect to a stockholder
proposal in the proxy statement and form of proxy for a stockholder's meeting,
stockholders must provide notice as required by the regulations promulgated
under the 1934 Act. Not withstanding anything in these Bylaws to tile contrary,
no business shall be conducted at any annual meeting except in accordance with
the procedures set forth in this paragraph (b). The chairman of the annual
meeting shall, if the facts warrant, determine and declare at the meeting that
business was not properly brought before the meeting and in accordance with the
provisions of this paragraph (b), and, if he should so determine, he shall so
declare at tile meeting that any such business not properly brought before the
meeting shall not be transacted.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) Only
persons who are confirmed in accordance with the procedures set forth in this
paragraph (c) shall be eligible for election as directors. Nominations of
persons for election to the Board of Directors of the corporation may be made at
a meeting of stockholders by, or at the direction of the Board of Directors or
by any stockholder of the corporation entitled to vote in the election of
directors at the meeting who complies with the notice procedures set forth in
this paragraph (c).</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Such
nominations, other than those made by or at the direction of the Board of
Directors, shall be made pursuant to timely notice in writing to the Secretary
of the corporation in accordance with the provisions of paragraph (b) of this
Section 5. Such stockholder's notice shall set forth (i) as to each person, if
any, whom the stockholder proposes to nominate for election or re-election as a
director:&#160;&#160;(A) the name, age, business address and residence address
of such person, B) the principal occupation or employment of such person, (C)
the class and number of shares of the corporation which are beneficially owned
by such person, (D) a description of all arrangements or understandings between
the stockholder and each nominee and any other person or persons (naming such
person or persons) pursuant to which the nominations are to be made by the
stockholder, and&#160;&#160;(E) any other information relating to such person
that is required to be disclosed in solicitations of proxies for election of
directors, or is otherwise required, in each case pursuant to Regulation 14A
under the 1934 Act (including without limitation such person's written consent
to being named in the proxy statement, if any, as a nominee and to serving as a
director if elected); and (ii) as to such stockholder giving notice, the
information required to be provided pursuant to paragraph (b) of this Section 5.
At the request of the Board of Directors, any person nominated by a stockholder
for election as a director shall furnish to the Secretary of the corporation
that information required to be set forth in the stockholder's notice of
nomination which pertains to the nominee. No person shall be eligible for
election as a director of the corporation unless nominated in accordance with
the procedures set forth in this paragraph (c). The chairman of the meeting
shall, if the facts warrant, determine and declare at the meeting that a
nomination was not made in accordance with the procedures prescribed by these
Bylaws, and if he should so determine, he shall so declare at the meeting, and
the defective nomination shall be disregarded.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) For
purposes of this Section 5, "public announcement" shall mean disclosure in a
press release reported by the Dow Jones News Service, Associated Press or
comparable national news service or in a document publicly filed by the
corporation with the Securities and Exchange Commission pursuant to Section 13,
14 or 15(d) of the Exchange Act.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
6. Special Meetings.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Special meetings of the stockholders of the corporation may be called, for any
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">purpose
or purposes, by (i) the Chairman of the Board of Directors, (ii) the Chief
Executive Officer, or (iii) the Board of Directors pursuant to a resolution
adopted by a majority of tile total number of authorized directors (whether or
not there exist any vacancies in previously authorized directorships at the time
any such resolution is presented to the Board of Directors for adoption), and
shall be held at such place, on such date, and at such time, as the Board of
Directors shall determine.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) If a
special meeting is called by any person or persons other than the Board of
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Directors,
the request shall be in writing, specifying the general nature of the business
proposed to be transacted, and shall be delivered personally or sent by
registered mail or by telephonic or other facsimile transmission to the Chairman
of the Board of Directors, the Chief Executive Officer, or the Secretary of the
corporation. No business may be transacted at such special meeting otherwise
than specified in such notice. The Board of Directors shall determine the time
and place of such special meeting, which shall be held not less than thirty-five
(35) nor more than one hundred twenty (120) days after the date of the receipt
of the request. Upon determination of the time and place of the meeting, the
officer receiving the request shall cause notice to be given to tile
stockholders entitled to vote, in accordance with the provisions of Section 7 of
these Bylaws. If the notice is not given within sixty (60) days after the
receipt of tile request, tile person or persons requesting the meeting may set
the time and place of the meeting and give the notice. Nothing contained in this
paragraph (b) shall be construed as limiting, fixing, or affecting the time when
a meeting of stockholders called by action of the Board of Directors may be
held.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 7. Notice of Meetings</font>.
Except as otherwise provided by law or the Articles of Incorporation, written
notice of each meeting of stockholders shall be given not less than ten (10) nor
more than sixty (60) days before the date of the meeting to each stockholder
entitled to vote at such meeting, such notice to specify the place, date and
hour and purpose or purposes of tile meeting.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notice of
the time, place and purpose of any meeting of stockholders may be waived in
writing, signed by the person entitled to notice thereof, either before or after
such meeting, and will be waived by any stockholder by his attendance thereat in
person or by proxy, except when the stockholder attends a meeting for the
express purpose of objecting, at the beginning of the meeting, to the
transaction of any business because the meeting is not lawfully called or
convened. Any stockholder so waiving notice of such meeting shall be bound by
the proceedings of any such meeting in all respects as if due notice thereof had
been given.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 8.&#160;&#160;Quorum</font>.
At all meetings of stockholders, except where otherwise provided by statute or
by the Articles of Incorporation, or by these Bylaws, the presence, in person or
by proxy duly authorized, of the holder or holders of not less than fifty
percent (50%) of the outstanding shares of stock entitled to vote shall
constitute a quorum for the transaction of business. In tile absence of a
quorum, any meeting of stockholders may be adjourned, from time to time, either
by the chairman of the meeting or by vote of the holders of a majority of the
shares represented thereat, but no other business shall be transacted at such
meeting. The stockholders present at a duly called or convened meeting, at which
a quorum is present, may continue to transact business until adjournment,
notwithstanding the withdrawal of enough stockholders to leave less than a
quorum. Except as otherwise provided by law, the Articles of Incorporation or
these Bylaws, all action taken by the holders of a majority of the votes cast,
excluding abstentions, at any meeting at which a quorum is present shall be
valid and binding upon the corporation; provided, however, that directors shall
be elected by a plurality of the votes of the shares present in person or
represented by proxy at the meeting and entitled to vote on tile election of
directors. Where a separate vote by a class or classes or series is required,
except where otherwise provided by the statute or by the Articles of
Incorporation or these Bylaws, a majority of the outstanding shares of such
class or classes or series, present in person or represented by proxy, shall
constitute a quorum entitled to take action with respect to that vote on that
matter and, except where otherwise provided by the statute or by the Articles of
Incorporation or these Bylaws, the affirmative vote of the majority (plurality,
in the case of the election of directors) of the votes cast, including
abstentions, by the holders of shares of such class or classes or series shall
be the act of such class or classes or series.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 9. Adjournment and Notice of
Adjourned Meetings</font>. Any meeting of stockholders, whether annual or
special, may be adjourned from time to time either by the chairman of the
meeting or by the vote of a majority of the shares casting votes, excluding
abstentions. When a meeting is adjourned to another time or place, notice need
not be given of the adjourned meeting if the time and place thereof are
announced at the meeting at which the adjournment is taken. At the adjourned
meeting, the corporation may transact ally business which might have been
transacted at the original meeting. I the adjournment is for more than thirty
(30) days or if after the adjournment a new record date is fixed for the
adjourned meeting, a notice of the adjourned meeting shall be given to each
stockholder of record entitled to vote at the meeting.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 10. Voting Rights. </font>For
the purpose of determining those stockholders entitled to </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">vote at
any meeting of the stockholders, except as otherwise provided by law, only
persons in whose names shares stand on the stock records of the corporation on
the record date, as provided in Section 12 of these Bylaws, shall be entitled to
vote at any meeting of stockholders. Every person entitled to vote shall have
the right to do so either in person or by an agent or agents authorized by a
proxy granted in accordance with Nevada law. An agent so appointed need not be a
stockholder. No proxy shall be voted after three (3) years from its date of
creation unless the proxy provides for a longer period.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 11. Joint Owners of
Stock</font>.&#160;&#160;If shares or other securities having voting power stand
of record in the names of two (2) or more persons, whether fiduciaries, members
of a partnership, joint tenants, tenants in common, tenants by the entirety, or
otherwise, or if two (2) or more persons have the same fiduciary relationship
respecting the same shares, unless the Secretary is given written notice to the
contrary and is furnished with a copy of the instrument or order appointing them
or creating the relationship wherein it is so provided, their acts with respect
to voting shall have the following effect: (a) if only one (1) votes, his act
binds all; (b) if more than one (1) votes, the act of the majority so voting
binds all; (c) if more than one (1) votes, but the vote is evenly split on any
particular matter, each faction may vote the securities in question
proportionally, or may apply to the Nevada Court of Chancery for relief as
provided in the General Corporation Law of Nevada, Section 217(b). If the
instrument filed with the Secretary shows that any such tenancy is held in
unequal interests, a majority or even-split for the purpose of subsection (c)
shall be a majority or even-split in interest.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 12.&#160;&#160;List of
Stockholders</font>. The Secretary shall prepare and make, at least ten (10)
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">days
before every meeting of stockholders, a complete list of the stockholders
entitled to vote at said meeting, arranged in alphabetical order, showing the
address of each stockholder and the number of shares registered in the name of
each stockholder. Such list shall be open to the examination of any stockholder,
for any purpose germane to the meeting, during ordinary business hours, for a
period of at least ten (10) days prior to the meeting, either at a place within
the city where the meeting is to be held, which place shall be specified in the
notice of the meeting, or, if not specified, at the place where the meeting is
to be held. The list shall be produced and kept at the time and place of meeting
during the whole time thereof and may be inspected by any stockholder who is
present.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 13. Action Without
Meeting</font>. No action shall be taken by the stockholders except at an annual
or special meeting of stockholders called in accordance with these Bylaws, or by
the written consent of the stockholders setting forth the action so taken and
signed by the holders of outstanding stock having not less than the minimum
number of votes that would be necessary to authorize or take such action at a
meeting at which all shares entitled to vote upon were present and
voted.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 14.
Organization</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) At
every meeting of stockholders, the Chairman of the Board of Directors, or, if a
Chairman has not been appointed or is absent, the President, or, if the
President is absent, a chairman of the meeting chosen by a majority in interest
of the stockholders entitled to vote, present in person or by proxy, shall act
as chairman. The Secretary, or, in his absence, an Assistant Secretary directed
to do so by the President, shall act as secretary of the meeting.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">5</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The
Board of Directors of the corporation shall be entitled to make such rules or
regulations for the conduct of meetings of stockholders as it shall deem
necessary, appropriate or convenient. Subject to such rules and regulations of
the Board of Directors, if any, the chairman of the meeting shall have the right
and authority to prescribe such rules, regulations and procedures and to do all
such acts as, in the judgment of such chairman, are necessary, appropriate or
convenient for the proper conduct of the meeting, including, without limitation,
establishing an agenda or order of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">business
for the meeting, rules and procedures for maintaining order at the meeting and
the safety of those present, limitations on participation in such meeting to
stockholders of record of the corporation and their duly authorized and
constituted proxies and such other persons as the chairman shall permit,
restrictions on entry to the meeting after the time fixed for the commencement
thereof, limitations on the time allotted to questions or comments by
participants and regulation of the opening and closing of the polls for
balloting on matters which are to be voted on by ballot. Unless and to the
extent determined by the Board of Directors or the chairman of the meeting,
meetings of stockholders shall not be required to be held in accord31lce with
rules of parliamentary procedure.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
IV</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DIRECTORS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 15. Number and Qualification.
</font>The authorized number of directors of the corporation shall be not less
than one (1) nor more than thirteen (13) as fixed from time to time by
resolution of the Board of Directors; provided that no decrease in the number of
directors shall shorten the term of any incumbent directors. Directors need not
be stockholders unless so required by the Articles of Incorporation. If for any
cause, the directors shall not have been elected at an annual meeting, they may
be elected as soon thereafter as convenient at a special meeting of the
stockholders called for that purpose in the manner provided in these
Bylaws.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 16. Powers</font>. The powers
of the corporation shall be exercised, its business conducted and its property
controlled by the Board of Directors, except as may be otherwise provided by
statute or by the Articles of Incorporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 17. Election and Term of
Office of Directors</font>. Members of the Board of Directors shall hold office
for the terms specified in the Articles of Incorporation, as it may be amended
from time to time, and until their successors have been elected as provided in
the Articles of Incorporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 18.
Vacancies</font>.&#160;&#160;Unless otherwise provided in the Articles of
Incorporation, any vacancies on the Board of Directors resulting from death,
resignation, disqualification, removal or other causes and any newly created
directorships resulting from any increase in the number of directors, shall
unless the Board of Directors determines by resolution that any such vacancies
or newly created directorships shall be filled by stockholder vote, be filled
only by 11le affirmative vote of a majority of the directors then in office,
even though less than a quorum of the Board of Directors. Any director elected
in accordance with the preceding sentence shall hold office for the remainder of
the full tern1 of the director for which the vacancy was created or occurred and
until such director's successor shall have been elected and qualified. A vacancy
in the Board of Directors shall be deemed to exist under this Bylaw in the case
of the death, removal or resignation of any </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">director.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">6</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 19. Resignation. </font>Any
director may resign at any time by delivering his written </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">resignation
to the Secretary, such resignation to specify whether it will be effective at a
particular time, upon receipt by the Secretary or at the pleasure of the Board
of Directors. If no such specification is made, it shall be deemed effective at
the pleasure of the Board of Directors. When one or more directors shall resign
from the Board of Directors, effective at a future date, a majority of the
directors then in office, including those who have so resigned, shall have power
to fill such vacancy or vacancies, the vote thereon to take effect when such
resignation or resignations shall become effective, and each director so chosen
shall hold office for the unexpired portion of the term of the director whose
place shall be vacated and until his successor shall have been duly elected and
qualified.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 20. Removal. </font>Subject
to the Articles of Incorporation, any director may be removed by the affirmative
vote of the holders of a majority of the outstanding shares of the Corporation
then entitled to vote, with or without cause.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
21. Meetings.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Annual Meetings. The annual meeting of the Board of Directors shall be held
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">immediately
after the annual meeting of stockholders and at the place where such meeting is
held. No notice of an annual meeting of the Board of Directors shall be
necessary and such meeting shall be held for the purpose of electing officers
and transacting such other business as may lawfully come before it.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)
Regular Meetings. Except as hereinafter otherwise provided, regular meetings of
the Board of Directors shall be held in the office of the corporation required
to be maintained pursuant to Section 2 hereof. Unless otherwise restricted by
the Articles of Incorporation, regular meetings of the Board of Directors may
also be held at any place within or without the state of Nevada which has been
designated by resolution of the Board of Directors or the written consent of all
directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)
Special Meetings. Unless otherwise restricted by the Articles of h1corporation,
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">special
meetings of the Board of Directors may be held at any time and place within or
without the State of Nevada whenever called by the Chairman of the Board, the
President or any two of the directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)
Telephone Meetings. Any member of the Board of Directors, or of any committee
thereof, may participate in a meeting by means of conference telephone or
similar communications equipment by means of which all persons participating in
the meeting can hear each other, and participation in a meeting by such means
shall constitute presence in person at such meeting.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)
Notice of Meetings. Notice of the time and place of all special meetings of the
Board of Directors shall be orally or in writing, by telephone, facsimile,
telegraph or telex, during normal business hours, at least twenty-four (24)
hours before the date and time of the meeting, or sent in writing to each
director by first class mail, charges prepaid, at least three (3) days before
the date of the meeting. Notice of any meeting may be waived in writing at any
time before or after the meeting and will be waived by any director by
attendance thereat, except when the director attends the meeting for the express
purpose of objecting, at the beginning of the meeting, to the transaction of any
business because the meeting is not lawfully called or convened.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">7</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)
Waiver of Notice. The transaction of all business at any meeting of the Board of
Directors, or any committee thereof, however called or noticed, or wherever
held, shall be as valid as though had at a meeting duly held after regular call
and notice, if a quorum be present and if, either before or after the meeting,
each of the directors not present shall sign a written waiver of notice. All
such waivers shall be filed with the corporate records or made a part of the
minutes of the meeting.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 22. Quorum and
Voting</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Unless the Articles of Incorporation requires a greater number and except with
respect to indemnification questions arising under Section 43 hereof; for which
a quorum shall be one-third of the exact number of directors fixed from time to
time in accordance with the Articles of Incorporation, a quorum of the Board of
Directors shall consist of a majority of the exact number of directors fixed
from time to time by the Board of Directors in accordance with the Articles of
Incorporation provided, however, at any meeting whether a quorum be present or
otherwise, a majority of the directors present may adjourn from time to time
until the time fixed for the next regular meeting of the Board of directors,
without notice other than by announcement at the meeting.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) At
each meeting of the Board of Directors at which a quorum is present, all
questions and business shall be determined by the affirmative vote of a majority
of the directors present, unless a different vote be required by law, the
Articles of Incorporation or these Bylaws.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 23. Action Without
Meeting</font>. Unless otherwise restricted by the Articles of Incorporation or
these Bylaws, any action required or permitted to be taken at any meeting of the
Board of Directors or of any committee thereof may be taken without a meeting,
if all members of the Board of Directors or committee, as the case may be,
consent thereto in writing, and such writing or writings are filed with the
minutes of proceedings of the Board of Directors or committee.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 24. Fees and
Compensation</font>. Directors shall be entitled to such compensation for their
services as may be approved by the Board of Directors, including, if so
approved, by resolution of the Board of Directors, a fixed sum and expenses of
attendance, if any, for attendance at each regular or special meeting of the
Board of Directors and at any meeting of a committee of the Board of Directors.
Nothing herein contained shall be construed to preclude any director from
serving the corporation in any other capacity as an officer, agent, employee, or
otherwise and receiving compensation therefor.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 25.
Committees</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Executive Committee. The Board of Directors may by resolution passed by a
majority of the whole Board of Directors appoint an Executive Committee to
consist of one (I) or more members of the Board of directors. The Executive
Committee, to the extent permitted by law and provided in the resolution of the
Board of directors shall have and may exercise all the powers and authority of
the Board of Directors in the management of the business and affairs of the
corporation, including without limitation the power or authority to declare a
dividend, to authorize the issuance of stock and to adopt a certificate of
ownership and merger, and may authorize the seal of the corporation to be
affixed to all papers which may require it; but no such committee shall have the
power or authority in reference to amending the Articles of Incorporation
(except that a committee may, to the extent authorized in the resolution or
resolutions providing for the issuance of shares of stock adopted by the Board
of Directors fix the designations and any of the preferences or rights of such
shares relating to dividends, redemption, dissolution, any distribution of
assets of the corporation or the conversion into, or the exchange of such shares
for, shares of any other class or classes or any other series of the same or any
other class or classes of stock of the corporation or fix the number of shares
of any series of stock or authorize the increase or decrease of the shares of
any series), adopting an agreement of merger or consolidation, recommending to
the stockholders the sale, lease or exchange of all or substantially all of the
corporation's property and assets, recommending to the stockholders a
dissolution of the corporation or a revocation of a dissolution, or amending the
bylaws of the corporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">8</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) Other
Committees. The Board of directors may, by resolution passed by a majority of
the whole Board of Directors, from time to time appoint such other committees as
may be permitted by law. Such other committees appointed by the Board of
Directors shall consist of one (I) or more members of the Board of Directors and
shall have such powers and perform such duties as may be prescribed by the
resolution or resolutions creating such committees, but in no event shall such
committee have the powers denied to the Executive Committee in these
Bylaws.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) Term.
Each member of a committee of the Board of directors shall serve a term on the
committee coexistent with such member's term on the Board of Directors. The
Board of Directors, subject to the provisions of subsections (a) or (b) of this
Bylaw may at any time increase or decrease the number of members of a committee
or terminate the existence of a committee. The membership of a committee member
shall terminate on the date of his death or voluntary resignation from the
committee or from the Board of Directors. The Board of directors may at any time
for any reason remove any individual committee member and the Board of directors
may fill any committee vacancy created by death, resignation, removal or
increase in the number of members of the committee. The Board of directors may
designate one or more directors as alternate members of any committee, who may
replace any absent or disqualified member at any meeting of the committee, and,
in addition, in the absence or disqualification of any member of a committee,
the member or members thereof present at any meeting and not disqualified from
voting, whether or not he or they constitute a quorum, may unanimously appoint
another member of the Board of Directors to act at the meeting in the place of
any such absent or disqualified member.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)
Meetings. Unless the Board of directors shall otherwise provide, regular
meetings of the Executive Committee or any other committee appointed pursuant to
this Section 25 shall be held at such times and places as are determined by the
Board of directors, or by any such committee, and when notice thereof has been
given to each member of such committee, no further notice of such regular
meetings need be given thereafter. Special meetings of any such committee may be
held at any place which has been determined from time to time by such committee,
and may be called by any director who is a member of such committee, upon
written notice to the members of such committee of the time and place of such
special meeting given in the manner provided for the giving of written notice to
members of the Board of Directors of the time and place of special meetings of
the Board of Directors. Notice of any special meeting of any committee may be
waived in writing at any time before or after the meeting and will be waived by
any director by attendance thereat, except when the director attends such
special meeting for the express purpose of objecting, at the beginning of the
meeting, to the transaction of any business because the meeting is not lawfully
called or convened. A majority of the authorized number of members of any such
committee shall constitute a quorum for the transaction of business, and the act
of a majority of those present at any meeting at which a quorum is present shall
be the act of such committee.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 26. Organization</font>. At
every meeting of the directors, the Chairman of the Board of Directors, or, if a
Chairman has not been appointed or is absent, the President, or if the President
is absent, the most senior Vice President, or, in the absence of any such
officer, a chairman of the meeting chosen by a majority of the directors
present, shall preside over the meeting. The Secretary, or in his absence, an
Assistant Secretary directed to do so by the President, shall act as secretary
of the meeting.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">9</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
V</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OFFICERS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 27. Officers
Designated</font>. The officers of the corporation shall include, if and when
designated by the Board of directors, the Chairman of the Board of directors,
the Chief Executive Officer, the President, one or more Vice Presidents, the
Secretary, the Chief Financial Officer, the Treasurer, the Controller, all of
whom shall be elected at the annual organizational meeting of the Board of
Directors. The Board of Directors may also appoint one or more Assistant
Secretaries, Assistant Treasurers, Assistant Controllers and such other officers
and agents with such powers and duties as it shall deem necessary. The Board of
directors may assign such additional titles to one or more of the officers as it
shall deem appropriate. Anyone person may hold any number of offices of the
corporation at anyone time unless specifically prohibited therefrom by law. The
salaries and other compensation of the officers of the corporation shall be
fixed by or in the manner designated by the Board of Directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
28. Tenure and Duties of Officers.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
General. All officers shall hold office at the pleasure of the Board of
directors and until their successors shall have been duly elected and qualified,
unless sooner removed. Any officer elected or appointed by the Board of
Directors may be removed at any time by the Board of Directors. If the office of
any officer becomes vacant for any reason, the vacancy may be filled by the
Board of Directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)
Duties of Chairman of the Board of Directors. The Chairman of the Board of
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Directors,
when present, shall preside at all meetings of the stockholders and the Board of
Directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Chairman of the Board of directors shall perform other duties commonly incident
to his office and shall also perform such other duties and have such other
powers as the Board of directors shall designate from time to time. If there is
no President, then the Chairman of the Board of Directors shall also serve as
the Chief Executive Officer of the corporation and shall have the powers and
duties prescribed in paragraph (c) of this Section 28.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)
Duties of President. The President shall preside at all meetings of the
stockholders and at all meetings of the Board of directors, unless the Chairman
of the Board of directors has been appointed and is present. Unless some other
officer has been elected Chief Executive Officer of the corporation, the
President shall be the chief executive officer of the corporation and shall,
subject to the control of the Board of directors, have general supervision,
direction and control of the business and officers of the corporation. The
President shall perform other duties commonly incident to his office and shall
also perform such other duties and have such other powers as the Board of
directors shall designate from time to time.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">10</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)
Duties of Vice Presidents. The Vice Presidents may assume and perform the duties
of the President in the absence or disability of the President or whenever the
office of President is vacant. The Vice Presidents shall perform other duties
commonly incident to their office and shall also perform such other duties and
have such other powers as the Board of directors or the President shall
designate from time to time.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)
Duties of Secretary. The Secretary shall attend all<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>meetings of the
stockholders and of the Board of Directors and shall record all acts and
proceedings thereof in the minute book of the corporation. The Secretary shall
give notice in conformity with these Bylaws of all meetings of the stockholders
and of all meetings of the Board of Directors and any committee thereof
requiring notice. The Secretary shall perform all other duties given him in
these Bylaws and other duties commonly incident to his office and shall also
perform such other duties and have such other powers as the Board of directors
shall designate from time to time. The President may direct any Assistant
Secretary to assume and perfo11ll the duties of the Secretary in the absence or
disability of the Secretary, and each Assistant Secretary shall perform other
duties commonly incident to his office and shall also perform such other duties
and have such other powers as the Board of Directors or the President shall
designate from time to time.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)
Duties of Chief Financial Officer. The Chief Financial Officer shall keep or
cause to be kept the books of account of the corporation in a thorough and
proper manner and shall render statements of the financial affairs of the
corporation in such form and as often as required by the Board of directors or
the President. The Chief Financial Officer, subject to the order of the Board of
Directors, shall have the custody of all funds and securities of the
corporation. The Chief Financial Officer shall perform other duties commonly
incident to his office and shall also perform such other duties and have such
other powers as the Board of Directors or the President shall designate from
time to time. The President may direct the Treasurer or any Assistant Treasurer,
or the Controller or any Assistant Controller to assume and perform the duties
of the Chief Financial Officer in the absence or disability of the Chief
Financial Officer, and each Treasurer and Assistant Treasurer and each
Controller and Assistant Controller shall perform other duties commonly incident
to his office and shall also perform such other duties and have such other
powers as the Board of Directors or the President shall designate from time to
time.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 29. Delegation of
Authority</font>. The Board of Directors may from time to time delegate the
powers or duties of any officer to any other officer or agent, notwithstanding
any provision hereof.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 30. Resignations</font>. Any
officer may resign at any time by giving written notice to the Board of
Directors or to the President or to the Secretary. Any such resignation shall be
effective when received by the person or persons to whom such notice is given,
unless a later time is specified therein, in which event the resignation shall
become effective at such later time. Unless otherwise specified in such notice,
the acceptance of any such resignation shall not be necessary to make it
effective. Any resignation shall be without prejudice to the rights, if any, of
the corporation under any contract with the resigning officer.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 31. Removal</font>. Any
officer may be removed from office at any time, either with or without cause, by
the affirmative vote of a majority of the directors in office at the time, or by
the unanimous written consent of the directors in office at the time, or by any
committee or superior officers upon whom such power of removal may have been
conferred by the Board of Directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">11</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
VI</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXECUTION
OF CORPORATE INSTRUMENTS AND VOTING</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OF
SECURITIES OWNED BY THE CORPORATION</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 32. Execution of Corporate
Instruments</font>. The Board of Directors may, in its discretion, determine the
method and designate the signatory officer or officers, or other person or
persons, to execute on behalf of the corporation any corporate instrument or
document, or to sign on behalf of the corporation the corporate name without
limitation, or to enter into contracts on behalf of the corporation, except
where otherwise provided by law or these Bylaws, and such execution or signature
shall be binding upon the corporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless
otherwise specifically determined by the Board of directors or otherwise
required by law, promissory notes, deeds of trust, mortgages and other evidences
of indebtedness of the corporation, and other corporate instruments or documents
requiring the corporate seal, and certificates of shares of stock owned by the
corporation, shall be executed, signed or endorsed by the Chairman of the Board
of Directors, or the President or any Vice President, and by the Secretary or
Treasurer or any Assistant Secretary or Assistant Treasurer. All other
instruments and documents requiting the corporate signature, but not requiring
the corporate seal, may be executed as aforesaid or in such other manner as may
be directed by the Board of directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
checks and drafts drawn on banks or other depositaries on funds to the credit of
the corporation or in special accounts of the corporation shall be signed by
such person or persons as the Board of Directors shall authorize so to
do.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless
authorized or ratified by the Board of Directors or within the agency power of
an </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">officer,
no officer, agent or employee shall have any power or authority to bind the
corporation by any contract or engagement or to pledge its credit or to render
it liable for any purpose or for any amount.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 33. Voting of Securities
Owned by the Corporation</font>. All stock and other securities of other
corporations owned or held by the corporation for itself, or for other parties
in any capacity, shall be voted, and an proxies with respect thereto shall be
executed, by the person authorized so to do by resolution of the Board of
Directors, or, in the absence of such authorization, by the Chairman of the
Board of Directors, the Chief Executive Officer, the President, or any Vice
President.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
VII</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SHARES OF
STOCK</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 34. Form and Execution of
Certificates.</font> Certificates for the shares of stock of the corporation
shall be in such form as is consistent with the Articles of Incorporation and
applicable law. Every holder of stock in the corporation shall be entitled to
have a certificate signed by or in the name of the corporation by the Chairman
of the Board of Directors, or the President or any Vice President and by the
Treasurer or Assistant Treasurer or the Secretary or Assistant Secretary,
certifying the number of shares owned by him in the corporation. Any or all of
the signatures on the certificate may be facsimiles. In case any officer,
transfer agent, or registrar who has signed or whose facsimile signature has
been placed upon a certificate shall have ceased to be such officer, transfer
agent, or registrar before such certificate is issued, it may be issued with the
same effect as if he were such officer, </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">12</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">transfer
agent, or registrar at the date of issue. Each certificate shall state upon the
face or back thereof, in full or in summary, all of the powers, designations,
preferences, and rights, and the limitations or restrictions of the shares
authorized to be issued or shall, except as otherwise required by law, set forth
on the face or back a statement that the corporation will furnish without charge
to each stockholder who so requests the powers, designations, preferences and
relative, participating, optional, or other special rights of each class of
stock or series thereof and the qualifications, limitations or restrictions of
such preferences and/or rights. Within a reasonable time after the issuance or
transfer of uncertificated stock, the corporation shall send to the registered
owner thereof a written notice containing the information required to be set
forth or stated on certificates pursuant to this section or otherwise required
by law or with respect to this section a statement that the corporation will
furnish without charge to each stockholder who so requests the powers,
designations, preferences and relative participating, optional or other special
rights of each class of stock or series thereof and the qualifications,
limitations or restrictions of such preferences and/or rights. Except as
otherwise expressly provided by law, the rights and obligations of the holders
of certificates representing stock of the same class and series shall be
identical.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 35. Lost Certificates</font>.
A new certificate or certificates shall be issued in place of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
certificate or certificates theretofore issued by the corporation alleged to
have been lost, stolen, or destroyed, upon the making of an affidavit of that
fact by the person claiming the certificate of stock to be lost, stolen, Or
destroyed. The corporation may require, as a condition precedent to the issuance
of a new certificate or certificates, the owner of such lost, stolen, or
destroyed certificate or certificates, or his legal representative, to advertise
the same in such manner as it shall require or to give the corporation a surety
bond in such form and amount as it may direct as indemnity against any claim
that may be made against the corporation with respect to the certificate alleged
to have been lost, stolen, or destroyed.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
36. Transfers.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Transfers of record of shares of stock of the corporation shall be made only
upon its books by the holders thereof, in person or by attorney duly authorized,
and upon the surrender of a properly endorsed certificate or certificates for a
like number of shares.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The
corporation shall have power to enter into and perfol1n any agreement with any
number of stockholders of anyone or more classes of stock of the corporation to
restrict the transfer of shares of stock of the corporation of any one or more
classes owned by such stockholders in any manner not prohibited by the General
Corporation Law of Nevada.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
37. Fixing Record Dates.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) In
order that the corporation may determine the stockholders entitled to notice of
or to vote at any meeting of stockholders or any adjournment thereof, the Board
of directors may fix, in advance, a record date, which record date shall not
precede the date upon which the resolution fixing the record date is adopted by
the Board of directors, and which record date shall not be more than sixty (60)
nor less than ten (10) days before the date of such meeting. If no record date
is fixed by the Board of directors, the record date for determining stockholders
entitled to notice of or to vote at a meeting of stockholders shall be at the
close of business on the day next preceding the day on which notice is given, or
if notice is waived, at the close of business on the day next preceding the day
on which the meeting is held. A determination of stockholders of record entitled
to notice of or to vote at a meeting of stockholders shall apply to any
adjournment of the meeting; provided, however, that the Board of directors may
fix a new record date for the adjourned meeting.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">13</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) In
order that the corporation may determine the stockholders entitled to receive
payment of any dividend or other distribution or allotment of any rights or the
stockholders entitled to exercise any rights in respect of any change,
conversion or exchange of stock, or for the purpose of any other lawful action,
the Board of Directors may fix, in advance, a record date, which record date
shall not precede the date upon which the resolution fixing the record date is
adopted, and which record date shall be not more than sixty (60) days prior to
such action. If o record date is filed, the record date for determining
stockholders for any such purpose shall be at the close of business on the day
on which the Board of Directors adopts the resolution relating
thereto.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 38. Registered
Stockholders.</font> The corporation shall be entitled to recognize the
exclusive right of a person registered on its books as the owner of shares to
receive dividends, and to vote as such owner, and shall not be bound to
recognize any equitable or other claim to or interest in such share or shares on
the part of any other person whether or not it shall have express or other
notice thereof, except as otherwise provided by the laws of Nevada.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
VIII</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OTHER
SECURITIES OF THE CORPORATION</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 39. Execution of Other
Securities</font>. All bonds, debentures and other corporate securities of the
corporation, other than stock certificates (covered in Section 34), may be
signed by the Chairman of the Board of Directors, the President or any Vice
President, or such other person as may be authorized by the Board of Directors,
and the corporate seal impressed thereon or a facsimile of such seal imprinted
thereon and attested by the signature of the Secretary or an Assistant
Secretary, or the Chief Financial Officer or Treasurer or an Assistant
Treasurer; provided, however, that where any such bond, debenture or other
corporate security shall be authenticated by the manual signature, or where
permissible facsimile signature, of a trustee under an indenture pursuant to
which such bond, debenture or other corporate security shall be issued, the
signatures of the persons signing and attesting the corporate seal on such bond,
debenture or other corporate security may be the imprinted facsimile of the
signatures of such persons. Interest coupons appertaining to any such bond,
debenture or other corporate security, authenticated by a trustee as aforesaid,
shall be signed by the Treasurer or an Assistant Treasurer of the corporation or
such other person as may be authorized by the Board of Directors, or bear
imprinted thereon the facsimile signature of such person. In case any officer
who shall have signed or attested any bond, debenture or other corporate
security, or whose facsimile signature shall appear thereon or on any such
interest coupon, shall have ceased to be such officer before the bond, debenture
or other corporate security so signed or attested shall have been delivered,
such bond, debenture or other corporate security nevertheless may be adopted by
the corporation and issued and delivered as though the person who signed the
same or whose facsimile signature shall have been used thereon had not ceased to
be such officer of the corporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
IX</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DIVIDENDS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 40. Declaration of
Dividends</font>. Dividends upon the capital stock of the corporation, subject
to the provisions of the Articles of Incorporation, if any, may be declared by
the Board of Directors pursuant to law at any regular or special meeting.
Dividends may be paid in cash, in property, or in shares of the capital stock,
subject to the provisions of the Articles of Incorporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">14</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 41. Dividend Reserve</font>.
Before payment of any dividend, there may be set aside out of any funds of the
corporation available for dividends such sum or owns as the Board of Directors
from time to time, in their absolute discretion, think proper as a reserve or
reserves to meet contingencies, or for equalizing dividends, or for repairing or
maintaining any property of the corporation, or for such other purpose as the
Board of Directors shall think conducive to the interests of the corporation,
and the Board of Directors may modify or abolish any such reserve in the manner
in which it was created.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
X</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FISCAL
YEAR</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 42. Fiscal Year. </font>The
fiscal year of the corporation shall be fixed by resolution of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the Board
of Directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
XI</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INDEMNIFICATION</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
43. Indemnification of Directors, Executive Officers, Other Officers, Employees
and Other Agents.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Directors Officers. The corporation shall indemnify its directors and officers
to the fullest extent not prohibited by the Nevada Revised Statutes; provided,
however, that the corporation may modify the extent of such indemnification by
individual contracts with its directors and officers; and, provided, further,
that the corporation shall not be required to indemnify any director or officer
in collection with any proceeding (or part thereof) initiated by such person
unless (i) such indemnification is expressly required to be made by law, (ii)
the proceeding was authorized by the Board of Directors of the corporation,
(iii) such indemnification is provided by the corporation, in its sole
discretion, pursuant to the powers vested in the corporation under the Nevada
Revised Statutes or (iv) such indemnification is required to be made under
subsection (d).</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)
Employees and Other Agents. The corporation shall have power to indemnify its
employees and other agents as set forth in the Nevada Revised
Statutes.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">15</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)
Expense. The corporation shall advance to any person who was or is a party or is
threatened to be made a party to any threatened, pending or completed action,
suit or proceeding, whether civil, criminal, administrative or investigative, by
reason of the fact that he is or was a director or officer, of the corporation,
or is or was serving at the request of the corporation as a director or
executive officer of another corporation, partnership, joint venture, trust or
other enterprise, prior to the final disposition of the proceeding, promptly
following request therefor, all&#160;&#160;expenses incurred by any director or
officer in connection with such proceeding upon receipt of an undertaking by or
on behalf of such person to repay said mounts if it should be determined
ultimately that such person is not entitled to be indemnified under this Bylaw
or otherwise. Notwithstanding the foregoing, unless otherwise determined
pursuant to paragraph (e) of this Bylaw, no advance shall be made by the
corporation to an officer of the corporation (except by reason of the fact that
such officer is or was a director of the corporation in which event this
paragraph shall not apply) in any action, suit or proceeding, whether civil,
criminal, administrative or investigative, if a determination is reasonably and
promptly made (i) by the Board of directors by a majority vote of a quorum
consisting of directors who were not parties to the proceeding, or (ii) if such
quorum is not obtainable, or, even if obtainable, a quorum of disinterested
directors so directs, by independent legal counsel in a written opinion, that
the facts known to the decision-making party at the time such determination is
made demonstrate clearly and convincingly that such person acted in bad faith or
in a manner that such person did not believe to be in or not opposed to the best
interests of the corporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)
Enforcement. Without the necessity of entering into an express contract, all
rights to indemnification and advances to directors and officers under this
Bylaw shall be deemed to be contractual rights and be effective to the same
extent and as if provided for in a contract between the corporation and the
director or officer. Any right to indemnification or advances granted by this
Bylaw to a director or officer shall be enforceable by or on behalf of the
person holding such right in any court of competent jurisdiction if (i) the
claim for indemnification or advances is denied, in whole or in part, or (ii) no
disposition of such claim is made within ninety (90) days of request therefor.
The claimant in such enforcement action, if successful in whole or in part,
shall be entitled to be paid also the expense of prosecuting his claim. In
connection with any claim for indemnification, the corporation shall be entitled
to raise as a defense to any such action that the claimant has not met the
standard of conduct that make it permissible under the Nevada Revised Statutes
for the corporation to indemnify the claimant for the amount claimed. In
collection with any claim by an officer of the corporation (except in any
action, suit or proceeding, whether civil, criminal, administrative or
investigative, by reason of the fact that such officer is or was a director of
the corporation) for advances, the corporation shall be entitled to raise a
defense as to any such action clear and convincing evidence that such person
acted in bad faith or in a manner that such person did not believe to be in or
not opposed in the best interests of the corporation, or with respect to any
criminal action or proceeding that such person acted without reasonable cause to
believe that his conduct was lawful. Neither the failure of the corporation
(including its Board of Directors, independent legal counselor its stockholders)
to have made a determination prior to the commencement of such action that
indemnification of the claimant is proper in the circumstances because he has
met the applicable standard of conduct set forth in the Nevada Revised Statutes,
nor an actual determination by the corporation (including its Board of
directors, independent legal counselor its stockholders) that the claimant has
not met such applicable standard of conduct, shall be a defense to the action or
create a presumption that claimant has not met the applicable standard of
conduct. In any suit brought by a director or officer to enforce a right to
indemnification or to an advancement o expenses hereunder, the burden of proving
that the director or officer is not entitled to be indemnified, or to such
advancement of expenses, under this Article XI or otherwise shall be on the
corporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">16</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)
Non-Exclusivity of Rights. The rights conferred on any person by this Bylaw
shall not be exclusive of any other right which such person may have or
hereafter acquire under any statute, provision of the Articles of Incorporation,
Bylaws, agreement, vote of stockholders or disinterested directors or otherwise,
both as to action in his official capacity and as to action in another capacity
while holding office. The corporation is specifically authorized to enter into
individual contracts with any or all of its directors, officers, employees or
agents respecting indemnification and advances, to the fullest extent not
prohibited by the Nevada Revised Statutes.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;Survival
of Rights. The rights conferred on any person by this Bylaw shall continue as to
a person who has ceased to be a director, officer, employee or other agent and
shall inure to the benefit of the heirs, executors and administrators of such a
person.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)&#160;&#160;Insurance.
To the fullest extent permitted by the Nevada Revised Statutes, the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">corporation,
upon approval by the Board of Directors, may purchase insurance on behalf of any
person required or permitted to be indemnified pursuant to this
Bylaw.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)
Amendments. Any repeal or modification of this Bylaw shall only be prospective
and shall not affect the rights under this Bylaw in effect at tile time of the
alleged occurrence of any action or omission to act that is the cause of any
proceeding against any agent of the corporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)
Saving Clause. If this Bylaw or any portion hereof shall be invalidated on any
ground by any court of competent jurisdiction, then the corporation shall
nevertheless indemnify each director and officer to the full extent not
prohibited by any applicable portion of this Bylaw that shall not have been
invalidated, or by any other applicable law.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)
Certain Definitions. For the purposes of this Bylaw, the following definitions
shall apply:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) The
term "proceeding" shall be broadly construed and shall include, without
limitation, the investigation, preparation, prosecution, defense, settlement,
arbitration and appeal of, and the giving of testimony in, any threatened,
pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii) The
term "expenses" shall be broadly construed and shall include, without
limitation, court costs, attorneys' fees, witness fees, fines, amounts paid in
settlement or judgment and any other costs and expenses of any nature or kind
incurred in collection with any proceeding.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii) The
term the "corporation" shall include, in addition to the resulting corporation,
any constituent corporation (including any constituent of a constituent)
absorbed in a consolidation or merger which, if its separate existence had
continued, would have had power and authority to indemnify its directors,
officers, and employees or agents, so that any person who is or was a director,
officer, employee or agent of such constituent corporation, or is or was serving
at the request of such constituent corporation as a director, officer, employee
or agent or another corporation, partnership, joint venture, trust or other
enterprise, shall stand in the same position under the provisions of this Bylaw
with respect to the resulting or surviving corporation as he would have with
respect to such constituent corporation if its separate existence had
continued.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">17</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)
References to a "director,&#8221; "executive officer,&#8221; "officer," "employee,&#8221; or
"agent" of the corporation shall include, without limitation, situations where
such person is serving at the request of the corporation as, respectively, a
director, executive officer, officer, employee, trustee or agent of another
corporation, partnership, joint venture, trust or other enterprise.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)
References to "other enterprises" shall include employee benefit plans;
references to "fines" shall include any excise taxes assessed on a person with
respect to an employee benefit plan; and references to "serving at the request
of the corporation" shall include any service as a director, officer, employee
or agent of the corporation which imposes duties on, or involves services by,
such director, officer, employee, or agent with respect to an employee benefit
plan, its participants, or beneficiaries; and a person who acted in good faith
and in a manner he reasonably believed to be in the interest of the participants
and beneficiaries of an employee benefit plan shall be deemed to have acted in a
manner "not opposed to the best interests of the corporation" as referred to in
this Bylaw.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
XII</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTICES</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
44.&#160;&#160;Notices.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Notice to Stockholders. Whenever, under any provisions of these Bylaws, notice
is required to be given to ,my stockholder, it shall be given in writing, timely
and duly deposited in the United States mail, postage prepaid, and addressed to
his last known post office address as shown by the stock record of the
corporation or its transfer agent.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)
Notice to directors. Any notice required to be given to any director may be
given by the method stated in subsection (a), or by facsimile, telex or
telegram, except that such notice other than one which is delivered personally
shall be sent to such address as such director shall have filed in writing with
the Secretary, or, in the absence of such filing, to the last known post office
address of such director.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)
Affidavit of Mailing. An affidavit of mailing, executed by a duly authorized and
competent employee of the corporation or its transfer agent appointed with
respect to the class of stock affected, specifying the name and address or the
names and addresses of the stockholder or stockholders, or director or
directors, to whom any such notice or notices was or were given, and the time
and method of giving the same, shall in the absence of fraud, be prima facie
evidence of the facts therein contained.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) Time
Notices Deemed Given. All notices given by mail, as above provided, shall be
deemed to have been given as at the time of mailing, and all notices given by
facsimile, telex or telegram shall be deemed to have been given as of the
sending time recorded at time of transmission.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">18</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)
Methods of Notice. It shall not be necessary that the same method of giving
notice be employed in respect of all directors, but one permissible method may
be employed in respect of any one or more, and any other permissible method or
methods may be employed in respect of any other or others.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)
Failure to Receive Notice. The period or limitation of time within which any
stockholder may exercise any option or right, or enjoy any privilege or benefit,
or be required to act, or within which any director may exercise any power or
right, or enjoy any privilege, pursuant to any notice sent him ill the manner
above provided, shall not be affected or extended in any manner by the failure
of such stockholder or such director to receive such notice.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)
Notice to Person with Whom Communication Is Unlawful. Whenever notice is
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">required
to be given, under any provision of law or of the Articles of Incorporation or
Bylaws of the corporation, to any person with whom communication is unlawful,
the giving of such notice to such person shall not be require and there shall be
no duty to apply to any governmental authority or agency for a license or permit
to give such notice to such person. Any action or meeting which shall be taken
or held without notice to any such person with whom communication is unlawful
shall have the same force and effect as if such notice had been duly given. In
the event that the action taken by the corporation is such as to require the
filing of a certificate under any provision of the Nevada Revised Statutes, the
certificate shall state, if such is the fact and if notice is required, that
notice was given to all persons entitled to receive notice except such persons
with whom</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">communication
is unlawful.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)
Notice to Person with Undeliverable Address. Whenever notice is required to be
given, under any provision of law or the Articles of Incorporation or Bylaws of
the corporation, to any stockholder to whom (i) notice of two consecutive annual
meetings, and all notices of meetings or of the taking of action by written
consent without a meeting to such person during the period between such two
consecutive annual meetings, or (ii) all, and at least two, payments (if sent by
first class mail) of dividends or interest on securities during a twelve-month
period, have been mailed addressed to such person at his address as shown on the
records of the corporation and have been returned undeliverable, the giving of
such notice to such person shall not be required. Any action or meeting which
shall be taken or held without notice to such person shall have the same force
and effect as if such notice had been duly given. If any such person shall
deliver to the corporation a written notice setting forth his then current
address, the requirement that notice be given to such person shall be
reinstated. In the event that the action taken by the corporation is such as to
require the filing of a certificate under any provision of the Nevada Revised
Statutes, the certificate need not state that notice was not given to persons to
whom notice was not required to be given pursuant to this
paragraph.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
XII</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">AMENDMENTS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 45. Amendments</font>. The
Board of Directors shall have the sole power to adopt, amend, or repeal Bylaws
as set forth in the Articles of Incorporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">19</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
XIV</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">LOANS TO
OFFICERS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 46. Loans to Officers.
</font>The corporation may lend money to, or guarantee any obligation of, or
otherwise assist any officer or other employee of the corporation or of its
subsidiaries, including any officer or employee who is a Director of the
corporation or its subsidiaries, whenever, in the judgment of the Board of
directors, such loan, guarantee or assistance may reasonably be expected to
benefit the corporation. The loan, guarantee or other assistance may be with or
without interest and may be unsecured, or secured in such manner as the Board of
Directors shall approve, including, without limitation, a pledge of shares of
stock of the corporation. Nothing in these Bylaws shall be deemed to deny, limit
or restrict the powers of guaranty or warranty of the corporation at common law
or under any statute.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
XV</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BOARD OF
ADVISORS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 47. Board of Advisors</font>.
The Board of Directors, in its discretion, may establish it </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Board of
Advisors consisting of individuals who may or may not be stockholders or
directors of the corporation. The purpose of the Board of Advisors would be to
advise the officers and directors of the corporation with respect to such
matters as such officers and directors shall choose, and any other such matters
which the members of such Board of Advisors deem appropriate in furtherance of
the best interest of the corporation. The Board of Advisors shall meet on such
basis as the members thereof may determine. The Board of Directors may eliminate
the Board of Advisors at any time. No member of the Board of Advisors, nor the
Board of Advisors itself, shall have any authority within the corporation or any
decision making power and shall be merely advisory in nature. Unless the Board
of Directors determines another method of appointment, the President shall
recommend possible members to the Board of Directors, who shall approve or
reject such appointments.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Declared
and certified as the Bylaws of VivaKor, Inc. on April 30, 2008.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Signature
of
Officer:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="TEXT-DECORATION: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#160; </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/
CHRISTOPHER A.
WILSON&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name of
Officer:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Christopher
A. Wilson</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Title of
Officer:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Secretary</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">20</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
  </body>
</html>





</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>vivakor_s1-ex1001.htm
<DESCRIPTION>2008 INCENTIVE PLAN
<TEXT>
<html>
  <head>
    <title>Unassociated Document</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT
10.1</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">2008 INCENTIVE
PLAN</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SECTION 1</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">GENERAL
PROVISIONS RELATING TO</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PLAN
GOVERNANCE, COVERAGE AND BENEFITS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.1 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Purpose</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
purpose of the 2008 Incentive Plan (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Plan</font>&#8221;)&#160;is to foster and
promote the long-term financial success of VivaKor, Inc. (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Company&#8221;</font>) and its Subsidiaries
and to increase stockholder value by: (a) encouraging the commitment of selected
key Employees, Consultants and Outside Directors, (b)&#160;motivating superior
performance of key Employees, Consultants and Outside Directors by means of
long-term performance related incentives, (c)&#160;encouraging and providing
key&#160;Employees, Consultants and Outside Directors with a program for
obtaining ownership interests&#160;in the Company which link and align their
personal interests to those of the Company&#8217;s stockholders, (d) attracting and
retaining key Employees, Consultants and Outside Directors by providing
competitive incentive compensation opportunities, and (e)&#160;enabling key
Employees, Consultants and Outside Directors to share in the long-term growth
and success of the Company.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Plan
provides for payment of various forms of incentive compensation. It is not
intended to be a plan that is subject to the Employee Retirement Income Security
Act of 1974, as amended (ERISA). The Plan will be interpreted, construed and
administered consistent with its status as a plan that is not subject to
ERISA.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Plan
was originally effective on October 23, 2008, subject to approval by the
Company&#8217;s stockholders pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;7.1</font> (the
&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Effective Date&#8221;</font>),
provided that with respect to Incentive Awards outstanding prior to the
Effective Date, such an award shall not be amended by any term herein if such
term would cause such award to be deferred compensation, a new grant under or
otherwise violate Code Section&#160;409A or would modify an Incentive Award
under Code Section&#160;424 resulting in a new grant, as determined by the
Committee. The Plan will remain in effect, subject to the right of the Board to
amend or terminate the&#160;Plan at any time pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;7.7</font>,
until all Shares subject to the Plan have been purchased&#160;or acquired
according to its provisions. However, in no event may an Incentive Award be
granted under the Plan after the expiration of ten (10)&#160;years from the
Effective Date.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.2 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Definitions</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;The
following terms shall have the meanings set forth below:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Appreciation</font>.
The difference between the option exercise price per share of the Nonstatutory
Stock Option to which a Tandem SAR relates and the Fair Market Value of a share
of Common Stock on the date of exercise of the Tandem SAR.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(b)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Authorized
Officer</font>. The Chairman of the Board, the CEO or any other senior officer
of the Company to whom either of them delegate the authority to execute any
Incentive Agreement for and on behalf of the Company.&#160;&#160;No officer or
director shall be an Authorized Officer with respect to any
Incentive&#160;Agreement for himself.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(c)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Board</font>.
The Board of Directors of the Company.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(d)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Cause</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>When used in connection with
the termination of a Grantee&#8217;s Employment, shall mean the termination of the
Grantee&#8217;s Employment by the Company or any Subsidiary by reason of (i)&#160;the
conviction of the Grantee by a court of competent jurisdiction as to which no
further appeal can be taken of a crime involving moral turpitude or a felony;
(ii)&#160;the proven commission by the Grantee of a material act of fraud upon
the Company or any Subsidiary, or any customer or supplier thereof;
(iii)&#160;the misappropriation of any funds or property of the Company or any
Subsidiary, or any customer or supplier&#160;&#160;thereof; (iv)&#160;the
willful, continued and unreasonable failure by the Grantee to perform the
material duties assigned to him that is not cured to the reasonable satisfaction
of the Company within 30&#160;days after written notice of such failure is
provided to Grantee by the Board or CEO (or by another officer of the Company or
a Subsidiary who has been designated by the Board or CEO for such purpose);
(v)&#160;the knowing engagement by the Grantee in any direct and material
conflict of interest with the Company or any Subsidiary without compliance with
the Company&#8217;s or Subsidiary&#8217;s conflict of interest policy, if any, then in
effect; or&#160;(vi) the knowing engagement by the Grantee, without the written
approval of the Board or CEO,&#160;in&#160;any material activity which competes
with the business of the Company or any Subsidiary or which&#160;would result in
a material injury to the business, reputation or goodwill of the Company or any
Subsidiary.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(e)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">CEO</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Chief Executive Officer
of the Company.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(f)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Code</font>.
The Internal Revenue Code of 1986, as amended, and the regulations and other
authority promulgated thereunder by the appropriate governmental authority.
References herein to any provision of the Code shall refer to any successor
provision thereto.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(g)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Committee</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A committee appointed by the
Board consisting of at least one member as appointed by the Board to administer
the Plan. However, if the Company becomes a Publicly Held Corporation, the Plan
shall be administered by a committee appointed by the Board consisting of not
less than two directors who (i)&#160;fulfill the&#160;&#8220;non-employee director&#8221;
requirements of Rule&#160;16b-3 under the Exchange Act and who is certified by
the Board as an independent director and (ii)&#160;fulfill the &#8220;outside
director&#8221; requirements of Section&#160;162(m) of the Code. In either case, the
Committee may be the compensation committee of the Board, or any subcommittee of
the&#160;compensation committee, provided that the members of the Committee
satisfy the requirements of the previous provisions of this
paragraph.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Board
shall have the power&#160;to&#160;fill vacancies on the Committee arising by
resignation, death, removal or otherwise.&#160;&#160;The Board, in its sole
discretion, may bifurcate the powers and duties of the Committee among one or
more separate committees, or retain all powers and duties of the Committee in a
single Committee. The members of the Committee shall serve at the discretion of
the Board.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
the preceding paragraphs of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;1.2(g)</font>,
the term &#8220;Committee&#8221; as used in the Plan&#160;shall mean the entire Board prior
to the time a Committee has been established by the Board and with respect to
any proposed grant of an Incentive Award for an Outside Director. In such cases,
the Board shall have all the powers and responsibilities of the Committee
hereunder, and&#160;any actions as to such Incentive Award may be acted upon
only by the Board (unless it&#160;otherwise designates in its discretion). When
the Board exercises its authority to act in the capacity as the Committee
hereunder with respect to an Incentive Award for an Outside Director, it shall
so designate with respect to any action that it undertakes in its capacity
as&#160;the Committee.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(h)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Common
Stock</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The common
stock of the Company, $0.001 par value per share, and any class of common stock
into which such common shares may hereafter be converted, reclassified or
recapitalized.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(i)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Company</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>VivaKor, Inc., a corporation
organized&#160;under the laws of the State of Nevada, and any successor in
interest thereto</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(j)</font><font id="TAB2" style="FONT-WEIGHT: bold; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Consultant</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>An independent agent,
consultant, attorney, an individual who has agreed to become an Employee within
the next six months, or any other individual who is not an Outside Director or
employee of the Company (or any Parent or Subsidiary) and who, in the opinion of
the Committee, (i) is in a position to contribute to the growth or financial
success of the&#160;Company (or any Parent or Subsidiary), (ii)&#160;is a
natural person and (iii)&#160;provides bona fide services to the Company (or any
Parent or Subsidiary), which services are not in connection with the offer or
sale of securities in a capital raising transaction, and do not directly or
indirectly promote or maintain a market for the Company&#8217;s
securities.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(k)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Change in
Control</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Any of
the events described in and subject to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.7</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(l)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Covered
Employee</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A named
executive officer who is one of the group of covered employees, as defined in
Section 162(m) of the Code and Treasury Regulation &#167;&#160;1.162-27(c) (or its
successor), during any such period that the Company is a Publicly Held
Corporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(m)</font><font id="TAB2" style="FONT-WEIGHT: bold; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Deferred
Stock</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Shares of
Common Stock to be issued or transferred to a Grantee under an Other Stock-Based
Award granted pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;5</font> at the
end of a specified deferral period, as set forth in the Incentive Agreement
pertaining thereto.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(n)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Disability</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>As determined by the
Committee in its discretion exercised in good faith, a physical or mental
condition of the Employee that would entitle him to payment&#160;of disability
income payments under the Company&#8217;s long term disability insurance&#160;policy
or plan for employees, as then effective, if any; or in the event that the
Grantee is not covered, for whatever reason, under the Company&#8217;s long-term
disability insurance policy or plan, &#8220;Disability&#8221; means a permanent and total
disability as defined in Section&#160;22(e)(3) of the Code. A determination of
Disability may be made by a physician selected or approved by the Committee and,
in this respect, the Grantee shall submit to any reasonable examination by such
physician upon request.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(o)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: normal">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Employee</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Any employee of the Company
(or any Parent or Subsidiary) within the meaning of Section 3401(c) of the Code
who, in the opinion of the Committee, is in a position to contribute to the
growth, development or financial&#160;success of the Company (or any Parent or
Subsidiary), including, without limitation, officers who are members of the
Board.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(p)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Employment</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Employment by the Company
(or any Parent or Subsidiary), or by any corporation issuing or assuming an
Incentive Award in any transaction described in Section 424(a) of the Code, or
by a parent corporation or a subsidiary corporation of such&#160;corporation
issuing or assuming such Incentive Award, as the parent-subsidiary relationship
shall be determined at the time of the corporate action described in Section
424(a) of the Code. In this regard, neither the transfer of a Grantee from
Employment by the&#160;Company to Employment by any Parent or Subsidiary, nor
the transfer of a Grantee from&#160;Employment by any Parent or Subsidiary to
Employment by the Company, shall be deemed to be a termination of Employment of
the Grantee. Moreover, the Employment of a Grantee shall not be deemed to have
been terminated because of an approved leave of absence from active Employment
on account of temporary illness, authorized vacation or granted for reasons of
professional advancement, education, health, government service, or military
leave, or during any period required to be treated as a leave of absence by
virtue of any applicable statute, Company personnel policy or agreement. Whether
an authorized leave of absence shall constitute termination of Employment
hereunder shall be determined by the Committee in its discretion.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless
otherwise provided in the Incentive Agreement, the term &#8220;Employment&#8221;
for&#160;purposes of the Plan is also defined to include (i)&#160;compensatory
or advisory services&#160;performed by a Consultant for the Company (or any
Parent or Subsidiary) and (ii)&#160;membership on the Board by an Outside
Director. Notwithstanding the foregoing, with respect to an Incentive Award that
is deferred compensation subject to Code Section&#160;409A a termination of
Employment shall be determined by the Committee under the &#8220;separation from
service&#8221; requirements under Code Section&#160;409A.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(q)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exchange
Act</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
Securities Exchange Act of 1934, as amended</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(r)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Fair
Market Value</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>If
the Company is not a Publicly Held Corporation at the time a determination of
the Fair Market Value of the Common Stock is required to be made hereunder, the
determination of Fair Market Value for purposes of the Plan shall be made by the
Committee in its discretion exercised in good faith, and to the extent any
Incentive Award is intended to be exempt from Code Section&#160;409A, consistent
with Code Section&#160;409A as it shall determine. In this respect, the
Committee may rely on such financial data, appraisals, valuations, experts, and
other sources as, in its sole and absolute discretion, it deems advisable under
the circumstances.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the
Company is a Publicly Held Corporation, the Fair Market Value of one share of
Common Stock on the date in question is deemed to be (i)&#160;the closing sales
price on the immediately preceding business day of a share of Common Stock as
reported on the New York Stock Exchange or other principal securities exchange
on which Shares are then listed or admitted to trading, or (ii)&#160;the closing
sales price for a Share on the date of grant as quoted on the National
Association of Securities Dealers Automated Quotation System (&#8220;NASDAQ&#8221;),
(iii)&#160;if not quoted on NASDAQ, the average of the closing bid and asked
prices for a Share as quoted by the National Quotation Bureau&#8217;s &#8220;Pink Sheets&#8221; or
the National Association of Securities Dealers&#8217; OTC Bulletin Board System, or
(iv)&#160;any other method permitted by Code Section&#160;409A as determined by
the Committee in its discretion and consistently applied. If there was no public
trade of Common Stock on the date in question, Fair Market Value shall be
determined by reference to the last preceding date on which such a trade was so
reported.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(s)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Grantee</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Any Employee, Consultant or
Outside Director who is granted an Incentive Award under the Plan.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(t)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Immediate
Family</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>With
respect to a Grantee, the Grantee&#8217;s child, stepchild, grandchild, parent,
stepparent, grandparent, spouse, former spouse, sibling, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law,
including adoptive relationships.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(u)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Incentive
Award</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A grant of
an award under the Plan to a Grantee, including any Nonstatutory Stock Option,
Incentive Stock Option, Reload Option, Stock Appreciation Right, Restricted
Stock Award, Performance Unit, Performance Share, or Other Stock-Based Award, as
well as any Supplemental Payment.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Incentive
Agreement</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
written agreement entered into between the Company and the Grantee setting forth
the terms and conditions pursuant to which an Incentive Award is granted under
the Plan, as such agreement is further defined in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.1(a)</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(w)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Incentive
Stock Option or ISO</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>A Stock Option granted by the Committee to an Employee under <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;2</font> which
is designated by the Committee as an Incentive Stock Option and intended to
qualify as an Incentive Stock Option under Section&#160;422 of the
Code.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">5</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(x)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Independent
SAR</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A Stock
Appreciation Right described in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section
2.5</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(y)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Insider</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>If the Company is a Publicly
Held Corporation, an individual who is, on the relevant date, an officer,
director or ten percent (10%) beneficial owner of any class of the Company&#8217;s
equity securities that is registered pursuant to Section&#160;12 of the Exchange
Act, all as defined under Section&#160;16 of the Exchange Act.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(z)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Nonstatutory
Stock Option</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A
Stock Option granted by the Committee to a Grantee under <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;2</font> that
is not designated by the Committee as an Incentive Stock Option.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(aa)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Option
Price</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
exercise price at which a Share may be purchased by the Grantee of a Stock
Option.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(bb)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Other
Stock-Based Award</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>An award granted by the Committee to a Grantee under <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;5.1</font> that
is valued in whole or in part by reference to, or is otherwise based upon,
Common Stock and payable in Common Stock, cash or other
consideration.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(cc)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Outside
Director</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A
member of the Board who is not, at the time of grant of an Incentive Award, an
employee of the Company or any Parent or Subsidiary within the meaning of 16b-3
under the Exchange Act.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(dd)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Parent</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Any corporation (whether now
or hereafter existing) which constitutes a &#8220;parent&#8221; of the Company, as defined
in Section 424(e) of the Code.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(ee)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Performance-Based
Exception</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
performance-based exception from the tax deductibility limitations of Section
162(m) of the Code, as prescribed in Code &#167; 162(m) and Treasury Regulation &#167;
1.162-27(e) (or its successor), which is applicable during such period that the
Company is a Publicly Held Corporation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ff)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Performance
Period</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A period
of time determined by the Committee over which performance is measured for the
purpose of determining a Grantee&#8217;s right to and the payment value of any
Performance Unit, Performance Share or Other Stock-Based Award.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(gg)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Performance
Share or Performance Unit</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>An Incentive Award
representing a contingent right to receive cash or shares of Common Stock (which
may be Restricted Stock) at the end of&#160;&#160;a Performance Period and
which, in the case of Performance Shares, is denominated in Common Stock, and,
in the case of Performance Units, is denominated in cash values.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(hh)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Plan</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>VivaKor, Inc. 2008 Incentive
Plan as set forth herein and as it may be amended from time to
time.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">6</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font size="+0"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(ii)</font><font id="TAB2" style="FONT-WEIGHT: normal; COLOR: black; LETTER-SPACING: 9pt">&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Publicly
Held Corporation</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>A corporation issuing any class of common equity securities required to
be registered under Section&#160;12 of the Exchange Act and listed on a
nationally recognized stock exchange or automated quotation system; provided,
however, the Over The Counter Bulletin Board shall not be considered a
nationally recognized stock exchange.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(jj)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Restricted
Stock</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Shares of
Common Stock issued or transferred to a Grantee pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;3</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(kk)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Restricted
Stock Award</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>An
authorization by the Committee to issue or transfer Restricted Stock to a
Grantee.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(ll)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Restriction
Period</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
period of time determined by the Committee and set forth in the Incentive
Agreement during which the transfer of Restricted Stock by the Grantee is
restricted.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(mm)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Retirement</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The voluntary termination of
Employment from the Company or any Parent or Subsidiary constituting retirement
for age on any date after the Employee attains the normal retirement age of
65&#160;years, or such other age as may be designated by the Committee in the
Employee&#8217;s Incentive Agreement.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(nn)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Share</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A share of the Common Stock
of the Company.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(oo)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Share
Pool</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The number
of shares authorized for issuance under <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;1.4</font>, as
adjusted for awards and payouts under <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;1.5</font> and
as adjusted for changes in corporate capitalization under <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.5</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(pp)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Spread</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The difference between the
exercise price per Share specified in any Independent SAR grant and the Fair
Market Value of a Share on the date of exercise of the Independent
SAR.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;(qq)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Stock
Appreciation Right or SAR</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A Tandem SAR described in
<font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;2.4</font> or
an Independent SAR described in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;2.5</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;(rr)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Stock
Option or Option</font>. Pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;2</font>,
(i)&#160;an Incentive Stock Option granted to an Employee, or (ii)&#160;a
Nonstatutory Stock Option granted to an Employee, Consultant or Outside
Director, whereunder such option the Grantee has the right to purchase Shares of
Common Stock. In accordance with Section&#160;422 of the Code, only an Employee
may be granted an Incentive Stock Option.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;(ss)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Subsidiary</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Any corporation (whether now
or hereafter existing) which constitutes a &#8220;subsidiary&#8221; of the Company, as
defined in Section 424(f) of the Code.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">7</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;(tt)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Supplemental
Payment</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Any
amount, as described in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Sections&#160;2.7, 3.4
and/or 4.2</font>, that is dedicated to payment of income taxes which are
payable by the Grantee resulting from an Incentive Award.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;(uu)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Tandem
SAR</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A Stock
Appreciation Right that is granted in connection with a related Stock Option
pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;2.4</font>, the
exercise of which shall require forfeiture of the right to purchase a Share
under the related Stock Option (and when a Share is purchased under the Stock
Option, the Tandem SAR shall similarly be canceled).</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.3 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Plan
Administration</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;(a)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Authority
of the Committee</font>. Except as may be limited by law and subject to the
provisions herein, the Committee shall have full power to (i)&#160;select
Grantees who shall participate in the Plan; (ii)&#160;determine the sizes,
duration and types of Incentive Awards; (iii)&#160;determine the terms and
conditions of Incentive Awards and Incentive Agreements; (iv)&#160;determine
whether any Shares subject to Incentive Awards will be subject to any
restrictions on transfer; (v)&#160;construe and interpret the Plan and any
Incentive Agreement or other agreement entered into under the Plan; and
(vi)&#160;establish, amend, or waive rules for the Plan&#8217;s administration.
Further, the Committee shall make all other determinations which may be
necessary or advisable for the administration of the Plan including, without
limitation, correcting any defect, supplying any omission or reconciling any
inconsistency in the Plan or Incentive Agreement. The determination of the
Committee shall be final and binding on all persons.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;(b)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Meetings</font>.
The Committee shall designate a chairman from among its members who shall
preside at all of its meetings, and shall designate a secretary, without regard
to whether that person is a member of the Committee, who shall keep the minutes
of the proceedings and all records, documents, and data pertaining to its
administration of the Plan. Meetings shall be held at such times and places as
shall be determined by the Committee and the Committee may hold telephonic
meetings. The Committee may take any action otherwise proper under the Plan by
the affirmative vote, taken with or without a meeting, of a majority of its
members. The Committee may authorize any one or more of their members or any
officer of the Company to execute and deliver documents on behalf of the
Committee.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;(c)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Decisions
Binding</font>. All determinations and decisions made by the Committee shall be
made in its discretion pursuant to the provisions of the Plan, and shall be
final, conclusive and binding on all persons including the Company, its
shareholders, Employees, Grantees, and their estates and beneficiaries. The
Committee&#8217;s decisions and determinations with respect to any Incentive Award
need not be uniform and may be made selectively among Incentive Awards and
Grantees, whether or not such Incentive Awards are similar or such Grantees are
similarly situated.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">8</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;(d)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Modification
of Outstanding Incentive Awards</font>. Subject to the stockholder approval
requirements of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;7.7</font> if
applicable, the Committee may, in its discretion, provide for the extension of
the exercisability of an Incentive Award, accelerate the vesting or
exercisability of an Incentive Award, eliminate or make less restrictive any
restrictions contained in an Incentive Award, waive any restriction or other
provisions of an Incentive Award, or otherwise amend or modify an Incentive
Award in any manner that is either (i)&#160;not adverse to the Grantee to whom
such Incentive Award was granted or (ii)&#160;consented to by such Grantee. With
respect to an Incentive Award that is an incentive stock option (as described in
Section&#160;422 of the Code), no adjustment to such option shall be made to the
extent constituting a &#8220;modification&#8221; within the meaning of
Section&#160;424(h)(3) of the Code unless otherwise agreed to by the optionee in
writing.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;(e)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Delegation
of Authority</font>. The Committee may delegate to designated officers or other
employees of the Company any of its duties and authority under the Plan pursuant
to such conditions or limitations as the Committee may establish from time to
time; provided, however, the Committee may not delegate to any person the
authority to (i)&#160;grant Incentive Awards, or (ii), if the Company is a
Publicly Held Corporation, take any action which would contravene the
requirements of Rule&#160;16b-3 under the Exchange Act or the Performance-Based
Exception under Section 162(m) of the Code.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;(f)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Expenses
of Committee</font>. The Committee may employ legal counsel, including, without
limitation, independent legal counsel and counsel regularly employed by the
Company, and other agents as the Committee may deem appropriate for the
administration of the Plan. The Committee may rely upon any opinion or
computation received from any such counsel or agent. All expenses incurred by
the Committee in interpreting and administering the Plan, including, without
limitation, meeting expenses and professional fees, shall be paid by the
Company.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;(g)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Surrender
of Previous Incentive Awards</font>. The Committee may, in its absolute
discretion, grant Incentive Awards to Grantees on the condition that such
Grantees surrender to the Committee for cancellation such other Incentive Awards
(including, without limitation, Incentive Awards with higher exercise prices) as
the Committee directs. Incentive Awards granted on the condition precedent of
surrender of outstanding Incentive Awards shall not count against the limits set
forth in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;1.4</font>
until such time as such previous Incentive Awards are surrendered and
cancelled.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;(h)
<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Indemnification</font>.
Each person who is or was a member of the Committee, or of the Board, shall be
indemnified by the Company against and from any damage, loss, liability, cost
and expense that may be imposed upon or reasonably incurred by him in connection
with or resulting from any claim, action, suit, or proceeding to which he may be
a party or in which he may be involved by reason of any action taken or failure
to act under the Plan (including such indemnification for a person&#8217;s own, sole,
concurrent or joint negligence or strict liability), except for any such act or
omission constituting willful misconduct or gross negligence. Such person shall
be indemnified by the Company for all amounts paid by him in settlement thereof,
with the Company&#8217;s approval, or paid by him in satisfaction of any judgment in
any such action, suit, or proceeding against him, provided he shall give the
Company an opportunity, at its own expense, to handle and defend the same before
he undertakes to handle and defend it on his own behalf. The foregoing right of
indemnification shall not be exclusive of any other rights of indemnification to
which such persons may be entitled under the Company&#8217;s Articles of Incorporation
or Bylaws, as a matter of law, or otherwise, or any power that the Company may
have to indemnify them or hold them harmless.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">9</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.4 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Shares of Common Stock Available for
Incentive Awards</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
to adjustment under <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.5</font>,
there shall be available for Incentive Awards that are granted wholly or partly
in Common Stock (including rights or Stock Options that may be exercised for or
settled in Common Stock) a number of Shares of Common Stock which shall equal
seven million five hundred thousand (7,500,000) Shares. The Committee may from
time to time adopt and observe such procedures concerning the counting of Shares
against the Plan maximum as it may deem appropriate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
any period that the Company is a Publicly Held Corporation, the following rules
shall apply to grants of Incentive Awards:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Subject to adjustment as provided in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.5</font>, the
maximum aggregate number of Shares of Common Stock (including Stock Options,
SARs, Restricted Stock, Performance Units and Performance Shares paid out in
Shares, or Other Stock-Based Awards paid out in Shares) that may be granted in
any calendar year pursuant to any Incentive Award held by any individual
Employee shall be two million (2,000,000) Shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The
maximum aggregate cash payout (including SARs, Performance Units and Performance
Shares paid out in cash, or Other Stock-Based Awards paid out in cash) with
respect to Incentive Awards granted in any calendar year which may be made to
any individual Employee shall be one million dollars ($1,000,000).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) With
respect to any Stock Option or Stock Appreciation Right granted to an Employee
that is canceled or repriced, the number of Shares subject to such Stock Option
or Stock Appreciation Right shall continue to count against the maximum number
of Shares that may be the subject of Stock Options or Stock Appreciation Rights
granted to such Employee to the extent required by and in accordance with
Section 162(m) of the Code.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) The
limitations of subsections (a), (b)&#160;and (c)&#160;above shall be construed
and administered so as to comply with the Performance-Based
Exception.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">10</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.5 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Share Pool Adjustments for Awards and
Payouts</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
following Incentive Awards and payouts shall reduce, on a one Share for one
Share basis, the number of Shares authorized for issuance under the Share
Pool:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock
Option;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) SAR
(except a Tandem SAR);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)
Restricted Stock;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) A
payout of a Performance Share in Shares;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e) A
payout of a Performance Unit in Shares; and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f) A
payout of an Other Stock-Based Award in Shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
following transactions shall restore, on a one Share for one Share basis, the
number of Shares authorized for issuance under the Share Pool:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) A
Payout of a SAR, Tandem SAR, Restricted Stock Award, or Other Stock-Based Award
in the form of cash;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) A
cancellation, termination, expiration, forfeiture, or lapse for any reason (with
the exception of the termination of a Tandem SAR upon exercise of the related
Stock Option, or the termination of a related Stock Option upon exercise of the
corresponding Tandem SAR) of any Shares subject to an Incentive
Award;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)
Payment of an Option Price with previously acquired Shares; provided, however,
that the Share Pool shall not be increased by the number of Shares withheld
(which would otherwise be acquired on the exercise) as payment of the Option
Price or for tax withholding; and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)
Payment or the withholding of Shares for taxes or the purchase price for Shares
under a Restricted Stock Award.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.6 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Common Stock
Available</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Common Stock available for issuance or transfer under the Plan shall be made
available from Shares now or hereafter (a)&#160;held in the treasury of the
Company, (b)&#160;authorized but unissued shares, or (c)&#160;shares to be
purchased or acquired by the Company. No fractional shares shall be issued under
the Plan; payment for fractional shares shall be made in cash.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">11</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.7 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Participation</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Eligibility</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Committee shall from
time to time designate those Employees, Consultants and/or Outside Directors, if
any, to be granted Incentive Awards under the Plan, the type of Incentive Awards
granted, the number of Shares, Stock Options, rights or units, as the case may
be, which shall be granted to each such person, and any other terms or
conditions relating to the Incentive Awards as it may deem appropriate to the
extent consistent with the provisions of the Plan. A Grantee who has been
granted an Incentive Award may, if otherwise eligible, be granted additional
Incentive Awards at any time. With respect to Nonstatutory Stock Options or SARs
intended to be excluded from the requirements of Code Section&#160;409A,
Incentive Awards of Nonstatutory Stock Options or SARs may only be made to
Grantees if the Incentive Award would be for &#8220;service recipient stock&#8221; within
the meaning of Code Section&#160;409A, as determined by the
Committee.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)
&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Incentive
Stock Option Eligibility</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>No Consultant or Outside
Director shall be eligible for the grant of any Incentive Stock Option. In
addition, no Employee shall be eligible for the grant of any Incentive Stock
Option who owns or would own immediately before the grant of such Incentive
Stock Option, directly or indirectly, stock possessing more than ten percent
(10%) of the total combined voting power of all classes of stock of the Company,
or any Parent or Subsidiary. This restriction does not apply if, at the time
such Incentive Stock Option is granted, the Incentive Stock Option exercise
price is at least one hundred and ten percent (110%) of the Fair Market Value on
the date of grant and the Incentive Stock Option by its terms is not exercisable
after the expiration of five (5) years from the date of grant. For the purpose
of the immediately preceding sentence, the attribution rules of Section 424(d)
of the Code shall apply for the purpose of determining an Employee&#8217;s percentage
ownership in the Company or any Parent or Subsidiary. This paragraph shall be
construed consistent with the requirements of Section&#160;422 of the
Code.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.8 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Types of Incentive
Awards</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The types
of Incentive Awards under the Plan are Stock Options, Stock Appreciation Rights
and Supplemental Payments as described in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;2</font>,
Restricted Stock and Supplemental Payments as described in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;3</font>,
Performance Units, Performance Shares and Supplemental Payments as described in
<font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;4</font>,
Other Stock-Based Awards and Supplemental Payments as described in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;5</font>, or
any combination of the foregoing.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.9 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Other Compensation
Programs</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
existence and terms of the Plan shall not limit the authority of the Board or
Company or any Company affiliate in compensating directors, Outside Directors,
Employees or Consultants of the Company, in such other forms and amounts,
including compensation pursuant to any other plans or programs (including but
not limited to bonus programs) as may be currently in effect or adopted in the
future, as it may determine from time to time.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">12</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.10
<font style="DISPLAY: inline; FONT-WEIGHT: bold">Repricing
Prohibited</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except in
connection with a corporate transaction involving the Company (including,
without limitation, any stock dividend, stock split, extraordinary cash
dividend, recapitalization, reorganization, merger, consolidation, split-up,
spin-off, combination, or exchange of shares), the terms of outstanding
Incentive Awards may not be amended to reduce the exercise price of outstanding
Options or SARs or cancel outstanding Options or SARS in exchange for cash,
other Incentive Awards or Options or SARs with an exercise price that is less
than the exercise price of the original Options or SARs without stockholder
approval.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><br><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SECTION 2</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">STOCK OPTIONS AND STOCK APPRECIATION
RIGHTS</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Grant of Stock
Options</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Committee is authorized to grant (a)&#160;Nonstatutory Stock Options to
Employees, Consultants and/or Outside Directors and (b)&#160;Incentive Stock
Options to Employees only, in accordance with the terms and conditions of the
Plan, and with such additional terms and conditions, not inconsistent with the
Plan, as the Committee shall determine in its discretion. Successive grants may
be made to the same Grantee whether or not any Stock Option previously granted
to such person remains unexercised.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Stock Option
Terms</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Written
Agreement</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Each
grant of a Stock Option shall be evidenced by a written Incentive Agreement.
Among its other provisions, each Incentive Agreement shall set forth the extent
to which the Grantee shall have the right to exercise the Stock Option following
termination of the Grantee&#8217;s Employment. Such provisions shall be determined in
the discretion of the Committee, shall be included in the Grantee&#8217;s Incentive
Agreement, need not be uniform among all Stock Options issued pursuant to the
Plan.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Number of
Shares</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Each
Stock Option shall specify the number of Shares of Common Stock to which it
pertains.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exercise
Price</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
exercise price per Share of Common Stock under each Stock Option shall be
determined by the Committee; provided, however, that such exercise price shall
not be less than 100% of the Fair Market Value per Share on the date the Stock
Option is granted (110% in the case of an Incentive Stock Option for 10% or
greater shareholders pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;1.7(b)</font>).
Each Stock Option shall specify the method of exercise which shall be consistent
with the requirements of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section
2.3(a)</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">13</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Term</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>In the Incentive Agreement,
the Committee shall fix the term of each Stock Option (which shall be not more
than ten (10)&#160;years from the date of grant for ISO or SAR grants; five
(5)&#160;years for ISO grants to 10% or greater shareholders pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;1.7(b)</font>).
In the event no term is fixed, such term shall be ten (10)&#160;years from the
date of grant.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exercise</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Committee shall
determine the time or times at which a Stock Option may be exercised in whole or
in part. Each Stock Option may specify the required period of continuous
Employment and/or the performance objectives to be achieved before the Stock
Option or portion thereof will become exercisable. Each Stock Option, the
exercise of which, or the timing of the exercise of which, is dependent, in
whole or in part, on the achievement of designated performance objectives, may
specify a minimum level of achievement in respect of the specified performance
objectives below which no Stock Options will be exercisable and a method for
determining the number of Stock Options that will be exercisable if performance
is at or above such minimum but short of full achievement of the performance
objectives. All such terms and conditions shall be set forth in the Incentive
Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">$100,000
Annual Limit on Incentive Stock Options</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Notwithstanding any contrary
provision in the Plan, to the extent that the aggregate Fair Market Value
(determined as of the time the Incentive Stock Option is granted) of the Shares
of Common Stock with respect to which Incentive Stock Options are exercisable
for the first time by any Grantee during any single calendar year (under the
Plan and any other stock option plans of the Company and its Subsidiaries or
Parent) exceeds the sum of $100,000, such Incentive Stock Option shall be
treated as a Nonstatutory Stock Option to the extent in excess of the $100,000
limit, and not an Incentive Stock Option, but all other terms and provisions of
such Stock Option shall remain unchanged. This paragraph shall be applied by
taking Incentive Stock Options into account in the order in which they were
granted and shall be construed in accordance with Section 422(d) of the Code. In
the absence of such regulations or other authority, or if such regulations or
other authority require or permit a designation of the Options which shall cease
to constitute Incentive Stock Options, then such Incentive Stock Options, only
to the extent of such excess, shall automatically be deemed to be Nonstatutory
Stock Options but all other terms and conditions of such Incentive Stock
Options, and the corresponding Incentive Agreement, shall remain
unchanged.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.3 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Stock Option
Exercises</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Method of
Exercise and Payment</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>Stock Options shall be exercised by the delivery of a signed written
notice of exercise to the Company as of a date set by the Company in advance of
the effective date of the proposed exercise. The notice shall set forth the
number of Shares with respect to which the Option is to be exercised,
accompanied by full payment for the Shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">14</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Option Price upon exercise of any Stock Option shall be payable to the Company
in full either: (i)&#160;in cash or its equivalent, or (ii)&#160;subject to
prior approval by the Committee in its discretion, by tendering previously
acquired Shares having an aggregate Fair Market Value at the time of exercise
equal to the Option Price (provided that the Shares which are tendered must have
been held by the Grantee for at least six (6)&#160;months prior to their tender
to satisfy the Option Price), or (iii)&#160;subject to prior approval by the
Committee in its discretion, by withholding Shares which otherwise would be
acquired on exercise having an aggregate Fair Market Value at the time of
exercise equal to the total Option Price, or (iv)&#160;subject to prior approval
by the Committee in its discretion, by a combination of (i), (ii), and
(iii)&#160;above. Any payment in Shares shall be effected by the surrender of
such Shares to the Company in good form for transfer and shall be valued at
their Fair Market Value on the date when the Stock Option is exercised. Unless
otherwise permitted by the Committee in its discretion, the Grantee shall not
surrender, or attest to the ownership of, Shares in payment of the Option Price
if such action would cause the Company to recognize compensation expense (or
additional compensation expense) with respect to the Stock Option for financial
reporting purposes. In no event will the Committee allow the Option Price to be
paid with a form of consideration, including, but not limited to, a loan to an
Employee, if such form of consideration would violate the Sarbanes-Oxley Act of
2002 as determined by the Committee in its discretion.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Committee, in its discretion, also may allow the Option Price to be paid with
such other consideration as shall constitute lawful consideration for the
issuance of Shares (including, without limitation, effecting a &#8220;cashless
exercise&#8221; with a broker of the Option), subject to applicable securities law
restrictions and tax withholdings, or by any other means which the Committee
determines to be consistent with the Plan&#8217;s purpose and applicable law. A
&#8220;cashless exercise&#8221; of an Option is a procedure by which a broker provides the
funds to the Grantee to effect an Option exercise, to the extent consented to by
the Committee in its discretion. At the direction of the Grantee, the broker
will either (i)&#160;sell all of the Shares received when the Option is
exercised and pay the Grantee the proceeds of the sale (minus the Option Price,
withholding taxes and any fees due to the broker) or (ii)&#160;sell enough of
the Shares received upon exercise of the Option to cover the Option Price,
withholding taxes and any fees due the broker and deliver to the Grantee (either
directly or through the Company) a stock certificate for the remaining Shares.
Dispositions to a broker effecting a cashless exercise are not exempt under
Section&#160;16 of the Exchange Act (if the Company is a Publicly Held
Corporation).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Committee, in its discretion, may also allow an Option to be exercised by a
broker-dealer acting on behalf of the Grantee if (i)&#160;the broker-dealer has
received from the Grantee a duly endorsed Incentive Agreement evidencing such
Option and instructions signed by the Grantee requesting the Company to deliver
the shares of Common Stock subject to such Option to the broker-dealer on behalf
of the Grantee and specifying the account into which such shares should be
deposited, (ii)&#160;adequate provision has been made with respect to the
payment of any withholding taxes due upon such exercise, and (iii)&#160;the
broker-dealer and the Grantee have otherwise complied with
Section&#160;220.3(e)(4) of Regulation&#160;T, 12&#160;CFR&#160;Part&#160;220
(or its successor).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">15</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As soon
as practicable after receipt of a written notification of exercise and full
payment, the Company shall deliver, or cause to be delivered, to or on behalf of
the Grantee, in the name of the Grantee or other appropriate recipient, Share
certificates for the number of Shares purchased under the Stock Option. Such
delivery shall be effected for all purposes when the Company or a stock transfer
agent of the Company shall have deposited such certificates in the United States
mail, addressed to Grantee or other appropriate recipient.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.2</font>,
during the lifetime of a Grantee, each Option granted to him shall be
exercisable only by the Grantee (or his legal guardian in the event of his
Disability) or by a broker-dealer acting on his behalf pursuant to a cashless
exercise under the foregoing provisions of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;2.3(a)</font>.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Restrictions
on Share Transferability</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Committee may impose
such restrictions on any grant of Stock Options or on any Shares acquired
pursuant to the exercise of a Stock Option as it may deem advisable, including,
without limitation, restrictions under (i)&#160;any stockholders&#8217; agreement,
buy/sell agreement, stockholders&#8217; agreement, right of first refusal,
non-competition, and any other agreement between the Company and any of its
securities holders or employees, (ii)&#160;any applicable federal securities
laws, (iii)&#160;the requirements of any stock exchange or market upon which
such Shares are then listed and/or traded, or (iv)&#160;any blue sky or state
securities law applicable to such Shares. Any certificate issued to evidence
Shares issued upon the exercise of an Incentive Award may bear such legends and
statements as the Committee shall deem advisable to assure compliance with
federal and state laws and regulations.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
Grantee or other person exercising an Incentive Award may be required by the
Committee to give a written representation that the Incentive Award and the
Shares subject to the Incentive Award will be acquired for investment and not
with a view to public distribution; provided, however, that the Committee, in
its sole discretion, may release any person receiving an Incentive Award from
any such representations either prior to or subsequent to the exercise of the
Incentive Award.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Notification
of Disqualifying Disposition of Shares from Incentive Stock Options</font>.
Notwithstanding any other provision of the Plan, a Grantee who disposes of
Shares of Common Stock acquired upon the exercise of an Incentive Stock Option
by a sale or exchange either (i)&#160;within two (2)&#160;years after the date
of the grant of the Incentive Stock Option under which the Shares were acquired
or (ii)&#160;within one (1)&#160;year after the transfer of such Shares to him
pursuant to exercise, shall promptly notify the Company of such disposition, the
amount realized and his adjusted basis in such Shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Proceeds
of Option Exercise</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>The proceeds received by the Company from the sale of Shares pursuant to
Stock Options exercised under the Plan shall be used for general corporate
purposes.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">16</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.4 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Stock Appreciation Rights in Tandem
with Nonstatutory Stock Options</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Grant</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Committee may, at the
time of grant of a Nonstatutory Stock Option, or at any time thereafter during
the term of the Nonstatutory Stock Option, grant Stock Appreciation Rights with
respect to all or any portion of the Shares of Common Stock covered by such
Nonstatutory Stock Option. A Stock Appreciation Right in tandem with a
Nonstatutory Stock Option is referred to herein as a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Tandem
SAR</font>.&#8221;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">General
Provisions</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
terms and conditions of each Tandem SAR shall be evidenced by an Incentive
Agreement. The Option Price per Share of a Tandem SAR shall be fixed in the
Incentive Agreement and shall not be less than one hundred percent (100%) of the
Fair Market Value of a Share on the grant date of the Nonstatutory Stock Option
to which it relates.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exercise</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>A Tandem SAR may be
exercised at any time the Nonstatutory Stock Option to which it relates is then
exercisable, but only to the extent such Nonstatutory Stock Option is
exercisable, and shall otherwise be subject to the conditions applicable to such
Nonstatutory Stock Option. When a Tandem SAR is exercised, the Nonstatutory
Stock Option to which it relates shall terminate to the extent of the number of
Shares with respect to which the Tandem SAR is exercised. Similarly, when a
Nonstatutory Stock Option is exercised, the Tandem SARs relating to the Shares
covered by such Nonstatutory Stock Option exercise shall terminate. Any Tandem
SAR which is outstanding on the last day of the term of the related Nonstatutory
Stock Option shall be automatically exercised on such date for cash, without the
need for any action by the Grantee, to the extent of any
Appreciation.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Settlement</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Upon exercise of a Tandem
SAR, the holder shall receive, for each Share with respect to which the Tandem
SAR is exercised, an amount equal to the Appreciation. The Appreciation shall be
payable in cash, Common Stock, or a combination of both, as specified in the
Incentive Agreement (or in the discretion of the Committee if not so specified).
The Appreciation shall be paid within 30 calendar days of the exercise of the
Tandem SAR. The number of Shares of Common Stock which shall be issuable upon
exercise of a Tandem SAR shall be determined by dividing (1)&#160;by (2), where
(1)&#160;is the number of Shares as to which the Tandem SAR is exercised
multiplied by the Appreciation in such shares and (2)&#160;is the Fair Market
Value of a Share on the exercise date.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.5 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Stock Appreciation Rights Independent
of Nonstatutory Stock Options</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Grant</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Committee may grant
Stock Appreciation Rights independent of Nonstatutory Stock Options (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Independent
SARs&#8221;</font>).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">General
Provisions</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
terms and conditions of each Independent SAR shall be evidenced by an Incentive
Agreement. The exercise price per share of Common Stock shall be not less than
one hundred percent (100%) of the Fair Market Value of a Share of Common Stock
on the date of grant of the Independent SAR. The term of an Independent SAR
shall be determined by the Committee.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">17</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exercise</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Independent SARs shall be
exercisable at such time and subject to such terms and conditions as the
Committee shall specify in the Incentive Agreement for the Independent SAR
grant.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Settlement</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Upon exercise of an
Independent SAR, the holder shall receive, for each Share specified in the
Independent SAR grant, an amount equal to the Spread. The Spread shall be
payable in cash, Common Stock, or a combination of both, in the discretion of
the Committee or as specified in the Incentive Agreement. The Spread shall be
paid within 30 calendar days of the exercise of the Independent SAR. The number
of Shares of Common Stock which shall be issuable upon exercise of an
Independent SAR shall be determined by dividing (1)&#160;by (2), where
(1)&#160;is the number of Shares as to which the Independent SAR is exercised
multiplied by the Spread in such Shares and (2)&#160;is the Fair Market Value of
a Share on the exercise date.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.6 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Reload Options</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At the
discretion of the Committee, the Grantee may be granted under an Incentive
Agreement, replacement Stock Options under the Plan that permit the Grantee to
purchase an additional number of Shares equal to the number of previously owned
Shares surrendered by the Grantee to pay for all or a portion of the Option
Price upon exercise of his Stock Options. The terms and conditions of such
replacement Stock Options shall be set forth in the Incentive
Agreement.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.7 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Supplemental Payment on Exercise of
Nonstatutory Stock Options or Stock Appreciation Rights</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Committee, either at the time of grant or as of the time of exercise of any
Nonstatutory Stock Option or Stock Appreciation Right, may provide in the
Incentive Agreement for a Supplemental Payment by the Company to the Grantee
with respect to the exercise of any Nonstatutory Stock Option or Stock
Appreciation Right. The Supplemental Payment shall be in the amount specified by
the Committee, which amount shall not exceed the amount necessary to pay the
federal and state income tax payable with respect to both the exercise of the
Nonstatutory Stock Option and/or Stock Appreciation Right and the receipt of the
Supplemental Payment, assuming the holder is taxed at either the maximum
effective income tax rate applicable thereto or at a lower tax rate as deemed
appropriate by the Committee. The Committee shall have the discretion to grant
Supplemental Payments that are payable solely in cash or Supplemental Payments
that are payable in cash, Common Stock, or a combination of both, as determined
by the Committee at the time of payment.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">18</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SECTION 3</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">RESTRICTED
STOCK</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Award of Restricted
Stock</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Grant</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>In consideration of the
performance of Employment by any Grantee who is an Employee, Consultant or
Outside Director, Shares of Restricted Stock may be awarded under the Plan by
the Committee with such restrictions during the Restriction Period as the
Committee may designate in its discretion, any of which restrictions may differ
with respect to each particular Grantee. Restricted Stock shall be awarded for
no additional consideration or such additional consideration as the Committee
may determine, which consideration may be less than, equal to or more than the
Fair Market Value of the shares of Restricted Stock on the grant date. The terms
and conditions of each grant of Restricted Stock shall be evidenced by an
Incentive Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Immediate
Transfer Without Immediate Delivery of Restricted Stock</font>. Unless otherwise
specified in the Grantee&#8217;s Incentive Agreement, each Restricted Stock Award
shall constitute an immediate transfer of the record and beneficial ownership of
the Shares of Restricted Stock to the Grantee in consideration of the
performance of services as an Employee, Consultant or Outside Director, as
applicable, entitling such Grantee to all voting and other ownership rights in
such Shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
specified in the Incentive Agreement, a Restricted Stock Award may limit the
Grantee&#8217;s dividend rights during the Restriction Period in which the shares of
Restricted Stock are subject to a &#8220;substantial risk of forfeiture&#8221; (within the
meaning given to such term under Code Section&#160;83) and restrictions on
transfer. In the Incentive Agreement, the Committee may apply any restrictions
to the dividends that the Committee deems appropriate. Without limiting the
generality of the preceding sentence, if the grant or vesting of Shares of
Restricted Stock granted to a Covered Employee, if applicable, is designed to
comply with the requirements of the Performance-Based Exception, the Committee
may apply any restrictions it deems appropriate to the payment of dividends
declared with respect to such Shares of Restricted Stock, such that the
dividends and/or the Shares of Restricted Stock maintain eligibility for the
Performance-Based Exception. In the event that any dividend constitutes a
derivative security or an equity security pursuant to the rules under Section 16
of the Exchange Act, if applicable, such dividend shall be subject to a vesting
period equal to the remaining vesting period of the Shares of Restricted Stock
with respect to which the dividend is paid.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shares
awarded pursuant to a grant of Restricted Stock may be evidenced in a manner as
the Committee shall deem appropriate, including without limitation book entry,
Shares issued in the name of the Grantee and held, together with a stock power
endorsed in blank, by the Committee or Company (or their delegates), or in trust
or in escrow pursuant to an agreement satisfactory to the Committee, as
determined by the Committee, until such time as the restrictions on transfer
have expired or the Committee may provide for the transfer of the Shares of the
Restricted Stock to a transfer agent on behalf of the Grantee pursuant to terms
as determined by the Committee to maintain the restricted status of the Shares
until vested. If the Company issues a stock certificate, registered in the name
of the Grantee to whom such Shares of Restricted Stock were granted, evidencing
such Shares, the Company shall not cause to be issued such a stock certificate
unless it has received a stock power duly endorsed in blank with respect to such
Shares. Each such stock certificate shall bear the following legend or any other
legend approved by the Company:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">19</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THE
TRANSFERABILITY OF THIS CERTIFICATE AND THE SHARES OF STOCK REPRESENTED HEREBY
ARE SUBJECT TO THE RESTRICTIONS, TERMS AND CONDITIONS (INCLUDING FORFEITURE AND
RESTRICTIONS AGAINST TRANSFER) CONTAINED IN THE VIVAKOR, INC. 2008 INCENTIVE
PLAN AND AN INCENTIVE STOCK OPTION AGREEMENT ENTERED INTO BETWEEN THE REGISTERED
OWNER OF SUCH SHARES AND VIVAKOR, INC. A COPY OF THE PLAN AND INCENTIVE STOCK
OPTION AGREEMENT ARE ON FILE IN THE CORPORATE OFFICES OF VIVAKOR,
INC.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Such
legend shall not be removed from the certificate evidencing such Shares of
Restricted Stock until such Shares vest pursuant to the terms of the Incentive
Agreement.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.2 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Restrictions</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Forfeiture
of Restricted Stock</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>Restricted Stock awarded to a Grantee may be subject to the following
restrictions until the expiration of the Restriction Period: (i) a restriction
that constitutes a &#8220;substantial risk of forfeiture&#8221; (as defined in Code
Section&#160;83), or a restriction on transferability; (ii)&#160;unless
otherwise specified by the Committee in the Incentive Agreement, the Restricted
Stock that is subject to restrictions which are not satisfied shall be forfeited
and all rights of the Grantee to such Shares shall terminate; and (iii)&#160;any
other restrictions that the Committee determines in advance are appropriate,
including, without limitation, rights of repurchase or first refusal in the
Company or provisions subjecting the Restricted Stock to a continuing
substantial risk of forfeiture in the hands of any transferee. Any such
restrictions shall be set forth in the particular Grantee&#8217;s Incentive
Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Removal
of Restrictions</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>The Committee, in its discretion, shall have the authority to remove any
or all of the restrictions on the Restricted Stock if it determines that, by
reason of a change in applicable law or another change in circumstance arising
after the grant date of the Restricted Stock, such action is
appropriate.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.3 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Lapse of
Restrictions</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon the
lapse of the forfeiture restrictions as set forth in the Incentive Agreement,
the unrestricted Shares shall be evidenced in such manner as determined by the
Committee and shall be issued to the Grantee promptly after the restrictions
have lapsed in a manner as determined by the Committee in its sole
discretion.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">20</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.4 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Supplemental Payment on Vesting of
Restricted Stock</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Committee, either at the time of grant or vesting of Restricted Stock, may
provide for a Supplemental Payment by the Company to the holder in an amount
specified by the Committee, which amount shall not exceed the amount necessary
to pay the federal and state income tax payable with respect to both the vesting
of the Restricted Stock and receipt of the Supplemental Payment, assuming the
Grantee is taxed at either the maximum effective income tax rate applicable
thereto or at a lower tax rate as deemed appropriate by the Committee. The
Committee shall have the discretion to grant Supplemental Payments that are
payable solely in cash or Supplemental Payments that are payable in cash, Common
Stock, or a combination of both, as determined by the Committee at the time of
payment.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SECTION 4</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PERFORMANCE
UNITS AND PERFORMANCE SHARES</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Performance Based
Awards</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Grant</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Committee is authorized
to grant Performance Units and Performance Shares to selected Grantees who are
Employees, Outside Directors or Consultants. Each grant of Performance Units
and/or Performance Shares shall be evidenced by an Incentive Agreement in such
amounts and upon such terms as shall be determined by the Committee. The
Committee may make grants of Performance Units or Performance Shares in such a
manner that more than one Performance Period is in progress concurrently. For
each Performance Period, the Committee shall establish the number of Performance
Units or Performance Shares and their contingent values which may vary depending
on the degree to which performance criteria established by the Committee are
met.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Performance
Criteria</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
Committee may establish performance goals applicable to Performance Shares or
Performance Units based upon criteria in one or more of the following
categories: (i)&#160;performance of the Company as a whole,
(ii)&#160;performance of a segment of the Company&#8217;s business, and
(iii)&#160;individual performance. Performance criteria for the Company shall
relate to the achievement of predetermined financial objectives for the Company
and its Subsidiaries on a consolidated basis. Performance criteria for a segment
of the Company&#8217;s business shall relate to the achievement of financial and
operating objectives of the segment for which the Grantee is
accountable.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">21</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Examples
of performance criteria shall include one or more of the following pre-tax or
after-tax profit levels, including: earnings per share, earnings before interest
and taxes, earnings before interest, taxes, depreciation and amortization, net
operating profits after tax, and net income; total stockholder return; return on
assets, equity, capital or investment; cash flow and cash flow return on
investment; economic value added and economic profit; growth in earnings per
share; levels of operating expense, maintenance expenses or measures of customer
satisfaction and customer service as determined from time to time including the
relative improvement therein; stock price performance, sales, costs, production
volumes, or reserves added. Individual performance criteria shall relate to a
Grantee&#8217;s overall performance, taking into account, among other measures of
performance, the attainment of individual goals and objectives. The performance
criteria may differ among Grantees. The performance criteria need not be based
on an increase or positive result and may include for example, maintaining the
status quo or limiting economic loss.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At the
beginning of each Performance Period, the Committee shall (i)&#160;establish for
such Performance Period specific financial or non-financial performance
objectives that the Committee believes are relevant to the Company&#8217;s business
objectives; (ii)&#160;determine the value of a Performance Unit or the number of
Shares under a Performance Share grant relative to performance objectives; and
(iii)&#160;notify each Grantee in writing of the established performance
objectives and, if applicable, the minimum, target, and maximum value of
Performance Units or Performance Shares for such Performance
Period.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Modification</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>If an Incentive Award is
intended to meet the Performance Based Exception, the performance criteria shall
preclude discretion to increase the amount of compensation payable upon
attainment of the goal or other modification of the criteria except as permitted
under Code Section&#160;162(m).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Payment</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The basis for payment of
Performance Units or Performance Shares for a given Performance Period shall be
the achievement of those performance objectives determined by the Committee at
the beginning of the Performance Period as specified in the Grantee&#8217;s Incentive
Agreement. If minimum performance is not achieved for a Performance Period, no
payment shall be made and all contingent rights shall cease. If minimum
performance is achieved or exceeded, the value of a Performance Unit or
Performance Share may be based on the degree to which actual performance
exceeded the preestablished minimum performance standards. The amount of payment
shall be determined by multiplying the number of Performance Units or
Performance Shares granted at the beginning of the Performance Period times the
final Performance Unit or Performance Share value. Payments shall be made, in
the discretion of the Committee as specified in the Incentive Agreement, solely
in cash or Common Stock, or a combination of cash and Common Stock, following
the close of the applicable Performance Period.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">22</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Special
Rule for Covered Employees</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>No later than the ninetieth
(90th) day following the beginning of a Performance Period (or twenty-five
percent (25%) of the Performance Period) the Committee shall establish
performance criteria as described in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;4.1</font>
applicable to Performance Shares or Performance Units awarded to Employees in
such a manner as shall permit payments with respect thereto to qualify for the
Performance-Based Exception, if applicable. If a Performance Unit or Performance
Share granted to an Employee is intended to comply with the Performance-Based
Exception, the Committee in establishing performance goals shall comply with
Treasury Regulation &#167; l.162-27(e)(2) (or its successor). As soon as practicable
following the Company&#8217;s determination of the Company&#8217;s financial results for any
Performance Period, the Committee shall certify in writing: (i)&#160;whether the
Company achieved its minimum performance for the objectives for the Performance
Period, (ii)&#160;the extent to which the Company achieved its performance
objectives for the Performance Period, (iii)&#160;any other terms that are
material to the grant of Performance Awards, and (iv) the calculation of the
payments, if any, to be paid to each Grantee for the Performance
Period.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.2 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Supplemental Payment on Vesting of
Performance Units or Performance Shares</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Committee, either at the time of grant or at the time of vesting of Performance
Units or Performance Shares, may provide for a Supplemental Payment by the
Company to the Grantee in an amount specified by the Committee, which amount
shall not exceed the amount necessary to pay the federal and state income tax
payable with respect to both the vesting of such Performance Units or
Performance Shares and receipt of the Supplemental Payment, assuming the Grantee
is taxed at either the maximum effective income tax rate applicable thereto or
at a lower tax rate as seemed appropriate by the Committee. The Committee shall
have the discretion to grant Supplemental Payments that are payable in cash,
Common Stock, or a combination of both, as determined by the Committee at the
time of payment.</font><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SECTION 5</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OTHER
STOCK-BASED AWARDS</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Grant of Other Stock-Based
Awards</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other
Stock-Based Awards may be awarded by the Committee to selected Grantees that are
denominated or payable in, valued in whole or in part by reference to, or
otherwise related to, Shares of Common Stock, as deemed by the Committee to be
consistent with the purposes of the Plan and the goals of the Company. Other
types of Stock-Based Awards include, without limitation, Deferred Stock,
purchase rights, Shares of Common Stock awarded which are not subject to any
restrictions or conditions, convertible or exchangeable debentures, other rights
convertible into Shares, Incentive Awards valued by reference to the value of
securities of or the performance of a specified Subsidiary, division or
department, and settlement in cancellation of rights of any person with a vested
interest in any other plan, fund, program or arrangement that is or was
sponsored, maintained or participated in by the Company or any Parent or
Subsidiary. As is the case with other Incentive Awards, Other Stock-Based Awards
may be awarded either alone or in addition to or in tandem with any other
Incentive Awards.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">23</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br>&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.2 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Other Stock-Based Award
Terms</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Written
Agreement</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
terms and conditions of each grant of an Other Stock-Based Award shall be
evidenced by an Incentive Agreement.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Purchase
Price</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Except to
the extent that an Other Stock-Based Award is granted in substitution for an
outstanding Incentive Award or is delivered upon exercise of a Stock Option, the
amount of consideration required to be received by the Company shall be either
(i)&#160;no consideration other than services actually rendered (in the case of
authorized and unissued shares) or to be rendered, or (ii)&#160;in the case of
an Other Stock-Based Award in the nature of a purchase right, consideration
(other than services rendered or to be rendered) at least equal to 50% of the
Fair Market Value of the Shares covered by such grant on the date of grant (or
such percentage higher than 50% that is required by any applicable tax or
securities law). To the extent that the Company is a Publicly Held Corporation
and that a stock appreciation right is intended to qualify for the
Performance-Based Exception or to the extent it is intended to be exempt from
Code Section&#160;409A, the exercise price per share of Common Stock shall not
be less than one hundred percent (100%) of Fair Market Value of a share of
Common Stock on the date of the grant of the stock appreciation
right.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Performance
Criteria and Other Terms</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>In its discretion, the
Committee may specify such criteria, periods or goals for vesting in Other
Stock-Based Awards and payment thereof to the Grantee as it shall determine; and
the extent to which such criteria, periods or goals have been met shall be
determined by the Committee. All terms and conditions of Other Stock-Based
Awards shall be determined by the Committee and set forth in the Incentive
Agreement.&#160;&#160;The Committee may also provide for a Supplemental Payment
similar to such payment as described in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;4.2</font>.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Payment</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Other Stock-Based Awards may
be paid in Shares of Common Stock or other consideration related to such Shares,
in a single payment or in installments on such dates as determined by the
Committee, all as specified in the Incentive Agreement.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Dividends</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Grantee of an Other
Stock-Based Award may be entitled to receive, currently or on a deferred basis,
dividends or dividend equivalents with respect to the number of Shares covered
by the Other Stock-Based Award, only if so determined by the Committee and set
forth in a separate Incentive Agreement. The Committee may also provide in such
Incentive Agreement that such amounts (if any) shall be deemed to have been
reinvested in additional Shares of Common Stock.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">24</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SECTION 6</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">PROVISIONS RELATING TO PLAN
PARTICIPATION</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Plan Conditions</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Incentive
Agreement</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Each
Grantee to whom an Incentive Award is granted shall be required to enter into an
Incentive Agreement with the Company, in such a form as is provided by the
Committee. The Incentive Agreement shall contain specific terms as determined by
the Committee, in its discretion, with respect to the Grantee&#8217;s particular
Incentive Award. Such terms need not be uniform among all Grantees or any
similarly-situated Grantees. The Incentive Agreement may include, without
limitation, vesting, forfeiture and other provisions particular to the
particular Grantee&#8217;s Incentive Award, as well as, for example, provisions to the
effect that the Grantee (i)&#160;shall not disclose any confidential information
acquired during Employment with the Company, (ii) shall abide by all the terms
and conditions of the Plan and such other terms and conditions as may be imposed
by the Committee, (iii)&#160;shall not interfere with the employment or other
service of any employee, (iv)&#160;shall not compete with the Company or become
involved in a conflict of interest with the interests of the Company,
(v)&#160;shall forfeit an Incentive Award if terminated for Cause,
(vi)&#160;shall not be permitted to make an election under Section 83(b) of the
Code when applicable, and (vii)&#160;shall be subject to any other agreement
between the Grantee and the Company regarding Shares that may be acquired under
an Incentive Award including, without limitation, a stockholders&#8217; agreement,
buy-sell agreement, or other agreement restricting the transferability of Shares
by Grantee. An Incentive Agreement shall include such terms and conditions as
are determined by the Committee, in its discretion, to be appropriate with
respect to any individual Grantee. The Incentive Agreement shall be signed by
the Grantee to whom the Incentive Award is made and by an Authorized
Officer.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">No Right
to Employment</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>Nothing in the Plan or any instrument executed pursuant to the Plan shall
create any Employment rights (including without limitation, rights to continued
Employment) in any Grantee or affect the right of the Company to terminate the
Employment of any Grantee at any time without regard to the existence of the
Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Securities
Requirements</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
Company shall be under no obligation to effect the registration pursuant to the
Securities Act of 1933 of any Shares of Common Stock to be issued hereunder or
to effect similar compliance under any state laws. Notwithstanding anything
herein to the contrary, the Company shall not be obligated to cause to be issued
or delivered any certificates evidencing Shares pursuant to the Plan unless and
until the Company is advised by its counsel that the issuance and delivery of
such certificates is in compliance with all applicable laws, regulations of
governmental authorities, and the requirements of any securities exchange on
which Shares are traded. The Committee may require, as a condition of the
issuance and delivery of certificates evidencing Shares of Common Stock pursuant
to the terms hereof, that the recipient of such Shares make such covenants,
agreements and representations, and that such certificates bear such legends, as
the Committee, in its discretion, deems necessary or desirable.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">25</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the
Shares issuable on exercise of an Incentive Award are not registered under the
Securities Act of 1933, the Company may imprint on the certificate for such
Shares the following legend or any other legend which counsel for the Company
considers necessary or advisable to comply with the Securities Act of
1933:</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (&#8220;ACT&#8221;), OR THE SECURITIES LAWS OF ANY STATE.
THE SECURITIES MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR
PURSUANT TO ANY APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH
ACT AND SUCH LAWS OR PURSUANT TO A WRITTEN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.2 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Transferability</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Incentive
Awards granted under the Plan shall not be transferable or assignable other
than: (a)&#160;by will or the laws of descent and distribution or
(b)&#160;pursuant to a qualified domestic relations order (as defined by Section
414(p) of the Code, &#8220;QDRO&#8221;; provided, however, that Incentive Stock Options may
be transferred pursuant to QDRO only if the Incentive Agreement expressly
permits such transfer and provided further, however, only with respect to
Incentive Awards consisting of Nonstatutory Stock Options, the Committee may, in
its discretion, authorize all or a portion of the Nonstatutory Stock Options to
be granted on terms which permit transfer by the Grantee to (i)&#160;the members
of the Grantee&#8217;s Immediate Family, (ii)&#160;a trust or trusts for the exclusive
benefit of Immediate Family members, (iii)&#160;a partnership in which such
Immediate Family members are the only partners, or (iv)&#160;any other entity
owned solely by Immediate Family members; provided that (A)&#160;there may be no
consideration for any such transfer, (B)&#160;the Incentive Agreement pursuant
to which such Nonstatutory Stock Options are granted must be approved by the
Committee, and must expressly provide for transferability in a manner consistent
with this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section
6.2</font>, and (C)&#160;subsequent transfers of transferred Nonstatutory Stock
Options shall be prohibited except in accordance with clauses (a)&#160;and (b)
(above)&#160;of this sentence. Following any permitted transfer, the
Nonstatutory Stock Option shall continue to be subject to the same terms and
conditions as were applicable immediately prior to transfer, provided that the
term &#8220;Grantee&#8221; shall be deemed to refer to the transferee. The events of
termination of employment, as set out in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.6</font> and
in the Incentive Agreement, shall continue to be applied with respect to the
original Grantee, and the Incentive Award shall be exercisable by the transferee
only to the extent, and for the periods, specified in the Incentive
Agreement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">26</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except as
may otherwise be permitted under the Code, in the event of a permitted transfer
of a Nonstatutory Stock Option hereunder, the original Grantee shall remain
subject to withholding taxes upon exercise. In addition, the Company and the
Committee shall have no obligation to provide any notices to any Grantee or
transferee thereof, including, for example, notice of the expiration of an
Incentive Award following the original Grantee&#8217;s termination of
employment.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
designation by a Grantee of a beneficiary of an Incentive Award shall not
constitute transfer of the Incentive Award. No transfer by will or by the laws
of descent and distribution shall be effective to bind the Company unless the
Committee has been furnished with a copy of the deceased Grantee&#8217;s enforceable
will or such other evidence as the Committee deems necessary to establish the
validity of the transfer. Any attempted transfer in violation of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 6.2</font> shall be
void and ineffective. All determinations under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.2</font>
shall be made by the Committee in its discretion.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.3 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Rights as a
Stockholder</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">No
Stockholder Rights</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>Except as otherwise provided in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 3.1(b)</font> for
grants of Restricted Stock, a Grantee of an Incentive Award (or a permitted
transferee of such Grantee) shall have no rights as a stockholder with respect
to any Shares of Common Stock until the issuance of a stock certificate for such
Shares.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Representation
of Ownership</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>In
the case of the exercise of an Incentive Award by a person or estate acquiring
the right to exercise such Incentive Award by reason of the death or Disability
of a Grantee, the Committee may require reasonable evidence as to the ownership
of such Incentive Award or the authority of such person and may require such
consents and releases of taxing authorities as the Committee may deem
advisable.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.4 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Listing and Registration of Shares of
Common Stock</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
exercise of any Incentive Award granted hereunder shall only be effective at
such time as counsel to the Company shall have determined that the issuance and
delivery of Shares of Common Stock pursuant to such exercise is in compliance
with all applicable laws, regulations of governmental authorities and the
requirements of any securities exchange on which Shares of Common Stock are
traded. The Committee may, in its discretion, defer the effectiveness of any
exercise of an Incentive Award in order to allow the issuance of Shares of
Common Stock to be made pursuant to registration statement or an exemption from
registration or other methods for compliance available under federal or state
securities laws. The Committee shall inform the Grantee in writing of its
decision to defer the effectiveness of the exercise of an Incentive Award.
During the period that the effectiveness of the exercise of an Incentive Award
has been deferred, the Grantee may, by written notice to the Committee, withdraw
such exercise and obtain the refund of any amount paid with respect
thereto.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">27</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.5 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Change in Stock and
Adjustments</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Changes
in Law or Circumstances</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>Subject to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.7</font>
(which only applies in the event of a Change in Control), in the event of any
change in applicable law or any change in circumstances which results in or
would result in any dilution of the rights granted under the Plan, or which
otherwise warrants an equitable adjustment because it interferes with the
intended operation of the Plan, then, if the Committee should so determine, in
its absolute discretion, that such change equitably requires an adjustment in
the number or kind of shares of stock or other securities or property
theretofore subject, or which may become subject, to issuance or transfer under
the Plan or in the terms and conditions of outstanding Incentive Awards, such
adjustment shall be made in accordance with such determination. Such adjustments
may include changes with respect to (i)&#160;the aggregate number of Shares that
may be issued under the Plan, (ii)&#160;the number of Shares subject to
Incentive Awards, and (iii)&#160;the Option Price or other price per Share for
outstanding Incentive Awards. Any adjustment under this paragraph of an
outstanding Incentive Stock Option shall be made only to the extent not
constituting a &#8220;modification&#8221; within the meaning of Section&#160;424(h)(3) of
the Code or with respect to any Incentive Award to the extent it does not result
in deferred compensation under Code Section&#160;409A unless otherwise agreed to
by the Grantee in writing. The Committee shall give notice to each applicable
Grantee of such adjustment which shall be effective and binding.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exercise
of Corporate Powers</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>The existence of the Plan or outstanding Incentive Awards hereunder shall
not affect in any way the right or power of the Company or its stockholders to
make or authorize any or all adjustments, recapitalization, reorganization or
other changes in the Company&#8217;s capital structure or its business or any merger
or consolidation of the Company, or any issue of bonds, debentures, preferred or
prior preference stocks ahead of or affecting the Common Stock or the rights
thereof, or the dissolution or liquidation of the Company, or any sale or
transfer of all or any part of its assets or business, or any other corporate
act or proceeding whether of a similar character or otherwise.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Recapitalization
of the Company</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>Subject to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.7</font>
(which only applies in the event of a Change in Control), if while there are
Incentive Awards outstanding, the Company shall effect any subdivision or
consolidation of Shares of Common Stock or other capital readjustment, the
payment of a stock dividend, stock split, combination of Shares,
recapitalization or other increase or reduction in the number of Shares
outstanding, without receiving compensation therefor in money, services or
property, then the number of Shares available under the Plan and the number of
Incentive Awards which may thereafter be exercised shall (i)&#160;in the event
of an increase in the number of Shares outstanding, be proportionately increased
and the Option Price or Fair Market Value of the Incentive Awards awarded shall
be proportionately reduced; and (ii)&#160;in the event of a reduction in the
number of Shares outstanding, be proportionately reduced, and the Option Price
or Fair Market Value of the Incentive Awards awarded shall be proportionately
increased. The Committee shall take such action and whatever other action it
deems appropriate, in its discretion, so that the value of each outstanding
Incentive Award to the Grantee shall not be adversely affected by a corporate
event described in this subsection (c). Notwithstanding the foregoing
adjustments pursuant to this paragraph shall be made only if permitted and in
accordance with Code Sections&#160;424 and 409A to the extent applicable to an
Incentive Award unless otherwise consented to in writing by the
Grantee.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">28</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Issue of
Common Stock by the Company</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Except as hereinabove
expressly provided in this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.5</font> and
subject to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.7</font> in
the event of a Change in Control, the issue by the Company of shares of stock of
any class, or securities convertible into shares of stock of any class, for cash
or property, or for labor or services, either upon direct sale or upon the
exercise of rights or warrants to subscribe therefor, or upon any conversion of
shares or obligations of the Company convertible into such shares or other
securities, shall not affect, and no adjustment by reason thereof shall be made
with respect to, the number of, or Option Price or Fair Market Value of, any
Incentive Awards then outstanding under previously granted Incentive Awards;
provided, however, in such event, outstanding Shares of Restricted Stock shall
be treated the same as outstanding unrestricted Shares of Common
Stock.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Assumption
under the Plan of Outstanding Stock Options</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Notwithstanding any other
provision of the Plan, the Committee, in its absolute discretion, may authorize
the assumption and continuation under the Plan of outstanding and unexercised
stock options or other types of stock-based incentive awards that were granted
under a stock option plan (or other type of stock incentive plan or agreement)
that is or was maintained by a corporation or other entity that was merged into,
consolidated with, or whose stock or assets were acquired by, the Company as the
surviving corporation. Any such action shall be upon such terms and conditions
as the Committee, in its discretion, may deem appropriate, including provisions
to preserve the holder&#8217;s rights under the previously granted and unexercised
stock option or other stock-based incentive award, such as, for example,
retaining the treatment as a Stock Option. Any such assumption and continuation
of any such previously granted and unexercised incentive award shall be treated
as an outstanding Incentive Award under the Plan and shall thus count against
the number of Shares reserved for issuance pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;1.4</font>. In
addition, any Shares issued by the Company through the assumption or
substitution of outstanding grants from an acquired company shall reduce the
Shares available for grants under <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;1.4</font>.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Assumption
of Incentive Awards by a Successor</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Subject to the accelerated
vesting and other provisions of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.7</font> that
apply in the event of a Change in Control, in the event of a Corporate Event
(defined below), each Grantee shall be entitled to receive, in lieu of the
number of Shares subject to Incentive Awards, such shares of capital stock or
other securities or property as may be issuable or payable with respect to or in
exchange for the number of Shares which Grantee would have received had he
exercised the Incentive Award immediately prior to such Corporate Event,
together with any adjustments (including, without limitation, adjustments to the
Option Price and the number of Shares issuable on exercise of outstanding Stock
Options). For this purpose, Shares of Restricted Stock shall be treated the same
as unrestricted outstanding Shares of Common Stock. A &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Corporate Event&#8221; </font>means any of
the following: (i)&#160;a dissolution or liquidation of the Company, (ii)&#160;a
sale of all or substantially all of the Company&#8217;s assets, (iii)&#160;a merger,
consolidation or combination involving the Company (other than a merger,
consolidation or combination (A)&#160;in which the Company is the continuing or
surviving corporation and (B) which does not result in the outstanding Shares
being converted into or exchanged for different securities, cash or other
property, or any combination thereof), or (iv)&#160;if so determined by the
Committee, any other &#8220;corporate transaction&#8221; as defined in Code Sections 424 or
Code Section&#160;409A. The Committee shall take whatever other action it deems
appropriate to preserve the rights of Grantees holding outstanding Incentive
Awards.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">29</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
the previous paragraph of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.5(f)</font>,
but subject to the accelerated vesting and other provisions of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.7</font> that
apply in the event of a Change in Control, in the event of a Corporate Event
(described in the previous paragraph), the Committee, in its discretion, shall
have the right and power to:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)
cancel, effective immediately prior to the occurrence of the Corporate Event,
each outstanding Incentive Award (whether or not then exercisable) and, in full
consideration of such cancellation, pay to the Grantee an amount in cash equal
to the excess of (A)&#160;the value, as determined by the Committee, of the
property (including cash) received by the holders of Common Stock as a result of
such Corporate Event over (B)&#160;the exercise price of such Incentive Award,
if any; provided, however, this subsection (i)&#160;shall be inapplicable to an
Incentive Award granted within six (6)&#160;months before the occurrence of the
Corporate Event but only if the Grantee is an Insider and such disposition is
not exempt under Rule&#160;16b-3 (or other rules preventing liability of the
Insider under Section 16(b) of the Exchange Act) and, in that event, the
provisions hereof shall be applicable to such Incentive Award after the
expiration of six (6)&#160;months from the date of grant; or</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)
provide for the exchange or substitution of each Incentive Award outstanding
immediately prior to such Corporate Event (whether or not then exercisable) for
another award with respect to the Common Stock or other property for which such
Incentive Award is exchangeable and, incident thereto, make an equitable
adjustment as determined by the Committee, in its discretion, in the Option
Price or exercise price of the Incentive Award, if any, or in the number of
Shares or amount of property (including cash) subject to the Incentive Award;
or</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)
provide for assumption of the Plan and such outstanding Incentive Awards by the
surviving entity or its parent.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Committee, in its discretion, shall have the authority to take whatever action
it deems to be necessary or appropriate to effectuate the provisions of this
<font style="DISPLAY: inline; TEXT-DECORATION: underline">subsection
(f)</font>.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">30</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.6 <font style="DISPLAY: inline; FONT-WEIGHT: bold">Termination of Employment, Death,
Disability and Retirement</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Termination
of Employment</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>Unless otherwise expressly provided in the Grantee&#8217;s Incentive Agreement,
if the Grantee&#8217;s Employment is terminated for any reason other than due to his
death, Disability, Retirement or for Cause, any non-vested portion of any Stock
Option or other applicable Incentive Award at the time of such termination shall
automatically expire and terminate and no further vesting shall occur after the
termination date. In such event, except as otherwise expressly provided in his
Incentive Agreement, the Grantee shall be entitled to exercise his rights only
with respect to the portion of the Incentive Award that was vested as of his
termination of Employment date for a period that shall end on the earlier of
(i)&#160;the expiration date set forth in the Incentive Agreement or
(ii)&#160;ninety (90)&#160;days after the date of his termination of Employment
(three (3)&#160;months for Incentive Stock Options).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Termination
of Employment for Cause</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>Unless otherwise expressly provided in the Grantee&#8217;s Incentive Agreement,
in the event of the termination of a Grantee&#8217;s Employment for Cause, all vested
and non-vested Stock Options and other Incentive Awards granted to such Grantee
shall immediately expire, and shall not be exercisable to any extent, as of
12:01&#160;a.m. (CST)&#160;on the date of such termination of
Employment.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Retirement</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Unless otherwise expressly
provided in the Grantee&#8217;s Incentive Agreement, upon the termination of
Employment due to the Retirement of any Employee who is a Grantee:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) any
non-vested portion of any outstanding Option or other Incentive Award shall
immediately terminate and no further vesting shall occur; and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii) any
vested Option or other Incentive Award shall expire on the earlier of
(A)&#160;the expiration date set forth in the Incentive Agreement for such
Incentive Award; or (B)&#160;the expiration of (1)&#160;six months after the
date of his termination of Employment due to Retirement in the case of any
Incentive Award other than an Incentive Stock Option or (2) three months after
his termination date in the case of an Incentive Stock Option.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Disability
or Death</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Unless
otherwise expressly provided in the Grantee&#8217;s Incentive Agreement, upon
termination of Employment as a result of the Grantee&#8217;s Disability or
death:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) any
nonvested portion of any outstanding Option or other applicable Incentive Award
shall immediately terminate upon termination of Employment and no further
vesting shall occur; and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii) any
vested Incentive Award shall expire on the earlier of either (A)&#160;the
expiration date set forth in the Incentive Agreement or (B)&#160;the one year
anniversary date of the Grantee&#8217;s termination of Employment date.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">31</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the
case of any vested Incentive Stock Option held by an Employee following
termination of Employment, notwithstanding the definition of &#8220;Disability&#8221; in
<font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 1.2</font>,
whether the Employee has incurred a &#8220;Disability&#8221; for purposes of determining the
length of the Option exercise period following termination of Employment under
this <font style="DISPLAY: inline; TEXT-DECORATION: underline">subsection
(d)</font> shall be determined by reference to Section&#160;22(e)(3) of the Code
to the extent required by Section&#160;422(c)(6) of the Code. The Committee
shall determine whether a Disability for purposes of this subsection
(d)&#160;has occurred.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Continuation</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>Subject to the conditions
and limitations of the Plan and applicable law and regulation in the event that
a Grantee ceases to be an Employee, Outside Director or Consultant, as
applicable, for whatever reason, the Committee and Grantee may mutually agree
with respect to any outstanding Option or other Incentive Award then held by the
Grantee (i)&#160;for an acceleration or other adjustment in any vesting schedule
applicable to the Incentive Award, (ii)&#160;for a continuation of the exercise
period following termination for a longer period than is otherwise provided
under such Incentive Award, or (iii)&#160;to any other change in the terms and
conditions of the Incentive Award. In the event of any such change to an
outstanding Incentive Award, a written amendment to the Grantee&#8217;s Incentive
Agreement shall be required.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.7&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Change in Control</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
any contrary provision in the Plan, in the event of a Change in Control (as
defined below), the following actions shall automatically occur as of the day
immediately preceding the Change in Control date unless expressly provided
otherwise in the individual Grantee&#8217;s Incentive Agreement:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) all
of the Stock Options and Stock Appreciation Rights then outstanding shall become
100% vested and immediately and fully exercisable;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) all
of the restrictions and conditions of any Restricted Stock and any Other
Stock-Based Awards then outstanding shall be deemed satisfied, and the
Restriction Period with respect thereto shall be deemed to have expired, and
thus each such Incentive Award shall become free of all restrictions and fully
vested; and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) all
of the Performance Shares, Performance Units and any Other Stock-Based Awards
shall become fully vested, deemed earned in full, and promptly paid within
thirty (30)&#160;days to the affected Grantees without regard to payment
schedules and notwithstanding that the applicable performance cycle, retention
cycle or other restrictions and conditions have not been completed or
satisfied.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For all
purposes of this Plan, a &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Change in Control&#8221; </font>of the
Company means the occurrence of any one or more of the following
events:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">32</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) The
acquisition by any individual, entity or group (within the meaning of Section
13(d)(3) or 14(d)(2) of the Exchange Act (a &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Person&#8221;</font>)) of beneficial
ownership (within the meaning of Rule&#160;13d-3 promulgated under the Exchange
Act) of fifty percent (50%) or more of either (i)&#160;the then outstanding
shares of common stock of the Company (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Outstanding Company Stock&#8221;</font>) or
(ii)&#160;the combined voting power of the then outstanding voting securities of
the Company entitled to vote generally in the election of directors (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Outstanding Company Voting
Securities&#8221;</font>); provided, however, that the following acquisitions shall
not constitute a Change in Control: (i)&#160;any acquisition directly from the
Company or any Subsidiary, (ii)&#160;any acquisition by the Company or any
Subsidiary or by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any Subsidiary, or (iii) any acquisition by any
corporation pursuant to a reorganization, merger, consolidation or similar
business combination involving the Company (a &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Merger&#8221;</font>), if, following such
Merger, the conditions described in clauses (i)&#160;and (ii) <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.7(c)</font>
(below)&#160;are satisfied;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)
Individuals who, as of the Effective Date, constitute the Board of Directors of
the Company (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Incumbent
Board&#8221;</font>) cease for any reason to constitute at least a majority of the
Board; provided, however, that any individual becoming a director subsequent to
the Effective Date whose election, or nomination for election by the Company&#8217;s
shareholders, was approved by a vote of at least a majority of the directors
then comprising the Incumbent Board shall be considered as though such
individual were a member of the Incumbent Board, but excluding, for this
purpose, any such individual whose initial assumption of office occurs as a
result of either an actual or threatened election contest (as such terms are
used in Rule&#160;14a-11 of Regulation&#160;14A promulgated under the Exchange
Act) or other actual or threatened solicitation of proxies or consents by or on
behalf of a Person other than the Board;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)
Approval by the shareholders of the Company of a Merger, unless immediately
following such Merger, (i)&#160;substantially all of the holders of the
Outstanding Company Voting Securities immediately prior to Merger beneficially
own, directly or indirectly, more than 50% of the common stock of the
corporation resulting from such Merger (or its parent corporation) in
substantially the same proportions as their ownership of Outstanding Company
Voting Securities immediately prior to such Merger and (ii)&#160;at least a
majority of the members of the board of directors of the corporation resulting
from such Merger (or its parent corporation) were members of the Incumbent Board
at the time of the execution of the initial agreement providing for such
Merger;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) The
sale or other disposition of all or substantially all of the assets of the
Company, unless immediately following such sale or other disposition,
(i)&#160;substantially all of the holders of the Outstanding Company Voting
Securities immediately prior to the consummation of such sale or other
disposition beneficially own, directly or indirectly, more than 50% of the
common stock of the corporation acquiring such assets in substantially the same
proportions as their ownership of Outstanding Company Voting Securities
immediately prior to the consummation of such sale or disposition, <font style="DISPLAY: inline; FONT-STYLE: italic">and </font>(ii)&#160;at least a
majority of the members of the board of directors of such corporation (or its
parent corporation) were members of the Incumbent Board at the time of execution
of the initial agreement or action of the Board providing for such sale or other
disposition of assets of the Company;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">33</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e) The
adoption of any plan or proposal for the liquidation or dissolution of the
Company; or</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f) Any
other event that a majority of the Board, in its sole discretion, determines to
constitute a Change in Control hereunder.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
the occurrence of any of the foregoing events set out in this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 6.7</font> which
would otherwise result in a Change in Control, the Board may determine in its
discretion, if it deems it to be in the best interest of the Company, that an
event or events otherwise constituting or reasonably leading to a Change in
Control shall not be deemed a Change in Control hereunder. Such determination
shall be effective only if it is made by the Board prior to the occurrence of an
event that otherwise would be, or reasonably lead to, a Change in Control, or
after such event only if made by the Board a majority of which is composed of
directors who were members of the Board immediately prior to the event that
otherwise would be, or reasonably lead to, a Change in Control.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.8&#160;
<font style="DISPLAY: inline; FONT-WEIGHT: bold">Financing</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the
extent permitted by the Sarbanes-Oxley Act of 2002 and other applicable law, the
Company may extend and maintain, or arrange for and guarantee, the extension and
maintenance of financing to any Grantee to purchase Shares pursuant to exercise
of an Incentive Award upon such terms as are approved by the Committee in its
discretion.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SECTION 7</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">GENERAL</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.1&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Effective Date and Grant
Period</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Plan
is adopted by the Board effective as of the Effective Date, subject to the
approval of the stockholders of the Company within twelve (12)&#160;months from
the Effective Date. Incentive Awards may be granted under the Plan at any time
prior to receipt of such stockholder approval; provided, however, if the
requisite stockholder approval is not obtained within the permissible time frame
then any Incentive Awards granted hereunder shall automatically become null and
void and of no force or effect. No Incentive Award may be granted under the Plan
after ten (10)&#160;years from the Effective Date.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">34</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.2&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Funding and Liability of
Company</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
provision of the Plan shall require the Company, for the purpose of satisfying
any obligations under the Plan, to purchase assets or place any assets in a
trust or other entity to which contributions are made, or otherwise to segregate
any assets. In addition, the Company shall not be required to maintain separate
bank accounts, books, records or other evidence of the existence of a segregated
or separately maintained or administered fund for purposes of the Plan. Although
bookkeeping accounts may be established with respect to Grantees who are
entitled to cash, Common Stock or rights thereto under the Plan, any such
accounts shall be used merely as a bookkeeping convenience. The Company shall
not be required to segregate any assets that may at any time be represented by
cash, Common Stock or rights thereto. The Plan shall not be construed as
providing for such segregation, nor shall the Company, the Board or the
Committee be deemed to be a trustee of any cash, Common Stock or rights thereto.
Any liability or obligation of the Company to any Grantee with respect to an
Incentive Award shall be based solely upon any contractual obligations that may
be created by this Plan and any Incentive Agreement, and no such liability or
obligation of the Company shall be deemed to be secured by any pledge or other
encumbrance on any property of the Company. Neither the Company, the Board nor
the Committee shall be required to give any security or bond for the performance
of any obligation that may be created by the Plan.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.3&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Withholding Taxes</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Tax
Withholding</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The
Company shall have the power and the right to deduct or withhold, or require a
Grantee to remit to the Company, an amount sufficient to satisfy federal, state,
and local taxes, domestic or foreign, required by law or regulation to be
withheld with respect to any taxable event arising as a result of the Plan or an
Incentive Award hereunder. Upon the lapse of restrictions on Restricted Stock,
the Committee, in its discretion, may elect to satisfy the tax withholding
requirement, in whole or in part, by having the Company withhold Shares having a
Fair Market Value on the date the tax is to be determined equal to the minimum
withholding taxes which could be imposed on the transaction as determined by the
Committee.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Share
Withholding</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>With
respect to tax withholding required upon the exercise of Stock Options or SARs,
upon the lapse of restrictions on Restricted Stock, or upon any other taxable
event arising as a result of any Incentive Awards, Grantees may elect, subject
to the approval of the Committee in its discretion, to satisfy the withholding
requirement, in whole or in part, by having the Company withhold Shares having a
Fair Market Value on the date the tax is to be determined equal to the minimum
withholding taxes which could be imposed on the transaction as determined by the
Committee. All such elections shall be made in writing, signed by the Grantee,
and shall be subject to any restrictions or limitations that the Committee, in
its discretion, deems appropriate.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Incentive
Stock Options</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.
</font>With respect to Shares received by a Grantee pursuant to the exercise of
an Incentive Stock Option, if such Grantee disposes of any such Shares within
(i)&#160;two years from the date of grant of such Option or (ii)&#160;one year
after the transfer of such shares to the Grantee, the Company shall have the
right to withhold from any salary, wages or other compensation payable by the
Company to the Grantee an amount sufficient to satisfy federal, state and local
tax withholding requirements attributable to such disqualifying
disposition.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">35</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Loans</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>To the extent permitted by
the Sarbanes-Oxley Act of 2002 and other applicable law, the Committee may
provide for loans, on either a short term or demand basis, from the Company to a
Grantee who is an Employee or Consultant to permit the payment of taxes required
by law.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.4&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">No Guarantee of Tax
Consequences</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
the Company nor the Committee makes any commitment or guarantee that any
federal, state or local tax treatment will apply or be available to any person
participating or eligible to participate hereunder.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.5&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Designation of Beneficiary by
Grantee</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
Grantee may, from time to time, name any beneficiary or beneficiaries (who may
be named contingently or successively) to whom any benefit under the Plan is to
be paid in case of his death before he receives any or all of such benefit. Each
such designation shall revoke all prior designations by the same Grantee, shall
be in a form prescribed by the Committee, and will be effective only when filed
by the Grantee in writing with the Committee during the Grantee&#8217;s lifetime. In
the absence of any such designation, benefits remaining unpaid at the Grantee&#8217;s
death shall be paid to the Grantee&#8217;s estate.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.6&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Deferrals</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Committee may permit a Grantee to defer such Grantee&#8217;s receipt of the payment of
cash or the delivery of Shares that would, otherwise be due to such Grantee by
virtue of the lapse or waiver of restrictions with respect to Restricted Stock,
or the satisfaction of any requirements or goals with respect to Performance
Units, Performance Shares or Other Stock-Based Awards. If any such deferral
election is permitted, the Committee shall, in its discretion, establish rules
and procedures for such payment deferrals to the extent required for tax
deferral of compensation under the Code.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.7&#160;
<font style="DISPLAY: inline; FONT-WEIGHT: bold">Amendment and
Termination</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Board
shall have the power and authority to terminate or amend the Plan at any time;
provided, however, the Board shall not, without the approval of the stockholders
of the Company within the time period required by applicable law,
(a)&#160;except as provided in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;6.5</font>,
increase the maximum number of Shares which may be issued under the Plan
pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section
1.4</font>, (b)&#160;amend the requirements as to the class of Employees
eligible to purchase Common Stock under the Plan, (c)&#160;extend the term of
the Plan, or, if the Company is a Publicly Held Corporation (i)&#160;increase
the maximum limits on Incentive Awards to Employees as set for compliance with
the Performance-Based Exception or (ii)&#160;decrease the authority granted to
the Committee under the Plan in contravention of Rule&#160;16b-3 under the
Exchange Act.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">36</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
termination, amendment, or modification of the Plan shall adversely affect in
any material way any outstanding Incentive Award previously granted to a Grantee
under the Plan, without the written consent of such Grantee or other designated
holder of such Incentive Award.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
addition, to the extent that the Committee determines that (a)&#160;the listing
for qualification requirements of any national securities exchange or quotation
system on which the Company&#8217;s Common Stock is then listed or quoted, if
applicable, or (b)&#160;the Code (or regulations promulgated thereunder),
require stockholder approval in order to maintain compliance with such listing
requirements or to maintain any favorable tax advantages or qualifications, then
the Plan shall not be amended in such respect without approval of the Company&#8217;s
stockholders.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.8&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Requirements of
Law</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Governmental
Entities and Securities Exchanges</font>. The granting of Incentive Awards and
the issuance of Shares under the Plan shall be subject to all applicable laws,
rules, and regulations, and to such approvals by any governmental agencies or
national securities exchanges as may be required. The Committee may in its
discretion refuse to issue or transfer any Shares or other consideration under
an Incentive Award if it determines that the issuance or transfer of such Shares
or other consideration might violate applicable laws including, but not limited
to, compliance with black out periods required pursuant to applicable law or
Company policies. Certificates evidencing shares of Common Stock delivered under
this Plan (to the extent that such shares are so evidenced) may be subject to
such stop transfer orders and other restrictions as the Committee may deem
advisable under the rules and regulations of the Securities and Exchange
Commission, any securities exchange or transaction reporting system upon which
the Common Stock is then listed or to which it is admitted for quotation, and
any applicable federal or state securities law, if applicable. The Committee may
cause a legend or legends to be placed upon such certificates (if any) to make
appropriate reference to such restrictions.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Securities
Act Rule&#160;701</font>. If no class of the Company&#8217;s securities is registered
under Section&#160;12 of the&#160;Exchange Act, then unless otherwise determined
by the Committee, grants of Incentive Awards to &#8220;Rule&#160;701 Grantees&#8221; (as
defined below) and&#160;issuances of the underlying shares of Common Stock, if
any, on the exercise or conversion of such Incentive Awards are intended to
comply with all applicable conditions of&#160;Securities Act Rule&#160;701
(&#8220;Rule&#160;701&#8221;), including, without limitation, the restrictions
as&#160;to&#160;the amount of securities that may be offered and sold in
reliance on Rule&#160;701, so as&#160;to&#160;qualify for an exemption from the
registration requirements of the Securities Act. Any&#160;ambiguities or
inconsistencies in the construction of an Incentive Award or the Plan shall be
interpreted to give effect to such intention. In accordance with Rule&#160;701,
each Grantee&#160;shall receive a copy of the Plan on or before the date an
Incentive Award is granted to&#160;him, as well as the additional disclosure
required by Rule 701(e) if the aggregate&#160;sales price or amount of
securities sold during any consecutive 12-month period exceeds $5,000,000 as
determined under Rule&#160;701(e). If Rule&#160;701 (or any successor provision)
is amended to eliminate or otherwise modify any of the requirements
specified&#160;in&#160;Rule&#160;701, then the provisions of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">subsection 7.8(b)</font>
shall be interpreted and&#160;construed in accordance with Rule&#160;701 as so
amended. For purposes of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">subsection&#160;7.8(b)</font>,
as determined in accordance with Rule&#160;701, &#8220;Rule&#160;701 Grantees&#8221; shall
mean any Grantee other than a director of&#160;the&#160;Company, the Company&#8217;s
chairman, chief executive officer, president, chief financial&#160;officer,
controller and any vice president of the Company, and any other key employee of
the Company who generally has access to financial and other business
related&#160;information and possesses sufficient sophistication to understand
and evaluate such&#160;information.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">37</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.9&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Rule&#160;16b-3 Securities Law
Compliance for Insiders</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the
Company is a Publicly Held Corporation, transactions under the Plan with respect
to Insiders are intended to comply with all applicable conditions of
Rule&#160;16b-3 under the Exchange Act. Any ambiguities or inconsistencies in
the construction of an Incentive Award or the Plan shall be interpreted to give
effect to such intention, and to the extent any provision of the Plan or action
by the Committee fails to so comply, it shall be deemed null and void to the
extent permitted by law and deemed advisable by the Committee in its
discretion.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.10&#160;
<font style="DISPLAY: inline; FONT-WEIGHT: bold">Compliance with Code Section
162(m) for Publicly Held Corporation</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the
Company is a Publicly Held Corporation, unless otherwise determined by the
Committee with respect to any particular Incentive Award, it is intended that
the Plan shall comply fully with the applicable requirements so that any
Incentive Awards subject to Section 162(m) that are granted to Covered Employees
shall qualify for the Performance-Based Exception, except for grants of
Nonstatutory Stock Options with an Option Price set at less than the Fair Market
Value of a Share on the date of grant. If any provision of the Plan or an
Incentive Agreement would disqualify the Plan or would not otherwise permit the
Plan or Incentive Award to comply with the Performance-Based Exception as so
intended, such provision shall be construed or deemed to be amended to conform
to the requirements of the Performance-Based Exception to the extent permitted
by applicable law and deemed advisable by the Committee; provided, however, no
such construction or amendment shall have an adverse effect on the prior grant
of an Incentive Award or the economic value to a Grantee of any outstanding
Incentive Award.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">38</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.11&#160;
<font style="DISPLAY: inline; FONT-WEIGHT: bold">Successors to
Company</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
obligations of the Company under the Plan with respect to Incentive Awards
granted hereunder shall be binding on any successor to the Company, whether the
existence of such successor is the result of a direct or indirect purchase,
merger, consolidation, or otherwise, of all or substantially all of the business
and/or assets of the Company.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.12&#160;
<font style="DISPLAY: inline; FONT-WEIGHT: bold">Miscellaneous
Provisions</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) No
Employee, Consultant, Outside Director, or other person shall have any claim or
right to be granted an Incentive Award under the Plan. Neither the Plan, nor any
action taken hereunder, shall be construed as giving any Employee, Consultant,
or Outside Director any right to be retained in the Employment or other service
of the Company or any Parent or Subsidiary.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The
expenses of the Plan shall be borne by the Company.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) By
accepting any Incentive Award, each Grantee and each person claiming by or
through him shall be deemed to have indicated his acceptance of the
Plan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) No
Shares of Common Stock shall be issued hereunder unless counsel for the Company
is then reasonably satisfied that such issuance will be in compliance with
federal and state securities laws, if applicable.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.13&#160;
<font style="DISPLAY: inline; FONT-WEIGHT: bold">Severability</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the
event that any provision of this Plan shall be held illegal, invalid or
unenforceable for any reason, such provision shall be fully severable, but shall
not affect the remaining provisions of the Plan, and the Plan shall be construed
and enforced as if the illegal, invalid, or unenforceable provision was not
included herein.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.14&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Gender, Tense and
Headings</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Whenever
the context so requires, words of the masculine gender used herein shall include
the feminine and neuter, and words used in the singular shall include the
plural. Section headings as used herein are inserted solely for convenience and
reference and constitute no part of the interpretation or construction of the
Plan.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.15&#160;
<font style="DISPLAY: inline; FONT-WEIGHT: bold">Governing
Law</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Plan
shall be interpreted, construed and constructed in accordance with the laws of
the State of Nevada without regard to its conflicts of law provisions, except as
may be superseded by applicable laws of the United States.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">39</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.16&#160;
<font style="DISPLAY: inline; FONT-WEIGHT: bold">Code
Section&#160;409A</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the
extent that any Incentive Award is deferred compensation subject to Code
Section&#160;409A, as determined by the Committee, the Incentive Agreement shall
comply with the requirements of Code Section&#160;409A in a manner as determined
by the Committee in its sole discretion including, but not limited to, using the
more restrictive definition of Change in Control as provided in Code Section
409A to the extent that it is more restrictive than as defined in the Plan,
using the more restrictive definition of Disability or disabled as provided in
Code Section&#160;409A and specifying a time and form of payment schedule. In
addition if any Incentive Award constitutes deferred compensation under
Section&#160;409A of the Code (a &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Section&#160;409A Plan</font>&#8221;), then
the Incentive Award shall be subject to the following requirements, if and to
the extent required to comply with Code Section 409A, and as determined by the
Committee and specified in the Incentive Agreement:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Payments under the Section&#160;409A Plan may not be made earlier than
(i)&#160;the Grantee&#8217;s separation from service, (ii)&#160;the date the Grantee
becomes disabled, (iii)&#160;the Grantee&#8217;s death, (iv)&#160;a specified time (or
pursuant to a fixed schedule) specified in the Incentive Agreement at the date
of the deferral of such compensation, (v)&#160;a change in the ownership or
effective control of the corporation, or in the ownership of a substantial
portion of the assets of the corporation, or (vi)&#160;the occurrence of an
unforeseeable emergency;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The
time or schedule for any payment of the deferred compensation may not be
accelerated, except to the extent provided in applicable Treasury Regulations or
other applicable guidance issued by the Internal Revenue Service;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) Any
elections with respect to the deferral of such compensation or the time and form
of distribution of such deferred compensation shall comply with the requirements
of Section&#160;409A(a)(4) of the Code; and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) In
the case of any Grantee who is specified employee, a distribution on account of
a separation from service may not be made before the date which is six months
after the date of the Grantee&#8217;s separation from service (or, if earlier, the
date of the Grantee&#8217;s death).</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
purposes of the foregoing, the terms &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">separation from
service</font>&#8221; and &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">specified employee</font>&#8221;,
all shall be defined in the same manner as those terms are defined for purposes
of Section&#160;409A of the Code, and the limitations set forth herein shall be
applied in such manner (and only to the extent) as shall be necessary to comply
with any requirements of Section&#160;409A of the Code that are applicable to
the Incentive Award as determined by the Committee.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">40</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
foregoing VivaKor, Inc. 2008 Incentive Plan was adopted by the Board of
Directors of the Company on October 28, 2008 and by the Shareholders of the
Company on October 28, 2008.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div align="center">
        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="50%">

                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VIVAKOR,
      INC.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/S/&#160;&#160;&#160;&#160;&#160;
      </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">TANNIN J.
      FUJA, PHD.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      </font></font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:&#160;&#160;Tannin
      J. Fuja, PhD.</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:
      Chief Executive Officer</font></div>
              </td>
            </tr>
        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">41</font></div>
  </body>
</html>





</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>8
<FILENAME>vivakor_s1-ex1002.htm
<DESCRIPTION>FORM OF STOCK OPTION AGREEMENT
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex1002.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT
10.2</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE
U.S. SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR FOREIGN
JURISDICTION, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED
PURSUANT TO THE RELEVANT PROVISIONS OF U.S. FEDERAL AND STATE OR APPLICABLE
FOREIGN SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL
SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER U.S.
FEDERAL AND STATE OR APPLICABLE FOREIGN SECURITIES LAWS IS NOT
REQUIRED.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-VARIANT: small-caps">VIVAKOR,
INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2008
INCENTIVE PLAN</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTICE OF
INCENTIVE STOCK OPTION GRANT</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-VARIANT: small-caps">VIVAKOR,
INC.</font> (the &#8220;Company&#8221;) hereby grants you the following Option to purchase
shares of its common stock (&#8220;Shares&#8221;).&#160;&#160;The terms and conditions of
this Option are set forth in the Incentive Agreement (&#8220;Incentive Agreement&#8221;)
that follows and the <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-VARIANT: small-caps">VIVAKOR,
INC. </font>2008 Incentive Plan (the &#8220;Plan&#8221;), both of which are attached to and
made a part of this document.&#160;&#160;This page is meant to be a cover page
for informational purposes only, in the event any of the terms hereon are in
conflict with the Incentive Option Agreement and/or the Plan, the terms of the
Incentive Option Agreement and/or the Plan shall supersede the information on
this page.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="left" valign="top" width="24%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Date
      of Grant:</font></div>
            </td>
            <td colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
            <td colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Name
      of Optionee:</font></div>
            </td>
            <td colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
            <td colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Number
      of Option Shares:</font></div>
            </td>
            <td colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
            <td align="left" colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Exercise
      Price per Share:</font></div>
            </td>
            <td align="left" colspan="2" valign="top" width="53%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
            <td colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Vesting
      Start Date:</font></div>
            </td>
            <td colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
            <td align="left" valign="top" width="25%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td align="left" valign="top" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Type
      of Option:</font></div>
            </td>
            <td align="left" valign="top" width="25%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font>&#160;<a name="check1">Incentive Stock Option</a></font></div>
            </td>
            <td align="left" valign="top" width="28%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&#160;<a name="check2">Nonstatutory Stock&#160;&#160;Option</a></font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
            <td colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Vesting
      Schedule:</font></div>
            </td>
            <td colspan="2" valign="top" width="53%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 9pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Decided
      by resolution of the Board of Directors.</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
            <td align="left" colspan="2" valign="top" width="53%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="24%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Payment
      Forms:</font></div>
            </td>
            <td align="left" colspan="2" valign="top" width="53%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By
      cash, cash equivalents, or Shares owned by the Optionee for at least six
      months, and if the Company&#8217;s Shares become publicly traded, by &#8220;cashless&#8221;
      exercise, as set forth in the Stock Option
  Agreement.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">VIVAKOR, INC.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">INCENTIVE
AGREEMENT</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Optionee:
____________________________________</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Grant
      of Stock Option</font>. As of the <font style="DISPLAY: inline; FONT-WEIGHT: bold">Date of Grant
      </font>(identified in Section&#160;19 below), VivaKor, Inc., a Nevada
      corporation (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Company</font>&#8221;), hereby grants
      an Incentive Stock Option (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Option</font>&#8221;) to the Optionee
      (identified above), an employee of the Company, to purchase the number of
      shares of the Company&#8217;s common stock, $_____ par value per share (the
      &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Common Stock</font>&#8221;),
      identified in Section&#160;19 below (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Shares</font>&#8221;), subject to the
      terms and conditions of this agreement (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Agreement</font>&#8221;) and the
      Company&#8217;s 2008 Incentive Plan effective February 1, 2008 (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Plan</font>&#8221;), which is hereby
      incorporated herein in its entirety by reference. The Shares, when issued
      to the Optionee upon the exercise of the Option, shall be fully paid and
      nonassessable. The Option is an &#8220;incentive stock option&#8221; as defined in
      Section&#160;422 of the Internal Revenue
Code.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Definitions</font>.
      All capitalized terms used herein shall have the meanings set forth in the
      Plan unless otherwise specifically provided herein. Section&#160;19 below
      sets forth meanings for various capitalized terms used in this
      Agreement.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Option
      Term</font>. The Option shall commence on the Date of Grant (identified in
      Section&#160;19 below) and terminate on the date immediately prior to the
      tenth (10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">th</font>)
      anniversary of the Date of Grant. The period during which the Option is in
      effect and may be exercised is referred to herein as the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Option
      Period</font>.&#8221;</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Option
      Price</font>. The Option Price per Share is identified in Section&#160;19
      below.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Vesting</font>.
      The total number of Shares subject to this Option shall vest in accordance
      with the <font style="DISPLAY: inline; FONT-WEIGHT: bold">Vesting Schedule
      </font>(identified in Section&#160;19 below). The Shares may be purchased
      at any time after they become vested, in whole or in part, during the
      Option Period; provided, however, the Option may only be exercisable to
      acquire whole Shares. The right of exercise provided herein shall be
      cumulative so that if the Option is not exercised to the maximum extent
      permissible after vesting, the vested portion of the Option shall be
      exercisable, in whole or in part, at any time during the Option
      Period.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Method
      of Exercise</font>. The Option is exercisable by delivery of a written
      notice to the attention of the Chief Financial Officer of the Company at
      the address for notices to the Company provided below, signed by the
      Optionee, specifying the number of Shares to be acquired on, and the
      effective date of, such exercise. The Optionee may withdraw notice of
      exercise of this Option, in writing, at any time prior to the close of
      business on the business day preceding the proposed exercise
      date.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Method of Payment</font>. The
      Option Price upon exercise of the Option shall be payable to the Company
      in full either: (i)&#160;in cash or its equivalent, or (ii)&#160;subject
      to prior approval by the Committee in its discretion, by tendering
      previously acquired Shares having an aggregate Fair Market Value (as
      defined in the Plan) at the time of exercise equal to the total Option
      Price (provided that the Shares must have been held by the Optionee for at
      least six (6)&#160;months prior to their tender to satisfy the Option
      Price), or (iii)&#160;subject to prior approval by the Board of Directors
      or Compensation Committee in its discretion, by withholding Shares which
      otherwise would be acquired on exercise having an aggregate Fair Market
      Value at the time of exercise equal to the total Option Price (as
      determined pursuant to Section&#160;2.3 of the Plan), or (iv)&#160;subject
      to prior approval by the Board of Directors or Compensation Committee in
      its discretion, by a combination of (i), (ii), and (iii)&#160;above. Any
      payment in shares of Common Stock shall be effected by the delivery of
      such shares to the Chief Financial Officer of the Company, duly endorsed
      in blank or accompanied by stock powers duly executed in blank, together
      with any other documents as the Chief Financial Officer may require. If
      the payment of the Option Price is remitted partly in Shares, the balance
      of the payment of the Option Price shall be paid in either cash, certified
      check, bank cashiers&#8217; check, or by wire
  transfer.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><br><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Board
of Directors or Compensation Committee, in its discretion, may allow (i)&#160;a
&#8220;cashless exercise&#8221; as permitted under Federal Reserve Board&#8217;s
Regulation&#160;T, 12 CFR Part&#160;220 (or its successor), and subject to
applicable securities law restrictions and tax withholdings, or (ii)&#160;any
other means of exercise which the Board of Directors or Compensation Committee,
in its discretion, determines to be consistent with the Plan&#8217;s purpose and
applicable law.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As soon
as practicable after receipt of a written notification of exercise and full
payment, the Company shall deliver to or on behalf of the Optionee, in the name
of the Optionee or other appropriate recipient, Share certificates for the
number of Shares purchased under the Option. Such delivery shall be effected for
all purposes when a stock transfer agent of the Company shall have deposited
such certificates in the United States mail, addressed to Optionee or other
appropriate recipient.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Restrictions
      on Exercise</font>. The Option may not be exercised if the issuance of
      such Shares or the method of payment of the consideration for such Shares
      would constitute a violation of any applicable federal or state securities
      or other laws or regulations, including any such laws or regulations or
      Company policies respecting blackout periods, or any rules or regulations
      of any stock exchange on which the Common Stock may be
    listed.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Termination
      of Employment</font>. Voluntary or involuntary termination of Employment
      and the death or Disability of Optionee shall affect Optionee&#8217;s rights
      under the Option as follows:</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Termination for
      Cause</font>. The vested and non-vested portions of the Option shall
      expire on 12:01 am. (PT)&#160;on the date of termination of Employment and
      shall not be exercisable to any extent if Optionee&#8217;s Employment with the
      Company is terminated for Cause (as defined in the Plan at the time of
      such termination of Employment).</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Involuntary
      Termination or Voluntary Termination</font>. If Optionee&#8217;s Employment with
      the Company is terminated for any reason other than for Cause, retirement,
      death or Disability (as defined in the Plan at the time of termination of
      Employment), then (i)&#160;the non-vested portion of the Option shall
      immediately expire on the termination date (ii)&#160;the vested portion of
      the Option shall expire to the extent not exercised within three
      (3)&#160;months after the date of such termination of Employment. In no
      event may the Option be exercised by anyone after the earlier of
      (A)&#160;the expiration of the Option Period or (B)&#160;three
      (3)&#160;months after termination of
Employment.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Death or
      Disability</font>. If Optionee&#8217;s Employment with the Company is terminated
      by death or Disability, then the vesting of the Option will be accelerated
      and the entire Option shall be 100% vested on the date of termination of
      Employment and shall expire 365 calendar days after the date of such
      termination of Employment to the extent not exercised by Optionee or, in
      the case of death, by the person or persons to whom Optionee&#8217;s rights
      under the Option have passed by will or by the laws of descent and
      distribution or, in the case of Disability, by Optionee&#8217;s legal
      representative. In no event may the Option be exercised by anyone after
      the earlier of (i) the expiration of the Option Period or (ii)&#160;365
      days after Optionee&#8217;s death or termination of Employment due to
      Disability.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Retirement</font>. In
      the event of termination due to retirement, the vested portion of the
      Option shall expire on the earlier of (i)&#160;the Option Period or
      (ii)&#160;three (3) months after the date of retirement, and the unvested
      portion of the Option shall expire.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Change of
      Control</font>. In the event of a &#8220;Change in Control&#8221; of the Company (as
      defined below) the vesting of the Option will be accelerated and the
      entire Option shall be 100% vested as of the date immediately preceding a
      Change in Control and the Option may be accelerated and the Option shall
      otherwise be affected as provided in the Plan at such time. For the
      purposes of this Agreement, a &#8220;Change in Control&#8221; of the Company shall
      include any event as defined in the Plan, and the Board has determined
      that pursuant to Section&#160;6.7(f) of the Plan, a &#8220;Change in Control&#8221; of
      the Company shall also include any other event that constitutes a &#8220;Change
      in Control&#8221; of the Company as defined in the Optionee&#8217;s Termination
      Agreement with the Company.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Qualification
      as an Incentive Stock Option</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Optionee
      understands that the Option is intended to qualify as an &#8220;incentive stock
      option&#8221; within the meaning of Section&#160;422 of the Code. The Optionee
      must meet certain holding periods under Section 422(a) of the Code to
      obtain the federal income tax treatment applicable to the exercise of
      incentive stock options and the disposition of Shares acquired thereby.
      The Optionee further understands that the exercise price of Shares subject
      to this Option has been set by the Board of Directors or the Compensation
      Committee at a price that the Board of Directors or the Compensation
      Committee determined to be not less than 100% (or, if the Optionee, at the
      Date of Grant, owned more than 10% of the total combined voting power of
      the Company&#8217;s outstanding voting securities, 110%) of the Fair Market
      Value, as determined in accordance with the Plan, of a share of Common
      Stock on the Date of Grant. The Optionee further understands and agrees,
      however, that neither the Company nor the Board of Directors or the
      Compensation Committee shall be liable or responsible for any additional
      tax liability incurred by the Optionee in the event that the Internal
      Revenue Service for any reason determines that this Option does not
      qualify as an &#8220;incentive stock option&#8221; within the meaning of the
      Code.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Independent
      Legal and Tax Advice</font>. Optionee acknowledges that the Company has
      advised Optionee to obtain independent legal and tax advice regarding the
      grant and exercise of the Option and the disposition of any Shares
      acquired thereby.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Reorganization
      of Company</font>. The existence of the Option shall not affect in any way
      the right or power of the Company or its stockholders to make or authorize
      any or all adjustments, recapitalizations, reorganizations or other
      changes in Company&#8217;s capital structure or its business, or any merger or
      consolidation of the Company, or any issue of bonds, debentures, preferred
      or prior preference stock ahead of or affecting the Shares or the rights
      thereof, or the dissolution or liquidation of the Company, or any sale or
      transfer of all or any part of its assets or business, or any other
      corporate act or proceeding, whether of a similar character or
      otherwise.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Adjustment
      of Shares</font>. In the event of stock dividends, spin-offs of assets or
      other extraordinary dividends, stock splits, combinations of shares,
      recapitalizations, mergers, consolidations, reorganizations, liquidations,
      issuances of rights or warrants and similar transactions or events
      involving Company, appropriate adjustments shall be made to the terms and
      provisions of this Option as provided in the
  Plan.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">No
      Rights in Shares</font>. Optionee shall have no rights as a stockholder in
      respect of the Shares until the Optionee becomes the record holder of such
      Shares.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Investment
      Representation</font>. Optionee will enter into such written
      representations, warranties and agreements as Company may reasonably
      request in order to comply with any federal or state securities law.
      Moreover, any stock certificate for any Shares issued to Optionee
      hereunder may contain a legend restricting their transferability as
      determined by the Company in its discretion. Optionee agrees that Company
      shall not be obligated to take any affirmative action in order to cause
      the issuance or transfer of Shares hereunder to comply with any law, rule
      or regulation that applies to the Shares subject to the
      Option.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">No
      Guarantee of Employment</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>The Option shall not
      confer upon Optionee any right to continued Employment with the Company or
      any subsidiary or affiliate
thereof.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">17.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Withholding
      of Taxes</font>. This Option is subject to and the Company shall have the
      right to take any action as may be necessary or appropriate to satisfy any
      federal, state, or local tax withholding obligations, including at the
      Board of Directors or the Compensation Committee&#8217;s discretion, to make
      deductions from the number of Shares otherwise deliverable upon exercise
      of the Option in an amount sufficient to satisfy withholding of any
      federal, state or local taxes required by
law.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">18.&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">General</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.</font></font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Notices</font>. All
      notices under this Agreement shall be mailed or delivered by hand to the
      parties at their respective addresses set forth beneath their signatures
      below or at such other address as may be designated in writing by either
      of the parties to one another. Notices shall be effective upon
      receipt.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Shares
      Reserved</font>. Company shall at all times during the Option Period
      reserve and keep available under the Plan such number of Shares as shall
      be sufficient to satisfy the requirements of this
  Option.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Nontransferability of
      Option</font>. The Option granted pursuant to this Agreement is not
      transferable other than by will, the laws of descent and distribution or
      by a qualified domestic relations order (as defined in Section 414(p) of
      the Internal Revenue Code). The Option will be exercisable during
      Optionee&#8217;s lifetime only by Optionee or by Optionee&#8217;s legal representative
      in the event of Optionee&#8217;s Disability. No right or benefit hereunder shall
      in any manner be liable for or subject to any debts, contracts,
      liabilities, obligations or torts of
Optionee.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Amendment and
      Termination</font>. No amendment, modification or termination of the
      Option or this Agreement shall be made at any time without the written
      consent of Optionee and Company.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Guarantee of Tax
      Consequences</font>. The Company and the Board of Directors or the
      Compensation Committee make no commitment or guarantee that any federal or
      state tax treatment will apply or be available to any person eligible for
      benefits under the Option. The Optionee has been advised and been provided
      the opportunity to obtain independent legal and tax advice regarding the
      grant and exercise of the Option and the disposition of any Shares
      acquired thereby.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)
      &#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Severability</font>.
      In the event that any provision of this Agreement shall be held illegal,
      invalid, or unenforceable for any reason, such provision shall be fully
      severable, but shall not affect the remaining provisions of the Agreement,
      and the Agreement shall be construed and enforced as if the illegal,
      invalid, or unenforceable provision had not been included
      herein.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Supersedes Prior
      Agreements</font>. This Agreement shall supersede and replace all prior
      agreements and understandings, oral or written, between the Company and
      the Optionee regarding the grant of the Options covered
      hereby.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 54pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Governing Law</font>.
      The Option shall be construed in accordance with the laws of the State of
      Nevada without regard to its conflict of law provisions, to the extent
      federal law does not supersede and preempt Nevada
  law.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div>
        <table cellpadding="0" cellspacing="0" id="list" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 1.25;">
              <td align="right" style="WIDTH: 36pt">
                <div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">19.&#160;&#160;</font></div>
              </td>
              <td>
                <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="TEXT-DECORATION: underline">Definitions and Other Terms</font>.
      <font style="FONT-WEIGHT: normal">The following capitalized terms shall
      have those meanings set forth opposite
  them:</font></font></font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
Optionee: __________________________________________________</font></div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) Type
of Option:&#160;<font style="TEXT-DECORATION: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
<font style="DISPLAY: inline; TEXT-DECORATION: underline">Incentive Stock
Option&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</font></font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) Date
of Grant: _______________________________________________</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;Vesting
Start Date: ___________________________________________</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)
Shares: __________________&#160; shares of the Company&#8217;s Common
Stock.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)
Option Price: <font style="DISPLAY: inline; TEXT-DECORATION: underline">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)
Vesting Schedule: Options for Shares shall vest as follows:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Decided
by resolution of the Board of Directors.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">IN WITNESS WHEREOF, </font>the
Company has, as of ____________, 200_, caused this Agreement to be executed on
its behalf by its duly authorized officer, and Optionee has hereunto executed
this Agreement as of the same date.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">VIVAKOR, INC.</font></font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">OPTIONEE</font></font></td>
          </tr>
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:
      ___________________________</font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">______________________________</font></td>
          </tr>
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:
      __________________________</font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Address for Notices
      to the Company:</font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Address for Notices
      to Optionee:</font></td>
          </tr>
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          </tr>
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2590 Holiday Rd.,
      Suite 100</font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">______________________________</font></td>
          </tr>
          <tr>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Coralville, IA&#160;
      52241</font></td>
            <td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">______________________________</font></td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTICE
OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VivaKor,
Inc.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2590
Holiday Road, Suite 100</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Coralville,
IA&#160;&#160;52241</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attn:&#160;&#160;Chief
Financial Officer</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td style="WIDTH: 36pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
            </td>
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Re:</font></div>
            </td>
            <td>
              <div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exercise
      of Incentive Stock Option</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear Sir
or Madam:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to the Incentive Agreement dated _________, 200__&#160;&#160;(the <font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8220;Stock Option Agreement&#8221;</font>), I
hereby elect to purchase _____________&#160;shares of the Common Stock of the
Company (<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8220;Common Stock&#8221;</font>)
at the aggregate exercise price of $____________.&#160;&#160;I enclose the
following documents (check all that are applicable):</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 72pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">o&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">My
      check in the amount of
$___________.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 72pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">o&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other
      (specify):&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Common Stock is to be issued and registered in the name(s) of:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">___________________________________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">___________________________________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">I understand that
there may be tax consequences as a result of the purchase or disposition of the
Common Stock, I have consulted with any tax consultant I desired to consult, and
I am not relying on the Company for any tax advice.</font> I understand that my
exercise is governed by my Incentive Agreement and agree to abide by and be
bound by its terms and conditions. I represent that the Common Stock is being
acquired solely for my own account and not as a nominee for any other party, or
for investment, and that I will not offer, sell or otherwise dispose of any such
Common Stock except under circumstances that will not result in a violation of
the Securities Act of 1933, as amended, or the securities laws of any
state.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dated:&#160;&#160;___________________,
200_.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">________________________________________</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Signature)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">________________________________________<br><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Please
Print Name)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">________________________________________</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">________________________________________<br><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2008
PLAN</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ATTACH
HERE)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

      <div>
        <hr style="COLOR: black" align="left" noshade size="1" width="100%">
      </div>
    </div>
  </body>
</html>




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>9
<FILENAME>vivakor_s1-ex1003.htm
<DESCRIPTION>FORM OF RESTRICTED STOCK AWARD
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex1003.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT
10.3</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Grant No.:
_______</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right" align="right">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">2008 Incentive
Plan</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">RESTRICTED
STOCK AWARD</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VivaKor,
Inc., a Nevada corporation (the &#8220;Company&#8221;), grants shares of common stock, $.001
par value (the &#8220;Shares&#8221;), of the Company to the Grantee named below, subject to
the vesting conditions set forth in the attachment. Additional terms and
conditions of the grant are set forth in this cover sheet, in the attachment,
and in the Company&#8217;s 2008 Incentive Plan (the &#8220;Plan&#8221;).</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Grant
Date: __________________, 200__</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name of
Grantee: _________________________________________________</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Grantee&#8217;s
Social Security Number: _____-____-_____</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Number of
Shares Covered by Grant: ______________</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Purchase
Price per Share: $_____.___</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Manner of
Payment (check appropriate space):<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;_______
cash/check&#160;&#160;_______ services</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">By signing this
cover sheet, you agree to all of the terms and conditions described in the
attached Restricted Stock Award and in the Plan, a copy of which is also
attached. You acknowledge that you have carefully reviewed the Plan, and agree
that the Plan will control in the event any provision of this Award should
appear to be inconsistent.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="justify">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="left" valign="top" width="9%" style="PADDING-BOTTOM: 2px">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Grantee:</font></div>
            </td>
            <td valign="top" width="73%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
            <td valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
            <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Signature)</font></div>
            </td>
            <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="9%" style="PADDING-BOTTOM: 2px">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Company:</font></div>
            </td>
            <td valign="top" width="73%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
            <td valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
            <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Signature)</font></div>
            </td>
            <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="73%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></div>
            </td>
            <td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Attachments</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">2008 Incentive
Plan</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">RESTRICTED STOCK
AWARD</font></font></div>
    <div align="left">
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Restricted
      Stock/ Nontransferability</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">This
      grant is an award of stock in the number of Shares set forth on the cover
      sheet, at the Purchase Price set forth on the cover sheet, and subject to
      the vesting conditions described below (&#8220;Restricted Stock&#8221;). The purchase
      price for the Restricted Stock may be paid in either cash or check made
      payable to the Company, or may be deemed paid by your services to the
      Company (if approved by the Board of Directors or committee administering
      the Plan). To the extent not yet vested, your Restricted Stock may not be
      transferred, assigned, pledged or hypothecated, whether by operation of
      law or otherwise, nor may the Restricted Stock be made subject to
      execution, attachment or similar process.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issuance
      and Vesting</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      Company will issue your Restricted Stock in your name as of the Grant
      Date.</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Your
      right to the Shares under this Restricted Stock Award grant vests as to
      the total number of Shares covered by this grant, as shown on the cover
      sheet, on the first anniversary of the Grant Date (an &#8220;Anniversary Date&#8221;),
      provided you then continue in Service. If, however, you are restricted
      from selling Shares on the Anniversary Date pursuant to the Company&#8217;s
      policy on insider trading, your Shares that would have vested on that
      vesting date will vest on the first date that is during a window period in
      which Company insiders are not restricted from selling
Shares.</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Your
      right to the Shares under this Restricted Stock Award will become fully
      vested on your termination of Services due to death or disability (or such
      other conditions permitted by a written employment agreement with the
      Company). No additional Shares will vest after your Service has terminated
      for any reason.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Forfeiture
      of Unvested Shares</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">In
      the event that your Service terminates for any reason other than death or
      disability, you will forfeit to the Company all of the Shares subject to
      this grant that have not yet vested (unless otherwise provided in your
      employment agreement).</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div align="left">
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Escrow</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      certificates for the Restricted Stock shall be deposited in escrow with
      the Secretary of the Company to be held in accordance with the provisions
      of this paragraph. Each deposited certificate shall be accompanied by a
      duly executed Assignment Separate from Certificate in the form attached
      hereto as <font style="DISPLAY: inline">Exhibit A</font>. The deposited
      certificates shall remain in escrow until such time or times as the
      certificates are to be released or otherwise surrendered for cancellation
      as discussed below. Upon delivery of the certificates to the Company, you
      shall be issued an instrument of deposit acknowledging the number of
      Shares delivered in escrow to the Secretary of the
  Company.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All
      regular cash dividends on the Shares (or other securities at the time held
      in escrow) shall be paid directly to you and shall not be held in escrow.
      However, in the event of any dividend, split, recapitalization or other
      change affecting the Company&#8217;s outstanding Shares as a class effected
      without receipt of consideration or in the event of a split, a dividend or
      a similar change in the Shares, any new, substituted or additional
      securities or other property which is by reason of such transaction
      distributed with respect to the Shares shall be immediately delivered to
      the Secretary of the Company to be held in escrow hereunder, but only to
      the extent the Shares are at the time subject to the escrow requirements
      hereof.</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">As
      your interest in the Shares vests, as described above, the certificates
      for such vested Shares shall be released from escrow and delivered to you,
      at your request, within 30 days of their vesting.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Withholding
      Taxes</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">You
      agree, as a condition of this grant, that you will make acceptable
      arrangements to pay any withholding or other taxes that may be due as a
      result of the vesting of Shares acquired under this grant. In the event
      that the Company determines that any federal, state, local or foreign tax
      or withholding payment is required relating to the vesting of Shares
      arising from this grant, the Company shall have the right to require such
      payments from you, or withhold such amounts from other payments due to you
      from the Company or any Affiliate.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 83(b) </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Election</font></font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Under
      Section 83 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),
      the difference between the purchase price paid for the Shares and their
      fair market value on the date any forfeiture restrictions applicable to
      such Shares lapse will be reportable as ordinary income at that time. For
      this purpose, &#8220;forfeiture restrictions&#8221; include the forfeiture of unvested
      Shares that is described above. You may elect to be taxed at the time the
      Shares are acquired, rather than when such Shares cease to be subject to
      such forfeiture restrictions, by filing an election under Code Section
      83(b) with the Internal Revenue Service within thirty (30) days after the
      Grant Date. You will have to make a tax payment to the extent the Purchase
      Price is less than the fair market value of the Shares on the Grant Date.
      No tax payment will have to be made to the extent the Purchase Price is at
      least equal to the fair market value of the Shares on the Grant Date. The
      form for making this election is attached as <font style="DISPLAY: inline">Exhibit B</font> hereto. Failure to make this
      filing within the thirty (30) day period will result in the recognition of
      ordinary income by you (in the event the fair market value of the Shares
      as of the vesting date exceeds the purchase price) as the forfeiture
      restrictions lapse.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div align="left">
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">YOU ACKNOWLEDGE THAT IT IS YOUR
      SOLE RESPONSIBILITY, AND NOT THE COMPANY&#8217;S, TO FILE A TIMELY ELECTION
      UNDER CODE SECTION 83(b), EVEN IF YOU REQUEST THE COMPANY OR ITS
      REPRESENTATIVES TO MAKE THIS FILING ON YOUR BEHALF. YOU ARE RELYING SOLELY
      ON YOUR OWN ADVISORS WITH RESPECT TO THE DECISION AS TO WHETHER OR NOT TO
      FILE ANY CODE SECTION 83(b) ELECTION.</font></font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Retention
      Rights</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">This
      Award does not give you the right to be retained by the Company (or any
      parent, Subsidiaries or Affiliates) in any capacity. The Company (and any
      parent, Subsidiaries or Affiliates) reserves the right to terminate your
      Service at any time and for any reason.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shareholder
      Rights</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">You
      have the right to vote the Restricted Stock and to receive any dividends
      declared or paid on such Shares. Any distributions you receive as a result
      of any split, dividend, combination of Shares or other similar transaction
      shall be deemed to be a part of the Restricted Stock and subject to the
      same conditions and restrictions applicable thereto. Except as described
      in the Plan, no adjustments are made for dividends or other rights if the
      applicable record date occurs before your share certificate is
      issued.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Adjustments</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">In
      the event of a split, a dividend or a similar change in the Shares, the
      number of Shares covered by this grant may be adjusted (and rounded down
      to the nearest whole number) pursuant to the Plan. Your Restricted Stock
      shall be subject to the terms of the agreement of merger, liquidation or
      reorganization in the event the Company is subject to such corporate
      activity.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Legends</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">All
      certificates representing the Shares issued in connection with this grant
      shall, where applicable, have endorsed thereon the following
      legends:</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8220;THE
      SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS
      ON TRANSFER SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE
      REGISTERED HOLDER, OR HIS OR HER PREDECESSOR IN INTEREST. A COPY OF SUCH
      AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE
      FURNISHED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY BY THE
      HOLDER OF RECORD OF THE SHARES REPRESENTED BY THIS
      CERTIFICATE.&#8221;</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div align="left">
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Applicable
      Law</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="73%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">This
      Award will be interpreted and enforced under the laws of the State of
      Nevada, other than any conflicts or choice of law rule or principle that
      might otherwise refer construction or interpretation of this Award to the
      substantive law of another jurisdiction.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      Plan</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="73%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      text of the Plan is incorporated in this Award by reference. Certain
      capitalized terms used in this Award are defined in the Plan, and have the
      meaning set forth in the Plan.</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">This
      Award and the Plan constitute the entire understanding between you and the
      Company regarding this grant of Restricted Stock. Any prior agreements,
      commitments or negotiations concerning this grant are
      superseded.</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="22%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Data
      Privacy</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="73%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">In
      order to administer the Plan, the Company may process personal data about
      you. Such data includes, but is not limited to, the information provided
      in this Award and any changes thereto, other appropriate personal and
      financial data about you such as home address and business addresses and
      other contact information, payroll information and any other information
      that might be deemed appropriate by the Company to facilitate the
      administration of the Plan.</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By
      accepting this grant, you give explicit consent to the Company to process
      any such personal data. You also give explicit consent to the Company to
      transfer any such personal data outside the country in which you work or
      are employed, including, with respect to non-U.S. resident Grantees, to
      the United States, to transferees who shall include the Company and other
      persons who are designated by the Company to administer the
      Plan.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="left" valign="top" width="22%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consent
      to Electronic Delivery</font></div>
            </td>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      Company may choose to deliver certain statutory materials relating to the
      Plan in electronic form. By accepting this grant, you agree that the
      Company may deliver the Plan prospectus and the Company&#8217;s annual report to
      you in an electronic format. If at any time you would prefer to receive
      paper copies of these documents, as you are entitled to, the Company would
      be pleased to provide copies. Please contact the Secretary of the Company
      to request paper copies of these
documents.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">By signing the
cover sheet of this Restricted Stock&#160;&#160;Award, you agree to all of the
terms and conditions described above and in the Plan.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">EXHIBIT
A</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">ASSIGNMENT SEPARATE FROM
CERTIFICATE</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FOR VALUE
RECEIVED, _____________ sells, assigns and transfers to VivaKor, Inc., a Nevada
corporation (the &#8220;Company&#8221;), ____________ (__________) shares of common stock of
the Company represented by Certificate No. ___ and does hereby irrevocable
constitute and appoint ______________ to transfer the said shares on the books
of the Company with full power of substitution in the premises.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dated:____________,
200__</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="56%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="21%" style="PADDING-BOTTOM: 2px">&#160;</td>
            <td align="left" valign="top" width="56%" style="BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="56%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Print
      Name</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="56%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="21%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="56%" style="BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="21%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="56%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Signature</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Spouse Consent (if
applicable)</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">___________________
(Purchaser&#8217;s spouse) indicates by the execution of this Assignment his or her
consent to be bound by the terms herein as to his or her interests, whether as
community property or otherwise, if any, in the shares of common stock of the
Company.</font></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="27%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="27%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="73%" style="BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="27%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Signature</font></div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="27%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="73%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">INSTRUCTIONS: PLEASE DO NOT FILL IN
ANY BLANKS OTHER THAN THE SIGNATURE LINE. THE PURPOSE OF THIS ASSIGNMENT IS TO
ENABLE THE COMPANY TO CAUSE THE FORFEITURE OF YOUR UNVESTED SHARES AS SET FORTH
IN THE AWARD WITHOUT REQUIRING ADDITIONAL SIGNATURES ON THE PART OF
PURCHASER.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">A-1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">EXHIBIT
B</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ELECTION
UNDER SECTION 83(b) OF</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THE
INTERNAL REVENUE CODE</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;The
undersigned hereby makes an election pursuant to Section 83(b) of the Internal
Revenue Code with respect to the property described below and supplies the
following information in accordance with the regulations promulgated
thereunder:</font></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="96%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="right" valign="top" width="4%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.</font></div>
            </td>
            <td align="left" valign="top" width="96%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      name, address and social security number of the
    undersigned:</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="62%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="76%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">________________________________________________________________________________</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="76%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Address:</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">________________________________________________________________________________</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="76%">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">________________________________________________________________________________</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="76%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Social
      Security No.:</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">________________________________________________________________________________</font></div>
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td colspan="2" valign="top" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="right" valign="top" width="2%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.</font></div>
            </td>
            <td align="left" colspan="2" valign="top" width="76%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Description
      of property with respect to which the election is being
    made:</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_________
shares of common stock, par value $0.001 per share, of VivaKor, Inc., a Nevada
corporation (the &#8220;Company&#8221;).</font></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="right" valign="top" width="2%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.</font></div>
            </td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      date on which the property was transferred is ____________ __,
      200__.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="right" valign="top" width="2%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.</font></div>
            </td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      taxable year to which this election relates is calendar year
      200__.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="right" valign="top" width="2%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.</font></div>
            </td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nature
      of restrictions to which the property is
  subject:</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
shares of common stock are subject to the provisions of a Restricted Share Award
between the undersigned and the Company. The shares are subject to forfeiture
under the terms of the Award.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">B-1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td align="right" valign="top" width="2%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.</font></div>
            </td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      fair market value of the property at the time of transfer (determined
      without regard to any lapse restriction) was $__________ per share, for a
      total of $__________.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="2%">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></div>
            </td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="right" valign="top" width="2%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.</font></div>
            </td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The
      amount paid by taxpayer for the property was
  $__________.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td align="right" valign="top" width="2%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.</font></div>
            </td>
            <td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" valign="top" width="74%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">A
      copy of this statement has been furnished to the
  Company.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dated:
_____________, 200__</font></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td valign="top" width="27%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td valign="top" width="46%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="27%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="51%" style="BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="27%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="51%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Taxpayer&#8217;s
      Signature</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="3" valign="top" width="78%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
          </tr>
          <tr>
            <td valign="top" width="27%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="51%" style="BORDER-BOTTOM: black 2px solid">
              <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
            </td>
          </tr>
          <tr>
            <td valign="top" width="27%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;
      </font></td>
            <td align="left" colspan="2" valign="top" width="51%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Taxpayer&#8217;s
      Printed Name</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">B-2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROCEDURES
FOR MAKING ELECTION</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">UNDER INTERNAL REVENUE CODE SECTION
83(b)</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
following procedures <font style="DISPLAY: inline; FONT-WEIGHT: bold">must</font> be followed with respect
to the attached form for making an election under Internal Revenue Code section
83(b) in order for the election to be effective:<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">1</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1. You
must file one copy of the completed election form with the IRS Service Center
where you file your federal income tax returns within <font style="DISPLAY: inline; TEXT-DECORATION: underline">30 days</font> after the
Grant Date of your Restricted Stock.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2. At the
same time you file the election form with the IRS, you must also give a copy of
the election form to the Secretary of the Company.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">3. You must file
another copy of the election form with your federal income tax return
(generally, Form 1040) for the taxable year in which the shares are transferred
to you.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160;Whether
or not to make the election is your decision and may create tax consequences for
you. You are advised to consult your tax advisor if you are unsure whether or
not to make the election.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">C-1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2008
Plan</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">C-2</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
    <div>
      <hr style="COLOR: black" align="left" noshade size="1" width="100%">
    </div>
  </body>
</html>




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>10
<FILENAME>vivakor_s1-ex1004.htm
<DESCRIPTION>ACQUISITION AGREEMENT
<TEXT>
<html>
  <head>
    <title>Unassociated Document</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT
10.4</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ACQUISITION
AGREEMENT AND PLAN OF ACQUISITION</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THIS
ACQUISITION AGREEMENT AND PLAN OF ACQUISITION (the <font style="DISPLAY: inline; FONT-WEIGHT: bold">"Agreement"), </font>dated as of
September 8, 2008, is entered into by and among VivaKor, Inc., a Nevada
corporation <font style="DISPLAY: inline; FONT-WEIGHT: bold">("VivaKor")
</font>and each of HealthAmerica, Inc., a Nevada corporation <font style="DISPLAY: inline; FONT-WEIGHT: bold">("HealthAmerica") </font>and Richard
A. Taulli (the <font style="DISPLAY: inline; FONT-WEIGHT: bold">"HealthAmerica
Principal Shareholder Prior to the Acquisition"). </font>Capitalized terms used
in this Agreement and not defined in context shall have the meanings ascribed to
them in Section 10.7 hereof.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WHEREAS,
the respective Boards of Directors of HealthAmerica and VivaKor have approved
the Acquisition of HealthAmerica by VivaKor with HealthAmerica being a
wholly-owned subsidiary of VivaKor (the <font style="DISPLAY: inline; FONT-WEIGHT: bold">"Acquisition"), </font>all upon the
terms and subject to the conditions set forth herein; and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOW,
THEREFORE, in consideration of the foregoing premises and the representations,
warranties and agreements contained herein and for other good and valuable
consideration, the receipt and adequacy of which are hereby acknowledged, the
parties hereto, intending to be legally bound, agree as follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
I</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Acquisition</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
1.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline">The
Acquisition.</font> Upon the terms and subject to the conditions of this
Agreement, at the Effective Time, HealthAmerica shall be acquired by VivaKor.
HealthAmerica shall continue the under the laws of the State of Nevada as a
wholly-owned subsidiary of VivaKor. Throughout this Agreement, the term <font style="DISPLAY: inline; FONT-WEIGHT: bold">"Subsidiary" </font>shall refer to
HealthAmerica in its status as the acquired corporation in the
Acquisition.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
1.2 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing.</font>
The closing of the Transactions (the <font style="DISPLAY: inline; FONT-WEIGHT: bold">"Closing") </font>will take place as
promptly as practicable (and in any event within two business days) after
satisfaction or waiver of the conditions set forth in Article VII (other than
conditions that require the delivery of documents, which may be satisfied at the
Closing). The Closing shall be held at the offices of Wilson, Haglund &amp;
Paulsen, P.C., 9110 Irvine Center Drive, Irvine, California 92618, unless
another place is agreed to in writing by the parties hereto. The date on which
the Closing occurs is referred to herein as the <font style="DISPLAY: inline; FONT-WEIGHT: bold">"Closing Date". </font>At the
Closing, each of HealthAmerica and VivaKor shall deliver the agreements,
certificates and other documents required to be delivered and which have not
been delivered prior to the Closing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
1.3 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Effective Time of
the Acquisition.</font> The Acquisition shall become effective upon delivery of
the Acquisition Consideration. When used in this Agreement, the term <font style="DISPLAY: inline; FONT-WEIGHT: bold">"Effective Time" </font>shall mean
the time at which the Acquisition Consideration is delivered.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
1.4 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Effect of the
Acquisition.</font> The Acquisition shall, from and after the Effective Time,
have all the effects provided by applicable Law. If, at any time after the
Effective Time, the Corporation shall consider or be advised that any further
deeds, conveyances, assignments or assurances in Law or any other acts are
necessary, desirable or proper to vest, perfect or confirm, of record or
otherwise, in the Corporation the title to any property or rights of VivaKor, by
reason or as a result of the Acquisition, or otherwise to carry out the purposes
of this Agreement, HealthAmerica agrees that its proper officers and directors
shall execute and deliver all such deeds, conveyances, assignments and
assurances in Law and do all things necessary, desirable or proper to vest,
perfect or confirm title to such property or rights and otherwise to carry out
the purposes of this Agreement, and that the proper officers and directors are
fully authorized in the name of HealthAmerica or otherwise to take any and all
such action.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
II</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Acquisition Corporation</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
2.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Articles of
Incorporation.</font> The articles of incorporation of HealthAmerica shall
continue after the Effective Time as the articles of incorporation of the
Wholly-owned Subsidiary Corporation, HealthAmerica, Inc.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
2.2 <font style="DISPLAY: inline; TEXT-DECORATION: underline">By-Laws.</font>
The by-laws of HealthAmerica shall continue after the Effective Time as the
by-laws of the Wholly-owned Subsidiary Corporation, HealthAmerica,
Inc.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
2.3 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Board of
Directors; Officers.</font> The members of the Board of Directors and the
officers of the Wholly-owned Subsidiary Corporation, HealthAmerica, Inc.,
following the Acquisition shall be the directors and officers of VivaKor
immediately prior to the Effective Time, and such directors and officers shall
continue in office until the earlier of their respective death, resignation or
removal and the time that their respective successors are duly elected or
appointed and qualified.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
III</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Acquisition
Consideration</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
3.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Acquisition
Consideration.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) As of
the Effective Time, by virtue of the Acquisition and without any action on the
part of any stockholder of HealthAmerica:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Twenty
five million (25,000,000) newly issued shares of Common Stock, $0.001 par value,
of HealthAmerica shall be issued to VivaKor in exchange for five million
(5,000,000) newly issued shares of Common Stock, $0.001 par value, of VivaKor
immediately prior to the Effective Time. The issuance of the Common Stock of
HealthAmerica to VivaKor shall constitute approximately eighty four percent
(84%) of the issued and outstanding capital stock of HealthAmerica following the
Acquisition. The five million (5,000,000) shares Common Stock of VivaKor shall
be issued to the shareholders of record of HealthAmerica as duly registered with
HealthAmerica's transfer agent prior to the Effective Time.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject
to the provisions of this Section 3.1(a), each share of the common stock of
HealthAmerica, par value $0.001 per share ("<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">HealthAmerica
Common </font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock</font>")
issued and outstanding immediately prior to the Effective Time shall, by virtue
of the Acquisition and without any action on the part of the holders thereof,
remain validly issued, fully paid and non-assessable shares of common stock of
HealthAmerica, par value $0.001 per share ("HealthAmerica Common Stock"). As a
result of such shares issuances, the shares issued to the original shareholders
of HealthAmercia shall represent approximately Sixteen Percent (16%) of the
total shares of HealthAmerica issued and outstanding as of the Closing
Date.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;As
additional consideration for the Acquisition, VivaKor and/or HealthAmerica as
VivaKor's wholly-owned subsidiary, agrees to pay to Rico Italia Investments,
Inc., as the nominee of the HealthAmerica Principal Shareholder Prior to the
Acquisition, the aggregate amount of One Million Five Hundred Thousand Dollars
($1,500,000.00) (the "<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cash
Consideration</font>"), payable as follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$25,000.00
was paid in advance on August 18, 2008;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$25,000.00
was due on September 18, 2008;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 13pt; FONT-FAMILY: Times New Roman, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">thereafter
$25,000.00 shall be due on the 18</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; VERTICAL-ALIGN: super; FONT-FAMILY: Times New Roman">th</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> of each
month; </font>provided, in addition, if at any time after the initial deposit
has been realized, if HealthAmerica and/or VivaKor receives cash and/or
securities in any equity or debt offering or financing or from any sale or
licensing of products, technology or equipment, then HealthAmerica and/or
VivaKor agrees to pay Rico Italia Investments, Inc. ten percent (10%) of the
gross proceeds raised in such offerings or sales, licensing, etc., commencing
ninety (90) days after the initial deposit, and continuing every ninety (90)
days thereafter until the Cash Consideration has been
sufficed.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) The Cash Consideration
shall be evidenced by a Secured Nonrecourse Promissory Note in the principal
amount of $1,500,000.00 (the "<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Note</font>")
which shall be secured by a Pledge and Security Agreement (the "<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pledge
and Security Agreement</font>") of the shares of capital stock of HealthAmerica
and all of the assets of HealthAmerica, Inc. In the event VivaKor fails to make
any payment under the Note, the Holder of the </font>Note may, as it sole and
exclusive remedy, foreclose on and retain the shares of capital stock and the
assets of the HealthAmerica. The HealthAmerica Principal Shareholder Prior to
the Acquisition acknowledges and agrees that, upon an event of default under the
Note, if any, the HealthAmerica Principal Shareholder Prior to the Acquisition
(or its nominees) sole recourse shall be to the shares of the HealthAmerica and
its assets, and no claim may be asserted against VivaKor or its assets, property
or business. If the HealthAmerica Principal Shareholder Prior to the Acquisition
elects to foreclose and retain the capital stock of HealthAmerica and its
assets, then its shall also automatically and without action grant VivaKor the
option to repurchase the VivaKor shares issued to the HealthAmerica Principal
Shareholder Prior to the Acquisition for a repurchase price of $1.00 in the
aggregate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) If,
at any time during the period between the date of this Agreement and the
Effective Time, VivaKor changes the number of shares of VivaKor Common Stock
issued and outstanding or HealthAmerica changes the number of shares of
HealthAmerica Common Stock issued and outstanding, in each case as a result of a
stock split, reverse stock split, stock dividend, recapitalization,
redenomination of share capital or other similar transaction with an effective
date or record date, as applicable, prior to the Effective Time, and in a
transaction that the other parties to this Agreement have provided their consent
to if such consent is required hereunder, then the Exchange Ratio and any other
items dependent thereon shall be appropriately adjusted.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
3.2 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Stockholders'
Rights at the Effective Time.</font> On and after the Effective Time, the
certificates that immediately prior to the Effective Time represented shares of
HealthAmerica Common Stock (the "<font style="DISPLAY: inline; FONT-WEIGHT: bold">Certificates</font>"), shall continue
to represent all rights with respect to HealthAmerica Common Stock. As of the
Effective Time, the holders of HealthAmerica Common Stock as of the Effective
Time who are entitled to receive shares of VivaKor Common Stock as Acquisition
Consideration shall be deemed to be record owners of such shares of VivaKor
Common Stock as of the Effective Time and shall thereupon be entitled to
exercise any rights as a holder of VivaKor Common Stock, including the right to
vote such VivaKor Common Stock, whether or not the Certificates are issued
pursuant to this Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
3.3 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Issuance of Share
Certificates.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
Promptly after the Closing Date, VivaKor shall deliver the Common Stock as
Acquisition Consideration pursuant to Section 3.1(a). The number of shares of
Common Stock that each HealthAmerica Stockholder will be entitled to receive
will be determined by the number of shares of HealthAmerica Common Stock held by
such stockholder. Notwithstanding any other provision of this Agreement, no
fractional shares of Common Stock will be issued in connection with the
Acquisition. Any HealthAmerica Stockholder who is entitled to receive a
fractional share shall receive the next whole number of shares of Common
Stock.</font></font></font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>
At or after the Closing, each holder of a Certificate representing shares of
HealthAmerica Common Stock shall be issued their respective shares of common
stock of VivaKor together with a duly completed and executed transmittal
letter.</font></font></font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) At
the Effective Time, the stock transfer books of HealthAmerica shall be closed
and no transfer of shares of HealthAmerica Common Stock shall be recorded
thereafter, other than transfers of shares of HealthAmerica Common Stock that
have occurred prior to the Effective Time. In the event that, after the
Effective Time, Certificates are presented for transfer to VivaKor or
HealthAmerica, they shall be delivered to the Exchange Agent and issued for the
Acquisition Consideration as provided for in this Section 3.3.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d</font>) In the event
any Certificates shall have been lost, stolen or destroyed, VivaKor shall
deliver the Acquisition Consideration and any dividends or other distributions
with respect to VivaKor Common Stock to which such holder is entitled in
exchange for such lost, stolen or destroyed Certificates, upon the making of an
affidavit of that fact by the record holder thereof and the delivery of such
bond as VivaKor may reasonably require.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g) No transfer taxes
</font>shall be payable by any stockholder of HealthAmerica </font></font>in
respect of the issuance of the VivaKor Common Stock under this Section 3.3,
except that if any VivaKor Common Stock is to be issued in a name other than
that in which the Certificate that has been registered, it shall be a condition
of such issuance that the Person requesting such issuance shall pay to VivaKor
any transfer taxes payable by reason thereof, or of any prior transfer of such
Certificate, or establish to the satisfaction of VivaKor that such taxes have
been paid or are not payable.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 3.4 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Resale
Restrictions.</font></font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
stockholders of HealthAmerica who received shares of VivaKor Common </font>Stock
as Acquisition Consideration may not offer or sell any shares of VivaKor Common
Stock unless such offer or sale is made (i) pursuant to an effective
registration of such VivaKor Common Stock under the Securities Ad, or (ii)
pursuant to an available exemption from the registration requirements of the
Securities Act. VivaKor shall refuse to register the transfer of any VivaKor
Common Stock not made in accordance with this Section 3.4 and for such purpose
may place stop order instructions with its transfer agent with respect to the
VivaKor Common Stock issued as Acquisition Consideration. A proposed transfer
shall be deemed to comply with this Section 3.4 if the applicable stockholder
delivers to VivaKor a legal opinion in form and substance satisfactory to
VivaKor from counsel reasonably satisfactory to VivaKor to the effect that such
transfer complies with this Section 3.4.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;
<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
certificate representing shares of VivaKor Common Stock issued as
</font>Acquisition Consideration will bear the following legend or one
substantially similar thereto:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;ACT'), OR ANY APPLICABLE STATE
SECURITIES LAWS. THESE SECURITIES MAY NOT BE SOLD, MORTGAGED, PLEDGED,
HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION
STATEMENT FOR SUCH SECURITIES UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES
LAWS OR THE AVAILABILITY OF AN EXEMPTION FROM SUCH REGISTRATION
REQUIREMENTS."</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
IV</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Representations
and Warranties of HealthAmerica</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each of
HealthAmerica and the HealthAmerica Principal Shareholder Prior to the
Acquisition, jointly and severally, represents and warrants to VivaKor that,
except as disclosed in the HealthAmerica Disclosure Schedule which has been
delivered to VivaKor prior to the execution of this Agreement (the <font style="DISPLAY: inline; FONT-WEIGHT: bold">"HealthAmerica Disclosure Schedule"),
</font>the following: The Disclosure Schedule shall modify each and every
representation and warranty and any exceptions thereon shall be deemed to apply
to all representations and warranties regardless of any section
designation.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Organization and
Qualification</font>.</font> HealthAmerica is a corporation duly organized,
validly existing and in good under the laws of the State of Nevada.
HealthAmerica has the requisite corporate power and authority to carry on its
business as it is now being conducted and is duly qualified or licensed to do
business, and, if applicable, is in good standing, in each jurisdiction where
the character of its properties owned or held under lease or the nature of its
activities makes such qualification or licensing necessary, except where the
failure to be so organized, qualified,. licensed or in good standing, or to have
such power and authority, when taken together with all other such failures would
not have an HealthAmerica Material Adverse Effect. HealthAmerica has heretofore
made available to VivaKor a complete and correct copy of the certificate of
incorporation, by-laws or other governing documents, each as amended to the date
hereof, of HealthAmerica. As of the Effective Time, HealthAmerica does not own
or control, directly or indirectly, any equity interest in any corporation,
company, association, partnership, joint venture or other entity or own any real
estate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.2 <font style="DISPLAY: inline; TEXT-DECORATION: none"><font style="TEXT-DECORATION: underline">Capitalization</font>.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
The authorized capital stock of HealthAmerica consists of 75,000,000 shares of
HealthAmerica Common Stock, of which 5,000,000 are issued and outstanding and
are validly issued, fully paid and non-assessable. There are no shares of
HealthAmerica Preferred Stock issued or outstanding. All duly issued shares of
HealthAmerica Common Stock held by the HealthAmerica Principal Shareholder Prior
to the Acquisition are owned free and clear of all liens or encumbrances
thereon.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>&#160;There
are no preemptive or other outstanding rights, options, warrants, conversion
rights (including pursuant to convertible Securities), stock appreciation
rights, redemption rights, repurchase rights, agreements, arrangements, calls,
commitments or rights of any kind relating to the issued or unissued capital
stock of HealthAmerica or obligating HealthAmerica to issue or sell any shares
of capital Stock of, or other equity interests in, HealthAmerica. As of the date
of this Agreement, there are no outstanding contractual obligations of
HealthAmerica to repurchase, redeem or otherwise acquire any shares of capital
stock of HealthAmerica or to provide material funds to, Or make any material
investment (in the form of a loan, capital contribution or otherwise) in, any
Person.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 4.3 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Authority
Relative to this Agreement and the Transactions.</font> HealthAmerica and the
HealthAmerica Principal Shareholder Prior to the Acquisition have all corporate
power and authority to execute and deliver this Agreement, to perform its
obligations hereunder and to consummate the Acquisition. The execution and
delivery by HealthAmerica and the, HealthAmerica Principal Shareholder Prior to
the Acquisition of this Agreement, and the consummation by HealthAmerica and the
HealthAmerica Principal Shareholder Prior to the Acquisition of the Transactions
to which each of them is a party, have been duly and validly authorized by all
necessary corporate action and no other corporate proceedings on the part of
HealthAmerica or the HealthAmerica Principal Shareholder Prior to the
Acquisition are necessary to authorize the execution and delivery of this
Agreement or to consummate the Transactions to which it is a party other than,
with respect to the Acquisition, the adoption of this Agreement by the
affirmative vote of the holders of a majority of the outstanding shares of
HealthAmerica Common Stock and the filing and recordation of appropriate
</font>Acquisition documents as required by Nevada Law. This Agreement has been
duly and validly executed and delivered by HealthAmerica and the HealthAmerica
Principal Shareholder Prior to the Acquisition and, assuming the due
authorization, execution and delivery by the other parties hereto, constitutes a
legal, valid and binding obligation of each of the, enforceable against each of
them in accordance with its terms.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.4 <font style="DISPLAY: inline; TEXT-DECORATION: underline">No Conflicts,
Required Filings and Consents.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) The
execution and delivery of this Agreement by HealthAmerica and the HealthAmerica
Principal Shareholder Prior to the Acquisition does not, and the performance of
this Agreement and consummation of the Transactions by each of the them will
not: (i) conflict with or violate the certificate of incorporation or by-laws of
HealthAmerica or such HealthAmerica Principal Shareholder, (ii) assuming the
consents, approvals, authorizations and waivers specified in Section 4.4(b) have
been received, and any condition precedent to such consent, approval,
authorization, or waiver has been satisfied, conflict with or violate any Law
applicable to HealthAmerica or by which any property of asset of HealthAmerica
is bound or affected, or (iii) result in any breach of or constitute a default
(or an event which with notice or lapse of time or both would become a default)
under, or give to others any right of termination, amendment, acceleration, or
cancellation of, or result in the creation of a lien or other encumbrance on any
property or asset of HealthAmerica pursuant to, any Contract to which
HealthAmerica is a party or by which HealthAmerica or any property or asset of
HealthAmerica is bound or affected, except in the case of clauses (ii) and (iii)
for any such conflicts, violations, breaches, defaults or other occurrences if
the type referred to above which would not have an HealthAmerica Material
Adverse Effect or would not prevent or materially delay the consummation of the
Acquisition.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The
execution and delivery of this Agreement by HealthAmerica and the HealthAmerica
Principal Shareholder Prior to the Acquisition does not, and the performance of
this Agreement by HealthAmerica will not, require any consent, approval,
authorization, waiver or permit of, or filing with or notification to, any
governmental or regulatory authority, domestic, foreign or supranational (a
<font style="DISPLAY: inline; FONT-WEIGHT: bold">"Governmental Entity"),
</font>except for applicable requirements of the Securities Exchange Act of
1934, as amended (the <font style="DISPLAY: inline; FONT-WEIGHT: bold">"Exchange
Act"), </font>the Securities Act of 1933, as amended (the <font style="DISPLAY: inline; FONT-WEIGHT: bold">"Securities Act"), </font>state
Securities or "blue sky" laws <font style="DISPLAY: inline; FONT-WEIGHT: bold">("Blue Sky Laws"), </font>filing and
recordation of the Plan of Acquisition as required by Nevada Law, except where
failure to obtain such consents, approvals, authorizations or permits, or to
make such filings or notifications, would not have an HealthArnerica Material
Adverse Effect or would not prevent or materially delay the consummation of the
Acquisition.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.5 <font style="DISPLAY: inline; TEXT-DECORATION: none"><font style="TEXT-DECORATION: underline">Brokers</font>.</font> No agent, broker,
finder, investment banker or other firm or Person is or will be entitled to any
broker's or finder's fee or other similar commission or fee in connection with
the Transactions based upon arrangements made by or on behalf of
HealthAmerica.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 4.6 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: none"><font style="TEXT-DECORATION: underline">Financial Statements; Absence of
Changes</font>.</font></font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
Section 4.7(a) of the HealthAmerica. Disclosure Schedule sets forth copies of
the unaudited financial statements of HealthAmerica as of December 31, 2007 and
August 31, 2008 (the <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"HealthAmerica
Financial Statements"). </font>The HealthAmerica Financial Statements fairly
present the financial condition and the results of operations, changes in
stockholders' equity and cash flow of HealthAmerica as at the respective dates
of and for the periods referred to in such HealthAmerica Financial Statements
and are consistent with the books and records of
HealthAmerica.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>
Since December 31, 2007, HealthAmerica has conducted its business only in the
ordinary course, and since such date there has not occurred any event having a
HealthAmerica Material Adverse Effect or, to HealthAmerica's knowledge, any
event or development which is reasonably likely to cause an event having a
HealthAmerica Material Adverse Effect.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 4.7 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Debts
and Liabilities.</font> Prior to the Closing Date, HealthAmerica shall pay in
full all Debts, liabilities and obligations it has incurred such that on the
Closing Date HealthAmerica shall have no outstanding Debts</font>, liabilities,
obligations or other claims, whether fixed or contingent, known or unknown;
including but not limited to any liabilities appearing on the HealthAmerica
Financial Statements.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.8 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Litigation.</font>
There is no suit, action, proceeding, arbitration or written claim
(collectively, "<font style="DISPLAY: inline; FONT-WEIGHT: bold">Litigation</font>") pending or, to
the knowledge of HealthAmerica, threatened against or affecting HealthAmerica
that, individually or in the aggregate, would, if decided adversely to
HealthAmerica, reasonably be expected to have an HealthAmerica Material Adverse
Effect, nor is there any judgment, decree, injunction, rule or order of any
Governmental Entity or arbitrator outstanding against HealthAmerica having, or
which would reasonably be expected to have, individually or in the aggregate, an
HealthAmerica Material Adverse Effect.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.9 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Environmental.</font> There
have been no Releases of any Hazardous Materials at, on or under any facility or
property currently or formerly owned, leased, or operated by HealthAmerica that,
individually or in the aggregate, would reasonably be expected to have a
HealthAmerica Material Adverse Effect. HealthAmerica is not the subject of any
pending or, to HealthAmerica's knowledge, threatened investigation or proceeding
under Environmental Law relating in any manner to the off-site treatment,
storage or disposal of any Hazardous Materials generated at any facility or
property currently or formerly owned, leased or operated by HealthAmerica that,
individually or in the aggregate, could reasonably be expected to have an
HealthAmerica Material Adverse Effect. HealthAmerica has not assumed or
otherwise agreed to be responsible for any liabilities arising under
Environmental Law that, individually or in the aggregate, could reasonably be
expected to have a HealthAmerica Material Adverse Effect. The term "<font style="DISPLAY: inline; FONT-WEIGHT: bold">Environmental Law</font>" means any
and all applicable laws or regulations or other requirements of any Governmental
Entity concerning the protection of human health or the environment. The term
"Hazardous Materials" means all explosive or regulated radioactive materials,
hazardous or toxic substances; wastes or chemicals, petroleum (including crude
oil or any fraction thereof), and all other materials or chemicals regulated
under any Environmental Law. The term "Release" means any spill, emission,
leaking, pumping, injection, deposit, disposal, discharge, dispersal, leaching,
emanation or migration in, into, onto, or through the environment.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.10 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Intellectual
Property.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
HealthAmerica has such ownership of or such rights by license orotherwise in all
patents and patent applications, mask works, trademarks and service marks,
trademark and service mark registrations and applications, trade names, logos,
brands, titles, copyrights, subsidiary rights, copyright registrations and
applications, trade secrets, names and likenesses, know-how, proprietary
processes, compositions of matter, formulae, designs, computer software programs
and other proprietary rights as are necessary to conduct and permit the conduct
of the business of HealthAmerica as currently conducted (collectively, the
"<font style="DISPLAY: inline; FONT-WEIGHT: bold">Intellectual Property
Rights</font>"), except where the failure to have such ownership or right by
license or otherwise, individually and in the aggregate, would not reasonably be
expected to have an HealthAmerica Material Adverse Effect. Section 4.10 of the
HealthAmerica Disclosure Schedule sets forth a list of all (i) registered
Intellectual Property Rights owned by HealthAmerica and (ii) material registered
Intellectual Property Rights licensed or otherwise used by HealthAmerica in the
conduct of its business.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) The
conduct of the business of HealthAmerica as currently conducted does not
infringe upon the intellectual property rights of any third party or violate the
privacy rights of any third party or defame any third party and there are no
such present or, to the knowledge of HealthAmerica, threatened infringements or
violations of the Intellectual Property Rights by any third party, except, in
either case, for such infringements or violations which, individually and in the
aggregate, would not reasonably be expected to have an HealthAmerica Material
Adverse Effect.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.11 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Contracts.</font>
Except as set forth on Section 4.11 of the HealthAmerica Disclosure Schedule, as
of the date of this Agreement, HealthAmerica is not a party to or bound by,
and<font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;none of its
properties or assets are bound by or subject to, any written, electronic or
oral:</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
Contract that restricts in any material respect the manner in which, or the
localities in which, all or a material portion of the business of HealthAmerica
is conducted;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>
Contract under which HealthAmerica has (i) incurred any indebtedness for
borrowed money that is currently outstanding, (ii) given any guarantee in
respect of indebtedness for borrowed money or (iii) granted any pledge, mortgage
or other security interest in any property or assets of HealthAmerica;
or</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) Contract in respect of
any joint venture, partnership, business alliance or similar arrangement between
HealthAmerica and any third party involving a material ownership interest in any
such entity</font>.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
Contract of HealthAmerica is in full force and effect and is a legal, valid and
binding agreement of HealthAmerica, as applicable, and to the knowledge of
HealthAmerica, enforceable against HealthAmerica, as applicable, and against the
other party or parties thereto, in each case, in accordance with its terms, in
each case, subject to applicable bankruptcy, insolvency, reorganization,
moratorium or other laws relating to or affecting the rights and remedies of
creditors generally and to general principles of equity (regardless of whether
considered in a proceeding in equity or at law), except for such failures to be
in full force and effect or enforceable that, individually and in the aggregate,
would not reasonably be expected to have an HealthAmerica Material Adverse
Effect. Except as would not reasonably be expected, individually and in the
aggregate, to have an HealthAmerica Material Adverse Effect, each of
HealthAmerica has performed or is performing all obligations required to be
performed by it under its Contracts and is not (with or without notice or lapse
of time or both) in breach or default thereunder, and, to the knowledge of
HealthAmerica, no other party to any of its Contracts is (with or without notice
or lapse of time or both) in breach or default thereunder.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.12 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Benefit
Plans.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)
HealthAmerica does not have any employee benefit plans, including any employee
benefit plans as that term is defined in Section 3(3) of the Employee Retirement
and Income Security Act of 1974 ("<font style="DISPLAY: inline; FONT-WEIGHT: bold">ERISA</font>"), or any other plans
maintained or contributed to by HealthAmerica for the benefit of its employees
(or former employees) and/or its beneficiaries&#160;&#160;("<font style="DISPLAY: inline; FONT-WEIGHT: bold">Benefit Plans</font>"). An
arrangement will not fail to be a Benefit Plan simply because it only covers one
individual.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) To
the knowledge of HealthAmerica, there are no investigations, proceedings, or
lawsuits, either currently in progress or expected to be instituted in the
future, relating to any Benefit Plan, by any Governmental Entity.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
4.13 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Taxes.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
HealthAmerica has filed all material Tax Returns required to be filed by it and
all such returns are complete and correct in all material respects, or requests
for extensions to file such Tax Returns have been timely filed; granted and have
not expired. HealthAmerica has paid (or caused to be paid) all Taxes shown as
due on such tax returns, and the HealthAmerica Financial Statements reflect an
adequate reserve (in addition to any reserve for deferred Taxes established to
reflect timing difference&#167; between book and Tax income) of tax for all Taxes
payable by HealthAmerica for all Taxable periods and portions thereof accrued
through the date of such financial statements.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>&#160;No
Tax Return of HealthAmerica is under audit or examination by any taxing
authority, and no written notice of such an audit or examination has been
received by HealthAmerica. There is no deficiency, refund litigation, proposed
adjustment or matter in controversy with respect to any Taxes due and owing by
HealthAmerica. Each deficiency resulting from any</font> completed audit or
examination relating to Taxes by any Taxing authority has been timely paid,
except for such deficiencies being contested in good faith and for which
adequate reserves are reflected on the financial statements of
HealthAmerica.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c) No
liens for Taxes (other than for current Taxes not yet due and payable) exist
with respect to any assets or properties of HealthAmerica. HealthAmerica is not
bound by any agreement with respect to Taxes.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d) As
used in this Agreement, (a) "<font style="DISPLAY: inline; FONT-WEIGHT: bold">Taxes</font>" shall include (A) all
forms of taxation, whenever created or imposed, and whether domestic or foreign,
and whether imposed by a national, Federal, state, provincial, local or other
Governmental Entity, including all interest, penalties and additions imposed
with respect to such amounts, (B) liability for the payment of any amounts of
the type described in clause (A) as a result of being a member of an affiliated,
consolidated, combined or unitary group and (C) liability for the payment of any
amounts as a result of being party to any tax sharing agreement or as a result
of any express or implied obligation to indemnify any other Person with respect
to the payment of any amount described in clause (A) or (B) and (b) "<font style="DISPLAY: inline; FONT-WEIGHT: bold">Tax Returns</font>" shall mean all
domestic or foreign (whether national, Federal, state, provincial, local or
otherwise) returns, declarations, statements, reports, schedules, forms and
information returns relating to Taxes and any amended Tax Return.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ARTICLE
V</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Representations
and Warranties of VivaKor</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VivaKor
represents and warrants to HealthAmerica that, except as disclosed in the
VivaKor Disclosure Schedule which has been delivered to VivaKor prior to the
execution of this Agreement (the "<font style="FONT-WEIGHT: bold">VivaKor
Disclosure Schedule</font>"), the following: The Disclosure Schedule shall
modify each any every representation and warranty and any exceptions thereon
shall be deemed to apply to all representations and warranties regardless of any
section designation.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
5.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Organization and
Qualification.</font> VivaKor is a corporation duly organized, validly existing
and in good standing under the laws of the State of Nevada. VivaKor has the
requisite corporate power and authority to carry on its business as it is now
being conducted and is duly qualified or licensed to do business, and is in good
standing, in each jurisdiction where the character of its properties owned or
held under lease or the nature of its activities makes such qualification
necessary. VivaKor has heretofore made available to HealthAmerica a complete and
correct copy of the organizational documents, each as amended to the date
hereof, of VivaKor. VivaKor does not owns or controls, directly or indirectly,
any equity interest in any corporation, company, association, partnership, joint
venture or other entity or owns any real estate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
5.2 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Capitalization.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
The authorized capital stock of VivaKor consists of 242,500,000 shares of
VivaKor Common Stock and 10,000,000 shares Of Preferred Stock, no par value
("VivaKor Preferred Stock"). As of the date hereof there are; and as of the
Closing Date and immediately prior to the Effective Time there will be,
approximately 45,200,000 shares of VivaKor Common Stock issued and outstanding,
all of which have been validly issued, fully paid and non-assessable. There are
no shares of VivaKor Preferred Stock issued or outstanding. All of the issued
and outstanding shares of VivaKor Common Stock were issued in compliance with
all applicable Laws including, without limitation, the Securities Act, the
Exchange Act and applicable Blue Sky Laws.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>
Except as set forth in Section 5.2(b) to the VivaKor Disclosure Schedule, there
are no preemptive or other outstanding rights, options, warrants, conversion
rights (including pursuant to convertible securities), stock appreciation
rights, redemption rights, repurchase rights, agreements, arrangements, calls,
commitments or rights of any kind relating to the issued</font> or unissued
capital stock of VivaKor or obligating VivaKor to issue or sell any shares of
capital stock of, or other equity interests in, VivaKor. As of the date of this
Agreement, there are no outstanding contractual obligations of VivaKor to
repurchase, redeem or otherwise acquire any shares of capital stock of VivaKor
of to provide material funds to, or make any material investment (in the form of
a loan, capital Contribution or otherwise) in, any Person.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
5.3 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Authority Relative
to this Agreement.</font> VivaKor has all necessary corporate (or limited
liability company, as appropriate) power and authority to execute and deliver
this Agreement, to perform its or his obligations hereunder and to consummate
the Transactions to which each of them is a party. The execution and delivery of
this Agreement by VivaKor and the consummation by VivaKor of the Transactions
have been duly and validly authorized by all necessary corporate action and no
other corporate proceedings on the part of VivaKor are necessary to authorize
the execution and delivery of this Agreement or to consummate the Transactions
other than, with respect to the Acquisition, the filing and recordation of
appropriate Acquisition documents as required by Nevada Law. This Agreement has
been duly and validly executed and delivered by VivaKor and, assuming the due
authorization, execution and delivery hereof by the other parties hereto,
constitutes a legal, valid and binding obligation of VivaKor, enforceable
against it in accordance with its terms.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
5.3 <font style="DISPLAY: inline; TEXT-DECORATION: underline">No Conflicts,
Required Filings and Consents.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
The execution and delivery of this Agreement by VivaKor does not and will not,
and the performance of this Agreement and the consummation of the Transactions
by VivaKor will not: (i) conflict with or violate the articles or certificate of
incorporation or by-laws of VivaKor, (ii) assuming the consents; approvals,
authorizations and waivers specified in the VivaKor Disclosure Schedule have
been received, conflict with or violate any Laws applicable to VivaKor or by
which any property or asset of VivaKor is bound or affected, or (iii) result in
any breach of or constitute a default (or an event which with notice or lapse of
time or both would become a default) under, or give to others any right of
termination, amendment, acceleration, or cancellation of, or result in the
creation of a lien or other encumbrance on any property or asset of VivaKor
pursuant to any Contract to which any of them is a party or by which any of
their property or asset is bound or affected.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>&#160;The
execution and delivery of this Agreement by VivaKor does not and will not, and
the performance of this Agreement and the consummation of the Transactions by
any of them will not, require any consent, approval, authorization, waiver or
permit of, or filing with or notification to, any Governmental Entity, except
for applicable requirements of the Exchange </font>Act, the Securities Act, Blue
Sky Laws; filing and recordation of the Plan of Acquisition as required by
Nevada Law.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
5.5 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Litigation.</font>
As of the date hereof, there is no suit, action or proceeding pending or, to the
knowledge of VivaKor, threatened against or affecting VivaKor, nor is there any
judgment, decree, injunction or order of any Governmental Entity or arbitrator
outstanding against VivaKor.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
5.6 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Brokers.</font> No
agent, broker, finder, investment banker or other firm or Person is or will be
entitled to any broker's or finder's fee or other similar commission or fee in
connection with the Transactions based upon arrangements made by or on behalf of
VivaKor.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ARTICLE
VI</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Covenants</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
6.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Conduct of
Business Pending the Acquisition.</font> From and after the date hereof until
the Closing Date, except as contemplated by this Agreement or unless
HealthAmerica and VivaKor shall otherwise agree in writing, VivaKor and
HealthAmerica covenant and agree that they shall: (a) carry on business in the
usual, regular and ordinary course in substantially the same manner as
heretofore conducted or presently contemplated to be conducted, (b) use all
reasonable efforts to preserve intact its present business organization, keep
available the services of its employees and consultants and preserve its
relationships and goodwill with customers, suppliers, licensors, licensees,
distributors and others having business dealings with it, and (c) use
commercially reasonable efforts to protect its intellectual property rights to
the end that its goodwill and on-going businesses shall not be impaired in any
material respect as of the Closing Date. Without limiting the generality of the
foregoing, except as expressly contemplated by this Agreement or unless the
parties shall otherwise agree in writing, prior to the Closing, neither
shall:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font>
declare, set aside, or pay any dividends on, or make any other distributions in
respect of, any of its capital stock or issue or authorize the issuance of any
other securities in respect of, in lieu of or in substitution for shares of its
capital stock; purchase, redeem or otherwise acquire any shares of capital stock
or any rights, warrants, or options to acquire any such
shares;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font>
grant, award or enter into any compensation or change of control arrangement
with any employee of VivaKor;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font>
issue, deliver, sell, pledge, dispose of or otherwise encumber any shares of
capital stock, any other voting securities or any securities convertible into,
or any rights, warrants or options to acquire; any such shares or voting
securities (other than the issuance of Common Stock upon the exercise of
Options) or amend the terms of any such securities, rights, warrants or options
or take any action to accelerate the vesting thereof;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)</font>&#160;amend
the certificate of incorporation or by-laws of VivaKor;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)</font>&#160;acquire
or agree to acquire by merging or consolidating with, or by purchasing a
substantial portion of the assets of, or by any other manner, any business or
any corporation, partnership, joint venture, association or other business
organization or division thereof, or any assets that are material, individually
or in the aggregate, except, in any such case, in the ordinary course of
business;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(vi)</font>&#160;adopt
a plan of complete or partial liquidation;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(vii)</font>&#160;incur
or modify any indebtedness for borrowed money or guarantee any such indebtedness
of another Person; issue or sell any debt securities; guarantee any debt
securities of another Person;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(viii)</font>
except in the ordinary course of business, make any loans, advances or capital
contributions to, or investments in, any other Person or settle or compromise
any material claims or litigation;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ix)</font>
take any action or omit to take any action that would cause any of its
representations and warranties herein to become untrue in any material respect;
or</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 108pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(x)</font>&#160;authorize
any of, or commit or agree to take any of, the foregoing
actions.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
6.2 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Stockholder
Approval.</font> Each of VivaKor and HealthAmerica shall each take all actions
necessary, in accordance with applicable Law and its respective certificate of
incorporation and by-laws, to cause as promptly as reasonably practicable after
the date hereof their respective stockholders to approve the Transactions. The
respective boards of directors of VivaKor and HealthAmerica shall recommend such
approval and shall take all lawful actions to solicit and obtain such
approval.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 6.3 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Further
Action; Consents; Filings.</font> Upon the terms and subject to the conditions
hereof, each of the parties hereto shall use its reasonable best efforts to
take, or cause to be taken, all appropriate actions and do, or cause to be done,
all things necessary, proper or advisable under applicable Law or otherwise to
consummate and make effective as promptly as practicable the Transactions and to
cooperate with each other in connection </font>with the foregoing. Without
limiting the generality of the foregoing, each of the parties agrees to take all
appropriate actions to obtain from Governmental Entities any Governmental
Authorizations required to be obtained or made by HealthAmerica and VivaKor in
connection with the authorization, execution and delivery of this Agreement and
the consummation of the Transactions, and to make all necessary filings, and
thereafter <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">.</font>make any
other required submissions that are required under the Exchange Act, the
Securities Act, the Blue Sky Laws, or any other applicable Law. The parties
hereto shall cooperate with each other in connection with the making of all such
filings, including by providing copies of all such documents to the nonfiling
party and its advisors prior to filing and, if requested, by accepting all
reasonable additions, deletions or changes suggested in connection
therewith.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
6.4 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Access to
Information.</font> From the date hereof until the Closing or the earlier
termination of this Agreement in accordance with its terms, HealthAmerica shall
afford to VivaKor and its accountants, counsel and other representatives full
and reasonable access during normal business hours (and at such other times as
the parties may mutually agree) to its books, Contracts, commitments, records
and personnel and, during such period, shall furnish promptly to VivaKor (i) a
copy of each report, schedule and other document filed or received by it
pursuant to the requirements of the Exchange Act or the Securities Act, and (ii)
all other information concerning its business as VivaKor may reasonably request.
VivaKor shall conduct its review in a manner reasonably calculated not to
disrupt HealthAmerica's business and operations. No investigation pursuant to
this Section 6.5 and no knowledge obtained thereby or otherwise shall limit any
representation or warranty of HealthAmerica or impair any rights of an VivaKor
Indemnified Party as a result thereof.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
6.5 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Public
Announcements.</font> On or before the Closing Date, neither HealthAmerica nor
VivaKor shall (nor shall they permit any of their respective Affiliates to),
without prior consultation with the other parties and such other parties' review
of and consent to any public announcement concerning the Transactions<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">,</font> issue any
press release or make any public announcement with respect to Transactions
during such period, and HealthAmerica and VivaKor shall, to the extent
practicable; allow the other parties reasonable time to review and comment on
such release or announcement in advance of its issuance and use reasonable
efforts in good faith to reflect the reasonable and good faith comments of such
other party; provided, however, no party shall be prevented from making any
disclosure required by Law at the time so required because of any delay on the
part of another party.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
6.6 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice of
Breaches. </font>VivaKor shall give prompt notice to HealthAmerica, and
HealthAmerica shall give prompt notice to VivaKor, of (i) any representation or
warranty made by it contained in this Agreement which has become untrue or
inaccurate in any respect, or (ii) the failure by it to comply with or satisfy
any covenant, condition, or agreement to be complied with or satisfied by it
under this Agreement; provided, however, that such notification shall not excuse
or otherwise affect the representations, Warranties, covenants or agreements of
the parties or the conditions to the obligations of the parties under this
Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ARTICLE
VII</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Conditions
Precedent</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
7.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Conditions to Each
Party's Obligation to Effect the Acquisition.</font> The respective obligations
of each party to effect the Acquisition shall be subject to the fulfillment
<font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">at or prior to the
Effective Time of the following conditions</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
This Agreement and the Acquisition shall have been approved and adopted by the
holders of VivaKor Common Stock, in the manner required by
Law.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>
The consummation of the Acquisition shall not be restrained, enjoined or
prohibited by any order, judgment, decree, injunction or ruling of a court of
competent jurisdiction.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
7.2 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Conditions
to Obligation of VivaKor to Effect the Acquisition.</font> The obligation of
VivaKor to effect the Acquisition shall be subject to the fulfillment at or
before the Effective Time of the following additional conditions, unless
waived<font style="DISPLAY: inline; FONT-SIZE: 10pt; VERTICAL-ALIGN: super; FONT-FAMILY: Times New Roman">-</font>by
VivaKor:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
representations and </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">warranties
of HealthAmerica contained in this </font>Agreement shall be true and correct in
all respects on the date hereof and as of the Closing Date as if made on the
Closing Date.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>
HealthAmerica shall have performed or complied with all agreements and covenants
required to be performed by it under this Agreement on or before the Closing
Date.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font>
HealthAmerica shall not have suffered a HealthAmerica Material Adverse
Effect.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font>&#160;VivaKor
shall have received a certificate of an authorized officer of HealthAmerica, on
behalf of HealthAmerica, that the conditions set forth in paragraphs (a) through
(e) above have been satisfied.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
7.3 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Conditions
to Obligations of HealthAmerica to Effect the Acquisition.</font> The
obligations of HealthAmerica to effect the Acquisition shall be subject to the
fulfillment at or before the Effective Time of the following additional
conditions, unless waived by HealthAmerica:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
The representations and warranties of VivaKor contained in this Agreement shall
be true and correct in all respects on the date hereof and as of the Closing
Date as if made on the Closing Date.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>
VivaKor shall have Performed or complied in all material respects with all
agreements and covenants required to be performed by it under this Agreement on
or before the Closing Date.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font>&#160;VivaKor
shall not have suffered a VivaKor Material Adverse Effect.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font>&#160;HealthAmerica
shall have received a certificate of an authorized officer of VivaKor, on behalf
of VivaKor, that the conditions in paragraphs (a) through (c) above have been
satisfied.</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE
VIII</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Survival
and Indemnification</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
8.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Survival of
Representations, Warranties and Covenants.</font> The parties hereto hereby
agree that the representations, warranties, covenants and agreements contained
in this Agreement shall survive the execution and delivery of this Agreement,
and the Closing hereunder; provided, however, that any claims based on a breach
of representations and warranties other than those contained in Sections 4.1,
4.2, 4.3, 4.6, 4.7 and 4.13 shall terminate twelve (12) months after the Closing
Date. The representations and warranties contained in Sections 4.1, 4.2, 4.3,
4.6, 4.7 and 4.13, and any Claims based thereon, shall survive for a period of
three years. Covenants and agreements of the parties shall survive until fully
performed. To the extent the survival periods specified herein exceed an
applicable statute of limitations; the provisions of this Section 8.1 shall
constitute a tolling by HealthAmerica and the HealthAmerica Principal
Shareholder of each such statute of limitations for a period of time not to
extend beyond the termination of such survival periods.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
8.2 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Indemnification by
the HealthAmerica Principal Shareholder Prior to the </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Acquisition.</font> The
HealthAmerica Principal Shareholder Prior to the Acquisition shall, jointly and
severally, indemnify and hold harmless VivaKor and the Surviving Corporation,
the stockholders of HealthAmerica and their respective affiliates, employees,
directors, agents and representatives (collectively, the "HealthAmerica
Indemnified Parties"), from and against any and all Loss and Litigation Expense
which they or any of them may suffer or incur as a result of or arising from any
misrepresentation or breach of any representation or warranty by HealthAmerica
or the HealthAmerica Principal Shareholder Prior to the Acquisition set forth in
this Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
8.3 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Indemnification by
VivaKor.</font> From and after the Closing Date, VivaKor shall indemnify and
hold harmless the HealthAmerica Principal Shareholder Prior to the Acquisition
from and against any and all Loss and Litigation Expense which such holder may
suffer or incur as a result of or arising from any of the following: (a) any
misrepresentation or breach of any warranty by VivaKor; or (b) the failure by
VivaKor to perform its covenants and agreements under this
Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
8.4 <font style="DISPLAY: inline; TEXT-DECORATION: underline">No Impact from
Investigation.</font> No Investigation by or knowledge of any party prior to or
after the date of this Agreement shall alter, diminish, obviate or impair any of
the representations, warranties, covenants or agreements of any other party
contained in this Agreement or limit in any way any party's right to rely on
such representations, warranties, covenants or agreements or to bring a claim
based on any Misrepresentation or breach thereof.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ARTICLE
IX</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Termination,
Amendment and Waiver</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
9.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Termination.</font> This
Agreement may be terminated at any time prior to the Effective Time, whether
before or after approval by the stockholders of VivaKor:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font>
by mutual written consent of HealthAmerica and VivaKor;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font>&#160;by
VivaKor, upon a material breach of this Agreement on the part of HealthAmerica
which has not been cured and which would cause the conditions set forth in
Section 7.2 to be incapable of being satisfied by September 30,
2008;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font>&#160;by
HealthAmerica, upon a material breach of this Agreement on the part of VivaKor
which has not been cured and which would cause the conditions set forth in
Section 7.3 to be incapable of being satisfied by September 30,
2008;</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font>&#160;by
HealthAmerica of VivaKor if any court of competent jurisdiction shall have
issued, enacted, entered, promulgated or enforced any order, judgment, decree,
injunction or ruling which restrains, enjoins or otherwise prohibits the
Acquisition; or</font></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e) by
HealthAmerica or VivaKor if the Acquisition shall not have been consummated on
or before September 30, 2008; provided, that the right to terminate this
Agreement under this Section 9.1(e) shall not be available to any party whose
failure to perform any material covenant or obligation under this Agreement has
been the cause of or resulted in the failure of the Acquisition to occur on or
before such date.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section 9.2 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Effect
of Termination.</font> In the event of termination of this Agreement as provided
in Section 9.1, this Agreement shall forthwith terminate and there shall be no
liability hereunder on the part of any of VivaKor or HealthAmerica; provided,
this Section 9.2, Section 9.3 (Fees and Expenses); and Section 10.6 (Governing
Law) shall survive the termination and remain in full force and effect and;
provided, further, that each party shall remain liable for any breaches of or
inaccuracies in such party's covenants, representations and warranties hereunder
which breach or inaccuracy occurred </font>prior to the termination of this
Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
9.3 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Fees and
Expenses.</font> Whether or not the Acquisition is consummated, all costs and
expenses incurred in connection with this Agreement and the Transactions shall
be paid by the party incurring such expenses.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
9.4 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Amendment.</font>
This Agreement may be amended by the parties hereto at any time only by an
instrument in writing sighed on behalf of each of the parties
hereto.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">17</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
9.5 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Waiver.</font> At
any time prior to the Closing, the parties hereto may, to the extent permitted
by applicable Law, (i) extend the time for the performance of any of the
obligations or other acts of any other party hereto, (ii) waive any inaccuracies
in the representations and warranties by any other party contained herein or in
any documents delivered by any other party pursuant hereto and (iii) waive
compliance with any of the agreements of any other party or with any conditions
to its own obligations contained herein. Any agreement on the part of a party
hereto to any such extension or waiver shall be valid only if set forth in an
instrument in writing signed on behalf of such party.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ARTICLE
X</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">General
Provisions</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
10.1 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Notices</font>.
All notices or other communications under this Agreement shall be in writing and
shall be given (and shall be deemed to have been duly given upon receipt) by
delivery in person, by telecopy (with confirmation of receipt), or by registered
or certified mail, postage prepaid, return receipt requested addressed as
follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 144pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If to
VivaKor:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VivaKor,
Inc.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 111.6pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c/o
Wilson, Haglund &amp; Paulsen, P.C. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 111.6pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9110
Irvine Center Drive</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Irvine,
CA 92618</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Facsimile:
(949) 752-1144</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attention:
Christopher Wilson</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 144pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If to
Health America:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">HealthAmerica,
Inc:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 158.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2820 W.
Charleston, #22</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 158.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Las
Vegas, Nevada 89102 </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 158.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Telephone:
(775) 781-4143 </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 158.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Facsimile:
(702) 870-1614</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 144pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 7.2pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If to
HealthAmerica Principle Shareholder Prior to the Acquisition</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Richard
A. Taulli</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 158.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2820 W.
Charleston, #22</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 158.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Las
Vegas, Nevada 89102 </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 158.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Telephone:
(775) 781-4143 </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 180pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 158.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Facsimile:
(702) 870-1614</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">or to
such other address as any party may have furnished to the other parties in
writing in accordance with this Section 10.1.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">18</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
10.2 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Specific
Performance.</font> The parties hereto agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms or were otherwise breached. Accordingly,
the parties further agree that each party shall be entitled to an injunction or
restraining order to prevent breaches of this Agreement and to enforce
specifically the terms and provisions hereof in any court of the United States
or any state having jurisdiction, this being in addition to any other right or
remedy to which such party may be entitled under this Agreement, at Law or in
equity.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
10.3 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Entire
Agreement.</font> This Agreement (including the documents and instruments
referred to herein) constitutes the entire agreement and supersedes all other
prior agreements and understandings, both written and oral, among the parties,
or any of them, with respect to the subject matter hereof.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
10.4 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Assignments;
Parties in Interest</font>. Neither this Agreement nor any of the rights,
interests or obligations hereunder may be assigned by any of the parties hereto
(whether by operation of Law or otherwise) without the prior written consent of
the other parties. Subject to the foregoing, this Agreement shall be binding
upon and inure solely to the benefit of each party hereto, and nothing in this
Agreement, express or implied, is intended to or shall confer upon any Person
not a party hereto any right, benefit or remedy of any nature whatsoever under
or by reason of this Agreement, including to confer third party beneficiary
rights except that the stockholders of VivaKor are intended third-party
beneficiaries of the representations, warranties and covenants of
HealthAmerica.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
10.5 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Governing
Law</font>. This Agreement shall be governed in all respects by the laws of the
State of Nevada (without giving effect to the provisions thereof relating to
conflicts of Law).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
10.6 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Headings;
Disclosure.</font> The descriptive headings herein are inserted for convenience
of reference only and are not intended to be part of or to affect the meaning or
interpretation of this Agreement. Any disclosure by VivaKor or HealthAmerica in
any portion of its respective Disclosure Schedule shall be deemed disclosure in
each other portion of such Disclosure Schedule to which such disclosure
reasonably relates on its face.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
10.7 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Certain
Definitions and Rules of Construction.</font></font></div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 144pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) As
used in this Agreement:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"<font style="DISPLAY: inline; FONT-WEIGHT: bold">Affiliate</font>" as applied to any
Person, shall mean any other Person directly or indirectly controlling,
controlled by, or under common control with, that Person; for purposes of this
definition, "control" (including, with correlative meanings, the terms
"controlling," "controlled by" and "under common control with")<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">;</font> as applied
to any Person, means the possession, directly or indirectly, of the power to
direct or cause the direction of the management and policies of that Person,
whether through the ownership of voting securities, by contract or
otherwise.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">"VivaKor Material Adverse
Effect"</font> shall be any circumstance, event or occurrence that would be
reasonably likely to have a material adverse effect on the business, assets,
operations, financial condition, revenues, results of operations of VivaKor
taken as a whole.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">19</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">"HealthAmerica Material Adverse
Effect" </font>shall be any circumstance, event or occurrence that would be
reasonably likely to have a Material adverse effect on the business, assets,
operations, financial condition, revenues, results of operations of
HealthAmerica taken as a whole.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">"Contract" </font>means any contract;
agreement, note, bond, mortgage, indenture, credit agreement, lease, license,
permit, franchise or other instrument, obligation or understanding, whether
written or oral.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">"Debt" </font>means, with respect to
any Person, all indebtedness of such Person for borrowed money or the deferred
purchase price of property or services (excluding trade payables and other
accrued current liabilities arising in the ordinary course of business),
obligations of such Person evidenced by bonds, notes, indentures or similar
instruments, obligations of such Person under interest rate agreements, currency
hedging agreements, commodity price protection agreements or similar hedging
instruments, capital lease obligations of such Person, redeemable capital stock
of such Person and any other obligations of such Person classified as
indebtedness in standard accounting usage.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">"Laws" </font>means any domestic
(federal, state or local) or foreign law, rule, regulation, order, judgment or
decree.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">"Litigation Expense" </font>means any
expenses incurred in connection with investigating, defending or asserting any
claim, action, suit or proceeding incident to any matter indemnified against
under this Agreement, including, court filing fees, court costs, arbitration
fees or costs, witness fees and reasonable fees and disbursements of legal
counsel (whether incurred in any action or proceeding between the parties to
this Agreement or between any party to this Agreement and any third person and
whether or not any action or proceeding is commenced), investigators, expert
witnesses, accountants and other professionals.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">"<font style="DISPLAY: inline; FONT-WEIGHT: bold">Loss</font>" means any loss,
obligation, claim, liability, settlement payment, award, judgment, fine,
penalty, interest charge, expense, damage or deficiency or other charge,
measured after accounting for any insurance proceeds actually received with
respect thereto, other than Litigation Expense.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">"Person" </font>shall include
individuals, corporations, partnerships, limited liability companies, trusts,
other entities and groups (which term shall include a "group" as such term is
defined in Section 13(d)(3) of the Exchange Act).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">"Tax" </font>shall mean any federal,
state, local, foreign or provincial income, gross receipts, property, sales,
service, use, license, lease, excise, franchise, employment, payroll,
withholding, employment, unemployment insurance, workers' compensation, social
security, alternative or added minimum, ad valorem, value added, stamp, business
license, occupation, premium, environmental, windfall profit, customs<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">;</font> duties,
estimated, transfer or excise tax, or any other tax, custom, duty, premium,
governmental fee or other assessment or charge of any kind whatsoever, together
with any interest, penalty or addition to tax imposed by any Governmental
Entity.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">"Transactions" </font>shall mean the
transactions contemplated by this Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">20</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b) Other
Rules of Construction.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td style="WIDTH: 90pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
            </td>
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">References
      in this Agreement to any gender shall include references to all genders.
      Unless the context otherwise requires, references in the singular include
      references in the plural and vice versa. References to a party to this
      Agreement or to other agreements described herein means those Persons
      executing such agreements.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td style="WIDTH: 90pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
            </td>
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      words "include", "including" or "includes" shall be deemed to be followed
      by the phrase "without limitation" or the phrase "but not limited to" in
      all places where such words appear in this Agreement. The word "or" shall
      be deemed to be inclusive.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td style="WIDTH: 90pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
            </td>
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      Agreement is the joint drafting product of HealthAmerica and VivaKor, and
      each provision has been subject to negotiation and agreement and shall not
      be construed for or against either party as drafter
    thereof.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td style="WIDTH: 90pt">
              <div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;
      </font></div>
            </td>
            <td style="WIDTH: 36pt">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)</font></font></div>
            </td>
            <td>
              <div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
      each case in this Agreement where this Agreement or a Contract is
      represented or warranted to be enforceable will be deemed to include as a
      limitation to the extent that enforceability may be subject to applicable
      bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium
      or similar Laws affecting the enforcement of creditors' rights generally
      and to general equitable principles, whether applied in equity or at
      Law.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
10.8 <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Counterparts</font>.
This Agreement may be executed in two or more counterparts, which together shall
constitute a single agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
10.9 <font style="DISPLAY: inline; TEXT-DECORATION: underline">Severability.</font> If any
term or other provision of this Agreement is invalid, illegal or incapable of
being enforced by any rule of Law or public policy, all other terms and
provisions of this Agreement shall nevertheless remain in full force and effect
so long as the economics or legal substance of the Transactions are not affected
in any manner materially adverse to any party. Upon determination that any term
or other provision hereof is invalid, illegal or incapable of being enforced,
the parties hereto shall negotiate in good faith to modify this Agreement so as
to effect the original intent of the parties as closely as possible to the
fullest extent permitted by applicable Law in an acceptable manner to the end
that the Transactions are fulfilled to the extent possible.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">21</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 2.35pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">IN
WITNESS WHEREOF, HealthAmerica, VivaKor and the HealthAmerica Principal
Shareholder Prior to the Acquisition have each signed this Agreement or caused
this Agreement to be signed by their respective officers thereunto duly
authorized all as of the date first written above.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div><table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">

        <tr>
          <td colspan="2" width="27%">
            <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">HealthAmerica,
      Inc.</font></div>
            <div>&#160;</div>
          </td>
          <td width="16%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td colspan="2" width="42%">
            <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaKor,
      Inc.</font></div>
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></td>
          <td width="31%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Richard A.
      Taulli as President</font></td>
          <td width="16%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td colspan="2" width="11%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Tannin
      Fuja</font></td>
        </tr>
        <tr>
          <td width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="31%">
            <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Richard
      A. Taulli, President</font></div>
          </td>
          <td width="16%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td colspan="2" width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">      </font>
            <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tannin
      Fuja, President</font></div>
          </td>
        </tr>
        <tr>
          <td width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="31%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="16%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="31%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
        </tr>
        <tr>
          <td colspan="2" width="7%" style="PADDING-BOTTOM: 2px">
            <div>&#160;</div>
            <div>&#160;</div>
            <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">HealthAmerica, Inc.
      Principal Shareholder&#160;</font></div>
            <div>&#160;</div>
          </td>
          <td width="16%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="31%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
        </tr>
        <tr>
          <td width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></td>
          <td width="31%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Richard A.
      Taulli as Shareholder</font></td>
          <td width="16%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="31%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
        </tr>
        <tr>
          <td width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="31%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Richard A. Taulli,
      Principal Shareholder</font></td>
          <td width="16%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="11%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
          <td width="31%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
        </tr>
    </table></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;22</font>

      <div>
        <hr style="COLOR: black" align="left" noshade size="1" width="100%">
      </div>
    </div>
  </body>
</html>





</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>11
<FILENAME>vivakor_s1-ex1005.htm
<DESCRIPTION>SECURED NONRECOURSE PROMISSORY NOTE
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex1005.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT
10.5</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">SECURED NONRECOURSE
PROMISSORY NOTE</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td width="33%"><font size="4" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$1,500,000.00</font></td>
              <td width="33%">
                <div style="TEXT-ALIGN: center"><font size="4" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Las
      Vegas, Nevada</font></div>
              </td>
              <td width="33%">
                <div style="TEXT-ALIGN: right"><font size="4" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 18,
      2008</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Principal</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FOR VALUE
RECEIVED, VivaKor, Inc., a Nevada corporation ("Borrower"), </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">promises
to pay to Rico Italia Investments, Inc., a Nevada corporation (the "Lender"), as
nominee of HealthAmerica, Inc.' s Principle Shareholder Prior to the Acquisition
under that certain Acquisition Agreement and Plan of Acquisition at the offices
of the Lender or at such other place as the holder of this Note shall specify,
in lawful money of the United States of America, the principal amount of One
Million Five Hundred Thousand Dollars ($1,500,000.00 USD) together with interest
at the rate of four percent (4%) per annum, payable as hereinafter
provided.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Payment
of Principal and Interest.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Principal
of and interest accruing on this Note shall be due and payable in equal monthly
installments of $25,000.00 commencing on August 18<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">th</font>, 2008
and each 30 days thereafter; in addition, <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Borrower agrees that if,
at any time after the initial deposit of $25,000.00 is realized, Borrower
receives proceeds from any sales of equity or debt securities, or any sale or
licensing of products or technology, that Borrower shall pay ten percent (10%)
of the gross proceeds to Lender as prepayment of this Note with the 1<font style="DISPLAY: inline; FONT-SIZE: 10pt; VERTICAL-ALIGN: super; FONT-FAMILY: Times New Roman">st</font>
payment 90 days from the date of the initial deposit. Additional payments of ten
percent (10%) shall be paid every 90 days thereafter under the same terms
thereof. Interest shall be calculated on the unpaid principal balance of this
Note on the basis </font>of a year of 360 days and the actual number of days
elapsed until payment. Interest shall accrue and be payable under this Note
whether or not Borrower, or Borrower's successors or assigns, should avail
themselves of the protection of the United States bankruptcy laws. From and
after the occurrence of an "event of default" as set forth in Section 6 hereof,
interest shall continue to accrue on the unpaid principal balance of this Note
at the same interest rate as set forth in Section 1 of this Note.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Prepayment</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This
Note may be Prepaid at any time or from time to time, in whole or in
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">part,
without penalty.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
such prepayment shall include all interest then accrued but unpaid on
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">this
Note.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any
partial prepayment of the outstanding principal balance shall in no </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">way
release, discharge or affect the obligation of the Borrower to continue to make
any other payments of principal or interest provided for herein until this Note
is paid in full.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Application
of Payments:</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
payment on this <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super">-</font>Note
(whether made when due or otherwise) shall be credited first, to late charges,
fees and other charges due, including collection costs and attorneys' fees,
second against interest then due, and the remainder of such payment shall be
credited against the unpaid principal.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Waiver</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Borrower
and all endorsers, guarantors and all persons liable, or to become liable on
this Note (each hereinafter referred to in this Section as the "Applicable
Party"); jointly and severally, waive presentment, protest and demand, notice of
protest, demand, dishonor and nonpayment of this Note, notice of acceleration,
notice of intent to accelerate, and any and all other notices or matters of a
like nature; and consent to any and all renewals and extensions of the time of
payment hereof. Each Applicable Party agrees that at any time and from time to
time, without notice, (i) the terms of payment herein, or (ii) the terms of any
guaranty of this Note, or (iii) the security described in any documents at any
time securing this Note, may be modified, increased, changed or exchanged, in
whole or in part, without in any way affecting the liability of any Applicable
Party.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Default
By Borrower</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any one
or more of the following shall constitute an "Event of Default" by Borrower
under the terms of this Note:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If
Borrower fails to pay any payment, whether at maturity or otherwise, of
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">principal
and/or interest upon the due date thereof.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If
Borrower defaults in the performance or observance of any of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">covenants,
conditions or agreements set forth in this Note:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If
Borrower institutes proceedings to be adjudicated a voluntary bankrupt;
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">consents
to the filing of a bankruptcy proceeding against Borrower; files or consents to
filing of a petition or answer or consent seeking reorganization under the
federal bankruptcy laws or any other similar applicable federal or state law;
consents to the appointment or a receiver of liquidator or trustee or assignee
in bankruptcy or insolvency of the Borrower or a substantial part of Borrower's
property; an assignment for the benefit of creditors is made by the Borrower; or
Borrower admits in writing of Borrower's inability to pay Borrower's debts
generally as they become due.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Remedies
Upon Default.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
to the provisions of Section 8 below, if an Event of Default occurs, at the
option of the Lender, and upon written demand, the Lender may accelerate the due
date of this Note and declare the entire outstanding principal balance hereof,
including all fees and costs (if any), and accrued but unpaid interest,
immediately due and payable in full.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each of
the options, rights and remedies provided herein or available at law or in
equity which may be exercised by the Lender may be exercised separately or
concurrently with any one or more other options, rights or remedies available to
the Lender. Failure to exercise any option, right or remedy shall not constitute
a waiver of the right of the Lender to exercise such option, right or remedy in
the event of or with respect to any prior, subsequent or concurrent transaction
or occurrence of the same or a different kind or character.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Nonrecourse
to Borrower.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Note
is a nonrecourse note and is secured solely by a pledge of shares of Common
Stock and all of the assets of HealthAmerica, Inc. (the "Pledged Shares and
Assets") pursuant to a Pledge and Security Agreement ("Pledge and Security
Agreement") of even date herewith, the provisions of which are incorporated
herein by reference and form a part hereof. Borrower shall be liable upon the
indebtedness evidenced by this Note, for all sums to accrue or to become payable
thereon and for performance of any covenants contained in this Note or in any of
the related documents to the extent, but only to the extent, of the Lender's
security for the same, which consists of all properties, rights, estates and
interests covered by the Pledge Agreement. No attachment, execution or other
writ or process shall be sought, issued or levied upon any assets, properties or
funds of Borrower other than the properties, rights, estates and interests
described in the Pledge Agreement. In the event of foreclosure of such title,
liens or security interests, no judgment of any deficiency upon such
indebtedness, sums and amounts shall be sought or obtained by the Lender against
Borrower.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Severability.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Every
provision of this Note is intended to be severable. If any term or provision
hereof is declared by a court of competent jurisdiction to be illegal or invalid
for any reason whatsoever, such illegality or invalidity shall not affect the
balance of the terms and provisions hereof, which terms and provisions shall
remain binding and enforceable.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 1.25;">
              <td style="WIDTH: 36pt">
              </td>
              <td align="right" style="WIDTH: 36pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.</font></font></div>
              </td>
              <td align="left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Governing
      Law.</font></font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Note
shall be governed by and construed in accordance with the laws of the County of
Clark, State of Nevada.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">
            <tr valign="top" style="LINE-HEIGHT: 1.25;">
              <td style="WIDTH: 36pt">
              </td>
              <td align="right" style="WIDTH: 36pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11.</font></font></div>
              </td>
              <td align="left">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Notices.</font></font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
notices, statements or demands shall be in writing and shall be served in
person, by telegraph, by express mail, by certified mail or by private overnight
delivery. Service shall be deemed conclusively made (i) at the time of service,
if personally served, (ii) at the time (as continued in writing by the
telegraphic agency) of delivery thereof to the addressee, if served
telegraphically, (iii) twenty-four (24) hours (exclusive of weekends and
national holidays) after deposit in the United States mail, properly addressed
and postage prepaid, if served by express mail, (iv) five (5) calendar days
after deposit in the United States mail, properly addressed and postage prepaid,
return receipt requested; if served by certified mail, (v) twenty-four (24)
hours after delivery by the party giving the notice, statement or demand to the
private overnight deliverer, if served by private overnight delivery and (vi) at
the time of electronic transmission, if a copy of such notice is mailed within
twenty-four (24) hours after the transmission.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any party
hereto may change its address for the purpose of receiving notices, demands or
other communications as herein provided by a written notice given in the manner
aforesaid to the other party or parties hereto.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Successors
and Assigns.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All the
terms and provisions of this Note shall be binding upon and inure to the benefit
of the parties hereto and their respective successors and assigns.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Assignability</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Borrower's
obligations hereunder may not be transferred or assigned without the prior
written consent of the Lender, which consent shall not be unreasonably
withheld.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Amendment</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
this Note nor any term or provision hereof may be modified, amended or altered
except by a written instrument approved by the Lender and signed by
Borrower.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Headings</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Headings
at the beginning of each numbered Paragraph of this Note are intended solely for
convenience and are not to be deemed or construed to be a part of this
Note.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Time of
the Essence.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">TIME IS
EXPRESSLY DECLARED TO BE THE ESSENCE of each obligation of the Borrower
hereunder and in all matters concerning this Note, including all acts or things
to be done or performed in connection herewith, and specifically of every
provision of this Note in which time is an element.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Compliance
With Usury Laws.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 13pt; FONT-FAMILY: Times New Roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Borrower and the Lender intend to
comply with all applicable usury laws. In fulfilling this intention, all
agreement between Borrower and the Lender are expressly limited so that the
amount of interest paid or agreed to be paid to the Lender for the use,
forbearance, or detention of money under this Note shall not exceed the maximum
amount permissible under applicable law. If for any reason payment of any amount
required under this Note shall be prohibited by law, then the obligation shall
be reduced to the maximum allowable bylaw. If for any reason the Lender receives
as interest an amount that would exceed the highest lawful rate, then the amount
which would constitute excessive interest shall be applied to the reduction of
the principal of this Note and not to the payment of interest. If any conflict
arises between this provision and any provision of any other agreement between
Borrower <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and the
Lender, then this </font></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">provision shall
control.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 13pt; FONT-FAMILY: Times New Roman, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">18.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Legal
Representation.</font></font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Borrower
agrees and represents that such party has been represented by such party's own
legal counsel with regard to all aspects of this Note, or if such party is
acting without legal counsel, that such party has had adequate opportunity and
has been encouraged to seek the advice of such party's own legal counsel prior
to the execution of this Agreement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 13pt; FONT-FAMILY: Times New Roman, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">19.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Jurisdiction.</font></font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.4pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
action whatsoever brought upon or dating to this Note shall be instituted and
prosecuted in the state courts of Clark County, State of Nevada, or the federal
district court therefore, and each party waives the right to change the venue.
The parties hereto further consent to accept service of process in any such
action or proceeding by certified mail, return receipt requested.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 13pt; FONT-FAMILY: Times New Roman, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">20.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Pledge
Agreement.</font></font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
parties agree that this Note shall be secured by the Collateral, as defined in
that certain Pledge Agreement of even date herewith.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.4pt" align="left">&#160;</div>
      <div>&#160;</div>
      <div align="center">
        <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td colspan="2" width="27%">
                <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">"BORROWER"</font></div>
                <div>&#160;</div>
                <div><font size="2" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">VivaKor, Inc.</font></div>
                <div>&#160;</div>
              </td>
              <td width="10%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td colspan="2" width="27%">
                <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8220;LENDER"</font></div>
                <div>&#160;</div>
                <div><font size="2" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Rico Italia Investments, Inc.</font></div>
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td width="7%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></td>
              <td width="20%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/
      Tannin&#160;Fuja&#160;</font></td>
              <td width="10%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="7%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></td>
              <td width="20%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Richard A.
      Taulli</font></td>
            </tr>
            <tr>
              <td width="7%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="20%">
                <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tannin
      Fuja&#160;</font></div>
                <div>&#160;</div>
              </td>
              <td width="10%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="7%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td valign="top" width="20%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Richard A.
      Taulli</font></td>
            </tr>
            <tr>
              <td width="7%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></td>
              <td width="20%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President</font></td>
              <td width="10%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
              <td width="7%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></td>
              <td width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President</font></td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br>&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT
A</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Form of Plan of
Acquisition</font></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Exhibit
omitted)<br></font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A-1</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

        <div>
          <hr style="COLOR: black" align="left" noshade size="1" width="100%">
        </div>
      </div>
    </div>
  </body>
</html>




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>12
<FILENAME>vivakor_s1-ex1006.htm
<DESCRIPTION>PLEDGE AND SECURITY AGREEMENT
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex1006.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div>Exhibit 10.6</div>
    <div>&#160;</div>
    <div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PLEDGE
AND SECURITY AGREEMENT</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THIS
PLEDGE AND SECURITY AGREEMENT (this "Agreement") is made as of September 30,
2008, by and among Vivakor; Inc., a Nevada corporation (the "Pledgor"), in favor
of Rico Italia Investments, Inc., a Nevada corporation (the
"Lender"),</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WITNESSETH:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">WHEREAS, </font>the Pledgor's
management owns ninety four percent (94%) of the shares of the Common Stock (the
"Shares") of HealthAmerica, Inc., a Nevada corporation (the
"Company");</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WHEREAS,
the Pledgor is the Borrower under that certain Secured Nonrecourse Promissory
Note in the principal amount of $1,500,000.00 dated of even date herewith (the
"Note"), which Note is issued pursuant to the Acquisition Agreement and Plan of
Acquisition dated of even date herewith between the Pledgor, Richard Taulli
(Principal Shareholder of HealthAmerica) and HealthAmerica, Inc. (the
"Acquisition Agreement");</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WHEREAS,
it is a condition precedent to the acquisition contemplated by the Acquisition
Agreement that the Pledgor shall have executed and delivered this Agreement,
pursuant to which the Pledgor pledges all of the Shares and any proceeds thereof
and 100% of the prior outstanding shares and all assets of HealthAmerica, Inc.
to secure repayment of all principal, interest, costs and charges in or under
the Note (the "Pledged Shares"):</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">NOW, THEREFORE, </font>in consideration
of the premises contained herein and other good and valuable consideration the
receipt and sufficiency of which are hereby acknowledged, and in order to induce
the Lender to permit payment of the exercise price with the Note, the Pledgor
hereby agrees as follows:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">1.</font> <font style="FONT-WEIGHT: bold">Pledge and
Grant of Security Interest</font>. </font>As security for the prompt and
complete payment and performance of any and all obligations, now or hereafter
existing, of the Pledgor under this Agreement or the Note, including any
extensions, modifications, substitutions, amendments and renewals hereof or
thereof, whether for principal, interest;<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub; FONT-FAMILY: Bookman Old Style, serif">,</font>
fees, premiums, expenses, reimbursement obligations, indemnification or
otherwise, the Pledgor hereby pledges to the Lender, and grants to the Lender a
security interest in, any and all of the Pledgor's right, title and interest in
and to the following, whether now owned or existing or hereafter acquired or
owned (collectively, the "Collateral"):</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;
the Pledged Shares;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;
all securities or other instruments in addition to, in substitution of, or in
exchange for any of the Pledged Shares (whether as a distribution in connection
with any recapitalization, reorganization or reclassification, a stock dividend
or otherwise);</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;
any distributions of cash or property as described in the Acquisition Agreement,
the Note and in respect of the items described in the preceding clauses (a) and
(b);</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;&#160;&#160;
all proceeds and products of any of the foregoing items, however and whenever
acquired and in whatever form;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;&#160;&#160;
100% of the assets held by HealthAmerica prior to the acquisition by VivaKor;
and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left">
          </div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right">
          </div>
        </div>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;&#160;&#160;
ten percent (10%) of the cash held by Vivakor and HealthAmerica from the
acquisition thereof, up to $100,000.00 as liquidated damages.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
any other provision of this Agreement, the aggregate of value of the Collateral
shall be limited to the value that is at all tithes not less than the aggregate
of the outstanding balance of the Note, plus all interest accrued thereon
through the date of Maturity of the Note.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">2. </font><font style="FONT-WEIGHT: bold">Delivery of
Collateral; After<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 3pt">-</font>Acquired
Collateral.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;
Simultaneously with or prior to the execution of this Agreement, all
certificates or instruments representing or evidencing the Collateral shall be
delivered to the Lender and held by or on behalf of the Lender pursuant hereto
and shall be in suitable form for transfer by delivery, or shall be accompanied
by duly executed instruments of transfer or assignment in blank, including
signature guarantees, all in form and substance satisfactory to the Lender. The
Lender shall have the right during the existence of an Event of Default (as
defined in the Note) but without any requirement for prior written notice to the
Pledgor, to transfer to or to register in the name of the Lender or any of its
nominees any or all of the Collateral. Except as provided in Section 12 hereof,
the Pledgor shall maintain all voting rights in the Collateral.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;
While this Agreement is in effect, if the Pledgor becomes entitled to receive or
receives any additional Collateral, the Pledgor shall accept such Collateral on
behalf of and for the benefit of the Lender and shall promptly deliver such
additional Collateral to the Lender together with duly executed forms of
assignment, and such additional Collateral shall be deemed to be part of the
Collateral hereunder.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">3.</font> <font style="FONT-WEIGHT: bold">Distributions</font>. </font>While this Agreement is
in effect, the Pledgor shall be entitled to receive all dividends, distributions
and other property (cash or otherwise) paid or distributed in respect to any of
the Collateral, except after an Event of Default, in which case all of which
shall be paid to the Lender and shall be applied promptly to the payment of the
principal and then to the accrued interest under the Loan.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">4. </font><font style="FONT-WEIGHT: bold">Representations and Warranties of the Pledgor</font>.
</font>The Pledgor hereby represents and warrants to the Lender as of the date
hereof and for as long as any of the Pledgor's obligations or liabilities under
the Note or this Agreement remains outstanding:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;
to the best knowledge of Pledgor; the Pledgor has good and indefeasible title to
the Collateral and has the right to grant the security interest provided for
herein, and none of the Collateral is subject to any lien, pledge, charge,
encumbrance or security interest or right or option on the part of any third
person to purchase or otherwise acquire the Collateral or any part thereof.
There exists no adverse claim with respect to the Collateral;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;
to the best knowledge of Pledgor, as of the date hereof, all of the shares of
the Collateral are fully vested, and none of the Collateral is subject to
forfeiture Of any nature;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;
the Pledgor intends this Agreement and the pledge of Collateral hereunder to
create a valid and perfected first priority security interest hi the
Collateral;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;&#160;&#160;
to the best knowledge of Pledgor; no security agreement, financing agreement or
other public notice with respect to all or any part of the Collateral is on file
or of record in any public office, except such as may have been filed in favor
of the Lender pursuant to this Agreement;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;&#160;&#160;
to the best knowledge of Pledgor the execution, delivery and performance by the
Pledgor of this Agreement will not constitute or result in a breach or default
under or conflict with any order, ruling or regulation of any court or other
tribunal or of any governmental commission or agency, or any agreement or other
undertaking, to which the Pledgor is a party or by which the Pledgor is bound;
</font>to the best knowledge of Pledgor; none of the Collateral is subject to
any unpaid capital call or dispute, any buy-sell, voting trust, transfer
restriction, preferential right to purchase or similar agreement or any option,
warrant, put or call or similar agreement or other rights or restrictions in
favor of third persons; all of the Collateral is duly authorized, fully paid,
validly issued and non-assessable and was not issued in violation of the rights
of any person; this Agreement accurately describes the Collateral owned and
pledged by the Pledgor;</div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;&#160;&#160;
to the best knowledge of Pledgor, no dispute, right of setoff, counterclaim or
defense exists with respect to any portion of the Collateral;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)&#160;&#160;&#160;&#160;
the Pledgor's signature on this Agreement is genuine and the Pledgor has the
legal competence and capacity to execute this Agreement;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)&#160;&#160;&#160;&#160;
the address given herein as the Pledgor's principal place of residence is the
Pledgor's true and correct principal place of residence; and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)&#160;&#160;&#160;&#160;
this Agreement constitutes the legal, valid and binding obligation of the
Pledgor.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">5.</font> <font style="FONT-WEIGHT: bold">Covenants of
the Pledgor</font>. </font>The Pledgor hereby covenants that, until such time as
all of the outstanding principal of and interest on the Note has been repaid and
all other obligations of the Pledgor hereunder or thereunder have been
discharged, the Pledgor shall:</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;
not create, incur, assume or suffer to exist any pledge, security interest,
encumbrance, lien or charge of any kind against the Collateral or the Pledgor's
rights as a holder thereof, other than pursuant to this Agreement;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;
promptly execute and deliver at his or her own expense such further instruments
and documents (including Uniform Commercial Code or other applicable financing
statements) and do such further acts and things as the Lender may reasonably
request in order to effect the purposes of this Agreement;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;
warrant and defend title to and ownership of the Collateral at his or her own
expense against the claims and demands of all other parties Claiming an interest
therein;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;&#160;&#160;
notify the Lender promptly upon change of his or her principal place of
residence;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;&#160;&#160;
if any of the Collateral is an uncertificated security within the meaning of the
UCC or otherwise not evidenced by any stock certificate or similar certificate
or instrument, the Pledgor agrees to promptly notify the Lender and take all
actions necessary to ensure perfection of the security interest under prevailing
and applicable law, including, as applicable<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub; FONT-FAMILY: Bookman Old Style, serif">;</font>
under Article 8 or 9 of the UCC, and, without any limitation of the foregoing,
prior to or concurrently with the pledge hereunder of the Collateral to which
this section applies (arid as reasonably requested by the Lender thereafter),
use commercially reasonable efforts to ensure that all Collateral that is an
uncertificated security is re&#173;registered in the name of the
Lender;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;&#160;&#160;
if any of the Collateral is a certificated security within the meaning of the
UCC, the Pledgor agrees to, simultaneously with or prior to the execution of
this Agreement (and as reasonably requested by the Lender thereafter), take all
actions necessary to ensure perfection of the security interest under prevailing
and applicable law, including, as applicable, under Article 8 or 9 of the UCC,
and, without any limitation of the foregoing, deliver all certificates or
instruments representing or evidencing the Collateral to the Lender, accompanied
by a duly executed assignment separate from the certificate in the form attached
hereto as Exhibit A;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)&#160;&#160;&#160;
&#160; pay all taxes, assessments and charges assessed with respect to the
Collateral;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 10.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)&#160;&#160;&#160;&#160;
shall not issue any shares, warrants, options or other security obligations in
HealthAmerica Acquisition Corp unless such shares are added as Pledged Shares
under this Agreement, or upon written consent of Lender;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;&#160;&#160;&#160;
Shall not sell, dispose of, transfer or encumber in any manner the assets of
HealthAmerica or the entity which is the result of the merger of HealthAmerica
and HealthAmerica Acquisition Corp.; and</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)&#160;&#160;&#160;&#160;
do all such other things as the Lender may reasonably deem necessary or
appropriate in order to assure to the Lender its security interests under this
Agreement, to the extent that such acts are not inconsistent with any provision
of this Agreement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">6.</font>&#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold">Event of Default. </font>Upon the
occurrence of an Event of Default (as defined in the Note), the Lender shall
have the right to exercise any and all the rights<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub; FONT-FAMILY: Bookman Old Style, serif">;</font>
powers and remedies of any owner of the Collateral (including, without
limitation, the right to vote the Collateral) and shall have and may exercise
without demand any and all of the rights and remedies granted to a secured party
upon default under the Uniform Commercial Code of Nevada or otherwise available
to the Lender under applicable law. The Pledgor agrees that in the event the
Lender shall, during the existence of an Event of Default, sell the Collateral
or any portion thereof at any private sale or sales, the Lender shall have the
right to rely upon the advice and opinion of independent appraisers and other
personas, which appraisers and other persons are acceptable to the Lender, as to
the best price reasonably obtainable upon such a private sale thereof. The
Pledgor shall have no right to redeem any of the Collateral after any such sale
or assignment. At any such sale or auction, the Lender may bid for; and become
the purchaser of, the whole or any part of the Collateral offered for sale. In
case of any&#160;such<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
</font>sale, after deducting the costs, reasonable attorneys' fees and other
expenses of sale and delivery, the remaining proceeds of such sale shall be
applied promptly to the payment first of accrued interest and then to principal
under the Note; provided, however, that after payment in full of the
indebtedness evidenced by the Note<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub; FONT-FAMILY: Bookman Old Style, serif">;</font>
the balance of the proceeds of sale then remaining shall be paid to the Pledgor
and<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub; FONT-FAMILY: Bookman Old Style, serif">,</font>
the Pledgor shall be entitled to the return of any of the Collateral remaining
in the hands of the Lender. Notwithstanding anything herein to the contrary, in
case of any Event of Default, Pledgor shall have; with respect to the
Collateral, all notice and reinstatement rights applicable by California statute
to foreclosure of real property security. <font style="DISPLAY: inline; FONT-WEIGHT: bold">In any event, the Pledgor
</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">shall not be liable for
any deficiency if the proceeds of sale of the Collateral are insufficient to pay
</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">the accrued and unpaid
interest together with the remaining unpaid principal on the
Note.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pledgor&#160;<font style="TEXT-DECORATION: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">7.</font>&#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold">Costs and Attorneys' Fees. </font>All
costs and expenses (including reasonable attorneys' fees and any transfer, stamp
or other similar taxes with respect to the transfer of any Collateral to the
Lender) incurred in exercising any right, power or remedy conferred by this
Agreement or in the enforcement thereof, shall become part of the indebtedness
secured hereunder and be payable immediately upon demand.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">8. Payment of Note and Release of
Collateral. </font>Upon payment in full of the Note and the discharge of all of
the Pledgor's obligations tinder the Note and under this Agreement, the Lender
shall surrender the remaining Collateral, if any, to the Pledgor together with
all forms of assignment.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No
Waiver; Cumulative Remedies</font>. The Lender Shall not by any act, delay,
omission, or otherwise be deemed to have waived any of its rights or remedies
hereunder, and no waiver shall be valid unless in writing, signed by the Lender,
and then only to the extent therein set forth. A waiver by the Lender of any
right or remedy hereunder <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on
</font>any one occasion shall not be construed as a bar to any right or remedy
which the Lender would otherwise have on any future occasion. No failure to
exercise, nor any delay in exercising on the part of the Lender; any right,
power Or privilege hereunder shall preclude any other or further exercise
thereof or the exercise of any other right, power or privilege. The rights and
remedies herein provided are cumulative and may be exercised singly or
concurrently, and are not exclusive of any rights or remedies provided by
law.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notices</font>.
All notices and other communications hereunder shall be in writing and shall be
given as described in the Note.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pledgor and Lender </font>Corporate
Offices. The address of the corporate offices of the Pledgor and the Lender as
of the date hereof follows:</font></div>
      <div>&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td align="left" valign="top" width="38%" style="PADDING-LEFT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc.</font></div>
              </td>
              <td align="left" valign="top" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Rico
      Italia Investments, Inc.</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" width="38%" style="PADDING-LEFT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2590
      Holiday Rd., Suite 100</font></div>
              </td>
              <td align="left" valign="top" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2808
      Cowan Circle</font></div>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" width="38%" style="PADDING-LEFT: 0pt">
                <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Coralville,
      IA 52241</font></div>
              </td>
              <td align="left" valign="top" width="36%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Las
      Vegas, NV 891.07</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.</font>&#160;&#160;
<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt">Proxy and
Power of Attorney. </font></font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">THE </font><font style="DISPLAY: inline; FONT-SIZE: 10pt">PLEDGOR HEREBY IRREVOCABLY GRANTS TO
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">THE LENDER THE PLEDGOR'S
PROXY EXERCISABLE ONLY DURING THE EXISTENCE OF </font><font style="DISPLAY: inline; FONT-SIZE: 10pt">AN EVENT OF DEFAULT TO VOTE ANY
COLLATERAL AND APPOINTS THE LENDER THE </font><font style="DISPLAY: inline; FONT-SIZE: 10pt">PLEDGOR'S ATTORNEY-IN-FACT, EXERCISABLE
ONLY DURING THE EXISTENCE OF AN </font><font style="DISPLAY: inline; FONT-SIZE: 10pt">EVENT OF DEFAULT TO PERFORM ALL
OBLIGATIONS OF THE PLEDGOR UNDER THIS </font><font style="DISPLAY: inline; FONT-SIZE: 10pt">AGREEMENT. THE PROXY AND POWER. OF
ATTORNEY GRANTED HEREIN ARE COUPLED </font><font style="DISPLAY: inline; FONT-SIZE: 10pt">WITH AN INTEREST AND ARE IRREVOCABLE
PRIOR TO PAYMENT IN FULL OF THE </font><font style="DISPLAY: inline; FONT-SIZE: 10pt">INDEBTEDNESS EVIDENCED BY THE
</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">NOTE.</font></font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">13.&#160; Modifications</font>. No amendment;
modification, termination, discharge or waiver of any provision of this
Agreement shall be effective unless the same shall be set forth in writing and
signed by the Pledgor and the Lender and then only to the extent specifically
set forth therein.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">14.&#160; Severability.</font> Any provision <font style="DISPLAY: inline; FONT-SIZE: 10pt">of this </font>Agreement which is
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without
invalidating the remaining provisions hereof, and any such prohibition or
unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">15.</font>&#160;&#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold">Entirety. </font>This Agreement and
the Note represent <font style="DISPLAY: inline; FONT-SIZE: 10pt">the
</font>entire agreement of the parties hereto and thereto, and supersede all
prior agreements and understandings, oral or written, if any, including any
commitment letters or correspondence relating hereto and thereto.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">16.</font>&#160;&#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold">Governing Law. </font>The rights arid
liabilities of the parties hereto shall be determined in accordance with the
laws of the County of Clark, State of Nevada, without regard to conflicts of law
principles.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">17. Acknowledgment. </font>The
Pledgor hereby acknowledges that (a) he/she has fully read this Agreement and
any and all related matters and documents, and (b) he/she fully understands all
terms of this Agreement and any and <font style="DISPLAY: inline; FONT-WEIGHT: bold">all </font>related matters and
documents:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="1">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">18.&#160;&#160; Construction</font>. The <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">language
used</font> in this Agreement is the language chosen by the parties hereto to
express their intent, and thus the Pledgor hereby acknowledges and expressly
agrees that the terms of this Agreement shall not be construed against the
Lender under any doctrine or rule which results in construal against the Lender
as drafter hereof.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19.&#160;
</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">Successors and Assigns</font>. </font>If the Lender
shall designate a successor to the Lender, such successor shall automatically be
substituted for the Lender hereunder and shall take free from any defenses the
Pledgor may have against the Lender or any other person whatsoever. This
Agreement shall be binding on the Pledgor and the Pledgor&#8217;s heirs, executors,
administrators, successors and assigns and shall inure to the benefit of the
Lender <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
</font>its successors and assigns. The Pledgor may not <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">assign
</font>this Agreement without the prior written consent of the Lender, which
consent may be withheld by the Lender in its sole discretion. The Lender may
assign<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: super; FONT-FAMILY: Bookman Old Style, serif">-</font>
this Agreement without the consent of the Pledgor.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 18pt" align="left">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">20.&#160; Captions and Headings</font>. Captions and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">headings&#160;are</font><font style="DISPLAY: inline; FONT-SIZE: 10pt"> </font>for convenience only, are not a
part of, and shall not be used to construe any provision of this
Agreement.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-WEIGHT: bold">21.&#160; Counterparts</font>. </font>This Agreement
may be executed in any number of counterparts, each of which where so executed
and delivered shall be an original,&#160;but all of which shall constitute one
and the <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">same
instrument. It </font>shall not be necessary&#160;in making proof <font style="DISPLAY: inline; FONT-SIZE: 10pt">of this </font>Agreement to produce or
account for more than one such counterpart.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">IN
WITNESS WHEREOF, this Pledge Agreement has been executed as of the date first
written above.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div>
        <table cellpadding="0" cellspacing="0" width="100%">
            <tr>
              <td align="left" valign="top" width="40%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8220;PLEDGOR&#8221;</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vivakor,
      Inc.</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:<font style="TEXT-DECORATION: underline">&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Tannin
      Fuja&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
      </font></font></font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tannin
      Fuja</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:&#160;&#160;President</font></div>
              </td>
              <td align="left" valign="top" width="40%">
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8220;LENDER&#8221;</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Rico
      Italia Investments, Inc.</font></div>
                <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:&#160;<font style="TEXT-DECORATION: underline">/s/ Richard A.
      Taulli&#160;&#160;&#160;&#160; </font></font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Richard
      A. Taulli</font></div>
                <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:&#160;&#160;President</font></div>
              </td>
            </tr>
        </table>
      </div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div><br></div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>
    <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

      <div>
        <hr style="COLOR: black" align="left" noshade size="1" width="100%">
      </div>
    </div>
  </body>
</html>




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-14.1
<SEQUENCE>13
<FILENAME>vivakor_s1-ex1401.htm
<DESCRIPTION>CODE OF ETHICS
<TEXT>
<html>
  <head>
    <title>Unassociated Document</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">EXHIBIT
14.1</font><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">VIVAKOR,
INC.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CODE
OF ETHICS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Introduction</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Code
of Ethics applies to the employees, officers and directors, and consultants of
Vivakor, Inc. and its subsidiaries, together, referred to as the
Company.&#160;&#160;It covers a wide range of business practices and
procedures.&#160;&#160;It does not cover every issue that may arise, but it sets
out basic principals to guide all employees of the Company.&#160;&#160;It is
intended to promote honest and ethical conduct at all levels of the
Company.&#160;&#160;All of our employees must conduct themselves accordingly and
seek to avoid even the appearance of improper behavior.&#160;&#160;The Code
should also be provided to and followed by the Company&#8217;s agents and
representatives, including consultants.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If a law
conflicts with a policy in this Code, you must comply with the law, however, if
a local custom or policy conflicts with this Code, you must comply with the
Code.&#160;&#160;Any variances between local customs or policies and this Code
should be brought to the attention of management or the directors.&#160;&#160;If
you have any questions about these conflicts, you should ask your supervisor how
to handle the situation.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Those who
violate the standards in this Code will be subject to disciplinary
action.&#160;&#160;If you are in a situation that you believe may violate or
lead to a violation of this Code, follow the guidelines described in Section 14
of this Code.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">COMPLIANCE
WITH LAW</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Compliance
with Laws, Rules and Regulations</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Obeying
the law, both in letter and in spirit, is the foundation on which this Company&#8217;s
ethical standards are built.&#160;&#160;All employees must respect and obey the
laws of the cities, states and countries in which we
operate.&#160;&#160;Although not all employees are expected to know the details
of these laws, it is important to know enough to determine when to seek advice
from supervisors, managers or other appropriate personnel.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Discrimination and
Harassment</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
diversity of the Company&#8217;s employees is a tremendous asset.&#160;&#160;We are
firmly committed to providing equal opportunity in all aspects of employment and
will not tolerate any illegal discrimination or harassment of any
kind.&#160;&#160;Examples include derogatory comments based on racial or ethnic
characteristics, religion or sexual orientation and unwelcome sexual
advances.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Health and
Safety</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Company strives to provide each employee with a safe and healthful work
environment.&#160;&#160;Each employee has responsibility for maintaining a safe
and healthy workplace for all employees by following safety and health rules and
practices and reporting accidents, injuries and unsafe equipment, practices or
conditions.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Violence
and threatening behavior are not permitted.&#160;&#160;Employees should report
to work in condition to perform their duties, free from the influence of illegal
drugs or alcohol.&#160;&#160;The use of illegal drugs or alcohol in the
workplace will not be tolerated.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FAIR
AND HONEST DEALINGS WITH THE COMPANY</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Conflicts of
Interest</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A
&#8220;conflict of interest&#8221; exists when a person&#8217;s private interest interferes in any
way with the interests of the Company.&#160;&#160;A conflict situation can arise
when an employee, officer or director takes actions or has interests that may
make it difficult to perform his or her Company work objectively and
effectively.&#160;&#160;Conflicts of interest may also arise when an employee,
officer or director, or members of his or her family, receives improper personal
benefits as a result of his or her position in the Company.&#160;&#160;Loans to,
or guarantees of obligations of, employees and their family members may create
conflicts of interest.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">It is
almost always a conflict of interest for a Company employee to work
simultaneously for a competitor, customer or supplier.&#160;&#160;You are not
allowed to work for a competitor as a consultant or a board
member.&#160;&#160;The best policy is to avoid any direct or indirect business
connection with our customers, suppliers or competitors, except on our
behalf.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Conflicts
of interest are prohibited as a matter of Company policy, except under
guidelines approved by the Board of directors.&#160;&#160;Conflicts of interest
may not always be clear-cut, so if you have a question, you should consult with
senior management or, if you are a director or other member of senior
management, the Company&#8217;s outside legal counsel, Wilson, Haglund &amp; Paulsen,
P.C.&#160;&#160;Any employee, officer or director who becomes aware of a
conflict or potential conflict should bring it to the attention of a supervisor,
manager or other appropriate personnel or consult the procedures described in
Section 14 of this Code.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Corporate
Opportunities</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Employees,
officers and directors are prohibited from taking for themselves personally,
opportunities that are discovered through the use of corporate property,
information or position, without the consent of the Board of
Directors.&#160;&#160;No employee may use corporate property, information, or
position for improper personal gain, and no employee may compete with the
Company directly or indirectly.&#160;&#160;Employees, officers and directors owe
a duty to the company to advance its legitimate interests when the opportunity
to do so arises.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Protection
and Proper Use of Company Assets</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
employees should endeavor to protect the Company&#8217;s assets and ensure their
efficient use.&#160;&#160;Theft, carelessness, and waste have a direct impact on
the Company&#8217;s profitability.&#160;&#160;Any suspected incident of fraud or theft
should be immediately reported for investigation.&#160;&#160;Company equipment
should not be used for non-company business, though incidental personal use may
be permitted.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
obligation of employees to protect the Company&#8217;s assets extends to its
proprietary information.&#160;&#160;Proprietary information includes
intellectual property such as customer data or information, trade secrets,
patents, trademarks, and copyrights, as well as business, marketing and service
plans, engineering and manufacturing ideas, designs, databases, records, salary
information and any unpublished financial data and
reports.&#160;&#160;Unauthorized use or distribution of this information would
violate Company policy.&#160;&#160;It could also be illegal and result in civil
or even criminal penalties.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FAIR
AND HONEST DEALINGS WITH COMPETITORS AND OTHERS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Competition
and Fair Dealing</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We seek
to outperform our competition fairly and honestly.&#160;&#160;We seek
competitive advantages through superior performance, never through unethical or
illegal business practices.&#160;&#160;Stealing proprietary information,
possessing trade secret information that was obtained without the owner&#8217;s
consent, or inducing such disclosures by past or present employees of other
companies is prohibited.&#160;&#160;Each employee should endeavor to respect the
rights of and deal fairly with the Company&#8217;s customers, suppliers, competitors
and employees.&#160;&#160;No employee should take unfair advantage of anyone
through manipulation, concealment, abuse of privileged information,
misrepresentation of material facts, or any other intentional unfair-dealing
practice.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
maintain the Company&#8217;s valuable reputation, compliance with our quality
processes and safety requirements is essential.&#160;&#160;In the context of
ethics, quality requires that our products and services reflect our ethical
obligations.&#160;&#160;All operations must be conducted in accordance with all
applicable regulations.&#160;&#160;Compliance with all regulations and laws of
governing or regulatory agencies should be given priority over the opportunity
to profit or gain competitive advantage.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
purpose of business entertainment and gifts in a commercial setting is to create
good will and sound working relationships, not to gain unfair advantage with
suppliers and customers.&#160;&#160;No gift or entertainment should ever be
offered, given, provided or accepted by any Company employee, family member of
an employee or agent unless it:&#160;&#160;(1) is not a cash gift, (2) is
consistent with customary business practices, (3) is not excessive in value,
i.e., it has a value of $50 or less, (4) cannot be construed as a bribe or
payoff and (5) does not violate any laws or regulations.&#160;&#160;Please
discuss with your supervisor any gifts or proposed gifts that you are not
certain are appropriate.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Payments to
Government Personnel</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The U.S.
Foreign Corrupt Practices Act prohibits giving anything of value, directly or
indirectly, to officials of foreign governments or foreign political candidates
in order to obtain or retain business.&#160;&#160;It is strictly prohibited to
make illegal payments to government officials of any country.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
addition, the U.S. government has a number of laws and regulations regarding
business gratuities that may be accepted by U.S. government
personnel.&#160;&#160;The promise, offer or delivery to an official or employee
of the U.S. government of a gift, favor or other gratuity in violation of these
rules would not only violate Company policy, but could also be a criminal
offense.&#160;&#160;State and local governments, as well as foreign governments,
may have similar rules.&#160;&#160;The Company&#8217;s senior management or outside
legal counsel can provide guidance to you in this area.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Confidentiality</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Employees
must maintain the confidentiality of confidential information entrusted to them
by the Company or its suppliers and customers, except when disclosure is
explicitly authorized or required by laws or regulations or approved by senior
management.&#160;&#160;Confidential information includes all non-public
information that might be of use to competitors, or harmful to the Company or
its customers, is disclosed.&#160;&#160;It also includes information that
suppliers and customers have entrusted to us.&#160;&#160;The obligation to
preserve confidential information continues even after employment
ends.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FAIR
AND HONEST DISCLOSURE TO THE PUBLIC</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>Insider
Trading</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Employees
who have access to confidential information are not permitted to use or share
that information for stock trading purposes or for any other purpose except the
conduct of the Company&#8217;s business.&#160;&#160;All non-public information about
the Company should be considered confidential information.&#160;&#160;To use
non-public information for the personal financial benefit or to &#8220;tip&#8221; others who
might make and investment decision to buy or sell Vivakor, Inc. stock on the
basis of this information, is not only unethical but also illegal and subject to
possible civil and criminal penalties.&#160;&#160;If you have any questions
concerning this, please consult senior management or, if you are a director or
other member of senior management, the Company&#8217;s outside legal counsel, Wilson,
Haglund &amp; Paulsen, P.C.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>Record
Keeping</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Company requires honest and accurate recording and reporting of information in
order to make responsible business decisions.&#160;&#160;For example, only the
true and actual number of hours worked should be reported.&#160;&#160;Many
employees regularly use business expense accounts, which must be documented and
recorded accurately.&#160;&#160;If you are not sure whether a certain expense is
legitimate, ask your supervisor or the Human Resources Department.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All of
the Company&#8217;s books, records, accounts and financial statements must be
maintained in reasonable detail, must appropriately reflect the Company&#8217;s
transactions and must conform both to applicable legal requirements and to the
Company&#8217;s system of internal controls.&#160;&#160;Unrecorded or &#8220;off the books&#8221;
funds or assets should not be maintained.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Business
records and communications often become public, and we should avoid
exaggeration, derogatory remarks, guesswork, or inappropriate characterizations
of people and companies that can be misunderstood.&#160;&#160;This applies
equally to e-mail, internal memos, and formal reports.&#160;&#160;Records should
always be retained or destroyed according to the Company&#8217;s record retentions
policies.&#160;&#160;In accordance with those policies, in the event of
litigation or governmental investigation, please consult senior management or,
if you are a director or other member of senior management, the Company&#8217;s
outside legal counsel, Wilson, Haglund &amp; Paulsen, P.C.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Company has adopted specific procedures regarding the receipt, retention and
treatment of complaints and concerns regarding accounting, internal accounting
controls and auditing matters and the confidential submission by employees of
concerns regarding questionable accounting or auditing matters.&#160;&#160;These
procedures are set forth in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit
A</font>.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>Principal
Executive, Financial and Accounting Officers</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Code
of Ethics is intended and designed to promote full, fair, accurate, timely and
understandable disclosure in the Company&#8217;s SEC filings and other public
communications.&#160;&#160;The Company&#8217;s Principal Executive, Financial and
Accounting Officers &#8211; consisting of the Chairman and President and the Chief
Financial Officer, hold an especially important and elevated role in corporate
governance.&#160;&#160;They are vested with both the responsibility and
authority to protect, balance, and preserve the interests of all of the
Company&#8217;s stakeholders, including shareholders, clients, employees, suppliers,
and citizens of the communities in which business is conducted. The Principal
Executive, Financial and accounting Officers fulfill this responsibility by
prescribing and enforcing the policies and procedures employed in the operation
of the Company&#8217;s financial organization, and by demonstrating the
following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Principal Executive, Financial and Accounting Officers will exhibit and promote
the highest standards of honest and ethical conduct through the establishment
and operation of policies that:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Encourage
      professional integrity in all aspects of the financial organization, by
      eliminating inhibitions and barriers to responsible behavior, such as
      coercion, fear of reprisal, or alienation from the financial organization
      or the enterprise itself.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prohibit
      and eliminate the occurrence of conflicts between what is in the bet
      interest of the enterprise and what could result in material personal gain
      for a member of the financial organization, including the Principal
      Executive, Financial and Accounting
Officers.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Provide
      a mechanism for members of the finance organization to inform senior
      management of deviations in practice from policies and procedures
      governing honest and ethical
behavior.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
Principal Executive, Financial and Accounting Officers will establish and manage
the enterprise transaction and reporting systems and procedures to ensure
that:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Business
      transaction are properly authorized and completely and accurately recorded
      on the Company&#8217;s books and records in accordance with Generally Accepted
      Accounting Principles (GAAP) and established Company financial
      policy.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      retention or proper disposal of Company records are in accordance with
      applicable legal and regulatory
requirements.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Periodic
      financial communications and reports are delivered in a manner that
      facilitates a high degree of clarity of content and meaning so that
      readers and users can determine their significance and
      consequence.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROCEDURES
FOR COMPLIANCE WITH THE CODE OF ETHICS</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>Compliance
Procedures</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We must
all work to ensure prompt and consistent action against violations of this
Code.&#160;&#160;However, in some situations it is difficult to know right from
wrong.&#160;&#160;Since we cannot anticipate every situation that will arise, it
is important that we have a way to approach a new question or
problem.&#160;&#160;These are the steps to keep in mind:</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Make sure you have all
      the facts.</font>&#160;&#160;In order to reach the right solutions, we
      must be as fully informed as
possible.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Ask
      yourself:&#160;&#160;What specifically am I being asked to
      do?&#160;&#160;Does it seem unethical or improper?&#160;&#160;</font>This
      will enable you to focus on the specific question you are faced with, and
      the alternatives you have.&#160;&#160;Use your judgment and common
      sense.&#160;&#160;If something seems unethical or improper, it probably
      is.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Clarify your
      responsibility and role.</font>&#160;&#160;In most situations, there is
      shared responsibility.&#160;&#160;Are your colleagues
      informed?&#160;&#160;It may help to get others involved and discuss the
      problem.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Discuss the problem
      with your supervisor.</font>&#160;&#160;This is the basic guidance for all
      situations.&#160;&#160;In many cases, your supervisor will be more
      knowledgeable about the question and will appreciate being brought into
      the decision-making process.&#160;&#160;Remember that it is you
      supervisor&#8217;s responsibility to help solve
  problems.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Seek help from Company
      resources</font>.&#160;&#160;In the rare case where it may not be
      appropriate to discuss an issue with your supervisor, or where you do not
      feel comfortable approaching your supervisor with your question, discuss
      it with senior management or the Chief Executive Officer or, if you are a
      director or other member of senior management, the Company&#8217;s outside legal
      counsel, Wilson, Haglund &amp; Paulsen, P.C.&#160;&#160;If you prefer to
      write, address your concerns to President and Chief Executive Officer,
      Vivakor, Inc., 2590 Holiday Rd. 100, Coralville, IA&#160;
      52241.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">You may report ethical
      violations in confidence and without fear of
      retaliation</font>.&#160;&#160;If your situation requires that you
      identity be kept secret, your anonymity will be protected.&#160;&#160;The
      Company does not permit retaliation of any kind against employees for good
      faith<font style="DISPLAY: inline; TEXT-DECORATION: underline">&#160;</font>reports
      of ethical violations.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="list" width="100%">
          <tr valign="top" style="LINE-HEIGHT: 1.25;">
            <td align="right" style="WIDTH: 36pt">
              <div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Always ask first, act
      later.</font>&#160;&#160;If you are unsure of what to do in any situation,
      seek guidance <font style="DISPLAY: inline; FONT-STYLE: italic">before you
      act</font>.</font></div>
            </td>
          </tr>
      </table>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reporting
Illegal or Unethical Behavior or Violations of this Code</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Employees
are encouraged to talk to supervisors, managers or other appropriate personnel
about any observed illegal or unethical behavior, any violations of this Code of
Ethics, and when in doubt about the best course of action in a particular
situation.&#160;&#160;It is the policy of the Company not to allow retaliation
for reports of misconduct by others made in good faith by
employees.&#160;&#160;Employees are expected to cooperate in internal
investigations of misconduct.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>Waivers of the Code
of Ethics</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
waiver of this Code for executive officers, directors, employees or consultants
may be made only by the Board and will be promptly disclosed if and as required
by law or stock exchange regulation.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*&#160;&#160;*&#160;&#160;*&#160;&#160;*&#160;&#160;*</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">EXHIBIT
A</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PROCEDURES
REGARDING COMPLAINTS ABOUT ACCOUNTING, INTERNAL ACCOUNTING CONTROLS AND AUDITING
MATTERS</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">AND
THE ANONYMOUS SUBMISSION OF CONCERNS REGARDING QUESTIONABLE ACCOUNTING OR
AUDITING MATTERS.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Receipt, Retention and
Treatment of Complaints.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Receipt.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
employee who either has a reportable matter or receives a complaint, whether
from another employee or any other person, regarding accounting, internal
accounting controls or auditing matters (a &#8220;Complaint&#8221;) shall promptly advise
the Chief Executive Officer, or any member of the Audit Committee (or, if no
Audit Committee has been established, any member of the Board of Directors) of
the receipt and substance of the Complaint.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Promptly
after the Chief Executive Officer is advised of such a Complaint, he or she
shall inform the Chairperson of the Audit Committee (or Board of Directors) of
the substance of the Complaint and forward to the Chairperson copies of any
written or other documentation received in connection with the
Complaint.&#160;&#160;Notwithstanding the requirement to inform the Chairperson,
however, the Chief Executive Officer may elect not to so inform the Audit
Committee (or Board of Directors) if he or she determines that the Complaint is
frivolous or without merit.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Retention.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The Audit Committee (or Board of
Directors) shall retain all writing and other documentation received in
connection with a Complaint, in a secure area, for at least five (5) years from
the receipt.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Treatment.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit
Committee (or Board of Directors) shall include the matters raised by the
Complaint on the agenda for discussion at its next meeting following the date
the Chairperson of the Audit Committee (or Board of Directors) receives
notification of the Complaint from the Chief Executive Officer.&#160;&#160;If
the Chairperson determines, in his or her reasonable judgment, that the matters
raised in the Complaint should be addressed before the next regularly scheduled
meeting of the Audit Committee (or Board of Directors), the Chairperson shall
call a special meeting of the Audit Committee (or Board of Directors) to be held
at a sooner time.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Audit
Committee (or Board of Directors) may invite the Chief Executive Officer and any
other employees, as well as representatives of Vivakor&#8217;s independent auditors or
its outside legal counsel, to attend all or a portion of the meeting at which a
discussion of the Complaint is scheduled.&#160;&#160;In addition, the Audit
Committee (or Board of Directors) may engage independent counsel and other
advisors, as it may deem necessary, in evaluating and responding to the
Complaint.&#160;&#160;At the meeting, the Audit Committee (or Board of
Directors) shall discuss and evaluate the merits of the Complaint and authorize
such responses and follow-up actions, if any, as it deems necessary and
appropriate, to address the substance of the Complaint.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">A-1</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="1">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br>&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Employee
Submissions.</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Employees
who have any concerns regarding questionable accounting or auditing matters
should contact any member of the Audit Committee (or Board of
Directors).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">An
employee who wishes to raise concerns anonymously may do so by submitting his or
her concerns in writing to any member of the Audit Committee (or Board of
Directors).&#160;&#160;Even if an employee submits concerns other than
anonymously, the Audit Committee (or Board of Directors) will endeavor to
protect the privacy and confidentiality of that employee to the extent
possible.&#160;&#160;In any event, employees will not be subject to reprisal or
public embarrassment for making good faith reports of concerns.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
concerns regarding questionable accounting or auditing matters will be treated
in the same manner as Complaints received under Section A above (concerning
receipt, retention and treatment of Complaints).</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*&#160;&#160;&#160;*&#160;&#160;&#160;*&#160;&#160;&#160;*&#160;&#160;&#160;*</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A-2</font></div>
  </body>
</html>





</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>14
<FILENAME>vivakor_s1-ex2101.htm
<DESCRIPTION>SUBSIDIARIES
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex2101.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exhibit
21.1</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SUBSIDIARIES
OF THE COMPANY</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
    </div>
    <div>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">
          <tr>
            <td width="10%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="TEXT-DECORATION: underline">Subsidiary</font>&#160;</font></td>
            <td width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline">Jurisdiction
      of Incorporation</font></td>
            <td width="40%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="TEXT-DECORATION: underline">% Owned by
    Company</font>&#160;</font></td>
          </tr>
          <tr>
            <td width="10%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">HealthAmerica,
      Inc.&#160;&#160;&#160;</font></td>
            <td width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nevada&#160;</font></td>
            <td width="40%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">84.0%&#160;</font></td>
          </tr>
      </table>
    </div>
    <div>&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25">&#160;</div>
  </body>
</html>




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>15
<FILENAME>vivakor_s1-ex2301.htm
<DESCRIPTION>CONSENT
<TEXT>
<html>
  <head>
    <title>vivakor_s1-ex2301.htm</title>
<!-- Licensed to: Publicease, Inc.-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
    <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exhibit
23.1</font></div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Consent
of Independent Registered Public Accounting Firm</font></div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We consent to
the use in this Registration Statement on Form S-1 of Vivakor, Inc. of our
report dated November 24, 2008, relating to our audits of the financial
statements (which report includes emphasis paragraph relating to an uncertainty
as to the Company's ability to continue as a going concern), appearing in the
Prospectus, which is part of this Registration Statement.</font></div>
    <div>&#160;</div>
    <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also consent
to the referenced to our firm under the captions "Experts" in the
Prospectus.</font></div>
    <div>&#160;</div>
    <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/ McGladry
&amp; Pullen, LLP</font></div>
    <div>&#160;</div>
    <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cedar Rapids,
Iowa</font></div>
    <div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">November 24,
2008</font></div>
    <div>&#160;</div>
  </body>
</html>




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>vivakorex301image1.jpg
<TEXT>
begin 644 vivakorex301image1.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86
M&#$C)1TH.C,]/#DS.#=`2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`0A`S`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#L/["T?_H%
M6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!5C_X#I_A1_86C_\`0*L?
M_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`T"K'_P`!T_PK0HH`S_["T?\`
MZ!5C_P"`Z?X4?V%H_P#T"K'_`,!T_P`*T**`,_\`L+1_^@58_P#@.G^%']A:
M/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH`S_[
M"T?_`*!5C_X#I_A1_86C_P#0*L?_``'3_"M"B@#/_L+1_P#H%6/_`(#I_A1_
M86C_`/0*L?\`P'3_``K0HH`S_P"PM'_Z!5C_`.`Z?X4?V%H__0*L?_`=/\*T
M**`,_P#L+1_^@58_^`Z?X4?V%H__`$"K'_P'3_"M"B@#/_L+1_\`H%6/_@.G
M^%']A:/_`-`JQ_\``=/\*T**`,_^PM'_`.@58_\`@.G^%']A:/\`]`JQ_P#`
M=/\`"M"B@#/_`+"T?_H%6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!
M5C_X#I_A1_86C_\`0*L?_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`T"K'
M_P`!T_PK0HH`S_["T?\`Z!5C_P"`Z?X4?V%H_P#T"K'_`,!T_P`*T**`,_\`
ML+1_^@58_P#@.G^%']A:/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%']A:/
M_P!`JQ_\!T_PK0HH`S_["T?_`*!5C_X#I_A1_86C_P#0*L?_``'3_"M"B@#/
M_L+1_P#H%6/_`(#I_A1_86C_`/0*L?\`P'3_``K0HH`S_P"PM'_Z!5C_`.`Z
M?X4?V%H__0*L?_`=/\*T**`,_P#L+1_^@58_^`Z?X4?V%H__`$"K'_P'3_"M
M"B@#/_L+1_\`H%6/_@.G^%']A:/_`-`JQ_\``=/\*T**`,_^PM'_`.@58_\`
M@.G^%']A:/\`]`JQ_P#`=/\`"M"B@#/_`+"T?_H%6/\`X#I_A1_86C_]`JQ_
M\!T_PK0HH`S_`.PM'_Z!5C_X#I_A1_86C_\`0*L?_`=/\*T**`,_^PM'_P"@
M58_^`Z?X4?V%H_\`T"K'_P`!T_PK0HH`S_["T?\`Z!5C_P"`Z?X4?V%H_P#T
M"K'_`,!T_P`*T**`,_\`L+1_^@58_P#@.G^%']A:/_T"K'_P'3_"M"B@#/\`
M["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH`S_["T?_`*!5C_X#I_A1_86C
M_P#0*L?_``'3_"M"B@#/_L+1_P#H%6/_`(#I_A1_86C_`/0*L?\`P'3_``K0
MHH`S_P"PM'_Z!5C_`.`Z?X4?V%H__0*L?_`=/\*T**`,_P#L+1_^@58_^`Z?
MX4?V%H__`$"K'_P'3_"M"B@#/_L+1_\`H%6/_@.G^%']A:/_`-`JQ_\``=/\
M*T**`,_^PM'_`.@58_\`@.G^%']A:/\`]`JQ_P#`=/\`"M"B@#/_`+"T?_H%
M6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!5C_X#I_A1_86C_\`0*L?
M_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`T"K'_P`!T_PK0HH`S_["T?\`
MZ!5C_P"`Z?X4?V%H_P#T"K'_`,!T_P`*T**`,_\`L+1_^@58_P#@.G^%']A:
M/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH`S_[
M"T?_`*!5C_X#I_A1_86C_P#0*L?_``'3_"M"B@#/_L+1_P#H%6/_`(#I_A1_
M86C_`/0*L?\`P'3_``K0HH`S_P"PM'_Z!5C_`.`Z?X4?V%H__0*L?_`=/\*T
M**`,_P#L+1_^@58_^`Z?X4?V%H__`$"K'_P'3_"M"B@#/_L+1_\`H%6/_@.G
M^%']A:/_`-`JQ_\``=/\*T**`,_^PM'_`.@58_\`@.G^%']A:/\`]`JQ_P#`
M=/\`"M"B@#/_`+"T?_H%6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!
M5C_X#I_A1_86C_\`0*L?_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`T"K'
M_P`!T_PK0HH`****`"BJUCQ"XRQQ-)][/]\^O;]/2K-`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`5-/;,4N#D">09_P"!'V_QJW5:QSY#YY_?28R<_P`9JS0`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`%73_\`42?]=I>C9'WS_GZU:JM8$F!\C'[Z7\?G
M:K-`!14-U(\,.^-`YWJ""P4`%@"<GT!)_"IJ`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HI`,9]Z6@`HHHH`****`"BBB@`HHHH`****`"BBFG=N7!&.^10`ZB
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`K6&/*D'&1-)G'^\?Z8JS56P),4I*[<S2?CAB/7VJU0`UP"H
MRF_D<<>O7GTZ_A3J**`"FQER@,BJK=PK9'YX%.HH`****`"BBB@`HHHH`*8\
ML:,JNZJS9P"<$XZTJ(L:!(U"HHP%48`%#(K$%E!(Z$CI0!`-0LF4,+RW*D$@
MB5<<=>_:IQ(C$`.I)SP#Z'!_(U773K%5"K96X`!``B7C(P>W<<5.L4:L&6-0
M1G!`]3D_F>30`GG1;]GFINYXW#/'6@31$$B1,#_:%02:983/NEL;9VSG+1*3
MG\JB_L/2?^@99]_^6"]_PH`O+(C_`'75OH<TBRQM(\:NI=,;E!Y7/3([51.@
MZ.1C^RK'_P`!T_PJ'_A&-$PH_LV#Y>F%YH`N)J=A)"\R7ULT4>`[B52JYZ9.
M>,TB:KI[H76]M]H<H29`,,"1CGZ&JG_",:)_T#8.F/NT#PQH@`QIEOQG'RT`
M7?[2L?\`G]M_^_J_3UH_M*P`S]MML$9SYJ_XU3'AC0QN_P")7;?-U^3^7I3/
M^$3T+!']F0\C'?TQZT`:(O[-L8NX#G/20=NOY5%)JVGQ2I$]Y`'>3RPN\9W8
MZ53'A/0@<_V9#W]?\:<WA?1&0H=-AVD@]QT&/Y4`3MKFEJJR-J-H(G7<KF8<
M\]OR/Y4HUO2R[)_:%MN5=S#S!P..3^8J!O#.BM$D9TZ':F<8!!Y]3U/XU&?"
M>A$`'38N#D<G_&@"_P#VG8?9&NQ>VYME.#*)5*@^F<XS3X+ZSN9/+M[N"5\%
MML<@8XXYP/J/SJA+X8T26)HSIL"!B"3&NQN,=".1T[>_K4K^']'==O\`9EHO
M(.4A53P0>H'M0!<MKNVO$+VMQ%.H."8G#`'KVJ:L@^&-$+9&G0J<Y^3*_P`C
M2#PMH@4*-/BP.V3Z8]>:`-BBLE?#6CKG;8HN>NUF']:&\-:0V/\`1"`,8"RN
M!P<]`?>@#6HK'_X1C2,?\>S_`%\^3/Y[J0^%M'(Q]F<#VN)!C_QZ@#8)`QD]
M>E+61_PC6F!]P2X48Z+=2@?HU(?#5AO+;[P9SP+N0`9_X%0!L45C1^&;!%4&
M2]?`P2;R3YOKAOY41^&K*-5`FOBP_B^V2`DXZ\&@#8)`ZG%+62^@0-G;>ZDF
M3GY;Z7^IIG_".QX(_M/5>N01>OTXXZ_7\Z`-FBJD=@L=VEQ]HN6*1^6(VF)0
M^Y'=O<U;H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"IIZXBD)`R9I>A//
MSGM^%6ZJ:?\`<G]//?ICU_SU_EBK=`#)95B0,P8@LJ_*">20!_.GU6OH9IX4
M6%PI$L;G)(X5U)&1[`C'?-6:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BL[6X[Z2WMQIXRPN8FD&X#]V&!/\A^&:T:`"BBB@`H
MHJK.UX-0M5AC1K5@_GL>JG`VXY^OK0!:HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@!.:6BB@`HHHH`****`"BBB@`HHHH`****`"BBB@"K8J/+=N<^;)WZ
M?.?\*M55L3B-E]992.?]L_U-6J`$(!ZTM%%`!1110`4444`%%%%`!1110`A(
M`R>!2T44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4BJ%&!GJ3R<TM%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`5-/4A)CA%5IY#P.3\V,G\C^E6ZJ:>`(I<#&9Y,^_S&K=`#
M7)`RHR<@?K3J**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"KIY!BD]1-(#S_ML?ZU:JIIS
M!HI@&W;9Y`1_=^8G']?QJW0`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4BL&&5((/<&EI``.@Q0`M%%%`!1110`4444`
M%%%%`%33B?+FR"/W\F,C&?F-6ZJ:<V8YAD';/(,>GS&K=`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`5-/<&.5=P)$\G'''S'_`!_6K=4].W;+@-GBXDQD]LU<H`:\
MB1J&=@H)"Y/J3@#\R*=4<R"1`I0/AE;!]F!S^&,_A4E`!1110`4444`%%%%`
M!1110`4444`%%%(2`,G@4`+2$@`DG`'4FN+\0^/$M)S:Z2D=R^"K2YX5NF`.
M_P!>E<3?>(=7ORL=W?RNBX&T?(I'J0N,_7K0![3YB;MN]=V<8SSG&?Y"G5X)
MY\F\MYL@]#N)-6K/6+^QF$UM=2QN#GAB01G."#U'`ZT`>XT5YWH_Q"D#JFJQ
M!U)PTL?R[!P/N]^A/KR<#%>@031W$"30N'CD4,K#H0:`)****`"BBB@`JAJN
MLV&CK&U_,8A*2%PC-G'7H#TJ_6%XBT.?6+S3I(YQ!';,YD925?D#&TCZ>HH`
MDF\5:+#:P7+WH\N?)CVHQ)`."<`9&/>B?Q5HEO';R2WZA;A=\9",<C..PXY!
M'/I6-I_AW6],:VFM#IHGBMVMW#,^U@3D-T^]GK^7TK2^#-4^S1+%-:><(60R
M"22,HS.S$#:.5PV.:`.E_P"$ET?^T1I_VY/M)8*%VM@DC@;L8_6IKG6].M;N
M2UGN0DT4?FNI5N%QG.<8KFI?#&J?VI'<I]G#^=&SSI(06"@9+(1@\YZ4:[X2
MO]1UZYO8)EB69HT!$A'[O85D!&.O`XSC!-`'0#Q)I!BCD%\A63&S@\Y8KTQZ
M@BKDE_:Q7T-E),%N9U9HX\'+`=:XJ/PEJ\5G;1J+5C"ZL$,AP,.S#!QGOC_@
M1K4N['7;C6[#5?LMH'M5D4Q"X.&!&!SM]SV[4`:C>)=&2YDMGU")9HW,;*V1
MA@<8Z>M2V.O:7J-QY%G>QS2X+;5SG`ZUR]IX?UF#59+J6W1EFO?M!6*[VJN6
M#<C;R!_2G>&?"VH:7J&GW-T$=8Q*&7S,^23T*^N?ZT`=O1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`%6P`,3_*,B>3G'^V:M54
ML,B*7C/[^3&!C^(_G5N@`HHHH`****`"BBB@`HHHH`****`"BBB@`KC_`!_X
MA;3K3^SK?'GW*'>2,XC((./?-=A7B7B&_;4M>O+F7&&D*KL/`4<#]`/_`*U`
M&;D9Y';M1QD<''<9I\)"2HSPB5>I1L@,/PYK0O(;2QO'BDMV:-AYL7[S)VLN
M4#$<'JI./<9H`31-*EU*[\E<AB"J@G:&;'*D_P`/&3TZC'>K^L>&7L3.R+*H
MB0R%&&2H`C[X`/S.PR/[AZTFGWD%NTKVJRVUE/%Y<N`)6WA2>.A`Y#9]5..!
MBFOJ277AVYBO+V>ZNF='B6>5CY9&=S#GDD#&#TR,=30!@#&1GD=ZZSP7XFET
MRYCL)MKV<S@<DYB).,CV[D?RYKEW\KRH]A<R<^9D#'7C'X4U"P92N05.X$#D
M4`>_451T2_&IZ1;78+$R)AMR[3N!PW'U!J]0`4444`%<MXVOKNV%A#97HM'F
MD;<2=NX`?WB,#Z'U%=36%XFO8[>)(I]*_M"$JTLFX@+'M&<Y;C/7W_.@#"L_
M&=U&+&W>);G>L?F3-\C-N8C[HR,C]?;I0?'5T1%Y=M9LT[_*GG'?&-Q7#C'7
MIT[<T]/$>E27L4TNCHD-LK+#<,1\C(A?:`?PQ[FEL;S3;_2]5U/^R84>"071
M!?>)'"ED)(/!^;D>Y&*`&W7C2_CGN[3['`DT0E0.)#@,B$LPR,$9'3CM19>-
M;I)K2UN+6*7=%'NF$W)8QALGY<9]NQ_"B/7="O;VWO9M.C\VXA9YKAB#Y>U2
M&4CJ3M`QZ[A4K2>!HK2-O]'$4K[UVK(3N0=\<C[W0]<]Z`!/&MV(83)IB>;>
M*K6:I+D2$N%*DXX/4_A6GK'B1],O%M5LQ-,MN;F;,NU509SM)'S'CTKFX-6\
M/W>KZ;*7DMK6Q0K!#(V4#;L*3U()X.>?NC-;_B[^RC+9)?:;+J-TQ;R(8BP;
M``+'@\C@=?\`&@"'1=3U&ZO]7O;N98K.VW1I`[+M1A@Y+?3^=85OXIUBRM;J
M6YG$\[QHT4<L:A>6'*%3\PP?SQZ&NCTK6?#K69FC>*V;49&>6)VRS.>#GK_A
MS56-/!5M;7-LK6ZQRE5F5I')R"2!DG(Y':@!+_QK+;7-Y:IIZF6!7PYEW+E0
M"0<#&1DY&>V.,U:M?&$,FM1:7-;^7*SF%V\P';(!R,#/&<`<]<^E0_V7X.2]
M-N5MEN#&3L$S$;2AY'.,[><_0^AJ?1K'P]-J*76DMYDMN,%D9BH^7;SVR0>I
MZX/I0!TM%<ROCC3&:7,5S'$L;R)+)'A9=IQ\I!/4\9_"M2WU_2;B,.FH6WW/
M,*F5<J,`\\\=:`-*BJ[7]HLD49N8M\PW1KO&7'J/7K3-,U*VU6R6[M&+0LS*
M"1@\$CIVSC//8B@"W1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`5%;RF:WCE*["ZAL9SC\:EI%4*,*``.
MP%`"T444`%%%%`!1110`4444`5-.8&.8`'B>0'./[QJW573UVQ2GC#3R$<?[
M1ZU:H`:SJF-[!<D`9.,GTIU13P+.J!OX'5QTZ@YJ6@`HHHH`****`"BBB@`H
MHHH`****`$)P"<9]A7@MPK13RQ-&T15RIC;DH<]/KQ7O=>/>--,DTW7[@N-R
M73&9')SG)R>F,<\4`8*J6Z5KQ370M5DANHUN[$,$\L@N8VW!OF'7'X\/QTK'
M(P2/2I77R60I(C$8.5.>P/I[X^H-`#6ED??ND9M[;FR<[CSR?4\G\Z;@!3SD
M\5L)8:K-!+-%#;31N"TLJ^4^W(+')_@."?3&/:L@A2`$#%N<_2@!TLAE;<W)
M`500`O`&!P.^`/\`Z]-`.WIG//`Z8_\`K4VI(D+L%P<-P,#))QP!Q0!ZO\/R
MY\+0JX8!9'"AEQ@9Y^O.?Y=JZ6L_0=/_`++T2TLL8:*,;^<_,>6_4FM"@`HH
MHH`*YWQA9:?<V]O-J.I-8B`LT1&"&?`P2O\`%C'0>I]:Z*N;\46EP=0TW48K
M9;R*V9P]N\@7)8``C/!/_P!:@"M:^$+"Z9[S[?+=17*LQQMVF1@0T@.#ZY`[
M$=35^W\+P6FF7]E;W,V;R,1F67#E0%V@8``X%<M_8VLR7%BMM#!%#"@+FVN#
MY2_O"2>6^]CZY!]N&3Z/KL=D)83=!IIR_DK./E4@[">05ZMG!Q@<]*`.@;P-
M9@(8KF2)Q:^0Y50-S#&'X^G([_S+7P>T-Y97,]]Y\D,\D\Q,6/,9PHP!G`'R
MC]:RY=-\1F^21WNGD`A=9(KG]UL4#<K#J6R?QR:T/"%EJUO-OO);P))9J2MP
MQ;$A=N@/3`'3KS0!G#PO:Q23V`UZV,GE/#'$Z+OC!82$GGD[0<DCOVP*WM7L
M%UR2RN]*U-+>[B4O'(F&+1MQT],C^=<U8Z'<Q7!M[K1I);FV>:62_+MB0;?E
M*X^\22..3^9Q1@T_4]*C%V8]0A9(H6&"VTD')0C\N,$#F@#HK[P3/</$L>JR
M"*-$!:;,CL0Q)ZG`'.1_DU2N/"_VB*VM+?5+;S4ED8RL@P[.6^56!R67:<C\
M:WO#5U<Q%=,O_M,EX(1<RRRG*@L?N#Z9Z>QKD;'1=7@GM)HK:=2[SR*'3:8Y
M`#C/3`;"?7'%`&U+X(N/M?[N\A>UW))B6,>875,?>QTSCC/?VYT=#\,OI>H_
M:3.A7[$ML1&-I+#&6_2N>LI/$W]FRW`_M`FV>-Q',6WR9WJX'`R,E3CD#`IT
MW_"266LP6MO)J5RR;%9R&\EOD7/)'(W$\F@"VO@Z\D>Z6XU"W,C0,D81,,V3
M\K28`S]<']*;+X.O%TR[66XLEN)7A9)<;53:,$9QD<]/7`X%9T-SJRVT]T)M
M0-SLABDEDA(9/F=F4<$XZ<X_#%:=])?7GP_M);M9I)C,ID#QECM#D#<!C/`'
MUH`A7P3=I?Z5(+V!HX43S.3U4[B%]1Z=*Z'PIIMQHNC"VN&MI/WA9'M_XE/(
M))QDYX^F*XB.VU.6\T@^1="Y58/+>3=E$RX.,<!?N]<'I[U8GTR*VTV[OQ:O
M;V,^H+$\:EB5MUW`G&<YW8/7J/2@#TB)]RCJ<#[Q&,GH>/PJ2O/[6WU*UN?"
MS32W!#!E,)R!&`!@'Z@]^F,>M6=8?7;S4M)>XTV2TM%NHR8XYED)?=G)*XP,
M9Y_QH`[>BO*GU%#'=-;7=Y]G:6)IHIF)DN%#D%V<?ZOJJ\>@JS'JNIQVVDVY
MN;@W4D"21#SFRV9F'('#93;U/`%`'IE%%%`!1110`4444`%%%%`!1110`445
M7OKM+&SDN9$=UC&2J`%C],T`6**SO[3FSC^RK[.<=(_7K]^E74IB,_V3?`8[
M^7_\70!H45GC4IR2/[(OA@@<F+_XOWIO]IS\?\2>_P">G^J],_WZ`-*BL[^T
MYS_S"+_GI_JN?_'_`.=!U.<?\PB_(XY'E?\`Q?O0!HT5FC5)^,Z/J`![_NN/
M_'Z/[4N.0=&U#(&<?NN?_'Z`-*BLT:I<D$_V+J'`SUA_^.4G]J7''_$EU#GW
MA_\`CE`&G16;_:ESM#?V+J&#[PY_+S*5M3N5S_Q)K\C)&08?_CE`&C16;_:=
MS_T!=0_[ZA_^.4U-7FD+A-'OR8VVMS#P?^_E`&I168-4N>`=&U#)`/6'_P".
M4?VG=D<:+?@YQRT/X_\`+3]:`-.BLS^T[HKN&B7^,=VA!_+S*#J=T1\NBW_/
MJ8>,_P#;2@#3HK,_M.[W[?[$OO7[\/3_`+^4[^T;O_H"WO\`W\@_^.4`:-%9
MAU&^!(_L2[/N)8?_`(NE74;QE)_L>['IF6'G_P`?H`TJ*SOM]Y_T"+G_`+^Q
M>O\`O_C_`)Q0;^]&<:/<GT_>Q<_^/4`:-%9_VZ\P#_9%S[@2Q9_]"H-]>@#_
M`(E%P?4"6+_XJ@#0HK/-[>@X&DSGW\V/_P"*H%]>EB/[)G`[$RQ__%4`:%%4
M!>WA'_(*G'_;6/\`^*H%Y>DD?V7*,=S+'@_K0!?HJ@MY>DC.F2KZYE3CI[_Y
MQ3&U*>)X1<6$D2RR+&&\Q6P3[`T`:5%%%`!112*-J@9)P,9/4T`+1110`444
M4`%%%%`!1110!6L<^5(#VFDQZ_>)Y_/\L59JK8@A9\CY3,^TYZ\_4]\C\.U6
MJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"L+Q7H":[IVU%07<7S0NV?Q4X[
M&MVB@#P*:&6WE:.:-HW1BK*PP01U%:,G]E7D640V$VX<`EX@F<9.3NW<_P`.
M>G0=O4]=\-:?KL8^T(8Y@<B:/`;MU]>G>O/M4\#ZSIY+PPK=Q=-T)RW7'*GG
MWXSCUXS0!0CT[RCL&HVLEO*0DC1[N%RI)&Y1Z#IUQBG1K##;FRNM34(DS,T,
M2DC=MP3NQCVXSGGV-0#0M7[:7?+];=^3^57+3PAK=XR[+*2)"Q4-/\@4#GH>
M?TH`Q[CR6N3]G1UCP."=Q!P-WU&<_A79>"/"DDURFHZC"Z11X>%&&-YX(;Z?
M_6K7\.>!8;!UN=49;JX7!2,9V1GU_P!H_I78T`%%%%`!1110`5RWBB*.[\0:
M):7:[K23SV9>Y(3C_/O74UR'C349-,O[&4")BT4OV?>F3'*,8;/H0V,=/7V`
M.<;0X(/"D-VUMB\U*Y$<:[F"PJ22!@G)^[GG/;K4U[I_V'Q'%9*&G2-(X=H\
MU6$?E_-)D';C);(Y'ZUH:?XUG68S7Q\RV58H-D:!6\XKEF+$@`95N^.1Z&E_
MX2R"\?4([J&Y;3)?)5=BA6BWKDD\Y/.<8S_+(`>?./AQ;/!.VU)0AD163]V)
M",G'.,8Z<UBQWMT)+*1FNT$:IM0R.9)B9R2T:_Q<<8;VY/&>C3Q1;C3Y++2+
M>2T>UBR@E56VA9`A!7=D'G///4TEOXZ$-N6O[&XWLTC(450-@;&.6ZCH?I0`
M>&;S49O%5V=0AN8FN8/-$3`A(QG"\$^@ZD`YSP._/VU[)<2RK=:E=M&8Y9Y&
MM;B1?);KL8$8P>0"!_%7HVGZC%J#3F&.4)$P42.N!)D9ROJ,$5F7'BS3(-2E
MT^2*X+HYC=EC#+TR>ASCKV[&@#DK\76A:9;P?;IXF6R6>,),55I3*N0.S87M
MSZXYS6IX9U&\NO%]TDEQ</$%E!21BP!!4?=_Y9\Y_E6@/%VB74,8-K/+*)%$
M5MY`:3D`AE&2,?CGBG/XRTN`O*]E>QD("SM;A>HR%))ZGG'8X.#0!T]%<N_C
M.#^T;:&.UF$,B.\A9#YBE=V5V@=1M!.3T-3IXQTQPA2.[8O(T:J("6+*`6&.
MO&X4`=#16&WBO2UM([G?*R2(K*%C).68J%^N5;C_`&35&\\:6\-[:+"@>TFA
M,TDK9!0`D$8QU^4C'J1SB@#JJ*YU/&.FR:C;6Z,WDSPM+YS*5`P3QTY^ZWY8
MI?\`A,-.>]LH8F)CN'=))9`4$149P0>^2/SH`Z&D!!`(.0>A%9$.O6]QI5]J
M-LPF2VC9S'RC`JN<'(XSV.*S[3QA:36UD;>,RAVCBG);!A)4DY^7YL;3T`S@
MT`=12$`XR.G2JFG:K8ZHCO8W"S*A`8J#P3]:N4`%%%%`!1110`4444`%%%%`
M!1110`5F>)/^0#=\@?*.2,CJ*TZR_$G_`"`;OI]T=1D=10!DW45S/X@U"WC-
MY)%_H_\`J[R1/)#E@S``X/KCIQTI@U![<O<E'Q:75UO03.P<+&3_`!$XR1TZ
M#M74);PQS23)#&LLF-[JH#-CID]ZC6PLU8LMI`&+,V1&,Y;ACTZGOZT`8T6J
M:E-,EE(MJLTY!20'CR]C'=A7)ZC`(//)XQBB2YD@\&V-P1YC!;8MN=LG+)W!
MR>3]#6J-)TX0>0+*`1;M^T1C`/K^1(^G%2M96C6JVK6T+6ZX"Q,@*C'3CI0!
MF)JUV-<%G*D'DM<O`-N=W$0E!ZXZ'!&/_KU/$$]Z%UE#,/LT-G'+&B91U)9L
MG<#G^`_IQUSNK86:R^:MI`)-YDWB,9W'JV?7WI9[&TN7+W%K#*Q4*3(@;(!)
M`Y]R:`,)]<U*0M!;00-<0M<!PPP)!&R@;1N&,ANISC!ZUIWMY=A(5L_LXEDA
M>7,I+*=H'`QCJ6'/H.E32:3ITN?,L+5MSESF)>6/4].I[^M2W%G;72*MQ;Q2
MJN=H=`=N1@X].*`.(O;^]U%-2O?.,7E16KP(C,-JRCE>&'/S<GO@8Z"M:POI
MX))=/MO)CE:]>%'G:210%C5NA;.><!00`/7!SNMI>GL6+6-L2^`Q,*\XZ9XH
M?2["2-XWLK<J[;V'ECYF]3[^]`&9I^LW=UJ"Q/%;"%6$4K)(#M?RP_!)Y&21
M@`]"<T7.LW<=Y*8XHOLL%TEK(K`^82X7#CGD9<<8Y'0UK)8VD=PLZ6T*RH@C
M5U0`A1T`]J5K.U>X^T-;Q--Q^\*`L,=.?QH`H^'(F728II#F:<;Y#N8@MZX)
M/7VJE<6ZW%Q,K0><B:HC<+O&/*0DD<UO0016T*PV\211+]U$4*H^@%9,]Q=6
MD&M3V=M]IN%N%\N(+][]U$.W)[GUXH`S86U:R$B6T=RMNTDKVL9B+]-H5&SD
MJI._T[8('!2YOM9%K(\1U`R[9!L-H/ED"Y`!"G<N1P>X.,D](W\5WVG_`-HQ
MZG;VSW%I$CK]F8[<L0-K9)Y!/Z&G-XJU"RM-3BO[6`ZA:",QA,A'\PC&<^F>
M>>>GO0!9DN-:6Y>17N'59<K"+=5#+YBJ!D\_=9B>>-H.<9%5TO=?FM6<&Z1_
M(FD*_9`I$BJA5!D<@DMVR>0"<9#)_$^KZ=;7T-]9V[7ML8B&B)\O8_\`$W.1
MC&,^I''JO_"57EKINJR31V]Q+9O''!+#N\N5G[=_NC!///MUH`O7-F]UX?M[
M>Y^U2S?:D/F%3YB_ON6R`,87=SV%5&_M>T&H3):NMTZNI>&('S654V..O7YN
M".,D<\8DBU[6!::I!)I\4VJ63(!'!DHP<9!ZYZ`G\NE4KGQ9JVGM=VMW%82W
M4<D:))"6\M2^?O9.>,>U`&A)-KGFLZ27(4O-L3R%(XF4(#\N<%"?3IG/6JT3
MZS96"V\`N1`L2*K?90SQ.`3M4#&5X49.>I!(/1T&LZY>"]TZW%D=4M)%)<$^
M6\9!Y'N#C\_8T6-]XIU#3[J:%=/$BS>5$=K;6"E@S`D^N`,^AH`W='%[Y,[7
M\TDC^?($#HJX0,0N,#N`#S6A7#Q^(]<&FS3N;%S+=)9P2*"$5CG<YS_#V^OZ
MV3XIO+:ROH;C['+J-O<1P1LC8A<OR,DGC`#9^E`'7T5C>'-1O+ZVE^W-:2,D
MFQ)K64,LHQUP"<'ZX^E9NN^(KVVU>2STZ2Q4VZ(76Z<(96;G:I)`^[SR>]`'
M5T5Q^I^(-6>]O5TR.W$6F0I-.'^;>2,LH8'&`,^^5-=5:3K=6D-PG"S1JXYS
MP1F@":BBB@`K-UK&RR!Q_P`?D77ZUI5F:V<)9<$G[9%T&>]`&G1110`4R*-(
M8ECB0(BC"J!@`4^B@`HHHH`****`"BBB@`HHHH`J6#@QR@LN?/D&`>GS'CZ]
MZMU5T\DQ2@C`$TF/<;S_`%S5J@""Z:1?*\I@N9%#94G*]P,5/110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!5*_TJSU&
M>UFNHR[VK^9$=Q&#D'IT/0=:NT4`8DOA32989(O*D023"<E)6!#C.,<\?>/Y
MU!'X*T:.5'6*3"E28R^4;;C[PZ'..:Z*B@#G[;P=I5M+-(HG8RJ4PTF0@+;O
ME].?Z^M1R>"=)E`#-<G&[_EKG[W7J/7)_&NDHH`I6&F0:?+</`TI\]E)5VR%
MP,`"LJ]\':??:P=1GEN"68,T6X;6(QQTSCCIGOVKHJ*`.2@\`V-O`WEWERMS
MG*3J0-F"<<#V.#ZX[5;_`.$-TW[!<6F^Y*SB/<S2;CE,X/3ODY_3%=%10!RK
M^"+<^5LOID^1TG(5?W@;KCLO/..?2G:9X-CTJXMKJWO999K<R.(Y`!&S,A7@
M`?+_``^O2NHHH`Y"Q\'SQV,JR7*6UW]K%S"UO\Z(5W;1@@<?,>.G`]ZED\%H
M4A6/4)04CD61W0.969LY.>WKZ^M=510!R(\$M%!#%;:H\12-T=A",MN(/']W
MD=N<<5&G@5O+"OJ6=QD,A$(R=X4''/'W?U-=B3TXS_2EH`Y6R\)3V=E=01Z@
M@:[4QS$0\,GELJ\$DY!;.<\U'_PA]X(U(U5#/')"R,;?"J(E95P,]?F)KKJ*
M`,CP[I$^CV\T4]TMSYDGF;@A!+'[Q8DDDGBM>BB@`HHHH`****`"BBB@`HHH
MH`****`"LWQ%SH=T.1E0,CJ.1R/>M*L[Q`,Z'=@+N.SIC.>:`(O[#."#JVID
M%=O^O`[8SP.O>H_^$:MV55FOM3F`!&'O'Y_*MJJ<D5X^J12"9$LHT.8U'S2.
M<CG_`&0,'CG-`%!O"]FW+7>HELYW&[?.>??WI3X;@"A8]0U2,#LEZ_KGU_"J
M>I>,;:VOI;&VC5[B(D.TTJQ1@CJ,DY)Y]/Y4D9U75[-[O^V([>SY;;8PEG(`
MY`=N>W4#G-`%NXTJ&VA4RZ[J%N%'WY+H=!U^\,5@_:[N6=1HNJZOJ)!^\L">
M6HR1@LX`)]^G!_!EG-I$5G_:#:9=7%S+.T,7V]]S,%&YG8MD*H!.2`<8KI?#
M^H7^IVZW5Q91VMLZ`Q_,2SD_Q`=E/;/-`%G1X]2CL\:M-%+<$Y_=+@*,=#ZG
M\!4U]?VNGP^==S+$GJ3R?H.I/L.:S)]=EN;Z6PT:V^TSPMLFFD.V*$^A[D\'
M@5QNLWDS7D^[47DE@?RI[QDVK&QR#%"N/E/!^;C..H&<@&]<^)[Z_EG@L8TT
MV"$_O+ZZP0HQG`7IO_V3D]<@5U5I<PWELEQ;2B6)Q\KCOVKR/SK,Q01BWN;P
MHH\N/##*\Y!;/`YZ(!U^\>IZ.'QZNFVJ6LVGL\T1*,%Q$HP>R\D<8H`[^BN<
MMO&FFS6<4K+.)W3<8(X6<CV!P`>_/3@U:LO$MG?726\,%YO<X!:W8`?4]J`-
MFL.47XCUH:6$^UM<J(S)P%_<Q<^_^-;E<].Z1WEZ[O<+OOXX<QSE`NZ&/G'3
MC-`&8GAB]N=%N=-EM8+:20"1KKSS(9I@<Y(P,`Y;Z9[TMUX7U#5(M0NKHVT-
MW<B/RX5Y4;,?>;'.<'MQQSVJZMU$Y0B[N0K.@;;>JQ17#$,0,X&`".>0?:K$
M$^FNJL=6E5O+#.HNR0.`3S_P(?I0!G7_`(>U/56NKR86]O/*8L6Q<NCJF259
MAC@G!Z'I^--F\+75W;ZF=D%C]I:-X;:)RR*R]22`.3R.*TG-L8K>6WO;V99[
M@0;DN/NGH<^G3I[U'#<VI=EO+N^M+A)3"87N,Y/RG((ZC#+^>.IH`B73=<B&
MJZA$MJFH:AL5$5SB%54C.2.3TXZ=_:JUMX?ODT.XLETZPC>3#LT\K3&9AU+'
M`P>XQT/U-:D/V&Z$)CU*]W3(9$B\\AF7KC'^339IM*B9XY]8GS&VUMUP0-WS
M<9'4_*1CU'K0!5T?P]<:9'J5S#%#!//$8[>WBD)5``<9<C).>_\`D:4>G7%M
MX573K8QBY6U\H$D[=^W!/YY-0;[1]1M[6"\NY&E!8LMRV%PH8?7(8?@1[5`\
MJH;Q7>[BDM(E=S)?$*NX,1GJ.J@9P>O?%`$AT&9?",&DQK:O(BKYBR[O+8YR
MPR.1SGD?I6='X.E^PW8`M;>::6&2*!-S1)Y8(`)/)SDY/K6FLNEB<0MJMP9A
M((M@N7)#;MNT^OS<9^F:GM[.SNEE%M?WT@20*VVZ?@\=R>G.?Y4`4;+PNSIJ
M/VU_LXO)EE6*SE($>`>^!R<\\5!J7A.9Y)EM/(FCN;=(&>Z)+Q;>C`@<G&/3
MD5O?V5&,_P"DWO/_`$\O_C1_9,)VYN+T[?\`I[D&?KAJ`,"?PSJ4,MRMA<6Y
MBO;1+><R@@IM4)E<`YR,\'\ZZBS@%K9P6X.1%&J`^N!BJQTF%CEI[T^PNY!V
M]FI/[(MN\MZ>O_+[-W_X%0!H450_LBV.<RWI)&"?MLP_DU']D6WS?O;WYNO^
MFS?_`!?%`%^LK7\>19[NGVV#MG^,>U3C2;9<8DO./6]F/_LWO6?J]A#;0VLD
M9G=A>VX'FW,C@?O%&<,Q&?\`'\:`-ZBBB@`ID4BS1)+&<HZAE)&.#3Z9%&D,
M211($C10JJHP`!T`H`?1110`4444`%%%%`!1110!5L@?*D(.,S/C./[Q'8#T
M]ZM55L%VQR\'F:0\C_:-6J`"BJ6HG$MB/.\K-R/XL;OD;Y??-7:`&2F14S$B
MNV1PS;1C/)S@]!DT^F2*S*`C[#N!SC/`()'XCC\:?0`4444`%%%%`!1110`4
MA(`))P!U)I:AO.;*<=?W;?RH`KRZQIL,PADOK=9"%(4N,D$X'ZU+;:A9W<DL
M=M<QRO"VV15;)4\\'\C^5>:>$?"MMK]G)/-/+%Y4FTJH'S<9K<;X;6I!QJ$H
M]/W:^W7UX_7F@#M+>>*Y@2:"19(G&5=3D$4\G%<*/AK#@$ZFY?.2?)&/RS2?
M\*TB'35'P1S^X'^-`'=@@YP>G6EK@V^&J%LKJA&`./LX]/\`>^E(/ANR,3%J
MVT$?\^YS^>Z@#O:*X+_A7=P'!76V&,<B$_G]^D_X5W<@';K9SCO">O\`WU0!
MWU%<#_PKV[4`)K`*]=IA('_H7'_ZJ6+P%J,*_NM::-AT*;AW.>_O0!WM%<+_
M`,(3JY7GQ!+NSG.7],?WJB?P5KWD@)KA+G[RM+(%YZ\__6H`[^DR,XSSZ5P4
M_@O74W/!K3.Q'>1U/4>Y[9_(?6H3X1\4!\+JVX;CAC=2#`YP>GT_3WH`]$HK
MSP>&_&"#C59,?*=JW;\>PSUQ]?SII\.>,MG&J3`Y/!O7SC'^10!Z+17G::-X
MVMY&,5[,XZ?-=[\CVW=.OZ4Y=-\<CG[3(.O'VA3C.!W].O\`]>@#T*BO/TT_
MQPI8?:I/G;+$S(>#Z#M^%3+'X]!W>9'R#P3$<<_3\O04`=U17"G_`(3\$']V
M>>WDX_SW_.@GQ]E6"QXP,KF'W[T`=U17"-_PGX`QM.,]/(&?2I/.\>!>+:$D
M#OY0)_\`'J`.WHKA_M7CS>R_8X>.X\O!_P#'JC6^\=D;OL2].FQ!Z>^?PH`[
MRFNXC7<P8C_94L?R%<-]O\=A2WV%#@<C8G_Q7-..I^-LLLFF18QSB,,#_P"/
M>_\`GF@#MO-CP#YB<C(Y'/;^HIV1G&>?2N%;4O&+;LZ:@9P`3Y';&<9#=,G]
M3TICZMXN@5I!I4091D[;8_,`.><]L#`ZG/MP`=]17#?\))XL0XDT-,[L8\I^
M<DX[^W]:BD\7^)8G$<FBJ')(VB"0]@1W]#_^J@#OJ*\_D\:Z]!,8YM&7<"05
M$;YXSGN?3\J9_P`+#OO+#C38MHY8DMP.Q].<^M`'H=%<*?'\\B`6^F%I3(1L
M);(7KT`ZXY_`^U)!X_G><++IP"`$MM+$XZ`].!N]O_K@'=T5P7_"Q9!)*7TM
MEC"GRP7.2>,9..G6K47Q!A>[CA;3IT\QE09(R"3_`"P10!V=%%%`!1110`5G
M>(,?V%>9&1Y9!XS6C65XG('AS4"6*_N3R#C'O0!HB>$R>6)8S)DC;N&<_2I*
MXSQ!;-<WVJI;PQ2`PP&0B,M(JAGW%.@+#*GKZ=ZL2:S=2:BWV2608<".!DRK
MP;"3+TSD,,=>P!&30!TY@B,AD,2%R,%MHSCZTOF1B01;U#D9"9YQ]*XIM:OO
M[.$HU!VVRM\Z&,F3Y%^X=H5QN.=IVM_#U&*U/$2F74[%[8*UY;Q/-$AX9B"I
MV_BH<8^OID`&W=_8V4K>>05VG(EQC;WZ]J>9[:%=IEB15(3&X``]A_\`6KD;
MZ=Y9+V\DS%--ICF`.@+!"V$4CIEN3CK\Q':FZJ89/[28^5NEGLF#*IY.1D]?
M0'IGO0!VJJ%SM`&3DX'>F2012KMDB1QNW890>?7ZUQUQK.H+97,T-[*;A<`Q
M>2#Y;B3!3[N!\N>#DG:#D=^PMD:.WC1IFG(4`R-C+>_``H`D``&!P*,#\Z6B
M@!``!@<"EHHH`*QC9QWEQ?&>1XT@O4F!!7!VPQ]<CIG^5;-<AXO>6+P_K1A^
M7==1K(5X.TI&.?T'TXH`V$TVQNYFN;:\8JSQL!`R;5\L$!1@=/F]?3&*I3Z!
M:+ITEO976Z2`Y822*`N0H.XA3M^5>.._0BL**]@T'6]5?1XC-:1V2-Y<1W*9
M"5"D_@3G'O533KQ8+#Q%!;3M/=71C57:-@7+G:QY`QRYQDY]NN0#J[6PB>RM
MH+K4$61K@7,'E/'EL=ON@-SR2`/\73Z+IBRQQW%](+B1LGS)5WS$LA!((]8U
M`P!TQ6#XDL=)LX`(9$6YL/LZS?,5D5!T\K/&X\GO[U7U46=RWB:>^_X^H?+-
MN)20\:GD;0>G)'3U]Z`.O@TFRM;Z)_M,AEACRJ-(.@RH8\9P`<>G3.2,U5AT
MG2II#?P:@\GEN9/-697"?>/+8/`WMU/>LL1V^J)K=YJ\CQVL0BMF=3A@8P&=
M>_!8CCO]:PKZ+_0+N\MX8K*RNI8$:W1QN$(R=[`$X).!^=`';:7I6FV_EW5G
M>O+#`,#$RM&"%"L3CO@#(Z#'`%2RV=E=P:A<"_8V]]$(Y'1TV(H!!VG''4YS
MFN&UK9;2>(;;3@%L`]OO6('8AX!''3G-+J*V\/\`PD%G9G;IYDMQ'M8B-9,C
M.3Z=<_0>E`':PZ987JO-;WSSJTA;>CHX#%T<]B/X%X]*GL(-/T@BRBN561\%
M(Y907V]%`!YQP<5C^%$6WUS6;<I"DP,3,MJ,0`;>-HZ@\\US_B*)8;C6SY5M
M<3&='6Y,FV6$G[J!>I/ICCN>G`!Z5427$$C2+'-&[1'$@5@2A]#Z5GQ1W-Q/
MJ,+:HNYHXU6.(+OM3MY)^IY&?PKBI(#8Z7XN@MVD+(\*EBVYF&X[B3UY&<_4
MT`>B6]U;W2LUM/%,%.&,;AL'T.*+FZM[2,274\4"$X#2.%!.,XR?8'\JX_PH
M\$&OM;+;61DFLUE$UDYPB@C"N">O3)'7C.<U%XKN/[4UQ[)+>ZN(+*W<.L-N
M9?WSJ0O3IC(.<]J`.UN+NVM=GVBXBAWG"^8X7<?;/U%(][:QW:6KW,2W#C<L
M3.`S#GD#OT/Y5Y]J=S)K'A_2`Q9+J`3QNJ\,)(XR0/4$X''O4UA=#5O%>GZH
M&96FG:->P54@4D#/J7-`'H59>O@&TMN1Q>V__HU:U*R_$'%G;D]%O;<D^G[U
M:`-2BBB@`HHHH`****`"BBB@`HHHH`****`*MB=T3X8_+-("/^!M_B*M56L<
M^2_IYTF/;YS_`%S5F@"*:(RM$=[*(WW$*2-W!&#CMSG\*EHHH`CF\W8/(V;M
MRYWYQMR-W3OC./?%2444`%%%%`!1110`4444`%0WF/L4^XX7RVR<9XQ4U5[X
ME;"X8=1$Q'Y&@#DOA@A72;QR.#.!G_@(_P`:[6N,^&0QHMT/F_X^,\C'\"UV
M=`!1110`445'+-%`NZ:5(U]78`4`24444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!112*P90RG((R*`%HHHH`****`"BBB@`K
MAOB$<ZIH*\Y\UNG^\E=S7"?$!RVMZ'%D8#DX&<\LO^'\Z`.[HHHH`****`"L
MOQ,0/#FH98*/);)(R/RK4K+\38_X1O4L_P#/L_;/8T`1WNL3PZD]I;00S/$J
MLT;2E9'4]T&#G'.:MG5M/!E'VN+]U][YO?''KR0..Y`ZU1U719]1ED#2P/$[
MJR&2(E[?``.P@]\9]B>]1?V!=(S>5<VZ^5*9K=C!\^XONVN<\KR1QCKGM0!I
M?VQIN^)/ML&Z4D(-X^8@X('XU&==T\O;K'.)//E,2E.BG;NYST&,?F*K#1;F
M6\^T7=VC[[5[>18X]N-YR2I[`8&,@GKDU&N@W.^SF:Y@6>WF+L8X-H==I7/7
M)?'.3D9[8Z@%_P#MS2O),QO[<1@@%BX&,YQ^>#CUJ6WU*RN0##<Q/ND\L88<
MMC./K@9K#C\-WH5`UW;G'V<MB-N3$6;^]W)[8P.@XYOV5LD^O7E^()H@H$6)
M8]H>0$@NOK\NT`^GXT`7VU"S2[%JUU$)R<",N,YP#CZX(..N*S+?7I)=(N=5
M:U4VB(SQ&.3<6"D@Y&..F<\\'VY2709&OI'2=/LSW27FPJ=PD4#`!SC!(&>,
MXR/<6;33;BVT4V*W:^:"Q681G'+;ONEO<CK0!'!K9VJ;F.+;+,D4,EO+YB3;
MNX.!T/7Z?0&Q+K6GQPR2BY201LJL(SD\L$!QZ;CC/L?2LY?#\X,DH>TCE:>&
M;RXHF6/*$DG&[J<]O0=>34+>&[QFG<W<+-)$J<HW)68R9)STP<<?R'(!T"W=
MN]TULDR-.J[B@/('^2/S'K4]9&GZ5/:7[S23021L6<$0`2;VY8;N3MSD@<GD
M#)`K7H`*Q_M%L+K4K6Z@FE264;@MN\BD&)."5!%;%<UK#8,VX;!_:4/S-&67
M'EIDG!&1P<\]O2@"UI?]D:7"Z:?974".V6_T.?)/XKG'Z4W;I!N&F^P79DDG
M69F^R3_ZQ1@-RO;)]OQJE#J=VDT=K`VV$K$"XA.-[NRL5SG`&0P!XP!^,-G=
MWTMQ;IOE@)"AI1$<2,UL"&<D$G#9X.!Z]*`-*[CT6]O%N[G3;F2XBQM8V4V3
M@@C^'!Z#K_C1?0Z+?WL5S>:=<RSQD`,;2;C'(SA<$<^]"S2:EH;27WF6Y>9$
MC>/(:,@JI8'''S[CDCIZ"H)+K4[0!YX?WWF^3*\,!82GRW*.O4]=@/'!SVH`
MEFBT>>S>TDTZ\:"24S,OV68;G))))QGJ/IR*C@L=!LXYDATFY"S+MD'V29MP
MR..1[`U6.M:KB24$;$$IQ]F;^!T`'XACG_=XJ*'4-2L+9((=YB$DB.SV[%H&
MWN4!P#D'@'\.1G(`-6#^RK2TFL8-+N5MWRKHMI)A^,=<<\=Z2)-(BTTV4>D7
M`M6.6B-FYR?4Y&2>!SUZ5;T.>[N8)Y+U_G6>2,)Y>P*%8@>O48[FM.@#$TYM
M.TF$PV&F7D,9.YMMLY)X[D\FFW":7-J"WL^DW#W*8Q+]E<GCZ#GZUNT4`944
M]I;W-S=16%X)KC8TKB!\O@8'Y#L/Z\QQM91-=LFEW1-T<S@PDB3J.0>.G\ZV
M:*`,73UT_3=_V+2;B#S#EBEN<G\?3D\?6GVTUK:SSS0:7=QR7!WRL(#EB,]>
M?\YK7HH`Q%CTY;@RC2;@.9&E+>0?O,I5C^(_G26T&F6_V4PZ3<1_9BWE?N&^
M3</F/Z8K<HH`HC4Q_P`^=Y_WY/\`G_\`55'5[Q9[>W3[+<J?MEN=SQ[0O[Y.
M3G_/-;E9NO$#3D)&0+JWS_W^2@#2HHHH`*:A8HI<!7Q\P4Y`/L>,TZB@`HHH
MH`****`"BBB@`HHHH`KV:A8GPN,RR'GJ?F-6*K6!!BDPNW]])GCK\QYJS0!%
M+-Y<D*;2WFOLR,?+\I.3^6/QJ6D(!QD=.E+0`4444`%%%%`!1110`4444`%5
M-6S_`&1>X.#Y#X.<8^4U;JMJ0SIEV`<$POS_`,!-`'*?##']CW>/^>_3_@(K
MM*XWX8@?V'<GC=]H/Y;1_P#7KLJ`"BBB@`KS+Q7>QZWKMS&UU%#!I\3K%O8?
MO)!U`!]3Q^%>DSB0V\@AQYA4[,GC..*YG0O!=E:63)JEO#=7)D8^9DG*]OI_
M]>@"A9^*+B/P)]LMEB%Q9LD!5E8C'`!Z]<5%JNI>*'\,3:A(]G!;2*C*T(99
M=K,`,<\9R/?!J6Z\'WZIJUI8M;K8W3K)"C'E6!!QT.!RPZYX%;VH:))>^$AI
M)=!,((T#Y.W<N._7&1]:`.3U^74([/PW]KDB#ESM\AC@IF/:3GG.*VI?$.L7
MFK:C:Z19V\D>GYW-(6RS#C:,$<G#?E5:Y\-:S>VNE)=M:&2TF/W"0L<6$P`,
M<GY3^=27_A_6K'4M0N-"EA,.H@^:DC896/<'UR6Q]>G%`&/XHU&^OK?1)KRV
MET^<R2(\9++N_P!7\P'4#D\'GZUJZCXUN5UB[LK&&S1+7>&DNY=N]EZ@<CJ1
M@?TJ"Z\(ZM+I^FPO<)/+!+([EGXC#%2%!(R1\I_/O3[SPQJ,&MW]S9VEA>0W
MA+@W*!C$Q))(![Y)]CQ0`DOQ`;^S+2:*TC\^9GCDWN0L;+MYX&2#N_\`UUJZ
M!XAOK_47L[RQ4@<K<VI+Q?=!&3[C_#%91\,ZS%I5A'&MA(\,C/+`8E"OD`?,
M<8)QD9X/(^M2>&?"EWI^O&_GC2TB1?DBBDW@Y4@@D\XYS]:`-WQ+K\?A^SCG
M:$SO(^U4W;>,9)SC_.:RK?Q9J$-_;6NJ:3Y!O!_H[*_WCR`#GU.WT(STJ[XS
MT>XU;2XS9J&N;>3S$4L1N&""`<]>A_"LB'3]:\27U@^K6JVEE9[797R3*PZ\
M'GG'?\S0!FV<VO:IXLN(F>\@\N5&EABNL)$NY0<\X8;<\#G-:_Q(O;JRM;%K
M2ZFMV9V#&*0H2,#K@U8\.Z?=6?BS6I9K>1(9F+QN>5;+9X..O^>U5OB)IMW?
MKIYM;::<)YBMY2;RI.S&1_P$\T`:&I>)KBUUJ72[32VO)DC#C9+@XP"<C'&/
MKZ>O$>G>-;.\T^_N9H6MVLU#-&6R7SP,<#^+CIW&<9I(;>Y_X6)+,UO)Y`M0
M!,1\K<`?3.2>G/ZUS-CH>H7Z:[%)9SQR2+OA:6-@&99-V`3QD\C\:`.BC\<`
M-:/>:5<VUO='$<Q.[(]0`,GJ*?J'C:*VO[BVM=.N+Q;?_62Q_=!'7MT!!&?8
MUEZ?JGB*5],TJWTPVXM0(YI94RC!/ESDC`Q@]"<FF(-3\+W&JVRZ6]ZEX=T<
M\2L54$L,M@'UZ>W?.:`-F3QM:KH<&IQ6LLBO-Y,D88!HC@G\>!G_``JN?']J
MD$<\NGW4<;2;"25XX!/'?K7/W&B7MEX.M(KJ`[I[]93&JG<B%"/FXX/UZ?GC
M4^)0D6XT46ZYD#R;%`ZG*8&*`-K1O%UMJE_'9-;3V\LJ%H_,``?&2<?D:I3_
M`!!T]9Y$@MKB:)#@RJ!COSC.<<502>Z\5^(K"XALI;:*S0^:TO0DYR/3&1C'
M<9K-TN_GT/1M5T:XTJ9[B0NN]!D$E=N"<=NH]<]NX!V&K>+K#2X+*X9)9H+Q
M&='C`XP!Z_7\*K2>.]-BLXKA[>Z#2D[(PJDLH)!;.<8R"/P-<\^GW6GS>$K&
MXC_?QW!E<*"=H:1#S],<_P"2=#QC>3Q^([:"6YFLK,PAO/MTS(QRV0".1W&,
MX[G-`%P^-;--#^UVD4LNV183$S8>,MNQDX/&%XZYXSSFHH_%\CV.ERJ\,+7#
MF*5986(W#9G;M/`^;OZ_A7/:9'+=>'?$Y_>/(3%(WFCYB%D9B6]3P<_YQ-=W
M4&HQ^$TMAAHIA;R[DQ^\40@]>O:@#L-8\7:5H]T+6X>22;^-85#;/3/(_*K#
M>)-'33DU`WJ?97D\H.%8X;&<$`9!P,\UR]CJ%IX=\3:X=8C=7GD\R&01E\H2
M3@'_`($/;C':N?FMGB\(W4YA,<$]^AA#'MM?H/H1_D4`>@Z7XMTK5=0^QVLD
MGFG.PNF`^,GCOT!/.*W:X;7DC3XD:/LC"LT:%B,#/+`?H/Y>E=S0`4444`%<
M'XYP/$^B$]"0.W]\5WE<%X\/_%3:(,?Q#G_@8H`[VBBB@`HHHH`*S/$@8^'-
M2VYS]FDZ>FTYK3K/\0?\B]J?_7I+_P"@&@#%US8+V\O'0W"VRH&5)/+F@'4E
M.S!L\CCICGI3&US4(K*_E22*6:*XN"`8\@)&HXQN&!TSU.3T[CI9;&TFE666
MU@DD4Y#M&"0?7-#65J[L[6T)9B2Q,8RV1M.>/3CZ4`<[!KEXTMW)YD"K)=1P
MQ&;_`%<(,>XY(Y.3QVY(^E:<^IW$.G6#CR&FNID@:09,:DY^8="0<8'3J.?7
M1:TMG617MXF63&\%`0V.F?7&*=)!#+!Y,D4;Q8`V,H*X'3B@#FK5Y-;U>%;Y
M(BEN)@`$8!VCE`WH=W&<#UZ$9(-37+75EK-]-:IY]JL*/<6BG+-NWY=>>&^7
MIQGZUOQPQ1;?+B1-J[5VJ!@>@]J<$4.7"@,V,G')Q0!S5IK-QYL-K#+8Q)&D
M,?ESLWFN712&7'498#'^R>1V>-<OYTB2!(1,9#;R)L+'SAOWA<L!@!0<DXP?
M7BM_[/#YJR^3'YB+L5]HR%]`?2DDM;>7;YD$3[9!*NY`<..C#W]Z`./N]:GU
MC2U<M;VXC>U<J2VZ1G9<E3D84<CD'.#Z9K<TG5KB]U*6WD$1A\KS8G12I(WL
MO0DY^[UXSZ5H_P!G66(Q]CM\1#$?[I?D'MQQ4D5M!"VZ*".-L;<J@'&<X_,D
MT`2T444`%8=Y?-I=MK5^D(D:*5#M)P&'EQ\?J:W*YW5+:>^T_P`06MNOF2R2
M(J(#@D^7'ZG'XT`/T[6[BY,+SR:4(FC+NL-T7D`VYX7;V[C-4XO$,]]]DAN=
M+B\G58Y/LX,VX';GAQCC/'(]?R;I5C)!]EAG\+16V(_*DNUFBW*-A!;CGGG\
MZBTG1]6^W:2EY:QP0:0LBB3S0?/+<#`'0=.OO0!=&N7]G--!<:=;1QVEJT\B
MP3%BB@?*/NXY(QCL`3Z92V\4NTED;NR5([V%I87AFWXP"=K`@8/'7_Z]3Z/8
MW8&LSW-NB7%W,PC2;!5D"X7."?ER3Q6/H7AV[75[2ZFTN#35LPY8I*9!,[`@
M8&XX4=>O7/X`&OIWB&:>^L;:]M8HO[0@,]NT4I?C&[:P*C!QWZ46WB-[_5[J
MPL;7<L4#O%/(2JRNK!2!QTR<9]JQ=-\+7DERLCV<>D-#!(GF12^:9'==NX#/
MR@9)`S6AH^@ZGINNVQDOO/LX+0Q!A`B#&>$P"3G.&W=\8YSP`6K36=1EUF2P
MEM+8^3%YLQ@F+E.N%Y`&X\<>E5_^$INK6[2'4M.6$RVSW*K'+N:,*I;:XQUP
M/UJQH-E=Z=:ZM=SVN;NXN99EB#C++_"N>G7/YUC:?IFL.E]#?:4(IKZ.59KZ
M6Y5MN02H"C.%!VCC_P#4`:$?BR:*".XO[%88;BU>Y@*2[B=O\!XZG(.??ZU)
M;>)KA)X%U&SC@2ZM6NH627.``6*MD#G'.:S+;0=6O;..TU""*RCL[*2")Q(&
M\QW'4XZ#`&?Q]>'6>@ZIJ$ML-2M$M([*Q:TCQ,&,I9&3/&<#!_\`U]@#:T36
MY]3N-CPVOEF(2%H+D2&,G^!QU!]_8U8U74;BUN[2TM(H7FN5D8&9RJ@(`3T'
M7D?D:P-)T'4&U*WDN+&+38[>T:W=X9`3<$@C/'3L>><_I-J?AZ:WM+:*"WEU
MI$F,CK=W6UU&.`K9``SR?6@#=T35$U?34NUC,3$E7C)W;6!P1GO]:T*RO#6F
M2:3H\=O-L\YF:1PGW5+'.![#I6K0`4444`%9GB%MNEA@0N+FW.3V_?)6G67X
MB!.E8`R3<6^`/^NR4`:E%%%`!1110`4444`%%%%`!1110`4444`5K#(BD#9'
M[Z3&?3<:LU6L<^2^?^>TF/\`OLU9H`****`"BBB@`HHHH`****`"BBB@`JOJ
M'_(.N?\`KD_\C5BJNIG;I=VP!)$+G`[_`"F@#EOA@2=%NO:X]/\`9%=G7%?#
M`8TB[]Y_7_9%=K0`4444`%%%%`!1110`4444`%-5U;.U@<>AJEKS,F@:BZ$A
MEM92".QVFN);0Y+O5=4L],CW1QK:JDC7#(JCRN&P/O8.#STQ[T`>B`@YP>G6
MEK@;Z\2RT[7;![O?J,DL2HJ_?E;9&"P7W.3Q_2J,RW,5Q?ZC%YB`:B]L;[[0
MP\I=XY9<8*]/Q`H`],HKSI]0F74VE?5)9(?[0VY2Y8,HW?=\EN,>^/3WJP-0
M=[/2RNHS?:O[29),SGY8PY+;AGH%QU[<=#0!W@(/0YI:\_A\0WAU>6[9KE;.
M^22.'<-L:'!\LJ>[':<\=^^*@L+W5+N71=,N;ZZ@,ZNZR1O@O$R?*20?O`JW
M7ID4`>CT5R_A2%IK_4KB:ZN9GM;J:UB624L%CRI'7OQUJBL=_:^(+NU.LWDD
M=G;?:@LCC]YCL>^.G^30!VU%<1;3ZA9P:'J`UF6\:_D1);9BN&WG)V^FW@''
MZ9K2UO4KK3=>2<2_Z`ENHG3.=FYF`DQZ`@`^QZ&@#I:S=6T:RU9H'NP^^`YB
M=7VE22/P.<`<UP":[J[QQ,+^^.RQ$CF"(28PYY;)'&.K?S`S6IJFH:\O^D1W
MV5@MT:4V2I*B/AFRX)X&.XR,`=:`.]HKF?$M]=QZ)9ZA8ZB820I54A#&Y9@-
MHY/`QDGV^E9.H:UKEAJ:0RW@86\</VAHH%:,%VP=Y_A.",8ZX'')H`[O`SG`
MSTS2UD^'KVXNK>YAO'62YM+AX'=0!OQT/''(-:U`";0&+8&XC!..2/\`)-1F
MV@+*Q@C)5BZG8.&/)(]ZEHH`AFM;>X96G@BE9/NET#$?3-++;031"*6".2-<
M81D!`QTXJ6B@"%[6WDG6=X(FF3A9"@+#Z'\3^=3444`%%%%`!7!>.AGQ1H@R
M!EEY/^^*[VN#\:L/^$OT)>I#H2/;S!_A0!WE%%%`!1110`5!?6PO;"XM68JL
M\31EAU`8$9_6IZ*`,L:?J0(SK4F/3[/'_A2FQU/'_(8;_P`!T_S_`/KK3HH`
MS/L.I9!&L/QU'V=,']*#8ZF0`-8<8[BW3FM.B@#--CJ6<C5WQD'!MT_*C[%J
M/_07;_P'3%:5%`&;]AU'_H+O^$">F/3UYH%EJ8QG5R3W_P!'3'^?\*TJ*`,W
M[%J63_Q-VZ?\^Z<4"RU(`9U<G'K;ISQ6E10!F_8M2P/^)L>._P!G3FE^QZEG
M/]JG'I]G6M&B@#-^Q:EC_D+'_P`!TJ*/2KZ*2:1-68-,^]C]G3KM"_R`K7HH
M`SC9ZB?^8KC_`+=UI/L6I=]6_*W6M*B@#-%EJ0Q_Q-1TYQ;+R?SIOV#5`X/]
ML<>AMDYZ?_7_`#K4HH`S/L.I[R?[7.WC"_9DXH-CJ6,+JY7D_P#+LE:=%`&8
M;'4S_P`Q<@XQQ;)^?-(+'4QC.LL<')_T9.:U**`,LV&J%<?VRP.>OV9.E'V#
M4\8_ME_K]G3_``K4HH`R_L&I_P#0:?\`\!X_\*0Z?JG'_$[D_P#`:/\`PK5H
MH`R_[/U+G_B=2\]/]'CX_2C^S]3[:U+^-O'_`(5J44`99L-3XQK4G'K;QY/U
MXH_L_4^VMR?C;Q_X5J44`97]GZGS_P`3N7MC_1X^.GM]?SI)-(NKAE6ZU6::
M!9$D\KR8P&VL&`)QGJ!6M10`4444`-<$HP7J1QFF6J/':PI(<NJ*&.<\XYJ6
MB@`HHHH`****`"BBB@`HHHH`KV0Q"W_763_T-JG)P"?3TJ&SSY+9&#YLG;'\
M9J>@"I>LZW5@%=E#3D,`?O#RG.#^(!_"K=,:-79&;.4.Y>2.<$?CP33Z`"BB
MB@`HHHH`****`"BBB@`JIJO_`"";SG'[A^1V^4U;JMJ6?[,N]O7R7Q_WR:`.
M3^&&/[)O,?\`/<?^@BNUKBOAAG^R+OT\_/7_`&17:T`%%%%`!1110`4444`%
M%%%`#)HDGADAE7='(I5E]01@BHK*SBL;6."$<(JJ6.-S[5"@L>YP!S[58HH`
MK36%I<745S-;123P_P"KD902OTIYM+<P20&&,Q2EBZ%1ABQR<CW)J:B@"D-(
MTX7@NQ96XN`<B01C=GIG-#Z3I\ES)<O90--(I1W*#+`C!!_#BKM%`%:>PL[B
MU6UFM89+=,;8F0%5QTP.U-_LVR\RU?[.FZT7;`?^>8QC`_"K=%`$-O:06IF,
M$2Q^=(99-O\`$YQD_H*1;.W6[DNA$OGR($=_51T%3T4`9%GX9TFQU)K^VM%C
MF.<8^ZN>I4=!^%7Y;."9YFE3?Y\0AD4GAE&>,?\``C5BB@#-L]!TVQ=VMK8+
MOA$!4L6&S)..?7-49?!NDR)"N+A!'&(CLF(\Q1V;UZFN@HH`IW6F6MU':1R(
M0EI*DT2J<`,O3\*IWWAK3K_4OMTXE\P[=Z+(0DFWID>U;%%`%'2=/;3X)EDF
M,TDT[S.^T+RQ[#MQBKU%%`!1110`4444`%%%%`!1110`5P/C%C_PG.BKE@,Q
M?3_6G\.W\J[ZO/\`QD?^*ZT4#!(\H@=S^\/%`'H%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!12$9Q[4M`!1110`4444`5[+
M_4O_`-=9./\`@9JQ4%F,0MP1^]DZ_P"^:GH`**K70D,]GY88J)COPQ``V/U]
M1G'![X]*LT`%%%%`!1110`4444`%%%%`!5/5QG1[T>MO)_Z":N4UT61&1QE6
M&"#W%`'F'@WQ19Z%9S0744S>;*&W(!A1@`]\]C73#X@:/N<,ET`I&#Y?4>O7
MI70C3K$($^QV^T#&#&.E5W\/Z0YD+:;;'S,;OW8YQT^E`&(/B%HYV@Q7>XC+
M`(#M/IG/-//Q!T/UN3_VR_\`K_YS6D?"VAMC.FP''L?\]J7_`(1?1,8_LV'&
M,=^E`&>OCW02H)GE4DG@Q'BG?\)WH/7[1+C.,^2V/Y5=_P"$6T,=--A_(\]Z
M3_A$]"SG^S(<_C_C0!3_`.$ZT+G,\PPVTYA;BC_A.]"X_?38(SGR6XYQ5Q?"
M>A*,#3(?QR?ZTG_")Z#@#^S8>.G7_&@"N/&^@%>;QE;G*M"X(_3%.;QKH"KN
M^VDC)'$3''7V[XJ1O!^@,,'38^F.'8?UIA\&:`S;FL`3NW']X_/ZT`30>*]"
MG0NFIP@`X^?*'\F`-.E\4:'%LW:G;G>P4;6W<^^.@]SQ5"3P)H;VJP^5*K!M
MWFB3YS[<\8Z=NWUILW@'198T4">,JN"R.`6/J>,9^F![4`:K>(M%7KJMG^$R
MF@^(M%'_`#%;/KC_`%RUB/\`#O1VQ^_O%P!T=/0#^[[?K33\.-((&+F]&/\`
M;3_XF@#>7Q#HS'`U6SZ9YG4?S/M4@UG2RH8:E9E3P#YZX_G7/CX=Z4#G[7?Y
MR3S(AZ]?X:;_`,*YTG/_`!\WN,8/S)_\30!T0UG2R,C4K,_]MU],^M!UG2U&
M6U*S`]3.OKCU]0:YX_#K22,&ZO=O&!N3K_WS41^&^F]/MEUCM]W/YX],?KZT
M`=.=8TP'!U&S[?\`+=?\:>NI6##*WML1G&1*O7\ZY<?#NQ!8+?W81N2ORX/3
MMC'4?R]*9_PK;3]J;;ZYW`@L2%((]AC_`!H`ZP:A9$`B[M\-T/F+S^ON*5;Z
MS8$K=P$+U(D'%<8_PW3+-%J3;M[$"2$."N1M!Y'/7)[YZ#O'_P`*XE`P-7&#
M\I!M^,?3=U_K0!WJ2)(NZ-U=?53D4ZN#3X?WB`*NM%5[A8B!G/'&[Z=,4O\`
MPAFN@<>(9=W_`%T?_&@#NZ*X3_A#-=Y_XGK?]_)/\:/^$,UPDDZ\^#V\R3'\
MZ`.Z!!`(.0>A%(\B1C,CJ@SC+''-<.O@[7E/&OR#IG;+(#Q^-`\*^*-A!U]R
MQ'7[5+P<_P"%`':B9?*WMQQG`YS]/7_ZXI8Y1(,@'W/;/U[_`(5Q!\)^)'*E
M]:;*Y&?M4IR,Y]/Y>@I?^$5\3X)_MY@W0$7,W(QW_&@#NJ*X.3PYXO4#9K>[
M`P,7$G/3KD4R70/&(#NNINW(78MVW/N,@<?B#0!W]%>?OH_C9[<,;]]^"NP7
M.#UW9X&/;KGMTXJRP\=A`$\L\`=8L@_CUH`[>BN&V>.1*\@&3@X!>+'4#@=.
M@!Z=SR,\KN\>8!V(21TQ",'WYH`[BN`\7,&\?:*@8Y4P],<9E-3,WC[?Q'&1
MG/!A`Z=.?\\55&C>*=0UK3[W5;=&\AXP2'CX4."3@'&>O04`>AT444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`06>/*8@+_`*V3H/\`;-3U6L`1%)DY'G28_P"^C5F@"*52TD)`8A7R</@#
MY2.1W'/3UP>U2TUM^Y-I4#/S9'48/3\<4Z@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHJ,29G,6Q^%#;\?*<D\9]>/U%`$E%%%`!1110`4
M444`%%%%`!1110`4444`5K'`250<D3/GKW8GN/?MQ5FJUDNV.3DG,SGDC^\:
MLT`-:1%959@&<X4>O&:=4$P/VJWP2!EL@1[L\?WOX?ZU/0`4444`%%%%`!11
M10`4444`%%%%`#695^\P'0<GUX%"NK[MK!MIP<'H?2N=\1Z3J.H716S2`PSP
MI%(TCD;-K[LX')_.L"+PMK%O!J0-O!+D@1*'Y<^:KY&>VW<#N)/;Z@'H0SWI
M:X75-"U"30-&B@LI));:*1)(C*A*EDQG)XZ],=/K@TRTM?$5C:7&EII8:6\V
MA[OSMRJ-H4DYYZ*>XY/`Z"@#O:*\VFTC7HTM]/EL9+RVM-\43K*4&6Y5_P`,
M]\\<<5LZ;IM_#XF%Q=VDDEM(]P(2&Q]GS(QR1G'(/\O2@#L**\Y73M?CLK`"
M"]0_NXI4CF8,09)&+$@\<'!STR.E6]"L=8@EO3=0W(NY-.'V>8$A$.P*%(/&
M_P"5?R-`'=T5YQ80:^DR1V$6HV\+/!(QN2Q^?!WY'&5)'/T'J*N:+>W=X);+
M4O[1C>^C1(7P6"N"Y<@DX&..#R,8H`[NBN:T==:MM)OKF99+K4`XCCAE<JA"
M`+N7/][EB>YK.\3W6I)K$$=O)>I,]K&\5M`6VR2"0[P2..%/)^GM0!VU%<1X
M:O=7GUV*.XDNW8>;]NCE4B.+)RFWZX_+/X9<&N:Z;1$DEN&*VWFF2+EA'Y@5
MF((Y8<\\X!YZ$T`>ET5YZAUB^CMI%U2^BADOOL]M*5QYD9#L)",`GC'MC]+7
MBG4]9T^>\CM+AS%%!`=_&5)8C.,').#QQ^(H`[BBO,+7Q%JY&G_:+Z597:,Q
MQA<^>F^0$GWRH7'&<CK4[^+-7A:R\^YC5/)1RRJ")AYNTL?[O"D8'N>XH`](
MHK@]:\4S-K4]G8ZK#%:;%(GC57(8#.U22%.?<^WM4<?C35)XI##'$RK)"AG\
MK`3=G)*$Y.>V#V)XSB@#T"BLCP_=WM\MU+=S0LJ3O"B11%<;&(+9W'KZ=JUZ
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HI",T
MM`!1110`45G2:YIL4=U(]SA;1Q'-A&.UB0,8`YY(Z9JK+XMT6*-'>\VB1"Z;
MHG&0"5/\.1R".10!MT5B3>+-%AA\R2]\O,CQ#=$Y(9<9!&,]Q^=3KXBTIK%[
MW[6!`DODEF1E._CY=I&2>?3U]#0!J45DKXET=KF.W%ZGFR;=H*L`=WW><8I[
M^(-)CMY9WOHA%%+Y+MSP_I[]^GH:`-.BLI/$FCR7$$"7\;2SA3&H!R=W0=."
M<C@T^77])AD,<M_`CB0QE2W.X'!&/K0!I452NM6L+.[CM+FZCBGEQL1CRV3@
M?J*C77M*:UEN5OX##$P5W#<`GI0!HT55EU&SAM!=RW,:0,NX2%N"/:GM>VJ;
M=US"NX;ES(!D>HH`GHJO]NM""?M4&%&2?,'`]:5+RVD6,I<1,)%#)AQ\P/0B
M@">BF&6,'!D0'.,$CKC/\N:C2]M70.ES"RD$AA(",#K0!/13/-C!4&1<ORO/
MWOI^8H\V/`.]<'&#G@\X_G0`^BF&6,=74?,%Y/<]!]>13Z`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`KV7^I?_KK)_P"A
MFK%5[(DPOD8Q+(/K\YJQ0`UD5G5R/F7.#Z9IU%%`!1110`4444`%%%%`&3)>
M:V'<)I-NRJV`3>8+CU'R<4P7VNYYT6#&>UZ/_B*V&R%.T`MC@$X!-8'AS4KJ
M1[R#5YX1<B[,:*IX^X&*KGJ!S[T`3F^US(_XDD73D"]&/_0:#?ZV"Q&AH0.@
M^VKSR?\`9]*T[N=;6SGN&("Q1LY)Z``9KA=.\;7T8BCU`1LT,32SE@$:4'&S
M:<XZ,#P.GXF@#?FO?$3@M#H_EN5V[6NHV0'/4=SQQVIT>J>(/+)D\.@L",!;
MU.1_]:LT^-9U@67^SE=5_P!:T<V1C*J"N0,Y+'UZ4T_$"*.)#-IT@EWLLB(X
M.P`@9SC!.21CV]Z`-O\`M+5B2&\/R%1Z7,1R?SI6U/4P,C0KCM@>=%^OS57U
MCQ5;Z5>/;M;2S>7"LTK*0`BE@HR#SU(_/\I-"U6[U2^U+S(ECM+>8Q0GRS\^
M#C.[//3ICC(YH`C;Q!>I&7;P_J)`/\(4GKZ`Y[U&WB:Z27:WA[5<#^[$&'KV
M_P`:Z.B@#G?^$HG"$GP]J^<9QY'_`->AO%$RYSX?UC\+?/\`(UT5%`'-'Q=R
M"-"UDC&3_HWTYZ^G\Z&\8QQ1R27&BZO"D8RS-;<*/<YXKI:QO%[;/"VH'_IE
MCMW(%`%<^+;?S@@TO5BIR1(+0[2,9R.<XP1VJQ_PD^G`$LMXJYP";23!''S#
MY>G/UJGHNIVNGVP@NYFC\R6&&%64GGR(?E&!QR>GUJ]/XGTBWF:&>Z9'5W0@
MQ/C*_>Y`QQ0`P^*=+!Y:YQC(/V67GG_=J$>,=$!"^=,&.#M^SOGD\=N]:5MJ
M]A=201P7`=KB,R184X90<$YQZ]J9/K.GV]G!>O.H@N'$:2!6.X\D`8&>QH`H
M?\)KX?\`^?\`X]?*?W]O;]13CXR\/CDZ@O(Z^4_/7_9]C5H^(-(2SDNVO8EA
M60QL3D$N.H`QDGIT%/&L:3)Y2?;;8B==\8+C#C)Z?B#^-`%(^+_#X`4WZ```
MC]VV/PX]J3_A,/#I3_C_`(]H'0Q/Z>F/2MMUA0-)(L:@*=S,!PO4Y/I6>MSH
MDEM]J5[(PMMR^%_B/&?3)]?2@"`^+=`W;#J,1/7HV.W?'^?PIA\0>&I26:\L
MV+LK$LO4C[I.1U''TK1_XECNJ?Z(SR`%5^4E@>1CUSUITVG6TJ%1$D98@ED1
M03@@D=.AQ@^QH`J6_B#0S#N@U"T5"Q)&X+R<L21[\G/K[U8BUG2YD5X]0M2&
M&X?O5!QSSC/L?RIKZ1;O:1P-R4VYE9$+.`<D'C'/?CN:KR>';=X(HQ-(CH26
ME$46^3TW?)CCMQVH`N#5=.(R+^UQT_UR_P"-2"^M#C%U`<C(Q(.G7-5H=$L8
M8W46\+E@,,\*9&`!V4=QGZD_2JX\.6HBD7*EWBV;V@C)#\_O/N_>Y'M@"@#3
M^U6X./M$6?3>/\]Q2FY@49,T8'NPK"O_``?IUU&RP)':Y;(,<"'`Q@CD?C[4
MA\%Z6'+(BIR^/W:-C/3J"./>@#?$T13>)4*YQG<,9]*#-$#@R)G(7&X=3T%<
MP_@2P:(*9/FV[2XB09/S<\#C[P'']WUYJ=_!.CF`JELJS%L^9R>"<D!<XZ<#
MTH`Z`S1CYFD0(1P=W7UIZL&&5((]C7.6W@G1XI9&FMTF4DF->5V#)..O/4#G
MTJ-?!&F>3#^YB28.K2$!F4J.J@$\?4Y-`'3@@@$'(/0BEKEK3P/I\-I!%(7W
M;@USLD=5FQNPN-W`!((/7Y?<FK?_``B]LA(M[F[A18?+B"W,O[MO4?-TX7CV
M'2@#>HK#F\,6\LK,NH:I&K*1L6\<C)[\Y.>G?'`K/'AK554LNL7A;(^0WCG<
MNW^]MX.[/8@CM0!UE%<N?#6I"S0C7M0-SA2Z^?\`+G(W`'&?7''I0?#6I><V
MW6]0$88;2UV22.^1M'J>_/MTH`ZBBN7D\,:@KJ(M>U)T)`<O=$';ST^4\CCZ
M\].M0Q>&]:(02ZS=J<_,5O6;L,D?(.^[CZ<C%`'745R4GAG6%\\0Z_>LJX-O
MNN#D\#(;CUSC\/P1?#>MYBSKMV-C$,?/)&W(P>G)P6Z]P*`.NI"<`G&?85RC
M:+XC:U;_`(G4HE3.Q<C#_)GDX_O\?05970-6:)=_B.[5\<@(I`./7OSWH`Z.
MBN;.E^(%*QC5_,C9BKLP7*KEN1E#DXV\<=QGO5Q=,U901_;TI],VT?IWXY]:
M`-BF2JSQ.J/L9E(#`?=/K6,MAKRRK$-84PB(9E-NI;<#Z?3O22Z?KXQY>N*V
M6P<V:?*/7KS_`)_$`RF\!*L#+;ZK/%+*FV=S&")#N#9QD$<CIG^N98O!)@5O
ML^JRQ-/&8KK$0(E5B2V`3\O7`QT_$U;L[;Q'.9#+J8MXUD^3?:H6=<=P#QSG
MZ]>.E$]AXE0`0ZTDA".Q)M47+#&U<>_/.>,"@"&?P9`S7OV>=8H[E8U6,Q;E
M3:5+=QG<4&>GXTX^$W?11827^YUN$G$GDD@E5"X8%B3G!)Y')].*+./Q#=;6
M;4);7))VS649P!C'1_<CUX/2IT@U\.Q.IA@90@4V2X`[M]\?+WZYH`KV?A".
MVDDG>Z:YN`B?9Y)=W[EU4C=C=R.F`>@`Y[U7MO!)L98)K*_`DB$;'SH0ZLZA
M@>,C@ANG4>O3&@D&O-<F(ZHJ@`_.;`;#C:>#OSSNQT_A/XI<Q:_;O$JZEYPD
M8*6BL%(3)`RV9!QSVST-`%'3_!KV.I17?VBWF*M&6W1NI!7J5P^,GW!Y_*HK
M[P1-=W5Q*M[!&L\DCG]P=V&<-R0PW8P.#Q_36G@UZV@,QU2.8KC,<5@"3SV^
M<5"DNO*NTW&YG(7+:?C9E00<B3'&<'K@YZXH`?K/AA-7O6NI;ET<6PAC*<8?
MY_F([CYNE9H\%3/+#))<VT9C6*-OL\/EEU5MQ.0>&X'/M]*T9)]=2&W?S4;S
M\9`L&+1#(^\/,X///T-6(SKDL[)]IMD"C)9K)@I^;&`?-Y^Z3]"/48`*1\,S
M+9:1$DMLS:>7#1O%F*4-QDK_`'O?U)-48_`S;[AYKB*1C;O'``N%5V#=5.=J
M@MQMQTK;E;6XI88_M%I(9-V"MHV`0,_,?,X_^M^1;W]_</9CRS`)"1*)K1@>
M,DX^?Y>!P3G^E`&%+X$:,68L[A1Y",7\TYWOD'!PO*\$?XTP>$-0AUB*_BBT
M[*E7,<9*(&!Y&"I..>N1TZ=JZ>>^N%FE:**3R+<#>OV5V>0[L?(<C/`/8]0?
MK?25'DDC5LM&0&&.F1F@#E-:\+7=_J5R\+VHMIV\[#ALAQ'LP<$<'KGZ\'OD
M'P-J+>666V^574@2!6QL"C+;,'I_=SUYYR/0)Y2BLL2AY]C-'&6V[\8[]N2.
M?>I:`.2U[PU=7]R98H;9WDBCB21I64VNW)++@8/..F/IUK-?P9J<122*2.4C
M),32G@^:&X)'=0.O?-=(NLW=Q*T-E9V\T\3!)HVN=I0[?F_AY`)QD=<'I44N
MMZI%N#Z7:AD*AE^WC*DC.#\G7'_UJ`(;?P^\VMV^IW4`A#CSI[=9RZB=3A&Z
M<\$_0_KTU8,&KZS<PB:#18)(F&4=;\$/]/EIDWB&\MI-EQI]M&2VQ<WZ#+_W
M>1UP1^=`'0T5SR>(+YVVKI<#/D#:M_&2203Z>BM_WR<5%%XHN9Y(DAT^UD:7
M[JC48\MST'KWZ>E`'345AR:MK4<;R/H`54!))O$Z#Z#_`#[UJV-R+VPM[I5*
MK/$L@4]0&`./UH`GHHHH`****`"BBB@`HHHH`;(VR-FP6V@G`&2:=110`444
M4`%%%%`!1110`4444`5K%0L4A!R6FD)Y/]XC^E6:K6+%HI`<Y6:0<_[Q(_0B
MK-`#2Q#@;20<Y;C`IU(3C'O2T`%%%%`!1110`4444`%0FUMRX<P1%U?>&*#(
M;&,_7'&:FHH`JZG'!+IEREWN\CRV,A4X(`&3BO/@J>6ESJ%C?1V4\:F%;>[9
MV89_=(5S[Y'U_"O0[^"2YL9X(91$\B%0Y7=MS[5RC^!I%7RH-041$+EGA!DR
M#D`,.0,@<"@#*2X\+I;1D2ZNBJ`6V2']T0QQG'0YR1QWSUS2-;^';EK1(-0U
M.':Q*QM\_P!F.[!+`_=!)_7FM(^"+LP&$7MHB,5W;+<@MAB1EMV3U/?TYX%(
MW@N_S$T=Q9QE?O[`X\SD$;SGYOF&<GU]A@`S'BTJ\N4FN=<U)727RUFFARI;
MU5N>,KP"<Y_.M/0-;M-#2>UF:\:V69MDDHW$8<*3@#/4^_1N_%.E\'WTKV,C
MO8&2RC5$XDP^#GYN>>=QXQG<:DB\)ZA$KA+BV5]ZF.3+EHP&+X!.>K,30!O1
M^(M)D$16]3$V/+R"-WS%?3U!'X5?MKF&[@6>W<21-G:P[X.*XY?!=U'YABDM
ME+R1R$EW)^4>O7))+9]<?2NJTJ*[@TZ&&^D22>-0I=6+;L<`DGDGU]Z`+E%%
M%`!6)XS_`.14U#I]P=?]X>_^?>MNL7QAC_A%M0SC_5]_J*`*]I8+J?AR2`^0
MDDB1M$R<M$XACVEO]H'_`,=Q4EKH<UI=:28VB:&TBE6<NQ+NS@$L..<L._K4
M_AV,16TZK&40-'MR."!!$,CVXQWZ5KT`<M;^&;RTL;ZU@NDQ+B*W<L=T,.XD
M@'&<_-^./RK2>$]1$$FEQ7<?]FFY6=)&8B5`.JX`Q[C&.GO7944`<K;Z-JMD
MVGW#I;7;6"21K%&VS<#C##(P'ZYZ9]:IR^$[QH5!$'F3L[RJI/EH3(KA,8^Y
M\F/8GI7;44`9-R;^XTG4('TY%?RVBA19E(E!7'?&!SCGTKG'\-:C(MQ=00"W
MED"1M;O(NV6(1!6&!E<Y&17<T4`<E!I5U9M(LNAP7TD=PUS'=><J%OX@!P6W
M#ICIQUKJHF9XD:1/+<J"R$YVGTS3Z*`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`$P/SHP/SI:*`"BBB@!,#.>]-$:+C:BC'3`I]%
M`&3J$*?:[F<'Y_L+H1@],Y';'KWJ;P__`,B]IG_7I%_Z`*K:K>21/J:%U:&'
M3_-\H#YL_/DYQT(7'7MTJWH:&/0M/C;[RVT8/U"B@"]1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`%6P.89.O$TG7_?/2K55-/_`-7-\N!Y
M\F#C[WS'G^GX5;H`**:7`D5.<D$]..,?XTZ@`HHHH`****`"BBB@#G38^*2[
ML-8M`&(VI]GX49SU_3_Z]2,OBQ>$?1GXSEEE'.>G'8?TK>I`0>AS0!SQC\7M
M+&QFTA`,AD428/'!Y&>/J*EB/BK"^:NCY)R=IEX'''UZUNT4`87G>)]N?L>F
M9ZX\Y\CCITZ]J0S^*`2!8Z:<-U$S8(_+\*WJ*`,'[3XG5-QT[3W()^19V!(S
M[C'3_/:FB]\3`DG2+1@`<`7."2!].]=!10!S7]K>)@"3X<3.1@"[7WS[=A_D
MU.NJZ\)5$GA]MG?9<H2,GCJ?3K_]?C>HH`P1K.KJ8C+X=N`K`[]D\;%3GC'/
M/OG%*-?O=R!O#^H!23D_*<`#@]?4_P#ZZW:*`,;^W+C>^=#U+RU7*L$3+'G(
MQN],8]>?3G(\6:K)=>&;V(Z5?PA@N7FC3:OS+UPU=A6)XS&?"FH=?N#H/]H4
M`8>G^(!9N)1::QY+[7DC%F",B,)][.<?*#5G2_$SPR2K?_VG<EF58E.G^61Z
M_=)SG(]*U=$DO9[+/GP>6JO'&OEG<"#M4DYP1\IZ=<]>*T2;O)4"$?NN'.?]
M9]/[OXT`8@\::=M)-M?C'7-N>/\`/6B+Q9;-=?.LJ6Q.`3;2;QQW`![ULV3W
MC1G[;'$C@#_5L2">]3R;TA;REW.%.T,>I[9-`&/-XHTY618I\G>`^^*0`+G!
M.=N,_6JD'BN,73+=R6L<`9OF7S=^W.%."F.I`/-:0N=7(N,V$2E'418F!$BY
M.2>F.,$?7\*26[U<06[QZ5$9F$GFH;D83'W0#CG=Q]*`,^?Q=:+-BWGM63S`
MN9&=#@@<_</?C\12#QA9>1G[3:>;Y*MC<^W>3@C.WI[UK7%QJ"NP33DF0(K#
M]\`=V&)'([$*!_O>QQ1DNM6$0V^&XW+)ED^U1@!MYXSCGC#?CZT`,E\6Z<P<
MVEY:2`!-HDE\LG+8;J.R\T\>)[(L0;VP`\_:#]H',>/O?7/:A4G=4\SPU;@L
MS;AYL9V@`8/3N21[8]Z2Z$\,I6'PS#/'L#%Q)&.<$E<8SG.!^.:`"+Q?I3W/
ME/<11HS%4D,JD$`D9//`R..^"#Q3HO%6F>6?M%U;)('52$G1@<MMR#GH,Y/H
M,]<5<M['3KB(M_9D"!79</`H.0V"?H2/QXJM?16$%VD7]B).[[2KK`I'+8;G
M'51S[YH`BL_%^EW31AI!`'C$A>66,*F20%/S9W<=,<=\5)+XKTJ-RD<PN'$H
MB58'5RY*A@0,\CG&?4&JLEQH<)4RZ*BPO'&\;K9AB=^[@@+QC8/TJ(7>BK(Z
MR^'PL*@E9!8[MPQE>-N1G#?3:<XH`V(]:@<1[H+B(N"0KQX(`SR1GC.WCZCU
MH;6K=;>";R;@^<.$$?S)_O#^'\:S+IO#$+%9M-BR)C%\M@Q^<$9Z+SR1]?>I
M);/0(7MV?1X!%<+O67[.NT'!8*1U'`)Z8XH`UAJ$3"4JDK>7$)#M0DMD$[5]
M6^7I[BII)UC2-BDC"1E4;8R2,]R.P]<]*P+G3O#$*?O-/A`=$8%(B#M=MH((
MYSEOKT]!B6+P]X>U*VBFBL(Q$FY%*!HR<'!)Q@G[O4_UH`WF!(X.#ZU2M=4@
MNKDPQB0^C>4V`0SJ0>..8VZX[5E3>#?#[2@-;['<*$43,/NCL,\\=>M1)X.\
M.RR/#&KLT>"R+.?ESE>1G_9/Y&@#HTG1[9;CY@C)O^92"!C/(ZY]J6WGBN;>
M.>!P\4BAD8=P:P$\':*%#KYY4`\_:&P?4]:C?PCHTS.4NKD8&2%NB=O'7G/K
MF@#HOM,&TMY\>`_EYWC[^<;?KGC%+YT6QW\Q2L>=Y!SMQUS7-IX.TQBRIJ%^
M7(!!%R-RC&...E7$\-QKN*:MJN6&UF^U$D_CCK0!JR7MK%`D\ES"D,F-DC2`
M*V>F#T.:07UH2H%U`2[F-0)!\S#JH]QZ5BP>%S"I4ZYJ109)42J,'@YZ<<Y/
MXC\6+X6NE@"+X@U`.'+!LC&"<GWS[Y_"@#=>]M(Y/+DNH4?>(]K2`'>1D+CU
M((XI#?V8\K-W`/-4O'^\'SJ!DD<\@#G-8!\+:CG=_P`))>;^Y*CZ9Z]<8Y^O
MK35\+:B53'B2Z*J,+B,<#CIS[4`=`NI6#!BM[;$*<$B5>#D#U]2!]2*LLP12
MS$*H&22>`*Y4^$]3YQXEN<$\YB[8_P![KQU]AZ5(?#6K%LGQ/=D#/'ECO^/-
M`'2^8GE^9O79C=NSQCUS43W<*2K%YB&1@3L#C.,9S@GI7.1^%=2B1HH_$=RL
M+9RGD@CGKW[G)_'ZY<?#.JDDGQ'(2>/FM5/&W'K0!TCS11L%>1%8X`!8`\G`
M_,TOFQ^:T6]=Z@,5SR`20#^)!_*N9_X1O6@RA?$;!%P%'V8<`=/XNQ/^>E(_
MAK6Y"7?Q(7;((W6BD94Y7OV//L:`.JI,C..]8`TC7O,#_P#"0*,*HQ]DR,CK
MQN[]_KVHCT75HE/EZQ`LC#F867SY^4$_?P2=@SQ0!T%-=UC1G=@J*,LS'``]
M36%!I.LPV<5LVK6TR1X_UEEZ$8'#CI_04R#1=1M8IH;=M)$4J;'4VKC>.0`?
MGYX)%`'145S4VB:G,'#C2&#/O/[B4;CSR?G]S^=,ATO78U>W1-&2W602Q@1R
M#+!L@D!N.@[GH*`.HHKD-0LO%%_A;FST:4!=H(:4<$@D=?\`9']*=%#XFM8X
ME@TS31Y2M&F)GX4D$]QUP/IB@#K:*YM[GQ>#A;'3#[B1L?SJCM\41(8$T:S>
M%]FX"Y;H```"7R,8'Y'KGD`[*BN.NI?%MQCS-%LR1P")\8Y5L\..,J/R]ZL#
M4?&&&+:):*.<9F!Q^3<__6H`ZFBN22\\6Q&1QH=L6E;+#[0#\P4`$?-P#@<?
M7-1S7/BM[>:"31@XF4EBMT`5SV4@C&/3GZT`=C17*KK'BL.-WAZ-EX!Q.HR?
M7J<=OI4$]YXJDA$4>EW$2E][R+/$9`"3E1D8P,C'&<"@#L:*YQM3U^2.:)]"
MFB)B(62.>,E6YY&3@\8/UJLFIZ^DX,FDWK*)M[*'C.4\O`3(]_F)_"@#K**Y
MJ76M5EDAVZ%J$7ER;F"NF'&",$GMR#^%5-.UW41?W4<EEJEPT9!,+)%A`2>,
MC&>OO]WTZ`'845QM]XHN!/(/L.K6[F+RA&L*L%<G[P/K@$4S_A*Y4<^99ZR-
MK1^9FV7^'KQVW4`=K17(_P#"=PD9&DZAC/)*``>O>H(_&MN]L4"ZHT@D#,ZV
MR94;P=@P<=..>><T`:VN(@76W\T&1M*QY8SD`>;R>W.>._!K3T?_`)`UCRQ_
MT>/ECDGY1U-<7?>+;&=-2D\J]WW-H8%7R5"X&[!.6)X+G)Z>U=KI0VZ59J>,
M0(.F/X10!;HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"GI
MV/+GX_Y>)/\`T(U<JM8D&%\'I-)G_OLU9H`A=1]LB8]=C@?(3U*_Q=!TZ=_P
MJ:BB@`HHHH`****`"BBB@"&[S]CGP)"?+;`C.&/'8^OI7(>"+Q;;%J+:\C6Z
MD;:KH2L15!DECW;&>G7C`KM:*`.+\?7`EN=/TSS-H<M*X:38K8!V@GUR./>L
MB#Q!K%J;*&&Z=X\)*ZLF]F!.63+<_*,#KGOGD5T_C#4H=+AMW-G!<2W,BQL)
M5R/+4[C^OX5A6FJ:%+*#>Z);JMQ<.D,D$8R4)(4E0=W)W#@8XH`JKXIU>[5%
M>5V9KI7C$(V*T:J69=PZ]4R.H[]:<OB?6P);Y94N$Q'&H16"1M("Y^7^(J!M
MY/H><FKYN_!JE@=,(C4G+^42H^;;G.>A(JYI'_"*ZO<-;6EB-RH9"'4@;00N
M>OTH`K+XJU;YYV@@\@G;MV,"FV+>[9Y!`_'_`!5O$-]:^$K+S#)=:EJ*R>4T
M2<J,Y+8'<`\`?TJ-M0\(RVC2R:?*(@0C`QL&RRD@C#>@//N*AN;SPH8K<V.G
M232NZK&JNZ*I9L$$@\'&3CGM0!):>,+ZUTRSCFA2>X:.1V>XD\LOARH4#'WN
M/TI__"?2_:[JV-B@>+*H2^,L"!@^G.>]5];L]&LO$EK8QZ-+.Y4NV;DJ'![C
M.2V,$\$<T6U[X(D;S&MIH6>8C<[R<D$'=D-TYS^!_$`U-/\`$>JZEK4%G':V
MT"1RRBX_>[\JA`..G<_C^!KK:X_3M4\(621WUN1"=[11F178@\;F`.<9!&3W
M[UT&GZS9ZE>7EK;,QDLW"29'!//3UY!%`&A6-XPQ_P`(MJ&3@>5ZX[BMFL7Q
M@VWPKJ!QG]WCMW(%`',:G?W=KH>EQVT\J2R74P'DOY9D02$8'J>1@_UJS:>+
M;R+[#;J+:\4PINE>78TI.[.,^FW!)'4'U%;EKIDHM;>1[B&58P98FN(@[19V
MD`-GH,-R,<$>G*W^DQ7DD-I9I8PP0@I.%C'F1JP^ZF/NY!//OT-`'/-XMN)%
MM;YE"[8KC8J2[8IF4`@E3S@`G`ZD^G>=O%][O+Q0VTHDBB$<3/L*R,')R3U`
MVD'D=L>IUM(\-65A%Y#VL%S&4!>24;\R="`#G`X]?Y5<O-+M<0^3I5C-\Z(_
MF1J-D8[CCG'84`8`\8ZA<P>?9:;`R,WEHK7`R6"[V]!@*1^-2:9XEFU;Q':+
M"?*M'21#%O5MS*`23QQR<#!YQGI6S+IB-8%)-.L+F;SM_EE-L9YV[N0<'9CU
MY%3Q6%O'?I<+IULDOEG,Z*-P/`V],D8[^U`&%_PDC1^)I(RSM8;6MT..&F0;
MB<XQDY*\'MTZ4V3QMY42R/IDF&7>`DFXA?+5R3@<<.OY^U:C:7&VCR0C2X`[
MRLX@+C:C$XWJ<':=O/`_*LRS\+_9K.>VN;2/4%,B["\QC^4!0"!R1P6!YY"`
M=*`"/QE)-"#!I;-(;A8%4SK@DG!Y';.!GIS5CQ!KU[I>HPQQK;);/&A9Y@3M
M<L1AB&^4;02"1S@]<5-=Z%8BV@2+1()0B#,8DV`'<O\`WUT)R?0CO4M_HMK?
MM%>W%B7NOW>^-9BH.".O9MO)Z<XH`S&\9B26!(;<Q&0B11,,^;$2PRN#P>.^
M0*>GC6&6XMH8;-V,ZJV[>/ERK'&.I.5Q_6KKZ#9VY?[-IV\1XE0>;]]@6Q'@
M\!><XZ<].*K67AO3PTQETZ>'R9"T0-P7!7YL%1G`ZGCMQ0!'!XS@5+4W=M*H
MEC4R31H2BN4WA0!DDXQ^=36?C"TN[^*S6TNDD=]A#I@IS@$CWR.G3-5AHFGV
MHA0Z3?;"1A4DWCH%#,H.-W[P\]@A_&:Y\,:<42]DM+R2X9T(C\]BT3,0"?E/
M;.20?X:`+VMZO-IMU8QQ1)(LY<R9SN"HNYBH'4X!X]<577QAI9MTF?[1&K%0
M0\1!7*A@3[8(YZ56EL4N["RCU*+4VGM805G3)9RX56SCG.3R#S@$YZU63PU:
MF=7_`.)F"L21/)M"[D4>64P.<,/3IC-`'945CZ;?B&R"RI?S8<@22P-N;<<C
M\MP&?:M2XF6W@>9E=E0;B$4L<>P'6@!Y4$@D`D=#CI34ACC=G2-%9_O$*`3U
M//YG\Z?3!+&9FA#`R(H9E[@$D`_^.G\J`'*H484``=@*@6QM%W[;6`>9G?B,
M?-GKGUH@O(KB>:%-V^$@.&7'7."/4<'\JF=E1&=V"JHR23@`4`,CMH(GWQ01
MH^W9N5`#MSG'TR2?QIHLK46TEN+:(029WQA`%;/7(]ZGIKR(A4.ZJ7.U<G&3
MZ#\C0`TP0F-HS$FQ_O+M&&^HJ*6PLY@?,M86R6)R@Y+#:Q_$<&I6GA6/S&E0
M)NV;BPQNSMQGUSQ]:='(DJ[HW5UR1E3D9!P?UH`C%K;K;BW6"-8%QB,*`HP<
M]*AETJPF1DDM(65HUB(*]54Y`^@-6V8(I9B%4#))/`%#,$4LQ"J!DDG@"@"O
M-I]G.LJS6L3K,%60%!\X4Y4'UQ5A5"*%4!5`P`!P!3#-$)1$94$AZ)N&3QGI
M]`?RJ2@!CQ1R/&SJ&:)MR$_PG!&?R)'XU']DA\V:94VRS*$>1>&(&<<^V:D:
M6-&"NZJ2"0"<<#&3^H_.EWKOV;AOQG;GG'K0!473+=5BR9'DC"@3,Y,A"MN`
M+=2,]?6K*PA;AYMSDNBIM)^48).0/7YN?H*7S$W!=ZY)P!GJ?2GT`5H;-899
MW6:=O.ZJTA*IR3\H[=?T%/M+9;2UCMUDDD$8P&E<LQ^I-2[@6*Y&X#)&>0/\
M@TM`$/V91!+$))!YI8E]YW#/H>V.WI@55?2@TCN+V^4MV$YP/D*\#MUS]0#6
MA10!5^Q?Z%#;"YN/W13,I?+OM(/S'WQS]35<Z03I\EH-1O@7E\SSA-^\7G.T
M'L.V*TJ*`*,6G-%.L@O;I@&!V/)D$`,,?3YL_P#`1Z4V?3I96#1ZA<Q'S"YV
MD$$''RX/;C]36A10`57CMY$OI;AKF1T=0JPG&U,=2/K5BB@#.-C>"SMX(]1D
MW)N$DS*"S@JP!],@E3^%6FAE-U%(MPPC16#Q;1AR<8.>V,'\ZGHH`@V3_;1)
MYO\`HXCV^7@<MGKG&>G'6H[..]5V:\FC?,:`+&N`&`.X^O)/Z5;HH`J21WQ9
MG2>(;0^R/9\K9`V[CUX.>G7-3%)#-&_FX15(9`OWB<8.>V,'\_:I:*`*]W]K
MV#[&80W?S02/TH87@,^UH2-@\G<#G=@Y+>HZ=,=ZL44`4V&H?:W*-;?9\?("
M&W?=/7G'WOTJ7_2=T7,.W:?,.#G=CC`],^M3T4`4)!JAAAV+9><%;S-Q8KNP
M=NWOCUJXGF;I/,V;=WR;<YQ@=??.?PQ3Z*`*\1N_WGFB`==FTGU.,_AM_'-3
M)NV+OP'Q\VWIGVIU%`%#7&7^PM1R1@6TF<\@?(>M+HF?[#T_=PWV:/.?]T5!
MKL4'_".ZML2/FWE9]H'+;#R??@5:TD[M(LB3G,"'/_`1]:`+=%%%`!1110`4
M444`%%%%`!137=8T9W8*BC+,QP`/4TZ@`HHHH`****`"BBB@`HHHH`JV"[8Y
MB/XIY#_X\?\`/'\\U:JII^W9/M`'[]\X[G-6Z`"BJ<B.=7MI`&V+!*"<<`EH
M\?R/ZU<H`****`"BBB@`HHHH`****`.<\6V%I)'#J-[?S6L=H&"^6%).[@CG
MKGCCTS6%+H>C+;6E]/K;QE+>.:**18@Y102,)CG]<\]:U/&,$L]_8*URJV_)
M$!G,1D<<[L@'&..3CDCUK`DT'49O+C"63!4C@E!G1FPA/&>V2N#QGY?K0!=.
ME:8EQ8V$6O.7R#$JQ1D1F/<WS\<<L_![GG.*DT_PM%81SQ6_B*)/.39*/*C)
M*;6)'+'`(.?PS],AM#N1;21M%9[(V4+Y=R@^21MP!;/4X"CCI4\WAC4HM0N)
MK;3H,,K*(TFRR!T*D?>^Z.<?4=N@!?@\)VMF@\CQ"D(;>%)2/)##:><]<'&>
MV>,9JS_PA]S%/'<V&K1F:`H-CPC8"J[02`<;@#QQ7,#1[^&WL5DT]``&VE]A
M,A(RW!."`N#GMM]J[OPBQDL)IVT_[&T\QE;Y2!(6`.X9)XY^GI0!B7?@[6KG
M46NVU2W9BZR'Y"JLZXP2@X["FKX/UA;8VZWMH086@9G5F)4L7&,C@Y)Z5W$D
MB1)OD=47(&6.!R<"GT`>=+X$U7,8E?3VB7ED5F7<>`>0G&=HZ>_KFNH\+Z5?
M:4EVMZ\+>?()1Y3EOF(^8\J#SQW/^.X2!U.*6@`K#\:#/A34.2/D'0X_B%;E
M8WBX9\,7V#@[!SZ?,*`%U5(=0T5K**>$-,NU5,H.0C#?SWQW_I7'S:)>F6Z>
MTU^"3;(!&PN1EB-BKOQT(7=D^H%=-/K&C:;91S"W0.\LT<,2H-S'S"KD>@)&
M3[?E59M<T>*]N;6UTD3&'][NBB0"1MX3*^O/5O\`9H`KP:5JAFBN5U)9[MRS
ML4N?E8AF4E5QT"E1CC!-7O"L%]I\,@U6Z9,[56&:12=V<%L]<,V<<U+:Z[IW
MFZ3';V$R?;(V\@F-5V+D9')]@>,YX/-1:AX@TN#5WM[O3)WGB>-!*8D(&3\K
M`ELXR3SB@#I:*R[?Q#ILR!I+F.VW$A%N)%1G`)&X#.<''!J>'5K"XNDMH+N*
M:5T+J(W#`@8SR..XH`NT5R%U?:'?Q-<3P7XD6]\IXMY619"JKDC=PN%`K5+:
M'.\Q74HR9MA8)>XX09&,-P,<G'7K0!M45C32:--#\VIQ^6L;6VX7G][U);EO
ME.">>#3/-T?16M!)=S%YA^Z9YI)=XP3GJ01S].E`&Y16%?W>BZA%#<2:OY4<
M:EQY%T8RP.#R`<]@?:K$DVFW<+%=5VHR;<QW>,!<Y.<]?G&3_NYH`U:*JVP@
MMK:69;@R0NS3&1Y-P`/)P>RBHH=1LM3798ZA&SAE8[&!8@$,1@]B./QH`OT5
MC6T(>6YCM-;N"V[9L8JYC95"G[P)SG#'Z^]:$;K9V8-W>B0#),\I5,CD\XP.
M!_+-`%FBJEM#."CO?&=-B\;%`8_-ELCURO\`WS[U8VMYN[>=FW&S`Z^N:`'T
MF!G/>FRK(R@1N$.X$DKG(SR/Q'&::5E`E*R!F8YC##A>`,<=1G)_&@"2@@$$
M$9![4R#SMG[\H7R?N`@8SQU[XHE\W"^5LSN&[=G[O?'O0!)2$`D$@''(]J:^
M_<FS;MW?/GKC!Z>^<?K4$IOQ<'RDMC#M.-SL&SCCMC&:`)_*CV%/+7:3N*XX
MSG.?SYI5547:BA1UP!BA=VT;\;L<XZ9J.$W!D?SEB5,?+L8DYRW7(';;^.:`
M)'571D=0RL,$$9!%*0&!!`(/!![TU_,W1[`NW=\^X\XP>GOG'X9I7+!&**&8
M#@$XR?K0`TPQ-)YAC0N,'<5&>,XY_$_F:DJ!C=?:8PB0F`C]X2YW`\]!C![=
MQ4IW;P`!MP<G/.>W'YT`(\,<C!GC1B`0"R@\'!(_0?D*/)C\WS?+3S/[VT9_
M.FQO*TTRO#LC0@(^X'?QDG';'3FDN'G15,$2R\G<I?:<8.,<>N.O;-`"_9X!
M()/)CWABP;:,@D8)SZXXJ6L^QOKB[NKE/(188)6B+[_F)`!!QCISZ]JL>?-A
MR;20;=^,LOS8/RXP?XNOMCF@!MII]K98^SQ[2$"9+%CM!)QDGU8U+<6\5U'Y
M<REESG`8CV[?6H+>\GFG\N2PFA7GYW92.I'8^P_,4]+B4QAFM)5.UR1D'!4X
M`Z]3U'TH`9%I=G"08X<$`@?.QX+!O7U`J9+:*-XW53NCC\M26)^7C\^@YZU#
M:7<]PX$MA/;`INW2,AYST^5CSWJPLA:61#&RA,88]&SZ4`-CMHHUC5`P$>=O
MSD]?QY_&FO9PO-),=^^2/RF(=L;?IG&>>N,U8HH`J2Z=;2YW*_*;.)&X&&7C
MGCAC^GH*)=.MY457\WY$V`K*PXP1V..A/^0*MU%),4FBC\J1A)GYU'RI@9Y^
MM`#;6TBM0XB,GSG<=\C-_,\5'_9\/FB0M,2'+C]ZP&25;L>F5''U'0U;ID3^
M;"DFQDWJ&VN,,,]B/6@"%;.)(#$&FVE"F3*Q(!]R>O/7KTHCL8HI8I%>8F.,
M1@-*Q!`SR1GD\]3[>@I1>0[MNXY\WR1\I^]C..GZ]*DCFCE>5$;+1-L<>AP&
MQ^3`_C0`Q[5'2=#)*!.<DK(5*\`?*1R.G;OGUJ2.,1@@%CEBWS,3U.>_;VI]
M%`$-Q"9O*Q*\?ER!_E.-V.Q]JFHHH`9L;SM^\[=N-F.,^M-GC>4($F:+:X8E
M0#N`/W>>QJ6HXIHIC((I%<QML?:<[6P#@^_(H`($DCC*RRF5MS'<5`X))`X]
M!@?A1.CO$RQ2^4YZ/M!Q^!H>98Y8HRKDR$@$*2!@9Y/:B.>&622..5'>([74
M')4XS@_A0!`EO=JSE[YF!GWJ/*4;8\?<]^_/6DO+>\F<&VOOLRA&&WRE?+$$
M`\^A(./;WJQ+-%"8Q+(J&1MB;CC<V"<#WX-.CD26-9(V#(X#*P.00>AH`;"D
MB*PEE\PEV(.T#`)X'X#C-*ZR%XRCA55LN"N=PP>/;G!S[>]0/J5C&0)+VW0E
MB@W2J,L#@CKU!(&/>K5`&9KZI'X>U0JH7=;2D[1U.P\U:TW/]F6F[KY*9_[Y
M%5/$TC1>&]191D_9W'3/48JUIG_(+M.O^I3K_NCUH`M4444`%%%%`!1110`4
M444`1W"J]O*CQF160@H#RPQT[5)110`4444`%%%%`!1110`4444`5K(YB?;@
M@32`\]/F-6:JV!'E2@#D329_[Z)_K5J@")HV-U'*"FU492"OS9)7&#V'!R._
M'I4M%%`!1110`4444`%%%%`!1110!QWB_3M0OM09H+":>W-L(]R,O+;PW(W9
M(X'IT_+#_L35;>Y8PZ3.;=I#*`P4L&7S`HX?@$."3Z]`<8.KXS;4WUN!;"/4
M/+C@!D-NK$/E^1QWQWK"EEU.U>V$/]J6R0%2,Q2?>"1[R0V<@L#@=!GIS0!:
M;1]3&E/:1Z+<,7DAW!W4!E1"".&R/G.<CKR>.E26MAKEN=7<65])/=P>5&[;
M%!7H68!L;L#`QGK^:6&KW%A;ZEMDU:Z<Q^7;"5&(Y'WSGIAL_7(JJ;S4I(5"
MW>L($.V%8_,!(/F-ESCD@[!GG@'`H`L7=GJUSIFG6<5CJ,<UK"YC<@(#(S`E
M3R?E";@.A[8[50B.K:<)(,:E#L1MGR,2HPC1_C\F#V`!Q[VEU763?J_VJ^AC
MDE9G5D=]CX/W1MSM()"KQR.>F:31_$\]O=0"]U&Y18HI/-#YD!?G`(QUW8^@
MXSZ`%2*:[DABBN'U8*/F5%+A01DCL2<E4P>QR>.`+]QK%^;'2;>&[NTEC9S*
M?G^5B04WMMRR@-@CV/'2JA\4:HJ'R];:4A00NQ5Y`3/+*/\`:]>G?.:T(O$%
MS=Z)?Q/JZO<Y\F':=KR+O!+C(7'RD@9QT-`&*;^[+-<-=WBRLZR@MELRJH8!
MAR"-P.WTQS[:<FOZC#<W3QZM>L#*53?"I#@,PR!C"C:!GIR>G&1O^&M5OKG5
MH[2:]26&.W(<.5WO+GG'<D8.<9'\ZZ^@#E?!VM3Z@]RE]<R/,[@Q121[2%`Z
M\```\<?J<UI>+LCPOJ!!*D19R/J*V*Q?&+*OA74"YP/+`Z]R1C]:`(K[2M*O
M;2YMVM'1K7=()&A8D98N2I/WLD'@'O5:7PK#)<7\,-]=0B6/Y1MRD2R/EU4]
M\[<>P/?-5/$FI:C!K#FSN98U@>!3;J`1(I#N6Y_W=O'IS69%XAUI&D,0N)7B
MN&NIH=A/E1%0VPD@8'S,!_N#`H`WUT@VLT$U]J-U<P:;$LAC\DX9QNPXQG.`
M<8&?K5G6]#L]5O45I8X[D6LJ!",Y4C:&V^BEB1[G\N<NO$.K0R7J1W/[MGNG
MAD91PJGY0,CJ,<=>&_*2XU_48;.2&UO/MTJW`$-ZD&?-79O=0HST;:..,$<\
M4`:-[X7L[G5;..&Z:W:"U"^2T(DRBG'![')Y]<U'IMA;^'+U)+C6HG5#Y#H\
M)W<JI50=Q(`!!^GH.D%YKUZNHWEY9WBRVD=@MS%$81_%P`3[$YZYXQZU#/KM
MY9S;4U*VOX_,+FYCMP^U2C,RXW#D;?7ICZ4`3_V#IUXT,\NM6[W8O?-2=0HW
MASN$>,\G.2.3C)J&+0=)CM+;[3K5BDJMO<Q;(P\.-K+C.3G!R?KQ4D6LZK/;
MPQ6\5D)'M5O!+M!5(U7##&?O;P,>F?;B?6]4U!+BPCTJQ@G%S:>:\9@W_*2/
MIQ\WZT`9S>%/($UQ)JVG.)7D1!(H$84Y$A'/#+R<`\;:U;JT,D.DPZ?J>GEM
M/0>4TKY,SJN#\H/`Q@]3U].L5GXL@>SC34]/S.ZNT81599&+NH4>YVL,]^?6
MH_\`A,;2;4+<0Z?N4*P:(PAI=Y("A2#@`DCK0!!<^$46T>2&>TNC+!Y*2.P5
M5F,O5>H_B88'<#N:FF\/QRPWXMK^W=V$96(3#&<IYG(Y7<549]O>I7\:64AC
ML[;3YDG\U-L<L:A0=P+=#D'AATX.*75_$(TK5[JV33K*2V2+G<XC+D!6(S@@
MGYA\O7CW%`%S1;>Z@\/7-F1:-"(&,$@DWQLS;BRGMA3QQVK$3PO>K;&:$6[*
MGGHJO<[@J-"4/S[1G#=CTQC/>M:?QGI5K</8365PB*QC;]VHCQG:W4C(W9'3
ML:LZ5XDLM7NXK""RD57A:1UD0#R\$8R.F#G.?I^`!B-H.JW`N&ME@7SS+N:*
MZSC<(B<';_%L8`8X#<^^HNEZG;>&%M8H4GNQ(WEB6XW>2A!7AL#)VDCH!\WM
MBH(_%&D1SW%S'8?Z7DQQB%=S2H"1G@<?=)Y[`=:LIXJTJ:X@GD1@4A)\T*Q"
M$D`J./F&1]X<?+0!N:7;"TTVVMQ$(?+C"^6'W[>.F<#/UJU7,P^)/#!NH;A)
MT6=]RJWEL",DDYXXR?7UK5L+C3M:TV5[4B6VF++(""#DCG(ZC@C\Q0!HT57-
MG;E0ICX!<_>/5L[OSR:G4!5"CH!@4`+130H#E\?,0`3]/_UTV./8\K>8[>8V
M[#'(7@#`]!QGZDT`245#:P?9X?+,TLQW%M\K9;DYQ]!T%.DC\QHSYCKL;=A3
M@-P1@^W.?J!0!)149C)G63S&"A2NSL<D<_7C]:8;=S>BX^TRA-FSR!C83D_-
MTSGGU[4`3T45#:PO!#LDG>=MQ.]P,\G...PZ4`3457FMWEF21+J:(+C*+MVM
M@YYR._3BK%`!5353$NEW1N,^3Y3>9@`_+CG@^U301O$K"29I279@6`&T$Y"C
M'8=*>ZJZE74,IX((R#0!S%S!=1^(--B>XGBCFO9Y`L4I`=0@8`@=LKT/J?6F
M3>,Q]JN5M+>*XMD5O*F$VWS'"@[<$=>N/7'%=+=Q6LD6Z\CA:./YLR@$+[\]
M*S+?36-LZQ_8)48,$<VW!!.4Z'!4*2./SZB@"GJ.HW-UX=L=<M9'B$#K<30Q
MOQ)&#AES@9_&JL'B"ZMIA.(9KM-0F:2*)FV>5$&$8P3QDY!QQUZ\YKJ'@VPI
M#`D*PYVO&R?*4[@`56N-/:?3?*9+7[2B,L3F+Y8\],#J,#'0]J`.<'CJ8V,M
MV--3R4*A7\XX).3L^[][`/(R!WK8T7Q"FJZC=VFV-#`3A0^6X.#D>F2.??VJ
MK:^$HK$,MN89E**JBZC\P*?FW$#H,DJ?7@\\UK6%@;2YE=8;**-@`OD0[&_$
M]^2WZ>]`&A167*FO;G,,VFXWG:KPO]WMD[NOX5*1JWVEMKV?V??QE6W[>_?&
M:`+]%42-5\I,-9^9L??D-C=_#CGIZU:'G>=SL$6SMG=N_P`*`)**JR->F:01
M1P"-5.PNQ)=L<=!P,YSUJ>+>8D\T*)-HW!3D`]\>U`#Z*I^9?LTH6WA0"0"-
MGD/*=R0!UX_4>E3*UPMNC21(TQ*AUC;Y1D\D$XS@<^^*`)JYB769('TFXC>2
M.TD5S<).<D*71`2?4,X[]*Z21G5HPL9<,V&((&T8//OS@?C4-SI]I=R"2Y@2
M5@C1C>,C:W48]\4`<CIGC"Z806@@2[E555Y_,^_(P.``!TR5!/:K$OCE(Q#/
M]C_T1WPSM*`VWY02H_B();C_`&36['H.F13PS1VH1H0H0!CM^7[I(S@D>IJ"
MZ\+Z3=/$SVVT11M$%C8J"IR<$#W)/UH`Q[SQ?<VTJW+:=,MJR.(=[*@D.Y0K
M')XQ@@CMG/?AUSXHDM]%_M.WLH[=)[I4+2)N#`Q@ECM(S\PVY]O;%:<OA/29
M7=C%*I9]X*2D;#QG;Z9Y_P"^C[8;_P`(Y`=,DLI?,>*.4O;;)3O1<#Y0QZ9^
M8>F#0!FP>,+F6YN(C:PY2&5U0,=RF-0<M_LMSCBIAXGN%.G^5IZ2&Z@BEFVO
MMPTAV*!^(QS[<U833H7N;@#2;A%O(A!+,TBYCC\K`"C)XXQ]>O%.NO#UI"ML
MT$$\TD2>3&/-X0#<RDDY^[DX]R/08`+6@ZK)JT5P9[>.&6UF,+;)-X+`#)'`
MQUK5`"@```#@`=JS-`T^*PL2$BF661RTC3L&D<@X#,1Z@`X]_7-799WCE9!;
M2.H3=N7')SC`R>O>@![PQ.`'C1L'(RH/O4E06<[W,'F26\EN=Q&R3&<`X!X)
MZU'+>O']VQNI#\_W0O\`"<=V'7M_2@#-\1?9SX:U?R4V_*_F?)MR^!SSU[<C
M^=:6E+LTFS7T@0<_[HK+\4R&X\*ZIFV==@*@2X7=AA\XZ\=QW..U:^G_`/(.
MMO\`KDG\A0!8HHHH`****`"BBB@`HHHH`**1CM4G!.!G`ZFEH`****`"BBB@
M`HHHH`****`*UCD1R@]!,^/;YB:LU5T]=L<V5()GD/(QGYC5J@`HHHH`****
M`"BBB@`HHHH`****`.4\3^*IM%U1;:%8F7[-YIWKGYLD`#YA]<<]NF21F'QK
MJ81B(M-:4J'")+NX#%67AN6)*L`.V>IZ=VT:,<LBDXQDCM5:;2M.G2-)K"VD
M2(816B4A1Z`8Z4`<A8>)+K4=7L);F[AM(E8J\228C<;#N)8D@\@8`Z9QG/-=
MT!C/O60?"VADD_V9;\^@K7````&`.@%``0#C(Z=*:T:,VYD4G&,D=J?10!7-
MC:'K:P'_`+9BC[!9_P#/I!_W[%6**`*\=C:12K+%:P)(N<,L8!&>O/O5BBB@
M`K"\;`MX4O0,=$SEL<;U[UNUC>+T,GAF\11N+!`!Z_.M`$^EYO`FISPP++-$
MOEE%RR(<'86[\\]`*T0`,X'7K4-B$%C;B.;SE$:@29SOP.M3T`01+)O=)((E
MC&0A5L[@?;'':@1"!(H[:WB5%8#:/E"+CJ`!^&*GHH`K1P(TTSR6L2G`B5^"
M7CQG!XX&2PQ_C4-OI=G;2JL%A;QQ)EU*C!#D;3QC^[QG-7Z*`,1=/Q;>5_9$
M48DC:V/E3`%(V!)YP,+GTYYSBK/[Y+N9UTI=\,.V"595PXX.SU7GVQQUK2HH
M`Q4T&VEFLY6MDM4M'W+!$1M8@DH3C'0LQQZL:C.C:8`D4F@*?-7YB@1E0D9Q
MDD$8VCH,<C'>MZB@#"M="TE3;3+H?DR>82-P7,1&2"V&/'`QC/4>]17NG6%Q
M=F]N-#N)I)(P'3"$-G:,D;OO#<1GV;V-=%10!SK^'])-I;7!TJ<F'(6WR"YW
M/G#<\@$YZ],TVRTFRL)%N+>QU`21([C[N6+JN1UZ@*`!P,YZ]:Z2B@#D7T+2
MIXB8])U&R:W@(#P@*[@C!'4[F()ZC/J:M6OA33%5V5+Q8UD.(7DPN`W8>A(S
MZD'TKI**`.6L/!NF?9H)%DU&,8WA)9=K+D#J,<'@9^F#6QH>C0:'8FUMY)9%
M+[RTK`G.`.PZ<5HT4`-DD6*-I)&"H@+,3V`IU%%`$$EW!%<Q6[R`32YV)@Y.
M.M(;ZU$KQ&=`Z.L;+GHS#*C\15BB@"$7=NT[PB9/-3.Y<\C`4G]'7\Q1;W=O
M=`FWF20`9.TY[D?S4C\#3WBC<$.BL&Z@C.?\X%((8Q-YH0"3;MW8YQG/\Z`%
M21)&=4<,T;;7`/W3@'!_`@_C3Z0*`20`"QR<#J:6@!D4B31)+$X>-U#*RG((
M/0BGTU$6-%1%"HHPJJ,`#T%))&DL;1R*'1A@J1D$4`/HHICQ1NZ.R`M&24)'
M*DC''X&@!]%%9UVD.FV#R6\)3'EI^Y`#8W8'4'/4_K0!!XCLY+NWMI%ABN8K
M:;SI;>5@HD`5AU/'!.>>*P)?#FI-=0-%;+;6T;(P6"Y^=`'E.%)&`0)/IZ5U
MPA-W9-#?PQMY@(>/JI&?\,5)=6T-W;26]P@DBD&UE/<4`9GAA-1_LT3:I+(9
MYB&$;C'EJ!@#!YR<9.?6MBJ\5E;0*JQ1*H21I%`[,<Y/ZG\Z:=.M#9"S,"FW
M`*A"3C!!!_F:`+5%51IUH!CR1CYNY_B&&_2GP6<%L5,*;=L8B'S$_*.@_7KU
MH`GHJHFF6B,[+$0SN)&.]N6#EQW_`+S'CWQTXJ>2%))(G<9:)BR<G@X(_D30
M!)13$C"/(P9SYC;L,V0.`,#T'&?J3ZTD,7DQ"/>[XS\SMD]?6@"2BHH8?*9S
MYLC[VSASG;[#VI+:#[.A7SI9<MG,K9(]OI0!-14-O!Y&_,TLNYL_O&SM]A[4
MZ*,QQ!/,=R,_.V":`)**J/9.^<7MRA,0CRK#@@YW8(/S'WHN(FC,]Q]HG*^4
M0(5VX!QU'&<\>N/:@"W16?&OVF2%DO;B.2.)"\.5Y!Y!8$=?E(R,=#4CV<K6
M<<"WLZNAYEX+-UZ\8[_I0!<JIJK[-+NFWS)B)OFA&77CJH]:L1(8XD0NTA50
M"[XRWN<<9JO`K27#31WKO$'<&+:N`1A<9QG@JW_?7TH`X2TU;6=,M3-)<7D[
M^7C;=0/L5F=!@9P68#^O'/.U?ZCJ-SX?LYYC<:>))2EQ+#$2X`SM8+]X!F"_
MG6TVGW;77F/J<C08'[AH8R-P7`;.,YW`-]:MP0RQ-E[AY5\M5VLHZC.6R!U/
M'Y4`<=;>(=7L5@MA:S7JJ,!IX)%FG!+8P>0"`!G/)S3F\4:TFEK.ED)IKAWV
M-Y,@5`JK\H&,G)).2<<$=JZM[6X,"1I?2JZNS&3:I+`Y^7&,<9';^$5+:120
MVL<4T[3R*N&D8`%CZX%`$BDE06&TD<C.<4ZJ]U#/+Y7D71M]L@9\(&WKW7GI
M]:>L<HG9S.3&>D>T<<#OU]?SH`QO'#;?"5^<L.$&5Z\NOZ5K:?\`\@ZV_P"N
M2?R%8?C573P5>++)YK@1Y?:!N_>+V%;>G'.FVI]84Z_04`6:***`"BBB@`HH
MHH`****`$(!!!&0>H-+110`4444`%%%%`!1110`4444`5=/_`-5+\I'[^3D]
M_G/-6JK6'^IDY/\`KI.H_P!LU9H`A:$M=QS^8P"1NGE@\-N*G)]QM_4U-110
M`4444`%%%%`!1110`4444`%%%(#D`^OK0`M%%(""`0<@]"*`%HI,C.,\^E+0
M`4444`%%%%`!61XI_P"1?N<`DY3`4D'[Z^E:]8OB_CPW<G`.&C.",C_6+0!H
MRW-I8B**22*`,#Y:DA00HR<?053GU#3;N."1=72%7SY;1SJH<XQCGJ1GIZ]J
MJ>(=-N-0U&V6--T3P2Q%\9$3$HP)YZ$*1TK/G\(W5WJ<EYOLK/S493''$)@A
MP`"-P')YR>.@]>`#IH=1LIY7BBNX7DC.&0.,@Y`Z?4C\Z29HIV'EWOE^7G?Y
M;K].<YZ$5C'PM#%*&MH;;;&;;RRR`/B-\ODA>2PQ]3UXK,D\+7;67V2.PM8G
MAC9/M:2Y:ZW#!)&`1CKR>HP,B@#L_-C7<&D3*G!YQCN/TJ#R'\EXUOI-W"[C
MM)4YSZ=2"!^6,5QS>$M8D26T>XB,;.9?.S@.54+'N4=#U;N.*LWUEJ[VVIK)
MIP+W_DN'AD&(Y`J=LYP&!R?;O0!U5Y!)<JB0W<ELRL&9HPI)7!&/F!Q]<=J@
M2PO$A,?]K7#$MD.8XRP&",?=]2#SZ5A>)=*UB?6OMVD_+FU%L6W[>&+ECUSQ
M\O8]1CIQ2?2O$-S-Y5[#)+:K*CK&9T*\8S@]1QOZ\<C@T`=A+;W+QE4OI(VW
MLP81J<`@X7D=`2#Z\4)!=1P./MAEF,056=%"AP#EL`=S@D9[<5PL%MXIT?29
M)))9%BA1E*M*&"+AOG'/;`P!GK6I9-K.K>&)%AN)7FGNV59RPC*Q`]01ZXQP
M._H*`.@^Q7XA"_VK(9`N-Y@3DX'.,>H)Q[^U));:HBL8+^-W(P!-"-H^4#/R
MX.<@G_@1]!7)W'_"6+<P3F"8FWB(5<)(`=FTMD$%B2"=I!&<>O$$%WXMT^SN
M)R+J93("!-$)#AB?F4`\?=`V]!N/M0!U\T6MLY\JYLHU((P8F.#EL$<^A0'.
M>A(]*N8O?MX.ZW^Q[>1M;S-WUSC'6N,;7?$^V_<V<D3*\013!E8R2N0.I.1G
M/7&1C%=Q"SM!&T@VN5!88Q@XYH`@/]H;H<&W(\U_,X(_=X;;CW^[G\:6#[=]
MC;[0+<77S;1&6V?[.<\^F:M44`4T.H^?<!Q:B$`^01NW$X&-WIWSCVZ5/"9_
M*)F$?F=@A./S-2T4`58&O38;IXX!>;2=B,2F><#)&?3/%312.[RAHF0(^U22
M/G&`<C\21^%244`%1I(S22*8F4(0`QQA^,\?RJ2B@""2Y,:W#?9YF\E=P"@$
MR<9PO/)[<XYHCN&=)F:"5#$S*%(&7QT*\]#4]%`%:&[:7R\VEQ'O('SA?ERF
M[)P>,?=^OMS31>MA2;.Y`;:/NCY26`YY[9R>V`:MT4`-#9D9-K#`!W=CG/'Z
M?J*:DN^:2/RY%\O'S,,*V?0]ZDHH`9%)YJ%MCIAF7#C!X)&?H<9'L:CMKI+D
MR*J2(T;%661"O<X(]0>OX\XZ5/10!5_M"V_M#[#O;[1MW[?+;&/][&/UJIK+
MB[TQXH<%FN(XL.AQGS%S^'N*U:*`,?2M9M;A2AF=IVF9&3:V$;)&!P..*N/J
M-M%<-#)*=XD5,"-C@G;@9`_VA^?L:I>*-2N=,L(9+8B/S)TCDG9"RPH3RQ'Y
M#\:PY_%%Y'923V]Y;W2QEP)!;M&KX,7/?H';./3\P#J3JEDIA!FP9U1H_D;D
M,0%/3C)('/K2?VK9AX4,K!IMIC!C8;MW3M[55T36CJTUW']E,/V5A&Y,@;+Y
M(8#CH,#GOFM>@"I#J5I/<M;Q2[I59E*[3P1P><>U":G9O(D:S?.[;5&TC)^;
MVZ?*W/3BK=%`#(Y$E4M&VX!BN?<$@_J#39+B*.:*%Y`LDV=B]VP,FI:0@'&1
MTZ4`1P7$5S'OA<.OJ/IG^M5EUC36176^MV5MN&#@@[B0/_06_(^E7JA%K#&D
M:Q0Q((WWH`@PI.<D>A(+<^YH`E9@BEF(50,DD\`5&UQ"HC+31@2-M0EA\Q]!
MZG@_E3I8HYHFBE19(W&&5AD$>A%$<4<2(D<:HB<*JC`7Z4`.+`$`D`L<#)ZF
MHX;B&XC22&5)$D7<A5LAAZC\Z<T:.R,R@LARI(Z'&/Y$TR*U@A*&.)5,:LJD
M#H"02/Q('Y4`2[@&"Y&XC(&>2/\`)%171S;3!9-C;&^8=5XZ\<TXPQ&<3F-?
M-"E`^.=I()&?3(%1Q65M#=S744*)//CS'`Y;'3-`&?IKV8U!P+B2:Z2T@1Y7
M7`*Y;;@GG+$DD$^GH:UMRX)W#`ZG/2N?\57ME91^7-I\5VUT,R!Y`@PG(+'!
M/7@<8]Q6=8ZSX>MK-E?3_L<5S<>4$"D[R@0[CZ`%A_/O0!U=R)Y8XC9S1IB5
M2Y(W!D!^8#T.,\__`*Z?"\I1C<(D9WL%PV<KG"GV)&.*YK2?$&@R-9V<,$EN
MZSL(D=#^[=MXZ]B<L,>];=_:0#S;[[(+BY2(!1NP6VMO49/`^89S0!?HKEX?
M%UE=6[I?V<UO%+&2,X?>I;9@!>>3D=.U6%U*QT[3XIM&LY+O[<Q>.*$]2%&2
M<GY0``.E`'045S]GXCTF%TMY1+933,\C13H05)9L[CT&<$]?2G)XPT0IO>[\
MI3*8EWH?F("DG`Y`^8#G'(-`&]14$MI!-*))$W,%*\DXP00>/Q-.2"-'5U!W
M*FP98GC_`#WH`Q/'?_(H7W_;/_T8M;&G_P#(.MO^N2?R%8GC"!;?PAJ*P[AN
M(=LG/)D!/6MVS&VS@![1J.F.U`$U%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`5-.)*3YQ_KY`,$_WOT_#^>:MU5LF'E28!`\YQ]WK\Q_SF
MK5`!129YQC\:6@`HHHH`****`"FNJNC(X!5A@@]Q3J*`,*Y\.Z':VDLHTD2A
M`7V1*2Y('\(SUJGI&DZ!KFG_`&E-.:-2Y5E,S=0<\$-R/I717MJE[:26TCR(
ML@P6B<JP^A%9FAZ`=&E9UO[B=74^8DA^5G)&7QV/&*`,;6;;0-.NX-.ETRYG
M60"0)#(V$YVEOO`Y/&?7`J#3].\+W]M>2^9<6XM)&#>;<$&)<\;>>F1D=\YZ
MTNO6&H7'BN/_`%3QO\T4(N-KN%`/&0=O(()'4>_-4#X5UG`1[%"!%&@:.=1N
M(;<V_)RV23W'8]J`-2?2_#[&.2;Q#>9:(.";L?,@'!Z>BX_^O4J:%I7VA'A\
M1W:OY8V#[6F<%20>1TVY_#FL0^'+Z:Q>VM[)9IHMBLWFQD1.J9,?7H2S$X[L
MOH:D3PSK%O.+C[%&6BM2B-YD8^?9L);/!'5N1G.,D=@#HH_"R,8YX]=U5B%.
MR07"MD'.#G'/WCS[U9/A^?/_`"'M4QG)_>)ZC'\/I5[3;B%M+LY`T*(\:J@0
M@+G'1<<?05#JT.H7D21:9>+:]=\VP/T(^4#/7K^5`$)T:]`^37K\';M&Y8VY
M[G[O_P!<>M0'1=:,P8>(Y@F#QY"9ZC;VQT'/_P!>M73#>FPC_M(1BZ&0_E_=
M."<'\1@U;H`PQH^JEFW>(;G8<``0Q@XQCKCKU_2JJZ/XE`)_X2,%@I"YMUP3
M[_Y-=-10!SJ:=XHCD:3^W+>8`96-[555CZ$CD#W!S63XBM?$:Z'<G4=0LWMS
M)&2(XCD?.,`<=`2#W/'Y]Q6'XR\O_A'9A(2%,L0X)'_+1<]/;-`%!].\9X.S
M6[/U_P!2!^'W*='9>,E^5M5L'!_C:/D?@%`KJ%SCGKDTM`',M:>,#R-1T[(Z
M?NV_PI#:^,3G&H:8.1@[&Y]?X:Z>B@#F?LOC')/]H:9TZ;&_#M4L,?BV-7$D
MVDRDJ=I.]<'CT'3K70T4`8-HWBD*&N(],8E1\F]T(/7L#ZX_#WIIOO$X`_XD
MUHQQSBZ^G_U_R_/H**`.=.H>*`%(T.V)R,C[4/Q_S[4U=5\3!0K^'(RY!.1>
M(!]/Y=ZZ2B@#GFUCQ"H!_P"$8SGTOD./TICZWX@1\?\`",,1DCB\4Y_3I724
M4`<R-<U\#)\+R'=@_P#'VO?IVXIW_"0:RN`_AFYR2<;9E/`/TKI**`.<;Q/=
M1/()_#^I*JG:I10Y8]N,]/<9H_X2^/\`Z`NM=,_\>H_^*KH))HXL>9(B;C@;
MF`R:<K!U#*0RD9!!X(H`YL^,H!UT?6!_V[#_`.*I1XRM#UT[5%Y(YMNF!D]Z
MZ2B@#FD\96.W/V'4P"><VY."?QI$\7V"*,6.IX4!<_9_Y\UTU%`'.GQGIB*3
M+%>Q$9)5[=@>.M3KXKTEG53-(N[.2T+`+['CC_ZU;=%`&5_PDNCX)^WQX'4X
M/^%,_P"$IT/&?[2@QZY-:OEIM9=B[7SN&.#GKFF_9H/+:/R8]C8RNP8..G%`
M&?\`\))HN,_VI:_]_13CXBT4==4L^N.)E-63IM@V,V5L<'(S$O\`A2#2]/'2
MPM?^_*_X4`5?^$DT7_H*6O\`W]%!\2:*/^8I:_\`?P59.DZ<>NGVI_[8K_A2
M_P!EZ?\`\^-M_P!^5_PH`J_\)+HG'_$TM><_\M!VI3XCT48_XFEIS_TU%6/[
M*T[G_0+7GK^Y7G]*/[)T[G_B7VO/7]RO^%`%<>(]%/\`S%+3_OZ*E_MO2NVI
M69YQQ.G^/O3SI6G$@FPM<CH?)7_"D_LC3<D_V?:<C!_<K_A0`UM9TMAC^T+-
M@1S^^7&,$_R!_*G"?3"GDB6SVH@.P,N%4]..P-(VBZ6[!FTVT)'3,*_7TJ)?
M#VCK(CKIEJ&0$#]V._\`/K0!)IRZ?91II]G-#E07$8<%CDY)P/<U=W+C.X8&
M>_IUK*?POH;N7;3+?)]%P/R%)_PBNA?]`R#\C0!K%U`R6`'KFD$B$9#KCIG-
M9/\`PBFA?]`R#H1W[_C2'PEH).3IL77/!(]/?VH`V=PP3D8'4YHW#=MR-V,X
MSSBL/_A#O#^W;_9R8Y_C?//OFGCPGH07`T]!QCAV!QSWS[T`;5%89\(Z$<YL
M0<D'_6OV_&E?PCH;XS8X&,?+*XS]<'GJ:`-NBN?/@O0R`!;RC&#D3OU'?K2_
M\(;H@`V6\J$=UN).O8]>HH`WZ*YZX\':7*/W;74+8QN2X<GJ,=2>@R!]:8_@
MVR*MY=YJ$3&3>&2X.0,\+SG@<<]>.M`'245RLG@V1F!77]4&,'YI2>?6E_X1
M"Y#!AXBU,8.0/,.!^M`&QJFBV>JM$]PKK+$<I+$Y5UZ\`CMS5!O!NCF7S!%*
MIR,A93@@8P".F!BJZ^%+Y3D>)=2`Y.`Y'?/K3CX7OLC_`(J74NV?G_\`KT`6
MHO"6D1:DM\D+^:LGF@&0E0W7I['FM/4;*+4K&6SG:18Y1M8QMM.,^M<\?">H
M<;?$^H\=,LQ[_P"]2GPKJ>?^1HOQT]?_`(J@":?PE"5B\B\N_,0QKODF)*QJ
MV2%/\)^E6F\-V@TZWM(9KF!K=S(D\<F)=Q!!);'.<\U17PQJJKM'B>^QDGE<
MG\\TT^&=:*`?\)5<Y'?R>W_?5`$Q\%Z:TFYY[QU8+YJ--E9BH(#-QR>?:D_X
M0VS",!<W+O(-DLLC;G>/Y?D)X_N`#TR>^#4+>&M<;&?%=Q^$&/\`V:G+X<UM
M60_\)3<?+US`.?\`QZ@#J**Y@Z!KZQ*J>)Y"5.<M;CGH!W^M6&L/$?VG>-8M
MM@CP`;;^(XR<9]N#GN>*`&>/7V>$KP?WB@Z9_C%;\*E88U88(4`_E7"^+H-?
MC\/3MJ5[9R6^X`I%$0Q^8;>?SS].^:[P#``SGW-`"T444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110!5T\YBEX(Q/)U[_.:M53TY@4N`&SMN)!
M].<_UJY0`4444`%%%%`!1110`4444`%%%%`'+:]I-_=ZN9K:>R0/$JJ)9623
MY0_3`Z9;=]5':LD>&=:PD\]U9S[$0(%NY%5E4Y].^?7'S<8XJSXNTZ_N]:\R
MVL)9D%NJI*H!*M\_`^88!)4'()QG'3G!_LR_GC1(K&>YN(70")I5"Q1@LS1X
M5\X+$#)_N]B*`+TGA/Q';D-%=P>8"7,D<[@[BWWVW8`..X'\([\TFI:9K$=K
M#$UK]CMX(7C4O?J=[')9@21U4'(.<+TQS4:6NKQ3/#);:HT+;8Y#MW/)&`.P
M;`P5`&.""<GUK"SUH/`MUI]Z(E(PK9D`XVMM!.!D;SC'3';F@#2N]"UN:^,T
M6FO#`L"QQ0I=+\I5?EY##C/?@_SJ"+1_$D4LBQB\\Q/G"0WB(J[BO)!8X)`D
MSUYP>:JRS:Q"#+=#5+9,QE'1C*JNQ3YLY^;(#_+TR5%:/]H7&H^,(;B"&^MK
M;[1$2PC90XVA?G'3KD#V8T`:?AN#7M.NW_M&WO+E)0D:LTL6$`XR1O/;OU-=
M?2;ANVY&[&<9YQ2T`%%%%`!6#XS=ET154X$ES"I/MO!_F!6]7/\`C3']D09X
M'VN'./\`>H`G\3Z;=:I8V\-G,T3+<H[E6Q\HSG\LY_"L>"S\4VZ21Q$+]HN6
MD+*R$0#<=V-V2=P(P#G&.U:_BFXU2TTQ9](4/,LBJR%-Q(/'`]<D5RMSK6O>
M?'=3M=0I-:R.L44!V1L5E$8)P23D(<^_;%`&C>:=XJGLVADNWG66-?,4&.,J
MV,D*0!T(QZ'/UIV_QJIB411N$;[Y\H%QN_CYXP/[OZTLNL:M;Z5=-<2M"\-\
M(!</;9S&>K;1PV.3QUQ5,^)-?6\$?E!HS9E@3`>9%AWD^O)(].H'8T`:EU_P
MD\>B6"VS-)>OEKEML>Y>"0!GY<=JB9_$EOHVI70B+ZBTP"(HW*L84'*+W.2?
M7.!UQ4^I:MJ^EM91-!'=23Q89U4A0X89]P-I/X_E6-;^+M3EOX7F$<<>PN8S
MPI0LG)_W?F&<]CG%`%];WQ3"QG%LTJLH#0/&.'\H'(((^7(Z>K$<FGKJWB<6
M8`TQ'EC4!W*,-Y+`!E'T()&!CGIC%48_'-^^HBV%A#M:1MK$D`INP&SW`ZDC
M^Z>G;M[=S+;Q2$J2Z!B5S@Y';-`'.:=K.NO<VZ7^EB.V,1>:<_)MP#SR1C)&
M<$`X-:NFRZI/!'/=?95614<*BMD`C)!Y(ST_6KUPI>WE52@)0@%QE1QW'<5R
M^LQ`ZAX?>&6)[R,@;T!"E2I&X8XVY'ZB@#=FN+HK+);261C1BH9Y#@8&"&(Z
M$-Q3KAM055\K[)N+,/WC,!][Y?QVYS[^U><6?$:0SB5=,8H+Y6W`M/L=L?7(
M7/;(7-7;_4&FTRRCU"X9;JUM9,`,PS.0ABSMZMM.1[YR>M`'<3-JVW]S'9;L
M?QR/UW>P_N_KQ[U)*U^+1/)BMFN2@W!Y&"!N.GRDD=?3M7GMU>78O+AY)IDF
M,LR:D%)*)$7C4!<]L<9'.*T(;N.3P_I-G=W7DVS7&^8O)M?R,NT>3U`.T#/L
M/6@#0U]8SXDM6U:T2>Q,+I%A'DVG*Y)`4_-V`_7TP;;4M9TW38(K6YNXU6;R
MEMI;`DQQGD,6V\GIQGO4<VL:G#''(EQ,MS]D2(J/F_<F(,9?J&).?J*[/PK)
M(UK=Q>:TMK;W+0VSN#N**!QGN`<C/M0!S5MK7BIY88I"P9XT()LB1EFV_,1T
MQDG\,4T>,=6BMR\GEO+M(,/D,&4*,^8?9NGH/TKT.F&-"Y<HI8KM)QR1Z?3F
M@#*T/4Y[V[U"VN3"[VTB[7ASM967(Z^A!YK8IJHJDE5`)ZD#K3J`"BBF&6,3
M+"6`D=2RKW(!`)_\>'YT`9>K>(['1[DP78DW^3YRA0/G^;;M&3RWM[4EOXFT
MNXN5MEF<7#2>5Y1B8D-SQP".,'G./>KKQ6B:HMP[H+IXO+1689*@YX'XUDZ;
MX=T6SU1+VSG8RY9HX_/W*,@@X'?@F@"S<^*-(M1^]NCNRPVB-L@@D$'CCE6Z
MXZ4^/Q%IKQN[3,A222-E:-MRL@)8$`>@S[].O%4+_2=!O;R6"679/=MYSE),
M;B`4[\?Q'CKDT-X<T6>4M]KD8R&1L"X!RQ!W-ZYPWX<>^0#;L+^UU*U6ZLYA
M+"V<,`1T]CR*EFD\J)GV,^.RC)JKI%C:Z;8K;63;H@2^<@YW'.>.._Y5`^K:
M9>BYMT<W)MV`FC12<'=C\>1^E`%ZWN#/;><8)HNO[N10&X]@:AAU#S;>*;['
M=H)9`FQX\,N?XF&>!67J?B.2TU=K6&!7BM_*-RS'D"1@HV_3(^N:HP>++UH)
M))+:W)4P2J%)_P!5(V.<_P`0R.>G/2@#KB<`G&?853M]0%Q<&$6MW&0,[Y(2
MJ_G5VB@"M)>+&DK&&<F/<=JQDEP,9VXZ]?QYJNNL0;97G@N;>.&(RN\T14!1
M_7VZ\5HU!?2&&PN)5@-PR1,PA'60@'Y>AZ]*`(-2U:TTMK<7;,@N'V*P&0#C
MJ?057_X232EB,DESL"YR"A)&-Q[#T1ORJQJ&EV^I20&Y&](MX,?9MR[3G\ZP
M9?"NDQK';C49(RL#@1LZL60AP&VD?PAVY'\^:`-%O%VAB(R"]W(HR2L3D`9`
M]/4C\QZBK`\0Z07"_P!H0[BAD`S_``@$Y_($U0D\,6MW#&\&H7`0GS(W1P1@
MF,\<8(_=@CZ^PJA<>`]+=%WWDD?F'[P"#=(1VXZ'KM'X8H`Z%M;TU8K65[M%
M2[.(68$!_P##\:A'B32OL9NWNO+@$S0AW4@,P&3CCD>],U;P]#JGDJ]Q+%$D
M?E.B`?.FY6QG''W!TJI<>$89M%32Q<LL:7!F#L@8G((([?WC@^PH`T8/$&E3
MM.JWL2M`2)`[;=N&VY.>V<<^XI[:YI21K(^HVRJZ[E)D'(SC/YUB77@R*6W>
M.&["RG>QW1*0Q9U<!O\`9!0C'O\`4&I+X*\ZV+6M[!-)PD<LD8/R;65@<=3S
MD'U'Y`'7I>6TET]JD\;3HNYHPP+*/<=J(+RWN)9HH9D>2!MLJ`\H?<5@:+X5
M?2-;%VERCVZPE`NS#%CM&3V_A[8Z#W-=!;VZ0;ROS,[%F<@9.23C@=!G`]J`
M'I+'(\B(ZLT9"N`>5.`<'\"#0LL;NR(ZLR?>`.2OUI515+%5`+'+$#J<8R?P
M`_*HA9VZV[VXA3RG4JR8X8'J#^=`$]%0RVL$MHUK)&&@9/+*'H5QC%+/;Q7*
M!)XPZ@Y`/K0!(2!C)Z]*6J']C:?]G,`M@(C)YA4,1\V2<]?4FD31-.CN(ITM
M@)(B"AWM@<8Z9Q0!H450.C:>1@VX/S,WWFZL03W[X%26^FVEK=2W,$.R67.]
M@QYR<GC..O-`%NBLV/0M/B<-'%(I"%!B9^A;>1U]>:FCTRUBBN8T60+=#$G[
MQB?N[>#GCCTH`N44V1%EC:-\[6!4X)!P?<4PPJ+<0HSHH4*"K<@#W-`$M%0W
M%M'<J%EW8!R-KE?Y5!=M`FHV/F+-YLCLL95CL!",2&&<=,]NWM0!C_$`@>%+
MC)QETQ[_`#"ND&<#/)[XKG?'@5O#I1NCSQJ>2,?-71`8`'IZT`+1110`4444
M`%%%%`!1110`R82&&00E1*5.PMT!QQFGT44`%%%%`!1110`4444`%%%%`%6P
M!\N8D#!GDQSS]XCG\C^&*M55L/\`52@@@B:3KG^\>F?Z5:H`****`"BBB@`H
MHHH`***:ZAT96SAA@X.*`'45D/X<L&39OO%&[=Q=R]>/]KV`I#X=MA&ZQ76H
M1LRD*PO)/E.,9'.,_6@#*\0:)JMUKWVZP2W=3;B(&60C:0Q/3'(K!B\*:S:V
MRK_9T#OD1EHY]NY"W(8#D@Y.2"#C'I78+H$X\S=K>HMNR%RX^7/X8/''/3J,
M'%)_8FH!45/$%V%3&,QQL>.F21D_CF@#AWTG7#=I(VC7)E4!'D$Y!;:"H`*D
M`#&W/KMSQDBG0V.LPR^8-$NGVQ211HWW8P^\$#.<J"^>>??%=RVE:JRX_P"$
M@G]\VT1!_P#':7^S=7Y_XGK$XP";2/C_`#Q_GH`<586FL6NF3VRZ=J`>5XR`
M%.%V*=IR6X).,\<;1ZC!;V_B.**WA^SZBD1"*Q#/E#AQN&&R,;NG0X&<=*[5
MM-U<@@:_(#SS]EC]>.U1RZ9KF[,.O!03\VZT3]/?'^?0`YWPI-J=OJB/JEMJ
M<LC1F#,L).TL^<ACSMPO-=]6$=.\0#[FO1GCH]HIR>?3'M^M3Q0Z]''M:\L)
M3S\[0,#^0;'M^'O0!K45D-#KY9B+RQ`+*0/(;@#J/O=_ZU9(U3LUG_WRW^-`
M%ZL+Q:0-/M28S*!>P9C7JWS=!]:O8U7(^:RQWX?_`!K&\2KJKZ=#YGV+=]IA
MV!0Y^?>`/PS_`)S0!U%%8AA\3%<"[TP''7R'_P#BO\YIC_\`"4IM$?\`9<I'
M+,P=0>.@'/0CKWR.F*`-34+NUL;4W-ZZK%&002,G/;`]:K-K^F+I7]IFZ'V3
M=MW[&SG.,;<9SGVK#U:#7M52&VFCTHHEP6VB=L2X!^0C'IU^G:JK:-KD6A76
MFBWLD2YN?-5OM)R@W`A1D<_=`!S0!U,&M:?<:8^HPW2&T3.Z1LJ!CKP1G/MW
MXJIX<U,ZQ%=R.ENR0W#1(T2D!AP<D'D=:P[[2->NM/OK9["U)N;G[2KQW)&P
M\#'(YX4>E7]*'B"Q:]>;2K>5KFX,P"707;D`8Y!]!0!T4P,=N[0P++(B$I'D
M+N(!P,]O3\:Q;7Q&S>$SK5Q;C>`W[F-L?-O*A>>G;\^E3G4-;XQH2?C>KQ_X
M[6`FE:NWA<Z*VFPO@MF870X?=N!(QT'0@T`=!HNIWMU//9ZI9K:7<0$@57#*
MZ$D`C'N"*L:@T.G:1<222SI%$&D+(V6'.<#V[`=`.*Q?M.OVU_-J$^A^<SP)
M&(X+E<*%W,2<\DDGC`]N:KZEJ6M7VB7-K>>'[A&F1EWP,'QCOMZ]<?49(Z4`
M.M]1MWO;Y[V?5+(^0EX8Y)0R&/*D[0`<#("XZ\D4ZVU..::>XNY=2L7BMUN4
MCED7#Q[=F[&WU]>YS],F\EO]2\R>YT74U+:>;10(BQWYR7.<''MBDO)=0NPP
M.B:C"#I_V)=D);^)22>F!QC%`'36.N?VN[6+0W.FW,D0FB,@!+)GJ/\``U>N
M[4K93/-=K%BU='G$0!7N'_X#R<>]<G%J5XVJV%_-H.I1_9(/)6-(F.YFXSD@
M8'^(JS/XFN-4T_4+230=1`D#P*T,)D"G!!W=.0>U`%JPUS[2]T\DUS%']C^T
M(\UHHRBXRP()R.IP?[WYFC:_%<RS0"^$*I^]C22S,?[D')8'.""O?C'7%8K:
MC<36<<#:-J:E=+>R!2W)RS;1GMQ\OZXIFHZRURMLDVEW\&RPF@YAR6+*%+#)
M&57'Z]J`.DT/7EU6]DMTO,L',J*]J8RT/L<D$9(YZ\'\-)VNK-GN;V]A^QQ)
MN?$)!X`YSD\9R>]<38>*K%-6@O;L2PM:68M60J6>5L\X`P!C'.<=>GIKZCXX
MT:XTZX@5IM\MNP`>+C)0X4_CQZ?AS0!JZ;J\>J&>'3]2M995&Y086!4%SR02
M-PVE1QCGG/(K1B6^\F=9I+<R$GR71"`!CC<"3SGWKA/#NJ:3:6JW-[K,QG-I
M]G6)4*F$<<+@'G*Y#9&<C(IVD>(+>PT.YD;6+@ZB8,)#<*2@95P-HQ[8Y[C)
M'J`=XPNB8MKQ`8_>?*>3E>G/3&[\Q5:TU:TFN%LFNX)+Y5_>)%G&0.<>WXUQ
MND^);=K2[CU/6)]DUMA>2SJ^6!*D*,'&TXYZCGKB#P[J^EZ;HUPT-[,E[Y,H
MACG4%4;)V[3C@G()&>3VH`ZG6/#QU?65EFD,=J+<(3'C>6#YZGI^'O3-#\)0
MZ/*S+<&92KJ`T8!&X("<_P#`3^=9.C^*,331:CKD1B>W1DE"#<DC=<?(!QUP
M0<9')P:33_$JMI4T][XB07<D(VQ+`!Y3@9XXYSQGMDF@"]9>!XK6(H;YG(!V
M/Y*AD8LAW`\G/R8_'ZYAM?`<<<<JS74;[TV*!"0$.Y3O'S9!(7G![D=`!4&G
M^(;F'1[B[N=:ANKHVW[NV:-8S')S]-QX_'&/2K">(IX](U'_`(FUE=7<:;[<
MHPW$!06R-H!QR>!0!K^'-.338YK=)X963:K[,EE;EMI)).!N&`?ZU4TC0+K1
M;S4+R.9)FN9DP@PB[-PW,PZ;@"V,<?G@5/"]]I]E+JC3:I'+ND0^;)M0OB($
MD@=^&SWR#WS6MXAN[.;1;B'[1&_F1YPCJ3M!&6&>"`#GZ4`9^CV-I?QVMVEE
MYC1N,N;TR8.YB0W]XJ<$9_O5)!HD8L;E7TMH"S)(B?:]Q8JQVIG^$#`P.1R.
M]1>"9[:.PN3BWB5I?EE0%%E`7&<'`XP0<<9S2Z_JECK'A>2:VE9[?S4\T`[6
M,8<;N.I&,T`=#//,HS;6_P!H'ELP(D"@L",+^.3SVQ[U(DN^5E&TJ`-K!LY/
M<8]N/SKB+B:S,/B0:=@6#PQD&$_(7P2^T9QG&,X].:T=+;1EN-8%I)"FER0Q
MK(%?:N[#AB#Q@;=O([^]`'4HP=%<=&&1FJNH@SVMS:)"TC26[XSE4;(QM+=B
M:Q?!-W:#13`DT0\NXD`4..A8D?I_*MJ[O8Q8SR6UQ"95B9D^8,,X..,^HH`J
M^(-*FU734M[>X^S3+(K"0$Y4=#C'/0GZ^W6N<'A/5E,<KW*7+QLQV3R,0?O*
MI!Z\+@\^N.U6M-\4736%]-=?9R8;>.9)0&"*T@X1NO.2/_K5;TS7=0NVU&"Z
MMXK6YMXEDB5P>=P/5<Y(!&,CUH`SY/"VJ1A8;:>,PA715:>11$3&@W+C)X96
MX_QX+CPYJ\S(TI@F6":/RD,S?,JR.Q8D]#A@..WI@5NZ!?W^I6D5Y=):QP3I
MNC6-FW`YZ'/!XK4E+F-Q"4\W:=N[H#VS[4`<9K&A:UJ&M:E/8S&VCW(JL9&7
MS!L3('8#KSZC'TT/#>A7MG---JL@D=HMB>7,Y`RS%N.,=5QCI1IOB.ZN4O9+
MJVCA6PB*S\G'GAF&T-R-N`">#C-2Z)X@N=0U,65W9?9V>T%TIR<X+8Q@CWZ^
MQH`R)?#WB,Q0NNHNTZ,S-^^8*P4(L8QGJ0&)/YYJ)O#WB2VED2SN0D<DCNC)
M*1Y?^MP,'UW#GL2/K6OX7GNE76E=Y[B.UNY(H1(Y<D+_``Y.>V*72?$UQ?6R
M74]EL@:TDGS&2S%D?:0!CGC%`#=`L=4LM3C%ZLS1>3(JLUSY@5=RD!A@#/)Y
MZX^E=)$ACC"EV<C^)NIKG=%\43ZGJ,5I)I;Q^9")O,1]RJIY&<@?3C//XXZ6
M@"&XN8[9':3=A8VD.U2>%Z]._/2HEU.S=`R3!@2@P`21N;:N1C(R01DUEZ7X
MBFO;F*.>P2W2226/=]HW$&,<Y&T?S[56TGQA9:A?6\"6XA^T[E1O,4L-N<!E
M'(SSCZT`=-)(D4;22,%1`69CT`'>HQ=6[*K+/&RLVP$,""WI]:R],UN?4[N6
M#^S)(XHI7ADE9P5#+U&._P#]>M@(J@`*`!T`'2@"+[9:^4LOVF'RW8JK;QAB
M,Y`/J,'\C3?[0L@NXW<`&UGR9`/E4X)^@/>L2Q\4VMYJ4%E%9X+S.B'S$)4J
M#DE0<C@'MZU#X=U>=_L]M?V3;IDF,=SA?WBJV2-HYZ%?J?SH`Z)+ZTDD$<=U
M`[LQ4*L@))&<C'J,'\C3WN((V=9)HT**'8,P&U>>3Z#@\^U8?A_7['6;C;;V
M:PL$,BDLA/7!R`<KU[XS4FCZU'K$SM_95Q`FPAKB9!L.UL;=W?G/XYH`VHY$
ME4M&ZN`2"5.>1U%,-U;C=F>(;20WSCC'7-8NB>)M/U*^:SMX6@=@94SMQ)W)
MX[\Y(/-;$EC:RQS(]O'MF#"3"X+9&#DCU%`$IEC#A"Z[ST7//K2EU5E4L`S?
M=!/)^E1BTMQ-YWDQ^8""&V\@@8X]."1^-2-&C,K,BED.5)'*G&./PH`7<"Q7
M(W`9(SR!_D&JE[#')>:>[SB-HIF9$/\`RT/EN,?@"3^!J>2WAE$H>-3YJ>6Y
MQRR\\$^G)_,T\(JJH`X7I[4`8'C<XT6(Y`Q=1<GH/FKH:Y_QF"VDP`=3=P@?
M]]5T%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`%:R&(Y
M<=/.?Z?>/3_/7/:K-5-/QLG``&)WZ,#W[XZ?2K=`!1110`4444`%%%%`!111
M0`4@(/0YJIJT-Y<:;-#I\ZP7+@!)&Z#D9_3(K+\'Z??Z5ISV5[!&BHVY'20-
MNR3D$8&,8'US0!O%E!P6`.,XSVI00>AS7`Z^QFU^ZG4S(P*VK)(C[)("#O(P
M/[W^-4(-1U3R)_,O-1CA:>-I=B.3$F7W!&Q@#A!TP<CCJ*`/3J*\F;7-4CMF
MCBU:>5G6-V8RD,N%.Y1D<88@'UQZ5J^'?$\O]LRRZAJ>;5@-V]PJ`X.-JG)[
M=O7G!XH`]$HKS?P_K<-MXHGO;V1MEXKYD9R%@YSM(.<]$'!XZ?17\273Z])J
M43HD<MK.L"NP.$1"R94=&+#//4'`H`]'ICS1I)'&\B*\A(12P!8@9.!WXKS0
M^)]31WFDO'"7"E$G\H?-M7@*F1MRQ/S?ETJ:?Q-J^G6D0%U!,BR2PQL4#$B,
M`!RQ/5N?KSB@#TBBO/F\9ZBLM[B6T"PQ(0)(G'S<`].<YSU&/?U3_A-=62YL
MT\JVD5X1-+A2.#DG'/8?7.*`/0JQ?%)06-J'(&;V`#/<[Q_3-1>$=8O=:M;F
M:\2!1%+Y:F($9.,G(.1QD#KZ_C'XR($6CD]!JD/_`+-0!N7UQ]CL+BYV[_)B
M:3;G&<`G&>W2IZ;(B2QM'(JNC`JRL,@@]0135@C6X>=4`ED549O4+G'_`*$?
MSH`Q8M5TRTO-.T]8647`9K>1@.&R<]>03SSWS4<?BC1KZ".2<C8;ORH0X!)9
M<$.!V`R#D]*672M.OU8:A`;;[+#\R&8%$3S"P;/J=F<^C?E5D\,VDUI9O_IZ
M&6;S9!%*K[2X'!/3:-JC(SQ]<T`::ZCH^JW,=JQ626:&3:CJ1E-Q5Q^:'\JS
M1KND7DT8GL)A+'/]E=7V_N6`;&[YL$8W\\]#[5=TS0;6SU1KB)[OS8-Z#?PC
M*[%\#CD`G\ZIGPO':&VN#=227B79D$ZP;F.\GA@#T!.=QZ<^M`$EF_AJ:WM,
M^3`QB6=(I)L%%&Y@3\V/XG)_6E%OX5,4:QRVA`3,:I=X+`9/]X9.0<D]QSTJ
MC=^&+>R6)9KJ[EB>/RO+BM]PWB(IO.,X&.W0D"E'A+S]6:1[^3S8U9I6%MM$
MC2;N5.>@'&WD=?[U`&M!;Z+J.%7:99X1,T(G.\(P3J%;I\J>WIU.;MSI%C=2
MR2SPEGD`#'>PX&.F#Q]T=*PK31GTC6HKE[Z:5(+4ED2T/SJ$1"NX'U56"@9Z
M_6NC6]MVOGLEDS<)&)&4#HI..30`Z2V21XV8MB/H@8A>H()'?&./QJO#I5K;
MV[6T0E6!D9#'YK$8;KSG(/I@\58FNH('1)ID1Y/N!C@MR!Q^+*/Q%)+=V\(<
MRSQIL(5MS8P2,@4`-N;3[3N!N)XPR[2(VQV(STZ\_H/2I4CVRR2>8[;\?*3P
MN/2D6Y@>80K/&TI3S`@<;BF<;L>GO4$>JZ?,4$5[;N7`*A9`202!_,@4`,FT
MUY=N-1O8PN?N.HSUZY7W_05+?6C7D:HES-;%6R7AV[B,$8Y!&.GY4'4K$0"<
MWD`A)"B3S!M).,8/XBIWEC1@KR*K$$@$X)`ZG\,T`49=,E:WCBBU&XB*EB6V
MQL6R<\Y7'K^9SFG7&GRS10*M]+$8TV.RQH?,Z<G*\=,\8ZU;$T1W8E0[<;OF
M'&>F:>2`"2<`=2:`*,NE0.P*!(UV[641(0W(.3D>Q'XTG]E1FZ>0^4(60JL0
M@3Y3Q\V<<]#[<U?+`$`D`GH,]:`0>AS0!`ME;[`)(8G;&&8QCYO\XH-C:$DF
MU@)/4F,58HH`K_8+/_GT@_[]BHI]-M)$`%C:.=PXDB&,=&[==I-7:*`*3:1I
MK(R'3[4H[;F7R5PQ]3QS41\/Z,1C^R[,#`'$*C/Z5I44`99\.:*?^87:?]^A
M56;PW9&0B+2M-\H#C<A#<8ZX_']/>MZB@#'7PUI+-*9=+LOF;Y=D>/E_H>O3
MVI[>'-&"DKI5H3C@>6.:U:*`,,^'=,V'_B26>YBF1QP#@-SCL,GWQVS3U\+Z
M*Z?O-*ME.XG`'X=?IVK9HH`P%\+Z1Y,CMHUN)1NVH')#8Z<]LX'TS3)?">D2
MH4_LB-/-!#.LA!3C@C\>/\:Z*B@#ED\-6,5HD8T$2X'1K@9)SC)[9P2?PJ-/
M!FFLB1G3Y8U&W<1<_?!8Y#>N`%/X^QKK:*`.33P5IJ@RI;7$$B`/&J71SNQR
M,]N>,T@\*0Y:3R+Q9#C</MQ^;"^N,]1CGU^@KK:*`.0D\&6AM1MBO`TC-YL8
MN^/XCDDCG.%'XCT-,3P7:QW,/DQZC%O1A)*EVHV9/0\9/X<5V5%`'+P^!--@
ME26"ZOXI$)(>.4*QS[A<U';>"K.WN3Y$^IVZJ,+)'<J,\@]AGG^E=910!REK
MX&L(X]R7.IV[GTG4%>V>!CI_,U'_`,(Y#]O:R74O$(8)_K?-_=XZ@;L>N>*Z
M^B@#C=/\%K'=W+3ZM?\`V@'/FP#R<[N3@_-GD=L=*9:^&H)YV_LW4-4M9+65
M\23Q?)\V5?R^%P3CJ#Q7:T4`<E!X6NX9G_L[Q!J$#1N?-\Y2ZNY`8L!D`_>[
MYYSW%2PZ1KTBI<1>)9<D`;9+-0"`3VS[GZ\<],=110!P%GX;U*VBAO(M:E*0
M2,L0:T9V5RS(3L)]23GWS4S>$]3L+7S?[<Q':QS%56V#85LE@!GG./SZ5W-%
M`'&6OA?6+":*.U\0;"B%8LVV?DXR#DD=3T/^-/M]!US2K?[/:^)41/F=5DMU
M(QG+')SCKG\:["DP,Y[T`<58>&=>M6BGM=;MR%C*1GRMR[2!T[=A^57&M_$L
M<JPOXAL5E;Y@C0J&(SCICID@?E74@```#`':D*JQ!*@D="1TH`YM=.\6;?FU
MRV!VXXME//Y46IUZ28+#KFF731?++'Y8Z@\YV\@C.*Z:F+&B$E452<DX&*`,
M1I=>225FO='"1*K2*R.-@Y))^;CCU]*>S^(E**LND2,P+;=LBD@8Y')SU'YB
MMDQH0P**0_#9'WOK2X&0<#(XS0!QNO2:]Y-M_:,6GI;K>0G=$[9)W#'7I_\`
M6KLZYGQC),UCL>$+"MS;^6^[)<ECGCMCBNFH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`J:>6*W&[@"=\#VS_DU;JK8ILCEVKM+3N22/
MO?,>?Z?A5J@`HHHH`****`"BBB@`HHHH`****`.9USQ1)INIBS@AA<J8MPDD
M(9@V[.T`'@8!)[>AJG!JFJV6AZ?+<2Q7-YJMP@C24X1$;&`,#TQU/?O4^NIX
M;M=6SJ/VD7<R@EDDE`",2,9!P!D$XI8]-\/7XDC:XN`L$[($ENW`W)GE06Y`
MYY^M`&1#XL1+'S=2TNWG+L"C%0N$._:&&T\_*?J&J3Q'J<-GI^ESV^E6:2WD
M9F83Q(P4!02.W)SUX)Z8SP-8^%O#\H2-Y9)%EVA%:Z8AMH(&.><#('H*:OA_
M1;^%(UOY+H[F6.9[KS65@06"J<KG"^G2@#*LM:TU8XTN="L'/DAGEC$0W,(O
M,&$ZXQW['TZ4R+Q%HLUNSP>&;5PH=G4+&-JKM.[E>^?TK8'A:PGN3/#JDDDK
M$AG/ER,RD`%22IXQP..!62MCX?@EEA3Q!)!)EK1T"1KDMD$$!.5Z9/3W%`%K
M3M1TVZBOKR;0K&"VLH58J(T=RS#C!`QC&*ACOK2]O;2TM?"]DLSSO#)YD:.J
M!=I;E1U`;\#ZUJ1>#_(MWM[?4I(H93F1%ACP_P`NW!XY&.QSSSUHT[PW!HMS
M:SIJS1QJ3$BLD8\S<V=N2.22`..<#`Q0!KMH6D,<MI=D><_ZA>OY5%-X:T68
MC=IT"@?PQKL4_4+@'\:U:*`*FGZ;:Z;'(EG&461_,?+LVYL`$Y)//`K'\8L/
M+TA!_K&U*'9S@]^?\^M='7.>+0S7&A!<G_B91$J!GIGG\.:`.CHKE[2XTA;.
MVO+O4I2]]$\8=IG42#A3P#@,.!GK_2_J$VD->-/<WY22R*/(J3L%3!(&Y0<=
M6[^W:@#-\0>&+S4[R\N+6:%&FCCC"R$[749+!AC@Y"D$>E5[7P[XA267S]2S
M;L`J11W4HVKYJDX]/D##KGD"MB5])N;>T/\`:#;;F5_(9;A@9"Q(8#!S@9_#
MBK+S6-E/;6KZDD#QDMY+RJ#("".<\]3D?2@#E7\/^+$@V6^HD!AF0-=.6+\\
MANH'(XSV&<UV>G17$&GV\5Y-YUPD8$D@_B;'-+':)'<F<23%B&&UI"R\G/0]
M.E1I9RQ111Q7LP6/8"7P[,`3NR3S\W0^F.,4`7**CCC=996:9G5R"J$`!!@#
M`[GG)Y]:J_9KI/OZI)R_RYCC'?.WISQQZT`7J3:-V[`W8QG'.*SXK*\AA82:
MM-(=C_.\48VDXPW`[8)Q[\U,EM=+"RF^=I#$4#F->&YPV.G&>GM0!:*@D$@$
MCU%-,:'=E%^;EN.OUJ#[/<>8K?;9-H9F*A$P06!`Z=``1Z\YJU0`W8N_?M&_
M&-V.<>E1K:6RA0MO$`N,80<8Z?E4-W#?%S)9W2*=H`BECRA.3DDCGN._:IO]
M)^T1\Q>3L.\8.[?QC';'7]*`&FQM&@6!K6`Q+]V,QC:/H*E>*.1@SQJQ7(!(
MSC/6J?\`Q-<W7_'EC:WV<?-RW\._VZ9Q3$_MO<^_^S]OE?+C?GS,=_\`9S^.
M*`+AM;<J5,$14[<C8,';]W\L#'I2W-O'=6TD$R!XY%*LI.,CZCI]:JQ'5OLY
M\Y;+S]YQL9]NW;QVSG=^GO3_`/B8FTE#+:BX+X0!FV[<CJ<9SC/3VH`G6VA3
MR]L:@QDE#W&>OYTZ&)((8X8P0D:A5!))P!@<GDU5#WZ6>XP0O<;%^19#C>3S
MR1]T<'\^.E27$UTK.L%J)/E78[2!5+'=G/<`87M_%QTH`FCB6,N5W9=MQRQ/
M/X].G2HH;."!YVB5E,[;G^=CD^W/'X4D$MR75)[;:><R(X*]3CKSTQV[TT7-
MS]I6,V+B(NR^;YBX``!!QG/)R/PY[4`644(BHOW5&!DYJ&XM5N"I,LZ8()$<
MI7<!VX_IC.,=.*=#+)(0'@>+]VK'<0<$YRO!ZC'/;GBJS:A..FF7A&,\>7GI
MG^]^'UH`OT5"LSM/Y9MY57!/F';M."/0YYSZ=C207$DHRUM+%\@;#[<Y.?EX
M)Y&!^8H`GJ`P,8)H_/DS+NPX(RF>F/I1/<F"S:X\B:3:NXQ1KE_H!GDU&]]L
M`_T2Y9RRC:L><;F(SG.,#&3SP,>HH`M`8`&<^YI:J17RRO$GD7"O)G*LF/+P
M`3N/3N!QG)/&0"18:0*X4ACD$Y"DCCWH`887VS@3R`RG*GC]W\H&!^6?Q-.,
M;&X67S7V!"OE\;2<CGIG/&.O>HH;Z&=E5%ERR;_FB88&%..1U^8<?7T-213I
M*2%W`@!B&4C@].M`$9MI#>B<7<P3C,.%V'`8>F>X/7L*<()0EPOVF3,I)1MJ
MYBX`P.,'!&>?6D6]@::6%2Y>*01-A"0&*AASCT(^E,_M*W$,DI\W9&`Q_<N3
M@D@8`'/0]*`+0Z=<TM5Q>VY5F9RBJA=FD0H`H."22!QQ^7/2FB_MB,AV(WA`
M0C$$DJ...1EAST_(T`6JCGC>6/;'*T3;E.Y0"<`@D<^H&/QJO'JEG*9O*E+B
M`@.51B!GT.,'\,U/)<0Q/L>15?89-I/.T8R?H,C\Z`):BFCD<Q&.8Q!7#,`H
M.\8/R\].W(]*D5@ZAE(92,@@\$4M`$;"7S4*,@CYW@@Y/I@YXJ2FR2)%&TDC
MJB("S,QP%`ZDF@NH=4+`,P)`]<=:`$B\S8/-V[\G[O3KQ^E$GF?+Y94?,-VX
M9X[X]Z5W6-&=V"HHRS,<`#U-$;I(@>-E=&&0RG(-`"0^9Y*>=L\W`W;,XSWQ
MGM3ZCEGBAQYTJ1YR1O8#.!D_D!FG@@@$'(/0B@!:9(SJH*)O.X#&<<9Y/X#)
MI]%`!1110`W+;P-ORX^]GH?3%.HHH`8S.&0*FY2<,<XVC'7WYX_&GT44`%1.
M\BN`L6Y>.0W/7GCVJ6B@!DC.H79'O)8`\XP.Y_"GT44`<MXGM)&A$TCL/M%S
M;*D9RWEX;D8'U[=<5U-8GBH@6%KG.#>P9P<?QBMN@`HHHH`****`"BBB@`HH
MHH`**9-*D$32R-M11DG&<4^@`HHHH`****`"BBB@`HHHH`IZ<<K<#Y.)W^Z?
M?O[_`.?:KE5=/8-'-@DD3R`C&,?,>E6J`*S!O[10X^3R6R<=\BK-%%`!1110
M`4444`%%%%`!1110!Q6O:1K<^KWL\-I'<65SY<;QI,JNZ`9ZD<#=U[\C'<UA
MQ:#J:P2VUUHER^]0GF"5&,>'+L4XQSD#KV///%[Q9JOV?6KEXKEHKF-XX590
M0R1[2W!Z8W]>Y''2LF7Q1J4HN2=5<+<2JN44HR!=WW!T5>5R<Y^N#0!:L-$U
M2&=7N-%ED1P#+O2-R&W$_(,@(#D9&#T]#21Z)=1O"PT_44(CB&1:J2DBKG"D
M-PI/))&>O?K8TWQ"L5EK3W&JYEN8&DAC(/RR-N&%/TV^G7L!FL^UUD03POIT
MD=M`9(V83N9-CA3&6(/J'R!GHE`$JZ/=PZC;7%CI]_;^4BH6:Q!PP&-^-QRQ
MY;M@X'/6M%HI(5E6UTK5D1+$VEN#:992Q)=B=W7GC'J?0U'8>+]7NXH";FV5
MVN`C':H`&`0&R1@'YN1_=/MF.S\3ZO:PPI/=).)5#%I8P?+#;</G.203C&.U
M`#9]/NWNFB@T[4H;)=A;="WF-L'&2&.<LQ)P<@#CM63&SO%#O2=9(Y'.]ED/
ME`H`K<8&0PR2!G([@8K<^UW]S(D@UB1IYH7N9(K=U01[%S&F.?F+$%A[D<]:
MLW'C#4[:*\WB%I+:61&Q"0O\"K@Y/<L>O0#UH`YV)F:W6*6_"-'*S/AI%ZA,
M%,#D_+CZL./2[IMZ5E?[1/)+!=7"Y#74GF*JMNW$[-K`D=@&.<#K6K%XIUE;
MU-PMI5ED$8BV-CA5)VL.[9/)X&/3IO>%M??6K>5YDC0B3$95C\P(W;>0,E1P
M3WP30!OU@^*2`^BGO_:<0[=PWK6]7/\`BEP+K0XR^TMJ,;#T.`?\<?C0!2NX
M=8U?1M,,$5K(LT0-R6PA8'!&#@X4]3C]*K)X9O8Y[SSK*.[MY6+,GVQX_/;>
M660XZ$`X([\5<\7:U>:?>006=S';@1-<2%POSA2,("Q`YYX'-0P>,Y6F<26D
M3H'DSME*O&J(';*D9)QD#IDJ>E`"6N@ZM;:Q8S;QA%C#S>:6V(N[?&0>N[<O
M/^SGBG7-A>VFIZ@O]CVM]!J,A*SO)M\L;>C<$XR.,=_<TQ/'3OY:#2@)I$\U
M4:Z4`QXSG)'7VZUHVNO1WFF:E=7D""UMF^4'G<-@8`CG!Y'-`'.C2M;MD@D9
MK]GNEV*C73$12>8"C-@]-H`/IR?I%&OB07%O=23:B$-TOF&1O*0@8SD=`O/!
MP01V]=:S\7PZC#!'/9QW-QYX(2)@`N%WA@7(P1COCH:KQ>*+3^PK=(]*B-J)
ME250RI$IY?"Y.=W0],9SS0!EV]QX@GTN.2SN=0>WN-HDE=\NI&[)0`Y"X`)Z
M<X_&:^CUJ>'[9_Q,)[R.Y+`,J_NHPC895`P"1],D#KQ5^XU_P]-<QR7>CRI(
M\:C<P0'8XVC@-DC;CH,@4P>)/#T<'VF+2&5GPC#Y0,*H(YSZ<`>HP<9H`77M
M.N+^+1X+:TN)G6TGW&ZCW-DH-NX]FR.,]\5)'>:_#\MK;WJP1PP>6DD`8L-F
M'W$C.X$`X'''O73Q:-IJ@LEE&@=2"N,##$$C'3J!^52SZ;9W-R;B>W224Q&'
M<W/R$Y(QTH`X*]O]>U#26MM4LKC;)N6+_1"3+)N!`(P"N%)(('.#U/`Z+7=0
MBU'P^\L)N8A'<B-V`*>6RGG?T.SL?K[5L6.CZ?ITHDM+5(G$?E!@23MR3CGW
M/\O04VWT33;:9IH+5(Y&C,9921\IZCK[=:`.*L]9U#3++3XEE%K;NJ%1(F]&
M!E?>0QYQMP>HP/SJ*W\0ZEIUM';Q2+&OV>V"&1"R1C:06)QP-V`?R'MV\NAV
MK1-'%)<6X<*&,,I!*JA0+GG@`Y^HS4]QIL,\L<N^9'C?>&20]=NWO[?YZT`9
M.H7$SCP[</+)%--.@DB0E0VZ,ELKUX..O3/-<O)J]X7BS?76Q\?VBPE9?LY\
MX@!<'Y.F..WYUWL>G*DD<AN+AY(_NLSY."%RO3H2@/USC`XIUQ9&>=)/M,T:
M@@M&A&U\>O'.>`?84`5O#,MS/X=L);P[IFA!+$DEAV))[D8)K4JC'I\L;ACJ
M-W)AT;#E><`@@X4<'J?<58\EP)\3N#*<J<`^7\H''XC//<F@":BJ<-G/&H#W
M\\F"2-RI_M<=.G(_[Y'OF:WADBSYEP\HVJ`&`&"!R>/6@":BF()`TA=E*ELH
M`,;1@<'UYR?QJ-HI_(*K<GS-^X.4'3=G;CTQ\N>O?K0!/138]XC7S"I?`W%1
M@$]\"DB\P*?-*EMQQM&!C)Q^.,9]Z`'T44Q/,WR;RFS(V!0<XP.OXYH`?113
M(O,PWFE"=QV[01\N>,^^*`'T44C9"G:`6QP"<`F@!:AO)6ALIY4:-62-F#2G
M"`@9RQ';UH+S"*,B%2[%=Z[^%'?G'./U]J)FGR1"D9^1B&=B,/Q@$8Z=>?:@
M#$&H7XN7@LUMI9I[J0!Y3L141%].6/YG\!D.C\3V]NZ6VJJ8+I?EF**6CC8D
M[03VW`9&>QJP]F+>[BNIQ`<7#OOW^4$#+CD='.0!V['MFLJ7289Y)_\`B7!A
M/,DKM]O8,RKNP^<<@;AW_'B@"V/%^FS)B+S=[1%P)8RJ@[2P#'MP,^F"*/\`
MA*(?[*\T@"[^S+(01B,.T1D`SGI@?J/6E'AVTFN?WVGA$,(4R+<L6`V&/9C'
M3;[XYI]MX>LI(V>>R-O*]N+5E2<M^[7&.>.?E'/M0!!;^(Y%G*W5M';1)<S0
MO\V=JI&'#9XZYK9T^^M=4M%NK5@\;?+DK@CU!K.NM%BFEN";-F5C-("+DKYC
M/&JD$8X!&1[;<]ZUK6VCM8V2+=M9VD.YB>6))QZ#)Z4`2@`#`X%+14:/(UNK
MM%MD*Y,98<''3-`#V4.I5@&4C!!'!%!4%@Q`R.AQTJ.1Y%MGD2$O*$+"+<`6
M;'W<]/;-2T`(RAU*L`RD8((X(I%544*BA5'0`8`I%D#2.FUP4QR5P#GT/>GT
M`1RPQ3`"6))`,X#*#U&#^E/`"@```#@`=J6HXI?,>5=CJ8WVG</O<`Y'MS_.
M@"2BBB@#+>\M+21IG+SR>0[K(N&WJK$E5QU(]J6+4[)[^T3$B7%];AX]P_A&
M6VGL#R3^'TJ2ZLYKFUGB5XH?,A>)<1[MA;OV[8X]:YZ]T$_:(_,NY?ML<MN8
M9UMF94494+P?7))SW%`'0ZQ;>=:-(C2QS1_<EA4LZ9X.!WX)J*ZN$@FN)]3(
MAL[=XVAE+8RQ!!Z')Y..:NW4LL%N'CA\Y]R*5!QP6`)[]`2?PK*UC1C=VMXF
M+1DN)DD?S0RD*J@'Y@>O'!Q@4`12WOAL73/)>1K*(&4J96'R-\QXSU.2>.>:
MN?;=(OEM;D743KYOEPD2%07X^7&>3P.#60^DZH[6T[SZ;<6=I$&B,J,3(VS&
M]SC_`",=QFJ8L50:=?ZEJ]A'*;QKE6CEVQRJ2I8@GJ<`+Z`4`=8LEGJ@=4?S
M/L\Q1MI9=DB\$9&.1FK:@*H4=`,"L[1[&6S>_DE\D_:KIID,6?ND`#.>_&3V
MYJR+^T,_D_:8O-W;=NX9SZ?7VH`F\M?.,O.XKM^\<8^G3\:?3(IHY@QBD1PK
M%&VL#AAU!]Q3Z`.:\4F-[7:D[2.+ZW#QAQF,Y&`!VR.>?6NEKD]<E\V:(QM`
M\<FIV@RB?,1@'DXP>V.O%=90`4444`%%%%`!1110`4444`%%%%`!1110`44U
MMV/EQG(Z^G>G4`%%%%`!1110!5L.$E&TC]](?_'JM54T\GRY@0!B>3IU^\3S
M^?\`*K=`!15<SL-0%OM&PQ%]WN"!_6K%`!130BB1I`/F8!2?89Q_,TZ@`HHH
MH`****`"BBB@#EM4\4S6NKR65M';.L9VDR2$-G:I.,>[`=N<^Y%#_A.YWC@6
M&VM'F(#2`S8`&3T_#:?7KQQ5G4=<T>>_EMH-,6YOHY0BO)$NQF9PA.[J>OZ5
M7-_X:CU::WN-/M-JS>4C1PAB,#!+\^I..^%)QWH`EO/$VH6=C8W+"WD:XEF8
MH#C?&K!55>N6^8'\/K5C3_&*WFEZG?O9D6]H<IAN74D@`CL>F>HYK..J>$3$
M)(M+=F3<0HA(*%>3WX^]VZ?A5J=]*MK>P0:"`MZ!+)&1A44J6.3W("YQ@=.U
M`"G6-,_L.ROIM&MWEN/,98%1>$C#%F!('``^OS<54EUO1VEDCBT"T#0O'$?,
MB3@MG<.`>0!T'HWI4]A-X?U#2?MU]I26<44GDH9"64$C)P1V'(_#'M0D_@JX
M@D)A00KM)=HY!N//XDCG)]^M`$+:WH4@01^'HYBT6\A(8R$4+N.3[<9'O3]&
MU+1-99@N@6J16\4DTK-&ORX/`''.1CT_2GQ+X(GV)%L4NQ50IE7).,J/7.0#
MCL<=*CU2+PE9I=B*.4RQ-LF@M7<;^0N#SC`R/Q]S0!%_;OAA=PG\/>2P*L?]
M$0[58##'V^8?F*GM-=\/1WD4T6@/`2ID686R#:@S\X`YQP>@['WI+G2/"MN[
M-<-<V;QJLS0AG`BSL'8'N5SSUI!8^$;A0RZC*Q6W+HWG-NCC&00HQQU)QC(]
M*`-/_A-M-2W#SPW<,O\`%"T)WJ/EY/MA@<TOB3$VI^'F4_*;L,"1[9I!X*TP
M*?*N+U$=<82?@C@^GJH/_P"H8LZXJG5M"#,21<MC'!/[MO\`ZU`&O+;P3$&:
M&.0CH74'%-E6UMHYKB1(T4`O(Y4=`.2?P%87BG5+NPNK2*UO4A>8$)$80Q=@
M1U)P%7L><\_B-L7,5U9S/;3I@!EW]D89!SGT-`&.]OI[PO:?\(]*]L&:0,B(
M4DP"000V3G&!G'45.QMA+,IT2?\`TKY)F$2X8+O`SS_L\?[RUC7KZ_-J&FP0
M:U&D=_`2CQ0@C*Q`LW3(RQ./0$>F*?%XW+02;-/DGDBD$9PX`;AOF+8P,[#Q
M_P#JH`U)5LM6:9;S1;L9B#LTL87=MSA00W7YF_6J26.COL?_`(1R\7[.HC4&
M+'#$CINY[Y/)'XBHYO&0EBN(X;:6W?[.9(IW`9=WE>8!CCMG'X>M7M+\2QW^
MH+I_D2I-Y9)E8#:6`!(&#[@_B*`'7FFZ5:7-H_\`9,TSH@1&@0D($P5W<_3&
M<]/:J%G8:#=W,,#:'>0,X.&N8V7/R@[2Q.3P.G3@_C5T_P`3:F+VY-XR36EF
M\B3>5;D,P7`!4YQDLPX]*NR>+XENFG$<OV*.U:0J4`<N)A'CKC]>XH`W+K4$
MLG=&MKEECB$F^.(E<9Q@'U'7'IS38M7M9!EO-B/'RRQ,I(+!0>G0DBK%G=1W
MMI%<PAA'*NY=PP<?2IZ`*AU*S`D)G4>4</G/'S%/_0@12)JEB\+S+<QF-"`S
M9X!+%1^H(JY10!1GU?3[:(RS7<2(':/)/\0."/KFK4$\5S"LT$BR1MT93D'M
M3P`.E(B+&,(H4$DX`QR3DG\SF@")KR!;T6C2`3&(R[?100"<_4U,""`0<@]"
M*:T4;[]T:MO7:V1G<.>#ZCD_G3@`H````X`':@!AFB&,RIST^84X2(0Q#J0I
MPW/0^]0?V=99!^QV^020?*7@GKV[Y/YT@TVP",@LK8(V<KY2X.>O:@"U35D1
MR0KJQ'4`YQR1_,'\JKC3K$"$"RMP("6BQ$O[LYSE>..>>*!IMBI0BSM\QG*'
MRQ\O)/'IR3^9H`M45!!9VMN<P6T,1YY1`O7&>GK@?E4]`!14<\,=S;R03+NC
ME4HXR1D$8/(IJVT:6Z0J7"(5(^<D\'/))R>G?K0!-144T$<YC,@)\MPZX)&"
M/IUZT_8/,+Y;)&,9X_*@!U%0"V0#@R9\SS,[SU_P]NE+;VR6^_8TAW')WN6_
MG0!-14"VL:F,J9/W;,PS(QR6SG.3SUX].U3T`%%0BW0/,^7S+][YSQP!QS\O
M3M3X8Q#"D2EF"*%!9BQ./4GJ:`,;Q-ITFH+8E+-;V.&??+`S[`R[2,Y]B17/
MW&A:FL'FBW%E#&Z2JD,Q+0J'=FYSR0".G'W<#@UVLT!DG@E$KIY3$E5/#@J1
M@_B0?PJ>@##\)_;)-+-W?3-))<MN`)X50`H(],XS^/UK<JK;VCV]A#;+=2NT
M>W,LF&9P""0<^HR/QJ>57=`$D,9W*<@`Y`()'/J,C\:`'T4R56>)E20QL1@.
M`"5]^>*KM;W1E#"^8()-Y7RUY7CY<^G!YZ\^U`%NBBJD=O=+?O,]\7MV'RP&
M)1M/^]U_R?P`+=%5)[>[>&=8KWRG=PT3^4&\M<#*X[\@\^_M4D,4Z7,[R7)E
MB<KY<90#RL#GD=<^]`$]%4KFWOI"YM[\0Y<%080VU=N".H[\Y_"I;1+E(T^U
M3+(_EJ&VK@;^=Q'L>./:@"Q12,"5(4X)'!]*@MENT$:7#QR@1_/(`5)?V7IC
M\:`+%%1QF4O+YBJ%#?NR#R5P.OOG/X8IJM<?:'#QQB#^%@Y+'@=1CCG=W/04
M`<EXNUK5--UN&&SN?+@-JTQ7RT^8J&/5NO0<#G'O56W\:7WFV]J4ADEFE=&=
MCM*$NRH"N!M(QR"22,<Y-=7(E]-<1&2QLGC3)W/*2RG)QM^0]@O/'6K%M;CB
M2>UMXY@21Y8SC/)YP.^:`.:\-^*KO4M0@L)H(YLP*\D\;8Y(R3CIQD*0.^>O
M;9\3WSZ?HLMQ'=BTD!4+(8_,&<],>_K5R"-UNYB;:".,`".1#\S#'((QQS4>
MH"YD_=QV%M=Q<$B:7;SSGC:>G'Y^U`')VWB._LHY%OI+:^4)$A0%8XU+)(Q!
M8`\_(%Z8^E7=1U9KF#3OL4EMI\<UL]P'NHP4QP#'[?>)X]!ZUO0Z?;S0*;S3
MK-9-V2BJ)%!&0""5'8^G<TFHQ>8F#IL-X%VB,.1P22&SD<`#'(SG/3B@#`B\
M<!K>*460E#C:6CE`_>!5)&W&0N21D^G.*;I?C&.YOK>"73B))9C$\T0!5&+$
M+@_Q=!D^YKHA;Q/,C3:9%YDR,LL@56"J,`*3U.>.,=J46L:I#(--MQ(&`P`N
M8USU!QVZXH`N@`=!BEHJ`SOY4KBWEW(Q`0X!?'<<]*`,CQ2PBCTA`@PVIVZC
M_9Y)X_*MZN8UF[CU"/1Y%1DV:M&C*Q&0RAN#@]0:Z>@`HHHH`****`"BBB@"
M*WD26,LC;@'9<Y!Y#$$<>X-2TU``IVKM&3QC'.>3^/6G4`%%,E=HXRRQM(<C
MY5QD\^]/H`****`"BBB@`HHHH`****`*UD<1N/+*_OI,\8S\QYJS5:Q+&%]V
M,>=)C'IO-6:`&>6/.\WOMVT^BB@`HHHH`****`"BBB@`HHHH`X;4=-\,:?>N
MDUS?&[1A*4C9F8OG(P<8S\WK_%59;3PY*B9U6\M'DC9U64=BS'<>-IR`V!GD
M'/>M&]TC2?[>DC&I7<>J73[VV8)51\XZC`4;5Y]L>M5X/">E-^YBU\.2K(5#
M1EB.`?R&![4`4--TG1]0U$6]EX@GDN#"ZH7A^\&4A@,]\$\=>>.E6)UM;B-I
M6\6;X;+<GER6RYY5E*CIG<H8#'^%:MAX86QO5:WUMS=!2_SQQNY4@+GGG'R@
M`]N0.IS1F\-:9!>1V=QKC&[<;0KJK.P)&!]#@<?[WJ:`,YFLX;!K.;7YI;-)
M8VE+62L-[*S*&YW'[F"#G'`]<3II&GW4-YYGB2(8E:2;?$@P<LFX#=PI+G'U
M4^E:47@BV5SY.IEBK[2&B1B"-I"^W`_)CV)SF7'@Y+.[M+<:Y;^>',EO!<1`
M!S\O&,]R/Q_.@!LND6\%@CQ>(X'>V4W*)Y8.Y=V[<><EC\O/MBIY_#\T%V[R
M^(=/%VKM=-%,H`C<E6)`)Z<`\CL..:</`^J*5=;ZS9@!E7B+`'@'DY[#]3@"
MI+SP;JU[=RW5Q>V4DSN'#&$\'Y>".C*`H`!R.OJ:`*<OAV[NKM[HZSI;3RC[
M2'5B"H!'SKCJ/E[Y'7O@U+IO@RZB>.\M+NQDR@"NAW(W!4GE3U!_/\J8/`6I
M`R?O[!LC"DJPV\J2>!QG!&.F&/K79>']/?2M$M;*3R]\2D,8R2I)))(SSWH`
MT:P=?=DUC0MKE<W3#Z_(1_7'XUO5@>(4W:UH''(N6Y_X#G^E`&O=6-I>E#=V
ML$Y3.SS8PVW/7&>G04XVL/V>6!45$EW;@H');.3^.34;ZA`MN9D\R8"0Q;8D
M+-N!((P/0@\]*KSZQ'!+/&UI>MY.,LD!(;..GKC.2:`,U;RPBOQ;W`M_M&G,
ML%J?WAD#.I5=P"`888Z9'/TK/EL-$71T:*#3W9)%CF1KQE19`'P`QY/+'KCC
MOP*U-6T"PDNGU*YN)XF,BL[1GJ`%`7@=-RJW/>LB#PMI,LP674)993E,-%M#
M':<,01R1O4Y/<'W``)?[(T-;6&2*W4W,@:)X?M[$C";752#AB%XQP,'TXK7M
M?#UE82+?65HZWB@L$>Y<C)`!!))_E6'=>%=)CAE4ZEY2#>`IC#*F%0,0.S9`
MR1CKBNG@U?3C!(4NPR6Z9D9LY4#N<T`5=/T2U.BS6LMD]JMVQ>>$S;R&/^UZ
M<"LP^%HDU&2&:":YT^?"HBSMB``[F+%FR<MZ>YZUTEQ?VMJB//,L:N"5+>F,
MTMO?6MU(4@GCD=1DJIR1]?3J/SH`IVQ;36BT^STRX-HA"K*)%*J#S_$V[`S^
MG>KES<2PR1)':33AS\S1E`$Y')W$>O;/2E-Y;*5#7$2EI/*4,X!+_P!T>_M4
M]`&>=1G"NW]E7AV@'`,>3GT^;MWJYYAS)NC8*G0XSNXSP!S2-<0(2'FC4CKE
M@.X'\R!^-(+NV8`K<1$,"00XYP<']2!]:`&P7)FCB?R)4$N<;@.!V)YXR,<=
M>><4ZWN/.X:*2)PH8I(.0"2!R,CL>`>.,]:07MJ02+F$@=3Y@XJ0S1@*3(@#
M'"G<.3@GC\`?RH`9-<QPR!'$A8HT@V1LW"XST'7D8'4]J)KF*"%99"P1F51\
MC$Y8@#@#/4BI&D11EG4#.,D]Z4D*"20`.23VH`J-J=LM\UFQE$RE1_J7*G.,
M?-C'?U]?2GB^MS>&T#/YPSQY;8X`/7&.C#O_`"JQN&[;D;L9QGG%`(/0YH`I
M_P!J6GVFW@#MON-_E_(>=GWNW^?Q&4M]7L;J58X)][-LQ\K`'<A=><8^Z":O
M44`,EE2&,R2-M4$#.,]3@5%;WUM=%1!*'+*6&`>@.#^O%6**`(H;B&?=Y,BO
ML8JP!Z$$@Y_$$?A4M-6-%=G5%#/C<P')QTS3J`&EE&<L!@9.3T%.J)[>&1G9
MXD9G4(S%1DJ,X!/IR?SJ6@`IC2(K;6=0<%L$]AU/TY'YT^J\]C:7+,T]M%*S
MIY;%T!W+G.#[9YH`G5@PRI!![@T@92<!AGGC/IUIL$,5O$L4$:QQK]U%&`/H
M*BBT^SAF66*UB21`55E0`J"22!Z9))H`G9U3[S!?J<4I(&,GKTJ"[L;6^0I=
MP1S*5*X<9X)!(_-5/X"G&UMRT3&%"8AA./N_2@"5F"*68A5`R23P!02!U.*K
M26%O*\C2*6\W[ZECM8;=N".G2II((9519(D=48,H(SM(.01]*`)*0$$`@Y!Z
M$5373+=9O-#W&[@X,[D<%3T)Q_"/UI$TFVCDW1&6,;U?8DA5<KGL/7<<COQZ
M4`7J*IKIT2ZD]]YMP9'&/+,I\L<8R%Z9Q_,U8FA6;9N+#8X<8..10!)14-K;
M+:Q&-'D<%V?,CECR<XR>U-ALTAB@B1Y=L";%S(?F&,<^M`%BBJZVBI:M;B6<
M@Y^<R$N,G/7VIALB"FVYG"B8S,"^=V<_+GLN<<#TQTH`MT4R&/RH8X][OL4+
MN<Y9L#J3ZU#=P7$VW[/=FWP&!Q&K;LC@\^AP?>@"S13-C><'\P[-N#'@8SGK
MGK45U#<2M$8+HP!3EP(PV\>G/2@"Q15?RKCS+=OM/RQJ1*NP?O3C@Y[8.3Q3
M+B"\DF5H;T0Q@Y*>4&R..,G\?SH`MT5'LD^T%_-_=%,>7M'!SUS_`$JBUIJG
MDA5U5`^TC>;4')PN#C/8AC_P+VY`-*BBJJK>K+:@R0R1K&1<,5*LS8&"HZ`9
MW9'TH`M45&3+YZ@!/)VG<23NW9&,#IC&?TJ*S2[C$HO)HYB9,QLB;<)@<$9/
M.<T`6:*I2?VE]JF9!;&W5#Y29.YVP,;CC"C.>F>U6(C,;93*B"?;\RJQ*[O3
M..GX4`2T5G&36/(5A;69E)&5\YL`8.>=O7.W\S5B5[T7D:PQ0FVQEW=R&!ST
M`QSQ[T`<X[H9M+3&)6U><CY<`A6D!('Y<^M=97-:O"T&M:$)'\W-W,V\@`KN
M!(4'TYQ[X%=+0`4444`%%%%`!1110`R*)(4*H"`69N23R22>ON33Z@M)%DA9
ME+$"21?F.3D.0?PXX]JGH`****`"BBB@`HHHH`****`"BBB@"K88\J4C',TF
M0.WS'K5JJM@&$4F3D>=)M^FX_P!<U:H`**CW2_:`NP>5L)+9YW9Z8^E24`%%
M%%`!1110`4444`%%%%`''RZ1J\&M75XLNF;KHR+$)I7#8(Z#CJ%4>OW3TSQ2
M/A+5@T4D=MI*/$WF?>?#'Y/E("],)C'3YC]:K:Y)?7.KW+2P7\@AF9(X_(\R
M,*VQ>%QC."_/?*_C234[RSGE5=0U,B-65&F1C@'9D8(SNSSSQ@#UH`O2^!]6
MD6-2NF@KD%@[`L"%]%XY#8_WCVJ[?^&=:O;V6=H=)"NBIM+NQ`$;)@,5_P!K
M/U"^E8%IK\T6I&X-_>9:1/,<X(9%(.&&.H7>#CJ<8SDU:.OZDUS$IU<M#(NR
M?S`H5"002,`'``R,9/'/-`#I?"/B".6=9(+:^6X#2.XE`_>;7`.2`<Y8D=LD
M9/%:$=OKM[K&F-<Z(L-K:2QA29`Q15!SDYY]>G4#&,\XMKKU[I^FV\=GJK2$
M`*()`N$&PDYR.FYN#N&`!P<<6/\`A)KYYV=M65UAED9!M502J/@\-\P/'![G
M%`'IM%>:0^+M34VZMJ$)1+8N_P`J$N0&QNR?O9VC`.3^-:?A/7DN]6:2]O(U
MN)K6&-PY">9)N;&T>N&'3U_(`[BBBB@`K&U8`Z]H>?\`GM+_`.BFK9K%UHA=
M8T,[6)^TN,J>F8V_S^!H`CU6:_TK36EL)[.11)*[FY^4DDDA$"X!8G(YYSZU
M0'BJ[EOM1CM[7<+=9%MX1$7>9T(!((.,`D$@9..E:-WH%M>(UM<6IEA$DEQ&
MYN&7]XY)(8#&.6XQG@?GD_\`"/YANV72[JU>1"BBWNDP`-IRH.=I8HH(R?K0
M`ZV\47TMW86LIM5DG=1,_EN%0[L>6/1_E?KZ>_%R?6=6N=6O;72;:T9+`H)O
M/<YDW`GY2#@=,<__`%JA_LA;6Y@EATFY(M1P!,A%PPRP9LMG(;.">YI-1TR6
M]N4O4L=0MGN5*W4<,T8WA>5#<]3@#CMP>M`$P\<:403Y=YD'D>3R`!ECC/08
MYJS)XLTJ)I%:63,<P@XC)R_H/IBL.709U6.WCMM4?RY)T>5'B`FC<\C!8``C
MOCK^&%O/":7"QR^5>J;F8SRQIL_=?>.TG//WB`>3_0`VCXNT=1.6N&4PYX9"
M#)\VWY<_>Y':J=[XYTV&>`6\@FB,NR:3:V$']X<<_2LYO"[ADLIKB[F59!L6
M&(>7;([%CRY^<949/48]\%U]X=T\1307%]?,JSQM+B'(8K%U!`Q_%R?P/.#0
M!J:WXB:SBL);.Q6[CN2[#S&\O:5P<Y/J-V/\YO6/B"PNK:U:6YB@GN(U<0NX
M#<^W^>*Q-5CM[IM/@N[NY>.UB)E6:S=VG#?(3D=\$XQGUYQ69!I=M<.EM'JM
MRPDB2`N;"5255MR%2>A&W;]*`.GU36](MM)FO`]K<`@[$RO[UQ@X]^2I_6K.
MI7MCI.E)>W-J4BC"*L:Q@LF2,#'08(!Z]OI7$M9Q`F&?5AYTT7E[6TR0$*P4
M9X[_`"J,]NF.HKH)KJ?[+-I5Y>Q37;E7CWZ>Q3RPH8JRX(_A;@9_/H`6K"\T
M"\C*M9VUJY;9Y-Q%&K-AMH(`SD;LCZBGV.K:+>VT:,D%N$B+B&94`1"2O497
M!Y[\@^]<VNAPVMM]H34(U5,AU>WDVQ`2>9QCD#]VPR?7U(IAT*UFB\IM3LI%
M@">9&ZN"?+5BP`!!.%D&<<@CMR*`.NOI-(LK:V\VTAD@N[E5C$<2LK2.#A__
M`*_6JUQK^B7GGV\X,HA.Y0\1Q(<[3LSUY.WWYZBH%M87TO0K&&[BS%-#)PK9
M;:-^-O49Q_%C'UK+_L7[>R3P:E8RQ6+?NMIV[RTI;#_W3G@'G/6@#KK%;"XA
MAO+.*`JR#RY$09`QC&>W`QCVQ2S:;9S0F%X%$9<N53*!F/4G&,Y]Z@\/Z<-(
MT>#3_.$S09#,!CDDM_[-5]98V8*LBEB,@`\X]:`*S:9:,6S&V&C,;+YC`$$Y
M/&<9)ZMU]Z1-*MDGGF3S@\ZLKGSW(Y.3@$X!^G3M5HRQJX0NH=NBD\GJ?Z'\
MC2AU9F4,"R_>`/(^M`$:6T<<HD7>"!MP7)'0#H3[4OD+OE?<^9%"GYC@8ST'
M;KVJ6B@!J+L15R3M&,L<D_6JRV"+P)KC'F"3F4GD,6Q].<8]`/2K=%`%5;+%
MJ;<W$Y0!0IWX=0H'\0Y.2,G/7)JU110!%+%(\L3+<21JA)9%"X?V.03^6*EH
MHH`KF"8W1D^UR"/C$05<#'OC//UJ61"Z;5<H<@Y'7K3Z*`*$%E=QEC)JEQ*2
MI5=T<8"D@8/"\D8/MS2ZD\]KI=S,EP!+'`Y5G``W8^4GTQ^57J9*$:,K(N]&
M^4J5R"#QR/2@"E:RSR2SW$SRQPJQ00L@X(XR"!D@T\6ERJE5OY`-P*Y16P-V
M<9/)XX_7K6!J*(T*#4X)[VS6]G\Q4+2D9)\O@=``<8[<51MY]6L)(K+1X;J*
MTSNA6XMS)O5G())!R@48(!P3SGJ!0!UD5M?I*N^^\V,L6;,:J0,\*,=L=>_2
MGRVUT\TSQWSQHZ81/+4A&Q][.,GZ&N.-_KUS,(M1CDDLIH2DJ+:D?/)&650!
MDD`[5R<=2#3I[C66T8::L*F!]*5^8F\U<)M9<;@<EL<XQ@]#0!V,"RM+YANQ
M+&#("JH,9W#'/JN"/?//2EN$NG8^1+'&H7(W)DEO?GI^M<+<M]AU]-D+QR+=
M--'!N^^WV<$X_P!YCC)]?K75^&]2NM4T]KB[B13O(1D1D5U[$!N:`-2'S/)C
M\_9YNT;]F=N['.,]JC070\O>T)^=O,PI'R<[<<]?NY_&IZ*`(8?M/FR^>8C'
MG]WL!SC)ZY]L?K3)'NEO(@D4;VS\.V[#1G#'/N.%&.O.:LT4`59S?>3-Y`MS
M+O'E;RP4KQG=CO\`>Z>U6(]_EKYFW?@;MO3/?%.HH`CGD>*/='$TK;E&U2`<
M$@$\^@.?PJ2BB@"I<74\5RL4=C-,A7/FJRA0?3DY].W>B:[ECLFG6RGDD&[$
M*E=W&??'./UJW10!4N[]+=WA2-YKD0M,L*=6`('!/'4BB6\E2T69;*=W+[?*
M&W<!G&3ST[\9J'[49-)>\*?9;DVQ8[TP\>`>H/8'UK`7Q++;7^EPSW/FQ,BK
M=RF/:HDD&5R0,#''&?XN>E`'4W,[P>5LMY9]\@0^7CY`<_,<D<<?K3XYXI7E
M2.16:)MK@'[IP#@_@145\`8%W0M,/.B^5201\Z_-QV'4^PK'U^ZUBPTJ\GM6
MCD<3[E(VDPPA`3P<9.0>.>&_(`VDDG,4K-;[75F")O!W@=#GMG]*DB9VB1I$
MV.5!90<[3W&>]<FVKZN;V]A%[9K$MNLPF:(@0<YQCDLQC#-CU]A3++Q5=7%U
MI-DSQ?:)/^/DE<;@RDQD#W&UCCID#CI0!U8F=KLQ+"P11\TC<#/&,>O?Z8J>
MLOP]J4NJZ:;B945Q*Z$("!PQ`Z^U:E`!4$MT(KB*$Q3,9`3O2,E5Y`Y/;K^A
MJ>B@#DM2NX]4\1^'Q`'39/.&$B%6!15)&*ZVN4O+2*#QII#Q2EVGGN9).AVG
MR4&W\@/SKJZ`"BBB@`HHHH`****`(;9"D.&!!+,V"`,98G'''?KWJ:BB@`HJ
M*XE,,894+DNBX'^TP&?PSG\*EH`****`"BBB@`HHHH`****`*MACRY=H8#SI
M/O'.?F.<>U6JJZ><Q2^T\G;'\9_.K5`$)A_TL39/W"A&[CJ#TQ4U%%`!13%?
M<[KM8;<<D8!^GK3Z`"BBB@`HHHH`****`"BBB@`HHHH`0@'J,T;1G.!G.>G>
MEHH`8L4:YVQH,C!P!3?L\'R_N8_E;</E'!]?K4M%`!1110`5@>(2/[:T`9`/
MVECSC^[6_7/ZZ-_B;P\@;#>9,V#TP$R?QH`=XQLKB_T86]O#+*#,AD6-@#L!
MR?E.-WTR.<'/%<[;:?KL"I%;65Q9L;811/'+N6+=,I+$,Q*G:.@)Z]N:Z_5M
M8@TGRO/BF<29^:,#"XP.22.I8`5HT`<',?&44^H)"9Y8@2L4A"9P&7#*,<DJ
M#D<=3WJUH0U[[?9WFJ/=M$()5D0;<!@Q^\..O;`SP.V:UM-M+F]T:WN#J=['
M)<6\;9W*=I^]D<=35T:?,K*1J-U\L2Q\[3DAL[NF,D<=.E`'*_;?$=K<S:H-
M/D9;Y=JQ-("(L?<.W.1\H.?4GM62VI:]Y%XBW-Y+'<2$+/\`9V#2,JCY%4'Y
M`1GD#L/?'=-I-R5.W6+T,?XOD..G08QV/YU))IURP<+JMTFXY7`3Y?EQ_=YY
MYH`Y&^UCQ+86[3)*DL8G-IDVYX*'[_4DEN0>HX..U3OXHUI;C4(Q!#F!F$0,
M+\8E1?FYZ;6/2NRABDCA9&N'D8EB'<#(R>.@`XI\*-'#&C2-(RJ`7;&6..IQ
M0!0\/W\NIZ/#=SQ>5))N)&"!C)P1DGC&*TJKF*=8Y!'/EVDW*9%R%&1D8&.V
M:?.)SY?V=XUPX,GF*6RG<#!&#[\_2@"6BJ=ZNHL<V,ML@XXFC9NS9Z$?[/Y&
MI)Q=E81;O`&WCS3(A(*X.=H!ZYQU/YT`3D`C!Y%-\F/>'\M-RDD-M&03UJ&V
M%X+9A=-`T_.TQ@A<=LY_6IH?,\F/S]GF[1OV9V[L<XSVH`4(BL655!/4@4P6
M\*A@L,8#D%L*.2.A/Y"FK]J\Z;<8?*_Y9``[AP/O?CGIVQ4D7F>4GG;1)M&_
M9TSWQ[4`."@$D``L<G`ZFFK%&I!6-057:"!T'I]*?10!&\$4C!GC1F'1B.1P
M1P?HQ'XGUJ-[&U<`&",8='^48Y3&T\>F!5BB@!H4!R^/F(`)^G_ZZC^RPB]-
MWL_?F/RB^3RN<XQTZDU-10!%+;Q3$&1<D#'4CC(/]!2&VB-H;4AC$4*$;SG!
M&/O9S^.:FIC.1*B"-V#`DN,87'KSW]J`&F",O$V#F+.S#$`9&.1W_&G/$KR1
MNV[=&25PQ`Y&.1T/XT^F.Y3;A&?<V/EQQ[G/:@!/)3[09\OO*;,;SMQG/W<X
MS[XS4E,>0H\:A';>VW*CA>"<GVXQ]2*61MD;.%9]H)VKU/L*`(C:Q&`PC>J%
MRYPY!R6W'G.>O^%22QB6)XR64.I4E&*D9]".0?>H[>X:8X:WFB^4-^\`'4D8
MX)Y&/U%20R&6,.4>,G^%QR*`(Y8&>2)DGDC$?51R'Y!YS]/U-%W;&ZB$?G21
M*2=_EG!8$$8SVZYR.>*:]TR&4?9;AO+5B-JCY\`'`YZG.!]#5F@#)GBBT2UG
MNOM$XMQ.9VC&&)+=5&1D[F.>O4\50OO$5NUN\LO]HZ?]G<;P\(4L.&[Y'.,8
MZ_-TQ6EK\=I/ILD%X9%20862.-G9&R,$8!/7%4[GPY%,D\M]J%U<,Z,'9@N`
MNPKPH&!C)/`ZT`6-.*RW,4D>N/>(Z%Q%^[PX'REN!G&[WQFK5Q9W,UT)4U":
M%`"!&B(1R/4@GWK,\/64.G_:)IG+W,MP4SL8[`3N"@D=#G<2,#)/I6S<W<%K
MY?GN5\QMJ_*3D_ATH`K1V%XD<X.JSNT@PC-''^[.>H&.?QJ.RT_4+>=&FU>2
MXB7.8FA1<]>XY[C\ORM-J%JJQDR<2`E?E/8@'MQRP'-2)<Q/(D:L=TB%U!4C
M*@@$_J/SH`DD5FC94<HQ!`8`$J?7FJMO;7<3Q&:_:955@ZF)1O).0>.F!Q2C
M4K0M.HEYMP#(-I^498>G/*MT]*MT`0M',8`@N")-P)DV#INR1CZ<4Z!9$@19
MI/-D"@,X7;N/<X[403Q7",T+APKLA([,I((_,&I*`*MVMZ9(S:/`$"MO64'D
MX^7&.P/6II?.WQ>4(RN_]YN)!VX/3WSC\,U)3#+&)EA+`2.I95[D`@$_^/#\
MZ`()1>_;4,7D&UVX<,2'SGJ./2K5,:6-<[G48ZY/2GT`5Y&O!=H(HX&ML#>S
M2$.#ST&T@]N_K3P9]\N4CVC'E_.<MQSGCCGTS_2GAE.,,#D9&#U%*"#G!Z=:
M`*4D(,+W-S'&99+<120N_P"[)Y^7)'0DXSC\*B;3UGM;^WGTZS$<Q.$5SB7C
M@L=HVG@=,D8R*H^+=+N]22T^RP),(7W,I8`CE>0&X/&[@USMSX=\317&ZUDV
MLQ3<\$^Q20BXRO&<%",GKD'%`'?R(QC"Q/Y9#*<A<\`C(_$9'MFL:ZT19FN#
M/:Q7HENC<('D*[/W04`\'()7&.F#GMBL6/2O$%OJT*VIGALQ=R,3YX8;"^2Q
M7G(*8`4]"">,FNMU+>--N?+MENG\ML0L,B0XZ'ZT`8B^$=+O"\M]IRI-)^\=
MH[B0_.2=W!/TY[U9M-*2"W39I,$<EH3);J)\[W^8?,V.N,')SU]JY:?3=4MX
MK![#3]0MG>1EO7B*;R7*;O+`/RJ-I`/&!C)K:N+34VT73C?13W9BN"T\(?\`
M>.AW;=V."1E<X]*`-.TM9M%LGM=,TU'B1R8P;G!;.#DDCCJWK]T>M:,<LS2(
MLEN4#(69@P(4@CC]<_A7#-;>(XBHL8+V`;0MO!Y@:-$;.[S&)!W9Y'I]*A2V
M\4P%GM([U4EN6=F<KYC?=Y8=`/O8Q[T`=V)[LW"Q_8L1^8RF0RC`4`$-CKR>
M,>WI4IDF%SL\C,7'[P./1L\>V%_[Z]C4U%`'(RP2P^+]',L?E^;/=R`%@3S$
MOI]*ZZN?U%@?&NCH2ORPS$`CD9`[_A_.N@H`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`KV0(A?)SF60_3YS5BJ]D?W+X&/WLG3O\YJQ0
M`P2*96C!^90&(]CG'\C3Z9L'FE]S9(`QGC\O6GT`%%(&!)`()'49Z4M`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%<YK(!\9>'N3G%QQG_8KH
MZYO5Y,^-O#\?'RK<-^:?_6H`O:SHBZL\9:YDB0*4DC"AE=3ST/0@]&'(JYIU
MH;&U$!GEGPS$/*V2`22!GV&!^%6J*`,^PN[.&TMK<7%N&6)5`CEW+P`,`GD_
MCR:L07UI<QB2"YBD0C(*N#QZ_H:X+Q!=/IU[J5M!9VBVD<D*PXLT;RI"$8_P
MX((W^^0,8HL/$;R+?M#H]BJJJPQQK&4Q&Q;ACW'<XQ]/0`]`6Y@<`K/&P/3#
M@Y_SBGAT(R&4CU!KS:37X;."+S/#MB"[M(N8\J(F4/M&%QN*D#/;N.M=W:6%
MB]O%*EFD2O&G[HK@*`0P!'3(./RH`NF1`,EUQTSFGU071M-4,ILH&4R"3:R`
M@,%"@@'IP!4Z6<$=T+A%*N$V8#';CC^'I_"*`)MR[MNX;L9QGG%.K-.AV1:5
MRLI>52C.TS%MI).`2<@9;.!W`]*631X'G2837:,K[OEN'`;DG!YZ<GB@#1HK
M+_L*V%N(5N+Y0.C"[DW#E3US_L_J?6KC6B,5)DFRJ;.)6&1D')QWXZ]>3ZT`
M6**S;+1+>RF22.>\<I]U9;EV4<8^Z3CI_P#6I]QI@GN&E^V7D>YE8HDQ"\#&
M`.PZ$XZ_C0!?HJN+=DADCCN)5W*0K$[RA))R"V<]1UR.!3X86B:4F:20.^X*
M^/DXZ#V[_C0!+147ER?9_+,[>9C_`%@49_+I4)M[HS3,+Y@CH0B>6O[MNS`]
M\>AH`MT552"Z4G=>%@8RH_=J,-DX;\L#'3BF16MXD6'O]\A4`L(@!G+$D#/&
M<@>VV@"[134#!%#MN8#D@8R?I3J`"BHY?.S'Y/EXWC?OS]WOC'?I3`;K[""1
M";OR^0"?+WX]>NW/XXH`GHJINOQ&Q*6Y?)V@.V,;CCG']W'X^U/E:[!N/+2)
M@(P8,L1N?G(;T'W>?<T`6**S3)K/GG;;V/D^8,$S-NV9&>-N,XSW]*FB?4#-
M$)8+=8CGS&64EE^48P-O/S9[]!^%`%RBFH6(^<`')Z'/&>/TJO?S7<,:FSMD
MN'8XVM)LQ[DX/'6@"U13(S(2?,1%&!C:Q//?L*K/+?\`D3[;6(RJV(AYV`XS
MU)VG!QST/-`%RBJ+7ES"ML)K&1WE?9)Y#!UBYP"2<$CG.<=,\4MQ>7,,MPJ6
M,DPCB#Q,C#]XQ)!7GH1@>O!H`NT50%_.6M5_LZYW3`;S\H$7/.XY^I_*G6E]
M+/'&\EE<0&20H%<#*@*3N;T'&._)%`%VBJ,NHF)238WC84G"Q@Y^]QUZG;_X
M\N<9I?[0S9K<BTNCN<IY8C&\8)&2,]./U%`%VBL^UU47&G3WAL;V$0AB8IH=
MLCX7/RKGGT^HIT&I>=*R&RO(ML0EW218'(!VCG[W.,>H-`%T`#H,4M4]/U%-
M0$FRWNH?+(!^T0F/.?3/6I?M48E>-@R;65-S#AB1Q@T`3TF!G..?6L^76;>*
M_:S>*Z\T*SJ1;N5<*,G:0.<9`^I`[U<AG2;A20VT,588(!S@X]\&@".XT^RN
MBQN+6&;<06$B!@Q&<9SUQDU9JJ+^W:>.&-S(SLR91"RJR_>#,!@'CH:5=0LF
MMGN1=0^0F-TA<!5R`1D_1A^=`!!86EN(1!;11B`,L6U`-@/7'IG'-/DM+>4.
M)(482%6?(^\5QC/TQ0UU;K$LK3QK&[!59F`!).,?7/:H%U?3'3>NHVC(,_,)
MU(XQGOVR/S%`%I8HTD>15`>3&X^N.E/JI)J>GQ221R7ULCQC+JTJ@J,XR1GC
MFE?4K%'='O;=61MK@RC*G!.#Z<`G\#0!/#%'!&(XE"(.@':H[FS@NQB="PV,
MG#$<-U'!]JCAU2PN"HAO;>0N<*%D!R>N/KSTIS:C9*<->6XY"\RKU.<#K_LM
M^1]*`)7B#R1ON<&,D@*Q`.1CD=ZDJ%[JW2*.5[B)8Y,;'+@!LC/![\`FFI?6
MDA01W4#F3&P+(#NR,C'KQ0`R&Q6$'_2+E\Q"+YY2>@QN_P![WJRB[$5,EMH`
MRQR3]:CDNK>%BLL\2$%1AG`Y;H/QQQ4BLKJ&5@P/0@YH`CM;<VT/EF:6;DG=
M*V6Y[5%-9-,)A]LN8_-92-C@>7@8PO'0]\YJSN7>4W#<!G&><4Z@#DOM1O?&
MNER;-FQ+F/!.2=C,F?QQGC^E=;7+P0PQ>*[%89%E`CNB2G9C+D@^F"2/K744
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`5['_4-_UUD_
M]#:K%5['_4-_UUD_]#:K%`!130X+E.=P`)X..<]_PIU`#0JABP4!FZD#DTZB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N9U5<^/-#/`Q%-
MR3U^4\5TU<YJ99?&>FNN6$=K,[*O4CT`[G..*`-ZVV&!6CF,R.3(KEMV0QR,
M'TYX]L5(<X..#VS5?31;KI]O':.'@C01H0V[A>,9]1C!J9)8Y(UD1U9&^ZRG
M(/T-`$$,%U&8/,NQ($4B7]T`92<8/'3%)<VUR\4ZV]V(9)'#*S1!@@P`1CC/
M0G)]?05:)`ZG%`(/0YH`RCI-RT+1/=P,IV`#[(N!M!!XSWR,>F/>M*-9%)#N
MK+@!0%QCU[T\D#&3UZ4M`%)+:^#)OU`,JLI/[@`L`#N!Y[D@Y'3%31QW"SEG
MG5HCG">7@CD8YSVY[<Y[8YGHH`K1)=I)'YDL4B[`)"%*_,,\@<]>.,\8I"EZ
M+IW6:%H"/EB,9!4\<[L\_P`78=15JB@!DQD$3&%4:3'RAV(&?<@&H,W^Y/DM
MMNQM_P`[9W?PXXZ>M6J*`*D37YB<S16X<!MH5R03GY<\=".M2QFYW1>8L6WR
M_P!X58YW\=..GWO?I4U%`%9I;I+6!S`CS$H)41N!GABI/7'7GL*LT44`5VN)
M%,H^RRG8I93E?G([#GOVS22W,J6*SK:2O(0I,`*[AGJ#SCC^E6:*`*0O90DY
M:QN28N@"I^\Z?=^;Z]<5=HHH`KV=R;J-G-O/`00-LR@$_*#V)]<?4&K%%%`!
M1110`4444`%1+<PLL3"1<3';'_M'!.!^`)_"I:*`([B>*V@>:=PD:#+,>U5F
MU>P6,R-=1A`6!)]EW'].:NT4`0->6Z7:6K3(+AQE8\_,1SSCT^4_E4L<BRQK
M)&P9'`92.X-&Q=^_:-^,;L<X]*CN(S)Y1WLNR0,<.5SVP?4<]*`$-W;*"6GB
M4!BIW.!R.HJ>J%M#%J5A:SWT%K<.RK("$W*">05S]:OT`1&Y@`),T8QR?F''
M&?Y4K31*`6D0`\9+#_/>H6TVP?.ZRMFW#:<Q*<C`&.GH`/P%+-I]E<*RSVD$
M@;&X-&#G&.O_`'R/R%`$J3PN0$EC8DE1A@>1U%.#*0"&!!X'/6JL&E:=;2I+
M;V%M$Z9VM'$JE<C!Q@>G%3"TMQ&D8A3;&^]!C[K9SD>_)_.@"171ONLIXSP:
M4L`0"0">@SUJ"VL;2TQ]FMHH<*$&Q`/ER3C\R3^-%W907GE&96W1.'1D8JRG
MZCG\*`)P01D<BEIL<:11K'&H5$`55`P`!T%(8P9EERVY5*@;CCDCJ/7C^?K0
M`^BHS#&TZ3E<R(K(K>@)!(_\='Y431":/86=1N5LHQ4\$'&1VXY]J`)*;M7&
M-HQZ8J&]M!>0^69YX>OS0R;&Y4KU]LY^H%0Q:8L8F'VN\;SI1(=TY.W#9VKZ
M+VQZ4`7-JXQM&,YQBD\J/:5\M<'J,42Q^;&4WNF2#E#@\'-5!$=,M;R=7NKL
MDM,(WDW$<?<7T''%`%PHAZJ#^%-\F++'RTRW+':.>,<_A5(VK7<T[M/?088+
MM#A5.-ARO?!QC/NWK5BTM#;-*?M,\PD;=B5]VSCH..E`$J00IMV1(NTY7"@8
MXQQ4*Z;8*)`ME;`2G,@$2_.<$<\<\$_F:L$-YBD,`@!!7'4\8.?S_.L[3+(-
M8HUS++-*ZL"YE/W2Y8#(..,XSW`_"@"P^F6#Q^6]E;LFXOM,0P6/4XQU-(-*
MTY8A$MA:J@SA5B4`9&#V]":D6WD5RWVF4@RF3!QP,8V=.F>?6HIK.XDB=%OI
M8RQ<A@HRH8'`'T/2@"2*PLX01%:PH&*DA8P/NC"_D.E20VT$!)AB1">#M&.Y
M/\R3^-5WL[ERF-1G38@4[43YF`(+'Y>^0<#CBIQ$X)_TB0CRP@!"\$9^;IU/
M'MQTH`B@TVQMG1X;2%'0!58(,@`$#GZ$C\:5M-LGCDC:TA*2OO==@PS>I]Z=
M96\MO%MGNI+E\+EG4#D*`<`#N03^-.NXYI;62.WG^SRLN$EV!MA]<'@T`8=Q
MY<7C;3XH@$'V64E%7`Y;.?J2#715R[*Z>-]-\Q_,/V.0>9USACUP`/T%=10`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!5T\DP2<@CSI<
M8_WS_7-6JK66[RGW?\]9,?3>:LT`%%%%`!14<<7EO*V]V\QMV&;(7@#`]!QG
MZDU)0`4444`%,DD2)-\CJBY`RQP.3@4^HI[>&YB,5Q#'-&<9210P/X&@!L=[
M:R2+''<PN[#*JL@)(QG@?05*KHS,JLI9#A@#RIQGG\#5,:-I8Z:;9C_M@O\`
MA2'1=*88;3+(_6!/\*`+]-9U3;N8+N.!D]3Z52&BZ5Q_Q+;,XZ9@4_TJ)_#N
MCN.=-MUY!^1-N"#D=/J:`-2BLS_A'M)W.WV),N<GDXZ@\#/'0=*A/A?2V`!2
MX("A0/M4O0'./O>U`&S162GAS3D4*@NE&<\7<HSV'\7;`_*G'P_8'O=YSG/V
MV;_XKVH`U**R3X>L]P*S7R`#&U;V7!_\>IK>'+8DD7FI`GN+V3_'_.:`-BBL
M=?#MNK$K>ZF,]A>R>OU_"HW\-DR!DUG5E`#9'VHD$G.#^&?T'OD`W*PY"A\;
MP`C++I[D=\?O%_+O35\.7`VYU_524QC]ZO;UXY_'K61J.E7S>+(8K?6KF*:>
M"1_-9%;:NX?(`,<<#\>>YH`M>+=?O-*N8;:PB@D^0S3*_)*Y(Z>F?3G^M63Q
M-;1P113Z;'.D,@-O''A0B)$K%\,<CAC@8]NM96II>V.JI9SZI=3SC`2233A(
M&P,G#;B2!G)`]3Q5Z!M0N+(7XU[1XTF`4M+!&IR0?E8^N`>/8T`/_P"$H\.1
MQ*#I,JAAN0;$P0`K#G=_L)Q_LCVJ_9WFB:K_`&E?3:<J16P&9Y5YE1ANS@_F
M![CUJI<:9J4;1_:M7T4&XXC$MM&/,X`P,CG(POTQ36L=0M_M&[6]%C27FX#0
MH%;:=I+`_P"U@'W-`#],\2::=+2-M/5FCN5^S6EJ`YRPWJ1SU!SGT-26/B[3
M"MO]FT^8?:"$F88*QY+L03U)Y8XQT-4IM.U2ZCFNWO\`09@H7?+M7&.Q+`<#
MG/X4TZ/KZO`/LVBEU7;%M4;MH'4>N`V/\YH`M0:UX8MAIQ%I)!)%F2%2I7RM
M_&YOF(`.!U)Z@TV/5_#`A-U:QWD3M*L9DCW!_E&[J3T(!'KR?6JW]A^(+@B8
M6>C/E556"@@*N-H'L,8_#Z5'_9FI17=O836&AJ\K!Q`I*LX7D_IGGV-`'H,,
MJ3PQS1-NCD4,IQC((R*KQ6/E312?:KE_+1DV/)E6R<Y/')'05@VVI:X+9EM;
M'2S';Q_<2Y("@#@=,=N.W%$>J^*I462/0[5D<!E87*X(/3O^-`&\+(A+Q3=W
M'^DDD'?S%E<?)Z>OUJ2ZMS<HBB:6':X?,;8)QV/L:YN/6_$DLLL4.E6,LL/#
MHEVI*GC@C/'7]*DDUOQ$DP0^',%\;0+C<!DXY8#'O]*`-<Z9(;A)O[2O0%<O
MY8==A&XMM(QG'..O0"@6-V;AY9-2D*M(K!$0*H16)V]^3G!/<"L-?$?B!AG_
M`(1F7H.LA&#DC^[]/\]&'Q3KR[0?"USEAU#-CO\`[/':@#JA'(+B23S?D9%5
M4(X4@MD_CD?E5/[/JH8?\3"%@(&4_P"CXS)V;J>/;V]ZRT\57)9=_AS5E0@;
MB(22&SSQCD8[_ACO4Q\3D#)T'6_PM0?_`&:@#3DAO05,-S&<S[F\R/($>/NC
M!Z].:>%O!;L#+"TWE`*=A"^9@Y)&>F<<5D'Q3C'_`!(M;Y[?9!G\MU,_X2U=
MV/[#UK_P$]\>M`'0L6,9*8#$?+N'?W%4"NL_8X\2V`NL'?F-RF<\8^;/3]:S
M)?&%O%L$VF:I'YG"!K;&\\<+DC/6F0^/=#=`TDLD1+[<&,D@?WCC\L=:`-^^
M:Z6TD-C'%)<8^02L57/J<#]/Y5(QE"+M5&?(W98@`=R.#^`_E6$GC?0'9Q]M
M8;>YA?YACJ./\XI__"9>']H;^T5P?^F;_P"%`&U(TBM&(XPX9L.2V-JX//3G
MG`Q[TV!YW+>="L>,XP^[/)'H.P!_'':L@^,O#XZZBG3/$;G^E'_"8Z`<_P#$
MR3C_`&&_PH`U7EN%F94MMT8V8?S`,Y;#<?[(Y]^@J2%W>/=+%Y39(V[@>_!R
M/4<_C62OBW064D:E%@>H(_I0OBS06Z:E#^.1_2@#3::<0W#+;,TD>?+3>!YN
M!D8/;)XYIEM<SS><7M&B"<+EN7/.<>V>A[YK/7Q9H3`D:E%P,]#G\L4]?%&B
M,^P:C#NSMP<@Y_*@"[;74T\"R-9R1$OM*2$`@9QNI]Y.UM;/,D$D^SDQQ<L1
MWP.Y]N_;FJ"^)M%;.W4K<XZ_-[$_R!_R14\.MZ7.^R+4+9FQG`D%`%^J%Y-(
MVHVEO'#+P_F--Y09%7:P(R>A[<<\^F:?'JVG2C,=_:L,`\3+WZ=Z='J-E*VV
M.[@9MQ7`D&<CJ/TH`B@O%/V...TNH4D+J%\G:L83(PW]T'''KQ3I=1$=ZUM]
MCO&P%_>+%E#D@=?QY]`#69XD_P!,M[5H$%W'%/YDL"7`0N-IQSZ9(-8$<>II
M=B9EFMH$>.6.**X$CA2SD@[NN`3E?84`=HU^BQP/Y%P?.3>%$1)4<<,.QY_G
M45SK$%LCL\%XP1S&=EL[<C'H.ASP>AJGX:O+F?35N=1NE+3D&)&`4A0,`]OO
M8W?C6N;F`$`S1Y/3YAS0`Q;N-O.PLG[E0S90C.1GC/6E^TIO@3#YF!9?E.!@
M9Y].M2)-'(2$D1B.H5@<4X$$9'(H`KO>QH)BR28BE2(X3.2VW!'J/G'/L?2G
M+=QMT$G^M,7W#]X?TXZ]*F5@PRI!![@T`@@$'(/0B@!:KRWUM"DCS2B)(WV,
MT@*C.`>,]>O;^E6*1E###`$>A%`$+7ELLL437$0DF&8U+C+CV]:;%?V<UJUU
M%=0O;KG=*'&P8Z\]*G*(6#%067H2.12>6FPIL781@KC@B@!L5Q!.SK#-'(T9
MPX1@2IR1@^G(/Y&GB1#(T8=2Z@%E!Y`/3(_`T*BH254*6.3@8R:`JABP4!FZ
MD#DT`(\T<;HCR(K2'"*6`+'V]:@U*%)]/GBD@:X1UPT2MM+CN,Y%6&1&*EE!
M*G*DCH:=0!4MK@F:\21H5CMY`J[3RJ[%;YO3DG\,5826.3/ENKXQG:<]>17(
M^+];O]-U)8K*XAAC6`3R*P0F4[B,?,1D87^'G^=0V?BXQ7=M8+8VR3SS&)S&
MV`AWF-.,<X`'X#MTH`Z:9X[G4+%H;G<$:1BL9W!OEQR0>VX=?45;M+6*SMQ!
M`I6,%B`23C))/7W-<UX?\2B^OX;/^R6AD>%9&DC4*,D`LV#_``?=YR3TZUMZ
M[J*Z5I,UV9(T9!\OF`D,?0`$9)Y__50!>5E<95@P''!S2":-D+K(A4'!8,,`
MUQ=OXI^R6[>?96D@)C<);[47>Q<DDEB,@1CWW<5;OM8C6TMH=-AT^VM+FU:Y
M/VU-J$#'R;1@9Y]_QH`ZKS$_OKTW=>WK09$!P74'(&,]ZY!O%>CQJC2::)(@
MOV=9(5C8%L?,B@D';@]\=>GK):^*-,-W:V]W8[;N:4!?+B4B,AV1`3G.0!VS
MC.*`.L+!<;B!DX&3U-+4;00M+YK1(9./G*C/&<<^V3^9I[*'4JP#*1@@C@B@
M#DP2_B_1R_DJP@GQY(.UN2./3CD^^:ZVL*2")?%NGQHD<206<K(J`#^)1C'8
M8/\`.MV@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"O8_
MZAO^NLG_`*&U6*JZ?CRYL?\`/>3T_O&K5`!1110`4444`%%%%`!1110!SGC+
M4KJPM+<6=Y':/(S$NPRS`#[JC!YR1Z=/>M;3=0M[ZQ$\4V]4^61F&W:P'.?2
MK4L,<P`EC20`A@&4'!'0U4U&2WT_3+B0P;D;.8XP%,C.<8^I+=?>@#E],\1:
MN;=]8O%1M.E^5$;:F&W[5"G.>YR2.B_A5M?&T?V1[G[$[1)&92RR#[OFM&O!
MYR2!^=9>/#7EQJ;#4X5D3'DB1BKJ"2>=QX!0GKSCC-.E?0WU&>TNK?4SL#Q[
MO.9@RQN2.`>F5<\]-N>]`&G-XV@ADN(VLW9K<MOV2J00-N2#W^]T]J:?'=F(
MYW-I.!$57&5)8L>.`?0$_EZBLMH_!WDJQ^U>6A)A)=@#S@E03R./TJ:#3?#=
MQ;M()[F%+F8P!7FVO*V\<A6&>"V?:@#I]%U?^V(3,EI+##M!5W93N/<8!SQ[
M]00:TZY2'4]`\/7MXOGW2R;TBF#JSA<#Y><=-H./85IVOBC2+MKD076Y;9#)
M(^QMNT=2#CG''YT`;%%8(\8:*69?M,F5?8?W+]><]NV.:FB\4Z/-+#&EX"TP
M+)E&Y`)&>GJ#^5`&Q16(/%NA$@?V@@;`)!5LC(SSQ^?IWJ6+Q-HLL,DR:A$8
MX]NXG(QN''4?YZ4`:U8DT1?QI:N"0([)R?FZY<`#%6QK>F&41+>Q,_FK#A3G
M#MG`X]<'GI5=@3XPC(?`%BV5V]?G'?\`S_.@`N+>VU36+:0FX5[-)@,Q$*V[
MY#\Q'7Y3C'UZ5DW?A:UU"5XDEEBG18P6DMLHP563(Z#G.>O;BJVHZ[JNEVFG
M!)E.=/$DB21EY#(N-V>0><\GM@FM*Y\80V]U/!]@N9#&2B,@R)'"AF4?0'K_
M`(B@"EK>EQ7T=I:`W`AT^)K=W:T:5WR%P5XP3A3R.F145MX?@G5Y5N)GL[9F
M!@EM""4\U9"H_OYVMR/45I_\)KI03S"9/*$8<N`",_)E1SDD;QG'H?2I_P#A
M+=,WA1]H8$(0RPE@=XRHX[GI]>*`.5E\+P:?+BYG"W(VF-%M&EBVEFR'VCYN
M1@="./;%R7PC]DO+57U1H_.C>%2D1+;BK#:#SA,'OV'&#S6UI?B#S=7N+.\D
MC`DD'V,I&P#*5SM8]`V.H..<^U6G\2Z6D\\)F??!)Y;A8V/SYP%&!R<T`9$7
MAPZ=X>O+:YU';/=-G>'8)QSM"CKD`@@#D=JFTK2(]+U2TN;NXBWO$\,";"`I
M9RX5<\C"G`!YZT_4/%EH%LO[/"7;3RH#G(\I6(&X\<'MR1^-:-UKNDV]V8+J
MX1)(7P6="%1MN<;L8!VD]_6@#F3X0?3[)YY+ZTLY0X+3@LB!<.,')XR67\JL
M:-I,NFZQ!<SZQ;LLB&!4^T%O.*@+A1QC##H"<=..M;\VL:3([V]Q<0D!=[>:
M/DXYQD\9Q@XZXYJKI^JZ9=,?M$$%I-#+(L2R``L`5)=,@'!)!]\4`<_8:3)!
M';6EI>:*EW#O6.XBF)GDRQR.G'`(_BQSBDCM=2%M<F#644>7LM[:*_#%7XZL
M<<85C]/QKJ$O]"6:U>*6S,L[;8#&`6)8L#C'(!(89Z9S5>\O=$T^ZM[;[/9D
M2RF.0H$`A.P_>';()'T)H`Q8K37&E+0ZQ&Q?'E1&\W^5\X;)P!O!4-[X^E+%
M:Z_!<6H743+&!$TP:\#$[GYQGL00!^GI721RZ(DC>7)IZNN-VTH",'8,_0MM
M_''>H9;_`$,31+BUE\UE'F(JNJ%5+)N(Z<9(SZ&@#GDT;Q'!$)+2[$ID@"F2
M*<%I&`.QBS#E>>E:ND6GB"WOA+?S--&PF,B"0%0<C9L!`QWZ^O:M./4-'@VE
M+ZS0%%11YZXVC[N!G_:_44E['I=[*OVBY4N!Y8"W)7J1V!ZY`H`YN+2O%C[#
M<7SY@5Y(RLH!=RG",.A`8=?0GI4X3Q5<WK+<[DA5HQ_H[*@X="Q!)R05W_EC
M'8[AATH+/']H0";`<?:#V)/KQR>GX5=@2`37$D+[G=QYF'S@@`8QVZ4`<OJ?
M]N1:;H;6?VKS(K;-PJQ^82^U`H8$C^+//4<GL:FM9];DOI8;ZSB2V27:`MOO
M`!D7&&_B!7=DX&.":Z9HPTR2%GRH(`#$*<XZCH>GX<U$;=S-O^TR@>;YFWC&
M-FW;TZ9^;ZT`.-K;DY,$1/KL%(+.U7&+:$8Z804^:(31&,LZ@XY1BIZYZBB"
M-HHMCRO*V2=[XSR2<<`#CI^%`##96I`!MH2!ZQBFG3[(XS:6_'3]VO\`A3KR
M&>>`I;W+6TF?]8J!B/P/%3T`5CI]D<9M+?CI^[7_``I?L%G_`,^D'_?L5'>6
MUU-_Q[7[VW3I&KCWZBIIXIGW>5<&(F-E'R!@&.,-^'/'0YH`J2Z#I,R[9-.M
M6!Q_RR&>!@<_2HSX;T4DG^S+7DYQY8P/H.U7TCE6X=VG9XRJA8RH^4C.3D=<
M\?E2"*?S]_VC]WN)\O8.FT#&?J"<^^*`*/\`PC6B\YTRV.3G)3)I#X9T0Y_X
ME=KS_P!,Q6M10!DCPSH@&/[+MO\`OBFMX6T-E8'3+?#')PN.V/PK1N/M7F0?
M9O)V;_WWF9SLQ_#COG'6GS^;Y$GV?89MI\OS,[=V.,XYQF@#+_X1;0L8_LR#
M\J/^$6T/G_B66_..U:4WVG[(WDB+[3L^4.3LW>^.<4R+[;]J;S?L_P!GP=NW
M=OSGC/;IG/O0!0_X170O^@9!^1H;PKH3')TR#.<\`BKM])=QA6MA`5.`?,W9
MR74#H#Q@M^..V:+4Z@1_IB6P.\_ZIF/RXX/(ZYSQ0!G2>#]!<D_V>B]/N,RX
MP>V#[U3;P#H9/"W`7'"B7@'&,_U_^MQ71@SF!B4C$WS;5W';U.W)Q].U*[N)
M8T6(LC9W/D87TXZ\^U`'-)X"TN*<31W-^D@Z,LP!Z$=<9[U-%X-LX4*1ZAJB
M*3N(6YP,\#L/0`?@*WK<S&,FX1%?<V`C9&W)Q^.,5")[N6*8Q6H1UD"Q^;(-
MLBY'SY7..,\'F@#'C\&VL9.W4M5&XEFQ<XW$]SQUI8_",,0`AU;5XP`1A+K'
M4Y]/7_/6M>"ZGE>,26,T(<9)9D(7V.">>GZU-/(\>S9"TNYPIVD#:#U8Y["@
M#''AH@DC7=:Y_P"GH'^:TW_A&&!!&NZT<'H;K@\Y]*V9YI(F18[:2;=U*%0%
MY`YR1V)/X'VRB3R-<-$;>14&<2$C!P%]\\[C_P!\GVH`QI/#,WE$0^(-763;
MA6><,`?<8&?SI&\-70VB'Q%JBKD[]\@8D<8P<#'3WK?+$.%VD@@G=V'3C]?T
MJ&"Y::9T-M/$$S\[@!6Y(XP<]L_0B@#G&\-:[@A?%%P0.5)C(.<YP?FZ?YZ4
ML?A_Q%$&">)G.X;26@W8'MD\'WZUU51><?(\WRI.OW,?-UQT_6@#FO\`A'M>
MWQ,VOI(T2[5:2U5CCOG/7ZT_^Q?$0=7&NVY8>MBG!SD\^YKIZA^TQ"W$YWB,
MXZHP/)QTQF@#G8]%\11$&/6K52JA`5LD'RC''3IQ3I-'\0SQ>7<ZQ:7"=<2V
M2D9]<5OQ7<4L1D7S`HD,?S1L#NW;>F.F>_2H'U:S1G5FERF<@0.>A(.,#GE3
MT_J*`,&;P[K4BIB_T\^40R+]C`4'GM_P)CTZDTR;0/$%RD,=U=Z7*D!!C#6H
M(7IP!CIBNB.JV2N$:4@GIF-L?<WXSCKMYJ:TO(+V-WMY-ZHY1N",,.HYH`Y4
M^&]<.Y_M&D"5A@N+)<GT_A_#ITIT?AW64N(YC_8SM"%6(M;G*@=OSSZ_A72'
M4K07$\'G?O8-OF+M/R[NG;W'YT^UO;:[1WMY0ZQD!C@@#(#=_8@_C0!CK%XK
MCEW?:-*E7?G:0ZY&,=><4FSQ:LLC!])>,[@BY<$9Z'..W'UYK;>[@2W2X:51
M"Y4*_8[B`OYDBFW-[;6CQ)<3I$TI(0,<;L<F@#G[234?^$KLQJL=N)3:2!?(
MD)'WE.<'OV__`%5U%8-T=WC33QN)46<K*.2,DCFMZ@`HHHH`****`"BBB@`H
MHHH`**0D#J<4M`!1110`4444`%%%%`!1110!5L,>3)U_UTG;_;-6JJ:?CRYL
M?\]Y,^WS&K=`!1110`44Q&9BX9"@5L`DCYACJ,?YXI]`!1110`5#=W45E;/<
M7!98TQDJA8\G'0`GO4U%`&0GB336=U:2:/:P7+P.H;/IQ^'/>J^I:GH>J6IM
M)[R0(S!L1AU;(Y'0>W\JA\6>)9=#GM(8%B9IE=G,BL0H'3I[Y]>G2NA$T1B\
MP2+LY^;/''7^1H`XH:7X1WM(;NY);+9RXZ\=E]_U]#0UEX/D7Y]3EPQ():=@
M#DYYXZ<U+IGCHW48DN((X@C.\P7<2L0`"D>I+$+]?TO7'BG1'MX4EM9IH717
M1#;;@`6*CCMTX_2@#&FTSPY/G=XGDY/.9DZY8GMW+,?QIT%EIZK%%;>+T5%)
M,2L(R5)(]>^3^/X5KPZSX=U":TL1;1N;M28U:`8`R_7TY#?]]>]+XA;0="LX
M[J32+.9Y'`5$A3<W<MT[#^E`&&GAW1[B&8)XFC82R^8[EDW$X(/.>X9OS[XJ
MZVC6KK=!/$\*F[),V!&<C)8@<\#+-Q[U+?ZEX5LKB*)=.L9"\BHSBW4(JL,D
M[L8.`1QUJ./5?";3RA],MXE"#:S6H!?*Y;C'&!C)]Z`*USX;MI\(OBB)%Q]T
M;<D;V?LX!Y;/(/2A?"[&,I%XG@9]P^?RQN'RLH`._C.YOQ)/6K\MSX+E@9VM
MK3R]_EEDM2.<%N,#.,=Q3XM"\(7M]+;0P027"+\R)*XQCCL<9&.<<\\]:`,4
M^$]0$@6UUFR*[&C:,L0JEP5(5>0,ACZ')-.A\,:NJ#;J>FE1&8U`9MJH2P&`
M!C@LQ&>]=&_@OP^S[_L&ULYRLKC]`:C/@?0?E*6TD9'=9GYZ>I]J`,.U\,:[
M`0\%UI\^Z19BQD8Y*D[#]W/!YZ\[0.W.OIS:E%XF5];DM5<6+[3!D*1YBY))
MZ'I4R>"](CC:-1<A&`!47#`$#/&,^Y_,U4N/"FD/?R+>/.T,4'FEY;@\$ELD
MDGC@#\J`+DMO?S0VTQM=)U"18`IN)FY9CN#;2%Q@\<<=2/>H[G2B9&C71M):
M+RS&KEMLG!P@W8R#MV\YR.W054M_"WA&Z<16TT<TA&0([O<Q`SDX!_SBFGPE
MX48!1<@,TAA!%T,E^/E_WO;KS0`^XT>1CY2^&;!\QB)R)]@(VJ<KQG[Q(SUX
M'/H^32I4GO(E\/6OV.=$27R;@KO4<Y5,8!!Y'0Y^M4W\%:#"S8U26$JI#GSE
M&#D=>./3%3GP#"68Q:O>*N>!D<'OT]P/IB@"6/3+:'4(Y[?1;Y9H?+*GSML8
M*D1]C_=YZ<@5%8Z39W>K)//H>H02S2--*\DGR)(-KGH<%<D`<9R#QP<1O\/X
MPG&L72@#G(XQU]?7FIH/!<L,GFP:_>(Q')CXR#R>_<C-`$O_``CVF011-'8Z
M@-DK*J)*W_+,NRL>>A(P"?[P]:I'3$OM8NI-4L=3N8;TQ-'B+RTAW+@;ANZH
M``3]<CI6C_PB]_N4CQ+J6`22"V<_K2#PUJ<8.WQ/>CDX+#/)Z=3[_P">*`(3
MIFF7(B9M-U$Q7D1(4H?W1C0KDC/RLRXP>^!WJ*VT&SD$&'UE95\TO(X(+<(,
M-VY!!]]ISR*O?\(YJFW'_"37N3G/R#].>*1_#NKY!C\378&<G=&#Q[<\=J`*
M<FF:1IUYY$]Y?H(9DN(L*Q2/!)"+@$=7Y]F'K5B3P[IOB!GOA)=)%,S&2%@5
MQ*!M)YY!'0C.,BAM`\0@ML\1R%<D*&CQ\ON?6IX[#Q/'G_B;VCY_OVYXXQZ_
MC^)H`I-IVAV4MK:7NHEI[68S%2H7>2!@'`X`PIX].:)?#>F6%O-%-J+1Q1JN
M_P#=HI"LLD:DD#DG<>>^.:T([?Q3'&J_;=-D*C&7B?+>YP>M+Y/BC(_TO2\=
M/]2_KUZ]:`.;_L^ROM:MK*'4A=+<+*DTWEH<X1`$`['"9S^7>M2W\/6%U#+?
MV]W&ZL69)"@VJID$N3GOCC/&`:O&U\3-@FYTK<#D-Y#Y4XQD<]<<?B:22'Q0
M8G3?HTB,N-C1R`8].M`&'_PB,C)'Y5_82`1O&JF/;E678K<<EL-GGOM'O71Z
M+8RZ0;U;BX@=)9O-7;PPRN#G\5X'MU[#/ELO$8RJV6@2*><E'P>=QR"?[V#2
MW*:_<R[YM#TR3<-K[Y<EE^;`S]&8?B:`.E2>)PY612$.UN>AP#_(C\Z07$).
M!(IZY(/`QCJ?Q%<VUOJS6TUL?#]@8)F#O&;KAF&.3Q_LK^5$EOJ#,LDGA:RD
M>($J4NE!YZ@?+]*`.HW#`.1@]#FC<.>1P<=>]<Q<-J5U9I:S^$89+>/'EQM>
MQX7`P,<<<<5$MO>IY2KX/A`C?<I%\F%(VX/3_87_`+YH`ZVBN2E.IW$4L;^%
M9$6Y8R2^7J*KO)7;\W3MCC\>HJ>VU?4T=4C\,70_<KM+3J/E7H#G@'GIU]J`
M.FHKE(_$NH*LLJ>%K\%V#/U!)QC.,9Z+_+UJ&#6KFW=YE\/:NH:1F6-=Y0DY
M+97&1DG/3J3Z4`=C17%OX@?]R9](UQ3`1Q\P#G((W<#)_P#U=#18^(Q9EXVT
M_7IDE/WIE+LO!X7I[=_?/%`':45Q]KXE@AF606/B&4JC*4>(,IR1R1GJ-N!]
M34ESXIAN4`73M?BQCF*`#NK>O<#\B?6@#K**Y(>)XUOFNO[/\0-E-HA-N/+'
M3G&<YXZ^YHO?%*7,02+3M=@?#%62W`ZJR@GGD`G/U4>E`'6T5PR^)UM[HR8U
MT#=YDJ36Z%=@'('/R#)!R.F/>G3>,K)SE[G4;=U8LI,"[=I/`(!YP,=>Q]Z`
M.WHKSZ7QH[W0$5XUO$@*F2XA)+Y8'*HHQD``<GH3WI/^$ACMFDGM_%$EVT0#
MB&:V*K*,DE`<<'MG&.?R`/0J9-+'!"\LSK'&@+,S'``]:Y*U\6V$^EIYFMFW
MNY$3<7M\[""-W`&.><<\9K*O]<L]5NEL+[6G.GQ2>;),(-AEP%VHH`R,$,23
MW/TH`Z#3);OQ%?F]G26WTN$YM8\E#.?[[=R,=!TY[X-.AMX+;QJL-C%';QBQ
M,DR0@*KDOA<@=3UYJM!XFTBWMO)CUR/:@54`M6"H`W0<=,<>W6LVPUVU%U=7
M\FMP17=Q+A8WMR0(U+!5)`XSP3@^GK0!WU%<['XITS:RG6+5AY2['*$-OYR2
M.F.G`]_:HX/%%DMU$)M9LI(O(42`*P/F#.6!Z8/''M0!TU8WBK6X]$TB2;(^
MT2`I`N>2WK]!U_3O5.]\56GG1FRU73A$/OK*'+,?8CH.G;\JYI-03Q!K_P!K
MU2]LH[.PXA1SM61CR#@Y)!(&?8`4`>@:8MRFG6ZWK^9<B,>8V,9-6JYG_A()
MG15BU/0?-(/#3MC[PQ^F?Q^O%A-=WH%34=',P'S@SD#[W'_COZT`;U%8']N2
M"41"]T9G"@L/M1&#DY['MM_7UXDU#7X;5))EN+'R(NK-/N9L@%<*H)Y)(_#-
M`&W17'ZCK6N_9I+R$6=I&CJJ6\GSS."X7+#/R]>G7K730WUO(B9GA61ADH)0
MV#Z4`6J*S(]58R2*\<(Q)MCQ<(=ZD@!NO'4G'H!U)Q5F6]01![?;<$L%VQNO
MM[^]`%JBHHY@\*.^$)`)4D?*<9Q4-W=36[!8K22?*L0591R%)`Y/?`'X_6@"
MW15>SN);B)FGM);5@V-DC*21ZY4D=_TIBW4Q$.^QF4R/M8;D.P8SN.#T[?6@
M"W3)4,D+HK!2RD`D9Q^'>J4.I2R>>&T^Y1HH5E`(7Y]RD[1S]X$$?_KJ&_OY
M_(N(1IU\248!H2`Q&[;E6SP<'<,X/Y&@"LZ?\5M:@X8II[G.<8^<#(']/\*W
MZY^%F/CN6,N66/3A@$<@EQ[>WO\`TKH*`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`*FG9\F7(/\`KY,$GK\Y_+T_"K=5=/\`]5+U_P!?
M)U_WC5J@`HHHH`****`"BBB@`HHHH`JWNG6>H>5]LMHYO);>F\9P?\]J8--@
MBLYK:T'V<2;CE>0"W).#Q5VHYU=X)%C.'92%))&#CCI0!QCZ7H<]N=WB*V*+
M$L).(!\HP0O3/;COQSFJEUI.E:3$DB:WYF#$ZPP)$TC\%491GG[Q)QUZ^]4+
M'0KB`S0KJ.E%X9T,GF3NF'0,,?=&?O#/7I[U/!X<N[2ZCE^WZ2\-LZ2F%KK&
M74;1D[.F>WN1UYH`?<Z%8)K5OIDFLRI<)$+<.ML%`)!*J6S]X@^^1D>E/CTH
MZGY%T=<L)$DME@1+F$*RIT&$W$`Y4X(J+4K/6&U(ZEYME.'\PHJ78($;+C.6
MQE/;\@,U4FT?6)VR=-MC$L>Q0)D._P#=",$'=SC;N'OF@#4C\+RR,]U_;5C-
M'+OB#9.P,R%#@`XW8Q^(I^F^&;D2W0@U*RO90K6]P9-[$;@N5R#P<+MSZ9%9
M-[I%Y//')_982U$[2>1')%@`E<@,#_=7.2..N,'-":=J<L[$V$BK*\BR&&)&
M8@N')`W8SQMQTQQS0!ICP#>879=6F`^7(##<!C`XX!&#R`#\QK6\+>%[O1=2
MFN[JYBG,L94E=Q;)*DGGCMZ9KD)="O)(K9(M-NB[;VG?8H+$D<K\QZ=.W8]Z
MU-6M-1U'5UG72M1CC2.,(Y/SQ;<D[?FP2V!R>G7%`'>VU]:W;RI;7$4KPMMD
M5&!*'W].A_*K%<[X(M$M-&*&VFAN?,/VCS5QN?U`SC&"!QZ5T5`!6'K)9)-2
MEC<Q.FF-ME!(V'YN1CGMFMRL758GGN+Z.,_,;';CR]Y(+-GC//3I[T`07.OR
MK>7L5GI,]Q#9\3RHX3Y^N!ZC!)/^<RVFN:5<6#7=Q)':E'??&\@W*02"0!ZX
M)XJG#IPDUVX-E>:A9K=;;B>(P;5?:V#AB,J3[<D9ZC%58M#@TL-?O=WDD=M(
M!)']F!,A5R=V!V^8\^AS0!KKJVG-8SW-X(8Q&S2;/,61F"_Q#'X_YS6C%<6,
M*>7%/;HJC=M#@``GK],D?G7'#PU;R+/<_;KNWCC;[.,VX7[[DG(/509!SQT-
M1R:5YD]Q':7\6HRQH;A$$2*<S#EV;@8`)(`]1Q0!U::Y:2ZRVF*3N$0E67("
M-\V-H/<_3W]*B72?#\(5!;V:B-PP7<.&4=<9ZCO^M<[I?A^*\AO;^UO;=TF?
M.?+*HC+,';;G^'`Q1HGA='U"WG6]T^]L8B[%$C&YT;<H)]>00,G`V\=*`.CN
M;?1[35;-YHE2[G=UA?)'/SD]\<^8WU+#VI;RRT72K);FXMTA@MB&#(K'9EU;
M^'G[RK^6.E8VHVB:M?7TSZEI[2^0JV*K-]S!WAC]<#D<8^E;D$L>H:1*NIS6
M,D<A\MF@DW1D-@`9/<Y'YB@#&5O"4S*XBD+)MMA^[GR/DP%Z?W5_3-:.@MH5
MQ.\FC\R01(C<2#"$#;PW7A!SUX]ZY_2?#:F.Z5-5@NIA9%6`?<JR.K*C[N<+
MLQCOWZ8IDGAS4KBV>>%K.3S%A`\B<[1LC*>@!^]GKQC@]J`.UGL8YMQ5Y869
M][M$^TL=NT9]L8_(4L]E'-YA$DL;R*JEXY"&`!)&/^^C7#KX:U>6[!EDCE\F
M>..;;-GS?FWF1AD;3M8#')()XYS75>%K6ZL=`M;6^XNHPQ=2X8C+,1R/:@"U
M<Z<ES*SM<72JP53&DI5>&+=/?.#[#%+)8E[;R5O+E#ECO#_,<[N.G0;N,>@]
M*N44`9TNERN\C)J5Y'OE\S"L#M''RC(X''ZU+=V<MVA3[;/`/,W*8,*P&W&W
M)!SSS5RB@#/@L;R(Q!]3DE"L6<M&N7Z8'H!@'/'))/%:%%%`%>&.Y6\GDEEC
M:%@HB15(*XZY.<'KZ"I8Q(%/FE2VXXVC`QDX_'&,^]/HH`J[+W=,1/!@AO*!
MB/RG`VY.[D`YSTSD=,4^%;H)$)Y(78$^84C*@CM@%CCMGK4]%`$;&7ST"HIB
M*G<Q;D'C&!W[_E4E%%`$>Z7,GR+@?<);[W'?CC]:AADO"5$UO&H,CJ2LF<(,
M[6QCG/&15JB@"D+B_-RJ&Q01%G!D\_H!]TXQW_2F6USJ4DT:SZ;'#&P^=Q<A
MMIY[;>>WYUH44`5X9+IYG66W2*,$[6$FXL,\<8XSU[TMK)<2>;]I@6';(RIA
M]V]<\-[9':IZ*`*UIJ%G>O(EK=13-$=KJC@E3TY%%K?6EXS_`&2[@N-F-PBD
M#;<YZX/M^E>?>/L:5KR7FGW1BN;F%EECC`!`(QDGWS]<KG/2NQ\.6UA9:-$+
M26-H?*5I"",9QDL3ZGW]!0!LUS#1-XGU>XCF=QI%D_E&-3@7$G\62#T'%:WB
M"]_L[0[RZ#;62,A3SPQX'3W(IGAFV6U\.V$8')A5V]V89/\`.@#2550848[U
MB>,;A+/PU>,%^>5?*7:H)RW']3^=;M4]1TVWU.**.Y#%8I5F7:Q'S+TH`Q9I
MY?#OA.RAB0RW[*L$"A>3(PSR/0?T%;6GV*VFGV]LY,K11A"[$DL>,\GG!(Z5
MBW\EL?&"3ZA*L5OI]J)(S(<+O=BN>>.V/K]*C"7WBPJ\A>QTA6RJC*RW''4G
MLO/^>P`\BVU[4EL[-=EA8MF>1%&))%8%8P?3J3CVJNCQ:[XE%K8I''I^GE99
MGC0#SG!!53QT!!X[X/M47B[5X],L4T31A`LL@\N1$Q^Z4\8Z\,<_7&3[TQM0
MM?#.@'3;"YMSJGFB*5RP7;(RY+G=U4#`S0!TT3:1)>O:Q"T:YBY:-57<M.;1
M=,:)HC86Y1I/-(V#[_K]:XRVO+6S\0VBZ+"^I&"U>/$9V^9*6RS[B.1ZGD#M
M3M:UO4Y+B1)KM;2.%2LEO:,&9F)(6,/@_.1D\=,`XS0!+XU_LY$>"SL;,SM;
MM+)/L&(T!(&,?Q%OE^IK7TGPAID6FQ"]LHI;AAOD)'W6/)4>PZ"LK4]%.E>$
M)FO',D]Q-"]XR@G*@CY<]<#KGN<^M:VJ>)T,W]G:&HO]1D4[=A&R/C.2W0_3
M\R*`+7_"*:%G/]F0?K_C6'HF@:5-K.LV<UA#+';3*T;Y.0'&=O!Q@8`_G4NG
M^(=<U*#[':::!>Q@I/<SG;%&X.",`<GIQ6B3#X2T%I')N)Y90TA+$&>9R,D=
M>PZ#TH`'\(^'8E,CZ?&JK@DF1\#'XUAZ+H6CZA]JU6>RCM]*0%+='9AN4=9&
M)/X#\?J;_C#4;::>+1IYEAMFVS7DN>5C!&%`P>2=O-+I]L_B8VMU=6PMM)MP
M#;6IZR$=&;MM&.!W!H`IZ5X:TK6IYKL:>(--&8[<`N&FY'[PDG(''`]S6C/X
M#T*:4R"&6('^%)"!^O\`GFNE`"@```#@`=JKWNH6>GQJ][<QP*QVJ7;&30!S
MLGP]T1U(7[3&>.5D&1@<]0>O7^6*:WP]TAXU4S788?>974;CSSC;COVJRNOW
MVK\>'K-6C7:7N+L%4Y/15')/.<^QZ\5?TJSU>WG+ZCJB7<;)CRU@5-K9Z@CJ
M,>M`&.GP^TR-"B7VHJIZJ)5`/!']WT)'XFGR>![=IEE75M4\Q?XVF!8=<8./
M<_F:ZJB@#E3X'A>)HWUC4V4XX,PQ^(QSVI5\%JK^8-:U3S=I7?YPSM.<CIZG
M-=310!S(\('.#KVL;!]U?M'3U[>E1#P;.%Q_PD.IX`P`)#QV]?3BNKHH`X[0
MM/;3/&UQ;R7D]VYL`_F3,2WWP,?2NQK`B5O^$]G;"E?[.4$X&0?,/'7V/^>N
M_0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!6L=QCD+-D
M&:3:/0;B/Z59JM8C$+^OG29'_`S5F@`HHHH`****`"BBB@`HHHH`***JZI<?
M9=+N[@$@Q0NX([8!-`'$V_AC4WMC%<6T$\F,-(\P/)D#MVX)`QG^50Q>%->B
M2V=K>REEMI%:,-MP0,D[CC+9)'?L:I#7)(WFM(-3E6V:-59I$)+D[#(<]=^2
M_)[#%1V?BB^MPBQ7EP%5';$B)C)&XD#'S'<QZXX`Z9X`+]QX5U(6@\S3X9)@
MR%&4@A%4$E=H/(9C^6.G05;C2[]1'MT>96'WF%L6\L^8S@QJ#C!X7!Z`>^:N
MZ)XI,>K>;>ZDS0&-XF648)V?<8CL3GMWS5,>,]1O8)HI[]+59MP5DCRRCL.!
MQG.-W4;3QF@"%=&O%N;%CHETUM"BF13;_,[@DMGGD$G&3VP.U.AT_4+2*TEM
M]*N[>>)5E:X$#%D*[^-O?=QG/TI)?$E[=W,;?VLT(W1G<I91".A&WG?CS.IY
M(0^U7++Q=J,"06RW=I)O4*99FSL9BK[V..>&9=HZ%>IQR`:/A"P@MM2M1_9&
MH02QVY+7$T;*K2'[V0>!P`!CWS7<UYZWBO5;A/LT[16K20*@:,$MO;80X/09
M5\CZ'IQ5^Z\9RIJ%P+9+66UC7:A\WJ<J`Y/0+\V/K]*`.SHKB#X\G254?3$^
MZ"<SE<`XP_W?ND,#GZUU6C7YU32K>],#0&9=WEL<XY]?U_&@"[5%#_Q/)AD<
M6T9Q_P`">KU94]Y'9:O,TN\B2.VB4*.[22*#U]2,T`8FL:UJEOJFIQ6HE:WB
M$4*LJ!O*E<9#=.1C@\\$CUI;+QE/>K,MO812RB4K&!/@,NV1@>A.<1].^>U=
M)/<B.Y$'V.>167>9%0%,YQ@\]>/2F*\4(CD33Y%:2;80L2Y4Y8;S@_=QGGT/
MO0!SLOCE(VB6;32$DVDXF!^1E1A@$#)Q)T]OKCK\#.<<^M9U\+6WDB!TIKDM
M\RF*%6V$;0,DXP<8Q[+[59:[VH6-O/P"2`F3]W=Z^^/K0!+'#%%%Y442)'_=
M50!^5*D:1@!$50!C"C'%0K>#!+P3QJ(ED+,F<;L_+QDY&.?3(JS0!`MI;*Y=
M;>(,0`6"#)`&!^G%/2"&.,1QQ1H@(.U5`&1C''X#\J@BU*TE@BF24F.96="4
M89`ZGIQ^--;5;)+>2=I\1QR^2Y*GA\XQC&>I%`$AT^S,31?981&P4,H0`$+C
M:#Z@8'%0'1=--RMP;2/S4.5//'X=.])+KNFP)&\MSL23[K,C`'DCT]0?\FF?
M\)%I.R-S>H%D)5"589(`)'3_`&A0!*VC:>R,GV555IOM!V$KF3^]P:1M$T]H
MTC:WRJ1B(#>WW`<@'GGGUI5UK37FEB6[CWP[_,!R-FS[V?3&:0ZYIBR/&U[$
M'C.'4G!7@MS^`)_"@!\6E6<+V[1QNIM]WE_O7XW=<\\_CFG_`-G6WV2*U".(
M8<;%$C`C'3G.3^-/-Y;"))#,@21_+5B>K9QCZYXI;6[@O(S);RK(H(!(['`/
M\B#^-`"F!"\3?-F+.WYCW&.?7\:='$L9<KNR[;CEB>?QZ=.E*LB.@=75E/1@
M>#2[AC.1C..O>@!:*;O7^\/S_"G4`%%%(#D`^OK0`M%%%`!4963SU82`1!2"
MFWDG(P<^V#Q[^U244`,8.70JX"#.X;<D^G/:GT44`5?*O1+$1=1%`[F13"<L
MI/R@'=P0.,\YI?+N]H_TF,L(V4_NN"_&&^]T'/'?/6K-%`%81W?V0(UQ$;C<
M"9%B(4C=G&W<>W'6EM4ND\S[5-%+E\H8XRF%]#R<FK%%`'%R^%W369KB?5[6
M6ZO0XV7-OD[3Q\HW?[HJWI.B:SI-JL%GJEM<VZMNC$L).WKG&&Z'/3/Y<U7\
M5Z3J=[K]O)96L<T4D"H7DQB-E9FSG&5ZC!%8QN/$5E-%86RW4<IP8HD`V[=I
M+?>7'4@]3MZ<'H`=#J6F>(]5TZYL;I]*$,B@*5\T,<,#D\G'3/>L^/7=9TZ9
M-+G;2[5X0L,;7*2A9,#A@PXP1ZXI+H^*X-BVSWDI5T8ED0Y)12P/3@,7'X8]
MQ6BL_$%M:F!8+E]^]D_=J3&_G*=V6/==WY_C0!>N?%&I6BJ\NH^''!;`$4DK
MGV^[G'U/%2Z3K?BC50YAL+)(QC;/*LB(>O0$Y/X>A]15&VM_%,&I6*K&#"7W
M.6A3"J7P02!_=`/;K]*[Z@#SV]T?7(M335=2M(=4<_(L2$E8SSM)4+RH_K6S
M%?>)]0M95M]*M[`L#LEFD(.,'&%QG(XZC\/3J:*`.&CT:]T>2QE.E?;G\[=(
M4NBSO*1\KL2@PJ_,/QZ^MR/1]1;5)M5OM-L[NX<`11&?"P@'(QE#SD=??ZUU
MM%`'-R6NIC5K?4(M)MU:"%X_+2Y'S;B"/X.._P"+?6L^QT>_T_4WNCHHN5,I
M,"-=)MM\G)89')R>#][``KM**`,*34-4F1X9O#3R(>&4W,15@1[]:JVEU<:6
M[06?A.2$,P!,4B8;T)/T/?W]ZZ>B@#G?^$AU/8Q_X1N]W]AO7!_'_P"M67*^
MJ3:H-1N=*GGD5=MO&T8V6I/5AU+G(')`_#MVU%`'`1VM]'K<FI7NBSZH\I&/
M,39Y//\`"I)!&,=><CKU-;,OB>^1!Y'AK43A@I#KM`&.HP#G\JZ:B@#C-3\3
M:E]F(BL[FP;:N\O;-(49F/1L@'C@<>OM5:UGT6PMQ/J-CJ=Y*[?\?%];%RQ'
M9<G`_P`]:[RB@#EAX[T6./`CND5!C'DXQP..OO0/'^B%MNZX!W8SY?'UZ]*Z
MFB@#ED\?Z$P8L\Z8!(#1?>]ABIE\<:$S!3<NI[[HF&#SP?R_45T=-=$?&]5;
M'J,T`8C^,="0#-^AR%.%!/WOIZ=_2I?^$IT/&?[3M_SK3^SP8QY,>..-H[=/
MRI?)BX_=IQDCY1WX-`&9_P`)1H?_`$$[?_OJGGQ'HH)']J6G'I**T'@BD`$D
M2.!G&Y0>O6HWL+-V5GM(&9!M4F,$@>@_,T`8EE<?:/'-[MSY:64:@]0V3N!'
M'3YC_GIT=<O8*L?Q"OU6/`^Q)AL]`"HQC_/2NHH`****`"BBB@`HHHH`****
M`(9TE<Q>5+Y>UPS\9W+SD5-110`4444`%%%%`!1110`4444`5K#'DOC'^NDY
M!!S\YJS5:P&('P`!YTO3_?:K-`!1110`4444`%%%%`!1110`5%=2F&UFE7;E
M$9AN/'`SS4M4]8N?L>D7=QNC5DB8J9"`I;'R@YXY.!0!PMAJ]U:Z9=74FKC[
M5(\,$"R.K*N2&<E<G@;F&[T].RCQ=K$,*>;<6DKNX<$8PW"YB&._SCYC@<'!
M-*=5/E)"+32)4<8C:94:1<;OO@'EF"'/3!8?2HUU^P+&,:+HQ3:Y,GE@*"H)
M*XQDYPN"..>]`&AI7B2\N];@M[S[$;:9"['"C`P<$G/)&,<<'<:IP^*;];RY
MG9+6XA4,%@P`V-S],#G"HV?J/6J`U#2;F=99-&L-KE78K*Z%LX+`#(`V_-['
MM[QI>:7;SB&32K&-O+'[V*Y<A24!QD-G^+!_'KC%`&_9>))M6N[=!I=G-;/,
ML)<@Y&XN"0"/[BL?_P!=;-GIUO+J^H07.G:>T$?E^4J6Z\9#9+$CD]!QVQ[U
MQC26$L/GI8Q-*D!G\Q[^1@`%R%Z@[LL!CZX/!KM_#NFZ;;1_:K%2DLB!94%P
M9`AX)4\D9!_SS0!;;0])9][:79%O4P+_`(4@T'1P`/[*LL`8&;=#_2M&B@#.
M&A:0K$C2[/D8/[A<8^F*ELM+L=/=WL[2*!G`#%%P2!VJY10`5CW30_VVPEB$
MQV6X5"PX;?(0V#Z8)XYX/%;%8LMO]H\3O]P&&&WE!89/#3#CD8/S=>?I0!F^
M&;VXFN-1MVUC[=;1I^[N"H4AL?-@=2!QSTY]ZR='\5:I8Z=]MU-)+NUF&(G8
MJAWJ#G&.2,+R<=?K716=M';7D]A'%I:7#P;W2&(QDH6QC@<@#CKG.#QD56FL
M;6>UDMMFD/!92%D1W;$3$LWS'/0[DR.G7V%`$%WXNG2^MY(K=OL8E,##<A$S
ME<KM;/&#C/;GK4GBG5M5T[4-/2SF"_:8I,VXA\TF11D#/7DD#C&.3S5U/"VE
MW$;"YL(%!)*>3(^/F`!/;'"C_)J2'0X3<V]U+96XGMH]L9260;2I(4>XQW(Z
MDT`9]KXKD@:5-0A:0BZ=-T0`\M`R+R,Y)#.!QSQ39?'ME#%(\EC>(4F,6UU`
M)(Z_0CC(]ZNR>$]+NKB66>R*22$R/)'.WSNQRP[<`@8J&?PAHR2VP339)5+D
M,WVEQLXSN/S>H[>M`&KK5_+8Z--=VT1DD51M4J>,D#)'7C/3K67I_BN!K>)+
MR1);EG;<UNA\H+YOEALGMR/S%#:9<)IMYIK6ES<V\DAD1_M*AE^<$!23GY0`
MV3UP?I52Z\,[BB);WA$0;S)(IHU-S\RODYZ$M],;?I0!+IOBZ*.P>;4F<A!O
M$JQ$;@9'4#&!S\OZ&M34/$-I:Z0NH6S+=B0$Q1HV#(!]['^Z`2?3%<_?>%F6
MVM@D6HSR+$3NBFC4Q/O+@D$C+`NPR/4U/<V$%Q:6^GS>';[=%%Y4<ID1BBD$
M9W!L?@?Y4`7KWQ1]EO;N#[(&6W*J"TI5G)(`PNW[N3C.>U:6D7XU.W>9X5BG
MAED@D0/OV,IP1NP.N`:R;W0=[S1LUS-E$2!HU1%@3S5.T`8!Q@'GL.*DT>YA
MTS3KC%EJ!=7$MP[P'>[NQR<#[VWC.,\8H`Z!E5P`RAL$$9&>:4J"""`0>HQU
MJBFJPO!<3^3<B.`*23$<ME0W"CG@,,\<'-36U]#=6GVJ+S!%R<O&RD@=\$9H
M`E6")(EB6)%C4@A`H`!!R./KS37M;=TC1X(F2-@Z*4!"L.A'H:JKK%H8HY"+
MA1(,J&MY,]<<C''/Z<]*D?4[6,`LTG+J@Q"YY8;AT'IW[=Z`)OLMOEC]GBRS
M;F^0<GGD^_)_.G""$1QQB*,)%C8H483'3`[8JO+J=I#*8Y92KAMF"C<GY>G'
M/WUY'OZ'$L=W#*L+1DLLW*':1VSSGI0`KVL#RF5X8V<KM+,H)QSQ^II884A,
MA0O^\?>=S$X.`.,]!QT%#7$"2^4TT:R''R%@#SG''O@_D:(KB&?_`%,J2?*K
M_*V?E;H?H<4`*D*I-)("Q,F,@L2!CT':A80HD`:3]X23ER<9';TJ*._LYA(8
MKN!Q$-S[9`=@QG)YX&*E$T1C$@E0H6VA@PQG.,9]<\?6@"&VL5M[06XGN9`&
MW;Y)F9SSG&[KCM]*L!,2,^6Y`&,\#&>WX_RHDD2)=TCJBY`RQP,DX'ZT(ZR(
MKHP9&&593D$>HH`=44T`E=&\R1"G38V`>G4=^G\_6I:*`*+VMZ8YE3465F51
M&QA4[".I]\_IFK95S,K"3$84@ICJ21@Y]L'\_:GT4`48[6^5T+ZB74,"R^2H
MR.>/;M^5+#;7J/(9-0,BL6VJ85&P9&!QUP,CWSVJ[10!1%K?>7&IU'YE0J["
M%?F.?O>V!QBH;R>^M;J0^9#]FE,8C:0JOEDL%9<D_,<98<=>.:U*QM:$+2;;
MJ:18<P$*NTX;SEP<=>3@9Z8S0!>6&Z^QP1-=`7"HHDD"9W$8W'!]>1^-$<-X
M&C\R[5E7.X>4,L=V1SG@!>,?CDUR-O'J2^)-0^SVSVL=S=$&>6W8@*H)#*2<
M8)#<]?FXP<5=>ZUV>&&2XMHU>.?:D7D.2SJK$OPPPN0,>O/M0!TT'VG+_:/*
MQGY/+ST]\U!<#4O-)MC:^7\P`DW9/RC:3C_:S^'O7+1Z]XC%JN;.0R$NY=K*
M0DC:I"JJ^A8C)..!D^O;4`1QK())2\@9&8%%"X*C`X)SSSD_C3)3=>;^Z6$Q
MY3EF.<9.[MZ8Q^-3T4`5[DW8_P"/58#^[?\`UI(^?C;T'3KFK%%%`#)3($!B
M56;<N0QQQD9/Y9JO]HNFMYW6R(E20I&C2`>8`<!L]AW]<=JMT4`%0^9*D,KO
M%N9-Q5(SDN!TZX&3]:FHH`K+<NRVI-M*IG^\"!^Z^4M\WY8^IIEU?26]PL26
M%W."`3)$$VKDD8.6![=A5RB@",2,;AHO*<*J!O,XVDDGCZC'ZBF6ER;J-G-O
M-!ARNV8`$X[C!/%3U3U)K=$B>>7RV5R8>3R^UL#'?C/'M0!/),4GCB$4C[PQ
MW*/E7&.">V<\4)*791Y<B[DW98=/8^]84&K7US/;6MK);;SIZ73O<(06+''W
M5/R^IZ]13[;Q"QU>WL;F)5CEC">>OW?M``9D')XP1CWXYH`V3<JK3^8CQQP@
M,9'&%(QDX^G>F&^M@L3"3<LJAT95+!@2`""!ZL/SHN8BR3/YL@!B*[`1@=>1
MQG/XUS2ZW=Z2^FZ:MKF-8((_WBE9)21MPHS@$<9Z]Z`.IN+B*V56F8J&<(,*
M3DDX`XJ*74;2&5HI)@'4@,,$X)QC/YBN;D\6W4%BYGM(A<^:R*\;&2(*H!9^
M.2%)`..X//!J_>>)H[)+[SEC_<+$8720$3&0';UQC[I/4\<T`:\M[;PW,=O)
M)MED^XN#SU[_`('\J9/J=G;0)/-.J12)O5B#@KQS^HINCWXU32K:]V!/.3<5
M!S@]QFKM`$<$T=Q$LL3;D;H:@FU.RM[..\FN8X[>7;LD8X!R,BK=1SA3;R!M
MNTJ<[SA<8[^U`&!I86;QOK,P`/E0P1AN.C+N_H*Z.N6\-+M\2ZOMB$:&"U(4
M<A/W?3/^![5U-`!1110`4444`%%%%`!1110`44A8+C<0,G`R>II:`"BBB@`H
MHHH`****`"BBB@"K8$&*7U\Z3/3^\?3^M6JK6!!AD&X,1-)G`Z?.3_6K-`!1
M110`4444`%%%%`!5'4M._M`1_P"FWEKY>?\`CVEV;L^O'/\`]>KU%`&"WAVX
M^SA$U[5!+P=[2@CJ">,>WKW[TZYT"YN$E!UJ\'F.S!2$9`"<@8([<=^W;MG:
M\ETWBVPBAO[V&)D\V4)+MC5$Y/`ZD].?45O7NH(-"N=0LY%D5+=Y8V'0X4D?
MRH`P_P#A%-0"G&M*6.22;./&<]AVX^O6G_\`"-:H87C?5[:3=_$^GH3WYZ]>
M36%!X@N]'(;^VH]8FG508<,5B9CDG<!R``1C@\].*O?\)9J]V\:06,<"R7$-
MOO?[V]@&8`=".#SZ,O>@#2?PY>L&WW6FR<@JKZ<N!@YSPW4]^O042>';R50K
M2:4-IR,:?Z$D?Q?3\_:N>.OZP]^DT-ZWV9Y`0A52=KNQ7CCHB$__`*^-A_'"
M1JGFZ9=!I$5D",K`@H'X/KM8''N/6@!#X,9@<G3`=O46;'GM_'5NQT34])LI
M(].N-/0D^8$^S.`S>A;S"<'IT..U9Y\</8W,L6IV;AGF81)$/N(K;.3WY5NG
MI6U>^(H[34HK3[)/(KM&C2@8"L^=HP><\4`,D'BD;_+;23RI3<)/;(/MUICR
M>+%2,B#2G8%MX5W&?3KT_P`]*F\*W]_JFE&^OO*432,T*(/NITP3]0:VJ`,5
M+CQ%M^?3[`MGJ+E@#_XZ:?\`:]=#'_B4VA4=/],//'^Y_G%:]%`&*VH:\,8T
M*%LXSB^''3_9_P`XK/BU#6?[:N9%T1'E\N*%T%X`$`,C!L[>1AOKQ[UU595@
M7/B#5@VS`$.W;G.-IZ_CF@#B;FSUF2Y>\?2+]+B65V=XWC;"ME"J_+N'R<`Y
M[9Q5!M'U)X!')H]X,LP9$A^1"0`"O.<_*,DG'7\?6JJZC?V^FV4EU=2B.).I
M/.?8#N30!YY=6-[)>)=0Z9K$+&1I'*C);,A<?[I'Z]>*BGL+D:<RI'JZSB;S
M#FU(9\],G<-QP">F>WO761'4_$6+H7,VEZ4RY1%P)I>X8M_".G0]/KFJ^AZ)
MIZZSJME/:QW"VCQM$TR[R%=,D<]1D'\<T`61XOM+9$BFLM4#@!3OMB"2/J?:
ME;QMI2#]Y'>)QG#6Y&."?Z'\C3((8!XW5+"WCBBM[0F8Q`*I+GY<@=>!73$`
MC!Y%`'-?\)WHGS`/<$KU`A/'K^5!\=Z(&V[[C/8>2>?;_/I7344`<R/'FA9(
M::9".NZ$U=MO%6AW49=-2@4#@B4[#^38]:UV16!#*"",'(ZUFZOJ$&F/8J]L
M)?M5PMN",?)N[^_..*``>(]%)`_M2TY]910/$>BD`C5+3D9YE`J_);02C$D,
M;C.<,H//^0*C^P6?_/I!_P!^Q_A0!`NN:2Z[EU.T(SC_`%R]?SK.U_Q99:78
MK+:S6]Y,S[5C24'@=22/\YK7_LZQSG[%;_\`?I?\*Y*>.TN?B-#9_8H_(MX2
MKJ8EV%V4MGISQCKZ4`:5EJUW!=6GVJ^M;N"^EQA`%:VRN53C[PR0N3[>O'0P
M3PW,?F02QRIG&Y&##/U%8VM>'K*?2+F.SLK:"?:&C>.!<@J00.GMBI--T_1]
M0TZVO5TNR7SHP^!`O!(Y'3US0!LTA.,>]9D_AS1;B+RWTNU"YS\D80_FN#5=
M_"&@O*9#IX#'^[(ZCICH#@4`:X4>8V40N1DMMQGD[1GOC_/6EB7;D,J!O]D8
M&.WY?YQ6+_PAN@_\^3?^!$G_`,52'P7H)/\`QYOCN//DP?K\U`&RMI;(KJMO
M$JN-K`(`&'H?6G^3'LV>6FW=OQM&-V<Y^N>?K6!_PA.BX&8IS@8YG?\`QIT?
M@[3(BQ@>\BW#:=ERPX[CKTH`WG177:ZAE]",BF);PQNKI&JLJ",8&,*.P]JQ
MQX7@`0#4M5`3&`+QNU'_``C$:L#'JNK*-V2/M;8(]*`->2UAEN(YW3,L8PK9
M(P*5K>)I)9"IW2H(W.X\J,X^GWCS6-)X;D)?RM:U2,$`*/M!.WIZ_0_F:A_X
M1F^_Z&34O^^J`-Q+*W1E9%8,L7D@AVR$].OZ]:?Y$?E1Q?-LCV[?G.>.F3G)
MZ=^M<X?"VIX`7Q/J``]<D_GNH/A?5"/^1HO\Y!!P?_BJ`.B^RQ?://PWF9)R
M7/&0`>,XZ`<?CUJ:N<A\/ZO"VY?$MR3VWPAA^1-3+I&LJP*^(I.IX-JA')R>
M_P"'L.!0!N,"5(#%21U'453N=,MKH?OPSMY8C+YP2`P;^8%45TS7`O/B'+9S
MG[$F._&,]/\`"B6PU\+^YUJ$D]2]H!CITP?J>:`$U:Y1KJ]L<7;2-9+(!$X4
M#YV`VDD88DCGI@"L]M7M)KNVM/[0U*$P[B\^T;"[-M".0,<$X]..IZT^_P##
M^K7;JTEUI]P0Q'[ZS!PN=P]3U[=/UJA>>%M>O(Y$EN-*^92/,$.'YY(SMXR<
MY(Y_E0!N6MK-J-J+JVUV\,4S%T8(@P,GC[O^<5=EL)F:X>+4)XWE1%5L*VPJ
M3R`1CG/(K%BM?&42!%NM(VKP!M?@<<?=]OUIYB\9\_Z1H_/L_'Z4`:D.G7D:
MH&U:XE"R!_G1,E0?N\`<$<'],=*;)IMZSY35[A%,LCE1&I^5L87D=%['WK-,
M7C,9/GZ0?]G#_P"'^<TT+XT!)+Z4P]!N]/I_G-`'3,K%U(?"C.5QUJ.>.:0Q
M&&?R@D@9QL#;UP?EYZ=N?:L:WD\4J!YUOISD9SB9EST_V3Z'\_:I!<>)$1M^
MGZ?*PZ;+EES^:]Z`->%'2)5DD,C#JY`&?P%+*)#&?**A^Q89%8;:MX@&W'AH
M,6&2!?)\O.,$XQ^51'7-?"Y_X19\?]?B_P"'O0!NP"Z&W[0T)^0;O+4CYN^,
MGITIR>?Y\F\Q^3QL"@[N@Z]NN:Y]M>UY<$>&)""%X^U+D$Y]O_U=Z>/$.I``
M/X;O0QZA64@'ZT`;D_VC(\@18VG.\GKD8Z=L;OTJ-C?"TR@MS<Y/!+!,9XYZ
M],5C?\)'J.<'PW?]<<$4O_"1ZB`&;PW?@9^;!!(^@[T`:UP=1_?_`&9+4XV^
M3YCMS_>W8'';&,U7D@O[QXDN8K:.-#N=E)<\JP.PD#!&1S]?I5&/Q1*P3S-`
MU=-S8/\`HQ.T8Z^O6K#>(XE4LVFZJJCN;-O7%`&6]O9/)9V6K3:7-]F1H'E:
MX,<V%!"\9[XR<GUI]QIB6^DO#+I5F\)N4EB6&[:,,[<%MQQCT`!/4<5S&IW&
MGW-_>227$D(D>;I:,'R5("L<X(!'IGKZ\4PU@EQ-/]H$MT6\Y`+9P-VY6`(W
M?=P"!QGYCZ#`!Z;:I?W2O_:<-ND,L6UK=&W]>N20/<>G\ZS=2:TAE@U#4+)D
MN?)*Q1R72(J'D;1\P!8ACSS7->'-<TG1+V[EFO'<3X&U(&7E<_,02>3_`#J3
MQ1XFL=4\I;6\A>VB(=X)H9!YS#H,@=/Q'2@#7_X1C3)9A;V]M=?9V96^TI."
MNW:P*`YSM.,$>X]!5V32=.NM4O;>[MG/FQQK'YFS80JD`Q]\C+9S7$6>K6D.
MI03&ZAC2.6(N420`*&=V"KC&"2!SSSGUJQJ>M6-WJUS]GN[9+:[=9'GN+9WD
MB*C&T=>"1D8]:`.YTM$TO2A;PV5PL5NG`8)N<[F!Z'&>-V?1A6D\C+/'&(G9
M7!RXQA<>OUKR9;R)X0)M1#`IL:W:XFVNQ4J9&;;TS@[1VK9\,:I;Z7J]TVHZ
MPDD9`B3:Y96+$$$#&%"CCT&<4`>@PR&6&.0H\9=0VQQAER.A]Z9=AC9S"-=S
MF-MH(SDX]*SXO$^ARR2HNJ6P,1`8L^T'Z$\-]1FI/^$AT;S/+_M6SSC.?/7'
MYYQ^%`&5H9=?&&KJZ'+06Y)(Q@A`,?Y]*Z>N7T::&Y\;:M/;3)/$T$6'C<.O
M3&,CZ5U%`!1110`4444`%%%%`!1110`4G.?:EHH`****`"BBB@`HHHH`****
M`*M@P:*7&W(FD!QZ[CU]\8JU5:P.89.&`\Z3KC^^?2K-`!1110`4444`%%%%
M`!1110!&T$3R&1HU9BFPDCJOI5>\L+*;33:7*!;-$`*AS&H4#ID$<8JY5'6=
M/.JZ5/8B=H/.`!D49(&02/QQC\:`.5MT\%RVUQ^YEBMXRC,K22@2$DA2JAOF
MZ'G'?ZT?8_!T]WY)U&1TGQ<?9VN'\O.T_,2?XB/4YI(_"5M>M<0V>MPC9+&\
MB6\*@QLF\#HW!Y;\LU,/`]PQE)U4;)3\T36H*'Y<#@/C(]?7I[@%(6/AM"D]
MMXCGA0%E0%LA01@@9'96Q3+;2?#\@AC&NS!8+EXXA(J8+X7.,KS_``\].*F_
MX0*&SAW3:PL+-B)6\K:'RW1@6YSP,#'XU/-X$R_FRZCY[APR1R)M0DL"P.23
M@\^_J30!5BT'0!NOHM?RT&9VD"QG#'OC'/(Z=CZ5H3^'+>]O8YY_$"S7)4;"
M8XB6'.#C'/7@UFGP1J:L`@T_,3*(9@6#*%R02N,')/.<TZU\,ZS;:C'>+I^G
MF:/E=TGR>9Q\Y`&>PX&,')XSB@#J-,^PZ'I)MFU!)4M0Y9F*@J,DD8'I6C97
M<-_9Q75N2T4J[E)&#BO/XO"6MJ+A%M[:-)0R@"49"LP)!;:2P^7`R<C/UKT.
MW4K;Q*T21$(`8T.53CH.!P/I0!)1110`5AZ.P_X277DPH*O`?E&.L?>MRL+2
M/^1H\0=?O6__`*+H`BN8[]+?Q$T(N0[$&V.X]?*7E/Q_SP:YJ^@\2&^LO.MK
MB^BM965-Z929ED(WNO\`#E6X/H,CO7>VNI6-Y*T5K>03R(,LL<@8@9QVIUG>
MVEZKO9W,,X!PQB<-@^^*`..M]0\4VMS9Q31O<17>'<R0%?(!;#*6'W0!@Y/K
M63IVM:K97K2*LL][)%%"T4T#!FX;YB3GH<<]\_EU5]K]W+/<Z9IUM)_:'G&.
M-PN5C3"_O&)&,<GC_)I>';!K'QC>PB[>9X[5#<,_)ED/.23TZ]/I0!6O&U7P
MHL,6GQ-?7-R?,NI6@:0NY.,9!!^@///Y/D\5ZND)E>W2%/-Y:6UE`C3YR`WJ
M2`O(Z=ZZ@:O"=>.D['\T0>?OQ\O7&/ZU@ZO=:U<ZOJ(TB?;_`&<D2FV*!A/O
M^8]?;`_`],T`9TGCK4X?-:?3XT`3Y5,;@J<##MG^`DGC@\CDXYT-%\1:C>ZT
M1=!4M/LLC1A(B%G*O]]"1D_+CO\`A2^(+O4[K5K;3[`1P2"T^UR0S*C^80WR
MIW&00>GKGM2VVM:QKUGLT6QCL45C&]Q,ZMY3#^$)CTQU'?IQF@"G!XVOGLGE
ME@LXW\U%#,S!$4ASAL9.["8X[GGTJAXA\3-J5M97!M4MEM;U6,<DN9F(&<[<
M<+[^I%6?(AF\7?V-KLIOU)\R-R?)57*[B-J]<\8R?7KGF3QA#I<&G7&F:;9,
M;N/;<OY$6\)R,[SVRN3SZ>XH`?#XY;[0C31J4*E-J$A&;>!O#%<X`..GK4L7
MCI))F98H"AC!"-/M*,`Y;DKS]U<8]1[UTFF"*]TNQNI((M\D*2\(/E)`;C\>
M:DFTRPN.9K*WD."H+1`D`YR.GN?S-`'.'QQMF:WDTR1+A%$C(9EP(RF[.?7!
M''O7.P:\5\3S:@8/,E>\VQH0%!4+Y8!/\)`8=1CK6]J.CVOAR:"[@MUETPOM
MN()4$GE9Z.I;)&#C-3>'[&SODUVRN;92HU"7``QM4D8P>HY0'\J`+VH^*+;3
MM8_L^:"0X0N9`1@#:6Z'Z?AQ6?X;U);/PA=7%N@=;>60QQ%P<*3D`[<_WJV!
MX=TZ1(_ML"WDJ1B/S9AEF4=,^I`XSU]ZY33[&[BT35[JSF0+'=R&6S"*RN$.
M2N[J./0]N.M`&G;>.;9(Y?[0@:.1'*KY><.`/F/S[<8Z8ZU9B\:Z?.OF0H_D
MK*$DDD(154A\-U[[.AP>:K:M'ILGB33(C96S1ZD&>67<59L+\HRK<@\9!!!I
ME]::1I_B?3K!=/C*79=V)9R4;G&!G`!);(Z<^U`%H>,-.0$3I-!&9S%$65@Q
M*A"VX=1@O^-2MXPL/-6.-9'8S+$05(X+%2PXY`/IZ@=:G_X1;2F14D@E)&27
M^T29.0`<_-GD*O'3BI)O#>G2RQ2&.1&C4*K1S,A`#%NQ]23GK0`^ZUNWM=7C
ML)%/S1EVE[(0"0I]R`Q_"HU\4:(ZAEU"+G&!@@\C/3''`K/U'3M*NM5>V@@,
M][/('N9$D;-NNW@Y'0Y`PO?/I3['P?;):&+49Y;N3(Q('9<`+M'&>..*`+\O
MB32XS(J7(F>,@,D?)&7"9],`L*DO=<L+"]^RWDX@;RA+O<@+@D@#U)X/Y54E
M\)Z:[Q[%DB1`V%1SU+J^?S7I[^PJ?4]!AU"[6\$\UO=(H198VZ+\V1@\<AV&
M?\D`GEUFPC2X87,<AMXQ+(B,"P4@$''I@CGWJ*U\0Z7=13NEY$/(W^8K,`0J
MMC=CT/&#[BA-`L$LKBU6([)XUC<DY)"J%7GV"BJE]X4M;R+;YTL;XE8R*2"9
M'96W''H5Z=.>Q&:`-274[&&TCNY;R!+>3[DK.`K<$\'\#4,>N::\T\/VN)9(
M,EE9@"0%#%@.XP>OL:S;OPO;'0+?3Y-0GB2WD\QIR_+,<[LYZ9W'\^_?#N-$
M\/AVAGURW"H05C"QEE(0*/FQD]`=O0GMWH`[:"_L[A"\%U#(@`)97!`SP/Y4
MZ"\MKE9&M[B*58VVN4<$*?0XKB&TKPS*VZ76H2'9VN-C*HE+'*XP?EVDY`]O
M059T?1=(72+VPM=;BF-X5C9U*@C!Z!<\DYQGZ4`=H6`(!(!/09ZT%@",G&:Y
M#4/`<%Q,_P!DNEM(';=Y:P!BO"@@,3G!P?SIP\!VJ20/%=-$8]A+I&`Y8,S$
M@Y^7.0.G&T4`=/=W<%E;R7%S)Y<4:EF;!.`/I4@D0QK('&QL8.>#GI7%_P#"
MOV%D\(U%"[8&3;@+@#@[0>&_VNOYFM+5_"7]IR6S"]$:P6X@V-#N'!!W+\PV
MGC&?2@#I:*X@>`S"?,:]^TJ@++`(M@9@A`/WL;LX.34=MX)U%M."37T4<D@`
MDBV%E`VD$DYY89)],B@#NZK17]K-=-;13*\R[LJ.VW;G\MR_G[&N/E\$WZPA
M8;Z.23SW+2.6#,K(`&/7YE;<<=\]14MQX3U'#I;SVXC621U7YE,RLT;;6(.1
MRIY'H/6@#M**XN+POJ]K=+>6]W&]R@0IO8@*`C@ICNN2@SUQGIW["`RF",SA
M1+M&\)TW8YQ[9H`DHHHH`****`"BBB@`HHHH`****`&O&C@AT5@PP01G(II@
MA(P8HR,@XVCK4E%`$)M;<KM-O$5]-@Q2-:6O!-M$<'(_=@X/K^I_,U/10!6&
MGV0SBTM^>O[M?\*/[.LN?]#M^3G_`%2]?RJS10!6.GV1ZV=N>,<Q+_A4,FBZ
M5+OWZ;:'?]X^2N3^.*OT4`8.B6T%GXAUF&VBCBB"VY"1@*!\K=A_A6]6+I;[
M_$^N###8+=>3D'Y">!VZUM4`%%%%`!1110`4444`%%%%`"$XQ[TM,>0(\:D,
M3(VT8&<<$\_E3Z`"BBB@`HHHH`****`"BBB@"M8_ZESSS+)U)/\`&?6K-5-.
MW>3*2P8&>7;CL-YX_/-6Z`"BBB@`HHHH`****`"BBB@`JKJ:W;:=.MAL^TE"
M$WL5&?KZXZ>]6JS]?NA9:%?3EPA6%@C'^\1A?U(H`XR#PUJZ"1+>WA,$C1O+
M'+=B3S`C$[>%[GN?0U&OA;7D9&>WCED5HC'*MR`T03).W(XY/OC'0]:SXW_L
M43MI.I6F_9&OFQ289DR2YVL<%@0H[9!X'/%F7Q5J\BW`?4(P/LY^5&B3DIC*
MD$DMNR<`CIVS@`%RVT#7;;"FSW*7#X6Y'+JK!7)/N2>V?EZ8S523P_K23+##
MILBJA$HWW&]`5CP,'^\3D\=R!P!5&/5;NWGCA@N;=UTT.]O%N&PD\?*W5SAB
M<''3IVK1M_$^O2/`LE]%&R.@>/9&7E#,Q.?3:JX/3'?F@".UT_6;8@C3]3C!
M$RG9(6QO4*O&1G;][/&3Z`#!!:ZQ;V\4?V?6VP5<A<[`0X)&W/(P.,XY/3O6
MG;:_=_\`"-PP17OVS4KUGWR%PGV,'.=Q[8YQG'?'``JJ?%VIVMA%9<1WBJ(]
MTZ&1Y'W8)X/''/(/XYH`?#%JD&B7<4$&HI?2WAFWA)!YB9Z;NH)__75[0+&Y
MGU^&ZU/[9-Y,),)GA951B1GEO3.!W.,\55LO&6M33/#)IRAS+M#%&VQ@#D''
M4\$U9L/$FJ3ZG''.]M&9DMPMN8VZO\S$'KG;VS@9'H<@':T444`%8.AOYGB#
M7WVX_?1+Z]$QU_SUK>KGO#W&O>(`?O?:$/;IMXH`Y/Q==Q#Q#+-H9F$WDM'=
MO;K\I[-^(XR?ITZUVGA.*PCT"W_LT?NF&6)(+%^^[!/-<OIEO86FM:K;66LS
M6TL8_?S2P1LK_-AADC@!F`(XS^%00"R\/ZA)9Z7KT\6Y(_-D"0R1LQ;:>2?E
MQG)]!GGI0!Z17!:7J$EOXVN[RX/^BWMS)9!B#\CIMV@\=QP/J?2M)GO1\J^-
M+0LR[UW0P_=QR>O(QDY]JS7F?4XA'J'B'3+JT&'474"QB3CJ,$,".>F.20?2
M@";4]5M%\>6-SN1K:"/R);@G]W&[!B!NZ9_^OZ5H^'+N&;Q+X@C216;S4(P1
MR`-IQCT(_45BR6,=EHTH&LZ/)IV\L8EA5A(P&=H.[);&.AR.,$5%<)+I<VEO
M;ZE!;^8"]NT5L=B1.1P_/W<D<G)H`VKXE?B7IV&&'LF4C&3CYS^'_P!:J_@Z
MXB7Q'KMO&_R2S>;%DD;@&8$@'KR>O^1GC0GOY3/<ZW:SW$[;HYGD='CVN00B
MY&`2".F..,8J[/H+W4%M#%<Z5;M`QCMI+5W1P2"2N<DMP22.O)Z<T`,U=@-4
MU#68BCQ:?>6V\KR2%!611QU&\?E^%007<!UCQ3<2W$<D<D'EQ_,"9-RG:JCO
MP,8K3TAA;Z;%96$NGRP3N\8$C29D;G=G([[3[''%+:^'Q:SH\%CI`E#%D)D<
MD$'G'';]*`)O#NHR::L>AZTT<%W"@$#EOEF3H,'U'3'_`->NER,X[USNN07-
MQID@U>+2OLRX)=W<;.V0<9!Y'2L2./7+9X-/L]7BEA>(,D8ND$C*1D%&*[@.
M<#KT]*`.@\2W7VF`Z+9A9;R\4H5W#]TG=V]!CIZFJVC'^S_&.KV4H*_;`MU`
M,###D,>#US^>,U4LTUG0;662/1;5G<[Y[E[P;W[DL3CW_/IUIVIQ:MK,"1W_
M`(<=6C)9)(;Z-6&0<@'/?@4`;6NZR-,B6&W3S]1N/EMK<`G<?4XZ`=>W2N6T
ME8[1M7TJVD6<RZ:97<'GS1N5P00,9+<9[`>M7=#M+[2&EF'AJ8S,`/,:]CD;
M:/X1GI]/\*GN[]K*[DU:Y\.O#*L?E23-<QC*]?7D\=N<4`9`UBWFU7PVT7S0
MVL<<<LBC.QY$("\'_9Y_^MBMC6;2/Q'KMK;6\P$5DK///`PWQN>$4-V.03CV
M^E5+W4K[6M,>&U\+O);3*#F5PF>X(Q@GMWJE86GB"S\N.&PN;*UC;+1VGE[I
M,@#)9F.3D>A_"@#=MKS7K$SK?VT-_;QC_7VKX9<`9W*3D\<X'.1[U!)K2ZT!
M;6%TMCIQ4^9>2R!)&]HP3D>F3_\`KYB]MEFN([..TUB?[),IN`\GVAURI(4*
MIVC..3U'Z5;L;RVTS6)F_P"$>N_L=ZNZ."2T&]7`.[9GJN,GVSTH`ZBRUCPU
MI-L+6VOK:-$!S@Y)(ZDGN:2#QKHD_P!R>;JH_P!0YY/0<`\_Y%4[;Q=86L(A
M@T+48$4G]W':JJCUX!_&I#XXLB/FTS5`!SS;CM_P*@"^/%6DD9$MP><?\>LO
MKC^[43^--`C<H]\RL.H,$@_]EIJ>-=#.1+<2PMNV@/`YW>XP#4G_``D^@R.0
MUP-Q`)WV[@G\U]_UH`?;^+=!N'"IJ40)&?W@*#\V`JY_;6E;0W]IV>T]_/7'
M\ZS!XH\,L.+R`;@,_NF!]1VI#XC\,;F1KBW5MQ#`PLISGG/'M0!H37^C72A)
M[RQE",&`:5#M8<@]>M-@U#0H7'D7>G(Q&!LD0$CKC@_2L_\`MSPG+M!FLNN1
MNBQ@CGN*AN+SP9.A$IL&^;><)@D_4"@#I\1R(>%=7&#W#"J\FEZ?*,26-LW0
M\Q+VZ=JY31+W0[347OEU&&SCE3:EDDF47.#ENP;@9`X&.IKIHM;TJ9=R:C:D
M>\H'\_K0!2GT&6T5Y=#NY;64'<('8O"Q`Z$'.`?:M'2[]=1L4N%1HVY62-NJ
M..&4_0U%J&N:=I]H]Q-=Q%5'"JX)8^@`[U#X=B2"TD#2PM<W$KW,J(P)4L<X
M_#@9H`UZ***`"BBB@#'A+VFG_:KO5P5CDP\K!?+*APOX$A<=>&8GVJ_<VTLM
MB;>&[DADP`)P`S#!'//'./UKD;NQ;5[."R,D4:0F=_LXES(TV25SN'3#@_\`
M`O2JEOIMUJ.N7)5D\R$6[22B4[>86!`YP=S8Y[8[T`=6SQZ=-%!<:S)OF<8$
MX0LP*D``@``[L'/MBHII98)(M/&OQ+?N0%$L2L2/F/W1CDC'.?X>`,XKG4T"
M[#6$<4<<<<1MS)NN0V6#,SM]<L!^5;-_:ZC<^)8&73H38PR+(9A(H9G"D*S=
M\+D\>]`&K97`O+*,V>I0W+*R^;,JJV><E<`_+D<=\>]%Y?1D2+;:E9PR6Y)G
M\Q@VP8(^89&WDCD^E8GAFTU/21%'<6>]KJ0+-(9`SQ*D8"[L<8X('L1WJM?Z
M7J%]>WTZZ3'%$4`CVRI^^`E5R>,Y9MO&<`4`=!#?!9+%)M4LF:2/E1@&X)QM
M9/FZ9SZYJ;2[AKA)F:^M;O$I`-OC"#^Z>3R*Y)/#5_LMU:U592T3%D=?]'7S
MI'8'D9X9>GH16OX/T^_T]+U;Z+RP[H4Z<X4`X`/3@8/!/>@#H%$OGON*>5M&
MP`'<#SG)].F/QIMP9QY7V=4;,@$FX]$[D>_2IJ*`&(7+.'0*H;"$-G<,#D^G
M.1^'O3Z**`(YVE2/,,0E?<HVEMO!(!.?89/OBI***`*=W=3V^]Q;*T$:%FD:
M8)C"L3U]PHR2.I/;FVIW*#QR,\'(I)(TEC:.1%='!5E89#`]013J`"BBB@`H
MHHH`****`,+2/^1I\0=?O6_?C_5UNUBZ2@'B/7GYR9(1UXXB'^-;5`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`%:Q&(I!NS^^DZC&/F)
M_P`_G[59JM8C$##&/WTIZ'^^U6:`"BBB@`HHHH`****`"JM_/=P1JUI9_:V)
MP4\T(1QP>>*M4C,%&6(`]30!DIJ.K'=OT*1>3C%U&01[\_YS0U_J,B%9=`F8
M$<KY\1!Z>K?7\JU5D1CA74G&<`]J=0!@-?SJ06\,7'&<8\HXS^/YTTW\D)WR
M>%[D;>"8UB<CH.`#S70T4`<S%K`:Z2V_X1F\1BVP,85V+SG[W0=,U7N=6TFX
ME$][X?NS*`48R66['/3./0L?^`G\>NHH`XXW/AEWESHTHA(&Z06+X8DD^GKG
M\^.E.W>$%0%]/*A!L.^RE.T<]3M_7K^5=?10!Q_VGPBA8-$P51S_`*/.`,G.
M",?YYIQN?"*2[MKAX&#9\J?(/8GCGOS7744`8P\4Z,<G[60`,Y,3CCGGI[&F
MCQ=H+=-2B_%6']*VB`1@\BH3:6Q7:;>';Z;!B@#*_P"$PT#&?[2C_P"^6_PK
M+T?Q!I-OJ^L&2_B$<TX>,X/S`(,G(XQQ^G>NH-C:$DFU@R>I\L<U(((EB,0B
M01L,%`HP1]*`.$?3?!CI$$U>2.5,[IEF^>3)S\V1C]!4B0>%TN[64:Z62W`.
MQB"9&$AD!8X]688QT(].>S>PLY/]9:0/W^:,&F'2]/.<V%J<G/,*]?7I0!P)
MT?PQY'E#7U*[#D$?><9PWX`XQTXJQJ.DZ/>7HG@\1VT<4+Q_NV`*[@@&<@@<
MB/TZUV?]CZ7Q_P`2VSXZ?N%X_2C^QM+_`.@;9_\`?A?\*`.#D\-:=!9((_$-
MJC2.YB>4C:T3*5Z$]<[N??M6MJ&D6=_);I9ZQ:A+>*.S`8[F5E<8VX(Y)P.<
M_P"'3?V-I>0?[-L\@Y'[A>#^5(=#TD]=+LC_`-NZ?X4`</JGA*]FU&W@1X9(
M)/O7#R`%?G=R%&<XVMT[XSQ4]QX`O3%&EIJ</E(V]`R%=K84;@1GDXR?H/PZ
MU_#VC.5)TNT&TY&V(+SD'MUZ4R3PSHLC*S:=""HP-H*CKGH*`.=B\%7\<R8N
M[81$Y<*'#<,[#'/JP';\^J:;X,OK/5+"X-PBQP;7EV3-DL#\V`1R&X]*WSX2
MT(@#^STX&W[[=/SI@\':""3]AZC'^ND_^*H`Y^\\(:Q*;]!<131S?=+ROE\O
MD;NP*C/3CFK6N>%;J?4A=621M%"(!'"SXW!"05R02.,<Y]>M;'_")Z-G(MI!
MSNP+B3'Y;J=_PC&FA'6,749<Y++=2Y'_`(]0!0U_2M7U[3;*VD6WMV\PR7&)
M"57&=H'&3P?6EN+?Q#=>%KBS=$CO0D<<;I/EI`,;R3Q@D`_G5UO#-D0P$]^N
M6W<7<G!_.D/AFT_ANM0!W`_\?<GKSW[CB@#GS:ZIH5C+>WES<KY$+0VT23^9
MYCNS!=PQ@XW*<CTZ=JHZ?X4U6W832VI22),%BR2;F+#!53GD`DY/?H..=G7?
M#,D&F//97^K3RPLKK";@OG!Y*@?Q<D@^HHT_2;3585EL_$^KOG/R-=?.N#R"
MN,@]/Y]Q0!G:]IFL7VB:9'<PW$]Q%+-'(40%@N<*<#`((`YR/QS5>[37XM*?
M2[R&2.V,4,-M'N!+R[DP`_\`P%CCL!CIS72MX28YVZ_K(';-SGC\JS+/0FU'
M5KE8]:U!UL"(5G>3>P<YWA21Q@;1D'/7UH`R[6/Q'8VEO9)8W0MY=_GE8MQ=
MRQ&XGJ."O7TSZTIM[^SBLYW2Y;4[C4'E598RS*B`ACM')Z@\>G'6NGC\.7T*
ML!XBOV!Q]\!^A![Y]!^OJ:S-+T^\U'Q#=7*ZM,RV`6".8HAW'@L,=/KWH`:K
MZN^G:EJ<\UQ]I^Q*D.Q#&/ON"=O][Y0?HW2K7A34M0MQ/;ZX;N2X+KL)B+*`
M4W?>''^?ROG3O$:&39KT+C;\GF6BY+>^.GUY^E0_9?%P``U'3FXZF(C^E`&?
MH_B2ZBU6[FU99H=.NCNM3(A.T[MH4`#/(R<?[.:DUS7+ZQ\0F)9;D*C)Y-I#
M:B3[2N,L=QY')V\9QQP:2:ZUU(S)-KVB!4.3W`YP.WK5*3Q)K$3.D6IZ7>31
MKG9!!+)N]@57';CGOS0`L7C34+E%\NVM3D[O-8.%*X#,@XZCE2?H<=ZED\5'
M[1"MQIEF[-GA22R_.XW<C@;D5CST(//9;74?%]TX1+&)5=0ZM-`54<#CEN/_
M`-=7H[#Q4LRS[]%67:`7$3;N_&<>]`&)%XHAFLQ*F@:>X4@-&,`]0.!M_P!K
M^?6MG1'MM?LKR2\TFULX$^3S`H#!L?.<XQP>_P"=5/\`A&O$4HV7=]!-#L*^
M7'.T(.<==L?(S_GK5N'P_/"R%=$TE_+0JHEG=L<#/52"<Y[?SH`EO-:\,0S>
M2L-O>3LR@1V]N)"Q(XP<8/X&HA::AJ886VC6&EVQ7*O=0*\I)[A1P"/]KVK0
MA&N6Z[8=,TN,'`PD[+@?]\=A_(^PIXN/$7G,IT^P*@9#_:6P?;[N?T[4`,T_
MPMIUJS2W$:WDSJ59ID7;@DDX7&!R?<UI6NFV-DY>TLK>W=A@M%$JDCTX%8RZ
MCXHW`-H5N<CJ+H``_P#ZN/K3QJWB'(!\-#/<_;DQ]>E`&_D9QWI:Y\ZKXA+!
M?^$;VY&,_;TP./I4?]O:Z"`WAB7)!QBZ4\^_'%`'245@V^MZHSJ+CPY=1C!+
M%)D;'IC)&?TQ3K;6M4D4M/X=NH^,_)-&WICJ1[_D/7@`K>(HW_M.SBLVL+>:
M7S)WGN(E8@KL"D$]#T_[Y'I6,VMZ7*CHV@V[2BS9T(*G^#S&&.JK\[<]_P"6
MW?W!U"2'[1X7N;B-0WS3"+<F0.@+'KWY&,5&SVCSM,?"MYY^""P@B&X;2N,[
MNA!Q0!6\/ZAI&IZI]GM])M87V>=YL;+RP*DC`&1\P'7TKHK;1]-M/^/>QMXS
M\W*H/XNOYX%9$%W':3F6R\+7<3L-K,L4:';QZ-[=.^!4MUXH^R[?-T;55W9V
M_N5;GCL&]Z`+QT#23)'(;"'S(E55;;R`HP.>^!QSZ#T%$VA:;.T3M:J)($6.
M)U8JT:KG:%(/&,UE/XWLHR1)I^IKC'+6X&2>@Z^]-;QYIRCYK+40?0PC_P"*
M_"@#6/A_3-LJI;",3$>;L8C>`2<'GH23D=ZF_LNV6"&"(/#!%N'E1.55@P((
M..O4GZ\UA+X]TPR%&M+],=28@0/R8TX>/-(+,&CO$VYSNA],>_O0!J)H4$(*
MVUS>0)A]J1SG:I88)`.><DL,YY.:F.FDWL5S]OO/W>?W7F#RWR2>1CW_`$%8
MI\?:*H^8W`.<?ZHT#Q]H1_Y:SC_MD:`-8Z4^[<-2OONJN#(,#"XSTZGJ??TJ
MU<6S3V9MQ<SQ$@#SHR`XQCN01SCT[UD)XRT%KE8!?*&8@;BI"C/JW05+#XLT
M*9W5=1A79U+G:#R1QGKT_44`:2V\@EWFYD(\TR;>,8V[=OT_B^M'V=S,'-S*
M0)?,"\`8V;=O3IGYOK5+_A)=$X_XFEKR<?ZP4?\`"2:*6"_VI:Y)Q_K1CIGK
M0!HP1F*".-I&D9%"EWZM@=3[U)5`ZWI(ZZG9#C/_`!\)T]>M']N:3S_Q-++@
M9_X^$Z?G0!?HJA_;>DX)_M.RP,9/VA.,].].76-,<@+J-HV3@8G4Y/7UH`NT
M52.KZ8%+'4;3`ZGSUX_6K!N(5E6(S1B1_NH6&6X)X'T!_(T`2T444`8VDG.O
M:[QC]]%_Z*6MFL+0R#KFO;=NWSX^5/?RQFMV@`HHHH`****`"BBB@`HHHH`*
M*CD\W?%Y>S;N_>;LYVX/3WSM_#-24`%%%%`!1110`4444`%%%%`%:Q_U+X&`
M)I._7YS_`%JS5>R;=`QSG][(/R=O<_Y].E6*`"BBB@`HHHH`****`"J6L6WV
MS2;NW$*3L\3;(WZ,V,K^N*NT4`</+X8O[)EDTN/RI+>S2/=`RJT\I(WG+=!@
M>Q-6+73]>BU%;J-9(H9[WS9H_,3(5FZD<[@$`&,@@YX-=A10!RFLZ5JUWXC6
MYMG\J+:(HICAO)RI+L%R.>`.?7UP0QH_%;W44BRB)8_+A*,H99#_`!2'!X&/
M?KQ[UUU%`'.Z`OB&.\VZI(LUKL<;F0*P(<A3P>I'/I@#G/6LNI>*@QWV-OM5
M5)_<L22S[0!\^"<?,3T`KJZ*`.1?Q'K/V0SKI;@K"[.#`Y",)2`.HR0@)..^
M.15O2+[6)+F6XU:-8(HK59#!%$Q))R<CWXQMY-='10!P=CXBUVST\F>SDNMS
M`>:T+CRF8\JP/+8&.@YSUK>O];N[/P];7QM1]IF9$*E7*H3_`!$`;L>V,\@=
M:WJ*`.0A\4ZBQM/,LXOF@,TRJK[GY8#RQCT4'G^\/0U'_P`)C>Q60GGM+?$T
MK+#(LAV``9*L<'YN@'J<^E=G2%0V-P!P<C(Z&@#F3XLF\U(UTF4ER5YE`*E5
M#/D8_AS@^X--'C:V,T<1M]I949MTJC9N3=^0XR>WX5U!`(((R#U!JM:Z=9V9
ME:WMHXVE9FD8+RQ8Y.3_`$H`YJR\=1WJGR=.DW[T109.&)SWQQC&?S]*/^$W
M!NE\JT,D+1K\H(!#E68_/G;@*%XZ\^V*Z2/3+"+;Y=C;)M.5VQ*,<8XX].*C
M?1=,>V6W:PM_)5MX3RP!NQC./7'%`&*OC%+J>R@L;5O-N7C!\Y@H0$Y(QU/R
M\Y`QR/QGU+Q1_9VN&S>V:6W_`'<9>,C<LK$G&,\C;@],]:U_[,L?MHO?LD/V
ME>!+M&X<8Z_2HIM&L);E[K[.B7;9(N%4;U.,9!/<"@"II_B2VOR7CB<6Z6PG
MEN."D9QDH3_>`J.'Q99R;@;6\1MRB-#%\TNX,5*C/<*3SBM2QTVUL+`64,2^
M1@@J0/FSUSVYK('@G0_+2,VSE%!&/-;YB<?,>>HQ^IH`DM?%NG7,2.$NDW;=
MP,)/E[G*KN(R!DC]:0>,-*(8YN=JIYA;[.Y&W.-V0.GOTI\?A/24O1=&`ET=
M6C&]@$VJJJ.O.-N>?6I)?#&E3&V\RW+"WB6)06.&5>@8=&_'UH`;+XJTB&21
M9;ADV;OF,;;6*X)"G&">1Q[U7'C+2@7:1I(X`!LD:-LR,1G`7&>A7GI\PJ6Q
M\)Z;9Q!662=P5)>1L\A@_`Z#)`R!Z4MSX3TJZGDGE24R2.SN?,/S9(./H,#%
M`$'_``FVC++.LTKQI&P57*$^9P>0!SCCOZCUJSK/B2VTR*S>-#=&\)\D1N`&
M`QD[CQW'UJ.Y\(:5<A_,67+O(Y._)R^">N>XR*O7.B6%TD*30`I!"\$:@X"J
MP"G'X#%`$,7B71Y('E_M"W41L$<%QD-Z#^]]1D<'TJVNIZ>TR0K?6QED`*()
M5W,",@@9YR.:PF\#Z<(OW,DD<X;/FE4;Y>FW!&.GZ\TD?@F&UN!<6&HW4$R1
ME(F8*^S((]!D8/3UYS0!U-9&H^&].OY7N/*:WNV!'VB!RC@GOQP?QK5C4I&J
MLQ<J`"QZGWIU`'.MX>U1+F.2V\27BJASMF029XQ@\@'\O>L_PO::J!J:PZI$
MA2_E$HDM=V]^,M]X8!XXKLJS;K0[.YO?MF)8;C;M:2"0QEAG/..M`&3J]UJ^
MCV1N+G5[4Y.U$6S^:1N,`?/[&HM)\+ZK:*&;6V@#@N\<4"Y5VY(R<\9_/`K8
MT_P]INGMO2'SIMV[SISYCY]<GIT[5JT`8,V@7T\BM)XAU``#&(PJ<=N@Z^](
M_A&QEGCEN+F_N&3KYMP6W#T/M6_10!F6_A[1[;:8M-M@R$%6,8+`CD')YK15
M57[J@?04ZB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***S=<O9;&W
MMW@!:1[A$$8`)D'5E&>^`3^%`&E17*0^*+BU5%OK5ILQK(3'@2!24!9DZXRX
M`QSD-QQFI[_Q1LW6]K;M]I82A6<@!"FX$D'KC:#CT/L:`.DHKFH_$D]YI^HM
M;01Q7%J5V%I%96#.RCOP<+T)'/I45MXO1-*MYKJ(RS&)FF,?RA6`<J.<<GRV
MZ9`(QZ4`=20""",@]0:``,X'7K6`OBNW,+R"TN6$>-VS:P!)`(R#@D!E/'][
MZU7TGQC#=3P65S#(EVRH6<`",[BNTC)SR&!Z4`=,45OO*#]1_GU--,$3=8D/
M0<J.W_ZA68WB*T^P07D,-U.D[[$2.++9`);@XZ8.?H:HGQ'<RV#7EM%`8?M;
M1K(Q.TP@??XYR20.G'?I0!MRZ=938\RT@;#!AF,=1DC^9_.HKG1=+NV+7&GV
MTC$8RT8S6?\`\);8*C^8K[U,I58B'WJF[+`\9!V-^F>HS9U'78;73I[NU47;
MPE`T*-A\LX4<8SZX]<4`'_",Z)S_`,2NVY_V*0^%]#(`_LRWX&/N^^:C@\3V
M'V6*2]?[+*[;6B(+%&P#@X'7#`GTY'8U>LM6L-095M+A9&9/,`P0=O'/(]Q^
M8H`J?\(KH7_0,@_(T?\`"*Z%_P!`R#\C5:3Q.T%VEM/ITR.]P(5(D5@?[S<9
MX&5S]:T)]:M;?49K27<ODP">27&549QM..<]#CT-`$'_``BNA?\`0,@_(TO_
M``C&B_\`0/B_7_'W/YTR/Q-I\BRD/M8?ZM7.#)QGZCGCFK<&M:=.852\A:2;
M&U%<$Y(!QQ[$?G0!6?POHCJ0VGQ<@@X)!Y]\^YIW_"-:1NW"TP1T*R.,?3!X
MI-3\00::=LEO<N_S'"QG`502S9/8`4J^(]/+2)F7>DGEA1&6+\D`C&>"0<>N
M*`+6G:9::7$\=G"(P[;G.22Q]235RBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@"M8Y\ERRE29I."H'\9&?QZ_X=*LU5L"#`^`H'G2_
M=/\`MM^M6J`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@!IC1
MFW%%)QC)':D\M,YV+GUQ3Z*`&+#&N[;&@W=<*.::;>!@0T,9!&""HZ<_XG\S
M4M%`$:P0JA18HPI.XJ%&"?7]*/(AX_=1_+R/E''3_`?D*DHH`K)8VR6\4`B4
MQPL&0'G#`YS]<\U.T:.0716QD#(SUZTZB@"I'IEE'+-*EK$'G.9"5SNX(_D2
M/Q-216=M#N\N%!N*D\==O3\NU3T4`<MJ%_9VFO20S6$`4.LQN'&!G8Q/)XW<
M(/IDG@5(FOVL5W!`FG_9[J1TC=650T89@ISCMG`!Z9Q6[/8VEQN\^WCDW'+;
ME!S\I7^1(_$T"QM0H46\6`V\?*.&W;L_]]<_6@#G;75-+S#?Q:9<&3S'WL@+
M&*:0K\A&>K9'MVZYJ.6ZT*:UMM1UFQ,-Q=GS&(5VP4(4<CJ.5QV/6MZZT33+
MN9Y;BRB>1T*,V,9!.3T]^]*VBZ<]M!;/:(T-N"(E;)V9ZXH`YYFT9])U"XDM
M[I5!#S1[B.5;`3S!_M<]>_H.'"_LRT1NM.,"Q^1(-C'EUE$8V@<[5/.,<C'K
M71MIMFT4T?D*$FB\F0+D93GCC_>//6I&L[9U17A1E3[H(S_^OK0!RD<MIJ$%
M[+/%<Q1W):3_`%X"@&&-N6.`NY#CN!@_6H]-N;2)VFCTNZ6]9A-'$\H,:DET
M51C'`._'!QZCMTHT+2ULWM%LXU@DSN49&<C'7KTJPEA:1S/,EO&)'*ECM[KG
M!]L9/YF@"S1110`4444`%%%%`!1110`4444`-9U4J&8`L<*">IQG`_`'\J=3
M616*EADJ<CV.,?U-.H`****`"BBB@`HHHH`****`(+,8A;.[_6R?>.?XS4]5
M=/\`]5)UQYTG7_?8?TJU0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!113#(1,L>QR&4MO`^48(X/N<\?0T`/HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`*]D"(7W$DF60\^F\X_2K%5=/P('VKM'G2]L?QMGL.^:M4`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`,97,J,LF$`.Y<?>].
M>V*?110`4444`%%%%`"'/&/QI:**`"BBB@`HHHH`****`"BBB@"K8*%BEP,9
MFD/3'\1JU573U98I0YW'SI"#C'!<D=OP_#-6J`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`K6.1"X/432?^ADC],59JKIY8PR!EQB>7!]1O/\`^K\*M4`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`45&0WG@[%V[3E^
M^<CCZ5)0`4444`%%%%`!1110`4444`%%%%`%:QQY+E<<S2<\<_.?3_/\JLU5
MT_F&0Y)'GRXZ<?.>G_UZM4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`F><4M1F4"X6'/S%"WX`@?UJ2@`HHHH`****`"BBB@`
MHHHH`****`*NG\P2<?\`+:7N#_&:M56L2&@<C&/.D'&/[[>@_P`]^:LT`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!590=3B;Y
M@1"X/R\'++W]L=/>K5-6-$+%452QRQ`QD^].H`****`"BBB@`HHHH`****`"
MBBB@"M8_ZE^"/WTG)4#/SG_.>]6:KV0`A<`Y_>R=@/XR>W^?QJQ0`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%-=MB,VT
MM@9PO4_2@!U%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`06?^J;C;^]DX_X$?Y]?QJ>J]D,
M0N-NW][)V`S\YYJQ0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!12$@`DG`'4FEH`****`"BBB@"O98\EQ
MGI+)GC'\9JQ5>T(\MP-ORROD`DX.XGG/?FK%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`-<%D8`X)&,XS
M2@@C(Y%#':I."<#.!U-+0`4444`%%%%`#(XDB!"*!DDG`[DDG]2:?110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`@'7G/\`
M2EHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
9**`"BBB@`HHHH`****`"BBB@`HHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>vivakorex311image1.jpg
<TEXT>
begin 644 vivakorex311image1.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86
M&#$C)1TH.C,]/#DS.#=`2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`0A`S`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#L/["T?_H%
M6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!5C_X#I_A1_86C_\`0*L?
M_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`T"K'_P`!T_PK0HH`S_["T?\`
MZ!5C_P"`Z?X4?V%H_P#T"K'_`,!T_P`*T**`,_\`L+1_^@58_P#@.G^%']A:
M/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH`S_[
M"T?_`*!5C_X#I_A1_86C_P#0*L?_``'3_"M"B@#/_L+1_P#H%6/_`(#I_A1_
M86C_`/0*L?\`P'3_``K0HH`S_P"PM'_Z!5C_`.`Z?X4?V%H__0*L?_`=/\*T
M**`,_P#L+1_^@58_^`Z?X4?V%H__`$"K'_P'3_"M"B@#/_L+1_\`H%6/_@.G
M^%']A:/_`-`JQ_\``=/\*T**`,_^PM'_`.@58_\`@.G^%']A:/\`]`JQ_P#`
M=/\`"M"B@#/_`+"T?_H%6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!
M5C_X#I_A1_86C_\`0*L?_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`T"K'
M_P`!T_PK0HH`S_["T?\`Z!5C_P"`Z?X4?V%H_P#T"K'_`,!T_P`*T**`,_\`
ML+1_^@58_P#@.G^%']A:/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%']A:/
M_P!`JQ_\!T_PK0HH`S_["T?_`*!5C_X#I_A1_86C_P#0*L?_``'3_"M"B@#/
M_L+1_P#H%6/_`(#I_A1_86C_`/0*L?\`P'3_``K0HH`S_P"PM'_Z!5C_`.`Z
M?X4?V%H__0*L?_`=/\*T**`,_P#L+1_^@58_^`Z?X4?V%H__`$"K'_P'3_"M
M"B@#/_L+1_\`H%6/_@.G^%']A:/_`-`JQ_\``=/\*T**`,_^PM'_`.@58_\`
M@.G^%']A:/\`]`JQ_P#`=/\`"M"B@#/_`+"T?_H%6/\`X#I_A1_86C_]`JQ_
M\!T_PK0HH`S_`.PM'_Z!5C_X#I_A1_86C_\`0*L?_`=/\*T**`,_^PM'_P"@
M58_^`Z?X4?V%H_\`T"K'_P`!T_PK0HH`S_["T?\`Z!5C_P"`Z?X4?V%H_P#T
M"K'_`,!T_P`*T**`,_\`L+1_^@58_P#@.G^%']A:/_T"K'_P'3_"M"B@#/\`
M["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH`S_["T?_`*!5C_X#I_A1_86C
M_P#0*L?_``'3_"M"B@#/_L+1_P#H%6/_`(#I_A1_86C_`/0*L?\`P'3_``K0
MHH`S_P"PM'_Z!5C_`.`Z?X4?V%H__0*L?_`=/\*T**`,_P#L+1_^@58_^`Z?
MX4?V%H__`$"K'_P'3_"M"B@#/_L+1_\`H%6/_@.G^%']A:/_`-`JQ_\``=/\
M*T**`,_^PM'_`.@58_\`@.G^%']A:/\`]`JQ_P#`=/\`"M"B@#/_`+"T?_H%
M6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!5C_X#I_A1_86C_\`0*L?
M_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`T"K'_P`!T_PK0HH`S_["T?\`
MZ!5C_P"`Z?X4?V%H_P#T"K'_`,!T_P`*T**`,_\`L+1_^@58_P#@.G^%']A:
M/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH`S_[
M"T?_`*!5C_X#I_A1_86C_P#0*L?_``'3_"M"B@#/_L+1_P#H%6/_`(#I_A1_
M86C_`/0*L?\`P'3_``K0HH`S_P"PM'_Z!5C_`.`Z?X4?V%H__0*L?_`=/\*T
M**`,_P#L+1_^@58_^`Z?X4?V%H__`$"K'_P'3_"M"B@#/_L+1_\`H%6/_@.G
M^%']A:/_`-`JQ_\``=/\*T**`,_^PM'_`.@58_\`@.G^%']A:/\`]`JQ_P#`
M=/\`"M"B@#/_`+"T?_H%6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!
M5C_X#I_A1_86C_\`0*L?_`=/\*T**`,_^PM'_P"@58_^`Z?X51US1=*BT+4)
M(],LT=+:1E98%!4A3@@XK>K/\0?\B]J?_7I+_P"@&@#0HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`*2EHH`CV-NSNXXXP.*5%*@`MN/KC%/HH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`K/\0?\`(O:G_P!>DO\`Z`:T*S_$
M'_(O:G_UZ2_^@&@#0HHHH`***:C!AD'(H`=1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!6?X@_Y%[4
M_P#KTE_]`-:%9_B#_D7M3_Z])?\`T`T`:%%%%`!44!S'GU)/ZU+4<`58E"G(
M`X/K0!)1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%)
M2T`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%9_B#_D7M3_Z])?\`T`UH5G^(/^1>U/\`Z])?
M_0#0!H4444`%-1`B!1G`&.:=10`4444`%%%%`!1110`4A.*6DH`6BBB@`HHI
M*`%HHHH`****`$HHHH`6BBB@`HHHH`****`"BBB@`HHHH`**;\V\\#;CKGO3
MJ`"BBB@`I*6FNNX$9(R,<&@!:6D'``I:`"BBB@`HHHH`*A@NH;AI!"^XQ.4?
M@C##J*FI,#TH`1FV@D]`,\4(^]0P!`(SR,&EHH`6BBB@!N]=^S(W8SC/./6G
M5!]FC^V?:L'S=FS.>,9STJ>@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`$`Q2TF:6@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`IN[YMN#TS[4ZH&'^F`_],_7W]*`)J6DI:`"BBB@
M`K/\0?\`(O:G_P!>DO\`Z`:T*S_$'_(O:G_UZ2_^@&@#0HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`*0#GK2T4`%%%%`!1110`4444`%%%%`!1110`44
M44`%(:6DH`1'WC(!`SCD8IU)2T`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`-50I)`Z\FG444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`)46,W).>B8Q^-2U$.;EOE_@'S8]SQ0!+2TE+0`4
M444`%9_B#_D7M3_Z])?_`$`UH5G^(/\`D7M3_P"O27_T`T`:%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`A
MZ4Q1F1CM[#GUZT^HT?,[IC[H!_/-`$M%)2T`%%%%`!6?X@_Y%[4_^O27_P!`
M-:%9_B#_`)%[4_\`KTE_]`-`&A1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%-;O]*J([;E"N^64;0X]0>O_?/ZT`7:*I23,AB9Y4B!0E@X`'0>
M]9<WB>QLD59[E;B0,5;R1G@#KU]<4`=#17'KXUL3/L'VMER3PBY[\?0<5=M/
M%-G<RI#'*F3P6F8H<9^F,^U`'1TQV*XP">0.*B,DA4L@C8'.WY^O'':F^;/C
M_4KUQ]_\/3US0!9I:BA9R/G7!'ZU+0`45FZ]<36VFM);N4DWJ`5`)Y/H:SHM
M4O&B2-)-PEG6*.:6/##C)RGJ*`.CHKFYM6OX&GM\)+)#*`TB)EBA&00F>3ZB
MHY==O1:03+Y&&5B[HC.,@XP1P5'O0!U%%8NI:M+9V%G=`1,)77S`IR-I&3M-
M9T/BB>:^:)(HO)\X(C$'E3OYZ_[-`'5T5C?VK-_PCL>HB-#*RJ2@SMY;'%+K
M6K2:8]N%CA*RDY,C[<8Q[4`;%%<U+XEFBC1OL]LQ,(E;_2,#&XC`R.:WK*<W
M-K'.8VC,BAMC=10!/1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!13%#AFW%=O;'7\:?0`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%,D+!?D7<<],XIPH`6BBB@`HHHH
M`****`"BBB@`HHHH`0U%&V;B5<]`O&/K4IZ57B8_;)P0<87'Y4`6:*2EH`**
M**`"L_Q!_P`B]J?_`%Z2_P#H!K0K/\0?\B]J?_7I+_Z`:`-"BBB@!"<`FF0M
MNB4E@V0#N'?WIYZ4R#!A0J`!M&`.U`$E%%%`!1110`4444`%%%%`!1110`44
M44`,E`*D$9'7@XK)O-06RM7N;@F*W9-Q99-WS'&%'N<]O2M9SM4GC@9YKS+Q
M;=R7%[):P._V6-QA$R06(^O/3VQZ4`5]7\47>HQB!W\JV^8!5Y8C'&<G)_'W
MK',B(N0H#\@_*-I'.<')%,DD,BQQDC8G1@H!'U[FK<*(J2".6-"`"S2$AL^W
MOU].W6@"ELF";UB8`94G;T/I]>13H[DAD+<!<8`4<_YYYK>TVVO)9DE21/*0
M_P`,I;;@-DCG(R>?RI=4L!Y+?/\`:</E""`P7TZG_.*`$T7Q)=::/+`:6'!(
M!S\G7D=@<>U>@6MU:7%N)8YH9(225;:3U)8Y]\C]*\E:,Q2^6TP4;<9#':>3
M73^#-4:VU'[#+EK>X.T;NF>Q&?7I0!Z!:F/8!&5QC)V=.:L5#`>7Q+Y@W8`&
M/E]N*FH`I:K]D^Q_Z<^R+<,')'(Y&,?2JBV.G:K'+/$S,LK9)1B-KCC</1L5
M/K5M+=602*))B'!*,VW(]CV-8=QIFHO:H!'+MWR'RA(&=<XP2Q//0\]J`-9]
M!LFMUC'F+(C[Q.&_>;NYW4V3P]:&%4BDG@PI5V23EU)R0Q-44L+N.:4RV]Q-
M*02LPFP,;,`$9YYJG=:3J<4UH+871CV(S$2D[7S\V<L/ZT`;EUH]CJ%M%;+(
M5BMLQA8V!QQ@@U5A\+6T$J2)<3G9MP#C'`89Z?[1K#N].U*%)(;2VO1B:1O,
M$IY&?E[^G>K=T+VS%QJ$DMRC1S)Y4<DAVNIZ@#/-`&F/#TPMOLS:I<-"``J%
M%PN"#_2B71KSS4F?7'$B9".T*<`XR*D:*YB\.PH[W#3'89FB),F"<MBLVULK
MJZU&Q^U+=/;P2R-&\R88*`I7=^.>M`&C+H`N26O+D3S>2(A(8@""#G<.?Y8K
M6MD>*W1)9!(ZC!?&,^^*Y;58I!K#RP6DKS>:I"O$65P,<JX^[^)JF]_J-BMT
MD8OM_GR,#L!7M@$E3^0H`[K-+7#SWNI6T]RT$D[/+,NXE%^1=N01GH,G'X5U
MFE2S3Z9;RW"[97C!8>^*`+E%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`"44M-(.[.>,=*`'4444`%%%%`!1110`4444`%%%%`
M"'I4,(7S9@.NX9_[Y%3'I440'G3$#!R,\Y[>G:@"6EHHH`****`"L_Q!_P`B
M]J?_`%Z2_P#H!K0K/\0?\B]J?_7I+_Z`:`-"BBB@!#TID*E(44G)"@$^M244
M`%%%%`!1110`4444`%%%%`!1110`4444`07EPEI:RW$F[9&I9MHR<"O&[J\=
MIY9(YGWR2,2IZ,#G_'&*];UU#+HUW&I4,\15=S`<_4UX_)$=C&-R&XRJJ<-Z
MX//3C\Z`)-';RKEF8D+P",9#`G!!&/0U;N(A!J-S:I9EPCL4VQ`LJ[@<_=.>
MA'TK-BSYR+*WDH"5;DC;V.<9-:W]IWDWE"+4FCN(E\K=EMT@)]1GCZT`.DU"
M*(9,<BQR;BIAE"H"!D':!@MS[<FF7NH6\]I^ZN6+*<OO!#$G'*=0.G.>IQ6;
M<74TZ^<7)9ODZDD``8&3[?RI4^T"\'E<2)ASYBYY&,^O^10!)=2PO!`5B:-S
MC=\V[=QR<D9Y//6F6<ICFB,8*.C?>7KGMTIMT;BYO`9G\V10`3C:.!TYQTQB
MB$2&9@JD;6Y'?Z4`>SV3>;$DX8[945@OH<<_SJS67X;W?V%:;\9*=ABM2@"C
MJ\DT5@SP31P$$9D<9VCO@=S7._V[J4!B^TE5$93S5*\NK$\GTXQ70ZO]A-H/
M[1&8MXP.<ENW3FJ<$.AS%90B;HFV_O2P8'J`0W)H`-'U5M0U&\4,GDJ%,0&,
MD<@G_/M67!XFNGG6"8(A-RJA@OWXR3G\1Q7116EC;7+SQI&DKKACGL/Y=JA.
MCZ;B$&%?DD,B98_>/7OS]*`*3>*+=8VDDM[A%,8DBR!F120,@9]352\U]WOT
MBDTQF598MJR1@N-P)X&>O''XYK5&A6"J4"ORH509"=J@Y`'H,U7OH]'M]2$U
MW<^5.767:9"!D<`XH`LRZNO]D?;K>)G+,%1'X.XMMP?QJ,ZI<V*R-J=J%`95
M1K<[]V<]NV,4Z)-+FL?[.28/%O,8&\YW?>X/KWXIMSX<M+I")99V=G5R[-N)
MQT'/'Z4`++XCTV".%Y)7"RIYBGRV/RYQSCIS3AXBTXVZSF2159BH4QL&)'7Y
M<9JN=*TV*.6T^ULH2V\IE+J"D>[=GI[TEMX<MT@A>SO)E9&9XY?E8`,,$`8Q
MC%`%G_A(=,$BQ_:1N;;@;&QSTYQ3-4UW[!>QVJ6_G.R;SF4)QGH,]3[4Q?#-
MM&)!'/*`^SK@XVG/^/YT:[HB:C(DKW?E*HVD2(KK]1GH?<4`2IXBTXW$T4DX
MA,6T$R<9)[59BU:PG<I%>0LP4M@..@ZFLVY\.--=%ENML!>-S&R;B2@QUS]?
MSJ,^&_,N[@FZ3R6#[4"G<I<'WQW';H*`-&77+!/(VW"2">3RU,;`C/'7\Q5F
M_O8["V,\H=EW!0J+DDDX`%8+>'KR)!-'=QO<I()0"C$$@'_:Z_E5VYL[W5-`
M2&Y\N.Z<!I(Y%RIY^Z<<_D:`)K77K*Y,0W21O*Y14E0J<CKFM&.:*528Y$<#
MJ58'%<H?#%\+."-I+>5D9\*=VV(,,#;G)XZUH^&]'GTJ*99_*&_:`(B?X1C)
M^M`&G9ZA;WLDR6\F_P`EMK$=,^QJW65H^GO87%[^[2.&20&-4]`,5JT`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`(>E1Q$%Y<#!#`'WX%2'I44&TR3$'G>`?^^10!-1110`4444`%9_B#_D7
MM3_Z])?_`$`UH5G^(/\`D7M3_P"O27_T`T`:%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110!#<QB1-ISU!X;&*\;U*UEL]1N+5\%1(Q.6VYQGG->R
M7!CV%9"F&XPYX(KA/&&BB>$7MH48KD&.+!PN3C&,?U[T`<2C>:P623:N?XB>
MIQ_^NGM&]K,%2YC)#CF-B1GL?2EC$;3M(\3B!>=@;],_X5H3Z=O`O+,Q)"_(
M1G#!>>!D\\XSS0!'+8:A%.)91$BORLBLHC/';MW_`)^E5I$\H@-%%T/S*Y/I
MSP:O06%U)`]HJ(I4;M[2(`O)'7N><=:9LW"-IS&0$W.$R&P.""Q'OV)[<4`9
MQWF+:T@"\MM)/)JUIELUS>P6ZJ2SN!CH1_D5#/&HFPLC.OW4<KC<.@KL/!^D
MR6RQZG<9C#C$&U"Q/8D@=J`.ZM(Q#%''&=T2(H0YSGBK%11D;W4?PG&-N,<5
M+0!GZG8O<0Q_9_+62*83`,.&(SUQ65JFF:GJ-J@D6U:0LQ('`0'&,'%7M>FD
M`M+>-GC%Q.J-(G!`STK*^S7"PWUQ)JUY]FMSM0A^6(Z_J<4`,?PS<213.\:&
M=F381*1A0N&'3';O0^@ZBUM'&Z0N5A*1A967RFW9W=\G%1W5QJ<4%J@O'`6+
M?<.KKN^8\<'T&*T8-3GBLM8#R>9+9L^QV],<#\*`&6^BW$6JQW;J6<3EFD\T
M\IL`Z>YYI][87:ZG=20V45Y%=J@/FN`J8]1W'>L-];U**+R5O7,P=BP>)2ZJ
M%W=>F*U[;Q$;G5+&U26+;MVSG.-TFWH`>>M`%"XT:_-RSSHZ1"YD;S$GVB-2
MH`(&>!G]!BKNB:A.J)=W1EF\^1;5%1\K\HP7Y]2,T^ZO]1EUV2VAE6.U#+$-
MT&]68KD@G/%4O[5UN+>%-I(@G6V1TB(`D/4@=P.10!)X@TR_N=4N;JT1@4AV
M`8XE##!'U'7\*BMH-9^WP6BM<P1")4W`G8J[/RSG//6I5\1ZAYEHCBW#$[91
M@_,=Y4\_PCOS76@?A0!Q=Q<:]%9BXD:\\PLL2QQ*/X1RQX/WF/Z5#JEQJ-[;
M11SK>9,<#K&L.0Y_C+<<<UW6/>EQ0!ROAK4]2O=2D2[,YA".?GAV@,&&!T]/
M<UD&*;^W+XQK.I*S[BBL2F>FX]".N,>HKT'%)C'2@#@K032Z<RI]HA2:Z6*U
MV3.`N<;FSP2._/?/O4_D30ZX;>SO9_ML<HCC$K%E\K9U.>O//X5VQ4'&0#CD
M4;%W;L#/K0!S.A7%S:0WVZ.YU"1;ME8KMR,`<X)'Z5FOJ]Q+/J9NKB^L$*J0
M/+/R#.,#T)]?K7;I&J;MJ@;CN.!U-0SV-K<[A/;Q2!\;MZ`[L=,_F:`.$.JW
ML-DLL.J23?+NB195+#+='W#+'Z5JZ1J6I2^(_*EG9XWDE#Q@@K&`!C'<8/'-
M="FCZ;'L*6%LIC.4Q$/E/M4\5I;Q7$D\<,:RR??<*`6^IH`FI:**`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHI.<T`+1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`"'
MI44))>;..'XQ_NBI:@MB"\^#G]YZ>PH`L4444`%%%%`!6?X@_P"1>U/_`*])
M?_0#6A6?X@_Y%[4_^O27_P!`-`&A1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`0W&X`."V%.2`,Y'Y$_E5)T$F_RIF"[\E3'DC@\8(YYK2IKQJX(
M/'N.#0!PNN>$H;MUEL9(X9I5XAVG#L!DD'M7)7.EZC8/YS6<T4?57"D@>AS7
MLYB0[<J/E^[QTJ&.RCC&U6;9G.WC&?RH`\974[TP>4UQ)A1A.?N]/QI(K+4=
M2=2D4]PS<`X)KV@V-J6#&WB+#H=@I\<"1QH@&=G0D#Z4`<-H_@I[8"YU!//(
M`VP1OC!ZY)/''I75(K^;Y1A,46]=FQU'ED`<8_PJ\UM"QRT:D\\X]>M(]G;N
MY=HE+$[LGUXY_04`%L'PV\2#YN-Y![#IBIZ:J*I8CJQR:=0!E:P]OFWAN$D(
M:3>CICY67GO4%KJVG75K$@@\N"='D(=5"J`><\^M6M;TXZE9"))!'(K!E8]N
MQ_0UES>&"[7>R5%60*(EYPN""<_7%`%ZYNM(:ZMEG2"3S$W1RL%*@#W-.CBL
MK&&ZBD<7$L@:65#@NXQG&/I6:WAVZ1(S']FD<+(&24$KECU'T%5E\+W\=U*\
M<EOL:-E#%F);*E1D$<'GG!H`U+6+0KZ+[-%!!A0)3$4VE=W2M06EJ9(W$,>^
M(?(=O(KE#X:U"(,(TA;*Q'(?!RHP5&01UYZ=JW-%T^>R\M9XXB4AV^:&W-DL
M25Z#CI0!9.DV1U$7WD+]H'\7OZX]:9)HMB]E]D,96'>9`%8@ANN0:J>(-'N+
M^>*2UD\L[&20YQD=5_\`'A^M94OA_57M(OW_`/I$F\W!\S\5Q^6,^]`&VWA[
M3M\#")@(0`%5R`V#D;O7GG\:U00.]<E<:-JWV>+[/(4GF#-<_/D!@=RA<G\*
MEFM]572Q:%)VN9'$SRK)T)?E>O&!B@#J<BC(S7)W.GZJB_Z'+<*6G>'+N7Q&
M<8;K^M1QP:Q!K$D<<MW(@BD"M(/ER%^7GH><>]`'89HR*X6XDUI+=_L7]HK!
ME0/,0M)NP=W?.VKDNL7T>B1QR1W<%RFPR2O'RX+8(7U;';K0!UV:*XNWU'47
MT\RFXNVB9I1&R1!GW`@*#QP.M7K*ZUS^U+>VO``LFV1F5.%4#E2<<<C]:`.G
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`JM<WUK:,JW$Z
M1E@2`QZXJS6?+G^VX`./]'D_]"6@!1K.FG_E\B_.G?VOIW_/Y#Z?>JE8:G)/
M:^9*WSA'=E$)`PIQP3P>WZU.M^-^9"IB\F.1<K@DL2/7V%`$W]KZ=G'VZW!]
MY!3QJ5B>EY;GZ2"J=QJ<)LI9;=5>5$=MI4';MZYYZ?2K4LL4=O#)(BCS&1?]
M7GEB!0`[^T;'_G\M_P#OX*/[2L?^?VW_`._J_P"-00WEG/<>2L?S;V3YDP,K
MU%17EY'";N.*W3S+>#S=S)E2>>/TH`NC4;(]+RW/TD'^-+]NM/\`GZ@_[^"J
M:WMB8\M$N\,%*>5SDC/3Z5/FR^S+<".,QL`00@.<]*`)A=VQZ7$1^CBGK-$W
MW9$/T-8]U?VWF0106R/YP?YC`S;=O8J!G.?RIMG<VTS1F:"UC25"P4P%3P,G
MDC!&*`-S<OJ*7-9F_3-C,8(OE/*F#YORQG'O4KP:>D(E-O;E&P01&#G/IQS0
M!>HK)<V;R11VMG:R&12P+1@#`(&.GO4UY96JQ1E;2`$RH#B,?WA[4`:&:,@]
M#63<QP6T<\IL[9HH&`(V#<1@'Z9YI<Z9*,+;HV[[H$?+#U'Y&@#5S1D>M9!&
MEQQAO**+@GHPX&">.O0BD5M++$%9%//WBXZ$`CZY(H`V,T9K">31PA8"9NO0
MR=<9QG/7%2W=K9VHB=HY?*8X<F>3*\=>M`&QFBL80Z>C&.4NC]>)Y",%L`YS
MZT)'I<P0)-*=Q^7$T@SZ=Z`-FBL2!;#R`[7<\?RJ64W+_*2/<_K5J&UMI]WE
M7=RX4X.)VZ_G0!H,,C%+FJ?]FQ_\_%W_`-_V_P`:!IJCI=7?_?\`-`%S(]:*
MJ?V>/^?JZ_[^FD.GY&!>78^DG_UJ`+F0.IHR#WJJMDZC`O;G\2I_I3OLLG_/
MY<?DG_Q-`%C(HR/6J_V:7_G]G_[Y3_XFC[-+_P`_L_\`WRG_`,30!8SQ56PZ
M3\@_OFZ#I3OL\O\`S^3?]\I_\33+&,PO<1F1I`'W98#/(R>E`%RBBB@`HHHH
M`*S_`!!_R+VI_P#7I+_Z`:T*S_$'_(O:G_UZ2_\`H!H`T****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`**8V[<N"`.X(YI]`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%1LC&16#D``@KC@U)10`E17%M#=1
M&*XB66,]589%344`0V]O#:Q"*WC6.,=%48%3444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%9\N3K4`'_/N_P#Z$M:%95X\\>LVYMX5
ME8P."&?;@;EYS@T`6(;$Q:>UH)<@AE#XY&<^_O43:6S+C[0P8(BJP7H4.0?U
MJ4S7^.+2'/\`UW/_`,336EU3=\MI;8]YS_\`$T`12Z7/*A)N_P!\\3122&,<
MJ?09XQ_6K$UH\EM#$)0#&R,6V]=I!Z9XZ5&9M4`_X\[8_P#;P?\`XFF/=ZHF
M`-,1_4K<#^H%`"PZ8\4XE\X-B9Y<;<?>&,=:+K37N)KIA*JI<0^405)QUYZ^
M]-?4-05<_P!D2GV69"?YTW^V)U/SZ3?`=R%5OY&@!LVC.\[3I,GFEE8!X]R\
M*%((S[5<GM&DM(XPP\R)E=3C`RIR.!VHT_4K?4`_D%MT9PZNI4K_`)Q5R@#)
M32IH[V.[65-X9W=2O!+`#CZ;136TFX>*W1YT`AC=,A3SD8K4GGCMXC)-(L:#
MJS'`I+>>.Y@6:%MT;C(.,9H`S9;"^G\N:<VLD\65"%3Y;`XSGOGBK4]M+Y,'
MD"/S(6!"GY5/!!'MU-7:*`,VUL)H;P3DIAMY<9)P6(/'_?-6KS_5Q_\`75/_
M`$(58JO=C*1_]=5_G0!7GM[<2M]HN#MD<-Y;L`I(QV[]!Q3)+&UCVEIC$P/[
MMO,P5]A536(K4W3HEO\`:;ZXBVA3@[!_>YZ54:R0ZBUM=A9O(L`%+<\^HH`U
MKC3K9U/F3.@92O+C'(`/7Z4RXTJW;$DES*HW,P;<HP6(.0<>H%8.A1KJ%U!'
M?Q[XX[(E`YR/OD9_*G6JR7$>DH(TN95@D/E3'Y2N2`<\\\>E`&[/I44J-YES
M+AF#$DKUVE?3WJZT(8(&8OL_O`?-D$<_G7)6B)='1+64M)`?-WJW`W#M^%.@
M@N+W2TLT021QWKJ!++MRJC@9ZG\*`.@;2(2(Q%+)&L8``7!&`VX#D>M":88T
MC43?*FT<J.</NK%*F>PA2&P<16UTR7%M$V<D#&021D>U0QI=7.F:C9VT,J_Z
M2@6*20!D7J1G/L*`-]M'C9TD,A+JJH"5!^5<\?KUJ[;0_9XRFXMEBV<>IS7+
ME"UC<65O9S1S13H;B*.4L63_`&2:9+-Y5IJ<$0N+2'$;1)-G=DYR!W&<4`=C
MFBN;T^)I);ZU+RV+/&A$6_<RCNP/3GI3M*:*UN+JYBGD.F1Q`&1W+!G!Y(SF
M@#HB<49%86I:S'<VBQ:;=1^9*"?-Z!%'4\]^P^M9<5P\NE:0JS33>8S^9%%(
M?,D&?7/;W-`'8TM9F@2.]@?,E+E7*X8Y9!_=;W%:=`!1110`AJO;_P#'U<_5
M?Y58JO;_`/'U<_5?Y4`6:***`"BBB@`K/\0?\B]J?_7I+_Z`:T*S_$'_`"+V
MI_\`7I+_`.@&@#0HHHH`****`"BBB@`HHHH`****`"BBB@`I*6DH`PH+1[Z^
MOMUY=Q"*4*HBE(`&/2IVT6;G9JU^#[R`_P!*71CNO-4.2?\`2,<_2M:@#'_L
MB]R<:U=`?[JFF_V1J0&!KD_XQ*:VJ*`,(:/JJAMNN/D\\P#K^=._LS61TUO/
MU@6MNB@#!-AXAQQJT)^L0_PJ+[+XHSQ?VF/]W_[&NBHH`YXP^*0.+JR/U'_V
M-)L\4KUDLG^G_P"JNBHQ0!@B7Q*O'D63>^3_`(TX7'B/G-G:?@Q_QK<P/2C`
M]*`,/[3XAQ_QX6N?^NG_`->F?;O$.W/]EP_]_!_\56_1@>E`&!_:.O#KI"GZ
M2C_&FG5=>'']B@_]M170,,8PN<_I2T`<]_:^N`<:$?\`O[3'UW68QEM`D(_V
M7)/\JZ2C%`',)XEU,M\_AZZ`]MW_`,34P\2RCA]&U!3[1DUT-%`'/'Q0%P&T
MK4`3_P!,:E7Q/;\;[*]C]<Q=/UK<Q10!B-XIL$7<8KKIG_54T^+=,7[XN%^L
M=;M!4'J*`,4>*])QDS.![QM0OBS1F_Y>6'UC8?TK9V)_='Y4UH(6^]$A^JB@
M#,7Q-H[*#]L`!]48?TIR^)-(;I>H/8@C^E7&T^S?[UI`V1CF,5`VBZ6QYTZU
M/N8E_P`*`&C7]*+;?MT.>O6I!K&FMTOK?\9!3?["TGG_`(EUKSU_="F'P_I!
M&/[/@`]EQ0!-_:^F_P#/_;?]_5_QH.K:<!G[?;?A*O\`C5<^&]'/_+A'^!(_
MK3?^$8T8#`L$_P"^F_QH`O+J%FWW;N`_20?XT[[7;'_EO%_WV*SAX7T<9Q9@
M?\#;_&F-X4TA@`;8\?\`31O\:`-<31GI(I_$4[</45A_\(EI."!%(,G/WSP:
MB;P;IY/$MRH]`R_X4`=%D>M&X9Q7.?\`"&6.01<W8([[E_\`B:5?"%LA)2]O
M5)&"0Z\_^.T`=%FC/UK`_P"$63MJ>HC_`+:C_"E7PR4^[J^H_C+_`/6H`WLT
M9K!'AZX'36=0'_;2J.L6E[I4$4T>K7DK/*J;'<\Y_P#U4`=92T@I:`"BBB@`
MJA)_R'(?^O=__0EJ_5%_^0Y#_P!>S_\`H2T`7:@AO(9YY8HB6,1PY`X!],^M
M3TT(%!"`+GDX'>@`DE2)=TCJB^K'`JC)K5FK;(6>Y?\`NP(7_4<#\ZH_\(])
M),TMS=1W;'&TW$);;]!N`_2M9;=EM#`'"MM(#QJ%Q[@4`4C<ZK<-F&UBMH_[
MUPV6_P"^5_QHCT\2O_IFH2W1(SY8?8F/]T=OJ:ADT.4:?'9QW3O&I9W\PD&0
MGH"1VS5O1](M]+ME1$4S$8>3')]OI0!;A@@M8]L,:1(.R@`5FWVN1(DGV0>;
ML!+3-Q$GU;O]!4UWIK7T_P#I4Y:U!X@4;0W^\>]5-2T!KZ4.TZB*)?W%N$PB
MG'5O6@#F?MS7T[3W"SW2(Q,*RGRU?\/Y`9/K76:%<W<\;?;&MD8`;8(N#&/<
M9K+7PK?[2?[89)&&UG2'!*^@.<@>PP*:/"5["@CM-9EA3`R%CVY^N",T`=92
MU@Z5I&IZ;#)&-224N0<RQ,^/I\U6OLFK%MW]JH!_=%J,?SH`U*JW[K'%&[YV
MB12<#/>IH%D2%5FD\R0#YGVXS^%,NAD1?]=%H`S9X-)NKCSY49I2`-V)%X_"
MG2VNE7(19$)V+L!^8';Z$]Q]:6X,G^E2B1RL)8D"4C^`<8P<=3S[4C7QA>=C
M\X4L5!DQP$4X_6@!TUAI=VL99$4QC:I1BA`].,<4Z>PT^6.%<K%Y(VQM')L9
M1Z9!Z4]K^17,0@#.,Y`?(Z@>GOWIMU)(+YD^T-#&+<OGC"D-UYH`9+IVF2V\
M,!\M5BYC*289?7!IKV&DFVBMU=(Q"<HT<NUE/<Y![T1ZK(R*AB59BFX@MT/R
MY'_CU6+:_$\LP*!$C)^8N#G!P<CMTH`K-8Z6;-;99E15?S`ZRX?=_>SZT'3M
M+>S-J)5Y;S/,$OS[_P"]N]:=_;!\CS!`3C=N&_H``?3T-20WLDVJ+&#B`QOP
M<<E6`S_.@"(:3I_V.6W\PGS6#/(9?G)'0YI%T>P^QRV\LS3&9@SRR2`N2.AS
M[4KSW,(NB]R["`#^%03D?XT^35=GFEK9RL1;)W#D*0"1^8H`@.D6S6TT9OI6
MDFP'G:0;]H_A^E/TW38=..!?22Q[-HBD<%1]!5NTEAO%9A``G!4L!\PY_P`*
ML&"$]8D/_`10!4N;+3KL'S8;5VV[0S*I(JG'H-K';VL=O<-'+;$E)DQDYZY]
M:UC:6QZV\7_?`H%K;CI!$/\`@`H`BL+2.RA,:,79F+.Y/+$]S5K(J/[-!_SQ
MC_[Y%'V:#_GC'_WR*`)**B-K;GK#'_WR*:;*U/6"/_OF@"?-5K;_`(^KKZK_
M`"H_L^T_YX+3;.)8I[E47:NY<#_@(H`N4444`%%%%`!6?X@_Y%[4_P#KTE_]
M`-:%9_B#_D7M3_Z])?\`T`T`:%%%%`!124M`!1110`4444`%%%%`!1110`4E
M+24`9>B+^^U%O6Z8?E6K69H?^KO#G/\`I4G/XUIT`%%,ED6*-I'.%4$D^U<Z
MNOZC<QO=66F[[1"<LS?,P'H/_P!=`'2T52TO48M2LEN(^,\,I/W35P,#T(/X
MT`+14<DJ1Q/(S#:BEB?85GG68VTUKZ&":2,-M"@<MSC(H`U**RKS6EM5M1]F
MFDEN4WK$@^8<9_.ETW6%U"XEA^S30M&,MY@Q0!J44F:*`%HJM>7MO91"2XD"
M*3@=R35@'(H`6BDHH`6BDJA!K%A<7?V:&X#S9(V@'M[]*`-"BHIYH[>)I9I%
MC11DLQP!52VUK3KJ810WD3.>@SC/YT`:%%5C>VPO!:><GGD9V9YJQF@!:*2B
M@!:*3-%`"T4E%`"T4F1ZT9H`6BBB@`HHHH`****`"BBB@`HI**`%K!\5C=!8
MKCK=H.GL:WJQ/$W(TX?]/B?UH`VJ6DI:`"BBB@`K/ES_`&U%CK]F?K_O+6A6
M?*3_`&R@7&[[,^,_[PH`+74#.8=T043*67#YQCUXJ<7ULREEF0@8R0?7@?G6
M;;:1);PIL\D3&,Q2D9`9?4<=10=-NOLH0K$7BC6)-LC+N`((;./E/`QUH`TH
M[ZVD9529"6Z#/U_P/Y4U[Y(KZ.VD!4R+E6[$^GUX-4[>QNX[J"61HV8*!+("
M<N.>",8SD]>.]3WMI+<.S)L!"J8W;/RN"2#CTYH`)-4C2XGB&W]R@8NS@`DG
M&*<=0Q),@B)\N5(LYZ[L<_K5*ZTNY99UA6'$L*QY9B#G<22>/>I&M;X/.1%$
MWF3Q2C,IZ+MSV_V?UH`OF]M@7#3QCR_OY<#;]:EBECF0/$ZNI[J<BL=[&[:"
M:$PQLVQT24R')W'TQQZGZ5KPC;$H(`('(%`$E%)FB@!:*2EH`*AN/^67_705
M-4-P,^5_OB@"G=ZI9VLSPR([L`&D*1[@H/=C3;J_L+=@C1^82N\[(]X53W/M
M6;?7,=I>ZM%*'#7$:B(8.&^7&!^)JK>[[!XO])>WFDLPCCR=X;`Q@>C?6@#;
MN3I[/"['*W*D*5'RX`R3[?6G6NH6%].$13OQE#)'C>!W!/6L2PM;B6R>W=27
MM;`H!WWN"?Y`4^SG%W<Z2MN6)M+=O.`7[IV@8^N10!JP:EI]W<")(R[DE=QA
M.#Z\_A4CZCI\#2%F56W^4P5,EV`S@`#)ZUSFG78L);5;.]N+A,.UQ%(N`@'.
M<=JT?MT6EZ-:RW"Q_:YR73S.`K-R23V`!H`OFYTG[,)\0>4S>6,1\EO3&,YX
M%/CO=,6!KU'B5<[2X7#9]/7/M6+;-!;+87#74<R&ZD:XF7[H=E/Z5`LH\]KX
M'%I_:8;?C@C!YH`Z$7>EO;2W6^$Q,0LC%>2>P(ZYI]N=/O5D\E(W&2KC9@C/
M/(/-<Q=.)&U"9"/L\MY$(YOX489RWO6UH1S?:BK2"X8.N9UX#\=.../:@#1D
MDL]-C,C^7`KMR0.IJUFN.\22R2S-)-;7*"*01PY3Y",_,V?4]JWO.VR2W:RS
M,_D;OL7&Y??;USVH`O?:H/M/V?S4\[&[9GG%0QZI8RW'D)<QM+G&T-SFN;T^
M=8O$$4LD%RL\L#&4O$P^8GT]!TS[4W29)+2>P\NY@NTN9&#*(\-'D]0<9_.@
M#J[F\M[15:XE2(,<`L<9ID6HV<T;R17,3H@R[*X.T>]97BC?_P`2_P`M5=_M
M(PK'`/L:@FT^Z6#4[V[CAA,ML8Q#"<CIU)P*`-TW]J+9;@W$8A;A9-PVG\:G
M5@ZAE(((R".XKAK@.(9=-^;R[<O-CL%*C;^IKL[#_CQM_P#KDO\`*@">J]O_
M`,?-SQ_$/_015BJ]O_Q\W/\`O#_T$4`6:***`"BBB@`K/\0?\B]J?_7I+_Z`
M:T*S_$'_`"+VI_\`7I+_`.@&@#0HHHH`9+Q&W7[IZ=:?377<I'J,4Z@`HHHH
M`****`"BBB@`HHHH`*2EI*`,S0%Q:SG^]<2']:U*S=#!%G)D8_?R?^A&M*@"
MAKD;RZ/=)&"6,9P!WJCH%Y:)X?C+2(BQ*1)D@8.3UK<K&N?#&F7,S2O$ZECE
M@CD`F@#(U;4UN]'M?L=O)'!+/Y;QC"[^G&>@'/7VHL(+FUU4)!826EJ\9$D;
M3A_X3@]2:Z&]TFUN[`6;)LC7&S9QM(Z$56L?#MO:3&=Y9I[@J5$DC9(!&*`.
M?TC2DNM#N;Z6>XW(L@1%D(48'^-!MOLO@Y[N.282SX!^<\`.>GI7466DQ6>F
M26*LS1ON!)QGD5G)X9?[#-9R7\K0N5V#'W`"3Z^]`%*XL1<:QI:?:KA&FM]Q
M*R<J0O49Z4D=[/:3ZY(D\LGV?"QF1MV#G&:W_P"RU%]:7(D/^C1&,+CKQC-5
MX=!C26_:20R+>?>&W&WDGU]Z`*5A9:C<VUK>1ZG*LLF697;<I';`JGJ^H>7>
M7H75+EG1?W<=NN%0_P"T?2KD?AB8O!'<7Q>T@;<D:C!]<&AO#5TD]VMM>B*V
MNB2ZE=Q^GZT`85_<W%YI&GS374CN[LGMP>OUY`_"M?4=0FMK]+"75&@BB3=)
M/MRS$\]OK4DGAFY;2K>V6>/S+>1F7@A6!J2?1M2^T0WL4T+7AC"3[A\K'UZ?
MYQ0!+X9U22^-U#+.)_)8;)`,%E.>?TI=:U&Z74;;3K&1(Y9N6=EW;1]*N:/8
MW%I%(;R82S2')V_=4>@JMK>D7%U<P7M@Z)=0G^/H1U%`&:NH:M:ZO)I<US'*
M7C+13&/!SC(X'T(Q4?@>*1GN)SL\O.WE/FS_`+WIUXJ[8Z)?/JCZAJ<D)D*%
M52(G@XQG/YU:\-Z5/I5O-'.4)=\C:<\8H`J^),7.JZ;82;C%(^YP.,U-=^%M
M,E$?DH;1T(VM$<$_G4VOZ5+J$<4UK)Y=U`=T9SC/MFLR72M>U2>!=1E@CMXC
MD^6<,WOQWH`AOEN1XQC2S9#,(P"\HR!\N"3^=7M*UB^D%_;7$:3W=KT$7`?D
MC^E2KI=RGBE;U5_T81;-Q89'R@?7M6:^AZH)-8>%?*>Y<&)Q(`67<21QTR,4
M`/'B#4;6]MUO$M76=]OEHXWQ\XYYX_&K%QK]]_;4^G6=DD[ITR^,#`.3^=8T
MFB7RK8-'HZQ>1(&E99`TDA[G/IQTS6WIUE<)XMOKMX66%X\*YZ$_+_@:`([+
MQ47TVZGNK?;);;5(4X#DY_+I44OBJ]M;>*:ZTW"3_-$PDZC\JR&T2=M.U(W:
M?9V,J/"TA"ASEAC/T-)KL]Y+H6GV\MKY,<0"[BX;S"!@;<=N*`.DU#Q#,E^]
MCIMDUW-$H9R&X7VJ[HFKIJUJ\@B,4D;;'0G.#7+:EH_V;7;BYN[2ZNK><;D-
MMG(/H<5N^%+-K:SDD:T>V,K`[6?<6'KCM0!4\2$MKVGP&XD@CE4J[1OM(&:K
M6\TEEXDM+6UU2:]BD/[Q7??M.#^'O4^NVOV[Q580RV[2VX4;B4.WG/4UMV6B
M:=82F6UM(XW/\0R2/IGI^%`$6GZXE]!>2B!D6U)!RP.[`S5*3Q=;Q:9%?/;2
M".20QXW#(QCG]:RM.O?[*MM3M9+>X:XD=RBK&3U!Y)]*S9X'D\,6"%#DW+G!
M[CB@#I%\;:>T180S,Y?8D:X+/TY'/N*OZ?X@M[UYHC#-!-$I9HY1@X%8GC&V
ML]UH&CEMRH&V>-,HOU''(P#4.@S7DNHW5NLJ7D/DMFX$6/F(&/F(S[=30!T5
MOK]O/I4VH+%*(H6VE2!D]/\`&B3Q%80Z?!>3NT:3_<7;EOR%<C#?P0^#KVR=
MR+DRX$90DGH?Z&GO=NMEHD`%O`RHK_:9TR%Y/3\OSH`ZV'7]/GL);V.4F&'[
M_P`IR/PJ(>*=(+(OVK!<`\HW&?7CBN,LWDDTOQ%(768MMP57`;Y^H'I5C6+2
M.+P9I;+$HD:0,S+U.03U_*@#H=4\3Q6FL064;Q[-P\^0Y.P>GY5T$;K)&KJ<
MJP!!]17"7,5JWBC1S*D20_9D9S*``W!ZD\'M7>(%5`%`"@<`=,4`.K!\2G,^
MEIE@#=*>/;_]=;U<WXF.=8T53]TS$D?BM`'0Q(T<:JTAD('+,`"?RI]%%`!1
M110`5GO_`,AM,'!^S-@_\"%:%9\F&UE5/3[,V>?]H4`4HKU[0@W:3I,%V[6;
M<DI)4;@>@Y/Y&KPOIVD:(6O[T`M@R8!`QC!QWSZ=J@6VT^Y!@\UY5"$!6<\#
MCD?IS3FT:W95'F7`89^?S6W$'L3Z<#B@!3JDHFEC:TQL94!\S.689QP*#J%P
MLGSVVT+$\A7?][!&,$@?K3I-*MY5F#M)^]*MP^-I'0C'3&,4KZ5"\>QI)CE&
M1BSY+`G/)H`B&L$JNRVWDRB+Y7XR5R.2*LPWS2L$,)60.5==V=O&<_J*KO96
MT<R>;=N)#(K@,ZY9@,#MZ5-;Q1BZN+EM@D8!&"MG`'KZ'_`4`-GU-(Y)`(RT
M<3JDC@_=)Z<?B/SIM@\]Q!+,TAW;G54.-HP2![]J>UA;SN\H<E)2K.JD;7*]
M#4L%I'#;O`K,5<L3G&>>M`&9%?SQ([SO*)XH&=[>4`;B,?,I`Y'7\Q5R34Q#
M*D+PMO;`&".21G('IVS2RZ=$Z'SI9&41-&"Q`VJ1SSCVIHTR-I!)Y\K9=9.,
M8)"X].E`$=MK!ELX9VMI&+J'8)SM!.!_(_E6J#D9K-AT=;=85ANIU$2>7U'S
M+UP>/UK2`P`/2@!:@NBP$6T`GS!P3CUJ>H;CK%_UT'\C0`SSE9PI,1<'@;^<
M_E3G+?>*1_+SDMT_2J<L=PLD[1QL26)3A3@[0`W/T/YU`\=_YCN/.8")PI)7
M[Q"XX^NZ@#2#3#+"%.><A^OZ4T,ZNVV%-QY.UN?QXJI_I*NH$KKN<@H^W.".
M"/H>U.O+>62^AEM^)8HS\S#Y6R1P?P!^E`%@!F1B+1"''.&'S"F31B4`S6$;
MA1P7*G'YU1EDU&",1P12!55-N$!P-IS^N*CNWOYX+B$+*X=2JJ8L=8R>N/[V
M!0!I")!$8A8+Y;=4&W!_"GD#R#$;)O+QC9\N,?3-4?/U!$551BI)VOLYQQP1
MV[_E5_3C.UE&]RQ,K*"P*XP<=,4`19`A\D::_E=-G[O'Y;J(7%NFR'398T'9
M?+`_]"J]10!2FD^T)LFTZ9USG#;",_\`?5"E1<-/]@E69EVE\)DCT^]5VB@"
MKMC:X6X:W?SE7:&P,@>G6HX;2TMYFFALA'(>K*G-7J*`*D\<%P8FF@9S&VY,
MH?E/K3I989XVBDBD9&&&'EMR/RJS10!GO;6,CR.]JQ:1-CGRFY7TJU'+$B*B
M*X51@#RVX'Y5-10!'YRD<!_^^&_PJ*U.;BY(S]\=01_"*LU7MO\`CZN_]]?_
M`$$4`6:***`"BBB@`K/\0?\`(O:G_P!>DO\`Z`:T*S_$'_(O:G_UZ2_^@&@#
M0HHHH`****`"BBB@`HHHH`****`"BBB@`I#TI:1ONGZ4`9V@OYFG>9_?ED;_
M`,>-:59?AL`:+#CH2W_H1K4H`****`"BBB@`HHHH`****`"BBB@"I>ZC;V/E
M^>V&D8*JCDDFK6:Y+Q5"&U:R'F,AEPI.>%Y'(_.GM;37FL?V9]KF6VM(U+,#
M@L?7]:`.JJCJ>JP:8L;7`8B1MH*C.*S-!NYH=2NM*F=I1$28W)S@<<'\ZB\9
MQF:.QB#;/,FVYQG&<#-`&U?ZE;Z?;+<3$F-F"@H,YS5:\\0V%E-Y5PSJV%/W
M."#7%WNHRQ:*^CW:@7%M.`HS_#@_X_D:VM1NI+;Q6/L]D;ME@&(E;&1CK0!N
MV6O:=?3+%;W"F1AD*003W[BEN]>TVSF\F>Y42#J`"<?E7-:?<3:WXF@F6SCM
M$M"3(N1N[]1P>O'2B:SO=-U6ZN$T^._MY6))(W%1G/X?E0!V%K=P7D/FV\BR
M)ZJ>E,N-0L[:3R[BZAA<C(#N%./QK'\*/8NMRUFDT3,P+Q28^7KTQ5[6+73E
MA>]OK>.4Q)C+#KZ#\Z`+,&H65RY6WNH)6`R0D@)`]:9%JEA+-Y,=W"TF<;0X
MS7.Z9I<4?A^\O7*VLEU&V&/"QH>G3UX_2L.$B6'3;80)`WFG_2R,+)\W8XYQ
M_A0!Z'>V<-]:R6]PNZ-Q@@=:Y^#P[I%O>)NOWD:)OW4+SCY.<XXYKI9D\R%T
M#,I8$;AU%<-KVFZ;I]HMK$QGU-Y05;/S#)^M`'<R2I$,R.J#U9L4@8.JLCC;
MUR.017'W43ZAXIM=.U`F1(X1G;D`MMR?Z5GPSRP:#K%M&[>7%,H4]<*201_X
M[0!Z"KHW"LI/L<T_&17`QFPTW4M(DTN<,TVU+A4DW=2.N>>_Z5WU`!BDVXIU
M%`#616!#`$'L:2.)(T"1J$5>`%&`*?10!$MO$DCR+&BN_P!Y@H!;Z^M-GL[>
MX0)-#'(JG(#*"`?6IZ*`*K:=9-OW6D#>9]_,8.[Z^M$NG6<T"026L+PQ_<C,
M8*K]!VJU10!2N-)L;D1">VC?RAA,C&T>G':K@&!@4M%`!7.^(.=?T7/3>W\U
MKHJQ-3!?Q'I:C'`=N1GM0!MT444`%%%%`!6=+C^V#D$C[,V0!U^85HU1_P"8
MT./^7<_^A4`8\K/':31177VF$0$IG(DBQC@XQ^OI4L]ZQU.%8;AO+\T(_P"\
MXP5SP.X]_6N@R.]&1[4`<S;7#BVM8ENS"OEEM_+9DSRO!Y/M[UJZC-MG@CDN
M6MXY%?YP<?-@8'\S^%:.1[49'M0!D:;F:\,EP<S?9XB5)Z'YNW;L?QHDC:*Z
MN;RW.YE<":(<[UVCMZCG%:^11Q0!S\5S)F.$7`MRJQ!%(Y=2!G`QSZ>V*LQW
M$S6A,LSHT1,3M@?,^X#CTSZ]MU:_!/:C`P>!SUXH`YH7[W$)@GNP@$<Q+97Y
MRK%0#Q@\58@NV6:S6.X+)O2(H,;1^[SCU)[YK<*H>J@\YZ=Z38F<[!GUQ0`^
MBDHH`6H9\;HL_P#/3^AJ6HI\%X?]_P#H:`,JZU.]&JS6EM]C58E5LSL5)S2R
M:A?(EM!'';2W<Q8_*_[L*.O/K44]I*NMW-P^FB[BD1`A.S@@<]:5H)UGM+VW
MTXQB`/&UN&`8@]QCCK_.@!QO;^>WCN+>R@,\9=)?,?;L(/8^E1IKEZ+&*1[.
M,RSS"*%0^%8?WLTZ2UO!H5RBPG[1=2,S("#M#'GGZ5/JUF'TR&!+,7(C*X0/
MM90.X/K0!&=;9;4[K<?;!.(/)W#&\\@Y].]6=/U(W"7"W<0@EMCB4;L@9&<@
MUE0:+Y.EW6^R+^=*'$/F_.JCH=W][DU%;Z%=O;7`MP+02S(RQSG>2J@_>^IY
MH`NVFMW.HP74EA9K*T4@5%9]NY>>>?I3[76;PF[^TV`46RY81/O);^[QWJMH
M]IJ=FVJ2S("7+,@5<>8W8CV_QJ[91S:;H"E+=Y+@*7,>,DN3W_/]*`&1Z\T3
M2I?VIMV2'S@%?=N7ICV-26FME]WVRV:V(A\]>=V4_#O[5DI93WME=QRV=TM]
M<)N:64`+D$$*.>*G:SN=4R6MI+?R[,PCS>,N?3VH`O66N&>81W%H]MOC,T;,
M<AD'?V/M3K#6OMMPJ?8YHXI`3%*1E7`_E6<EO<:A+"KVLT"V]H\+&08!8KC`
M]:K:1IUS!=V0@MY[>6)6%TS_`'#GICG!_"@#H]2U!=/B1C&\LDC!(T7JQI=/
MOA>Q.3&T4D;;7C;JIK+O[*[^PC[?))>LLJLC6R"-XNO/?-3>'[5X6NIV\_;,
MXV>?]\@#J:`-JBBB@`HHHH`0\"J]L/\`2;H^KK_Z"*L57MO^/BZ_WU_]`6@"
MS1110`4444`%9_B#_D7M3_Z])?\`T`UH5G^(/^1>U/\`Z])?_0#0!H4444`%
M%%%`!1110`4444`%%%%`!1110`4R;_4O_NFGU'-_J)/]T_RH`I:",:/;_P"[
M_4UHUGZ",:-:_P"Y6A0`4444`%%%%`!1110`4444`(3@9IL;;T#;2N1G##!%
M/HH`R-8TAM0E@GCG\J6$Y7(R#W_I4<VCW7VE+VWO-EWL"2%ERKX'7%;=%`&7
MI.D"QDEN)9#-<S<N_0>N!3=8TV:^N[%XS&(X)-[ANO4'^E:U%`'+^)?#;ZE<
M1W%KL67'S[CC.._2KL>F7'_"3'4&*>3Y>T<_-TQZ5MT4`<[<:)/#X@BU&QV[
M&)\Y6;&<\''\_J*@CTG5=(N93I+0RP3')$W4'\ZZFB@#%T#29]/:>>ZD1IYS
MDA.@Y)_K2^)[.ZO[%+>UCWY?+G<!@#Z_YXK9HH`SM2T_[5HLEC$1&2@5>PXZ
M?RKFCI.JW=I9:;);)!';$[I<@@C/7ZXKMJ*`,5[S5DNKQ19K)#%&6APN#(W&
M!G/UKF+2+6[+49[^;2//GD8D2,"VWZ`&O0:*`./U)+ZSU6VUM+)YMT0WQ)G*
MMMQ_A3;'3KVWT+4+MK42W%V0?(<'.STQP0>2?PKLJ*`.#T32H[Z^M9(M->QC
MMR))6?<=[9'`SSCBN[%+10`4444`%%%%`!1110`4444`%%%%`!6+??\`(T:8
M/^F<A_2MJL:]_P"1HTWIQ')_*@#9HHHH`****`"JTMH'G\Y)I(Y-FS*X/&<]
MP:LTE`%;[//_`,_LO_?*?X4?9YO^?R7_`+Y3_"K5%`%7R9_^?N3_`+X7_"E\
MF?\`Y^G_`.^%_P`*LT4`5?)G_P"?MO\`OV*/*N/^?H_]^Q5JB@"MY=SCBX7\
M8_\`Z]!2YQQ.@^L7_P!>K-%`%;9<\_OT]OW7_P!>D\N\_P"?B'_OR?\`XJK5
M%`%8)=_\_$7_`'Y/_P`51LN_^>\/_?D__%59HH`K!;L=9X#_`-LC_P#%4UHK
MIBA:>'Y3GB$__%5;HH`K[;G'^NBS_P!<C_\`%4FV[Y_>P>W[L_\`Q56:*`*F
M+_\`OVW_`'PW^-&+[N]O^"-_C5NB@"I_I_K;?DPH'V\=K;\VJW10!3)U#LEL
M?^!,/Z4!M0[Q6O\`W\;_`.)JY10!0,FI8XMK4_\`;9O_`(FD\W5/^?2U_P#`
MAO\`XBM"B@"AYNI_\^EM_P"!!_\`B:!-J>?^/.W_`/`@_P#Q-7Z*`*/G:AWL
MX?PGS_[+0)[[/-E'CVG_`/K5>HH`J"XNR/\`CS_\BBC[1=?\^1_[^+5NB@"I
M]IN?^?%_^_B_XT?:;G_GQD_[[3_&K=%`%3[3<8_X\I/^^T_QI+!GE$L[1-&)
M6#*&(SC:!V^E6)F*PNR]0I(IMJ"+6$'J$7^5`$U%%%`#$8L6SV./TI],0$,Q
M(ZFGT`%9_B#_`)%[4_\`KTE_]`-:%9_B#_D7M3_Z])?_`$`T`:%%%%`!1110
M`4444`%%%%`!1110`4444`%1W'_'O+_N'^524UT$D;(W1@0:`*.@C&C6N?[@
MJ^>E9@\/Z:$"^00`,#$K<?K3#X<L#_SW'TF;_&@#57=SN(//&/2G5C_\(Y9#
MH]R/^VQH'ARU'2XO!])S0!L45B_\(Z@^YJ.H(/19O_K4O]@$=-6U+_O]_P#6
MH`V:*QQH;C!&K:@<'(S*/\*5M'NBX*ZO=A?0X)H`UZ*Q?['U#/\`R&I\>Z#_
M`!IHTC5`QQK4F.W[L?XT`;E%8O\`9FK;?^0R<]OW(_SZ5%_9VOY_Y"T>/7RQ
MG^5`&_17.FQ\2`\:G`P]U`_]EH^S>)E;B]M6'N!_\30!T5%<_P"5XGP<3V6?
MI_\`6IH7Q0K#]Y9,/<4`=%16")/$H/,%B0/<\_K37N/$PZ6=DWL&/^-`'045
MSIN_$W_0.M3Q_?QG_P`>I?M_B)<;M)A;_=D'^-`'0T5S?]J>(`?FT93ST$G:
MG#5M<`YT//TEH`Z*BN<_MK6%SOT)^/[LA/\`2@>(-2R`=#N/S;_XF@#HZ*YX
M>(+SG?HMV/H"?_9:>GB%]C-)I5^I!P`(B<_I0!O45B+XB3:=^FZ@K#MY!I?^
M$D@'6QU`#W@_^O0!M45ACQ1:G_ETOO\`OS_]>E_X2:U_Y];S_OU_]>@#;HK$
M_P"$GM/^?:\_[]?_`%Z</$MB21LN1CUB-`&S16-_PE&E]Y9!]8S0?%.D@\W#
M?]^V_P`*`-FBL8>*=((_X^6_[]-_A4B^(]*9=PNU`]U(_I0!JT5G)KNF/TO8
MOQ./YT\:SIK#(OK?\9`*`+U%4QJNGGI?6Q_[:K_C2_VG8DX^V6__`']7_&@"
MW6%>-_Q5]@H[0N?SS_A6I_:%E_S]P?\`?Q?\:Q9IH[CQG9-#*DB+;-DHP/.3
MZ4`='1110`4444`%)@9SZ4M%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!'/CR),D`;
M3DGM3;4YMHCC&4'\J6Z;;:S,,DA">/I1;#%O'_NB@"6BBB@!*6BB@`K/\0?\
MB]J?_7I+_P"@&M"L_P`0?\B]J?\`UZ2_^@&@#0HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBF@Y)&*`'4A&00>]+10`@&!BEHHH`****`"BBB
M@!**6B@!,`T8'I2T4`,9E4J#U;H/6G8%!%%`!1@>E+10`F**6B@!,"BEHH`2
MBEHH`2BEHH`2BEHH`3`]**6B@!NQ?[HIC6\#9W0H<]<J*EHH`KO8VC@![6%@
M#D`H#BHWTK3G<NUC;ECU)C&35RB@"A_8FEXQ_9]OC_KF*3^P]*_Y\+?_`+X%
M:%%`&8/#^DCI8Q#Z"D_X1[2<G_0D&?0D?UK4HH`R&\,Z.W6R7_OMO\:FLM"T
MW3[@3VML(Y`NT'<3@?B:T:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@"MJ!(T^Y()!$3<CZ5+#_JD_W14.J?\`(,NNO^J;I]*GC&U%&<X`ZT`/
MHHHH`****`"L_P`0?\B]J?\`UZ2_^@&M"L_Q!_R+VI_]>DO_`*`:`-"BBB@`
MHILC;$9L9P":=0`4444`%%%%`!1110`4444`%)2TE`&)=:Q=0F41PQR%+AHE
M3D$@)N%9P\4WGR*((69F(Z.2,8ZJ!D=:WY=(L)IGFDMD:20$,3WS4:Z#IRG*
MP%3SR)&'I[^U`%/4]<GT^^$'E1.FU2<L58Y...,?GBI[C5S!HRWWE`NS8"`]
M?FQQ^`JU/I5E<S>;-#O?`&=QP0.F1GFF#1;#<K-"7"G*J[LR@^P)Q0!7N=7G
MCFD\BS\Z"(+OD$@!Y7=P*33M9EOK:2Y%L$@CC)+&3)+@`E<8Z=>:F;0=/9T=
MH260!1EVYQP,\\XJ6'2;:!'6$.BO%Y3`,<$8QGZX[T`92^*4>$NMO\REMZF0
M#`&,$>O)_G6BFJA[*:\$#F%#B/!!,G.,@?6HSX<TXIL\L@;"F<\X)S5@Z7!]
MGGA5I$29MQ"MC:>O'IS0!5_M^W67RIXIH)1N^20`=!GU[]JECUB*2UDN/+D5
M(I`CYQ\N<<_3D5')X>M)PQN7EGD92#([<]OY8_G4L>D1Q)/&MQ-Y,RL#&<$`
MGOTS0!9L[M+R-Y(U8(KE06'WL=Q[54DURUBO'MI1+'L)!D*_)G&>OTJR=/@:
MWA@;>4AQMPQ7IZXZU5FT.&>60S32O%(YD,7`&[&,Y'/2@"2TU>VNXY7C\Q?+
M3?AUP67U'J*A/B*Q`'S2$E58`(23GH/T-.@TCRA*9+AI7:$P(S*!L3TXZ_6J
MR>'5@836UR8[@;6#;`5#;2#Q[YH`G/B&RWQH/.)DQMQ&3^'X=ZGEUBSB\T.[
M9BD\ML*3@XS_`$-)#IK12VDAFW-!YA?Y<;RW7Z<U1O/#[7$LTZ3`2R2[P3G`
M7;C%`%I]?TY9`C3\E-Y^4\#;NY/KCM4_]J6F^)/.&Z8*4X/.[./Y&L4^&;S8
M+=;\"VY8K@YW%<<^HSSSTH_X1F:V,,NGRQ)+'L)$NYE9@#GZ#F@#:GU6RMA+
MY]RB>4P5]W8GI3O[2L_*60W,85MN,MC[W3Z9KG;KPWJ=Q++=?:X5N9&Z#.S!
M4`]1P?Z58'AV?RT1I=^)8B^&VJRJ.?EQUS0!OPW=O<,5@GBE*]0C@X_*IZR]
M&L'L5N?,5`TL[.-O]TXP*U*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`IDAD&WRP#EOFR>@I]%`"#IS2T4
ME`"TF:RIM=BBO[FT$>YH(C)NW<,0,X]JS(/%K7LPMK2S5KASA,RY7/).>!Z4
M`=316`/$N(R)+-EF)"I&7^^VXJ0#CL13]-\1I?P7$OD!!#$9"%D#$@?A0!N4
M5SB>*T:V$WV,X,@3_7+C.">3VZ5;B\002SQ1B)P'B\UF/1>,XH`V**P?^$F4
M0"=K&X6)\>6[$!7S[U/+K\,%E!=30.JS%L!2&(P">WTH`UZ*R(M?@DTJ6_\`
M(E"1D`H<9.<=.<=ZC_X22$+N>SN0`-SD*"$&>"3GVH`VZ*R[77;6ZO?LJ)*&
M)8(Q7Y7QUQ43^);)(WD9)A$N=KE,!\$`[?SH`V:*Q5\2V;$#R;K[GF']R3A>
M>3CZ4X>)=.RH+2C<!R8S@$C(!/K0!L45FV^MVES;37">:(X0"Q9".OI4=SXB
MT^UG:&61_,0X8*A..`<_3F@#6HK.L];L+Z<PVTQ=QG/R,!QUYQBF+XATMC(%
MNT/EC)X/3....?PH`U**J0ZE:3RM%%,KNN<@>V,_S%+;ZA:W3(L$RN74L`/0
M'&?SH`M4E+24`(K*Z[E8,/4'-.I`,=*6@`HHHH`****`*FIX_LVX!&<QD8QG
M)JQ'G8,]:@U$,UE*%7<Q`P/7FK"]*`'4444`%%%%`!6?X@_Y%[4_^O27_P!`
M-:%9_B#_`)%[4_\`KTE_]`-`&A1110`UUWJ5/0TZBB@`HHHH`****`"BBB@`
MHHHH`0D`<T4CHKC#`$>AI1Q0`M%%%`!1110`4444`%%%-.<C&,=Z`'44E+0`
M4444`)12T4`)4=S,EM;23R?=C4L<>U2U3U41OIT\4LJ1+(I7>YP`3TH`I0ZQ
M<2-:L^G2+;W)PCJX8C/0D=JN1:I8RW;VL=S&9D&2N?3KS7/V6HWH-G:/<65O
M;P@!YEN$;S`!C@5DZ?:&'4(_,NT41N[F3[3%L(/H.O.>AH`ZN]\1Z9;0LZ7,
M,T@P!&L@!.3CO45WXEM;6.:3"2+&4";)E)?=_*L*."PA\.0&2.U>]652XW(S
ML`_U].U0ZC%'<07[1I"/.EB\N/S$^50.<<].U`'6V&K)=B1G1(%B`+$S(P&?
MH?UJV+VU,'GBYB\K^_O&/SKA=6@#W%^UN83"LT3"-74"1%4@@<\\D<4M_<P3
M0J;73(HK5Y3N889P./F$>>._6@#LKG5K6W:W!DWBX?8A0@CZYS5M9HS*8O,0
MR#G;NY'X5YR%M[:ST^:]@9HX+M_.!CYVD`CCT^E7+)9)=3M\02>>MQNDD6,@
M[<YR7+8(P>E`'>,ZJ,LP`]2:HZGJUOIHB\T22-*<(L2[B:R/$31C5+)[P/-I
M^&#I&"P#<\D#\/RK'6T:2XTQYX'\F:Y98PX8D0\;0?3JU`'8ZAJ=MIMLL]T6
M4-PJ@98GTJK#XDT^:TGN$=\0XWH5PPSTX_&JWB4F"YTZ],+S0V\I,@122.G.
M/:L?4KU+ZQU6ZM-.,2G8HN2"KR_,O8CVH`[9'5T#`\$9%.R*X+43_9+74-LU
MTL;01LP25A@D\DGG%16E[-_9NHK%.Z%9XMA21N,D\@GGTH`]"R*,C-<3J=S<
MV*ZA;17-RT4<\(8EBS(C*2QSUQP*HSZG<0_VD-.OKF2VCDB1)&DX56!Z,?H!
MF@#T3-4I=8TZ&=X);R))$^\K'&*R_"MS/.EXDTYE5'`4M*)&&1R-W?M7.:G:
MO#!?.+B23;>B'$@#9XSN/J:`.^@N[>Y+B"59-APVWG!J4L!U-<#/J-Y:R7<-
MLYC+WQB+*57`QV8\"K4.JW]S%8P2WH@\QY`9P4.X*O`STS0!UR7MK)`\Z7$;
M1)G<X8$#'7FDAO[.=ML-W!(W3"2`FN>TO_D1KF0-R\4S$]@>1Q^59>D:5<7M
MEITL5C#%Y<N][O>"[`,<\8H`[W-&:Y)=7O?L=S*+D%QJ'DHI4`JF>F#5>76=
M:WZA+;RP/!;3-&%90&//&/7%`':Y%&17$KXEOUTZZ>29/.AE0`/%L<`YSE>G
M:M#5]=N;)KX))$/+:)(]RDG+`DX`Y)XH`Z:C-<6OB746A6./89?MBV^^2(ID
M$$\KVZ4FI:IJ<NF7L;2QK);W:Q,T:D;@>PYH`[7(HS7.>*9+V'0H`C*&=U20
MKGDGIC'O4!UK5?+N7CAM_+T]A',"3F0CJ1GM0!U611FN?\52O+H,36[$--(@
M7G'4<5@?VI=7-];V\[O'<VMM,EPF[JP4X/OZT`=_D49KS[2[RXN)-/BM3>Q7
M+'=(\\A$;IWP">?PI]U<W<6IR7$]U>^3Y^$N(&WPA<]"/IQUZT`=]FDSGI6?
MJL9GL!*E]+:I&#(9(B!N&#7-/<:E!I-O<O?W+"ZF`5,;I=G/"^_>@#HWT*Q<
M$['#LS,7#G<=V003W'/2HH_#FGQ)A%E#Y!$@D.\8]#VZFHO"MW<7>FS/-,TI
M69E3S/O@#H&]ZRFO]3L=7VR7PN2JR27,**2D*@$CG'7VZT`="NC6:R6TBHP:
MW!"?,>_4GU/O26NC6]LDJ)).RR1^60\I.![>G6N=M]8U2V-L[S->->VTDZQ;
M,>60"0!CD]*M^']6GFU86DE\E[')`)-RJ!L;N.*`-*'PY8Q,&(ED(</^\(.X
M@8&>.:DDT*SEF::0.TA?=NW=L8V_[N.U:E%`&*?#L'DB(7%P50KLW,&"`=!@
MC&.>]2SZ)'/9P6[SRCR2Q5UVJ>0?0>]:M%`&1%H$$>GSV@D<K.P9CM4#@CH`
M,=J+K0UE9A;3&VBE0)+'&@VN`?T/)Y%:]%`&19Z''97:W$#X;+"0%<[P3D=>
MF/UJK+X9,L0@-V?(0L8T,8^7<>>>]=#10!C?\([:+<2RI&@#1>7&NW(C//(_
M.HH]!N(%,5O?E(6`++Y8)9@N,Y]..E;U%`&#9:#+;6%S;&>,F90`Z1D8([D9
M-5;GPQ>7699;^,7#-N9TAVXXQP0<UU%%`&!I7A^6PNI)7G259`V[A@W)S_>Q
M^E02>'+R6&.W>Y@$,*E(]L9#$$@G)SZ#M7344`<Y8:'?Z=*'MYX9/G?_`%N<
M[6V^G?Y:U+'3EL[R[G4*!.X*@=ACG]2:OT4`%%%%`!1110`4444`%%%%`%>\
MS]G./[R_^A"IQ5>^.+<'_;3_`-"%6!0`M%%%`!1110`5G^(/^1>U/_KTE_\`
M0#6A6?X@_P"1>U/_`*])?_0#0!H4444`%%%%`!1110`4444`%%%%`!1110`4
M44E`"T57CO();I[>.0-(BY8#G%%U=PV<8DG?8A8+G&>30!8HJ!;J)KI[96S*
MBAB,=C[U-0`M%%%`!24CNL:%W8*JC))Z"FP31W$0DA=9$/1E.0:`'TM%%`!1
M110`44AXH!STH`6DP*6B@!AC0]44_A1Y4?\`SS7\J?10!'Y,7_/-/^^11Y$/
M_/)/^^14E%`$#V=LYR]M"Q]T%,_LZRQC[';X_P"N:_X5:HH`I#2M/SG[!;9_
MZY+_`(5E7SZ9::@MDNB)<2LGF?NX8^!WZ_2NAKE]3@CO/%"K)/+#&D&&DBDV
M$'.<9_'I0!<MM+T:6W2>738K?>=H25=ISG&*E;0=&!9C:0C=U.2*Q=82UBU*
M)KX2WMDL'EH5D#,'SU.#G/O55;1;S4-(@O@6C^SG?A]NT9)"DCT&/SH`TM6T
M[0-,,!N;>8"=M@99G^7IR?F]Z;#I.B3ZM-IR0W?FPJ&9_.?;V/7/O2^+(8;V
M33+7.Z-Y=C;.2`<#/Y?RK!$-_%)K,;%VD2..,R`'YU#*,@CGH.U`'6?\(IIA
M4KMN0#V^T/\`XTJ^&-/3(5[I0<<"X<?UKE[&&[>QO+F!R(;5DEB5-^TD?>QN
MYQCK4M[/<G38[^8SQ/?3E@0[A(U[!@O/<\=Z`.@G\+64T;*;B]&1@$W#'!_&
MJ>E:)IMRES]FU&^F<-Y<TGFLI)`Z>_\`]>L*TU&1X[6*_O;R.S\^1&D3*GC&
M`3U`Y'7UJ*RNW2P2&*6=$FO)/WKR>6"`JXWD`G-`'8)X=@M8CY>H:A&JY)Q/
MT'?M65%'HUY,(5\073/(VX(S`9;UY7K5[PS<2W'A>5YY6E<>8-S')QBLO2-#
MN-3T^S,QM8[17,FZ-?WQY/!/3K0!MCP]B*2,7\YCD?>P>.-B3ZY*U%=Z4;:S
M(N-5"VJ?\]H(R$[<<#%9HGO+>RO;Y+ZX?;=-``?F5%_O?AZU3U::6:WU"T34
M9;FT@$;*^0=S,1\I.,'U_"@#;MUCN+&6*VUNV:VC'[P"W3:H/K5J+3]0M;94
M@U.".-!P!:*%`_.N7GC=/[3@:Y8)%=P*3L0;LY&3@<UT/B<O'X<PDC21`JLK
MCDE.YXH`I1Z5]ONI&@U33)YMV]]MJI;<#U.&XJS_`,(_>B":'S[%XYFWNIM<
M9;UZU38:#IVH6\^F[_M1@>2-(3N1L*3\WIQ3K+7KPVUA=27*3&\=D:$1@&,`
MXR,>G7F@"=?#=XMI+:;M/,,IRV86RWU.[/ZU&/"]V+>2#_B7[9""Q\M\Y'0]
M<YYZYJO!JVKG2[.\DU"-%N;@0C,*_*,D$G\JGN]<OK69K$7,$DIN4B%R4`50
MP!Y`XS0`1^%KJ*0NAL0=ZR?=DQN'0_>I\WAS4)HKF-I++%S())#A^6'<<\4R
MXU[4(4O;=)(I)[:XCB6;9PP;U%5]3\0:EI\DL;7*320;0XAMLIDG^-B>./2@
M"_>Z3J]U8BUGN+'RD(*G:X88Z'.:JR>%M0ED#^98]%##][A\?WOFY-9^H2W,
MC:[++*LD:QPLT3`X&=I`&#D8S^-:T.KZ@]G=R6GV:.&P5%V2*69\+D\YXH`L
M7>G:U?0"*Z_L]HU8,%3S$Y'3D5!<:#J-Q?->21V'FLAC8QO(NY2,'VZ&H[KQ
M'?B?4#;K"(;2..0AXB2=P&1G([FDF\3WR7BCR8HK<^659XV*L&`)^8=.O3':
M@"W)HUY):VEL;6V"6IW1LERX93]=M4Y?#ETUQY@LXQ$QWO;K>L(V;UV[?TKK
MU.0#2T`<_J4&J7^GO9OI\2QL!_J[K:1@_P"[5:\L;^ZL[6$Z68I+8`PRQ7:A
MD.,>G^<5U-%`''QZ3J%HT!AM+K<DAEE9+P?OF./O9QZ5!I^CZE9SM+]DU!]Q
M+2(]XFV3U!QUS7;48H`XVRT^]MY-TNF7D@2-HK<>?&#"A[`@]?>K>AVES;7R
M27-I=/(4\L32NF$7Z`]S^-=/BC%`"T444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110!4U($VG#;3O3G_@8JT*KWN?)&.OF
M)V_VQ5@4`+1110`4444`%9_B#_D7M3_Z])?_`$`UH5G^(/\`D7M3_P"O27_T
M`T`:%%%%`!1110`4444`%%%%`!1110`4444`%(:6JFHNZVV(W*,[HFX=0"P!
M[>E`%2*".SU>YD6$K&8`Q95)R=Q)^IIFOHMYIUNI5VCEGCR`#G:>OTJVMBZY
M(O[HG'<J?_9:/L<_&-1G`[_(G_Q-`',7)O+6>]#B17CBCB6=&(++NX8G&<8Z
MXI]K+?7,EO"]S<HIDE+%9'7("*RC+#.,UT?V.Z*X&I2_C&A_I3!9WX)_XF6?
M0F!>/RH`P/M%_%9^8EU/))/:"1M[Y$>6&2...#6EX<NKJ:"\\R3SDC;]T^XN
M#QR-Q`S5TV>H=M10#&/^/<?XTU;35%&!J$)'_7MC_P!FH`PGN))K";%_/,'M
MC).I/$3C''3@')&/:M>Y+V>DVD8N3`I94>X.T%1C.>F.O%2_8]2PP^U6IW=<
MVW!^O-$L&K.K`SV)4_P-"Q'_`*%0!CMJ\F)`FK#;"A:-VB`\\Y/'/7H!D4CZ
MCJ#2S2&^%LJ72P^6R*0H(SR?;FM<VNI?+_R#B%^[F%OE^G-0W6FW]R4\Q-/(
M602,`C#>>>O7/6@"HNIW<EY]B%]&%0O_`*44'S[0.,=.YSCTID>NWLD4MP7A
MB6*W64JR%@Y)(ZCD#H?QK2:SO&@$;6FENBG*J0VT?ABC[/>NL@EL-/8LNPX8
MC<!T_A/%`&-/J=Y=QO:23+N2:$ABH4D,>X!/&<5?@NKE;J>UM6@@"&69F=2P
M;#D8ZC'2K`L9TC*)I.FA6QN`?@XZ<;:1K6<J$DT:S=1D@"7@9Z]5H`K1:Y>3
M13SJ(5CB$+;&0DG?C(SFMZW$X:3SG1@7^38",+Z'WK,6&?;(ATBW`DQNVS`;
ML=.W:GQ->VV]HM)C!=MS;;@9)]>10!KT5FB]U'OI1'M]H6F_VC?\_P#$HF_[
M^I_C0!J45E'4[T#G1[H_1T/]:4ZI<@\:3>$>N4_^*H`U**S%U2<CYM*O%/T4
M_P#LU*-4E[Z;>_\`?"__`!5`&B>E59-,LI9&DEM('=CDLT8)-0_VH<D&PO1C
M_IE_]>D_M8<9L;[I_P`\#0!(=&TUNMA;'_MD*C?0M+?KI]N?^`"G+JJ'_EUO
M!];=J!J\))S#=C'7_1G_`,*`(3X;T@KM-A%CZG_&HSX5T4G/V%0?9V']:NC4
M[<Y.)\`9SY#XQW[4S^V;'G]ZW'7]T_\`A0!77PSI:`A(9%!&,"=Q_6D?PUI[
M9_X^?I]H?'\ZL'7-.!P;E1^!_P`*/[<TX`$W2#ZY%`%,^%=/[/=CG/%R_P#C
M4J^';9,[;F^&>?\`CY;_`!JQ_;>F_P#/["/JU`UO3"2/M]MD=O,`H`@_L&((
M56]OP#U`N#_6D_L+;Q#J-_&N,!5GX'X8JXNJ6#$XO;<X./\`6"E.IV(&3>6_
M_?P4`9P\.8A:)=4U`*Q)P)%P,]>U1_\`"+J(/)&HW>S.0K;"H/KC%:PU"T89
M%U`?I(*D%U`1D31D>H84`8K>&BZR*^H2.),;]T,9W8Z9^7FK"Z/<I#Y*ZG((
MMNWR_(CVX],8K5$J$9#J<>].H`P(/#;VKE[2^6!B,$K:1?X4L'ALVS&2"YB2
M4YW2"T0$YZCCM6_10!S5UX7EN;6*V:[@$,<GF!!;`+GOP#SUJ1?#)6U-KYMI
MY#-O*?8Q@GU^]70T4`<ZOAV>.W^SQ3V:Q!PX7[+_`!#H2=W6HY_"[W,\D]Q)
M9R22<L3;MR?4X>NFHH`YF7PW<3R2/,]DQD`5L1.-P&,9^?V%)<>&[B5Q)Y>G
MLV1N7;(H<+TSAN?QKIZ*`.8DT/47DNW:+32;I0DF#(,@?CQ4+^&[]I_,"V*!
ML>8B22A9,="P[]*ZVB@!D098E#[=P`SMZ9]J?110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M!6O&"QKG'^L3D_[PJP*KW@++&`/^6JY]AG-6!0`M%%%`!1110`5G^(/^1>U/
M_KTE_P#0#6A6?X@_Y%[4_P#KTE_]`-`&A1110`4444`%%%%`!1110`4444`%
M%%%`!5'5!F.`<?Z^,\_[PJ]5#5,[;?;G/VB/I]:`$>YEAU,0S-&L#QEU.,'(
MQD$Y_&JL=_?/<VD9\A1=*[K\A)4#D9Y[C%7=1T]+](U8D;'SGU'0C\1Q3)[*
M1]4M;I"@2!&3:0<G./\`"@"LFHW+VD?RQ"Z:X,!4J=HP3[^G-33ZEY.I6]J0
M"K\2/V5B/E'XX-.CTQ4U>6]W95U'R>C=-WY<55N=$>YBN)&<BZDDWHWFMM7!
M^7CIP/:@!T^J317\]J$B+*JF(9.79CP/T.34LU[=H]O:)%"UY(I=_F.Q%!Y.
M>M5;G2+NXOI+PF-)O+`B9)&RC#\.0:L?9KY[N&^=(1.B&-T#DJRGG(...:`*
M\FM7**%%M'YR3B"5&<@`D_*0<<@UH:9?&]$ZR1B.6"0QN`=PS[&LZ?2KR?,C
MB-I)9TED7>0H5>BCCGCO4ULMUI,?D+`DT)FQ&0^'P?7CDCG\J`+%_>7-O=01
M06Z2^<2`3)MP0"?3I@56CUU9+*698,R0-MEBW_=YQD'N*GOUN3?VLL=J\R0[
MB2&4<D8XR:RSI%W)I406-H+E#ME4E3YJ[L\D$CCK0!J/J$_F.(;3S1"/WI$@
M&#C.!GK5ZVE$]O',%*B10V#U&16<@N;":X2*UDN$FD,BN&48)QD')J[;R3-(
MZ2P[%3;A@00W'./I0!9HHHH`****`"BBB@`HHHH`**2B@!:***`"BBB@`HHH
MH`*:5!ZBG44`-**?X1^5)Y29SL7/TI]%`$?DQ_\`/-/RI#!$PP8HR/\`=%2T
M4`0?9;?G]Q%SU^04PZ?9GK:6Y_[9K_A5JB@"I_9EE_SYV_\`WZ7_``H.FV1`
M'V2WP.WEBK=%`%,Z99'K9P?]\"E_LVRSG[+#D^B"K=%`%(Z38'_ETA_[YH_L
MJQQC[+'CTQ5VB@"G_9=EG(MHP?4"D&E62DX@`SZ,?\:NT4`4SIMM@@(XSW$K
M#^M']FVWI+D_]-G_`,:N44`4QIEN.AF'TG<?UI?[/ASUG_\``B3_`!JW10!3
M_LZ#^]./I<2?_%4'38#_`!W`^EQ)_P#%5<HH`HG3(B01-=#V^T/S^M']F)S_
M`*3=\_\`3PW'ZU>HH`SSIAP=M_>+D_\`/0''YBF'29#_`,Q2^_[[7_XFM.B@
M#/33Y(U_Y"-VV/4J?_9:46,K`$:A=#/^[_\`$U>HH`HG3Y\`#4[H>_R?_$TA
MT^X(XU2Z'X1__$UH44`9PT^Z&/\`B:7''JD?_P`33OL5YQC4Y?\`OTG^%7Z*
M`*`L[WG_`(F3_P#?I/\`"D^R7^?^0EQ_UP6M"B@#.6TU$,I.I*0.H,`Y_6E^
MRZEN!_M%,9Y!MQ_C6A10!GBWU,*/]/@8^]O_`/94YHM2XVW-M_WY;_XJKU%`
M%()J6.9;3//_`"S;_P"*I"NI[!B2T+=P4;'\ZO44`4-NJ<9:S]\*W^-(QU4?
M=2S/']]NOY5H4E`&;YFL_P#/&R_[^M_A1%<Z@MS"EW;VZ)(VW<DA)S@GICVK
M2JI>,RW5FJGAI3GGMM-`%RBBB@`HHHH`****`"BBB@"I>NR^4%0-NE4'+$8[
M_P!*M"J=^2)+0`XS.,_D:N4`+1110`@&*6D4@CBEH`*S_$'_`"+VI_\`7I+_
M`.@&M"L_Q!_R+VI_]>DO_H!H`T****`"BBB@`HHHH`****`"BBB@`HHHH`*I
MWX#&W'4^>AZXJY5:Z.)+?G&90.F>QH`LT4E%`"T4E%`"T4E%`"TA&<444`%+
M244`(I)&6&#]:=244`+1244`+124M`!1110`4444`)38RQ!W`#GC!SQ3J*`%
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`JC>$_P!H6.%!_>-DD]/E-7JHWG_(1L.3]]^!_NF@"]1110`4444`
M%%%%`!1110!3O?\`76F3@>=_[*:MU2OE#7-D2"2LW'_?)J[0`M%%%`$<6=IR
M,<G^=25'#]T_[S?S-24`%9_B#_D7M3_Z])?_`$`UH5G^(/\`D7M3_P"O27_T
M`T`:%%%%`!1110`4444`%%%%`!1110`4444`%130^;MP[(5.05QGICO]:EI&
M8*I9B``,DGM0!#Y$N5_TJ3`Z_*O/Z4"&8'_CY8CW44RSO[:^W_9I=^SKP1^/
M/4>]1WVJV>GNJW4I0N"1\A/'X4`2R0W)(V7(`_VHP?ZBF-!>\[;N/KQF'H/S
MI;/4K2]"FWEW[@2!M(/&,]?J*M9H`H^3J6>+NWQ[VY_^*I?+U`=;BU^ODL/_
M`&:K1EC$BQEU#L"0I/)`ZT_B@"D%U#/,UKC_`*Y-_P#%4A74NTMGG_<;_&KV
M12.Z1H7=@JCJ2>!0!2`U/`^>SSW^1O\`&G@WP/W;8CV9A_2K8((!!R#R#37D
M2/!=U7)P-QQ0!7W7W9+;_OXW^%&Z^_YY6_\`W\;_`.)JT2`,G@4@93T(.#CB
M@"L7O^,0VY_[:G_XFFF6_&,6UN3G_GN1_P"RU<XHXH`IM/?K_P`N4;?[L_\`
MBM(;J^"Y_L_<<9PLXZ^G(J[Q1D4`9_VZ^[Z4X_[;)_C1]OO?^@3-^$J?XUH4
M<4`9S:E=*<?V1=GW#1__`!5*=2N`<?V5>8]?D_\`BJT**`,_^TY<'_B67F1V
MVK_\52_VFX^]IUX/HBG^M7Z.!0!0_M3`RUC>C_MEG^1H&JJ<_P"AWH`_Z8FK
M_%%`%%=40D@VEXH`SDV[4X:E%Q^YN1GUMW_PJY@4<4`5/[2M\$XG`'4F!Q_2
MFMJUFI`:1E)_O1L/Z5=HQ0!2_M>QP";@`'U!I/[8T_&?M4>/?(J]10!3.JV`
M^]=PCMRXH;5K!<YNX!CKEQ5S`]!00.X%`%-=6TYAD7UMC_KJ*<=4L%SF]MQC
MUE%6/*C/6-/^^::;:!AAH8R/=10!$NH6;?=NH#CTD%2"Z@8X6:,_1Q1]EM\D
M_9XLGOL%,^P6?_/I!_W['^%`$PD0YPP..N#2[A4/V&T_Y]8/7_5BD^P6?_/I
M!_W['^%`%C-&:K_V?9?\^=O_`-^U_P`*3^SK'_GRM_\`OTO^%`%G-&?:J;Z5
M8.I!LK?GKB,"FC1]/5=HM(L?[M`%X'-&?:L]M$T]B#]F`QZ,0/T-(-"L!C$3
MC'_39_\`&@#1S1GVK/\`[%LL8V2XSG_7/_C0VBVC!>)AM&`5F<$_4YYH`T,^
MU&?:LT:'9CH;@?\`;P_^-(VAVI&/,NQSG(N7_P`:`-//M1FLS^P[?_GM>>O_
M`!\O_C2_V+%SFYO#QC_CX;_&@#2HK-.C1%B?M5[R,8^T-C^=/72PJX%Y>?\`
M?\T`:%%4#II*[?MMX![2\_GBE^P2<8O[L8_VE/\`2@"]15`V$^<C4;L<Y_@_
M^)I!I]R,_P#$TNCD=UC_`/B:`-"BJ*65P!SJ-R3C'(3_`.)H-G=[LC49A[;$
M/]*`+U%43:7F#C49/QB3_"C[-?`'%_D^\*T`7J*HBWU`?\OR'G_GA_\`7I#!
MJ7.+V'IQ_H__`-E0!?HK/\C5?^?VW_\``<__`!5-\G5\_P#'[:X_Z]S_`/%4
M`:5%9HAUCO>VG_@.?_BJ41:OWN[0_P#;!O\`XJ@#1HK.$6K9YN;3'_7%O_BJ
M79JP)Q+9D8XS&W^-`&A15%?[4&-WV0CT&X4I.I9XCM2,_P!]O\*`+M4KH9U&
MR.>A<_\`CN/ZT;M1_P">5J?^VK?_`!-(D=W)=Q23I"J1AON.6))^H%`%ZBBB
M@`HHHH`****`"BBB@#.U*,R7=CB1D/F$#!Z_*?SJ[$C(I#/O.>N`*BFYO+?/
M;<1S[59H`****`&HNT$9SR3^9IU%%`!6?X@_Y%[4_P#KTE_]`-:%9_B#_D7M
M3_Z])?\`T`T`:%%%%`!1110`4444`%%1NKEEV-M`;+<9R/2I*`"BBB@`HHHH
M`*CG9$MY&D&4526&,\8YJ2D8A5)8@`#))H`P=-U&T>22[DF"D1JHC"$"-,X`
M]STJ]K9"Z5,_'0#)]R!5A;ZT959;F$AC@'>.3Z5*98]Q0NN[NN>>:`,?5X2U
M]&(YI86%M*=T3;>F,9]JQFU#46O5?[5LVM$!'YOWPP7)V!>>O7-==/.L<#2!
M3)A<A4&2WTIXV85RH4X[CD4`9&MNJ7=L7O#:8CD(92.?N\<]?I65!JM[-!)-
M+=&*:)8S'``N)LXYZ9Y/ITKJ;AH5B:295944DY7/`Y/\J;`;>[BAN4C5@RAD
M8KR!VH`Y<ZQ>+?(1=$Q2F0`'9V!Q\HR1R.I-.O;B\^P"*XO^)K1IR6106./N
M?2NH^S6^\MY,>X]3M&32R6T$J+')#&ZKT!4$"@#,EG>'2].CBF$`E")YK*#M
M&W/?OT%4(6GU+4+>&YE5D@FD!.SB7;MY_7%=')#%)$(WC5HQC"E01^5-2WAC
MV;(D7RP0F%QMSUQ0!B^()IWCN46:,0Q^6#&5R6R1SG/%*L]UYDJ6LL,(62=V
M_=YSM8#UZ\UKSVEK,WF3V\3LO\3("1CGK3;9;.9!<VZQ,&W8=0.<GG]10!AI
MX@NPBN\2_OT#1Y``4D@>N2.?;I3[^XO8M0M$>Z@<QLS%4!!("Y^89XXK4DMM
M,M(G=X+>%'^5CM`S[4UK/2H@A,4"!?WJG`&,8Y_E0!G3:U>6\*2R"!UGA,T8
M`(V8`.#SSP:6?5]0LKR*"=;9@X'SX8`Y/J,XQ[]:TDTW3V1F2"(I*N,CH0?3
MVIT^EV=Q<"XDA!DP`2&(R!TR`<'\:`*FKRW$>I6'V=U!(D^5B=IPN><51G\4
M.EK%.D<(W1ARA9F8\X(P!Q]2:WIX(&ECGF`W19VL3C&>#5%_#NG,@3R6";=I
M42,`1DGG!]S0!#)KKQ33P/!B2*8``<[H]I;=]<`TFC^(_P"T[T0?9]@9"X()
M.,=CD#]*ORV%BEP+R5%$BQ^5O8]CQ@TVTTVSL+@21;E8J416D)`'7`!-`%'5
M/$G]G7X@>!"@8!CYOS$'N`/Y'%5+S7;B2YLY8XWBLVF<!PW^L"]<CMR.*UIM
M"L9[AYW63<[B0@2,%W#OC/6HO^$?TY[D2%9&:-BPC\P[5+=>.W7-`$9\0M#:
M?:+FS,:O%YL0$@)9>.#Z'FHKG7;MD1([0PSB:,,I<$%6/'/O^E%]X?B;29XK
M)I)I#'Y<*R2[E09&0,].E6TT6W,)0S2F;<C-)ORRLOW1]!Z4`5+?Q;:R2#S$
M6.)B0K>8K,,9^\HY'2I+/5+B\UN&-HWAA>U,H1B#N!/!_P#K5(OAJR5U&Z;R
M06(AW_*"1S[]^E36.C1V=TMP+B>5DC\I!(00J]AT]J`$EUM(KIH6MY0JN(]Y
M*@DD@9`)!(YZU-?:I%8S11/%*[R*S#8!P!U)JH_AV![MIS*_S2B;;M7[P.>N
M,XJW=::EU>PW#L<1HZ%!_$&&*`*2^*;`QM(RSI&$+JS)PX'ISG\\4Y/$MI)%
MO6"Z+%@B((\ER1GC!YXJ&+PM%$&V3E<*5C98U5ER<\D?>_&H[7PL]JPFAO%2
MZ#A@ZP`(."/NYQGGK0`DWBA%O8BJL+4HWF*RXD5@V,8S[BK.I>(H[.[%K%!+
M+(LJ))M0D`,,C'J:JR^$EG#-+=;I&5BS[,$N6#9Z].!Q3I/#MY).UR]]$;DR
MQR;_`",#Y`V.-WO^E`#[;Q-`L`-R)'E+.=L41)50V,L.U69/$=A'(%/FD$*V
MY4)4!AD$GM52W\/7EJ6:"_C#RAEES#D,"2>!GJ,FGCPX8X+V&&<!)XXXTW+D
M@+ZX]:`-._U2VTZ-)+EF"R'"[5)R<9IG]LV11W67*I$)20I/RGC^AXJIK273
M3Z=':J#*LA(=ERJD*>OY^M53X>O(8/+MYX&\V$Q3>8I'5B25Q_O']*`-%_$&
MFI(\;7'SH<,/+;@^G3K4L6KV4XB,4ZL)=VP@'G;UK-FT&=K&[A#0NUQ<^=A]
MV,?4<@\=14,'A_4+:.V*7$$DD1E^5RVU5<8P#U./>@#5EU[38O+WW2#S%W#@
M]/4\<=>].?6K".Y-N]R@E'53GTS6!<^&-1E@6)9H"HA2/[[+R.N<#G\:O2Z%
M<REV+Q`O=1S<$\*HQCZT`7(->M)M,FOP<10DAAU(YP/SI8=?T^2*W9[B.-IQ
ME48\CG'\ZAATJZ&@W.GR-&)'WA'#$@[B3D\<=?>JRZ1J'V:6W\JT"SQ)$S%R
M2FT8R..>,'ZT`:>JZM#I20R3JQ21]A*_P^]1W.MP6_V@^6\@@\O.S'._IC)H
MU/3WNVL!L61(9@TFXXXVD=/QK'?PY=+!>6XQ)#--"$PP!$:^O3H/\\4`:TFO
M0V_V@7=O-`\$7FE6"MN7..,$]ZDLM6^U7`@DMI8)&3S$W8(9?7(_E6>NB3VK
MWT-FD9AN(PRO-AB&!Y1LY)4C\J71--N+?46N!:FQ@V8:$2[U=CW`[`4`7+C6
MUMKH0265T-T@C1]HVL?SZ4Z+6H9+U;?RI5#NR)(5&UF7J.OU_*G/!/+K0ED3
M_1X8OW1R/OGJ?7I6-;:;>VUXLXL0US`9'>X\P8N,@X`';G'7IB@#8N]:MK.9
MXY%E;RPID94R$!Z9I&URU6]-L5EX<1M)L.Q6(X!-96I_VK>3Q))I+O;)L<JD
MZC<_H3W`],5)]EOOMEQ:FR_T>:Z6?SMPP%!!(]<Y&*`-.UUBUN[D01"7YMVQ
MV0A7QUP>]7FD1#AF52?4XKFM(T^]34XO.BGAAMFD(1F!C^;IL/7OWZ57\0V5
MY+>7?DV!E$J*(W5`Y.`,\D_+^`H`ZW>,X!&?2H&O8XYXH9"!),Q5`.>G//IQ
M7-RZ9.3).+1_M!NXBKXY"!0#^'K4FE63QZM;%M.DADA,GG7#=)"<X.>_6@#H
MQ=PFY:W+XD50Q!XX/2I=P]?PKGM7L!=7.H3&W,DB6Z+"=I/S9)XK)%E=2:J2
M;:56^U@NQC9F"$@??)Z$'H!0!V^:4'(KC4TW4GBN8MTO^@(T=N6R#)DYR,?[
M/'XU?\.).+FX8%_(*#K$8UW>P))SZT`=$SA023P!DU#]L@^RK<^:@A8`AR<#
M!KF#',;D`+/_`&@)7,[8;RS'@_ACIBL^6VC?1\62W6Y+4&X!+XW!EQQ]-WX4
M`=ZK!E#`Y!&<U';W,5RA>%PZABN1ZCK7&BX_TM3:W$^!-&J*S2$[.,GTP??-
M,M$N9X[J6:ZN08[>2:-5D9<-O;''?I0!W=1M*BR+&S*'?.T$\G'6N-AN;R6Y
MBEENY$O"T96'YOF&!G"CC!R:FT:7[1J]HT\TSW8\XS*Y.$/8`=N*`.OI:Y+7
M;XPW]Z1=RQ2Q*GE)YQ4=`20N,-U[FFVT]S+*9OMLQ9[\P;/,^7803P.W>@#K
MZ*P="N;F]NG:8R*EJ@A(+<.XZM]>/UK>H`****`"BBB@`HHHH`****`"BBB@
M`HHHH`J3D_VC:CC&U_Z5;JI-C^T;;D9VO@8^E6Z`"BBB@`HHHH`*S_$'_(O:
MG_UZ2_\`H!K0K/\`$'_(O:G_`->DO_H!H`T****`"BBB@`HHHH`****`"BBB
M@`HHHH`*@O%9[*=$&YFC8`>IQ4]%`'-7^F2F&-8[8R![<1[5"@(W<G/3ZCTJ
M&XLI8+NV22#=(UVC"Y9P`1@#;[]#V_G75TQXT=E+*"5.5)'0T`<F;2[?3/LK
M64P:"W>(.<?,Q8=/;%276E-]E\W[*^?M):0*NYF3MQW&>U=52T`<8;*=+-!=
M6=S*C12"&->3&Y)()QTXQ]*U+N&4>'+.(1RDCR@ZJ#D#'.0.3]*WZ*`.%7Y)
MX(KN&]909B(U5@0#C;P.WXU-<17!N!#)]H>\6VC$00M@/GJV..GK[UU[01-.
MLY0&5055NX!ZBD6VB6X>X6,"5P`S=R!0!S,\`W2W%S]J$;7;),49\[`/EP!V
MSZ4CM>06:-$)F6XWP0AL[PA(VD^_7K[5UE+0!Q=W)/!>;?-N,QRI'RSDE!@$
MD`;<&M"V>6+P=&R>8K`'<4'S!=YR1^%=)10!R,ZBY,?E75Q+;)=QK&[.>21\
MW..W'TR:M>)HD+!VF=#]G<*H8`$Y7C'XG\JZ/&*:\:.?G56XQR,T`<HEY>VM
MM<QQSN\<:089R!Y>X9.#CW]*TM'N[B2PNVFG63RB=D@RV.,]<`-CVK8,2D$%
M%P1@\=12K&J*%10J^@&!0!P[7]W<K]GN;W<DOEOO5U8+\Z\DX&WKT/I5]=7O
M8PLPN1-)]H,7V;"_<Q][@9]#FNE^RP;67R8]K')&T8-.6WA63>L2!\8W!1G%
M`'(7]]+<Z6!)J"S/<(K&W$:C:=Z_Q#.W\:MI-=7C6327/E7'FRA@8U/E;5/`
M'/IUK?%A:X8?9H<,<D>6.><^GK3_`+)!YIE\B/S#U?:,GC'\J`.9BUR]ELC)
M]HCA:*W,I9D&)F!(QSTZ=JCM]3N9=5,<+QVWVO8\CNN=I$8.,'ZUTKZ992)'
M'):0LD7W%*#"_3THGTVSN`RRVT3!F#MD=6`P#^7%`'*V.K7\-K#;6L8?"/*S
MA`0Q\QO5A@?XU<M-2OI8KVZA2VC9`C-&5'S,5'5MWY>M;,NB:=-%'%)9Q%(\
M[5`P!GGM4ITRT,<T?V=-LV/,']['2@"KH>H37T<OVC"O')M`\LQMC&>5/3\Z
MUJHV^D65LL0A@"^4Q=>3PQ[U=`Q0`M%%%`!1110`4444`%%%%`"4M%%`!111
M0`4444`%%%%`!1110`E%+10`E&*6B@!,48I:*`$Q1BEHH`3%&*6B@!,48I:*
M`$Q1BEHH`3`I-HIU%`#=HHVBG44`-V+G.!GUHV+G.!GUIU%`#2B-]Y0?J*;Y
M28X`'T'ZU)10!7L[.*RA,<6X@L68L<EB>I-6***`"BBB@`HHHH`****`"BBB
M@`HHHH`****`*TBYOX#QPC]_]VK-59(RVHP/D@)&_'KDK5J@`HHHH`****`"
ML_Q!_P`B]J?_`%Z2_P#H!K0K/\0?\B]J?_7I+_Z`:`-"BBB@`HHHH`****`"
MBBB@`HHHH`****`"F3.8X7<(7*J2%7J?84^H+N.62W=8)/+E(^5L9YH`@TZ_
M:\::.2+RI(2NX!MPY&>O]*34;Z>R&]+7SH\@%A(%.2<8Q^5065O=0323_9X8
M_-9%:)&X`&<M]:L:I;R7-H(X0"WF(QR<8`8$_P`J`(8]81;K[->(+63;N!>0
M$'D@`?EFKPNH#-Y(FC\WKLW#=^596HZ;-<W5W(D:,)+8(A8C[V35.+1KD7D3
M/#PLPD,WGG&.OW?7M0!T4L\<)422*F\X7<<9/I2^='C.]<9QG/>LC4;6Y%_)
M-%9Q7BRQ!`)",1D$]CVYJI+I]\6EB2T^1KMI@_F*`05QTH`WQ=0'&)HSDX&'
M')J4,#T(-8#:/N:("UC7%D4W%1\LG&/QK*&C7H7*6TV=JAP^Q0QW*<<=?7)H
M`["6YCA>)6/,K[%QZXS_`$J45@R6`BO8V6R_<QW6X"-1P#&!G'INJ75K1[F>
M<B%GQ:L$(Y^?/&/>@#:HKF+U+LHL*6T[.TT4FX+D`!5!Y]<@TEGISBS@:6"3
M=Y<QD#9ZY^7([\=*`.BCN$DN98!G?$%+<>N<?RJ:N/MXYQ$PFMKMKN2.,12!
M6&UAZGMVZU8B@NQJ2[GNO,6X.XB([63/&6S@C';%`'45%//';PM+*X5$&236
M;9P2)H),(=;F2'.22&W8]ZRKJ-I[:86\=T8OLR!U=6P9-P]>^,YQ0!T]M<1W
M5ND\)W1N,J2,<5+6/K9>"U@$2MY8;##<X&`#C.T$UB6%Y<PRR2W,MV8V@D2-
M2KD;@W&.^<>M`'637<$+A)9D1CC`9@#R<#]:GKB#;^==Q^?YZR,+7+%VRP/W
MB/Q_*KN^6.46]Q<W4=JMU*ID#-D#:"HW=<=:`.H9@JEF(``R2>U)'(DJ!XV#
M(PR&!R"*Y:`W%U;@R7%UMCM9)(R6*F3#$*6'<XJMISR3R08U*=%2)&D1IP-S
M@<(H].F30!VE,$J&1D#J77JN>17$P7NLHKRK<^;(\+L8S)O*D=/D"_+S^?-:
MOAXAM7NV%PUP3#&2[$'DCIQ0!TA.!GI2*P90P.0>A%<=%JMXM^?M-RSPL\B&
M-`#P,\%3@K]:3[9<Z?;Q1_;I3'+9I(#L5O+)90`HXXQZF@#M**XV'4K^3=;+
M?,'^U1QJ^$9@K`YZ`CM2PZIJ_P!O<F:,VZ.R?O7C4<`\D#YLYYH`[&BN9\/:
MG>W-\\%[,')B+@!5P<$#(9>,=>M1'7+AM9"+.&@^U"#8(P%VDXY8\Y^G%`'5
MT5Q\>O7T<8G>5)4E24JOEXV["0#D5I:6T[:W.L]TMPPMU.47:HR3T&?UH`WJ
M*Y.?[<=6BC%XK2-=,%#`A5P@/0'GCH/4>](WB/4-J(T$:.59BZ(T@."1T'3D
M=S0!UM%8TNJS#1+6\BC0S3E%VN"!D]:H3^([B(O;NENEQ&[*[8=EXQC``SS0
M!U%%8NFZI=7]PBK#$L?E)(Y).1N!X`_"B\UI[2[GMC$C2[HUMUR?WF[U^G-`
M&U17+3^(9Y#-`$BC#"50R2$LF%)!X&.W8U-!K%Q#IN\1+,8H86+LYRQ;UH`Z
M.BN;L_$YNM3%L+=1"TAC5@Q+?4C'2M+7)S!H]Q,A<%0,%&VGD@=>U`&E16#H
MC7D^H7\US(WE(YC1!+E01CM@?G5=/%),K*UH@Q')(`LX+#:,X88XH`Z:BN>7
MQ(RSK%/9^4S-'DF3(57Z$G'';\ZU;"[^VPM*%"IO94.<[@#@&@"Y16/>:T\%
MW/'%:--%;!6FD#XV@C/`[TVQN;A]0U&>XE86T#81,J5QC.>!G..?QH`VJ*YV
M'Q/$RN[P$+L+QB.179@#T*CD'FG1>(]X=&M")PZHD:2JVXMGOV/!XH`Z"BN?
MDUVX^TH$LI_E63S864*1M*_,&Z$8/:M%]4A33([[9(R2!2B*,LQ/0`>M`%^B
MN>FUYAJ4$8CEA1?,,T4D?S$*N01CK3SXLL$1S)'<(RJK!"@)8'IC!Q0!O45A
MGQ38_NQY5T7?)V>7R`#@GK_+-:-UJ$%I9K<R;RC8VJJY8D]!CUH`MT5D_P#"
M0V6R,[+C?([((_*.X,,9!'XBI[_5K;3PAG$N7!8!$+$`=2:`+]%99U^P\Y(P
MTC;MN7"$JN[H">W6H3X@MY+N.&'=CS3'(SHP48!Z'IGB@#:HK*B\0:=)#)(L
MS!(UWEF0C(SC(R.?PJW8W\%_$TENQ(5MIR,$&@"U16-JNM?V?=/$41L1*ZC+
M9)+$<X!XX-69M6MK.WA>]<1O*N55`S$_08SW%`&A166_B+2D"%KH#>`P^5NA
M[]/8U,-7L60NLX($@B.`?O'H*`+U%1RS1P1-+*P1%&2QZ"LRZU^SCMEEMY$G
M+2>6%W;>?RH`UZ*:N2H+``XYP:=0`4444`%%%%`!1110`4444`%%%%`$#`?:
MT/\`%L;\LBIZ@;/VV/T$;=_=:GH`****`"BD!!&12T`%9_B#_D7M3_Z])?\`
MT`UH5G^(/^1>U/\`Z])?_0#0!H4444`%%%%`!1110`4444`%%%%`!1110`57
MOKM+*U>XE!*H.@ZFK%4]0:,PF%WD4R@A3&I8^O0`T`9DFNRGR'AM)SEV5H=H
M);"Y!4YQCWJ:?7X(1&PM[AT*JSNJ\1@],Y_I5>RLH[6=9S-<-("S,%M'53D8
MX&.*BN=,6;`%S*$,80[K-F;([@D<#V%`%^?7;>%Y5:*?$9V!MG#O_='O0^O6
MJQ1NJS,7!)54RR`'!)],&J=Q9VL\#QF=O,-P9U+VS%03Q@C'(J"YLHGM88TN
MX!M!#@VF!R>JX'RD4`:^IZBVGPVK+&9_-D"'`Y/'8#O22:W:1PQRGS3Y@)V+
M&2R@'!R.V#UJIJ<D=S!;"UO8XY;=PZM*I.[`.*S[K3[>4+*M_:&X;<)BXRN6
M.<@=L=*`-;^W8UO98Y%984"[6VL2Y/0`8J=M9L56!C*2+@E4^4GD'!SQQBLB
M6WACNS+;W]J)5\LP!CQ\J[2#CBI([.#S%>?4+4LXE:9DD"X+@#CGMB@#8M=2
ML[R1HK>4.RC)&",C.,C/7FL]_$4"7C0LA15F$9=L\C!YZ>O&*KZ1;PV%WYDU
MY9;(T*(4F))YZG)P/PIC1QG6/M"WEDT#3B4DS#(`!&,4`;#ZQIR(CO=Q`."5
MYZXZU9EN8(8//EE1(CT=C@<UR<MH?,,BW-JP<2(5^TA,`L2#QC(YZ5IWB1'3
M[.*WN[.1[4AMCR#:^!C'4T`69-=LX[J*/SHO(D0MYV_Y00<8JVVHV4<J1/=0
MK(^"JEADYZ5@K$T]Q)--]BC+P2KL1UPI/0'GD^]4I].NFMFB00,VQ`K"=0O`
M&<CJ3QW-`'6I?V;W'D)=0M-DC8'&<CJ*:FH6,CE4NX&9020'&0!U-84=KB+<
MPCCD^UO*\BNI(0@X_GTK-B1M2=H;:&&+99["Z.,.<CKTP3[^M`'9Q7=M,@DB
MGC="P4,K`C/I4^*YK1[5[:XFEDMB%=D`5YD8@C.7XXX_.NC#J>`P./>@!V!G
M.*,49%&:`#`Y]Z38N0=HR.GM2YHH`0(H8L%`8]3ZT!5#$@#)ZGUI<T9H`9Y$
M6YF\M-S##'')'O36M;=P0T$9!7805'W?3Z5+FC-`$$=E:Q`".WB0`@@*@&".
MG\S1]AM/M7VK[-%Y_P#STVC=^=3YHS0!!;V5K;22206\<;R'+E5P2:C.E6!N
M3<&TB,Q.[?MYSZ_6K>:*`*B:58QLA2UC!0,%XZ!OO?GFEL]-L[`DVEND1/!*
MU:HH`I'2;$WWVTP`W&=V_)ZXQTSCI4<^AV%Q&D<D&0A)'S'/)R1GTR>E:5%`
M&;J.E)=V$5G$%CBC=3MQ@;1V&.E1GP]IQABB$)58V+95R"Q.,Y/4YP/RK6HH
M`HV6EVUC,9+=67*"/!8D`#I3KC3K:XO8+N1,RPYVGZU<HH`QAX=M`Y827&T%
MBD?F?*F00<#\339?#=M+Y69KE5C1$VJX`;:>"1CK6W10!E0Z';PWAN%:;&\R
M+$7^16/4@?G3QIC3:.UC>3-*SYW.#SUR.M:5%`%.VT^*WCN(P6=)W+L&]P!C
M]*S$\+0JV?MMT5"/&JY&%5AC'2M^B@#!U+2'\J=K=&N'GB6`HS!0@'\73UQ5
MNVL;BU:Q2.7%O!$4D0?QM@8./KFM.B@#)O=$6ZNI)EN)8EF4+-&O20#U_E5N
M&Q2'[2-Q9;AMS`@<<`8'Y5;HH`P!X93R7A:\F:(ILC7`&P<=<?>Z=Z2+PRL:
MDK>2"0%&C<1J/+*YZ`<="1BN@HH`R(-%9',DUY+-(T;HQ<<?-CD#MTZ5(^E9
MTF"R6<J\`79*%&05Z'%:=%`&#)H-S<2^;<:G*[[77*IMVY`'&#QT_'-0Q>&&
MCD>07,6XJHP+8!3M/0C/(/?FNDHH`YT>&F2%8TGA*@NQC>#*`L?X1G(Q]:TK
MK3VFLH8DF*RP,C)(PSROJ*T**`,2'1)1>Q7D]PC3"5I7VH0#D``#GCI4NL:2
M^HM&5>/"`C;(F1D]P1@@_C6M10!S0\,,+A7>6.?+*S32J3(I&,XYQSCO5DZ$
M3:QP&5<+.\I(4]&##`_.MRB@#EH/#,T<3(3;96/8I*NX?D'+!CQTQQ6C807]
ME+'')MDCE8[@K,PB`7L6YZUL44`8][ID]QJ,LZF,(T2(,]3APQS2ZU9W]S)`
M]E+M"9#H7*9SC'(YXK7HH`YJ/0+E8I5=HB7M/)&"<;MS'///>EL=-9-:0AF,
M<,:M*`"%\T+MXSUXKHZ`,4`9LT=QJ.C%7B$,[\A&Z<-D`_7'ZU333KR>5KF:
M)(GDN(G,6[(4(,9SWS6_10`E+110`4444`%%%%`!1110`4444`%%%%`$#*?M
MB-@8",,_B/\`"IZA/_'V.G"'MSU%34`%%%%`#(FW1JV,9&<4^HK<8@C!_NCO
MFI:`"L_Q!_R+VI_]>DO_`*`:T*S_`!!_R+VI_P#7I+_Z`:`-"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"JLZYO;8^F[^56JKR'_3(1G^%OZ4`3DA1DD`5#]K
MM_(,WGQ^4#@ON&,_6I)-H0E\;<<YZ8KEK66!M.MI&=?(BORTA[+DG&?09(H`
MZ-KVUCC25[B)4D^ZQ<`-^/>IG>.-2[LJJ.K$X`KDXIHT>=[L*ME)#+]F#G`.
M6Y`]R,?F*LWLX;2].BDD4M#-"MRI/W>,_-_]>@#H6GA559I8PK<*2PP?I2F6
M(2",R('/12PR?PKD+;RU6?[7L^Q&*<VH;'=NW]*9:^:+9VNAC4/-A$6\C>1Q
MTSVQF@#LWDCCQO=5W'C)QDT%T#!&90S=`3R:Y[4IK6[NI9&DBE@6S=HR2"`V
M><>_2J=H9)(WFN,F_C>W6+?C<!QG'ZYH`ZT,C$J"I(ZC-+A0,8``[5S6B[?M
M-K*I_?RM,9L'G&>`WT.*=J-_/)<WMM(R_9O+=47;D,0F2,^H]*`.A$<><A%^
MN*0P0DY,49/KM%<U;:A>6U@L/F0*VV(1$@G`8'C'<\>U3VVJZC<QI(&MD7R#
M,^4)X#$<8/?&:`-S[):D8^SP\#'W!37L+.3[]K`WUC!K#36M0>+?Y4060+(C
M`;B%[_*#EL>M7QJ4HT6&Y/E--*0@*GY-Q.,_2@"V-,T\<BRM_P#OV*5]/LG&
M'M(&`]8Q68-3OS.EELMA=DOEBQ*X'(X'(S41URZ=&F@MX?*CA29MY.3DX(''
MJ#S0!J'2--./]"@XZ80"F_V+IF3BSBR?053CU6_/F1&VA::.<1<.0O(R.W;O
M3+;7Y&B\ZYMT2/$@RKY.Y,9_`YH`O?V'IG'^AQ<>U`T33@`!:H`.F":IRZU>
M6Y\J>P7SV570++P06"^G4$BKUC>RW$%PTL`22%V0JK;@<#/!Q[T`']CV&0?L
MXR.A#'BG?V7:_P!Q_P#OZW^-8\>OW5R8A#%$"9D5QO/`(/RG*\'BK`\1!"LL
MUL4M9-PCEWYRR@Y&/P.*`+_]EVF>%E&/29_\::=)MCT:X&/2X?\`QK(U'5KI
MHK>26.2P3ST)?=E60@GG`ZC'(K?LKAKJ`2M"T0;E0Q!)'8\4`5VTFW(_UMT/
MI<O_`(TC:6AZ7=XO':X;FLG6[N^M]9C0W@M+5U/ER$#;N`Z-D>M2+J-V%>Z,
MN]%O?LXBP`&7.,YQG.3F@#0_LD=K^_'/_/<F@Z43D_VC??\`?T?X5!J-U<G4
M)+:VG6$1VK3$[0<D'`!SVJA!KES<QS7V[9;P21(8L#YMV-V>_?C%`&M_93GI
MJ=^/^!K_`/$TG]DS#&-4O>/]I3G_`,=I;.:X.LW<$LP>((KQJ$QM!S^9I+[7
M;:PN'BFCG^0`NZQDJJGN3Z4`._LVXV[?[3N_7/R9S^5-_LV[!&-6N\#L50_^
MRTUO$-B)VB!D8JI;*H2"!UQW_'&*DAUJVGL9;R-)C%$,DF,C</4>M`#4LM05
MBHU*0H.C-&I)]1TJ0VE^3_R%&'.<>2OY5$-?L]H9Q,FY0RAHS\P/3'N?2H+G
M6<7.GR6S[[68N)`(R6^4=AU_2@"ZT&I;?EOHR?>#C^=!@U$D'[;$,'H(.#_X
M]34UJQ<,5D?"QB3)C894].W-2)JMD]F;L3J(%.&<Y&#Z$'F@!PCOP/\`CXMS
M]8#_`/%T;+__`)^+8_\`;!A_[/42:WITEN\Z72-$A`8C/!/3BF_V_I>$)O(O
MW@RHYR><=*`)MFH8_P!?;9_ZXM_\70RZA_!+;'ZQ,/\`V:ENM1M;5TCGF5))
M#A%)Y;G'%4])UF.Z:>"XGMQ<Q2.-B-_"O?F@"SMU/!Q+:DXX_=-C_P!"I&&J
M<[9+0\<9C;K_`-]4?VUINS?]M@`SCEP.:DBU.RFD2.*[A=W&54."2.O2@",C
M5?X6LS]58?UIN=7`^[9$Y]7'%:-%`%`MJN.([//^^W^%&[5./W=I[_.W^%7Z
M*`*`?5,G,-H1V_>M_P#$TOF:G_S[VO\`W^;_`.)J]10!G&75@1BTM"/^N[?_
M`!-)Y^K=K&V/_;P?_B:TJ*`,_P`_5><V-O[8N#_\32+/JN/FL;?\+@__`!-:
M-%`&>;C4PV!81$>OVC'_`++2BYU';EM/3=Z"XS_2K]%`%);F\P-]@>?[LJG'
M\J<;FYQ_QXR_]]I_C5NB@"D;NY'_`##IS_P-/_BJ:;ZX&<Z=<\8Z%#U_X%5^
MB@"D;V;'-A=`_P#`/_BJ8=1E`S_9UX?^`K_\56A10!0&I,2?]`O1C_IF/\:0
MZF1G-E>\?],O_KUH4E`%#^U%_P"?2\_[\-2'5HP<?9;S\+=JT**`,[^UX_\`
MGUO!_P!N[4?VO#W@NQ_V[O\`X5HT8H`SO[8@P<PW8Q_T[/\`X4AUNV7K%=_^
M`S_X5I8HH`H#6+4GI..,Y\A_\*/[8M/64?6!_P#"K_XT8H`HKJUFP_UC#C/,
M;#^E3VUY!=;A!('VXSP1C-3XJM'_`,A&?IGRX^WNU`%JBBB@`HHHH`****`"
MBBB@"'_EZZ<[.OXU-5<'_3FY'^K'?W-6*`"BBB@"&V(-O&5Y&T8XJ:HH"K0H
M58LI48)[U+0`5G^(/^1>U/\`Z])?_0#6A6?X@_Y%[4_^O27_`-`-`&A1110`
M4444`%%%%`!1110`4444`%%%%`!4$A_TR(8_A;^E3U7D/^G1#L8W_FM`$Y&>
MM5[R:WM+9I)D_=CJ%3=^@^E3LVT$\GZ52UERNEW`"NS.A10B%B2?:@!+V\LK
M<1BX0-QO"A-VP?WO;K23BRL4GN)@66Y90P(W[ST``K,O)`DT\_ER%;JT\J'$
M;9+8/RXQQVZTD[HPT_S`[1V+A;@!2=K;>#[C(ZT`:4^H::(K=Y=C(_S1_N]V
MW'?IQCUI\D]@U\D;>6UQC"MLR5SVSV^E<]$DEM#<-.CK]JMW6W7:3DL[$#V/
M(HL()[2!K*7<+PW,;CO\J@?-],`T`;7D:7ID45O.$(+%U,B!L'NW`P![\"K,
MDFGG48U<1&[4?*=OS#\>W2L:[NX9KJYN%D+17%F8H"!]Y\G*_7.*AA6X47%L
M28[Z6XC=,G)(`'/N!@C-`&]:/I[7<ZVAA\_K)L`S3+C3]-0337$4:A^9')QF
MLS1BC75A'$2TL$,@N/8D]#[YS45W=R"XU!)KL&(QR"-=PV\`<$=01Z]Z`-5=
M%TN15=;96!`(.6Z#IWJ6UTBQM)_.MX!&^,<,0,?3.*P9;^ZMX6MH[\-DQE7W
M*"`5)8`]`*6VOK^Y@,L>HL3';B78$4[B"01^E`&TVB:>491"4RV[*.P.?8YX
M')XJP]C;-9_8_*408QL':N<CU*_>#`NT?S`'S&X+@8.0,J%[=#SP>M:5S=7/
M]A6UU!=A78)N9H_OYP.E`%QM(LC$D8B*["2K*Y#<]>>IS44^B6LS2,SSH'4*
M520A0!T`'I68EW?S7*V?]H!'$[1&18U.X!=P_P`*BAU34KA3NN(5CE23&,;@
M5!Z#GTYS0!JPZ39O*TD-Y.[[]S%9\_-C&3[T^+0K:+:-\SH-WR.P(^;KVK#A
MFDTQ]EL\'G+!&[EU5/,SV)&.`/3N:LF_U@Q-(MQ;\W9ME4Q=#G&<YH`TCH5L
MRX,ER6^4!C+R`O(`]L\U/;Z?%`)U\V1_M&2VXC.<=1@5D)K%_#-)YYA:*VD\
MN8\+NX^\,G.?;%.TR26YUJVNYO))FM6<>6N,#(X)SS0!:/AVW*_-<W)?<K>9
MO`8;00.0/?KUIZ:!9J=I:5XAN*Q.V54MU/2JEWJU_%=74(\B-45S&6'+`#.0
M<\GMCM1'J>HK:&11#(+:!))MX(9\C/'/IW]:`'MX:C)C)O;D^4007(;@=!T^
MOYU8M=/N[::V2*\=[:($,KX&1C@8`[>N:J2ZI<7,4[B.$61$D>6?:^54_GD]
MA4_ANYN)["+*Q"W2,(N"=Q(`!S^M`!J&A&^O-\EW(+=L[XOJ`,`]@<4^/18X
MIB5G?[/YIG$)4$!\<'/7CKBH/%D=V]@)+67"QY,D8;!;T/X'M50W$ES(4CGG
M$$5DTZG<5;?N.,]^.F#0!I3:-)($87L@E,9AEE*@ET)SCV/O1_8B)=9BDVVS
MLCR0E<Y9?ND'L.!D>U1W]W<?V;II$AC>YEB21AP<$<_2LVWU"ZGU633&N)5B
MBDF_?%L$@#@$^V:`-R"QGCU6:\>Y5TD79Y?EXP!TYS_2LZ_L[O4-8N($\R"V
MDA5))&3(8`G[ISP:6RO+FX.D2M/(/-9DD7@*^U3STSS6CJ6H2V4MM%#:F=YV
M*J-X4`@9[T`9I\.W2W+217R!<.%#Q;F"L,8SD=/TK8L;5K:PAMI663RT"9"X
M!`XZ?2L?_A+$S&#9N,D!PS@$98KP/XNE:.GZI)?7$\7V.2)824+LP(W#'''U
MH`I?V!+%ITUM;3(K23^9E@2"@/"GVIL.CZA'):[GM=D,DC':I'#YS@?C4ZZ[
M("5EL75UE:-D60,0`,EOIBJMUK7V_3)Y+1YK9X0C[AL.03C'?^E`$/\`PCFH
MO$J27%J1'&J("A.=I)`.>Q[U=FMI;+P_>+<>5YLJMA8(\*"1@`8&?Q-3G788
M_P#612J@G,#.=I`8#V-2V.KV^H%Q`K@HH;Y@.0?3!H`R#HEU<Q_;%-L9R(_+
MCD!:,JHQ\W`.3].*L6&C7=M?P3RK:;$5@RQ#8!N]!CG&.YJ9/$UC\NY)XT(8
MAWCPIVYR`?7BC_A)K':3MF^4`D!,]>G2@`U+3;NZU2&XB\L+%MVOO(9?FRP(
MP001^M9_]CZHJ@PQVRR>9,^6?=]_M]WMS6Z^I11V<=S(DJK(P54*?-D^U9DO
MB**"^0R;_LDD"2*PB.5);;\WH./UH`IVNA7]O/O^SPNGG1R8>X+'Y5((R5]Z
MM6^A2Q:LUP8XF7SS,LI=MR@_P[>GXU</B&R#3C$Q6#=N81$J=N,X/?K4?_"4
M:=M#;I<'OY9X']X^W/6@#:HIJ.'0,IRI&01WIU`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`55B<-J%R`Q)
M5$!'IU/]:LU2M2IU*]P1G*`_]\T`7J***`&L2`3@G'8=Z4=***`%HHHH`***
M*`*Z_P#'](>>$4?J?\*L573_`(_I>.L:<^O+58H`****`(K8$6T8;((49S4M
M)2T`%9_B#_D7M3_Z])?_`$`UH5G^(/\`D7M3_P"O27_T`T`:%%%%`!1110`4
M444`%%%%`!1110`444W<-VWOUH`=52XD$5Y$[!BH1@2JDX.5]*MTA&:`*W]H
M6W]Y^F?]4W^%'V^V!Y9A]8V_PJSBC%`%8ZA:#K,H^H-0)J.FPM(PN(DRV7/3
M)/K6AC--**005!SUR*`*G]L:;D@WD*GG[S8Z?6C^U=.?Y?MMOSV,@%7"BGJ`
M?J*:T,;_`'D4_44`58+O38(5BBNK=44<#S!4OVVSW8^TP9_WQ4AMH2"#$ASP
M<J*3[+;YSY$>?]P4``N+8$XEBR>OS"D/V5B2?*)/7IS2&QM#G-M"<]<H#FD.
MGV1ZVD'_`'['^%`#O+MO[D7;L.U"Q6XDWJD0?LP`S3/[.LLY^R0?]^Q_A2'3
M+`G)LK?/_7)?\*`'M;VSH5,,3*3N(*C&?6J^IV1OK<6Z3+$@(RNP-G&"!C\*
MD.E:>3G[%;],?ZL4G]DZ?G/V.'/L@H`5+"U"1[[>%GC'!$8&._'IS3S96S"3
M=;Q'S?OY0?-]:8=*L3UM8_RJ,Z)IQ.?LJY^I_P`:`)1I]F-F+2$;#E?D''TI
MO]EV&,"RA'S;N$'7UI%T>Q5LB#!_WV_QI#H]D1CRW`QCB5Q_6@";[%;&Y-S]
MGB\[&-^T9_.F0:;96\WG0VD4<G/S*H!IBZ/9H,*)E^EPX_K2_P!DVOK<?^!$
MG^-`#CIUF7E<V\>Z4$.2.N>M1'1=/)C(MD_=C`&3C&<\COSZU(NF0+TDN?\`
MP(?_`!I3IT1'^NN1_P!MW_QH`AFT33YY)))8!OE^\P8J3^1JI+X:M%BV66Z!
MF*[F,KMP#V&>M:!TV,]+B['TN&_QH&G*N<75UR,<S$T`-U'2K;4D47`<%1@,
MC;3US_2FRZ-8RK"&B($2[%PY&5ZX.#R,^M2FPZXN[H9_Z:=/TH^POG_C]NO^
M^E_PH`8^EVS";<K_`+TACAS\I'0KZ?A4<FCV;VL<&'01Y(='(?GK\W7GO4_V
M)\?\?UT/Q3_XF@V4N"!?W0_[X_\`B:`(VTR!I8'5Y8_LX`C5'P!^%0:O;7%S
M=V7D+(JHY9I8V4;,C'0_X5;%G,`1_:%R<]RL?_Q-.^S39_X_9_\`OE/_`(F@
M#+E\*6+G,;W$60-P23&X@YR?4UH:=IPL/-VSSS>:VYO-(//KT_SBGFVGP0+Z
M8#']U/\`"D^S7'_/_,?^`)_\30!'-I5O+<7$[;@]Q'Y;$'H/;]/RJ@OAM%AE
MC^W3_O5520%Z+TXQ6F;>Y[7K_C&O^%'D77/^F-[9C6@#+F\,K<.?.O'>)I?-
M:/8H!)&#V[U<L-.>Q#,]W-<[4V1J<#:HZ#`ZGWJP8+OG%Y_Y"%`@O`>;Q3_V
MQ'^-`&#IFBS7^FK#JC2+`I?;;F/8RDYYSGGKQ5F70K^2W2-M3,CJPP7B&W"G
M*\>N>I[UJ>5?9XNX<>\!_P#BJ#%?]KJW_P"_!_\`BJ`&:O8RW]EY,3QJ<C<)
M$W*P]"/UK&G\,77V9[:"\C\IXDCS)&=RA6W<$>Y-;9BU#'%U;Y][<_\`Q5(L
M>IX.ZZM<]L6[?_%T`8TGAN_\ZY:*^@59R^2T&6PV,@G/M5G^QK_,$BWD*2I$
M(7(CR"HZ$`G@\G\ZT`FI<;KJUZ\XMV_^+I=NI8_X^+4?]L&_^*H`MQKL15R3
M@8R>II]4,:F#_K[4_6%A_P"S4C?VJ`2LEF3VRCC^M`&A15$?VD>KV@X[(Q_K
M29U3/_+F1GT:@"_15%#JG.\6?MC=3=^K;>$L\X_O/C^5`&A16;OUC',5CNST
M#OC^5*)-7S\T%GCVD;_"@#1HK,,NL#/^CV9_[:M_A2^?J^/^/.U)QVG/7_OF
M@#2HK/:?4^UE`>1UG[=_X:/M.I!B/L$)';%Q_P#8T`:%%9_VK4?^@>G3M<#_
M``I3=WX./[.S[B=:`+]%4A=W>>=/<>_FI_C1]KNL\:=+CU\Q/\:`+M%4OMER
M`2VGS#Z.A_K3C=7`/_'A.?\`@<?_`,50!;HJG]KGQ_QX7'_?4?\`\50;R4$`
MV%SS[H?_`&:@"Y15)K^1<_Z!='Z!?_BJ9_:3YQ_9UY_WPO\`\50!H450_M)L
MX-A>#_MF/\:3^U0<XL[SCUA-`&A16>=54'!L[SKCB`FE_M-,`FUO!G_I@U`%
M^BJ']J1YYM[L?]L&I1J<1R?)N>/^F#?X4`735"R7&IZ@=I&70Y]?E%*NK6Y.
M/+N<_P#7L_\`A3--<RW=]+MD56D7;O4KP%'8T`:5%%%`!1110`4U00/F.33J
M:&!8C/(H`=1110!6C_Y"$Q_Z9I_-JLU6C!^WSGMM3^M6:`"BBB@`HHHH`*S_
M`!!_R+VI_P#7I+_Z`:T*S_$'_(O:G_UZ2_\`H!H`T****`"BBB@`HHHH`***
M*`"BBB@`HHHH`*@N[J.T@:60GT`'5B>@'N:GJO=V5O>*HN(]X0[E^8C!_"@!
MFF73WEC'/(@1FSE0<XP2/Z55OKK4(KR."WCMW$I.PNQ'09.<4_3+"73H(H$=
M"@+&3.223TQ4\]N\E[;3*P"1;]P/4Y&*`*UMJ\7GO;W1$<PE\M<*VTG`/WL8
M]:LVVI6EU+Y<,A+;=PRA`8>H)'(^E4I],F>56#H`+P3G/]W`&/KQ4.DZ)-97
MRS2M&5B0HI#,2^>Y!X''I0!H-JUDMS]G,V)0X0KM/WCT&<4-J]BD:.TX574L
MI*GH.O:JG]FW#2S.2OSWB3#YOX5Q_A5)M'OV01E8=D44L<95R"V[H3Q0!JIK
MNFRNJ)=J6<[5&".?RHL]7MIYGMW=([A&93'NS]T]?ZU#/83/]H"QQ$.8MF>O
MRD9JD-+OI+=K0PQ0Q%WD$HDRV2#@'CWZT`:ZZOI[1O(+N(HG#'=TJ1[ZU2W6
MX>=%A;&UV.`:YN+1;S:V8`G$:[6F+$X8$D=@..F*VM6MY9!;200+-Y$FXQ$@
M;A@CC/'>@!LNMVPN[>W@99VF/!5Q@#UY_'BKCWUK%,()+B-)3C",P!.>E9%C
MI\XU6&Z>W6-")&*9!\O)&!]>.WO5;5K&]EOYY%M'D7<C(8R@!`QG.>2>/UH`
MZ"6^M8D+O/&`"1]X=1U%5(-<LI70&58U>,.&=@,\D8^O%9;VE[)=+";)O+6Y
MEE\UF7;A@<<5#;Z9</831R6)61+,1+N`.7#,21^=`'4&Z@$RPF9!*PR$W#)_
M"H)-5LT=4\^-BQP=K`[>"<GT'!KGX]/NPCPO9.]Q)*CK<DCY!QGGJ,8/%(;&
M>*TML:<TDB3R.Z;1DCYL9]CF@#IDO;6092YB88W95P>/6G&XA$0E,B[#T;/!
M^E<U'I^RQ4+8S"9Y%>?$2\CGA0>,`XX]JC2PDCC0RV-S-;AI=D)5<JQQAL#@
M9P:`.IM[F.XMEGC)$;#(+#%))=PQM$K,3YS%4(&03C/6L86TW_"(I;M#-YOE
M@&-.''/O5&RTZ5VAAN+9FM1<,Q)1DR-G]WL,\>AH`ZS<OJ/2EW"N*FM+QM.M
MD$$VZ.%@NZ)W.=YQ@#H<8Y/:K,EA=-ITLX2;[7MA4MSNV[%W@#N?7Z4`=7N'
MK2YKAWL;ORC`#="V$V5Q;L(_N\[E!W8_K6Y)YZ^%E41R^;Y87:I;=C./KT_&
M@#<S2%@JDDX`&2:XB&WNV;[.T<XA-U#PGFJ"I#;L9YQ4YCDC86]\UT+!9)53
M`<D8/RY(Y/M0!U:W<#6HNA(/(*[MYX&*6&Z@G9UBD#&,[6`['TK`FA_XHL(P
MD1DBW<%E(.>_>JFGQ[+R>Z@FF*_:XT0[SMD4CDD=#]:`.OR*,BN0T6\OWUE%
MGN,NQ831,[%@`/[N,+VJSKMUY-_/C4)89$@5HHD?[SY/&._&/SH`Z;-&0:XB
M75;P:C'^_=)EG6.1&F7&,X("8Z>YK;T'[1>:*;E[J1IYU8!B00I!(&!0!N9J
M.6YAA>-))%1I3M0$XW'T%<D-7U!["XF>9XS;A8#M5?GDW'/L.,<U7M=3NKS4
MK:.XDW"*X4J=Z,PRISRO!YH`[G-%<A/KMTMFDD%R'=+5&?;MX<L`<Y[XK5T+
M4Y+DW"W,G"NJQ[RFXY'3Y>#0!KM/$C[&D16"[L%@#CU^E$4T4\8DAD61#T93
MD'\:Y7Q.<ZA+&2JAK0'<%&X_O`,9/:M74YCIEG;0VSB-F8*%2++,,<[0.,_I
M0!L9HS7(P:YJ-TR11MY;*9@=RJ6;:H(X'&><<5*FLZDR6R$*)+R-#$Q7@-G#
M?I@_C0!U5)FH+^X^R64UP%+&-"V!WP*YNZU#4FMG@FEB;[19M<*\:8V`?P]?
M0]:`.K!S2U@7$\^E:180V>TR2$+G9N[9)QGG\ZJ-KU^RI$IC692_F8A9WXZ?
M(.@]R:`.IHSFN;@U?4;QG>)K:%((T>19>-V>O/84NGW=[!<VX:2*2UNIY5``
M^9>2<YSS0!TE)61>7M^=0E@LOLZB",2-YP/SY[9SQ]:R4U>ZM_-6V:'+S2N0
MX:0\$8`V]N>M`'745S<OB"[2>US;QQPRI&27)PQ8#.#T&,]ZFTW6;JXU)K>Z
MCBB4E@J8(88/J>&_"@#>HK#O]8N;>6Y>&*-[>T95E!SO)/7';C(JSIEY>7<U
MRTJQ+`DC1H%!W'![]NE`&G17-?\`"321/<&YCB18@Q\LL5<$'`!SUR2.12+X
MAO71T6"(S`H58*P0ACC'.#D$]>E`'2TM<JFO75O<36LBQM=M,1\S'RT``)[9
MQ_\`7J67Q.ZBV*VZ#S$W$2/MR0V"JG&,\'KB@#I*,TU6W*#ZC-<WI=[?W=Y;
M1.S[%5W8[QDX?'/'3H,4`=/16-<ZXUOJ2VK6PVM(L8<R@,<]PO4C_"HH?$$L
MNX_8&"'S`C"0'>R9.,=LXH`WJ*S=/U5-0DQ"AV")79R>%8_PT[4-1DM)(88+
M9KF:7)"*P7`'4Y/UH`O,,\<_A2U@V^J75[JL*Q1NEN8@[K\IYR0<]^",5,^N
M;KR:UBMI&\O<ID&.&Q_=ZX]Z`-BEK`T_Q"7M?])MIA*L(E&T`^8,XR`.GXU)
M_P`)"JPLSV<ZRK(L?E94DEAD<Y]J`-NBL-/$ML9<-%(L1SMEX()&<C'7L>:M
MZ5J@U)&=;>6)1R"XX8>Q_"@#1HK&;7OFD5;*ZX#;&V##D9Z#-4=,\22L-]\A
M,;1"0.L>`#NP`,$YS0!T]%9BZW:F,';+YI(7R?+.\$C(&*T5.Y0<$9'0]:`'
M4444`%%%%`!1110`4444`58<?;K@CT3/'UJU56#_`(_;G'JO\JM4`%%%%`!1
M110`5G^(/^1>U/\`Z])?_0#6A6?X@_Y%[4_^O27_`-`-`&A1110`4444`%%%
M%`!1110`4444`%%%%`!69K=Q<6\5N;8@,\Z(<G&03TZ=ZTZS-3$5W(MJ3.LD
M964/",E>N/ZT`4X-8EMD8W<)\C$KI('W,VUNF/Q%6]*U5=0,R%51X\$A7##!
M]ZC:PMGABBE%S(J(Z8,9^;=U)XZU-801V8?]Y=3%L?-(A.`.@Z4`4;S6)Y=-
MGFMK>2-&C8PS@@Y*G'([9J9=<(@.ZSF\]'$;H2H`)&<EN@%1-I$)@E@6XO5A
M8$(FQML8)R<#'/XTRZT2"ZDED,]TK/*)!F`D+@8Q@CF@"1/$D<D8:.TF?$;R
M.`1\H4X//?IVJ9M?ASNC@FDB!16D7&%+=!U]Q52WT>&TBE7[1<MYD+PC-N3M
M#')/`JA)8W37?D1"YCM"T;.PA;:^W'."N<G';B@#:B\06TTRHD4N)"RQOQAV
M&>`,Y[5J02&6%)"C1EAG:_4>QKG+71X;>X,R7$PV!O*!M""A/3)QDX]ZVX;M
M(XD6621W"\MY+#=[XQQ0!<HJD-4LS@"?)/3"'G]*/[4LQUF_-3_A0!:`;?VV
MX_'-/K/DUBR$;,ES&S`<#.,GTS3O[7L,`F\A&1G!:@"]15#^V-.'6^@_[[%'
M]L:<3C[=;_\`?8H`OT54_M.Q/_+[;_\`?P4@U2P_Y_;?_OZ*`+E%5EU"R<@+
M>6[$G`Q(.OYTG]HV7_/Y;_\`?U?\:`+5%5O[0LL9^V6^.O\`K5_QIXN[9AD7
M$1'LXH`FHJ(7$+=)HSCT84Y9HV!*R(0.I#"@!]%)D>HHR/44`+129HH`#2%0
M>PI:*`&B-0Y<*-QZG'-0BSB%V]T!^\=0I)YZ9Z?G5BB@!AA0L6,:$GN12JBH
MNU0%7T`Q3LT9'K0!&8(RK*8T*O\`>&.#]::MI;JP98(@5.00HR*FS10!"MI;
MJ6*P1#<,-A!R/>F-I]J?)Q"B"%_,0(-H#8QGCZU9HH`ADM+>:3S)88W?&,LH
M)QG./SYI;BU@ND"7$4<JCH'4$?K4M%`%9-/M(_N6L*D9`Q&!UZ]N]1)IB+?1
MS[@(X8]D,(4!4]35ZB@"M:6:VJ2JIW>9(TC$]R:1--LXUD5+6%5D&'`7J/2K
M5%`$$]G;W,2Q30I)&O(5AT^E0MH^GLB(UG"53.T;>F>M7:*`*0TBP!'^B0X4
M8'R]LYJ7[#;?NOW*?NF+IQ]TG.3^M6**`*UQI]K<R!Y[>.1L8RPZCT/K43Z/
MI[L6:TCW'))`QG/7I5ZC-`%'^QM/W*WV6/*@`=<<=,^M/@TRSMY?-BMU5^2#
MR<9ZX';\*MT4`5)M+LYYS-+`KR'&2<\XZ9'>IH;>*`,(D"!V+-CN3UJ6B@"B
MFCV"%B+9#G/WB2!GKC/3\*2/1K&,Y6'G*G)=B?EY'4U?I'+`?*`3Z$T`4)-&
MLY)'EV,DK.7\Q'*L"1@X(]A39=#LY0BXD1%7:420@.,YP1WYK2HH`JV=HUL\
MQ,FY';*)DX0`8`%,L]+M[.17A#95"@RV>"V3^M7:*`,N70K:2_:[,DREV5V1
M7PK,.A/?MZU)'I<5K$GV="QB9Y$4OU9@<Y/XUH9HH`R+'39;>RD$86":682,
M%/W5W?=!'7C/YU:O].%X\4BS202Q9VO&><'J*NT4`4K32X;.998RV5B\K!/7
MG.?KFJ\NA12WWVJ2>5NI"$YP3Z'KCVK5HH`QYO#EM(H"R2)B`0`@Y.T-N!]^
M:9#X<CAV;;ER5F2;[BC)7/H.A!K;HH`P4\+6RW1E$I";F95"*"I/^UC-6=-T
M4:>962<L[KL4[%7`['`')]S6K10!@6OAG[-=>>+PNP#`%HER=P(.3U/6DD\+
M1R(L;7)*"$1$&,'.&W`^W/:N@I:`,&S\-I:W23B9"RNKD)$$7@$``#ZUNCI2
MT4`%%%%`!1110`4444`%%%%`%6W'^FW9Y^\O_H(JU5:W_P"/NZ_WE_\`015F
M@`HHI#TZT`%+34!5`"<D#DGO3J`"L_Q!_P`B]J?_`%Z2_P#H!K0K/\0?\B]J
M?_7I+_Z`:`-"BBB@`HHHH`****`"BBB@`HHHH`****`"JD0']I7+9YV(N/3J
M?ZU;JO%_Q]3G:1]WG/7B@`O)XX("9)1%GA6(SS].](M];?9!<>>ABZ;\\$_X
M^U1:K?16%MYT@!?I&#W;Z]JP98V%IOMH%N+1%;YS+M'FL>6P1S@\"@#HVO[5
M;D6YG02DX"D]_3ZT^XNH+95:>14#'`SW-8DU]:S7MO!.R0R0R"25%&[,G900
M.<9Y/M3]7ELKB-)X]0\JXC4M#LD^\<],=^1B@#4;4+59DA:9!))C:N>N>E.C
MO+>2=H$F0RKG*@\\=:YJ:24&ZBD)%]-<PE4W=.A!'L.:EL9D$NEAY%#P),UQ
MEN4]<GZT`=`]Y;I.L#S1K*W1"W)I%O+9Y6B6>,R+U7=R/6N?N7Q'=H&5KF2]
M1XAORQ4X*D>V,_K52[8/H]JD6#.%F,P&=RY!W?3F@#KH)X;@$PR)(`<':P.*
M666.+;YCJFX[5W$#)]*QM.?9J$[Q,/)6UCSZ9`]N.E9C7MU<K$EQ.WF&6)E^
M5=N"Q^=3CIT&.M`'7[12%%/4`_45S5UJ=Y$1&+O+Q-)NVJHW`'`)SVYZ#FI)
M]3O4-[+'=1F*&58U^08PV.<Y[4`=#Y:?W5_*D\B,DDQID_[(KFVU;48BJR2P
MX4_,Z%9",D8WXZ<'J*U=0NIUO(+6WD2)I59B[C/3H.M`%[[/#_SR3_OD4GV2
MW_YX1_\`?(K"?6;L17$@:`_95CW*HR)"W4@YX]J235M25D5#;EI+AX%!C(QM
M[_>H`W#9VV0?L\.0<CY!2&PLR,?98,?]<Q7.GQ#J/V6.?;;`&W:9E*L3\IP>
M_>K']LWXE%M(L`FE:+RW&=JA\GD'N`I^M`&T=/M#UM8#]8Q3?[,L<8^Q6W_?
MI?\`"L<:MJDDKVT4=KYL<C1,SD@,0,YQ]*M_VM*V@Q7R19D?&5QG'."<=_7%
M`%T:;8CI9VX_[9+_`(4UM)T]F#&RM\CI^[`K+&KW)MUOB\#1I#([1IDYPP`Y
MSP3D?3-#ZY=Q2+;2Q0_:91$8MI.P[S@Y^G/UH`T6T;33D?8XN3D\>E-_L?3<
MD"VC#<D@$CK^-9=QJ%S:WT#W**EVZ21J@;Y'.Y<'KQQ6_"C;5DF6/SRH#%1P
M/8'KB@"J-&L,8\DX]/,;'\Z5=(LAG$<@Y[3./Y&L%)KBTU*Y%W=RI.@,D8+D
MQS##$#K@=NW:KFFSSKJ-DIDE=;FT$D@=R<-USCM_]>@#171[)1M5)0/^N[_X
MTO\`9%IG/[[_`+_O_C6-<WMSY=U?B9@;:[$:1A\*R@@$$?C4UA)<M+87#W,N
M;U)-Z%NAP2I`YQB@#1_L6TSG=<_^!,G^-']B6H((DN@1_P!/,G^-1:/+.+.3
M>9;AA<NFXL,X!QGM5;_A)U29EGL+B)%=HRYP?F`SC`H`N_V+!_S\7G_@2_\`
MC2?V(@4`7U_Q_P!/#<U33Q.KV[R+93,59%VJZG[V<9YX/'2K=WJTMI8174EC
M*"[;60L`8^>"30`Y-&5,XOK[G/6<FE&DD?=U"^`_ZZY_F*JW7B2*V=D>VE;#
MLH8,-I"_>.<]JAGUM[2_N'822VP6$@`C]V'SSZ^E`&H-.81[!?W?7.2ZY_/%
M/%G(JX%]<_4[#_[+5"X\26EO&[.DQ=)6B:,+D@CDGKTQ4][K=K906\SB5UN,
M>7Y:%LY'`^OM0!9^RRY_X_I\?[L?_P`32&TF('^GW&1WVQ__`!-9\WB>PAM8
M+AC*5E!.U5RR@'!)'L:EMM>M;F\^S0K.[$XW"([1[Y]/>@"U]BFQ_P`A"Y_[
MYC_^)H^R3YS_`&A/_P!\Q_\`Q-9VJ:]'%'=06[2K<1*V)!'E`RC)&3[4EGXE
MM&T\2SF;S41#(OE$$EN!@=\G-`&@;.ZVX&HR@XZ^6G^%-^Q7W_03?_ORG^%5
MX_$FG2F$(\I,PRH$3'OCGCUJS8:O9ZA(\=M+N9.H*D9'3(SU'O0`@M+X'/\`
M:1/UA6C[)?[\_P!HC;W'D#_&KSNJ+N=@H]2<4M`%#[+J&[/]H+C'0P#_`!H^
MS:ES_P`3"(^F;?I_X]6A10!G_9]3Q_Q_PYSU^S__`&5'V?4\?\?T&?\`KW_^
MRK0HH`SO(U7_`)_K;_P'/_Q5)]GU8];ZU_"V/_Q=:5%`&<(=6!YO+0C_`*]V
M_P#BZ!%JP'-W:$^OD,/_`&:M"B@"B8]4[7%I_P!^6_\`BJ0IJO&)K,GO^Z;_
M`.*K0I*`*!35L'][9YP/^6;=?SI5&IAAO-HRY[*PX_.KU%`%`#4P!D6IYYY;
MI3F.I8^5+0]<Y=N?TJ[10!3+7^.(;;/_`%U;'_H-*LE__%;V_P"$Q_\`B:MT
M4`5@]YQF"#_O\?\`XBE#W>>8(?\`OZ?_`(FK%%`%8R7><?9XO^_IY_\`':0R
M7G'^CQ?]_3_\35JB@"H)KS&3:QY]!-_]:A9KTCYK-`?3S@?Z5;HP/2@"H+B[
MP";/GN!**0W5V!_QX,?I*O\`C5RB@"F;RZ"Y_LZ;/IYB?XTTWUR&Q_9MP?<.
MG_Q57J*`*0OI\<Z;=#\4/_LU6;>;SXM_EO&<D%7`R,?2I#TJ&VX$G!'[QN^>
M]`$]%%%`!1110`4444`%%%%`%2V_X^KL\?ZP=/\`=%6ZJ6O_`!\W9P1^\'7_
M`'15N@`HHIK'`)]!0`ZBF1MOC5O49I]`!6?X@_Y%[4_^O27_`-`-:%9_B#_D
M7M3_`.O27_T`T`:%%%%`!1110`4444`%%%%`!1110`4444`%0Q@B:8\<L.GT
M%356A_X^;C']\?\`H(H`L$`]:K7-U':>4KJQ\UQ&H4=S5JLW5=^^SV1R.%N%
M9BBDX'/)Q]:`'-J-HE\+=LB0D+NV\!B,A<^M,N+FQTWRXI`222_"EB!G)8^V
M>]5)K>8SM"('RUXL_F8R`@P<Y_#&*BNS)<7,EU%#,\=Q:O"GRGY6ST/H#ZT`
M:;ZA8K?I"S`S'"AMN0">BY]3Z4U9K&\DFM8SM>0$.RH5W@'!PV.>>*Q5T^[2
M![`J[3O=++YH4[=@`YW>V.G6I+<M9M8O)'-&EC$ZSG83R<#`]?7B@#6%QI\5
MY';_`">?&!&C%,X./N[O7`Z9I+>]TQYYC"T*R$%I&VXW`<$Y[XK(D21_.M(H
MY3/)>BX1MGRA."&)Z?AUJI>03W&EVUO!!*9K:-_.RI&,D<=.2:`.GL'LIK=A
M9!/*)^8*N.3[57GT_1K9HQ+9VR&1MJ?NARWY4RS):YOKN'<L!B14.WG*@YP#
M]16+([,MND\\Y/GQ,TAD;&/FR1N'RGD9'3B@#I#HNFG&;&W.,G_5CO3TTJQC
MBEBCM8ECE^^H7AOPKFFU"X(94O96\DML()&X;^#GG<<=JM2WTT<%Q=0W\LH6
M<)C@A4..>G'0]J`-A-%T]"A2UC79]W''O4MY86U^JK=1+(%.5SVKG(]2O8YE
M$EZ9(T(QLP&<$]0"/G&,CBM;4[F6&_MHA=_9XI0Y9F"\8''44`69-(L)9$=[
M9"R`!>O0=/KBH9=(TR*+=+'LCB)?)D8;21R<YK+&IWTA;R[H%DMQ+Y85<L<G
M@=^@S4=Q?27%M*MQ?0M'YD141D'&6&06*@'&,X_.@#3MM%T6XMD:WB62$J54
MK*Q&,\CKZU8;0]/8-N@))QSO;/'3OVK#_M.ZC-PEO<VMNL<DBB,X+$`$@[0O
MMUS@YJ2&]U21[91J<!,T!GQY`)&,?+UZ\T`;']BV>%P)5*Y.5F=22>I.#R3Z
MT)8V,EK]AC;]W`P(59#N0]1SG(K!@U[4#$DDMQ:@2J`!N!,9+`98`<``]S6E
MI#K%+J966.5U<,7``W?(.<#WS0!9_L'3]B)Y)PH8??;YMW7///XTO]AV1@,3
M+(WW<.SDLNW[N#VQ7/MJ>H70C$MXD.)HB<Q@#DGD$-RO`_\`K59EUR_@1;C*
MSQF5XF@5,.-H.&X/MG%`&E+X?L7XD:;!!7F0\DD'.?7('Y"I[&QFM;J9WNI)
M8F`$:.Q;;CN<]ZY^[OYYK*.>\DMY\-#,B0@[UR?F7'.:V(;Z3^RGN;J02F1"
MZQPKA@,=.O)`Z_2@"AHT&F7U].8II93;-M6&0_=QD9XZCTK571H5R5GN`X01
MHX<!HT!SM4XZ?7-<QX<F2VT34;^.!4FB41H^WVQU^O)K;\/J;>\OH7E9^(G)
M9NK,O/YF@"\^DP23>87DVF02F,'"LXZ,>_;UQ26NCQ6TB,DTI$080JQ&(@W7
M''/XYK`U*ZN1G4H[B995O/*2%7PI1>H([YI(=3OH-%O(YYYOM4?ES++C)*N1
MQSZ<\4`=)IUA_9\4B+,\P9B^&`&&/)Z#O63::-)>RW+:BLT433-)%%N48+#&
M<KSFM"^N[VWEACMXH91(K<R.5((&>P/%9MOXFDN9K18K,;92JO\`/]PDD=AQ
MT[XS0!+_`,(QLC"0W\B@&,G,:8^3[O0"MF\M5O+*6VD)`E0J2/?O573KV[O7
MF9X(HXHV9`1(22P..F!Q5.'6[MS*AM(C+`[B5/.VX5<<Y([DT`)=^&DGM[:!
M+HHL,;(0T8<,3U;!Z'-1R^';F:*ZCEOT;SHT4$0!2I0@@\'Z_G[5%/JKZC9!
M@KV\L5S$F%D;D,1UZ9_E5Q=>VS+'/;[,SR0EA)GE1G(XY%`$">';J*1KF+4`
MMVTK.9/)^7##!&,^PIVOP3B#3H;=9I7BN4<R%"^`,\MCZU;TK6!J3.HM98L(
M'5G!`8'Z@?U%5H_$B>6DLUI)'$X?8V\'+*,D>W0T`,_X1V6/9/;7JQ73;_-D
M\H%6W-DD#/!].:O:9875I<W,DT\4J3;>B'<"!@9.>>*K0Z^\R9CT^8MY@C"D
MA<D@D8+8]#5K4=4&G6T$LL!WS,%VEP`IQGDT`9=_X:N+NYN)DNK>-YMZEA$<
ME&_A8`X./6EE\/ZA-&J&\MU41I%M6-L,J=`?F[]_PJ0:Y)#<F62"X:!XH9-O
MR_N=Y(QZD]*E/B-?-G06<[>4'.`5W$(0"<9XZY'K0!%I6A75EMCN+F&6!86A
M`1"C!6.3SFK&B:/-IQ!EFADVIL4QPA"1[GJ:CG\2+;G$]A=(X4.5`!.TG`/!
M^OY5MQL)$5QT89%`#B,CFBEHH`0G&.,T444`+1110`4444`)344KNRY;)R,X
MX]J?10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`"4T$DG.,=J5
MAN4@]#Q0BA$"CH!@4`*:@M`-C].97Y_X$:G-0VG^J8X/^L?K_O&@">BBB@`H
MHHH`****`"BBDH`JVH(NKLY!!D'0=/E%6ZRDU2TMYYUEE8$R_P#/)O0#T]JT
MXW61`Z'*GD4`.IK<`G':G4U\;6STQ0`D1S&IP1P.#3Z9%CRUQTP,4^@`K/\`
M$'_(O:G_`->DO_H!K0K/\0?\B]J?_7I+_P"@&@#0HHHH`****`"BBB@`HHHH
M`****`"BBB@`J@;R&VN9UE+J2X(_=L01M'I5^DH`IC5;0_\`+1O^_;?X4AU.
MSS_K6_[]M_A5VB@"@VK:?G8TZ@GL5(_I1%J.FQ1*L=S`D:C"@,.*OT8H`I#5
MM/;I>V^/^N@ILU[IES$T4MW;.AZCS1_C5_`]!2;%_NC\J`*HU&P(P+VWXX_U
M@_QIWVZSS_Q]P<?]-%_QJ<Q1GJBG\*3R(O\`GDG_`'R*`(C>VA'-S`1_UT%'
MVJU(P+B(C_?%2^1#_P`\D_[Y%)]G@Q_J8^?]D4`,%S;X'[^/'^\*7SX#_P`M
M8S_P(4GV*U_Y]H?^^!2&PLR,&T@/_;,4`/$D);.^/([[A5*ZL5N-0@N6N5"P
M_=C*J1SU_I5@Z;8GK96_K_JU_P`*0Z78$Y-E;D_]<U_PH`G"Q;L@+D=Z:\%O
M*H5XHW`.0"H.#4#:1IS=;&#_`+X%(-&TT=+*'_OF@"P\%O+DO%&^1@[E!XI$
ML[:-@T=O$C#H50`BJXT331G%G%CZ4O\`8VG?\^D=`$PLK8;\6\0\SA_D'S?7
MUI8+.VME*P011!A@A$`S5<:)IH.?LD?ZT?V+IW7[(@^F:`'+I6GK"\2V<`C=
MMS+L&"?7%/CT^SBN3<QVT2SL,&0+@FH3H>GG_EWQ]'8?UI@T'3P,"*0?]MW_
M`,:`)&T;37&&L;<\[ON#KZU$="LA=P3Q01Q>4Q8A5P6...:=_8=B$VA)MN<X
M\]_\:#H=F00!.O?BX?\`QH`=)I%NVDR:='F.%E(&.H.<Y_.H;70((K5HYI99
MI'D65Y"<$E>GTJ3^P[09PUR!Z"X?`_6E.B6Y&#->8]/M+_XT`01Z!&+V2:2=
MY(6+LL)Z*S?>-1-X:C%C/;BXDD>=D+R2_,=JD8'TQFKG]CQ`DBXO`2,?\?#?
MXU-%8"-FQ<7)R<_-*3_.@"IJMA-?7%JJ@"",DNRRLC<C&!@?UITWAW39BA\D
MQ[0J@1L5&`>*N&T.[/VB?Z;Z:UEG/^D7'4'[_2@`T[3XM.A:*%I&5FW'S&W'
M./\`ZU-GTNTG^U%XQFZ0)*1W'^32M9.W2\NE^C+_`(4?89.OVZZ_-?\`XF@"
MF?#MJ8B@GNQN*$MYQ))4?+UI?^$=LS=K<&2X)60R!3)\N3UXJU]BEQ_Q_P!U
MG_@'_P`32_8Y>AOKGV^Y_P#$T`1V&DP:=O:%I)&(VJ9&R57LH]!65I/AW-CY
M>IF0NH=5C+@JF[^)<=^>]:XL[E>FHSG_`'D0_P#LM'V:]'2__.%:`*:^'@DL
M4@O[EF1P[&3#;R.!V[#/YU8U?2_[3@CB\]H=I.2J@Y!&""#Q4AMK[(Q?J/7]
MP/\`&D^S:AWU!/\`OP/\:`,UO#;B)X8[]Q$5C0*T8)4(<J/SI!X6V;Q%J5PB
MMO&W:I&'^]V]JTUM]1'6^C/_`&P_^O1]GU#O?1?]^/\`[*@"I<Z$;F.$->2H
MPB\F9D&/-3T/I_\`7K8C0(BHO11@51\C5,<7EOG(ZP'_`.*H\C5,G_3;;';_
M`$<__%4`:%%9?D:SS_IMG[?Z,W_Q=+Y&L\8O+3\8&_\`BJ`-.BLPPZSVN[/_
M`+\-_P#%4>5K/:YL_P#OTW_Q5`&G1684UK/RSV./>-O\:!'K6!F>RSW_`';?
MXT`:=%9@76L<R6.<_P!Q_P#&EVZS_?LO^^7_`,:`-*BLW;K/]^Q_[Y?_`!I<
M:P!ULB?^!B@#1HK-QK/K8GVP]!_MK^[8G_@3C^E`&E16;NU<#_4V9^DC?X4H
MDU;'_'K:=/\`GLW_`,30!HT5G&;5L`_8[7/<>>?_`(F@3:KSFSM^G'[\_P#Q
M-`&C16>)M3[V<'X3G_XFG";4>,V47X7'_P!C0!>HJB9]0P,V$9/M/_\`6I//
MU#=C[`F/7SQ_A0!?HK.^U:@,9TPGCM.M'VR_QG^RY/IYJ?XT`:-%9PO;[`+:
M7-[XE3_&F_;[P-SI-SCU#I_\50!IT5F_VC<_]`FZ_P"^H_\`XJGF_F"Y.G77
MT&P_^S4`7Z*SQJ,Q'_(.O!QG[J?_`!5-_M27=C^S+[Z[%_\`BJ`-$]*AM0!"
M0/[[_P#H1JG_`&I(3@Z;?#_MFO\`\55RR+&V5G1D+%CM88(R2:`)Z***`"BB
MB@`HHHH`*2EI*`*]L"6F/8RG_/YU8%0VW23_`*Z-_.IZ`"FN,HPQG(Z4ZDH`
M2/(101CBG4E+0`5G^(/^1>U/_KTE_P#0#6A6?X@_Y%[4_P#KTE_]`-`&A111
M0`4444`%%%%`!1110`4444`%%%%`!6;JNI-8M`B&$-*3S,^T`#_]=:59NJ6U
MU-)&]JEN^%9&$PZ9QR#CVH`O1L[1*7V[\<[3D9]JR#J.J+>26YMK3,:B1CYI
MY7)Z<=>#6A8PS6R"W;:88HU5&S\S''.?TJ,V<AOKJ?"XDA5$]<C=G^8H`ATS
M6[>]LO.DECC=5W2+GA1GU-7;>\@NHR]O,DB@X)4]/K6$VAW;Z9';DJ'6!DQG
M@L9`V/R%:.D6D\`N)+B)(I)2,`2M(2`.I)H`G35;&0.4NHFV+N;YN@]:<^HV
M<;,KW,2E,;LMC&1D?RK".BW@M;6-8D#Q03*_S=2V<#]:G73KR>[FGN+=$$L\
M+%-X;A,Y/\J`-)M7LS'(8;B&5TC,@17&2`,U)!J%M-"95GBVJ`7.\?*?0FN?
M.BW0CAVVR^:AN"6!7(W*0O.?>DN=)OKCRV2S$$<42(8DD7,A#9R.W'O0!T@O
MK4QJXN(MKG"G>,'Z4^2>.(@22(A;IN;&:PM/TB19(!<0;HEFDDQ(4.W(7!PO
M&<C/%6-9M6EGW&Q^V*T)11E?D;UYH`NI?K+J#VL:%A&H+OD8!/08I]U?0V]O
M-+N$GDC+*I!-9FA:;)9/.TT*B0HBA^,MQEN?K61_9>H1Q7"PV;DS1.CA]N5Y
MR-I!^;)]10!UT<Z21+*K#:0#R>G%.,R#^-.>GS=:YR?3)([4V\-H!"YC+;5W
M8(7DA<@'GU_*J]CH;/)!'<VS>0AE)\Q``,@8X''7G%`'6*X;.&!QUP>E*KAA
ME2"/45Q]OI=W%N;R[II&C=9,(J9)!Z'/S<^U:FA6L]M!<1>2R1\&-F786;'/
MRY('UH`V9)DC1W9AA!EO85%8WJ7ML)T5T4D@;Q@\=_I7,FQF:U55L9UN3#(+
MB1L_.2..>_.#^%7[RSG@\.6UO9QNC?)YJ*I)P?O<=>IH`W]PV[LC'KVI37&+
M:W:61@>WD>W,PVH\,@4#;_=!+8S[]:EM([H+"NH17GDB-Q&D88$/NX]QQTR:
M`.H@NXIY9HXVR\+;7&,8-3URJ6]VM[]H2*YB8WJ*<D\H5^;/8_6IO$DEP+F.
M.))F5HR0`7V;L\?<')^IQ0!KW.J6=K,8IIU5P-Q&"<#WQTJS#*LT22IDJX!&
M1CBN,-M>76GW3SK=-,UO#_>RYW<C'?`IRS:RE[Y43R;A,0BR>86*#IQC;C'>
M@#LI9$BC:21U1%Y+,<`4Y2&`(((/((KB[@R3:5,/M&I33&#?-&R90-D9'(_0
M55-_K`O%%O,^0RB*-MX+IQ_#@@CWH`[I[B*.1(WD57?[JD\M]*D[5Q^FF2ZU
M/3S+<W$MPI=IXI%($1P>G''859U*^E35;B.;4+FU*;/LT<<6X29Z\8^:@#I(
MI8YE+1NK@$J2ISR.HJ2N!;4WMX/+CNID.Z5BH(C&=Q`.2"2?]FIX-=O'U"T>
M6YD,3B/*1KURN3\I'S9/<'B@#MZ*Y;P[J=Q=:BT<UQ),2K$A0"@P?P*^F#4=
M]JUY%>WFR[V20SK'#:E!^\!QD^OKS0!UM,D9D0E5WMV7.,UEZ/<W-S;W%Q/-
MN42.JIM`"@'VZUB#Q#?16SR22!W\HLH$:E>N-V0<C'N!0!V(.1DTB.K@E6#`
M'&0<UR]IK%]=R-`DP5O/1!(R*>"I)X!([52BUFYMS-!;;41/,E9EC&&P2.=Q
M&.@Z4`=O2$X%<M!KUY->)O>-(MZ)M50X^;U(.0?PK?O75M.N74JX$3^X/!XX
MH`LA@2!D<C(YIU<EX>C:XU=9I'0BWM(]JA,;-R]!_C4D&NW<]P&62(PO*Z*J
MQ'&%!P02<GIZ4`=317+1:IJ_V42[H96>V^T(HCQT8`@\^G-:^DW_`/:*37",
M#;E@L1QC.!S^O\J`-*BN?UJ^N]/O3<(8G@B@+F-BPQD@9)SCJ?3IFK.EWUW-
M=2VUX("ZQK*&AS@9['-`&O17,QZA=:;-.\BQM:27DBCD[P<$_3'%3:3K=Y=W
MT45Q;*D4R%T9588Q[GK]10!T%%<C=ZM=V6K7HM8DEW2*I+,S8`3/W1_2IO\`
MA(KS=#(8(?(94WN-Q`).",_P_C0!U%%<W#XAE:WBGEA38TDRG:#T1<C'-1+X
MAODMWDGLT!,8>/Y'4`E@,'(YZCD4`=316)I4U])JM['?%04CC(6,DISGD9JD
MOB2\EO/(BAMOWC-'&2S?*PS]XXQSCM0!U%%<3IVK:A9AKFZ)FA\GS2OF%B2S
M[<\CCD=/2M)->OS&$-DOVCS$4`[U5@V>A('I0!TE%8.KW>IPMIRPHBO*X$H5
MN^,E?IUY]JJ:?K]S;V$,FHP`QO"[K*'RSE>Q&..HH`ZFBL+0O$`U:>2%H1&R
MC<"K9&/?CK1-K%U+YYM++?;(63SQ(."!R=OH*`-VBN9L-?NDM/\`3+4EQ`9E
M?>!O&<<]-M%MXI-P`B6?F3>:(PL4@*G(.#G\.:`.FHK&&ML0J)9RO.-WF1H0
M=H4X//?FH)O%%M$(2(F(=`[98`J/3W/M0!OT8K,O]16`6LJ.3'+DX"CYAMSW
MZ5)8:F+N8Q-!)$3&)4WX^93WXZ4`7\48K$;Q);#4C:>6Q`?R]^Y?O9QC&<_C
M4G]O0!6)M[@>7Q("HRC9P%Z\DGTH`U\?6C'UK`GUYTN[=!:7"$[_`#(F0!B5
M`.02<8Y/2IW\0VRQ1R^5,8V56WX``S]3S^%`&QBC`K+37+9IRGES*@E:'S2H
MVEQU'7/8TBZ]:;=S),B&,R*S1\,H[B@#5Q152SU&*[E>)5=)%4/M<=0>AJY0
M`4444`%%%%`!1110`4E+2&@"O:<K(>?]:_7ZU9JM9',;G&/WC_\`H1JS0`44
M44`%%%%`!6?X@_Y%[4_^O27_`-`-:%9_B#_D7M3_`.O27_T`T`:%%%%`!111
M0`4444`%%%%`!1110`4444`%9&JW<]M>0X++;JK2.4(RV,<8(/J/SK6K'N9!
M>W+?Z'<R1J'A+*4QVR>3GL*`&R:W<0X273G68LJB,R#Y@V0"#]15G4-4-BL(
M\GS)IND>\*!@<\GBLY;.0RI)+%J$TD<BL&<Q]%S@<'IS4NIP_P!H-&7LKU'C
MSM(2-@0>N0210`YO$2^0)DLY6C6,/(=P&SDC'N1@]*=-K@!D$=O*$RR).0-I
M8+GZXK*GTE7!B\O40I7:V8(V]\@]O?%61!,`\:R:DL&6/EB!1R1CKW').*`-
M+2M5^VXBDAEBF6-7/F*!N!XW#%5DUY(FF282S.LSJ!''RJJ>O7D<TVUF2WNO
M/$%\P$"PX^SGMWK-N+59=Q*WOS2.V#9%@NXYX]"/6@#<_MNV-T81',P!*^8$
M^7(&2,T3:Y:1",OO'F0^<ORYXR`!]<D5BI:K]I$F^^VY)+-:,)&&,8+=Q^%0
MS6+S>49Y;D^3$(XP+)L<'(SSSTH`Z!];MTM_,9)EDW%/*,9W@XSR/3'/TI;3
M4PVBI?W97!!),:D`\X&!60L:P'S8C+'/N;)73WVX*XQCK[]:L!HDT0:?YDWF
M*/O-:.`W.>F*`+%QK\43P%$<HS.L@*'>I`!`Q^(J>;7=/BCB<R,5E7<"J$X7
MU/I63:+'%<03O.<QL[;%@DVC*@`#(]JJ_9L68B^TH1Y)0YAE`4Y8Y&!SU[T`
M=`=>T\,Z^:WR+N)V''^3FK=I=PWL'FPL2N2#D8((]1VKG8X8A8/!YZ>;YRR+
MNC=5(4*,'BK]C+;PV\T<\T*23L<B`-A>,=3].M`$\VNV*1S-'+YCQ*6V#(W<
MXX]>:8=:C@L+>XN-A:=PJB,G&,]>1V'\JSA`\B*DES9A(+=X8]CG+%AC+<<5
M<U)X[BTM%BN;5Y(98W(:8#.WK@T`6;#6;6[`1I$CG&[,>[D`$\_UJS:ZA:7C
M,MM<1RLGW@IZ5SGV+S+**W-[9H3),7=)5X#*0/KUJQHR1VMWYT\MI%L@$1*7
M1<L1CGD\#B@#<^W6OVO[)]HC^T8SY>[YJ8FIV#^84NX3Y8RY#CY1[US=Y:M<
M:G)+#+9QAG9UE\\%3\N`"ASR3WJG%82[&4RVJCR63FZ0Y)([#``X/^-`'7QZ
MKI\C*D=Y`Q=MJA7!R?2IEN[:2Y:W2>-IE&2@;)'X5S5Q:0O>SR6TMB%>:%H]
MLB#A?O8]^E0Z=:&#64DDF@*1R,QE^U+A@<XPH&<\]S0!U4UW;02I'-/'&[G"
MJS`$_2H8]4M3`9II$@42-&/,8#)!Q6)JN1J<S);6EX+A557DE4>41GC'7WR*
MSKFRN5$*[(&'[S_5.F02Q/._/&,>]`'9R75O%*D4D\:/)]Q2PRWTHCGMY9GB
M25&ECX90W*UQ4ME=R"VVI&TXAC`+R(4RHY#<Y&/:K^B6[PZP97C2)5#EV+H5
MR>FUAR1]:`.H:6))51G4._W5)Y-&^(RB,,A=1NVYR0.F:YS48W:^N5-G]H>=
ME\BX5AB,#'!/;'-6O#]K]GCNYYH$CG>=RK,`"5XQSZ4`;(6%F*@(2AR1@<9H
M$</RN%3Y1A2`./I7#+9:B1<BV@N(W:-EE,JX8#<"0K?QDC/4=.].M=/F=X%,
M-RUJUS&&$L/EYP#EMHZ>F>]`'9VCQ2M.R0-$RR%&+)M+$=_<5,T49<2&-2X&
M`V.1^-<#?6EVEY*#'<I9+<R;$B@\P*<#!V\<8[TZ[2\A2R6:*[:7RE"1L"=Y
MR3C*G*GI^E`'=P1B.(#:BD\D(,#-(MM`A8K#&I?[Q"CYOKZU7TYH6$_DQNC"
M3$F_/+8&<9J[F@"*.UMXP!'#&@4Y`50,'&,_K3'L+-P`]K"P#%AE!P3WJQFC
M-`$!LK4S+,;>(RKT<H,C\:99V$-I:-;("8V+$AN^3S5K-&10!#!9V]LS-!$J
M%@`2.X`P/TJO_8VG"9I19Q"1CDL!WJ]FC-`%&XT_;;@6)2"94\N-V7<%7()&
M/PJ*'1X([>SBRV+5MX(_B;U/X\UIYHS0!6N-/M;F599X5=U4J"?0]1[T66GV
MM@C+:PB,,<MCDFK(_"C-`%&'1["&X-Q';CS3D[B2W)ZGFG6^F6=G(\UO;JLC
M=\_H/2KF:,T`9DNDZ;=2OYUNIF8B1_F.X$C'6G_V'IHD1Q;*"@"@`G!QTR.A
M_&M#-&10!GQZ'IT5R;A+?#G=GYCCD8/&<4V/0--C29%M_EF38X9B>/09/'X5
MI9HR*`*ECIEK8;_LT94R8W%F+$X^M5E\/V"3"55E!!8J/-8A<@@X&>.M:F?K
M1F@#+;P_8,L:LKE$B\K;O."N<\_CS3X-$LX"&"NSAU?>[DL2O09]*T<T9H`J
MW^GPWZQB;>#&^]2C$$&H#HMF;>&$HYCA5T4%CT;K6C2T`9^GZ3!8R-)&TLCD
M;0TCEB!Z"HY="M)9F=FF"LVXQJY";O7%:E%`&3+H-K(B*'E7RXA$ASG`#;L]
M.3D4V'P_:QW"7#2SR2JXD+.^=Q`('X<UL44`<]J6D3!P;(.P?S"[+,$;+GIT
MZ4H\-1O;PH\[(PC5)0@&'Q]>GX5T%%`&?J&EQWT<*-(T8B!`Q[C%/MK".WF6
M4,2ZP+",_P!T5=HH`Q)?#Z->/.EP\>YS(JA%^5^N<XSC/:C_`(1Z,[@;F4^8
MH\PYY9PVX/\`G6W10!B0Z$4G6>6]EFFPX9G`P=PQP.V*J'PJ?)6(7G!C".3$
M&.1W4GH/85TU%`&$VA'RF!E\S_27N2NW&[((VY[=:SK'2+N\80W23PV\<)C4
M2!<J<@C&.N/7Z5UU%`&5I.EO8SRRRR1,\BA<11!``/8=ZU:**`"BBB@`HHHH
M`****`"D-+2&@"O98\IB#G]X_P#Z$:LU6LCF#/8NY'.?XC5F@`HHHH`****`
M"L_Q!_R+VI_]>DO_`*`:T*S_`!!_R+VI_P#7I+_Z`:`-"BBB@`HHHH`****`
M"BBB@`HHHH`****`$-4=*_U$H.>)Y/\`T(U>-4M*P;9R">9I.O\`OF@!U]?1
M60!D21N"QV+G:HZD^U6#+'Y/FE@$V[L^V,U0UB4^2(!'*5F!#ND9?:O<<#J>
ME-O$GN[>**S58T0J724,F1C(7IT]:`'C6[+R%G,C;&4L,(3A0<$G`X%2-JEH
M)HH5D+O(H90BEN#T)QT%98,J:3':30LAF+JSK&[;4R<D\=3D_P`ZEDBB\VWD
MT];A+A&13E7563`SG(QTH`W.#Z9HX%8^J!WO0LC7*PB$E&@#']YGV[X]>*I>
M9<-(92;J.Y\_:Z,Q`$7J.W3G([T`=+Q1Q7&VTMRROYUW=*?LID&7;_6`G`_E
MQ5J66;SG*WUP%,\:C#'`4CYCT]<T`=1Q1Q7,17<TB[);N5502F.0'!9@WR@\
M<\<X[TD-_-YV^YO'CD!A+1E@%4EOG!&/3\LT`=0<"HK>XBNHS)"^]<E<\CD5
MC:W=RPW4)CN"L6P$JC<G)Z@?Q<#I51;XP7.Z&[VK+<3!EP"H7!(;'KG\Z`.I
MXHXKE(=3FDCQ_:'E-YD8!+(W#<$]./IVJ9[R]MYI(VU&$&%MN)@,L,?>V@9_
M'-`'2\4F!61HES+>P7(EN&=P0,A0-F5[$<'UK.L]1G^SQQ+>"+]W+)NDVDE@
MQPI_#GUH`Z21X8M@D9$WL%7/\1/:I"JD8(!%8]]++=:19RDB*5Y(FRPSM.1S
MBLZXU?4DC6**6!W\QU$YVJKA0,8R<9Y/Y4`=+,\,*;Y61%R!N;BE^SP`?ZJ/
MG_9%9-]<R/HMK-*L)9Y(MZLNY3D]L_G5&;6;U9;@+/']U_)!C&&PP`PV>3C/
M![T`=']G@S_J8\]?NBC[-;Y_U,6?]T5SD>KWS6LDANX5*Q.X+0X(93]TC/7%
M,&O:@+A&$44D";%EY5220"2,GW]*`.C-K9&3:88"_P![&T9Z]?SIC:=I\K$M
M:6[,!@_(,BL73;A[G6X+N5XLW%N^U5&"N&X!.>:2\OKBSO\`4&B%L)`T0!*-
ME@<]>?>@#:;2M.;DV5N>G_+,=NE)_8^F?\^%MUS_`*L5%87=P;6Z-WL>2WD9
M28Q@$`9Z&LE-:U22-V$=O'E/-C,A`ROIC=S]:`-@:'I6.+"W_!!1_86E]/L4
M7';%9\6KWK6ENP2!I[AGVJ20%51G!]&JG!J$EOJUS<K$A6186F&_)3<<'&.#
MR:`-L:#I:]+*,?G2C0M,&,6JC!R,,?\`&J/]N7/GW$:VL9\M9"OS$<)UR<8Y
M]J8?$%Q$YCN+.-6)CVXD^50^>6...E`&@=!TLC'V11SGAF']:/[!TS.?L_/K
MYC9_G68/$T[$1K8;I26P$9F#*O5AA>A[5:UN^G'AQ[JW7RRR`ON)R@/7''6@
M"V-(LQD8E(QT,[\?K3O[*L^PE&/2=_\`&LJUOVTV&15MG>".54E9IRY5V`X&
M1TY%:6FW\][)+YEGY$<9*[_,#98'!%`"-H]J<X>Y'TN'_P`:#H]N>DMT/I</
M_4U4_MY_G;[#*T>"8W!P#@XY)&!Z\9H37S+&@BLWDG(9FC1P<!3R0>]`%K^R
M%P<7M^/3_2#Q2?V..U_J`_[>#5#3=2ECU2ZA9+B:%IU42,01'N7@>O7VK2U#
M5!:2I#%"\\[*7V*0,*.I-`#/[(Y!6_OQ_P!M\Y_,4#1_^HA?_P#?[_ZU5+CQ
M1!"5*6TTD9B64N`.%)Q_.K4.O6T^H?9(TD;DKY@P5R!G%`"_V2V3_P`3&_\`
M^_H_PI1I3CKJ5^?^V@_PI5G:ZU>2!'9([4*6"G[S-T!]L56@GO)-)N+CSCYT
M,LA&5&&"D_*?PH`L_P!EO_T$K[_OX/\`"D_LJ3G&IW__`'VO_P`33Y=4CBM+
M>=8I)6N,".-!RQ(SWJ";7DB"#['<E_+,DB;0#$H)!)Y]J`)#I<A((U*^&/\`
M;7_"D.DRG_F*7X_X&O\`A4#>)K999%^S7+1QLH,JJ"OS#([]Z>WB&W7RQ]GN
M3([,FP1Y*LHR0?\`/>@!PTFX[ZM>GCU7_"G'2[K_`*"UW^2_X4D>OV3H9/WJ
MQ^69%9D(#@<';Z\D?G2IKEN01)#<12!@AB:(ELD<<#/6@!/[,N\C_B;76._"
M\_I1_9EY_P!!BYY_V$_PJQ;ZI;W%@]XI98XP=X8<KCJ,50EUD-<6CPM((7=E
MDC$)9C\N1C&?TH`G.F7V?EU>Y`P!C8A_I2C3[X$?\3:;\8T_PIK^(;!##AW<
M2<[E0X0$X&?QXH_X2&Q"S,XG01.8R6B89;T^O/2@!XL+\<?VK*>O6)*7[%?`
M-C5)<D=?*3BIK;4[6YLFNXY/W*YW%@1MQUS42ZW9-*L>Z4,S!1NA<<D9`Y'<
M4`+':WZ#!U$N/5H5S^E.^SZAGB_3'O`/\:C.NV`909'!8$@>6W.#@CIZBD&O
MZ:4#BXRAZ$(V#UZ<<]#0!/Y5]Q_I<7O^X//_`(]2E+X=+F#\8#_\54']NZ:0
M"+I2"`<A6Q@]^G3WJM=ZYC=]FCSY<RQ-YBLN<XZ<>]`%\)J&[F>W(]/)/'_C
MU&-1[2VO_?IO_BJ<E_;.`5DZR>4.#][TJ.6_C@NI%EFA6..,,PR=X).!^%`#
ML:AS^\MO;]VW^-(1J.!A[;/^XW^-(VKV*A2;A>?KQSCGTYI8]6L975$N$)8$
MC.1G'7\L&@!2-1[/:GC^XP_K28U#CY[;W^1O\:%U6Q:,R"YCV@@=><GI^=)I
M-ZU_:M*P0%9&3Y"2#@^]`"_\3/UM/R:G#^T,_P#+MC_@56Z*`*>=0]+;\VI,
MZE_<M3_P-O\`"KM%`%(/J7&8;4_25A_[+1YFIX_X][7/IYS?_$U=HH`H-/J2
M*Q:UM\`9R)S_`/$U9M)C<6D4Q7:9$#;<YQD4Z?\`U$G^Z?Y56T]BFCV[!2Y6
M$$*IY/':@"[37)5&*C<0.`.]"G(SC%.H`:I)4$C!]*=110`4444`%(:6D/2@
M"O9`"W``P-S''_`C5FJFF@BS0').6R3WY-6Z`"BBB@`HHHH`*S_$'_(O:G_U
MZ2_^@&M"L_Q!_P`B]J?_`%Z2_P#H!H`T****`"BBB@`HHHH`****`"BBB@`H
MHHH`0U2TH8M#@8'G2?\`H9JZ3TJMIV!:X4Y'F/VQ_&:`+.*,4M%`"8%&!2T4
M`)BC`':EHH`2C%+10`F!Z4;1Z#TI:*`&E5)!*C(Z<=*7`]*6B@!NQ<8VC'TH
MV+NW;1NQC/?%.HH`9'%'$I6-%0$YPHQ39+:"4`20QN%.0&4'!J6B@".6&.9"
MDL:NIZJPR#4;65J\*PM;1&)#E4*#:/PJQ10!%-;07"!)HDD4'(5U!&:KMI&G
M,TC&R@)D^^=@YJ[10!2;2=/>..-[*!DCSL4H"!GK3DTRQ299DM(5D0;58(.!
M5NB@"C#I&GV\_GPV<*2@Y#!>1]*1](L9)9)'MD9Y#EF.<G_.*OT4`5K>SAM=
MXA3;OY;DG)JJ-"TU<[;102X<D9Z@Y'Z]JTZ*`,UM%L'B,;0%D+[R"['GUZU'
M)X?L)&=MLJ;P,JDA`XZ<5J*",Y)/]*=0!E-H&GL7/ER`MNY$K#[W7OWJCJ?A
MM9(U%KN<EEWK+,W(7I@\XQ71T4`8-KX?22#_`(F&YI`V4"S,VP8Q@,<$YK1N
M=,M[FR6R8.ENH`"1L5X';Z5=HH`S'T:V<DL9B&*LP,APS#H2/7_"K%E9)9(Z
MQO(P=BYWMGDU;HH`QY/#MI(L@9[@ACE!YG$?<[1VIO\`PCMLJ_)/<HV6+.'^
M9@>H/'0UM44`8D/A];<,(KVX"-()"N%ZCIV]A^56K[2UNYHYUFD@G0%?,3&2
MIZ@YK1HH`P)O"\4H91=W"(8A"%`4X0'.,XSUYJU::*EM=>:+B9TSO\IB-N_'
MWN/Y>]:M%`&:MI)%JD\\0(6XC"LXQE6'0X/M4(T^XM=-FM8I'N&N&;+-M79N
MSD\5L44`9]UI44]K;Q(S1-;$&%UY*$#'?VJM)H9+AX[V9&>,QS-@$R@DD]>G
M7M6S10!@/X<9O-_TY\2.CE3&N/E^Z/R%/;0KCSUD6_'RRM,`T(/S-U[UN44`
M87_"/N;9+:2]9HTB,2XCP1D@YSGU`J4Z*[2B=KO=<;E)D:($87H,9K8HH`R[
M?2Y(+&XM_M)+3,6WA,$$]>_-5;;P_):3"2"Z1,.7V"#Y02,<#/%;U%`',GPK
M)L`6^VD`#/DYP0Q;(YXY/-6WT262V>-[L>89O/1Q%@*W?C/(K;HH`H?V>TFG
MS6US.TS39W/C;C(QP/3BJ+Z+>.(I#?YN(F4KE/DPH/\`#GKSUK=HH`PK;1[R
MWN(I3<PN45U_U;`_,V3WJ(^'YOL-K$)('DM6;;YB$JRGKD>M=%10!SLFB7OV
M>6)+B%A+$L9)0KC!SP!QW/Z4ZXTR_>24YMO*:5)^0V05`X_3]:Z"DH`PM*@C
MNM6N=0B\SR#@H&4@%R/F8`_3%.U6POKJY=HH+22$H$Q*[9;!SZ<?7M6V*6@#
MF1HNH;(EWJ2#G<96S%\V<9Q\X^O>HI/#^H23!2\`A4R[7#-NP_MBNKHH`YBV
MT2]M_(N%AMUFA9<QHW#@`C);&<\].E7M'@U&V8I<0PI"S/(Q60L=Q.1VK9I,
MT`%+110`4444`%%%%`$-VVRTF;&<(3C\*9IP_P")=;=/]4O3Z"G7AQ9SD]HV
M_E3=-.=-M3S_`*I>OT%`%BEHHH`****`"BBF;CYFW8=N,[NWTH`?2-TI:9)C
M:<XQ[T`5]-.;"%FQR,Y'3K5JJ>FS1G3K<AEP0%&,8SZ"KE`"TAX%+3)!E""<
M#'6@!]%%%`!6?X@_Y%[4_P#KTE_]`-:%9_B#_D7M3_Z])?\`T`T`:%%%%`!1
M110`4444`%%%%`!1110`4444`(>U9EK=?98O)EAN2X=N5B)'+$CD<=ZTZ,4`
M4'U6!/O17?X6[G^E-&M6V2/*NQCUMI/\*T<48H`H?VO;9`*W`S_T[O\`X4AU
MFS&,M-D_],'_`,*OX]Z7`H`H+K5B<9DD&?6)Q_2E&L6)_P"6K?\`?MO\*O8%
M&!0!1&L:?D#[0`3ZJ1_2G+JVGMTNX_Q.*N48H`K#4;(C/VN'_OL4?VC8_P#/
MY!_W\%6",@CUH"C`[X]:`(/[0LO^?RW_`._@_P`:/[0LA_R^6_\`W\'^-3[1
M36AC;.Y%;/J`:`(O[0LQ_P`O<'_?P4?;[,_\O4'_`'\%2&WA+%C$A8]]HS37
MM+>10KP1,!T!0'%`!]LM?^?B'_OL4?;+;_GXA_[[%(;&T/\`R[0_]^Q2-I]F
MWWK6$\8YC%`#Q=VQZ7$1_P"!BAKNW5=QF3'`X;-1?V;8_P#/G!_W['^%)_9=
MA@C[%;X/;RQ0!8\^+_GJG_?0I?-CQGS%Q]:J?V/IN,?8+;'IY0I/[&TS_GPM
MO^_0H`N"1#T=3^-*)$/1E_.J7]BZ8#D6%N"/^F8I1HVFKTL;<8_Z9B@"[N'J
M*`0>A%4&T736()LXN.F!C^5`T330,"TC%`%_-&:HC1M/``%N./\`:/\`C2_V
M18CI"1]';_&@"[D452.D617'EOC_`*ZM_C1_9-IG.V7/KYSC^M`%W-&:J#3;
M8#`\X?\`;=_\:!IT`7`>XQC'_'Q)_P#%4`6\BC-4O[*M^,/<C'_3S)_\53CI
ML)_Y:7/_`($2?XT`6\BC-55T^)>DMS_W_?\`QJ.32XI%"M/='!R/W[<'\Z`+
MV11FJ0TT!B?MEV0>QEZ?UI/[-.`!?78Z\^8/\*`+V:,U0.F.<_\`$PO`/3>O
M_P`30--D&,:C>>_*\_\`CM`%_(-&:H?V;-_T$[S\T_\`B:0:;/\`]!2\S_P#
M_P")H`T**H?V=-_T$[O_`,<_^)I&TVX/35+L?@G_`,30!H`@T9%4&T^Y8DC5
M+I<^BI_\31_9]QU_M6[S](__`(F@"_FC(JB;&ZR2-2G]OW:?_$T?8KK.?[3G
MS_N)C^5`%[-&:IBTNAC_`(F$A`/.8TY_2G^1<C_E[/XQB@"S157R;O'%V/\`
MOT/\:00WF>;Q",]H>WYT`6\T54\F]Y_TN/\`[\__`%Z417@(_P!+C/UA_P#L
MJ`+6:*K".['6YB/_`&R/_P`52A+K&#/%]?*/_P`50!8S1FJVR\_Y[P?]^C_\
M52E+O)Q/!_WY/_Q5`%BC-5ME[CF>#_ORW_Q=)MOL_P"NMR/^N3?_`!5`%K-&
M153;J.?];:D?]<V_^*I=M_C_`%MMGT\MO_BJ`+5%5,:A_?MO^^&_QI"-1"GY
MK4GZ,/ZT`7::``20.3UJH/[0];7\FI?]/];;\FH`MTM4LZCCA;4_\"8?TIID
MU39GR;3=Z>:W^%`%^BJ._5/^>5GC_KJW_P`336EU0#Y8+1C_`-=6_P`*`-"B
MLPSZN&`%G:D>OGD?^RT@N-8ZFPMOH+@__$T`7+__`(\+C_KDW\C2V(Q8VX_Z
M9K_*J,[ZG/;O"]A"/,4J2+CID?2M"WC\JWBCZ[%"_D*`):***`"BBB@`I*6B
M@`IDGW#BGTR7_5MZX-`%?3`ITZW(7C8#T[U;JKIHVZ=;CGB,=:M4`%13C,3C
ML5-2U%<?ZF0_[)_E0!+1110`5G^(/^1>U/\`Z])?_0#6A6?X@_Y%[4_^O27_
M`-`-`&A1110`4444`%%%%`!1110`4444`%%%%`!6#J.HW4>HR11,Z1QE`2L.
MY1GJ6/I]*WJS[K2X[BY:8S3IOV[T1AM?'3(Q0!=<%D8(VTD<-CI6%++J$<.H
M2B^8_925`,:<_*#GI[UMQ1F,R$R,^YL@-CY?88[56DTZ*2"[B+MBY?<^,<<`
M<?E0!G_\)!Y,)%Q:3)."JA&91NR,@YS@5>BU6&72WOE!*Q@ET4@D$=1GI45[
MHD%[,TLDC;RRLO`(7`QT(P<T3:88="GLK;+NR,!G"Y)^G`H`B?Q"D:@2V=PD
MS2*BQ'&X[LX(YQV-.CUZ-R=UK<HH)7>5&"X!)48/7@TG]A^;)'/<7+27"21O
MOV@<+T4#TYJ1-'VRKFX9K=)3,L)4<,23][KCGI0!%=ZW&@582P)6.0OL#`*Q
MZ=>M-;7HYH2\$<\:@J1*\658;PIQS[T1^'8H[.2`3,"\JOOQR%4Y"BF#PZ<G
M==CH!E(MNX;@?FP<$\>G<T`6SKEJ&;*S!0'VL4X?;U"GOT-(NO6AB\S]ZH(4
MH"G,@;(&!^!J"30&E@-N]V?)4R-&-F""P/4YY')I]SH[S0)$ERHV1)&-R9!V
MG/(SWH`T;6ZCNHR\>X8)!5A@@CK65JVM26$DJ)&'P45#L8@$C//K^%2Z?:WE
MA<1P;Q);/O=SCA#QA5R<XHO]*EN979)$4/-&YR#P%'2@"S<ZG;V2QK<N?-9-
MVU$+<#J<`=*CDUW3X]O[\D$!LA&(`/<\<"H=:TF?49(WBE0!%*[7W8Y[Y!_3
MI5:'0;B.PGA::-GDMUB7J`""3G]10!K1ZE:R!2LGWI#$.#G=3M1O%L;*6X(!
MVC@'N:Q[.Q/]MW5U&LJI$IVJZX#2D8)'MQ^M:=S#<7FD&-@B7$D8R.<!N]`$
M=GK=E.8XFNH3.P&0F<9Z]2/3L:EBU:SN()I;>82K"I9MH/O[>U45T>=9W3S(
MOLSW`N"<'>#_`'?3'`JSI]A);:1]D=EWD,,@\<D_XT`5;?Q/:RM;^8/)26-G
M+,?N$$#'3WK2?4[*.>.![F-99,%%)ZYZ5A1:)?"(QRK;'9:/`F'+;BQSGD<?
MK3?^$<N/M()V,KE"SF9P5P!D;1@'IP:`-V[U!+2[MX9-H64,2[.%VA1G//6C
M^U]/\@S_`&N+R@VW=GO6=XATRYOY;9K982$613YK$#YEXZ5GG1-3:U4%(?,2
M164>;AP`I'WL<_\``L\4`=(-2LBK,+F(JJ>86#9`7.,Y^H-+]OM/.2+[1'YC
MC*KGDUS;:7K$,+QI#;2^=`8F8.$V?,Q'``SU]!44VA:F\AQ%%CS4?*LJ@@8Z
M\9S^-`'3PZE93S^1%=1/*!G8&YHBU*QF\SR[N%O*^_AQ\OUK!MM$NX_LKLD4
M4PDF:61""0&!V_7K56[T.^N4B$>GP0&%55F24!I<')Z<<^XH`ZZ&XAN(A+!*
MDD9Z,AR#^-03ZC;107$@E63R!EU0@D>U4-)L+FWL;M)5$3S$[%#+Q\N,G:`,
MUE-H]U-;!!IL<4L4#([DK^^8XQC\LY-`&R=<C72$U!K>0"1MJ1@KN/.!WQ5^
M&ZC>)6<K&^T%D9AE<]C65J6FF72K*WBMD)CEB9D`&%&?F_K66^ALEO!)]@+,
ML\C2*JJ6*D_+P>,?RH`ZTS1!0QD4*>ASP:IMJD0NVMTCFD=9%1MB9"[AD'/I
M7,Q:1=QH#>::]S&8W2.(./W;%B1T(P,8Y'2BVTFZMK]`+%T;SX7WJ=R@!2#\
MQY/)H`[,.ISR.*1<AF+."O88^[7&C3+E86\BSN(I$MW6Y=N?.8CC&#SR>M,N
MM*NK:%TM[>8P[(3(%R<G'S';GYC[4`=C)=Q1W,,!)WS!BF!QP,FIF=54L3P*
MY/0[6[CO[8RPSK%%)+LWQ[0JE!CC)Q3-2@G.O%T@N2YD7^$E2G<A@<`>Q%`'
M5V]Q%<0)/$V8W&02,<?C4H8&N(:QEMK*UDM8;LS2VK^8%9QR",#V[\57@2XC
M2X1!=K%+'&PQ&Z@MO7=U)/<]_P`*`._R/6C(KB[NREM=3,8EN4"%1:+&C2?+
MGG^(>O.:DTYY;;799)&NFV[VF\U6!50"1T)4CTQB@#L"<49%8^LSO<Z5#-;>
M;Y#NC2F,$/Y9ZX[^E9,<*SM;V\$EZ+*2X(3)<-M"<\GD#=C]:`.FNK^VLS&+
MB789#A1@G/Y58R#7->(K287VGO9^:T\:R;3EF'"\9_&LX/<M:2_9+B^,?E()
M_-W9$I8`A<].^<4`=C<W4%K%YEQ*L:9QN8]Z(+F&Y1FA<.%8J?8CJ*P_$-C'
M#H4:*T["W=6!WECUY)[GO6?&MQ:B.YL7NG>:ZD41L3M9><$@]/K0!V.11D5R
M?AR6Y?4`6N)Y0R'SE=&PK>Y8\'Z43W+KK=TJ7%X9TFC$4*%BA4[=V1TZ9ZT`
M=9D49%<3IEW>W.J>5-=S1-(TJE&+97(.W((P/PIZ76I7<'GR3RQ`3Q6V(SMW
M?WC]:`.SR*-P]:X^:6^LT:>WN[B>2.^^SK'*^59<'KQU]ZHP:GJ?V2<K>O(W
MV=F?ELQL",=0,'KZT`=W)-'$A:1U11CECCKTI^17':FMP;.=9+RXD2(P2?,1
MU;.<X'0<5LZO<;&M%:[DMK:3=NFCP"2!P,X..]`&C->VUNZ)-/'&\APJLV"W
MTJ?(KE;&)KK6["XFN9)3Y#E=X'(#$`XQW`!I]_/>_;-0:.\EC6WDA5$4*1AL
M`YR/>@#I\BCBN6EOKB.Z-E-?O%;K.R-<G&\84$*3C`R2:$OK^:T:87;(8K62
M0'8/WFUOE)!!QD>E`'4Y%&:XY->U)Y6(EA&T1D(Q"[P0#G;@DYR>AK5T^\OI
M=2-E</S`SM(P7[ZG&S^9_*@#<S1FN>U#5IXKB]6.X2,VWE^7$4&9<]?<_A5K
M0[FYO?M4T\V52=XDC"`;0*`-7S8]X3>NX]!GDT[-<5"TPN+5DN`)$^TL7*`E
M<$GD>_-6I]9U/*21F%(UAC=MS*-S,,]#SCZ4`=464$`D`GIGO2\5S_B&Y>"3
M3Y@D(D4LP,N=JG;Z@5377;[R2K2Q";>G!V#(().SG!Z#KB@#K,BC(KF8=>FD
MMYG,\8*6;2`LFWYPQ'3GVJ.'7KZ6[0`KL,L:$>6`O(7/S$YSDGH*`.JR**Y5
M=?OH--2\N/)E$BR;45",%2`,G/(YI;K7M0L]B,UK<23;=@A4EU!!)RN>>G'-
M`'4\49%8=IK4SZ'<WTL&)(-PVXV[L>V3BJ6IWU_+936\C08,22^9%N&`6`V]
M>M`'4TM0VL2P6Z1)G"KCDD_SJ:@`HHHH`****`"HKDXMY#Q]T]?I4M0W7_'M
M+SCY#S^%`$6FK_Q+K<'/"#KVJW5>Q8-8V[#&#&IX^E6*`"HYE+0NJC)*D#\J
MDHH`****`"L_Q!_R+VI_]>DO_H!K0K/\0?\`(O:G_P!>DO\`Z`:`-"BBB@`H
MHHH`****`"BBB@`HHHH`****`"N?U+59K/5BGG+Y(*CRP`S$D>F0?H1FN@J-
MX8F<2-&K..C%02*`,"/5K@VR2_:8/,FP1"4YBRX7'!]^])]MEM=3>S62%)))
M")+AT/)$:G.,XS_A6BMUIQFVI%EW?;E8"=Q'7G';UJ:?3+:YNHIY8PQCW?*5
M!5B0!DC\*`,Z]O9Y_##70812-QE">1NQD'/?K0NIW2&.1VB:/[1]G\L`[F[;
MLYZY!/TK6?[.S_9'\LEDSY1&<KTZ>E-2PM(I5ECMHDD48#*H!`H`H:GJD]I<
MND21%(T#,QY*Y/<`Y`]\&JUI?7JW#0,\3/+-(5=]VU54XQU]<8]JTF73KZ/[
M8\<4BQY'F.G3:>>OH:8EGI-]),!;02N&#2'9R21D'-`%"VUVZO%>2&*")(D5
MG$S$$Y)'&.W%5)-2G2VOX%+*L?F2"1W.YOG(&WV%=$^FV4DB.]K$S1@!25'`
M'2D?2K&145[9"J;L#M\W7ZYH`RUUB[B9+-X8C=%HT!,AVD,N<GOG@U!)K4XF
M$DJ;)+?S(WC1_D=LH!SZ?-6N;+3[MIUV(YW!9,$Y#*./I@&G_P!DV`C$?V9-
M@4IC'8XS^/`YH`RSJ=[;3W*R0!YVD14169E'RY.,#/Z=Z?!K%[<R)`E@JR[&
M>02.5Q@XXXJ\-%L!$T8A(5F#'#MG(XSG.:?#I5E`RM%`%*H4`R<8)R<CO^-`
M%72M6FO;J2":V$#*FX`O\Q_`@?F*8^L7`D5UM%-L\Q@5S)@[N@)&.F:OVFFV
MEF^^"+:VW:"6+$#T&>@I@TFS^U_:?+)DW;@"QVAO4#H#[T`84&K:D)(;AX_-
M06C2.@D`!PWWNG7VJX?$):Z6.&SFDBWA3(`3@GKC`(X^M7DT2QCW[4?YXS$<
MN3A2<D#TI!H=D)-P60#<&*"0["1T)'2@#/C\2/\`9UNIK3R[5P^R3S0<E0>,
M8XS@U`_B1[LVRVL3K^\C\T@@D98@I@CVK8.BV1L8;,HQ@B?S`I;J<D\^O4TT
MZ'988!6&^?[02#@EO\*`,Z#Q9;D7'GP-$85)92XW`Y`P1P0>:N:-K]OJS2H@
MV/$NYAN!&/7(I(_#EBK/O\Z3<NQ=\A)09SP>O4"K=CID-CYA1I9'DP&>5RQ(
M':@#,7Q99M,R>6Q!5C&0P)?:,XP.F<=Z;=>(IELV9+-HI61)(]SJ059@,]??
MI5Q?#]HK-AY]F&"IO^5-W7`_QI;K0K>YC"&25=L*PC:>RD$'IUR*`*!UV\34
M%@-KE9)70YVY0A`V.&YQGDTB>+[2)(5G!9MBF5U(`4D`\`G)J]_84>^*3[3-
MYJ,69\@EL@!AT[XIG_".6X($=Q<1IA0ZJP^;``'.,CIVH`:^NM-<6HM8G\B6
M?R_-9<JX[XYR/Q%3WVJ_8=06*6/%OY+2-)WR.PY_SD41:'#%<1R+/-Y44AE2
M'(VJQZ]JFO\`2XKV=99'88C:-E&.0?\`ZX!_"@!]IJ,=S</`89H954.4E7!P
M>_6HQJT)NUMWBFC+.45W4`,WH.<_I2V.FBUFDGEGDGGD7:7?`^7L.*I6_AV.
M"_6Z\_<4DWK^[4$YZAFQD]:`':IK$MEJ"0B,"%4\R1RN25SC`&?>I9]<AMDW
M36]T@`RQ:/&T9QS_`/6I-2T2/4)WE:9D+0^40`#QN#9JIK/AG^U;MI3<A$9<
M;3$&(P,<'M0!;DUZW!80PW$P`(WQQ$KN`SC(JK9>)$DB66ZB\E7B5E502S,2
M1@#'/2GPZ#/&3"+]ULR2QB5<$L>N3Z9YQ4,?ARX\N/S+Q#-`J+;LD6`FTD@D
M9YZT`:2ZQ;&+<4G#[_+\HQG?NQGI]*L1:A;367VM7VP\Y9AC&#@U1MM)G2XC
MN;FX2:<2^9(P7:"-A4`#\:6+2BNB2:?+,&+[OG`(ZG/K0!%=>(H5M&DM$:28
M,J^6Z,IYZ'ITJ]<ZG;V7EK<EA(RY*QHS8]3P.E9R:'=E9&GNHY)6>+!V84(A
MZ?6GZWHUQJ4R-'<!4"[=C%@`?7@\T`:<U_;06@NI),0MC!P3G/3CKS6=<^([
M2/[.T>7CDD,;G!!C(&>5QFI;K3)I]"2Q#Q"155267*G;_P#JJC9Z!<PM:&:=
M'2*1W:,%B%RN!@G)/X^M`&C+KNFPJADN0-Z[A\I/'KTXZ'K1<:OIJL\,TRD;
M`6!4E2I`QSC!SD5@S^&+U[6VB6YBVQPLC*68#DD\8Z_C5N3P]+-97,,CHK2+
M#M(SU10,'IQF@#9L=0M+Q'^RR`B+`8;2NWCN#4,6OZ9-(R17:LRJS<*<87[V
M#CG%5/#VC2Z7]I:5H]\V,!&9@,9[MS6=;^&M1CN3+)/"V$E49D=B2RD9P>!R
M>U`&ZFN::\4DHNE"1`%BP(Z],9'/X4W3M9AOX[N5`1#;OMW\G<,9SCK5";1;
MN1MX>`2110K$3DJ70DG<,=.:NZ+975I'=->&'S9YC(1#G:..V:`*Z>*-/\U1
M*YAB9"P=_8XQCZ<U>DUG3HI4CDND5W`(!ST/3)[5DV^B7BQR^<;<O]F>&,H3
MC)8MDC''7M5<^&;P.R^:C)+L+-YSC:0`#\HX;IQF@#H[O4+2QV_:IUBW9V[N
M^*J"]TFSF,_VB*.2\`?);[X'`-5];2=]2TX6L:2.GF,%DX7.`.N#ZUFW'AJ\
M"JL3QOYD>R0ER@4YST'4<]/:@#>NM4TW]]!->1J54B0;\%1CU_&H[:_TFQLH
MUBN8DA)(7+9)/?WK/ET*<VLZ($9Q.DL:EN)`J@8/IWJK=Z-J5S*+SR(E9F;,
M$+B-ESCDN!R?6@#H)=9TZ$J)+R)=ZAER>H/0U$NOZ;YEPK7*((&"LS$`$GCB
ML:W\.W4%O<1.L4A:S,2-N_CW$]^>_6GW.E:BMS<M';I+&\J2+M=5;@8X)!P1
MZT`;C:QIZ6ZSM=Q")SA6+=32OJ^GHL;/>0J)>4);[WTKCFAN-%NX9;V.-FD,
MIQ*Y*@,`<[L8R._'-20:#?26D3I$7\ZV$>/-V>6<DY(/4<C@4`=M+/%#&9)9
M%1!_$QP*I3ZQ8QRPQK(LLD[801D'/.,_G5>_L9O[.L8XHDN'M70LC'[X`(/7
M^M5K32[A;BTFE@1<7$DS*N,1*1\J_P!?K0!M3W%M`0D\L49?H'8#/YT/<6RA
MM\L0"X5LL.,]`:QM2L;EM0NI%LQ=+<0>6C%@/*.#Z]N<\55DTJ_6:6$6WFI)
M<12&4N,87&<@\YH`W(KZPGC$Z30[5<QAF(&#GI5>PDLH+V[`O3-/P96E8?*!
MG@'I@5@7.CW2Q;(].<LK2@,K(0VX\94]1CCL1276EWB2G.EHS-Y)9XU4@`+A
ML#/)SV((H`ZV26S8).[P$8RLC$=/8TDEQ:V:.[.B#:9"%QEAW..]<OIFDS_:
MX5NK%O*\^5GWJN,,HQP..HIATN[73_(FTUYI6MPL3C'[DAF..O'6@#J(GL7,
MD@2)3DAF90,Y`/7OP14CI:+L\Q81@?)G'3VK`ATN1]1C\^U+P^;)NWJ",;%`
M/Z5E&W:"SEBO+1Y94@4(Q(_<?,W7)]^V<T`=O-'"^UYEC(7[I8`@9JJ%TQ97
MM1%`I($C+Y8`.>`>F*H^(;266QM8XH))@CC<J*&P-IZJ<`_F*RXM'FDL[C[1
M9GS5M5$''0@MP.3@XQQF@#IWL[%MD;V\!VC"*4'`]J8=-TYY?/-I;E_[_EBN
M2DTZ^&I^;]DN`_VD,7"ESMS_`'R>GL!23:+<1:;I[1V\RAE87,<:;BSG[I*Y
M`]>?>@#M%M+5(UB6",(H(50HX!ZBH5T?3U@>%+*!8I#EE"8R?6N3-CJ"R6?F
MQW;SJB[2XRO4G&0?E('7.<UW0Z<T`006<%O;^1#"B0XQL`XJ&/2+".)XDM(E
M1R"P`ZXZ5>HH`0#%+110`4444`%%%%`!4-UC[++DX&P\_A4U07O_`!YS<X^0
M_P`J`%LT$=G"@Z+&H_2IJ9'Q&O.>!S3Z`"BBB@`HHHH`*S_$'_(O:G_UZ2_^
M@&M"L_Q!_P`B]J?_`%Z2_P#H!H`T****`"BBB@`HHHH`****`"BBB@`HHHH`
M2N=U2SN9M19HX)"PD1A(H&-G&>2?T&*Z(G%9T,5Y/"LOVUU\P;@IB7@'F@#(
M.DW/E@PP>7*#<%6W8P2PV\]N.E-AL[M+=G\N\,*NADA8!2X&=V`.O;GO6V;6
M_&<:@3]8%XH%K?8_Y"`_[\#_`!H`P7ANA.\EO:W4)DMW$)+$LN&SSS\O&>*6
MW%P$::3^T&LQ*I:/:5;&TC@9+8SC/:MW[+J'_007_OP/\:3[-J0;=]OB/L;;
M_P"RH`H:;&Y\*SQF&16*RX1@0QSG'O68D<JQW%U:BY1A+`L?WQD8`.0>OXUT
MGDZECB]MS];<Y_\`0Z#%J>[(NK8#_KW;_P"+H`YJ-[_&UI;L7:+*9@$<C&#C
MDG&.F,"GWHNH?LX\V\C#VP9-AD<F7C/?K['CK70B+4_^?FUQ_P!<&_\`BJ=L
MU+/^NM?^_3?_`!5`&`/-^V2*KW*W4DZ@JNY4*;0&)ZCUJS:7!V7,5Y<7")8C
MR6D#'<Y+9#<=\`#\36OLU`J0TEJ?HC#_`-FJ"SL;BSB*0K;`,<N2&))]3DG-
M`&DOW1@D\=33JIG^T,<&VS[AJ!_:&.3;9^C4`7**I9U+^[:G_@3?X4I;40>(
M[4CUWL/Z4`7**I!M1QS%:YS_`,]&Z?\`?-+OU``@P6^>Q\X__$T`7**I&740
M?^/:W(_Z[M_\31YFH\_Z-;GC_GN?_B*`+M%43+J(SBUMR?\`KN?_`(BE\_4-
MV/L46/7S_P#[&@"[15,3WIQFS0<<_OO_`*U(+B]W8-CQZB4?X4`7:*H&[O0V
M/[-<C&<B5/ZTTZA=!U0Z;*&;H#(G^-`&C16>;V\`_P"09,?I(G^--.H7@_YA
M-R?^!Q__`!5`&E16>=0N!C_B67?)Q_`?_9J%U*4]=.O!P"?E7C_QZ@#0HJA_
M:+%L"RO/KY8_QH&HOD9L;SIG_5C_`!H`OT5GC4S_`,^-Z/\`MC_]>C^U/^G*
M]_[\T`:%%4#J8SC['>?]^32G4H\<P78X_P"?=_\`"@"]15`ZK""<PW7_`(#O
M_A2_VI!W6X'UMW_PH`O452_M*WQG]]C_`*X/_A31JUH>CR?]^7_PH`OT52.J
M6H/+2>G^I?\`PIO]KV>,[WQ_UR?_``H`OT5G_P!L67'[U_\`OT_^%+_:]E@G
MS6_[]M_A0!?HJA_:]CC)G`^JL/Z4AUK3QUND'U!_PH`T**H'6-/!P;I!GID&
MD_MG3\$_:XR!U/-`&A16>=:TX=;R+\Z<-6L&^[=Q'OUH`O451&K6!)`O(>.O
MS4#5]//_`"^Q?]]4`7J*H_VM8?\`/Y#^+4?VQIW_`#_6X^L@H`N%0W4`THX%
M4QJNGMTOK;_OX*&U*S)4K?VX`ZCS%YH`NT54&I6)Z7EOS_TT%*=1L@<&\MP2
M,_ZP?XT`6J2H%O;1R=MU"V/204[[5;YQY\6?]\4`2(I10"Q;'<]:=47VF`_\
MMH_^^A2B>$G`EC)_WA0!)13=Z'^-?SHW+ZC\Z`'5!):6\LJRR01O(O1F4$BI
MLCU%%`!2TE%`"T4E%`"T4E%`"T4E+0`4444`%%%%`!1110`5#=DBUEQ_</?'
M;UJ:J]\";*?"[CY;8'KQ0!.OW12T@I:`"BBB@`HHHH`*S_$'_(O:G_UZ2_\`
MH!K0K/\`$'_(O:G_`->DO_H!H`T****`"BBB@`HHHH`****`"BBB@`HHHH`:
MQP,^E0:?_P`@^WZ<QJ>#GM4\F-C9Z8J#3O\`D'6W(/[I>GTH`KZO<W%JD#0/
M"@>4(QE4D#/?J,4ECJ7F6C2W.`5E,89`2),="HZD?X5+J-F]X(5#H$20.P=-
MP;';K5/^S+N+:L$D12"4R0*X/?/RGV&3B@"W_:UE@GS3@*6^XW0'![=J2/6=
M/EF$27*,[$``9Y)Z"L^32+P*6B>`22I()`5.T%CGC'TQS4,6DZG%&R8M</+&
MY*LPQM`'H?2@#275H7O_`"DEB:$1,[.,\;2`?;'^%2OJEH;=I([B,X)49/\`
M%CH1UK'31=2$"VI-KY4<3Q*YR68,0>1CU%2QZ9?12K=I#:K+EAY"$JH!&,YQ
MR?PH`TTU!$TJ*]G^4-&K$#U-2)J%J\PA6=/,/1=PR>,_RJLEK=?V&EL5C%PB
M*H`8[3M(QSCT%4X=.O\`[2%F6$Q-<"X:56((..F,>O&<]*`+FI:O%9^;$I4S
MI'Y@5C@?3COC-31:G:/!YOVB+:H&\[QA2>QJEK5I>SR2&UA619+<Q'=)M().
M?2JTEA?/(LJ687RC'B,S8WX!!P1TQD4`;K74"0B9IHQ$<8<L-I_&FF^M1"93
M<1>6#M+;QC/IFLNXL[@Z$UJEJ#*S9,:MP`6S@$]>.*KSZ?>,YDBLLQK,76`R
M[,@J!D%3P>/UH`W?M=OO1?.CW.,J-PR1ZBFB_M"'(N82$Y8[QQ]:YTZ3>QM&
MT=@I",C;$D&W`SD$MR3SCTHN-#DDA1ETY3LF<O"65-ZDY&"#V]*`.E:Z@1E5
MIHP6&Y06'(]:(;J&>`3Q2*T1_BSQ7.?V1<FXMB+!8TCV*5\P2+MR<YR<Y`],
MYS6G963'0VLI;40DQE"O!R<?>X]Z`-%KB-49MZG:.1N%0:?J$=];B4#826RC
M$9&#CFL*ST6\^V13WD4;)(`\R8!(9!A1[YZ_A4:Z7<BU*V]E)#<.DRNY*C.Y
MLJ"0?0?K0!T-YJ"6UL9XU\\!@I$;`XR<59\Q-^S<-V,[<\US,M@X$K0:;-`D
MD<2-"@7YF#9)X/8#&?>I+"QG76!<W%G-YOFNQF+C;L(..ASGH,=*`.@EE\M6
MPI=@,A`1EOI3+.[6[M4G"L@89VMU'UK"O8)_^$@6[-G)(D3+D[2WR[?O*1[Y
M&WG/%9OV6YPJV]A<MYL#"92K("V_()Z9(&>,T`=KN&,Y&/6C()^E<=;V)-Q!
M;W5K>F$3ONS&RJ5*C'"G`&:OZ-9RPZB7E6]\X;@[2$>61DXP<9/;OQ0!T=+2
M4M`!1110`4444`%%%%`!24M%`"8HQ2T4`)BC%+10`F*,4M%`"8HQ2T4`)BDP
M*=10`W;]:-HIU%`#=HHVCT%.HH`;M'H*-HIU%`#=HI#&AZJOY4^B@!GEI_=7
M\J/+3^XOY4^B@"+[/#_SR3_OD4GV6#.?)3_OD5-10!";6`]88S]5%(;2W/6"
M(_\``!4]%`%<V-JQRUM">_,8I/L%IU^RP9]?+%6:*`*WV"T_Y]8/^_8_PI/[
M.L^/]%AX_P!@5:HH`J_V=9CI:P?]^Q2BQM`<BVB_[X%6:*`*QL+0YS;0\]?W
M8H^P6N,?9H<?]<Q5FB@"D^FV8C;;:1$@<`*!F@Z79N0S6RJV/X21_*KE%`%#
M^QK+/^K;_OZ_^-*-(LU?<$?(_P"FC?XU?HH`R+[3;>WLY)(O-5U'!$K'O]:U
ME^Z*IZN6&FR[,[N`,''<5<%`"T444`%%%%`!1110`5%<C,#C`.5/4XJ6JU_G
M[')CTH`L#H*6DI:`"BBDS0`M%%%`!6?X@_Y%[4_^O27_`-`-:%9_B#_D7M3_
M`.O27_T`T`:%%%%`!1110`4444`%%%%`!1110`4444`17!*P2,,DA2>*;99-
MC`3U\M<_E2W9`M)B?[C=\=J6V`6VB`X`0#]*`):*3-&:`%HI,T9%`"T4F110
M`M%)10`M%)2T`%%%%`!1110`4444`%%%%`!1110`E%+10`E%+10`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1124`+1110`4444`9^MMM
MTYC@']XG49'WQ5\=*H:V<6*]>9H^@S_&*OT`+1110`444T@[A@X'?WH`=111
M0`56OR%M')&0<`_B0*LU5U''V0AFV@NHSC/5AQ0!9I:2EH`*:Z[L<D?2G5%.
M2$&#CYU[X[B@"6BBB@`K/\0?\B]J?_7I+_Z`:T*S_$'_`"+VI_\`7I+_`.@&
M@#0HHHH`****`"BBB@`HHHH`****`"BBB@!DJ"2)D/1@0:A2*XC14$T>U0`/
MW9_QJQ1D=*`(-EU_SVB_[]G_`.*IK)>8^6>$'WB)_P#9JLTC'Y3CK0!6V7V?
M^/B#&?\`GB>G_?=+MO1C]]`?7]T?_BJL*<BEH`JE;[/$MOC_`*YM_P#%4%;[
MC$MO^,;?_%5:HH`ID:@!P]L>/[K#^M-)U/'`M"?]YA_2KU%`%+?J8/\`J;0C
M_KJP_P#9::9=5!XM+1AZ_:&'_LE7Z*`*/GZG_P`^=N?I.?\`XFB2YOT&?L<(
M'J;C_P"QJ]10!2%QJ'>QB_"X_P#L:/M-_P#\^"?]_P#_`.QJ[10!2^TWW_/B
MG_?\?X4GVJ^SC^SQ_P!_A_A5ZB@"DUU?#[NG;O\`MLM-^V7W&=,/X3KQ5^B@
M"C]LO,G_`(ELN!W$J?XT[[7<Y_Y!\V/^NB?_`!57**`*8O9R<'3K@?\``D_^
M*H:_D7K871XSQL/_`+-5RB@"E_:#]?L%W^2__%4-J+#'^@79^BKQ_P"/5=J%
M[N%)&C+,67J%0MCZX%`$`U%LX^P7@]]@_P`:0ZD%7)L[O\(LU-]M@]9/^_3?
MX4C:A:KC=(1GGE&']*`(GU148`VEWG&>(2:8=8C#8-I>YZX^SM4QU.S!P9@#
M_NG_``J%M9LUN%C\SA@3O[`C''K0`W^W(,\VMZOUMFH.NVX&YK>\4'H3;/S^
ME3'6-/7&;E!DX'!IIUO3`2#=Q@CKUXH`C;7K1,%H[I5/\1MWP#Z=*&U^Q0D,
M9ACK^X?_``J1=;TQNE[#^)Q1_;>EG/\`I]OQU^<<4`1?\)#IN,F60?\`;!_\
M*5M?TY6(,S9!P<1/_A4PUG3&&1?VW_?P4[^U-/V[OMMOCU\P4`5QK^G'/[Y\
MCMY3Y_E3EU[3F_Y>".,_-&P_F*G.IV`SF]MQC@_O!1_:5A_S^6__`'\%`$0U
MK3B,B[CQ[\4HUK36Z7D/XMBG_P!IZ?C_`(_;;_OZO^-!U/3AUOK8?65?\:`&
MKJ^G-TO8/QD`I?[6T_\`Y_;?\)!2C4=..,7EK[?O%IWVZQ.?]*MSZ_.*`&G5
M;``DWMMQ_P!-1_C2_P!IV'_/[;_]_5_QH%YI_.+BV]3\ZTX3V9.%D@)QV(Z4
M`,&JZ>>E[;D]?]:/\:/[4L-VW[;;Y_ZZK_C4JBV;E1$?H!3A'`PX2,CZ"@"$
M:I8'.+VW./\`IH/\:/[2L?\`G\M^?^F@J7R8!SY4?_?(I?*@QGRX\?[HH`8+
MZU(R+F$CV<4?;K4YQ<P\=?W@I?*MC_RSB_(4&&V8?ZN(_P#`10`?;+;'_'Q%
M_P!]B@7=L>EQ$?\`@8IOV6T(QY$/'/W!1]DM"2/(A..HV"@!WVNW/2>/_OH4
M"[MSC$\?/3YQ3!968/%K!GU\L?X4U-.LE!Q:PG)SR@/\Z`)OM$6?];'_`-]B
ME$\1_P"6L?I]X5#_`&?9#_ES@_[]K0-.L><65N`?^F:_X4`3">,G`D3_`+Z%
M.\Q>?F''7FJ_]G6/_/E;_P#?I?\`"D_LVPP1]BM\'K^Z7_"@"UO4]"#]*';:
MA;!.!G`&2:I_V7I_(^Q6_//^K%!TJP)R;6//TH`N`Y%+FJ!T;3N]LGYF@:-I
MXY%LOYG_`!H`OYI,U2.D6/\`SP4?\"(_K0-)LNT6/H[?XT`7LT9JC_9-EG/E
M-_W\;_&D_L>Q)SY'/J';/\Z`+](."3GKVJE_9-E_SR;_`+^-_C2?V18X_P!6
M_P#W];_&@"_16<VC6+=5E&/2=_\`&D&BV?.#<#V6XD']:`-.BLPZ):9!$EV,
M>EU)_C0-%MNTUW_X$O\`XT`/UI2UG&`"3Y\?`./XA5\=*SVTBV9T9WGDVL&`
M:=B,CD<9K0'2@!:***`"BBB@`HHHH`*J:B$:V429P9(^GKO&*MU3U/'D1@D?
MZZ/&?]X4`6Z6DI:`"H;G;L7=_?3\]PJ:H;AR@4A<Y91^HH`FHHHH`*S_`!!_
MR+VI_P#7I+_Z`:T*S_$'_(O:G_UZ2_\`H!H`T****`"BBB@`HHHH`****`"B
MBB@`HHHH`2LR+S?[8,"7<SQQ+OD5MI&3T&<9]?TK3J`6D:R3NNX-/C>0?08X
M]*`(M7FD@T]Y(6*OE0",9Y8#OQ61<WMY'9RRP?:XY`Z1_P"DJBCD]5P.:V)=
M/CEL5M&>78H&&W_-QT.:A.D*RE9;JYE7<&P\F<8.?2@#$_MVZTYI%N!YLGF%
M%5I.%"]^%SDGO_*M"/7;B["M86/VA%16F^?:RDCH`>M6I]&BE8R1S3P3%R_F
M1/@\]1]*BDT"%F4I/.B$*)4#\2XZ;J`*$&MWJ@2W$0(`DW(K#`"N!GIV!/Y5
M9NO$8@>55B1L2E(RS[0P4#<<X]3BI[?08897=II90RNH5B,`/UI1H,,=M#%;
MRR021$D3+@L<]<Y]?Z"@"5=6CDTE+Z-"WF8"(>"6)QC\ZSH-;O1/>)):`O'(
MJJA=55!C)RW2M633D?3ELU=U"`;'SE@1R&^N:S1X:8$2_;Y3<[][2.BMDXQT
MZ4`-7Q*#<JQBQ;&#?_M;MVWUZ9X_7I6EINI"_5P8Q'(@!*APXP<XY'T-9Q\,
M*T2QF[?`1E)V#YLL6!_`UHZ;82V2N);DSEL8.P(%`]`/K0!5EU^/RI#%!*3L
M=HF*C:^WKW[4R35KF+1(KID#3R@$`+PN2.<9Z<C\Q4G]BR%"CW99%1TA4IPF
M[N>>:GFTTR:1%9"0`QJ@WD?W2#_2@#*DUZZA4AVC^4/N;R>ZL!T#>_K6G'K=
MNUP(/*G7+L@D:/Y"5SGG\*HS^'9)5D'GH-Y8_=/&7#?TJQ+I$GD1J6654EDE
M=,8WAL\?7GK0!)%KUO*[*(;D8C,H)B/SJ.X'?K5F]O?L]LCH`9)65(U;NQ..
M:Q=.M]5^U[V+#RK<QQM-&%`.1CH>>G6M75+9YH+>0`M);RI+A>^#S^F:`$_M
MJU%W]F/F9W^5OV'87QG&?6JDGB>U-K++!%,Q5&9-T9`;'4`TX:3=+<%1<(;,
M3_:-NS+ELYQGIC-4;;0[VZT](;N2.-$BD6)0IW!FSRW/;-`%VW\0QE9'N!A0
ML6U$C;>6<$XQWZ=JED\1V$<4<A,K"0,0%B)(V]<CMBJ$&AZE%*+KS+47*-'L
M`SM(52I!^H-26^AW<,V]I8W+I*9.2,.^.G'08H`O3Z_80+&SR.4D0.'6,D`'
MH2>U16NL237!#QQB#[2\`<$YS@%?SY_2LV;P_JC60MO.@=3"D>6D<!,=<`<'
M)[FI[?3YH94LY6R[W9NRR9(51V)/<D8H`Z/J*H:?S?ZB3U\U1^&P5?Z"J&FC
M%WJ)SUG'_H"T`7\48HHH`*,#.:6B@!NT4N!2T4`-V+Z#\J;Y4>2=B\]>*DHH
M`A-K;MUAC/U04?9H,8\F/'^X*FHH`A^S0$Y,,?K]P4&UMSG,$9SP<H*FHH`K
M?8+,C'V6'&<X\L=:5K&T9MS6T)/J8Q5BD)Q0!7%A9@8%K"/^V8I#IMB3DV<!
M)Z_NQ_A5A6##*D$>HIU`%/\`LO3_`/GRMO\`OTO^%-&D::.EC;>G^J7_``J]
M10!2_LC3L8^PV_\`W[%`TC3EZ6-O_P!^Q5VB@"D=(TX];&W_`._8IIT732VX
MV4.?]VK]%`&>-$TP'(LH>F/NBAM$TQ@`;*'@YX7%:%%`&:V@:4QR;./\,BC^
MP=+[V<?3'>M*B@#,.@:9VM57_=8C^M)_PC^F9SY#?]_7_P`:U**`,PZ!II_Y
M8-_W]?\`QH_L#3LD^2X)])7X_6M.B@#,_L#3^/DEXZ'SW_QH_L"PY.V;)[^>
M_P#C6G10!E'P_9'O<#_MN_/ZT#0+,?QW7_@0_'ZUJT4`98T*V'2:\_\``E_\
M:>-'@`P+B[_\"&_QK1HH`SSI$7/^E7G/_3PU-_L>/(/VN]X_Z>&K2HH`S?['
M3C%[?#'_`$W--;1(VZWM\?\`MX-:E%`&8-%C"[?MM]C_`*^#1_8R`Y%]?CG/
M^O-:=%`&>-)4?\OE[TQ_KC2?V5C[M_?#'_37/\Q6C10!073G7IJ-X?JR'_V6
M@6$P;/\`:5V?8[/_`(FK]%`&;/'<6[0,MY-)NE"E65,$=^@!Z"M$=*IZCC=:
M`@'-PO?IP:N4`+1110`4444`%%%%`!534"0D.!G]\F?;FK=4M3R8H``3^_C)
MQVPP-`%P=*6D'2EH`*:RANHSCFG44`%%%%`!6?X@_P"1>U/_`*])?_0#6A6?
MX@_Y%[4_^O27_P!`-`&A1110`4444`%%%%`!1110`4444`%%%%`!12&L;3]5
MGNM2>WD2+:"_"YW+@X!.>#GVH`VJ*I:M=R6=F98E#-N"Y;.%SW..PJC#J=R+
M>*21[1U:<1F5'.UE(R3WP1[\4`;=%947B#3Y(Y75Y-L:>8Q,3<KG&1QR*4:_
M8&(2*TK$OL"+$Q?/^[C-`&I16(/$EF]V(U#F+RC(9-AXP<8QCVJW<:S9V[2K
M*[AHV52`A))(R,>O`H`T**SH];L))S$)B&&>JD`XZ@'H3[5+-J$$>FF^R6BV
M[A@<G/3B@"Y16=_;-E%\ES,D4R)ND4Y^3IQG\:5=;TXVXG^U((RVW)X.?3'6
M@#0HJHNI6;H76YB*A=Y.X8"YQGZ9J(ZI;1F0SS11*K;5)D'S<`_UH`T*2JT>
MH6<LK11W,3.HRRAQP*IOKMMYTJP@SI"@=WC8$`9P?RH`U<48I$=9$#J<JPR#
M[4Z@!`,48I:*`"BBB@!*,4M%`"8XQ5%[*59I9+:Z:+S6W,"@89P!_2K]%`%`
M6U\/^7_MCF$4C6VHGIJ*#_MW'^-:%%`%#[/J(Z:A'^-O_P#7IOD:EC_D(0Y_
MZ]__`+*M&B@#.$&J9_X_X".W^C\_^A4TP:O@XO[;/;_1CC_T*M.B@#,\K6!T
MO+,_6V;_`.+IP35@.;FT/_;%A_[-1K<TL5DJP/Y<DTJ1!O3<<$_E6;-K&I+<
M2PV]O;.JM*J&20@D)C.?SH`TT&J<[YK/\(V_QI0-4[R6G_?#?XUGC7G-H)1'
M#O,A4(9,9'E[A^N!52RUN]O[NQ'[J+,K)+&"<D;<@D'D?XT`;?\`Q->?GL_;
MY'_QH']J@<FS)^C#^M9=QX@FMIK@RP1_9XI7B5@QW,P7(X]Z%U+4I=2M()(8
MXL2%90DN0PV@^G8'\Z`-8MJ('W;4G_>;_"D#ZB>3':D8X'F-_A6,^LW.GWU[
M)<H9+%)MN[(W)\N0`/3C]:MZ-KK:H9D>#R2(Q(A!)R#ZY'%`%]3J(&/+M1]'
M;_XFE#:AWCMO^_C?X5SUEXHG$-K$UN)WD49E\P#DYQGCC\<4MEXKD*0)/:LS
M;5\V1<\%NF`!Z8H`WWDU'G9#:^V96Y_\=I/-U('_`(];8C'_`#W/7_OBLNYU
M;49/#LM]%:I"Y"F/$@8[2>3TJO;^(KJW63[9;9!>;8WFCDJ?N].G;-`&Z9M0
MY_T2#I_SW/\`\32^=?\`_/K!_P!_S_\`$5BIXFGECS%8*[J)&D'G8`"!3D''
M/WJGU;5)HX;)XIQ:Q7"%VD\OS",`$#'O0!IM-?C.+6`X_P"FYY_\=I#/?Y.+
M.'KU^T?_`&-8=EK5[<36]R2H@DF2W:';@Y*@[@>OX>E3:IKEPEP8[6WD\J&X
M2.68$<DGE<'MSUH`UQ->[<FUBSCIYQ_^)I!/?<9M(O?$_3_QVLFU\3^>N]K7
M8@D0,PE!"HV0&/OQT]ZFL?$/VN^AMC:-'YB@EF;U&X8'<8[T`7S<7_:QC(_Z
M[_\`UJ1KG4`N181D^GG_`/UJKW>MK;WS6BV[N^0H(9>25)Z9SCWK)TOQ%<H-
ME_&TKR^68L;%^\"3WZ<=?Y4`;WVG4-QS8)MSP?/&2/RI?M5[WL"?I,M5+#7H
M]1NA!;6TQ*C,C-@!.OOSR*IKXCN(WE,]A,5C,I94`)4+M[YYQDYH`US=W@_Y
MASG_`+:I_C2?;+W_`*!DG_?Y/\:KVWB&SN+U;:,.0QVB3C&['3KGVZ4V]\16
MUE<2++#<&*,['F5,J&QG'\J`+7VR\Q_R#9?^_B?XTAO[L'!TNX/T>/\`^*JC
M%XFM[E4%M;SRRNQ41C;G@9]<=*S9O%-WY<2K;[))!'D[-P7())^]SD+[4`;X
MU"ZSSI5T/^!Q_P#Q5+_:%SGG2[G_`+ZC_P#BJHVWB2%X$DD@G8!%,LD<1*(Q
M7./7\LTU_$\)D@\N&549\2EUSM&W/&"10!H'4+G'_(+NOSC_`/BJ!J,Y'.EW
M8_%/_BJ99:U:ZBDIMBP:-=Q#C''8\=JCT[7(+QXH#N\]T#'"$+TSC)]C0!8_
MM";!_P");=_^.?\`Q5"ZC(2?^)?=C`[JO^-8UWXDN8+Z\A2V4QP':K.&&2!D
M^V/_`*U:/_"1:<'EC:;YXAS@<,>,A?4Y.*`+`U"0G_CPNQ]57_&D.I2`X_LZ
M\^NU?_BJ@L]8:YG0&'9#)(\:E@0P*\\@^V:UZ`,\:F^<'3[P?]LQ_C1_:3_\
M^%Y_W['^-:%%`&?_`&D__/A>?]^Q_C2C4FQS97@_[9?_`%ZOT4`4AJ"D9-O=
M#_MB:<+].<Q7''_3!O\`"K=%`&;<SFXEM5ABE.V<,Q>)@`N#SDBM$=*6B@`H
MHHH`****`"BBB@`JM=\M;@]#*.WL:LU7NOO0?*3^\[''8T`3BEI!2T`%%%%`
M!1110`5G^(/^1>U/_KTE_P#0#6A6?X@_Y%[4_P#KTE_]`-`&A1110`4444`%
M%%%`!1110`4444`%%%%`#6Z5F0:9-"8]MPF(%<1?N^[=VYY_2M6B@"I=6\\R
M1&*X,4D;!L@95O8C/3\:HS:0\B2M(ZEG<R%8TV@_(5P.>ISUK9HH`Y6UTV[O
M4FCE1X%%JD"N\.T\-G&-QS]<U<DT:\^URSPW8599-[(-R[N,#)!SQ6]4,]S#
M;)NGE2,>K-B@#`A\/7-NK(DL#*T#1,Q5@1EBWOZ^M6HM-G6_^TW$L"R23+(4
M3/(5&7C/4\YJ:;4+J9BEC9L5Q_KYOD0?AU-9NAV,]YJ+ZA>3>>L1*Q/C`9L]
M0.P&/QH`GM]"FAG4[T>..0RH3(_)ZXVYP.>_-6]6CGFT1Q)"K2@*SQID@X()
M`_*M2@T`<]<:3<W=M=O&PC::=)HP&(.`.A..*CMM*U&UG6\(6XD)(,4\Q8@$
M`9W8Z\>G2NEZ"LJ[GEU&5K.QEV(O$TZ]O]D>]`'++-.T'V2U@%Q/-`\+QH<&
M,^8QR<C'0UJP:9JQO+>9[:")5D+X9R^WY%7D`@'I716=G#9P+%"H"J.IZGW)
MJ>@#CK?P_K(:2!YH5@4/L;8.2V<].><\YH87>F":6YTU$CFMQ;J(7!`/3)'7
MG\>E=E32H/4`_6@"A9WUI%I<,C7<7EJJH9"P`W8Z'T/M3'\0:5&1NOX>?0YK
M/\1Z%YT?VBR3]Z&W/&.C^^.F?YU<TF6"^C(-@L9"C+A!L?Z'^E`$PU[2F/%_
M`/JV/YU9MK^TN_\`CWN8I?\`<<&AK&T?[]M"WUC!JM<Z#IMR<O:1*>>4&P],
M=J`-&BN<E\.7=M,LVF:I.A7I',Q9?\/S!JS%JUU:R"/5;-HEX'VB+YH\^_I0
M!MT5%!<17$8D@D61#T93D5+0`4444`%%%%`!1110`4444`5K^T%[;&$NT9R&
M#KU4@Y!H2RMUR3$A=@VYL8+;L;OSP*LT4`4?['T[S?,^QQ;]NW..V,?RI(M&
MTZ$0B*U1?)<NA&<ACWS5^B@"I_9MGE\VZ'S&9FSSDL,'\Q3(=(L(%B6*V5!"
M_F)@G(;USFKU%`%`Z/I[737+6RF5\EF))W9&.1G'2G6>E65CN^RP"/<-IP2>
M/3D\"KM%`&4OAW2D9&6T`V,&`#MC(Z'&>M">'],0KMML!1C&]L''3//.*U:*
M`*CZ=:OI_P!A,7^C;=H0,>!]>M5IO#^FSPI');DJFXK\[9!;J>O6M2B@#*@T
M&QMX&C1'RZ,CL7)+;@`3^@J2[TBVN[>"%]ZB$;49&P<8QCZ&M&B@#.31K-+Q
M+E8R&3&U=QV@@8!`Z9QQ27&B65S<&:5')8AF42,%8CH2,^E:5%`&-+H4:6\L
M5F=IG`21I69_E'ID]:MII-G'=_:4B*R;MQ`8[2V,9QTS5ZB@#.DT>UDO&NF\
MS>6#8#D+D#&<=,XJ!_#UDS(Z&>-T0*KI(01@8!^N#BMBB@"A8Z5;V$KR0^86
MD558NQ8G&>Y^M0OHD+&[Q-,OVE75@&!V[\;L9'?%:M%`&;;:/!;7(ECDEVKR
ML1;Y`<8)QZU'<Z#:75Q))*TQ5SN,:R%5#XQNX[UK44`94.AP17$4YFGDEC8G
M>[Y+9&.?P]*JQ^%;1``9IWP01N(XP"`.G^T:WZ*`,-/#%I'`;>.:Y2!E`>-7
MP&(&,]/TZ<4G_"-6^03<7&0V<C:.-N,<#TK=HH`S;+21:1RK]IED,B;`S@?*
M/H``?QJ&#0(HKV"X:>600*%C1L<$#'7K[XSBMBB@#%O?#\5X9B\S`2N7(V@X
M^4#'TXJ)?"]NF\+/*$SNB4`?NFSG(/4X-;]%`&3!IDT5S"9)O.6-VE:1A@LY
M&.@]!6M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%5KI=T]I[2D_
M^.-5FJUS_P`?-I_UT)_\<:@"P.E+24M`!1110`4444`%9_B#_D7M3_Z])?\`
MT`UH5G^(/^1>U/\`Z])?_0#0!H4444`%%%%`!1110`4444`%%%%`!1110`E%
M(^[8=F-V.,],U@#Q&8#=Q7T`BG@'RJ&X<_YQ0!T%+5#2+NXO;03W$`AW\HN[
M)(]?:K]`!5(Z=;O?B\DB5I`H"DY./PZ5=HH`J:HYBTRY=`-PC8C/KBG6%L+2
MSAMQC]V@!QZTW5$,FFW2>L38_*C39_M&GV\N[=NC'/OCF@"W12=JSEUW3_,D
MCDN%B>-MI$GRT`.UJ:2'3W$1Q)(PC4^FXXJ>PLXK&U6"$851U[L?4UD:UJUA
M+8@PW43R1R)(H!ZX.?Y5>37+"5ML,KS,>T<3-_(4`:-+6:^JOG$6G7C\]3'M
M_G4;:I?Y/EZ-,1VW3(N:`-6BL5)M?F4$6UI!Z[V+']*>+76I&);48(O:.#(_
M6@#7K(B)T[6/(/\`Q[7;%H_]A^X_&G_V9?.09-7FSWV1JHJKJNE!+4W#7EY*
MT3*XW2X`P1G&!P<4`;V11D>HK,.B6TBXDFNG!];AN?UI7T#39!AX'8>AE?'\
MZ`-+(/>D."*H+H6G(,+;@#_>;_&D.AV!_@E'TG<?UH`I7D;:'/\`;;1/]$8_
MZ1$#TST85NJP900>#TK)N]&M193(;BZ2/8<YN'P!]"<53T_3]1>PLY[?5)E)
M52T<HW+CT'3M0!T=+2#I2T`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!124UY40X=U7ZF@!U%0RRJR%8YXU?CD\]_2G":,_==3]&%`$M%,\Q",AE/T-
M'F+G&1GZT`/HINX#K1NH`=129HS0`M%)FC(]10`M%)D49H`6BDS1GVH`6BDS
M1GVH`6BDS[49]J`%HI,^U&3Z4`+129HH`6BDI:`"BBDH`6BDI:`"BBB@`HHH
MH`****`"BBB@`HHHH`*K7'-U:_[S'_QTU8JO*1]L@&"3AC].E`%BEI!TI:`"
MDI:CDZIU^]V^E`$E%%%`!6?X@_Y%[4_^O27_`-`-:%9_B#_D7M3_`.O27_T`
MT`:%%%%`!1110`4444`%%%%`!1110`4444`(:X77;B.[U9[J&#S(;4J)3_>P
M?\C\*[.\2.6!HI93$).,J^T_@:K6>GV-M926L6UHY,[\L&+9]:`+5G/%=6L<
MT!!C=05QV]JGK/TNPM]+B:*"5V5CG#L#@^U71(IZ,#]*`'T4W</6JUOJ-O<S
M/%"S,4ZML(7\^AH`M$`CFN8EDDL].U2Q4E?);?'CJ(V.>#[<UTVX>M8^L(!?
MV3`J#,3`ZG^)&'-`&PO*C!R*9);03',L$;GU9`:H:7>%<:?=D+=0@*,GB1>,
M,/\`"M/-`$2VT"*0D$:YXX0"LT.=$<I(I-C(V4<<^23V/M[UKYI&4,,$`@]0
M:`$21)$#HRLIY!!R#3LBLR?2`K&2PN9+-R>0G*'ZJ?Z4P2ZW`V&M[>[3^\C[
M#^1H`UJ.*SO[4EC4F?3KI,#^`!_Y&HFUVS.W?]IAP0>86!/MTH`UJHZY_P`@
M:\Z?ZH]:A/B'30"3,PQUS$_^%4M5URQN!#;13%T>13*51CM4'//'>@#>@&V"
M-3U"BI*R_P"WK#Y</(Q;D!87/]*%URWDQY4%W("<`BW8`GZD"@#4I,BLR74;
M\DK;Z5*<'[TLB*/T)-0FRU2_;-[=BUC'_+.U)RWU8_TH`75)O[0E_LNV96WC
M,[AON)GI]36NB+&BHHPJ@`"H+.RMK*/9;1+&IZXZGZFK-`"4M%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`AZ5EBUANM9NFN((Y0D<87>H;'WJU#T
MJA;!?[5OF"_-B,9_#I0!(=*T\@`V-O@?],E_PH&E:>!@6-O_`-^E_P`*N44`
M4O[)T\C'V*W_`._8IIT;32P)L8,C_8%7Z*`*+:/IS=;*#\$%-&BZ>&W?8XL_
M3C\JT**`,_\`L73O^?1/7C-!T73SUME_[Z/^-:%%`&=_8FG_`//JI_X$?\:/
M[$TX];./]:T:*`,[^P]-_P"?-/S-(VB:>5P+8+_NLP_D:TJ:W3!Z&@#..B:>
MW_+(C_=D8?UI/[`T_J(Y/^_[_P"-8UK870=KBR1+9(9YF:3>3Y@#'"[?3CUJ
MQ#JNJS)`@2W\V6'SAM7''`P=S`=?2@#1_L.P_NS#'_3=_P#&@Z+8[<[IPO7B
MX?'\ZRTUN_EG:"6*W7<KG:<E6`7/#`G/?(I+JZDGTF:"".".&*T21AALG<,X
M`[8]>:`-)-!M1(S>=<["!@"X<8_'-/.AVA(/F7?'_3R_^-48=5O2YCMK=&@B
MD\H,2,8`QG.[U[8J--:O;BT<LL,):U\Y2H+$?-MH`TO[#ML8$UX/^WE_\:!H
M<"MN$]W_`.!#?XUH0[O*7S&#-CD@8!_"I*`,W^QX_P#GZO.?^GAO\:/['3C_
M`$R]X_Z>#6E10!G?V5CI>WHY_P">V?Z4X::1_P`OM[_W]_\`K5?HH`SSIC?]
M!"^_[^C_``I#I9.,WU]Q_P!-?_K5HT4`9XTMATU"^_[^C_"C^SI5&$U&\'U9
M6_FM:%%`%%;*Y4Y_M*X/U5/_`(FD^QWF3C4I?^_:?X5?HH`SH/M4.H)#-=-.
MKQ,W,:K@@KZ?6M"J+`G6XVSP+=O_`$):O4`+1110`4444`%%%%`"'I5:3_C_
M`(.O^K?^:U9JL[K_`&C&F1N\ICUYZKV_"@"R.E+3=PW!<\D9IU`!24M-.<C'
MXT`.HHHH`*S_`!!_R+VI_P#7I+_Z`:T*S_$'_(O:G_UZ2_\`H!H`T****`"B
MBB@`HHHH`****`"BBB@`HHHH`@O/LX@+W2QF-/F)=00*H0OHMQ@PQ6KEF"<0
MC.3T[>QJWJ<,EQ830Q",LZX`D'RGZUB0Z5>Q1LS[4C4[@N_S&7",,@XR>HP*
M`-O^S['_`)\[?_OTO^%']G6./^/.WZ_\\E_PKE=-MI+T+$D9V+Y2RG>WS?,2
MQYQSCM5A=&U)9(B,@1N,8EZ+N.1UZ8Q^=`&U<Z587-K-'%;VZNP*[Q&ORFLH
M0RQ`1-X9@F9!@NC(%;'<9%,;2=0AWBWBEV'S@%2<#EONGD^G\JBDT;4VA=R]
MP)#,HVK/UC`YX!'<>N:`+ATB[N0/]!TRS4]<1>8X_D/YU-!H>D6<BQ3;9)I?
MN^:W)]<"G36^H?V+:PY=Y`5\_:^'*]P#ZU#I6FW2W\%Q>"4LD)(+29P2QP#^
M!H`F?2M$W?9<Q).>%'F?O!],FLCRM.TNY,>H%98LX\^*=\J?1UW?RJW_`&=<
M+;2VGV)C<-<;UN05``SG=G.?P]ZSVT&\4>:L<[2%)CRPZG[OYT`;UMIFDW2+
M):RO(N./+N&/]:D_L*U!^6:[7Z3M_C6!-I-R\T\GV>Z6\`S'Y;!8]N!CD8YZ
M_C4UM!KDP@3[5=1JSD,77[HQU.<$\T`;8T6+_GZO,?\`7=J0Z%#C'VN^_P#`
MEJ=Y6L*H"W-H_'5HF!/Y&F#^W/,VEK#;_>VMQ^&:``:'%C`O+W_P(:F2:-;Q
MH6DU"]11U)N"`/SJ5;;595_?W\<1]((L_JW^%.31;4R"6Y,MW(.\[;A_WST_
M2@##:V^VSF#2KF]FV\/</<L(T/X=36E'X;BC.];V]61L&1DEV[CZ]/YULI&L
M:A44*HZ`#`%.H`R3H60`=2U'_O\`_P#UJ9_8#J?W>K:B/9IMW]*VJ*`,A-'N
M(QQJ]Z?8E3_,4[^S;_MK$^/>)/\`"M6B@#+^P:D#QJ[]<\P)2_8=2[ZNW_@.
ME:=%`&>+741_S$E/_;N/\:0VFI$_\A)!_P!NX_QK1HH`S#::K@XU.,>A-L#C
M]:!::J!_R$XS];8?_%5IT4`9QM]6VX%];9]3;G_XJCR=6!_X_;0CWMF_^+K1
MHH`SO*U;O=6A_P"V##_V:E\O5NUS9_\`?AO_`(JM"B@#.\O5O^?BS/\`VR;_
M`.*H\O6/^>]G_P!^V_QK1HH`S@FL=YK+_OVW^-*%U89S)9M_P%A_6M"F@8SR
M3]:`*)&K<X^Q'T^]2@ZH!REF?H[#^E7Z*`*>Z_`_U-N?^VK?_$TX-?<_N+<_
M]MC_`/$5:HH`8FXH-X"MCD`Y`JJEO/#=W,R+&ZS%2,L01@8]#5VB@"N&N><P
MQ>W[T_\`Q-(S78Y6&(^WFG/_`*#5FB@"J9;O/_'JA'M+_P#6I!+>=/LJ=#SY
MO&?RJW10!5\V[W`"U7![F4<?I2&:[Q_QY\Y_YZBK=1EG\U5"90@Y;/0_2@"`
MSW08#[&2"3R)1Q[THFN3C-H1D9/[P<>U6J*`*J37+$;K4K[F04/-<K]VT+?1
MUJU10!3^T7/'^@2_]_$_QI);B;;AM/FD4@Y`9#_,U=I*`,@;8X3%'H<HCDY9
M%$0'X_-22")HUA?09&CC^XNV(@?3YN*V,5%<^<(6^S;/-[>9G;^.*`,@QPDL
M_P#PCTNYA@_+%R/^^J1[>VE"+)H$FU!A<K'P/^^J4:I>0VXGNXX2FYT"Q!R2
M5W?_`!-,B\3P`,;F.1"2`B*I+8V@DD=NM`$K6]H\C2/HLN\KM)")DC&/[U`M
M+*)=JZ/.`R%3M"_=]/O5KQ.LL:R(<JPR#ZBGXH`SXKOR8ECBT^[55&`H1>!^
M=._M%@!_H-V?^V8_QJ]BC`H`I#4#C)L[L?\`;/\`^O3A?J?^6%R/^V+5;Q]:
M,4`5/MJ_\\;C_ORU'VY/^>-S_P!^6JWCZ_G1B@"K]N3'^IN?^_+?X4BW\9./
M*N?^_#_X5;Q1B@"J+Z+/^KG'7_E@_P#A2B^A/\,__?A_\*LXHQ0!6_M"WV@Y
MDP?^F+_X4TZI9@9,K#C/,;#^E6\48H`SK:XAN]6,D#AU6#:3@C!W?_6K1H``
MI:`"BBB@`HHHH`****`$JL0/[0!R<^4>,G'459JL"3J)7MY6>OO0!9I:2EH`
M*8QPR].33ZCD/SH,=3^7!H`DHHHH`*S_`!!_R+VI_P#7I+_Z`:T*S_$'_(O:
MG_UZ2_\`H!H`T****`"BBB@`HHHH`****`"BBB@`HHHH`**J:G?+IUD]RZ,Z
MICY5ZG)Q66WBNS07'F12JT!"LIQDG)''/M0!OT5COXA@CD(:WN-B;=\FT$+N
M&1GFE/B"U$I&R80A_+-P4_=[O3-`&O35R2<C'/YUEOK]JEP\3QW"JC^69?*.
MS/UI\6MVTMV+54G$^[:4,9&WW)Z8H`TZ*SHM:LYX[IXG9EM<^8=OIGIZ]#3#
MKEIY,4H\QA+'YBA$W''X=^:`-2BJ&GZK#J!;R4F``ZO&5'7&,U;FE2&)I)&"
MHHRQ/84`2455M-0M;UF%M.DNW&[;VS3_`+7!YY@$R></X-PS^5`$]%)2,0H)
M)``]:`'44F<C(IJ2H[,JNI9#A@#T-`#Z*9)(D2%Y&"J.I)P!3L\9H`6BF(ZO
MN"L"5.#@]#3Z`"BBB@`HI,TM`!1110`4444`%%%%`!1110`4AY!P<4M%`#4!
M50&.X@<GUIU%%`!1110`4444`%%%%`!1149D`E$>#DC.<<?YYH`DHHHH`*2E
MI`H48'KF@!:***`"BBB@`HHHH`****`*4FG(]NL/F.`K.V1URP;_`.*-9Y\.
M#=Y@NY/.[N44\8`P!C`^Z,5NT4`,B3RT5`<A1C)I]%%`!1110`444UB1C`SS
MSSTH`=12"EH`****`"BBB@`HHHH`2@$$9!R**``!@#`H`6BBB@`HHHH`****
M`$JLF[^T),CY1$N#CW-6:K1DG4YAG@0IQ^+4`6J***`"F.,LIQG!Z^E/I*`%
MHHHH`*S_`!!_R+VI_P#7I+_Z`:T*S_$'_(O:G_UZ2_\`H!H`T****`"BBB@`
MHHHH`*0TM(>G%`"+NVC=@-CG'3-.I*6@`HI**`,_7+&;4=/-O`R*Q8$[R0,"
ML63PS=/<33&6/,@E^7<>2V=O;_:-=510!CV>C*MS<27:(X=E*`,V.`.HZ=:J
MMI%\T/\`9[>1]B\[S#)D[\9SC']<UT5&!0!SMQH]UN\Z-8W<732F)Y#L=">,
MCID592RO(;_4[F)(RTZ*(?F[@8YK9Q2%E4@%@"QP,GK0!RXT*]LTECMV69;B
MW:.3.%PW;Z]3S[U;TO2+BQU-G.W[*(2(UW9V,2"1].M;V!1B@#&MK*6+1K:V
MFM1*ZR99-^-HW$YSWQ5W589+C3;B*)=SNF`*N8HQ0!@:EIURMI'%;>=+DY8[
MLE2%P,<CCOGFJ*66JAH99(IB\2@D^8"QXCR,YZ\-76X%%`'+_9]5FDN9"MS$
M#N>$&4_+DCC`/7&:NP17<VBWL<HF9G#>6)`5;[H[9)'.>_>MO%&!Z4`<SIHO
M#<VZJ+Q<-EO-SL\K'3GOFG7=M?M>7!A%Q'&7D?=&^W=A!MQC_:!KHV16921D
MJ<C\L?UI<"@#CKDW\]I)%<I?FY('R*/W6SCKVS^M227E\$\I3?#R#(9VVG[N
M\8P>Y"YQ76X%&*`.#EFU.(N]K]K2WFF9DD96WN3M`R`/;O@&MSQ'=7D%G;_9
MFD21@2Q0'KCIP#7048%`'*Z?+J5U#%-)=7,;RS"-EVC"CRLYP1Q\U6K.[U&7
M1[N]<GS<;8XP-VW;P3CU)S^5;TL22Q-'(NY'&&![BDBAC@C6.)`B*,!1T%`'
M*B62_N;2%YII[?[2,/(@`;Y"2#QS@C'YU-?Q/)KWE"[GC/F!EV@':-AZ#'3W
MKI]H]*,#TH`XRTUK5)KV!7GB`WHHC/!D!ZG&#GOT-7=>UBZL[_R[>1%1-A97
MVC.3^9_#&*Z4JIQD9QTI#&C?>4'(QS0!Q^GZE-%9!+.\$H*L6#K_`,>^9``2
M<9/#'KZ58;6;V)Q$)A*)F:&WD"#YV#*-WZGIQQ73B&,`@(H!ZX'6@0Q@*!&N
M%^[QT^E`'.Z-JU_=:H8IC&\3!CPRY3!QT'([<&F-J5W!O>-@J)NED0C>6_?%
M<=>./3T]ZZ98HT8LJ*&/4@<FD,,9!!C4@]L?C0!R-GJES;K-(;B/<XDE!DW'
M>0Y4(N6_D*OMJ]\3.R-;JD8F<;HVSM0@#^+DG-;K6L#;=T,9VG*Y4<'UH-M`
M2288R2"#\HYSR:`.?OM=NK3$;-$96P1MC/0KNZ%L?CFJ<NM7CF"X+@JWEN88
MR5[.3WZ<5U4ME:SC$UO%(..'0&F?V;8^8LGV2$.@PK!!D?YS0!B#6[YKF&UC
M:TDFFV,'4-L4$$D'GKQQ4TFM7"Z%;782+[1,^S;AB.IZ`?2M:+3K*``16L*`
M-O`5`/F]?U-+)I]G+;"VDMHG@'2-E!4?A0!@+XCN3$)S!$8D,8D"Y+9<'I].
M*L:=?7D^I2-/Y03[()%CC?*Y)[^_:M5--L8TV):0JNX-@(`,CH?PHM]-LK4N
M;>UBB+C#;%`R/>@#%L/$4]S,D=Q!%"[NB[26!P<Y(R.1[@XJ*'6KV749Y56(
MV\,?SQE\#AR,CCD\>M;@T?3A&8Q90A"`,!?3I31HFF!E8640*'(P.G.:`,G_
M`(2&\:`RBT@"%'<$RD$JIP3TIVCZC>7.IO#OWQ;)'^<\C]X0,8'08Q6O_95A
MLV?98]H5DQCLQR1^-+;Z996LJR06ZQNH(!7/0G)_4F@#)7Q&S/Y'V=1='"",
MOQYF_:5SCTYS5*'5=9DNH$C\E\E!L=\;LH2<D+QTS^5=(--LQ.)Q;KYH<R!N
M<[CU-)%I=E#.LT<"K(HP"">.,=/I0!F7NJWAT[3KBTC0/<S*K*QS@')QG\.M
M5?\`A([RUMH_M%HDDDB(\95C\P)/7`X/'2N@^P6WD10>7B.$[D`8C:?KGW-1
M2:182JBO;@A%"+\Q^4`Y&.:`*L>KR2:-]N6V_>;MGE$D`G=MZD>]59/$C19#
M6HW1AC.!+]S#;<#CGG%:=QI<,EB+.+]W"7#,.N?FW$=>Y[TJZ18*<BV7)0H2
M23D$Y/Z]Z`,Z37;F*3R6L`UPNYI$67(50`<YQSP:K-XOAWN4MRT*J2'+$9.,
MCM^%:<^A6DLL)*MY:!MP+L68G`Y;.>@J5]%T]]V;?`;.5#L%Y&"<`XSCO0!2
MU#4KR+1HKD1+;R2R*I^8-M4]QQR?:JR>+(C&S-:R=A'G/S9)'/''3/&:V[BT
M@G2*"6(M&I!4`G`V],U"-$L0H'E28!RO[U_D_P!WGC\*`,^+Q,LC6R_9'7SG
M*$LVT*0>Q/7U[5<U/5CI\A'V5I41`[LK`;03@8!Z\U(=%L203$[$=29&);G/
M////K4]S86]UO$Z;PZA6Y(X!R/UH`RF\1;(&>2T,;QR,LBM,HQMP3CU//05>
MMM46XNOLXB82`MGGH!C!_'(IDF@Z>\CR>2P:1F+E9&&=V,]_:IK2P%O>3W'R
MYD"HH4'A0.,Y[_X4`5+C7XX1(_V.Z>)&*"55&TL#@]^!GN:(/$-M,LFU&W1H
M[,`5/W<9Y!YSFGW6@VMTK+*T^PN9`@?Y58G)('U]:#H-L(]B/<+G=N(?E@V,
M@^W`H`B'B.V#S!XI$6$'>6*@@^F,Y_&IH]9CGTFXO88RQA#93<#R!GJ#3)O#
MUI<7/G3M-+@?*KMG8?4'KUYQG%6X]/1;.:V:65UF!#,S?-R,?RH`RD\2Y%P9
MK62)4)"N5X!"[MI'KP:NZ?K<%[/]G19"ZJ"7"?)G'(S_`(TDNAV\MN\$DDS*
M\AD)R,D[=OIZ4MIHD%K?+=+)*[JNU=^#@8QC.,GZ$T`4QKMS)/<1Q6RKLDV)
MYF1GYE'/O\PXI\'B:TVKYPEY.&=8SM7)(&3^%6FT6%I'?S91OD,A`(')*GT_
MV15=/#=NEI+;^9(ZR.KG=CL20.!TYH`MV.LVM_YGD+,=B[\&,C<#T(]>E5+/
MQ+:SA!)%,C,<$A"53G`R>V:70=,NK%G>Z93^[6*-0<[5!/?CCFG1:"(PZ?:Y
MC$_#Q[0`P!)`Z>]`$EYK45CJ'V>>.3R]BMYB*6"Y)'/H.*DM-:LKR\DM8)"T
ML9((QP<=<&FWFE?:IW<SR)'(@22-0/F`.<9[=:;8Z+#8W/FQL"%!5%\M00">
MYQDT`))XCTV,D-+(,-C/E-CW[=!WHCUZS7_7S1KND94*$D8!QDG'%5Y_#,$T
M42-)DQE\%HPV=QST/3%5D\+K<)YD^(96+[DVAQ@DD=>,_2@"]=>)M-@=XQ(S
MR(VW`4X)S@X)X.*D'B+2_GS<X"#.=C889`XXYY/:JS^'G\A8(KPQPQOYD:>4
M.#NS@GN/RJ&+PJ(6C:.Z`,#;HB8R3U!YYYZ=L4`:^FWZ:A%)+&/D5RBG^]CO
M5VJ&GV<]H&#SHX=V=\1[<L?3DU>H`6BBB@`HHHH`****`$JM"#_:%QQQL3'_
M`(]5FHH_]=+[8&:`)J***`"BBB@`HHHH`*S_`!!_R+VI_P#7I+_Z`:T*S_$'
M_(O:G_UZ2_\`H!H`T****`"BBB@`HHHH`****`"BBB@!FX."%;D<''8TZC%+
M0!'+-'"NZ5U1<XRQP*;'=02MMCFC<^BN#3;]9'LIEA7=(R$*/?%9-U87CSQ-
M`'00)&BLK`9YRQZ\\#'-`&VDJ.2$96P<'!S@T>:GF>7N`?&=N><>N*P[>+43
M>6WGQS+_`!R$2?*.22.#SU`QSQ3;ZVG&HRW&VZ\IF"'R&.XC:,8'IDG\J`.@
MS28!QFN92VU?RXOM$]R)"X0B-LA4"Y8].23QFKVD"ZB:4W!N'Q"C,)/[W)(7
MZ#`^M`&S17,QMJ>]&,UV2OE$IL!!9CDCIT`X^M1F]U&2Q\W?=1%5VN3"3ARQ
M/3K@`8S[T`=5N&<=Z`<USFDM=B]FFO9)V>*W!"LH&0<GL,$\#WJI#>:A%822
M123!9"&D9H^8G+9./E.>/;TH`Z^BL.XOKZVT&*:3FYDP,[#\H.3R/7'MUJC!
MK%\1$LLLB.H.Q?(W&?DCD#&,8]NM`'545S*ZK=,=IO$1).6D,)Q"<$[1ZGIU
M[TD>L:A,L1W)%^\$9W1'+':26Z\#&#0!T]%<TFL7K0Q'S8C*-I\H1G=+ECCO
MQ\H!IT>NW<US)'"D)#`>4#V);`W<^F210!T1.**Y236KQI?,7RY#$QC!4,J,
M68`$Y..Q[T]M?O9H9(Q'#"XCZL3E\DJ"O/MGO0!U%%8.JW\UC-!%%*K20PF1
MQ(W^LZ`#ZYJS::E<W%XUJT*+)&Y,G)P(\#'XY./P-`&M17-77B.>*[=(HXGB
MRRID\G'?KP,\8QWZU)_;MV)WMC':B52/GWL$QM)/..HX_.@#H:*YN'Q#=W*Q
M-%:Q#>PC(DD*X?;N/..F*=_PD<WE.ZVT+>4!OS-C)+%1MX.<XH`Z*BN<N];N
MA(CI$J0`NX*R9:15^7&-IZL5QCFJS>)[B012B#R8T9S*N2=RKM'&1GJWH*`.
MLHK&T[6WO;"ZN&M_*:#/WF(4\9ZX_I6;9>))X9!%?))*SL"S*O$8(!`&!R,'
M)SS]:`.KHKGK?Q-YR7+?8Y`8D#IU^?)P!TZ]^_%;-C<_:[..?;LWC.W<&Q^(
MH`L4444`%%%%`!1110`4444`%%%%`!1110`4E+10!'&KJ[EW#*2-HQC;Q^M2
M444`%%%%`!1110`4444`%%%%`!29I:@O`YM)?+W;]C;=O7..U`$V:*Y"XDUZ
M"+,`G,D:(C-L+!AR<@8Z]`?K2SWOB&&&4/YS/'MP88`VXMSCIV''2@#KLT9K
MBS?ZZQ\]X[D2JI_=+;D*N=HR#CD\DXYJ_<7.H/HEK+*\\<I9M^(R,@$X#8&1
MV[=:`.EI:XXZSK`N2BPW45N$`WRV^XJ.,L<#D]:?=:QK,4"31*9%,GEX^S,I
M.%!R0<]<X_"@#KJ*XT:[JT+%1%),WFON#0L`!G@`^GX5K6]_J7VF6*6..001
M&1BB$;R5!51SP<YH`VZ*Y_3+S4+^^B\]@D2!F.U"H?A>.?0DC\*STU2^@=_]
M*E<;P2QBWC&3P<#*DXQCG\*`.QI"0"`2.>E<9_PE%_YC2%5$:*0%\EOF.1SC
M/;)[]JT-0U*Z;3;"=7\F20%VP,=!V)&!UZ$\T`='2UR,7B#4(WE1PDFQ^`\9
M5W&0,*![<_C4NFZW?76JQ12R0,CC#>4#L4]<9(Z]NN*`.IHKDY]>NK2^G;SA
M-$'9$0@`#D#YN-PZ]>AJ#_A)+Z2_CBC:-29%5A_RSXX)SCH>N:`.SHHHH`**
M**`"BBDH`6BFH25!88/I3J`$J.(?O)3D]1_(5)44/^MGZ_?'7_=%`$U%%%`!
M1110`4444`%9_B#_`)%[4_\`KTE_]`-:%9_B#_D7M3_Z])?_`$`T`:%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!24M%`"48I:*`$HQ[TM%`"8HQ2T4`
M-Q2XI:*`$Q2;03D@9IU%`$20HC.ZC#.<L>YXQ_04[RUSG`SG.<4^B@"+R(MA
M4QH5/4;1@T/;PN07B1BO0E0<5+10!$\$;N'=$9EZ,5Y%1V]E#;,[1AB\ARSL
MQ8GTY-6:*`*4^EV=P6+P1AF(W,J@%L$'!/IQ0=)L2R$VT16,$*FP;1D@DX]>
M.M7:*`*SZ?:2(4>VB9&;>5*#!/K40TBR\_S3;QLW`7*C"X'``[5>HH`I_P!E
MV6S9]FB"[!'@+CY<YQ],TQ=&T]0`MI$``R@8[-U_E5^B@"HFG6D=J]LL""%_
MO(!][Z^M-.DV)N//-NADQC/;ICITZ<5=HH`SET33TC*+;@`L&R&.<@8&#G(X
M)%6;6R@LPRVZ;%;'`)QP,58HH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`*2EHH`2BD^;<,8QWIU`"8HQ2T4`-(I
M<4M%`"8IB0QI([JH#.06([X&*DHH`0CWKF+?Q!=PHTEU"CAE!14&QF+'`QR<
M_7BNHJ!K.V=0KVT+`#:`4!P/2@#GW\4LR_+:-$59=^]@0%)`Z\>I_*E/BN)P
M-UA*RCE\,&V\D#^5;_V.UQC[-#C`&-@Z#H/PI@TVQ#*196X*_=_=+Q^E`%?3
M+V:]#L\*HN\@8;..%(^IY-5[B_N+/5'2<PM:*F]MD9+KDX&>>N<]JTH;*VMR
M##!''C.-BXZ]?Y"I%BC5V<(H=\;CCDXZ4`8=]>1,MR+^W5$7:4`!9I."1D@<
M<@55777^TK9W5I!(V]5D*]-IVXX/^]WKI#;QYD;8,RC#\?>XQS4"Z79($"VL
M0\L[E^7G/UH`NT444`%%%%`!1110`4444`)4%LQ:2XSVDQ_XZ*G/2H+;)>?<
M>?,/?H,#%`%BBBB@`HHHH`****`"L_Q!_P`B]J?_`%Z2_P#H!K0K/\0?\B]J
M?_7I+_Z`:`-"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**2FH'!;<1C^'`Z"@!
M]%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`"5!:G)E.2<R'K^53GI5:P</%(RG(\V0
M?DQH`M4444`%%%-W#=MSSC.*`'4444`%9_B#_D7M3_Z])?\`T`UH5G^(/^1>
MU/\`Z])?_0#0!H4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`(3@<4B%BBE@`V.0.F
M:=10`4444`%%%%`!1110`44QY$0J&8`L=HSW-/H`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`**2D5MPS@CZT`.HHHH`****`"BBB@!*J
M:8`+>3'_`#VE_P#0S5NJVGL'MRRJ%!D?@?[YYH`M4444`%-)^?&1TZ=Z=3?X
MNG;K0`ZBBB@`K/\`$'_(O:G_`->DO_H!K0K/\0?\B]J?_7I+_P"@&@#0HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$(!()[4M%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`"44M%`!1110`444
M4`%%%%`"4R"%((]D8PN2?S.?ZU)10`4444`%1@GSV'8*/YG_``J2HA_KW_W5
M_F:`):***`"L_P`0?\B]J?\`UZ2_^@&M"L_Q!_R+VI_]>DO_`*`:`-"BBB@`
MHI.E+0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444E`
M"T4F:6@`HI,T4`+124M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!4>T^:6[%0/RS_C4E)0`M%%%`!6?X@_Y%[4_^O27_P!`
M-:%9_B#_`)%[4_\`KTE_]`-`&A1110`E+110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4E+10`W:`0<<@8IU%%`#=H]*6EHH`2EHHH`
M****`"BBB@`HHHH`****`"D-+10`4444`%%%%`!1110`4444`%%%%`!1110`
ME-PW]X]?2GT4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4G./>EHH`:-W&?3G%-;S=WRA<>YJ2B@!GS[^@VX_&G4M%`!1
M110`4444`%%%%`!1110`4444`%%%)0`M%)2T`%)CG-+10`4444`%9_B#_D7M
M3_Z])?\`T`UH5G^(/^1>U/\`Z])?_0#0!H4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!6?X@_Y%[4_^O27_`-`-:%9_B#_D7M3_`.O27_T`T`:%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
;%%%`!1110`5G^(/^1>U/_KTE_P#0#110!__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>vivakorex312image1.jpg
<TEXT>
begin 644 vivakorex312image1.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86
M&#$C)1TH.C,]/#DS.#=`2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`-B`LX#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`I*6B@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***8TB(
M5#,`6.!D]3Z4`/HHHH`****`"BBB@`HHHH`****`"BBB@`HI*165L[2#@X..
MQH`=1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`44A)R*6@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`I*6DH`*6D%+0`5#,@>2`G'ROG_`,=/^-344`%%)2T`%%%%
M`!12&B@!:***`"BBB@`HHHH`2@`#I2T4`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%)0`M%%%`!1110`4444`%%%%`!1110`4444`,:-7=&8<H<K[<8I]%
M%`!1110`4R5`\;*1G(Z9Q3Z*`(;2266V1YX?(D89:/=NV_C4U%%`!30Q+E=I
M`'?L:=10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!30RER@(W
M``D9Y`_R#3?)C\[SMB^9MV[\<XZXSZ41P11,S1QJA8Y8J,9Y)_F3^=`$E%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4E+24`%+24M`!1110`E+1
M10`444E`"T5!:O.\;&XB$;;V`4-GY<\'\14]`!1110!!=3M`BLD32EG5<+VR
M<9_#K4U+10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!4<T;2H
M%61HSN4Y7KP0<?CC'XU)10`4444`%1SS1V\$DTK;8XU+,<9P!UJ2D(#`@C(/
M!!H`1&#HKJ<JPR*=24M`!1110`TNJLJE@&;H">33JBDMX998Y9(U:2(DHQ'*
MYX.*EH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`2BEHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`*@;SOMB8;]SL;<,#[V1CGZ9J>DH`6BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`***CGGBMXFEFD6.->K,<`4`245S,_CG2HUS$L\ISC`3'
MX\FL_P#X6$G_`$#3_P!_O_L:`.VHKD[;QY828$]O/$3UQA@/Y']*Z+3[^VU&
MU6XM9`\;?F#Z'WH`M44E+0`444E`"T5B6OB>RN;T6PBN4W.8Q*Z`(6';.?:D
MM?%>F7,KJ6EB50S+)(F%D"YR5(]A0!N45BP^*](DMFG:X,2JVTJZG=[<#KTJ
MX-7L3IO]H"<&U_YZ8/KCIUZT`7J*RV\1:2A(:\0%5#G@]#C!Z>X_.K']J67V
M!K[[0OV93@R<XZX_G0!<HJ":\MH"HFN(HRPR-[@9'XTP:E8E@HO+<DG`'FKS
M^M%P+5%)2T`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5#'<))<2P`,&B"
MDY'!STQ^5355@MFBO;J<MD3;,#TP,4`6J***`"BBB@`HHHH`****`"BBDH`I
M:MJMMI%H9[E\?W$'5SZ"O,-8UV]U>3-Q)B('Y8E)"CKSCUYZUH^-M5>^U4VP
MP(;;A,$'<3C)R/PKFQCN<4#"BI'A>-BK@JX`.TC&01G/Y?SJW:6\?VD1^4;P
ML@<")L8&,L#QU']*!%$@KU!!//-7=-U6\TN7?9S%,_>7JK?458U>\@O5,D%H
ML(0JB[2",!0``<`G_P#568\;Q[=Z,NY=RY&,CUH`]9T/6[;6+?=$P\Y%7S8\
M'Y2?KU[UJ5Y'X>U$Z9K$$_S%,[7"]2IX_P#K_A7K8Y%`"TE+24`<<?#-_'&&
MBE!D:XD+HTAV;&!&X#LV"?SILGAS5KF&*VG>U6*SC=8&5<F3/'S>F16);WUY
MIVH3W-OYT\H5S^]5ODYY+#IZ]#6BWBG6#8V[LT<3.SCS#%D/C;@8'?K0`'PE
MJ[1&1S;M)N7Y"Y)P!U#=1]*TX]#U!/"$NF.8VG:0%0K<!=P)&?S-9;^+M7@B
M$[_9WC:9XL>2>-N#ZC^]^E-_X2O4X;B>9YK<!A&1#(A^7<N?E`.?J2>]`$2^
M'-8B:0"R#EE5"Y=3T<$8Y]%%7WMM8'AA](.E.78;C*LBX/S[NGK3H?%.K3*\
M\<-JUO`L;SD*Q90W7'/U^E:+:[?#PX=2\J$2S3`0(P.`A;`W<]>O/TH`Q]=M
M=4U<VA.D3Q"!2K896+=/\*I/X>U!UEE6RD15\KY-B[F&WYL8Z'/IZUKVVN:K
M?:[8VAVP*"PF$>"LFTG)!.>./YTR;Q)?V_B"6!I4:)9'18BHP0`<?-UW9XQ]
M*`.S3[BX!''0]:=7(6WC.4?9X;FQW3RJ.8Y!\Q(^7`]^/SI8/&H3[,M[:%/.
M7>SHW"@L0.#]!WH`ZZBDI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBDH`6BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BD9@JEF(``R2>U`((!!R#W
MH`6BBB@`HHHH`*C17$CLTFY6QM7&-OX]ZDHH`****`"BBB@`HHHH`****`"D
M/2EI*`/%KQM]W,^%7=(QPO0<]JAK5\2V"Z=K=Q`F-F=R@=@><5E4#+EU/'<M
M%<.JJ<"-HH_EX55`.??Z=JJ,5R=H(^II4D=$95.%?&X>M-7&[YN1[4`/\Z7R
M?)\U_*SG9N.W/KBFYY&><4T4Y>""1D>E`"]\CBO8M)F\_2K279LWPJ=N<XXK
MQ^*-Y95CC4L[D*H'<FO9K6!;:UB@7[L:!!^`Q0(FI*6HYW2.%WD;:BJ2S9Q@
M=S0!Q']LZR9[J#[1;S(94@#E!MC9CTZ<X&0>M36GB@W%QI=JZ0!O,VSN4P%/
M(&WTR/YU4@BT&1E>[TF>TMI0S1W#3L0P'X]3Z<\UM11>%G6SG7[-&%RT3OE-
MVTXYSC/)[T`4M8UY;/4K^P>UM/*B7?#NAW9D*@_,,]\GG^=2/KFBW%T4NM-2
M1\,//:%=KLJ\@$_E^57+ZPT#4!<W4UY%MN&16D$RX5U!`P?7!Z55?1/#:3R%
M[U%,PRB&<`)N'51[\>M%P,F_UNWFB:&TLOL=K,$\THFQW&2,9'!&,_YS6_=7
MVFCPB9([8S6@'E)"^020=HSZ>N:H:Y!HEGJ%LMU<7GF0QQC;$`5"KPI;CZU9
MM9M%O]/?0XKJ0B1VV,1RQSOR"../?%`$%A=V&F7`?5-._LZ:U7RX64LP93DD
M#UZGGWJ1[OPK#JKWK2C[2PW$[7*G<.N,8Y!I]]X.6ZB&-0G><N6:24[LC&,8
MK,GT73+>PU"%[_<]O)$2RQ?-&<;0#ZC)SQZ4`7TLO"L4]G*)"LDN'A)E?L>,
MYZ#C'/I3[32?#=Y>)';SM++&"WE^:W(ST_#T']::?"$NR.%;_P#<M&D<X*Y+
M;6W?*>U6])\/2Z=>V\QGCD2))%("X/S'-`$K^*].BOI;203(\1<,Q4;?E!)[
M^U7K36;"ZMHYEN8XPXW!9'"L![C-<K+X::77+B-]1B:62-V53GS&#`@;NW![
MTQ/!]U%9W7VAK02`)Y+[B`"#SGCN*`.W2Y@D"^7-&^X97:P.1ZBDMKJ&[B\V
M"0.FXKD>H.#7!VW@_4!<V\AFM2NX,<.>!NSQQS6WX9@GTJ>?3IH8Q&%\[ST8
MD,2<`<\#@=*`-2'7],FGFA2[CWPYW9.!QU(/>M".1)8UDC8,C@,K#H0>]>?'
MPSJ32W1:TA4-"S*%;(+9XVCJ#^GYU8T+2=6BU^"8V[VELB\@ME=N/N]>2?Y\
MT`=O]HA^T_9_,7SMF_9GG;G&:EKG[/3S:^+[FX"R&.:W+>8Q)&[<,@?IQ6_0
M`M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`",
M`P(8`@\$&@````8`Z`5'<2F&WDE"-(44ML7JV!T'O3T;>BM@C(S@]10`ZBBB
M@`HHHH`***0$'I0`M%%%`!1110`4444`%%%%`!1110!R/CK1I+R".^MH]SP*
M1)CJ5_KCFO/L5[=7*>(/!L%U&9M,189P<F/.%?\`PH`\_=)&C\]B&!.W.X9S
M].M/23?;^0+='?.5<`[@._3K^-/NM.O+,@75M+#G.-ZD9Q2K?7:RB19F#A"@
M/HI&,`=!Q0,K`+L[[L_AB@J5<J<9!QP<U+;VEQ<OL@ADE;KM12375:'X+FN-
ML^I[H8^OE#[Q^OI_.@1#X(T9[J^74)4!MX20,GJ^!CCVSFO1*CMX(K:%88$"
M1H,!0.E2T`%1S1I-"\<H#1NI5@>X/6I*JZEG^S;G$BQ'RFP[-@*<=<]J`.+F
MM=%>W-J/$<Y0*5C1L[%YSZ8QFH+/3-+$3LVM02QPHY*F`X5G`4-SR<''Y"M;
M3--BU"73)G%K]GMK92\)&V0OC&YAW&1P:IWGABY;3/-2S5KHSNTJ!\;ER0NW
MMCOVH`99^%0^3;:A;S7,3I(0Z$IM*Y&0>N<TV'PI+'`7-Y9.RR(PPW\(SW[9
MX_*M?1;25-9N8RIC\BQA@D..'?:/F_`#%<ZGA;5ULI4-IG,J?*'7+`!LD?G0
M!T.L:;?R:O\`:]/N;=4O(Q"YD(.T?[.>OX=ZQKK0)[*_::[EA>U0L7.X"0H1
M@L%'?N!ZU-;:%KRW.EM,D9AMV4K&7XCP<DGW^F:=J.C75YXL>26UG:$S(Q?^
M#RP.>1WXX`H`E\-?VC8-:+]G+_;&/G-(K;HT7A?8=^O7(IFH>&]2O;N_N(D5
M6EN"NQR,/'P0P/;D?K4$^FWD7AY;B*WNUN+BXW2HI8LJ@-LXZX!P>?:ETA=:
M&OVOVPWK+N&\'<$QM[GI0`1^'=:>.\D=Y4E!\P#S.)7#9SU]"<=.:CN+#Q''
M?VVPW)<@2E@Y*JS'YL]AUZ>E>A44`>;M;:M%+=3"*[-Z@5&E#G/+G)4CL<`<
M>]:=RNH7/@P17,,TLT<Q$S.QWJ`V<X_BZXQ7:T4`>706=\+K3Q##<"1@NUFW
M#:-S=^P(/(JQ_9R6]A]KVRBTDO?+FC3/$2G@'UKTFC%`'!6(OX-4TB?+7#/;
M/Y4.[;\H4X!/O@'ZT[6-2U5]8LFNDFTR`.``&##MN;(X.!CBNZV+OW;1NQC.
M.<4R:WAN`!-%'(`<@.H./SH`\WFU:7[%(8KV\:'S\8:4AV^4_-NQQD]O:KNE
M:WJ\VO6D+RR.S%5DC(PNS`R<8Z]3FNW;3[-HC$UK`8SCY/+&..>GXFGBU@%R
M;@0QB8KM,FT;L>F:`)J***`"D[TM)0`M%%%`!1110`4444`%%%%`!24M9^N#
M=ICJ>ADC!]QO7-`%^C-<Y=Q6D.H26B:?:EEC1U,D[+O+,0`!@\Y'ZBI&M=/$
MBJME`V;@0MAVRIVY].M`&_FC-8A@T`[R8XCL`)&UN<G`(_O<\<9IFG6VFWMK
M/<-80HL4KIT)X7OR,_AB@#>S1FL#R_#\4<7G0VZM)$LO"$C:<<YQTR1UJ>YT
M[1K:2!)+"(M._EIB/(S@GGTX%`&QFBN;L!HMQ"QN;&VAF0R97RR1A&P2#CGM
M[\U>AL-$GCD=+.WQ$2'#1;2IQGD$9'&#0!K45SEP-"2!F@L('D#1KL:W((WL
M`&P1G'/XXQ4$/V%Y2LNF6$:QW"V[DPMR3C!'R\9SC!_.@#JLBC(]:Q?(\/\`
MF&/[';[ADC_1^&P<$*<?,<X&!4D=CH<UL]PME:^4F[<3"`5QUR",C&*`-;</
M44FY?45SMT-%2-1;Z;;M*TRPE7ML%">Y7&>GYU>FTC3UL)&;3K19!$2=D0P#
MCMQ0!I^8G]Y?SH\V/^^OYUAW-C:I>3PQ:?I^V.W$HWVXY.2,$_AZ4V*31)((
M)6TR!%GP%)@7`;;NV_7'X<4`;WFQC_EHOYTGG1?\]$_[Z%8[)I*2"-M)B5RZ
MI@P)P6)`/T^7]141GT11F32XD7"DL8$P`4+@\>RG\:`-WSXO^>J?]]"D\^'_
M`)ZI_P!]"L-IM)23:VC@=.3;H."P4'GGJ1^!I\EO;/I45W;Z79&1RA\MHEP<
MD#&>QYZT`;/VB'_GJG_?0I#=6XZSQC_@0K#@ETIM[G3[=DRVS;;J"H5`S*WO
MDD?A2O=:5'YO_$I7$:R,2(8^1'C=CGW%`&W]JM_^>\7_`'V*0WEL#@W$7_?8
MK#MKG3P(4NM/A\R9I!&R0*0VURN,=0<8J[IZV-]YA72TB$;;&\R)`<X!Q@9]
M:`+_`-MM?^?F'_OL4GVZT_Y^H?\`OX*:-.LATM(/^_8_PI1I]F/^72#_`+]B
M@`^WV?\`S]P?]_!1]OL_^?N#_OX*46%H.EK!_P!^Q1]BM/\`GVA_[]B@!/[0
MLO\`G[@_[^"D_M&R_P"?RW_[^#_&G_8[7_GVA_[]BC[);?\`/O%_WP*`&?VC
M8_\`/Y;_`/?U?\:0ZIIXZWUL/^VJ_P"-2_9+;_GWB_[X%`MK<'(@B!_W!0!#
M_:NG?\_]K_W^7_&IX+F"Y4M;S1S*#@F-@P!_"C[/#_SQC_[Y%5K)0NH7RJ`!
MN0X'^[0!>HHHH`*CBB6+?L&-[%C]34E%`!1110`4444`%%%%`!1110`4444`
M%)2T4`-=%=2KJ&4C!!&015)]&TUY_.>QMS)@C)C'.?4="?>K]%`#8XTC14C5
M511@*HP`*6EHH`CCD+R2J8W4(P`9APW`.1^>/PJ2BB@`JIJEK]MTVXMLD&6,
MJ"*MT4`>86>C7DLMJKI,J78*2KL(*JA''X[>*?+K&I7=H5N\B&*>,)((@/)8
M9/0#G"@Y'M7I=)L7&-H_*@#SR7Q5K*-:L6"AD&X-#@2<GG\1CI5*QU:ZTN**
M2WN/F-N0(R"5YD;KSU'7/O7J!C0XRH..G'2F-;PNZLT2%E!`)4<`]10!S_AW
M6+W47MA<26P#1,S)M(D8!BH8=L9X_`U#XC\27FEZQ%:VZ6YC958EP<\G';IT
M]ZZ=(8HR"D:*0-H(4#`]*AN-.L[J>.>>WCDEC^XS#)'>@#D7\:7:WD\,=O;N
M"Y6)F)79\V!O_3TJ=O%.I$@0PV<QBMS/<!&)X#E3M(/I@\^M=)_9&G_O_P#1
M(OW_`/K?E^]SGG\:9#HFFP*XBM$0/$86QGE#U%`')'QAJ,R6DBQP1_OG#C.U
M7``.,GI][\\5?M_&-S=11&#3!)+)*R",2]<*#Z>Y_*MC_A&=',:QFR7:I+`;
MFZG&>_L*2'PY86TR2VR-$T;%T&XD*Q`&?TH`RX_&;RQH8],D=F*Q@!\#S"?N
MY(]*K_\`"8S27JR);NEI'&&G4('8'=@X.0,9(&?TK4B\+P-ILMM>2M)+-,9W
MEC^7#_[([4P^#-,\HQJTZ@QA#A^I!SNZ=?T]J`*T7C-9IE9+*8VZPF2;`!9<
M'''.",T]_&=N)[9E@E%K(CL[LOS*02`!@XZC]14G_"%V`A$:3W*#:48JPRXS
MGGCUJ-O!%D4"+=7(&-K<KRN<XZ>N#0!=N/$,9T"XU.TC+&%]ACE^4@[@#G\\
MU7C\66\MS:QK$XCE#>:S`YC*CD8%1MX.B6V:VAO[A(67#(0""=P.2./0?E37
M\'LQ60:I,)P6)EV#)+8![\<<4`=!97UMJ$)FM)?,C!V[@".?QJS5#1]/;2]/
M2T,RRJA.UA'LX]_UYJ_0`4444`%%%%`!1110`4444`%%%%`!1110`5GZYQI;
MGT>,_P#CZUH5G:^VS1YVP6VE3@=3\PH`4Z?YFJR7<HC=&C1%4KR"K%@<_4_I
M4;:;*9WD\U,-=+<8VG@!`N/TSF@:K<%01I%]SZB,?^S5&=4U)@?+T2<D?WYD
M7^M`$$>A7$4$2I+;>9;%?*?R<%PI!`<_0=N_-7M/L9[6WNDDDC9YI7D!52`-
MU0?VCK'_`$`C_P"!:4?VEJJC+Z&_L$N4-`$,N@2R6Z1?:4&VR%IG8?4'=U]N
ME:=Y;27#6K*ZJT$HD.1D'Y2"/_'JJ+JE]M)?1;H'T$D9_P#9J:==D1<R:/J0
M.,X6)6_DU`$#>'I62,&Z0%#,V?+SS(<]">Q'XU?AT]FL;B"X$"FX4J_V>/8,
M$8S[FHK3Q!975VMIB:&Y89$4T14],UJ4`8\ND7$^'EN(A*JQH&6,X(1P^<9[
MD#Z4KZ-*YG/VE!YMVES_`*OIMV\=?]D5K22)$A>1E51U+'`%5;#4[74C+]DD
M,BQ-M9PIVD^Q[T`4_P"R;G[(]H;J,P*=T0,62"&##=SR`1CMFK*V#-ITUM*T
M:M*#DPQ[54D=A_B:OT4`9$FD2S7`N9)T$WF1.VV,[<)G`Z_[1YK0O?\`CRG_
M`.N;?RJ>H+W_`(\I_P#KFW\J`*.J_P!EVV;C49/+\U?+.7;YP.<;0>1SZ5%<
M7&ABT^VS2Q&"?*@Y)#'&TX4=\#&<9I/$5U9V0MYY8XY+W)6V$C8`)X)/;%8,
M=O;Z==Z$SW4,]LLDIDE5AY:R$#C/;M^5`&]*VA1V4-])(GD?+Y<F]CD@DCCJ
M3DGWZTCR:"EBE\TBFW)558LQR5!4#'T)&,?6N9M"L<UC<286P&I3%6/"@';M
M/TR#0>;=G1Q%`^L;H9S]U!_>]Q_A0!TJG0/[/-XKJ+:,",MN88PP8#'7.0/>
MIH+O2&TG[1%./L<#[L[F&U@<X(Z]3T^E<N6'V>9G(EABU9))[@?<D4YYQTP.
M/S%:$4VG^=KUW<*DVG[XRN.5D<#G'J<XH`TQ=:#>VD]WOC:&)R\K$,N&(QR.
MIR./>HEO/#TEC/=*V8(\I+@."-^`1CKS@?E648K;4-+U*^N;V!;B;RY&6#]X
M(57[H8#D^]7/#\LEQKFHW,TUM+'Y*>8UN#Y>[MUZX&:`)$U3PU<03@'=&B[W
MS&_R@L.GI\Q!XJSIFMZ&S2164H3"F1\HR@```GD>@%+X;@5[.74IAF:]8R$G
MLF?E'TQ52SM(=0TC4K^8LHOM^&5<E(UR%`'X9QWH`U].UJPU.1H[2?>ZC<5*
ME3CUY'2I5U&U;46L%ES<JF]D`Z#CJ?Q%<;ITUT^J6\UI+#>FUL6"B%"N0`0J
MM[YQQ4FCRSP^*(FDL;A;B:W;SC(,$L6R7]E[4`=PS!5+,0`.23VK..NZ?_9_
MVX3$P%_+4A"2S9Z`=363JMSK-Q:QP7&ENL4KXF%M)O8H.V>V?Y9K'CE)T1(C
M;O:11ZD")VY$/S'G\.G/'-`';6%_;ZA$TENQ(1BC*RE64CL0>E6JP/"[AI-2
MVN)T-QN%T!@2Y'/MQTXK?H`****`"J-K_P`A.^_[9_\`H-7JHVW_`"%+WZ1_
MR-`%ZBBB@!**#5#0[B6ZTR.:=MTA9P3@#HY`Z>PH`T****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"L_7?
M^01/_P`!_P#0A6A6?KO_`"")_P#@/_H0H`OU!<7D%M)#'+(%>9MD:]2Q^E3T
MQH(FF69HU,J`A7(Y`/7!H`?5.]U6QL!_I5S'&>RYRQ_`<U2UC2[^_O(V@OO*
MME7#PG<`QYY)4@GZ9J72]'2QR6CM-W\)B@VD?B22:`(UUB[NR!I^ES,A/^MN
M#Y2X]1U)_*G36>HW:XN]12VC/!2U7!^F\\_D!23:3=":\N(-0E,TZ%(U<_)%
MD]0!W':H-)\.);7DMS=DS.),Q;G+<`8#G/5CS].U`&EI^E6>G`FVA`=OO2,=
MS-]2>:AO]9AMI#;P*;F[QGRD/W?=CT4?6IM1M+B\1(HKMK>(G][L7YV'H&_A
MJE>>'HIK6.SMI?LMKG,RQK\TWH"WY^M`'(:QK$VKS;))#):QD%Q%\D8/^\>3
M]3^`K>\/7]SY]O;R?9+*U*XAM@#YD@QUYYQWR>M,B\'W!E=GOQ"@R(DACX3T
M//?WZ^].7P0B*6CU.Y68G)D'?U]^?K0!U=%<S9>$IK*\%U%JTWF@$9,8.>,=
MR:O_`-CW;?ZS6KPGML"+_2@#7J&]_P"/*?\`ZYM_*F6%I):1LDEW-<ECG=*1
MD>W`J2\YLY_^N;?RH`J7,$%[M:ZTHS,HP/,$9(_\>H%M;"V-L-)_<$Y,>V/;
MGUQFF3(\FMJF&$9MOF)5MN=WKT!K.CDN\F;[,=QCB&SR6V\3-GCL<<_K0!KL
MJ-;BW;37:'&/+(CVX^FZD(0VPMSICF'&/+Q'M`^F[%9YU/4$BC\R-MT@C^[`
MV1G?N`'.2-H/XU9N)#)_9<S!I`6+2&-&(P8V[>F2.M("PJQK;_9UTUA`1CRP
M(]N/INIOE0FW6`Z2?)!R(]L>T'UQNQ5"":_MS%"L<RPLY*YC+%8RY`!/."!@
MX/;\:?IUUJ#36L,R3!1&N]I(C\WR\G/8AN/Z=Z`+<,,,`<0Z08@XPVU8QN'O
MAN:DAVP1F*'3FCC/\*^6`?PS6>]]J1N9(UAD5/-158P$X7>P;_QT*<^_X"))
M+^YO]/:Y@E7RW#'$6%P8F!)/8[CC'TH`UTD,48CCL9%11@*I0`#Z9HB=HHQ'
M%8.D8Z*I0`?@#55[5#K*`0-Y0@9B=IV[_,##GUR":HVMQJIC12CPJ'5-JVV,
M*4R3T[$4`:\7[C=Y.GF/<<G;L&3Z]:"[F7S?L#>8!MWY3./3.:J:5<ZC/*GV
MR)HAY0+*8\#)`.0?7.X8_P`G7I@5A/.?^71Q_P`#7_&H\OM9!8#8V<C<N#GK
MFKM%`%6-I8T"I:!%'10P`%.\VX_Y]Q_WV*L44`5S+<?\^X_[^?\`UJ/-N?\`
MGW7_`+^?_6JQ10!6\VZ_Y]T_[^?_`%J@LBYU.],BA3MCX#9[&M"J5O\`\A6\
M_P!R/_V:@"[1110`AZ5E>%R6T&`D%26D.#U'SM6J1D$>M5M.L8].LH[2%F9(
M\X+')Y)/]:`+5%%%`!1110`4AZ<4M%`$5N)5MT6=E>4##,HP"?6I:**`(U=S
M,Z&,A5`(?(PV<Y_+^M2444`8WB?4KG2["*>T"F1IE3:RY#9!XK-_M+Q:I^;2
MK<CT'_[56_&&W['9*W\5Y'Q^=;]`'*_VKXKSC^QX>F?\_-1_:WBD9SH\73M_
M^U75TE,#F1XBUD`;_#TQ.,G#G_XFFCQ5?@9;P_=C\6_^)KJ**0'+?\)==?\`
M0"N\?4__`!-'_"77?_0!NOS/_P`374XHQ0!S<'BN5I,7&BWT:8ZHA8Y^F!4L
MGBZRA`:XM;Z!3P#)#@']:W\4V2*.1=LB*X]&&:`.?_X3;2/[T_\`W[H_X3;2
M/6?_`+]UM?8+/_GT@_[]BC[!9CI:0?\`?L4`8O\`PFVD>L__`'[J:'Q?H\TR
M1BX9-W\3J54?4FM3[!9\_P"B09/_`$S%4G\-:.XYL8NF.,C^1H`E_MW2?^@C
M;?\`?P4?V]I/_01MO^_@JM_PB>B_\^0_[[;_`!H_X131?^?(?]]M_C0!9_M[
M2?\`H(VW_?P4[^VM+_Z"-I_W^7_&L^;P?I+Q2+%!Y;,``VXG;].:K2>!=,=B
M4EN4R>`&!`_,4`;L>IV$O^KO;=^<?+*#S4PN(3TEC/T85S'_``@5A_S]7/YK
M_A1_P@6G_P#/U<_FO^%`'4>?%_SU3_OH4JR(_P!QU;'H<URI\!6/:[N/QV_X
M4Y?!0@W&TU2YA+#MQGTS@CWH`ZJBN47PMJJ_=\0W`^F[_P"*I_\`PC.K_P#0
MQW/_`(]_\50!U%%<L?#.KXX\17.?^!?_`!5.BT'7HONZ\YYS\REOYF@#IZ6L
M%;'Q%'&%75;=]HQEH.3]34`@\6Y&;NQ'X?\`UJ`.EHKG1!XJX)O+$GN"A_PI
M&/BU>@T]OIG^M`'1T5R]Q<>*[>WDF=+#9&I=L9S@#/K6OH-Y+J&CV]U/M\R0
M$G:,#J1_2@#1HHHH`****`"BBB@`HHHH`*H:Y_R"+C_='\Q5^J&N?\@>Y_W?
MZT`17VKM97,L9M3(D4/GLRN`=F<'@]^/6K8OK7=$K3QJ\P#(K-@L#TXK-U32
M)=0U!Y3M6/R%1"6)^8-N^9>A7MBDEL+V>27S(X@+D1;F5\^44.>,CGU'O^=`
M&D=1LAOS=0_NSAOG'!SC^=1ZAJ*6>G_;43SX1M)V'JI(&1Z]:RAI%ZJLB[EC
M#AXPLHW1MDDE21TYZ'/4UJ&WN&TVWA=8FE4Q^8!\J_*03CCVZ4`+=ZG%;BTV
M#S3=.%3!P,'^+Z<C\Q43ZJ1);+'''*+B62(,DN0"H8CMWV\^GO5:/1[B%(P'
M23RID\H$D;(E8D+T//./P'I2IIMVLMLQ6']U=S3GYSR&W8'3K\WZ4`6K'6+>
MYLK:>5D@:X&5C9\GKC^=68+VUN9&2WN(I63[P1@<=JQ++1;RU2!'2"9?)6*0
M&1@%*LQ#``?-][H?2M/2;.6S2Y$PCW2W$DHV$GACGG@4`:%%%%`!1110`5#=
M_P#'I-_US;^535#=?\>DW^XW\J`*&JZL]B]K;6UO]INKDG9'OVC`&22:2TUR
M"?1GU"5&B$1*R1GDAAQM'KV_.JFMQ3PZEINJQ027"6X99(XQEL,N,@?C5"TT
M359;*!\P0YN'N6@F!/S'&W./3TH`N/K$=]X;34)K*-Y&E"1PLV?FW;1SCZU)
M)K=S:7L4,NF&*T><6\;[_F)[$+CI67HEAJ+)IMM=0E(([A[@Y0@J5SC/U)R*
MGU,ZC>W\4::;+#>P3_NKI3F,1YY)/T[4`6I_$DT4UQ*MCNT^VF\F6;S/FSG!
M('U(JW=:O-#<WL<%HUP+:)&Q'RS.QX'TQSFL.[L[[RM1T9+*5A>W?FI<`?NU
M4D$Y/MBM.)[JRT_4;V.UEDNIIV$<>PYP,(I(],#-`"?\))+;17PU&T$4]JJM
MLC?<'W=!GMS2IXBEMTO5U.T$,UM$)0J/N#@\#'XX%94-C<W^C7]O]ANDO9=L
MSS7`QYK`@[1Z#K@5-/I][KIU*Y:TDM#);I#$DO!8A@Q_48H`O0^(KB,W$=_9
M>5+';?:D6-]P=?3V-/T;Q!-?WR6T]O&AD@$Z-%)NP#V;C@UGI:ZKJ-Q/=QV[
MV<D=E]FC\W@L^<DCVZ\_2G>'-/N;?5(Y(K*6R@2`)<B4Y\V3U'^-`&GJ6K7<
M6J+I]A:I-*(?.<R/M&W.,#WJ>PUNUN[:SD9Q')=@[(R<DD=1GVK-\2V;R7T$
MZZ=-<#RRADMY2KCT4^W/\ZETJT?3+32K2:P\^4;RTP`(@).3S^../2@"6/7_
M`#]?33X8&\H[PTK@C++UV^H]ZC&N7DNI-%;VL,ENDY@(\X"0XZL!Z"IKRVF?
MQ/I]PD;&&.*0.X'`)'%8=WHMS]MGB@T]A<2W?G1WP;A%)SSZ8YXH`["XF2WM
MY)Y#A(U+L?8#-97A_6I=4$BW,*P2A5D10?O(W0_I4GB.*ZN-,^R6B,SW#K$[
M`?<4]2?\]ZS(M,U+3-9L;GSOMD6S[-)LB";(^W?L?Y4`-L_%<TVF7]S-!&LE
MN%,:C.'R2H_45M:%?RZEI<=S.BQR,S`JO088C^E<O:Z%?@Z<K0,L;N1<CCA5
MD+KGZYKIO#UO+:Z6(IT*.))#@^A<D?I0!IU2MS_Q-KP?[$7_`+-5VJ-O_P`A
MB]_ZYQ?^ST`7J***`"BBB@`HHHH`****`"BBB@`HHHH`****`.;\8@E=,7/6
M\3^M='7.>+Y%$FDH3\YO$8#V'7^8KHZ`%K.UW4%TS29[DYW!=J8_O'@5H5Q?
MC6ZEO]0MM&M2K,65F&?XCP`?P.?QH`F\&ZO>7-W<6>H3-(^Q9(]Y&<?_`*B#
M5R7QGIL5S)!(DZF.3RR=HQU()Z].*YUTU#P_KEC?:EY1WCRSY9ZJ`%.<#L"/
MRJSX:LK>\\3ZHT\*3)&[E0ZY`)?@_P`Z`)5\7M=Q:BK3I:MMQ:X5CSSDYQ].
MU:>CZY%;:%%<ZK?K(TDC*K[22<'IC&?TKEK`6:6.LK/Y7VHAA"K+\PQG=CCC
MK^E11)$C:(]\K?82IW;LD9\QL_\`LM`'9ZEXCA_L2:^TN9)FB95(93QDXY'!
M'UJQ#KMM%H]K>ZC+'`TZ!MHR<GO@=:Y&_;2O['U,:2MP0TJ%V;A`-W``S]<<
M5%K/F/?Z4A$31BRC*+.VV/.WGG(]/Y4`>@0:C9W%K]JCN8C#QE]P`&<<'T/(
MX-,L=6L-0=DM+I)609(&<X_&O-X)%?3M1M?M4=K&\RND>696QN^7(S[<GT%6
MM$'V7Q':1S6H\XE`IMI1@#:>3USZGD=*`/2JBBNK>=F6&>.1E^\$8''UQ7/^
M.[FXM]'C6!V022;7*]<8/&?K6'JUE;Z)>Z5)IDS;Y^7/F9W#@9^AR:`.A/B=
MFUQM-M]/DFV2B-Y0WW><$XQT'UK1UC5[?1[43W.X[CM54&2QKE/#6GQ+XPO`
MC.%M&<ISG/.WD_C4WQ`+^?8!]WV?DMZ9R/UQ0!8L_'%L\HCN+>5`[?*_!`!/
M&?IQ769%<WKESX>6&R6]"21@_NA$,[5QCG';IQ]/2LMENM=\136,5\]K;6J?
MNA'D';P/7G\:`.XI:\Z74[\:!J5LUV[-931K',C$,06(Z^G'ZU*E[JFG7>CR
MS:C)<&[4,T+'A58@#ZGG]*`/0**X.36-2TD:M9W=R\LL8'D,Q&X`G&[/T(.*
MAO-;U:UAL[.:]\B62/SI)G4Y4')`X&>GMWH`]"HK@8?$FH-H=X!/OGM)4*S@
M??4L1R#]/UH.O:]IMI;S730E+S#1M(-VT8'/R^V.*`.\DD2*-I)&"HH)8GH`
M*BAN8[NV\VTE20,/E8'(SCC-<K8>(+K48-2ANTMIX5MI'#0L5W`#D8/S8.>O
M%4M,UMM+T*UM[&W5[V[D9E3DC&[:#^F,9[9H`[N+>(E\T@O@;BO3/?%/KE[#
M7]2CU![#5K...<QM)&4.%(`)YY/H>:IVWC:Y^Q-<SZ:'02;-Z28&<9Q@@^AH
M`[2BH+*Y2]LX;F/[LJ!A[9J>@#/UYBNA7Y4D$0/R/I4'A1=OANR&?X"?S)-3
M>(3MT"_/_3!A^E,\-*5\/6(88/E`_GR*`-2BBB@`HHHH`****`"BBB@`K/U[
M_D"W?^Y6A6?KW_($O/\`KF:`*FM7=Q:W*EII+>U9`!.BAE1\G[X(S@C`!^M3
M2ZRJ2.%MY9(T9DWJ#]X#ITP`3QG/6EU*TMY96\^]:`3Q^4\>Y0'49]1UY/(H
M;1(&>;$TZPS`[H5;"!B,;AWS^F>:`'3ZC<PO'&;$M))(43$HVGY"W4_0CI5:
M;77^R//#:,4*%D=L[?O`<\>^1@]NU6H=*"&!I+RYF>%]X9V!R=I7TZ8)_.H_
M["A$4\(N+@0R@[8]PVQY.?EX_G0`Z35FCO%MFM\.[,JCS!DX0MG']TX(S[=*
MKQ:^S06TTEF8X[E&:(^8#G"[L=.IYQ]*DDTFW@<W,M].@60REF90`Q7:3G'H
M:2.VMUAL;.%HI+>/:\,C2@L=IR,`#GCO0!<O+TV[V\2QAY[ABJ(6P.%).3CV
MK/@OIM4OK8PN\$/E>:5##)(?!!XYZ$?CFM"Z@M[YU3SBLT#!U:-AN0XQ[]02
M.:;;:9#:S1R1/(-D?EA<C!&<\\=<\YH`H7US<6^K*+B6>*V>1!%)'@QCIE''
M4$G//N/>I?[8FCM))Y+92$EE0D28`"$XZ]SCM5J;3(Y9G=I9@DC*\D61M8@#
M'4<=!TJK_9%G<M(4NI6VR2;@CC"EQ\R]..OUH`/[9822YA!3,2Q`$Y8N,\X'
M\L]*T+.=[FV662%H6.04;J,'%5#HENR.IDF^94&=P!4I]U@<<&KMM`MM`L2L
M[`9^9VR22<DDT`35%=?\>LO^X?Y5+4<_^HD_W3_*@"N+V&$1QR/A_+#XVD_+
MZ]*LEPHRQ`'J:SGLY9;JWN5^[';E0`Y7+94@'VXJD^B73-N+J_[PN0\A(.)@
MZ]?]C(_&@#<CD$@RON.00>N.]-FN8K?9YSJGF,$4D<$GH*QIM,:&VF><C>5Q
M'(N68-YC,O;)^\H_"M&6Q%Q9P0RQJ5W;I5)ZY!S^IH`LI*LI<1G)1MK94CFG
M_-ZK^58=QHUZ]N8UF1WV2IO9B"0P`5CP>1MH.BW)DD?S%#,)2/WC<,7!0_AS
M],T`;$$ZW$0EB8,AS@[2.AQ4GS>H_*L+^Q+I%'ER1A6SYL><"3YF/7!QP1V[
M5?TK3C9><TAW22.2&W%CMXP,G\:`+_S>WY4<^U+2T`)S1S2T4`-(;U'Y48;U
M'Y4ZB@!F']1^5+AO4?E3J*`&X/K^E+@^M+10`G/K5&V'_$YO<G_EE%_[/5^J
M%O\`\AJ]_P"N,/\`-Z`+]%%%`!1244`+1110`4444`%%%%`!1110`4444`<O
MXRF(NM(AQPUR'S]"!_6NHKE/&G_']HQ_Z;G^:UU5`!2;5W;MHSZXIU%`#2JM
MU`/U%`159BJ@%NI`ZTZB@"A_8VG":286<7F29WMMZYZTY])L)+1+1[6-H$.5
M0CA3[?G5/Q#=S0?8[>&0P_:9MK2@X*@<\5RL.H:_]B:]CEN7MS"^]Y,;5/(!
M4_@*`.U&D:>+1K06D0@9MQ0#@GUIE[H=A?6D-M/#F.$`1X)!4`8Z_A6#JFKW
MBP0&UO`KBP,S[0#ELKS[=ZSX-?U:&UO&:Z#E`B+]H0(ZN3V`ZC&>3[47"QU,
M?A[3TLI+(P(;9B"!CYL@8R3ZU'IOA?3=,NA<PK(TJCY3(V=OTK%TG5=3-[':
MWEPQ9+M8W#H%;!1C@XXQD#&*N:CX@GT^'4F,D;NEP(;<%>!\H)SCKC)_&@+&
M_J%C!J-G):W*DQOUP<$<Y!K'TSPA8V%TMPSR7#I]P28POX56F\5E)-/G55-G
M+'NG.T[D.<>O8XIL6N:S-:V%P@L`MY(8E#*_!!(YP?:@#9T_18;#4;N]21W>
MZ;<0V,+SGBK&I:=;:G:M;W2;D/0CJI]0>U4-4U#4=,M(KAX[6485)`&9?G)Q
MD<=*8FLWTMW=6L%A%+):*#*1/A<G)`&5R>GYT`5;3P1I]O<K+)++,JG(1\8/
MU]:DU/PE!>W[7<-S):NX^8)SD^O6G7'B;R?#]MJJVA;SI-ABWX*_>'7'/W:K
MW/C`1R2""U69!)$B.9=H;>I;/3CI1<"=/"-M'HTNGI,P:5P[3%1GCH/I_B:=
M<>%HIGTYOM#K]B54`"CYPIS^%0#Q:^QD^PC[4LOE[//79T)SOZ=NE7E\0P?V
M--J$L,B"%_+9.#ELX^4]",GK1<"+5O#,6IZM#?/,5V;0T93(<`YQ1J^@27>I
M1:C9W"17,2[0LB;D;Z_F:B_X2=;8);3VT[WJ`B2/"@\+N+=<8(YX-6!XFM#-
MI\95P;U05)(^3/`!_&BX%.?PM<S:?/;-J6?-D$@`B"J#DDCKG'/X8%6+S1K^
M73[>WBO("(H4C:&6$-&Y'4YZC\/2K.M:[%HYC#P33%U+?NQG:!CD_G38/$EA
M/?\`V2,R$D'$FP[&(&2`?7'-`&/8>#I[>2XF>YA622*2-8XP0GS+@9)YQSTQ
M35\)7L$-A/!<PF[M,_*0=C?.6'/X^E;5GXFTR\6+RY6#2N(PK(00QZ#TK7HN
M!SBZ/J%WJ9U._:%66%HX[>/G&5(P6/?D\UG'P[J$?A1[`1HUP;CS<*PPPV^O
MZ5VM%`%73+7[%IMO;9SY484_6K5%%`&/XL)'AN]P<?*!_P"/"K6B#&B6(_Z=
MX_\`T$53\7-M\-WGN%'_`(\*N:(<Z)8G_IWC_P#010!>HHHH`****`"BBB@!
M,TM-90Q4D9*G(]CTH3?CY]N<G[OIGC]*`'5GZ]_R`[W_`*Y-6A6?KW_(#OO:
M!S^E`&?KK+#>23AX9"+<"6UF.!(FXXVGLV<_I[4C7SQ7-TK7;1EKE%5'V_*I
MB#8YZ<YYYZ=S6^R*V-R@X.1D=*"B$Y*C/KB@#E8]6N6M8[LSG>]G&S*`,`[\
M.P&.PYK4CO)QHUY<03I>/&',3(,@X&0,@`''M6L$48PH&!@<4H4*,`8'H*`.
M8ENWFD$?V[S[;S;9TF^4'<6Y7ICL&]LUH:Q;(ZV%M#(MN_G$Q$`#:0C$$#ZX
MXK750O0`4M`'-RW]W$K/<H;1O-2*>4?=4;6.Y20?E)VC)'>IK>:^\Z&*2[:8
M7,8*2+&%"E6^<].ZD$9_PK=(!&",BC%`'*'6KD2J!=;HFAW,^U<I^]52V.V%
M)XYZ#-1Q7XMX[T6]X<O=3,K#!W@1`CYOKTP.<?6NNVKZ"C:,8Q0!%92F>R@E
M8@EXU8D=,D5/2=*6@`J.?F"3_=/\JDJ.;_4O_NF@#`\0ZC<6$&G""Z6U69MK
MR,@<*,#G%0)K,\&E7MTNIQ:BZ%$C"P[`C,<<^O\`]:KVK6%W>QZ;-9^27MV$
MA64D`\>U-N-/U+4M/N+2\6T@W`-&T!8X8'/.>W%`$5O-J[7%YI4EY&;M8TFB
MN!$,8)Y!7]*J6NHZS#%J=U+<I=P6BE$Q$%#2#&3QS@<UK:987J7]SJ%^T'VB
M2-8D6+.U5'/?U-2Z=I\UIH:VF]%N-C;G`W#>V3GGKR:`,&U\1W<#RQR7,.H%
MK0SH8U`V,!G:<?\`ZZET;7;@ZE;VUU?07:74)DRBA3"P&2IQ[`U/IF@74-X;
MNX-I#*D)BC%M'@9/\9&.OM4=IX9FDN#)?FUC"PO$HM$VEBPP6/'7!H`DM=8O
M+_Q`8(SY-G);NT!*@E\'`?U_#TIMB=9_MX6DFJK<10*'N,0JN,]%Z=3UI]MX
M:DM=9M[I+ZX>"&+:`\F6Z\+TQMQVJ_HVG364E_-<,C2W-P9`5.?E_A'3ZT6`
MS1=ZO::O9QW-U%*UU(0UFB#]W'S\V[KQ[U%%JFI;K/4GN$-E=W7D"V\L9122
M`<]<\5+IVDZS:ZH]W*UC(T\F99#N+A,_=7TXI\6@WHEMK9YX/[.MKCSXP`?,
M/)(![=2:+`5&UC4Q_P`307"FS^V>1]FV#[F<9W=<TQM?N9-7DVZE#`B7/DBW
MDB.UE!P27`X)JVWAV\:0VGVB$:;]I^T8`/F=<[?3%)>>'+R;[1:1SVZV%Q<>
M>^5/F*2<D#M18+FOKE[+9:1<W%L`\T:Y`ZXYZ_AUK(\/:S--JGV&:^2^62$2
MK(J!2C=U.*TSH=M%)<W-F/)O)T9?-)+8)[X/'4"JVBZ'-:7QO;QK;S5B\I%M
MTVKC.2Q]S0!O44E%`"T4E%`"U0M_^0W>_P#7&'^;U>JC!_R&KS_KC#_-Z`+]
M%%%`$%ZLKV4ZV[;9C&PC/HV./UHLO-^PV_G@B7RUW@]=V.?UJ>B@`HHHH`**
M**`"BBB@`HHHH`****`.6\70O<ZIHT$9&YI6//3C;745SNO-_P`5+H2_[;G^
M5=%0`M%%%`!1110!3U+3TU"*-6(5XI%D1L9P0?3N",C\:DALK:"T^R1Q*(,$
M>7U&"<D?J:L44`9$?AG2HH)H8[;:D^`_SMG`.<9S4ESH.FW3EYK969HQ$3DC
MY1C'X\#FM.BBX&1_PC6F"WFA6)E\TAB^\E@PS@@GH1DT^#P_IT$D4JPEI(F9
M@SNS98]2<GDUJ56U&=[73KFXC`+Q1,Z@]"0":+@4(?#MI%>33`LT<JNIA.-@
M#8S@?A^M/M=#BM;6P@65RME(TBDXRQ.[K_WU66=3\2KIPOS;V#0^5YN!NSMQ
MGU]*V(=:L7TV*]DG2*.1=V'8`CL1[X/%%P)=4T]-2LS;R.R`LK97KP<UGZEH
M4]Q?M=6-ZUF9T\NX"KG>/7Z]LUJ1WMM+:_:DF0P8SOSQBF0:E97(B,-S$_FY
M"8;[V.M`&=/X=C;2K*QAE*K:2K*"PSO())S]<FJ#>#@LSF&6-8FNDF"%3PBY
M^7_QZNG,T0;:94#=,%AFGT7`YB7PS<AKJ.VGA6W><31Q.N5&00RD?ECZ=JLQ
MZ!-'X:GTPSQM))DJ2OR)DYP!Z?XU8/B"T;6H=,@/FR.6#LIXC(!./?H:UJ+@
M<._AK6UT\6T4L.V1R\H$C9/``!/<<59E\+75[#<7%RR07055MXH'^1=HXSQ7
M844`<OJVGZWJ4<"O';*JLPD19"`Z\8R<9P>>*KQ:+JH=8O)MD"--)YF\[3YB
MXV@`9&/\*["B@#@FTVXM[-H5B^QR74\,<$98L0Z_>?/8=37>#I2,B,RLR@E3
ME21T/M2T`+1110`4444`8'C7(\-7&/[R?^A"M>P54L+94&%$2@#TXK)\:_\`
M(M7'^\G_`*$*V+7`M(0,8V+TZ=*`)J***`"BBB@`HHHH`****`"J]_;?;+"X
MMMVSSHV3=C.,C&:L44`9_E:K_P`_EI_X#-_\72^5JO\`S^6G_@,W_P`75^B@
M#/\`)U;_`)_;3_P&;_XNCR=6_P"?ZU_\!F_^+K0HH`S_`"-5_P"?ZU_\!C_\
M71Y&J_\`/];?^`Q_^+K0HH`S_(U3_G^M_P#P&/\`\72?9]5Q_P`A"W_\!3_\
M76C10!G_`&?5?^@A;_\`@,?_`(N@6^J8YU"#_P`!O_LJT**`,_[/J?\`T$(?
M_`;_`.RH^S:I_P!!&'_P&_\`LJT**`,_[-JG_01A_P#`;_[*D:UU)E*G48L'
M@_Z-_P#95HT4`9J6>I(BH-1CPHP/]&_^RI?LNI_]!*/_`,!A_P#%5HT4`9WV
M74_^@E'_`.`P_P#BJ3[)J?\`T$T_\!A_C6E10!G?9-3_`.@FG_@,/\:/LFI?
M]!-?_`<?XUHT4`9WV34L_P#(3'_@./\`&C[)J/\`T$Q_X#K_`(UHT4`9WV/4
M<_\`(4_\EUH^QZC_`-!3_P`EUK1HH`SOL>H_]!0_]^%H^QZA_P!!0_\`?A:T
M:*`,[[%J'_05;_OPE'V*_P#^@J__`'X2M&B@#.^PW_\`T%9/^_*?X4?8;_\`
MZ"LG_?E/\*T:*`,[[#??]!63_ORG^%)]@OO^@M+_`-^8_P#"M*B@#-^P7V/^
M0M-_WZC_`,*ELK%[:>::6Z>XDE55)95&`N<=!_M&KM%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110!S6O\>)]"/^V_\`2NDKD/%,D]OXETZZ6WFGB@0,
M5C4GG)S^/2K*^,X,KOTZ]4'J=@.*`.GHKG6\9Z6F!(ERA(SAHL?UIO\`PF^D
M?]/'_?O_`.O0!TE%<U_PF^D^EQ_W['^-*/&^D'_GN/\`MG_]>@#I**Y]/&6C
MNP'G2+DCEHS5G_A)M&_Y_P"/\C_A0!KT5D?\)/HW_/\`Q_D?\*/^$GT;_G_C
M_(_X4`:]9OB*1H]`OF7KY+#\QC^M.AUS2Y_]7?0$XW8W8X_&IEO;&YA.+B"2
M-L@@L"#V(HN!REKH.LWVFVR/JP%G+$A\O!R%P#C\JJ:W8VL6K6UA#&'-O`!_
MI$P2,J,GM@Y[]:[A;FT1`JSPJH&``XP!4<Z:?>(&G6VF5#U?:P4T7069YS!)
M_H5W;95+62[A$OEL65%^;D$_0<_2M!K:TM/%</\`9!1HHH&E.'WC(5C_`(5U
M.M:%#J-MBWV6\X8.&"C#$=F'<53T7PY)8ZF=0NIX2^TJL<,>Q1GC/^10!QZ6
MTLFFO?21PN68G[09\2(WN,_TSS7I&CS2SZ1:2SD&5XE+$=SCK37T;3'N/M#6
M4!DYR2@YR<Y/O[U>&!TH`XUK&VTSQKI=M:1!(_+9R>I)(?J?P%=E5673K2;4
M(KYX\W,2[4?)X'/;IW-6LT`+124M`!1110`4444`%%%%`!1110!@>-F`\-7`
M)`)9`/<[A6Y%_J4_W17.^/?^0`O_`%V7^1KH8/\`41_[H_E0!)1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1124`%+24M`!1110`4
M444`%%%%`!1110`4444`%%%%`"44M%`#'ACD_P!9&C_[R@U";"S8@FT@)'K&
M*LT47`K?8+,?\ND'_?L4OV&T_P"?6#_OV*L447"Q5;3;%SEK*W)]3$O^%53X
M=TAB2;"')]!6I11<#+_X1S1_^@?#^51'POHYF\S[&@Z?*"<<>U;-%%P,IO#F
MCL,&PA_`8JG/X,TB8J1')%M&,(_7W.:Z&BG<#FO^$'TGUN/^^Q_A3AX*TL(4
M#W.T\E?,X/Z5T=%%P,`^$K+;@7-Z..#YW2F/X/LGZW=]CT\W(_E7144@.5;P
MC<AV\C6KJ.//RJ221^.12?\`"(WG_0=NO_'O_BJZNB@#E/\`A$+K_H.77Z__
M`!5(?"%YVURY_$'_`.*KK**`.63P[K5NJB#7I3@]&!QC\2:A_LOQ;C_D*1?]
M]?\`V-=?11IV`X_^RO%O_04B_P"^_P#[&G)8^+XU91?0MSG+,"?Y>_Z5UU%&
MG8#F(E\70J-QLI^,?,>>_/&/\BD-SXOR<6-F??=_]E744E&@',?:?%^/^/*S
M_P"^A_\`%4-?>+(T<G3;5L9/RMD_ENYKIZ*+(#G(-:UM05N-#9GXY23:.3CO
MGOG\/SIA\2ZG'+(DF@7)PV!M)/Z[<'G/(KIJ*-`.'U_4[_6=.%L-%NX3Y@;<
M5)'&?;WKMU^Z/I2T4`+1110`4444`%%%%`!1110`5%-.D&S>3\[!!A2>3]*E
MI*`"EI*6@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@!CLRN@5"P8X8Y^[Q3J*6@`HHHH`KM<$7ZV^T8:,OG//!`Z?
MC4],\I//$VW]X%VY]LYI]`"T444`)2TE+0!#=2216[O#%YL@^ZF<9_&I:6B@
M!#THI:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`I,\XI:*`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"DI:*`$I:2
M@G':@!:*K7UXME%'(ZLP>18QM]6.,U8H`6BBB@`HHHH`****`"BBB@`HK.U+
M5DTZXAB>-F$D<DA8'[H1<FLS_A,;)9;I)89D^S_3+?,%X&?4_E0!TE%8Y\1V
MBZ7%J#PW"PRN44;06.,\]>G!I]GX@LKVPN;R+S!#;`E]RX/`SQS0!JT5C-XF
MT\0P2*9G$J>9A(RQ1<D%FQT`(YJ2P\06&H$"W:1CL+M\A^0`]_0GG%`&K163
M_P`)+H^TM]NCP,=01U&?2I8]<TV6":=+M&BAQYC`'"YZ4`:-%9:^(M)<9%]%
MTW<DCC.*G35;"2..1+N(I(_EH=WWFSC`H`NT5%!<0W,?F6\J2IG&Y&##/X5`
M-5TXAR+ZV(098^:OR\XYY]30!<HJN+VU,"3BYA,3MM5]XVL<XP#]:/MUIE!]
MJAS(2J#S!\QSC`]>>*`+%%-9E52S$``9))Z5&EU;O)Y:3QL^,[0X)Z9Z?2@"
M:BFJZ.NY&5ATR#FER/6@!:*3(HH`6BBB@`J,-)YY4H/+"@A]W)/.1C\JDHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`*2EI*`(A=0&[-H)!YZIO*=]N<9J:LFWC0^)[R7'SK;1J#GL2V?Y"
MM6@!:***`$[TM%)0!!=0&<P?*C!)0YW=L`\CWSBIZ6B@`HHHH`****`"BBB@
M`HHHH`S=6T6TU8QFYWAH\@,C8.#U'XU4_P"$2TK]]^Z?]Z,'YSQSGCTZ5NT4
M`9$GAVRDTV.P=IC!')YB@OR.",9].:JCPA9HABANKN.!VS)$)/E<>AKH:*`.
M>7PG;12[[:[NH>HPK\;"<[/IFI=.\-0:=O\`(N90)(FCDSCYLDX/U&:W**`.
M5N/!%I+$%2X=7`^^5!SA0!^'&?QJPOAIXM+N;"*[)B9U>`.,[".3GU!-=%10
M!R$G@Z:XDFFGNH_.E!(*(5"L6]/3&15A/#=T=%N-.DFMRK,'A8(<H=V22?IQ
M73T4`9ZZ:T;V7V>Y:"*W7#Q(ORR<=_RKF6\'7<D:LTEJKQY95"'YR6SAS^E=
MM10!RG]A7TVA"U>..%Y;SS3&A^6%/;^>/>LN/PKJ:6YB>T@F:50!*9>8,$YQ
MS^-=_10!SVF:";&WU+"_O)S(D0W$X3^$=:P[CPSJ_P!H=XB7)C51(9`"1L`*
M8_3/M7>T4`>=KX<UB.>9X;=K=#'(%"N')!!^4\]2#C-64L]5@TC[`NGW(E6Y
M$PEC8`8Z#!SFN[HH`X"QL-<%[$3#=(#/&SO*2P#?Q,1GD=:T-,TJ_FU6TDO7
MN@D<;2DEL#S/-/'T(P<5U])0`M%%%`!1137=8T9W8*JC)).`!0`ZFA@21SQ[
M5!8WUO?VPN+9]T1)`.,=#BFSZE96TCI-<1HZ)YC`GD+G&3^)%`%NBHXI8Y85
MEC8-&ZAE8=P>]1V=[;7T)EM9EE0':67UH`L44E+0`44QI8T<(TBJS=%)Y-*6
M5>I`^M`#J*2EH`****`"BDHH`6BBB@`HHHH`*K7U_;:?&CW<HC5W"*2#U/\`
M^JK-96L:%#K$D9N9IA&BD"-"`,G^+ZT`))XDTJ*>6![K$D1(9=C<$=1TYI1X
MBTL[\W#+L!+!XG4\8]1R>1QUK,_X0FU,KR->W19\G=D`YZYSCGFK`\+I,%>]
MO9IYQ,LK28"YP`,8],`4`7K+7=.OYVAMKC?(BEF!1EP!UZBFQ>(=*EC9UO8P
MJML);(P<$]^V`>:IV'A:*PN)IH[V=C-&Z.2!N^;OG'6JUMX,AB=1)>22PB4.
M82N%8`8&<=_?]*`-PZM8*[H;R$,B;V!<<+@'/Y$?G4(\0:48Q)]MB522!N.W
M./K]167/X.BFN7F%Y(GF%@P51C8?NJ/3`P/PJ"[\(WEYL,^J"1ER,-#\HX`&
M`#UP!0!T-QJUC;*6GNHT"JK')YP>G'OBB35K")(GENXD68;HRS8W#VK$U/PG
M)?N#]M"@1QI@QYY4$9Z^]3W'A>.[73H[BX8Q6<7ED*,%CQS[=*`-(ZUI@+`W
M]L"GWOW@XYQ4@U.Q:U-T+N$P*=IDWC:#Z9KF)?!]U-;B&2>W`A&(C''M+Y8$
MESSVXJROABXATA[**:!BEUY\1D3(8`8PU`&S_;FE?+_Q,+;YNG[P<T^'5].G
MW>5?6[[06.)!P!WKG$\$AY;B:YN%+2`LBPKL56SGWXZ5!+X+G2VM_LSJ90A,
MH=OE+\<#CIUH`ZX7]F8UD%U#L;&UO,&#SC^=2^?#DCS4X.#\PZ^E<8WA2_-Y
M9S!+10AW2K'E0OSEL#UX.*EU3PUJ-W?70B%N+::4S!V/S;MI&/UH`ZN.]M98
M3-'<Q/$/XU<$?G4ID0'!=<^F:\\_X0[5O*13%`2K$_ZSZ=?RK1U?0-2N[^25
M;:!Y)?+(G$A7RBJ@,`/0F@#L?,3(&]<GH,TH=2<!AGTS7"P^%M6M;^"X0+*L
M!1E#38/`Y`XX&<UKZ/HEQ#KLU_=#:NW>B*?E$CCY\<]!TH`Z6BBB@`HHHH`*
M***`$I:*2@!:*B(F^TJ0R>1M.1@[MV>.?3K4M`!24M%`&;;12#7KV5HF6-HH
ME60]&QNSC\Q6E110`4444`%%)2T`%%%%`!1110`E+24M`!1110`4444`%%%%
M`!24M%`"4M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444E`!6-X
MH2\N--%G8PL[W#!&<'`1<C)/\OSKFO$]S.U_>S1W$T20RQ0`+(5_A))QGFK<
M-QJGAY)GF$TMM)-&D9NF&>0=QX)QTH`H7.E:K90WEB+5IO/$+*]NOR*5/\^/
M\YJOJ.FO9SWL"VMTSF",*Z!F5F^4N2<\CK6_-XGOVO3;65G!,6GDBC/F8W!0
M#GKZ&HHO&LC&[66Q"-"I91O[@XP:`*TT\\5R\,PU3[2)%:-+9SL\L(.,'CUS
MQ6'#)JMK:Q+']JBMSO*A-RAFZ=1U[=:[2?Q;:VZNTL+86.-P%923O&<?44Q/
M&%M+&K1V=PS'S-R_*"NP`DGGT-`'-0WFJC5K;[5/>J6FC4Q;G7/3)QTYK<\6
M7]U;ZI!$;J:SM/)9A)$#\[\_+^@_.K=CX@;4]9@@AM#]G:#S=S;=P.0,]>@Y
M'KSZ5$^O1RZG=6NH6)DA2416ZB,.6<=?T((]J`,O0+:75=?@N[YY#)#;I)M?
M.20<+U['[WU-.U5M.CU/4_[=69Y<K]F"DYV'^[VZ^OI6X^L6\NDWNIV,2K<0
M*5?S8\,"/X3CK^=8+^)#?>0[VEG),L$K2>9%DJR@L,9/0\?K0!%J&J7ECE;;
M4I8H[>.%H(90"TH89.3[4^/4=5EOR8=0D$4MV]LJL`0N1P?PS^E2Z3X@;4+V
M1[S2[>XFBC,BR11X<8'3FM#P]JECJ=X88]*BMV7,P;*G#9P3C&0:!F/'KVJ^
M0\@FD5["!A.)!D,Y<J/Q&1_WS45MX@U=X8K4W?[X7,>V0X;(8'@D=1TK>;6K
M0:I<V8TI6\Z1H692NZ5@.A7KCGJ>.:@M+W38WN+>?1H;5[./[1@.K\KTR1T;
MG]:-!%2Q\3:FFL0Z=<203QB40M*H.6YQG/\`]:JNE^(-0@L?)AFB5D22=GN2
M3Y@S@!>>O!KH]"ET[6GDO/[-C@NH7PQ8`G)YS]:S;B;0X9%M]0TAK:VC+^2[
MYRQ_B^4'(&>AZ4:`5Y_%.K^7+-`L*Q111.X=.<L!TYZ9.?I7<1$M$C'&2`3B
MN*N-:TAH)FN=*`G)BS$7^\F`5.1QP,<5N6'B&*XELHFMS`MVK>4V]6&5/3B@
M#<HI*6@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"DI:*`"BBB
M@`HHHH`****`"BBB@`HHHH`***9(S+&[(A=@"0H.-Q]*`'T4U"612R[6(R5S
MT]J=0`4444`%%%%`!1110`44QI$1T1F`9\[03R<>E.H`6BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M2EHH`QY="ANM4N+BZ5);>54Q$1_$O&X_@<5H7=E;7T(ANH5EC!R%;UJQ10!0
MAT;3K<H8K2-3&6*\=-PP?S%0IX<TF,2".T53(A0D,3P>N,GBM6B@#`F\'Z1+
M]R%XAQ]QSSC/KGUI8?"6FPS22(9LNKK@OG&X8../0UO44`8=IX9M;*]M[F">
MX4P)L"[N&')YX]ZAO/"D5S?3727<T3R,)%VG[CY&2/P&*Z*B@##B\.K!H-SI
MT4[&2XRSRN,Y8XY^G%9]_P"#FN&A>WNDA9+986(3[Y`QDX]1Q7644`<W>^%A
M<SPO%/Y">3Y<X3(,A`^5N.^?6ET+PW/IVI&]N[M9W\KRQA<>G)]>E='10!R4
MGA2\.LW%]%>I'O+M&V"75F!`Y]!FJL/@W40#%-?1&WD<-,%SN<9[G'/XUV]%
M`')RZ!JFF7,AT&X58YE!<RD,P*Y]1WS5./PKJUU-/-?W$1:X!5R?F9>,C''`
MS@8':NXHH`X>#PUK$<3W+?99+H;(UCD56!11CN,`]/RJ>QTE[?4M'T]\.]H)
M+F9@#M!8_*`?J/TKL:2@`I:**`"BBB@`HI*0,"Q7N!F@!U%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%)2TE`"T444`%%%%`!1110`4E+2
M4``()(!!QP?:EIJHB%BJ@%SN8@=3C&3^`%.H`****`"BBB@"I<(S7UHVQ2BE
MCD[LJ<=L<>O6K5%%`"T444`%%%%`!1110`4444`%%%%`!37=8T+NP55&22<`
M"G5D^)K;[5H5TOFO'L0R?)_%@$X/M0!J*RN@=6#*1D$'((I$EC=%=)%96^Z0
M<@UDZ-?1^5%I9BD2>WM(V?*_*/E''UYK@K-M1A@M#^]2W5WG@;9N&Y02<#ZC
M^=`'JU%>=P^)M;G1?+N5RTA4$PKV&?2FGQ9K,4;!YHW+QJP;RP-F3]/2@=CT
M:BN/F\17X\(0Z@K*+EIO++;>"`3SC\*SX_&.J'#D6H40;R'!&XAL<<]?:@+'
M?T5PUOXBNM5UK3UWQPQ"X(V(Y!;C^+U'7%3S:O=6/B/4'256A:>&#9,Q"KN4
M_,/3&TT".SHKB/\`A+=1O6GM[.UA+")VWAR,`9^8?I2Z=XS*RV]M-$TJ"(!Y
M2?F+8Y.*`.VHKSV_\2ZI+.K12/:I+'&510K=>I!K;U+Q/-%ILUQ:V,X"DA9G
M`\O[VW)YS^%*X'3T5Q]AXM='N!>0S2RF1BD,:C,:*H)S^OZU<?QE9)*B/;W`
M5@AWX&!N&1W^OY47`Z2BLG4_$%KIMR+>2.:1PGF/Y:YV)G&XU1T?Q%-J6HW9
M\H1Z=`K$3;3VQC)Z=,FBX'245A#Q;I+*[+)*0@RQ$3<#.,_GQ2#Q?H_F*AG<
M$D#)C(`^M%P-ZBL5?%6CM$TGVK"JX0Y1LY.<<8Z<&FOXKTM+B%/-)BF3>)<'
M`YQ@CKV-,#<HK.CU[2Y654OH"S-M4;N2<XJK!XITR>\6V21LLS#>0`HVC)).
M>G%`&W4%U<-;B,B&27>X0^6,E<]S[5$-5T\QB07MOL)(#>8,$@9//TJ8W,`M
MOM!FC\C;N\S<-N/7-`$U%9]WK-E:3VL,DFY[I@L809SDXS].:O;E)(R,CJ*`
M'44FX>M&1ZT`+15%-8TYW"+>PY.<?/Z'!JXK*RAE(*D9!'0B@!U%)FF^;'YO
ME;U\S&[;GG'KB@!]%%-9U0`NP4'CDXH`=135D1\;65LC(P>U.H`***:SJI`9
M@"QP,GJ:`'44E+0`4E%%`"T444`%%%)0`M%)2T`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1347;GDG))Y.:=0`4444`%%%%`!24M)0``@]*6J.FLK
M&\V@\7+`Y]<"KU`!1110`E+24M`!1110`4444`%%%%`!1110`4444`%%%%`!
M24M%`"8&<X&?6DVKQ\HX]J=10`T(HZ*/RICV\,F=\2-E=IRH.1Z?2I:*`('L
M[9[86[P1-```(R@VC'M4/]DZ=M"_8;;`&`/*7@9SZ>M7:*`*BZ98)*)5L[=9
M`=P<1@$'US52#P]I\4ET\D9N/M+AW$V&`(SC''N:UJ*`,Z/0M-BF:6*T2-GC
M,9VY`VGJ,"HX_#NDQ70N$LHUD'3K@<8Z=*U:*`,9/"NC(05LQD$'EV/3\:5O
M#&DL9"UKD29R-[8'.>!GCGTK8HH`P+CPAI4L`CC22$AB=Z.2QR,$<YXJ63PM
MI;A1Y+`!T8_.3NVJ0!SVY[5M44`9&I>'K/4;K[1(\T4A79)Y3[?,7T;\J?IN
MA6NFP74$1D:*Y8EE8_=!&,"M2B@#F4\&6R=+RY(X&#M^Z#NV]/7FL^^\-:C>
MZU(KX6QDG:8L'!`S@=#SG`^E=M24`<=%X'=(@#?`OYB.3Y?&%SQU]Q3YO"%W
ME7MM02)PK(3L/1F)/.?0X_"NIN7F01^1$)"9%#Y;&U<\G\/2I:`.)_X0B\:2
M!GO("(\#`CQP"3^/7O3Y?!4[LQ$UN.),;4()W9QGZ$_E7:44`<6OAF^=X9)H
M+<)YA:2V1L(H"@#'N><_A2RZ!JC^%K.S"*TT,Y=H6<8(R<#.??\`6NSI*`.0
MT?PY/;:E:7%U;(,&5V57XAY&P#GGN?QJ#4="U=M5OKBV@!,Q8I-YP!VD8VX^
MG'-=M10!P$?A^^,T"2:9)'!O3<//!P`N&.<]SC\JJ+H?B+?;_N)QY:E5Q*!M
M&3D9SQUKTJB@#S!_#NJ&#:NGS*R*0V6!#'?V'TQ^5:*0^(V\N**&[C6-W:/>
MPPHVX4=>W]:[ZB@#SL6GB9K5@RW>3(.=_."#N[].E:>BVVH)K.GSZBMTKFV:
M,MCC.YB%8^F,'ZXKL:*`.#F;Q0TU\8_M0!SLR#TWC&WT./TS4ES8ZC,@%[+?
MR"&XD`*C)`V`JV,=,DC\:[BB@#S&"6^TA!<&6Y@=4C\M)`0LF#EDZ>^?SKH)
MKC68?"$=P))S>23;B0NYE0DX_#I^==1=6EO>1JES"DJ*P8!AD`CO4P&!0!Y\
M-6U]K8,+BZ\Q(BQ'V?@MOP!]WT.:L07&J7NNV37IFQ'=-B(VY4(N.&S_`/7-
M=S10!Q.K7^NQ7VI26=Q,MO;N@"F('@^G'3W^E4V\1ZXJ6>6D[M(1!RXW'VQT
M':O0J*`.`NM9U.[MIH$EN-_FS;E\G!5`N5&0.N<^]4[>;4EGACDN+DG?`5C8
M-DC&2?H,X/\`O>U>E@`9P.O6C`SG'-`'G\?B/6HK5I9[A,O;[T#1`;29`F>G
MN36AI.OZBUEJL\SQWB6J_NY%&T$\]@.G>NGO-/M;Z!H;F%71AC'0_@:9IVEV
M>F1-%9PB-7.6Y))^N:`.4A\8W\L:KY5L)GE14X8J5()/0]0=OYU1OM>U.[1+
MAKM;>-[<.8HV*9_>%3CU/&?I7?BSME556WB"H<J`@PI]12&QM&"AK:$A1A<Q
MC@>U`'$P>)M3L;F],^R>-9G0J23L8!MH'L2/TKH]#U6\O[FXAO(8(FB5"51C
MN!8`\C\?TJW=:-97<\4LL7,;[]JG:&;L6QU_^N:N)!$DKRI&JR/C>P&"V.F3
MWH`DHHHH`****`"BBB@!*2-2B*I8L0,;CU/O3J*`"BBDYH`6BBB@`HHI*`%H
MHHH`****`"BBB@`I*6B@"&WMH[;S?+S^]D,C9.>3UJ:BB@`HHHH`3O2TE+0`
ME+5`2S_VZ8MW^CBV#;=O\6XC.?H.E7J`%HHHH`****`"BDI:`"BH9+C9<Q0>
M5*QD!.]5RJX]3VJ:@`HHHH`****`"LG6Y[V.>QALI5C,\I1F:/</NDC/Y5K5
MEZE<-#JFF*91'$\DF_)P#\AQG\?Z4`,/]K6<#O<7UBT:<F22(J<>^#BJE]K%
M]:?8@LEC,;R14CVJW0_Q=>G(_.J?C*:2\CMK2$V\L4LHP4?YP0#GV`]ZHV6D
M7UH\C7#Q-%:6\PM2KJ26.<'&>IS_`"H`Z&TU.ZO)98;>\TV65!D*FX]QDGGZ
M_I5V7^U/+7RC9^9N;=O#8V]L>_K7`VNJ3VPCATM8XYDA"@F#]Y_>;GIR?TQ6
MCX@-M-H-MJ%S.&U*2",`+)MR#R3M_&@#HY)M?C^[:V4W./ED9?QYILE_K$4H
M62RLPI8X)N=I8=L<56\.3Z3:.UE9WYFEF?=L.3@A>0#CIP:9XM2XEN=.^S0R
M%DD+&58?,"9P.1_GI0!=74]4D#&+2H9`/[EXI_I31JNJD,RZ3$54X)%XF!^E
M<C#)JMM9)&D5U:#+R!HH2&EESD!@!PN"/;\J9<7%['97MN+:5(KF>1V'E$[F
MW*0/8`4`=D-3UAB`NC(W8XNU./KQ36U;5HF59-#<ES@&.<,!]>.*Y*QU'4;!
M)Q:.8E=Y'P;4EF(QC/IG)^F*=_PENK,\N;I(PF<*8A\W(&!QUH`ZF37-2C=E
M.@W+$'&5<$?GBF#7]1(./#]UQ_MC_"FZ5K,.HZ-/#J$C"XCA9K@,A3"G//Y8
MZ5SAU"TA\'_98)Y#?2$3.%).T[@.3VXQ^=`'5Q:_.21-HVH)CIMCW9_SS4HU
MU?E)T[40&&?^/<G'..<?2L'4-2LKH:99Q7LBV49"W$RE@,[?E&_UZUN>&XX4
MM)VMKI[B!IW,9?/RCT!/4>]`#QKB;2QL-04`9.;8\5"OBG3V=5V70R<9,)P/
M<UM44`8T?B?3I"H)GCW$C+PL`.*G;7]+4$M=``=24;C]*TJ1E5E*L`0>"#WH
M`SAK^EG'^EJ`>Y4@?GBE77])9=POX,>[8K0**5"E00.V*8;>$YS$ASZJ*`(8
MM4L)@3'>0-CKB04_[=:?\_4/_?P4C6%FYR]K`Q]3&#2?V=9?\^=O_P!^E_PH
M`<+VT/2YA_[^"E%W;$X%Q%D_[8IG]G67_/G;_P#?M?\`"@:;8A@PL[<,#D'R
MES_*@"PKJ_W6!XSP:%96SM(.#@X/>D2*./E(U7C'`QQZ?J?SI4C2,$(JKDDG
M`QDGJ:`'4444`)1157^SK?8Z'S2KH$/[UN@_'K[T`6J*S&T&R9V8FYR<_P#+
MS)Q^M-/AZQ/>Y_\``F3_`!H`U:*RO^$=L,];G_P)D_QH;P[8,23]IY.?^/F3
M_&@#5HK)/AO3CU%P?^WB3_&C_A&]-SG9/G_KXD_QH`UJ*Q9/#5L^-MW?1MW*
MW+9;ZY]*C7PK$#DZEJ3<$8,__P!:@#>HK"7PM"').H:@RD8"F<\''7^M,?PI
M$S$KJ6HJ"<@";.!Z=*`.@HK$A\/RP!ECUB_"L<X+@_J14RZ1=)G&LWN3ZA#_
M`#6@#5HK,.E77_08O/?B/_XFD.E79!']LWF?]V/_`.)H`U**QSI.H[?^0Y<[
MN.?+3'OQBHTTK6E&#K['ZVRF@#<HK%_LS6O^@^?_``%2D73==7DZXC>S6J_T
M-`&W2UC0V6N1MEM5@D]FMN._H1Z_H*G\G6?^?VS_`/`9O_BZ`-*BLUXM9VG9
M=61;'`-NP!_\?J*5?$`_U4NG-D_Q1N,#\S0!KT5SUU/XDM;26X<Z85B1G8*K
MYP!GBM^,EHU+#!(!-`#J***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BDI
M:`"BBB@!#UI:2EH`II"W]KR3E3M\A4!QWW,3S^56Z6B@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`K*\2N(=$N+CR8I7B`9!*@8`YQG!^M:M07MI%?6LEM<`
MF*088`XH`X6UU^S%R9+G3[5[80KO2.W4,LF<$<^^3],5HG7/#Y1'71R^^/=\
MMLAQ\Q7!_$?K6I+X4TB5F9H&!;&<2$=.!3K?POIUN)419/+D55VESQAMW!^M
M`&9)XA\-B-&>P!9LJ4-NNY,>M6+R3P]IK1N;!9S=CS%\N+S,J!G//0?2IY_"
M.DS.SM'(&=BS$2'G)S4^IZ!!J"P8FE@D@0QH\9_A(P1^5`&;HFN)>ZS);65G
M%#81(2)!'M.?7T`/-/EUW0=4B>2XDFC6`X&2Z$Y[@*>>E7]*T"WTM+I(I'=+
MC`(;^$`$`?K6:O@J';AM0N69=OEGCY-N<?S-`$4EYX6V*QNIP&'`$DW&#Z9X
MJ%SX<9I0FIW>Z.-GVK._/'\)/4CL,]JOQ^$84G:0W<KEXI5=F`W,S@@M^1JO
M#X'BAF\P7\A.UA_JP#RI']:`,B.]TE)&)U#5UB55*MYP)8DYQC';&?P^F="V
ML-"CDCN+?5IXI9S(5F<K\V,;N2N!_7-2'P;<!&*WZM+B(HQBP`4&!^&*CE\&
MWLZI'+?Q&*,N5_=\Y;D_K1<"=(-/#^<OB.17N5):0M&-X``P3CJ,C@TEM;Q7
M.I3V5MK=TTPC$FX*FTYP1SCYNH-00>!I8_*WW4;@%]RE21R,#`J]HOA^\TS5
MQ.6MW@,"HQ"_-D*!QQZB@"!]-EV&./Q-$%4@,K*A`/Y^M.DDN-/MVW>(%D,L
M;"+9`I"A!N8@`XS@8_&J">"+T1S!KBW+2``'+8^\#GI[?K2W?A>^1F-M:02*
M)IRBEAPC*`G7T.3]:!FGIMS>WZR);:W"\C+YFU[7#1AAP/O8_G6@L&M[1C4+
M-O4_9S_\57(7&E76CVS//8IO8Q^3-&V660`<8'8X;-=KH-B-.TBWM_X@N6_W
MCR:!$31ZZ"H6ZL6&"6)A88/8?>IB'Q%Y3E_[.#C&P`/@\<YYX[5LT4`8L<GB
M)?\`6P:>_!^[(ZX/;L:LO/JH(V65LPP,DW!'..?X?7-:-%`&2UWK2Y_XEENV
M%W<7/7V^[UJ%=5UG!+Z"_P"%RE;E%`&/_:VH+(`^B7.PC)*2(Q!],9_K3WU>
M=<_\2>_./0)_\56K10!G+J<IA+MIEXI'\.%R>G^U[_H:K)XB#QM(NE:D57J?
M)'^-;-%`&5=:ZEJ8@UC>N\L8DVI%DJ#V//!IO_"0PA=[V-^B8R6:#[O..>:U
M\48H`SH]>T^1"RS-A0"V8FXY`]/4BD_X2#33_P`MW_[\O_A6EBB@#-_M_3?^
M>S_]^7_PI1KVG$X\YO\`OT_^%:-%`&>-<T]F"B9LG./W;=AGTIA\0Z6$WFZP
MOJ4;_"M/%(RJZE64,I&"#T-`&9+XCTB)RDEZBL.H(/'Z4G_"3:/@G[='P<'@
MY_E6@UI;.Q9K>)F/4E`2:/LMN228(N>OR#F@#._X2;1BI;[='QQT.?Y4I\2Z
M..M_%TSWJ_\`8K7_`)]H?^_8I3:6S#!MXB/=!0!23Q!I+[MM_"=JECSV'6I4
MUC3I`I6^M_F&X9D`XJ?[%:@DBVAR>OR#FD-A9DY-K!_W[%`#/[4L/^?ZV_[^
MK_C2?VII_P#S_6W_`'^7_&I/L-I_SZP_]^Q2&PLV7:;6''IY8H`0:C9$\7EN
M>W^M7_&G&]M``3=0@'I^\'-13:3IT[;I;&W<@8R8Q33HFED*#I]L0HP,QCCO
M0!.+ZT)P+J`GT$@I5O+5CA;F$GT#BJG]@:3C']GV^,Y^X*&T'26?>=/M\]?N
M"@"\)XB6`E0E3A@&''UI^1ZUF_\`"/Z3_P!`^#G_`&:&\/Z4QR;&+ICC(H`T
MLCUHS67_`,(WI&<_8DS_`+S?XTX>']+`P+10/]X_XT`:5%8LWA73)7W!9H^,
M824@5"?!^G%]RS7:<8PLOMCTH`U-8.-'O3U_T=__`$$U<4!5`'0#%8!\'Z<2
M#YMT.`,>;UXQZ5OT`+1110`4444`%%%%`!1110`4444`%%%%`!24M)0!%;.S
MQ$LRL=[#*G(X8\5-5/2_^/1O^NTO_HQJN4`%%%%`!124M`#0REBH()'49Z4Z
MFB-%=G"*'8`,P')QTS3J`"BDI:`"BBB@`HHHH`****`$I:2EH`****`"L3Q+
M<>3':*\TT$#S8EDB)!"A2<<<]<5MU@^)6\M[.8R+$$,A+N#M&4(`)`.,DB@"
M*%+&)K4QZU?$W8VPDR!@V/JN`>?K6@=,G)R-7O0/3]W_`/$US2>$IK86JB^C
M4R*X97<X#E"`4'&?_K4B>#]1C6(M<AG,A5PLAPJ<$$=.<Y_.@#I#I=SN!&LW
M@4`Y!"?_`!-06UEJ9A$D&NB9'P0[0*P(QVP:Y^'2O$%M%Y2DB1V#LJW>UW`+
M`X]OF7]*LZ/8:Y9ZQ;A^8451(@N<JJ[=O*^O4].M`&W]@UD\?VRHP3S]E7)_
M6D^P:UN4_P!M)@9R/LHY_6M<NJJ6+`*.I)X%*"#T-`&,MEK@VYU>$[1C_CU'
M/N>:FBM=85B9=2A==I``ML8..#][L:T\@=Z*`,)5\3)*A9K"1.-R_,N>.><>
MM.9_$8,3"&P(&=Z^8WS>G../UK;R/6EH`Q_M&O?]`^S_`/`@_P#Q-+Y^N\_Z
M#9G_`+>&_P#B:UZ*`,I+C6MP\RPM2I(!*W!^4>OW>:B.I:PMP$.B%H\\NEPI
MX^A`YK:HH`R8;_4I3<>9I#QA$+0YF4[R.@..A/XTV+4]4*GS=%E5ANX$RD<#
M(_,\5L44`98U:?D-I%^"/0(?_9J)-8DC3<VE7^,]D4G]&K4I*`,:3Q`8VPVD
M:GGVA!_D:L-K4"[<V]Y\W_3L_'UXK1HH`SQK5J>B77_@+)_\34<GB'38@#+-
M)&,X^>%U_F*U*@O]@L+@R#*>4VX`=1@YH`DAFCGA26)P\;C<K#H14E4=%$:Z
M/9B(.(_)7;O&#C'>KU`!1110`4444`%1+<0,Y19HRPR=H89X.#^O%2UQEJE@
M+^.V?25N&O+F;$TI&?E<[NHSP!0!UJW5NT8D6>(H3@,'&,YQC/UI_F)_?7\Z
MY1V\-QZA<VUS96T20$*).3N;G(P!QC%$DOA</&+>SMIU;=OPI!4!2V<$<]*`
M.K\V/^^OYT>;'_?7\ZY6&;PA<PC,5O$2-^QT*L,?3Z=.]58DT:[TZ_OXM%4B
MV8J5$I`8=R/3`YH`[7S$SC<N?K1N4]Q7(7.G:-"ME)=Z<(3>L6?-P1Y0`+9X
M[<_RILD'AE+N&!0AMW5R9ENFVJP`!!&>X(H`['<OJ/SHW+ZBO/[E]!CFEQI;
MS(LDB>8+IL':H/KW_I5^QB\+SB-LM!*B*P4W#_*2-Q"G/:@#LLCUHKE;N+2+
M>"WEM%N[N6Y9O(2*YDRY_B.<_F:=8_V5<*PNVNK&82>7Y4UZX8G`/'S?[5`'
M445@1C0F81QZHQ+':%%^_7I_>H:'1WW[=7F!@'[PB^;(&1G//X4`;]%<XEGI
M98)_;]TS2*"@^W<X]1]<&K*Z?#.K6\&MWA94"L$G5F[\GC/?^5`&U16.V@,;
MAY5U;45W9^439`Y[9%/.C7&Y3_;-_P#*20-R?K\O/XT`:U%99TNZVX&LWH/K
MB/\`^)IG]D7G4:W>[CU.$Q^6*`->BLJ/2[Q#SK-TWU1/0_[-+_9M]G_D,W/_
M`'ZC_P#B:`-2BL673-7V_N=<D!W?QP(>/RZTQM/U_?%MUE-H'SY@4$\_X8%`
M&[17.74FLV%S8-<7\$D4DZP,JPD%]W<]<'@],5T5`"T444`%%%%`!1110`44
M44`%%%%`!1110`4E+10`R*)(4*QC`+%L>Y))_4FGT44`%%%%`"4M%%`!1110
M!"MM&MT]R"_F.H4Y<D8'MT%3444`%%%%`!1110`4444`%%%%`!1110`5#<RI
M%$=S*&8$(#_$<$X_0U-534M.M]3@6&Y#[5;>I1MI!Z=?Q-`&)9>*(Y-/CGO+
M25F1HT+HH.79<Y`SD4I\86R,TDMO,EOL0H<#>Q;=VSTPM6I?"FDR$?NI%4`#
M:LA`.!@$CUIDWA'2Y@=RS#Y548D/`48%`%+4_&$,+J+.W,CJ<,\JE5`*YQGK
MGIQ[4LGBS3X0]Q]F9[I8U4NJ_*YX)0-STR3^%67\'Z<[$%IUBP,1J_&<8W?6
MHI_!MJZM'#=7$4.,B,-E0W`+?I0!)#X@TIK%H[W9`LYD)BV,05+L,G`XR<YJ
M[::OI5SJ'DV\H:Y*E,;&&0N>,D8]:HGPE"VS?>7!!5EFP0#,"Q;G\35BR\.Q
MV=Y:7"W#M]F5P%(^]N)/]:`-6:VBG*F1<LF=K`X*Y!!P1TX)J6EHH`S[/1[.
MRFFFA5Q+,,.[2$D_B:O(NQ`H)(`QDG)IU%`%>6U67SLRS+YJ!#M<C;C/*^AY
M_E4X&`!DG'K2T4`1-$S74<HE8*BLI0=&SCD_3'ZFI*6B@"LT$YMT073!PA!D
MV#+'&,XZ=>:EMTDC@1)93*X&"Y`&[WP*DHH`B191-(S.#&<;%QROKSWI[;]R
M[2,9^;([8[?CBG44`5;G[:)8C;>08]P\P/G=C/)!'M5FEHH`*@O8GFLYHH]N
M]T95W],D=\5/10!%;1""VBA``$:!<#IP,5+110`4444`%%%%`"5Q`BE(M[C-
M]:SV\TV%6T,F-[9)!QZ&NWKSW5YK,^*KJ*=596EC`DDF=0G`W=.W\L4`3KI-
MO:70D\[5&5E##;:$MG!7DD?7MW%36NEV;#?+)JC,JA"?LI0$;"@P,9^[_.J=
M]JFH30VPGU(11389&0%3@2%.2#Z9)^@J+2]=U"R>:=KDW,2*`R.2Q(+,`1SZ
MX_,4`:UIX9LKB-DBFU"'DE&DC"GY0`#G;G'/3OBK*:2]SI=Y:'4C+]K(F:?R
M,*"&^;&#_LCCV]ZKZG<:O'9:,S7*QW<DC%E((5B1E0W\L>_M5>3Q3J4T:7$/
MV6W@DW!?.!.6102,^Y.!0!)?Z;)*D/VO6R408C9;7"KU7L>/0_A5*+28()I+
M)=7P3N1R;4XPP&X!O7Y0*OZ1XKO[[6(;66VB6.0X(`.X?+G/7^E;5E8ZI%K,
M]Q<WXEM'!"18Z<\=N,?K0!SEUX?A\Y[1=02+)\U0T!QL;"+SZ_XYJ35-.8W$
M5D[M-%-Y4K-''L2$*JJS9]U!P/\`ZU=M10!A:Q8^0=.GLIH()K0F*!)\[&#`
M+CUS@5E:MI`EO@=1U2`R2J!+NBP50'(V>AXQGWKLJ*`.#7PU/*F^&XL7L\L%
MF"$,`6!SCZC;UZ&JMCIE]J<4R6XMX-AD55=-K2#>I.3[''TZ5Z-2!%4Y"@'G
MH/7DT`>>MX?O;96^U1V<H@5)'"-F38I)/&.<YQ^%:OA.WMM)MFO+V2.W:YX@
M\XA6\L?XY'Z5U9AC+LYC7>PVEL<D>E*T:-'Y;(I0C&TCC'I0!6BU73YY%CAO
M;>1V.`JR`DU(M]:.I9+F)E#!<AP1D]!]:5+.VC8,EO$K#H50`BE6TMT38D$2
MKG=@(`,^M`$CNJ+N=@H]2<5&MU;NA=9XV0'!8."`?3-.FACG0)*H90P;!]0<
MBHTLK5(S&EM"J$AMH0`9'0X]:`)'FBC/SR*OU.*>""`0<@U!+8VLSL\MO%(S
MXSO4-G'`Z_6I?*3*?*!Y?W<<8XQ0`^BBB@#*UM(IGL(G=ED%VC)M]0&//M@&
MM2F")!,TH7YV4*3[#./YG\Z?0`M%%%`!1110`4444`%%%%`!1110`4444`%)
M2TAY%`!2U#:P+:VT4"LS+&H4%CDG'K4U`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!116/XEMM1NK**+3)&CD\T%V#[,+@]_KB@#8IJN
MK,RJP++]X`]*X:33_%"NKI-<[MJJ%$X(^Y\Q//K6IH^=)UNXMKYIY9[QE\J5
MQG>%7G)]LXH`Z>BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHI*`%HHH
MH`****`"BBB@`HHHH`****`"HFMX6;<T2%CW*C-2T4`1F")@`8T('0%1Q4-Q
MIUG=(J3V\;JI!`QWJU10!'+#'-&4E174C!!&:KQZ791F'9;1CR`1'Q]T'K5R
MB@!HC0-N"KN]<4M+10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!5>XN&594M@DUP@!\HOMZ],
MGMT/Y58JC:R1MJE\HA19$\L,X(RXVY&?IS0!;<N%!10QR,@G'&>3^5.(!()`
MR.E+10`4444`%%%%`!1110`5'+,D.W>2-[!1@$\FI*2@!CS1I)'&S`/(2%'K
M@9-24A`)!(&1TI:`*\UY;V]Q#!+*J23Y$:G^+'7^=2R2)%&TDC!4499B<`"L
M7Q?9FXT5YHU_?6Q$J-W7!YQ^'\JJ:WJ+7'A.V$?,]^(XU`/\1QD9_,4`=%'<
MP2VPN4E0PE=V_/&/7-/$B%@NY<D9`SV]:Y>*>WL)=4L[=7,EG8YVR.6C)"\X
M0_AGUYIVJZDIT&QOU@A:^NO+2/(R`<AC^&5'Z4`=.KJP)5@0"0<'H1UK'M[V
M8^++NT=V,*VZNJ]@>,_SK,?6$MM:FTRZM8OL,C+'(RC`\QQN))],DUG^)[BX
MM/$DJV6Y6GM5C8H"2JYY(Q]*`.FTF]N-1O[R=)5;3T81P@+R6`&3GTK6K-\/
M/8MH\"Z<VZ%!CGAL]\CUJ2YUK3K2[%K<7<<<QQ\I[9Z9/0?C0!>HK-OM4TU"
MT5Q?+"T4B;L.0<_>`^A`YJY9WEO?0":UE66,]UH`FHK)U>RU6\D"6>H+:P%?
MFVIE\Y]<_P"<5EVVFWAUBZLFUJ^S'%'(KAO7((.:`.JI:S[/[/I@AL);UI9Y
M,LOG/EV[G'M5J2YABGA@DD"R39\M3_%@9-`$U%5+O4K*Q=4NKJ*%F&0'8`D4
MMAJ%MJ4!FM)/,C#;2<$<_C0!:HIKABC!&VL1PV,X-$898U#MO8``MC&3ZT`.
MHHHH`**8N_<^[;MS\N/3'?\`'-0V:72HQNY4=V.0J+A4'H.Y_&@"S1124`+1
M5*V.HM,IN5MTAV\JN2V[^6*=J#7JQ(;!(7DW@,)20-O<\4`6Z*KRM<J(?+C1
MR6Q)S@*-IY'XXIUOY^P_:/+W=MF<=!Z^^:`)J*C@9WA1I8_+D(!9,YVGTSWI
M[$A20,G'`]:`%HK.2\OV`W:6RDQEL&9>&!X7\?6KT+.\*/)'Y;LH+(3G:<<C
M-`#Z***`"BJL5S.]TT3V;QQ@G$I92#C&..O.?TJ2&9Y'E#0/&J'"LQ'S_04`
M34532]=K);AK.X5F#$1;<MP"1GTSC\R!4_G8CC8QN"Y`VXR5SZT`2T5&90)Q
M%M?)4MNVG;QCC/KS48NE-SY/ERYR1N\L[>`#UZ=_SS0!8HJM=WT-F\*S[P)G
M"*P4D;CT!QTS5B@!:***`"BBB@`HHHH`****`"BBB@`HHHH`***BN)X[:!YI
MFVQH,L<$X'X4`2T4V-UDC61#E6`(/J#3J`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`$K`U47=OJ:>3K"VHNV"I&\0?+`8X]!T_$UT%<_
MXFTB[U6>R%L0B1%V9RV-IP-I'XB@!UC-J4H+6^JV5Y$6P'>(J<CJ/E.*W1TK
M@'\-:\XA)$>]`6W>=@HQ<L2,<`]*270?$"HH'FLX5B2MP3GD8[T`>@49KCM.
MTW7E\3"6[FE,(8L\@?Y'7'`QGZ<4V\T_6GUBXV)<DR39299\1B'G*X['!_2@
M#KX+B&X5F@E20*Q5BC`X([5)7'?V5<V/A*""W\Z&[GG1I"I.5)..W;I5.=?%
M-E>3QPM=3Q+N16(R"N.#]<?K0!WM)N7=MW#=UQGFO/K>X\110^?<M>F.&X3S
M!SG;C)X],8JC-_:4C?:G:[68(HE<`AL;R.?R%`'J`(.<$'%+7FUG?:I;W%RE
MG-<(CO/,&,7^L(&0<$8R<>G>K=MXBU*2_M8I;UT=[B)'@,*XV$#)SCU/2@#M
MKZY>TM'FCMY+AUQB./JW-9L.NS.6$VCZA'CH1'NS63J>MZI;>*DM4)^S&2-5
MB$8_>*PY.3[GU[?6LB;7-9ETZ59KHD2P>8,(%(`DVGD8ZT`=C+K*"(^9IVH%
M6X*_9R<US207-EJ-@DMO.=(@G,D1>,[E+=`P]F_G5>SU*\#VGEWPVM=RX+ER
MKD(N`>^"3T]ZZ?PWJUWK$<TT\,<42$(`,[MX`W9]N:`,B;5+,>(9M1D,J0-;
M"`J8F#[CSTQTP/U%9MA.(M1L+&\8QPZ9)(7=@2K?,<'&..:]$P*3:,YP,GO0
M!YC)&+ZUOKF34O(,LKS"U9#^\/4']<5H6&I0)JNC74]PP=('2Z=@>!SMS^GZ
M5W^T>@I-JGJ!^5`'&W>IVEKK\.I:9<B6*4B.ZAC4\CLV,?YQ[UG_`-H6,=EJ
MD=U#Y]]=2,8GVALJP^4@]L?UKT+8N,;1^5,6V@56588PK#!`4<T`<?8VT$>N
MZ7<,T4\;6HB=P051T7!R?PQ6W=ZA;:5>VJ00P"*\EVRNA`(;`P3BM`Z;8L<F
MRMR?>)?\*R/$>D+-;VRV-I$'-U&7*QCI@C)]A0!KW&I65M"99KJ%$'<N/R^M
M<W_PD&F)XH%V+D&"6U\LN%/RL&SR,>E;[:+I;J0=/M<'TB`I?['TT2)(+&W#
M(<J1&!@T`<SKCQ:[JVF?V9<@-B0&=,J5P`?KCG]:FM+N^O/$MA;:C`J36B2,
MSJ?E?*@!A6_=:-IUW(9+BTB=RNW<1SC_`":B7P_IB1K&EN5122`LKC&<9[^P
MH`P]%LK34I=6OM456<SM'^]/^J4#U[<'&?:NEDNH8M-DN;<I+%%&S`1L"#M'
M0'IVJE_PBVC?\^*_]]M_C4D?A[38MPBA>-6&"JS.!^6:`)M'OQJ>F0784*9%
MY4=B#@C\Q5VLM/#UA&"L8G1<Y"I.Z@>P`-30:1:V\ZS1^?O7ING=AZ="<4`7
MJ*RFT&-@0+[4%R#]VX88).<_AT^E26^C10')NKV7*E3YEPQSG'/7K_C0!HT5
MD2>'HW=F&HZD@)X5;DX'YT_^Q%%X]Q_:%_\`-GY/.^49&.!0!J4M9B:0R21.
M=2OF,?0&08/7KQSUHETJ:20N-5OD!Q\JLN!Q_NT`:=%90T>8?\QC4/\`OI/_
M`(FGMI<QV;=5O5VKMZH=W)Y/R]>?TH`TJ2LM=+O%7G6+IFW`Y*ITSTZ?K37T
MF]9R1K5TJDGY0J<#TSB@#6I:QET:\C0+%K=X`#QO"MQZ=.3[U(--OQ+,_P#:
M\Q5PVQ?+7"9Z?7%`&K16,-+U4'_D.RXX_P"6"5+#8ZG$#G5O,)[O;CCKZ$?Y
M%`&I16?]GU/(_P!/B(SS_H_;_OJHTMM8R-^H0'DYQ;]!SC'/TH`U**REBUS(
MS=V6.>?(;)]/XJ3R]>R,W%@!ELGRGZ=OXOS]/>@#6I*R&C\0;?EN+`MM'!B;
M[W<=>G3FD"^(A$V7TXOCY?E<#/'_`-?]*`-BBL7_`(J8,>-+(S_M]*D#:_LY
MBT[=GKO?'\J`$UYB)M+3`(:]3.1GH":UZQ7M-5O+BS:\6S5+>82GRW8D\$="
M/>MJ@!:***`"BBB@`HHHH`****`"BBB@`HHHH`*H:Y%)/H]U%#(L3LF`[-M`
M_'M5^L_7H'N=%NX8U+.Z8`49/Y4`7(`5@C4L&(4`L._%25'#&(H4C'1%"C\*
MDH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`2LN:^U!KV
M>&RM[:5(6527E*G)4'ICWK4KF_%<1AT[S/M16<W2-`V0I0G`(R.O&30!>-SK
MO&+"S/'/^D'C_P`=I/M.O`$G3;1O87!S_*N1_MF\TZYO+C8L=_)(D4JR,2H.
M#E@,^P^@Z5<D\4:Q#(QD2#:D?GD;3M9&V[<'ZM0!T4FH:NL,+)HP:1@2ZFX4
M;,'`&>^1S36U/5P7`T0G"@@^>O)XR/U/Y5SU[XEN-1@MHHYXK/+1F62.4AAD
MD'CT'!.?:MSPUXA.LM.DJ112)C:JMDL.Y_E^=`%F+5;PH/-T:[5N<A60C\]P
MI?[5NMY!T:\VCH<QY_+=6I10!G?VI-CG2;T$#)X0_P#LU*-2E.S_`(E=Z-YQ
MRJ<>Y^;BM"B@#'3Q%;L^QK2]1BVT;K=N??CM53[7H4ET+MK&;[06#[C:OD,/
MPZUT=%`&4?$.G#&XS@GH#;2?_$U#-KNBON,P+?)AB]LY^7T/R]*VZ"`1@CB@
M#G)-<\-/"8'\ORP>5^SL`#T].#4UEKOA^UM@EM/'#%N;`$;#)`!/;W%;1AB8
MY,:$YSRHZTW[+;X`\B+`S@;!QGK0!3BU_29F=4OX<IUW-M'X$]?PJ1-8TUT5
MUO[;##(S*`?R-3_9+8$G[/%D]]@I/L5J#G[-#G_KF*`(QJNGL?EOK8\9XE7_
M`!IRZC9-]V\MS])!4#Z%I3NSM80%FSD[>N>M,/AW2#C-A#Q[4`:*2QNNY)%8
M>H.:=D5F?\(YI&,?88L?C3X]"TV)U:.U"LIW`[CU_.@#0S167-X=TV8`-$X(
M[K*P/?W]ZCM[&STO5X1;APUQ&X(:1FZ;3W-`&S1110`4444`%%%%`!14%[(T
M-C<2H<.D;,I]P*P0;FWBCFO/$*P&="ZI(B#:2!^>*`.EHK!@TS5=F^/7VD5\
M,I,"L"/SZ<U(VF:NR@'7&&&SE;=03[=:`-JBL8:;K&\O_;AR1C'V9<?EFEN+
M?48%DF?6UCB7+'=;+A1R>OM_2@#8HK'%IJ[H&CUF,JP!4_95.??K0]EK04[-
M6B+<=;8`#D9/7TS0!L45C26>N`?N]5B)W'AK<=,<?C436?B/;\NJ6Q;T,``Z
M#^N:`-ZBL%+3Q*K9;4+1A@\&+OV[5+%#X@!427-E@*`2%.2=W)Z?W>*`-FBL
M&.'Q,LL9>YL'3^,;2._T]*5%\3`IN;3FPQ+<L,CL.E`&[16*W_"1F565=."`
M<KN<Y/KTIZOX@4-N@T]^>`)7'?Z4`:]%9/G:]C_CSL?^_P"W_P`33/M'B#=C
M[!98]?/./Y4`;-%8HN_$`?#:;:LNTG*S]\<#I0U]KH+`:1"P!."+H<C\J`-J
MBLI;[5?)!;2?WO.0)UV^W/Y4X:AJ`4;](EW<9VS(1GVYH`TZ*RSJ&H93;H\V
M-WS9ECX'M\W)I4U&\8DMI%R%.-IWQYZ=QNXH`TZ*HPZ@SWJ6LMI-`\B,ZEBI
M!`(ST)]15Z@`HHHH`****`(Y9/*3=L9^0,*,GDXS3Z**`%HHHH`****`"BBB
M@`I*6B@!*6BB@`HHHH`****`"BBB@!**6B@`HHHH`****`"BBB@`HHHH`***
M*`$JE>M]G@<RW!!ED"1,8PVPM@`8[\^OK5ZN?UZRU6_G6"$0FSWI(&W;64CJ
M#ZT`:4EN9[B-Q<1F(*"\?EJV_K@Y[5'+#::KI\C6C0,)5""38&!"G@$=P#FN
M7;PUJ=Q-:FX@C585AA.V;[R+G<:CB\.:Y;W%H\$<:F$$`^:"!EF/3C^]0!?E
MTR'[2ME->Z2LBY58_LRAP3R`!GU-:$UA!I<D<\+Z?8DH%:0Q`$G^+'/3%<VN
MA:Q;SK]GLC%*H5@_F[AD*XSGMGT^E)+IFL_8XW-M>./F5$:3<5)')VXX!.?T
MH`]"1E=%92&4C((Z&JC-J/VV156W^S&,E&.=P?C`/MUZ5R$Y\0%6C@2^BDC#
M>:=Q*O\`.-NSZ#T[9KIO#ZW20W:W3W#A;EUB,_WB@P`?IUH`U:B+3"Z51&I@
M*$E\\ALC`Q],_E4U%`$1>47*H(\Q%23)NZ'(P,?G^5-N)I(GA"0M()'VL0?N
M#'4U/10`4444`1Q,[IF1-C9(VYSWXJ2BB@`HHHH`C$P,SQ;7RBAB2O!SGH>_
M3^5,CNHY(_,PZ*$#DNA7`.?7OQTJ>DH`A-Y`('F\P&-&*L1S@@X(_.IJ,"B@
M!&8(I9B`H&23VK-G1Y];T^XBP]N(I"77ISMQS[UIT4`%+110`4444`%%%%`%
M/5F":3>,6V`0N=V,XX-<]+&UM>S37.GRWT5S:1I&(XPP7'5>.GKFNIG19()$
MD4.C*0RGH1Z5PNFZ_%,L/VJSMDM;(>:!"6WH<@#`SZD4`!_M^"T\F.._25&*
MD)\R*GR[0OKCGI37NM;:\NXM-N[RZ\IL9(!`!4DY]&ST'M3KK5]+@M[@:;8W
M*>8!YC,[J.&`*\'C@_R%7=(U'072&>.QDMYX&6-%4Y9]Q('.?F[GGI0!4!UX
M2R@2:E%;+'(T1*Y;(7(![\GC\JIS+KUQ%_IT>H-L215*Q=2P&`>.AY%=#_:=
MA9W]QILJ7<2QN9/.,S?O&V$D$YST'`SS4=KK6BW%SL\^_AW!LF:=U5>,]=W!
MZXH`R;F\UZVMY<+>1!%`VB,*D:<;<>^00?;-=!X1O+NYANEO)97,4@"^<N&`
MQWX]:=:ZOIT]G<7UJUU*+7YW3>Q/()Z$XQR?;CV%3^&G>;3S<2?:P\K99;AB
M<''.W/\`#0!L45!]F3SS-OEW$@X\QMO`QTSBGK&%E=]S$MC(+$@8]!VH`DHI
MDL8E4*688(.58@\'/:FR1%Y8W$KH$))5<8;C'-`$M%%0RPN\L;K.\80Y*KC#
M_7(S^6*`)J*9*I>)T5RC,"`PZK[\U%%!)&REKB20*N"&V\\`9X'MG\:`+%)3
M9%+*`K%>0<CZ]*KFVN2]R?MC!)`OEA47,6.N">N?>@"U15*6TO#L,-^ZD/EM
MT:D,NX''3TR*FMH)82?,NGF!&!O51CDG/`'J!^%`$]%1VRS+;QBY=7F`^=D&
M`3["BX$Y5?L[(K;QNW@D%<\_CB@"2BJEU#?/=0O;7,<<*D>:C1Y+#/8]N.*L
M2B0Q_NBH?CEAD=>:`*$C'_A)8%VG'V23!_X&G^`K2JA'97']LM>S2Q&,1&*-
M%4@@$@\G/M6A0`4444`%%%%`!1110`4444`%%%%`!1110`57O)F@MRZ&,-N5
M1YAP,D@?UJQ5>]3?:NN]4Z'<W0<T`3TM(*6@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@!&&Y2#WK#C\+621F
M(SW3Q%`FQI!C:"&QT]16[10!@W/A.PN;EYF>=3(S-(JO@,20?RR*BT[PU]CU
ME+C<C6UNA$&<[^>?F[8&6Q]:Z.B@#G]:\-_VC=B9)B%ED0S(QXVJ"/E]\<?C
M4<?A2":6[>]9MLLS.D<3X4+C`R,=<$UTE%`&3HFA0:-YWE2/(9MNXL`.F?3Z
MUJTM%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!6?K8D.FN(E=F+QC"#)QO&?TS6A10`@I:*
M*`"BBB@`HHHH`2EJ"RCFBM(TN)/,E`^9O6IZ`"BBB@`HHHH`****`"BBB@`H
MHHH`0\"N?T+7[G4M3N+2XM!"(U+CGE>0,-[]?2N@/(KG_P#A#[!2[0SW43.<
M[EDR>H/<>HH`E\4:XVBVT#0JK2ROC#=-HZ_T_.KMYJUI96\$\SL8YR%C**6W
M$C(Z51UC1M.EFDO]3GD,00(%9OEC)P`1COFFW^@RRZ;IUE;7)5+696,C'#X&
M1Q@8R,T`$?BNRDO9$4YM8X/-,PSD'<%VE<9[BIQXHT?Y/],`#C()1@.N/2J<
M7@VPA258[BY!E38S;AG[P;/3V`H3PE9P6QC-W,%$;IEL<;L9/3V%`&O>ZM8V
M$:27-RB+(,ISDL/4`=1S5*+Q%;W&NKIMLHE4H6:97!4<9X]:2_TD7,-H]G>"
M*2VC:)'8!U92,'(]>*CT+P[#I4L\T%P95F0*C%1E?4YH`OQZYIDK2!;Z#]U]
M[+@8_/MS3CK.F!0QU"U`/0^:O/ZUSI\&*ENR3WZA(^(6\I1MY)&X]3UI/^$&
M#2-*]XI9U?*B+"AB#@@9Z#T]J`.D75].?[M];-R%XD'4]!2G5+`!B;V#"OY9
M/F#AO3Z\&N?@\%VL5Y;R"Y+>4@,D9'WGQPW7@9[>U5[;P1(FT3WB.GFQLR*F
M%95SG(]>?YT`=)-K>G1022BZBE$:;V6-@S8]<#ZU8@O()XX7611YRAD4G#$8
MST^E<=-X,O!/=26T]N%??Y:;2.&[>V*5/"-_%J$+QR0!497,P+!N!@KCT_QH
M`[.*>&;/E2I)M.#M8'%1VM_:W>[[/.DA4D$`\C'M7/\`AWPY/I.HQW#%-IM2
MD@5L_/N!_+`K'E\):KYK2Q)'OD\S</,Z9R`/R-`'?[E]14-U>0VOEK+*B-*P
M2,-_$WI7"R^&=;DTZ&U\B,".5WXF'.X#_#]:U_$&FWL^DZ5"UN]W+"5\_8W)
MPO/)]?6@#J@0>E&:\_AT_P`40/;1Q-.B%0%`D^5`#T;\*C%GXC6VU#>MUN;:
M&`))D).,CVQ^F*`/1*"0!DG`KE[*/4[+1=6CB6X=TF=;8.<R$<?,/4<YX[YK
M(5O$3::(Y8K]D$S%B,^805X'/\.0<_6@#OD=)%#(P93T*G(I:X&RN=?TZP@L
MH8)XCMS'F(;1\S%MQ(XXYJ)M0U74[>[@2:XF0J[L5C&W"GY=I`]C0!Z'17`1
MZ]K8OQ':++-#Y>V-9(2,KC[QXZY[U?\`"=W=WVN7%Q<-*X-LH8LNU0V1T'3L
M:`.PHKSK3-:UJV@9+?=+%%NED\U"2H'4;C["M&YU35KWPG=Z@9!`IEP@5<'R
M\X.#]3U]C0!VE+7G.E:]J-E/(_F"YBEE;*D%LD#/RG/`K;\/>(=0U&UU&26%
M':WCWQA%QDX/R]>>E`'5T5PT7BS4'A*-+9"69D\M\D+$""2&^F,?C4:^+]4D
M!95MPL**TORGY_GV_*??(_6@#O:*X.3QAJ+R7T:"WC*!C'E3D8./H3CGGTJ(
M>)]5CO@AO;>6)77+8&P_+DC.,X_6@#T&BN)/C2YCM58PP22>2KD@G[Q;!!].
M*9_PFUZ81(EI;D"/S)/F/R_/M_P_.@#N:*Y?2]>O9+?5KB\2(BTR5B3[PX/'
MT]_K5"#QO=W!"1V<`D)P-SD`\$_T_6@#MZ*X2?Q9JDTL(1([6.3RSD`.2&)]
M?\\5.OBW4;>&:6[M(FB$CQHZ'@..BG_&@#M**YK6]7U"QMM.N5\N(R([31,,
M@D+N"YZ]B*GT?7;B\NY(+NU6$BW6X0J^[*GU_.@#>HKDXO&+R1+BR!EG<"!1
M*,<G`W=P>#V]*)/&+1X7["2\0;[0N\?(58`X/?O^E`'645S!\91B9H3IUQYJ
MXRNY?0MZ^@JK=>*;R6XM'L%C2WG5,B49(8R,OK_LF@#L:*Y9?&UJT<[BTFQ"
M`3\R\Y(`_G4T7BZ&61K=;"Y-V'9/(&"<@<\Y[4`='16#!XJLYM6&G&*:.4ML
MRX&`WH>?PJ.\\76EE,\%Q;3I,DFPIQTQD-G/0T`=%17'KXNNQ*Q^PAXGF6.-
M<X=05SSUR>1^M7?#OB7^TS%;743)=/&9`P7".`Q''/M^AH`Z.BN2?Q?,+B/%
MBXB$TL<BCYF(4`\=!GGD<U=C\7Z;)<P0`2@S;`&*C"[AQGF@#H**2EH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`**2B@!:**2@!:*2EH`****`"BBB@"*W@
M2VMT@BSL08&3DX^M2T44`%%%%`!1110`4444`%%%%`!1110`4444`9GB&SFO
M]'FMK=0TKLF`3@<,"?Y5S']@:X);G+[$9&=!',Q7>&##J>I-=S10!RGA[2-4
MM]3D.H3SM%$-R'S3M=V`SQGG'/6LRXTG79H)(9!=-Y:R>:QN"5G_`+NU:[ZB
M@#D-<T::/3=*2V2[E^SG#I&<D`C)/U[9K--MXAL[:*"T^W[#`I<#HC9SA?3C
M'ZUZ#10!QU_<3+X(1-1D,D\[J$\T8?&X'G/4X'7Z5GMJ6K"(6P:]66+[093@
M@8V_*`?8_P`Z[Z6"&<`31))M.1N4'%/H`\^NY]9T[4+BZ$LLDS1Q"200+T(^
M[TX^M5]1UC6[BQ6.]>1(YH@Z;(@-^&ZD]OP]O6O1HH_+C"EV?&?F;K3SC%`'
MGMIJ]_96B".22W@EFF?SI(MY.`,+@U"M[<BZC,SO/.+WS1&%*9RH]^.<<>U>
MD8'I1B@#@3XGUA(%:.59]_E[G\G`B8Y)3WR!UK8_X2"]7PW>7[1Q-/!/Y2X4
MA2,@9QG/<UTV!Z"HY[:&Y@:&>)7C;[RL.#0!QZ>+[PW/D'[&5WA?M&&$>,$^
MM">+]2<!18Q-)*NZ$KD@J"P8GG/5376VUC:VB;+:WCB4G)"J!FI]H]!0!Q-O
MXQOYXI<6L'F@IY:@-\V6QCKUJ:3Q-J<%WY%S#:8\X6[^66W!B.HSVY_2NOV*
M?X1^5,,$)ZQ(>=WW1U]:`./L_%=Y#8J\EL+E(5C$DA?:S,PR.U:FG^)S>ZA:
MVWV(QK=!V1S)D@+NZC'JI[ULBRM0NT6T07Y>-@Q\O3\NU4;'PYIMA>B[MXW$
M@SMRY(7/7`H`P;CQ1J46I-$UD#&LLBF,'EE503S[=?QJ6P\86INK>TAL!$DS
MC)5^$9CSQCGDUTYLK4NSFVB+,26;8,G(P?S'%1+I.GK(DBV5N'3&UA&,KCIB
M@9GWWB6&SU![;[+-*L1`ED0<(2,BJ0\:P@9>PG4,H:/D$N-VW_'\JZ"33;*6
MZ%S):Q-./^6A0$U7&@Z6-^VRC7>P<X&.0<C'I]!0(Q+SQ/I=U;FVU*RN%8/A
MX2/NX]\BH/\`A+(DE-E%IJBS0.FUN#M5<D8K?G\.Z5<SM/-:*\C.7)+'DG'7
MGIQTH_X1S2OM#3_9<R,6))=L'<,'C..]`%.P\2V7]F":6!K<1+'N14X&XD#'
MMQ21^*M#A1S&_E@ODA8B-Q.>??IUJ<>$]&&,6S<?]-6]<^M*GA31DE$@M3N#
M!^9&Z_G0,SK?6/#]S<1Z=;6/F1W#Y($'R[O4C^O:K-WJGA^*ZEM)XHS)`FPC
MR<C:OS;1]/3VJ[%X=TV&YCN(H662.1I`=Y^\>O\`*F7'AG3+F9Y)(Y/G9G*B
M0A=S#!./>@1FS:YX?F9F2U$[7+B&1EB`+9Z9S@D?X4RSU7P_,(+6ZL(;=BJD
M*\:E0><#/TYY]:TIO"VGR%6C,T+JR,'CDP1L&!U]JJZIX3CFMT2PE,3!!$1(
MQ92H)/UR#TH`N66GZ'>12M:VD#1EC&Y$>`2#_C5HZ+IA4*;&WP%V`>6.F<X_
M/FH[#1+>QE@DBDE_<P^4$W?*><EB/4Y-:=`%:/3[2)YGCMXE:88D(4?/]:BB
MT?386#164"%22"$'&1BKU%`%,Z5IY,1-G`3$`(R8Q\H!R,52G\,Z;->I<^6R
M%6#-&F`CD$G+#'/4ULT4`5KJQMKLJ;B%9-H91N'0,,'\Q38-.M+>4RQ0JKF-
M8B>ORCH*MT4`9$?AG1XXI(ELDVR?>R23^!SQ^%.?P[I;PK#]F`14*`*Q'!()
MYSSR*U:*`,6]\,:=>2AV1E#.'D4,?GPI`[\=>U2MX=TMEB4VV%B"A0&('REB
M._/+'\ZU:*`,5/"FCQQ21K;,%D`#?O&YP<^M.F\,:5,SLUNV]W9RXD8')Z\Y
MZ>U;%%`&3;^'-,MKY;R*`B5/N_.2!QCI3K[P]INH7+7%U`7D90I.XC@?2M2B
M@#(E\-Z;(6)B=27#_+(PP0,<8/I4]EHME83)+;QLKI%Y()8GY=V[O[UH44`8
M_P#PC5A]H,W[[)=WV^9\N7&&.*BB\):5%<QSJDA:,J0K/D9'3-;M%`"4UI%1
MD5C@N<+QU.,_TI])0`M%%%`!1110`4444`%%%%`!1110`4444`(1D$>M-B3R
MHDC#,VU0,L<D_4T^B@`IK(KXW#.#D?6G44`)2T44`%%%%`!1110`4444`%%%
M%`!114:+()'+.&0XVKMQMX]>]`$E%%%`!1110`4444`%%(2%!).`.M5K/4;.
M^W?9+F.;;][8V<4`6J*A6Z@>Z>V653.B[F3/('K4M`"T4E0O=VT<BQO/&KLV
MP*6&2WI]:`)Z*2B@!:*CDFCBQYLBH"<#<<9-/H`6DIJ2)("4=6`."0<\^E.H
M`*6DHH`6BBB@`HHHH`**2EH`***2@!:*2EH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`CF#F%Q'MWE3MW#(SVS7*Z1IFL:;=
MRW45G;(+B11)%OSL7N5/U/2NNHH`YJ[@U6S\1W%_96*W4<T2IS*%QC'K]*QE
M\/ZYND>-7BD9)!*S3@B;)Z`#IQZUWU)0!Y[/X>UYXDCCA=8DD9D1KA6VYQ]/
M\YI/[`U&+566&&88N%D25OF7@$Y/X]_>O0Z*`/.H(O$,,,C6XOHDW#>&&2SG
MJ0,=*W+8ZM%X7O5C$[7*2NL9DSOV#'(]3UQ74T4`>>/9ZKJ/V%;Y+V2'[2RD
MNAW*OR\GT[_K5WQ#?ZK%X@EAL)+EMB(ZQ1+N&?<>E=M4*V=NMXUVL0$[+L+]
MR/3]*`/.?[7U.P7R;,/&JSO(_P`N0QSG'TP/YUN:=J5^^JV[R7C/!)>30>40
M,8`R.>_6NL*R&<#">3M.<_>W?X8S3O+08^1>#D<=Z`.1O]<U*'Q#-;1-\PD2
M.*VV9WJ>K;NQZ'\?:C1[B[T_PO>ZD)9+J<L<+)DA<';GZ=_PKKO+0MNVC=ZX
MYI0BA2H4;3VQQ0!Q#^,+H*H6XM#D,?,\A\<*"%QZYXJ2/Q3J4BB0K;1K]HBB
M(93P'4G.<]L&NP^S08QY,>!VVBFFTMF;<8(RV0<[1U'3\LF@#D'\4:LL=Q^X
MMU:UQ'.6!XD+8&.?8TV'QCJ<N"MI`0L)E8DD9"D@D<^U=B]I;21RH\$96;_6
M`K][ZU$NEV"-N6TB!\ORN%_@]/I0!Q;>,+JYN[27"VZ1R8D56R'4XSG(]NM6
MF\;726Y=K.$MA6!60D8.>#[UTJZ'I:*H6P@`5MP^7OZTJZ'I:1-$MC`$8@LN
MW@D=/YFGH!G:7KMY?7JP26UO&%D>*7]\-P91U"]2.GZU%>:_>07UR(K?SE69
M;:&(<;GP26)_+BM=-'L([_[:ELBW`).\<<G.3]3DU%/H-E<R733J72X97*9P
M%91C<".<T@,*/Q?=?:5WV:^2_E[ANY3=P?K4R>-$#W7FVC!8ON;6R6.[&#Z5
MH#PKI2_<B=?N='/\/2@^%-*)G)B?$P((WG"\Y^7TYH`HW'BXV\T8DLI$W(<Q
M,/GW[@`/R.:T-5\0)I8MQ+:S/+*A<HF"4`'.?I_2HE\(Z4J,OER,64KN9\D<
M@Y'H>*LW^@VM^L(DDG0PQF,-&^"5(P03WH`I_P#"7V)NTA2.9XW95$P7Y<D<
M?Y]J@_X3*&2W:XM[5VBBE5)2[!=JMG#?I5A?"5DBF-))5A,R2^6#W4$8S[DY
MJFW@T0VY@MKHE9I4,I<=$7)P,=\XH`ZL'(R*6D'`I:`"BBB@`HHHH`****`"
MBBB@`HHHH`***2@!:***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`&JZ.6"L"5.&P>A]#3J:%522J@%CDX'4TZ@`HHHH`****`"BBB@`
MI*6L^\N9(M7TZ!7PDQD#KCKA<B@#0HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`*R[W1VN[IIQJ5]`"`/+BEPH_#%:E4[C5=/M9C%
M<7D$4@ZJS@$4`43H4V<KK6HCZN#_`$I/#L]P\^I07%R\_D7&Q2^,XQ[5=BUG
M3)B1'?V[$#/^L%9_AMEDN=7D1@RM>-AAR#P.]`&K<ZA96D@CN;N"%R,A7D"G
M'KS3[:[M[M"]M/',H."8V#`'\*S-?TN&_>S=K596$Z!VQR(^<Y/I7/2Z;K%I
M<SSZ=#-#FZ*+#&?W9CVX#8_K0!W-%<MX8768K.^6]^T9"`P^<,G=@YQGKVK(
MMU\4`(DLEXBO<1@DC<0#G)^@QR.E`'?22)$A>1U15&2S'`%.KSW5(M5NPLM[
M'>2N%E2,1P#V`R`.AR?RXJV9O$=IIC&W>?$-P;=(1;ACY8'#9QDCH*`.XII=
M0P4L`QY`SR:Y6YU35;7PC'>3EX[TRX.Z,`XW'J,>E9+WFM->1WLT,[30I((7
M^SD9'`!*_B:`/0:6N"CUOQ))$!MD5AYC$_9>H"@@=,>M;%[J]Y!H.FW1E$)G
MV^?-Y6[8"N<[?<T`=)2UQ&AW%]K'B2*6]E=1;P>9L52J^@R/<'-.E\4:E'+<
MX6,NF\?9S$VZ(`\,2.O'7\*`.UHKASXLU(SK!"+67+L%GV,$<8SQSD$5)%XI
MU>18HQ91&>Y4/!M4[2HSNSSGMVH`[2BN%MO&M]/(8OLL!DE8+%R0%)./F]?T
MHO\`Q?>JES9F*..X0LGFPL>".I`(Z<&@#NJ*Y&W\72*B"6"-Q\L63+AV<IG)
M7'W<]ZT=#U^35;DPR6BP9A$RD2;N"<>@^M`&[17%VGC&ZCN(K:\M!(99,"17
M"_*6QTQ_6M35/$XT_6HM/%L)=^P%Q)@J6..F*`.@HKCXO%][YJF;3P(@TF\J
MW.$`SC)ZC//Z5)%XW2:(K%I\KW621$CY&T#).['IGMVH`ZRBN6B\6>7J4JW,
M1^PL4$4H&"A90V&'Y_3%68_%^G31%XX[ECN5`HCR6+9QCGV-`'045S(\3S#0
M(-0:TWO--Y81#P.?SSQTJ[8^);&]OELXUG61L@%TP,@9(SZB@#9HKDY/&835
M&MOL;^4DOELW);C/;\.E:+^*]*C>%7F8"5`X;82`#ZX[\4`;=%<^/&.D%)&$
MLF$QQLY;Z59?Q'IZ:4FH[I#`[^6,+\V[GC'X4`:]%<[<>,M.CA#Q)/,S1^8H
M"8XR1R>W(ID/C33W>594EC";<?*26R,GCMC%`'2T5S\?BNQ%S<+<.(X$\ORI
M`"2^Y-W0#BK</B+29[A((KQ&D<@*`#R3TYQ[T`:M%)2T`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!45U.E
MK;23R9V1J6;:,G`J6DH`1&#HK`$`C//6LG4O^1CT;_MO_P"@"M>L2]9G\7::
MA/RQPR.!CN>*`-RBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`JM-86<\ADFM8)'/\3Q@G\ZL5Q6NWVKQZ[>RV5RZP62H6C'("LN2=
MO0]^M`'4'1]-;K86O7/^J7_"I[:TM[-76VA2)7;<0@P,XQT_"N$A\2ZU>2C3
MX)HWGEDPLH0`@<'MQTSGBNI\-ZK/JMM</<+$'AF,>8P0"`!SS0%C8HHS10`4
M4M%`"48HHH`BN;:&[A,5Q$DL9ZJPR*EQ2T4`)BD**5VE05],<4ZB@!H158L%
M`)&"0.M)Y4>]G\M-S#!.T9(I]%`$:P0J`%B0!>1A1Q2B*,%2(U!487`Z?2GT
M4`5X[*UC9F2WB5G;<Q"#)/K4,VCZ?/-+-):QM)*NQVQU%7J*`*#Z-ITDOFM9
MQ%]GEYV_PXQC\JEMM.M+23S+>!8WV"/(_NCH*M44`9C^']+DDCD:S0M']TY/
MKGUYYIUUHFG7ET+JXME>88^?)'3IT-:-%`&-<>%]*N"2\+#+%R%<CD]?SX_(
M5$_A#26MO)6*2,YSYBN=WZUO447`P_\`A%-,P%*2%!(K[-_'"[0/7%-'A+35
MMVA4S@%PZL)3E",X`_,_G6]10!D/X=LFTI=.4RI"DGF(RM\RG)/!_&F:?X9L
M=/O5NHGG=UR5#OD`D8)^IK9I$W[%\S&_'.WIF@#&7PO9+J9O_-N/-,IE*[AM
MW'/M[U7/@K2B(QF?Y!CAQ\W)//'OVKHZ*`.9'@?3`C+YMQR00=RY&/P]ZLMX
M6LVTB/3?.N!$DGF!@PR3SUXQCFMVB@#G[7PG:6T<L8GF998&@.<9"EMV1[U$
M?"*B\-Y'J-RMR?\`EH0I/0@]O2NEHH`YBY\'1W$DDAO9"[;,%T5L!5V\^M$'
M@Z.WN89H[V0>2`5`C4?,!P3CKSZ_G73T4`5=.MYK6S2&XN6N9%ZR,,$U:HHH
M`****`"BBDH`6BBB@`HHHH`****`"BBB@`HHHH`**0<4M`!1110`4444`%%%
M%`!1110`4444`%%%%`!6?)9NVO0WF/W:6[1YW=RP/3\ZT**`"BBB@`HHHH`*
M***`&LRKC<P&3@9/>EIDT$<X42J&",'7/8CH:?0`M%%%`#)%+QLJN4)&`RXR
M/<9IU+10`4444`%%%%`!1110`4444`)7"ZOJ8M=2UF*-E:XNS'`@'\("X))_
M'\Z[JL>;PWI]SJ<U[<1&5I0`4;[H(`&?KQ0!R<-JOAC5[&Y^UQSPN-LYC(.P
MD<CZ=Q]*Z;PB,VE[+P1+>2,&'<<5*WA;160I]A49&,AFR/UK1L;.'3[1+:V4
MK$F=H)SU.?ZT`8VN:/'=:K8R)'(?-EQ.RNP&T+QT/'2L!!K>GETM?M8B)GP@
MC+!<`[3S76:CKUCIMP(+IY!)L\S"H6^7)&>/I5"+QA8AIA=!HMDS1J5!<,!C
MYLXXZT`1>'K[4[GPW>S2F22X7>86=>6^7C'KSFL;^WM3$(Q?W!MF<!KQK4#8
M<'Y0._:NH_X2?2!.83=!2"024(&1COCWJU;:KI]Y%,\%Q&\<(S(>@4>IS]*`
M.%G\0ZQ]JBC^V21,Z1_*8QC)`Y_'K^-2W7B+4X52-KTQLL3`MY8/F,LA`^F<
M8_"NDO/%&C00F5)%N'!`"QK\WZXJ&?5M)AU6VN;J)XI)K,,K.`5522<$#OFB
MX'-P^*=3B6;$V6ED+EG&X+QG"Y.!]/I5I_%>J6DTID:&1I51T4@[8PP##]#C
MZUU7]N:.4WFXB`\SR\E>C?E^M5[GQ%HZPAT*7(:18BL:@D9SC@]N*`*5UXIN
M$\-6^H10()YI/*.3E01G)_3I6<OC'49)8HQ]B1I0`"V<1G."6YZ=?S%=&=1T
M*\M9+9I;9X%02.A&`!Z_J*6.301$$7[&(YU)&=H#`87O^%`'.Q>-[M5F\ZVA
M8D?N=C=#G'S<]*NCQ7.F^.7[$62WD;>DF5:1>@'KGCBML66CRW,R>3://(/W
MB_*6(]Q4,NE:$H*26MKF(%BO&1QD\=:`.=C\:74%U=?:(%F!*^7&C`!!@YYQ
MD]JL7OBV>XME:PB6+!C\QV<%@6Z@*>H]ZNX\+7<+7CQ0B-G">8ZLF6`Z#I^E
M36^G^';Z3S8(8':'Y.I&-OMWQZT`+JWB*33KV:W6S\Y(85E=_,"X!;'3'O65
M#XSDMTD>YA:=))W\L@JNV,8P/<\__7K9FT&RU+4GO[@K<1LBJB@\`J3GD'D>
MU.G\+Z1/]^UYW,V0Y')Z]Z`*EEXMBNKN&+[)(D<LQA$A8$`]N/?_`#FI]1\4
M6VG7,L,EM<NL3!&D105#$9`Z]<5-!X;TR#R3'"P,,GFKF1OO<<GGGI4=[I.C
M2:LLUWM^T.-_EO)A6Q@9Q[4`06'B5VT.35+^`1Q"39&L>27[=_\`/!I7\7V<
M:J3;7>_#,\8C&Z,`X)89XYJRVEZ9>:5)I$+@QPG!"OEHVR2#^>:J-X1MVPWV
MRY$K!EFD#?-*"<X/M0`G_"9V!D8)!=.F2%D"#:Q`S@<]ZEN/%^EP%5S,[%%?
M"Q]BNX=?:G0>%[6$J%FD,2W'G^7QC.,`?053D\$6;6J1+<RB16)\U@"2,8Q]
M!@4`7)/%VCQ/LDG<':K?ZLGJ`>WUJ(^+K#[8JK(AM#"9&FR05.[&-O7_`/74
M/_"%VOV.6V6ZD`=T?.T<;01^N<T#P=&D(2.^E#+&$5F4-@A]^<?IB@"ZWBS1
MD4%KHC.1CRVR,>HQQ4EWX@M;5K([7>.[1I%=1]U0`22.O0UF?\(<3<22R7QD
M>:-UD=DY);OC/:I[_P`,R74.G01WGEI:0O$S;>6!4#(%`&K9:O87\,DUM<HZ
M1??/3;[G/;WI?[6T[:6^WVVT$`GS5P#^?L:Q]*\+/8V-];27AD6ZCV#"X"\'
MG]:J6_@^Y$UO+=7$$GDO&/+5<*R+GKQR:`-[4=;M+'3#?AA/%N"CRF!W'/K6
M?8^,+*\F$9BDB`5W=G(PJJ,YXZTZ7P_*_AW^S1)$'\XR;L?+C>3T^E9USX-N
M+B:Z)N85B=I&B4*?E+,",_EB@#I(-6L;BP:^BN%-NN=SGC;CU%0MKVFB>VB6
MZ20W#%$9""`1C@GMU'YUBVWA*YAT.\LC<Q-+<.K9VDJ,?UING>%[[3Y[.036
M\GDW!D?(/W6`!QD=<"@#6N?$VGV]X]LSDM'(L<C#&$)SSUZ#'/IFKXU&R81D
M7<&)#A/W@^8YQQZ\UBR>'KF369KEY;=K:::.1D9,MA>WI6;<>"[F1SBXA926
MP#N`CRV<C%`'6SW]I;2+'<7,,3MR%=P"?SI@U33S'O%[;E-P7<)!C)Z"LO5?
M#IU"\CE\R,(EJT*AQN(;G!Y],US%QX8OM(5;AXEO5#\PQJ74\$98<'O0!VR:
MW8O??95E!;R_-$F1L89QP<]:F.HVPOX[+S,S2(9`!TP#CK^?Y&N(M_"&IR66
MXF&,R1C,;L=W!R`>.*GF\(:D\%NBFV#I"RLP8CG<6]/?'YT`=HUW;IMW3Q+O
M)"Y<<X../QI\<\4I<1R(Y0[6"D':?0^]<1'X+NWF!GDB"$2?*&)V';A2,`=^
M3]*DL/"FH6ZR>:T1&Z,F/?E9<$DYX!H`ZS3]1M]1BEDMBQ6.0QMD8Y'_`.NF
MWVJV6GVRW%Q,!&YPA7YMWTQ6)9:'>Q>&+VQVI%/-(SJH?C'R\9'L,5F+X2O"
MC2>1;HQD9EB,A8(NTX&?KB@#J]/UJPU*5XK2<.ZY)&",@'&?IS6A7!1^%-6C
MA01&&,^0$E`D(+GS"V,XXXQ^5)/X9UF25'MU%LHXV_:F<J<_>S0!WM%<QXFT
MF]O&MVA$DJI$4VI)MVR'&&/J/7Z4SPGHU];7=S>:BT@D)*H"^0W)W''X#%`'
M55"EW`]U);+*IFC`+IW`/2O/;73=4N;,R6T5R,QL7=I3MER?E"CVX-6;OPY>
MQ:JBQ)=2P,\:M*).2NT;LT`=_4-I=P7L`FM95EC)(#+TKAX],UN9+5;J*Y:2
M.$&$I)MVX<G#D]\8_(57:RO8%L[>".[2Z6T#A(3C:WF-@M[<T`>A7%Q#:PM-
M<2+%&O5F.`*D!R,BO-[BRUR3^T$E@NW$W+`J2&(<$>W3TKT=!M11C&!T]*`'
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`E%%%`"T444`%
M%%%`!1110`4444`%%%%`!112#/>@!:***`$IL;^9&K[67<`<,,$?44ZLF3Q#
M9QNZ&.Y9HY3&VV%F`(."<CCW]:`->DK%'BS1B<&[([<Q-_A6O!/'<P)-"VZ.
M10RMZ@T`8NI^'O[4U9KB>=XX#;B';$V&;YB3GCI5>7P3ITB;5FN5&68#>"`3
MCU'M7344`<W+X/MI68-=W(B:1I#&I`&Y@.>E3Z9X9MM/M+N#S7D^U#:[8"D#
M!Z?G6[10!S!\&PNT3RWCN\10*=@'R+T7^7/M5C6O#9U2^6Y2[$&V'R=IB#\<
M].>.M;U+0!R<_@UG8"*_*Q;PY0QY.<8)SFF0>"WMS&%O5D03([AHL$A<\`Y/
MK77T4`<=<>"GDBB6.>*-DMUC;"D!VW9)/^>U5Y_`URZPA;N+(&'W`X!R3Q^=
M=S10!RFC^%;C3M<%Z]Q%)&N['7<<C']?4U#=>$;JXU6:Y^T0[))7DR=V_!'"
MGVKL:*`.7N_"S3:!9V,9A$T#[F<YP<YS^?'Y50_X1._A@Q:M%%*XF61PQ^X<
M;5'UP?P-=O10!REEHFHVWAB]LCQ-(08D63ITSSVS@UGMX;UN&XM)+69@512[
M--G8_?ZCZ9KNZ*`.'.CZXEG,";AI'"X'VC)SOY`YXX[U7NM#UB^N;QY[217=
M7:/,P91EAA<Y]`:]`HH`X2UTC4?M:(L5[:PO*QD97`;`C`7)'7G(_$U735M6
MCN$MKNXNH[H+&B*-HQE@#N!')QC'_P"NO0ZB:WA:42M#&9!T8J,C\:`.>\0R
MZ[%JEN-+$C0%%W8C#*6W'.3VXQ6=./$$MM,DCW<B/'*-GE!3PP"\@9Y&:[>B
M@#SR"TU6UNS=*UY;H&),K0Y4?)]YAV'X<5L^']=O)S&U^3*+B3R8O*084J/F
M8GT.:Z>2-98VCD4,C@JP/<&F6MM#:0)!;QB.-!A5':@"6EHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*2EHH`10%`"@`#L*6BB@`I
MNQ=^_:-V,;L<XIU%`!1110`4444`%%%%`!1110`4444`%%%)0`M%)2T`%%%%
M`!1110`4444`)12T4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`"5FZ(
M,)>\?\ODO_H5:58J6>LVLDRVD]EY+RO(/,C;<-QSC@^]`&I<D16LTH5241F&
M?854\/*%T"QQ_P`\5/Z54N8?$4L#1>;IQ$@*MA7&`>_6M'2;:2STNVMI2"\4
M85MIR,@4`9=SJ^J0ZP-/2UM2SJTD;&1@-@)Z\<'BJ]KXTM6MBUS;S1S*@;8`
M"'R<?+GKU_G6U/I=M/J`O9`QF$1B^]QM.>WXFJ#^$],=AO5V00B(*6Z8.<Y]
M:`+5OKEI/I!U/YT@4D,&7+*<XZ#-5QXITWR?,)E'+@KY9++M(R2!T'(ZTS^R
MM+_LJ;1H;KRPK98[QN#?>!/KV_*JL?A.&6!)(=3N"TH;S90<^<C<D=>/UZT`
M6AXPT4G_`(^6'OY3?X5,_B?2(Y$1[L*7"L,HV,,`0<X]ZS!X'@52JWL@7<Y`
MV#@$8'Y5#!X2F>]D$]V18[(T`3K*%`X/IR*`-&U\7Z;)`KW,@MW=BH3EN!W.
M!P*6'QCI$BR,\KQ!&VC<N2WN`,\5E-X$1R?+U+`Y!'E9[Y_O47/@:3:YM[Q&
M^<LJ21X'/J0?3VH`ZBXU2RMH(IY[E(XYAN1B?O#&>/PICZUIB>7F^@/F,%4*
MX/)Z=.E9&O>&IK_3;"WM98U>T79\V0K`@`GOZ?K6?!X.OH9Q+]HMV8'R\%>/
M+*D$_P"]Z?SH`ZO^T[`H7^W6VT$`GS5P"<X'7V/Y4JZE8LK,MY;E5QN(E&!G
MIGFN,MO!FI0KYADM7D2166)\LC@9Z\?YYJ9_"VK#S!')9A+C89552@0J<X4`
M=/>@#J;?5]/N8R\5Y"5!P<MMP?QI\^I6D#Q(TREI)5B`4Y(8YQGTZ5Q<WA'4
MF(416Y"EAN5PI?))!Z'&.E6-,\,ZG:W]LTT5NR13B1I@Y+,,#CZ#'ZT`=IYB
M?-\P.S[V#T[U7T[4;?4[07-LQ,9)'(P017+ZAIU]?^([\6L/RAX&,K.5"X49
MQZYK/C\,ZW!(FR#&'#!DG`QSGI0!Z%2.ZHI9F`51DD]JYCP]I&H66HK<7*.H
M>.02`RA@"6!7`SZ5D:IHNLS3WK^7.Y,CL7$V5=,?*H7_`#V%`'<6EY;WL/FV
MLRRQYQN4\9J?-<C?Z=<67A6QMHHYR%=6N4A.7.>2!_P+`JB8==$O[P:B)9/+
M%O\`.&4`-D^81]:`.\I:X"*/Q%,%VW%]&TBR,0V["%3PN3ZX_6H[^^\3(T=P
M6N8Q<Y9(D3.P9X!XXHLP/0Z2O/;J]\2>6]R)+M`TQ01"/D8&?3IVI$EU9%FO
M3]JCN7:&-Y1"2VS82<+T/*K_`)-%F!Z'1FO/4UK7FMI)WGEA%K"KX>$8E^8#
MKCOG]*T/%(NCK5M/#N?R+8S*B@\$'V/T_*C4#LJ*\^@UO6[V:&QM;Y6:1_DG
M,>T-\N2#QV^E6/%USJ-M=E)+YHXI+481!@.V0&''YY/;B@#N:6N!N_$VI:=&
MMH95EN(I`S2E.&0H"%/YG\JV;[6]0BT[2Y8(X?/NURZNIQG;G`YH`Z6DK@F\
M:ZDL#.8K;<V&3`)VC)!!YZ\>WZU,_C*Z%D7;R4E,`9%,;89]^#^&T9_K0!V]
M%>:/K&H_9PZWTNQFGP3(P/`&,<_3'XUL6/B>^(BE<0FS61+=MY/F%MF=V>G4
M&@#M*2N5\/\`B&^U/41',;4Q>0966(-N7D``Y[\UEOXHN_MD>I.\9BV2!+5'
M(/7`WCUYS^%`'?T5Q<GBS4%<VJQVC7*%MTBL3&P"%N._%1_\)I>"TF=H(!)N
MC$9&2JA@3\WY?K0!W%)7'Q^-7DN+;_156%L+.=WW6)(&/;C-5;;Q5=1M'=7$
M@E3;*3`A&?O#;GCCKU]*`.[HKG'U^:XT?4YHXA;W%IQPXD&?RQ659^*K^UEE
MANA]LDP&525C*@)N;D#!^GM0!W%%<6_B^>Y,"QPFU?[1#G#!PZ,"2#P,=O>F
MV'C.>.WMUO+<S22L6+APH";L#`_,8/H/6@#MJ*Y8^(;NYUNS@@A,-J\[Q%F(
M)EV]>.V/ZU/>^)FMM3:U6R9XDF2%IR^%!;GTH`Z*BN4A\:QSBX:.QD;RPIC7
M>,R98#'&<'G..>AH_P"$NN(W?SM*<`3>0%64$[@,L/PX[8YZT`=717*GQS9[
M[5?L\F)0#*2P'E9_GZ]N,5%)XW,<44K:7((Y20C&3AL'G''/:@#KZ*Y5?&`%
M]-#-:M'"N[9(P(P57)##U[8J;3?%T%T(5GMI8WD=8]R@%-S=!G/I0!TE%<]J
M'B-=.UF6&=6:VCC08C7+>8V2._3`K9LKI+VTCN8T=$D&0'&#CZ4`6****`"B
MBB@`HHHH`*:RAU*L,@C!!IU%`#54(H50`H&`!VIU%%`!4*M-]J=611`%!5L\
MELG(Q^5344`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4E+10!R>NV&L3ZK++;"9E4(;8QRA40Y&[<"?K46A6&IVVJ6+W"
MW>")?M!DDW(.H4?RKL**!W/-[[0KWSY3;V5P[FXF&YAG,>!M.3]3]:MVJ^(H
M-1L46*9(D6-`H4^7LP,Y/8\<YYKO:*!'':E-K9\2&&!KU+)I%4ND>54'&2#B
MB.&]B\&31))=QW,4AP/+*L?FZ+WP>O'O78T4`>=Z9+JFF8E@>X:.6Z(9&A.'
M!`PY/7G(P*UO#^K:I<V^HK=F0F&'>CO&%*MC./ZUUU&!Z4`><S:_X@M8;5Y+
MD$7"B5"8QR,D8/'MG\15N3Q-JL=Y,R%9&(<?9-AS"1QGISZ]:[K:N`,#CIQ1
MM7.<#/KBE89Q$?BG5YEBCA2W>2641I*$;8V0./7()Y^M4SXKU#^T/M,S+'LC
M=1;C<`#VW#U_PKT+RT&/D7@Y''0TV2V@D#!X8V#C#94'(HL!S>D^)KFYT6^N
MY[=9);09Q&<!LY_("L]/$&KZBD-M`\4=P9US)&PP592P7D$9X.?I]:[.&UMX
M(?)AACCCY^15`'-1Q:=9P(B16T2+&^]0J@8;!&?KR:`.)L/$VIP79:[D::)8
MW?RSL&XY*CD`8YK4NO&9M$02V`\XD[D6<,%7C!W`$>O'M[UM_P!AZ9DG[%%D
MJ5Z=B23_`#--/A_2FC6,V,.U22!CIGK_`"H`KZKK[V$MJD5F\XGC,AYP448)
M.,>E9T/C>.=Q'%ITKR,X55#CYLYYZ>U=%)I]M+<QSNF7C1HUYX"GKQ6>_A;2
M6MS"MMM!(;(8YR!@<YH`JIXPMB79[:41+$9=P8$X$FSI^O6J^F>+(Q<7%O?F
M1W$[[&1!M2,>N/3!YYJS#X-T_P"R00W+/*\0(WJ=NX%BV"/QJU#X8TR&]DNE
MC<O)OW`M\OS`@\?B:!$$?B_3)D)B$[-N"A!%EB2">!^%5QXDN(O#-MJ4D,;2
M2S>65'<9/3WXJXGA73XXU1&N%*,&1A*<KC/3_OHU+)X=L9-+ATX^:((GWKA^
M<\]3^)H`KCQ?I1+J6E5T'*M'@DYQC'K2ZIXA73K^V@>(".>(OO<[2IP<`CZX
M%5T\)1)K45UN#6Z,9<,27:3(ZGN.,UIZEH=GJ<PEN@[,(S&`&P`#SGZTP,%_
M&+;(S-I\9B>,2,&F&<9(X!'/2KX\661U-+/[+.)7=8]Q4#!/XY[TY?"=G]F,
M;RR._EJB2'&8]I)!7TZTQ?"%M]KBFENIY40[]DF&);.2=WH?2D!+>:U9:?K%
MMIJV>78_>50`F[N/7WIMGK.DZ[+,IM#(;9"VZ:$-Q[=3^%.O_#,5[JZW[7,B
M<J60=RO3!ZBH[/PJECYAMK^>-W`0,H4$)G)'3K[TP*K>)-%G$Q?3)':,@LK6
MZDGL#[8'K5H>)],G:S)MY6,GS*QC!\K+%02>W(QQ49\),3,S:K<&250A<@9*
M^C?WNW6E7P?"IM2MY,!``&``P^'+?AR:`-W[#9D-FT@^?EOW8Y^M*UE:NJJ]
MM"P084&,'`]!3;""XM[?9=71N9,D^84"\>F!5FG<"N;"T8*#:PD+G`\L8&<9
M_D*2:PM)X'A>WBV/R0$'7U^OO5FBE<#)TGP]8Z1.\UJ)-[+L)=L\9S_2K3:5
M8,9BUI"6GSYAV#+9]ZN44`4%T;35@$(LH`@S@;!W&#SUH_L73?*>/[%#L<*&
M&WKCI5^BBX&>-#TP2Q2BQ@#Q8V$+C&.GUIJ:#I:/,ZV<8:8%7Z\@]?I^%:5%
M%P*$6CZ?#9R6D=LBP2G+H,_-]:1M#TUF+-9Q$DL2<=2PP?TK0HH`S1H.EAPX
MLHMPVX..FT8%1)X9T=&5ELU!4Y'S-ZY]:UZ*+@947A_3X=2%_%&RR@D@!CMW
M'J<>M5+3PI:+,\]Z3<2O*TF"3L&>G'?%=!10!@6?A'3K.2-XWG)25)1N8=5S
MCM[_`*4#PC8"\DN?-N"SESM+C`+`@GI[UOT4`8$O@_2I&B;;*OEH$.UL;\#`
M)]Z2Z\(:?<QVZ&2=%@78,/\`>'OD=?I7044`8$GA*RDC"F:X!_>%FW`EB^,G
MIUXQQ46E^%([2Y6YN+AW=)FD6)3F//.#R.N.]=)10!@WGA6VNY9I&NKI3-(9
M&`88R1C&,=!VK5L+..PLHK6(LR1+M!8Y)JS10`4444`%%%%`!1110`4444`%
M%%)0`M%,#,9&4KA0`0V>IYX_E^=/H`****`"BBB@`HI**`%HJ&YCEEA*0S&%
MSC#A0V.?0U+0`M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!24M%`!1110`4444`%%%%`!1110`4444`%%%5[=I6FN1)]
MQ9`(^,?+M4_CR30!8HHHH`****`"BBB@`HHHH`****`"BBB@`K.UK5XM'M4G
MF1W#.$`4?Y[5HTUT5QAU##.<$9H`K2ZE9VYB%Q<1PM*,HLC;2?SI/[5T_=(O
MVVW!C.'!D`VG..:S=?T>ZO[F*:T:W^X8G$R;@%)!R/?BLK_A#YY+F`R-`L4!
M"G`),R[R26XZXX[T6`Z<:KIQZ7UL<#/$J]/SIRZE8OLVWD#>8<)B0?,?0<\]
M:X>+PY>7L1DM;>"-%FEPS,0SKG`7&.!P?SJQ_P`(E?&>27R;94<2%(2Y*QD\
M#!Q_G%%@.ODU*SCC1S<(5D5F0J=VX*,G&.O%3I-&X7:X.]=RC/)'K^HKSR'P
MQK*,\K6B'"LH7>!R05R,>G!J5_#NJD20Q6>R1&=Q<^8/W@/1<=J+!H>@U2BU
M>PFO?L<5PKW`+`H`>".N:P]'%QH^MM8/;N8KLC8Y<D#:F6(S[GVK(FT35)-6
MNB+2989KAOG5L?*9`<_D*`.[N+J"U0/<2K&K,%!8]ST%+!<17,0E@D61"2`R
MG(X.#7`/I&IVNP+'>,'E(8$[@55UV9'YG\JJI:Z[:M;+!'?((^%4*<!L\\>G
M\Z-0T/2#<P"Z%L95\\KO"9YQZU+7$>&XK@^(4GN%O-ZVQ$[W(QAL]CZ=*I1Z
MSK$D+R07%U*,$.=HVI\X"E3C\/SHU`]$)`&2<`45YZL^L:A9SI<7%R8A9N^U
M5QN(<C#<<\>G;%.6ZUV*R2Y@NKJ4&62)(S%_"%X;_/I19AH>@4%@,9(&>G/6
MO/--U'Q!>7$5JUS<1`LS&4Q;L#'?VX_6BUU'4-6FLH;B8B9;L%)#%]P[2>>@
M/THLP/0Z*\^MO$NH)>;WDBB%QL#O,K%5(4<@9P.O;U%='9ZU]O\`#]S+(RQW
MD5NS2(AP4X.#[9QF@#>HKSS2->U:.WD:%TFVH\CM<NS<(JYQSP?FI-3\1ZK.
MP0NEO)&C[A"S`,&53^8YP?>EJ,]$HKAXO&=W'=R0/%#+'$C@.@(+%5)SU/!(
M_6K-KXDEA_M)=2G5;@#]T(5+HIV]B,CKZTQ'7T5Y_8>++RRM0)#]J=GR3*QR
M%"KP,#J<GGV/K5P^*KX6EU*4CVN[K`X8$H0NX`KCD>]`':4M>>6WBG6#-Y@<
M3C"DQ[5&!OQ^9R!^/M72Z;XC&I3B*&W/RVYED;/^K?.-AXH`WJ*XJQ\8W2PL
MUQ;_`&E]N_;%A=BA023^9^F*DNO&<VS-I:!64,S)*#G;A2K<=B#G\*`.QHKG
MX_%VG>9Y,WFI*JDOE.`0,D=>O:I;37TFAO[J5"EI;,`K;2&/`)R#]:`-NBL-
MO%NDI`)6ED&3@*8R&/&<X]/>H[SQ;8V]U%$N]U+@2/M.%4KD$>O:@#H**R!X
METHV[3_:#L5@I^1LY.<8&.>AH;Q/I"EQ]L4[`"2%)';H<<]?YT`:]%8L?B2Q
M>[N(?.BVQA/+8./WI()P/T%3:=KEI>00&2:&&XE4'R#*"PST_,<_C0!J450U
M75H-*B1YTD?>2`(P">`23R1Q@4AUS3%X>^MT8=5:09!]#S0!H4E9<'B"PFN)
M(#)Y3Q[RWF8`PI`SG/0YXJ6ZUK3[6R-T]U$T>"5V."7QV'K2N!?I:S-0UJVT
MX0>;'*PF0LOEJ#P,>_\`M"G7.MZ=;(6>ZB8*RJP1@Q7)QR.PI@:-%9<VOV$,
M\<;2,RR+N65!N3^+N/\`=-36^KV%RY2&ZC+@9*DX/3/0^U%P+U%5Q>VIB27[
M3#Y<GW&+C#?3UJ3SX=Y3S4W@9*[AD47`DHI@FC).)$X_VA1YL>,^8F/7-*Z`
M?13#+&.LB?\`?0I0REBH8$CJ,]*=P%)`QD@9Z4M1R+&VUI`OR'<">Q]?UIBW
M<#736PD4S*H8IW`/>@">BF[UQG</SJ,74!G:$2IYJKN*;AD#UH`FHI,@]#1F
M@!:*CDFCBV^9(J;V"KN.,D]`/>GT`+13'D2,`NZKD@#)QDGM3J`%HHHH`***
M*`"BBB@`HHHH`****`"DI:8(P)3)ELD!?O'''MT[T`/HHHH`****`"BBB@`H
MHHH`2BBB@!:***`"BBB@`HHHH`****`"DI:*`$I:**`"BBB@!,#.:*6B@!*,
M4M%`"8%,A@BMXQ'#&L:`DA5&`,G)J2B@!,48I:*`$Q2;%SG:.N?QIU%`%"ZT
MBTN[Z"[F0M)!]WG@_45-#86T-S<7"1@27!'F'UP,"K-%`$7V:``CR8\$$$;1
MT/44UK2V;.ZWB.>#E!]/Z"IZ*`*46DZ?"I$=G"N1M^X.F,?RHM-)L;."2&WM
MUCCE^^H)^;C%7:*`,N3P]I,K$O8Q9/ID=L=OI35\-:0K%ELD!*E3@GH1@]_2
MM:B@#(;PUI+-*WV0`RC#X=AGD'U]0*?HVD'3;.>*282O/(9'94V\D`<#\*U*
M*`,&/PGI\*N(C*A:)HB0W4%0O/'MGZDT2>$[&21Y/,G#/'Y9PPZ;0H[?[/ZU
MO44`<Z_A&VDB$3WMTT8);:67&XC!;IU[_C4L^A-#H-[96TLMQ-<'=OF?))X'
M7Z"MVB@#E+CP6MPB,U_*957:6D4,,8```[`8/YT]_"DWV'R8KX+)YPD#^7VV
M;,8S7444`<G=^#?/B4)>D,D<:*&3(RH(_(YZ4J^#RFFO:K=C+2))RF0V!@@\
M],DUU=%`')?\(:ZZ:+9+W#F5)&)3CY01@<^]06WA>\2Y8NZ".W:-XR$&Z5EC
M`&#V&1TKM**`.;UO1K_6-,L5:2-+F-#YN[@%BO.,>]5I_"<TTDC&2V)<2X8Q
M]"Q&/R&?I76T4`<?-X3NIE>,RP`-N^?!)ZH1_P"@FD3P?<+;RQM-;R-+W="=
MGS`Y7\L&NQHH`YC5?#5S=/"8[R294))2X((ZK\HP.!@'\A6-_P`(AJOG^<5M
MFP^2C.<2<YYXZ&O0**`."D\'ZD277[,N]6.Q20$)W<#V&11=:!>6YAA2V59I
MBBI/"N=GR!)`W8#J<_6N]I*`.>UW0Y+B*R2SMH)8K='C\J1BHPP`R#[8S6-+
MX5U%K9[?R8"ZDL+D2'=+G'RD'L!_*NZI:`//=7\,7-K;7,UM;+M68[`C%F\L
MC`]^]+/X8U22V"16D"1R2;A$)"?+^4#))]>:]`HH`X23PQ-':>==QA7CE3S)
M`Y;]SY8#X`[YJ]H^F7S:/J%T6)N[N$1Q')7*JNU6YYR>M=;1TH`XJUT>[OKN
M);NVNXK$NHDCFG+$E4;)Z\`G'YU)K>D7=SX@+06LI5HD6*=7*K$0>2?PS^==
MC2T`>=#2=8^QBU%A,ODQNC,'X?=("<>V!^/--LM#U.6:".^M;KRW>-)#NZ(-
MV<\]!Q7H])0!YY#8>(#-:(4O(HXRHA/78`W5AG&0#WJ$V7B)[25634&_>(0&
M8]L^^>N.G^%>DT460'&:I9:C)HVCSR+<?:H)%5T#$XYX8^_`_.G/'JMI9-"&
MU*>::."0/RVQMQWKGMQBNQHH`\XAM]5E,,FI_P!I-%'<185MQZYR0#Z8'YUW
ML5]')J$MF$D#Q(&W%<*V?0]\<?G5K%%`"T444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%)5:SNQ=-<*$*>3,8N3][`!S^M`%JBBB@`HHHH`2@=***`%HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**9+*D,;2
M2N$1>2S'`%.H`6BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*9+$DJ[9!D9#8]P<
MC]13Z*`$I:**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`2J&EP20R7QD7`ENF=>.V`/Z5H4E`"T444`%%%%`!1110`444
M4`%%%%`#2ZAPA8;B,@9Y-.J)K>)KA+@H#*BE5;T!QG^0J6@`I@?,K)M8;0#N
M(X.<_P"%5-8DFATNXFMYO*DB0ON*AN`,XP:YZWUK5()K)[EUN(IHD:9=JIY6
M]L*<]_I0!U]%<IHGB6YGOX;"YB$S2C>)HC]T$9P1[=,U7L_%MX=4N5GMP]HD
MFQF3_EB,[02>^30!V=%<>GC:7Y?,TIP&4,,29SGIV[XK1O/$Z6^D6=_';-*;
MGI&&P5P#GMSC%`&_17,1>,H)"X%I(I7><,V#A4+9([=,?C4<WC-2\L5O8S&5
M&4`..N2`00.AR<4`=716'<>(H;36I;.Y`2%$7]Z.0&()PQZ#BK%GKUC>6,]Y
M&[+%!_K-ZX(XSTH`U**PU\5Z4T4,@E;$K[,;>4YQEO0<CFGCQ1I.PNUQM`D"
M888)S_$!_=]Z`-FBLYM>TI7*&_@W`X(WBE&MZ85E;[=#B+A\MC%`%\@$8(R*
M*H_VSIOF)']MAW2+N4%QR*2RUBSNTXFC214\QXRX)1?4XH`T**QW\0VJPW\R
M(\D=EMW.F"'S_=.><5>74;-HP_VF$+@-RXX!H`LT5$UU;K,(6GC64]$+`-^5
M,^W6BHK&ZA"DX!\P8)H`LT5`UY;(Q5KB)2#@@N!@T]98W=D5U9E^\`<D?6@"
M2BH(+J&XDF2)]S0OL<8(P<9_K3K>YAND9X)%D56*$J>A'!%`$M%0?;+?[9]D
M\U?M&S?L[[<@9_6IJ`%HI*6@`HHHH`****`"BBB@`HHHH`****`"BBB@`HI*
M*`%HI**`%HI**`%HI*6@`HI**`%HHI*`%HI*6@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$HI:*`"
MBBB@`HHHH`****`$(!&",@U`]E:R!@\$;!VW,"H.3C&?RXJQ10!72QM8[DW*
M0(LQ7:7`P2/3]*KRZ'IDS;I+*)CC'3MS_B:T**`*<FE6,N?,M8VW8SD>BE1^
MA(I+K2K*[C5)K="$0QK@8VJ>H'I5VB@+&3)X;TF1E+6:8!9MH)`R<9/Z"G#P
M_IJ',5N(SYBRDJQR64Y'6M2B@5C$N?"^G75W-<RHY>4'<-W&3_%CU%2+X=LX
M]&DTR,R)%(078-\S$$<_H*UZ*`L<V/!>FA44/.`HPV'QOYSSQ3O^$0LMO^ON
M2Q^5F+C++@#;TZ<5T5%.X6.7D\'6L5M-]G>0RE?E!Q@X;<!_(?A5:+P6\EM"
M\UZR7(P6PH*CO@?B>M=C11<+''/X%S%L74"#NSDP]L8`Z_7\ZD?P4&AEC-[P
M2S1XB`VDD=3GG@8KK:*+A8Y\^''716L4N(R[W'GR.T7RMSG&W/3@5F:5X6D3
M6!)<1!;:`<YQB9\D@@`\#D=?05V=%`SAO$'AB\%W<:A;RF5I9!M14.X;CC\A
MQS4,GA6ZEU*:U18A&`7,S1LJ#=CA!GJ,>O>N_HHN!P^I>$[@1HUM%%(Q1Q,S
ML2<[LAAW)QQ46G>'M4N62YG58$E<>='DJSH7W-N_*N]HI`<!<^$M3:6,P!$!
MY8B4\'<?Z8J33?#>L6^HV;LWEV\;H[@39`QR1CW.?SKNZ*=QW.)U;P]J<]W/
M=6T:^9).^")<'9@;>_KNX^E4Y=-\1QS7#YN)653&SJ_WU(Q\H[UZ%12"YC>&
M/MD>FK;7MN\3Q?=9CG>#D_GZULT44""BBB@`HHHH`****`"BBB@`HHHH`***
M*`.4N-1UV&_NG2(R6L9D,:"/EMN`!].0??!J*/Q)K0M5=M*,C`%BVUAD;B.G
M_?/ZUV%%)H=SC9?$^L,L+Q:9(N.74Q/E^#G''`R/K4]WKNHOH"7L:"VF^T>6
MRE"?EP?7ISCK754$`]12L%SBH?%>KQP#SM-9@$!,SHRKVY/'`ZTK>,-22)G;
M3D(WJH9=V.1G]<C%=H0",$9![4FU?04<H7.)E\7ZC9RM%/;1R'=(H(##!#$`
M?R_"M2R\17<CRI<6+*UK"SW"H"2&X*@?49KHMH]!38X(8G=XXD1I#EV5<%C[
M^M%@N<KI?BNZU*]2(6RQ1JDDDAY.X`<8_'%4K;QG?1O(US%%(F_E%X,8Y/7H
M?3KVKN0BKT4#Z"F^3'S^[7DY/'6BP7../CLF$.MF`VPYRW&[C].:M:EK6J32
M:>NE1[3<P>:RM'NV@D<_3WKI_)BQCRTQZ8IP1000H!`P..@H2"YS2^-+5VVI
M:7#85GXV_=4$G//'"GBI[3Q9;7-RD+6T\`=6??)M"@!=Q/7TK<$,0SB-?FY/
M'6@PQ'&8U..!D468CEHO&J/@-;[#YP!!)_U6"2_3L!TJS%XG>;2VNEME5VNQ
M;1JS$+S@AF...#6_]F@W;O)3=M"YVCISQ].3^=--G;-%)&8(RDIRZE1ACC'/
MY"G8#G8?&MJ,)>021/SDH0Z<$C@]^E3#QEIIC=BEPK+_``,GS'GGOV')]JV&
MTVQ;9NM(3Y:E%^0?*IZ@>W-4=<MX;/2KFXM;6'[0"&7,8;+-A3Q[@XI68%2/
MQKI;E?EN`I&78Q\)SCG'X=/6FQ>--/+R";<JAR$=%+!EQP3Z9Z8K#L]<MK.!
M;:[TNWD$@*R[$"'AC@%<=L'\Q4<.O:?]HD+:-;"#Y_*^7&/EZ=.23CZ9H#4Z
MP>*---D]SNEPC!"GEG=N.<#ZG!J,>+M),C*)G.U`P.P_,3V'?-8EG?V&NWL-
MA)9)`CRF>?#\/(`<8]13-7FT*WU*>Q;1V)4JH>$[6+=>!^(^O-,6IT>G^)M.
MU"ZCMH7<32+D*R8YP3CZX%30ZW;S65U=K',$M79)%*8;(`/`_&N?-SINDZ7;
M:K:Z3\S,$B9WPV-O7//N/PJ*ZUZVBM+FW?3%AEN95>2&20_/N`+$G^'M0,V5
M\7:9MW.)T4\`M'P3C../:I[3Q%:7EQ#!#'/NFSM)3`XZ]^U<T+K28;1[E]&A
M5DA#(#*2'+,R8&?8$Y]JM:'J,;ZI:0VFFVT(R\1=)2Y"@;SCCU(Y_"@5F=E2
MTE+3&%%%%`!1110`4444`%%%%`"4453TJ5I[/S6<MOD<C..!N(`X]L4`7:**
M*`"BBB@`HHHH`****`"BBB@`J-$=7D+2%@QRHQC:,#CW]?QJ2B@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`*0@'K2T4`,,49.3&I/J13'M;=\;X(FQTR@.*FHH
M`K-86;KM:UA(_P!P5(UO"S[VB0O_`'BHS4M%`$3V\,D0B>)&C&,(5&./:DDM
M;>;/FP1OGKN4&IJ*`*_V*UPH^S1850H^0<`9P/U/YTEOI]G:L&M[:*(KG!10
M,9QG^0_*K-,8,64JV`#\PQU&/TH`?1110`4444`%%%%`!1110`4444`)5/2;
M22RL$@E*,X9B2@P#EB?ZU=HH`****`"BBB@`HHHH`**2B@!:***`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`I*6FL@9E8YRO3F
M@!U%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`5'+YN4\K9C=\^[/W<'I[YQ4E%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!39&V1LP4MM!.
MU>I]A3J2@!%.Y0<$9&<'J*=24M`!1110`4444`%%%%`#2H+!CU'2EI:*`"BB
MB@`HHHH`****`$HI:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`***2@!:*AMDG2+%S*LCY/S*FT8[<9-34`%%%%`!1110`4444`%
M%%%`!1124`+1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
..4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>vivakorex312image2.jpg
<TEXT>
begin 644 vivakorex312image2.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86
M&#$C)1TH.C,]/#DS.#=`2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`-)`L,#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"FE@
M.I`IU5+O3;.]=7N;=)&48!;TI/R`L[U_O#\Z-Z_WA^=9[Z#I;@@V<8R,9&15
M1O"6ED#Y)1CTE-*TN_X?\$>AN!@>A%&1ZUC1>&+*#/DS7<>?[LY%(OAN)/,$
M=_J"B3[P$_7\Q1[PC:HK*_L0CIJFHX_Z[#_"C^Q&_P"@KJ/_`'^'^%'O?U_P
MP&K165_8C?\`05U'_OZ/_B:4Z3<#[FKWJCWV'_V6G[W]?\,!J45E-I-Y@[=:
MNP>V50_^RU"VCZL6.W7Y0,\`P*3BC4#;HK";1]8W'9K\@7/`-NIIRZ;KB@#^
MW0<>MJM&H&W16,-/UO'.MI]?LB_XT'3]<[:VG_@*O^-&H&S2UABPU\=-9B;Z
MVPJ46VN[A_Q,;7'I]G/_`,53U`UZK&1SJ"Q*R[!&6=2.<Y&"/R:JL<&LJF'O
M+5VSG/DD<8Z=?7FFFWU5+@S*UB[G@L593MYPO?N<T#-6BL]6U8'YTLR/9V']
M*?OU''^IM?\`OZW_`,30!=HJGOU'_GC:_P#?UO\`XFF[]2_YX6O_`'^;_P")
MH"Q:>:..1$9@&D.%'J<9_D*DK+/]HRRH\ME9[HFRC>>QQQC(^3WQ2376LHSB
M/38)5'0BYQN_-?\`.*`L:M%8IO\`7?\`H#1?^!0_PIIU#7@<#1$/N+M?\*`L
M;E%8G]I:WCG0>?\`K[3_``JQ!<ZM+'N?3H(3G[KW))_1"*`L:=%9[3:J,?Z'
M:G)QQ<-P/7[E1W%UJ\(!CTV"?/9+G&/^^E%`6-2BLB2]UE9`BZ3$X('SBZ&!
M^:YH:\UI6`&EP-DXR+K@>_W:`L:]%8WV[6_-"_V/$%)QO-T,#],U&=4UM3@Z
M`6]UNE_PH"QNT5A?VMK7_0OO_P"!2?X4?VKK?_0OM_X%+_A0%C=HK"_M76_^
MA?;_`,"E_P`*8VLZTIP?#TGX7`/]*`L=!16(NKZHS,#H4PV@GF9>:D;4M35$
M;^QG.\XVB=21]>*5PL:]%88UC5#C_B0S\_\`35:;_;FI8!_L"ZQ_OBBX6-ZB
ML%->OB?GT*]7Z`&GC7;HD9T2_`SR=HX_6BX6-NBLI=98YW:7J`YP/W(Y_6A-
M9<CY]+U!3G_GD#_6BXC5HK/BU5)'1?L=ZA8@?-;L`,^IH?5D1F'V2^.WTMV-
M%P-"BJ<^H+#*D9M[IRX!RD)8#/J1TJ,:M&91']DO<G'/V=L#/OCWHN!H45!:
MW*W4/F+'+&,D8E0J?R-3$X&:8"T4V-Q(BN`0&&1D8/Y4Z@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHI,'.<\>E`"T4E+0`E%%%`!2TE+0`44E%`"T444`
M%%%%`!1110`4444`%%10B8-)YKHP+93:N,+CH>>3UJ6@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HI*6@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@!,C.,\^E+51[")]4CO\L)4B,6,\$$Y_P`?SJU0`M-8,2NT@<\Y&<BG44`1
MW$*7%O)!)G9(I5L'!P:=&@CC5%SM4`#)STIU%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`5_L<1OA>8;S0FS[QQC/ITJQ
M110`4444`%00Q2)/,[SM(CD;$(`"8';US4]%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!3&5BR%7*A3D@`?,,'C^OX4^B@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHIC[]R;-NW/SY],'I^.*`'T444`%%%%`!1110`4444`%%%%
M`!1110`444UV5$+,0%`R2>U`#J2N(UGQR0_EZ4H(!!,SCKQR-O\`6N<G\1ZQ
M<*!)?S8']P[?Y8H`]:HKR$:YJH_YB-W_`-_F_P`:U;+QMJL,P-PZ7$>>59`I
MQ[$8H`]*HK)T?Q#8:QE8',<P_P"64F`QXZCU%:M`"T444`%%9^NRR0:+>2Q.
M4D2)BK*>0<5QJ>(=5@B=1<N$5D4M<("\>[G=[C_$4`>A45P=UKVHI/<6T.HI
M-#%,BK*H4.RX)('8G^>/>J\OBS55MX)%N$R8R6`B'4.1SZ#&.E`'HE%<?K_B
M.[TW4K%8Y!Y$D22S*$'(+'.">>@K*B\6ZN\;,TT8(5FQY8XX&/YT`>BT5SDN
MLSIJNDVWVF#;-&QN<8P&"_7CGWJE=Z[JS:[+;67EM;+(B!_)9QR!U(^I-`'8
M45QFA^)=4O-4@MI8XI4E)W;492BCOD]O\*[.@`HHHH`****`"BBB@`HHHH`*
M***`$[]:6BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$K@O&GB*5[E].
MLY=L2<2LAY9NZY]!78ZS=M8:3<W2`%HT)&3CFO'I':1V=V+.QR23DDT`-S10
M.3@5-&L!G59)6$1'+[>0<>GUH`;##)/((XUW,>@HGADMYGAF4I)&Q5E/8BM'
M3;U[)?,0VZ?+L+;5=^0>1GIZ'GBJVJW$US?O)<;3*`%9A_$0,9SW^O>F!%:W
M,UG<)/;R&.5/NL.W:O6-!U--5TN*X4Y?&V0>C#K_`(_C7D(KI_`E\+;63`Q;
M;<(5`'3<.03^&?SI`>D44E+0!5U-[6/3YVOB!;;2),]QZ5F6+:%JD5Q<0QQL
M'`AE,B[>`.!S]!^56_$%I-?:1-;P+"SMVESCCGMWKC)?"VMO;KGRY-SEBID!
M/0`$GH:`.R_L321;"S-I%Y>[>$[Y]<]:1]#TA_)WVD9$(V1Y)X`)..O/.:YJ
M#0-8CGF:6+S9&C<).;DY7*$!<?7%4CX:UH7,*,K^60&)\TD*<'<#SW.?SH`[
M*;3=)UH+<R11W(`\M75CT!/'!]<U&?#&CG/^AJ`5VD!B.,@^OL*XL:5K5H8!
M':7:+$<.(W)R0V20`?0C\C4D\>HV4=K#]JGCU&[=HWB:4]"V%;VY!YH`Z<^"
M]&+[O*E`SG;YAQ]*KVF@:(+N2"VO;E9HS^\A$^T\>HQG'/7WJ#Q!::M`+**W
M:[GMXX/+)MV(<R8(#-CG'3]:32=+N8QJUU>13/>^28P3_P`M"4!./7D`4`:%
MII^B&*U>UO=RZ:2X=)@=H)R=WMUKH,C&<\5YI;Z;>_V9J"_9)X42%269"K,0
MV=N.XZ\^PI5;6+NUO8Y%U%XGB'E*4."`P]L?=STH`]*I:XK2+[6?[=A@*WAL
M"Q7]_%_"`<9.T8[5VM`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`E+110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`&!XWS_PC-QC^\G_`*$*\NKV'6[1K[1[JV3.YXSM
MQW(Y`_2O'C0`Z-VB<.AP13F95(\L#LP8]>G3TZU&>O7/O3E=E1D&,-C/%`QN
M:*?-!+;R>7-&\;X!VL,'!IE`@%;'A:1HO$-D00,OM.1V(Q60*ZCP%;>=K32D
MC$,9.".N>*`/1J6DI:`,?Q2)GT.>.W$[2/A0L*Y)SV/MZUQ1LM56UM$2WORT
M:GR0$*^6Y;+?A@<=*[;Q/>W&GZ0T]JZH^]5+E<[03C.*YF7Q/=:6\T%O>QWZ
M(^U7F4YZ$]0>>>_T]:`+F@MK3>*)Y=1MI55XBK$GY$'!&WL?3\36)-?:G;7,
M(@>:>);B62WR2V_DCGUZ9_$^M:T_C#4HEGD%G;F*,HN=QX+*2/KT-/B\9RML
M(L$**JM*PD^[DXX&.>O2@"&W\2ZC<FWABE!,T\4?G&#@%A\Z^AP2*QIM7NTU
M(W`G::>%Y"#(N0!GCCM_2NITOQ.U[K::>]FB*[.%=6SRN>WX&J(UO4&^U7'V
MNR@1+B2);:X3#8`SVYSSCZT`6=5U2Z>WTF:>9[.QN4#SRP`[E;'3/8<C]:H6
M'BW4(KBUM95657=5,DJ[6*L<`]?3G-%KXIU!I8A?6\+V@1/-R`.&(^<_X5T6
MG7B:QI)NS9Q(^&,2MAC@=#[<C]*`,6Z\:W4"JWV2!@[,``S9&TXYXQ^5/F\9
MSQ[BMM`%WNJHSD.`HR"1C@&L^R\42%+6.>R@:.+>T@6$?<QP5[`Y!_2M!/$V
MCW,3S7.F8>17#G8K9('3=ZD`?E0!H6/B">ZT[4)Y84C:V@65?+);[R%AU_"L
M&#Q'K*VUPSW4#NIC(R%(`8]01Q]0>E7[3Q+H<44D1T^6W\V+]XFP88!>!UYX
MX%5+?6=(1+Q)]&9;0N,".'GC^_DX'7C%`$[^.;B(;GTQ2C$[6$IP<'![4EQX
MYG*2+!IX1@"5=Y,@8Z\8&?SJ3Q)<Z=IMCIPATVWG@EW.BOD;0=I./KD?E52/
M4=/FU"XA_P"$?CD=L[5C8;B`.<_TQ0!TD.J3#PY]MG,"7*Q996<!0QZ9/;/!
MQ[USUIXIUI7%M):QS7#RH%)&W@C..#CG&0:BM-?L;2UN8X=+E:&X;S)5=@55
M,A3CCIV'O5[2;+2-0NKRPBMI%B@96$S2'<Q!(X]!U%`&EHGB>/5[R:V2UDC:
M-2RDL""`<<^AYJUHFJ3ZDUT+BW%NT,@3R\Y(XSR:Q+;4=&T+4;^*SM)W:-<N
MRG=T(!49Z`$TVS\3:=:W#-;6ESF[FWS[B/DR<9'XXX]Z`.RHK'TGQ#;ZI?36
MT4<B;`61F'$B@X)'XUL4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`)7G?B_PV]G</?6:,]O(2SJHSY9ZG\*]%IKHLB,CJ&5A@@]"*`/$TV@G>"1C
MC!QS2B/+`;@`1G+<"NZU;P-'*\TVGR^63RD)'R].1FN;NO"^L6I&^S=QZQ_-
M_*@9GO!(]DMVSH4W^5C=\V<9SCTJ``<[B1QQ@5H1Z1JLJ,B65R51CE=AX/\`
MC6G8>#-4N)4\^-;>)@"69@2!]!W^M`&#:VTMY<QP0KNDD;"CWKU/P[HR:-IX
MCX,[_-*P[GT'L*72/#]AI*(8H@\RYS,X^;G^5:E`A:***`,S7]0BT[3C)-`+
MA9&$8C.,,3ZY[<5SLL\<TTUDWAJW)M?WTBK<*H7/?(&.G;VK6\7B.73H8)&:
M-I9U$4F/D#]MWMC-94%WH]U'=1I/=;]4D/F-M`\K;@G/HOS=>>,T`5?[0TI8
M([1]'15O%61D^T8VXX4Y[''/;K5\1Z5%IC7]QIP6;3)/)\M6(Y##;WY^\#D^
M],O;+09]0L5DO77,*JLBLNR4(<#)]>,58>/3QI&I6^HWT)GGE::=;=PQ3!&`
M!UXP.U`&1!K>C6$\5]!I$RS_`#X8R\>A(/?J16O;1Z-?^*KJ%+$_:(E9GFW'
M:6R`?E]>>M9D>@>'I48C57B"'8[2%5RQYXR/3^5;NDZ#IMGJTMS9W3R2("KQ
M^8&VD^O?\Z`.9NCIMU/=6=A97:21+Y9DC/F;D5@/NDCVJ?2M5TR+4//_`-+"
MM:"VVB,?*H(4-N!]AVZFM!O#$9O;\0:FJ7$JG"*!N16;)W8.3W%.F\*"[:TD
M@OP(XX4AEV#[^PC..>.1^8H`CTFVT'5G%G%%<A[='`+$KE"QXR.O+5L#PQI8
MLTM?()B23S0"QR3TY/I5?0/#ATB^GN7NO-,BE0,8ZG.3ZGI6W]IA-T;82*9@
MF\IW"YQF@##N?!NFW-S).SSJTC,Q"L,9/X?C4,O@BQE&9+JZ9R22Y8$G@>WM
M73YHH`P=4\*VNI1VJM/+&;>(1`C!W*/6HE\(V\5Q//#=3(\D9C3H=@(Q^/%;
MJ7=O)<O;I,C3(,L@;D"I0ZL2`P)7J`>E`'-W7A&.=+9$N6B5(5@E51PZ@[CC
MT);FK]QX>L[J[FFN=TB2J@\K)4+MST(^M:H=2Y0,-P&2,\T,RKC<P&3@9/6@
M#E9/!:QW#/87DD"/&4(.21D\^G&.,&D3P8RO;!K[?%`1A3"`<;MQYS]:ZS(S
MC-+0!@:)X<_LS49KQYQ(S*RJ`N."V>??I6_110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%)2T4`)BBEHH`****`"BBB@#*\2:4VKZ2]O'
MM$H8/&6.`"/7\":Y\^!W!NA'<>6I11#SG)Q\P;VR*[6B@#@CX.U,)&FZTD4*
MR_,3\NXGD?3K]::O@J_C>XVRQ.!'MC.<;R1^E=_10!YY=^#M5DG9D6W;)R6W
MX+9Z\5TV@Z5/I]Y<O-&GS(B"8,2TF!@DCM6[10!Q%UH&IR>)KN>)=L<J2%92
MW'S(5`^N351O#VL6UA%&]MY\8F9C"DO<J`#Q]#7H-%`'GUUX>U7[+=3)&ZRJ
MR)Y:2$[T"C./7D#\JJRZ1K$,2EK2YDDDMPN48_(-W0XZ\8XKTNBG<#SVSL-6
M-L8KC[=;16T#.I#$#S`Q*\=_\FI)7UR2"&\)U$B='_=P,1L8'`R.P/6N^HQ2
M#0\SN+#6H+VX:WAO`9&R[A"2Q&#U`]:=.=:C^U?Z/?1SW#(TC(IZ!>F0/?\`
M#%>E8HQ3&>=S2:G`[30C4?MDR1;G,?10OS#IZU-=WE]>Z;80W,-V+FUN$DEG
M$1)`.2#CU`]NU=]@48%(-#SB:]U2UF^UR&X@NY($3>(^&Y/WLCT':NZT:X-S
MID,AG:X;&&E:,IN/K@U=P**`%HHHH$%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%0R7=O&[))/$K*-S*S@$#UH`FHJ&.ZMY9#''/&[@9*JX)`]<
M?B*7>?/V[TQMSM_BZ]?I0!+140N(6<()4+'.`&&3C@_E4@(8`@@@\@B@!:**
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`2N/U#3+?5?&\EO=!C']
MF#?*<'(Q_C785S,3;OB#,,?=M<?^@G^M`$H\%Z0.BSCZ24G_``A>E;PW^D8`
MZ>9^M=%2T`<P?`^G;PPN+H8[;Q_A2?\`"$68`"WMX,=/G'^%:NNZU#HMHLTJ
MF1W;:D8."?4_2IM*U&+5;".[A!"MD%3U4CJ*`,-O!%H?NWUV/JP/]*;_`,(/
M;_\`00NL?45TUQ<16MO)/,X6.-2S-UP!6/<>*+2/2TOXHII8WE,2KC!.`23]
M.*`,Z7P.FW]QJ4ZMGJPR,?ABFKX-O%W!=;E`88/R'GG/]ZNMBD$D22`$!@"`
M>M5-6U6VTBV6XN@Y1GV#8,G."?Z4`<Z/!U\&5AKDN5Z?*?\`XJK$7AS6($$<
M.OR!!DX,>>?SKIE8.H8=",BEH`Y<:#KZ`*NO-@<#*GI1_8?B'/\`R'C_`-\F
MNHHH`YE=&\0IG&NCGUCS_.G_`-D^(_\`H.K_`-^1_A71YK(A\2Z;/J`L8I6:
M8N4&%.,CW_"@"E_97B3_`*#B=?\`GD/\*BDTWQ4)`$U>)EQRQ4#'X;:Z2ZNH
M+.$S7,JQ1CJS'%4M/U_3=2?R[:X!D).$8;6./0&@#$6S\7QNC?;8),')5L8_
M'Y:D$7B\ELS6@#$$=/E]AQ_G%=310!S,LGBX,`D5DP4YRO\`%[<G_.*//\7_
M`//I9?G_`/95TU%`',_:/%__`#Z67Y__`&5!N?%X'_'G9'Z'_P"RKIZ*`.4:
M^\7)(J?V=:L2"<CI^>ZI?[3\41@&31X6&1G;(.?IR>]=-24`<S-K7B"!U#Z%
MN!R<(^[CZC.#_.H6\4ZLN,^'YAGI][_XFNLI:`.17Q??]6T&?'L6_P#B:7_A
M,+P_\P&X_P"^F_\`B:ZVB@#DQXOO3TT&Y_[Z;_XFFOXQNT1G?0IU11DL7(`'
M_?-==69XD('AZ^R<?N30!8TN\.H:=!=F/R_-7=MW9Q^-6ZS]`4+H-@`,#R$/
MZ5H4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`E+3=B[P^/F`QFG4`%%%%`!1110`4444`%%%%`!1110`4444`%%)38I4F
MC#QMN4YY_2@!]%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M)7,6X#?$&Z.?NVPZ?1:Z>N8L`#X_U$GJ(!C\DH`Z>BBB@#@/%U]%<>)(89(V
M>"TP)-JY+9P2/Y#\Z=X-O&CMM2L)#*#Y1D15R&&!@X]#TKKK'2+6PNKBY@#^
M;<'+EFSWSQ^=13>'[&;4);TB19I4*/M<@$%=I_2@#C-/TJ>Y\.76I-J,RJJ.
MIA#'#`<X)SW)Z8_G42J]IX/2Y6ZF#SS[40,0%`W9Q]><UW5EH=G9Z;/8(&:"
M8DL&//(Q_2LI/!%D(7BDNKEU/*#<`%/T_&@#+A^WZOXDGL#J5S;I!$0IC8C.
M`!ZCJ>:JZNTQ\*JLFI1WZI=J%=<DK\C9!)Y/6NGU#PK;7TZSBXFAGVA7D0_?
MP,9/OP*9)X1LVTI+!)9(PLGFLXY+M@CG\Z`.>U'4-2N=;N+6*XO4AMQM5;52
M3P.X!'4]ZCGU3Q!-HT`)N5V2,&E4$.PP-N>_KS^==/?^%(+R\-VEU/;S.NV1
MHSC?P!_2JTG@BS^S0I!<RQ2QMN\WJ3^';I3`S_!VJ74^K&WEOY9HV0G9,"23
M@=#SC'UJ_P"+M3O8KVSTVQE\AKD@&0=>3M`SV^HYJYI/AI=/U%KZ6[DN9BNT
M%EQVQ^/%2Z_H$>LB%_.:":$G8ZC/^><<T@,`7&I:/J_]DW6HO.EY%B*0DY1F
MRJG)R1R*C\#6<KZC<3LT31Q$JP*@MN/0@XX[UL:9X9DBU!-0U.\:ZN(QA!SA
M<=*O:'H:Z.;DK.9?/8,<KC&,_P"-`'/>)O\`3O%MEI]S*PM#M.T'')S_`#QB
MK>JZ!HL&H6K?:?[/=R=BKPK$<YR>G6M77M"BUA(V\UH;B+F.11T^M9%EX/GD
MO$N=8OFN60C"@EL@=,L>W7B@!@U37=9U"\&CS0Q6]LVT;E'S]<<D'DX]JKW/
MBJ^?PZLT3"*\BN!#*VT'=\I.<'@9Q^E7I_#FJ6U_=2:-?1VT%QRR-V/MP?P-
M13>#Y_["CLH98C.TWFS2.3@G!``X]Z8$$6MZ[%JEM:W,L+&]A#1A5`"%@=IZ
M=B.G-2?\)3?VVDW3W$<1O8+D0E6'RXP>P/\`LFM"Z\/W,^N:=?"6(1VL:(XY
M!)4G../>H+WPC]J\0_;/,06CL))(^=Q;_P"N:0%:\\2ZM]IAL[>*V6Y$:RS%
MR%4Y`(4;CZ$9[YJ1O%UR-`2_$,)E6X,,J'..A((YI/$'A^^EU>;4K:WM[M'5
M1Y,I.0<`>H]/6J]WX<U-?#@M(X(7F>X\YEB(&T;<`<]:8#[GQAJ=FZQ7.FQ1
M2OAE#N0-I'K_`)[U(FO/K.C:E%>6CH(H]Q:%OE(&.-W(SW]Q4_B;2;^\EM)8
M;:&ZAC`#0-A6SSGYN#C\:S+#PYJ<-MJ<HM_(,T!BCMPX8G)'.<^@/YT`6K'7
MDT[1;"WT^UEGFN2_EI(X)'SD<X`_I5^U\4MLNHKVRD@N[:(R&/\`O@=<5CQ:
M3JVGVVEZA#:[Y;1762W)YP68Y_$-_*K#:=JFIMJ6I7%LT$KVYA@@!^8@TK`2
MGQI*+6*Z_LR0P%BLC[N`<]!QSQ760R":%)%^ZZAA]#7&3:??+X(@L3:R&X,^
M/+QD@;B:ZZQ1H["W1QM98E!'H<4`6*S?$0SX?O\`_K@W\JTJS?$9(\/W^W&?
M);KZ8YH`=H/_`"`K#_KW3_T$5H5GZ!_R`;#_`*]T_D*T*`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`I*6B@`HHHH`2BEHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`2N8TW/_``GNJ'!/[E1].$KIZYK3/^1YU;_KDG\EH`Z6
MEHHH`****`"LO4M96PNTMEMVE<PO,Q!P%503^I&*U*PM4TRXGUE;B%`T<UG)
M;.Q(_=DY(/Z]J`*DWB]K=E2;3B'<!E"3JP()QR1TJQJWBA-+U!K1[-Y&&W:P
M<`'/UZ477A>U?3/(LXX[:XRK>8!G)'K[53G\+7MY*TU[>Q2RO+&S?)A2B@@C
M'XB@"=_%\4*3B>SD66%U38KJP)8$CYAQVJYIWB*&_NDMUMY8Y&9T.[!`*@$\
MCKU[5EW/A.?=/#9RPQVAE6:.-QD9P05/J.F/2F0>'M7T_9<VDL!FCE=E@.=F
MUL#`STX'\J`-6Y\2V]MIOVYX)-GGF`*",D@GG]*63Q+9I>/;[)&*P&X5QC:Z
M[=W'/I62GA:[NI+>'4)?]&CC=W\ML$RN23C]/RJ-/"MY)97*7'E^?&JK;2*W
M)V[A@^@((XH`OCQC;MY>W3=0/FY\O$8^?'7'/-6-1\40:=)&DUE=DNJL"$&,
MD=.3UJ&QT:[AN=$DD"`6<4BR_-W(P,>O6KGB"PGOX;-;=03%=)*V3C"C.?YT
M`4Y/&-G&P4VEV2%#2`(/W>?7GTYJ_>:[9VD-G,Q9X;M@J2+]U<]S6=>V6KPW
M.HI9VMO/#>\EW?!7Y0N,?A4%_H$[6NBV"IYT4+$3MP``<9/ZG%`&C+XITZWO
MY;2X,D3QMMW%,@G';&3WITWBC2X[#[8LQE0ML"HIW$@`G@XZ`YKFE\,ZD]]`
M+E9#FX<R722#<5P`#ZCH?SHG\/WL,<<9M[B989Y"\L+@22!E4!AGZ8(]J`.Q
MCU6RETXWZW"?9@"2YXQ_]>JK^)M(2&*9KQ=DN=IVL>G7C''XUDC2[O\`X0IK
M5[9OM"ONCC7`8?/P3V)QDUD'2]5CM3$VG&1KEF>681*7521\H[`\$_C0!W0U
M"U-Y':"93/)'YBJ.Z^N>E-FU2R@O4LY;A$N'`*H>^>G\JY);#68[V/58K9@(
M&2..!V_>^6!M(].023[T_65O=2NXG&B2QQ$J9V*!I'`/0'/`H`ZZ.^M99I(4
MN(VDB^^H;E:$O;61U2.YB=GSM"N#G'6N%CTC5`CQQVLT4T2S>;,%'[X-C`!/
M7O3UM[N![810R(XNX_LX>,12/A?GW8'3H,\]Z`.^HH'3FEH`2EHHH`*QO%__
M`"+-Y]%_]"%;&X;@N1DC.*Q_%W_(LWO^ZO\`Z$*`+VE0?9M+M8"VXQQ*N1WP
M*MU%;?\`'M%_N#^52T`%%%%`!1110`4444`%%%%`!1110`4QS)O38JE"3O).
M"!CMZ\T^B@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`2N:TWCQWJG_7%?Y)72US>GC'CS4O>W7^24`=+1110`4444`%)2T4
M`%%%%`!1110!1UG4/[*TR:]\KS?+V_)NQG+`=?QK$B\8MY2S7.DW44!&3*OS
M+[=0*O>,O^18O/\`@'_H:UEV]IKVHZ);VP>RAM)844G#;]F/3'7&/RH`ZJ*X
MBF@2='!CD`*MZYZ5)FO.]8A0:K]@C:\NX[2)$$-NN-F`,DGGG.#T[]>*CT^Z
MGO-,ATL7$D237A4N?O*N`<9[\_RH`](R,XSS17"Q6YT3Q%<A;F6=;6QDFC$C
M9P?0_G62;N^6%+T2ZF;G/F"1E_=$=\?X_I0!Z=(Z11L\C!449+$X`%8]OXJT
MF>Z,"SE3D!7=<*Q/H?\`'%:,L$>H:?Y5TA*2H-ZY(]\5R=\8=7:+0-'@46T+
M9:Y(+*N,G@_C^-`':T4"EH`2BEHH`2FF-2ZN5!9<@''(SUI]%`!1110`4444
M`)@9SWK(\6_\BU>_[J_^A"MBL7Q@Q7PS>8[A1_X\*`-6U.;:(_[`_E4M0VG_
M`!Z0_P"XO\JFH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$KFK.1%\=:B691_HZ
MC)..RUTM<_J7A*SU*^GNYYYA)*1PI&!A0/3VH`WHD$<8522!W)R:=7-1>#TB
M`5=4OE0#[JR8&>YJ,^$+CMKEW^.?\:`.IHKEO^$0N/\`H.7?Z_\`Q5.'A.Z4
MY&O7@/L3_P#%4`=/17,-X6U#/R^(;L#W+?\`Q5(?"^I8&WQ#=Y]RW_Q5`'44
M5SL>A:S%&B+X@D(1MPW0[C^))R?H:E_LO7?^@_\`^2JT`;M%<_-IGB)5/DZX
MCG'`>!5Y_(^]5O[/\6_]!6V_[Y'_`,10!T&HV4.HV4EK/N\N0#.TX/!S_2IK
M>%+>WC@CSLC4(N3V`P*YH:?XM!R=5MN#_='/_CE/^R>+/^@A9_\`?'_V-`%J
M]\+V5Y>S71EN(GF&'$3A0>GM[5D:KX9CL;()9V\UW"9P[JK?O$&,?+QS_P#J
MJVUMXN'2^LV_X#_]C2?9O%Y_Y?;,?@/_`(FD!3T#29)M7N+B2UNX;22W:)_M
M3Y=R<?CC%7O^$/0@VYU&Z-B>1;[NA^O_`-:D%MXOQ_Q^6?3N/_L:DC7Q9&`K
M/I\N3]YL\?D!3`U]0L3=Z7)9Q3-`64*KCDC&/\*P;?PKJ-G%Y5IK;Q1YSM6/
M'/YTK7'C!9&Q9VC`<#!&#[_>S3UO?%NWG3;0GUW#_P"*H`Z6-2D:JS%B``6/
M>G5S7VWQ9_T"[3_OL?\`Q5'VWQ9_T#+/_OO_`.RH`Z6BN9-[XM`S_9EF?H__
M`-E35U+Q7GYM(MR,'HP'_LU`'3TM<DVO>(H@1)HF2`>5#$<'';/^>:6/Q-J_
M_+70;CJ/NHW3OVH'8ZRBN;_X2:\_Z`%__P!\G_"F-XHO=R[=!O=O.[*G/X<4
M!8Z>BN:_X2B[_P"@#??]\G_"G)XGN#][0M0'TC)_I0%CHZP_&0)\,W>,?P9_
M[Z%1#Q/*>FB:E_WZK,\0ZQ=ZEI;6D&DWT9D8;C)">@.>,=\XH"QUMES90'_I
MFO\`*IZALU*V<*L"&$:@@]N*FH$%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4E+2$'/6@!:***`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`$HI:*`$I:**`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`*3(R1D9':EI*`%HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBDH`6BF1R)
M(I9&#`$KD>H."/SI]`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!24M)0`R.:.5Y$1@6B;:X]#@'^1%24E+0`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`55FU&SMY&CFN
M8D=`&96;!`)P#^9JU7+Z[X>O+_4WF@>'R+A%CE#Y!4*P/'KTH`V?[:TO87_M
M"VV@XSYHZU)+J=C"D3RWD"+*-T99P`P]1Z]:XJ3P9J11MHM0/,&$#M@@#KD\
M]^E7M5\.ZI?Z;ID.(!+;1M&X#8&.-OZ#F@#K?M$)C>3S4V(2&;/"XZYI&N8$
M9%>9%,GW06'S<9X_`5R::'KPTV;2_P#1%MY9"QE#-N'.?RXJ-?#>JIL\Z&RO
M-T0B)F9OW84\8Q@],4`=EY\()'FID+N(ST'K]*3SX?E_>I\_W?FZ_2N4T?PY
MJ%C:7\,HB9KFU*(P?E6Y^7/ISFJ!\):P8V4O"=Q+8W\`\8/3O_04`=[N4YP1
MQU]J7</6N3&A7T&C2VWE)-*;D22,)B#<(,]<]#VK*N/#.L&.62VB$<3@A;<S
M;F520=N>G7G\*`/0<CUHSFN.33=2DT86+V4L4]H6E@N%F4[WW'`Q]#^E;-M9
M7]C;6%O9&(01X-P)22[9/S8[=R:`-C(/>C(QFN#;2-8$MVUO%<1.TDC._F@"
M5"1A0/7KS5F'3+^?0KF"*"XMQ+>*8D=_FCC!'OVQ^E`'9TM><MI^N)')Y\=^
MSLS"(PN<"3=R2/[I&>:U]+T:YC@U&2XFO2ZQF-$:0\Y4'(]3GCB@#KZ2O.;:
MWU];Y/EO-P@)0C=M!\H[<YXSG`^M2:</$,;IB.\,9WE1,6Q]P@Y[YX&/>@#T
M*EKSZ*_U)=(N;5X]2:]E,9B;#?*`%SSVSS4<%SKWGW2L;TNP7<&!P&\Q>GH,
M$CB@#T6BN*@_M*?5[3SKF\3S;F19HUSL0(VX`'T/3/I7:T`%%%%`!1110`U=
M^6W`8S\N/2G444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`45
M6O[R.PLIKJ7)2)=Q`ZGVK!G\:V<,,,GV>5O-4M@$94@D8/Y4`=/17,R>,(Q:
M)=)8S&!Y#&KEEY(Y/&<],U!>^-5BV&ULFDC=F5'=MH?!`R!UQU_SF@#K:*YW
M5O%2:7JGV26U<J%W,^X#(QD8_'BH8O&]B\#2/!+'AU4`X.<]3^&*`.HHKG;C
MQ5'%+(8;.6>WBR'F4C&0N>/T_.F0>+X;BRFN4LYBL3I&5R,DMG'\OUH`Z6BN
M>L?%EO>?;`MO*C6L+3$,1R%ZCV-06WC*.[!%MI]Q(ZAG=01\JC'/ZT`=116%
M:^)H+K6O[-2!P26`D)&#@9Z5%/XNMK?+26EP(VW>4^!B7:<''/\`.@#HJ*Y-
M?'=DS86SN2?3Y?\`&K+^+8D@DG_L^[,$9VM)M&,\`CK[T`='16%:^)[>Z@MI
M4MY0+B<P*"1D'&<GGIS58^-+)9-KV\X_="3(`/50V/UZ]*`.FHKGXO%=O+I_
MVI;:?)F$"1#!9V(SV-1GQG8)O#Q3K(B@F,J`=V[!7KU%`'245B3>);6WM;:Y
MFAG2&<-\Q3[A7/RM[\5K6\PN+>.8(Z;U#;7&&'L10!+1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%(2
M`"2<`=Z6D90RE6`((P0>]`&!I/B4:IK<]G%&@@124D)Y;!`Z?B:9XC\0W&CW
ML,,<,3I(F[+D@Y!Y_I5F7POIKS22I&T#OMP83LV8_NXZ9[U8O;.UCO(]5N97
M7[+&PQG*@=SC&<T`58_%%EYD<,PD28@!]JDJCXSMSZ\5&GC'2V1G)F557=ED
MQNY`XYYZU'_8>E7FK/.EU*TDF+@Q*PVG.0&Z?6I9O"EC/;6D,SR-]E4JK#`+
M*>QXH`<_B[24F\LS.><;@AV]AG/I_@:?_P`)7I&2OVD[P=NT(Q).<<<5F/X%
MM7CC4WL^Y`0"0,8R3T^IIR^%;.>U,5IJ+%HKDR>8-KE6P`0<=\C-`$]KXNMI
M9XTG00QO&SF4MP,.5'YXK03Q%I;1"0W2H"S+A@0<KUX_$5A:EX6MDAA^U:N(
M`(O*W2*`'^8OW/O^E9VJ:$SW"II=W%>22M)*RB1`P5P.V>1CO0!VDFL6$-I#
M=37"QQ3@&,OD9XS52^\3Z79VXE\_SBP!5(^203C/./0U5N=`GU'0M/LWN3;/
M!&JR*!N!^4`CK6=_PA[7,2QIJ<7[I/)D"Q[N0Q8=^#R*`-H^*--%U%;B0L75
MF9AC$>T$G=^1Z5,OB+2'956_A)8X'/>L)_!<ZR?N=04)F3K",@.N#SWIMSX,
M$LT2PWZ))'$BLH3!..-W7V_2@#HCKNE@R@WL0,7WP3]WG'\ZD75K!K)[Q;J,
MVZ':T@/`/''ZC\ZY4^!KCRYV%^OF2*1M*<'G(R?P':M33/#CVOAZ[TZ>9':X
M+'(7A"0`#[]`:`+]QX@TN"!Y3=QL$)7:IR21U`J6VUC3[FV$\=W$(R<99@N#
MC..>]<E%X*O0'\Z6%_W;%`&.!(?PZ4NH>#]0DW+;/;^4"NU,D9^4`G]*=@N=
ME_:%D3@7<&<9QY@Z8SGKZ<U(EQ#)"98YHVC&<NK`CCKS7"IX,OC:W/F^4TY5
M!"0YP/[P/X<5J6/A^^M_#5]8[T6>X8E5#9`''&??%*P'2B[MVC\Q9XBF<;@X
MQGZTOVB'S/+\U-_]W<,_E7$)X4U%53?#`\(?+6OG$*3MQNSUZUGQZ3?/J<MM
M%&\MU%Y.;D,1Y/&#]1V_X#18#T*TU"UO(DDMYU=7)"]LD=>#5@.K,RA@67J`
M>17F\/A_7(;BV=+:3?&<JWF#"MN/)YZ=,UJ^$]/U2TUZ:2\@F1&B*NSMD$Y&
M.>__`.NBP'9LRHI9B`H&23T`J*VN[>\C,EM/',@.TLC!@#Z<5P[:7K<M[>+.
MMT04F+-YGR."ORA??-3:A;2:1X4T]+=KF&>>=&EV,5<L4.5_0#'M1J!W%%<%
M%8^(9X7\R2_B\J!VB_>G+G=PI]\9_2H\:Y'IDN]=3"B2,N2S>9@*VX@]EZ4:
M@>@T5Y[-)XB%[9B!;_8`/*$IY<9R=^./S[8JLEWXC73I)&:^$9*N)CNX'.>?
M3G]*-0T/2Z*XG[9J4OA6S>2:Y2X>\$7F`D,5Y'XUFP:OJZ6UP3=7#,L4BX;)
M*?,HSGU&3SVHU`](IK2QHZ(SJK/D*I/+?2O-K;6M5%CYBWDLTDC-;",N=PR`
M58>ISD9^E:OB:26Q.C)+=NLT*.QG*;CNP/SYXH`[:BN%37]8FUC3H2VQ'$)*
M>61Y@9?F;Z<G\O:I=<U_5[+Q(UK;DF+<FR+R@=X('3N<G-&H':T5YY!XDUEH
M9VDN?N%,E81F,EL$<C&<9_SFK-K?W$_B"PDO+R0A+B:!"(P,XV@9X[[L'TQ1
MJ!W"RQM(R*ZETQN4'D9Z9IU<";VZL_%%\EM<&-Y[I$*%`P8'//MC^M:VA:EJ
MFK/<"29(5MX3$YV`YFR?F^@':@#IO,02"/>N\C(7/./7%.KR^RN+N*Y2>VN]
MTMO!*^2F0.6X_'K^-;.D^(M7GUV"UNL!)&PR&+;@;<@YZ^]&H'77]C;ZC`(+
MI-\88/MSC)'K[52?PSH[DDV2#K]UF4?H:Y'Q.5?7+AS)<+*)$40[<;EP.58<
M?GZU(?%&N?:;H*L:B(/^Z91E,?J<4:@=5#X;TN&Y:9(",A@(]QV#(P2!ZD<4
MV;P[8%[816D0BCRK9=PP7D\$'^\>]8,.N:I<K;PP7\<DLLP3S!;8"_+D@YX.
M#Z5F_P!O:OJ>GW4,\V(Q&&=A&`0-P!''KG]*-0.TO/#VFWLWFS0$N5V$ACR,
M8&?<>M/N-"T^Z,/GP;TAC,<:$G:H]?KQUKCW\4ZBMRZ0W2R1)&RAO)"Y(4X;
MG)Y(JZ^L:Y;BS1Y8Y6U"%3`PC`V.2,Y]>#_*C4#<?PMH\C*SV@9E4+G<1G`Q
MDX/7WI1X9TQ;66V6)Q#*5)3S"0"N<$9Z=:S?$NLW^DRVL$,L0W1%GD>/.Y@.
MGMG^M4=$-Q=Z[JERT\FZ.)BJ+GJP[#/:@#?@\,:9;"Y$,3+]HB,1^<G:IZXS
M^=.N?#UE<"#!EA,2>43$^W>G]UO45P$&H7T3M.ER\DD\4@<B3)`QU(['C-:*
M>*=4@GBM8KB">,!4#^7P<@=\YR,_I0!UD?ANQBOTO8O-299#)D/UXQM^E0R^
M$M/FE+RO<,-VY$,F5CYR0H]#7)V'BK4K*VM[>(Q2(G]Y26.3T)S72>(_$%WI
M>H1PP>0$$'G-YO5^2-HYH`U'T*S>>[FVD-=1>4V,#:,8RO'!YJC-X.TN4O\`
MZ]%;D(CX5#QD@8[XJEX5N+W4]8O+VYG940`>1D[1NY''MBNNH`Q%\,62:>EF
MDMPHCE\V.02?.C8QP<5%)X/TR5@S&XR(Q&/WG0`8S_GBN@HH`P8O"MG%IK62
MS3X,HF63<`R,.XXJ%_!>G/DM+<ES@ERX))R23T[YKI**`,%?"\/V>6WEO;N6
M&1P^QV&%(;/''&>?SK=I:*`$I:**`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*H:Y')-HUW%$C2.\
M1554<DFK]%`'GMQHFLVB3FW21A%&B1R*2',>2Q`P>H.,_2K%OINNN;:%WNDC
MN%7SV9SF/:?7/!(KN:*-`U/,$_MXN_F?VB(R-[X+9`#<D?K3)8=4M[=?*CO8
MMS22,WS`N..6QZ<]:]2Q1@46079QGB>627^SVN-I22SE94(X\W9[]3R,"J_A
M>UECNK^Y9626&S0(-O<H/UX_6NSNK&VNVB:XA60PMOC)_A-6,"@#BO`U]>2W
M%U;7$DK@Q[U:3)VG.._U_2LNSN]0TJR)MY_*6;>XD6#<9'#;=A/;H3^->DX%
M-2)(UVHBJH[`8%&@:G`RZYKZ65Q=FY")'.("AB4E#C)[=NGXU437KPW(O!,D
M-S*D<+R;<X7)RV,8[#^E>DM%&P8-&I#<L".OUJK>Z38WT:I<VR.JD$`<=.!T
M^IHL@NSB8]?UJ82[=2CQ%`\VX1*=P#;<=.,UIZYK^H6NEZ3<0.D<ES$7D^4$
M9VJ>_P!371VVDV%I"8H;2)5*E3\N20>H)/)%33V=M<Q"*XMXI8UZ*Z@@4607
M9Q<_BC4S)YHDBBA>18_**Y*[D!SGV)K*M[^\,)EBO6600*LCF0Y&9NOUP1^!
MKT<Z?9L<FUA)W!^4'W@,`_6HUTG3E1T6QMPKXW`1C!QTS19!=F+H6LWU[J2V
M3&.5((W%Q(HX+!R%P?H!^9K.N/$D^D7U[#%&LX,\CG>Y.P9Q@`=.<_G75V6E
MVEA-/+;1;'G.9#N)SU_+J:)M(TZ=BTME`[$EB2@R2>M%D!SNO:O>I=:<]JXC
MCGM7D*[\#)7/7OC@CWJDGBBZBL(?.C8S0F+E9>9@RD_-P>./UKL+K2[&\\O[
M1:Q2>4,(&7[H]*B;0M,;.ZSB((5<$<?+D#]":+("A<>(I(]&L;Z*TWO=N(Q&
MSXP3GOCU%4?^$X427*FPE(C4E<,#R.#N]!GZUT1TNR,4$/V=/*MWWQH.BGGG
M]:JS>&]*FEFD>T3=,,,1QCW'H:+`9UMXN6YC,B6C[5@DE;+#@KCCZ<UFCQ)>
M7%VYC19+:9_W9=03$1'D@>^3^A]:W)?">ER6\4(CD18\X*/@MGKGUZ"AO">F
M&,(JRH!(9!MD(()`&![<46`I:;XI*6,(OH9I'"IYLZ*-HW'@GG\^.QK1TKQ#
M#JMSY,-M.@*&0.X`#*#CCGUHB\-:?#'Y<8D5-\;E0_!*=,_S-&C^'H=(N9)H
M[B63<NQ5?HBYS@46`IMXUTM6=6CN,H<?<'/...:AO/%SK+LMK-U412$F=<$,
MHZ8!]OU%7&\'Z4S3'9(/-.?O?=YSQ4MSX9L;EV=VF!8R$[7QG?U[>U%O,#/M
MO&$6]OMUM)'&%7;(J_*6V;B.?T^HJSJVOK9:?97L-OF.Y;Y@ZX8+C)X]:AU'
MPDEQY,=O<,D&Y#*CG/"KM!7CKBM;4=&M=2ABBG#;8@0H4XQE<46`S[/4M*U6
M<W*6$IGM(O-7=%AL'IMYY/I6=9^,_.N";RR(MPA8LB%BOS8!/M[^M=#IVC6V
MFS/+`9"S1I$=QSPHP*I1^$M/C25%DN,2)Y;?./N[MV.GK1\P)K/Q!IMYJ36,
M+-YZY`++@''4"H3XJTGSIU9G'D@X<IPY'4+ZGFI=/\,V&G7OVN'S6E&<;V!`
MS^%0MX1TYED0O<>6[,VP2<`G'(X]AU]*+>8"CQ1I8*JRS([$[HS$=R8P?F'T
M.?P-)_PE6D$_*SM\ZKQ&>=PSGZ<<T]?"]B+DW#/.\S;@SL_+;EV\\>E)!X4T
MZ!U9?.)6-H^7Z@@C/UP31;S`:_B?09HG62?<C#:V8FYR#QT^M5&U[3+#3)(]
M"$;-%AS&R.!@L`3D]\D5:M?"&G6L\<J-.3&ZN`S#&5Z=JC'@O3Q*\@N+L,YR
M<./7/I1;S`MOXDTJ,O\`O"2N\';&<$J,L`<8-12^)+4/')&I$"RK',TBE64,
MN58#T-,7P?8@$&>Y=3OPK.,`N,$].N*=J'AT7)CCBD(@>1&G#-R51=JA>*+>
M8&GI]];ZI;_:(%;8'*@NN.0>M6O+3).T<]>*AM+8VT90S22Y8ME\9&>W`'%6
M*`&A%'10*-B_W13J*`&^6G]T?E6>VB6CZNFI,&,L:A47/RKCOCUK2HH`CDAB
MEV^9&K[3N7<,X/K3E1%)*J!DY.!U-.HH`A2UMX]VR"-=PPV%`S]:2.SMH4V1
M6\2+QPJ`#CI4]%%P*O\`9MC\O^B0?(VY?W8X/J/?@4^:RM;B1))[>*1T^ZSH
M"5^E3T47"Q%';PPN[Q1(C2'+E1@L??UI5,OFN&51&,;2#R?7(J2B@!*6BB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HI*`0>AH`6BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`2EHH
MH`***RM5O;R"\MK>S^SJ94=V>?.`%V^GUH`U:*PQ=ZN8//6?2#"3CS-[[?SI
MT4VO31+)$=+>-ERK*SD-0!M45B+)XD*,QATX$9PNY\FH/MOB7>ZKI]G(%_B6
M7@G/UH`Z*BN;&JZ^I97TNV)7DXN5&!CZ_2G1:MKKL`-)@?N0ETN<9^M`'145
M1AO+N109-.DB)?:09$.!C.[@^O%5SJFH`A3HLVXC.//C_P`:`-:BLH:EJ.>=
M$G_[_1_XT?VEJ/\`T!)O^_T?^-`&K160-8N=BLVC7H!!/&PGCVSGM^--&NR;
M4;^R-1&]BN/*&1C'7GW_`$H`V:*PAXE.#G2-4&/^G?\`^O3U\0DQRO\`V5J0
M\L`X,'+9(''/O^E`&U16,WB%%$F=.U'*$`@09S[]:D77K0D9BNU4@G<;63''
MX4`:M%4XM2MY?.V";]R,ONA<?ED<_A44FM6D;NK>?E&VG%O(>?RYZ4`:-%9G
M]O6.<?Z1_P"`TG_Q-)_;]B>GVG_P%D_^)H`U**S/[>L?^GG_`,!9/_B:#KUD
M!G%STS_QZR?_`!-`&G169_;UB-N?M`WYVYMI.<?\!H.NV*@D_:`!R2;:3_XF
M@#3HK'3Q1I$C!8[HLQZ*(W)/T&.:63Q)ID3%9)948#)#02#`]>10!KT5G2ZY
MID*!FO82"0/D;<>>G`JM_P`)7H^0#=,,],Q/_A0!M45C)XHT=V91>!2HR=R,
MO\Q5J;6M-@N!!+>P))G!4N..,\^E`%^BJ*ZQIK*66_MB!U(D'IG^0-,M]<TR
MZN#!#>Q-(#C&<9/3CU_"@#1HK+7Q#I3M,%O$/DJ6<X.``<=>_7M6A#*D\*2Q
MG<CJ&4^H/(H`DHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`$IL<21;MBA=S%CCN3U-/HH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#/UV]%AI-Q-N
M(D*%8@.I<\+C\:XHZYJ]O9PQ"Y(E@DE#"4$.P"[E+9^IQ]!7?7-G;W?E?:(E
MD\IQ(F>S#O4%UI%A>2&2YMDD=L`D]\`@?S-`'+VWB369+>.0"S:*21;=9'RO
M[PIG)YZ5KSRO_:&FR72I+(+.=I%A&X-]S(`[U?&AZ:+06HM(_(#E]G/WB,9^
MN#3+C0[64P-&TULUNGEHT#[2%]*`.$FBU!M,GA^RS+:O+]H51"<[SE=OT&,_
M@/6GW-WJ'V62&-;[R&!4Q[6"H@*D8R..`PKM?[$.3C4]1Z8_U_Z]*;_838'_
M`!-M2_[_``Y_2@#(T2]_LWPU>W+)="02MM64$DDXVX_3/XU#X?U-M!:ZL]7+
MH#B56"E\E@,\@>X_6MHZ!-O4C6=1V8.09>3Z<XILVA7K1E(=:NT&00S'<W&>
M^1ZC\J`,C7U6;Q%$;%(_M"6S2M&T?^N_V3ZY7-8%K=26,J-!((/-B"LZ+DP(
MTA/X\8_.NR&A:H')_MV9E*LHS&,C(ZYSZ\TZ/1=46-E?6G<GC)A'3!&.ON#^
M%`'/Q^)K^UV%KG[1L8*(S"09X_F_>9[=ORJNOB*[8K?SRQ_:4BD2+]T.#N3W
MYR,_3!KKC8:NL@,>I0$$`'?;@X.`#CGOR<>]-:PUKC%_:$#UM?\`Z]`$GAG4
MI-5T=+B=E,P9D?:,<@_X$5KUC"SUQ1A=0M`/:V_^O3UM]<'6^LSSWMS_`/%4
M`:M%90AUW(!N[''<^0V?_0J22/7U0F.XL';L#$P_7=0!K45CLGB%67;-I[CG
M(,;CM]?6FL?$B+\JZ=(2!_?&#WH`VJ*QTD\1!U\RWT]E[A9&![__`%J<)M>&
MS-I9ME#NQ*1AL4`:U%9,USK:R/Y5E;.FYPF9<''&TG]<BB.[UH8\W3(#QSMN
M,9.?I0!K45F_;-6_Z!4?_@4/_B:>]UJ2R$)IT;+GAOM`&?TH`OT5FF[U7'_(
M+C_\"A_\32_:M5R/^)9%CO\`Z5_]C0!HT5G-=:J!D:;$W7@7/_V-,>_U17"#
M20QP"6%P-HR<>GXT`:>U1V'Y4N`>U937VK!R/[)0@#.1<C'?CI[?J*8=3U4/
ML&B,>,AA<+C..E`&OM7.=H_*@HI.2H)]Q62-2U42*'T5MK=UG4XXXS^?Z&B/
M4M5>"21M&*,HRJ&<9;]*`-8HAZJI_"@QH3DHI/TK'.K:H2HCT.7)`R7F50#W
M]>/>D_M?4PK;M"GW+D@"52"![T`;`C0=$7\J41H#D(H/TK"_MO5@,GP_-^$P
M/]*GDU3450%-&E<[F4KYJC`&,'\<G\J`-4QI@@HN#UXZU%8RM-;"1_+Y9L&,
MY4KDXY^F*Q_[=U3'_(O7&<9_U@_PK0T*WEM-&M89U"R*GS*!C&><?7GF@#0H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`I"<`D]J6B
M@!J,'0,,X(R,C%.HHH`****`"BBB@`HHHH`2FM(B,JLZAG.%!/)/7BJ6N_:?
M[&NOL>[S_+.W:#GWQCOC.*XPP:E<(\ZKJHBMF5E\QF,I+$`[>.R@_3-`'H59
M%[J>HQWDT5EIPNHXBJL?-"G)&>A[8Q67X9>^:_`OEU+A&\LS?<*9XW?[76GZ
MGJ%]IUYJ%S9QQR(L\2.C`DME!TP?<4`:":IJF")-%DW"/(*S(07].O3W_2FQ
M:MJKK(7T.1"J@J/.4[CD9'Y$D>N*R#XLO9KQH;.&"7S@@@!."C,.0W/8@TC^
M(M:6Z6T"V#S>>(=RDD$GIQG(Z&@#;BU:^V?O]%NU;T1D88^N14[:C.ID']F7
M9V="-GS<XX^;\:T!G'/6EH`R_P"UKC'_`""+[\D_^*H_M:?&?[(OOR3_`.*K
M4HH`RIM:\DH'TZ_)=0WRP[L9['!ZTV/7DDECC_L_4%,C!06MR`/<G/2M>B@#
M&;Q#$N[-AJ.00/\`CV/-.7Q#:^5OD@O(\@D![=LG'TK7HH`S1KM@<?--SV^S
MR?\`Q--&OV!SDSK@XYMWY]^E:E%`&=_;EAL9_,E"J0#F!^_3M[4DFO:=$Y1Y
MW##J/*?_``K1HH`H#6M/)XN/S1A_2B76M.AV^;=(FY=XW9'&<9_.K]-:-&.6
M12<8R1VH`S?^$CTC_G_B_6E3Q%I#G`OX?Q./YU?-M`W6&,_513!8V@SBUA&>
MO[L>N?Y\T`5%\0:0W34+?IGE\4_^W-+W;1J%N6)Q@2"I_P"S[+_GT@Z8_P!6
M.GI2#3K(,&%G;A@<@B)<Y_*@!C:MIRIO:^MPOKYJ_P"-2-J%FF-]W`N0",R`
M9!Z'K2?V;8_\^=O_`-^E_P`*=)8VDK!I+6%R!@%HP<#TH`9_:=@3@7MMG_KJ
MO^-']IV'_/[;?]_5_P`:4:;8@@BRMP1Z1+_A0--L0"!9V^#_`-,E_P`*`#^T
M;$D`7EOST_>K_C2_;[/;N^U08ZY\P4?V?9`@BT@R.A\M>/TH_L^S_P"?2#IC
M_5CI0`U-3L),[+RW.#@_O!UI_P!NM/\`GZA_[^"F?V98'_ERM_\`OTO^%(-)
MT\>9BRM_WARV8QS0!(+VU()%S#@=3O'%)]OL_P#GZ@_[^"D_LVQPP^QP8?&X
M>6.<=,_2F#2--`P+"VY_Z9+_`(4`2_;[/_GZ@_[^"D_M"S_Y^X/^_@_QJ,:1
MIHZ6%KR,?ZI?\*7^R=.QC[!:_P#?I?\`"@"1;VU=@JW,+$\`"0&IZR=2TRRC
ML]T%G`DGF1[2L8!SO7O6M0`M%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M)2T4`,C+DOO50`WRX.<CUI]%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`5R6IQ6MU/?F[OWL42[3#*WWF$:X_Q_"NMKC]02[GEU2.QL5GF:ZPLA56
M$?[M03SW-`#[O2M$>:25[X1R:@Z20%."I]1CU+=_6H4TO3#++*-<D::VE$TS
MM@D%>!G/IS^=4XM'U>'48G6TG5E\K!24;1$O#*3W)P./K37TB],<DL=C<QZ<
MTRD6V<S#@C=Z\'G'_P"NF!W$=_:R60O$G0VY!/F$X&!U_E3K6[M[R,R6LR3(
M#C<C9&?2N2NK'44T;19);>2Z^SONGM]N2<GC(]0.*KW*7]WJ4DFGVVHV"R!W
M"C<JNX&02.@S@C\J0'=T5YQ=-KHB40?VMY6Y<AMV_=M&[GKC/3M^51I+K`G0
M75SJD0DD*@C>"W!/"^O';UH`]+I`ZL2`P)'4`]*\U-[KK>?)</J2;8L$H&`5
M@`1GT]^]3Z-/)%KZ%KRX6WFE0><$SY[@`!6/_`C^>?>@#T,.A8J&4L.HSS2U
MP&KS6R>*I9#(L<,4\;RO&OSKA<'\">#4%WX@U")KH0W\KAR=^4QY6&(`4]LK
M@T`>C9`[T9'K7F\6L7.LWVFB\F0F.[C`C"8)!(RV:N:Y=D>)I9X'!>#:@3J^
MX`D8'<9QF@#O**X'^W+O4H[4/>6X*S1$[EPZ/R"0.X'6FZ'XAU);ZPLVNA+%
M(P#!URW+$8)ZYH`]`HKE?$4Y@U"^:WF9)_[/S\K\@[QT].*PI=0F,DZ#4;D6
ML43?9Y!(WSR`+D9SSR:`/1Z6HK<LUO$6^\4!/UQ4M`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110!0UEE%AAB1NEB48ZY+K5ZL_60#;V^1G_2H?\`T,5H
M4`+1110`4444`%%%%`"$X!)Z"D1Q(BNIRK#(^E+10`M%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5R$][<6;W45O,EN
M;G5&C:9USL!1>?2NOK#TZTM[W^U8;F))8S?,=K#.#M6@#,?5M4TRYN(C=6^J
M*(C,#N"%%7[W3OST]J9/XQO8+?SWTZ,1E]BGS>IQGT]"*Z`Z#I1C$9L8-H8L
M!M[GK0=!TLH4-C#M+;R-O>BP&`?$]Y9O)+/%YMM)*VQC\NP;`P3Z\XYIEOK>
MM3WWE,$MM\[($=-VP^7D#/IT/X]:Z/\`L/3?LS6RVJ+$S*S*O&2.E5Y?"^ES
M3O-)"Q=Y#(3O(Y/7\*`,_1_%#W=U:6<EN[EHE\VXZ`.5W=,59UN+=K>D.$A8
M-(0&8-E<?-D8(';TI)_"&G_9W6U5HY3&45F8D9.>2.YYQ4UQX8LKFVM897G_
M`-&38K*^"10`S2?$":EK-W9!`$C&8F'.X`X8G\<8]JBGU>_'B"2PBMHE18RT
M(E!!F('9N@_+M5I/#-@C6C(95-K]PAL;N<_-QS22^&;*:XGG>2YWS9SB3[N2
M"=OITQ]*`,TZWJ`L9+A[:S=8I&C=\D"<@@;4'7/OSTJW:ZY'=ZU-9Q6\9ACA
M9W?KN<$9`]1S3%\&6`^4W%V8E.43S!A3Z]*NCP_:Q3O+;8@)MC;KM4?*3_'G
MUH`FT69;_2[>\DMXXWD&["KTY.,5>\J/?O\`+7?_`'L<U6TJR.G:=#:&5IO*
M&`[#!QGC\NE7*`(?LT&[=Y$>0<YVCK0MK;K)O6",.#G<$&:FHH`C,$1D+F)"
MY&"Q49(]*;]EM\*/(BPIRHV#CZ5-10`E+110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`9^L9\FV`ZFZAX]?G!_D,_A5^J&KEE6T*_\_48/';-7Z`%H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$IL
M<L<H)C=7"L5)4YP1P13J``.@Q0`M%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`)63H3AI]5VD$"
M];D>NU:UJRM"">9J3)G)O7W9/?`H`UJ***`"HYIHX$#RMM4L%!QGDG`_6I*2
M@`I:2EH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`*.J'"VW`/\`I$?7ZU=JEJGW+;'7[3'_`#J[0`M%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`E16UPER
MCM'T21HS]5.#_*I:@L[86L3H#DO(\A/NS$_UH`L4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`"&EHHH`
M2LS0T5?M[*RL'O9#@=CP,'\JTZAMK2&U\SR$V"1S(PR<;CU-`$]%130^<%&]
MTP<_(V,\$?U_E1!$88]A=GP2<L<GDYQ^'2@"6BJMW:/<,"ES-"0I'[L\'((S
M]1G/X59`P,4`+112,-RD9(R,9%`"T54OK>YN(T6VNS;$-EF"!MP].>E6J`%H
MID@9HV"-M8@@-C.#ZT1!UB42,'<`!F`QD^N*`'T45',LC1,(G"/V8C./PH`D
MHI*BN?/V)]GV[O,7=N_NY&[],T`344R4N(G,:AG`.U2<`GMS1$7,2&10LA4;
M@#D`]Z`'T5"C3&.0O&JN&8(`V01V/MFHS+=^3;L+93([*)5\S_5CN0<<XH`M
M44E0B2X^VM&85%N$R)=_);/3']:`)Z***`"BDJ"W>X>283PK&BMB,A\EQZD=
MJ`+%%%,D+A"44,WH3B@!]%(>E1V[2O!&T\8CE*@L@;(4^F>]`$M%%(<X..M`
M"T5FV%Y?W+)]HT[[,A!W%I02".V,<YJ[YK?:?*\I]NW=YG&W.>GKF@#.UW_6
MZ7V_TY/_`$%JU:HZI;2W+V)B4$0W*R/DXPH##^HJ]0`M%%17(E:VE%NRK,4.
MPMT#8XS^-`$M%-0,$4.06QR1ZTZ@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HI*AM&B:)C#OV^8X._.<[CGKVSGV]*`)Z***`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*S]=OVTS2+B[3&]%PN>F2<#
M^=:%0W=K#>VSV]P@>)QAE-`&7X7U275=-:>XDC>02%2$4KMX'%<^/%VIF_>U
MC%M)B4HN8F#/@^QKI;3P]IEG-'+;V^QX\E3O8_GSS41\*Z093+]G?S"VXMYS
MYSZ]:`,"'QCJ221/=6T(A9/-.Q3EDS@8YXY]:T7\;62Q1.()69]V]!C,>#CF
MM"3PSI4D81K<X6(1`[SD*#D=^N:@7P?I0C5625F"X+^806YSSB@#+E\9W6]#
M'8E5$SJZLI)**`3CT;&<^E:4OC#3(I"K&0@*#N5,C)&=OUJ5?"NG+>BX_>L-
MS.8V<E22.33+KPEI\U@EG"9($20R94Y))&.<T`6Y]>LK;3;>_F9A#<8"[5R<
MD9Q^AK+T[QG9R1*+YO+E9CMV(<;<X!K4N="MI]/MK-7EB2V=7C9&^8$>_P")
MK,?P39-)$ZW,ZE.O(.[DG/Z_I0`ZQ\8V3P,]\3;MYC*H",<@8YZ=>>E:M]K5
MAI\,,US-M2;F,A2V[C/:LB3P5:O(S_;+@9+';\N`&Z@<5>O]`6YAM!!</#+:
M1F.-]H;(*XY!H`KV7B=-0UT6-K")(-I;S]V/X<]"/7BK"^*-(82G[6!Y0RV5
M(]N..?PIF@^'DT:XN9$E+K*J*H/48'/ZUEOX-F99D%XH0?ZC"<C!)&X]^M`&
MP?$^D+%%*UVH64$K\ISQP<C'%65UG3F3<+N+&Y4Z]VP1_,5A-X0D9]S7@<O'
M()"4Q\[#J`.U)_PA@EN4>>X7RQ;+&0J\[PFW=_6@#>_MG3=I;[;!M#!,[QUJ
M'4==M+2PFN8)([HQ`$I%(">3C)]!S7/1>!YD>%WNHWVR@NI4X*CM]::?`USO
MN2+R-0_"!5QD;L\^GX4`=7%JMC(@87<(.S>59P"H]QVJ:WN[:Z#&WGBE"]=C
MAL?E7*77A*]EN9VCGM@CO(RL5._#`C!..1S5[1_#LVG3S,7A,<EJL)"`@[@!
MDY_/]*`-.RUJRO!*4E"".4Q`N0-Y&.5YY'-69+VUC61GN(QY2EG&X$J!UR*X
MVW\+7MQI\:/'#%(D;PD3`\'>6#KCV.*C3PIJ-S)=*RQP@RN1,V=S]<#']TYS
M0!U=GKNGWA(CFVE45SYGRX!QCGIWQ6@)$8X#J>,\'MZUQ,/A?5%M-KI;922)
M_)+?+*%!SN_/^=(OA._6*X\Z.*=VM]D(#X\MMV>/IS_*@#M;BXAMH6FGD6.-
M/O,QX%,M+ZVO83+:S)+&#@LIZ'&?ZUPX\-:W"UVBPQ2)-&8\B7`^\#GGZ=ZO
MZ)873Z?K:")E:5/(1">KJA#'\3WH`ZNVN8;N$36\JR1G(#*<BGRRQPQ-)*ZH
MBC+,QP`*X?3M'N;VQBGME>)XQ"B$.4P0Q\PX]>E13>&M=>UDBY8Y)D)GSY_/
M'!].3SZT:@=V;B(&(&109>(^?O<9X_"I*Y&^T2ZDM=*>WM)%N((BK!9P/+..
M#G/]XYX]*LZ!I^HVEO>>;'+%(\"*GF3;\R`-DC!X'2@#I:*\Y.F^(X%=IEOF
M=\%#'-NP^<Y.">,9JS%:ZXTUH8(+U&C4`&23"AP3O+9Z@YX]NE&H'>TR::*"
M,R32+&@ZLQP!7G*VWB7[+>!A=[?E,@;.YCG^'^N*=?6.M3V44=[%=W+&`&%5
M4XC.[G?QR<?CS1J!Z*9$7&YU&>F32B1"VT.I8=L\UQGBS2KR]GT]+2U9V,/E
ME@.%P0>?[OUIN@:;>0>(U:2VE!A,OG3MG;*#]W!/6@#LWGBCD2-Y$5Y,A%)P
M6QUQZT^N`U.WU>?5I2D5W)+;RS2(^T[%4J-FWCKQ_*JG]HZ_;[#-/=1R2/Y2
M1S`C=D$9'T)'YBC4#TJ@D`9)P*XJQ_MY/%"6\LMVUJCG<SYV%<>O2HM<DUI]
M:O(8DOFM2C*$3.TC9VXQ0!VT-Q#."898Y`"1\K`U)7G$FFW^G?9Y-.M[V*62
MS5I/+!^]N^8'\!TJ[HT.LWU_:K=RZA"D9:1VDW!64$87ZY!_"@#N&D1?O.HQ
MZFG5Y_K>F:A)XDN%1;IHIY(R)%0LH''7Z<T7<WB>*(*C7C*LDBAA&=QP1C/'
M3T_&@#T"@L%&20!TYKD?$=SK,$%E]G^U>:8?WA@7Y0_&<\$^O^<UF-_;-S93
MW%Z]^5CN(_W`0C*[LY`QVP*`/0`RMG#`X.#@]*4$'H17GOFZC9E#`FHP6TDT
MKLR19D;D8W`]3TZ^]5WEURT\_P"QPW422W4CEA$=S=,9XZ<_3K19@>E45Q.C
MWOB"?Q*JW:W"P%F\Q"N$48[=NN*9>WVO#7+U81=B`>:$`C)'"';CCUQ0!W-&
M:\]N+_Q)$+0+-<EIDWG,.-IR1M/'L#^-7O%5G)/K4)EEE,?V9W"JI/*CD#'K
MQ0!VF:*\LM[W5+)98M.^T`,REV"$G@8Q[<Y_*K\U]J5U=6BWLTL<J7$&VWV<
M'@?/GUY''^U0!Z)2TE+0`4444`%%%%`!1110`4444`%%%%`!1110`4444`)5
M+2)9)K`22N79I).3V^<X'X=*NGI6;X>!&CPY!!+.2#USO-`&G1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`E5+S5+*Q<)=W,<+,,@
M.<9%6ZY_7M`GU75(9TFBCB2(QMO3><G/('3O0!I_VOI^2/M<602I^;H0,_R!
MIBZ[I;E`M_`2YVJ-_4UDCPFPD?%^?*<[BIB&<["H.<_[1JJ_@5&DC87NT(JC
M`A')'4]>_OF@#HDUK3I`2EY"0$+GYOX1U-..KZ>((YC>0".3[C%P-W../QKG
M3X,D<.CWX\L(R0A8_N`MN]>G7\Z+;P0(D=9[M9@8G1`8^$8]&Z]NM`&^FM:=
M(]PJ72$VP)EZX4#W[_A4UIJ-I>P">VG1XR<9SCG\:Q],\+I8_;%DDCEBN8PF
MWR\8QWZ^O-9X\#L%"_:XN$"[A$0P^;.1\W7M0!T=UK-A9W8MKBX$<Q3>%(/(
MY[X]C55_%.C1L`UX`2`?N-T(!';T-0:YX:_M:[6X^TM&4A\M>,X.<YZ^YJC<
M^"O/$I6\VL8XD3"X7Y5"G(SSG&?:@#:C\0Z7+>BS2Z!G+[`NUOO>F<8JP^JV
M4=^+)[A%N3TC/!Z9KE[?PIJ%OKT=T)H3"DHD,F,$C@D;>Q[5/J?AJ[O?$AO$
M,:VQ9'8[CN)4#CVH`VX]>TN6&65+R,I#CS#S\N3@?K5N.[MY;07:2J8"N_S"
M<#'K7$Q^%-5=9(REM;^<P#R(YR$_NXZ8R![UJ0Z9JUII(TP6]K=6^7#;Y"N5
M/(QCISF@#;CU>PELWNTNHV@C^^^?NTYM5TY20U];*0,D&4<5QQ\(ZO+9.C26
M\;&0NR*3\_`QR...<#MD^M.DT*]M9'N+NUCFCB68O)&>9MR;54*.1@_E0!VI
MNK<)$YFC"RD",[AA\],>M2USL'A]=1T+38M0:6.2W3.$^4C/8Y'H!6E&)1KD
MN5N/*,"X8M^[SGL.QH`+O5&MI71+"ZN-A`)A4$9(SZ_3\ZK_`-O-N(.DZD`,
M9/D_3W]ZYS69[A]69H%>*]CN7,<B(VV150;0?4Y&*J/K5Y%J,^H*&-S(JA$*
M,513U';G`7]:`.S77(F)S97ZC/!-LW/'THBUN)XPSVE]$W=6M7)'Y`BN8A\2
MZU);M.1"(E=$?$+%DS_%C/(X(ZTFC>(+W^V$-QY9CO)5C?.[*D``8ST&3^M`
M'6#6(#_RPO/_``%D_P#B:1=9M2Y3R[H-@M@VT@Z#/I[5C?;O+\7^6+V26-DD
M5TW<0D#/(QC''7KZU/X;U9&L[>"ZN6FN+B27RV;DD*>Y[4`7_P"W;/C]W=<]
M/]%D_P#B:D@UBTN&41><P;.UO(?!P,]<5RFLZS>6FJW4=KJ32@;E9-G^KSV7
M'=1G)JO/JMXAG%OJ<S01!C;2'`:=MR`KCOC)H`[,:S9GO,.">;>0=.O\-1/X
MBTQ/+WSNOF<IF%_F^G'-87AG5+Z\UZ2*ZN)'1HW/EM@!2&`QM_A[UV&Q3C*C
MCIQTH`S!XBTLY_TDY&>#&_;KV[4V+Q-HTL@1;Z,$_P![*C\R,5J&-"02BG&>
MWK3#:6QZV\1_X`*`*46O:9,SB*Z5]BLQVJ2,+U[46NO:9=RB*WNEDD(+!0IS
M@=>U7U@B082)%'/10.M(EM!&^](8U;^\J@&@"BFOZ7()"EVC"-=S$`],9].:
M637=,B$K->1XBP'(YP3G`X[\'BKRP0J"%B0`]0%%(;>$YS#'\W)^4<T`9G_"
M3Z-@'[='SST/^%#ZSH4URGF75JTL1.QF(^4\9P3_`)-:0M+<=+>+_O@4?9;?
M_GA%_P!\"@#+/BK10,_;5_!&_P`*?_PDVC?\_P!%UQW]_;V_EZUH_9K?_GA'
M_P!\"C[);9S]GBSG/W!0!FIXGT:3&+Z,<@?,".OU'ZU-+KVE0XWW\'(SP^>,
M9[5;^QVW_/O%_P!\"C[);<?Z/%QC'R#C'2@"M_;>E?\`01M?^_HIRZQIC?=O
M[8_24?Y[&I3869ZVD!_[9BE%C:*<K:PCZ1B@"'^V-,Y_XF%KQ_TU7_&E75M-
M8$B_M2`,G]ZO'Z^XJ3[!9_\`/I!_W[%*+*T&<6T(R,'$8YH`B_M;3?\`G_M?
M^_R_XTY-3T]\[+VV;`+'$JG`'4]:<VGV3?>M(#]8Q0MA9HY=+2!688)$8!(]
M*`(O[7TS_H(6O_?Y?\:4:MIK'`O[4G_KJO\`C2_V5IW_`#X6O_?E?\*4:9IX
MSBQMN?\`IDO^%`P74]/8X6]MB?:5?\:#J%@2";NVR.A\Q?\`&F/H^FR,"UC;
MY`Q_JQ_GM3O[*T_G_0;;G_IDO^%`ARW]CGY;NWS[2+2"\L)&`%S;LW&/G4GM
MC^GZ5`N@Z4DBNMC"&7I\OMBJ.LZ;86B02P6<<<LEU"NZ-.GS@_ATH`WZ6DI:
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@!#TJO8;/LJ^6K(N6P'.3U-
M6#TJO82^=:)+QA\D8STR<=>>E`%FBBB@`HHHH`****`"BBB@`HHHH`2BFR1K
M+&T;Y*L"#@XX-$,20PI%&"$0!5!.>!0`^BBB@`HHHH`****`"BBB@`HHHH`*
M*8C.7D#)M`;"G.=PP.?;G(_"GT`%%%%`!1110`4444`%%%%`!1110`4E+10`
ME%+10!6M+..T\_RRQ\Z5I6R>Y_\`U56ETN62=Y!JEZ@8Y"*5VK[#Y:TJ*`(V
MC+2QN)&`3.4&,-GUIES;":%T1O*<])%494^O-3T4`4;6REC9'N)DGDVNKMY0
M!<$Y&?H,C\:KSZ076V>%XH;B!OE=(\*%)RP"]`2.,UK44`59K-#N:"*W25S\
M[M$#N7/S`_442V:>5&+>*!'B.8RT8(3GG`&,<5:HH`I6UD8;@SDQ!W7$@CB"
MAVSPQ/7IQUJ[110`5&_F^8FS;LR=^>O3C'XU)10!'-YNS]QLWY'W\XQGGI[5
M)110`C9VG;C..,TV'S/*3SBIDP-VWIGOBGT4`1R^84_<E0V1]X<8SS^F:9&+
MGSSYC1&+G`4'=VQ_[-^E3T4`)2T44`%0*UQ]L=61/LVP%6!^;=GD$>G2IZ*`
M(F,WVB,*J&'!WDGD'C&/UJ2EHH`*A=YA+A8E:/CYB^#UYXQZ5-10`R,N5)=0
MIR>`<\9X/Y4^BB@"-FD$J*L>4(.YMV-OIQWHB=G#%D*$,0,GJ,]:DI*``Y`.
M!D]A4/FW&(/]'^__`*SYQ^[X_7GBIZ*`$8D*2!DXX'K6;?Q3W]O8LL&W%Q')
M+'(V-JCD]#S@XK2HH`*6BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`0]*J:48&TV`VT310E?D1NH%6STJII+(^F6[Q0^0C("L><[10!<HHHH`****
M`"BBB@`HHHH`***2@!:*2EH`****`"BBB@`HHHH`2HS<0B41&6,2'HA89/X5
M)7"ZGIFH1>*'NDM))XVE64,L0<;0.1['C`H`[EF5%W.P4#N3BFB:([<2(=QP
M,,.:Y_Q#]IU7PT##8SAW<$Q,,.H!ZX[]N*Y&'2]5M/+G^R2P^69'\UD(VC;W
M].E`'J-+7F5C=:C>7)BM+S4''[LD%R6&2-QXXQ4EUJ>MP6]K&9;T2_,1D$;B
M&.0>,G@#Z4`>D`@D@'I2UYI:WUU8:@9!<71C6^Q.!GYQ].Y.&X]A4T5UKFUY
MH[V['D6PN,2J</\`-R.>HP3]<4`>BT5Y@WB#6QI\9\Z<1^8<3%?O'KMW8^O%
M=C%J.K1:-93BQ^VS2INEVL$*]QQCTH`WJ*X_Q-K.IV-]!]F<1#[-YCQL`PR3
M@_7'%4;'Q3>QS*+N[C:+SQO;9T4@DC\#Q0!WU%>;+XSU<,F6B;U'E_>YJ_IM
MY<S>&-8,]X9)%RP7HZ$GDGT!]/8T`=U17GJ>)]3MM/,2/%+L$*I,!D)E2<'/
M4\?F#6O/XCO%\)P:BJQ"XED\OIQU/./PH`ZNBO.V\47BRVE_(0[B)E,:L50_
M-C)'T/\`*M:/Q7>32F&&WM9)#,(DQ*=K9!.<_@/SH`ZZBN*F\<3QF`"SC.]`
MS_,>#DCC\J?8:Y?:GXCL@0((,RIY8;.[`SR/7@<T`=E17'7WB*_TS5[XM&L]
MHDL<8#,%\LE<\=SGG\J</&<TBJ(+%9)!&#+F3:%;=C;R/\_A0!U]%-0L44L,
M,1R/0TZ@`HHHH`****`"BBB@`HI*6@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*2EHH`****`"BBB@`HHH
MH`****`"BDIL:LBX9RYR>3CU]J`%;A3]*I:'+)/HME+*Y>1X5+,>I.*NN=J,
MV"<#.!4&G/))I]N\R!)&C4LH4J`<=,'I0!9HHHH`****`"BBB@`HHHH`*2EH
MH`CAC\J)4WL^T8W.<D_4U)110`4444`%%%%`!1110`4444`%-=%D0HZAE88(
M(R"*'8)&SD$A03Q61H6OIK4UR(X&BCA"E2YY;.>WX4`:5O9VUL6-O;Q1;NNQ
M`N?RJ8J"02!D5BZ]XB319HXY(#)YD;,"&QR"!CI^M/\`^$BLX+*UGU!OLS7*
M>8J8+X'U`]"*`-;:I/04NT>E92>)-)D$Q2[!$*[GPK<#(&>G/)'2D_X2;2/)
M24WJA'8H,J<Y'7C''4<T`:NU>F!]*6N9/C6R6ZD0Q,8H]V9%8')#8&!WR.:U
M8==TV98V2Z3;)OVEL@'9RW7I@4`:!53U`--,$)SF)#DY/RCDU6.KZ<J*YOK8
M(Q(5O-7!(Z_S%-L-6M-0EN8[>0,;=MK'(P?<>W^%`%EK:!V5FAC+*<J2HR#2
MK;0JTC+$@,GWR%'S?6J_]K:>(_,^W6VS=MW>:,9]*IW/BC3+>?R3*9&^7F,;
MA\P)S[C`R?J*`-$65JJNHMXMLAW.-HPQZ9-#V5M):_9G@C:#&/+*C;CZ5%;:
MK97-JEPMQ&L;X'SL`02,@'WQ0NJ6IN[BV=_+:!D5FD(526&0`>_%`#9-&TZ6
M(1O:1[50QC`QA3V&*9;:#IEJB+#:*`D@E7))(8=#DFK\DL<2;Y9%11_$QP*A
MO+^WLA$;B0()7$:D]-Q!_P`*`*K>'M)9E8V,64Z=:EBTBPAOC>QVJ+<$D[Q[
M]:EM[V"YEGCB?+P/LD![&K&1ZT`9]QH>FW-PUQ-:JTS$$ODYR.AZTR#P_I\-
MM)`T)E623S':1B69O4FM)W5$9V("J,DGL*;!-'<0I-"X>-QN5AT(H`?2TF::
M\B)C>ZKDX&3C)]*`'T5'#/%/&LD,B.K#(*G((I]`"T4E%`"T4QY$C&7=5`[L
M<4X$$9!!%`!1110`M%(""2`1Q10`M%(2!U(%!('4T`+129&<9&?2EH`**2@$
M'H<T`+1124`+1244`+1244`+1124`+12$@#)(`%(CJZ!T8,I&00<@T`.HHHH
M`**2B@!:**2@!:***`"BBB@`HHHH`****`"BBB@`HHHH`****`(KE@EM*Y.`
MJ$DYQVJOH\OGZ1:2YR6B4GYBW;U/-2:E_P`@VZ_ZXO\`R-0:!_R`K#_K@G\A
M0!H4444`%%%%`!14+7*+>);'/F.C./3`('_LPJ:@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`2L6YT?9/>7*:D]HUTZ$LH`V[01C_/I6EJ)G&G7)M<^
M>(F\O'7=CC]:XV2PU/4I[=+H7\EL)XLB=1QP=YQCH.!^=`'0:UX=CUB2"22Y
MDC:%=H*@'/(.?TIVKZ"-0NDN8;DVTHB:)B$#!T/;!_'\ZRM5EUV'76-L9Q;!
MD6*-(PRNI'S<]N_6LJ"^\2IGSFO5@:15:3RMS(-V#@8Y-,#6E\(Q3QR6PU$L
M80WEKL&4+'/S$=>E1WG@I;F>:4WZJSR%RHCX52?KZ55M/[0BDFU&"6Z3S)H4
M/FPA3/EL<_ACIZU+KRW<6M:C=6J.@CM5$JGD3*V02/3'_LIH`L/X2N'EN72^
MC\N3>8UV?=W,&Y_+^507/@Z^N`(FO8?)BWM&0A#;FY(/MFLN#4]<MY;;3[:8
MQYC2..-H^>0#GD>IZ^U33^)M:5([H,8DERFUHQMRH&X@^Y)H`T;/P=/$RF>:
M!@!+\@!(RR!1U]^?P%6]$\.7-CI]]974L+Q7*X!3.0<8Y_2L"_U_4;J"(FY9
M94DB988XR"PV9)R.HW9XK2T'7-3U8W4$DZJPMS(C^6/E8$`T`1VG@N[CGB>:
MXMI(PZ%TV$[E'4=*<O@RZ6.*+S[?;E#*V"6^4MTR/1A^54-'UF^62,17!W2@
MAC+F3:$C!X&>_-)=Z]K-S<V\1F59/),H\C(R&CW8(SV%`%O3-#D;6XK1XV%M
M;!6N2H/ER2KG&,^S#/XU/XA\.:EJ%_=3VXB,<DB,JE\$X0+]/6J,'C._ADB0
MK'-%&@5L_><XZYS6MX>U.\N]4O6N+J*<);JP$1/E@]?SYYI`-UKP_?W6GZ7%
M&%F:UC,<@#`9X&",_2I[C0[JXT?2]/GC$@AE!G8/T49''Y_I68OC#4$L!(XM
M))'VX*DC9DD88>O&>O2HV\6ZK=VEP;<00F&(.[@9/4*<=1U(ZT`1W'A35_M,
M@P9H.0NV15+!5PI(/?I^M6H_#>KK%Y;N2BQ-.`).6G*[<9_+_&I?^$NOHU65
MH+:6%C(B^6S9+)CG)['<*FB\2:HQCMWM+=+G+L^]B%"*H;WP<&@#*M_#VL)9
M^5/:22(9"QC6=5)^7`.<]B:GL=!UB+5[&:2WVQ0^5N;S1P`H!&,_6I(O%E]>
M302111Q[6??"7X=0A8DG&1C':I8/%=[\SK:"?S,NJ>8%\M5C1F`XYZDTP(O$
M.F:Y+X@>XL$<QR*$5E<`8V\@\_6JG]AZG8PVMS+!<2)"\<LD:.&(8,>@]AMK
MH+OQ*\=C8W-M9B4W4;N5:3;MV#)YQSWHTOQ%/JL=Y)%9F*&&-BLI<'YL9`(I
M`<D?MVC317(6>&81QE/,4[6X(*_7GI[&NKTI+^&TU%7-S+?^6IW2<*7*<!/I
MT/N*Q4\332PK]JM(]09`LH!`7R]JC+9P>YS[<U/?>-)AY+6T)A8`EXI%SO!`
M*G.>!R:`(]+EURZ41W$M]$#,N7*$$*%<GJ.Y`JP=0U,>&+":1[H,]P1/*B9D
M"9/05=3QI8`E)8+A)%4[N%QD#)`.:1/$VV;4TNF%J8T5K:.8`/DIG!`Z\X_.
MBP'-74=UJ;Q2WT=XT@5%4[.J%SS@#T_6I;:_U2QT^WBMWN8V"!HXDMP5/SMN
MW'KZ?G6MI_C(BQ#WD)EEY_U0`X`4L3D_[7:IQXM`BNA)$(Y$ED6%F!V.%P<$
MYSNP?Y4`8]OJFO7$EO`;R9#-*B&3R<;=PY'(&<5HZ]JVHVVO"WM[DQJHCV1^
M5N$I)P<_2D3QI+]I*-9JT0E"!HR2<9(Z>N`<5J/XBLY[>XFM8S)-;VQN%WK@
M`$=,]CZT`8UB]UI_A.YU*V=WO+F;,CE>4^;'0]>_Y^U4&\3:X;>W(D8?>_>"
M('S!GTQBM?3O&T<RN;ZT=%_A,*EQ@#YL_3C\Z6_\91VHC%G9L4P5V2*4*GC'
M'I@T`8NJ7^I:G-!%/+(K&X_X]Q`0(B#@$GOW[UNZA<W-QX7ODN9AYT%R(?.5
M"N=KK\V!W^E77\6:9$\Z2&53#D?=X<@X(7GD\TRVU^!].OKRYM3';V\X79M&
M\\CDKV.30!S][JNHZ;?2ML!O(HU@EG*<,N6(?'TQ^1J>UUO7)%@)DW_;%WHR
MQ#$80G?QW)`'?OVK6E\6:2(W,L$^\Y1XFA^;`ZY[8YIDGB[3X[B&.VA=H59D
MD=8^$4`_=QUZ9^@H`Q+3Q9?S)(D]ZD)E==LOE9$2\[N/^^?SJO9>(M0LFMXX
MYE,1=G;<G^MW.<GU_+%=-_PD6B?97D>U940J-C6X!.[)!`].":23Q-H:_.L+
M2*H!WI`"!DGCV.<T`1>)=;N['45A@G6W1(1*NZ/=Y[9QL]N*RX?$&JSR)&MZ
MHFF<!HS!CR#O50.>H(-:;>*-/N-2C$MJ)(MBM#,8\LC$XY].?3THL_$VF.T?
M]H6R074Q!9Q%\O!(4[CSVZ]J+`9C>(]3LIYU>\%W+`\L+0F''"YQ(2/?MZ4D
M?B/5'N(;."^6;+$FY\K&[Y02N".W//N*WH+[1K/3)M6CMV$<TK;V,>78DX/7
MMGM4D6J:/'I`U2*W5;>-\#;"`RDD+P/R_"@#F(_$VI7T<ZR7D=O$K([.L9W*
M"ZC`P<X&<GOV[U)!XCN-/1(K:4/`I9T$B,S7.96&`>WRX//<5MQ:]X9='P($
M!7+!K?&>AQTY/3CVIP\0>'%2*0>6`K$1D6Y^4C!....N:`,J'Q1J326YN)[2
MWAG#_O#$QV;3CD9YS_6M+Q9KMWH\ENMLT>9$8D,F<D$>_'4TV[U/PS>(+2<H
M@(##]T4P#ANN.,\58DUSP_?0-//Y<RPE5_>PDG+9P`",G.#T]*`,/PIJ%S=^
M(6CGNY)HF$A"ER5[=C2-XNU"W9Q%#:^6N\"`*0T(4X&>WY?I71V=]H?VVVCL
MXX5N+F,R1%(<$J<YYQQ]T\>U83GP_IM]?WD<[W4ZA\V[`E<DX(SCGDT`%OXJ
MU6:4PG["DB^;DX+`[%!P,-WYYZ5%<>.;O[3B&W@6+9_$2QSMSUR.];%OJ&D6
M>GVMS?VEM9/>1DA4BW!E..X'0@C@T]]0\,K>M`ZVGG+\A/DY`P,8SC'08H`Q
M/^$OU59[>*1;/$H1CM1LJK8]_0U;L]9OK?PI97"2I+<2W/DE[@DC!+<D_@*F
MEU_PX+FW/V:)X\8$_D<1[>@Z9].GK4^N/I,46E031[;26;S(Q"`$]LCT^:@#
M+/C:[$UNI@M@CX$ARQ_B()![#CWHN?$NK0B*]?[*(GCD\N-=Q#X<+S[UI0:K
MX?N!BZM((-DA@C$L0.<>F!P.:L2W_AQK:%I?LAAPQB#0\`9P<#''-%@,B7QE
M?0DVYLHY+N.5EDV9*X&.GOUID_C#5(8_--M;!&E9%4[MV%ZY`/N.:T[[5/#<
M5IYSI;W&\M*J",,S$G!//0\=\=*GLSX=U*/^S[:.WE"*6\OR\%>Q(..O3D4`
M;%G-]ILX9\;?-C5\`YQD9J:FHBH@1`%51@`=`*=0`4444`%%%%`!1110`444
M4`%%%%`%;4,C3KG'7RF_D:@T$8T*Q'_3!/Y"I]0_Y!USG_GDW\C3=*`&EV@"
M%!Y*84]N!0!;HHHH`****`$P,YQS2T44`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`%35)7@TN[FB;;)'"[*?0A217':9XJU/=<)(T5P41I077;@*,XX
MKMKO8+28R('0(VY3T88Y%<U!K.DW44,KV$2>;Y@F#`9C7;N)Z<@@4`9^H>*M
M329%3R(2,`C&0=P4@G/(QFIKGQE>6\LH^R6\D2.Z*ZN<,1QD?I6FNH^&[M7?
M$+DHSMF$YP`-W;T`_2EBU#PP]S(R/:B4IAG*8!7@8R1CTI@9\7BF6%K^*[S+
M(#^Y:V4/&GR^OU]:HP>-+Z%'^TQPS/NQCI@`>WXUL6.M:!%8SIY4=K:R2M$!
ML)$V`,G`'3!'6F:C!H6GW-K'<V%LMI.K,LHSD$#)SZ@\8H`HS>*[];&:X5("
MCR&.-U/S1G9N''.0*9:>+M3F$H$%J^P@G((P"X7MUZ@5K/9>%8QYS);!"PBW
M!CMR1GZ=.],F;PXDGV.*.W\F\1A++%(`J;<$9.>.2,?A0!/I>ORZE?K;+;(O
ME1EKDDG,;`D;1Z]!^=4O^$IO%,*KID>+LXM2)`-WS8^;TJWH2Z9I,5Q,VJ6T
MS3R9>3<JC/)`ZU&^C>&6FN%>6+S#EG'G\QXY..>*`**>)H_,)71H2(@$G*D`
MJ6.T@<<C@5.WBN1%W'21F$9N,.,Q@.5XXYZ5-+IGAZUT>>Z3,EKM57:*3=G:
MW'XY-,.A:+=Z@TIN8FB$>\Q+-R#N+,3STY%("NGBVTMC<Q0Z<@B@4^5L(&<'
M'([=:(_$5K;?:8/[+6T<0N6"$`E@20N0/]K/XFIY?#_AQ%GF:Z(15WR!9@0%
M/(X'..F*DN?#T5YJB7%J\#6WG+--EBS;AU48X`(Q0!7>YT?1-.CL[G3V99(D
MD^<*S29/?W6JYUS2?M!M;;1%E@E*Q;E4`N"QZ#&3R,BNAU+2K'6'M[F60,D&
M[E",,.A!/L1_.L\>$K;=#);7TT80(4*X/*YP<_CF@!FA7ND:IFW&F);-'$TF
MU@-I#<-CU'2JEOKV@V^UX-(G08)#"(8P<*3UZ=JW+#08;*<2K,[D6HM@"!TS
MG-5H_"T<=F;<7;X-OY&=@_YZ%\_KB@#.AUCPY%YQCTUE%N&.?+'S`D(<<^_Y
M5!=7?AJ[:S$\%Q;(I;,83:%Z+EL?[H''XU8NO"=G;,\D^IF)9VV+N0#DL&`S
MGD\59U'P>E_=23M?R(LC%MFS(&3GUI@)J%[X;U!EL;D@):@F-DR%("Y(!'L*
M=:ZQX=M=.:&*5H8+@OE-K94X`(XZ=16?!X.O9)5@NIT2RCWE!&V3DC`."/H3
MS5VS\&_99)6^V[_-B>-B8^1NQSR3GO2`+*Q\-W-K<W-J6\J*-ED?+#:"F#U[
MX'\ZKW$7A._=97NFWN0@P6!X4*!T^E:&E^&OL&FW]BUYO-VI4$+P@P1G&>O/
M\JBM?"]RFJ6E]<W<4AA/S(D>U<`87']:`(;G2_#=K=K97%S+YK'(A9V(+,,9
MZ=3Q^E5=%.B26.I3R6,HCBC4NUQB1N0<;3C@_P#UJTM3\,3WVNC4$ND2/=&Q
M0J<_+C\^E%CH#Z;I=_:RW4+?:T6-"V0`VW;_`#-`&3I^F^'-3`A$TT#@Y5&E
M&6!123T[8_0UI0^'=#837*WLLJ0LWF,9`0IX)[=:CC\)W)L1%--;B7>Q+HI^
MZ8M@'3UY-/TOPW<:?I.IVTD\#-=1A%()VJ<$9/'O0!&FF:"6,]EJ`-Q)*)H@
M\HVF0$X!&,XR?K4VC:98Q:1>13WEOYEXS+*T+@!>HVC/IS7-W]O;1RK:0S0S
MRM)$%:U3<555(/IDDD'KS5G3?#.J&8/]CCCAVYV7,F0QVD9P.AYSR.*`-,Z/
MH5AY,:WDT@N2T&5E4A=R\D\<=!^E7KOPYI-[.6:ZD661%`"2CD``#C'/W:Q(
M?!FJ1312?Z`PC*G8Q8JQ&>3Q6;?Z%?6%S`E](D47")<J247J<'C(Z]\4`=*G
MA70FD&+V1W)^7$RYR>_`SFJVN_8=/T^]TJ.XN9+NXDCD_>_,6)8'(.!Z5#;^
M#[[=83`VT9B"F1<G.0Q/;(/&*U=1T6XN_$T-V88GMD,>2QYP`V?U(_2@"CJ.
MEZ(U^8KR^NOM!E59&9AR67C/&!P.M6W\.:7Y"V\6H.C2,70^8K,P*[2!Z@BF
MZEH$]WXE$[6\<ME(R/(2W(VJ1@C\JSX/#&JJ^G[F15B/SG<"8MKEACZ@]OQH
M`U+O1M+O$6,ZDN=D42?.AY3...Y.[I31X4TZUMIK5[QU^U[`-S*#N7T'?D]*
MRKOP;<F&R-I&BNT*K.&?[C]2V>_IQZ5H^*M%U#4)+0V:+)Y<15F+`8.1R,_2
M@!$T+28HYHEU@A71%8-*AP5;(/\`]:HE\,0P7TC:A>*NGD*$#R@&3'."<#'<
MX%9\GA&__LTL+=3<?:&)3S!EDQQSTX.?KFNC.BM+I>F6EZ@N?LYS(-V`3L;`
MS]2!0`-8)J&BPZ=>ZA&TSGS`\17+#)(QZC'>HQH>GVVDR:2]_@RRB5F=E#DY
M';\*RK?P]J7VVT,MN@V)#B<R?ZH+R5P.I[5=UO0)K_4+RX%NLA80B(E\=&^?
MOZ4`.N?#-A<P[7U`@3SO-&1MY+8X'KTIEKX:L+6<R-JID*I)N5V7^(;2W^?2
ML>Y\-:U^[\BWXC+>7B493YR01D^E6+[POJ#K&]M`HF?SS.WF]<L2H_$?_7H`
MFN?"MI]FDN;?50Q";%+LNPL%VX)_SC--MM!>ZA>'5=2@C8+$T9BD4G:BOSVX
MPV<^U8U]8W.EVL45]:OAWE*0A^,E5`;(ZX(Z?2K)\/:RTRS+:N0;8("9%&/W
M6TK@\^U`'4Z)I6G:=<"2"\2=O)")EE.%R22,>IS52Y\*6MQ$9)=1?R?G:,X4
M*N\YSGO6+<^'+NTE@FCL6\J*&-I668=0#Y@SG^0K8U#3[G4/!]C#9VS*RE&,
M+/SM`/<XSU![4`6O$6C6NI+;W,NH"UCB&U6XV\^G-4AX$MPY/VZ7R^<+L''&
M*8-&U!O!T=G);,US%.'6,R#IGUSCH34']EZM9:=;O%;7,MU+#-%.OGYVD\(>
MO89Z4`7CX7M[>.5[O4%*+"RY:)$";@%W?H/RJ[<^'(;NWT^%KAC!:1E`NT?/
MD`9SVZ5R]QH&K23S!K:=T`/WI<[AD8`.><#U'K4L>G>(A<R-%]L@C*2!5,H8
M*NT[5&6//0>U`&G+X'1[:.,:C+N0L263(.?;/'2H+[PW8V<)AO-2V1R;4MS(
MN61MV6P!V/'TS4FD6>O1:)J:W#3^<Z`0!Y,L#@YQSQV[U7T_1]3GUNT:]AO!
M91.9!YTP8H=H[Y_O`?A0!:3P0(H)(DU`_O5VN6@!Z'(QSQ5K1O"G]E:BEW]M
M,I4$%?+QG/OFLS5[#Q#)K=S):FZ,+$[-LNU=NWMSQ^54H[+7XU"WBZD8`Q)\
MF3+$D87OTSUHN!W\%S!<[_(E63RW*/M/W6'4&IJX_P`/:?J%E=VLD[7*&>:4
MS1,V4QMX8X[Y[UU]`"T444`%%%%`!1110`4444`%%%%`%35B5TF\8=1`Y_\`
M'33[#_D'VW_7)?Y"H]7_`.01>_\`7!__`$$U+8@K8VZD8(C4$?@*`)Z***`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`&31B:%XR2`ZE2
M1[U@S>$K24QMY\RLL/DL01\_R[03GOBM75W>/2+R2-BKK`Y5@<$'::X.:\UA
M;8O:RZD;=F3][)G=NVG.,?P\_I0!TB>$K6.T6![F4DS;PYP"1C!7Z$"HY/!5
MM+<2RO=S'S"QQ@<%N?YUE7*7UU;&ZNY[]/*>W(5<@`E!N8#'4'/3UHEU#7+.
MQ"Q&ZN!/!'(TC+EHB>"!Q[8_7O0!H7'@H2QJHOW!,CN^4&#NQG`'3H*O:OH;
MZB+.*&ZB1[6)E821A\A@!G';[IKG;?5=<E@N+EGNUDMXU"*D658YQE@1SQ2V
M]]K#//?J\HNDMX]Z&`?O/WK#&,>GI[T`:;^#[C:8$OU^R[@X5XMS;@FWKGI5
M5O`D[6Z1_;XQL+$'RNN0/?VJIIVM:E:H]J9FCD1@8H&A+/+E^1D].*VM9UJX
MM-8DMTNHX518RD9CW&4LV#SVXH`JS>"96>0I=0E&D=E1D.`&&.Q'(J/_`(0>
MX$DK+>Q8="N#&?\`&B3Q#J,4@>&Z2Z6/Y[B,6Y!A`(!!/XGGVJNWBW54NXP8
MXC'P^S;@R*W(`^@../2@#83PY<P>%Y]*2>-Y)9`V\@@`;ES_`"-01^%+BUM5
M-O);-<>7,C%D(#!Q@=/3GVYJH^NZQY!F%U;C%H+O!AQU?;MZT@\97^R60P6X
M7D(K9RI#*/F&[/0^@H`9'X+U",,3-;N&B92O/7;Q^H'^%:UI9WLVCZC;-906
MMPP$:F,E5DPH'^>U48]0NIO#>M7#7:O(LQV&)CA1D=,]N>*/^$LU&.40F&VE
MS\B2Q[F61\`@`_B*`+6@Z'?V&D:C;S[!+<(1'M;H=I'X=166OA/4XK:0QA!.
M'C\O$I&!M._\SBMK7M1O['4;-K8>8JPM)/"O1E!4$COW_2N:N-<U;*O;WDSJ
ML*N^W&%R>_'T_.@"Y9>&=9RD5RP%N75FQ.<@`'I^?Z4'0/$*26L@<%H`N&$Y
MXP2<<TZ77=3345=KV,V\?EQMY(5U+$#=P2#USS6UK7B"XT^^:&""&1(HU>7>
M^UCN.`%H`XQ;*^U)BEM')+(FTR,')^;G).>AY'%7I(+_`$RQ5KS[=%"9(B56
M4CG:Q;'ISMJ_#XKOK.Q4W-K%)(T2R+)OVY!)&6`[Y':IXO%<UY&%;38I4(0-
MF4`99MHX(.>:`*?VBYB\+Z.5DO!/+<L"(G(9U+-Q]>F*C4>*(+NV\TWLB+L9
M]A+#&>0>V:LVGC(K';1W]D)&+9\Q6&%^8@$#'!`]ZTW\0W4WAJ74X+00N)`L
M:N=P<9`R.F>I'X4`8-Q9ZTDUM.IU)YY+90T@))1B_*GT&.WTJ6Y;Q+#,T4+7
MSK;NPC?86\[YOXO;'X59CU_6YK&&X3[(K23_`&<1E&W%_<9XX]?3WK5TSQ':
MM:S_`-H7ELLL$K(2IP'&>"!DYH`K62ZNFBZE<F2Z-T[GR(I1DJ`>,`^H/Z5D
MVMO>ZIJ-LNJ_;GL4=GW3IL`PF>?3GBNBNO%ND00-)'<B9AT1`<DUE6EY!XDE
M4:G?Q11MD)91N5)/&"S=S[4`,35=7N?$]PNF'[1:!B@#_P"J7"]=P]P:S;G3
M-1G>YD;S;H->&*6.(E5#`J=^WG@C(]N#7H4$$5O$(X(UC0=%48%/Q0!YU97>
MJQ7M\EK%Y(@;<T,,70*_W`0.XS]<5:;7]9M=4MH9W`$Y#B*2/&%<\+D>GKZD
M^E=W@`YQS36C1F#,BEAT)%`'GC>(;V,O<_:,W/DB%\Q$"-BYXZ]0.<_ABK&J
MWMY?^#[>>>=A))+Y31JF-^"W7\!^E=UY$1S^[3YNORCFG;%(P5&,YZ4`<#IF
MIZE'<#35O9$Q'N'F1ABB^7OX.>HZ#ZU4MM3NFO(]4!/GN\A:-2=KE(EQQ^)-
M=K>H(_$&F2*@_>++$S?\!##_`-!-:8B08PBC'3`Z4`>?GQ/?W.FS)<2".*7S
M%$WED\[>$&.G7K3[Z[OFTG3X9;>ZMT2!V6839,N(R1TYQTZ]J[SR8]NWRUQU
MQBG%5(P0#CVH`\UNO$NHM%-:M)B/R_*`3(92.^>OUJ6ZU:ZOX8[9;N1V60".
MY7,>X-M!!`]"?RKT3RTY^1>?:@1H.BC\J`/.M'UF]LYKF?SR\<8#/"Y9LKOP
M2N3QC(KIK[6+RQT:PN;IH899Y0LI\LLJ*03T!SG`%:][IUI?PB&YA#QA@P7.
M.?PJ2>T@N?+\Z,.(FWH#T!P1_(F@#BX?&5\][;Q-'"$9U5B$.6!;J,GTQ2#7
M]2DCMK\W5O&S0R;8BA"N0ZC'WN3W]N:[?[/"65O*3<O`.T9%'V>'`'E)A>@V
MCB@#BK_Q5J]E));M%;&2*1D:4*=IP`<#)Z]:23Q7JILY+M&LA&)C$J[6)/&<
MYS7;M#$_WHU;G/(!YH\B+;M\I-N<XVC&:`.%N]<U!+&ZNHY$-O<,B,IW;D9X
M03M/8`U:T?Q#?&[LK-S#)&?+C(.?-.8P=QYZ"NO^SPC=^Z3YCD_*.3C'\JAM
M].MK:ZGN8T_>S,&8GG'&./2@#E=8UN\M-6O9XI0%M7C@2!L[&W*S$GD<\4^Z
M\0RW'AJUNDFBCOA."88FP6`8C&W.<'CBNFDTRSEO&NI(%>5E"DMR"!TXZ9YZ
MTO\`9ECY@D%I"'!!!"#C!R/UH`YV;Q6R>'X;E9K5KYV&Z,!B`"3VSUP!WJ[8
M>(!>Z/%-YMM%>,`S(^=H'F;,^O/;W(K2.CZ:5=?L-OM<@L/+'."3_4TAT;3L
M$"TC3.T'8,<!MP''OS0!E:UX@N[&_DM[:*V(C1&Q*Q#.6.`%`]*SXO&EW*UP
MOV&)&3!0,QX^=5(/OS6YJ/ARRU+48;V<R;X\`J#PP!R,U:;1].:624VD7F2D
M%VQR<$'^8%`'+2>-[I,+]D@+1LPD(8E7QC[OI^.:63QCJ"6XE-O:_.[A4RVX
M!>N1^/7V-=.=%TUEC5K*$K&Q905X!/6DDT33)0@>RA(0EE&WH2<F@"OX<O9=
M0@O)Y6W#[2P09R%7:N`*UZBMK6"T0I;Q)$I;<0HP"?6IJ`$HI:*`"BBB@`HH
MHH`****`"BBB@`HHHH`IZO\`\@>]_P"N#_\`H)J:U!6UA!`!"*"!TZ5!K/\`
MR!;[_KWD_P#035J'_4I_NB@!]%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`%74W9-.N&3RMPC/^M^Y^/M61X=UN2\1OMTD*^9*4MB!
ML\P#K@$Y_P#UUL:@8EL)WN(A-$D9=D(!#`#..?I6187_`(;DD4VB6ZR(&D&V
M$@K@9)Z>E`%;4=2U!-3N[>WEC2(31*)'8#RALW-QCD$`U8O/$DMI=SQG396@
M@8*\@<9Y&<A>XZ?G1J&MZ)9B*Z>$323KYJ%(OF;C&<GIQQ4WVO0)0-1=K0L[
M[/-<#=NQC'/M^G-`&<_C"=)(X3I1^T2%=L?G#)#?=(X_SQ4<WC81S!%L""T0
M;<TF.2N['3D9XK6EDT>PN[%4M+<&YW-%-&BA5`7);/TI$A\.F5`JV+,D60<J
M1LX')[]AS0!SL7B6YM;Y[F73XGDG1"V&P0!&#U^ASC%6=9UC2!>1SWFG&6Z$
M<3H5?KGYL'Z?UK9_L70)8'80VYB1\LPDX4@8Y.>..U0C2?#"P%<6GENV<F?N
M/0Y]^GO0!57Q;;F9`-/;R9@I:4$?Q<<C'J"/PJT-;M_[!36+NR"LI*H@`)SG
M`P>U3?V/H(C^58%0D-Q,<?)GW[9.?UISVVA+IYLWDMA;2DR!3,.3GJ#GU]*`
M,P>+=(D4`V4C)Y0W@1`[0#T/M_C5>X\40Q(9SHZ_O&=064`N`P'7'US[XJ^M
MCX=LBD,<:LMZKP[UD++@<G)SQVJ\?#6DGS?]&XE&&42,!U#<#/'([4`0V.K:
M7>/#9P6I7[4K$QF)0!M)!W#\*R(=9T:\GL9+R%HIX9#Y<<7,:DM@$]/3-:5N
MEAX<NI'O)P)+UV96V<(H[9_$?4U+'X7TAF@G@C=54B0!9"5?N,@_6@!^HZQI
M%GJ0ANO^/AD",X3.U3V)[=<UG7E_I&E:H]FE@JCR=D[YVCR\9P!_$>16CJ7A
MBQU*\:ZE:9)'`#;'X)'0X^@J35O#]KJTXFN'E5UCV+L;&WG.?K0!B+=>$XYK
M646VUB`R-M.%`)'S<]MO>K%S?>'M3U&U>2*.=V++YC';L"\_,.X-6XO"EE&T
MS-+/(\T+0NSMDMDYW=.O3\JQ]:\/Z7I]N9;G4)3.5(C$[YW<`=`,\<=*`-!Q
MX4GA7>]N4C`13O88`R<?J:<FDZ!8.FI.T2POL:`NQVJ1SD<\YZ\^E86C:#J=
M]%O)%O!(<^;*-S,-NW@'VSUQUK9G\%6LFGK;K<R^<I!$S_-VQC'I0!AWLNB&
MYDCTK3$N3$K2,\D[*N!SP,_-2K=0W=M;V%QJ"6%H5#+##&S`9^8$N3Z_D:W1
MX.MTLX;=)R"DZS&0H"QPH!7Z9YJHO@L6I6Y>[29H<$HT(574#&T\\9]?QH`E
MM-!T%)!;75W]KN'.]1),5)W<\`'O5&6TM=)O8X;3RIM37?)(YPL,*MW8'T'0
M9IGA_29=2M4"8B@#'S;G`:1\<;$)Y4`=ZVW\)V@G#Q")8Q*'VM'N.`FW&2><
MGF@`TG3-.M]\MY-%=7DCJDCR`##=E`[=,CUI+[2O#UX(HPD2/))Y2/;\'<!R
M...W>JUOX1N80D:ZD%B#(Y"P_,67.""3[T6'@\V#1S&ZBDDCF63+PY&T`Y'7
MWS^`H`T]`N&0W6FS3-+)9R;0[]60C*Y]^H_"MBN/307UWSM1-Q'"MU(67;'E
MU"Y5<-GH>":TM'T";3;.\A-PI:=`JE0<`@$;L$]>?TH`UKB^M[6:"*9]KSMM
MC&TG<?P^M6,CUKA9_!NHPVKM#=I(ZY98U!&<C!P34^C>';J=)9+Z!+=7!`BQ
MP?EP#C/&#S]:`.SR/6JW]H6OG7$7FC?;*'E&#\H(SFN4A\(ZG'<J_P#:/(0J
M)0[!E&"`,>G3O6CIVA2V,-_).\$7VBW"$1@[4PI!8D]?6@"\TT-WKMF$?=Y=
MN\XQT^;:JG\MU7;V_M;")9+J98D8X!/<X)_D#7!VVBWTMI#>6P99;EQ%$85V
MA(\%2[?4<UT>K>'Y)M/L[;3S&IM@Z@RD]&4@_CDT`;MO<0W5ND\#AXG&58=Q
M4F17)WOAB^DB1+:XB51%$KH<A9&4$$D8(Z;?RJ=]"U#^Q;*U^T1SRP.3(DK-
MY<B]E/<XXH`Z7(]:,C&<BN/MO#6K021AKF"0*`5=G<F+`Y11Z'H:ANO"FI&)
M4M9(44P1K(@<@.Z]21C!_&@#JKC5;*VN!!/<*DA95"D'JV<?R-6HI4FB62-@
MR.`RL.A!Z&N1M_#>JV\@19[=E.UVD8,3N",N,=Q\W7_]5"Z%K3[(2T,$):$L
M8Y6)01C'''7H?P%`'84WS$\SR]Z[\;MN><>N*Y2UT/75NX?M-^S0(P5L3MEE
M!SD<=?KGK5W3]-U.WU.*XG9)5V2QR,TA+`%RRXX^E`'05#=7=O9Q&2YE2-`,
MY8UR\NB>(3YBQZE+PS%7:X.&!QC@#COWI=1\/:I<0R;9UED663RO-<D^6R`$
M9/3Z4`=7%+'-&)(G5U(R"#FF/<PQW$5N\BB64$HO=L=:Y"33=0M&BM89IX)9
M;GK`7*&-A@DXX!%7_$&D:G<7=M-IDI7RX?++&4JW4=Z`.E9@JEF(``R23TIL
M<L<H)C=6`)4X.<$'!%8!TS4?[$U2SDD>9Y9&^SF27<2G&`35&'1=8BMS/:2&
MWN)I69X]^%"[?ER/[V:`.OHKG]&MM9@BO#?RR.3$!$&<,=^#DC'X5GFP\0X<
M1W-R9$6'&Z4!2Q&7Y[@&@#L**XJWL_%*RQK=33B%I$5V252R@L`2,>Q_2B*'
MQ&\4[2R7B>3`3'AAF1]QQQWXZ_04"U.UHKB0OBR(3JQG8A1M(V'!+#H>_`.?
M2KVO3ZA:75C:6,]W.[1R%PFW>W3:2<8P"?RH&=102`,DUQ]S_P`)#!:K<22W
M;LLNV6.%5^[@<KP3USZTD]GXE:U:*XF\Z)[<R.-JGYL$>7^/J*`.PW+QR.>G
M/6ES7!6\&OO<QJD$OVBUCD56E`\M`5^79TYXQSG^=-F?Q')I[?:A>R6TJLA5
M8EW[L=QC.W(//I]:`._ZTM5-*A:WTJTA<$,D**0>H(`JW0`4444`%%%%`!11
M10`4444`4-<.W0[\XS_H\G_H)JY#_J4_W15'Q""=`OL'&(6/Y"KT?^K7Z"@!
M]%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`$-W`+FT
MF@+;1*C)GTR,5R=[X5F!2*)FN))G!>X.$$2J,8P.N03^5;NJ7]U!>VME9Q0M
M+<ARKRL0J[0#T`]Z9_Q47_4+_P#(E`$&N^'!J-G;0V<BVQMPRJ,<;2,$5GZA
MX/GN$80SPKF8R!2I48*@8X^E:S7&MPO&LL>GL9#M55=QEL9ZX/8&I?-UO_GT
ML?\`O^W_`,30!G:CX:FNK+3[:*Y5?LD3QLQ7[V5`Z?A6=%X'G$1$MVF]G^8I
MD93'(_,"N@2?7&!S9628)'S3MS[\+4)U#75)4Z(CX)&Y;I0#[\B@"K_8<]CX
M3N;-/W]R[>8VSG>VX'O[`9K%M?"NI7%FTCQP1O([_N9<CRP<?,H'0\'\`*Z5
M]0UQ>FB*W`/%TO<?3MTIO]IZ[_T`?_)I:`,B?P=>&.:**\7R0I,"$G[QV[L_
M7'O5<>#[]K./>L!9(G'EESN#'..>G!Y_.MYM4UQ5R=`S]+I3_2FC6-:W#.@/
MM/I<+G%`&3=>%;Q6<6L:>48WVIOZ,44=_<&J.IZ=J>G3LOD3S6KEA&D;L0IV
MX!X.?P-=4-7U+8/^)%<;^X\U,?GFE;7)TA\R31K\`$@[55N?IG/:@#,UO1[W
M4;'346!F>*V<29D`(?8-H/K\PK:T0W@M1%=V@MEB54C7S`Y(`ZG%1C6+@@$:
M-?8/^Y_\565>>)[NY5H-+TVZ$P.)&9,^7^`/7ZT`=,;A//$(RSXR<#[HYY/Y
M&I*Y?3]>MK"#R3IVI*Q?+M)#EF)R2QJ2[\7P1VCLEK<I<$8B26(C>?\`ZU`%
M[5M:^RRBRL8OM6H./EB7HONQ["H-.\/EG^U:TZWUTPQAQE$'H!TK/\/7EI9K
M-=7JW)OK@[I6-J_'^R,#I6U_PD%A_P!/'_@-)_\`$T`:8``P.E+64?$%@`2?
MM``ZG[-)_P#$TP^)M+49:64#W@?_``H`UF944LQ"J!DDG@5S\KS>([EX8)7B
MTI,J\J<&<]P#Z"L[6?$-MJKC3[>Z^SVCC][<-&QS_L@8^G-;%CK.AVMFL-O>
M1)%"`H!R#S['DT`:\,,=O"D42A(T`55'85)66GB+29(RZWT6`0#DX.?H>:EC
MUG3)(UD6_MMK#(S*`?R/2@"]63JTDUW<1Z7:NT32`//*O\$><8!_O'H/QHU#
MQ)IEE"S_`&J.9PN52)PQ;\1P*J:3?Z=9NQN=5BFO+G!D/F94>B@]@,T`;\,2
M00I%&`J(H50.P%/JA%K6F3/LCOH&8C/WQ[?XBIO[0LO^?N#_`+^#_&@"S157
M^T;$?\OEO_W]7_&E_M"R/2\M_P#OX/\`&@"S6'KLDE],FC6KE7F&^=\<)%_]
M?I4VKZY;6%H6BD26=_EBC4@Y;W]JCT:*&S$T]S>PRW=RP>5MX`'HHYZ"@#7C
MC6*-8T4*B`!0.P%/J#[9:_\`/S#_`-]BC[;:_P#/S#_WV*`)Z*@%Y:GI<0G_
M`(&*/MMJ.MS#_P!]B@">BJ_VZT_Y^H?^_@H%[:$X%S"3_P!=!0!8HJN;ZT_Y
M^H/^_@I?MMKC/VF''^^*`)Z*@^UVW_/Q%_WV*<MQ"^=DT;8]&!H`EHJ,31,,
MK(A&"<AAT'6G;AG&1GKB@!:*":,T`+12`@]#10`M%)10`4M)10`M)@;@V!D<
M9HHH`**,T4`%%%%`!2T44`%%%%`!1110`4444`%%%%`&?KW_`"!;L'HT94_C
MQ5Y1A0/05G>(VVZ+.>!R@R?]X5I#I0`M%%%`!1110`4A(`))P!13(T*H59S(
M<DY;'<]./RH`6&6.>%)8F#QN`RL.A!I]-1%1%1%"JHP`!@`4Z@`HHHH`****
M`"BBB@`HHHH`****`"BBB@#$OR3XKTH#'$4Q/Y"MJJ&JA+>WDU%8(Y+BUC9D
M+\8&.1GZ5A1>,H)P4N;9A"8?WH7+-O+;=N/3W-`'645S+>,],C"(8;CRF3@[
M1D<D8QGVIX\5Z5;VJ3*+C:Q,8BVY*[1Z9XZB@#I**R]0UVUT^.V>1)I/M(S&
ML:9)&`>GXBLRU\0KJGB2"VMHYA#&C'?N(#97.2N/RSZT`=/25C/XITJ.>6)I
MR#%NR=AP2O4`]S20^)-'A@^>^;[QR)5;<"><=.W2@#:HK#/B'11=),=3.9(P
MH3YMG4\D8X/U[5C'Q/:K>P-'->/##N4[I,!PN?G/'.<XQQTH`[6BLB#Q+IDM
MDMR]RD0.T,K'E21D`X^AK!U3QBES-##ICM"5ERTTO"$8(Y'7'.?P%`&UJ^HR
MRW)TG37073J3)*3Q"O\`\5Z5HZ9I\.FV26T`^5>2QZL3U)KC;.WT6*Z@^VZA
M)J$UW*"`F50,3C<?Q!'X]*Z?4/$.FZ>)A+<`R1$!HUY;)'`H`U'940LY"J.2
M3P!7%ZEJ3ZSKD/\`9R*8M/W.9Y#A`?[Q]AC\:BNYWO[>*XU[41!:2-A;:V.X
MG()&['I@=ORJOHUI97FI3P?:3!;&?>;5H_O*IX#-GCKTH`U_#NGWE[?KK5Y>
M/(!D1C&`W49QV7DXKJZ9"8O+"PE"B?*`I&![4^@`K`UC49KN[_L;3/\`72#]
M].IXA7OT[U:UO4)H#!9605KRZ8JFX\(.[&GZ/I;:9"$\T2L^6F<K\TCD]<Y^
MM`$VE:;#I=@EK"2RKDEFZL3U-6]J^@_*EI:`&>5'G.Q?RJ&Z^S6MK+/+&@CC
M4LWRCH*6^O8-/M7N;E]D:=35*.&;5##/>1&"*-]Z0;LEL?=+=O?'ZT`+9VBW
M5RFI2)L#0A8H2N-@/)W=B>GY5?:W@<DM#&Q/4E0:DI:`(/L=MC'V:'_O@4?8
MK7_GVA_[]BGNT@=`JJ4).\EL%>.P[UES^(;?[4;6RCDOK@'#+"/E7ZMTH`T#
M8VAZVL!^L8K'O[JQBNOL&GZ?;W5\X)*!%"IQU8X_2GSVFM:D0)[A-/MSU2`[
MI"/0MV_"M'3M,M=,B\NVCP3]YSRSGU)H`H:3X?BMO-GOT@N+F4\XC&Q!V515
MLZ'I1`!T^VP#G_5BK]+0!G?V%I?EK']@@VJVX#8.O^33#X=T@J5_L^#!QGY>
M?SK4HH`RO^$;T?)/V"'GV--'AC1A_P`N$?YG_&M8YP<#)[5',TRP[HHE>3^Z
M7VC\\&@#.7PUHZL&%A%D=,YH'AK1P,"PB_')_K6G&7*Y=0K9/`.:)&*)N5"Y
MR.!C/ZT`9I\-Z.>MA%Z=#3?^$9T;&/L$7Z_XUK4M`&,WA716))L5Y]'8?UI!
MX4T4=++'_;1_\:VJ9(Y3;A&?<V#C''N:`,D>%M&`P+,`8Q_K&_QIW_",Z3N#
M?93D=_-?_&M*&1Y-Q:(Q@$@;B,GDCM^?XTLKLBJ4C+DL`0"!@$\G\.M`&<OA
MW35&%AD`]IW_`,:#X>TX_P#+.;_O_)_C5E;JY*REK)U*?=&\'?R1Q^`!_&K,
MK,D3LJ%V"DA0<9/I0!E#PSI@)(CF&>3B=QD_G2_\(WIV.EQ_X$2?XU=^U2B\
M\@VDNSR]XE!&W/\`=Z]:D$K-;K*(G#,`?+.`PSV/O0!FCPUIHS\LY_[>'_QI
MZ^'[)3E6NA]+J3_&M2J\ETR(K?9IVW/LPH!(YQN//3O]*`*0\/VH&#/>GZW3
M_P"--/AVU[7-\/\`MZ?_`!K2:8BY2'RI"&4MO`^48QP3Z\U-0!D?\(]:YS]H
MO?\`P*?_`!H_X1VT_P">][_X%/\`XUKT4`9)T"`#"7E^G()(NG_+K0V@Q'I?
M:BO':Z:K]Y<_98?,\F:;D#;$NYORI@O"4+?9KC`0O@J,G';&>M`&)J&B-9V%
MU<IJNHL8H695:<XR%_QKH+5M]K$Q;=E`<COQ576]YT6\6.-Y':%E54&221CI
M^-6X`1!&",$*,T`24444`%%%%`!1110`4444`%%%%`&7XC7=HDZ^I0?^/K6F
M.E9GB,E=&F(`/S)UZ#YUYK3'2@!:***`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`(KJ!+JVEMY<[)4*-@X.",5CW'A32[F:61DD0RXW!
M&P..];AS@XZTV)F:)6D78Y`++G.#Z9H`Q(O"6F0XV>=QCK)Z-N_G3+GP?IMR
M26>X4EV<D,.2QSW%=#10!E7^AV]\EJK2SQ&U4K&\3X;!`!YQ[5'I'AZVT>ZE
MFM9)"LB!2KG/([YK9HH`YI/",*BZ1KR5HYE*QKCB/)SGW.?I4$G@UGN4N3J4
MC3#)=F3J<8!'/&./7I75TV25(D+RNJ(HR68X`H`Y9/!JQ7MO/'>NBQ(H<*@!
M8@>H['WS6)>:;!:/+:)>MJ%[Y9CB@AB(V;CDDD$CUX]ZZ.?6;G5[EK+0QA!Q
M+>,/E0?[/J?\^]7M/TJQT2UDG.#($+33OR6QDDT`<A<Z!'IMM'?ZS<Y\QB3:
MQIDEB.@.>/\`ZU7],\$?)!->7&<[7>'9Z#[N<UHZ5;/K=^-9O%9(4RMK`>P_
MO?CS_G%;UU<PV=N\T[A$0$DDXH`XZ32T\./9W]W=1SR0AE$`CYD8DG@_CUQV
MK/U'P_,;4ZE?7(BN+A\K;;2SEF/`'/6M%7^VWT6JW$1GO)7`L[,-@1@'[[GL
M._\`GCH;'2"+H7^H.L][C"D#Y(AZ*/QZGF@#`@\*74C+>K]GMYBZ.L#*2J``
MC!]2>/UK%ATB=;C5;=8_M$D)VX5/GSG(9?RY]C7IU<SK,$FC:JFMVH)A<A+M
M`,DCCD?E_+UH`T_#M@;#2(4D!$TG[V7/7>W7/TZ?A6G4%G>07ULEQ;2!XW&0
M1V]C[U6U^_.FZ/<7"_?"[4^IX%`&?HJ_VEK=YJ[9\M#]F@!Y&!U/Y_S-=#5+
M1K86FD6D`!&V)<Y&#G&3^M7:`"J]]>P6%L]Q<R!(U[GO[#U-,U+4+?3+1KBY
M;"C@`<ECZ#WK+L+*YU6>'4=6"JJ?-;VH'"9Z,V>K8Q0`^QMI=5N1J.H1LL2G
M_1K:0?<']YAZG]*VZ*IZAJEIIT>ZXD^8G"QKR['T`[T`7*R[[7;6UD,$(:ZN
M\[?(AY8'W]!4<3:EJJMO5].M^0!UE;IS_LCK[U;L[&WTM(XK6W^^V)).K'@G
M<Q[\_P`Z`*!TW4=5=O[4G$-H2<6L#<GM\S=_I6I96%KI\/E6D*Q(3D@=S[U9
MHH`2EHHH`****`"BBB@`HHHH`*2BJM[J-I8)NNIU0]ESEF^@ZF@"U3)I8X(F
MEF=8T7JS'`%9L=_?:AY@LK7R(P`8Y[D$;S[)U_&K4=@OG>=/+),^,`,?E'`!
MPO3U_,T`6Z**6@!**6DH`**6B@!**6B@!**6B@!*6BB@`HHHH`2BEHH`2BEH
MH`****`"BBB@`HHHH`****`"F21K)MW9^5@PP2.13Z*`,GQ/_P`@"ZQP<+SZ
M?,*U1TJ&[M8KVUDMYUW1R###.*F'%`"T444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%5-3OAIUFUT\,DJ)C<(P"0/7FL]?$]G-=06
MUI'-<RS*&Q&!\@/][)XH`VZ*2F33101F2:1(T'5G8`#\30!)3)98X8VDE=41
M>2S'`%9D6M&]#_V;9S3@9Q*_R1DCW//Y"LB^C*.LFOS/<RS,%AL+9OE]LCC/
M/>@"WJ?BN"WCE^QQF<H=OFGB(-]>I^@K.MM'U+Q&R76L3M%;CF.%1@D>N.WU
MZUHZ7H!:Y:\U2*(N#B&W3F.$<=!ZUT-`$5M;16END$"!(T&`!6!K$[ZUJ(T2
MT?$2_-=R`=`"/E!]?\^M7M=U22S6.TM$9[VZ!6$#&%Z?,?89_2HK7[+X<TV*
M.<F2YF;+A/F>60]<>M`&PH2WA"C"1QKCT``KC[MKOQ=>^5;*L>G6[G]XX)#M
MR,_KTI][<ZGXBU&?3+<I;6L1'FL&^;!Z@D<9YZ5UEM;Q6MND$*!(T```H`K:
M9ID.FPE8_FD<YDE/WG/J:NTM%`!2$`C!Y%+10!@R:!+:W+W&C7?V0R,&DA9=
MT;8]NW?_`.M6/XDN]2EMK>PU&S"F69</;ON\P#KA>O<5VU<WXH?RM4T61U_=
MK<<MZ'CC_/I0`^/QEI3*2YGBP>CQ?X9J6;Q9I2VLDT5P)'5=RQX(9CZ<U-J&
MJ6Z3FPB@-W>,N?(4<8]6)X`JOHVA[)FU#4HHS?.Q("_=C'8`#O[T`8D&K?VA
M='4KBQN[R6'_`%,$,9,</)Y)[M[X]/PW8]0UNZ'[C2TME(&&N)>A]<`9K;P!
M10!A#3]?N)&^U:K%!$W&RVCYQ[$C(J[I^B6.GL)(HM\W_/60[G_,]*T:*`"B
MBB@`HHHH`**K7E_:6"JUW.D(?[NXXS53_A(]'_Z"$'YT`:E%9B^(-)8,1J$'
MRC)^:G?V]I6,_P!H6V,D9\P4`:-%9QU[20"?[1MN/205G77C#3DMS):EKAL[
M0,;`#VSNQQ_A0!T-9M_K=K9R+$H>YG8X$,`#,/7/I6"EW_:4N_5=<M[>$'Y;
M>UG`S[,U:UE>^'M/0BUN;.+/WBKC)^IH`>5UJ^'+1:?$6XQ\\NW_`-!!J>QT
M>ULY&F.^>X8Y,TQW/],]A]*3^WM)_P"@C;?]_!2'Q!I`_P"8A;_]]B@#2I:S
M?[?TG&?[0M\?[](?$&D#_F(0=,_?H`TZ*SAKNE''_$PMN?\`IH*<=;TL`$ZA
M:\C(_>B@"_256_M*R^7_`$J'YE#+\XY!Z&FRZI80NZ2WD",GW@T@!'^<T`7*
M*K27]I$VV2YB4XS@N!V)_D#^5'VZT\T1&YB$A.-N\9SC/\J`+-%1^=%_SU3_
M`+Z%/)`ZD#ZT`+13=R_WA^=&]?[P_.@!U%-WK_>'YT;T_O#\Z`'44T,IZ$'\
M:7(H`6BDHH`6BDI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`**2H@\H>7=%\BXV;6R6XYX[<T`344E+0`4444`%%%%`!
M1110!E>(M6ATK3G>0;Y)`4C3LQQW]JY7P\__``CNJ1I?&`I>(`)$<,8SZ''3
MDC/X5T7BV98=,3=8K>!I`H1B<*2"`>.:Y6WNM&,ENUWI4,,$D;,2KN[,0<#'
M/L>M`'H,K--:N;65`[*=C_>`/8^]9TFAQ7KQ3:H[7,JJ/DW8C4XYP!ZGUK#>
M7PQ#'EK.YCVN8]OS@@@`GC/O2-<^&=Z(([QB5R-IEY^7..O6@#I]1O[;2;!I
MYB%1!A4'5CV`%4=#TV3)U/4CYE],,C</]2I_A'I7*O-HMQ<V<LD4L-O%"99H
MW=BSDD``9////':KQN_"BE@RW(*-MY>3W]_:@#MJ1F55+,0`!DD]JY"=/#_R
M1V,$U]<2)N2.*:0_]]'/RU3U;1);+1[F]N9&MV.U4MH9691D@88G.>/PXH`G
MTZ:_OM7N]0MK5GEF8QV\T@Q%&@SSGOT'&/QJ]J'_`!)+7$;F[UB\;:LA&6R>
MI`[`>E+9^%8#8VY-]?1GRP6$<V!D\G'%4-$T,ZG++>O=W:0H6BMF\P%RN3DD
MD>Y_.@#I]&TV+2[!((P=Q^:1B<EF[FK]8::!<1L636KX$@#JIX'3M4G]C7?_
M`$&[W\D_PH`V*2LC^QKO_H-WO_CO^%02VE['=Q6RZM>NTH)8[$`50.N=N,YP
M/QH`WJ6LB+2+R&(1IK5WA>!N1&/YD9-4]12ZTV$S7/B*6-,@+_HZ$Y^@'-`'
M0NZHA=V"JHR23P!7,:_(WB"$V6EQ?:/)<2&X5P$5AG@'N<$_I4-KI^M:W92"
M[U.2*TD_U8:%0TB^I`Q@?C5^'1-5M8A%:ZRL<8&%06JX'ZT`-\+2V1$L8$BZ
MER;@3G,AQQU].170US5]X=U"^GCN7U"&.YC(VRQP%3CT/S>O/XTRYO\`Q)IG
M$]O#=1#DSQQDX'NH(Q0!U-%<U9>('O2534+"-QU2:!T/ZO6B#J[,-EQI[+C)
M/EO^'\5`&I162W]O#=@Z<<=.'&?UJ%I?$@8A;?3V`Z'>PS0!N45A>=XF_P"?
M33_^_C4>?XE!_P"/33R/^NC4`;M%<[)J>NP2)%-:Z>'<$J//(SCKUJ&W\6+&
M[_VBULJ@?*+9S(Q/I[4`:>IVZ3ZOI?F&,JC2'8_)8[>P]NM7WM[=UP\,9&0>
M5';FN<DU:^U2\MYM)TZ4K"&):X^13N'UYJO?:=K=^J?;+R.16)\RUAD$:C&.
M">_(]\4`:5[JGAZW")(;>9HSN1(D#X/MC@52,5_=3!M,TJVTR)/^7BXB42`>
MR]N_^-2:?;W6EV:FTT:U$[,0?])&=O8Y/4GG\J?J@US4;#R8[(VLN?O)<J00
M1@@COUH`YA+2VCT74-2F`N':8P6SG"J?]H+^M=0R:;IFF:='K%O!-<LJQ+^Z
M#'_]0S6+_P`(QK3VHLU6**WCD::,,X)W>Y`]/YUI:GIFHZP;)M0T_)@R'$5P
MJALX_(<4`65G\,RWT5G%:V<LDA91LA4@$>IQ2V\WABX>X2*VM"($+R-Y`VA1
MW!QS6<WAB:QN([G2X9TFX;/G)\F<AE&1SP>M9\^B7VFVUQ]M:06I00AH2A8C
M=\HV]3R<D9&?6@#;6^\-R6]U/%I\,BVS*GRVZ_.6X&W_`#VJU:IH=Q%-YVF0
M6C0L/,2XA5"N>ASTYKE5L]86]-D88XI-1Q*%!`VE.001G&*U4T+56NU>_!OX
M)<23(7$>7&0`>Y`ZXH`U;"+PU>RE+."RD<<[?+&?R(J\="TH]=.MO^_8J@I-
ME)$T'AYLQED1HV3(&<9/U'K5S^T+TE0-*ER5#',J@#.>,^O'ZT`._L+2<8_L
MZV_[]BE_L+2?^@=:_P#?H4TZC>[0/[)GWX)(\Q,#\<TPZM=?8EG72;HN=VZ+
M(!4#^>?\:`)?[#TK_H'6O_?H4G]A:3D'^SK;C_IF*L_:6^P_:3!+N\O?Y./G
MSCICUJ"*_G:R>>2PF1T(_=#!9@0#Q],D?@:`(_\`A'](_P"@=;_]\4O]@:1_
MT#K?_O@5"NM7&T&31[U<J2,`-SG&#Z5I"60S*OD$(4W%]PX/]W%`%"71-'@3
MS3IUOA2,G:!@9QGGTJMXE,7GV'VB,30*99&B/1ML3$5;BU%KF;[/-IMR@9RI
M9T!3`!YSZ5!K\#RW%B?L\LT8:1)!'U`9"N?UH`Y]M0TORF8^'H0%B64_O!]Q
MNAZ?3\ZGO&TR%W:VT.*>.&%99SN`V;L;1WSQG-1+9M;H!#'K4:R(5;Y%;Y`"
M`N/;)_GZ4^)(HM*GT^#3-6A2=@6E:$.>W'T&,4!8L7IT*WU>WT^/3H'D9]LS
M%>(QC/7UJA;7>D73;7T.-87F6(2HV""V2G'7G'/M3K^WM+[]^=.U>WN\Y9T@
M.96Q@GK@>O:GW,-LUQ',;35_*`20VZV_REU`4?CC'MQ0%BWX<73-92Y/]DP0
MB-EPR\@@C.,^H[_6MA_#NEL%'V15PV[Y6(S]>:QM":UTMY9A;ZCOE54*FS*@
M!>`<*,9-:ZZ]$TP3[%?@$??-LV/Y4#L-_P"$9TK'_'NW;_EHW;\::WA;2F8G
MR9!GL)6P/UJQ_;4/E>9]FO<;MN/LSY_+%*-8@PV8+P;6V_\`'L_/7V]J!%6#
M3X;#7;=+2,1QFV??P23AEQDUMUCV\QO->CN(HIEA2U=29(F3DLOJ!Z&MB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHJGJ6HQZ;"LLL4T@9MH$2;CF@"Y152ROXKRS^U*DD<?/^M7:<#OBFKJU
M@SQ)]JC#3('C#'&X'H>:`+M%5I-0LXVVR7<"-DC#2`'-/2Y@>/S$FC9,$[@P
M(P.O-`$U%1&XA#,IFCW+]X;AD?6F_;;;S8XOM$9>7)C4,,MCKCUH`KZKI-MJ
MT"Q7.\;&W*R'!4^U8]WX+L6M2EH6CFV[0[G<.H))]^,<5O+?VCSM`MS$94.&
M3>,@^F*DDN(8I(XY)41Y20BDX+'VI`<[I_A%(HB+ZY>9][,"AQ]Y=ISG.:FB
M\':;#=1W$4ERCQE2`'&,C\.]:4FLZ9$VV2_MU//!D'J1_,&G2ZMI\+*LM[`A
M=0RAI`,@]#0!D2>"]/EV^9/=L$4*N77@#H.E1/X(M'A\LWESPS,F=I`S^'/0
M?E71S7=O;LBS3QQL_P!T.X&[Z9Z]:1+RVDG:!+B)IEZQAP6'U%`R+3=.M],M
M$M[=``HY;`RQ]3[UB^,G9AIMN4)BENEWGMQV/UR?RKHH9XIU+0RI(H."48$9
M]*P_$B-J.G))IKI/+9W"RE$8$G;GCCOS^E,0_P`43O\`98=,MLB>^;REP.B\
M;C^1_6M:RMDL[.&VC^[$@4>^*YS0[N/5=:GU::1$C51;V\;L`RY]1[GCWKJ`
MRDD!AD=>>E`#J*3-5[B]AMYHHI#@R9.XX"J!W)/N0/QH`;>7BVTD$6UGDG?:
M`O51W8^PX_,5/&#%"HDDWLJC<[`#/J:R)/$MD;XVMK%/>3J=I\A`0/Q)`QGO
M4%WIFK:S*!=W`LK/&##"Y+M[,<8_G0!+<>(5FN#9Z1']MN<9+`_NT]RW^%.T
MW0V2Z^WZG-]JO#G'=(AG.%!K1L-/M=.@$-K"L:CK@<GZGO5F@`I:2EH`*2BE
MH`I7VE6.H*1=6T<A(QN*X8?0]:S7\(Z:/^/9KFU/<PRD$_GFMZBBP'/2>%F$
M1%OK&HQOV+2Y'Y#%/;2-;Q\OB!L^]LO^-;]%&H&!]A\1"%HAJENW7$AA^?\`
MPJ)M&UYP`^OG;GG;$`?S%='10%C`C\(V)D\V\EN+R0$8::0GCT]Q6O::?:62
M;+6WCB'^RM6:*`$KE=3T*-_$#W$=@)8S;/(W7#2Y./QZ5U=)0!YNFBZM&T2_
M99W_`-20#@JN.3SVQ_4UT7AA]=:]G.J"7RF3</,&,-GHOIQ7344P%HHHI`%9
MFNV5Q>V<?V1E$\$JS(&Z,5[>U:=%`&/IFGW?]I3:EJ3)Y[+Y<4<;96-.N.G)
MS6O2T4`)12T4`)12T4`)12T4`)12T4`)12T4`<-XL>"/Q"S7%Q<0A;3="83_
M`,M,D#Z#%4Y?%&KN\ENTB18B8'*88$)D_0YKT-D5OO*#]11L7.=HSZXI@<%I
M/B;4?[2L;)I(IH6,<9..3D#OUR,\^XKOJ;Y:9!V+D=#BGT,!**6BD`E%+10`
ME+110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4E+7*^*;B_BU*!+>6ZCC,6Z,0(&#2AN`WMC%`'2W"&2VEC7&60
M@?B*YU_#)338GCS+J,<<2J99"47:P)`]!P:QK34-<4-''<W7F,5$GFP`^6Y<
M`X]1C/I5F'5?$"NL>]IS.76)FB"[2C_-G`[@8_'VH`AD\):C+)=3S16I>17*
MJLC8WDYX_#-11>'M:BLEC^R1$R1O$1YN"@+!@3SCL>GXU'9^)=<G;R#.VZ61
M(Q*8EQ&2<'/'^<5'<:SJ5U<K:WKNZ)<H5S!M(*MCM_+F@"23PYK7GW4GV4D2
ML4/[P?,"P(/TX%7=/T&ZM/$R2?89/L<<[^6V_A5ZJ>N?\:K6_B/6)'CA2\$C
M3,B&0V^/*9L@C^OX5KR:S?+X5M+TW4<<[S>6\C1Y!&YAG';@9_"@#(U'0M0^
MV7?E6-S+$TSNC"0#)(^5OPY_.MO6=,O]032$.X30JS23)C".%!!_[Z%4$\77
M/V=]\D*RA$\HE#B4B0AB/3(%5V\7:I!#;S/Y$BS9;&PC:`2N/SYH`@MM`UB4
MRL8G@=K9]^]`0[%R=OMFB_TV]N0&&F7,3""-(T$8D#!1C!/53QVK6N/&+0QI
MA(7E)E#(-V5*G"`_6J]MXRO[I)3':6X\B-I7W,W*C'`]^:=P#QO9W4MY;/#;
MO,KPF/`4MM;.>/0^]4;6*XL[EKQ=-NH)4B9(55&;S7.1N9OQK9AU;49-!UBZ
M+QB6&5A&<Y*#/(_`=*;IWBZ26\M[6:W3#NL)9906W8'./3-("+1WD\--/87\
M<CK+L>-K9&<9((//K\H-<_)$ZP221VEQ#!&\9>,QMAD7(+,>Y)(X'O6WJ>O:
MA9W6KJN^2`,(XY%(_<-CCMWY_*LV[O\`6+V::U^U2>1/<M;`N`(^O0GZ4`9K
M:?<^5`&MI$E>,-$$B)\W+'DGZ?TK1NQK3Z9>N566"2?]_,N-[%6V@$9X'`X`
MJ;0]?O;?4+=+NZ;[(`8RIC)7`&!MV@DFB]UJ=-7N!IZI;12S)MW(8R6*D;B?
MQS@^W'6F!&+O6HFO=.MVC4DF25(P6V@H2P!.<#]<FFV.BO?:9J%S+-*S6T*E
M$.<Y"!L8^G%7['6WT?2[L1+%.J,JQ3A"!+(<ELDGYL<\_P"-;=OK$ESX<;4+
M**#[41F8,0JJP^\QYSC`^N,4@.9TV_U'3+'[9;7$36[3[/*$0^9_*#=A[`<=
MZW/#6OWU_;ZC)=*LC0+YB!<#'!^7CGM5(^*8K32"%@MFNEE)@$<16,KTWX/3
M^(>M6;;6YXM279:V@L;F[^S[XA\S.0/F)'!ZT`9L'BO5#Y<#7EH6FP_G.N!%
M_LG`QV]^M3V7B+6[_>\3VZ!G\I4*\AG4E,9[97OZUI^(&M-)6VBATFVE29G+
M#R00"%XX_'\@:KVGBG2H[17GLFBN1M?RTB`W'&-R^P'KVH`HR>,=3CV3+#&T
M+*$^=?XU`+XQCNPJR_C*\-L;J*U@:(,D>TL=VX@G\>E:4NHZ(=(M[H6*S0RR
M%8H5@!.\YR,>O%5TUOPVT:1&S5;=F#,3;C8C]!N]R`?RH`I1^+I_.D9/+D,N
MUE$D@5(\1Y8#@'.[CFKUCXHNKR[M@+-%MII5B+[OF#%0QXJ*75/"YB=Y+$;1
MM908,;^,`J/3K^55[O6M.MKA#::;OCC=)U;+*#^Z.".P(`''UH`LWOB/4-/U
M"\BDAAD590L2;^=H7)X`R<@J?SJ.'Q@[3W#+`94VK*%+JNQ`@+`>IS3VE\.:
MJ8KV]MV6>X=8SN+\-M!`],8(YJ(3^#S`.T:MT*R=2N/Y"@"5?',219N+&97W
M`84C&,`]3CGK6EJ/B>TL([9S%-,+B/S5\L`X7WYK'TZQ\,ZI<RVEM%(R0IYO
MF%V&[/!'/IQ^=69YO#]_>+9OY8@M(>)DFV(`2!LR#SVH`S=2\4ZFMX)8?W%J
M2NU&168C:K<\]PP__76W;^+[6XW".SNV90S,`JY``!)Z^]1S6GA9MKR3VI7!
M*KY_&,!>!G_9'Y56:S\-LHW7\H:?#^89&R5;Y<$XZ<=Z`-&Q\1++I=UJ%S$R
M113E(P@^9AD`<9Z\U')XPL8Y)(WM;T219\Q?+&4`]>?>E2RT&VTZ[B2[C%K(
M0[@3@A#U!7T/'Z56:TT`1RQC4<27J;3(\NXL"<YR?]WO_6@#2U+Q'9Z;';R3
M),RW";T**.GXD>M0ZAK_`-DO+%_+=K2>!I6"KEATP?U_6L[5TT._TV._FN9V
MC@'V=1%@%B.V".O>D6/1_$:1PRFYMA91*BEV5>&''KD_+0!;?QA;"966"8VH
M1C)(4Y4@@#C/J?U%6;'Q38:A=);VJ7#R-Z1\*/4\\"LBYT#2-/:*![NY87CB
M$*A4]2"I/MD5H:)I&FZ3<275O?>9MC:*0,1@$'+'CZ=*`);CQ/;17Q@5)#'$
M9!,Y0X!4?P^O/\Z;'XML)9(PB3;"',C,F/+"C.2/>L6Y3P^]]>22:G.$D9RT
M84D!B0"00.><?E5T^&M+MM-,GV]U1=V^92.<KM(_^M0!M6>OZ=>6UQ<0S'R[
M89ERA!4<\X_"HU\3Z2^=ERSX!)VQ.<`=2>.!S5#P]I=A'97T%K?M-YQ,<C*H
M1EVY!Q^?6J!\,6UHC3Q:DZ6HA<7$R,#GD?+@=L9_2@#</BG1E&3>#'KY;8Z9
MZXK.U7Q@EO-Y=C'YV(]S;T92&R,<$#CG^59MII/A[5+N?[-J,BKLW&,IMV]!
MG+#IG^=:/_"+VQ9OM6K22R2QA068`E0RD8_!<4`3:=XOLY;>,W[I#*[$80%E
M49XR<<=*O6.NP:CJ0MK4,8_):0NRE<X8*,9ZCDUD0^#[".2(K?[A_&K*C;^>
M,9Z5;\/V=G#<-=VNI-/;H'MXD<`!!N#$`]__`*]`#K;Q99M(8KE7BD$C+\JE
M@!N*@D]N?YU:U?7X-*F\J2&:1O+\SY%X`SCD_P"?UJA%X:MD%ZHOPQN75VX'
MR;7W>OX5=U?2EU&:*7[<8$V["H`(D&X,/U%`"OXGTF.)'>ZQN8KM*-D$8SD8
MXQFI;_7].T](FGGXF4.FU2VY?7Z5SE_H>F3ZG-;OJ92Z9Y;A@8=RJK<GVXQZ
MTNIQZ+K*11KJ^Q+"'!Q'G(X&>V>@Z4`;%[XHLH,+!OG8MMRJG:/ESG..>W2H
MO^$MLO[,,^Y?M/E[O(R<9QG&[&.E0?\`"-QVE@R_VF(Q'+YWFNH^5=FP@\^G
M>FQ>$9([66V@U9EMYD&Y/)!R<`9SGI]/SHL!H0^*](>&-I+I8W9=Q4JW!QDC
M..U78M8L)K"2]CN`UM&2&?!XQ[8SWKFU\"(K.1J+<J1DQ`G)&.>?<UI6OAE;
M;0Y--^U;BTHE$ACX!!!P1GD?+18`N?%-K]HLX-/`NWN)-K;<C8,XSC'U_*N@
MK`L?#AM=634)+H22[G=PL6T$L,<<\5O4`+14<LT4";YI$C0<;G8`4IEC$BQF
M11(P)"D\D#KQ0`^BD!!Z'-+0`4444`)113(XS&""[/EB<L>F3T^E`$E%%%`!
M1110`4444`%%%%`"'IQ12T4`%%,=]A4;6;<<<#I[FG4`+1110`4444`%%%%`
M!1110`4444`%%%%`!6/JNO1Z9>+;O;22_N_-=DQ\J9P3^%;%<QK=KI]SK\9O
M[]85\C9Y2OM9B6)Y]L4`21>,-/F#;(IBP("J`,L"P7/7CD]#3I?%VG6]P\$L
M4\;)D8*#DC'&`>^:S_[.\.6=Y#LNI6:?$BJK@JJYW[NG`^6JVHZ;H%R[M9:D
M%NIM\B9;*`]3DXXX!ZF@#;/B2PWI$UG<`LS;D,7*LH#'(_'--3Q;I<HRBSL0
MP&!'DYP3_(&L_3-/LDM/MFIZLDS2&51(LN00RA3R1G(`J,>'K"UO88;/46!.
M99B9%W*FUAD<>]`%W3O%=C<:E);M`(5DD412!<F0GH6XX/2F>(=3LX;J*RDL
M3-;6TD;R%&VA&.<#;WXR<5-IWAO2FCBFL[N62-9DF4AP02O`'2JNM6B#59+D
MW20P7+1LDRG>1,@.T;<'(_PH`T;+4=+O+ZWABM(\21F2"3RQU!.Y?]DCK^-0
M'7O#CAHWCB*P-@!H.!DX)''3-5;&UM-.\00H]TI\A=N[/,D\F<Y`Z#`_E3'\
M$(;F:1+_`!D[H04!P<YY]10!9D\1:,FLR6KVL85LI+.8QRV<8/'(]ZLPZEX<
M+W#1BW3R4*R'RMH*DC(Z<\@5G'PC=-<[YM31O,!$N(@"P+%CCT^M,3P2PBG1
MM14^9C8=G0@Y]?KTH`V&U?0;>.,%H$2]!<_N^&'JW'UZU6LM5\.I+&T4,,&V
M(.LS1JN!G;C/7/!K/D\-C2[;>^H0);LBK</+%N/#9^7.<=:2'P^7NX3!J%G+
M=6R#9'LW)M#,#D?B/QS0!O2W6A2LUL\EJ6NRK,F!^]S@J3Z]JBO%T5+M-)EM
MU>2[D,IC4?Q8)W$]NE9</A6\@ADC,L4K%H"DF,%-K$M_/BMZ^T]IM4L;N)(_
MW4A,K'AB-I`_4T`5Q;:#8:NK8MX;Y_N@M@Y;/0=.>:8UOX<NKF>[+VDLK(3(
MWFY`7H3C.!]:J>(/#\VHW\]QB+RS'&JLQP5PV6.>W&:PU\-W8GE%G/8N+@.B
MIYV2JYSQZG&/SH`WH[?PMIV;V)H3Y)Y*2-)MSD=,GWJS<:-H#S;Y5B1[L$@"
M4KYG0\#/T-<W+X1U5C>XBAVR',8WCKN!_EG\ZT-;T"^U'5+6>!8FCC1$D0N/
MD(.2,?C0!HVMGX<FT];:$0>3=L2@9CN<@X.">>W:G#1=*OUEO;$[99`XCE5F
MVH^-NX+Z@BN9?PEJWFAH[:)0A^7;(.?F)S4EWX5U7S!]CMUA",VTK,.?G)!]
ML`@?A0!O:S!9PZ=9Q:G=S;K9`2T>=S\!"3^+C\^]*_A#398=K/,7V(BR;N5V
MC&1]>]0>*]$N-2N8)+:V,K^5L9_,VA?F4C@]>-WY^U8^I>'-76X<6L+M;)*W
MDCSLE02,'KF@#J9_#MG)IL5E"\L`@??%(CG<K=SD_6J9\'VI8*MY=+`V#+%O
M)\QA_$3Z]/RJKJ^D7E\MGYJRRR16+AV1^#,`,?F:IO8:VNK3R*MSLF4JWS95
MAL..<^O;%`&G=^#H+I81]ME7R8EB'R@@@9YQ^--7P5"BE$OIA&5Y4J#EMI7/
M_CQXJBUEK=K:-]CEO-^8AL+!O^67S=?]K`]JLZ,NNPZ;J(F$V?)+0[U^?S2"
M3CUY_P#K4`2_\(7$VU)+^=X5P3&0.3MVY]N`*9:>$;?3KJ.:2_S\X"AD`R<$
M8Z^_Z5FV+^)[B\@BF:]CA9AO?;MQQSR12+'K]Y<6:WJ7A"SQ-M:/"8'5B?7-
M,#:T/09-*N'5YH3'+;"-U!Y+Y//(Z8S5.'PKJ443*;NV+1F/R08\@A"2-W'O
M[U5UFTO)?%3^2\PS+"R2"/<$^5L'\#G]:B@UKQ%]NL8YO,^9MI3RQ\^&(;/'
M7C]*`+I\)7I"0?;(?+F`:Y^094Y8_(,=,GVZ?A1:>%K^*]MY+JXMWBA=$"8^
M\BDXSQU]J=KEW+9^)3<Q7)BB"QQS%1NSG>0N.O.*R9;S6+F&.>ZF>5[:YB58
M&AYWE3R<8.?;WH`T;CP?=R6Z)$]O$R1#D9Y<,Q].F&Z^U21>%+N*P\G=;22;
MXF#$'@`L6'3W_&LL:_JTFDS+=3#R9`\9E>$YW;?N@C`_'M46GZO=::&CADCM
MP3G<Z,XE8*HVXZCJ3QWQ0!T$F@ZA-H\5DZVBM%=B12I."G/7CD\UFW/@K49=
MSI+;!CM&T$@=,'M5.TUZ]M9FDGF+7"YC)E#'R@6YW#/..>*THO%&I/ODW6QB
MA*9_=L/.#.5RO<<<]*`'VOA2^M]0M)";5XHGC=G)._Y0,@>V:L:QX9O;K4I;
MBQN4BBEQN0\8RNU^WIC\S5CQ'KUSI5ZD</D[6C5E1T8F0EB"`1P,#'YUAV<M
M[;>'FU".]"/+>`2.<\C./7IR3VXI`37/@NY,K_9Q;B)G;@N00FX$=CSC(K4'
MA^9-#U&Q6*)A+.9+>/><*N1@$_A6%;^)M1TVP14$4L4@>2)W!+?ZPCYN?K^E
M;</B.\D\+OJ1AB\]9?+X!V`9`W'OCF@#.E\(7S01F`003'S3+LD.#G[JCCIV
MJSIGAK4+31M3M6>,27(41J6W+QUSQU[53/C2_4K\EH^TX*J'S+\Q&5].`.O_
M`-:I)?%6KV]A'<3)9GST#1;0W][!SS[4P*@\*:JUK.5A6'+`&`2`^9@]0>PZ
M<'TH3P=JL8VO';3&12H9I#B'G.?\^M))KNI7<RR?;(H]ZQNL?S``@-G`STR.
M?PJ_I/B6Y6QCCFGAFG62,$$DLR$$MWY(Q2`KWW@V\\RU:R6%,1(LA#GY9!U;
MI4,OA'5G@B@6.`!)'^;S.N>=WTP`/6I[3Q?JUTR0+'9B:61$0DG`SZC.?3FK
MOAG6[_5=9/VMT2/[,2L:@@,0V-PYZ]10!G7>CR62VMLI1-4O))%;RLE3&W!R
M?;-;'B#1)7M=/BM+47,-LCQF+?M.2H"MGV(S5"'Q9J-RKE+2U\P.JQEB>[;<
M$9SGD?D:9?\`B#4Y(8WWQVQ`9)`C\DB15)4'O^?!-`%[1="NK/\`M226(-<2
MVZI$SMD,Q3Y\^V[%9"^%-1V%!:D")#N#S*1*W^Q@<=.]7=-\0ZJEO';.L-S<
M3'$#9)W,'^96.>,#^E7=9\37.GZXME%#"T8*;RY.X[NN.PH`P7\+:M)<3R"U
M\N-P^U/-!P"I*K[X.!]:T+#1]4B\26T_ESPVXYYD#!4V_=//KQ2R>+[^`*\T
M%LR3J_DE">H;;ELGIP:=;:GJ3>&-6OFNB]Q'/L4K@J@RN=OM\U`%2ZM[N]U7
M58[*&9I5N,B592JJ`#D8SU.!0+'6+FXM0]I=K;J88Y-TI4D`88\'H?6IK7Q)
M?6,=Y/<Q131R7$B1NK#AU&<>ZXQ@U)8^)K_4M3T]46*&-I71QOPKC"^O.1NX
M]30!GVNE:]#<^<(+HI#*K%&FY<!N@YP>*#9^)!>B5(KU(VD+A!+P`6SC&:MO
MKFK'7'A21<)=,/+##!4#[O3T!Y]:TH?&"3ZC;V\=DQCE,:F3?]UG`QV[9-`&
M-?Z1JKV\(*W\JLC/+&92V,/\HQSSC!Q6CXBL;I[V&:RMKMI#:;$='(,;9'WC
MGKMS^/K77T4`<_X1M;ZUM[A;E9D@9\P),P+*.<Y].U=#24M`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`E%07-HER\#L[J89/,4*<`G!'/MS4]`"T44
M4`%%%%`"4WRP)3)ELD8QGC\J?10`4444`%%%%`!1110`5SVJ^%8-2OYKQ[B1
M)'"[0%!`(&.?6NAKD==TB_NM4OKNV,ZO'%']GV/MW'HW/L,\>]``O@K$I'VM
M3$V23Y0#`D$8'MSTH?P5''&!%>E<;\LZ#HRX/-9'V;Q&FEPJHOEQ*61`<X'&
M`><C&#U&*FO!KC0W%H]O>,7EF9]N60J4&T9[X/:GJ*Z+%KX,:)D\R]BEB^?*
M$'`)7`('KG'Y5(/!MPH`26WRT8#2,&W*VS:0O;'?FLFTTJ_A=!]CO5;S8'7(
MRHP.2?<'IZ9-27-UKME812RW=YF:/=(74@1'?@#/J1_.@+F]HWAFYL-.O[>2
MZ`>Z7:ICSA.#SVYYJ"T\'LEQ;S3&!/*D0E(RQ!"CD]N2<?E1HU]?7/AG5)8[
MB:XG21UA<_>QM&,#]:QX-2\0210(]U/$C^8RRF/)?";AU'/3C\:!FQ=^%9+C
M7Y;EUA:UDE65M[$,>#E1^.*I)X0U<75G(;N$>3M&\,24`8D8R.<5G7+ZA,UN
M;R^F,UP(61&C.,%CR,<<8'N<U+::AJ=O:1_9]0:=KB1K?8QYBD+#!YZ\?SI`
M;.N>';S4-4O+J$[3Y*B!M^,OT(_+/YBL@>&=?-O:KD?NW.Q?-'[G.#NSGUST
M]*DU2XU+PU<0VL%Z9M[&=F,9RY.!@YSGIV/?Z5K'[1X6\+R.DIGFDEWJ7C.$
MW8ZC/M^9H`SIO#^MW5GY#QJJVZNJYE!,VY]WT&,#K19^'=2^T3QR6[Q1.0AD
M$P)*^:&)'/IFI+;Q+J]\D<<+6J2-%)(Q9#P%STY]O2L_2M>OH)I96N?./D(H
M,C.4C)91EAZ@=<4`5]8CU2T\NUNFG*_,MNN_)"Y`'3KD<8KJ/$T&MR/;'26E
M"!"'$<FPY]^>:QY_$=W'?->+<13,EKPD6_RBQ?&<-@YP?TZT2>.;[R(-D,*R
M<^864[3SQCF@":73/$LMLYFGN7>5I%:)91M"[3CJ>YXJDNCZI:&&XF-S;!`X
MWJP_=8C`#$@]"1@^PKO=/O[?4(/-MY%?!PP!^Z?2K-`'.Z<VL3Z+=WX<_:KE
M=\$+?=C`Z8]R.?RK$C'B"RMWF:.Z5I9MTCJ@9V(4!>/3(YKO:*`..75O$B,J
MR6<C2CYFC$`VE<#^+/7.>*N:1J>L7.GZA)=6[+)%'NA9HBI9MI.-O?!Q72T4
M`<3+K?B"-$;R]R%$>1Q:MF/.?EQW^HJUX>NM3N=>EDU$O%OMP5AVMM.<<CL#
MQ^M=910!P6FZWK=KIDL4=GYH@7=O=&RI+\Y_O$Y/2ED\7:O'#F6&WA8`L-\;
M?/R!@#-=Y4%Q8VETZ/<6T4K)]TN@)%`'$6FN:K:PW4D*1N%+7,PE5B>7VX'/
M3']:W-8\0RZ?(@\J-8Y+0RH[9.9.R\?YYKHL#T%(RJRE6`(/8B@#D;OQ3?F&
M2."SCC<B4++O)VF,98XQ^5+X6U&[O-0E$LSR?NY'"N^5W;ATXZ>GIS76&-"I
M!1<'.1CKGK0L:*05500,<#M0!QD?B/4H;RY>58)A!$YDB$A`7;(1Z=><>XP:
MU-/\4+?:S]@%F4!9E#EP3E1DY'85O&"$[OW2?-][Y1S]:1;>%9FF6)!*PP7"
MC<?QH`XE/$D6DW^HLUIY\DUT^3NVD*O`[8/>I8O&4\#SQW%HD[B1R-L@4(H[
M9QSWY[UUS65JYR]M"QR3DQ@\GK0]E:R.7>VA9B<DL@)S0!DV.OK?:3=W[66V
MWM\E07!+D#/3'':LV3Q=#$TKW%JD@W+Y4:,K$#;DDL./2NK%M`L;QB&,))DN
MH48;/7([U7_LC3=NW^S[7;G./)7'\J`.:7Q4@:XFFL(Y(F>,1(A4MRI8Y]?Z
M5NVE[;ZIIK2Z<(//\OY4<#]VW.T,!T&:G_L;3/\`H'6G_?E?\*EM["UM97DM
MX(XF<!6*+C('2@#E9M4UI%N99SI[BSF2)MJ%CN)'3\_S%6[GQ%9&2,".,V49
ME$J21C)9=N-HZ=6K<?2[%XY8VMT*S/YDG^TV<Y-1-H>ELFUK*$@[CRO<XR?K
MP.:`*<.MZ==Z)-?BV9H8?E>,Q@G/!QZ=Q51?%-K+:0R16J^3)(\<L;D94!<Y
MQWR*V8]&TZ.Q-DMK']G8[BAYR?7)YS47_".Z28!#]C3RPYD"[C][\Z`,67Q+
M:RQH]AIT<KI.L`W@*,,&(*GMT-./B;0B@86NX1H``8E^5=P&,=NQK4'A?1EC
M:,62[6()&]NHZ=_<TYO#6CMOS8Q_.=QP2.?;GCZ"@#/?7M)AE#SV0C$9DA\S
MRU.UE(RHQ[$'TJO9:UH\D220:4J,)&2,;%!W8W#GMFMU]"TR0,'M$8,[R$,2
M?F;[Q_2F0^'M+@C6..T4*K%A\Q/)&/7TH`S])U"SU74HXXM.ACB$(N$=E&[=
MNQP!Z'(_"HK76-&@\FZ2R:%?*=4D5!P%.67`^H/XUL6NB:?9S0S00;)($,:'
M>>%))(Z\\D]::?#^F&`0_9OW:[\*';C=C=W]A0!CG5?#REYQ:<F:-F81<[R"
MRG]/S-,N-3T&XLVEMK)+EH6#[&3&"[@'\<\_E6O+X9TB:59)+-2RA5'S-C"C
M`R,\\4B>&-(C@FA2UPDP`?\`>-S@Y'?CF@#'O4L-'\4V3B-TA,;R[4/RJVTY
M.T#DX'^<58EU?PQJ-PLLJQRS;E12T1W'/3M6K=^'],O5A6YMRXA01I\[#"CM
MUYID?AO28KN.YBLU26,@J58@`CH<9Q0!EZC/H]GJZZ?>:?&(1;Y23:2?F;[H
M`]\G/K4MK?Z`EK+IUK#(8Y2P>%(G))``;WZ8_*M*_P!!L-1NUNKF-VE4!01(
M1P#D=/K44OAC2I8RC0-S(TA(D8$EL9YSTX%`&+!?:+(EQ:7FG^1#;S/Y8PQS
M\IR3Z'`Z?X4LESH-L+9K'3S,T<L<F0'41;\88M^`X-:Q\*Z3Y+1"!U5FW'$C
M=<$>OH33F\+Z6TD3^2X,84*!(<?+TSZT`4%O?"\M[+>*4-QM+,X1QG/RG''/
M7M4&G?V)<7M[=MIWV?\`LTIB3+Y(&<$IV(VUI#PEI`>5Q"X,@(/[P\9]*LZ?
MH-CI\5S'")&6Y4+)O?.1@C^IH`JW7BW2XH)6@F\^1!PBJPW'ZXJ"7QC:JT:Q
MVMPQ9U1\H1LW#/IS].]6(_".DQ<K$^?+:/)?LV03]<&@^%;(W$<WFSAD9'(W
M_*S+C!Q]`1^-`"?\)7I_VWRMQ^S^5O\`/"M@'=MP1C/XU=&MV+Z?<7L,C2PV
MY(?:AR".V#CUK-;P;8>65CFN49@`Q$G7D'I]15^#0[:#3[RS5G,=V[,Q)Y&X
M8XH`KV_BBQENIH9=\*HR*CNC?.6&<8QP?K5VPUG3]2E:.SN1*ZKN(VD<>O(K
M-A\+A&C>6_FF=9XYV+@?,4&`/_KU8T7P[;:-<3302.YD&T!L?*O7'OS0!LT4
M44`%%%%`!1110`4444`%%%%`!1110!'(DC-&4DV!6RPQG<,=/:GTA=5*@L`6
M.`">M.H`****`"BBB@`HHHH`****`"BBB@`HHHH`***S;W7M,T^X-O=70CE`
M!*[6.,_04`:5%9C>(-+601M=J'+*N-IZL,CMZ5;LKVWO[9;BUD$D39PV".GU
MH`GJ*YMH;N$PW$2RQMU5AD&I:KW=]:V(4W5Q'"&X4NP&:`%M+*VLHS':PI"A
M.2J#&34VQ<`8''3VJ*UO+:]C+VL\<R`X)1L@&IJ`&^6F0=HR.G'2JCZ39/>Q
M79@4319V$<`9[X]:FN[ZUL@INKB.$,<+O;&30U]:+*D37,(D<`JI<98'H0.]
M.[%H22012E3)&CE>5+*#BG,BNI5U#*>H(R*0RQAPA=0YZ+GDT[(/>D,B6V@0
MY6&-2!CA1TI!:6ZA@L$8#<,`@Y^M344[L5D5S86A&#;0D;=GW!]WKCZ4/86<
M@4/:PML^[F,''TJQ2T78616L[&VL1(+:(1B1R[8.<DU9HHI#"BBB@`HHHH`*
M***`"DI:*`(;>5YD+/$T1#$8;'(!QG\:FHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`*2EI*`%HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`*&HQF2YL-LJ(RS
M[L,V"PV,"!Z]:O5!<16\EQ;M-%OD5B8FV$[3CGGM4]`"T444`%%%%`!1110`
M4444`%%%%`!1110`5QVH:9>:CXLNTMKN6S'DH3(H/S=!C((]:[&DH`\\UJ&X
M&L7H$4[)]KA<%%/96R159;2Y^QVJQR7<3+:R2,%+#Y@S;1BO3.*,"@6IYC?W
M=TY/VV[NHKA;>+R45CA\@9)/8]?QKH?%L%Q.FCQ!1YID`8L-X5OEZ\<C\*Z*
MXTRQN;A;B>UBDF7&'89(QTJWBF,X37!JFDK9P6TXB;8[R-;1^6C-[@#&<`"J
MUSJVN)?6Z^;.H\N$D!>&RH))'US7HF!1@4A'$^.RJ:A82E#)L'*.IV,,],_A
MS^%9FJMIT[6L\$%S;W2&-9+=U8Y4#^'/X>E>CO%')C>BMM.X9&<'UI=J^@H&
M>97)W:K<7;`2O-),0F'62'`.TGITX]>E:GA^ZL].OH95=HX38K]H))($A8#\
M/PKNMH]*0HI&"!CTH`\V-QY-RUU&91J(O9,I\W*$''`Z\Y_.K>@9AUO3!9RN
MYE@)N\,6Y^8X;T_AKOMBD@[1D4!5!)``)ZT`+2TE+0`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`44E+0`4444`%%%%`#&<*RJ0<L<#`]
MJ?24M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`(2`0"0">GO2U')!%*\;R(&:
M)MR$_P`)QC^1J2@`HHHH`****`"BBB@`HHHH`****`"BBB@`K`\31W;2V(M+
MJXA::81%8C@8/)8_0`UOTE`'##4-1L)[AHKN2ZB+201K,6+$HN2XQP.>!]:L
M>']?OY-3MM,E7S$P0\LBMYF0I)!Y['BNQHQ0!PUUKFH)K9N4N5CM?-EB1'#>
M60@ZD>IR,8[U:3Q==W!006L"DM'&PE8@[V!S@#L,5UQ56&&`(Z\BD,49.2BY
MSG.._2@#GM)U^_OM1@MY;.-8IHC+O1CD)R`3]2/UJK/XJO!<3+!!:O$AD97,
MA&44XW?B>![UU:11IC9&BX7:,*!@>GTIGV6W_P">$73;]P=,YQ^=`'-)XP+/
MM:V13YHC*L^TC"Y8G/3!XJ&S\5:C?RPPP6D"NTP0[G/3!)'Y#K75"SMED:1;
M>$.V<L$&3GKS1'96L0`CMH4"MO`5`,-Z_6@#G]4\27&GZQ-$(8WM;=4\W+8?
M+?W>>>#T]JD\-^))-:NI89+81;$WAE)/?&#_`)]:VVL;1[C[0UK`TV<^88P6
M_.BWLK6T+&VMH8=WWO+0+G\J`.:3QM$+NX26V(BC#;"K99B#CGTS4P\62+<S
M6TFGGS8MS-MG7:%'OTSV^M;::5IZ"0+96X$F=_[L?-SGGUYIIT;3"RL=/M<J
M,#]TN/RQ0!BQ>,H3(&GLY8H&9E63<#RHYR/Q%2P>+H9+E();&XA+.$9F(*J2
M,C)^E:4NA:7-)-))91%YOOMCD_X?A4%]X<LKFVF2)!!+*[.9!EL,W#'&>XR/
M;-`%(^,K9$9I+2=<1+,!E3D$@#H?>D_X32T,:/':7,F4,CA0#L`;'/\`GO5Z
M/POH\=N8?L:LIP2Q8[B1WSGC\*D7P_I:Q&-+554J%X8YP&W8SG/7F@#'?QM!
M!<3K+;N\8D*Q-'W4=2<^]69/%D3W44%G:RS+),L0E(VH2>N#ZBK<OAC298T1
M[8[4S@"1AU.2#SZU-%H.G0WXO4@Q,&+#YC@$]2!G`H`S[KQ2EEJ\]I/:2&"(
MA?/C^;YBH(!&/?'6KEEX@M;Z>"&%)2TT9<G&1'CLV.AXIEUX=M)9I+J+<EX6
M,B2,Q8(_9MN<<<?E5C2M)BT^Q:`D2O*2TTA&/,)Z_P#ZJ`*4/BW396N-QECC
MAY\QER'&[;D8R3S3QXJTK)5I94<9RAA?(QZC%59_!MD9H6M9);=%;]ZH8G>!
M@@9)XY%,_P"$/C:ZE)O)TB=`I9'^>3));<>^>/RH`T9/$VE1R^69V9N`-D3,
M#D9&"!SP:8WBK2$56-PV&7=_JFZ9(YXXY%,;PO:+81VUO-/`T4OFI*K?,&QC
M^55(/!X22=7OY_(D9=T8/^L4<G<?<EOSH`OMXGTL2!%F+_.5+!2%&.IR<`@>
MU.'B336%NR3%UG<J&`QMP`26SC`&>M49O!]O-;1P&[F"Q[BN`!RS9)_(`4J>
M$($C"B[E.$D3+`'[XQF@#:AU"TN(7F@N(Y$C!+%&SM^OY56L=?TV_P`^3<HI
MW;`)"%+'V!Y-5].\/)I^F75K%<N9+@$&8KRHQ@#'MS^=46\%6K744AN'$2!`
MT07&XJ,=0>,_U-`'0K?6;%PMU`2G+`2#Y?KZ5)%-%.I:&5)%!P2C`C-<I_P@
MZQPR^5>LTK`!2RD#&>0<'G-:V@Z5=:2ABDN8Y8F!9@$PV\GJ3WXXYH`V:***
M`$I:**`"BBB@`HHHH`SM:-\((!IS%9FF`SMRH&#G=[?3VKGH=0\6"58FLP=S
MGYGCX'MD'@"NQHH`Y:/4_$ANXE?3P(WW.1L/RC'"DYZ\?K3-.U+Q)]IC2ZL&
M:-I\2,4QM4XZ>PP3GFNLHH`Y75;GQ#!J\TEE')+;*0$C\L%3\H)YZ]<]^M5V
MUKQ,OE*=/'F.I^7R6Y.3SUXQQUKLJ*`..;5_$D=T8YK4".*0!W2$D,,X&.>0
M::-<\2)%(]Q:1Q"`;Y&DC(##C"CGKUKLZ,4`<Q?ZSK-OIMI<)9_O9G8LGEEM
MHS\BGT)'>HIKW7(M`ENGE<7+W&P)Y(/E*"1Q@<]!S7644`<4/$7B"*WR]@7*
M[.3`P+`YYZ]\?K5J#7]:;5;>VDT[;#),59C&WW=V,Y]AS75T4`<U>76N07U]
M=QAGLK<@1P;!F3@<@X)(R2>M4W\1:^;=)ETU$0`;BR,=_!/&.GW3^8KL:*`.
M?CU?4_[)FEFL@MXTBI;QA6PVY01G/IDY]Q65=>)-;B=]]E)#^YV8,)(67N0>
MXQ7:T4`<[J>HZA"]F%F%M&T(D>0P&0N^0-FT=.N?_P!59_\`PE.KGS(UTT&0
M_<)1AMP>=P]<#U_.NRHH`X^X\5:K!\K:2=X`8_>P`P!7GZ9STYI9O%FH13HY
MTTI:O)Y?SAM_&,]..X_(UH>*(=3E:T.F-*C1^9(Q0X&0N0".^>F*HQ:SXC^<
MG2MZ1D##1LKN#QG.<9Z9P*`&KXNO=T4)TT^<65"'8J2<#G&.,D\58G\3W$5I
MIMP+5&-RCM)$6(;Y<#Y?K]#Z53BU7Q-;6PC&EF01QK\[JS,Q('4YY//3M^%:
M>F/?S:]?3W5LRK''Y<.5*@@,>A/KQTH`SCXY=L;=/"8!=@\P&5]!QUJ[;>*7
MO;:_>.R,#6L>Y6E8D$YQ@@`'\*I/J6O3R.9]%B<P_,H>W8Y.X#`.<>^1Z58O
M;W6C>Z=):*[P2Q+N"Q84N3@[NZ@`YY/:@`N/$.HP>'H-1>&V5Y'(VMNP5[8&
M>#]?2JC>+]12<Q/:VP(?:6+-A.2/F/;Z^])J-QXAB6(Q?:#Y*E9'6,GS&WM@
M[<?[(_!O>G7=WX@"RQF*?(F+F5(^B8"X"CK@MGKVH`UM!U+4[^ZF6ZB@\A%#
M>9'D8+`$+SUP#S6]7,^&_P"V9=0N)=1FE6,*I\MDPK$C/'ICC('<UTM`"T44
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!124BNK,RJP)7A@#T^M`#J***`"BBB@`HHHH`****`"DI:2@`
M!R`1WI:2EH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"DHH'`H`6BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`2BEHH
M`2BEHH`2BEHH`2BEHH`2EHHH`****`"BBD`P:`%HHHH`****`"BFEP'"<Y()
MZ?U_&G4`%%%%`!1110`4Q%<.Y9]P8Y48QM&!Q[\Y/XT^B@`HHHH`****`"BB
MB@`HI,C.,\T4`+1110`4444`)1BEHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@!.]+110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`1M$#<)-N;*JRXSP<D'^G\ZDHHH
M`****`"BBB@`HHHH`****`"BBB@`I*6B@"$VL!N1<F%#.%VB3'S`>F:=##'`
MI6-<`L6/.>2<G]34E%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%)2T4`5;:ZDGFDC>TF@"='?;AN>V":M444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!4<DHC>-"KDR'`*J2!QGD]NE244`)58WT8OA:>5/O(
MSN$3;.F?O8Q5JB@#.DUFVC5F>*Z`60QDBW<\C\.GO2)K=H\@0)=9)P,VT@S^
ME:-%`#!,I9%PV74L/E/08Z^G6J<^LVEO,T4BW&Y3@[;>0C\P,&K]!H`SDUNS
M=@`+D9SUMI!C`S_=I!KVGE@HDE)/0>1)S_X[6E3:`(%O[=X6F5V,:QB4G8?N
MG)!Z<].E6(W62-77.U@",C'%(GW1]*=0`M%%%`!1110`PLPD"["5()+9&`>.
1/\^E/HHH`****`"BBB@#_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>vivakorex312image3.jpg
<TEXT>
begin 644 vivakorex312image3.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86
M&#$C)1TH.C,]/#DS.#=`2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`.D`O`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBD
MH`6BDI:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**2EH`***
M*`"BBB@`HI,TM`!1110`44E+0`4444`%%)GG%+0`4444`%%)2T`%%%)GG%`"
MT444`%%)2T`%%%%`!129&<=Z6@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`2EINWYRV3R,8SQ3J`"BBB@`HHHH`***:[A!D@]0.
M!GJ<4`.HI*@N)WA60I;R2[5!`3&6R>@SZ4`6**I1WLKL@:QN$W*"2VW"\XP<
M'\:L12LX&Z)TRH;YL<9[?44`2T50DU)XY`G]GWC9Q\RH".?QJ)=8+#/]FWX^
ML0_QHU[!IW-2BLM=:!&3I^H+]8/\*C_X2"(-S97VS'WOL[=?2BS[/[@T[FQ1
M6`GB8L\@.E7P4`E&\HG<>PQCC-,7Q-,7;=H]^$P-O[LY)YS_`$IV?8-.YT5%
M8!\3,.NCZEG_`*Y4W_A*ANV_V3J&[T\K_P"O19]@^9T-%<[_`,)8@.#I>H#C
M/^K[?G2_\)1YCJMOI=ZY+;>4V]LT6?8#H:*YJ#Q1<3-M&C7>0I+8'3!^GI_A
M4(\7SD'_`(D]SGJ!D\COVHL^P'5TE<U;^*IYI`/['N]F%W%>2,X[8]ZD_P"$
MFE>[D@ATB\<QXW<8(SZBE9]@T[G145@R^(V2+Y=*O6G'+Q>6?E'.#G\*G'B&
MV.?]&O>.O^C-Q1KV#3N:]%9/]OV__/K??^`S?X4X:]:E<F*[!]#;/G^5&O9_
M<&AJ45D_\)'IW=YQ_P!N\G^%'_"1Z;_?F_\``>3_``HU[?@!K45D_P#"1Z;_
M`,])O^_$G^%*/$6EG.;@J1U#1L#_`"H`U:*RCXCTD'!O%!_W6_PH_P"$DTG_
M`)_$_P"^6_PI7'9FK164OB/26.!>I^1_PJ0Z[I8&3?P8_P!\47069HT5G'7-
M+`S]OM\`X^^*F&IV31I(+F(I(^Q&W##-Z#WHN@LRW124M,04444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`F.<TM%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4E+10`E+110`4444`)12T4`)BC%+10`E&*6
MB@!,48%+10`F!1BEHH`3`HP*6B@!,"C`I:*`$Q1BEHH`3%&*6B@!,"C`I:*`
M$P*3:N<X&:=10`FT>@I`BJ``H`'0`4ZB@!H10,!0!]*0QH1@HI^HI]%`$?DQ
M9)\M,G@G;UIWEI@#:N!R.*=10%A*6BB@`HHI*`%HI`P;.#G%+0`4444`%%%)
M0`M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1124`+12$@$`GKTI:`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`2EI*6@`HHHH`****`"BBB@`HHHH
M`*2EHH`IZ?:/:&YWR^8)IVE7C&T''%7***`$HH(!'(S10`M5[>&2*:X>24NL
MCAD4_P``V@8_,$_C5BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"DI:*`$I:**`"DI:*`$I:**`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`***2@!:***`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HI**`%HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`*0=Z6B@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BDHH`6BBB@`HI**`%HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$(!!!&0>
MHHZ4M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1244`+129HH`6BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*2EK$\4:V-&T_
M,9'VF7B($9';)_#-`%S4]9L=*3-W.$8J65.K-]!7+7_C_*8T^TPQ_BF/3\!U
M_.N-N[N>]N'GN96DD<Y+,:AH`Z4^.-7,@8&`#/W1'Q_//_ZJLVOCV^6<&ZMX
M)(NZQ@J?S)-<FB,YP/S/05/<V%Q;.%D3)*JX*G<,$$CI[`T`>G:=XGTO4&VI
M.(FXPLN%))SP.>>E;->(`UVOA'Q0XE%CJ4N5;B*5SDYX^4G^M`'=44E+0`44
M44`%17)Q;2D`G"'@=>E2TUF"J2<X`SQ0!YMIJ7T'V*=/,ADDCE,<F6?S&Y`4
M@\#GO[U<AEAB%E)I[WIO#$YN<EC_``'/7OGD8K;TWQ?;WURT;V\D,2J6,K'*
MKCGGTZ5H_P#"0:5]G^T?;8O*W;,Y[]<8ZT:`<-8N\4-TCS3-YMJ294+L%Y'#
M*0.?<'O6WX2G=;;48!(\IC3<)`Y:/.#TR`0?\*W'\1Z.KE#?PY'7!R.F>M12
M>)M)BE@C6X5A.2-ZD;5QZGM1H!PT&H:D8883),%BD$IDWMDAMH`^G_UZV='U
M3[+KN;Z[=(0DJ_O&.W/F''XX'Z5U"ZWI+1&5;V#8"%+;AP3D@?H:E34=/E$6
MRYA?SF*QX8'<?04:`<[9:S`E]K0GO<"1A]GW,>1@XV_I6'8W4C6#N;Z595@E
M.#>,2QP<?)CCUZ]J[^6^L8IFBEN(5E4;BI<9`^E9MIK=C<:1<ZC]E,<,!*X9
M1EN!P/KD"C0#-\)RW1U=XIY;A5^R*_E3RF3>3CYU]!@]/>NPK!LO$VGSKNEB
MEMI/,6$+(G)+=.1VX-:%QJ^GVT4DDMW$%C^_AMQ'..@YZT`7J*B2Y@DD\M)4
M9\`[0PS@].*EH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHI,<YH`6BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HIK,%4LQ``&23
MVI:`%HHHH`****`"BBB@`HHHH`****`$)`!).`*\G\3:H=4UB:4-F%#LB`.1
MM'<?7K7IVJRO#I5W+'C<D+L,].`:\;-`"Q1F60("`3TW'`J5;29MXV@-&Q5E
M+`$$9S_(U!6K<)9W-S!<O<+;P31XD$:[FC95P01[D9Z]Z`+>AVRV5Z3=QJ[R
MP%H8P-ZS`J<@X[<?F!6A<:I;:G9W;VVGRQF&-I"&DPN#D$\<_P`1X'7/M7+I
M<FW9FMY)5=3A)58J=O/!Y^E(M]<I'+&)24F'[P-@[O?GO[TP(_*D\GSMC>5N
MV[\<9ZXI%-*XPJJ)-X(W$#/RFFBD,]:\-7YU'1+>9R6D`V.2.I'>M6N)^'5P
M2E[;M(3C:ZH3P.N2/TKMJ!!1110`4UUW(RABN1C(ZBG5#=[3:3;]VW8<[>N,
M=O>@#EO^$3.7>:]A\I(I%618PK'<,9<]\"HH_",EM9QNE[`;KS,J9!F,@C&,
M'.36)-;EO-=-/GMV&TFT6-\>4#DLS'D\_P`J=)IVJ-#9[K6X9(T)A18F.,R9
MPQ[<9.?3%`&]!X4,-K?V;W,)DN41H2!M(*]3CTR0.*KQ^#;V,)*ES;&8.Y;<
M"5PPQ^)ZU8\31WDFO:<UFI^T1PO)@`D<<X_'&/QK%M+S4-,L((5DFLU*2,F(
M=QEE#$;3GIP`*`-.S\'WD$\8EFMI(//CED!SD[<Y&".^34_A[2''B&[NY+:2
M&VB9C`DHQAFQDKVQ@8_$5EWMSJUY;:@\]]*B6TZH\2("`">>1S@8JQX4N;J/
M4(5%TSP7-U,C1LG4J@;=GL>G%`%VZ\,W<VI2G=:M;27/VCS'!,O3[O\`N]JO
MIHL\?A7^S4,"W!7YB1E&.<\\?KUK#UW[.^M7\>IBZ:<A!9+"3@@]A[Y_K4-Y
MXHU2WU&2(3,JQAT,;Q+NR%.&/OW]/;%`%U/"FH+:;3+;AEN4E2WRQB``.>3S
MSGI[54?P;JCM<L9+7,BGE2>3N!Z8XZ4M_K>LZ=/:(VHB<RQK*5%NH/.,+TY_
M`U(_B/51=7*I.K2!I5^S&'F%5&0^>_3O0!9TOPWJ%MKT5W,8EA1B_P"[(R,K
M]WIT'3Z>E=A7->'=2OI[V>"^E^T&.!)5=5V\.`<$#@^WXUR]O<SQ:E(]K>2R
M.T,Q)&X,I"L?F!&.H'3VH`]-I:X.SU[5(K.>2*ZAFALH(B5,7WMP`QGKP3^.
M*9-XTU%;&W9(XA(2V]V7AL=,#MUH`[ZEKF_"FHSW\^HF>96/GEEB.=R#I^7&
M/J#724`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`UU#HRMT88-+2T4`%%%%`!1110`4444`%%%
M%`!1110!7U"W6ZL+B!RP62-E)7KR.U>,,"#@C!'4&O;J\R\9:1_9VJ&:)"+:
MX^8'L&[C^M`'.C@@XS[5*LV(GB**5?!]P1G!_4U%CGBI;B&2%MLL#0D\X((X
M_&@8AB3<^)DP,[20?F_3C\:BJ_;_`-G-;R&>.<2JN4VRJ`Q_%?QJLL:NCN9`
MN#PI/)H$14HI6C9"`ZLN0",C&0>].AB>:58XU+.YP`.YH&=K\.K=O],N3D+\
ML8Z8/<_T_.NWK-\/Z9_96E16Q.7^\Y_VCUK2H$%%%%`!45S,+>VEF()$:%R!
MWP,U+4<VP0OYN/+VG=GICO0!S5IK.I?9[>_NFLVMYT=C"AVN`H/W<GYCTSZ4
ML?C.WEA#Q6-P[&01A%())()&/RK!/]GB&&4:/>RV\Y9(`\^0N<CY1ZG&<5/;
MOINGW8C.FWL;VJ?:6\R09+`<$CZ\?C0!MIXSTYI)E:&=/*4D%E`W8[8SP?K3
MG\56BQEGLKH2K*L?DL@WY8$@@9[XK%LX-(O;^%YK6]9;QI(U>>7(0X/0]23[
M]#5JZMM)L+^*T:2^DN8IXIW<#?N(X4$^G..*`-6ZUZ`:`FI6T!?[0VR-'P,M
MDCG\C5&?6-7TY7:\L;3Y9$`:$YSN.",9SG%+:3Z1>Z%+I@$XMH(#)YCK@E03
M\P/?D57M-,TN?19=1-U=.F\2/-*,L0A^[B@"Q8^+K2X!>\M'B?:\D;;00RJ3
MP#Z]?;(-;=W+%%I<]\MNNX0M+M=<$_+G!_E7$7,>FQ6]OMEO)+>!S(JM;$,0
M<$J'X`7G/XGUK=BU*TFM[JRN[Z9C?%MA>(@0AUR(\],B@"K9>*;::YC>[@3;
MY;22%ADPLHX"\=#@'ZMUK2B\0Z/*P?R"C2"0.TD84KM&2&/N"/6L^RTK1=<E
MF:UGFR+=8I%*[<\#:_\`XZ/:KB^#+,:<;5IY&)E\SS,8(XQC\J`)8O%&DBY2
M(1R1-(J_.8L#[H(!/L#5>W\2:<;BYE6U$5LD(=I/*P[$MC&.X/K3KWP=;WM\
M9Y+N41Y&(0.%'H/0<4?\(HYMY8GU*1B\20JWE@;44Y`X/-`$\FH:8-`N-2LK
M2*2(+M9/+"[L$#:>.@S61/XCL5T^V_XE%N^"Q9"%V*`V"4R.<Y[5LQ>'%C\/
M3:3]I)$K;C)LZ<@],^U4[CP:L]LD37[9#N['R5P2Q'0#ITH`1==^R:E(#I,2
M(\;7#S1.N\Q\D,PQU/H3WIT?C*);"6>ZLY(Y4?8(U.X'@'[V..M7QX>ASJ!,
MAS=Q"%3MYC0*%Q[],_A5=/#)&C7=E)>%Y;EE9I2G3;C`QGT'K0!K7.H06NGF
M]F;;&$W8)Y/'`^M9!\4[;>VN)-/G6"4*9)<C:F20,'^+IVJ>Z\+Z?>,7G\TR
M,JJ2'(&0,`X_"J3^&+P+9K%J09+0*4CDB)7<#G/6@"U;^*;:=I?]'F"JN^,@
M`^:N_9D>G/K6GIVH1:C%(\2NICD,3HX`*L.HXXKGQX0D#7[F[4M=*57]W@+E
MPQR,^W:MG0M*&D6)@W[V>0R,1G&3Z9]@*`-*BBB@`HHHH`****`"BBB@`HHH
MH`***HZQ+)#IDTD+E'&W##J,L!0!>HK&GD,5S)`)-1D>-`YV%#\IR!_(_E2L
M^PQAYK]?,E$2DE>I7.?IV^HH`V**H_95&[_3[CY>O[P<?I5>T"7J3-'=7@$4
MC1G,@Y(],?6@#6HK.C@1HHY'O+F/S`"%:49&>WUI9+:.)D22_N5:5MJ`R]3@
MGC\`:`-"BLBR2*]B+K=7D;*S*4>8;AM8J>F>X-6$LXY5W1WURZ^JS9%`%^BL
MB[^RVULT[7URRJP3"3Y)8G`'UR:K0W,<\_E1C4,JXCD/V@81CZ_-SU'3/6@#
MH**S_LL&]T^W7&Y!EE^T'*CU-.2RBD0,EW<LIZ,+AB#^M`%ZDK(NC:P0+*MU
M<R^8XC0)<GEC[YQ4DUKC3I)A+=QN(B^&G8E3C/.#B@#3HK%N5,-RT*"ZEVP^
M:<73`D9P0!Z_C2Q2:=+''(M_<[73>N9W'&`?7K@YQUH`V:*QU.GN2!>W600"
M#-(,$DC\.5(_"DCETR4J$O[DY`(/GR`8(R#UZ8[T`;-%8OF:;O"?;;K>3C;Y
M\N>H'3.1R1^=-?R/[.6_A-]+&6&5^TR*V,XR!GGZ4`;E%8@-E\[/<7(B`RCK
M=2MO&W<3P?2AYM*0MNO;KY<Y/GS8&,$]^P.?IS0!MT5A6LMC(\R2S744D;NN
MTW4I#!6VY!SSU'`]:GM1IUY(4MKJZD(4,2+B;&"!CG..XH`UJ*I_V;!_STNO
M_`J7_P"*I?[-@_YZ77_@5+_\50!;HJG_`&9!_P`]+K_P*E_^*H_LRW_OW/\`
MX%2__%4`7**J?V9;_P!ZY_\``F3_`.*I/[,M_P"]<_\`@3)_\50!<HJE_95M
MZW'_`($R?_%4ITJU/7S_`/P(D_\`BJ`+E%4_[*M?2;_O^_\`C4-E$(-7NXD9
M_+\F)@K.6P29`>I]A0!IT4E+0`A.!D#/M12.6"$H`6QP"<9-+0`M%%%`!111
M0`4444`%%%%`!1110`52U33+;5;-K>Y3(/W6'5#ZBKM%`'DFN:%=:+<;91NA
M8D1RCHW^!JK%J%Q';"U9A);[]_E.,C/\Q^%>PS017$9CFC61#U5AD5S%[X$L
M9N;6:2`^A^84`<,UU;D*5LHXW5@P*,W..W)-.34!$Q,5M""7#[F&6X[9[`^V
M*ZC_`(5])_T$5_[]?_7J>V\`0J<W-Z[\](U"Y'XYH`XM1<7TR1J'EDQM10"2
M!UP/:N_\,^%$TQTN[M@]SMX3`*QGV]_\:U=+T'3])^:UA_>8P9'.6Q6E0`M%
M%%`!1110`5!>H);*>,D*'C9<GMD5/5?4(1<6%Q"PR)(V7'U%`&#I-@9+?2I+
MUEA:P1]T#@9SG`;K[`U.VB)_Q,[B6:%S>,&1Y$R$48(!YY'`_(5QK6FJ2VB7
MK1/MF"VA4`EMH`P2/PJQJ6HZL%O-+*E[6(M&%\K[J*?E.<9[#F@#:BTF:QU2
MRMUVR&:X^TR&.(K'&%!X7TSG^56M7\-MJ&L&[CO$B8[#]S+IM[J<\=*PO^$B
MU6"S;[*Y>WB$:+(80"IV\KZ=<^O0>M0W]W=70M[N;='+):IYD@7&?WQ_^)!H
M`VX?!S;2DEX(XR@5_)3!D^8G+9)]:NVOA^:WT"XTYKA)3*Q*[E(5>0<<<]JQ
M++Q'JDE_-#),#&JS?-Y0PH520WJ>G2NO@G=](CN%?S7,`<-MQN.W.<=OI0!A
MP>';R"T:`31>5-<I)+"FX*$!Y"Y/?T]J34_#U[<ZGO@DB$$DXN"[?>1@N,8[
M]*QH?&.JM'-\D4A1,@K'PHR!D\^_ZU-!XOOYT4S/#:JJM^\\HN)6&.`,^]`&
MUX8T"?1Y;AYW0^8%4!.<X[Y/\JZ&N'E\2:S%8&[W0&-K@P#,1&TCG)R?T-0+
MXENQ>M>R3A!]D^6$@E2Q('`SZC/TS0!Z!17%:7XFU74[J*UA^QI*^_)9&P`!
MD=&^M2KXJOI+6658($\HI$Y?.!(Q()Z_=`'ZT`=A17!:CKM]</:2B>.,0R39
M,;LL<QC`8=^0>F/K3XO$VHWOV1C);0%+G;)R55AC/)YXZ_I0!W5%<)=>*[V[
MMKA(#%#AD*RH2/E)Q@Y_#GCO6CH_BR6_U7[-/;QQ0D-APQ^7`Y))XP?ZT`=5
M17$_VYJ%O=ZC&94>%KF6*,L_SQD*2"/]D8%6]!U^[N;FTL3Y$H,(>20R$N..
M<^^:`.KHHHH`****`"BBB@`HHHH`****`"BBB@`K/U[_`)!$_P#P'_T(5H5G
M:^0NC7!)P`%)_P"^A0!'-IYN]8DEF2181%&%=9,`LKEN@//4=1ZU6%A=+=2L
MML0C:@LXPR_=V@$]?4?6K0\0Z40"+M2#Z*W^%,_X2332/W<DTF.H2WD/]*`,
MV+3+V*++VA>2)D$F)%Q<J'SD#U[_`#?2M'2+6:"TOEEM/+$L\DB1;E.5(''!
MQ1_PD=EG'EW>?3[,_P#A2CQ)IX4E_M$8Z9:VD']*`,V;1[J32XX39J9TL!`&
M)7AP1CG/MG-;-_#+*^GRK!O,,V]UR,@%&7U]2*B7Q'I;+N^T,![PN/Z4J^(]
M'8`_VA"/]XX_G0!FOI5ZR,4MPCR&ZW$N.0[;E!P>G&*T-.M)A9W>;<V<L_8R
M!R&VXSQP.@_*KMO?V=T<6UU#*<9PC@FK%`',3:5=30@IIZPN$A1D#IABCAB1
M@],#`[\U-)IERUQ<2+:@!KV&=/F7.U=N>_\`LG\ZZ*HTFBD=T21&=.'4')7Z
M^E`'/RZ=?-'+%]BB:2*1I$N#(`907#;?49'!SQQ5M-/FDT2\MTC^RRW&\A3)
MOP2.YZ#)]/6MBB@#GWTZZENQ=+9B%#+"S0;E_A#;FXX[@?A6QJ`SIUR/^F3_
M`,C5FJ]__P`>%S_UR;^1H`BN;))9'F-P\1:'R<J0,`G.1GO55]"LO)V)))%"
M&#J%(`5@FP$''I^M1>)8+.2TAGOFD>&)LK;H?]<Y&%'KG_Z]8,=A.BZ+IFH;
MA;W$TLC0EC\H`!52?S_.@#J'TR)I5N)+N4L`F6.W#;6+#/'N>E0C0[06C1FX
ME,+1)&22/NJ"!SC_`&C7,VJFXBM]+E=WLUU-X0"Q^9`,A<_6GE=MI=:8@:2*
M/4U2"%B=KCJ4)[#C-`'3QZ5;JJ2&YD?8A7?\H!&Y6SP,?PC]:L6]I%'8QP1S
M,8XV#!L@]#G'2N0C4I:3Z<ZM")-2CCFMU;*QQMS@-Z''M5VWLK9)M>TSSGM]
M/3RGRK?<R,L,GUQ0!L?V/9212"&5UC9W?Y&!"[D*D#C@<D_6F-H]B]JP:ZD\
MLELOO7^)-AYQZ?K7.IILTVFZI<Z?"UI9SJ@BA=L>8`02V3TR,_G4FCVT4^L7
MFG2Z>]K936ZR/;NY.&##!R.G>@#>?3M.E!S=Y(9I%(D7Y"6#$CCU4=:M6$=I
M!+)Y-R)7EVY!<$_*N.WTK!\.Z+IUXEY>I;[;:8M#%'N/W!P3G/4G\JBT;2K:
MX_M*^L(Q;JJO;VIW'TP7R3WS^%`'7)-'(6$<BOM.#M.<4+-&[LB2*S+]Y0<D
M?6N$LVFT^]M3;:>UF[6DH<^9N$Q5,AA^('/O4NB1K8WNDW$UGY9N(VVRQS%C
M(=N277'\C0!W#,J*68A5'))Z"FB:-HO,$BF/&=P/&/K7)Z]JHU2UM(;6"79)
M=HCI,IC#]PN?2L^0B.QDT[R6MU_M*-+A%EW)M8'H>,#C^5`'>QR)*@>-U=3T
M*G(-/KG/#J+:ZWK%E;C%M&R,BYR%)'./\]JZ.@`HHHH`*H0C_B>W?_7O#_Z%
M)5^L^'_D/W7_`%[0_P#H4E`&A1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4E+24`%%%+0`E%+10`E'3I2T4`
M1?9X2KKY28DX<;1\W;GUH:WA=55HD(4Y`*C@^M2T4`1O#')&T;HK(WWE(X-,
M>SMI)5E>WC9U!56*@D`]14]%`%5M/M2@5(4C(4JK1J%*9&#@]J@L=%L[*SDM
M50RQR,6?SL,6)]>*T:*`*ITZS(B!M8L0Y\L;!A<]<4PZ5IY@$!LX?*#;@FP8
M!]:NTASCCK0!0&B:8L<D8L8`LGWAL'-+_8VF[I6^Q0YE7:^$'(J]2T`9XT33
M!,\OV*'S'SN8KG.>M);Z%I=M,LT%G&DB'*L.H-:-%`!1110`4444`%%%%`!1
M110`4444`%%%%`!6?KO_`""+CZ#_`-"%:%4-<_Y!%Q]!_,4`7@`!37D2/&]E
M7<=HR<9/I3JK3V$%Q>0W,REW@!\L$_*">^/6@"S2.Z1H7=@JCJ2<`5BZQ+KG
MVQ(M/A7[,1EI%*[\^GS<#\C3++11<Y?5H)967[HGN?,S_P`!`"C]:`+,OB&P
M$OE6[/>2_P!RV7?C\>GZU&YU2_.([*WLT(QYEQB1\?[HX_6D:+4['[8]O%;O
M"$`M;>%=N#G&6Z?4U!I-IJEQ=S2ZC>3B**7"QJ-@D([\?P>@[]Z`+6F^'[>R
MN_MDKFXN\8$A4*%XQPHX%7K_`%"VT^(27,@7/"J.68^@'4FF:B;\K'%IZQJ7
M)#S2'(C'KCN:RKS1+Q3&;.;?=RY$U[,<M&OH@[9]J`,C7/$5W=2BSA<V2D_.
M$):4#T..A]A^)%7O"=TGFM;6&G2"V'^NO)6^9V'M_3/&:RH/#&IM),D5K%%$
M.,SR$F7W.W^7`^M7(_#^OP-'<1W=MYT7$:<[8P00=HQ@=?2G8#M**YBQM_%,
M5X)+FXMYX\'*%@H_1:T?^)^W3^S4]CYC?X46`UJKW_-A<`]/*;^1IMB+X(WV
M]K<OGY?(#`8]\T^]&;&?_KFW\J0&9J=EINJ^09[UD,/*>7,%Y]?K41TS239B
MWDO9)"LGF)*T^9$.!T;MTJU//<IJ,-O$7*/!DA=ORG<HW<^Q-00ZE(YC?<^Q
MPHV$KD'SMF<X]_R_.@`.G:*=.6Q614C5O,5UDPX;^]GUH73]&&GBT$HV[_,\
MSS/WF_\`O;O7WI4U\LD9-M@R(KI\^1@EAS@<?=[9ZU:FN9633V&Z`SR`.A`)
M`,;''U!`_*@"HNGZ.MA-:F;>)CN>1I,R%NQW>HJ+^S-&%A-9_:7VSL'E<RY=
MR/4TZ'6Y(P8FV7#"4QK)N"[ANVJ<`>O!/L:FL-::Y-I&T2EYHT9V5@`I92>`
M>3TH`KP:3H\,<L;7,TT<J>6R2REAC.>/?BI[&STFPBE2&5BTR[7D=R7(Z`9]
MJ5M=_P!+:W2!6.X*K>9P?GV<\>OUIL6L->7%LL>V+]ZJR*7!)RC'`XY'3GB@
M"S8BPL;!+2WD/E("!GD\G/7\:;8QZ=86`LX&S`,@ALG.>N:<[SKJJ6_VAMC0
MR28P.H9<=NF"156WUN1H[<);AA(L0!>7G+J2,_+[<T`+I]AI&FRL\!<N5V#>
M6;:O7`ST%)9Z;H]G="Y@#[USL!+%4SUVCM5BPU@7TZQQP[04#$EQE25##CKC
MGK6G0!0OOL&H6S07.70\\*001T(/8U4CT[1X]/DLQ&S12G<Y8,6+>N>N:VZ*
M`,O3HM.TR%H[4.H8[F8JQ9C[G%6S?0#^)_\`OVW^%6:*0%;[;!ZO_P!^V_PH
M^VP9QE\_]<V_PJS13`K_`&V'_II_WZ;_``JI;2++KMT5W8^S1#YE*_Q2>M:=
M9\7_`",%Q_UZQ?\`H4E`&A1110`R5F2)V0;F`)`]33J6B@!D8<+^\8,V3R!C
MC/%/IJ)L7;DGW)R:=0`4444`%%%%`!1110`5!>7D%A;-<73^7$N,M@G&3CM4
M]8?C/_D6;KZI_P"A"@")?&>CM,8S)*H!QO*?*??U_2I+;Q=H\\1<W)B(_AD7
M!/Y5E^&?#NEWVB6]U<VV^5]X8[VQ]XCIGTK1;P;HQ&!`Z_20T`68O$^CR1J_
MVV--P!VMP1[&G?\`"2:/_P!!"'\ZI_\`"%Z-C'E2_7S#2?\`"%:/G[DW_?PT
M`7?^$DT?_H(0_G3E\0Z0V<:A;\<\OBL\^"M'Q]R8?]M*8W@;22<AKD>P<?X4
M`:W]NZ5_T$;7_OZM']N:5_T$;7_OZO\`C61_P@NE?\]+K_OL?X4'P+I7_/2Z
M_P"^Q_A0!K_VYI7_`$$;7_OZO^-*-:TLG`U&U_[_`"_XUB_\()IF.)KK.>NY
M?\*;_P`('I__`#\W7YK_`(4`=!_:FG_\_P!;?]_5_P`:3^U-/_Y_K;_OZO\`
MC6!_P@6G_P#/U=?FO^%,'@&RWG-W<;>,#`R/7M]*`.C_`+4T_P#Y_K;_`+^K
M_C1_:=A_S^VW_?U?\:YA/`$`A8/?2&3G:0@`'ID?_7J*3P`<MY=_@;N-T>>/
MSZT`=<NH63'"W<!/M(/\:?\`:K?_`)^(O^^Q7%_\*_FQ_P`A!,_]<S_C2?\`
M"`3]K^/_`+]G_&@#M?M5O_SWB_[[%/$D9&0ZD>N:X8^`+CM?1'_@!II\!WV`
M!>PX^C4`=YN7U'YTH((R#Q7!?\()?XQ]MAQG./FIR>"-33&S4(EQTP6&*`.[
MHKB/^$0UD=-5`_[:/2?\(CK?_05'_?UZ`.XHKA_^$1UO_H*+_P!_7_PH_P"$
M1US_`*"H_P"_K_X4`=Q17%CPSXAQC^VF_P"_\E(?#7B7/_(8/_@1)_A0!VM%
M<3_PC?B;'_(7_P#)F3_"E'ASQ,"/^)Q_Y,2?X4`=K17&?V'XJ``&K`X_Z;-_
MA2'1O%G_`$$Q_P!_F_PH`[2BN);2/%H&1J!;V$Y_PI/[/\818VW9?)Q_K`<>
M_(H`[>BN':V\9K'N\YF.<;0R9IFSQFL7F;I>N-N4)_*@#NZ*X,77C-,9CF/!
M_P"62'^E/CU#QA%G?:O+R#\T(XQVXQUH`[FBN(DOO&)W2"U95<_*JQ*=GT'7
M\Z5-2\7K;O&;(LS9Q(8AN7Z8X_,4`=M2UQ5MK'BJ+:LNFM,1N)+1$9X]O\G-
M7?#_`(@O[[5I-/OK=(GC1F;`((.1Q^1H`ZBBBB@`HHHH`*S]=.-&NCZ)G]:T
M*S]?_P"0)=_]<S0`ZYU6VM)7CF\Q3&@=B(V8!?7('3K^57%964,I!!&01WK#
MU;3[J]OIQ"71&MU0]`LN&)*$]1D'J/6H;FVN9Y<I9RQ2GR?LS<8@"GYE)!XX
MS]0<4`='FJ]]?0:?;^?<L5BR`6`)`SQS7.M877ESJ+=SF<2!WASOY<[77/S#
MGJ.>1Z5J3V[RZ-:0/9GK$'A!W!0",C)//`H`O75]!:>2)6.9W$<849+-2&^B
M62.-ED5Y&=5!0\[>O\N/6L,V.H@6(FC:46EPJJ5():-<_.?<C:,>Q]:L6=M<
M13V[&UD5$NIW[<*V=O?OF@#6LKN*^M8[F`DQR#*Y&#4]<G9:;=I%9QW5K<$+
M&JIY93]RX<DDD]`?EY'IBM;0[(VS7DLEN8I)+ARI8Y)3.5[]*`->BBB@`HHH
MH`*@O!FSG'_3-OY5/4-U_P`>LW^X?Y4`4;Z^L=,C@N;F/=-(H1-B;I&[D#VI
M;272KJP%[#'`+<*<L4`V@')!],'G]:SM7F2RU/1M0N,BUC5T=P"0I9>*R].M
M[^?3?W%DTME=7KSR)N"EDXVCD]"1S]*`->6?2K[11?QQM'`CA5VPIN/.T#!!
M!&6Z4Y-1TB.YBTMHGD\I_)5WBRBO_=SV-8V@L\]AIUD8BBM>M+G<"&5,L>/8
M[15O5M2ANM1@BB$JWEM=@+:.ORRG/WR1[9(.?PH`TKC6-*AU!;22++1LL?F"
M+*1DG@$]N<5/<WVFZ=,ZR1+&;>'S"ZH,(I.`![D]JYJ[D6*#5](<-]MN[W?"
MNT_,&92#GVQ6E'>P0IK.JW2"6#S5A1",[MG`QGU8F@"S!K&CSK<3/!Y$EN/-
MD6:$*_/\7OSC]*6RUG1YXY9EA^SM:IN(DB"LJ=<CV^GK7-221:K8ZG<BX^T:
MC+$KF)(V`BC5E)4$CGM^52:D?[=N=0N]-5VACL51CM(RVX-C\A^E%@.DL];T
MR^>67RGBEAB,A\Z+#&/U'J*33-2TR_G6"*S:!R@DC$L(7>HZ,M89N1JFI/>6
M$32QV^FLC@J0"Q!^3WZ_I3_#13^V+06T\EZHM-LK2`YM_P#9'X\8H`W]0U*P
MTB6-3;N\S)\J6\0+!!_(5?M+J&\MH[B!MT4@RIKG?%+BRU*TO8[F2UD:-XC-
MY7F)MZX(ZYSTI-&MK:VTO14U#S%N/,9X%P>I)//X&@#8EUJSCU:'30Q>XESP
MF"$P">?RJ"X\26,%\;5EG;:XC>5(\HC'L35#4;6&V\6Z.8(EC\QIG<@?>8KR
M36)-]HTZ^O8TN[J.^:[\R"!0?+F#'J?7_P"M0!Z#GC-9VE:W:ZL\Z6PD!A(S
MO`&X'H1STXJ+Q+>M9:+(4!\Z;]S&!_>;_)K%MH+O1]8TV:>V2"%XULW*2;]Q
M[$\#'-`&U:>(K.[AOI$6519`F0,!D@9Z<^U6]*U&+5;);N!75&)`#@`\'':N
M#2*6)A'&A*ZE(UNV.Q$H.?R)%==X4&W1L`8Q-+_Z&:`-JL^/_D8+C_KUB_\`
M0GK0K/C_`.1@G_Z]8_\`T)Z`+]+24M`!1110`R,.$Q(P9N>0,4^BB@`HHHH`
M****`"BBB@`K#\9G'AJYX/)0<?[PK<K!\:DCPU<8.,LG_H0H`D\(*5\-6@/<
M,?\`QXUM5C^$_P#D6[+_`'6_]"-;%`!1110`445'+-%`NZ:1(U]78`4`244@
M(8`J00>A%%`"T4F110`M%)10`M%%%`!1110`44E%`"T4E+0`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%)CG-+10`4444`)7':3_P`E!U#_`'&_]EKL
MJXO1BS^/]0;KA7!_-10!VE%%%`!1110`5GZ]_P`@2\_ZYFM"L_7_`/D!WO\`
MUQ;^5`$&J:E+:W:PK+#!O0&)ID)21LG*[@1MXQ^=2R:W913-%)(05W#.,@E>
MH]<_S[4NI6+7@DB:Y189DV-&\>[UY7G@\^_05"=$)CF@%Y*+60EQ'M&Y6)SG
M=]><>M`$\FK11,B207`D=RBIY>23MW<=NE0SZ_:QPRO&KRF,9`7'S?,%_#DC
MK^&:D73)VFM9KB],LD#L_$84'*[<8SQP343:(YLIK/[:_P!G88B0H#Y?S;NO
M?&/RH`MC48OM7V<I*'R0"5P&(`)`_`_2H8-;M9XXY`LJI(C2(63&Y0`21^=1
M?V5(EZ;Q[T;@S."T?(RN,9ST'4#Z_6DBTQ$AT^RQ))':X=9P0`<9&TC.3D'Z
M4`:%Q=I!Y0*.TDI(2-1R<#)_2J2:C)?74"V#J(6C\UF="=PW8(Z@@\'\:LWM
MH;F2"2*;RIH&+*=NX<C!!'I45CI:V,J-'*658RFTKU);<3GZDT`076HW$6K+
M:EXH%9D\OS4.)A_%ALX##L/\>)O[7C6WEFDBE"QR2(<#/"9R?TI;S3&NV=9+
M@F!W5S&4!*D8^Z>W3_\`54$VB^?'+%]K/EO)(Q78#C>#[]1G(-`$W]L0>9+N
M4A$$>UB0-Y<9&,]/QJW9W45[;+/"24;(YZ@@X(_,5G_V(P&4NV5PL>U@@X9!
M@'W!!QBM*VB>&$)),TS]2[`#/X#I0!+45S_Q[2_[A_E4M1W'_'O)_NG^5`%1
M+C$$<<L<.2@^5I1S^&*L;YP,"!,#_;_^M65<PRO=6TJ12,BVI#;5!#Y9#LY]
M0#SVIDO]J.XW"<H)2VU=H^43+M_\<W?E0!JQNY`,4$1`)Y63OW[4,[JZEH(@
MY.`3)R?IQ6/_`,3")GN)7>(B-PNXJ%+"4E5Q_M+@<#/XUJ30O<Z>L<X<22,&
MRG6,YR/R]?:@!XD>1R1!"SH<9$F2I].G%./FE=IMHRO7&_\`^M6;.-6BB!2/
M=*1(K&+;AFVC8_/3D?\`ZZ9*^L%I6C\X`>;L7"=0R[!],;ORH`TXG<J&A@A*
MGC*R?_6IX,Z\+;Q@>TG_`-:L.*+5[:!5MUD$8+^8F%)Y<X*<CL<G)K4TI;W;
M,;YY"V_"A@H&,#GCWS0!8#3J.+>,?23_`.M0IG!.+>(9ZXD_^M5BB@"NQG(Y
M@B/L9#_\32YG)!,$?'_30_X5/10!`3.3GR8LCI^\/_Q-&9\@^3%GU\P__$U/
M10!`3.>L,7_?P_\`Q-!:X./W,7_?P_\`Q-3T4`09G_YXQ?\`?P__`!-`:X'2
M&+_OX?\`XFIZ*`(=US_SRB_[^'_XFJ<!<Z]/YBJO^C1]#G^)_85I503_`)#T
MO_7LG_H3T`7J6DI:`$;)'!P:6BB@`HHHH`****`"BBB@`HHHH`*YWQS_`,B\
MW_75*Z*N?\;C/AV3_KHG\Z`)_"1SX:L_HW_H1K9K'\)*%\-V>/[K'_QXUL4`
M%%%%`!7"^*KJ/5-<336N8X;>W5F9V8`;\'CK]!^)KN'W;3M`+8X!-<MI7A&-
MC<3:TBSSRON!60X&>3TQSDF@"#PSK3_\(Q=QKL$]C$S(,'D8)!/XTVUU?Q)J
M.ES7<2VB0*K_`#X(;@<XYJ9_#%U::A=_V8(EL[FW:(H[GY25_P`?YUI:-H\M
MMX:;3;G:LDBR*Q4Y^]G_`!H`YB*74)?!5]+<.CP,RE7+$R%O,&<UI1:Y=VMA
MH^GV$"37,\"MESP!G'3\#3(=!UF+0+S2VCMC&V&C*M\S-N4\GZ#^533^']1@
M32[RQ:+[99Q"-T8\-U[_`(F@!M_J6K2Z9J5KJ5AY6R,E9XP0AP1Z^OUJM8Z\
M=%\*V(C037%PTFT.>%`8\G]*M?V5K]Y'J4EY*J_:(]J6ROE<\8QS@?UJ"3PO
M>MHNG`1QM=6CL6A=OE=2V<9Z?_KH`L6GBVX2\EMK^*V8B%I$:WDW`D*6P3D^
ME5XO&.HW&Z>"SMVA1U4Q!R9><#CUR?:I[+1-0&JRW:V%C9*(B(E^_M<@@'CZ
M_EVK,E\,:E);;&TZ(7*MD3QS!01GNO\`^J@#O+6?[1;1S>6\>]0VQQAE]C7-
M3^*;V?4+BUTK3O/^SE@[%NN#C/\`/ZUT6G6\EKI\%O+)YKQH%9_7`KE4@U;0
M=:O6M+)KN&[+,A7.%.21GZ9_&@`O_$MSJ/AR>6TMFB=3LG(DYB'&".YST]N:
MN^#(+P6TEU>/<$3*OE^;+O!')R!VZBJ)T&^B\.ZI+./,OKTK(T:#D8;<>G4]
M>E=-HD;Q:)91R(4=8$#*PP0<4`<[9W=Q_P`)W>0^<[1A6*QLYVYVCMVIT7C2
M:6U>Y32)##$0)'$N0OZ5%9Z?=Q^,[ZX:VD\HK(58K\K9`P,].]0Z';7$7@W5
MHWMY1(S,%0H03\H'2@#9N/%=K#H]M?K$[M<':L(/.1UY]OZBDL?%4<^H+9W=
MI)9R.NY3(<@\9]..*YJ/2KXZ#874-L[26L[LT1!!(R#G'_`?UK9M]2U/7+Z6
M!+!;>U:%E+S(=RDJ1P?J>GI0`C^.HOWC0Z=-)"AQYF[`_'CBKE]XNMK6SLKI
M8'ECN@Q&&`*[<9!_.L&VNKW2=&O-&ETJ9Y7+KYBJ2OS#&>G-1ZGI$UI8:'9W
M$>YC+)Y@3)QN9>,^N*8&T?'%LL<<CV4ZJ[%<DCC&/\:LZ7XNM-0ODM#!+"[_
M`'"_0GTK+\>.R7VEA$W%"S*N.IRO'Z5'-<3>)=>T][6TEMUM2&D=^,#(/]./
MK2`T[[QI96MU)!'!+/Y9PSI@#/>KEUXDLX-(AU)5>6&5PF%QE3@]?IBN9TF_
M_P"$=N-1M;RQEDE=OO(,AAV'/;G-5;FRN+'P8GGK@W-TLB+W`VGK^5`'4Q>,
M-/>SENGCGCCC8(-RCYV()P,'V_4467C#3[Q9]J2QR11M($<`%PHR<8.*J>+[
MJXLM/LEMXT1),AY#&#LX[>AZ_E6+X?D$WC"U;[3+=+M8>9*N"WR-VSTH`V=.
M\7M?QWP9%MWBB,L9(+J`,#G')Y/85J0Z[;0:)#?7US&WF9P8T(WD$\!3S7(Z
M?<PV^A:QITGRW>78?+V&`>?PI;J'RM-T"\GC,EE&,2J!D??R<CWH`Z_2O$>G
M:L_EP2%)><1R##'Z=C4-SXNT>W'$[2G=M*QH<C\\5AS7-MJWB_3Y=)0LD6/-
MD5"HQG//X<5#I,,3>'=?9XPQ#-@X!(P#C]:`.YM+F*\MH[B!]\<@RIJ:L/P;
M_P`BS:?\#_\`0S6Y0`4444`%<;H7'CS5!_LO_P"A+795Q>@-O\>:F0,<2#\F
M`H`[2BBB@`HHHH`*S]?_`.0%??\`7%OY5H50UT9T._\`^N#_`,C0!0UR+,L\
MQBANHTMQYL,AVLJY8[E;L>OY"FP:A</+<J)CN>Z"1*RC(7R@V!DX'J<^_<UM
MR6\,S*TL,;LO0LH)%!MX68L8D+%@V2HSD<`_6@#G;?6+N2$W;R(H:UA8J1\B
M,TC*6^@QFM+[?/#I5Y.S0W,MN&*^43@C&0#[\]JT%MX5&%B0#;MP%'3T^E.C
MBCBC$<:*B#HJC`H`YN_N+B6XM[26:.:/S[=_,5,`[BWRD9_V<_C5[5;(`:=%
M9,MM*DY$3*HPO[MSC'H<<BM1+>&-0J1(J@Y`"@`'UJ0J"02`2.GM0!S2ZE*E
MU*7CCLYY9E@E>3HI"$\'N#Q@GUJY'>WOG10-+`[7"`QR1H=H*GY^_(Q@BM=X
MHY%*R(K`]0PSFE"*,84<#`XZ4`<V^MW4>UO,1HYD4K(5PJ`R!=V,YVX;OZ=J
MBBO);*'4A!.AE^UROG:/FVQ*2?0<]:Z46T`!`AC`(((VCH>M*+:!1@0Q@>@4
M>F/Y4`):2F>TAF8`&1%8@>XS4U(`%`"@`#@`4M`!4<_^HD_W3_*I*CF_U,G^
MZ:`,?5=3GT^WTY8#;K]H(1GGSM48Z\$5'+K5Q::9=W<LUA=&(*$6U8]2<?-R
M?\@T:O8SWEMI;P6R7(@97>-F`##;[TRYTV>_TR[M$TN#3V<*5=74AF!R`=H_
MSF@"2+4=4>]GTV2*T%XL2S1/\WED9`.1U]:K?VYJD']H/<0VDD5BN&,.X;G.
M,`$^F>:MV%GJ#ZM/JEW"D+FW\F.$.&)YSDGZU)IFG7-OX=:VD2(W<BNSB3YE
M9V)/..O:@"E_PD5S:N8[V.WD9[1KF(P,<<#.TY^AYJ?3]:NFO+*&]6V*WT1D
MB,!.5P,X;/MWJGIGAZ>.\^U-:6MIY<#1K&'+AW(QN/\`L\]*CM?#,\DRN]O!
MIY2)T+PN7+NPQN`[``],T`7H-?FO=<:RM8D$'EN8Y7!^=EXR/]G-+#J&L#6X
M=/G%BX*&24PJ^47MU/4FJ]GH&HVFLV<IOO-MX(MF[RU7`_N8_K6EI5C-;WNI
MW<Z#?<3?)@YR@&%H`I3:SJMI<6K7=K;QQW-QY*P!B9`/[V0<&H8O$EZ\<-^T
M$`T^:Y\@#)\P#^]GI^&*+6TU?^V'OKS3HII&;:CFX&(4]`,=>O-10Z#J*PPZ
M8RP_8X;KS_/W\LN?N[?7F@"7_A([WRWOO)@^P+=?9RN3YF,XW9Z?ABG_`/"0
M7,NI20P/9!([CR!%*Y$DF#@D<X__`%5`=!U'R7TW$/V-[OS_`#]_.W.=NW'6
MG7.@7A:^M8K:W:*[N/.%R7P\7()&,9]<?6@#H-4NS8Z;<72IO:*,L%]:S]/U
M6Y;4H[*\:VD,T/G1O!G`]B"3^=33:./M%Q=Q7$SS2(P6*63,62,<KZ50T30Y
M+;4EO);2"T$<10)$Y;>QZMD]!Z"@#HZ6BB@`HHHH`*H)_P`AZ7_KV3_T)ZOU
M07_D/2_]>J?^A-0!?HI*6@`HHHH`****`"BBB@`HHHH`****`"L#QM_R+<_^
M^G_H0K?KGO'#;?#L@_O2(/US_2@"SX3.?#=G_NM_Z$:V*QO"/_(M6?T;_P!"
M-;-`!124M`!1110`4444`)12T4`)117&7T]V\KW`NKD;]2\A4A.2JH&'`Z9)
MYQ]*`.SHKD["35$GM!=//'%)>_)YQ`=@8V+!@.,9'%0:MJ%Y)?7-LES<;/MB
M1JMM@/M\LD@?CB@#LZ*XRVU?59M/DEAF=XA<K&A94\\KCY@%Z$]/?K5S3-6N
MYI+>.2X=BUZ8F26,+(J>62`P`QG([4`=/17+3:Q<VD>JK+=@^7*D%O(Z@;6(
MY)P.W7\*K3>)+UM*TV:T;SIS,8YT"C,A7MTXR.>/6@#LJ*XY]8U"ZM]5O;2_
M"P6K`Q*(E.X$=R17016UZ-.D"7Q>YE(=9)$&$Z<8';C]:`-&BN1M-5U@Z7<7
MLMQ#(1)]GC3RP,.6"[C[#/2M&SNM2M-9AL=1FAG6YC9HWC3:5*XR#[=:`-VB
MN8N=?N;74=4AE*K"B,+9RO`D5`VT_7.>?2L^3Q3?I-(KW%I"8XXV"21,2Y*`
MD9'3F@#H]7T.'5;BVGDED1[<Y7;C!Y!Y_*M2N1U#Q!JEO.`XM[4".-MLR,0[
M$9(##@8Z<XK:UFYOK?3A<VCVJ;!OE,V2,8[8H`U*1D5B"R@[3D9'2N1OO$^I
MV8MC-;VL1>#SF5]WS\G"C'0XP>:W],U"2YN+NVN$5)8&&-IX9&&5/]/PH`T"
M`P(8`@]C33&A96**63E3CIVX_.GT4`02V=M,S-+;Q.S+L8L@.5ZX^E!M+<VO
MV4PIY&W;Y>WY<>F*GHH`K6EA:6(86EO'#N^]L7&:;'IME'#-#';1K'-GS%"\
M-]:MT4`0VUM#:0+#;QK'$N<*O09.:FHHH`****`"N*\.J3XYU0]AYN?^^Q7:
MUQOAG_D<M8^LG_H8H`[*BBB@`HHHH`*KW]L;RPN+8-L,T;)NQG&1C-6**`,_
MR]6_Y^;+_P`!V_\`BZ/+U?\`Y^;+_P`!W_\`BZT**`,_R]7_`.?JR_\``=O_
M`(NCR]7_`.?JR_\``=O_`(NM"B@#/\K5O^?JR_\``=O_`(NCRM6_Y^K/_P`!
MF_\`BZT**`,_RM6_Y^K/_P`!F_\`BZ!%JW>ZL_\`P&;_`.+K0HH`S_*U;_G[
ML_\`P&;_`.+H\K5O^?NS_P#`9O\`XNM"B@#/\K5O^?NS_P#`9O\`XNCRM5_Y
M^[/_`,!F_P#BZT**`,_RM5_Y^[/_`,!F_P#BZ&@U1E*F\M,$8_X]F_\`BZT*
M*`,V.VU2.-4%Y:$*`!FV;I_WW3O*U7/_`!]VG_@,W_Q=:%%`&>(=5Y_TRS_\
M!F_^+H,.J]KRT_\``9O_`(NM"B@#.\G5O^?RS_\``9O_`(NE\G5?^?RT_P#`
M9O\`XNM"B@#/,.J_\_EI_P"`S?\`Q='DZKC_`(_;7/\`U[-_\76A10!G>1JW
M_/[:?^`S?_%T>1JW_/[:_P#@,W_Q=:-%`&=Y&J_\_P!:_P#@,?\`XNCR-5_Y
M_K7_`,!C_P#%UHT4`9_D:I_S_P!O_P"`Q_\`BZ/L^J8_X_[?_P`!C_\`%UH4
M4`9_V?4_^?\`M_\`P&/_`,71]GU/_G_@_P#`4_\`Q=:%%`&?]GU/_G_@_P#`
M8_\`Q='V?4_^@A!_X#?_`&=:%%`&?]GU3_H(0?\`@-_]G3[6SGCNY+BXN%F=
MD"`+'L``)/J?6KM%`"4M%%`$<P<H/+^]N7\LC/Z9J2BB@`HHHH`****`"BBB
M@`HHHH`*YWQS_P`BZ_\`UT3^==%7/>.,?\([)G_GHF/SH`G\(?\`(M6?T;_T
M(UM5B^$/^1:L_HW_`*$:VJ`$I:**`"BBB@`HHHH`****`$K+M]%CBO9IG8/&
MUP+F-,8V28()]^N:U:*`*>I:;;:G;>1=(67.00<%3ZBJUGX?L;);<1*Q,$AD
M#,<EF(QDUJT4`8]UX;T^YFFF99$DE97+(V"K#/S#T/-">&[%+3R%,V[S1+YV
M_P#>!AT.:V**`,BW\.6,#Q/^]D,;,_[Q]V]FX);U.*&\/69U);U3*CB3S=BM
M\A;&,XK7HH`R(_#UG%:WUO&9%CO#EP"/E^G%:J*$15'11@4M%`&8FA6BZ9+8
M$R-%*YDR6PP8G.1CTXIFF:*]I>O>7=Y)>3E=B,XQL7TQZUKT4`9%WH,%Y#?1
M3.2+J42@XYC8*!Q^7ZU#:^&;:"WO8'D,L=TJK\PY7:,`_7/-;E+0!SDOAR\*
M%(M4=4FC5+A6C#;\+M+#/0D"M'4=)2]TN.P#[8T*=1G*J1Q^0K2HH`P=7\/2
MZA>O/#>"!981#*IC#97.>/2K6F6#VU_>SR(JJ^R.+!R=BKC)K4HH`****`"B
MBB@`HHHH`****`"BBB@`KBO"ASXOU;IUDZ?]=!7:UQ/A3_D<-6^LO_HP4`=M
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`)2TE+0`4444`%%
M%%`!1110`4444`%%%%`!7.^.21X=?&.9$'ZUT59^MZ8-6L#:M(8U+JQ(&3@&
M@"AX.GB/A^TB$J>8-Y*;AG&X]JW%D1E+*ZE1U(/%<HW@*U&#%?3J?4@&JK>`
MYQ&0FHC=N[H0,?GUH`[8,IQ@CGD4N:X3_A!+W(_XF$?'L:/^$%OO^@A'CZ-0
M,[O-%<.O@G44&%U-5'H-U!\%ZIG_`)"BD?[S4".XS1FN'_X0O5/^@HO_`'TU
M'_"%ZIS_`,31?S:@#N,T5Q`\'ZS'GR]5`SUP[BE/A?Q!@@:MGC_GL_/Z4`=M
M17$P^'?$EO,7BU,95?E)E8@GTP14BZ=XO:.3=?JI'0%AEL^^.*`.RI:X>+3?
M&$$7EQW?RKTS(I)_$T?9/&G_`#W/_?<=`'<45P_V3QI_SW/_`'\2GK!XU7CS
MA^)C/]*`.UHKBS#XU_Y[+^<?^%(T7C8#/F@^P,?^%`':T5Q&SQMUW'\XJ"OC
M8?Q'\XJ`.WHKBC+XU!(V+P,](_\`.:AEU#QBNT^1)@J#\L"GMWXZ^U`SNZ*X
M+^U?%XCV_99MV<[OL_/TZ8JTFO>*``&TC<?4PN/ZT".SHKCCXFUT8_XD;_\`
M?MZ/^$GUW_H!R?\`?M_\*`.QHKC?^$GUW_H!O_W[>E7Q/KN?FT*0CV1Q_2@#
ML:*XT^+M47[VARCL?O?_`!-'_"7ZG_T!)/\`Q[_XF@#LJ*XW_A+M4_Z`<O\`
MX]_\33O^$RO8US+HDH]]Q`_]!H`["BN-_P"$YER!_9#\G`_>GK_WS2)X]!8H
M=-??T"B7.3Z=*`.SHKD(/'MJ2PN;*:/'38P;ZYSBI6\>:<%^6VNB<]PH_K0!
MU5%<HGCS3RN7MKH'/0!3_6E_X3S3?^?>[_[Y7_XJ@#JJXSPF/^*JU@\<,_\`
MZ,JS_P`)YIN1_H]U_P!\K_C5'P3*D^OZG-&"$D!=0W7!?/-`'<4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`)
M2T44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`"&EHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`I*6B@!**6B@!**6B@!**6B@!**6B@!**6B@!**6B@!-H]!ZTT11AMPC3
M=G.=HS3Z*`(FMX&.6AC)]U%-^QVN<_9H<_[@J>B@"#[':YS]FA_[]BC[':_\
M^T/_`'P*GHH`@^QVO_/M#_WP*?'!%$28XD0GJ54"I**`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BD.>PS2T`%%%%`!1110`444
M4`%%%%`!1124`%&:Q;SQ$EG)*&MV=8Y_))1@3]S=G'Z50@\9I):>:;,A@^TC
MS5`Z$CD^P-`'4YHS6%J7B:+3[6RN&MG<74?F`;@"HP./?K4]MKT%QIMU?^6R
M00$@%CR^`.W;KB@#6HK`/BFW.GP7,=O+*\H8F*/DH%^\3^GYU8@\007%\EI!
M#+)*796QCY%&/F//3F@#7HK%;Q1I\;8E\U5S(N[83]PX/3\_PI]IXBLKV\BM
MK=97=]V<)]P`XRWIG^M`&O16+_PD^FBXDC=Y%C4'$Q0['(Z@'N15J#6M/N9H
MXH;C>\N-@"GGC=UQZ4`:%%9]OK-E<3_9UD83^8T9C*'((Z_A[U:N[J&RMVGN
M&*QK@$@$]3@<#GJ:`)LT9K)/B72%C5S=\-G`\ML\=<C&15F?5K"W\LRW**)8
MS(AZAE`R2#]*`+N:3=68_B+28W*O>H&`R>#QQGTZ^W6EM?$.F72S-#<Y$"EW
MRI&%'?I0!IYHS6>VNZ8DZ0O=HKNH9001D$9!STZ46VN:9=?ZB[C;Y@G<<GH.
M:`-#-&:JVVI65W(\=O<QRN@RP5LX&<9_,5&-:TQGC07T&Z494;QS_A^-`%^B
MJQU"R4(QNX`'Y4F0?-].>:EAGBN$WPR)(F<;D8$?I0`^EHHH`2BEHH`*2EHH
M`****`$HI:*`$I:**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`I***
M`"EI**`%I**6@!**6B@!**6B@!*6BB@`HHHH`****`"DYI:*`$I:**`"BBB@
M`HHHH`****`"BBB@`HHHH`3K38HUBC6-<[5&!DDG\S3Z*`"BBB@`HHHH`***
M*`"BBB@`I*6JU]9K?0>4\LL8SG=$Y1OS%`%BBN?N]&L;*$S7.J7\48[M=&I%
M\-PE05U+4L'G(N30!N45@7.BV]I"TUQK.HQ1KU9KHX'Z4)H=M*66+6=09@`Q
M"W>2`>A_&@"W-I&DW=]+--"DDY^5\L>I7'3.,XJL_A+3#;F&,2Q9??O20[L\
MXZ^@)%)<>&5N@!<:I?R`'(!D&`?RI8_#7E`"/5]24`Y`$W'\J5P)]0\/VNHV
M]M#-+.!;KL5E?DC`!R2.>E5?^$0T\2';+<K`6W&W$GR'_.*MIH\Z.SC5[XE@
M`<E"/R*TT6<LDK1QZ[<&1/O*/*)'U&VG<"K<>#[":=I$DFA#-G9$P"J",$`8
M[U;B\/VD-XEU"TD<JRF3<I'((`*GCD<5&VDZML.W7I-^>,P)C_/6HSI.N#[N
MO]N<VRT7#42?PG:3QS(9I?WA8C)!V%F#<?EC\:DLO#-M8W4%Q!-()(V=F8X)
MD#=C]*3^SM>_Z#B?^`JT?V;KW_0<3_P%6BZ#4@F\(P3;HVNY1;[G=(0`%1F]
M/I3/^$4:"\-S87I@=7#1@H"!QALC\_SJ<Z?XB[:S"?\`MW'^%"V'B,'/]L0'
MV,`_PHN@U-"'2TCU(:@[[K@P"%R%`#'.=WUXJO)H2)IMU;6<SQO-()0TAW!6
M!!''IQ6;8W6NW_G(E];QM%/)""8,[RN/R_SUK3$>O*%'VBQ;;G),;#=^O%&@
M&8WA*<,TT6H;;BX#K<N8^'5_O8':IM2\++>6UI!',J);0-&I8')8XP?T/YU>
MQK_KIWY/37/B(`E1IK''`^<9HT`H0>%IXIEC-\&LS,MP\93YBX]_0UH?V.RZ
M;J5LLB;KQY74XP%W=!49?Q(H_P!3IS]1PSC'O2^=XC_Y];#_`+^M_A1H!C7'
M@=I;B,I<HL0C56!W$D@8)&??M4D/A*\,A:YNXG5WC+JH(R%/8]1Q_.M7SO$6
M?^/2P_[^M_A3#<^)`N?L-D3Z>::-`*&D^&M0TFX>6*>VD+PF+YMPQDYS5>'P
MCJ5O`\4=U:D,RL69-QX[<@UKK=>(\_-IUH1CM-BG"Z\0]]-M?^__`/\`6H`Q
M[/PI=P"!I'5RL$JLC/N`9@0H7T'.?KFNJTZV^QV$%OA<QQJK%1@$@8)K,DU'
M6XVPVEP\@D8F)X'T7WHN=5U6VARVD,S[2?DD##C'H,]*`-RBL6?7+FW=4DTB
MZW,-PV$-QT[=.M2_VG?>6S_V1/A<Y_>IV]LT`:M%9*:S(\9<:9=X"+(?N=#T
M_B]CQUIMQKK6J,\VEWH"L%.T(W)&>S>E`&Q16.-=8YQI=[P=O1.O'^U_M#_(
M-1CQ(IB\W^S;[8<X.U,\8SQNSW%.P&Y167!K#W$7F1:9>,GJ?+';/=O>HX]?
M666.)-/NR\J>8@_=\KZ_>]J+`;%%9AU=@[(=.N@Z@DC,9P./]OW%-MM=ANIS
M%%:W)9<%OE4[03U.#2`U:*H+JL+0-.8IEA`RLA3AP>F/_KXZU*;^`>8/WA,8
M!<")B1GV`H`M450EUBSB95D^T`N,J/LTG/\`X[40\0:<3A9)B>>!;2$\=?X:
M`-2BLO\`X2#3MQ&^?(&2/LTO'_CM']OZ?_?G_P#`:7_XF@#4HK*_X2'3<D>9
M-QP?]&E_^)I1X@TX]'G/;_CVE_\`B:`-2BLC_A)=*V!_/DV$X#?9Y,$_7;0W
MB;2E;:T\@;&<&WDSC_OF@#7HK'/B?25QFY<9_P"F$G_Q-/\`^$CTS_GK+_X#
MR?\`Q-`&K165_P`)%I?'[]^>G[B3G_QVI%US3VSB5^/^F+_X4`:-%9@U_3"`
M?M/7.,QMSCKVH;Q!I:'#76/K&W^%`&+>>*)XM0NPL;?8PCQPS;,CS5!.>GKQ
M6=:^)M5FP'N!'"9%#730`B/@Y!`XZXKJ?[?TG[OVD>N/+;_"D_M_1PNW[0H!
M[>6W^%`&##J^ON]M$&C87K%893%C`5N6QZ8P>:?X<U[4+ZZG6YF20)`[JFQ1
MR",=.?TK<_M_2N#]IZ=/W;?X4+KFD@@BX49XSY;?X4`<Q#XIU::-4C,;7$LJ
M*BB,8`.X8SGKD#KBM!O$>H6ES:17D"_(%^VE1D1ECA>>W&#[YK8_MO20?^/J
M,$'/W3_A2'6M';.;F([NORGG]*`.;N?%>I1PM*KVI+Y_=`'=!A@/FSUZUIKK
MM[%H,%Y,;9YFN/+;Y@%V\]2"<=*T#K&BL6S/"2WWLH>?KQ2KJ^C!0@GA"YZ;
M"!G\J`,O0?$5YJ-O?M,L(>WB\Q-@.,\\'D^E5(/$FM,L:SQ6UNTXW123*50@
M#)[\YR,5T"ZMHZ`A;FW4-U`&,_6A]2T:=0LD]M(J]`P!`H#0P[?Q;>7-];K'
M;1K`YC23=G*LV?XN@Z<#O5[4/$4MIJ4\(BA\JV*!E9R))-V.4&.V:N_VEHIX
M,]KQCL.W3\JDCO-)N+H,DUJ]QG"G@M^!H`PE\6WTEN)X])9XVD")AF^?KT^7
MG[IIQ\5W;W,EH+."&>,%B99L+@#)'0<XK=M_[-W)9V[0;K=B5B0C*$9!X_$T
MV2STJ\GECDB@EF+!I%/)R!@$_A1J&AFZ1XGDU/4_LGV18E!8&02[AQZ8&/UI
ME[XJ:T1#]D5V+3*P\W&THV/3O6JNAZ:EZ+Q;1%N`Q;>">OKC.*631M->>:>2
MUC,DXVR,?XL_R[=*`.=B\:W$CQQ#3T:1SM^64]?IM)%:^JZY)87+QQV@F2&)
M99F\T*0I..!W/!J5O#>C[$!LHP(\X(8CWY.>?QJ:]T_3+R2.6[AAD=""K,?\
MY'M0!@GQPFU=MBQ8EL@OC`!`!SCG//Y5K76LSV^J)9+8L_FD"&0/P_3=GCC'
M/Y4LVD:+-$L;PP[5#!</C&XY..?6I+6PTRS6!8"BB!F:/]YG!88/>@#2I:8)
M$.,.ISTP:7</44`.HINY?44;E_O"@!U%("#T.:6@`HHHH`****`"BBB@`HHH
MH`2EIKKN``..0?UI:`%HHHH`****`"BBB@#,U_3%U/39(Q$LDZJ?*W'&UCQF
MK5J+A'>*5%$2*@C<'EN.<CMS5FB@#G_%R27%G;VJHYAEF7SF1"Q51R<8!KCY
M[>]MXW4&65V<*?W<B$HJX3C`_P`@5VGBZ\:UTD!)O*\V0(Y!&[8?O;??%<M+
MJSZ>K?V/>3I%(S'$^V1N`,8')`.>X'2F!#.)Y$$C27;S`*AP)%RBQ@>G4M_*
MFQ7EY;ZC8)-J<L<4:H69@ZA1G)!!ZU=G\3ZP5647%O%N?;Y2J'(PH.>YP:G3
MQ%J'VB,WD$(58QO1HLEA@Y?(Z<C&*`(-:UUY-9,EEJ3+"`AC*.P08Y;<N.23
M[5N>"XX6LI[N.8R2SR$R`_P')./R(S68NKZK;7MG!<VD$K7.V0A8>0I[`^HY
MJK8ZKJ,3F:"8;2P\[S%(CC+,<`@=.!V]:0'H-%<C!XKOW=$EL8T(*!\[AG<W
M&!].:Z/3KIKRT6X)C9')*&/."N>.H!S0!;HHHH`*2EI*`.3\/K<O:W9MF42"
M[GVLW.&VKCCO0^O7\MD3;NBSV<#M>;H\C>#@+]>">*E\+%5-P&C!+7LVUB>5
MX7.*WFT^T>.>-H$V7#;I1_?/O^5`&#/JNI65RUK/,DDD\"M:L(MNZ0L!MZ^_
MY58DU_[/KMKILI#$KLF<+@>80",9[?XBM>6PM96@:2%6-N<Q$]4^GY"HY-*L
M98I(WMU999/-?D\OZYH`Y_3]?OKG5'M'FA`BF<NQ3&Z)?[OJ?\*FCUC598K:
M\"VRVUXYAB3!+(3G:Q]>0<BMB/1M/B$02V0&)S(AYR&/4YIL.BV4$\<D:OB(
MDQQER40GJ0/6@"AX=URZU25XKBWC&V-9"\9.!NY`(/MZ9JSK>HWEE/;1VD,4
M@D#NYD8CA1DC_P"O[4_^P+%8BD8EB.W8'CD*LJYR!GV]ZDOM)AOKF*>2:=&B
M4J`C`#!Z]NXXH`Q3XM8>5)]G&W8?.AR1)&^0!UZ@[A^OTK9L;K4)+IH;VR2%
M`@99(Y-X)].@YID_A_3;F3?+!N8Q>4W/WAQC/N,#FG0Z0L+1M]MO9&1@V7F)
MR!GY2.A'/UH`T:*6B@!**6B@!**6B@!**6B@!**6B@!`H!)`&3U]Z`H!)``)
MZ^]+10`F!C&*,4M%`$4D$,K(TD2.R'*EE!V_3\J06MN)Q.(8Q*`1OVC=@]>:
MFHH`BDMH923)$C$J5)90<@]1].*6*&*$$11H@/95Q4E%`%=[&UD#![:)@W!R
M@YY)_J?SIT-K!`<PPQQD@+\J@<#H/PJ:B@"L;"T**AMH=BDD+L&`3P:7[%:_
M\^\7W=GW!]W&,?3'%6**`*KZ?9R1B.2VB9%)8`H"`2<G]>:LTM%`$#6=LSQN
MT$9:,Y0E1E?IZ5-2T4`,,49F$I1?,52H;'(!ZC]!2NBR+M=0R^A%.HH`KQ64
M$5U)<JI\V089BQ/'H/05)+#',%$B!@K!QD=".AJ2B@"BNE6R.[IYJ[R"0)6P
M,$'@9P.0.E6C$ID#DMD*5X)Q@X_PJ2B@"N]I&\,<1:4+&,`B1@3QCDYR?QJ9
MT#HR'(!&,@X-.HH`@M;9;6'RU>1QG.9'+G\S44FG1R7#S&:X#.`,+,P48(/`
MZ#I^I]:N44`5XK58I-XDF8\\-(2.3GI3(;!(I)'$]R_F$$AY20.<\>G^%6Z*
M`&1H(XD3+-M`&6.2?J:@FLQ*)`9YUWL&^23&W`Q@>@[_`%JU10!`EML$H\Z8
M^9GJV=N23QZ=?T%(MKM,9\Z8[&9N6^]G/!]0,\58HH`9&K*I#-N.2<XQQG@4
MC1[G.\ADP,*1T(.<_P`ORJ2B@!KJKH58!E88(/0BLY-&@:20W20SQ9'E1M"H
M$8`P`/PK3HH`RGT#3V#C[':A21M_<#('&1GOFFVWAW3T@5;BSM99!U=80H/X
M<UKT4`8\_AVQ92(+6TB/&"T`;'KW'M3#X;L3*S-;6NTJ0`(<8.>#U]/Y5MT4
M`<[+X7A+R&**R521L#0$E1WS\W/:IKO0M*MX%==,AD.]$(YZ,P4G\,YK<J"Z
M9!&H>14S(@!8`Y.X8'U-`&=H,$5K/J<$"".)+D;5'0?NTK8K+TC_`(_=5_Z^
MO_::5J4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!3695&6(`]2:=53
M4-.MM3@$-W&7C#;L!B.?PH`LK(C?=8'Z&EK&'A72E_U<,B<8^69Q]._KS2_\
M(U9_\]KS_P`"6_QH`TY8()W1I8TD:,Y7<`=IJH^A:5(SL]C`6<Y8[>IJHOA7
M3U9F5[H,WWB)VR?K4G_"/6X`"W=^,<#%TW%&H$A\.:.PQ_9\/X#%,/AC1B>;
M%/P9A_6D/AZ(X_T_41C_`*>FII\.Q_\`02U/_P`"31J`[_A%]%_Y\5_[[;_&
ME_X1G1P,"TP/:1A_6F#P\`@`U340V`"WV@\^O%-7P](N2-8U'=SSYU&H:$__
M``CFDDY^R\GG_6-_C5NQL+;3X3#:H4C+;L%B>?QK)/A^_*D?V]>9.,'_`":D
M&BZB-A77;C<#D[HP03D'IZ<#CZ^M&H&W16*VE:KL4)K;9#%R3`#DYZ=>GM3C
M8:WVUB+J/^74?XT`;%%9)L]:)4_VI`,'/_'MU^OS4HM=:QSJ5M_X"_\`V5`&
M9X9E&6_>%-UW.VW'#<+W_&NF,J!PA=0QZ`GDUQ&B6.J7=I,()+%HDN9/]?&2
M=V,$CVP:TY=,UV6YCN9/[*EFC^Z[1MD8Z<T`=-16&?\`A)P!@Z6?7A^*:Z^)
M9`JNNFXW`G:TBDX.>M`&]161`VNQ1*CVUD^T8SY[\_FIJ&6WU:92KPQKF42D
MQWKKVQ@?+T]J-0-VBL5/[7BM3;BS1P01O-Z2PSGOM_*JS?VQ',91I\C_`#A]
MHO\`Y3RW&"O3GI[#TH`Z.BN=^V:S`T;?V-+)A6X%V#U.>>.O''L:B2[U0;,Z
M3?Y7S./M*G.XYYX[=O2@#IZ*YT:EJL?S+HUX2(]@W3*1QWQZU%#JFLB-XI=)
MNF+J<,K`$$EN_L"!^%`'3TM<O-K.N?9RD6D3K+N8AV4$8YP,>W'Y46VM:U'(
MYNM)N9$.`H2,#'U.:`.HHKF)M9UIR!#I<\0,G+/%NPG'8$<]:LKJ]ZH@\RSN
MR1_K<6;?-]/FX_6@#>HKGFUF_P#LB!;.Y%P#\[&R8J1ST&[Z=ZE&O,LD2RVE
MXH*MN!M&!8Y&,<^]`&Y16+_PD-NMB)I!.,C`D^S/L+?_`*ZC'BW2UC4RRR@G
MC(A8`GOCB@#>HKEIO&EF+H+`ZF`I]]T;(;GMCD=/UJS%XOTIF;S+H!>-O[I\
M^^>*`.@HK`7Q=I7GN'NE\K`*,$?.>X(Q3V\6Z,"NV[!!.&.QN!CKTYH`W**Q
MH_$^ENF\7<07=CEL''K@\_A4KZ_IJS1)]MMRL@/S"4'![`_KS[4K@:E%9$_B
M"TB9L2P.H(`*W"?-RO;/N?\`OFI#K=D$F/VFV)3[@$Z?O.,\<\<\<T706-.B
MLC^W[3S-OFP;<J-WVF/'/7OV_P#U4/X@M5\S;)`^UL+BYC^88Z]>.>.:+H+&
MO165'KUF[(&GMT!)R3<(=O`]_7(_"I9=:TY(RR7MM(1_"LRY/ZT706-"BL\:
MS8O"LD5U`^['R^:H(R1[]J:^LVJ/)F2,QHI.]95.[&.`,YSR?RHN@L:5%47U
M2U5@%GA;)`R)5&/?KVI&U:S5R#/$5^7#"13DDD>O;O\`6BZ'8OT5%]I@RH\Z
M/+`,!N'(/0TW[5'N``<C=MW!?EZ$YSZ<=?6F(GHJ&.YBEC=XVW!"0<#)R/:F
M17J33M$L4ZLI(RT3*IQZ$C%`%FBJL=Z&'S0SH<,V#&>@)';N<<"EM[V.X;:D
M<RG!.7B91P<=2*`+-%0BX0VPGVOMV;\;#NQC/W>N?:H4U&%S*!'./*3>VZ%A
MD>V1R?84`7**0,"`1WJ.6X2)PK;\D9&$)[@=OJ/\B@"6BF"13(R#.Y0">..<
M]_PID5Q'*VU"V<;N5(XR1W^E`$U%-9@JECT`R::9HQ#YS,%CV[BS<`#KDYZ4
M`244QI44H">7.%]S@G^0-*S*BEF(``R2>U`#J*B-S"OEYE0>9]S+#YOIZT]W
M6-"SL%4=23@"@!U%1B:,D`2*225`SW'44YG5<;F`R<#)ZF@!U%1)<0R,526-
MF!P0&!(//^!_*G-(BL%9U!()`)ZXZT`/HJ,31$`B1"""V=PZ>M/H`6J.J8V6
MV4#_`.DQXR"<<]>*N;U+%=PW`9(SR*J:A.(TMRJI)YDZ*I;H,GJ/?'2@"MHG
M,^J'))^V,/\`QU:UJRM$_P!9J7_7Z_\`Z"M:M`!1110`4444`%%%%`!1110`
ME+110`4444`%%%%`!1110!5O=0M-/5&NYTA#G:NX]35E6#*&4@@\@CO7/>+;
M2\NHK9;.T$^"WF$8W*I`&`3TSS^5:6D//]G\J:R-JL2HJ`ONR-H_ETH`EN-2
MLK:Y2WGN8XY7&55CC(JR&5@"""#R"#UKSS7$>ZU>\GF21(S,L2C9]]%X<AB.
M.WY^U9K7<T4\[QW+[`C1*0^#LX"X'TQ0!ZH9$5E5G4,WW03R?I2AU+%0PW#D
MC/(KRM+^Y2"#9<[&A1F!,@+?,0#C/0X'3Z^M'VRYMT=[.\<+-*0-T@W[4QL)
M_,^W%%@T/5<TFY=N[(QZYKS=M5O?(EF.J-F4RAHMZG"A0%_$Y_2KTVI);^%;
M+3K*YCEEN%(EW2*"BGEE.>G7`S0!W8(89!!'M17FD&NW=CIEO;6]Z(/+64G:
MJR$G=POL/>GR^*=7M[R:(WBR(JE`P12"<8##`]>:6H'I%+7`QWVJ7UREG-JZ
MX^T(FZ-0"?E)/([9P/K7?4P"DI:2@#D/#"!I[LR3.D4<LAP)"J@AU.3^7Y5T
MT7E2^8UO<[MSAF*ON`QC@>@('ZFN,L89!9:U(B%@RS(,#/.[IBH+"/4+"QN?
M*BGM[EUB)=8SM$>.2`!][.,_4T`=S);-]H\\74D:#EDR"IQCUZ<#M5E75T#*
MP92,@@Y!KS]=7U.2Z6TEO02UOM*/&<-E>`1UW'C\Z='J&J/#/#BXBB%M$$$4
M141D%,_INI:@=I>6US.?]'OFM^`/E16]?7_/%*;:X^UB47C"+<28=@P1M`QG
MKUY_&N0CU'79KUHUNB%G<1<0-^Z&[;NZ8''/6GIJ6L)<3QR77F1N_ELWD,?(
M`?;N(QC!&>_>C7L!T\%M=*TCMJ1E1M^T>6H"YQCGOC!_.D>UOV\DQ:D`JL"V
M80=ZX''MT)S[^U8.EW#V7@C:JL)W9XHU(P=S,0.OUS42:S>Z3I,%DP2*XMY&
MA8RH2"H4E2,<>@ZT`;IL-8R<:R,<\&V7\*N""\^U,YO%\DD8C\H9`QSS[GFN
M.NO%FL0W!B$<`)4;1L)+<#D8/0\XK3T[6-0N-?BLKBX@"H)`ZHA'F,K$8]C@
M`_0T?(#46UU=)-QU.*10^=AMP,KSQG/TYK33=L7?@-CD#IFN'EU>:QUF>7[3
M/<1[IFB17+(>H"LO50ISS4S^(+Y;B60A#+:QR@["3#*`R88#/7!/^>*!G13'
M51</Y7V=H02RYR"PV\*?3GO1/+JL<TGDV\$T1;Y-TFT@;!UX_O9KF9O%5Y+<
MW,0,4<*).$*M@L1]TY]?YU8'BZ>*5G:U$EH0PCVO\Y*`$D^W7M0(V(I->25F
ME@M9(RS;5$A4J.V3CGI^OM5B6XU)5)CL8W/FE0//QE.S=.OM6#;^+IWU.&UN
M(8(5:0I(Q?[I#$=<^PK2\27,\2V`M;@Q&:X"EE(^88)QSZ\4`:+/>?Z.RQ)A
MA^^3=RI..A[XY^O%*\MT(D9;4,Y#%E\P#:0.!GW/%84?B[<B*;!O.<*R1B4?
M.I#$D?3;^M=%;SI<0),A^5U##VR,T`,M9)Y48W$'DL#@#>&R,`Y_/(_"I)2%
M0MY9?'91DU)13`KN8TE1/L[-O_B5,@?6GA(RQ7RAP`<[>#4M%`%6=H$(1[9I
M`2/NQ;@*C=+-2Y-EDKDY$&<XQTXYZ_H?2KU%`6*9M[-70&T3,G0B'./J<<?C
M3)K'3I9=DEC&[*.ODY&"<=<8[5?I*+L+(S9M)THH4?3XBJ#=Q#ZYZ$#GZ5$^
MDZ,]QM;34WD[<B`XX`[@8[]?\*UZ*+L+&1)H6BK(D;:='E\XQ&2/Q(X'XU&N
MD:$711IHRY(&87QQZG''3O6W1BG=@8O]BZ&"@_LY?F8J/W3'D''/H/<U/_PC
MFC_]`^'\JTZ6B[`R3X?T;S`G]G19QG[IQ^=1MHNA()B]A"BPC+LR$`#&<Y/!
MK9H(!!!&0:+L#".B>'_W9^R1[7`97^;:<D`<].21@4__`(1G0RYC%FFX`$C>
MV0#G'?V/Y5L[5P!@8'04NT9S@9Z9HNQ6,1-`T&2=X5MT:6(`,HE;*]QWXI]M
MHFBSQE[:)7CY'R3,1].OO6N$4$D*`3U..M"JJC"@`>@I7&9,?A[1UWQQ6^T@
MY8+*PP?SIC6.BJJ9GVAL[?\`2W&<<''S5M8&<XZTPPQ-C,:''(R.E`&5%HVE
MW&XQ22R;&*MLNG.".Q^;K4"Z-I-Q-&(;R8G9YFR.[8[USC/7.,]Q6\J(F=JA
M<G)P.IIJP1(04C12%V@@8P/3Z4!J<Z='TFY(:WU6<*Y`41W>1GVSGT-.70;*
M.-9$UF]5'0L&%U@,N,YSZ#K6\EK;H`$@C4`Y&%`P:7[/#Y8C\I-@7:%VC`'I
M]*`NS#B\/Q2AO)UO47VMAMMSG!]#23>'%BC:1];U&-0,EGN.!]:WHH8X=WE1
MJFX[FVC&3ZTLL4<\;1RHKHW56&0:`.=_X1Q@R@Z_?[G^Z/.^]]*!X:9F*C7K
M\D9R!+S_`)Y%="88F=',:EH\[#CE<^E,BM88I9)40!Y&+,?<@`_^@C\J`U,)
M/#<CC*:]?L`>JRT'PQ+("IUR_93P09,@^HKH(H8H%*PQJBDEB%&,D]34:6<2
M1E%#`&0R'YCG<22?YT`8*^&;IEROB"]*GH0Q_P`:<GAV\#-CQ!=L?X@>1SZ@
MFMZ"VC@M$MH@5C1`BC/./K34LX4*E`58$$L"<M@8&X]^/6@#$'ANZ\T-_;<Y
M*CY04!"Y]!T'X5/_`&/J`#AM;D<.`")($8<>QK9$:"1I`H#L`"V.2!G'\S^=
M1SVJSR1NSR*4Z!7(!Y!Y]>GZF@#&70]221636N59F!:V4G+=3]:D;2]7?;NU
MM6*G(S:)P?6M46J`RD-)^\<.?G/!&.GH..E1O8(]P\QEG#-U`D(4<$<#MU_/
MF@#&MM(UF*YD/V^TC0G<)$MEWL>>2,#GD]Z+G3_$+R@B[L)0`0&DAP0#U'0]
M16Z;93)"^^3]T"`-YPV?7UJ`Z:AB6/[3=85RP;SCDY[$]Q0!A_V9XB55C273
M-@0I@18`!ZCITJ3R?%N['VJQQZ[?_K5T,<(C(.]V^4+\S9Z=_KS48M`+II_.
MFR3G9O\`EZ8Z?K]:`,!+?Q4DSOG3F=@`7*\D#.!P/>F-:^)OW?[K32(N$4`X
M7IC`Z=A741Q^6&^9FW,3\QSCV^E*7`D"<[B"1P<<>_XT`8OAC[3Y5^+S9]H^
MUMOV=,[5Z5N5D:#S+JC`8!O7_0*#6O0`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110!R&N>([JQU>XAA&;>*+8=JAL2LI*D_P"'UJ.'Q>UL
MS6]_`DCQ1_,Z,.7`Y!XQR>.*FUVPTBUU*-[N6]\Z]E!Q$XP""`"?89J&XTGP
MW!<LDFH2F9W*./.7(/4[N..E`$[>,(8LF;3'0`E?O`_,%SCI[C\ZMZ9XDM=0
MLKRZ:V$"6J@G>P^;(/'Z8_&LEM/T"YO'B.K7!(3>TS3)L.[@C)'4U.F@Z,EK
M+;IKD@@)!E07";>HQGCUQ0`Y?%]O-`S)I328+;E5@<``$D\=.:9+XDCO%A6R
MTL,\DB(6D4$*QY(QWXSS1'X>T.(!(]991,I7`G3YP3C'3GD?I4X\*6\DWVJP
MU27[3&VWS3M?:0,8P`.<4`0^(;XV>K6\-I86;+'@M+(HP&;/RD_PG'KZTC>)
MK>.>9)=$;".RJ54'.W[Q/':GW7@VXN;W[6^JLTW!W/""<CIWQ21>#;J`$0ZJ
M%W!E8^1U#8R.O3B@"2#Q;HY6:X%HR-$0JE4&YP<]/2M*P\00ZCJ26UM%(T9@
M$IE(.%)_A/\`C6`/`UTJE!?Q%"02#&><=._O6OH>@7.F:@]P\T)1TVLD2LHX
MQCC..WZFBP'04444`<WX8LDEAFN]SQR?:)5^0X!&X'G\OU-:C7-L;;R8[\%Y
MF>))0P8J^"<<>G]!5#PU<VT.G2H\J(XFD=@3S@N0#^F*Q=1\/VZM'&NIPV]S
MOD:568@-U8''J%;\J`.CCTFVCS<I*DEVRA5N955CN&>?KSC\!6H&0A?F'S=.
M>M<5;^'(P+B'^TXGACWO$@D.8L,/F./8$'ZU+)X=O(;FWF^V+'9PY(=)2OD)
MN+9&?]DXH`ZJ&&XPIFN-Q61F^1<`J<X4_3(Y]J>B3"=V:13$?NJ%Y'`[Y^OY
MTZ*:*8,8I$D"G:2IS@^E/H`@$<YAB5WC9P1YAV<-ZX&>*I:OHRZL<3,H1%/E
M8!#*YSDDYY'3CVZUJ$@#).!2"1"<!@3Z9H`J0VLL4D8'D"&-0H58R"`,\`YX
M[?E2O#=BY#PFV6,M\V8SN(XSSGKP?TJWD>M&X#O0!7^R1K<^:D,*[P?,;R_F
M;TY_.HVM#L8)';`C*)F+@(1ROY_A5P$'I1D4`9\%A&ENPDL;,R8Q\D857R!G
MC''IWZ4Q[1TF&S3[-T==COC:=O(QC'(``X[_`(5IYHH`SY]-@\D-'86C3,R[
MR8P."1N(..N,FH1:.MK%;2:;#<001`Q!G!(8*`%Y'7KS6M10!@MH=L\>PZ1#
MMC4A09<E@.5&?<^O09'>KEHDEJUP(--$2LX?B4?.>`3CMP`:TZ*`&H2R*67:
MQ&2N>GM21LS("Z%&/52<XI]%`#'D";<JQW''`SCZU%<7#PR1!;>217."R_P\
M@<_F3^%3T4`+3%D#2.@!RF,Y!QSZ'O3Z2@!:C\Y,@<\L5'!Z_P"14E)0!$]S
M$D@C8MN)P/E)]/;W%2T44`-9U5U0GENG%#R+&4#'!<[1QWQG^E.HH`ABNHII
M7B0DNGW@5([D=_<&IZ2EH`B-Q&)C%D[QCC![YQ_(T+/&TS0@_.O48/M_B*DH
MH`@%Y`9(XP_S2,RJ-IY*]:GHHH`ABN[>9PD,R2$J6&QL\#_]8J5F5%+,0H'4
MDTV.&*(8CC1!Z*H%.95=2K`,#V(S0!$EW;/]RXB;G'#@]L_RJ3S8\`^8N&;:
M#GJ?3ZTU;>!?NPQCZ*/I3O*CP!Y:X!W`8Z'U^M``9$&[+J-OWN>GUI6D1-N]
MU7<<#)QD^E(8HV#@HIW_`'LC[WUH>*.3;YB*VQMR[AG!]1[T`'FQ\_.O!VGG
MH?3]12":)@2)$(&,X8=^GYT>1%\W[M/F8.?E'+#&#]>!^5-%M``P$,8#%2?E
M'..GY8%`#O/BW!?-3<>VX9IQ95QN(&3@9J/[);^8)/(BWCHVP9ZY_GS3WC23
M&]5;:=PR,X/K0`"1#T=3]#2[UX^8<].>M1I:V\>-D$:X.1A`,<8_EQ]*<8(B
M4)C0E`0OR_=[<4`.#*PR&!'J#2Y'K4<=M#%$8HXD2,]550`?PH:WA<*&B0A1
MM&5'`]/T%`$E&:*C\B/[0)\?O`NS.>V<T`2TE+3%C"N[@G+G)R?;%`#J*9)$
MLC1LQ8%&W##$<X(Y]>M+%&(DVJ6(W%OF)/4Y[_6@!U&:9-&)H7C8LH=2I*G!
M&?0]JC%H@DD?S)<R%209#@;?0=O?UH`GHJ&YMEN516DE3:P;]VY7/UQU%+;V
MX@&!)*_`'[QRW3ZT`2TTR*)5CYW,"1P<<8[_`(T2)YD3IN9=P(W*<$?2G4`9
M6A'+:EP1_ILG7Z+6M63H1+-J1*E3]M?@_1:UJ`"DI:*`"BBB@`HHHH`****`
M&22"/;G/S,%%.I&SQ@`\]Z6@!:***`"BBB@`HHHH`****`.#U'3KFXUJ^PUO
M-,'$D;-<X:$`Y'!&.@Y';C\89=&U2X=V,5N86:1E7[0I`9^,Y[GD?I3-1TC4
MI[V>1M.G8-/(XQ@Y!Z=_I4(TK5A`L!TZ<HN`IQSC()/7V%,"S!I6H-=6\TT-
MG=,CA-C3IAMBXVX]1UJM)X:U2".4+:(ZL#DK(#@#GGWZ5:DL-0-E801:;=QO
M!)([R#&<LP(8<\G`QS445EK$.C7=K]ANVFN)@SDCC:.O?J3U]J`*QT_4K-K=
MWL=GD*2"RJ20IR3Z8YZ_K7;>&))9-,)GLEM'WDD*FT/GG=C]/PKEM2BU.[@L
MX8K2_#06WEY:,C?GA\^V,50@GU6SB:"0WT;@-A-K?+PI7!^J@?3/K2`]/=U1
M=SL%'3).*6O*Q-?20+#<2:@5&6"DMC(Y'Z@?2M*?5[M=#BABN+Q9_/9B/FW*
MG.T%B.><4:@>A$@=317E-Q>75S-+)-<7!>12CL,@<D\`?W.E7?[=U)&C8:A<
M;EB`XC!49'(QCJ#CGZT:@>E4E<1X=\07MQJR1ZA=GR3'T>-5!?@`9`KMZ`.=
MT.\M+2QE,H6,Q^9))*<=/-<`>O44YO%%G]@AN1"6:5FQ&",JH;;N8]AT_.C1
M8+-K0+/!YCSR2H<QEE(65B`>PY/>F?\`"-V7V>)8Y9HU21HVVJ1YB%_ND>F<
M<^@S0!:BU^%S=J;*Y1[9#(08_OKDCCZX[U(VN0KHJ:FUO*86ZJ`I*C.,GG&*
MI_V%<6KW<\6K3H]RPP0F0I+#&1WXP/:K]O96<&E2:<Y9H8T(E:3(SNY)S^)/
M'2@""T\2V-U&'59(P93&=^T;<+DL>?N@=ZOIJ=@Y`2]MV)X`$JG/ZUD6_AFT
MACDD:7<KV8@+*N.W+_4\52MO"T<<-I.NI_NT;>&$84-NVX[]\#KZT`;=YJMB
M=+CNV4SV<SJI95X&3C+9Q@9%5;>YT/\`M&[")#'(,&2=MH63>,\-GG//ZU`T
M-O\`V3%I4FKV^;=UWL5`RJ')7&>HP,__`%ZJS>&;)993:7\$8\Y2(Y%5U0D$
M;2,^IXH`W`VC(8IA+9CRU$4;[UX"X.T<]LBF2QZ)>?NI'M)?-D\T+Y@^9\;<
M]>3VK#G\/V$L<Z6VJ09EC41*Q4A2"N2,'OM49Q1;^'8K">))]2MMJ31RN7`6
M3<N<*.>`1_*@#=74=(L+F6V$B0R+@R`(<#//)QCO3)WT)KQ;R6>U-QE5#^:,
M@YX[UGW=C/<7]_+%?V44=RHAG!.XHA!"GJ.3GO\`K5=O#*6KQF-[5D^UK<++
M*V&\I1DKTYZ4`=!*NFLFZ26+:6$V3+@9/`;KTXJ>,6UA9#:RQ6T2YR6X`^IK
ME9/#ZMI4T45Y#/MN`RAIN%B`8*A;M]XG_.:UX8;I/#TUI)]G_=QB.*1WRDB[
M1R?0=10!H17UE?@+;WB.0P.(WYXP?RZ9^M5[>VLGDG%M>2@E]K(DQ^5@NT@?
MAC\A7-Q^%[R%//B:#`\U0C3$@(Z;<[L=CGM4O]BZFZ.8O(#/+,VY)B=GF(O.
M<>Q_.@#JX%CM;8!KAW3KYDKY/YTV*-)@LL-U(Z9)!5P5.2#CZ#&/H36/IVG7
MVGZ#)%%!&]T9-\4<LFX)T`Y]L9K2T.U>STN*&2(12#)90^_))Y.??K0!==-V
MWYV7:<\=_8TXC((SCWI:*`(DB*^7F5VV+@YQ\WN?>D5)A<,S2J8B.$V\CIWS
M]?SJ:B@!*;&'"8D8,V3R!CC/'Z4^B@""5;G[,PBDC$_\+,I*]?3/I[TVW6\&
MS[3)"WRG=Y:$9.>,9)XQ5FB@".42$#RBH.1G<.V>:(!*(4\\J9=HWE.F>^*D
MHH`8HDWON*[,_+CKT[TDGF93R]N-WS[O3V]^E244`01"Y%S*96B,''EA0=P]
M<U(-^YMV-O\`#CK^-/HH`B@,S*_G*JG>0H!S\N>#^5,N6N%9##Y93(#ANOWA
MT_#=^E6*KWC(L(,@)4R(.!GDL`/UQ0!7T^YNKJ21W6)8%>2,`9W95R![8P*L
MK).2V8,`;L?..<'C\_TKG+F!X?$.E+<2LH>6YD.)#C&=R@_F.*6?Q<%NKE+:
M.&6&-"8I#)M\QAC(&?J?KB@#=@N+MY=LMB8EW$;O-#<8Z_GQ4HDF+*#!@%V!
M.X<`9P?QX_.L*>[N-8\,+?VS>5/"_F[(V/.PG*G\/Z53/B*:!3?Q0M*+YR(8
MY&PJ)&N#SZDYH`Z2&YNWG"26)CCRP+F13C'0X]ZLEF$@7;E2#EL]/\_TKEO^
M$NN6:X9;!!'"/F)D)VG@`$@8.21P*LZ;XG%]=V4+11Q_:(\M\^2&RW`X_P!G
MOCK[4`='1110`4UR50D+N('`'>G4E`$=O(\L*O)$T3'JC$$C\J4R$3)&(V*L
MI)<=!C'!^N?TI]%`#9)!&`2"<D#@$]::\Z(LK$/B/[V$)[9X]?PJ2B@`HHJM
MJ#A(HR86ES-&,*2,98?-]!UH`M45Q>H:Q=6EUJ:?:)/),RK"QZHRE"RCZAC^
M53VWC":1GEELO+MAA@_.0FX*2>Q/(Z4`=;17'_\`":O%/']ILU6%DW$(V7&<
ME?;ICKCUJ*?Q1J%A=S&ZLUWM''LB$H*KG<<\<G(Q^5`'8PS1SAC$X8*Q0X[$
M'!%*\FUT7:QW'&0,@<9YKE]5\1WEOH]K>PPI"9W8@.-WR[<KQGOQS2GQ'=KJ
M%U#Y<.$24K&0<KL7<&)[AJ`.F25'D=%;+1X##TSS2O(L8!<X!(`^IX%<W)X@
MOE2Q,4$+EK6.XGW$C(9@N%].3GFM'1=3N+VXO+:[BBCFMBH;RR2#D$]_2@#3
MCD252R'(!(_$'!IDMW!"',LJH$(#$]L]*EHH`;%*DT2R1,&1AD$=Z7<H8*2-
MQ&0.YI:8643HI0EBI(;;P!QQG_/2@#)\-.734F;K]OE'Y8%;587A;F/4F!!!
MOY2"/PK=H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`I*6B@#S
MFZU*_N-7FB:]NH[,W)QC<-JA_7Z$_D*B@UC49+@1R:E-!"P";G).!D'/U]36
M]>>,_LMQ-&+-9%CE:,%9#R!W^[39O&4L#JD^ELK!]L@#YVGT'')QS0!GP>(9
MX]%F$U_*]S+*@4A<M&O&XCM["J_]OZF3',=0;S`0/)4#:<!>2??YC^%=%H6L
M76J:M)O$:6OD[EC1@^#\O)./?I[&NDP/2@#SJ/Q'J8G417VZ,AG)G0+@[>5Q
MGIGI5C1O%%VUW;QW=[&(%B8R&4`$MSCGUZ5W9C1BI*@E>02.E0-IMBS,S6=N
M6;J3$N3^E`'!GQ=K"("9[9B0.%0$CA3_`%_0U?L?$NH7%I>&::WWPPLRA<!G
M8@8VCOCYLUU#:+I;?>T^U/\`VR%)_8>E?]`ZU_[]"@#G]"UO49;NPL9`LBE6
M,TC`[L9;&?0X`Z\G-=A5"/1=,BE26.PMT=#N5E0`@U?H`*2EI#G!QUH`Y1+V
M:VT&+[)*(I);J;#E01@,[8_'&*I)XJO@;/?NRD;"<>6,2.5)3'_CIX]:TO##
M+>Z<+:2VREO.69F/&[<2-OKCBNC\B+(/EIE3D?*.#TS0!QZ>*+\6]FS(#*GF
M"Z4QXR`%VL!UZ,#V[U)!X@OI;E)I)K<6_P"Y#V^/G;>JDE>_!.?PKIKG$<@9
M;0S,X(+*!D=.#GU_I2BPM!,LPMHA*HVA@@R!0!S,'B6ZN+34S&T*O$K36Q9>
ML8)SGWQC\Z=)KFHI;X+68>W@6XEW@CS0V2%0>PQ^-=!)##-:D26>0<P[-HR$
M)VGZ#'/TI+K2[&=XIY;1))(!^[P.>.@]_P`:`.='B&YFOI+>"SMI&\V541E9
M6(4$Y)/'.,8ZU?L=8FO+VW9K6)+*[9A`S?ZPE1G)'3L:MRP6L,<%R-,E>4R-
M*%1071V!))Y[]/3.*$@MH6B>"TN,62R)&BC@<#ID\D]C[F@#`;Q-=QW;J=*B
M:!)O*$BQGIOQUZ9_K6D_B?1GB,SQNS!MI4Q`N,#J1Z<D9JZ5M&L(42PG>&5C
M+L"D%6!W<@D'.?UJ$>';&*6YEEB\Z.90BQ*N-B[LG!')^;G-`%.V\4:=+-<!
MH"4W*5,<19F4#.YACM4]IXET[4M0MK2VC:0R;E)=,;1M)_IBG?V+H*AP+1EV
M<-M$@)R=N..HRO\`7O4]KH^D:=<B>WMBDT:;@V7;`.1_C0!E1>);9+N>UDTU
M$B\W8"NT9&[;E@:N?\)9HLI,#.Q0@@[H_E(J.;1=`@F=YHY`&`VI\^V/D_=Q
MTR0?\FGR>'-&"PW$B-Y8B$8!S\W&`3@9SB@"U8:YIVI7"V=J"ZM$7(*X"X(&
MTC\:I0:QH/VF>\V^3/$WEY(Y?C`*@'D8'Z4_3-(TW2Y?/@N)=RH^XD=0P4]A
MV`%1+HFBRNLEC-);S6ZY\R(G/U.1UX/YT`6O^$@T>>2UD>8!POF`D_ZO('!Q
MW^;%/DU/07E$[WD&]),AMY&&QC^0JG;>%;([/*O+AHX7!5,C`;Y2>W?:*@_X
M0S3;H220W<X5G.0,8!!(QT[4`=%:75G=R3-:S)*R$))M.<8S_P#7I4T^V1'1
M48*^-WSGL2?7U)JGHVAQ:1-<RQS/(;ALD-T')/\`6M:@!D<:Q[MN?F;<<G/-
M$D:R;=V?E;<,''-.!!Z'-#,%!+$`#J30`R1"[1D.R[&R0/XN",'\\_A2/&[3
M1N)655SE`!A_K]/:G[UP#N&&Z'/6C<N,[ACIUH`6FHK*#N<L22<D=!GI2[EX
MY'//6ES0`V)&2)4=S(P&"Q&"?>F6T<D406:9IG_OLH&?P%2T9%`$=Q')+"R1
M2F%SC#@`D<^AJ2BB@")8I!.7,S%.?W>!CMWZ]C^=2GI2TE`#(5=(4223S'50
M&?&-Q]<4]E###`$=>:**`([B*"6/_2(XW1?F^<`@>_-4X[.00,`MHY.[8?+X
MV[OE!QV"\57\0P23+:MY$ES;QR%IX(\9<;3C@GG![5S]Q87[75O]GL[NSM49
M<%7WL@W/V[?>Z#.*`.S,9CB5+=8T`(^7'&W/.,>V:C-G'+`([B"W<(Q,:[,J
MHYQP>^*S?"\^H7=I)<W[Y#$)&NT#[HP6_$YK;H`YR#PNL5V;QQ#//(',BRY,
M>YF!R!CIC/7VK2M].$$\,J6EC&0#YC1QX8'G[IQ6C10!4N?[2\YOLOV7RMGR
M^9NW;L]\=L5&QU?R8]J61EYWY=@O;&./K5^B@"JAO\/O6VSM^7#-][WXZ4Y3
M>>4Y98/,R-H#'&.,YX^OZ58HH`;(65,HNYLCC.._6H8#>&51.D`C\L$E&)._
MN,$=.O-6:*`(;EY8XMT$7FOD?+NV\9YY^E(6N?M"@)'Y/=BQW=#VQCKCOZU/
M10`P,QD*["%`!#9&#[?Y]:`Q,C*4(4`$-Q@]>/\`/K3Z*`*;:78OYFZUC;S'
M$CY'5AT/UJ*'0].A:<QVJ#SQM<'D$'J,=A6C10!DS>'-+GO6NI;8,[@9&3MS
MZXJ'_A$M)QCR7Z@_ZP]L\?3!Q6Y10!BR:'!_9:V]PDDXMBQB".=Y3LF2>XX]
M*<UC"UU<`6,H^T*())=P`$>S^'GH,`?4U:UE]FDW+>;)"0AP\8RP^E<=::SJ
M%E"DO]H&Y=T.Y)0Q2(ET`R>I.">E`'2W.A6:1PO'!+*\">6D?F<,N<@'/8'G
M\*GT73XK%)2@N#(S;6DN&W.X7@<^GI6=/JMW=>'H)R3:-),(IIE4X1<D%USV
MX'/O5"+Q#=:>$MUD&HH')\YE8/(NX#:N?O-U]J`.O>0HZ*$9MQ()'1>,\U';
M7)G,@:":'80/W@`W<=L&N6C\6W@@NKE[:-@I1(XU)&PMO^\?7@<5TVEW4E[I
MMO<RQ^6\J!BOI0!)-<&(N/(E?:%/R+G.3CCZ=31'<&214,,J;@3E@,#!Q@\]
M^H]JGI*`,/PH`+2\`0)B\E^4=N1Q6[7/^#CG3KHAB^;N3YFZGIR:Z"@`HHHH
M`****`"BBB@`HHHH`0G&/>EI"`>M+0`4444`%%%%`!1110`4444`9<WAW2)]
MQ>QBRS;B1D$G\*KS^$M'F8D6YB)'_+-R/TZ5N44`85IX3T^SNH[B%[@21D$?
MO/3L>.E;M%%`!1110`4444`%%%%`!24M)0!@^$+=HM/FE.,33.5QUX8CT]O>
MM^L;PO"D>EB5<[I9'+9]G85KONV-LQNQQGIF@!U%10>=L/GE-V>-F<8_&I#0
M`M%0P&<C]^(P<#[A)[<]??-+.9P!Y`C)YSO)'8XZ>^/PS0!+13%+^800-FT8
M(/.><_TJG-)J@ED\F"U:,$;"TK`GUS\IQ0!?HJKOO,_ZF+&S/^L/WL=.G3KS
M2S/=K(HAAC=,KDM(5(ZYXP>G%`%BBJ\TMTD(,=NLDI8C&_"@<\DX^G;O36EO
M0!BVC)RO_+7MDY[=ACZYH`M453-U=QA?-LF8D@?NG#8YQSG';!IAO[G)`TV<
M\;AEEZ8!(Z]>2,>W6@"_BC%0?:'^V&#[-+MVY\[C9].N?TH:Y8+&?L\QWR>7
M@#E>OS'VX_44`3XHJ*WG,Z%C#)%@XQ(,$\5$MZ6NE@^R7(W`'S"GR#C/)S^%
M`%NBHH9O-!_=R)C^^N*;#<^=+-'Y4J>4V-SK@-[J>]`$JJJC"@`9)X]:22-)
M8V210Z,,%6&013$N$9PARKDL`K#!..I'M4U`$7V>$I&GE)MC(*#:,*1TQZ4-
M;PO&(VB0H&W!2.,YSG\Z=)*D6W>P7<P5<]SZ422)&NYV"C(&2<<DX'ZT`0M8
MVSH4:%2A4H%/0*0!@>@P!TJ3R(_)6)EW(N,;CGIT_E2-=0)+Y;3('R!M+#.3
MT_F*62XBB8+)(BL06`)QP,9/ZC\Z`)*8\4<CQNZAFC;<A/8X(S^1-(9X@<&1
M.6V]>^,X^M$=Q#*Q$<J.0`2%8'`.?\#^5`$E-,8:17);*@@`'CGU%*CK(@9&
M#*>A!R*;YT?E>;YB^7C=OSQCUSZ4`24P(!*9,MD@#&>/R_&AY$CC,CLJHHR6
M)P`/6G`@C(((H`1U#HR$D!@1D'!JK*RV448#O\TB1Y;+D]!W/Z_C5L$$D`CB
MJ.JLWEVVPMS<QYVGG&[G\*`)TS>62F1)(3*@++G:R$]LCO4D\0G@>)F=0PP2
MC%2/H1TJ&PNA>6<5P",2C<N/0],^^,9]ZLY'J*`(8[98P0KR'+[_`)G)Y]/I
M[4JP!8B@>0@MNR7)/7/7TJ7(]11D>HH`K16:Q(%$T[8(.6D)/%+%:"(C$T[8
MD+_/(3VQCZ=\>M6,CU%&1ZB@"+R!]H\[S),[=NW=\OUQZTOD?Z+Y'F28V;-^
M[YNF,Y]?>I**`&LK%D(<J%/(P/FXZ?UHVMYN[>=N,;<=_6G44`,D5V*[)-F#
MD\`YYZ4DJ2.R&.8QA3EAM!W#T]JDHH`CF21POERF/!R<*#D>G-/<,=NUMN#D
M\9R/2EHH`:P8LI5L`'YACJ,5%%%<*4\RY#@;MP\L#=GI],?K4]%`%-1<6\2"
M>Y\UVE`W+$%X],9_6E>*ZD\UH;U5#<)^[!V$<'OSS4MSYQ\KR"N?,&_=_=[X
M]ZBTV-8H)`LPFW32,6!R`2Y./PZ4`27,5S)M^SW(AQG=F,-GI_\`7_.IZ*CE
M:4-'Y2!@6P^3C:N#S^>*`&0B4OO,Z21G=@*OOQSGMR*JM9W\DR^==0/`,'88
M.=P'7.?[W-7H'#Q!A&T?)^5A@]:?0!%$DP;][(KKL`P$Q\W<]>_'%-:.Y,1`
MF02>9D,8^`N>F,]<<9J>EH`K645S'"5O)8YI-V=R)L&/IDU+,)#"XA95DVG:
M6&0#VR*DHH`@*W.V("2/('[P[#R>.G/'>GJ)1,Y9E,9`V`#D'OG]*DI*`.?\
M%_\`(,N?^OJ3^E=#7.^"_P#D&7/_`%]/_2NBH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBJ=_%?2[/L-S'!C.[?%OSZ=QB@"Y16-(FK1,H?5+)2_
M`#0$9^GS<TXP:[N&+ZSV]R;=L_\`H5`&O16)*=9+MY=]IZ;5RR%"<''/.>F:
M8C>)5\N0BPF4X+1J2IP>N&_SUH`WJ*Y_SO%.3_HNGX[?.W^-`O/$JLV[2[9E
M(^7;,!CGOSSQ0!T%%8*7OB,2J7TF`Q[<%1.`<^N?3VQ4OV_6O^@(G_@6O^%`
M&S160=1U8`$Z(Q.,D"Y2HFUG4EE$?]@W&XG`(E7'3/7I0!N45BKJVJ.<#09L
MX!YG0=:@/B*]64QOH-YN4G.WD8'H<8-`'0TE8"^)9V95_L/4`S'`S'@?G3CX
MGB\W8-/OR,'YO(/7'3%`$-M)M\(!E<JID8%P<$*9B"<_0FLJ]6_2WD\B;4CJ
M>Y_,0;MGE_-@@].F,8YS4FC^(?)TE()-)N[A27)98\JV6)_K6@/%HS\VD:@!
M[1YH`J_V5J;0AY[F_A`EB2-%N=[;68!V)`]_PQ2SW%U#*RZA?7=M9QR2(LR+
M\S'("@D`\8R?>KO_``E<7_0+U+_OQ_\`7I&\5P8PVEZC^,`_QHL!C#5-;5R9
M&F^SY@BD<C!1CM)./<9S]:E37-1\J^EF,\2SJDUJ2N%5`XSCZJPK3_X2R#G_
M`(E>H?\`?D?XTO\`PE5L<*=,O]N,?ZC@?K0!/%J@N;^Y^R72S0-:>8A7GRV!
M(_7(Z^E<Y;>+[^&*V25?-9$=IF9?OY!9.1TXK>/B32X75Q;7"R3##8MB&P/7
MU[],U.=?T=8]TD@0'@[X6&.,8Z>E`'+W/BW46`N('2,';^ZQN7_EH#R>?X15
M[_A,[E44/90B5D\Q<RX!3:3U]>.E:P\0^'P.+B$?]LC_`(>]5=0U+PQJ*)'=
M7"%4.0%5U[8QP*0#]9\0W%A+8A(TVNBR7/!8HI(Z8_X%S[5FMXSG\^5DA3:T
M>(4,@P3D_,3P1P.GTZ5O#Q#H>T#[9!@KC&#T].E12:GX;E!WRV39()R@.2/P
MI@9%IXZ/DH;NS.20I>-^#C[QP?J.*L#QO!Y,LAM),),$`W#E3GGZ_*>/IS5M
M[[PQ(BH\EF55]X&WHWKTIGVCPJ4*;K/:7\PC;_%ZTK`=$C!U##H1D4ZLU->T
M@CC4+<?5P*E35M.D<HE];LPZ@2"F!=HJO]NM/^?J#_OX*/MUI_S]0?\`?P4`
M3T5&MQ`XRLT;#V8&G>;'_P`]%_.@!U+4?G1?\]$_[Z%*)$/1U/XT`.H(!ZBC
M(]:*`$VJ3G`S2E03D@9HHH`-H]!2!5!R`!3J*`$``&`,"DV+LV;1MQC&.,4Z
MB@!"`1@@$'M38XTC7;&JJOHHP*?10!%';012R2QPHDDO+LJX+?7UI1!"`H$2
M`(Q91M'!.<D?F?SJ2B@#&OS8Z*D+0:?&T\TJI$D:A<L<]^W4U6O-5CM_WM]I
M&V8$MU5R<-&`0?\`@0_[YK9OK&WU"#R;E-R@[@0<%3Z@CH:H?\(UIWD-$5E.
MX$,YD)8Y*G.?7Y%_*@"2RGTN],<5O&C&-"54Q8V#=@C!''*]/:KDEC:2ILDM
MHG7^ZR`CN?ZG\ZIZ-I(TTW,CR&6>XD+/(>XR=H_6M2@"$VEN9_/,$9EX^?:,
M\=.:;)96LK.TMO$Y?ABR`[OK5BB@!JHBMN50"0!D#L.@_4TDL4<\31RH'1A@
MJ1P:?10!&(8U<.(U#`8R!SBHWLX7NQ<NI,BKM&2<`9ST]?>K%%`$-M;1VR,D
M2;06R><YH^S+]I\_=)NQC;O.W\NE344`,2-8]VT8W$L?K4;6J,P8M)D2>8/F
M/7&,?3VJ>B@!D:"-2H+'))RQSU.?ZTQ8`J2+YDA\PDY+<C/IZ5-10!7M[58(
M$B9WFV'(>4[FSGUK&OI=,MKJ*P-[<VLA=F_<L5&7.?F/UZ5T%<]J7AM[W5#=
M"ZQ&[*71ER0`1PI'3I^IH`MQM9S:2"NI3+$P:03-+A\<YY/8?TJY;O!(L!BN
MO,`3Y?GSO!`Y/K_]>N87P1*9HC-?J\<:;`!'@@<\#GWJ;2/"$NGZI!>/>JXB
M_A5,$\8]:`-Z\\NT$E]/=3)$@!90<J`,]L9YS^E1VNKZ?JB216EXI?9SM.&4
M'N,_6IM3ANKBRDBLIEAF;`#L,@>M<S)X8ODBB!-HX0+$L:1MM(,BL6;)YZ<T
M`=&TL&DVLDUU>,8BV=\K9QQT'Y=*ELKJWNHS/;W0GCD;*\C"\#@?S_&LM=$N
MH]&M+83127%M+YJ^8"8^_P`OK@`\5GR^&=2N+E)Y+BU1LY/EJ5\H[LDICJ<=
MS0!U8D0N4#KO`R5SR!Z_I39HVE"A97CP<Y7'/MS7'IX2OT0EY(&``W11LP$^
M,GYCZY(KK-/@>VL+>"5][QQJK-DG)`]Z`)/*?C]\_#[NW(]/I2^6WV@2>:VS
M;M\O`QG/6I*0\"@#!\'#&FW'`_X^I.GX5OU@^#G\S1W?&-UQ(<>G-;U`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`<SXNM+J[:V2VL//8$;9@P
MRIST/HOOD5MV=X\]HTUQ`UL4+!E?L!W^E6J"`001D&@#S!;@SW6I3QQI^_5E
M8NX`4NP'RGN.<\^E3-JNIPV\=K8WDCP1SL(90>64$``]\<]^.W:K@URVM9KA
MI;2TG5I#A"%7RQE@`!M]`">>XI9/$MC^]>/1[%HU)VEBH9@",'&WW_0^E,"I
M?ZEK,<,=T;^9&FD;]R#RB@_+D#IDY_*K,6O7[7%^MQ?S)'C:C"(#RV+`#Y?H
M#W]>]0VGB2V2.*"31[2>3&TRD*NYNQ^[QS5O5M7MHI#96^F6!F:-0)E",J.W
M<<<@>OK0!V\>1&H9MQP,MCK[U5U/4HM-@$DL<LFXX58DW$US5WXIN+.Z^R0P
MQS+:JID=6XD79SVXY(QBEB\9L8S,^F%PA8&5'P,9`XS]5S2`ZFRO(;^U6XMV
MW1MG&1@Y!P1BIZPO#_B"'5KB2""T,"H@D8DC[Q//'U[_`,JWJ`$HI:*`$H/2
MEIK$!23T`H`R?"@(T"WW#!+.<9SCYVK7K"\.2^1X2AF"E_+C=]O<X+'%5[+Q
M8)Y[.&>V,;3@[P,G9DC:?<$'K0!TM%8*^+;%]VR&Z?:P0E8P<$D@#KWP:CM_
M%]D[R&9)(X-V(YMN5;Y0V#Z'VH`Z*BLFT\165Y=16T2S>>[,I1DP8]O7=Z5!
M)XILRSQ6R22S[@D2$;1*Q..">V>M`&[@>@H*AA@@$>]9&H>([#3[EK:8N9EC
M+E57T&<9]<4+XFTEHHY/M2J)&V`,""#[^G;\Z`-0P0GK$A^JBFFUMV))@B.?
M5!5(^(-*$J1_;8BSOL`!SS[^E2PZOI\\$LT5W&\<6-[`\+GIF@"?[';?\^\/
M_?`H-G:GK;0G_@`I+:]MKM%>WF616!*E3U`.#^M1_P!J6&U6^V0X?[IWCGDC
MC\0?RH`>=/LCC-I`<?\`3,?X4G]G67_/G;_]^U_PI9M0LX"!-<Q(6`(W,!G.
M<?G@_E3)=4L(1F6\@3(4_,X'!!(_,`T`*=,L"0396^1T_=+_`(5')HNF2'+V
M%L3_`-<Q4\M[;0PB66XC2-EW!F8`$<<_J/SK*U357.JV^FV-W;PRL"TCR#=C
ML%`SU)/2@"R?#ND'_F'P_P#?-)_PC>C_`//A#^1K/@\5):P&/5(IEN(24E=(
M_DW<X&<]2,?G3_\`A,])S@M/GT\HT`6SX8T8_P#+A'^9_P`:;_PBVB_\^*_]
M]M_C3$\6:0[*!<,,D@DQD!<>OIFKECK5AJ$HBM;@/(4W[<$<9QWH`K_\(MHO
M_/BO_?;?XT?\(OHV"!9`9&.';_&MBB@#&7POI2`A89%!Z@3.,_K3_P#A'[0!
M!'+>1JO\*7+X(QTZ_P`JUJ*`,67PY"\A9+_4(E(QL6Y;`]^<FDF\.*TA>'4]
M2A!_A6X)`_/FMNB@#`/AR?MKFI?]_:3_`(1NX_Z#FI?]_:Z"B@#G_P#A&I_^
M@YJ7_?VC_A&I\_\`(<U+_O[7044`<_\`\(U-C_D.:G_W^I/^$:F_Z#FI_P#?
MZNAHH`Y\>&YE.5US4OQES3_^$?N<_P#(<U'_`+[%;M%`'/G0+[=\NO7H7'0G
M)S]:?#H^JI)N?79V!&"!$O;IC.?_`*];M%`'/MI.N>>)$UTX7.`T`QCW`X-/
M.G^(.VMQ_P#@*M;M%`&"=/\`$&1C6X^O/^C+3?[/\1_]!J+_`,!UKH**`.>_
ML_Q)_P!!J'_OPO\`A0NG^)`>=9A_[\#_``KH:*`,$V?B/'&J6W_?BE-GXCP<
M:I;9[?N*W:*`.>^R>*,_\A&S_P"_?_UJ/LGBG_H(V7_?O_ZU=#10!@+;>)PI
M!O;%B>YC.1^E19\6`XQ8M\HYZ8.?K^-=)10!SAG\4PN5-G9S@8&Y7P#[\G_.
M*C_M#Q5NS_9%OCT\P?\`Q5=-10!S8U+Q.,[M&@/':4#G\Z>-2\1_]`2+_O\`
MC_&NAHH`YTZKXC'_`#`T_P"_X_QIIU?Q$"1_82\?]-17244`<U_;'B/_`*`2
M_P#?T4Y=9U_H^@$GVF`KHZ*`.;_M[6]N?^$>D_[^_P#UJ3_A(-:&,^'9O^_G
M_P!:NEHH`YL:_K.!GP]-G//S_P#UJD&OZD$8OX?NL]@&S_3ZUT%%`&$?$DB0
MQ-+H]^KNP!7R\@<\X/?\J)/$T2$JVFZB#CH8/_K^XK=I&^Z:`,+P2<^'(?\`
M??\`]"-;]<_X(_Y%R+_??^==!0`4444`%%%%`!1110`4444`%%,D<(4S_$V!
M3J`%HHHH`*2EHH`2EHHH`****`.)G\10I<3C^S+-PKG;DJ&*@G.[_:..!3IM
M?M%N8]VC0^0S$JQ"A\`A2=OKG/%9]U<Z3_IDHTQ]\<C%6-TXW,&&#C_@1--M
M+RQ:6&2^L)1+O&V5+I\*A8Y8<D\'/'?-`&A-KNDRQ&0Z+$\JX.,(1L]<CZXQ
MZD52EU#2)ITCM=)AB4;C*9$#$!>3@`^@:JT-SIH::,:9=HNWY5CN3\P8K][V
M/R_I4@&DF.[N+*SG5;>`-EIR,LV%Q].2#ZTP-,7F@-<);OHK)(SB-\`$(3P.
M0>?PITD>C1Z^^GRZ:C*\BQQ^63P=H))&?<?D:RTBTPV"WUM]KLV2X56429.`
MA;*_D3^/I4MG/HR7L=^UUJ+W2[93N"MGC)[<\#%`6.O@T#3+>598;;8ZX((=
MNWXUI5CZ;XBMM4U!;>TRR>6S,S#!!!48Q^-;%(!:***`"HKC_CWE_P!P_P`J
MEJ.?_42?[I_E0!C>&98XO"=O+,0(DC<N<9P`QS45WJ7AN.V61_(E54\E51-S
M;>.,=AR*N>'85?PS9Q2`,CPX8'H0>WZU33P;IL<,T:M-^]55+;AD8.>..^!0
M!-I]UH<THM+>**-V",L9CQNP`XQZD;LU`_\`PBVZ=6CM`8!B0>7C;SM]/4XX
MJS9^&[6TG@F$T\C0.77>PYRH7GCL`*KGPK'-%,MS=2L9&D*A<!4W/N],GH.]
M`$NGMX>@N%-CY"S>69`5!SM(R3^E*+?P];R"4-:Q2.RN#Y@!)R&4]>F<&I=+
M\/6FF[]C/*7C$9,F#QSGMWS^E9<_@JRVJ%NI$.2,O@Y!'`[=,"@"W):Z!JS/
MJ$I0D@QNS2%,=5Y&>#P0*>VCZ!>S&51%(\K,,QS'YFP">AZ\9JG_`,(<#;_9
MVOF,3L&DQ'AF(+D8.>/O^G:K.B^&UT>19!<K(=^6+1@$C:0`#GCJ?K0!9D\-
M:5*4+6WW..'(S\V[GGGFH_['T[3$58%6%9KB/=N9B7(.54<^M;1(`R2!4=QO
M$>Z/&5()!7=D=P!ZXZ4`8UUKK6;ZG')`B?9(U:,[L[RV=HQCCG%5!XE?`B-J
MGGVQ8WJ@\1HK;25]>N?SK0O-+@EN9_M#S/\`;D\O"QC";<L#D#@^A-9%OI-E
M,@=&OT:4E;AGMB#,&<$YXX&5[=*`-74]96TOTC6V$D**CSS$@>6K-M7'KWJD
M?$UN[&,Z?N>7;]D3(_?@L5!Z?+T[^M-.GQW-UY,]U=N6(64&U(655DW*,XP,
M;L<=J6;PW:V4<<TM_,K1,B02%0?*^?(&,>IZF@"]-K$9TFTN$M/.ENF$<=OD
M=>XSCH,&LN]U33[R]M;B7S[9(TS]JB(`5W4-L/!SP.M6GTTV]K#)!?HL5G%Y
MT+B/>W(.]B.X.<U6;0+&026G]IC[,BJ\D0(W!@A4-],#/X4`+INDV&JV=Q`9
M;V(F023P/("=Q&0QX[C!JZ?"&GD+^\N<J7.X.,G<,'M4^CI;V+79FOX)KAB#
M*0P&U5`5<C/'&/Q-:1O+82R1&XB$D8RZEQE1ZD=NHH`Q)/"JAY1;WT\<-R?]
M(0@-O`Z`'''6K-GH0M+BRD2X)6T5T52H^96)/)]>GY>]:+WUI&VU[F%3NVX+
M@<\C'Z'\JD,T8DV%U#\?+GGG./Y'\J`'TM0I<P2/L2:-GY^4,">*?YB88[EP
MGWCGI]:`'U5U..273+J.`$RM"P0`X.<'%2LPE1TBE"N5.&&"5[9Q]?Y5'J$[
M6FG7$ZX+Q1,XW="0":`.6U'2=;L[6&6PNKF>>0`2X8*5`7``'Y\UH0QZVN@B
M7<[:D)2_ER$8(SC;QQC'-9R>+M1,MJALH]DK`&4*P5\D#Y<^F?>K-]XDO;/2
M=-N3%`TEW\SX5MJCC@#UP?7MTH`H7%IXH^UR(DMPZJ5"/O4*<$8/\ZLRR>)I
M+Z!XHYHH3*-RMM.!A0<CT^\:K?\`"5ZG::=%YD<,DS!65F4C*_-UY'/%3V_B
MZ_>2V\RRA,=P_P`NUCNV[MH&#U.1^7I0!V-5KFU^TRIOSY04AMLC*<Y4C&#[
M?YR:H:E?7">%Y+R.2))_*!WQG>F3CD'^50:'>SSZ%!?RFXN;A$DS&N`9/F].
M^,8!^M`&E<O8R0RVTUPJB)0T@$Q5D'8D@Y%.CDLY7MGCG5B5;R=LN0PXSQGY
MNU<K/HVH/).PMVRK/*7R,S*SHP3\`IZ]ZN6&GW4$NEN]JX/VJ:4CC]RC`X4_
MH:`.GDC66,HV<$8."0?S%0P644$S2HTQ9NH>9V'X`G`JQ10!"]LCHZ%I-KYR
M!(0>3G@]1^%5SIJ113"VGGCD>,HKO*S[??#'K5^J]^@EL+A#'YH:-ALW;=W'
M3/;ZT`4/$%M>745I%9320.9LM(A(V@(Q&?;.*Q!+XBB#*\-P7FE&"GS+&1)D
M_0$<5T>K:C_9>G->-"9%0KN4,`1DX_'DBN:G\:2S3PBS@*`D*RR@8)W`=<\<
M&@!DD?B-=/#^=>R3.@)0`#;E7S[Y!5?SJ.6X\4H@^SBZ>)6^5I(1O/`X(].O
M-:=MXHF41PW%J))Y7(B*R*JLNYP.3T^[BB;Q<ALY&BMV24H2F]AP?++YQZ<4
M`*)-;'A]YYFF%W+.,HD8+0INP=H[\>OK46EG7))KF6\%PFVT80;AC+9."5'&
MZKMWXC-C96DT]JSF:'S7VN/E&5'X_>%5;;QG'=WB6UM82R-(^U/G`R.>?;I0
M!G6\WB2>V\PR7*2P"1^8<"3[A"XX]^WK3X]8\03WTL*JT0DE\I"\&!%U/7UQ
MCJ3UK=U'Q'!IUX]K+!,SJN_Y<<IM)+#GMM(JE!XMAN+JS"P.L5P[1$-@%7!7
M!Z],-0!B/XCUV.WN-TF2C`._D<PMD_+Z=N]=B)+F^TFV>*1[::=$8NJ`[,C)
MR#^7XUEP>+[*Y<QQ6MP[%"0`H.YL$[>O7`-;T=QOC@8QR*91G:5^[QG!]*`'
MRH[Q[8Y/+;(^;&>_-$HD*@1%0<\DC.![>]/HH`CQ,'B`*%`#YA/4\<8IS;]Z
M;=NWG=GK^%.I:`(+C[5@_9_*S@X\S/7MT[=*8YOA)%L%N4Q^\R2#G/;\,U:H
MH`I1'4O._?):^5M/*LV<X'MTSFGH;[*;TM\;1NVL?O9&<<=,9_&K5%`%:W-X
M7D^TI`%_Y9^6Q)/7KD?2H(I-5+*);>U`VG<5E;KGC''I6A10!7A>Z*R^=%$I
M'^K"N3GCOQQS4REO+!8`/CD`\9IU%`$4+3&!6G15EQ\RHVX`^QP*4L_DAE3Y
MR`=I./UJ2B@"!GN1;*RPH9B!E-^`#WYQ_2IF^Z:JZID:;<E<[A&Q&WKG'%6)
M>(F^AH`Q/!2%?#L)./F=R,?[QK>K&\(_\BU9_P"ZW_H1K9H`****`"BBB@`H
MHHH`****`$HI:*`"BBB@`HHHH`*JWM[]CV?Z-<3[L_ZF/=CZU:HH`RFUQ%EV
M'3]1ZXR+<D=<4C>(;2)0UQ%=6ZGH982M:U(0#UH`Y*4>%7S+):MB1L[BL@!)
MZD>P[^E,GM/",CK&)ECPI^Y(V.WKW_\`KUV&!Z4FU?[HH`XHZ5X3R<ZD_(P?
MWW7]*4Z+X;;=G6V^?&[_`$E/F^O%=F8T)R47/TIOV>'_`)Y)_P!\B@#CAI'A
MQ8/)&NL(LEM@N$QG&,]/2FC0_#`8,-8Y!S_KH_\`"NS^SP_\\8_^^13'LK60
MJ9+:%BIR"R`X-`',:;8Z-872RVFO@!>B&6/D9R1T[X'Y5U,-W;SIOBGB=?57
M!%1OIMC(H5[.W8`8`,8.!41T32S_`,PZU_[]+0!8>[MT)#SQ*0,G+@8%2AE8
M95@1[&J/]AZ5_P!`ZU_[]"E_L32\8&GVP^D8H`O9'K3)L&%QG^$U4.B:6<_Z
M!;\_[`IDFAZ658_8(,X_NT`5O#=S;QZ!9(]U&6$0R&<9'M^'2M1;RU<X6XA8
M^SBL/0-$TR?0[.6:RA>1XP69ER2:OOX=TAUQ]@A'.?E&#^E`&@)HF`*R(<C(
MPPY'K7*66O:G/K43,4.G3SF&/"@9X.#S\V>/IUJ^?#.DBX6%;&3:4)+B5P!T
M&.O?^E+!X3T@HCO8M')U(\YCM/US0!574]3_`+<NE-RAM;>ZBA\HQCY@YQPW
M7(ZTS6KB6^U1[:3REMK*XMMRLN6D+L.0>W!Q5R+PMI,H<R6,B$.1\TS'=@\-
MU[U!_P`(OI4K$O:7A/E[\M(>?]GKUH`Z:L'Q;`LEG;2_-O2YC"X8XY/ITJ+^
MRK56"B+5L;BF1,V!COUZ?X4R;1[)\JUKJLNTJ5#2M@DC(ZGMW/:@";5X([_7
M[.QNPQM3"\FP.5#L"/3T'\ZM>&)I)M$B>:4RD,ZAVZD!B!G\JSO['L)V5I+;
M5<JK,I=V...1UX)]*;/X<MYF6S2;5(X?N@;LQ``;OZX^H-`%WQ-/.DFF0132
M0QW%TL<C1G!(],CI63)=WMO'>6<=U.\8U".$2EB65&Z@-UR.!GWITNB-.L,0
MO-7$9=0HDCR(R`,'V^]U]CZ4^7PXT4<T`U6[<'$LBK%N)/8Y[G(X[\4`-N;F
M\LAK%E'=2%(WA$<DCEG028!Y-:6FO-:^(;G33--/;^0LRF5BQ0YQC/OUK.7P
MV3%,/[6NSYVPRJT66;/W<]^/TIQT:2P:5AK]TKD#?\FYFQC`ZY/WQQ[T`='J
M4[6NFW-Q&JEXHF<!NAP":P[475C>6C27D]RMU:N[J^"%90IR/;DBHK7P_J"K
M<1+KK9=CYJ^5O!)]<GN,57.E/9RP,WB4HYC\N+=%GY20,#)]<4`6+)K^TFTV
MZGOS<QZ@I,D3(!@^66&/:HK*ZU#[3I=Y+>&2/47*O"8P%0=@*CGT.ZLH;6Z.
MOJL$((C>2/`0$<;1SUZ?2JL&FW\"Q746L6,D%N2(FE8[4+#)P,8'!XH`[IX8
MG(+1HQ!R"5!_SU-<E:ZU>OK36YN(YG6\:$P>1@^6#C?N'3&:?O\`$`L5N1KF
MG&`9!E.-I)..NW%1:=;:]8^=<03Z;*MU,6+LQP7)P<$`=3QCVH`VCK.G)JWV
M(02?:E<)D0],C[V?3H,_TJ2?6]*@NWLY95$C,$<>62NXX&"<8]*PHX_$-O=2
M:B;K30+G`.YOD;`X`XSZ]ZKR^'M<N+V:X+6)=Y`[H')`;@XQCOQUH`TM9UZ:
MVU;^S[&(128&97B+`D]!QVYY/UXK3N]4TV)6LM0N(BY0"5,$CGCG'3\:QY;'
MQ4VH"]$EF)`GEA5Z!<@GJ/455O-"UR[N;N>2WM`UTJJP65@!C'/Z=Z`.FNM7
MTW3RL5Q<)%\@91@D%>G&!3;G7-+M2BW%RB%D$BY4\J>A'%8\EGXADN;>=K33
MB8(VC52200<9_E^IIEU:>(+F^M[J73[)C;!E5-_RG=QW/M0!O7&IZ8D,#W$\
M(CF`DCW]P,$']14.MZK:Z;:!V,33%2T*MR"<=>/\\U@WUAK,]^L\FD12((/(
M\N.XVICKV(/KQ3;FUUR95*Z0$<6K6AQ*I&P@8(YSGK0!U=@4N=*MV:%426%2
M8L?*`1TQZ5B^*9X]-M8(K>V16F4Q*^XJ(U4@@<>]+9WVO00P0R:)E8U"L5F4
M9P,<<_2JVL'7M00K%ICQH59&C:9"K*<<D9Z@C\C0!MZ?"MYI<;74'EO(IWJD
MC$=<\'/?K3-1G%@+.VMK;SI)IL(K2%0."22>:S+:36[+14L[72G69%PLC2H0
M#G)XS27KZY<&RG3276YM6W;C.FULC##&>]`%MM58VQF^PL;W[2+7R1+QO&2.
M?3!)Z59M;^Y>&^+6)%W`^#"LN0_`P0QP,$5AF/71#N&EG[3]K^U;O-0KG&W;
MC.<8JQ;7NO0BYF?1F>>X?*XD4*H```(SF@#<TB^.I:9#>&/R_,!^3.<8)'7\
M*GN(XFCD,Y!A*%75ON[>^:YK1KK6-,TV.TDT263R\X995&<DG^M6KC6-0-M*
M)M`N/+*$-B16X[\=Z`->*XLKZ)XXI(IHU`#*""`",C/X5&+'39Q(!;V\F_._
M`!SN.3GZD#\JX_1H=4M[9GBTJ7+6K0+D`!SN)W,"0>^/I3M&FGT:\:5=*U`P
MM!Y;`ID[U/;`''/4^]`'6?8=*GB6#R+5T&-J``CC../Q/YFG_P!DZ>7+_8X=
MQC\LG8/NXQCZ8XKD]+O8]/FGN'\/W?GO.\D;+"051OX?P]*W#XGC!'_$LU/;
M@Y/V<\?K0!;DTW2Y'@+Q0%;;,<:'&U22#C'KQ4D6E:;!<"6*SMXY@=P94`.>
M?_KUR;SV_P#PD?V\Z9?K:L!(T9MOO3#(!Q]"3]:S[NXEN-3>_P#L=Z)/M*R+
MB(@>6.GOG'H<4`=I?36!U6&TN[)FDN4:-)2@*L,9*YSG_P#74CZ+I+!E>S@P
M26.1W..?T%<[J6O+<ZKI]Q'IU]Y=HSLV8L$Y&!BJ>LWJ7U]<SK87KI<67DA6
MB(V2;MP/T!`H`ZS_`(1[2`H'V&+IMR<YQC%:$,2PPI$F=J*%&3G@5Y]KMU)J
M,L+Q17ZF.!55?*(\M\\G\1W]JW;'Q19VEE#!-'?M(B@$R198_6@#IZK-;S9A
M*7;CR\[P54^9]>./PKE=?\0:9>PVN^*X98YU=T9"NY<'(ZX/:J!U1AH0M;<W
M".+GS`A#\19X7(_#O0!WL4<JN6DFWY51M"@`$9R1WYSZ]J=*)"H\IU4\_>7/
M8X[^N*X&+60-"O;.:YF-RTA-NJ;]R].Y.<'T-;>D:[HEJCI]NGWG&_[27)SW
MQGI0!T4JS$-Y4B*=N!N7.#Z]:AOYWM;:6X,J)'&FXDQEB,'GH>>*QM7\3:>^
MC7)L[T>>R$(%R&!Z9KGX]6C>QU..2^+A[8+&K.Y#-DYX8DY^G%`'=1-<3(98
MYH3&ZJT9\L],<YY[]J6%;P.OG2P,N!D+&0<XY[GO7%IK%E:VVHQV=].!):QF
M+>[%A)R#@GH<%>GI[5-H&N6T#W<=[JA>-HUV,3(><'=@MT/2@#LB)O,;:R;/
MEV@J<]?F[^G2EA$H#><R$[CMV`CCMGWKD-$U>T@TU[B76)I+HQ$"&=R0K=L#
M'TYJ#0-<*:C"UWJP>.2,^:LK-A6Z]P`.?2@#L6^V!9"IA)R=@VGIC@'GKG%*
MK719=R1JNU2>23GG</Y8JK_;^D_]!&V_[^"@:]I).!J-M_W\%`%^3S-O[K;N
MR/O=,9Y_2AM^]=NW9SNSU]L5376],8`B_ML$[<^8.M63=VP8*;B($]!O'-`"
M_O7B<<1OR%/WL<\'^N*=)_JV^E()X6^[*A^C"AW78WS+T]:`,KPA_P`BS9?1
MO_0C6S61X4`'ANRQ_</\S6O0`4444`%%%%`!1110`4444`%%)2T`%%%%`!11
M10`4444`9^IZO:Z8\"7!8O.X153!/UZ]*OUDZMX>M-6N8KB9Y8YH\`-&V.`2
M<?K5T17$.GM%'*9YPA"O(0-Q[9P/Z4`4HO$=A*<*7`\YH22``I49+'G[N.]7
M#J=@L:2&]MPDF=C&08;'7!KE)O#>HE"!%;QGR/)>03X#G.2Y&SJ:K'POJ4=L
MA$-O<KT*+)VW;B5)'&<8H`[5=1LG5&6[@97;8I$@PS>@]ZD@NH+C?Y$T<NP[
M6V,#@^AKSJ?P[K`E^2QD"I(S*JNNWJ.G/'U]JO:'!JVB>>QTF>229<?*5^7W
MSR3]*=@.NL]7M+Z]N+2W=FDMSA_EP/3C\:E%_;MJ+6`?_2%C\PKCHN<=:XG1
M1K6D74DRZ5<2+(F&7&-S_P!XDY/K^=5_L6M&X>Z-K??:)5D$I"X'S+@8.<X'
M''M18#T/SXC,T(=?,50S+GD`]#^E-CN5N(8YK4I+&Y^\&XQW(]:\Z_LS5UWR
M)ITX,A.Z':=@^7`.<Y)&3UI9M,OHK(I%87PG,J[6"''EA<8P#Z\T6`]*S17F
MR0ZVDT<QL]0/E0^4I&\'I@8QT_6H[@:O!I\2.-0A996+L2^".-O?K]ZE8#TV
MHKN7R+2:8KN$:,V/7`S7'^%I[ZX\02-=RW!4PE@'9L'D`<'COG\:ZS5/^07=
M_P#7%_\`T$T`5?#7_(NV/_7(5):S30K.;A)3NNBL8ZG:2`#["F>&QCP_8_\`
M7(5I4`9>M74]O:7;1%D,=LTBN!T8'U/\JY^+Q+?RM81L-K+,([@X`$A.<8]L
M8)QZCUKH]8NET^#[9+*5A7".FW<IRPYQUX&?SJLNN:8=0EC>YCB6%5P7VA6+
M#.5/7I_.@#(M/%EU/:&5EA#B5AM'/R^6S*/KD`5<NM5OVT/3+VVD0W4S@&),
M%9>"2O/(/'YU86]TB"'RQ=:>)%D+IP`!DG'`[[3C-7D?2KJ=+:-K:22V;<L:
MD90CN!0!S</B*]1&NI'=XQ/*#$P"D;8MP7IG&<\^PJT/%<X\Q3:0.\09W9+C
M*%1M^Z<<GYNGT]:W#IEO)<R236T#@DLIV\Y*[6S]0`*JQZ-'N\N6SLOL\;LT
M*JARN<8S^7/X4`9</BQKF55-OY&R?8P\T$D;6/.1QTK8T'5_[7M9)'B6&1&`
M*!]W!`(/XY_2BWT.P2%?-L[?S3AY-@."V"#C/;DT[3M-73VD\BWMX@\G/E[L
ME`#MSGOD_2@#1HJ&TDGDC8W,(A;>P50V<KG@T[S)/M!C\D^7C/F;ACZ8ZT`2
M48%0&:8*I^S,27*D!AP`3@_CQ^=/620RR(86"J!M?(P^?3Z>]`$E&T'L*IQ7
MEPY3=I\T88`DEE.W)QC@^G-.:[F%HLWV*8N2<Q`KN&,X[XYP/SH`M%01@@$4
MA12,%01Z8IAD8>5^Z?YS@]/DX)Y_EQZTU9V9E!@D7*ELG&!@XQUZF@"78FW;
MM&WTQQ1M7&,#%"L60,5*DC.#U%0K=J\+R+'*2O!380?PSUH`E>*.3;OC5MIR
MN1G!]?UIV`*:LBL[(,Y7&>/6@R*)%C.=S`D<=AC_`!%`#Z*AFN8H)(DD)#2M
MM3"DY/U'3\:>)%,AC!^90"1['/\`@:`'TU4569@.6.32L0JECP`,FF131S%A
M&X;;C..V>:`)****`$J&*T@A(,<84@8')Z8`_P#91^52LRHI9V"J!DDG``I&
MD1"H9U4N<+D]3Z"@!8T6.-40850`!Z"AT#KM)('L<4ZDH`9Y0W`Y;@Y^\:<J
M[5"C.`,<G)I!+&0"'7!.T'/?.,?6EW*6*Y&X#)&><?Y%`#1$HB,8+X.1DN<_
MGUI/)&5PS_*<_>//&*43Q&4Q"5#(.J;AD<9Z?2E$L9WXD7]WP_/W>_/I0!$;
M1"A7S)N1C/FMGM[^W\_4TX6Z@$;Y.01RY[G-2]:6@!BQA3D%CUZDFHUM41B0
M\IX(YD8]\^M3TE`$2VZJK@-)\XP<R$X^G/'6FFU4H5\V89.<B0YZY_S[5.K!
ME#*001D$=Z"<#)Z4`(B!$5<DX&,DY)ILL0D7!9E_W6Q3P0RAE((/(([T4`)M
M^8-D\#&.U-GC>2!TBE,3L,*X`)4^N#3Z6@"HUD9+0132^;(N2)7C4D'/IC'M
M4EU#++`4@G-N^1APH;'M@U-FEH`KI:JJ9;:T^W!FV`,3ZU&^GPNHRD1ERI>0
MQ*2^",YX[U<HH`HW.E6DT$B);6Z2,I"N85;:?7!'--.CV7F1E;6V"`'<GD+\
MWISCBM"B@"C)I-D0/+M+9#N!)\A3D9Y'3O0-)LO,8FTMBA``7R%X/.3G\ORJ
M]10!G3Z5:E2(K"R/R-@/$/O=NW3KFG#1=,(&=.M?^_2_X5?HH`RI=&LQ/'Y6
MF6!B_C+1@,.G3CZU,-%TL#_D'6O_`'Z7_"K]%`&0-'MC=.K:7IXMP1M8(-Q&
M.>,>N.]2-HFG><H&F6?E[3N/EC(/&.,?6M.B@#*30[`P_/IEF'+8(5!C&?7'
M7%-E\.:1Y;'[#$"!VR/ZUKU4OB@\G?)(A+X4)G#':>#CMW_"@"GX4_Y%NR_W
M#_,UKUC^$_\`D6[+_=/_`*$:V*`"BBB@`HHHH`****`"BBB@!*6BB@`HHHH`
M****`"BBB@`IKNL:,[L%51DDG``IU(P#*0P!!X(/>@#S>75;W4I'@?4'6&9A
M%*K,@49<_=]5"]ZN^(KJ.&2"STZ]VV\5MA%CE&UV+;><=\'/-76UW3HPTDNC
MP);GS!#-A2)2G;`&1FITUSPX(U^TPV\4NT%XQ!NVD]L@<T`<\=>U:W\NV@U!
M6196A1SLY`V@9XZ>_P"M6?%^H7%UJL%O8W!E40C"V[$Y<DYZ?05N2ZGX70R1
M,+0X3><0@@@\X!QR?:B&_P##-U$(E6!`J>?Y9CVXP#Z#D@9XH`QH?$&IPRW4
M7GM)Y$3J%\H-MV@`.6[DGKVIEMXCUF[M"4N%26&.29R8E^=1MP/K][IZ5M6\
MGA6[ECB@,)=0=B_,G&22.WJ>*STN-$D=!_8LV&),;9.#$."_)X%`#M$UG4)X
M=1OIIVN3;0+Y:!=JLQ!8\#N,?E5>QU;5]6F@M%O<!Y5)F1-AP%)9?P_PK;6R
M\-,`$F@PO]VZ/';^][XJ)HO#%@J7,<D?[N0;?*G9L,?8-[4`=+15;^TK$([_
M`&R#;&=KMY@PI]#4@NK<G`GCSMW8WCIUS]*`):J:NVS2+UO2!S_XZ:M(RN@9
M&#*1D$'((JGK?_($O_\`KWD_]!-`%;1)X+70=/6::./?$NW>P&21G%:1N8!&
MTAFC"(=K,6&`>F#7/Z5MM[-99-.DE*6EOAD4-YG!Z#U&?7I5A=?T^2.%/L\@
M>YF:,0F,9W`@$MSCO0!?NX[/4[>-&G1HRPE4HP(;8P/XC/!KG_\`A$]$NIC]
MFOGS(2X2.13@>@XZ<BM&#7-.#7(6W:*&R#*9M@"=<87![^E3K?6%GIJZ@]J;
M9.B+Y8W'/3`'KQ0!3F\*V;6J0FYE5%9V!)')9`OIZ"ET;PW8:7?K=PW+2EU/
ME!R#P>X]>/YU=T[4+"YB,"(83#C,,R[2N>G6K9CM98PN(RJ`J,8^4$8P/3B@
M"QFBH&M[=EE5AQ)@/\QYP,4^>**XB,4HRIP2,XZ'/:@"3-&:S!#IEY)-;+\[
MQ,HD4.PP22P_F343W>BF[.GO/B<RC*%G&7``'/T`^M`&Q14+VL4@4,&P'\P8
M<CG_`">E12&TM;F#S'V22?NX\L?F]O3-`%RDJ.>XAMHS)/(L:`9)8X%0&WAN
ME%Q%-(OF`,'C?J#C\.P_R:`+=%11;92EQ',S1LGR@'Y2#R#]:A2V\B=Y7O)V
M$I(5'8;5)/;B@"W15**S,4R,;^YD\M<%'9<-UY/'O^@I;>S>)''VZYEWXPSE
M3M^GRT`7**AA@>,L6N)9=P&`^WCZ8`_R*2"WDB!#W,LOS9^?;TQTX`X[T`3T
M5"D<ZPJK3AW#99BG49Z`=N.*8D-RN"USO8XW`H-O?.`.1GW)Z4`6:*KR)=E(
MQ'-$KA3O)C)#''!`SQSS0$N]G,L6_P`L#.PXW]SUZ>WZT`6*`H&<`#/)Q4-P
MMRP_T:2)#C_EHA;G(]".V?TID:WOS>9)`>1C:A'&3GOZ8_&@"U14!%ULB^>+
M<#^].TX(]N>.U/3SML>\H6_C(!P>.U`#F574JP#*1@@C(-(T:.5+(K%#E21G
M!]144_VOSXO(\GRN?,W@Y[8QC\?TII-\9>%MUCQT)+$G=^'\/ZGVY`+5)4<1
MG+$RJBC`P%))SWY_STH=IQYFR-#@#9EB,GOGCB@!^Q```BX!R.._K2[1N+8&
MXC!..:AWW'SYBCX/R?/U&>_''%2J6);<H`!X(/44`-$,0D,@C0.>K;1D]NM+
MY4>'&Q?G^_Q][C'/KQ444TLC2#R@`LA4$D\KCKT]?_UT![ORF)@B\P=%$AP>
M3WQZ8/XXH`GI:B5ILC?&H&"3A\X/&!T^M,26X=2WV<+W`9^?NYYQGG/'ZT`6
M*0C(P>14"33M<.GV?;$HXD9_O'V'ISU]NE/,CJD9:(EF(#!3G;^/I0`]$6-%
M1%"JHP%`P`*4@,"",@\$4V-RX.4*X)'/?WI]`$?E)Y/DA0L>W;M7C`Z8&*>H
M"J%'0#`I:C60LT@V,NQL`G^+@'(_/'X4`.*`N'_B`('/K_\`JIU,A?S8D<HR
M;E!VL,$>Q]ZC-P1=K;^3*<IN\P+\@]L^M`#A`@??\V[);[QZD8J6DJM'>^9<
MF'[/<+@L-[)A3C'.?0YX^AH`M44E+0`PH3(K[V`4$;1T.<=?\]Z?24R.6.4N
M$8,8VVMCL<9Q^HH`DI@4B1FWL00`%/04+(CLZJP)0[6'H<`_R(IIN85G$)D4
M2$9"D\XH`EIK*6*D,5VG)`_BXZ'_`#VI'ECC9%=@ID;:H/<X)Q^0-0-J-FDF
MQKB,-M9\;OX1G)_#!_*@"U144MS#"8Q+(J&1MJ9/WCZ"G/(D:AG8*"0N3ZDX
M'ZF@!)49_NRM'P1\N/SY':G."R$!BI(P".U".LB!T8,IY!'0T,ZJRJS`%SA0
M3U.,\?@#0`J@A0"22!U/>H)K=9#OD^<H=T8/\!P1Q^9JQ3)6"QL3Z&@#-\,#
M;X=L0!C]WG]:U:RO#/\`R+MC_P!<A6K0`4444`%%%%`!1110`4444`%)36+`
MIM7()PQST&#S^>*=0`M%%%`!1110`4444`%,E5FB=8V"N00K$9P?7%/IDS^7
M"[X)VJ3P,G\J`.'?PMJ,D!MX;NSNHHU90&)'E,2"P&._N:8_AG6WM%MO*LT1
M)&D5ED(.3UY],52DN;R*:)[5KJ)E@+.1$P/FD'=GCDEL<_X56^TZFL:+FZ(&
MYE!#?*6SG/'/!IV8&M#X>U6&RGC:.T-M*-X"S8"G'W@2">GO0V@7D_G&*T0I
M,S,HCO%PI.`W.W)],>]1K=+%X?GLE-U,?M*E(GC8YB!'?'0X/%58;^ZAN998
MV?3H")&14B.$)&0O*],JN:-0+\F@:N]\;E+$0*R[&CBN$7Y>F`<<<5<ET[57
M>?;I2QQR6HM41;I<1KG)QQWK'M_$.I2VZ!]2^<L^<[5QP,9R.1][IWI8-;O+
M&"*%;^1N!O)*,%5@#D9.2P)/6D!=FT'4Y;J-ETV.*"-4`B$R'.W.,G'/))/K
M63'HVIQ(T;:5.S"56W!`1M&00.OK].*O&2*[6&:74'GN)8I))4,VP#:N8T.,
M<Y(_'-/?Q)J5HTT+W?FO&BL&PA&2G(XZ_,P_[YH`H1:1=K;S0/87J[I%99/(
M)&`",$?\"//M3X-,NX9I94L+K/E^6B26[,&!&#N.>./2I7U_54A%S_:`,A5$
MVA5Q@@DG;Z@@#/O6YX?\17-[JTUO>S6RHJD#:,#<"`,$GG/6@#HM."KI]NJ1
MM&HC`",NTC`].U1:U_R!+_\`Z]Y/_035VJ.NL%T._)_Y]W_]!-`&=IT5]<::
M\4-PT"M:P"&0KG8=GS8]>U5CX3E:.`&[B\Q,AF\G)^\&R#GALYY]ZL7=Q);>
M#()(93%(;>%0X_ASM!.>W!ZU@VOB74[<+&9DE1&DP\@W"3:N0-PQDY]NXH`V
M+CPL\ZS,9+6-VV[$AAV1L5)/S#)SUQ5J/1+B/0[>T6Y7[1!()49EW*&!SMQZ
M=JR9O%NHVUU%%+:0MA5,@7.6W#(V`GT/OS3[3Q/?W#VZ2+9@R2QDLC\!&R"I
M]&XH`DNM%O=;EC^WS6>^(D2+$AS&2O'.<GJ#Z<5DR:!=LRVJRVL),BPLB2D;
MV5<[R.YP0<5MZWXBDT_5U@A4&&%0UQ\AR<XXSCC@YS5:?Q8Z3PR+;QF$S2*`
M'&]L#`R/X><<^E`&3/I%Y:3RQW&R4/*'DC69L;=K_,S=A]?>FM8W*W$A.IP7
M$A0PJ_VO:<`<C'7@XXK9/BFXAU&[MY[*.7;DA$D'RJJ;F!.,'O\`J*:GC"W:
M*25=*)*8/RD$88'.3CCI^-`$%M8I;ZW!=)]F?3V:,HOVK[N%.'YZXPV/H:?)
MIT]YK,]]`T$L9NHI(XO-'[S"YSD<@@$-CN#6AI?B*+4=6CLHK-4B\LD-D'!`
M!`XXXR170K#&F-D:KCG@8[8_E0!Q4BZTFGOMU!%D#&*7==C[X8G@Y^4[1C'I
M1"=5EE@DN6%W]D=9G=+A2B*H.5(SC=WS7:&V@964PQD,=S`J.3Z_6A+>%%94
MB15?[P"@`_6@#F==N(=7TNWGAC\SRU,D@0AG@)4XW+W&>#6>KZQ9S1HS7"V\
M:1JWD?.J?N]I&.@.<<?C7:+:6R^9M@B'F\/A!\WU]>M0W.DV-TI$UNK`DL>2
M,DXR>/H*`..=M;BE\NV%TBLD(;:H)7$8#`+UR"<X'M70ZQ%)-9Z4'C:2Y6YA
M<@=01]XX'XUJ3V-M<%3+$"5;<".#G&,Y'MC\J/L%L5"F/.&#@ECD$8Q@_P#`
M10!QM_9WKW4C16EQYBO+]JD"G]_$7&U0>_RCM72>&8IHM*Q*C1J97:*-A@HF
M>!C_`#UJ_<V<-UM\X,=O3#E?Y&HGTRV=I&;S<R`JV)G'!.>.>.?2@"[13!&H
MD,G.XJ%/)Q@9[?C5?^SH/,>3,VYQ@_OG]"..>.M`%NBH/LR>9OW29W[\;SC.
MW;T]/;UYJ4J2X.X@#MV-`#J*84!D#Y;(!&,\<X[?A38XBDA82.5/\)Y`.2<^
MO?\`2@"6BFLI+*0Q`!R0,<TM`"T4UP61@K%21@,.WO2J"%`)R0.3ZT`+13)%
M9HV56*,1@,!G'O3J`%HHJ.82&,B$JK]BPR*`)*BN21"2K.IXY1=QZ^E*PE\Y
M"K((\'>".3Z8_6FR),S,%D5%(&TA<D'//Z8H`Q5N+I[R*SBO&B\Z:X9G*[FP
MK#"C(P.OY"H9/$<FFR-#=*+I(&V3W$9`(+%M@V]S@#/I6I=B.RD@N9[B%8TD
M?<]Q]X!OX5/;_"J)MA<OF*32GCFD$J@P9++DX[\GD\^I-`%>#Q:\DUI'+I[1
M?:%#;O,!P#G##U'!]*=IOB.1K6UCG3S;F6-''(4OEF#$#T4*36LNGGS8@T5F
M84XVB+D`$[,<\8!_G2VFGI&`9X+7=&2L)BCQL0CIS]3TH`QH-6OB(6:<,DIM
M&7,84[9&8,#^5:FCZO\`VH\P-K)"$PR,W21&SM8?7%3O8KYT82&W$";!@I\P
M"[L8^A*X_&IK:V2&-/W<:R"-8R47`P.@'MR>*`)J6BF+OWMNV[.-N.OOF@!]
M)34\S<_F;<;ODV^F!U]\YH3S-TF_;MW?)CKC`Z^^<_I0`ZEIDC,J@HF\Y`QG
M'&>3^`YIU`!12U'.[QPN\<9D<#(0'&X^E`$E%(*6@"*XV^2P=696&"%!).>.
MU4KR]NK=3Y=NA/VA(@68@%6P,].N36@X+(0&*DC@CM5:YL8[E`LCRX$HE&'Q
M@CI^'M0!5@UJ*779],(`9%RKY^\<98?49J_<Q":(*4#8=&P3CHP/]*S(M)MH
MKJUVV\^ZWD=EGW\DL`26[G.<?A6I/YNU?*QG>N[)_ASS^E`&;=ZG%I4-U=W,
MS3QF<*B*.4.T#;SQZG\:CGUU(9%$NF7GS_*A"*VXE=VT8//\N*MZG8K<V<B2
M3RK%NWN%4-N`'W<$'Z_6L]M`"&*>/4;M(K:,^3'M#>7\N.`1R<?C0!8.O6@A
M5[B*2*3[0+<1.H+!^/0XQ@]:N6M_'=WEU:A'5[5E#%L8.1D8K#72[&.TMFNI
M;JYD>;S8Y#"VX992<@#C)'4^IK;LK7R[FYO!*S_:MK!67&T`8`H`N`8&!00"
M02!D=/:H9;N**3RW$F[VC8CH3U`_V3_DU(LBL[(,Y7&<@XY]^]`#ZJWK1AH@
M\1=F+!&"YV':><]N,C\:M5GZ@YD*B)I@T9;=L7CF-L9]N1Z\XH`B\,?\B[8_
M]<A6K6;X=&/#]@,`?N%/Z5I4`%%%%`!112$9H`6BDH;&.:`%HI*6@!*6BB@!
M*6DI:`"BBB@`HHHH`*CFE6&%Y7.%12Q/L*DJ"]F@M[.:6YQY*(2^1D$?3O0!
MQR^,;\HS^79!>WWB1G'7G_:Q^=$OC.ZD>584ME15?:QR2Q`."!^'>KUI<:#J
M5V?LVG1-'L:2:1X]H4+C''X_I5&UN/"LML7N;2..4+N=4W$`$X`'/7YAG_ZU
M`&AJ_B*;2;V",B.95B!F0?>8G/*_3;SGU%-3Q3(/#@U*YM$+--Y2J&PK<9SW
M_P`BJLT_A2,`Q63S2.@*HH<%@3C')JUJ$&B6<CVKZ<[Q01-,_P`S;5QC`&3@
MD[J`'W.NP0:797,]A')+<1&0QC`P!CD9'N*SY_%$`DF6+2X`(I%0EU!Y).[M
M[?H:M6D?AV_T]+NYM6MX@YB3SI6[#/'/M^E-$7@^5)6`38FTLVZ09SG'?GO3
MN`S_`(26PF55BT>.9BF]E&SY<`DYX[``_C2Z/K-EK-\MJNDVT:_,SED4@(!Q
M^.<4];3P@Y"1S1HS'`VS.#SVZ]^E+?6/AK3C-^]>WE1/G2"9@[#^[U[T7`K'
MQ+HREQ_8JDKRNV-"&'KGMP,U(/$.E_)/%H9,1<*LOE(OS<$_B*4:+X<:*'?)
M/:^?$)1"TF"0`3N(YYQFG1:3X<N(XXDU!Y$+D(GG\;L9...O`HN!<7QC8EV#
M6]TJGB([.93G!`'UJ>]OX]3\)W=U$CJCP/PXP1@$55MO"^EW&R]M+NY8LQ=9
M4D!R<]>GK5V_LH]/\*7=K$[LD=M)M+D$]":0%W2T"Z19H<$"!!TZ_**L^6G]
MT?E6?=3FST`2QS+!Y<28>1=P4<=AUINAW\MU:J;R2/SI"SQJ!M9H\\,5SQV_
M.@"6ZF"W`:WL?M4T1*,5*J8\@'&6]>.E1&)8U<QZ.N7_`'C!=@W,,D9]\]_>
MFZFVH$7*V-W;Q%`K<KN9!ALY'O@8_&LBTUZ\T^"SGU27[5'?@&/8H4Q=,YQU
MZC\J`-N6>09SI,LGG*?,P4YQD`')YR/YU%=6ULKK=?V*9IY4^<J$W+D8(.3Z
M''&:I#QA$'</87`P"RXP2PW[/PYH3Q5&\PE6*5K<P!C&(_G#F39C.:`-&QL;
M-7*II*VX4;@S*O)9<,!@^G!JK);6D,4L2>'G:/S.B*F'(SAOO=.3U]:;J&N3
M-X?CU2PVQ[G"[)DR3\VW'!XYI++Q$(X(QJ.6EE&]&BB(&PMM!(/0Y_F*`+NE
MVMD7>YBTS['.K%3O0!N@Z8R,8/:G_P!J.J*SZ?>*68KC:I/08Z'H<_I5&P\2
MPR"TBNE=9[J1U4!,``.5&<_05O4`5DOXF`RDJG#$@QGC;C/\_P`>U(^HVZ1>
M8QDV[BO^K;J`2>,>U6L48H`@6]@958,V&94&4(Y(!';T(J&35K.*&*5W?9*,
MJ1$Q_D.*NXHH`9#-'<1++$P=&Z$5&]["EZEF6)F="X4#.%'<^E3*JH,*`!DG
M`HV+O+[1N(P3CG'^30`*RNH92&5AD$'@BHWN[>,$O/$H5MIRX&#UQ]:D5510
MJ*%51@`#``J%[*UDW>9;1-O;<V4!R<8R??%`#UN8'8JLT;,HR0&'%`N(&5F$
MT953AB&&`?>F+8VBEBMM""WWB$'/UIO]G67ER1_9(-DIW.OEC#'U/K0!,9HA
MUD0<9^\.GK0)HCTD0\9X8=/6HFT^R;&ZTA.$"#*#[HZ#Z<FD73;%,[;.!<KL
M.(P,KZ?2@"U1110`F><45"+6(7AN@&$I383N.",Y''3U_.I50*S,"?F.3DT`
M+13(X4B:1D!!D;>W.><`?R`H,*F(QDOM/?<<_GUH`?14;P*[,Q9P6`!PY`X.
M?P_K0L*K;^3N?;MVY+'=^?7/O0!)131&!(TF6RP`(R<<9[?C3J`"BH6M4:&2
M(M)MD))(D((SZ'.1^%3`8&*`,K7-.FO7M);=+>5K>0DQ7&=C`C'YUB7GAN^E
MB,C?9HP)!*88,C:`6)"G')Y].IKK'AWSQ2^8Z^7GY0?E;/J*D-`&+X8ANELW
MFO'E+NVQ%E&&"+PN1ZGDUM56MK,VUD+9;F=R,XED8,_7/4BK#@LA4,5)&,CJ
M*`%HHJ`P2E`HNG#;`N[:N<^O3K^E`%BDI$!5`&8L0.2>]17,,TNWRKEX,'G:
MJG=^8-`$U%-96+H0Y4*?F&/O<5!]GN,_\?C_`.MW_<7[O]SIT]^M`%JBFN&8
M#:Q4Y!R!^E4TMKY;DEKXO"48;3&H*MG@@X["@"]12#ISS3)%=F0I)M"MEA@'
M<,'CVYP?PH`DHJ./S?)'F[/,YSMSBA/,\A=^WS=O./N[O\*`'UP5_?:K!K5^
MD<]SE68Q19)^7#<@8QC@>]=LOVK[,^[R?/YVXSM]L]ZC47_G2;_LWE[ALQNW
M;<\Y]\?K0!Q9\2ZO)N@C)"K;YW^40PPN2WY\>E;'AW6M3U'5KBWN(T$,0.24
M*D8.!^)ZUTL8?RU\T+OQ\VWIGVIL'G8;SQ&#N.W83T[9SWH`RO%=W]CT=G66
M:*1G"QM$<'=SU]N*YY-;NM/D81ZB+Q0B*9)064,0[$#H>H`KL+DWOF?Z,ENR
M<?ZQB#[]!]*EA61HE^TI'Y@)/R<@>G7VH`Y[4M5N&ATPSS/IT%U&7EE4<HP&
M0O(Z53'BJ]AA4+&LI"_*LJ,LDJ[6/F#'&.!^M=7<>=L?RH8Y.!M#-C+9[\=*
M%$@\O?`I8L5)0\(O.#S^'YT`<8WC+4(9&!BM[A3)PZ@JA``RJYYSSWKN@<J"
M1CVJ';)Y<N(H]P)\L9X/'&>.*FH`6H+US'93N,96-B,^PIX=O.*>6=NW._(Q
MGTK/O+TO%=6LD#1.;:1QEE.0`!V/O^E`$GA__D`V'_7!/Y"M"J6C`+HMB`,?
MZ.G_`*"*NT`%%%%`!1110`5',P2/+#(R/YU)3)2`F2,\C^=`#J6DI:`"BFL6
M!7:,@GD^@Q3J`"BBB@`HHHH`****`"JVH6<>H6<EK*[K'(,-LQG'XU9J&[C>
M:UECCE\IW4@/C.WWH`Y-M.\/6,<HBU:5!,C1-LD#\=2"`#39O#FDLLK1ZR(E
MC?YLLOR>W;!SFFQ^%(G)BT_5HV*89LH&(!P1R#T^4?KZT'P/.VXMJ$19FW%C
M#DYY]_<TP$L_#EG++)+9:TC/`5W$1#Y-I&#C/MUJS?V#W=I)<W7B&"2V*>67
M$*XQN!['KD"I+/PM=V45PD%W;`SQ&)V,!S@YR?O8SS^@JE_PA;EUC.HP;@=V
MSR\?D-W';IZ"@!9;&'RDTVXUZW<0S!]KV^<N<G!.><Y-">$UO(=ZZNLD>6VY
MAX7DY`!;CDFF_P#"#7*X5+Z%E!SS&1@^N`:@;P;J,(")-:R9)RA+*9%X.#ZC
M(H`L2>%I[>R4_P!IVX%NS2J&CP#SG<QSZ`=O:EG\,ZI>!KE[RU9YG\YHPI"$
MXXYZX(_G5(>%-<RI*P'";,>9_#SQ].3^=6M0T+7[^[-P8X(6""-!',1M7!&/
MH<F@!-1\,Z[J%TUS//:&1P%^5V```QP,5`/!^K_:!<%K1I%;=PQ`)!STQBA?
M#6OQ-'@`K"28PEQC83GD>G./RKI/"FGWFG6,T=\")'E+\N&SD#F@#2TN"2VT
MZ"&9(DD1<,L0PN?:H?$!`T&_R<#R''Z&M&LSQ)_R+U]_UQ-(">&!+O2H8KJ-
M75XEWH1P>!2VNF65FRM;6T<3*"`5'3.,_P`A3[5U%I""P!$0.,]L=:C;4[-(
MHY6G79*Y1&`)W-G']*`*>I8L;AY5BAE%]MBD$LHC'`(`&1SD$\57;3=-OI[:
M`01R6MLA2.59^CYY3'?&,U;O[6T\0V@B$I,44_S[1SE001^O6L6?PTA$47]L
M*IB=F8D`,K,1R,$8/RXY]Z`'6^CVESJ4D<^FRVX^;=,ET2"V=VWCZY^HJS;^
M'K!IY(FM;B)5R$=9R5=0P///!W9X]JKQ^$D4B5-1?<2#Y@)R9-^=W7!.WY?U
MJYH>G+H\TADU*.2-TP$W=3DG<<D\\]J`))M*@AAMM-6SGELS)YAD$OW&Y/(Z
MX_QJ?5M$M]2)F?<)UC*QD.5&<Y&<>^#6D)8V("NI+#<`#U'K2>=%NV^8F[TW
M#-`'/:;H-L5A:[CN&N[(Y\S)"N=[/E?7DG]*V+/4!=R&/[+=0D`G,T14'\:M
MAE*Y!!'K1D9QD9H`KM>J+B2'R9R47=N$9VGC.`>YIJZ@C,B^1<#<Y3)B;`([
MGT'O5NCB@"/ST$+RON1$W;MPQP"03].*(Y@^SY7&]=PRI&.G!]#STJ3BCB@"
M.&>.;[A.0`2I!!`/3(/2E>:-)$C9P'?.U2>3CK3^*.*`(GN8$M?M+RJL&W=O
M)XQZU'/J-E;2+'/=11.R[@KN`2/7]*LD`C!`(/:D*JW50?J*`(IKRVMV59KB
M.,L0%#,!G/3^5$UY;6ZNTUQ'&L9`<LP&W/3-2E5;JH./44C11N"&16!Z@C.:
M`(FO;5)O*>XB63.-I89SC./RYJ9&5T#HP96&00<@BD,49;<8U+`YSCG.,?RI
MP`4`*``.@%`$1N[979#<1!E!+`N,@#N:D+JI`+`%N`">M-,,39S&AR,'(ZT3
M013J%E17`((R.AH`?1101D$'H:`"EJ*.WCC8,BX(0)G)^Z.@_6I:`"DS2U2E
MTJSF`$D1;#%OOMU./?V%`%RBFRQ+-$\3C*."I`..#3(;6*&:66-2'EP7)8G.
M.GTH`EHJM<V$%TP:4/D$'*N1T.>QJ5H$:992#O7H<GT(Z?B:`)**@>U61G+R
M2E7SE=W&",8_SWJ1X4D558'"D$<D<@Y%`#Z*KM:DRA_M$XQGY0W!YS_];Z4C
MV2GS-DTT8D'(1^ASDD>AH`LT57FM#+=1S_:9T"?\LT;"M]1BIW7?&R[BNX$9
M7J/I0`M%11PE)2_FR-E0NUCP,=_J<TK0EC+^]D'F+@8(^3CJ/>@"6BHUB(F,
MGF.0?X">!T_P_4T>4?-W^:^.?EXQV_P_4T`245##%(A!DG:0\]@!V[?A^IJ:
M@`HJ&%)E+>;,'R3C"8P,\4Z%76)5E<2.!RP&,_A0!)1598KH3EFN%,6[.SR^
M<<\9S]/RJ5%E$DA>0,I/R`+C:,>O>@"2BJL,5VLVZ:Y1X\`;1%M.?7.:?(EP
M89%CF59"<HQ3(4>F,\T`3T54$=[YJG[3%L&-R^4<GDYYSQV_*K+ABC!"`V."
M1D`T`.HJ']_]I3&SR=AWGG=NR,8]NOZ4YC)YRA54QD'<2>0>,8'YT`2457M1
M<CS?M3QM\Y\LHI'RX'7WZTV0WOVU!&D(M@,LQ8EB<=,=N<<T`6J*KV;W+P!K
MN)(I<G*H^X8^N*C6:^(D)M8QC?L'F_>QC;GCC//TH`N5CZM(BRW2N#Q82-G'
M`'?O]/RJZ\MZ+6-UM8VG)`>/S<!1ZYQS^55];1SI-[(2,?97!CQQG'7/6@"U
MIW_(.M?^N2?R%6:K:?\`\@^V_P"N2_R%6:`"BBB@`HHHH`*:ZAUPPR*=4<[;
M8\Y(Y'3ZT`/I:2EH`****`"BBB@`HHHH`****`"J]^TR6,[6R&2<(=BCNV.*
ML5!?3FUL9YU4,8HV<`]R!G%`'&65E>VFDRV<NFWJO/*&>2$C)48XSGOC]356
M*QUF$'RK?4QNC49\S&'`'/7D#D`?2K-OK>IW%ZTL=S$IFP$5CA`!C/!Y_B//
M'W:E@\77Y0[X[7)`(/S8!VGY/=L@?G3`KVMOKD.H0W'EZEL9E>X!.=Q!.0!G
M&,8'--N+35&U.XOK;3[V*:20E'W?=&5P"/H&XZ<CTJS9^+;Q`_FB&X.UWVC(
M9>&('T&T`]^:FN?$^H/-=6,=O$LZQL1(C'Y<#)/([#/UH`Q3/KUNTT5PVHQN
M?W@*%C@]_P`.I_"M&758=6\1::\4%PIBD51(W&X=\@=.:E3Q=?6UK$US;P2,
MPP"K$%CM4@^G\0_6GIXQN))9!]EBC2(L3E^6P#@>QR!0!V-+7(Q>-)"]NLMB
M%\Q"[GS`!CG&,_3O5K0]?FU74XE("1M`Y>('.U@P&<^X/2D!TE%%%`!6;XC&
M?#]__P!<6_E6E6=X@&=`U#_KW?\`]!-`#G1XA]IB@$Q6WVA`WS,>H'/&/>LQ
MO%$<4"B6T,5TTQA$#2*`",9);H!R*OSK(8XR+J2))H1"NQ,['/1O;TKFKK1;
M2&:&SN-3G$OS[3)#D%3]_P"AX//K0!LOXG@2\NXE@W0VBDRS"0<-CH!U//'U
MJ;^U+<:0=2N+,(KD;4&UR^3\O(XYS61=65O?F22[U6$@OY=KLC`VEL,`W'S<
M8J6&#36T9]+CU"+SV/V@%1A5/W\@?W<?I0!I6VL6P)BO[;^SF4Y19]H5SGJI
MZ$Y_G4WGZ*_F$O8GR>')V_)SW].:PK@#4?*FU#5+&6!)D9D`(505;&,\Y.<\
M^E9\>CPW\0LH-2L9)U4)&(P?F4%CDX[\T`=K]HT^)S^]MD:%0I^9047L/8=*
M:[:;OW.;7<R%\G;DH>I^G6N/?0IWU"XG@GM+T^>&DMQ@`X)SNST_#UHA\*RS
MSR&*\M)/+79(F2?+)4@C\,\?04`=3:ZIIMQ<7%A$8PL04?P['#?W?7KS56YU
MS3+/77AEBE6YPD32A?EP<$<Y]_2L^T\+RVVK6MRK6ABA$8*8/S$`;F^N>1]:
M?J.D7M]JUS<H(U4/$\0,ORR;.S#WS^&/>@#JJS-2@TZ*VB2Z5_*:147:[?>(
M"CH?05SLFB:O^]\L)DNS,1.<3*64A<=L<\T1:3K"2P22VT<TD+1>6?M'"A."
M,>_7\:`.FU,Z?;QF>_D\I6PFXLPS][`X_P!YJK6VE:5=V:R6YEDAD.Y6$\G/
M;U]JBU&.YU/1H&DL#]I#AC$LP5XB,_,I]>G%8D.AZQ:2VD@B,H4QLZPRA,;=
MP(Y(&<$<CW^M`'50165U:1)#(SQ*A"8D8-M(*YZY]>:;<6MC:V+QW$TD<#N"
M6:=@=Q(QALY'TKEY='UGY=D$ZEXH4D9)U#852&'7UP?PK:U2RNKCPS;6GEM)
M=XB!R0<,,%B3^!Y_QH`T;B6TF22S^V>7)&@<E),.@'?].]%K:VKQ02V\\LD:
MC*,)V8-SGGGFN5U?1=0N+F6.UM3&RM/*TP;`F5S\JY]>V#70>&K66WM+AY8V
MB$]P\L<3=44]!CM0!H_9L/,Z2RJ\N,_-D+@8X!X%0QV4L<2*+ZX+!@6=L$L`
M3QTQWZ]:NT4`4)+&X.T1:C/&`Q)^56SEB<<CWQ^%63%(6SY[`;]V,#IMQM_/
MFIJ*`(V1RB@2$$$$M@?,._YTH5A*S%R4(`"8Z'G)S^7Y4^B@"*9)69#'+L`S
MN&W.[CC]>:9Y=R&+"=6X.%*<9P,?J"?QJQ10!&%D\XL9`8R.$V]#ZYI]+10!
M&HD\Q]Y79QM`'/OFGTM%`$,0GW'SC&1DXV@CCMW^M.F\W;^Y*!O]H$BI**`*
MT(O-K><T!;(QL!`Z\]3Z4ES--;VIEV!W4+E5!Y.><?TJU45Q!'<1&.9=R$@X
M]P<C]10`RVF:=I'#(T08JN`000<'.?<&@BZRV##]X;>#]W/.??%8MU<2R_8H
M+B]ELTE:9GE&(F.UL*.>F0?QQ53^WYM-5H(IXM26%LM(\NUV#,0`./F([D>M
M`'1@WPDP5@*%^""057U/J>@J1_M'VA=GE^3CYLYW9]NWI7,0>*;FZFM(WMHX
M8;OCS%ERT8.5';`.5)%267B&YBM["W>W^TS7*920R;=S;B"#QQ@<T`=#']KR
MGF"'MNVD^ASC\<?K4DK2@+Y2*Q)P=S8QP>?SQ^=<7_:-XL=K(EY,'N4B9PS`
M@$R;<].!@5OZ1KZZI>SVZVYC\L$ABV=P#8Z?ETSUH`U('F</Y\0C(8A<-NW#
MU]OI0[R@OMB#`+E?FQN//'MVY]ZEHH`BD>56C"1;PQPYW8VCU]Z+AY(X6:&+
MS9!T3=MS^-244`0K,[QQND+?.>0WRE1ZD4D<T[73QO;%(5&5EW@[CZ8ZU/10
M`M1B0&8Q;6R%#9QQ^?K4E)0`54&HQF1T$5QE6VD^2V"<@<''(YZ_6K=%`$3W
M")-%$0Y:3."%)`P.Y[5'<7\%NI+%GVL481H7*G;NY`Z<?S%2W$RV\7F-TW*O
M7'4@?UJIJ#/96SS6:1"669-V\'!+%4SU],?E0!9EN4B>%65R9CA<(3CZ^GXT
MLMPD,D:,&S(<+A21^..E9L&L[_$,NEL@PD8(<=VQDCKZ$?D:TKAU01AG9=S@
M#;W/I]*`)00>ASBHEF)21C$XV$C!'+8[CZUDZKJD^DV9F2T3<]P5Z$+M_O,1
MZTVXUC48M3DLH[")W9-\/[WMNVY;T'>@#;C?S(U?:5W`':W4>QIC7"K<+"%=
MF/)('"CG!)_`UA1>*!(FFH(%\^[DV2*&XC`;;G\>U:FDZB=12X+0B)H)FA(#
M[LE>IZ"@"_1110!%<7$5K$99WV("`3CU.!69KM];MI&H0K*K2BW?*=QP/_BA
M^=:]87BVT\W3);G>5\B&0;1_%NP/Z4`:UBA2QMT;JL:@_E5BHX?]2G^Z*DH`
M****`"BBB@`J*;!0#&<L/X2>]2TE`!2TE+0`E%,DE"/&ISF0X'Y$_P!*?0`M
M%%%`!1110`4444`%,FBCGB:*9%>-AAE89!%/HH`RV\.:.R[3I\.,8X7!_.H&
M\):(PQ]CQ[B1O\:VZ*`,)?".C*<K;N".XE;_`!IX\+:6OW8YEXQQ._3TZ]*V
MJ*`,0^%-+(`"S@#H!.W'TY]J;_PB6EX(Q<<DD_OFY)&#_GWK=HH`PAX3TT%2
M&N<HI1?WS<+Z#VY-%OX4L+63S+:6ZA?/5)B./[OTXK=HH`2EHHH`*S?$)QH%
M_C'^H;K]*TJRO$Y(\.WN#C]W_6@"U'+Y6DI+D#;`&R<X^[[5Q]IXGU%(W:XN
M(7=D#(I0%1E@.2IXXSP:[.RXL(,\8B7.?I0MI:A6"00[7^\`@PWU]:`.:O?%
MT]F#)]@C>%YG2)Q+]\(<$]/I4$GC5C<2QVVGJ0J,49B0<!<\C'3@UT5T1YS6
M\.GPSF-`X#$*/F8@]1[$TQTE^TS.-(B;RT/E2>8H,G`&,8XR..?2@"IJ&MBS
MT6"XV6YNKA040'<I/<^N!5&Y\71K:K)86JNX53*7P!&2<8QU)Z]*VV$JW,;Q
MZ8A,8V*_F*-JG;G`Q]?^^?>JAL5N)/.GT*,2*PD'[U?F8D9_J>?2@#/_`.$L
M,LYV:=OM)(BP&Y=[98+R,X^\<8_&EC\66<;2VLVG20[(R)$`4_,!@K],#K6E
M'I=M'<R*FCHB2-EI`XYPZD<=AQG'M[U-=:-8277GM8)+),=LK[L8!!YQ^0XY
MYH`RD\0:/++;LUG('E?`)5?E(90,\^J*?^`BMC^P=**@?88<`D_=[G&?Y"HY
M/#^EI%N2P5VCRRJ'(W'KCKZ^M:32A9$CVL2X/('`QZGM0!4AT;3H-WE6D2;\
M;@!UP<C]:9#H.EP3B>*S19`0003P1[5=\]?M/D;)-VS?NV';UQC/3/M4+WZ)
M.L)AN"2VW<(F*]N_ISU^M`$<>C:?'<O<);*)7.YFR>3D'^8%++I-G+;?9VBQ
M&!@88@KQCC\!4\]TD#QJR2L7SC8A8#`SSCI1%<I+:_:%20+@G:R$-Q[=:`($
MTJ!)FD$D^'+%T,IVMD8Y'L.E2+80JL:@R%(ON*7.!R,?EC^=3QN)(U=<X8`C
M(P?RIJ3H\S1`/N7.<H0.W?\`$4`5X=.2$3A+BYQ-NSF3.PDDDKZ=:M!,/NW-
MTQC/'UHC<2QJZYPPR,C!_*GT`0M!NV_O91A]_!Z^Q]J6:(RIM$CQ]>4.#T(_
MKG\*EHH`A>%GD1O-=0C;MJX`/&,'U'>A(Y5A"--N<'E]H&>?3Z<5-10!'.DC
MQ%8I/+<]&V[L?A3^<>]+10!$B2A\M(&7TVX]/?Z_G2[9/.+;QY>W&W;SGUSG
M]*?0"",@YH`;&'"G>P8Y."!CC/`I0&^;)!R>..@IU)D'/M0`R%9%CQ,ZN_JJ
M[1^633G#%"$(#8X)&<&@,"2`1D=10SJ@RS`9XY-`"$/O4AE"_P`0QR?\*5PY
M7Y&"G(Y(SQGG]*-RX)R,#J<]*6@"/,_VC&(_)QUR=V:)A,=HA*#/WBP)Q]!3
M]R^H_.G4`9GV():&.^6WGA29Y"\PX"G+9P1@$$X^GY5&TFG.L4MD-.<0G8&9
ME&P=2`0#CC)JQK=I+?:7+!`P#G!`/1\$':?8XQ6#?Z'>7Z/LL;:R7:0%C?YF
M(0@9('3.T8],T`:\5E*S1)/I^G>3@;MG.W&XC`*^_P"IJ2:S>.[MGM+2VV19
M&XL5*!C\V`!@U0T&UN_MTSRSSBW@8JD;.QRQ`W#)ZA2.#[UT%`&.VE?:W2.]
MT^S\F-0$\N1N/;&!QFHK*TO[.>26'2]/B:9LR,D[9_\`0?TK=HH`*K227P>7
MR[>!E!7RR92"P[Y^7C'XU9HH`;E_,`VC9CKGG/TID3S-(PDB55&<$-G/)Q^F
M#^-2T4`!JO9SRW$*M-;/;N5!9&(.#D\9'T_459HH`B24NKGRW7:Q`!Q\V.X]
MJBL;I[J%6EMI;=]H)23'!]*LT4`%0PW!E:0&"6/8>K@`-].:FHH`A:57MT=X
M7(<K\A7)7)'4>W]*BFM0Z@3M(X$PE4(3Q@Y`//3(JW7*^(-3OK378$ADF$*[
M3Y2)GS#GG'][CMD>M`&C;Z-8B*WFBBGCFBF+B1A^\8ECG<>X.3^%:[[_`)=@
M4\\Y.,"N+M?$^K?;([.6!6+R%=SH0WWB.W''':I]+\47LU[8VDD4<HF5`TF"
M"Q(Y([<<@CU!H`T[^UEN8&CO)+KRS-(3'"N[S(^P..GMWJL^@R7\UQ/]NO+=
MKE071D`PIR`N?89XK;U6=;;39YGF>%47)=`"P^@/%<I_;]_9PV<IOH;IKICB
M-BH\L'&W>5'OD]*`-"S\/Z>BQ2A;DSVKK(TCQLI<*2``O3MVYZ>M7M.CBTI;
MH$W$IEE:X8B!N-V.!CK4#ZQ<3:+;W2A+=I;@1/)]Y47<07&>W'?UK/?Q1/;,
MT:2P7J1?,\Q'EF0%L;4'\1'J.*`.GBNXY51@DJ[VV@/&RG.,\Y'3WIMQ?0V[
M.L@ER@#';$S<$X'05R+>,[N&5I7AB='C0I%&^0A.<[FQG/M78V-Q]KL8+C;M
M\V-7V^F1F@!TTR0@%PV#G[JD]`3V^E87BQG-K*H+B,6LA<8.TDLF.>F>#715
ME>*/^1>O!C.4`_44`:47$:XZ8%/I%&`!Z4M`!1110`4444`%%%%`!1110`UD
M5BI(!*G(/I2TM%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!6-XN8KX:O"/11U]6`K9K$\8G'AF[YZ[/_0Q0!<OXVET=T2`3DH/W1;;O
M'&1FJ'AN"_L8%M+BU"PDNXDW`,/FX!4<9.2>.*VXO]4G^Z*?0!41$_M69]ZE
MS"@*8Y`W-S^I_*K59.N7KZ<BS-=I;PR$1;C`796(/.=PX_`U2;71]IDSJUK&
MJ,T:HUN<,Q&5.=W0>O'\J`.DHK)GU-?MD<4.I62_,J/&REF+'/0AN*6TN[FY
M=TBOK&9H@1($0\,1Q_%TH`U:*I2MJ!M]\2P"78#Y;9(W8.1GCOCG'K4H%WYS
MEGA,7\*A2&Z=SGU]J`+%%5A)=?9MQ@C\_/W!)\O7UQ_2H(I=4$8,UO;LY)X2
M0@`8.!R.><#/O[4`:%%4/M&I;W'V&(J`=I\_[WI_#Q2F?4!Y?^A1G)`?]_\`
M=&.3TYQS0!>HJK-+=)YOE6RR;<;/WF-WKVXQ3+.>^EDQ=62P+@G<LP?GCC&!
M[_E0!=HJE-<WB2LL=@9%#`*WF@9!')]L5821R0'B93C.<@CKTH`EHJ&*5Y'=
M6A>,``@MCYLC^8IZ/OW?(R[3CYAU]Q[4`/HJJ]X4E2/[-<-OV_,J9"Y]3GMW
MI?MG[PI]GGX<)GRSCGOGT]Z`+-%55O0UPT/V>X!4XWF,[3^-2PS"920CI@XP
MZX[9_K0!+2<Y]J6DH`*%4*,*`!Z"HDN87D$:R`L=V`/]DX/Y'BDDNH(YEA>5
M%D;&%)Y.<_X&@">D"@$D``GK[U%'=029V2HV$#G!Z*>A^AQ3'U"TCA65[B)8
MW3>K%A@KQS].1^=`$X10Q8*`QZG')ILL,4X`FC20`Y`89P?6J\>J6,K,L=W`
MY4`G:X.`3@?J14T-U!.&,4T;A/O%6!QQGG\*`'&&(QM&8U*/G<I'!SUS3Z`0
M0"#D'N*AEN[>!]LL\:-\O#,!U.!^9!H`<+>$9Q$@R0?NCJ#D?J2?K4M-#!LX
M(..#BH#?6@B:4W,(C4@,V\8!/0$_C0`ZYM8;M-DRL1[,5[@]C["I64,I4]",
M4D<L<L:R1NKHPR&4Y!H,B!F4NH*C<PST'//Z'\J`&"VB"A<-@;?XC_"<BBYM
MH[J+RY=VW.?E<J?S!S3_`#$,8DWKL(R&SQBE#JQ(#`E>"`>E`$/V.+:%S)@-
MN_UC==NWKGT_7GK3EMHU4`%\!@W+D\@`#O[5+FC-`$3VZ/<),2^]>F'('?MT
M/6GQQK&"%SR2W))ZG/>G49%`#3&#*LF3E01C/'..WX4ZBB@!:*2B@"(PL+4P
MQRNK;=JR'YB/?GK2+%*+II3.QB*X$6T8!XYSU_\`UU-10!%<1R2*HBF,1!R2
M%!R,=.?\\4Y$=3(6D+!CE1C[HP./YG\:DHH`C5)`L8:7<5&&.T?,<=?:EC5E
M4;VWMSSC%/HH`8Z$J=A"O@@,1G!H$:`@[1D=\4^B@"*:.20@*ZA/XE*9SR/Z
M9'XU')90.%3R(3'O#,I0=NA^N<59HH`8T2/&8V160C&TC(_*JJ6I\R+?;VOE
MH#C:O*G/&../\:NT4`58;.'R<36UN'<#S`B#:3^7-20^<)'5TC6(8$>TG./<
M8XJ:B@".0RAU"*A3!W$GG/:L/Q).Q\/74,YC6YVJQ1"2-N\#/(KH*YSQ1;.T
M%W-SL-O''T[^:#0!T5+24M`!1110`4444`%%%%`"4M%%`"4M)2T`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%<_XWS_PCDN/[Z9_.N@K
M`\;?\B])_P!=$_G0!M0M\B+M/W`<]JEJ"%I3+*CIMC4@(W]X8Y_6IZ`,K6(+
M/4-MM<R,/LY%RRA<@J,CGCIUXZUB-X+L)(UE2]N-CD%,@'@XQVSTKKZ*`..G
MT?28[N7-XRM$&,F8B64EP<@@=LXJQX?TFUTC4[R5+TR".,J5*%=HSG)/0_A7
M4XHQ0!%<7,-J@>9PBDX!/T)_D#2)>02+(RR`K&`6.#P",C]*FHQ0!$+J$H'$
M@VE]@/\`M9QC\Z=%-',"8W#8.#CM3\"D"(K,RJ`S?>(')H`BMKRWNDWV\R2+
MG;E3W]*E=TC7<[*H]2<4;5R#@9'3VILL,<R;)8UD7T89%`"F1`Q4NH(&2,]!
M0)8RNX2*5QG.>,>M--O"SL[1(79=K,5&2/0TBVEND/DK!&(]NW:%&,>GZF@"
M0.I(`8$D9'/:@,I4,",'H<]:01H&#!%#!=H..0/2F2VL,MM]G>,>5@`*.,8Z
M8QTQ0!+114;0(TPE);<.GS''0CIT[G_(H`DHJ*&W2"(QH7*DDY9B3R<]3446
MGQ0NCK),2@(`,K$'DGD9YZT`6J*C@A$$>Q6=ADG+L6/)SU---L#=>?YDN<`;
M-YV]^WX_RH`GI*6B@!,`=J-H)S@9I:*`&[%!)"C)&"<4ABC*A3&I`&`,=!Z4
M^B@!@BC!R(USTSBE5$7[J@9]!0X8@!&VG(YQGC/(I`&\QB6!4@87'0\YY_*@
M!U1R6T,LJ2R1(TB?=8C)%).DS[/)F$6#EODW;AZ>U1+!>#9NO%.,;OW0&[IG
MOQT/Y^U`%K`%,,,17:8TP3G&.],V7!EE/G((R,1C9RIQU)SSSFG%VC\I6!?=
MPSC``X)R?R_6@"*?3[6X>)I85)A(9#TVD=*?-:03[_-B5O,38V>Z^GZU&YNW
MC5[:2!PQW!F!P5.?3VQ5KM0!5.FV9\L>0F(B2@[`DY/'UIR6-NB.BQ@"23S&
MY/+9!S^@H/VSC'D?=YZ_>P?TSC]:5OM>T;?)W>7SG.-_^%`!+903%BZ9+=3D
MCL!_04V/3[:(2A$(\Y`C_,>0!@=_2F*=2XWI:_>&<,W3OVZU8/G[I<"/&/W?
M)Y.._P"-`$%MIEK:7#SPQE9'&"=[$8SGH3BD;2K1Y3(R,6,HE/[QOO#H>OMT
MJ4&Z\[E8O*R,$$[L8.>WKBI9-_EMY04OCY0QP,^]`%:33+:6[%RPD\T,&&)6
M`R,=LX[59>-7*%L_(<C!QSC']:CMGN)%W3PK#D#Y-VX@Y.<GIZ5)*S)$[(F]
M@"0H.-Q]*`(;BR2Y@:*624J6+95RI'T(Q38;!((D1)9B47:':0D]^>>,\G_(
MJSEC'G;AL=">]";BB[P`V.0#D`T`(Z,P7$C+@@G&.?:H%L_+C*0SS)EMQ);>
M>F,?-GCH:G5V:1U,94+C#$_>JI<WES"["+3I9P.C*ZC/3U/N?RH`FE@E>976
MYD10!E`%P>0>XST&/QIMU;3S$F&\DM_EQA%4\YZ\@_3\:ECD=G"M"R#8&))&
M`?3ZTVYGD@0LEO)-A2V$(SD8XY/7D_E0`U+>=6!:[D<;LD%5Z;<8X'KS20VT
M\;*7O990"<AD09X'H/\`.:G1BT:L5*D@$J>H]J@6ZE+A39S`;MI)*X'3GKTY
M/Y&@"'[%>^3M_M27?S\_E)W(QQCM@_G4MO;7,13S;YYL'+;D4;NOH..H_*I;
M69YX=\D#P-DC8Y&?KQ3RXWE<'(`/3USW_"@#-%IJS1G?JBJ^XXV0+C&..M22
MP:FUF(X[V))P_$OE9W+CH1GKGTJQ;7,EQ`DP@9%=58*YPPSU!';%/68DL/*D
M&U]G(Z^X]J`*,-KJZJAEU&)V&`P\C`(SR>O4CCTJ40ZBX<27<49*`*8XL[6S
MR>34\ET44GR)F^<KA5Y/&<_2F+>DI`QM;@&49P4Y3D#YN>.OZ&@"2-;A9&\Q
MT9"Y*X7!"X''USFH7743,"DEN(PS<;221CY?_KU/'.9$B;RI$\P9PPP5X[^E
M-M[KSY'3R)H]C%<R+@'!QD>U`#F\_P`[Y?+\K;WSNW?X5C>(%NAHT\EQ*FW8
M@,:#C=Y@YR>>F*WJY_Q#>K<Z!=!(Y8RK(")%VDCS,?T-`'04M)2T`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!125G7E_?07!2#2I+B,#_6"55SQV!Y
MH`TJ*RDU._\`+)DT6X#]@LL9'XG(Q^5._M.Z&`=(O/P:/_XJ@#3HK,_M.Y&?
M^)1>]/6/_P"*J+^VY1(%;2-0`P>0BGD?C0!L45D?V]^[\PZ7J03N3"/Y9SVI
MK^)+1&P+>];D#(MF_K0!LT5DIXALV7)BNU'O;/\`X5)_;EGMW8N,?]>[_P"%
M`&E164?$.GK]]YE/H;>0?TI#XCTP'!FD_P"_$G^%`&K2UDCQ'I98#SI`3TS`
M_P#A0WB32%.&O`I]"C#^E`&M6)XMC\W2%BQGS)XU_-A4O_"2Z/MW?;X\9QT.
M?Y5G>(=8L)K2S\J[C?-Q')P?X0W)/I0!T`+Q/*\L@\G&X%CC;ZCITXSGW-+%
M/YKMM"F+`*.&SN)SG^GYU@:YJVG:AIDMI!>P,TF,@R[.`03S]*Q;#2KNVM4D
MM;RU)65GBVSCNA7<3C&1QV]:`.T%S<8R;)P<9QO7K@\=?8#\?K3GGG6-F6T=
MV#$!0ZY(QG/7UXKD%@UZ!QLUJ%E&,%YE/7ELYZX/\Z:DGB`M&;B_1HUEC9MD
MJ9(SR..WK^%`'7175P\JH]A+&IZN70A>`>QSUX_"I'GE4.1;.Y#$`!E^88SG
MD^O'_P!:N;UUK^\O5DM)[406FV6-3,`97Z],^V.<=:I2W'B.YN6F@F93ER(P
MZ>6HV\#KR?KQF@#L9YY8O*V6SR[V"MM(&P>IR?Y5$;R?R9G^PS;HWVJF5RX_
MO#G&/K7,V[>(4>1A-*R^8SCSGCRP"\+C/&3@<57^V^+O*Q@;V((.(\CKQ_*@
M#L+6]:=PDMK-;R%2V'`(QQW!([]/:K$L@BB:1@Q"C)"C)_*N8L;SQ!)K,*31
MG[,0OF#8N%^49.<^N>]=2*`(HKA)GE1-V8FVME2.<`\>O6F0WD4UM'.@?9(0
M%W(0>3CH>:L=^E%`$4UPD+Q(X;,K;5PI/.,\^G2J\6JVLMPD"-)YC_=!B8#I
MGKC'2KM%`%7^TK0NR+.K%65#MYPS$@#COD'Z=ZF$\1N&@#CS54.5]`20#^AI
MRQHHPJ*!G/`[^M+M4,6P-Q&"<<T`0K>VK,BK<PEI"0@#C+8ZX]>AI1>6Q#D3
MQ[44,S;N`#T.?>G?9X=ZMY,>Y,[3M&5SZ4&WA:,QM$A1@%*E1@@=!B@!RRQO
MC9(K9SC!SG'!IP(89!![<4U8HTQM15QG&!TSUI555&%``R3P.YH`02QEV4.N
MY?O#/(I4=77<C!AZ@YJ+[';>;)+Y$?F28WMM&6QTSZTZ"WAMH_+@B2),YVHH
M`S0!(&!)`()'7VHJ*"UAMWE>)`K3-O<]V-2*H48'J3^=`"TM0-:QLH!WX!8\
M.P^]G/?W_"I70/&R$D!A@D'!_.@!U%0+:HJ*F^4A2I&9#GCISWZ<^M22()(V
M0E@&&,J<'\#0`^BH+FV^T`8EDC=0=K(V,$C&<=#U[TU[0-9_9UFF3`XD#G<#
MZY[_`(T`6:*CCA$83#.VQ=H+,3GIU]3QUILT)E,;+*\91@WRGAAW!'<4`35!
M<,!L4!"[DA-_KM/^?I4U0&V<WHN/M$NT(5$7&T'U^M`$EO'Y5O'&`J[%"X7H
M,#M4E9%[.^F"R:2>ZN7+>4(T1<S,0>3TQC\*IRZU%_:4:S7-Y:%RJ>1)$N,[
ML=>3@X//3F@#HZ*SX&^T6\<=OJ7F2(FYI%"DL&!"DCIUY_"I+BVN9`_DWKPE
MF!4A%.T8P1R.<GF@"Y15>"&:/9YMPTN$PV5`W'/7B@PS?9]GV@^9NSYFT=-V
M<8Z=.*`+%%1E7\U6#X4`@KCJ>,'\,'\Z9%%,FSS)S)M4AOE`W$D8/X<_G0!/
M134#+&H9MS`8+8QD^M(RL60JV`#EAC[PP>/SP?PH`?15<?:LS9\G&/W6,]>?
MO?IT]Z8/MW[G/V?J?-^]TSQM_#UH`M45#.;H$_9UA(Q_&Q'//H/I^M2G.TXQ
MGMF@!:*1-VQ=X`;'..F::OG><^\)Y7&P@G=[YH`CN49I;8JC,$D))#8VC:PR
M?7KT]Z?;A1;QA)#*H4`.6W%O?/>G.@9D.6&TY&#C/&.?7K6?%<Q6D4>GQ36I
MNHU'[K?M&!U]2.,T`:55YKI$O(;0C+S(S`_[N/\`&GQO*;<NXC#\X`;*GTYQ
M]*CB6Y::.281H!&P94;=\Q(Q@D#L#^=`#[+?]CA\R+RGV#*9SM..F>]34$A1
MDD`5!#),Z-YB1*V[@)(6!7US@?E0!/15=)+@6[/-%$DHSM4294^G.!C\J%DN
MBL),$0W9\S$I.WTQQS^E`%BBH!)=%1^XBW;"2/-/#=ATZ>_Z5)(T@QY:*W7.
M6QVX[>M`#ZP_%;@Z)>*"F4$9X/S#YQU'IQ_.MP=.:P/$44KZ9J$DD,2#8B(X
M.68!\\\=.G'UH`WZ6D'3FB@!:***`"BBB@`HI**`%HHHH`****`"BBB@`HHH
MH`*2EHH`B$\)F,(E0RCDIN&X?A4A(4$DX`ZFN6CM[NR\0W5]'I\\RLQ#,Q4D
MY(P4[X`ZBK?C.8QZ&8PQ0SR+'N'89R<^V!0!N1R)*@>-U=3T93D4ZN`>_CTJ
M`1:3?++YWF9$8VJK;5"\,21U)Z]:L-XDNH,>=?Q[?.>(B-%8A57AO?)-`';T
M5P'_``ENJ#RU:2#S,*<!058')))SP>@Q3!XNU7[&7WPE_,QG:.!CT_ST]Z`/
M0J*R/#^H37ZSM/<1/(A4&.->(SCGGO\`6MB@!**6B@!,#.<=*:T:-C<JG!SR
M.]/HH`@-G;$Y-O$2>^P5B^++:`:0@$*`&>,'"@<9KH:R/$B++9V\;YVM=1`X
M]-U`&;XAT6UM-.:ZLK.T7R^762,G(Z<8/%9W]G6MC<RIJ6FV\R(44O;EEP6R
M>F>:["9FE?RHT@E0$"57?E>G;![9/Y4Z>-BRM'#$Y+#<7.#QT/0^]`'*:/;Z
M#JD-U(FD^6;=0Q#2,=PP>^?:JT5QX><[7T?9)M+X,F1M"%ASGJ<8Q76R6*0Q
M&*QM;>-)CMF*_NR%(Y(P.35--+,<26XTG3S`"N<OD],$_<Y/6@#F9)=""(YT
M*41'`#K*>NT,1U]#2,OAF7,HLKR*WQ@2*W!8#.W&>N*ZJYT.UDC2$6B&"`;X
MX]Y`=\$8;CI@+S20Z-;3W$LUYIEO&Y78-DA8,,8Z8`!QW]Z`.1"^%C"DA2\4
MLS*R;P2H'?\`4?KZ5H7.C>'+6=8F^V$E!*2N<(A(`)XXY-;T'A_3]HCDT^-$
MAE+1D.6+^[?X'/2IKW2[:_O8Y+BU+>7\N_S"N1P>@/(SZT`<O:V-A'IUQJ$5
MO>Q(LPA18[C#2?,!GIZGIS31+I;VD4DEQJEO*Y3Y&N#DJ6P6!QR!@_E75#3;
M::VGTZ6U=+56#*=_#Y.XX(.1ALU7O]&T\+`IL)YO*CV(8I,%`N2!RPYR>*`,
M:"VTFXTZYOH=4U5HK?[X\W!_E20V<$2%K^?5[$CE&:X#!_0*0.3CM6S;:79V
MD-Y8I8W#Q.F9)&(/FX'`'/7GT%4TT.W;S0T>J^=&N8YWE4L,=D(/N:`*#PVA
MD9H_%ER(NREV)''<Y]?:FI;1,RH/%\Q9\;>3SV_O5>718(K*6.VM]0A,I1W<
MA6?*'.1SP3G]*=%X=L9&,1COU0D&7>5Q*PR<D]>YZ8H`S4ME=E2/QA(6<@`?
M-SG@?Q5+#=W#2,Q\3LB1HH5Y+<!7#9[$\GCJ15V;P];FZMY`U^IM5A1,*I!P
M>/RZFG+X7M))HY(;FZBF2$`;U4[5(*XZ8SC-`"PRWMQ<_9X?$T#S==BVJY]?
M6HI[N\@W[_$T`,;B.0?95.TDXY_6K-OHMAHTEINN9=R2LZ9&=Q*!2.!Z#-5T
M\/Z;=:D+S[3*[LQG*F/"L-P;G(]_UH`D8ZJBQNWB.U"RC*9@7YA[>M1^?JG]
MG27L>OVSPIU=K;`R<8SW[CMWJ%/"MI+J,+QWSE=@F12G.-V>OIS]:T/["^S^
M'[G3FN$Q*ZXD8=OE`S_WS0`R`^(?EE2^TVYB9>-V0,^V!3]WBC"?)IS;>IRW
MS\5FR^$)'N+>5KF&,[R7B4$(HSG$8^E=59)Y=JBXB'4XB^[R<\4`9BS>(\_-
M:Z>?I(PI3/XA'_+G8?\`?UO\*UTEC=BJNI8$@@'D8Z_SIU`&']J\1X'_`!+[
M,_\`;8\4HN_$/\6F6I^D^*V@RL2`P)'7!Z4O2@#&-YKW_0*M_P#P)_\`K4U[
M[7U7(TF!O87`S_*ML$$X!&:,CUH`Y]]5\0*V/[#4^XG%`UC72I)T`^W[\5T`
M((R#D49!Z4`8`U?7.^@G/M.O^?2I%U?5MK;M!EW<[<3+^M;E%`&*NKZF1\VA
M3CZ3)2+K.H8._0KD8)'RR*:VJ*`.<U*XN=0B16TC4(GC;?')&Z!E;!&>OH36
M>MG-&[2QZ;J?V@[3YKNC$L&+9Y/>NSHH`Y30FO=+MY5?1KAY)9"[%2H`'91E
MN@K4.L7HZZ)=_@R?XUKT4`8S:W=H?WFBWHX)^7:W`_&H'\5*@RVE:B!DCF'T
M_&N@HH`YMO&$"G#:=?@CJ#&./UJ=?%=D7"F"["[<[O).,^GK6[10!BGQ18!@
M/+NCGOY#<4A\4V`;!CN@H&=Q@;%;=%`&,/%6DD?ZZ4?]L7_PH_X2K2/^>\G_
M`'Y?_"MFB@#&_P"$KTC_`)^)./\`IB_^%!\5Z."`;AQGIF%_\*V<4AC0N'*@
ML!@''(H`Q_\`A*]%_P"?W_R&_P#A1_PEFB?\_H_[]O\`X5IO:6T@8/;Q,&.6
M!0')]ZA_LC3<8^P6N.O^I7_"@"K_`,)1HWE"3[<F"<8VG/Y8S7,7=M87FJW4
MXU.R3>[$OYI'!4@#!'/N0:[#^QM,_P"@=:_]^5_PI/[%TO.?[/M<_P#7)?\`
M"@#BS;2,_P`VOV'EB`0A!.<8"8'&/7G-:>D3+9ZK-<7?B&WFA?)VB8?,>V1T
M'X5OG0M);&=.MN/^F8I/[`TG_H'6_P#WP*`*&N7]GJ.ER6UI?:>SN0#YTH``
M]1[UA-";584LM0LH`ZK$XBNUW#&]LEMO3..WM76?V!I/_0.M_P#O@4A\/:01
M@Z?!^"XH`PM1:.YBT]Y[ZPOF@0K-"UR$5V(QN].*KF>_2,);ZM8P&-0L2QW:
MF)5`Y!#`DGWKHO\`A&M&_P"?"+]?\:/^$9T;_GPB_,_XT`<VTNIQQE['4+<3
M3SL[EIXBQ7"@$GIC(;IZCBNO34+38H>[M]V.<2#K5/\`X1?1M^[["G3&,G'\
MZ:_A716W?Z$HW#'#,,?3F@#3DNK>)PDD\:.>BLX!-4=?=7T:X"$,0R9`/^V*
MK/X0T=R"T$F0,?ZUO\:H:OX:T^PTV:Y@\X2J5()D)YW#MWZT`=72TE+0`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%)5*[O;B!V2'3KBX(7(960*3Z
M<G/Z4`7JP?$.L3Z;-"L`B("F23S`>FX+V_WL_A5U=3EVC=I=Z#Z80_\`LU07
M#V]VX>XT*>9@,!I(8R0/Q:@#"3Q:DC2G[);'RPV",Y?AB"!CI\HS_O5':^+)
M0DGGV=K*5Q@)E"X`.2.#Q\I-;3QZ>JD-X<EQTXMHS_(U%.FC!0D^@S)N'&VT
MY/XK0!2N/%7V=W1["W<H<,5?Y3TR`2.2,\UJV,R7$5D9]+7S+A-[NL0V(,$C
M)]>GYUFR6OAU&W/H]V"3T\F3K426?AEG_P"/6]0]>4FX]J87%/C&&WFF6UTZ
M-D60H&5]F\<X.-M:%GXH-PMZ\EDT26L1DSY@);!(QTX/!JE%8^&6C'[B[0!M
MP4I,,'UXIQM?#.)8S]JPWSR+B?GW(H`'\9NBLS:>%')7=,!D!MIR,>M30>+O
M.FA06+8DDVDB4':-P4'\3G\JI2VOA-P"\LZJ!W\W'7/<>],%MX1`*K>RHK8+
M#>X#8Z=J`+Z>,5D53'82-ND\M?WB\MGCWQCO4D'BZ*56D-G,L(9D#[E.6'.,
M9]*PWTWPUO1X]:EC=<8;.3QT[<4BZ3H`8;=?<%>0>."!]/:EH!T/_"56[L8H
MK:=IA'(^T@8&S.02"<?=_45+JLR7NE:?-M(2:X@;'0X+#_&N<CT;1FD8P^(B
MLC?>8D#((Y[CW_E4]RD=K';2'Q"MY%%<1DP[EX`8<\'H*`-CQ!!.NGZA)&KD
MN8F3RBV_((!Z>WI6/:ZIJMA8M#%#(TJW))61'?;&1E0#C)R0>3T[UK/K6FR2
M3-;ZRD3/M^\N0N,YQGU_SUIAU>#[.5_X2*W\WG$GE+ZC''L`?S]J+H+&:?%V
MI(EP)+1%9<$-M;$.<\.,=>GYU*?&5VK3*^GB/RPOS.6`!.,;N.,@U:?5H?GV
MZ]:-O/\`%$/E&TC/N<X/X4BW^;60-XAL&F<KAO+4``$YR,\DC'TQ1=`5M5UZ
M>2.YLYX_L\\.&#0R-V(.XG`^0YQUS[5H/XG5=";4/)5I%F\GRUDRN<_WL=,<
M]*B_M*%58/J.DW;E=IDD(0D8;@@9XSM_7VIJZ@O[M%N-%,9*[X0^!GN1QU_P
MHN!'_P`)K&7CVVI="JERC\ABI)`&.<$$5+H6KSW=[J5Q-*'C2%)(X5<':""<
M=!SV-7]/,4U@CNFGM(7&3$1L8`XW=.N,\?A39X0WFP1V]FD$GR,T<NQBO'H/
MKQ1=`58?%T!F6&:`[V7>IA<.N-N[!/'/M23>*5,?DB,13S(#%('#(-P.TDXX
M/'3'6IM-M+FTLXH?L%D6C"X*R<G)PS?=[@9]ZDET]##/;_V9:/")`T2E\;L\
MDGCC!)_.@"O;^*[460>8.\J*H?8!\Q\LN2!GIP15V#7(9]46RC3.0QW[P1D!
M3@8]F_2DBTNS>=9WTVWC;A0<C(79Z#C.21C\:@2)+*3;;:$V;=F\AT=,$,.3
MDG(ST[]J`*UQXN@CNK614D%I('5QM!<L"`,#/^<U>'B.UW0*UO=*]Q_JU9`"
M<-M/?C'7Z5,NBZ;)OE>QC1YD(<'WQGIP#P.14:0VUM-&D6E3D6JL(I!M(YZX
MRV>?>@"H_BN'=$Z6TZP'/F-*FTXV,P*^OW34[^)[5)6C^S79=<Y`1?[N[U].
M:<^C:9!YFS3&D*X;@YW9!7`R>P)XZ<UESZ6CW]G'!IES#9B4^<2QW,2NT<[B
M=N,9H`T/^$KT\C(CN",,1B/L%W'OV!!I9/%6GHY79<L-Y0.L7RL0<<'ZU+'H
MUA*DW^BR1!MZX)VX#*`=N#TP!6>V@Z7.=X>]C);<@.[Y&Y8D`C`SC/\`G%`&
MO8:M;:A*8X%ERJ!R63``)(Q]<@_E5^L2RTNSTJXBN(YK@EXRN""0_5LL`.N"
M>O\`.M.&]@GD\N-FWX)P4(Z'!ZCUH`G:-&96902O0D=*$18T5$4*JC``&`!5
M4:G:&,R"1MH#$DQMV(![>I%2VUW#=!C"Q8+C/!'49'7V-`$GEIY@DVC>`0&Q
MR`>WZ"G52&KV)D9!.-RG!&T^A/I_LG\JF-[;B-7,H"M)Y0/JV<8_.@!\5O##
M)))%$B/*<NRK@L?>GNBR1LCJ&1@0P/0BHEO+=I98UF0O",R*#RH]_P`C3S+&
M(O-+#81G=VQ0!%#86D%P\\-O&DKYW.JX)R<G]:D%O$K!A&H8;L''3<<G\S2R
MRQPQF25PB#&23QZ4Y9$895E/;@T`,@MX;:!8((UCB7.%7H,TL,$4"[8D5!@#
M`'H,#]!33<P*[(9HPRC+`L.!G'/XT\21E`X=2AZ-GB@!]%-5T?.QE;'7!S07
M0$`LH).,9H`C:W5KM+C?(&52NT.=I]R/6EN(1/`\1=TW#&Z-MK#Z&GAU8D!@
M2.H!Z4I8+U('U-`#)8_,A:(LR[E*[E."/<'UID=L$G,OF2L3GY6<E1G';\/U
M-2K(CDA75BIP<'.*"R@@%@">@SUH`@O;8W,)59)$;!QL<IR1CJ*;%9"+=B>X
M;=)O^:0G'L/;VJUD>M)O7.-PSZ9H`:D>QW;>S;SG!/"\`<?E2-$XA"1RLI!'
MS'YCC/(Y]>E29I&=40LS`*HR23T%`$4FR!I;F64J@0;@S?*H&3G]?T%9\NLV
MPN+9Q-*+:0??\DF-B3@9?MR/UJBF[Q/?"7<1I%NV`IX^T..Y']WI_GI;\3#S
M-/ALT'-S<1QA0,\9R?T%`%Y+6XCWA+Q]K$E=ZABN23U].<?A5M00H!.3CD^M
M`-%`#(U=0V]]Y+$CC&!V%1QQ7"Q;7N`[[E.[8!P,9&/?!_/VJ>@D`9)``H`;
M'E55)'#/CKC&??%-=93$0D@5\\,5S@9Z8^G%<]I=VVM^)9+Q,_8[)&CB/9F.
M,G\OZ5TM`#8@ZQJ)&#N!RP&`?PI7#$?(0#D<D9XSS^E+10`AW9&",9YXZTDO
MF")_)"F3!VAC@9[9IU%`#7W_`"[`O7G)[4R,W!MT,BQB;C>%)VCUQ4M+0!2=
M]1VMLBMLX^7,C=<CKQZ9_2I)'NPP\N*)AGNY'&#[>N*LT4`06S7#*WVF.-"&
M^78Y;(]>@Q39)+H3.(X8VC$9*L9,$OZ8QP/?]*LT4`5X7N6F830QI&!\K*^2
M>3VQZ8/XU*I<J2R@-DX`.>,\?I3Z*`(&>X%IO$*FXV@^7OXSZ;L?KBLWQ"[2
M:!-OC*-OC&"01]]?TK9K%UU83HDPMRIWSIG:<Y;S%S^.:`-FEI*6@`HHHH`*
M***`"BBB@`HI*6@!I/(I:*6@`HHHH`****`"DI:2@#E=%U^XN->O(;VX5+="
MP164*%.X`<_XUJ>)M0GT[2C+:D"X=U2,8SDD]A],UH-:6SLY:WB8N07)0'<1
MTSZXJIK45HT$<U[=26T<3Y#HVWGH.U`&!;>,EB5Y[S?)&P1$C11N#!07)Z<9
M(JW+XTLHY'46ETX0D%E48X.">OO5.2S\-W#1B35)7+MO7,@Y).">G<BH_P"R
M=#EODT^VNKN21RX;RW!$6TY.>/4?G0!NV7B.QO=1GLX]RM""3(^`IP0..?4U
M#XA\1)H]Q:PJ$=I'S+GG8GKQW]/I7-O;Z+/J%Z[3Z@LT)>3S&V_.R\G''7CO
MBKITFPG>X:7Q!\\Z[IED5`_`SSGIB@#2U'Q9;VMXD,<;LBR%99"AVX`YV^IS
M@4V+Q?;F]GCF@GCB105'EG?G&6W#L!Q6<GAS3Y-]P-<1_M),9?:OSDG)'7KF
MG:;HEJ))_L.LQL4W1S;X0=P.-P.3R.!TH`U3XNT=HW;?(RJP7'EGYNIR/;BK
M%OJ.C7EZEK$L3SLF0IBQ@8SCD>_3ZU@'P5`8PO\`:D8P<D^5S],[JT=(\,1Z
M3J2WC7RR<$!3'MZ^AW&BX&\UA9M]ZU@/&.8QTIK:;8,,-96Y'7!B7_"DBU&T
MFO9+..=6N(QED'4=/\15N@"F-)TX'(L+7_OTO^%4M2TRP06NVRMES<(#B)1D
M>G2MFJ&J]+3_`*^4HN!"T&BQRF,V=L'SC'V<?X4][#28Y`CV-J&8$C]R.@Z]
MJJ3:E-:RPVEK")KFYGEVB1\*`K9.3SVZ?Y%-MO$$J:@MMJEM'9!E8JQESDAM
MO<#KVI@2/H^A31F<V<.QT(R%*\#T`Z']:8/#OA^8O&EM&6!V';(W4=0.>M2_
M\)#9/<HL4\#0`,99&DV[<8Q@$<@DXS4R:YIC22K]JA7R@K%F8`$,,Y'KU'YT
M@*O_``B&B?\`/H?^_K_XU'+X6\/PE?-B6/=PH:=AG]:O7>N6%O:S21W5O-)&
MA81+*N6P,XI+35M/O;*&YFFMD)`)5Y%.QB,X^M`%!?#7AQ]VU$;:0&Q<$XSP
M,\T@\,>'3&9`JE,XW"<X!],YK8MY]/GD>*VEMI''+K&RD\'N![U%I]S87AN8
M+:.,?9Y"CKM&,XQGCMU'X47`S?\`A%]`W;<88<8\\Y]/6FKX;\.N?D=3GCBX
M)_K5_4M0L--N8DN+5FDE#,I2('..3^/>J8U71T",NFMRB2*5MQT)PO3O0`D?
MA'19'WQ^8R=-JRDC_'N*C3P78J`8KZ\4@@Y61>H_"MG2KJTN[);BS01Q2$\;
M0IR/EY'X5.T$#2)(0H:/.T@XQGK_`"H`PX_"^R,QQ:SJ"KGD"7CWXJ8Z%<*/
M^0[?CZN*UWMH74@H`"XD.WC+`@@G'T%1O86\DQE>/<Q8-\Q)&0"!QT[TK`9O
M]@W/_0=O_P#OH4AT&Z[:[?@_[PK5>SA>`0D,$&<8<@\@@\YSW-1/IENZR*3*
M!(Q=L2L.2"..>.O:G8#-.@Z@"2FOW?MN`-,;1M;VKL\0/G'S9A%;,MFDL1B=
MY/+(4!0Y&,'/4<_K4":2D4;1QW5TJL><RDG;@_+D\@<DYZ^_%`&6=-\2E"G]
MLQ8Q@-Y0S_*GBR\2@`?VI;'`ZF'_`.M705#+#(\\4BW$D:IG=&H&'^N1G\J`
M,86?B8?\Q*T/UA_^M1Y'B@$XNM/(_P!QO\*W=I\S=O.,8V\8^M-EB=Y$99WC
M"@Y50,-D=\CM0!A^1XH_Y^M._P"^&_PH,'BGM<Z<?^`M_A6TL,HN/,-U(4VX
M\LJN,^N<9_6I45EC56<NP&"Q&,^]`'.`>*8S\L.FLQ4DL`1[X_4_K37N/%J1
MHPLK)RPY53ROL<M_+-=)&'$:B4J7Q\Q48!-$N_RG\HJ'P=I8<9[9H`YA[KQ:
M5VG3;1PP]1CZ<M0]QXDA"I#HEH%7!^4@@L.XY&*Z.Y%R8_\`16B5_P#IHI(Z
MCT/IFED%QL?RS'NW#9N!QCC.??K^E`',/<ZP[R;_``U`T<H^8':2W.1D]^_X
MU)#?:NMMY$_AI'B48"(RJHZ]CFMP#4=CY-KOR-O#8Z<Y_I3[<7N)/M!@)_Y9
M^6#^N:`,:/4]4A!$/AED!ZA9E';'IZ`4UM1U-Y!(_A@LX((8S+D$<9Z>YK=C
M%UY#>:8O.Q\I4';G'?OUS3X3*+=3<;/-`^;RP<9]N]`&!'J.J1/))'X9*/(<
MNRS*"Q]^.:;<WVJ7<92?PR9%((^:=>,^AQQ6O::S87EM+<07"F.$9DR""GU!
MYJ33]2M-3B:2SE\U%.TG:1S^(H`Y_P"UZ@DF\>%V0A_-8QS`%F&>3@?,>3P<
MU#=:Y+%%YM]X>N(U5MX<R$8.0>N..@XKL*P8(TUO5Y[B;$EK8R&*%.JL^/F8
MCOC(`H`PKN[O[N:/&EZA;6P7.V-69W)7;]X_=!`QQ]>]2>7I+.V[0-6C<K_K
M0CEP?7KU]Z[?%5M2NA9:=<7.,^5&6P/I0!RVA:X#8R1W-CJ-PP9T,L2%L@]C
M@\'I5?4+F&Y9;>RT[5%C+*ET2'+!./E`R1DX[UH:-)_8/@\WD^?-E)E"N?O,
MW"_F`#6QH5@]E8[K@[KJ=C+.WJQ[?0=*`,JWU2QM2BP:1JJ>7A541-@=>,;O
M<U2?4[.[U&*Z.G:G);Q(VP*C'YRQ)/WNW(_''85M:I=R7]R=)L&.XX-S,IXB
M3N,_WC5/6)?LZ6GA[2B8Y)@`S`G,<?<Y]^?UH`2WUFS2/$-OJ^UBI#>46X!X
M4=>.ON?6BZUFSFD<&+5XGF"@!(B#\AW94>OK[5J3WNG>'[2""1_+C`VHH!8X
M'4GV]36DI#*&'((R#0!S8\3V2V;0%=1S&GEO*8?F4XQDGH#6!J^N0-9/;V5]
MJ;N_RE9B``._;/Z]Z[G4K^'3K5YI6&0I**3C>P&=H]S7+Z'9W.H>(Y;C47WM
M;HDCQG@)(<E!C'8$_C0!'IVKZ-IUG:6\>HW*^22TGE1864DY.<C..WTJ>WU[
M38V69M<OY`AYC>,?-SGLOX5UWEI_<7\JS/$L4'_"/WGF;441Y!Q_%V_7%`&8
MFNZ8Y#_V[.H./D:/_:S_`'?08^E%IX@TU',K:Y,P.<1S1<#WX7/ZUMZ=#YNF
M6K7<*F8Q+Y@=1G=CG-5=;N(=/M56WMX7NYVV01E1R<]?H,T`9-[XC@C.ZSU9
MII9>%C9`L4?'4DKG'MFJ7VFWM[ZRN(]>$]R6<S22,3&/E./E],UMB*UT#3%B
M\L75].<A#@M+*1R?8?R%6]*TE(81->QQ2WDC>8[;!\IQC`]`!Q0`G_"2:/\`
M]!"'\S52V\06L<2K/J]K*X(RVPC(R<_I@#Z5HMHFEL26T^V))R3Y0I)="TJ7
M.^PMSDY)"`']*6H%:X\0V#P_Z)J-F).<><3CI_CBK$.N::\>3?VQ*CYB'XS@
MG^AI#X>T@J%.GP8'^Q@_G3?^$;T?_H'P_E1J`ZYU.)9`L-Y9#*])'YR2`.G;
MK19W[*CG4+RPXP5,,GYYR:C;PQHS8S81\>A(_K2?\(MHO_/BG_?3?XT:@2G4
M#Y;XNK`NQQ%^\X/)Z_ABGF\F%W&-]H;<EMY$GS*/X?\`Z]5_^$6T7_GQ3_OI
MO\:3_A%M%_Y\4_[Z;_&C4">2\N03LDLB,X&9#G&3S^6W]?:LO6I=VF62S-;^
M>;V,LMNV5^\>?7_Z]6SX2T0G/V,?A(W^-9FMZ#INFQ6D]I;^7)]KC&[>QXS[
MFF!UM+110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!6)XLL7O
M]',:S10JCB1WE)```/H*VZR/$]K=7NC2V]FI:20J"`0#MSSU(H`Y2T\/SO:A
M8[_3Y(W5<_O2"5#%O3BK>DZ1>Z7,)_M=A-B-HH\SE=N3DX..3S^M5KC0=1EB
M8)I3+(3*V\R)DEF&,G=T"@C'O4#:!K/SNVF1L9%*N,1X3)'*`'K@#FF`L^BZ
MK!*ZRFWNFE0(Y$Z@@!P?F)P23C&:C?1M7DF#RZ=&T88G8'0$@ON/.>?3/I4E
MWI%\(XY)-+;[4'DDG=EWJ^XC``4GIDFJ,MK<9(^S7",J%0[1.6X3;L],=>?>
M@"V^CZB]_'.VFGR%F,GDATP,MDC@^F!47]F:L^Q'LY5!W*_E(N6!;<><]>WT
M`J&2U;[8FRTF^SQQ8&('&YMISGCNW?T^E/@66W:W:*&:W=`K^?Y3_NB`0PQC
MG<<<T`.GT*\DM($BTVY$P9S+(5'SY/&!GM6AK%G>W_V6.+2KP100"$>9R5P1
M\PP>3@8JUX6^PC4+*)8YFN%@9VE;<!YC?>7!XX'?O7:4@.:\'6OV5+I9K6>*
M[+[I'E'W@<X`/?W^M=-24M`!5#5>EI_U\I_6K]4=3Y-F/^GE/ZT`95Y9I*\1
MWW<5S#<.8YH8<8$CMU'0CCD_0]Z6Z\.QRSV^^]NS,(PHEP#RK[\D]N3^E6?$
M.H3V"69M07D><;HE&2Z!26`_2L2Q\7SK<P13Q&:.>1B'QAE4OM48]L4`33:3
M;:A';6(DO4,!:#>\&`PR&))Q_L\'Z4R71[?3HI9(]7FB:U*R#S8PV"!M#8QD
MC!P*LMXLDB&Z?3&12@D4B8-D,K,O0=]I^E:6A:Q%KEO)*L!B9&VLK<^_6@#F
MYM""%K"29+:&9D6W+KN>5U4_,,'@9;FK6H>'`MQ`6U""*4)&L:R("&\M,,<'
MKZUUK1HS*S(I*]"1TI6C1B"R*2.A(Z4`<_IVFG1M'N`+NV%Q.69+AEVC!7/Z
M`$U7M[(:=);7.G7]B%$'DRF5^)&'S9X^N?I73M&CKM=%91V(SVQ_*F?9;<H$
M^SQ;5Z#8,#C'\N*`,SQ%8VVHVL4,TT4,BR*RN[8(&<$#ZC^E95KHBQZ2DEO>
M02?Z4DT4DOW=BDA5_4_G752012X\V)'QTW*#4;65JRQJ;>/;']Q=HPOT%`'%
MR>$;XO;(MQ"F%93*KGCEFZ<>N.*9)X6U"X*W"I;CS!)NBC8;(SMP,?4\\=*[
M.+3+*%V>.W16;.3CU_\`UF@Z79E(T\D!(U*JJD@`'KP*`)[?*P(C-EU4!N<\
MXJ3-5)-+LY9))&B^>3&XAB,_D:D6R@25)%4AXUVJ=QX'Y\T`3T9J'[+%Y,<0
M#!(\;<.>W3G//XT\Q*?+^]^[.5^8^F.?7KWH`?2TU4"LS#.6Z\TZ@`HHHH`*
M***`"BBB@`HI*;$KK$JN^]@.6QC-`#Z*8@8`[VW')(.,<9X%$JNT9$;[&R/F
MQGOS0`^BJQBN?-D87`V,5V+Y?W0/O<YYS^E)/%=.A$-RL;;\Y,>[Y<=.OKSF
M@"U25#/'.X'DSB,X()*;LG'!_`\T0QS+:B.:;?+@@R!=O/KB@#SGQ88[?Q%<
MI;W#+'.%\]4Z`]Q[],_4UZ'IT5M#80I9;?LX0;"O0CU]ZYM/"3J+F#^TTD:<
M`S%X`S]>#DG([_E5RPT35M.@$%MK"F(?=62#=CV'S4`:FLW?V'2+JXS@I&=O
M^]T'ZXJ'PU$(?#]DHSS$'.?4\G^=9M[IWB*_L[BUN;BQ,;C`PK9/(_+U[UG1
M:EK5A,-+DN=/@,`6.-IE8!UQP0<8H`[>HKFWBN[=X)T#Q.,,I[URL^JZU;Q^
M9+J>C!<XX9F_D*ATW7/$>I,Z6L%O*H_Y:E"J*<^IZ_2@#5UE;>/4-&M92([2
M,O*<G`'EJ-N?;FF2WESX@E>TL-T%A_RTNP#^\'=4X^O/M63J^EZ_-.E[?QP7
ML=N<B!"<,.,@#&>U6K'5O$5P/)MM(AA5%`S(K(H^F<?D*`-'4+FR\,:5Y5G$
MHF<$11CDNWJ?7%8V@7,.GQR:SJLW[^^+>6<<84\\]LG^5+/HVN-%>7$\-O-=
M3*1YHE)9$[J@Q@9&1^-6#;ZMJL5GNTR&"Q@((M7E*ER.F>.GL10!EW>IV]UI
M-]<SRM->W:[4C521;Q[LA<_S_"M/4=5U9-*C;RULO,`6%%;?-)P.@Q@#KS5Z
MYCU2?3IK)='M8XI$9,+<`!<]P-OXU4U2PU34!:++ID8^SY^[=?>7`RI^7O@?
MD:`*VAZ7_:.HB>XNI+N*T89E9B5DDZX&?X5Y^N:NV>IV>E:IK'VZ3R7:8.NX
M'+KCC`[]ZFM[_5+6W58O#@C0'[D<ZC'X8I)KR]F<33>&/,>/[I:5&8<]N*`*
MLNMZRS0ZE%8O_9Y)00#F1^.&/'`J[%::GK#Q/JR1VUHA#?94.XR$=-Q]!UQ2
M?V]J>/\`D7;CKC_6#_"H[G6-6N%\J+2;JU5AAI@H=EX[#@?K0!J)JB2:RVGQ
M+Y@CBWR2`\(<C`/UKG9-;6XUF2YBB^T3PL;>SMP>2<_.YXXXP.?>DMEU*WMG
MLX+6[MHR26G6W!EE)/)//!ZXZ]J71Y;S15DB71)YXR21.(\2/SGYNM`&YI.C
MM;W#W]]+]HOI1AGQA4']U1Z5K5S$_B+5MZ?9]"N`I'/F*Q/Z55U+4Y[N<1RR
M:C!:R,0(XK3:[8[!L^OM0!T.HZW8:;A;B<>802L:C<QQ[#^M4A<:SJF3;1#3
MK?.`\RYD89Y^7M5.#5=%TF./9IMU#O\`F5W@^9O?).34_P#PF>E@9*7(_P"V
M7_UZ`-/3=.FL78R7]Q=!E`Q,V<'N16A7-_\`";:3Z7'_`'[_`/KTH\:Z2>\X
M_P"V=`'1T5@Q^,-'<#,[)D@89",5(WBK1UC#_;%.5W;0#GMQCUYZ4`;5%9?_
M``D>CX_Y"$'_`'U0/$6CDX_M&#_OJ@#4K&\3*6M+0`X/VR'G_@561KNDD9_M
M&U_[^BLWQ#>P7%MISVTL<L;W\2[D.0"#GM0!T-+110`4444`%%%%`!1110`4
M44E`"T5&48S*X<A0I!7L2<<_H?SI]`"T444`%%%%`!1110`5B>)KO[/!;Q&Z
M^S)-(1(X.#M"DD#TR0!GWK;K$\5W/V72UD$,4CF554R*&"]R>?8&@#E&\3ZC
M/:\WL<07)!1<-T4;<9Z#<2#_`+-21>,=0;?NFA"D@AC#]W@G`&<\X'/O6A)>
MFSL[)I-*L[FXN4\UE5%4J&8!0!C_`&L?A4"^([(1JTFB6X)4@X52-_)4#CH1
MW]Z`+&E>)9%COYKRX1T"&:",D;AEF`7KST'%9LGC'4KBW"YMX&W`DH,,PST&
M2<=#^E:FF7NFWT]Y#/H=M`;6-G;Y%;[IY'2J%KKFF,DDE[H5NJ<!#'&IYP,@
MY^HYH`A?Q5JDUV/+NH(U.W[J_(!CG.>2>?\`QVKEIXNO1''`T,,LS`(K,^"7
MR.6QP!@_I3[:]T#5KF&V71BOFG9O"*H!(/<'VJU:^'M)N-2N[5M+,26X7#&9
MB7SGGKTXH`I2>,[QX=BVT<4K1\'.3O/W2!Z8(-:=[XG;3;DVTD*S^3&/,D60
M`LQ7(POU_+-3OX0TAV4^5*-H`'[YNW3O3?\`A#='R2(I1GKB4TP*C>-X$R&L
MI-R,5<"13CZ>O0UL:)K,6LPRR10R1"-MI#]^,]JI?\(;I.]6VSX48"^:<"K>
MG:!::9,'M9+A%&3Y9E)0DC&2*0&K5'4?]=89_P"?G_V1JNU2U+_6V.?^?C_V
M1J`'/=6[VD-[L>1.'C*QEF&>,@#GH:B^QZ=//%(;)#(F2C-#C;AO7'J<^_6J
M'VN?3[C3;>V^SOI\VR*)26\[&/O?05!JWB&[TW7A9B"*2!@C``-OP>#T_$_A
M0!K+;Z==6WVC[(#&%QAH2IPH(QM(ST)'XTS2GTZ)'2PMGA4D%A]G=,DG'<56
M;Q5ISVY>W9W=FV(IC8`MC(!XSBI-*UT:KI\LL$6+B-,LK9"!L<#=B@#0-]"#
MC$N?*,O^J;[OY=?;K4R2H[;5;YMH8J>"`>F1^!_*N6T[Q=->-&C6D()\LNRR
M<*&?8<\=<D''I6D/%6C^293=8`;;@H<_7'7'O0!K2S1P[/-D5-[;%W'&X^@]
M^*8]Y;(F][B)5RPR7`&5Z_E@YJM::OIVH7+6]M<)-*B[\`=!TSG\:IZOK8L;
M]+-+1)B4$C;G"X!;'`QSW)H`U)+ZTB=4DN8D=P"JLX!()P"/QJ-M5TY&96OK
M967@@RKD?K5*\URP6!Y+66WN)4V?*&'0MC@_@>/:I+;4M*OE1@\&9)&1`^W+
M$'''KZ_C0!;74;)I5B6[@,C#(42#)&,YQ].:6*_LY@3%=0N!C)5P<9.!^9XJ
MO>75C9WMK'+$IGN&V1E4&1VY]NU48]=TU;7S8K241LVV,+"/WF,GY1GH,$^U
M`&LM_9LH9;J!@3M!$@P3QQ^H_.IA+&51@ZD/]P@_>XSQZ\57MK>RD1;B""("
M5%((0#(ZC^=3-;Q-Y647]T<IQ]TX(X_`F@!T<L<J[HW5QZJ<TZFI%&BE415!
MZA1BHTM84M1;*I$2KM"[CP/KUH`GHJO+902V[0.K&-F+$!R#DG/4'/6A[*!W
MD=@VZ52C8<C@@#UXZ#I0!8HJ)($CB:-=VUBQ.6)/))//XTR6TCECCC+2!8^F
MV0@],<D=:`+%%0K"5F#K(X7DE"<@DX]>F,=O6EFC>39LE:/:X8[0#N'H<]J`
M):*8ZL2I5MH!R1C[PP>/Z_A44D,S74<B7)6)1\T6P$-^/4?_`%J`+%%1LCE9
M`)""WW3@?)Q^O/-/'2@!:**@*3@L5D5LYP&7IUQT_#\J`)Z*KPB[_=^>8.AW
MA`>O;&34A\W8^TIN_@R#CIWH`DI*K*+WYMYMS\AQ@,/FSQWZ8I5^V^6VXV^_
MC;@-CISG\?TH`Y/6=,U.?Q+/+;6GF1E0PD8X&-NTC/\`3G]:SX-4\06GE:=`
MLPECC^6/R@<+M]QGK_A7>K]KW+N,&/ES@'_@7],57GN+V.698[5)2-GE,"0,
M'(.3[8SQV-`'-WE[XH@;9`DTVU_O&!3N&U>.!TR354?VZMG+'/:3SLS,R"2W
M#[7WKSR#QMW?G7<'SS$A41B3`W`Y(SQG^M)_I6Y<^3C)W=>FX8Q_P'.?>@#A
MY(M=BD1HM-A(,IP/LB94`\9('3WKO@`*CC:5G<21JJC[I#9SR?;CC'YU'=2W
M497[-`DHW#=E]O'.?RX_.@"Q13(S*3EU55V]`<D'_"B5Y%*>7'O!)#'=C:,'
MGWYP/QH`?14,DLZVHD2`--@'RMX'/<9]J?$[MNWILPQ`YSD>M`$E)2U7-P5F
MBC:&3,C,,@9"@=R>V>U`$]%1I*SSR1^6RJF,.>C$^GTXITC,J@JA<D@8!Z#/
M6@!U%1O.J7"0E7+."00I*C&.I[=:6.99&D`5AY;;3N7&>`>/4<T`/HJK:W\5
MT[)&DZE>\D+(#^)'O3I+V**U>Y<2"-"01Y;%N#CIC-`%BB@'(!'>HS.@D:/Y
MMR[<_*<<G`H`DQ00",$`BD#JS,HSE>O%-29'5V!("$JQ8$8Q]?YT`.V)_=7\
MJ-B?W5_*FM/$KA&D0,<$`D9.3C^9I9)$B7=(ZHN0,L<#).!^M`"-#$_WXT;Z
MJ#2?9H/^>,?_`'R*;+>6T+%9;B*-AC(9P",]/Y'\J>\\4;*KR(K,<*&8`GZ4
M`)]F@_YXQ_\`?(H-M`0088R#U&T4&XA6/S#*@3.W<6&,YQC/UXH@N(;A-\$J
M2J#C<C!AG\*`(Y-/LY%VO:PE<YP4'6L3Q/;PVT&G"&)47^T(V(48!/-=#YB8
M<[UPGWN?N_6L/Q(T=PNDJK!DDOH\,IR".:`-^BDI:`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HI*R99=>$I$=M8,F3AC*W3WXH`UZPO%4ELMI"EU$
M949R=H<KG"G@8(Y/0?6IA<:XI8-86C_+E2DY`SGH<CTY_"J&JVVK7KQ-+IR2
M>5RODWA7GUY`Z8H`Q9)]'+MYNF:@'B.V3%P6,9!.`/FYZ'Z4UCX>W.HL=1\R
M,B)B)0=A/`&=V.WZ5<DT:\+.S:-,[N&#-]O'(.?\3^9H?P\&14_L>^5<\J+N
M/``S@_7D_F:`,J-]*!D>.YUA/-!65@5^=N3@\\Y_K3%CTE3+"LM^C+PZS1QM
MCD;N.>F,_A6TGAU-VY]/U-""`-MQ$<@8QW&.GZ4DWAJ&1BRV6JASG+&6(Y)_
MX%ZFF%S-@^S6/[^UNKY)HQYA3[*@,8('S')P,AJ[+2M/FMYY+N2_:Z^T(N=T
M2KG'0\>U<R/#MZ`X_P")EB10K<1'(&,`_O/85NZ9+?Z=92"\M[^Z8'=O/ED@
M>@`<FD!O45DMKJKD_P!FZE@`'/V?UQ[^]-/B&%8P[V.HJ-VTYMCQ0!L45D)X
MALW7)AO%]C;/_04X>(+'^[=#_MUD_P`*`-6LO6T,C6"`D%K@C(.#_JW[]J:?
M$>G`$EIP`<<VTG7\JH:AXATZ2:Q*R2XCN-[9A<<;&'ISU%`%F32XO[0@O'LY
MWGC5%\Q9_3';(R!SGU]#0UF!J4E]]FO&ENHS"ZB10(UR!ZY'3/!]:Q/$?B..
M[:"+3[P0HA\UG=74EOX1]T\=_?BLR[\3WUQ<I+'>"/;EDC`PB_*1R<9)S^%`
M&WIWA^*VN8VA35(7Y`=VC(7*XSCZ-C_@-6[?0AI4$]M;SWLL5Q$P(79A2`/7
MN>E<_!XCO`DS+JNUCN=?-C!).%PN,$#^+IZ58L_$FJSO;J][9J/.VR$E0Q7U
MYXQ@'I_A0!M?V)!!H\6GLUPD<9\\SHHW`@YQQSGGC&>E5T\%HBE!J,I0LK;3
M&IR5SC^='A[7[B:[NHM6NK10F"N'4`$]@0>1^==`NI6+G"WEN2>PE7_&@#F[
M71AIUQ<WUIJ<QGB?9,9(20P)!(Z9/'<5)J]O;:S=(ZW96,1;W1X&RJJQRRG&
M0>WOBNB^V6O_`#\P_P#?8H^V6O\`S\P_]_!0!QRZ(LER_D7\12>0QQJ\#9^^
M'(SV(XYJO<Z/:0WRI<ZK&%@F.8S"W"ELXX[]:[G[9:?\_,/_`'\%*+JV?[L\
M1YQPXH`YJXM].U/5TNK+4W^U;U<H22N%X`Z<<X_,U'/I0CF><75G!.)CF)$(
MC4^4<_CM^:NL2*)6+HB!FY+`#)IV!0!GZ:]GI^GPVJW*,L6(MVX<MC=C^M71
M<0E782IM1MK'/`/H:B&GV0@,`M(/*)W&/RQM)]<4][2VDB>)X(FC=MS(4!#'
MKDCUH`E1U==R,&7U!R*1948`AU(/3!ZU3N[FQT33PTB+#;*=H2-..?8?C5""
M>U_T<76D);P,_EVC;58?-GL/NYH`W-R@9+#\Z7</457>PLY(RCVT+(0%*E!@
M@'('X9I9K*VN/];"C?=[>AR!].3^9H`G!!Z45"EI;1P-`D,:Q-DL@4`&GR0K
M*4+%AL;<-K$=L<XZ]:`'T5$+=`5(,GRD$?O&[#'K45QI\5S,)7EN%('2.=T7
M\@<4`6J*B%NHN/.WR9Y^7>=O;MT[?J?6I$7:,9)Y)Y.:`%HJ(0`3/*)),N,8
M+$J.G0=.U/C5EB57<NP4`L1C<?6@!U%1P1R1H1)*93G@E0,<>U-2*91#NGW%
M/OG8!OX_3F@":BH4BG4$-/N/F%L[`/ESPO\`]>I,-YF[=\N,;<=_6@!U+4<2
M2*29)-XP,?+C'K4E`!6??Q^?/$K3(@BEBD7((YR01GH<C@#_`.M5V3?L/E[=
M_;=TJI>6#74@;SBH5XG"XR`48M^O2@#`L=8N%UF\M89$N&ENF2/SISM0*,X`
M`/7D#Z59_MZ>ZCW+;>3Y4XC?]]@EQDE1\O(P!GV-:%U+;PR7*+);0SQQ><K%
M,E.H+'V_^O4'VLS-:I#+IQG<F:1=Q^8$8!7C.>10!FCQIB+>;2-RY&U4F^Z"
M,X8XZ\&NHMY?/MXY0``ZAN#GJ,UE_9IW1Q#9Z6T?R[>I!(!SGY>QZ5?B%VI7
M>L`7RAE5)X?VX^[0!:HK-636-K;[>SW;>,2MC.1_L^F?QJ6Y?459OLT-NR^6
M"#)(1\^>1P.F*`+M%0HTYM\ND8FP?E#';[<X_I4ISM..O;-`"T5!"\[!/-C5
M,H"^&SANXZ<CWJ:@!:*B:1U=@(78!2001R?3KUI[L57(0N?08S^M`#J*:IRH
M)!4D=#U%1B9CM_T>49)'.WCG&>OX_3\J`)J*9O/F[-C8QG?QCZ>M0&[<",FS
MN/G."`%^3GOS^-`"7;-`PG$RKDI'MD.$Y8#_`+ZYP/PJJ-4N9'N/(LA)'!.(
M2?,PQ/&2!CH,^M,OH9+QO.@M6#JL3!I,<@2;BNT]#QU]Q58Z;NN;J2"34K59
M2)G1"FUFP#\N<D'UH`T++5X;S4[NQ08>WQSGA^QQ]#Q4E_"\EC>H\B[)(F"@
MCA?E.<GO6,+&WL$TZ4)>H]H[1C;$&:13R=V.Q[?6ME)9;E9UF@DMXL#:V[#G
MCGITQ0!FSZ]'9W8M3;-,L2QJ\B')W,"5`7'/0?G2'Q-$MI*UU:/#/'*L0A=A
MRQ&1\W0<<^U+>VUI/J<5^\\B/Y(\H+!RI.<,>.HST/3%9TGAQ%F-HVJ3--(V
M4W19&&#!LGH20#SGL/:@#>_M"V\Z[2YB\HVT:22.P!4@@\@]^A%.TJ^AUBPC
MNUB*@L0`X!((-9S:5;W%]=V+W#>6UO$AC4$.`G0[NAZU8T&VAT?3VM6N#*T;
M.[MM(`QC./S'ZT`:QC0KM**5SG&.,YS_`#HCBCB7;$BHOHHQ223QQ1J[MA6*
MJ#CN3@?J:6.1)02AR`Q4_4'!H`7RTPPVK\_WN.O;FN7U.&&WN;)(8S&/[50E
M<\9*]O0>U=57,:NX,MC@8VZLH/)/:@#IJ6BB@`HHHH`****`"BBB@`HHHH`2
MEI,#=GOTI:`"BBB@`HHHH`*9(S+&S(NY@"0N>I]*?24`9&A:Q-JKW*S6@M_(
M8*2)`X)[C\./SJQK&I_V9!&R0/<32N$CB3JQZ_TJ"ST/[%%;1P74B+'(TLH7
MCSB?7VINO:?J%\]N;"XCM_)8OYA)W9P1Z=,&@!+7Q):,$2]#65RS[!#*#GV.
M<=/?ZTYO$NF;F6*<RLJ.[!%/`4$G.?I7/R^#]1FF6::[BF<##&1V;=SGTZ>U
M(?#NLM:K"D-K"L<!A^_DOEMQ(XX)QW[&BP&M9^,;&YNQ`T;Q`@9D8C:#C)R<
M]JUQJNGE`XO;;:>A\U>?UKBI-#U9Q<K)I9+2,[HRRIA69E/KR`%Q^)I/["U-
M[^&XGTMR@.^5(V0;VW$\8/`Z#\*`.RM=:T^Z#&*ZCP)#&-S`;B,=,]>HJT]S
M!'*L4DT:R/\`=5F`)^@KSI/#FJB[BEN-.E:)&RR(RY(SGUJ_JEKJ=]JINUTJ
M95W(WS*I==O8<]">M%F!V&G:G;:F)6M69UB?86*X!/L>]6ZR?"UM+9Z'#!/"
MT,B%LAL<\DY_6M:@`Q1BEHH`3%9FH%?[8TM#U+R'I_L&M.LG49"-?TB//#&5
ML8]$]?QH`TGMX9#EXD;C'S*#Q3/L-I_SZP_]^Q45U=O!?V5NJ!EN"X9B?NX7
M-85QXQ%N]XDEDP,#NB-O^60JP7'3W!HN,U=0?2].B!EMH6=L[(DB!=SZ`5A:
M@+Z6-;C^R[2PMBZ(6DA623YB!G&.QJOI.L:?;3_VA=>?=7DJEIYMO$`SC&.P
MZ#\JM:WXEM+RP,5HKR*Z[]P!RC(ZD9'I[_2BXBQ<^&$6PFDN+M&D5"[,+>)5
MR`3_`'<@?C3]"T33+W1K:XN+"$RR+EB`1G]:;J.L+K"+IFG!]TX(N6*_ZF,'
M#9]_;_&I[7Q1I"0"&$R@1;46,1'/0X`'X47`G/A31,8^PK_WVW^-)_PBFB?\
M^(_[^/\`XTK>*-*21D>=EVC.XHV#QG&<=?:E/B?21Y7^E#]YT^4\<XYXX_&@
M>HW_`(131,?\>*_]_&_QIA\(:*?^70_A*W^-3VWB*QGTN346+Q6Z/L)=>2>.
M@'UIZ>(-+<VX%Y'FX&4!./S].1CF@1731=+2<6J2SK($W"(74@(7IG&[IVIT
MGARV<Y2ZOHQZ+<M_7-94^L6">,TN/M,1@6S\MI`<@')/7OVK>BUJPD:7_28D
M6-@N]W`5LJ&XYYX(I!8ICPS#_P`_^HG_`+>#2KX<1?NZEJ0`.0/M!XJXFLZ>
M[RHUW#&T3E&$CA<D`=,]1S4PO[,JC"[@*N=JGS!ACZ#GDT#.0U/2H[OQ)::4
M]_=2Q^69',DN\J>>!GIT%:FH>'YO[-D2'4;R9D7='$[*06&"!T]0*RX+JW/C
M*?4'81PI,82['@'9M'YD&NT>6)75'D0.WW5)&3]*87,?3;*XGLXKF/6+L^<H
M<Y",`<<@97BIY-.U':WE:S,&_AW0QD?CQ47AV4QVM[!*0%M+J1`<_P`.=P_G
M5ZSU2ROW9+2YCE91DA3R!0!F/IOB$8V:Y&>.=ULHH.G^(^VLP_\`@.*W))8X
MT=W=55!N8D]!ZFD\^+>B>8NZ0%D&?O`8R1^8H$89T_Q)CC682?\`KW'^%-%G
MXG!_Y"EJ?K"/\*Z&F&>(0F8RIY0&2^X;<>N:=P,(6GB<?\Q.T/UB_P#K5/M\
M1+(6WZ?(I4#:=PP?7IWK95@P!4@@\@CO128C(W^(?^>6G?\`?;_X4GG^(5#D
MVEBVWHJR,"_';C^=;%%(+&#)?^(D.!H\+CU6<?UIAU+Q&/\`F!Q_]_U_QKH:
M*8SG/[5\1_\`0"7_`+_"@:MXBSSH2X[_`+X5T=%`&%%JVL^6WG:%)O\`X=DR
MX_'FI1JNI9.[0[CVQ*A_K6S10!D?VM?#&=$N^?1T/]:5M6NUZZ->\],%#_[-
M6M10!RM_+=RW;7<-CJMM(\?E.8DC;(!SZG'4UD7UM)(T\MKINJK<R<[I(E()
MR"#GKQCM7H%%/0+G,:9JHTZS2W31=4`'+-Y.=S'J>O<U=_X2'_J$:I_X#_\`
MUZVL44[KL!BGQ$1R=(U3'_7O_P#7IG_"41]?[+U+_OQ_]>MVC`HNNP&-%XC@
MD!+6=^F"!S;L<\CGC_/%6!K=F6"XN`3ZVTG_`,36CBC`I:`99\1:6K.KW)5D
M&65HW!4>XQQUIG_"4:-_S_)_WRW^%:IC1LY4'/!XI/)B_P">:?E1H!E_\)1H
MO_/\G_?+?X4J^)M&<X%_'^((_F*TOLT'/[F/GK\HIIL[4YS;Q')R<H.:-`*7
M_"1:1_T$(/\`OJC_`(2+2/\`H(0?]]5;^P6?_/I!_P!^Q1]@L_\`GT@_[]BD
M!5'B'2#TU"#_`+[J:+5M/F)$=];M@9XD%/?3;&3[]E;M]8E/]*9_9&F_]`^U
M_P"_*_X4?,!9[VT:WD'VJ`Y4C'F@=O7M7"6B7MO)YRO.50H2&N!N)R"0!NPP
MXZFNWET32Y5*M86X!!'RQ@?RJI_PB>B_\^0_[[;_`!H`Y6.]UL[)KBZ=O+?*
M+O3J5;&<'D`[?SKH_"]]=O#.FIW`9@_[HR%0Q&.>AJ<>$]%`(^Q#G_;;_&F'
MP?HN,?92/^VC?XT6`J^*[I&:WA"7.Q2&>XMV/R`GH`#R3COTS[UG:=JFHQ:A
M#;B><QF0#RY4#$J96R68\CY16U_PANB_\^[_`/?QO\:0^#=&Q_J'_P"_C?XT
M[>8%+6;UTU6:-GO3(P7[']F?"=!NSVSG/4'BJ:ZYKA0AW"JN!-)]G/[@Y(QC
M^+/!X]:V#X+T8K@12#GJ)#2'P9I1Z_:#_P!M318#-T75]:;5+.RNHG\HQY<R
MK\Q&"=Q/UP*[/(]:P&\'Z:Y&^2Z;"[1F8G`]/I4B^%[19A*EU?+(%VAQ<'./
M3/I28&WD5A^)_O:3C_H(1?UITGAQ)`,ZGJ7!R/\`2"<'MVJC=:*;2]TQI;^[
MN@;L?+-)D#"L0<>N11J!U-%)2T`%%%%`!1110`4444`%%%%`!124M`!1110`
M4444`%%%%`!7.^*[B^"0VMD)(Q+DR3(CM@#M\H)&:Z*LOQ!?3V5A_HD;R7,I
MVQA5W8[DD>P%`'(Q7^LQQVL)-^J1@[Y!$YY\PG+9&6&W''O4;:QXA\J1E:[6
M1SEE:`X7G^#C@?6MBW\4W*:?"TENLUPL;23[CLV@/M&!CJ?2E_X3-@C2G3SY
M#;_)8/DN00!D8X'-`&0NL^)&969KA5`"$BWR"<'GIUHBU7Q%;I&JK<*JAD8S
M1D[I#D]3WR0`*V?^$IFD4.EM\\!?SHD.Y7`("X;'<MZ=C4<WC)T*%]/V`%PZ
M,^22I`&TX]3[]*`,G_A)]52,C[=&X.P%O+&]3C+87C//!_I6C9^*KR34DBGN
M+);8#<\A&,KCMR?F]JGC\6P,CO/I;IM1V&"K9(."/UZTV+Q-I<ELDATDAR<,
M!&I51NQDG\?2GH%RE<>,;T&Y4/`N-P0(N[;TVG=G!ZUUFAQR1:3;K+<FZ<KD
MREMV23GK[=/PK)M]9T]K6\NY]/C2VAG$2,L:DO\`A_GK4B>(DN+VUL=,MCN9
MR)!(NT1J.O3O0!T5%)2T@$K&U+/_``DNC<\8GX_X"*V:QM2Q_P`)-HH[XG_]
M!%`&I);Q2S13.N9(22C>F1@U3ET+39MWFVJON9V.XD\OC<?KP/IVJGXDN]1T
MQ8KZUD#6J,!/#L!.,]<_I5;3M9O=:UT_86\O3(1\[,@RY_IG^0H`T$\/Z1!$
M\*VZ()T,1!<Y8?>[GKQG\*YGQ%;Z=;VDEEIMM(TEJI,DJR';&&(R#ZD\<5V&
MHZ='J"1AY9H6C8LKQ-M89!!_0UC>)+:UTGPE<6UN-@=E`SR68L"23ZX!H`O:
M)I5I96;2Q>:6NE#R/,?G.1W].Y_&JDOAG1K."2[_`'T8B4N9$F;<``>AK3O0
M+G0)PC<26S8(]UKGC/)+\-V=\`B,(#G.0'`H`33[+1-7F:WC^VP`KYGV>1V5
M7[!QZGI^=4[/3-$NM6:&#4)E55V.&X$YR=V&]#QQ78+9VZQQ70B3SXH=J2$<
M@8Z5R5M:Q7_P_+M&&FM2[(W0CYLG]*`+FH+I$&GR:3!/<3EI#,B6X\PH>N/I
MU/YUEV6B76JPD:=,$L&4(WG."SX8L,A<XY/KVS77:*+<Z%#-;V\<(DBW%4`Z
MXKFO`[&SEEWO^[GMO/"_[K,I_D:`*FKZ1+IM_I,<]X0A01"6.,+Y>#V]?O=3
M6V/!,"G$5_<HF#\O'=<?Y]N*Q)(A>>'7UFY=WN?M8+,6.`N<8`Z=Z]"C=)8U
M>-@R,`01T(H`Y.3P9,IF>#4=S2*PQ+"#G.,Y.?8<@5GV^@M)J4UM>LMI<7!=
ME3R0\94D'Y#D8(KOZQ/%D:'2#<EMDULZR1/W#9%`'-V7A;[:E]+%<9F@N9(U
M5UR'VD8R??G\ZT=0\/WVJ:G!J<3I;-M0M'(#N1E[<=?S%7/#`V:EK<9^\+LM
M^!)Q70G@4`<)HD\NC)JUK/')-$AVF2&/*JV,$D_E3M3T'R;:*[BU,+#*D:CS
M'9@YZA0>?E/7D<8K1\.733ZSJ:2(GDW1,T6!C>H8IG\<52O29/!&G,64%)E&
M">P9@`/\]J`*LWAN^T]OM%Q?0"/RO+W2.W5E*[>G3)Z_I5QO#6KCS2EP/,,;
M()?..6RRG`&/EX!''M6KXTMQ/X?D)E6/RF$G/\7;'ZU8TC6K6X@AMII!!>*`
MCP2G#[@/3OZT`8L'A[61`CO=M]HA51%^^.!\Y+9XY^4BK3:3J;>';33$6%,-
MB??(2"H.<9'8UTCR)&C.[!449+$X`%8OFWFN3,MN\EKIJ\><G#S\_P`)[+[T
M`8FW6HK^UL8)IBBJL:30M^[**Q!)&,9P!QGMWJW!IOB<G;/J&$ZDJX+$[3C'
M'3.*ZBW@BMH$AA0+&@VJ!V%2T`<WIUIJG]B:DMTK+=SKE<MR3Y2C\#D55L+;
MQ#;VS6J-(ICB*@MLV#ILV'&2>N<UUU)0!R^LZ5JL]S;B&>1QY"QO(I"Y8.&)
M([<9/'IBHVG\2Q:G;0A7EMA*RF0H!O4/U?`XXZ8Q^-=910!S&N3:ZNLJEA%*
MUJ47.%&TYR#SZ\COVK.@G\21VD:K]L6%`!N-N#(&V_=VYY7/>NKO(=0FG'V6
MZBMX0O4Q;V+?B0`*AATR\$>)]8NG?/WD1%&/IM-`&+<7?BJ.WD5(%9U&\NJ9
MX;&%7U*G/Y"K]I=:R=`MV>+-^\H0F1#PN[[S`8QQ5F;2[TI^YUFZ5L]72-AC
MZ;13!:ZY;A/+U"WNL9RLT.S/IRM`&5-K7B.&X\I=-60ABI*P/M/)&0<]"!4I
MU;Q&@0G3HWW*K;5C<'D,<9)X(Q^M:,&LM%+';ZK:O:3.=H?[T3'V8=,^AK7H
M`XNXUSQ#/82+_9\D1<%0Z0.&!P.@SQUZ^U:%]JFL6=IIZV]FTTCVZM*S1,YW
MX&0<=._6NDHH`Y&+7?$4LJQ_V8J%G"EF@DVH,D<\\]CFFV_BK4YK9Y4L%D`8
M`LD;D)R<D^O`[5V%(B)&@5%55'0*,`4`<@WB?64@EFDTZ-%CVYW(XR&)^;GM
MQ22:UJA:VNI4=5=%9+>)#\_[S!Z^HQ^==.+Z)I)4"OF$XD^7[O&?Y?SJ='#[
MOE(P>XZ\9XH`Y2'Q1J<YC6.SA8MG+A7VJ0I8I_O<&N@TC4XM3M%D3B0*ID7!
M^4E0<>_6EMM12X/RVUPBX)W/$0.*D6\B,I0))G`;.PX(QUH`M453L]2M;YF%
ML[/M&2=C`#\Q5F.5)5+(<@,5_$'!_44`/HJM'?6\MP8$?,@!.-I'`;:?U%(V
MH6RV\4[2@12D*C$'DGI0!:HIKNL<;.Y"JH))/84*P=0RG((R#0`ZBF"1&D:,
M,"R8W#TSTIP(8`@Y!Z$4`+1129`(&>30`M%)2;AZB@!U%%%`!1110`4444`%
M96LD?:M*&>?M8_\`0&K5K'ULXO\`2/\`KZ_]D:@#8HHHH`****`"BBB@`HHI
M*`%I**6@!,#=[TM-**9`^/F`(!]CC_"G4`%%%%`!1110`4444`%87BFYLK*T
MBN+JRANW+[$63`Z\GD@^E;M9>K6=Y<W-M);+:NL.XE9]W4C';V)H`Q+&^\-W
M447VJPM;6:1RH0H&!YQG<!C'O['TI+NZ\*Q0&2WLX;E]P4(B%<DY[GZ&H9O"
M%^_D^6;./R1A<2.>-Q;'(]3447@R_7'F&SD.[/,CC/!]![U6H%Q+CPJUSM2&
M`1)%O:7D`'(`7'4FE:S\(M-(/,C+21^9@,V%7&[(].!G'6J(\$7\I`N+JWQ\
MH#@L64`8P!@9[?E4:>%]2MY&B6T21/FQ(LB\[EV]#CIDGW-("^FD>'9=(?48
MVN4MU!RP=L\'&,&I!HNA26,5U)?W*0F,%#)/@A.HXJK+IVL7%G:6UWI@>"S'
M$<<RKYIZ`DYR"*SG\/ZZ8EB%H[Q[0N7="0H;<`.>*`.ACT31GMYH(]2F,);=
M(@N!M).#D\?2I[*QTG3[^$Q:BYE6,[$:8$;/RZ5S-GX9O8+Y9);&XD@#YV?N
M_F&>`?GQZ5+'HNH6[P;=,9QL"2;TC)SYFXD?-QQQS0!Z!2T@Z>E+2`*PM1/_
M`!5ND#'_`"SF_P#0:W:Q-07/BO2CD#$4QY[\#B@#*\87-S-?0::/,CLG"M-(
ML;'N>.![=*SM+O5T'6)!9F>ZTQ\>8QC8&/W(P.1]*V?$FHZC;ZC"+&*9H+4"
M6XV#A@3]W\@?SK/O?%-Y=V;)!$;9E.YY0&^0;P!V[@\T`;Q\5:.!S=D?]LG_
M`,*H:MJVA:JMO%+J*HD<HD93$WS#!&#D<=:HV_B>^MK4"ZMA+OS(LCYPJF0K
M\W'0?X4R3Q'<WD<DK6,,,4*H\A922=S+@CCI_0T`1+JEQ:Z<NEK>6C6DC&-+
MOS/F6/./NCG.*CRD=A<Z9;ZA:MI4L@/GNW[R,9!QMX)Y`Z?_`*I$\7*_E[M(
MMF5I-IVC)QQTXZ]:MZ;J\6HZQ()K.VCM8X)'9#$"R[6ZMQUQV%`%JR\6V-OI
M6R[?-S;CRV1!GS".,J>F#C-8^FWLT.DMHH6.-[GYO/\`.7:D;?>SSP<<8ZU'
M8:JX9I+RWMIT8+(J^0API)R`1T_'FI3XHM%ZZ!:;L`\%3VS_`':&!;M]6N-+
MM#HL:)<RG*VTZ2`H5)/+'/!'I]*OW]@MO961TN>W>:S0Q[78#S5(Y!/ZUCW7
MB/31YT=KI-KD;/*D,2D$'&[(XQUIR:YI#2.SZ'`8]GR*L:%@=V.?8Y'T]Z+@
M6](TVX6WMK&_DL5L86\UU5PS2-U`;/&!_2K3M+H&^33I8KJPR6:V,@WQ^NP^
MGM4&FWV@WT]S&='BA^SQF1BT*GA>O2JLFIZ7.($L-$@$TDR(5EMU^ZPR",>O
M]#1<9M#Q?I)CR))3+C/DB)M_T]/UI+5'U::.]U7RHH4YAM=P.,_Q/ZGICTK`
M#Z4_B!M/;1H?+\\P@H[!LY^]Z8Z_2KGB33]"T>UCD_L\/)*2J*)6`Z=3S]/S
MH$:=_%/8:I_:FG0FY29-EQ!&>6(Z./4]JB+ZIKY\A[=M.L>/-+-^\?U`]!0^
MD:%9Z9_:&R98`@D!69P<'ICG_:_6J.GOX;:Y@ALUNX9+D<;977!R1@X;U%`&
MF-(NH/$-E/#L:RAC=`.C(".%]QG&/QS52?PI+):_9I-1_P!'0NT$83&UB<@D
MYYQS65-K5BTCQVHU$L&(5FO6"''<G/H":>;:Q.B/?ZA?W6IB)PK1K*0J,3CC
M//XT`3C5OM1B_MR:W2WM\'[/$_F/,XX#'&>.IQ5W4M3M[N.21]`N)TB3>LTJ
M",8]0QY'X52T>#PY/$LZ2SV4I8QA&N2K'ITP>>M51/::O+Y'V^[MK"-?WYNI
MR=[$_*`"<=LT`,+:C,]E-.H33;J0+%%/(TD:=ANZ$^V:ZI;76WD`:^M;>(+@
M"&'//_`C7*WHM[ECIT.JZC=R/N"*6!C)"[E_`]JG69H]+AO#XBO&=U13!&1(
MX8]L9]C0!T,VCZE/(&;7)UP,8CC"C^=2KI-WMP=:O2V3R`G3M_#6&25O19GQ
M1="X+!-AA/WCT&>E6[NTO]+A\^?Q'(D991E[??SV[TK("]-I%^4Q#KEVK9ZN
MB,/T`J$:-K0.1XADX];=?\:=+;:Q;PO--KD2QHI9F-H,`>O6H[2>^O8C+:ZY
M:2(&VD_9L8/8?>H`MQ6FLQ+@ZG!*0."]KR?R85(8=8P<7MGGWMF_^+JJ8->^
M8+J5FS+C(\@_KSZ5')#XG!/EW=@X[90BF!::+7@6VW5@?EXS`PR?3[W`]ZA_
MXJ5)5XTV5,<_?7G]:8J^*1UDTP_4/5>\7Q/(8[8M9!9B09(@^%`YP3VSTHLQ
MFKH^I2:C'+YUL87B(5B&W(Q[[2.M:5<_#!XC@1(XAI2QIP%4.`!Z4L^I:E81
M[KU]*4+C=^^<$_AB@1LW5O%=VTD$ZAHW4A@:H>&Y7ET>,LQ959TC8G[R!B%/
MY"LMKG6]>L3]FMHK6W8@,6D96E7N%.W@=L^];>FB[CC$4]K;V\4:A8Q%*6_#
MH*`+U%)2T`%%%%`&+J>J26$-Z50//O5+>,8)<E1V'/&3^545\2W4.FVS-:+/
M<GS5G4OLVM&,GC'<<U;U2W^RS27I2T9#)')ON&V;&&T8!]P*HSZ.E[/!=6EK
M:SVN]W<),0)<@C)..V!]<T`/_P"$BNKN-&AMC;Q-.D0EWAB25W$8(^E/AU6Z
ME\*6^H2WD5O*=QDD9`=P!8`*/4X'ZU+)IKR3!CHUL?G\PG[21ANF<8]*=-I8
MFM8;.32(&MX0S(HN2`K9.!TSSQS[F@"I#K&H#4["WE:/$L432@J`H)#%OF['
MY1@?6M+7[RXM-/%S9SPH1R`Z[O,..%7W-0S:5%',3#I4<HBB6.-FG(R.1C'/
M('?KS3'TOS],@AGTO=]FC'DQFZ(.<X(R/8`Y]\4`9]SXDOX6>5DA$>TQB/&2
MLGE!\Y[C)Q3+GQ%J-I#)'*T+307)B=UCX90`>F>._/TK073D56>/05\TH8G0
MS_+MQ@8/0Y``SC-2'2K:XNVB;26\@NS/.TQ!+$<\9R0<#V]J`-X$,`000:*H
MR7DD*J8K&5XE+*V,`K@@#"]P><?2I([T2$CR)UQ(4RT9&<$#/TYZT`60JABP
M4`GJ<=:%4(H50`H&`!VJK;Z@MP"1;W,>&"_O(BOX_3WHM]02=D407,9?IYD1
M7'7KGIT_E0!<IC1HSJ[*I9<[21R,^E-DF$<D2%7)D)`(7('&>?3I20W"3!"H
M<;T#C<A'!]??VH`EJO<VRR1R>6D0E;HS(#SC'/KQQ2F\CQG;+C:[?ZL_PG!_
M'T]:GH`6BBB@`HHHH`****`"LC61NU#2%`R?M)/Y(U:]9.J_\A;1_P#KN_\`
MZ+:@#5I:2EH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$K.GTA)I&<W
MEZFXD[4G(`SZ5I5F:AK<-A=I;26UW))(,IY46X-ZX]<4`/\`[*Y4_;[[Y>G[
MT?X4-ICD<:C>CW#K_P#$U%%XATZ6QENQ-A(LET/WQSC[OUJ_!=P7#,L,R.R?
M?4,"5^H[4`4_[*DS_P`A2_\`^^T_^)ICZ3<<>7J]ZO7.XHV>/]WUJ:VUFQN9
MY(HYUW1N$R>`S'LI[_A4YO;56=3<P@Q_?!<97Z^E`%"/2]15W+ZU.X*D*/*0
M8/8^]-_L[658%=94X[-;#G]??^5:ZNKYVL#@X.#T-+0!D+8ZT&9CJT)SV^RC
M`_\`'J>;;6ATU&U/UMC_`/%5J4WS$\SR]PWXW;<\X]:`,LV^N\XO[/V_T<__
M`!5!M]=[7UE_X#M_\56G#/%.I:&19%!*DJ<X(ZBGT`92PZX#S>6)^L#?_%5`
MS>*`3A=,(YP?GY].];E%`'/B;Q5\N;?3N>O+?+^M0BT\0W=_;W<\=A#);*ZH
M3N8'=CL#7344`8<DWB5"VRVT^0`X&&89'KU_SFH7N?$[+M;3;%E/!&__`.O7
M144`<P]UXG<$/H]FV1@Y<'CT^]2FX\2&-E.B69W8!'F+@@=L;JZ:B@#F(AJB
MO\WANS"AMXV.@(89VGZCU^M+#-K,#22IX=MDE=OG>.1`6'?/<UTU+0!S,(G3
M=_Q2Z1Y`YB>,'/UJMIMJEDTJIX9F(8@$R.C\=.,_4]*Z^B@#DF?3RQ)\*76<
MX.+9:#/8+O\`^*5NQOX;%L.><_TKK:2@#E+74K.VFGFA\/ZBCS9\QA"3G/)[
M\5%;OHT$D31:#J4;)()`WD-PP]\YQ[5V%%`'+2'1+L227&FWT9E<2LS02`[N
M1U'3^7-23S^'Y!#]HMKAUMH_+19()2JJ/8C';K72TM`'*B3P]%8S6OE7:6\Y
M4/NCEYQC:,D<=JI3:EH6G6ES-H\K+?NGEJS^82,L"3\W'O\`A7;$`]:K7]E%
M?6,UK(`%E0KG'3T/X'F@#D(#X1AAV&\D<[".0^`2,%@,8!J>>\\,S65U:M?R
MA+EE=B$;((`''R^U7TO)=,(M]4T[S(U&%N[>+<I`'5AU!XJS'K.@2(K"YM0"
M.C``_D:`.5N8_#-O;K<V=U-/<Q'*(21O;/&<@8`/IBI8M-\.2P^4=8=99=F_
M!PN[N>1[GZ5M'[+J'BI8@L'D641;`QAV8?T%;/V+3O\`GVM?^^%H`Y39I6CV
M5U>V.I_:)_(,*+N&<D*`0!SV%2Z;HNDI]EG&IP,Z;&4?(#D-N/O[5-KHTYM:
MT^R=;:WMUS/,_P`J@XR%7/UJ]<GPQ/$6F.GL!CE2N?TYH`KS:'8S:K)J*Z@B
MW!E612"I"8ZC&><U+JFEQ:M%#%>:JICC!)"A5W-SANOOTJG=GP@P:5HX9"0`
M5@##]!BJPL]%N-C6/A^\N8W!(?+HOYDT`:R6#W&C3:7<ZA`ZD*D+Q@9"KC&1
MGD\<UGW/A:[NMLDVI0&0LQ8"$!5SW7'?CK4?_"/"X5S#X?AMR.%\^\?)]\+G
M^=(O@=YG4RRP6Z[>5AW-S_P(T`.7PE(C$_;(V(P=V2&;#DGZ?+@5GR^';Z+3
MD:[U2VM27&(Y)B%''7/3=_G-;EKX'TV+!N))IVYS\VT'\!S^M6/^$.T7'_'N
M_P#W];_&@#E+VU+W3M97C7=PTC$"U+'#%MP).,8QZ'K73Z;+J5KIT-K8Z4X\
ML[3)<R!=WJV.3R:M1>&M/@4K`UU$I.2$N74?SI__``C]M_S\WW_@4_\`C0!$
M-/UFZ/\`IFIK`ASF.T3!Z\?,>>GTJU::'I]JQ=;=9)2VXRR_.^?7)J+_`(1^
MV_Y^;[_P*?\`QIG_``CD&UQ]MU#+=#]J;*_3_P"O0!L4M8`\+J/^8MJG_@1_
M]:G_`/".OG/]LZI_X$?_`%J`-RBL,^'7_P"@UJO_`($?_6IO_".S@\:YJ6#Z
MRT`;U%8D6@W,3*RZW?G:21N8-U]<CFGIHUTDA<:U?$EMV#M(SSV(Z<]*`'>(
M;>>XM(/(M5NC'.LC0LP`8`'UXKG+W2==VK-8P-;>9*TGV>&8`1<*!T(!S@^W
M-=(^EWC@`ZQ=#!SPD8_DM*=.U#/&LS#ZPQ_X4`<O)HOB%;V3R/,6W:Y=QMG`
MP&(Y//I_(UW8Z5E_V;J/_09F_P"_,?\`A3#I>IK$5BUN;<!A2\*'\^*`->BL
M3^S]?"\:U$3[VJU&;'Q)@_\`$WM_;]P/\*`-^BN?^P^)O^@O;?\`?@?X4X6?
MB3`']IVF0>OD]:`-ZBL,VOB0#C4+(GWB(IAMO%&>+VP(]T/^%`&_16)%#XD1
MP7N=/D7N"K#^0I47Q(I?<^FOD?*?G&T_ES0!M45DK)KX4;H-/+=R)7'_`++2
M&?7Q*J"SL6#9RXF;"_7C/Y4`:]%8<M]XAC?`TFWE`/5)\9_/%-_M+Q!_T`D_
M\"EH`WZ*Y\ZIX@'_`#`5_"Y6D_M7Q!G_`)`(_P#`A:`.AHKGUU;7L?-H&?I<
MJ*4ZOKG/_%/M_P"!*_X4`;]%8W]K:EY:8T.XWD?./,3`/L<\_I4O]J77_0&O
M?SC_`/BJ`-2L?5S_`,3C1AV\Y_\`T`T\:O.1DZ1?CT^5/_BJJRS3ZCK.GE+"
MZACMG9Y'F4*.5(&.3F@#>I:**`"BBB@`HHHH`****`"BBB@!-PW;<\XSBEIN
MQ?,\S'S8QGVIU`!1110`4444`%4+C3C-J<=[YN&BB9(UV\!F_B_^M5^B@#F3
MX4988HHKJ-56-5DW0Y\PA]Y)Y'4XJ[HV@KI-S+*DWF"1`""F"#G)P?0GM^M;
M-%`',0>#XHEFS.&D9?W4FS!B;<3N'/T_*D/@Z)]SS3+)/(LA=V4_,['@XST'
MI7444`8-CX<%A!?Q07&!=0K&.#\K!2"W7N3FJD?AB[AE62._*NC)M.YB,!3D
MD$\DMCCIBNIHH`Y.XT'6);)46Z5)%A6,@2L=Y#$DDX[YJWH^AW&F7<]Q+*;J
M0P*D;/(>O=>G3('-=#10!Q4?AO6K>"3[+<I%)(NV0"9CORV2P./E["MC[%JL
M?AEK6.<F^.<.9,D`MG&XCKCC-;M%`'(+I&N_9[6)KF8(LK.^+C+*.-H+8Y'4
M_C1-I_B-)+JZ%PYD8$!$<%2N[^`=C@=ZZ^B@#DTM_%45JL<<Z?*IV[MC-U``
M8GK@9.:CNKSQ##<&PA9YKC=O\U8DQLP`/8#=NZ]A77T4`<:][XICOL&"0Q(H
MW@1*0Q"9."!SD@X]R!3YI/$#*+.6-[DNL;M)Y6Q5(.XKD=>@'U-=A10!QEOJ
MWB);5Y&MI)$"JNYK<AT8]2%ZL!Z^]6E_M`^$;J6Y6=[NZ8G8(SN0$A>%'3@9
MKJ:*`.2@UC65CMHY8E::X>6-`R[&Z#8S*>@X:K>N:O?Z3:6T>(Y+B1#NDV$J
MS#'R@#N?PZ5O&"(SB8QIYH7;OV_-CTSZ4\@'J*`.//C*9B-EN@,9S(N&)90/
MF(.,#D$<U9M/%-Q=#$=FA8O'&#O8`.Q/RG*]L'IFNB:V@:)HC#&8VR&7:,'/
M6I`BCHHZYH`Y(^,IHU=IK``Q[A(BL2T9!P-W&!D\58C\3W,C.D5C'*59OWJ3
M8C*J,L=Q&>..U=%+;03+MEB1QD-AESR.AIPC0#`48],4`<;;>,[A94@DM/-=
MVR27V[0W(&,<X!Z]\4EGXSN5:**YL_,DE?.5<#Y6/RX&.>N*['R(=V[RDW>N
MT9H%O"""(DRO0[1Q18#`\2ZO>6-Y#%:@K$B>?.ZJ&.W.,8-5T\<0-'DV,^_<
M?E##&!U.?7':NJ:-&SN4'(P<CJ*K2Z98S6Z6\EK$T2$%4*\#%`&5;^+;&XO8
M;:-)/WJYWM@*O&2#D]JWP00"#D'O5&71M-F=G>RA+,I4D+C@_2KJ(L:*B#"J
M,`>@H`4\C%5+C2M/N2#/9P2$="R#-7**`.2GT_2]-UN=KZQB2QF1/*<QY17'
M!''W<U)(OA=IC#;VL-S.1E8[="V?Q'`_$UU#*&&&`(]#35BC1BRHJD]2!C-`
M'.:1X8LW@>XU"Q19)G++#DXB7L.O)[GZUN+IUDJA1:0``8'[L59I:`(HH(80
M1%$D8/4*H&:DI:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M2EI&SM.!DXZ4`&1ZBBN532=7MX$="`T,*+''"^&[G:2>,`D=^0*T`VO1PRJR
MQ2L-XC884]BI(Z>HH`VJ*Y9X/$.Z*Y7?Y[@>8J[`%P6PIYY'S$Y^GX2W^GZ@
MGB$ZE;1/*JJ0J;P`3L.._3/!'XT`=)17.-<>)%G`%N&CP0#M3KP`6^;@#KQG
M-&HKXA9HA$(V\M2Y9``"RDXZGN.W0>M`'24E<X+_`%ZULFDN[:)I5D"A1T?+
M8&,9]C5O49-5DN7MK0QJK6^<X8'<<C(;&!@[>.IH`V**P;VWU)+E)+4S.8+<
M1A2^U&8@C=WW8XX/ZU#;ZQJTMI]H2QWPHF26&UG*@[N.V3CUZ=\T`=)16/J$
MNHWMFJZ;NMY?M)C9V'\(!R>1TR!VJ)]5U&%8HXM.>=MTD99FQRN<$\?Q`9].
M:`-VBJ-E=W<\FRYLC;_(26W[AG.,=!]:QGN=774$@ANS*CW7E_O(E0!57<PR
M`>N<`^QH`ZBBN?U77)]/U)L1.UK#'^\'ED[W()`![=!^9J*/Q!=I=W0N+8>7
M"H+;&^6(9;DG&23QQ[4`=+17/V>O7)TN.XFLG+&)I,E@NY5QN;'ISD>M6]2U
M&:%I(;5H3,(A(%?.0O.3[G@8'L:`-6BN3B\27:3B-Q#*L>]';&"^W>=XQT7Y
M?U-=-:M,]M&UPJI*5!95.0#Z4`34444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M(0#UHI:2@`HHI:`$KG)KO5(+V8D.UL9G$;*NXCY<`%?[HY;CKC'>NCHQ0!@O
M?:N9T3[+E-RDR(I"D?*,<\]<YXZ5!_;6IP11K=VR)<*3YB%6PZ\_,I`(&,=.
M]=+1B@#G(M9OH-%M+B2V%U)*[(<$J3R<'&WC-26FH7ES%*\VGQ;GB,B'D;U"
MAE7D<X+8/O6_BC%`',6UYJ[V<4\VV6W9F9OW7WT,6X<>@;CU/%%I?7UU>3O)
M!"+B!/N-$3MPY'#>I7</\FNGP*,4`<M#=7JZCO@MXF@:4PP[K?:50;]P!'8%
M/_'JZ*Q,YLXS=$><1EL#&,]!^53X'I10`M%%%`!1110`4444`%%%%`!24M)0
M`F[]X4P>F<]J=24M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4E+10`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%)2(25!9=I(Y'I0`ZBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`I*6B@!D2%$VLY<\\FGT44`%%%%`!1110`G>
MEHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBDH`6BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HI!GO2T`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
9%%`!1110`4444`%%%%`!1110`4444`?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>vivakorex313image1.jpg
<TEXT>
begin 644 vivakorex313image1.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#`!`+#`X,"A`.#0X2$1`3&"@:&!86
M&#$C)1TH.C,]/#DS.#=`2%Q.0$1713<X4&U15U]B9VAG/DUQ>7!D>%QE9V/_
MVP!#`1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C
M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P``1"`0A`S`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#L/["T?_H%
M6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!5C_X#I_A1_86C_\`0*L?
M_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`T"K'_P`!T_PK0HH`S_["T?\`
MZ!5C_P"`Z?X4?V%H_P#T"K'_`,!T_P`*T**`,_\`L+1_^@58_P#@.G^%']A:
M/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH`S_[
M"T?_`*!5C_X#I_A2?V'H^X#^R;+D9S]F3'\JT:*`,_\`L+1_^@58_P#@.G^%
M']A:/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH
M`S_["T?_`*!5C_X#I_A1_86C_P#0*L?_``'3_"M"B@#/_L+1_P#H%6/_`(#I
M_A1_86C_`/0*L?\`P'3_``K0HH`S_P"PM'_Z!5C_`.`Z?X4?V%H__0*L?_`=
M/\*T**`,_P#L+1_^@58_^`Z?X4?V%H__`$"K'_P'3_"M"B@#/_L+1_\`H%6/
M_@.G^%']A:/_`-`JQ_\``=/\*T**`,_^PM'_`.@58_\`@.G^%']A:/\`]`JQ
M_P#`=/\`"M"B@#/_`+"T?_H%6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM
M'_Z!5C_X#I_A1_86C_\`0*L?_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`
MT"K'_P`!T_PK0HH`S_["T?\`Z!5C_P"`Z?X4?V%H_P#T"K'_`,!T_P`*T**`
M,_\`L+1_^@58_P#@.G^%']A:/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%'
M]A:/_P!`JQ_\!T_PK0HH`S_["T?_`*!5C_X#I_A1_86C_P#0*L?_``'3_"M"
MB@#/_L+1_P#H%6/_`(#I_A1_86C_`/0*L?\`P'3_``K0HH`S_P"PM'_Z!5C_
M`.`Z?X4?V%H__0*L?_`=/\*T**`,_P#L+1_^@58_^`Z?X4?V%H__`$"K'_P'
M3_"M"B@#/_L+1_\`H%6/_@.G^%']A:/_`-`JQ_\``=/\*T**`,_^PM'_`.@5
M8_\`@.G^%']A:/\`]`JQ_P#`=/\`"M"B@#/_`+"T?_H%6/\`X#I_A1_86C_]
M`JQ_\!T_PK0HH`S_`.PM'_Z!5C_X#I_A1_86C_\`0*L?_`=/\*T**`,_^PM'
M_P"@58_^`Z?X4?V%H_\`T"K'_P`!T_PK0HH`S_["T?\`Z!5C_P"`Z?X4?V%H
M_P#T"K'_`,!T_P`*T**`,_\`L+1_^@58_P#@.G^%']A:/_T"K'_P'3_"M"B@
M#/\`["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH`S_["T?_`*!5C_X#I_A1
M_86C_P#0*L?_``'3_"M"B@#/_L+1_P#H%6/_`(#I_A1_86C_`/0*L?\`P'3_
M``K0HH`S_P"PM'_Z!5C_`.`Z?X4?V%H__0*L?_`=/\*T**`,_P#L+1_^@58_
M^`Z?X4?V%H__`$"K'_P'3_"M"B@#/_L+1_\`H%6/_@.G^%']A:/_`-`JQ_\`
M`=/\*T**`,_^PM'_`.@58_\`@.G^%']A:/\`]`JQ_P#`=/\`"M"B@#/_`+"T
M?_H%6/\`X#I_A1_86C_]`JQ_\!T_PK0HH`S_`.PM'_Z!5C_X#I_A1_86C_\`
M0*L?_`=/\*T**`,_^PM'_P"@58_^`Z?X4?V%H_\`T"K'_P`!T_PK0HH`SCH.
MD$$?V58CW%NG^%+_`&%H_P#T"K'_`,!T_P`*T**`,_\`L+1_^@58_P#@.G^%
M']A:/_T"K'_P'3_"M"B@#/\`["T?_H%6/_@.G^%']A:/_P!`JQ_\!T_PK0HH
M`S_["T?_`*!5C_X#I_A1_86C_P#0*L?_``'3_"M"B@#/_L+1_P#H%6/_`(#I
M_A1_86C_`/0*L?\`P'3_``K0HH`S_P"PM'_Z!5C_`.`Z?X4?V%H__0*L?_`=
M/\*T**`,_P#L+1_^@58_^`Z?X4?V%H__`$"K'_P'3_"M"B@#/_L+1_\`H%6/
M_@.G^%']A:/_`-`JQ_\``=/\*T**`,_^PM'_`.@58_\`@.G^%']A:/\`]`JQ
M_P#`=/\`"M"B@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`**0G&/>F>>GG>5\V_C@*>,YQS^!H`>,Y.0/;F
MEICR+&"3N.,<*I8\G'05`^HVT84L[?,<#$;$_=W=AZ?X=:`+5%0-=Q+;F<>8
MR#/W8V)X]L>U-6^@:)9`S[6.!F-@2=VWIC/6@"S15--3MWC215FVN1C,+`C.
M['!&?X3[]/6FKJMLQX6XZ`C]P_()QZ4`7J*HC5;9B543L^YEV"%\Y&,]O<5*
M]]$D_E%9BW/*PLPXQW`_VA0!9HJL;V(2QQE9-SOL&$.,_-U]OD/Z>M2"=#<&
M##A]N[E#@C..O3\.M`$M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%(<\8_&EH`****`"BBB@`HHHH`****`"BBB@`HHHH`***3`SG'/K0`M%%%`!
M1110`4444`%%%%`!1110`@SSG\*6BB@`HHHH`****`"BBD)`ZG%`"T444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%)M&[=@;L8SCG%+10`4444`%%%%`!1110`
M444F1G&>?2@!$14W;1C<=Q^M.HHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"DP,YQSZTM
M%`!1110`4444`%%%%`!1110`44C,%&2<#(%,DGBC`9Y%52,@D\8_R:`)**JK
MJ-F_W+F-@3@%6R#P3P>_0_D?0U:H`****`"DR=P&.,=:6B@`HHK*O?$%E8W;
MV\XGW1A6D9(BRHI!.21T'%`&K16/=^)+*UO1:M'<R2%%<>5"7^]G`XY!XZ&I
MI-;M(6L4N!+#)?$+%')&0V?0CMV^F>:`-*BJCZE:1Z@E@TC?:74LJ!&.0!GK
MC';U]/44TZI:#2CJ6\_9MF_=M(./H:`+M%9TVMV$(B+S'][`;A?D;F,#);IQ
M]#S38=>L)HY)$:;9&,EC`X!&">"1SP,_2@#3HJJ=1M5TU=0>4):LBR"1@1\K
M8P?U%)>ZC;V,,4LWF%96"((XV<L2"0,`$]J`+=%8G_"5Z1]D-S]H?RQ(L9_=
M,#N8$CC&3T/Y5=TS5[+50_V.4LT9PZ,I5E^H-`%ZBBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@!,\XI:**`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"HXY1(\JA6!C;:21@'@'CU'/YYJ
M2L_3B3?ZJ">ERN!_VQCH`T****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MJ.J:M9Z1;^=>R[%/`&,DG&<?H:DU&_@TVS>ZN6VQIC/(!/TR17G=UJ,^LZJ\
M]TT#16S-B!Y(TVH6('+_`"[P0,\].G)S0!=U/7]7U(2+;EK")W,2Q.HWM\O.
M2>%Y*#'7+'D5DAX)G=I!YML9#')*Z$Y0>7\^]OXL_B/,XXIMJTT+O;[7EQ,Y
M3)((D5/XT'(.X)R>,J><<A8F2&Q>/S2D4,H=HC"?,"<*K.@PO3G.<G<`3@YH
M`6WL6MF'VFVBCAMC'O<PY;G>2QRI+`'=QZ)@CY3AJ7OV20+$9K>5VA;,3X*!
MD!!`&2RY;H>P7J2:L6VE-=63EHEMY-T:1-,R[L`ON+8`(/R8Z\_E3KBQNT\Q
M9H6:9)<AW7,SJK($"$C@#N5+'M@"@#8T_P`77-K.D=_$LUG))MCN48[\<$%E
M[\$$[0/I79P317$*302+)&XRKJ<@BO*;>=/LKK;IY0A1@'4<.%/#*3C(WG+<
M9VG'-:_AS71HD\UA(K_8XYF1D<?/$<XR#T*_*Q([?0$T`>AT4@((!!R#T(I:
M`"L"]LM5CU2[GT^.VD2\CC1FF<CR]H8=`.?O9_#WK?KF==U'4(+VY:V<M:V<
M*R2+%M)4\D[P2&VD#M0!6D\/7UG=6[6T$=]'#:)!E[AH22K$YP/J.I/2IIO#
M<^HRR"=_LD`MD@C5'WE>0[8]/F`&<G./>K:>)8Y-1^SI:RF$3+`9@#@LP!!!
MQMQSZYY!Q3T\0B2QFODLIOLD:2.)&95+!#@_*3D=\9].U`%,Z->WMTMQ=F"*
M[2RB5'4Y*S*S'<`!P,XS[<5/)I-XW@S^RSL-V\.P\_+N)R><4RY\4K;&$2V+
M+*]NTY4R`E5R,#(SR1SCV'U"0^(I_M.I&6*+[-;M"(RTFPXD`.6)X[]O3`SU
M(!4/ABZB-MY7S$:?)!(S3DD2%,#G^[D8X[>U26.CWUM%+`;'#R6;0F8W[2(3
M@8&UAQDD_3GUJ>W\6"\:%++3YIWF,BJ!(J@[,$G)QP0PP35NP\0)J$\,,%LY
M=PYD^=2(MK[#D]_7Z4`9[6FJW/AV;1Y;!(?*@6**42AUE*[0..H!P>O;KS3M
M535M3LU231E0P7,4L<8NA^\49W#(X'X]CZXJ]J&OBRN)T%G++#:[/M$RL`(P
MW3@_>XY./\<,T;4KR^UC4HIE46]NX6/:!R"`0<YR<CGICF@#*ETC4;C3H[5=
M.-NJ7D,GS7?F,5&=S`D\8XX_'K6KH.ERZ9>7B/")$9MRWLDFZ64'&%/?Y0,>
MGMZYYUK5(-;\N[VQV;7'EI^Y(1U_AQ)DC/*]0.<C(YPMEXG=+&.XO+-?M$\T
MD6X2(ORJS8SSG`)QW[GOR`=717.'Q3&G^DS0M%9BR6Y+'!.68*JC!]<CI^5:
M>G:JM[<S6S020S0@%U)##DL/O+D=5/'^!H`T****`"BBB@`I!G)SC&>,>E+1
M0`4444`%%%%`!1110`4444`%(2`"2<`=2:6B@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"J-E!)#>ZE*V2LTZL@]A
M&BD_F#^57J*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#B?'&H&2[@L
M8W4)"#*_4[F*LH'`)X&<X_O#C@D8-T\$#W$<CQ.U\@+",;"0IR1DG()*#KU+
M8P,5)J@EEU6_+/'AY)MTKKN\G;@,N&'S@!@>,X!R!G(JCJ<IA\]M\D=Y][?$
M\IW'`!X8#:NUSC@\=_4`OZ9-<FQ+^='-');#.T*LT3?*BY.<!<QJ.2<[LD<D
M!;>WC54$;01-DI'-,Q1G9@N3N'/,B9SG[KGG'271Y"UHD+,$%]:"!!@.%?&R
M-MW!7+)C'(!ZD$U";E9+2<"3[+,KE7M<RR&)"P5V=^J@>V/NC.<X(!IVC*KI
MI\4C/<O.QDD(:5T'F,#\W(1CR,G^Z,YSD33QP65K=([2R0@JXEB(:-F88\S(
M.1C"\=1CN"*S8&M9)Y)!YEL(FVDI=,(X]RDY&S&T':V>O49&:KJ;Q%Q?W\%L
MT2)*GVB`[9#P!M/4<;?NB@"M/(UU"98+26&-YE0$Q`K(X)8*!C@X^F?;&*?Y
M,%TI@B:-O*+>7L<?NEY)W,2!L9Y`N0H!Y/`X9[G`*!XI7W@2-&Q;8<*67$8)
M"X8H,''#^U.EA^V3%8K:'?UVA!*4782"H9AT!48/7@@<8`!UG@763JFBK%*V
M;BV^1R>K#L??CJ?7-=+7#>"9G?5Y&!@>*:*5A(B%&?:ZC)'8?,<?TKN:`"N;
MU*XT636)HKJTFDEB\E9YER(UW'Y`^&&>O<'@UTE8=]I%Y?ZL+B:6!K6$J8(6
M#\$`'<<,`3G/4&@"M%<>'[K67?R72X65E#LK!'>(9)&.#@`'GTIVEV^AZG)<
M?9[&90R,-[AE61'8Y*X.`#@^AQQZU77PU<7,QBN)PMK";D0OL_>.)@P;//;)
M.>_'2KGAK1+C2=_GM"%6,0JL(($@4D^8W^T<_A0!%++H&H+>RR02.VF1&*49
M9&*`$XZC<"`<9]_6K3Z/HEP&E>%%:\5#S(5)VCY2!G@@#J/?WK*U#PO>746I
MR1R1QW4UP[P.A(/ELH4JWL1_CWQ1>>&+V::Y0"R>*[2-3*Z'=`57!*^O3VY(
M["@#5N+/1M)$NHRA(F1WE\QLN4=\!F`Y.3@5#X=M%BO=1-UY<E^)4$K+&%0`
M(I4)U.`"/\!5.Y\*R3VNH[DMGGFO_M,;,.63@["V.._8_CFI9/#<TT>H,Z6P
MENI8)(\?\LU3;E,X[`$#'Z4`6=<L=&@'VR]MV9WD4^3%DFXD'0;!PYY/7L3F
MGZ%-I+?;+JQ<Q---_I$<C8*2>F#T_P`^E3:SIDU[<6%W;2*)K*;>$?A7!P""
M1TX[\_2J=WI>JWT!-V]JY:X60VZDE`@&,!F4X/?A1WQ@G-`#U\/Z+'=+=;@(
MS)YZ1&7]T&`QN"].^:1?#^DS9AANI@\9EP(KGYDWD;QQ[CI5&P\*3+=69U!;
M6>"V$N5R3N+/N4@8P/3\*9:>&K])[B%TM([>:":-I>'?+C^$[01@D]3R#TZ8
M`-I]%TJ8(A4-%%`;<Q&0E2@/`8$_PGH>QJ;2;"SLE<6KO(Y`5Y';<S8)(S^+
M,<]\FN8'AJ]ETNX@ACM8B+;[.&B?(NF#`[WST(VGWY]L5L:3I,UEK"3+;PPV
MR6*PML;EI-VXGW'7D\_G0!:N?$>F6DXAGG*NSF-?D."P(!YZ#!(Y.*OQW4$N
M1',C%6V$9Y#>GZ@_0CUKG+W1]4GVHL=L)7D9GN$)4*"5(RN?G/R]QC!_&HM0
M\-WD\TOD1PK&^HQW+$-M+(!R,X/<YQCKF@#JA-$6VB5"WIN&:<74(7S\H&<C
MTKE[G0+@WL@A@7R//C:$JZJ(44("!QD'*]!@<#)-0VWAR^2>*.Y"2LJ-NF+L
M1("K@ANYY,8`Z?+D>E`'66\\5S;QSP.'BD4,C#N#4E9^A6TEGH]K;30K%)%&
MJ,%;=N(`&<^^*T*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`/,]6C,.HZD\L32)%<R2M&(0=P^0C.6&Y
M>0>AP,XP,FJK!8Y!]IG^6:7Y@SQ@N&RFT[7^084YYQD#/0&MKX@P/;,;F-9B
MEVGEDQNP"R#'W@.""N5YKFXD$=D;>4B:$6[O*877>B^8=J\GIN7=TS\^,=*`
M+.GDV^G^1,_G1EUC1DQM.06R2R_=4L3@'KG.,@U9NO)FOU.W9=1HTCJSG+G(
MW$`#=NXW%2.I;@$'*!X#,Z/#Y$1B9V@CN`^[;MB9>&&T\/\`,#@K[9J)X3%<
MA;Z*WEDW%EF>%XY`&(;>^TY`Y&."1G''8`DMK-SLDNYVE8S"3SY[@*0K90EP
MQ/&%YS@C@<XQ426UO>W*S2K-=VD&VV@>)617?[W4]%`##U^Z3WJ]:Z?>6MG(
MQ/G0*B.465N`",G88\[MP;H0<L<Y!-2QW5PMU(HED(C1W98@X)!=@H\O'0$-
M^#C/<@`R;J"W$T,T'V-U7YG)D4/*6.X[57#'C@#;P20,8!J0B6<)#+$9HG`W
M@.JK(JJ3P1R<[0>!P!P.YAN;BZ#6TL"36KB;]XX7<P\O:-Q7VSNQQR><X!JO
M?,T,:1?90P1HTD,J%&,G)^Z>AVJJMU&0?7D`ZCP=&X\12`(!%%:,.N2NZ084
MY^8?=.,\XQGKSW5<WX-TY[:VGNY9#(T[>7'N!RL<9*K^>,]!G-=)0`5R6M-O
MU346O[Z:S6UA22R\N39D=7?'\9S\N/3Z@UUM96H:C!!//&MC+>301([K#&';
M#/M`'O\`>./04`9-QXHGM]36T5$E5/)$I9"CKNQG(8CG!)`&??&.9)_$%^MB
MUU'':,C7C01?/@E%+9.&(R3M['OG':GR^)+8VJWK:-?.@WON^SC*[`OS$D\#
MDC/^R:E?6[6Y6TMSI5Q,MTBRLAA!$>]C@L/J&/&>`30!`_B:5[:V,'V59)+>
M29I)BRQL8SAD3(!)SD^P'0U#-XIO'CFN;2&U^S0V<5RZNS%P7SQQ@=OY'O@;
M>GW%EJ,$T,<46VUG:%HB`0A1B`<=NF16?%K6E7$=Z\ME+Y)C\UI);8XN$&!W
M'."<8-`#_$EV1;Z<(KPV\%Y<+$\BX#;6!.03]T\#GMFLN&]D2T*PZG<70BU*
M.+?NP1NV_*6(^8`\=!GGCH:V!JFFS:5<-?0BWAM&VRP7"C*XY7COD8(`SUQ5
MA9[!M#BO'A5;6*);A4VAO+``8<#N/:@#`L?$=SI^C6US?R0W,1>=)98W+D2#
M+(I_NYY'0]%]>.ETZZ>:"-+HQ)>B-7FA1N8\]L9_SBL*^@T]T2XELM0AM+>4
MRR6Z0;5=U5<.V.2,'\<<]*DCUO38)AJ4<5PRWR[WD\@_NXT^7)[[<G.>>]`&
M->ZM?6UIK(:65(7O9(8)1AC'(&4A2.,`C.#GC'TSNQ>(;BXU)K6"Q^0RS0([
M-@[XUSD@XX/&/QYJ274-&:_;39K53YDX#.T0,1E9<@9_O$?S]36K]@L_M8N_
MLD'VD?\`+;RQOZ8^]UZ4`8H\3,T+RFT6(0)_I`E=L1R>8$V;E4\]3TYR*0>*
M&9XHQ:1AWF$)WSE54X8]2O/"]NYQU%;36%F\4L36D#1S-ND0Q@ASG.2.YSS3
M1I>GB%H18VWE,VXIY*[2?7&.M`',Z1XANK?1_,NU-W<;KB20ER"%CQT`4@#M
MS@9[\UHZMJMRVB:=<V3&"2^>%5X#$;\'&2"!QD9(ZXK4DTK3Y8XXY+*W:.,D
MJAC&T9&#QTY_P]*EFL[:>V%M-;Q/`!@1L@*@=.!0!R$FNZM_9MG+YQ63;/O*
MK&6DD0MP5Z;5`Y(.3UP.M:=__:TFKVT%IJ9@^T1B1X&@5O*5<;B6ZDDD#`QU
MK6DTG3Y;5+62R@>!.51D!`_SC\:L^1")EF$2"54*!\<A<@X^G`H`YG3=8U*:
M_A+/%,EX+ADM]NSRO+;:HW<]<<G!^E6M$U6Y-E>/J"R3R0WTEN/(B+X`/H!T
M'//T[UKP:?:6US-<P6\:3SG,C@<L>/\``?CS3K6T@LUD6WB$8DD:1\=68]2?
M>@#G8_$OVW5[=;>6*.V<2JJR,=TC+@`XR,#)/![`]P*ABOM8^PW@AO$OCYJ+
MYPBV[<G#F,`@N!P!TR<XS743V=M<RI+/"DCQJRJ6&=H;&<?7`JK%H6E0P20Q
MV$*QR`!@%Z@'(_7F@#G5US5IX"JS+&L,\\4UP+9F/R#*Y0<@'<,]QBNITRZ:
M^TRUNV389XED*^F1FF-I-@T441M8PD))C4#&TDY.,>IZ^M7````!@#H!0`M%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!14-W<):6LEQ("8XEW/C'"CJ?P'/X56L]7M+QHQ%YJB2,2(TD3(KK
MP."1S]X?G0!?HILDB1+ND=47(&6.!DG`_6F+<(Q?.Y`K^7EQMW'CIGKUQ0!+
M1152]U"&R($NXDHS_*,\*,G],_E0!;HI%.Y0<$9&<'J*6@!!GO2T44`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4@))(VD`=_6EHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`*VH64.HV,UI<+NCE7!]NX/X'!KS+4=
M.?3[RXLW3;=3/Y<;?O"[*WR[P`YW;^^?IUXKU:L_5M&L]72,72N'B.Z.2-MK
MH?8_@/R%`'!6A42)!/:XN)(1%$CL/*G1P%#IQ@-A!@$_-@\YK0GA<7H%F5DA
MED_?6\S>0SG*N>`0N2%`!&,[FSWQ#JO@R:U!EA@%XB)P(W,;$],D<],\8Q[]
M.:=[J$]JDH%PT3QS,Y@D9F"#.T?*P+`;9,?PY`&,D&@"QI>F:A<&!)X8TMUC
M1U(V2K-C#@=]H;Z@<C(.[ES1O+:LK7JB!]SQBUVJ/E3+!Y>`<<C^(G<3SU%:
M6^0F2XBDMX&*IY<@@#(I8EE#'!7HB],88'L.$GN_[08P&:61F#I]D0'&?W:X
MVI_M!B-QQP#U.``0:O*AFG>P8,L2;7)C,BPDL"BKG.TD*`<^X]*GT;3)-;O$
M18985"HUP[N&8*1\S9(SN8J"/0'(X-:>E>#KJ6T1+IS;)*0]P"V]Y,8VC;]T
M8RPYW<\XKL=.TZVTNU%O:1E4'))))8^I)H`L11I#$L42!$0850,`"GT44`%8
M$UK-_:NLPVS%)[RTC,<CL2JXWJ<<<8R#CGK^`WZY36-5O[;6;FPMI$-Q,(Y+
M7S(L!$56:0;OXA\G_CWMP`:=]I,LFG6%A:F%;>&6+ST<9#QJ02O3J<#_`":B
MUO1Y]1N%\M;=$Q$!./EFBVN2VT@=QCOQS67!XIO9[9[ZW@2>.YGCMK>(9)1O
M++,3ZX;''&1WZ&K5OK.H2W%NQ2"-WMI9)H990JJ8V"\,`2.<D@\CD$\4`6=!
M1KB;6;ID_<7-RR(A)^8(-A.3ZD?A6?:^&K_^S9;=Y+>`F!K?"K_K1NX9^I^Z
M```?QJP?$UT!"_V*(Q31HWFB1BJ,P!VMA<CU!.`01Z9IDFIZC]L412@K_:K6
MIWD#Y-@8#`7IQU//O@T`*OAJZ,<CM<P0,TAD2VBC+0HQ39GG!]_;)XSR+MKI
MMY!X8CL3(LLXM]K"9=V6XPG7&W&5_6JNG>)IK]H66T"QW$4LD)W'`V$@"1MN
M%SCJ,X_GKSW=Q%I`NDMA-.(PYBC8$=,G![]_K0!BQZ-J,F@W\+K%#/=W"RBV
M1\)$@9<KD>JJ<]N>@YI_B#1+Z[D9-/,:PW,"6LNYB#$@;=N`[C&1CKS39_$\
MZ6ML([:-[NXG:+RUWG9@9(90-P(!'&*<VN7MU'$UM;I`R6HNI_M)9%4;L=>N
M,*YY'3!H`A_X1Z^AU:W:W\DPPSI(MRS'S!&L80H5QAB0!\WUKJZYB\\2W<`O
MY4M(GM[1$+.LF3ET5ACL0"3SGGC'NV;Q!J3Q(D$%O'<"Z$#/*'$;D@D!<C=G
MCD$?S%`'4T5S9\32&^>&.&*2)C*D<BN3AD0M\W&.<=`<COZ!T?B&ZCM[.ZO+
M.*.WNK<R(4ER0X3<%P?4#C%`'145SS:]>1J=]M`S6]L;B[`D*[002H7/).`<
M\8X-0C6[F2]>[A#R6J(A$*`\J^-CGY21W)QT'K0!T]%<Z-?FO%TZ:R$0CFN6
MCES(&!54+$@@9'`[@'VYI)/%!^SS-':H98[5Y]OF[@"FW<I(&"1N/0GIVS0!
MT=%<R?%L5JD(O(P6,<+2F-\G+@GY5QD@``G'3(ZU8U^\O;75]&6T'F+-+(CP
MY`W_`"\'.#@#DG%`&]17*1^(I[W4+26TBDV&VE=[=G"J65MIRV,<8SG/2MC0
M=4FU>R-U)9&U0MB/,@?>.Y&.V?SH`TZ***`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"EK)QHU\>?\`CW?&
M.N=IKEFG"^&]D%U<R31Z=RJMCRGPIQD=,8Q@\\XYS76:E:&\LWA%S+:D\^;$
MV&7UP>W%>>Z3-=:O:0P6NN:D=4EBD9D:9A&A#<#..X.>#QC\*`-?5%VW%U'O
MD-HL]G*,LTBI\QWGL5P%'&??C/#I2#<#?Y[I'K7&X,2$\HYQWQN!JYJR-?:M
MIFCSN3!-"9+AD)!F"C[I(P<9)-2:1$8-2U?1`2+5462`<GRPX.1DD\9Y_.@"
M;3K*:#5I[>;SG@B8SP2%S@AN`AYYVD-C/8BJ>MV#W6I3)_"T:+N);'SOA_XL
M?*HY]0X![&L[5_#-C8V%K9)YLU]>SK"+AI#W.68C/8#&/I6MXN7R;"QB9GBT
M[SECNBF<B+TSUQQS0!T,1!B0J000,%3D'Z4&6-9%C+J';[JD\GZ"N4\.7MHO
MB:XT_27=M.^S^:JY.Q7#`$ID\@Y_,&LV^2R6353JQF_M?S9#:A"V\)U0IVQU
M_+MB@#T"D!!&1R*Y\:_)#X6LM0:+S+FX141/[\I'3Z'!/M5?P;;?8[K5[<ON
M=9UW-TW':"Q`]"3^HH`Z<,"JGINZ9&#^1I58,,J00>X-<3J_AK3=)T<A(5GO
MKF<10R/D?.YQC`/89Z_K6[>:";O2K'33=LEK;A%F0+_KU4#Y2001T[4`:\4L
M<R!XG5T.<,IR/2CS$W[-Z[LXQGGIG^HKF=`A@/B&YGT>/R]+6+RG*X$<DH;.
M5`ZXYY]\56M[2+7(-<OKY6:Z@N)88'R08`@RNWT.3D^IH`[$D`$DX`ZDTD<B
M2H'C=74]&4Y!KDM1O)=3\,:&LC.!J%Q##<%&(+*0=W3UQ5^RMH=+\4FTLP(;
M:XM#*80?E#JP&0.V0>?I0!NR2QQ)OE=47U8X%.5@PRI!![@UQ5W/_:7B&_-U
MITNHP:>=B0@@)&".7.?O,>>.P%;L>JZ=8:#;75G;S/9/Q&EO$6*]3R.W(/XT
M`;-1RSPPLBRRQQM(=J!F`+'T'K699>((+R]CM5LK^)I,[6FMRBX`/.3],?4B
ML34)+"+6[\>(0\[2!18H(V8!<'A..')_7'-`'945C>$;VXO_``Y:SW19I?F0
MLPY;:Q`)]^/SK9H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`J`V=L9/,-O%OSG.P9SZ_7K^9J>B@#*C\-Z/$X9-/A!#;A
MP<9SGI]:TDACC.8XT0_[*@4^B@`HHHH`****`"H6M8'NDN6B4SHI57QR`>HJ
M:B@"I)IEE+;/;R6T;1._F,I'5LYW?7/>F/HVFO"D)L8/+12BJ$``4G)'';/-
M7J*`*$VBZ;/,LLMG&[JH4$CJ!T!]<>]/?2K"1][VD+/YHFW%1DN.C?6KE%`%
M&/2-.B\_R[.%/M"E)=JXW`]1^/?\/2I7L+5]/^P-"IM?+$8C/("@8`_"K-%`
M%$Z-IK6IMC90^46+D;>=Q&"V>N<=^M$^C:;<1Q1S6-NZQ`*@,8^4`Y`^GMTJ
M]10!4_LRR_T@&VC(N0HF!&0X`P!CV%12:)ITMD+-[8-`'\P*6/WO7.<YK0HH
M`H+HVG)()%M4#*SN#D\%QAC^(ZU7U#1!>16EJLRQ6-N4S!Y>=P4C`W9R.!CO
MU/X:]%`%._TJQU(`7ENLH`(Y)'!QGIU^Z/R'I3;G2;&Z:5IX`YF*ESDC)7[I
MSVQ[>I]:O44`9[Z)I[PQ1-`2D4PG7+L?G'<DGG\:1M#TYF=C;_?B:$@2,!L(
MP0!G`R,=/0>E:-%`&:=$LAY7E+)%Y2!%59&VE1G:",\@$Y^M.GT6PN`!+$S%
M96F4^:V5=NI!SQ].@K0HH`R)_#>F36Z0>2T<:0M`H1R,*3G^?/\`/-6=,TNW
MTN)H[=I65MH_>2%L!5"@#/08%7J*`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`K7_VW[*_]G^3Y_&W
MSL[>O/3VZ>]<I%X;UV'2H]/BDTT1K')%O;>7`=B3M/;M^5=7J)9=.N63[ZQ.
M5/H=IKG[=FL-'T.]CGFW3>0DRO*6$@<98G.>1G/'ICI0!:GT6\2#2I[*:!;_
M`$^'RCY@)CE!4`@GKVR*GT/2)+*>[OKQTDO;M@7V?=15X55SST_IZ5'_`,)#
MY4*7=U;&.RG1I(9`V6("LV",<$JN1SWQVIZ:S<HT,=UI_E22SB%2)@4)*%P<
MX]L'CCWH`LS6#SZY;WDC*8;>%E1.^]B,G\A^M/U1+]XD_L_[,6#9=;@$AA@\
M<>^/RK-3Q!/-81W$%B'9H9I2AD(_U3JK#IU.21]*5O$92:>%[4A]L30;6+!_
M,Z`\<=#Z_GU`)]$T>2P=[F\G6>\D4(61-B(@_A51QCO52\TG6=1F>*YO+:"U
M\QL26Z'SS$2<+N(P#@@9'Z\Y4:_>9,*:<!,ML\Q664K]UPIZKG!!##/-3Z3J
MLVI7\H\D+;FV@F0$\@.'/Y]!CV/)H`LWFAZ?>6L%O+`-MLFR#D_NQ@#CGGH.
MO]:SO#OAZ;2=1N;J8VA\Y`H$49!7&.A)Z'&<>N*3[6^G:OJ4[EGL1,BSJ,MY
M68U._P!AR=P],'URMOK#6-HL/DK*8[-[G/F8+88?+WP?F_ETH`TKW3OM>IV%
MT[CR[0NWE\\L1@'\.:B\0V%]J5A]EL;I+8.<2LP.67^Z".F>]47UZY:=U2!3
M&@MPV&RP\T$`XX/WBO&<XY]JAFO[F[U"S/DJEQ#>26[1"8^4Q6)F'.`3U7MU
M%`&CI%CJUE*D=U>6LEHB%5CB@V'.>#[=ZJ7&@Z@LUY%I]]%;65](7F7R\NA(
MPVP]/FQ^%/'B"YE7$&G.\T:;IHLD\[V0A2`1U1NN.W;)%NUU"]O&NO)M8E\B
M?R<22$$XVDG@$?=8_B._6@!;[18KG2H+&%_(-LR-!(%#&-DZ''K_`(TS3-*N
M(M1EU/49XIKUXO)'DH41$!SCKR3P<GZ5KT4`8=UI.H1WUW/I=U;Q)>@><DL1
M.U@NW<I!].<'N/>M'2["/3-.@LXF9EB7&YCDL<Y)_,FK=%`!63J%CJUW<,D.
MI1VMJ2"#'#F4#&"NXG`[D$#(K6HH`@LK."PLXK6V39#$,*N<U/110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!B^(/$EKX?>W%U%*XGW
M8,8'&,=<_6LAOB-I0SBVNS@\?*O(_.J'Q/;$NEEQE1YN._\`<Y_^M7;FPLV)
M+6D!+=28QS^E`'+_`/"Q])`&;:\_!5]O]KZ_E1_PL;225Q;W?(YRJ\'\ZZG[
M!9_\^D'_`'[%+]BM>/\`1H>!C_5CI0!RO_"Q]*VY^S7>?3:O^-'_``L?2O\`
MGVO.N.57IZ]:ZH65JN=MM",C!Q&.10;.U.<VT//7Y!S0!RI^(VDX.+:[/I\J
M\_K_`)Q1_P`+&TKDBVO,`@?=3/Y;JZH6=J,XMH1G@X0<]OZ"@V=LW6WB_P"^
M!_GN:`.4_P"%D:5_SZ7G_?*__%4O_"Q=+,8*VUV6S]T*N0/7K73-IE@Z%6L[
M<J5V$>6,;>>/U-5SX>T9F+'2[0DY)_=+WH`QA\0=%+@$7`4_Q>7TZ>_O^A]L
MNC\?Z*T3.QG1EQ\A3DY.#CMQG/X&M<>'=%&/^)59\#'^I6C_`(1[1LY_LJSZ
MY_U*_P"%`&:OCO02S*UTXVX^;RF(;CMQGVY`I1XZT`_\O3CG'^I;\^E:/_"/
M:-@C^RK/G_IBO^%+_P`(_HV2?[*LN<?\L%_PH`SCXZ\/C/\`ICG!_P">+\_I
M2'QUX?S_`,?;],_ZE_RZ?YQ6D/#^C#'_`!*K+C_I@O\`A2C0='``&EV6/^N"
M\_7CF@#+_P"$[T#`_P!)DZ9_U+<>W2D_X3S0?^?B7_OTU:IT'1R,?V58_P#@
M.G^%*="T@DDZ58DGJ3;I_A0!DGQYH/'[^7KC_5-^=21^-=%F$ACEE81C+'RB
M`!D#O[FM,:+I0((TRR!'0^0O'Z4AT/2BCH-.ME5T*,%B"Y4\D<4`9'_"?:%Q
M^]FZ?\\C2#Q]H990'G.>I\H\?6M)/#.B(ZN-+MB5&!E,COU!X/7_`#BHSX3T
M(NK_`-FP@KTZX_$=#0!2_P"$]T/S`GF3<G&?+X'XYI[>.=#6*)_M#L7ZJ$Y3
MZ_\`ULU9/A+0CN#:>A##&"S?*.>G/'4]*1O!^@/,TK:='N8YP&8*/H`<"@""
M/QOH3P"3[2ZDDC8T9SU/?H,XR.:D3QGH90.]TT88$J7C;Y@/3`J1?".A!`OV
M!2`=V"[8SZXS0_A'0GP&T]2%&%'F/@#).!SQR30`C>+M$2W2=KPB-V9$8Q/A
MB.N#CW'/O3#XST$1>:;T^66*AO*?DC&<<9XW"K#^%]&D@6%[&,QJ[.JY("EN
MN,'V'Y"F_P#"*Z'Y1C_LZ/86+8RW!.,XYX^Z.G]30!$/&6A&%9OMA\LMMW&)
MP,\<=/>EE\7Z+!(J3W$D+,H;$D#J0#TX(S4G_"*Z'L"?V=%M'.,GTQZTY_#&
MBR.'DT^)V`QEB3^?/-`$$?C#190?+N)6(4NP%O(2JCJW3I4?_";^'R#B])([
M>4XSSCN*LCPIH:J%&GQX"[<[FR1[G.3_`/J]*CD\':"\0C_L]%`[JS`]".N?
M?^5`$7_"<>'P<&]/_?E_\/\`.*DA\8Z%,DCI>';&`7)B?@$@9Z=,D#/N*C;P
M1H;1"/[,X4<\.<YP!G/X?2FIX'T1$=5CG"OPP$[`$9!Q[C('Y"@"=/&.@.S+
M_:*`J2#E&`_`XP:</%VA%]O]HQ]`=VUL<YXSCKQ5+_A`-"P1Y<^2>OFGCI_A
M^M2KX)T9(VC5+@(W.T3-@'!&?R.*`+`\7:"<?\3*+GV;_"D_X2_0,`_VE'S_
M`++?X56_X0/0-Y/V:3!.0OG-@=..O^<U&O@#0QU2X;C',OZT`7V\6Z"N<ZE%
MQZ`G^GO2'Q=H()!U*+CT#'^E9X^'VB#_`)^3\V?]9V].G3]:7_A7^B8(`N.?
M^FG_`-;_`#B@"_\`\)=H./\`D)1=,_=;_"@>+]`/34H^N.58?TJC_P`(#HNU
ME'VD!L9Q+_\`6I/^%?Z'C&+CIC/F_KTH`O'QAH`7)U*/''16/]*L+XCT9F(&
MIVO`S_K1[_X5B1?#S2U4>=-<3.'W98@!AQD''..#W!YJ5?A_HHQN-RY[EI!E
MCZGB@#:77=*;&W4+8Y?8/W@^]Z4B:]I+D!=0MBQ;:%\T9)SC`'XBL0_#W1O-
MC8-<!%)++O\`O],#/8#GWYZU&/AUI(FWF>Y,>XG9N'3L,XH`Z8:C9'&VZA;.
M,;7!SGITI3?V@;!N8O\`OL8'XURTGPYTMY0RW5TB<94%>F/7%-;X;Z:6RMW=
M*/3Y?\*`.K_M"RR1]LM^`2?WJ\8Y]:<;VU7.;F$;1DYD'`Y_P/Y&N1_X5MI^
M#_IUUGG'"_X4?\*VT[G_`$VZ[8^[^/:@#K1?6A(`NH,MT'F#G_.13XKF"?'D
MS1R9&?D8'CUXKC_^%;:=Q_IMU[_=_P`*H?#%`E_J0[JJCJ?4T`>B4444`%%%
M%`!1110`4444`%%%%`%;44233KE)&=$,;;B@!;&.<9!'3UKCE>YL]/LM1NK-
MWTZT("03RKYL:#"!RH0`GIU)(SQCDUW#NL:,[G"J,DGL*XJ;Q!I6LW:RZA>1
MQ:;;N&BM\DO,P(`9UQ]WG..O<T`6=1LXK&.TL+99-1>8/]GMY654C4IM+/M`
M8X&0/KCJ!3K"U>X>XM;F>6._TZ6*7>S;PP`;!#%>006'0D'GG@5/KCI8Z_I>
ML3Y^QJK0O(%)$>X<,?0<XIVC[=2US5=2MR3:2QI!&^,"4@')!]NE`&.CF/1Y
M=12W*Z2!+#N\Q3,T<CC>V"F"-PX![?A6EK-EI^FV9O9;B]G>9(;>%8G7+LI#
M(5P,`\9SZ9Q61:ZC!:^#YO#SDG55+VP@P<L6<X(..F&S^%:WBS3F.BZ:&++#
M9S1FX:+.5CQM8CCL*`$T_2KQY0UQY*"6WEA:2"9I'#,0S;B5(SD=L>W857L9
M[BW%SJ6G6X?3[,?9V1Y3YDJ19PRX&!C)X/4=>3D2^'GMAXEF70]SZ6UN#+C.
MQ9,C&"><XSQ]35*TO(M)T&^T)VE_M$/(L$*JVY\GY<8'3OVXS0!N2FXCN8;W
M283=QZEAI3*^$1=HVG@9]/6LVSL[F?7'TV9%B6UT_P`HO;EL8;`"DL",G&[.
M#T.<\UT^EVSV>E6=K(07A@2-B.F0H']*S/"J>;:W.ILFV2_G:3TPH^5?Y$_C
MWH`PDC\V.\O+.-7T^W9$)FF/F3^1DY3`P.`<>OM6J]A%-90ZGI4=U<33R_:$
MVSHA0NN"22".!@$8)K.AOH](T[5=%G$RWSR3?9E6-CYV_P"Z5(!'4CZ5N6UQ
M!X<T"PBU)]FQ%B8I&S`-C/8'T/-`%/0M/@U/2X+Q_,MY&62%Q!*P$BB1OO9Z
MGKSQU/3H(WM=3TR.[:!+2&TCF%PS2SMOF"[2<8&$!"@8(/7\SP9JUFUA%9+(
M_P!IDEE?88VX!8MDG&.F.]-UZ_\`#>J![;4?.:YM_,18PCJZGID`<')`QGV]
MZ`+UYK\JZ!::G:6^&N9(U$<HZ!CCL:M:7<7MT[FYETZ:#!`-J[,=W&0<\=#6
M7NA_X1+3T\1VDLB':)-BL1'@$AGQ@@8'/O3-,-K+XGAET&+99"!UNV2,I&QS
ME<9&"V3U]._:@"^^J:DFO6EE-9Q06T\DBK(9-[N$4L"`.!GCK[^QK<KD]4UW
M3VU[3I3-(JV4TRS;H7X.PKQQSS6U-#;:_I\3[[F.+>71D+1.<97ZX//Z4`:5
M8/B?79M'A'V2!)Y0IED#G`6,$#.?7)`Q_DSV7AVVL;N.XCN;UWC).);@LIRI
M'(/L:YGQ7;WMJ+^2XDMI#J)V1A8W9EC4C:HQP#R"?4^N*`.EUW5IM,T5+R%$
M:5VC4+*>/F^E.TNZO[F=O.GTV:!1@_979F4^_;^55;N>RN_#<#:O;/<6TCA7
M\B-P$P3AB,[@.`/QJG8/97'B.TDT&V$4*1NMW(D)1"N,*OH3E<_2@#K****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`\^^*@^;2SCM+_`.R5
MZ#7GOQ3;,FF)@\"0]/7;_A7H5`!1110`4444`%%%%`!1110`53L-5LM2,HLK
MA)C"</M[<D?T/Y4S7+T:?I%Q<'.X(53!QESPH_,BL"RM)/#&JZ<'8-;WL26L
MS#G]^,E3^.6`_6@#KJ:74.$+`,V<#/)Q61JVJW5GJME8VT,3M=APK2$@*P&>
M?;]?3VQ[]]5_X2C2!-'IZW>)=@#2%67;SSC@@9QQWH`ZB'4+6XO)[2&9'G@`
M,B`\KFK-<[;:K%:ZEXB>6VCC2S$<KN@P\N4)YR?8`?7WH_M36X[./4I=/B:U
M//V:%F:<JS`+@8P2`<XS_P#6`-M;RV:]:R$R&Y5!(8\\A<XS_GVJ>N8LI(Y/
M'-Q.,;9--1U8#((+#O\`_JJS9ZKJVI0+>65E;?9#DKYLC!Y0&8?+QQD`8SZT
M`;U%<]%XG6YT[3I[:WW37TGEJCMM52#\V3@^A[5?L[K4OMBVM]9QX\LO]I@<
MF,D8XP1D'GU/2@#2JE?:M8:<I-Y=1P[2`0QYY!(XZ]C^52:E=BQTVYNR,^3$
MSXQG.!FL/PIIEK-I<>I7,27%U=YD+R+N*`DX5<]`/:@#>M+VUOHO,M+B.=.,
MF-@<<9Y].#45[JMAI\D<=Y=Q0O*0$5FY.>^/3WZ5@:O:0^']3T_4=/3R8995
MM9K>)0$;<#M;IP0?S]LG,$#7-SXVODDLK665(8U(DD.$CSGC*G)P1GMD'F@#
MLJK7.H6=HZI<W,43-C`9L$YX%)JEX-/TVYNRI;R8R^`,YP*P_#6C6]UHT%WJ
M<27EQ<#S29TW!0<D``]L'_/%`'10S17$8DAD61#T93D&I*YC4VB\.ZKI<EI"
MD%E<SO'.B?*H9E0*0HX_@ST]?6K,^N7RW]U9VFF?:I+=EW$3!0%*JW<9S\Q'
MX9H`WJ*QO[7N[JXNX=-LHY3:2B.1I9M@8XR0N`>G3G'^#%\1H(;^>:TGBCLX
MHY"K`;SNSD8[$$8H`W**YVZ\17=IIB:I-IA%DRA@JR;I/FQM)&,*,9SSW%2Z
MQXB.EZI:V7V*6X>Z4&,1D`[LXQR?\_R`-VHH+B&X#F"19`C%&*G.&'45DV&M
MW#:O_96HV7D7)1I4=&W1NN>,=^G\JJ>'[R'['J,ND:9(3]M8/$9@,G`RP)Z#
MOB@#IJ*Y]O$=S'?6=G-I$L<UWRBF4':.Y;&<>M3#79;B\NH;#3)KI+5VCDEW
MJB[P,[1DY)[?E]:`-JFET"ABR@'H2>M<YJ.MSW'A[4VM[6:*ZMM\4JJ^#$0I
M.\,,9`&#5)Y(SX;TD7MK.L4<ENL($R_.,+A^,_3!QP?I0!V5%8UQKQ_M9]-T
M^RDO+B(`S$,$2/.",L>^#_GG#4\1(VF7UU):3036.?-MY<*?;!Z$'G!]J`-N
MBN<;Q1+]B-_%I%Q+9(JLTRL!QC)*@X)`Z9XK?@E6>%)4^XXW*?4=C^/6@"2B
MBB@`HHHH`****`"BBB@`KSSX>1[]0UF(%XMRA<J<,O+=/<5Z'7G_`,./^0OJ
M^/;T_O'TH`[]5"J%&<`8Y.3^=+110`4444`%%%%`!1110`4444`%-$:+C:BC
M'3`IEQ-]GMY)BI<(NXA<9Q^-4+37;6Y:WS'-"MR`87E7"OD9`SG@_P#UO6@#
M3(!&#R*``HPH``["D>1$5F9@`HW-[#UI58,H93D$9!H`3:N[=M&[UQS3JHWF
MH&UNH;=;669Y@3'Y97G'7.2,<8_.FQZFS0"1[&XBQ$\C"0`;2IQMZ]^Q'&,'
MO0!?``&``![44R"9;BWCF3.R10ZYZX(S4<MW''>06Q!+S!L$=!M`//YT`6**
M**`$I:**`"DP/RI:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@#SSXG,HO;#=MRL;,!C.X[AP?:O0@,`#.?
M<UP'Q%4MK.D``@MD!L_[0]O\YKT"@`HHHH`****`"BBB@`HHJM/?6]O=VUK+
M)MEN=PB']XJ,D?E_GI0!B^(;(ZUJMAII\Y;:,M/<.H8#@?*,],DY_(U5U?PG
M;0:=)=V<MVUW:@S0%YBV&&#P#ZXKK:K6-[%?1/)#N`21XF##!#*<&@#"M+I]
M4UC1;XPO&WV>=9D88,;#:"".W/\`,4OB"?[%XCT:]N'D%HID0A4+#>5(&<#C
M^?7C&372TAZ=,T`<;<6$M[<>+88T<2NL31K@X;"'IGUY%3P>+(O[#B2T02:H
M(506A5@PDX7I_=YSUZ#\NAM]2M+DW0BF!%HY29CP%(&3R>.*GB>*9%FA9)$<
M`JZ$$,.Q![T`<U:+-)XSNQ(NUI=-0NN"`&R!C/YUB:9:>'X+2&'6;B>UOX\K
M(IE=02K$`C'';'X5Z'@?G00#C(!QS0!Q44:6^C6*WNBS)9/(2SO<$M;;L?/T
MW+G+<`\=^2*?IK6L6M6</AV_DFM)%:2XBW%U494#D\J?O''7CIS7607EO<RS
MQ0RJ\D#;)%'53C-2R2+%&TDC!40%F)[`4`17MLMY8W%JYPLT;1DCL",?UKG]
M%U:+1K:/2=8*VL\+>7&VT[)%SPV>0,^YQG-=';SQ7-O'/`X>*10R,.X-13WM
MK#<1VTTR)+-Q&C'E_H.]`'.W=S'XJU#3X=/8R65K*MS<2E63##[J@]R<D_3O
M4UAM'C_5`&))M8R1Q@=/\_C72*H10J@*H&``.`*@N9;6QBDO+AHX44#?*PQZ
M`9/Y4`-U.S74-.N+1_NS1E.N.OX&L31-833-/MM.UK%E<PJ8EW@A'1.`P8C'
M;U]^]=%%(DT22Q.'C=0RLIR"#T(JM<36(OK>VN!&;B<,8@R9W;>3@X[9H`Q+
MIE\2W^E36.Z6PM;AGG?``W``KC(^89R./7\1?TMHQKNM+N7S3-&<=\>4G^-6
M$UC3ET^6[6XC6UMV\MV'13QQ@?4<5;1H3MDC,9\T;@RX^<8ZY[\8H`YS1KFW
MT&;5K;4IQ`&O3-')*>'5\8P>YXY_6JMSJ-R+'7;ZUMI$E,,+JC8.P?,"^"/0
M;OICIS6M=:9J23SO975O*LTGF!+R,N(OEQA<'N?R]ZMZ1IG]G6[B69[BXF(:
M:5\$L<`8Z=!C^=`'&ZL+7_A'Y)EU:YU.ZFC.Z!;L%$XR6V*.`N>G3MTK7:8/
MXM\/NARLMDY&&SD;<]>]=0(8@21&@+#!.T<BJPU+3!(L8O;0.I**OFKD'I@#
M/MT]J`,F4[?B'!E1AM..T\?>WG)_(?YYK$\/ZS#H>A:G/*P9OM\BQQD\NVT8
M&?RR?2NZ\F+SO.\M/-QMW[1NQZ9J.*RMXEQY2,22Q8H,L3U)P/8?D*`,+PX]
ME:))/>ZI:3ZG>/NE;SE8KZ("#T&#[55L;N;6+N[GN]8^Q00S&,VJ%4*A2"K$
MGD9*D_2NE&G6(&!9V^"0<>4O4=#TI9K"SN)1+/:02R#H[Q@D?B1["@#D=,>'
M_A'/%`MIC/$&F"R%BQ9?+P#DY)^O0_3I9U657\+Z,$8-\]KN*G.,[2`>^#U[
M=!74+:VZ>9M@C'F`!\*/F`&!GUP.*C73;!$*)96RH7$A41*!N'1NG7WH`P/#
MTZ6.LZY;WTODS271FC$I`W1G."#GD<8]N/7%5M6FCU"XUVXM2CP0Z:8'F`&#
M("Q*@]^,?YZ]5<V-I>;?M5K!/M^[YL8;'TS2I9VL=L;9+:%;=@08E0!"#UXZ
M4`8JHB?#PA!A?[+)_.+-:FC#&BV`Z8MX^^?X1WJR8(C;_9S$AAV[/+VC;MQC
M&.F,=J='&D4:QQHJ(@"JJC`4#H`*`'4444`%%%%`!1110`4444`%<!\.3G5]
M7).22.?7YFKOZX#X=Y_MK6-W7(S_`-]-0!W]%%%`!1110`4444`%%%%`!111
M0!6U$XTZY]XV`QZD8%<U;&/4=&T/3[8,\\#6\LI\LCR@H!)SC@]ACDY]#FNJ
MG+B"0QQB5MIPC'`;VS6;I=_?7EOJ!DA@%S;SF)(U<[<A%."V,]2><4`<L79H
M[K,EP'GLKMV1I&W>:N``P..0,]`.#TQQ5P!)=00DW$5QYD36I@B(,D>U=XW8
MQC=OW9Q[DC%=!H]Y<:A#=I?6\4<L$YB9$)9<;58=1R<,!Z'&:C^U33Z]-#:E
MO)L8/WL>-HDD895<GT'_`*$/P`$U>)I]4TY%DGB'[W+Q`Y'R^O0?Y]:S[E?L
MFH"U9I9$BTAX6;RV(9OEP2<$'(#=SWK3T?4+R[NKZ"]AAA>V9%"Q,6^\@;DG
M&>OI^?6DN;F2X\006,&X);IYUP=O!!.$49XZY.>HV\'DB@#`ME9[B".=+F.Y
M#0F`QH1\@C3@'!`Y#;@W8^U3:3+']HL_M0F^V()TO-\;Y#$!N<<=#Q[9Q6G:
MZEJ*ZM;VM]'`%ND=TCB5M\..?G;.#P0..YZ8J*RUNYEDM;AQ$UA=SM;1'D29
M&_#GM@[,8P.N?:@#;L_)%I"+;_4A%"#GA<#'7GICK4U<W;:]>RO#>O#"-.N)
MS`D8#><GS[`Q/0Y;JHZ`CD\TT>()+K5OLT=U;6:+,(RDT;,[%2=PS]U2<<<Y
M/\P#IJ*0D`$DX`ZDUREWXDNHM0D1);4%;M;=+%E)FD7CYPV<#<",9&,=\\4`
M=9159[V--0BLBDA>5&<.%^4`=B?7_"L_5]4FM]4LK*UQF5QY[%"=BMD+CMR0
M?RH`V:*YK4=6N8M8GM5U&"TC0QX,MJT@&[U8$!1GU]3SQ6W+?Q17]O9LLGF3
MJS(P0E1CG!/;\:`+5%8%YK%[%<W<\21"QL94BF5@2\A(!)!Z#`8<<YYZ5;N+
MN^AUVUMV$/V.X+!=N=^0F<GMU':@#4HHK%U?5[G3M0A58XGM-BO.QSNC4N%+
M>F.1^1/:@#:HK"F\1"RO[^WO8L)`%:%X^?,)`PG^^2>!Z<]JTM+FGN=,MI[H
M1B:6,.PCSM&>0.?:@"W1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`'G_P`266+4M*E7F5,G;CD@$$5Z!7G_`,2@T5_I5P#RN[`')R"#TKT"
M@`HHHH`****`"BBB@`K"U@L?$F@*IP?,F8_01\_S_6MVL+75O(]7TR[M+&2\
M6!9MZHX4C<%`Z\'O0!NUS":I/;>'-0N[>&(317LBX4`!LS8)//7!ZYJ];ZMJ
MDL\4<N@3Q*[`.YG0A!Z]>?I64NEW\7@J[LY(,W)G9E1.X\T'(`[<$X`Z=J`+
MFIZOJ6E:A:K-';2PWLPAC1-P9&(`&6/!&3Z"GB_U+3=2M(-3:"X2]D,<;0@I
MY1`SR#][/Z<TWQ39W-U>Z));PO(L-\CR%1G:N1R?;BI->LYYM7T:>*$O'#<?
MO&49*#!Z^U`&2]P;C0/$4<=M;Q)!<RQDXQN`[G'\6>YXYYX%7I-8ETFSTRT,
M=OYMV`EN<E4C4!>6^F3TQVJ'3].N7TWQ'$;>0/<7<SP"1=N_(!4C..,XY)Q^
MM03Q7>H0:;J`T^X=--++-:3H%:0%%#;!_%@@]>N<"@"\_B":Q>,W<]C=Q/.L
M+-:L082QZMDG@`_R]:L0:M>:CJE[:6"6Z1V3;)))6+[V/8!>F,'.36=)(VJW
M=C%8Z%):F&X\R22\LE5!&,YP3_$200!S[CFIHA>>'M2U%_L=Q>VE[+Y\9M4W
M-&[9R"N1[<_3UX`#P]<>7JNOSWAAM\3QAR'^0';CJ0.I_G6IJ-Y:W.D7RV]S
M#*PMI#\D@.!M//!K-T>R;4)M:;5+%HX[JX7$4JXW*H&WV)Z9QWJ]<:/96>FW
M_P#9]E'%++;NN(DP6^4X'%`#O##;O#6FGC_CW0<>PJKJ$JQ>+])B>%)3,LVR
M1L[HB$YV_7'.1WJEI.MW&GZ7:69T'57:&)8V808!8#G&3TSFK%S'<WOB70+]
M;.>.)8YC+O7F,E,`-Z4`6+O4[Q;J2)IK#3D1L*;MMS2CLR@,,#@]<]/:LZ]U
ME=5\,:VMQ%&C6JF)BK;U9L<8_&JGV+R]1U>75M"NM1FEN=T#!`Z^5N&T!L\<
M=O08-1Q:9>#P]XB@DT^2&664.D4:_*0#QMYY'&3S^'8@&R+N^LO#MKJ)MHGC
MM[=)&MLG>!LP2&P,$`CC'][GI@N;^";Q!H+K;1O]LB=TD;.^,;-PP1V()!Z_
MAWIS:G=W.A#2;73[Q+YX5@967(C!7[Y?D;3R/7@U8_LFYMM:\.+&&DM[*"2.
M1@/E4^7C.?<_R[4`4-"F3_A#=:ENK<3*MQ.S12=&.`<$_7N*EU2*9=<\-)&(
M8G$<HBR&*J1&N`><D9]ZK:5;R6G@/65N(IH@[RF-9>"054+CUR?SJ]K,AL;W
MP_JDL4AMK:.1965,E2T8"@@=,F@#9L]4>75[ZPN(UC:%D,)&?G1ESGZY5NGT
M[4FAZPNM)<3P1XMHY/+1SU<XR>/3D?K65XL9K.&WUNSBW2Y$;JS;2RLK!3]0
M7]#U],UT.GVWV+3K:UW;O(B2/=Z[0!G]*`,7Q%)<7.I6&CV[O`+PEY9XS\P1
M`25]LDCG/%3R>%-&:R^RI8PQC;M\P(/,'H=W7.><^U-\365PYLM1L8O-NK&7
M?L`Y="/F7Z^G_P"NH6\8V94QQVMZUT1@0B`YW]ESTS0!)<W=SX<T*VCFD.H7
MC2+!%D%?,).`.`>P[]34M]JM]I:02WUI"\+R+&[P2$E23@'!4<=._P">:Q[_
M`$_5H/#>GS7;&ZNK*Z2ZF`(^6--QP!D`D9[=>G84[5M13Q18+8:;!<NKSQK<
M.8RJ(FX$G)QGH.W8T`:LNKWK>(9-+L[2)Q'$LK2R.5"@]N`<GIC\:BT[6]0U
M&[O+1+*WCFLFVR[YB5).=NW"^QS^%+9*4\::A\A"-:QA6V\<=1G\13O#^[^U
M-<W(RC[6""1C/RC_`#F@"I-XIEM_#US?R6)6>UN?L\D1?(+<<AO3D8_R:M3Z
MOJ=E96]Y>V5N('*^=LF.Z$,0!GC!QGGGM7.S>9;^#?$$FQHR=2\U,J5X+QD$
M9J_JFMQ:]ISZ7:13/>S*N^/RW3RE."2W'/&2.QX[T`;D]_?G5I;2UM$\J.-7
M:>?<JY.<@$`Y[?3GKV6PU"ZFGO(+J"%6@"NC12[ED5MV/H?EKGM4BL?[;N;;
M7[FXBLPB_8X02L<BA`&Y'4Y'3W/K3M`^R6^HZA%I5L\-NUHLD!<$^<!N!;YN
M=I+?CCTH`OV>NZMJ&F-J%KI<0A6,L!+,5:0C.=GR\CIUQ4\GB'8VCRB#-GJ/
M#2[A^Z8@;0?Q.#5?PJ$?P+$I)9#',"2>HWODU7M[1KSX<1QQ#]\+82(0.=RG
M<,?B/UH`V)M2<>)+?3H8HW#0M)-(3R@'0#\2/SK5KF_"<@U*XU'62`?M$HBB
M)'(C4#IR<9)/Y?2NDH`****`"BBB@`HHHH`*\_\`AX-NN:N....!@?>-=^3@
M$^GI7`_#L#^VM8PNW!&!Z?,>*`._HHHH`****`"BBB@`HHHH`****`&3"1HG
M$+*DA'RLPR`?I63I^FZG9M>EKZWD-RS2@_9V&V0A0#][H`O3WZUJW$1GMY(A
M))%O4KOC.&7/<'UKG+>:]L[;7+T7LURUD[HD=PRE"%1&S\H!!Z],#GI0!H:7
MIVH6-S/)+>6\L<\AE=%MRA+$`9!W''3T/^$VDV,MEIS([)]KF9YI7VY!D8D\
M],XX';@56T_5+Z:\MTO+>".*ZB+Q^4S%D(QPV0,YYQCT[]:V3G!QR>V:`,G3
M=,OK/4+BYGOXIUN<&51;[/F"A00=Q[#I[U+HUC-:6LCW7D_;;F1I9VC'R[CT
M`[X`Q^M9.CR:G=1ZC;ZA/"(_-FC9XV?<&P/N'/"@'IUZTW1M5O[33-):\CAE
MM;A1"IB9FD#!203G@YVGITS0!>TC0[O3;KSFU".;><SYM\/+UZN6)ZG/X`>N
M9+?0A#=1L;IWM89GN(8&4?([9SENI`+,1]>IJAIWB.^N;BU+V9>WN&`S%!*#
M&&!VMDC:P]<'CD\X-=/0!BP^'_+E1#>R&QCG^T1VP0+M?<6^\/X0QSC'8?B3
M:!YL[#[8XLWN/M+P;`27R&X?J!D?J1GTJIX@O&L$U;R+<Z>\@41A_P!]M)P#
MZ9_V?USQ4*6.H:AKMVEW/"$@>-L1M*C;2.Q5@`>#SS^'2@#JJP'\-%YKA!?R
M)97$_P!HDMUC7)?<&^_Z9`[=!C-5)=/O-1\1W,,\T1@MC%(H'FH55B_*[7`W
M\'YCGKQCI5X2R'Q@D<AA=/LLC(4#!E`9!AN2"<D]AC/O0!I&UF.H1W'VI_*5
M&4P[1AB3G.?;I6=J?AJVO[R.Z5C%,)%D<DLP<J?ER-PQCD<>M5[G5]4F74)=
M/CM=EG*T7E2,-[E<`L3N`5><\]E]ZCE\17@NI&M[1WM8'\LKY+DR8."0^=O^
M[UW>U`&G>Z5/=M<1G4)$M;@;9(A&I.",,`QZ9%6GM93=V\L=T\<,2D-"`").
M,#)//%6JYR[UV[C-_=1&S2UL)"DD,I/FR8!R00<+DXV@CGKQTH`NW6AQW%[)
M,)WCAGV_:(%5<2[>G/4=L^H%)>Z3>75^ETNI^5Y3$PJ+=3L!7!Y/4GGGWK.U
M2VN]3UR&)I$6W,`F6.4,I0[@#]U@0V>,\XS731HL4:QIG:H"C)).![F@!1D`
M`G)]:Q;WPY%?W=U<74JRM.@CC#0J?)4?W<_B>>_/M6W10!AP>'GCE,LVH27$
MORLLDD2Y1U&T,/4[<CG/K6GIUL]G8PVTDQG,2[1(5"D@=.![8%6:*`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`.#^)7%QI)+`*6<'C/=
M.H_B'M7>5Y]\303>:9]WH_WC@=5]>*]!H`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"JTU_:6V[[3<P0E`"^^0#;GIG/0'!QFK-<7.HNH=4NV4R746J
M0HF["A0LBA5SC'\3$]?O<YH`ZJ+4K&=%>&\MY59Q&I20,"_7;QWQSBG2WUI`
M91-<Q1F%0TFYP-@/0GTS6!<V=Q93PWMSY*&2\@5A;[MJ*-RAB3W)<`^V/K3+
M^..]U'6!^ZE5(K4D.H8*0['!YY&!DCOG%`'06VI6-W'+);W<,B1?ZQE<83Z^
ME)#J=C/:&ZANHY(%.TNAR`<X[5R=W$F[5H+N.*SD-L%\JUA"B1&<8EY(S@DY
M!`QSSS4FJQ#;J,$R6C.UNDH>VRB;$=3\XYP<YP<]!VH`ZYKB)+A(&?$C@E5(
M^]CKBF_;;7RI)3<1B.)RCN6`"L#@@GZ\5B:Q>1PZW97:.LBVUK<NV&&!C8.O
MN<"L>:TEL-&U&PN()($N+$S9!&&F0?/]W(^;Y3]`?P`.SFO+:"-9)9XT1_ND
ML/F^GKU%)#?6LY017$3LXRJAADXZ\=:YV*-SJNEV<P5[>+<T.6W!H3&=JG^\
M05].@!ZY-7/#4$*7&KLD<89=0D4,J]!M3B@#5;4;)"0UY;J58H<RJ,,.HZ]1
MD9^M+)>VD4B1RW4*._W5:0`M]!WZC\ZS[^UMVUG3XV@B*2><SJ5&&.T<D=S[
MUFBWMI]/UYM2A5)4FDRS("R+L7RRN/\`9"XQU(H`T[C26FO!/>:A(]LEPLR0
M,`%4@'"Y[_,0>?05H3WEM;[O/GCCV!2V]@,`G`/XGBL'54EN/"=@E\,3R26P
MD(/(8NN3GUZUG:Y)+^^:Z54N4L85FC(R"?/&#N[@\^N,GJ>"`=?#>6TZ.\%Q
M%*J?>,;AL?E1;7EK>!C:W,,X0X8Q.&VGT.*Y74XXXI-4$YCL/]`2$I;\JX=R
M-P!`S@G'X]>>-'3(UL=<\F:RBANKFW#E[5R8FV8!RAQMZC'KTSD4`;?VB'[1
MY!D42XSL)P2.>1Z]#^5*T\*"0O+&HC&7RP&T>_I7'0P;=2DNUQL76&4,9"TF
M2,;-N.`7(/)''YEN@6=N3#;SVR(VH6DB,4;YQ]W?NSUY'&.%Z=Z`.WHK.T"X
MFNM%MI+C)E`*.QZL5)7=^.,_C6C0!F>(=,?6=)DL4F$0E9=S%<\`@_T%:"QH
MARJ@'&,]\?6GT4`,:-'QO16P<\C/-.P,YQSZTM%`"!0!@``>E4-3M]1DCC32
M[F"V&"K[XMW7&"N",$<_G6A10!6T^RATZRBM+?/EQ+M7<<D_6K-%%`!1110`
M4444`%%%%`#7R48#KCC%<%\.!C5-7'/!`Y_WFKO7.U&;T&>`3^@ZUP7PZ!76
M-84G.".3R?O-WH`[^BBB@`HHHH`****`"BBB@`HHHH`:Z+(C(XRK#!![BJ4>
MC:;$LJQV<*B9#')A>64]035^B@"HFF6*2Q2+:0AX5"1'8/W8&?N^G7M5NJ5Q
M=31ZE;0A0L#Y#,1G)P2!UXZ'J.>E7:`*CZ98R3M.]G`TK]7*#/0CKZX)YI(]
M*L(U@5+.$"W8M$-@^0DYR/2K$DRQR1(<[I&*KCV!/]*@O;SR$VQ`-*SK&@ZC
M<?49[#YCTX[T`":7IZ2"1+&V5U.01$H(.<Y''7-6ZR+G65L7DMS&\[01J78'
M)+$D*N`,EB`6X'`&>E:RY*C<`&QR`<@&@"L--L5NOM0LX!.,GS!&-V2<DY]?
M>D32[!+A;A+.!9E)(<(`V3[U;HH`J)I=A'<BYCLK=)P<B18P&SSSG\33&T?3
M7D:1["V:1GWEFB!);US5ZB@"M-I]E<2>9/9V\LG]YXE8_F123:=93R&2:S@=
MR-N]HP6Q]:M44`(``,#@5#)9VLLPFEMH7E7!#L@+#\:GHH`K&PLS<?:#:0&;
M.[S#&-V>.<]>P_*K-%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`<%\347S=+<LJME^I()P4[]NIKO:X/XGEE.DD#<`\A
MVXZGY*[R@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*HKIL0O9I2L9A
MFVNT1C!S*#]_/K@#\LU>I",@C./<4`-EBCF0I*BNAQE6&1ZU7M],L;6W-O;V
ML443-O*(N`3G.3Z]*M*"%`8Y(')]:6@""6SMIIUGEA1Y%1H\D?PMU!]1Q45O
MI6GVJR+;V<$2R??5$`#<$<COP3^=7**`*":+ID:3(EA;JLY!D4(,-@Y&1]>:
MGN[&UO0HNH(Y@N<;QG&1@_G5BB@",PQL\;E!NCSL/]W/%)#;Q0-*T480S/YC
MX_B;`&?R`J6B@"*2WBEFBEDC#20DF-CU4D8./P-17&G65U,LUQ:PRR*"`SH#
MP?\`]56J*`(IX(KF,1S)O0,KXSW5@P_4"HIM.LYWD>:VBD:7:'++G<%.0#[`
MCI5JB@"&6U@F<O)$CL8S$21_">H^AP*BL=,LM.W?8[:.'?\`>*CD\DX^G)X[
M5;HH`I'2;$ZI_:1MD^U[=OF8YQ_4]L]<"HFTB"WCO7TZ..WNKI3F3D`,1UXZ
M>O&*TJ*`(+*V2SLX;:/[L2!![X'6IZ**`"BBB@`HHHH`****`"BBB@`HIBRQ
MO(\:NI>/&Y0>5STS3Z`"BBB@`HHHH`:YPC'G@?P]?PK@_AV-NLZR.,@@<#`^
M\U=W*`T+J<8*D')Q7!_#T!M:U<L@R&R,]0=S?_7_`#H`[^BBB@`HHHH`****
M`"BBB@`HHHH`*ANDWP-B21-OS9C(!^G/%34A`(P>10!SDL""*]O9Y)]T7[NV
M$S9(=<M\O7<2<+P,_+QD\FQI6N+//<0W#EF\PF/;']U3]U..K`<GT)QU'.JM
MG;+/YPA0R9)#$9()SG'IU[5(D4:*JHBJJ_=`&`/I0!6>:SO+!IWB$T"C?B2+
MKCG(##VKGK6WNWN;D^3(DZ,02K9\OS!A7&3\S)&`!P/O-76,H=2K`,I&""."
M*1552Q50"QRQ`ZG&.?P`H`Y>2*[V">"SDE<1FX!D4_/,VX`,,J<*`!TSAA[Y
MW;>:\9UC>TVHO!E:4?,/4#K^!QUJ[10`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`<WX
MN\.7&OO9-;W$</V8N27!.<[<8_[YK/?P]XK>=Y/^$@`WMD@,P`'L,8'TKM**
M`.0?1O%WEQ(NNP-L.<E2I..`"0.>.N>_KUJ-=+\:QV[!-5M#G<Q0J`<DD\'9
M_7%=G10!Q0LO'3,2VHVR9YZ+Q[?=]A_G-/%MXZ&!]MLC[[5_^)[Y_2NRHH`X
M]8/'.,FZL<G'!`XX_P!W_)/I2&#QR2<75BO&W@#K_>Y7_..GKV-%`'&?8O'(
MW'[?:-A<=N?I\O7G]*%L?'(>,G4K,A<=0,?C\G-=G10!Q:V?CD.'-]:$,V[8
M<87_`,=Z=L9-/>T\<EG(O[+!7;A0,>F1\O7G-=C10!R?D^-B^3<Z=A,X&#AN
M/I[_`*4WRO&L6UEFL'`"#823G&`<\=^IY^E==10!R=U-XU4L$@TXX4D-%DAC
MSQ\QSG].E1RZAXW3=C2[)AC/RG.,D\??Y-=A10!QCZEXW4X_LFVZC."#VZ9W
M_P"?6D^W^.B/^07:#(!'*_3^_P"]=I10!Q?]H^."H(TJW`"^JY)_[[J2*\\:
M.LGF:?`I"$H1L^9N.#\_3KS]*Z_(SCO2T`<7]L\>%2/[-M`>#G<F?I]^E:X\
M=98K9VN".,E!CC_>_P`XKLZ*`.,,WCO?Q;6>"/5<#G_>H^T^.1)&AM+3G(SP
M1^.#Q79T4`<C-=>,H['(LH&G4H,H5.X=SC/K_,TJ:GXN6RBD&DPRR8/F*Y`;
MC!SU`YSTZ\5UM%`'*)J7BM;-YFTN)YC*&,)XVQ[1]TYY.<]>1^(Q`^M^+([8
MS#10S/*<(5SL3C'`.3WY]O>NRHH`XL:_XH%G+(=&Q.KJ%C,+D%3DDC![<#_&
MI+W7/$\+*EOI'G'R49V\I@%<KN(Z\XZ<?H:["B@#C(]9\4^>5.DE0$+.3&6!
M;'0?-TZ#CN2:A_M[QB`H.B`D<$^6>?U]Z[FB@#A_[<\9$G&BH`QX^0_+C\?8
M]?;\71:WXP*OOT=02/W>(B?FW`8/S<#KS]*[:B@#AUUKQH`2=&C/&,>6>OK]
MZHY/$/C"/S2VB@;,'_4L>I&`,'GCCCGU]N\HH`X9?$/BR!$FN-"+Q!LNJH0Q
M'/&!DCIUQ3?^$F\3R.H;P]-@#.!'*O/;G\1D>W:N[HH`XF+Q9X@(B!\.S,2H
M5LHZEG!^8CC@8S]#^5(/&FLK*F_PY<;`,.-K@Y[X^7Z5V]%`'%?\)MJ1"D>&
M[KDD=6Y/H/EH/C;4P3GPU=*%<*P.[CV^[UKM:*`.+;QKJ:[B?#5SA3S\S=/^
M^/I36\9ZHX)'AR[4#!X+=B,Y.SIVZ=Z[:B@#BD\9ZGN0'PU=9?.<;ANX[?+[
M?I2_\)IJA"G_`(1NY4%L98M@^@SLZUVE%`'%CQIJI.T>&+O<'VL,L?P^YUII
M\:ZL$<GPU<\`,#\^`/?Y>E=M10!QC>,M65R/^$;NL=1C<>/^^?\`/XU'_P`)
MOJ@D1&\.SAG4E02P+8&3CY>@KMZ*`.(?QS?Q!7G\/W$4?F!"6+#KV&5'/!XJ
M'X=I.NIZA+<Q>2UPBRJIXR"QY`/..:[VB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HJ..>&5V2.6-W7[RJP)')'/X@C\*2.X@ED:..
M:-W7.Y58$C!P<CZT`2T444`%%%%`!29&<9Y]*6B@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@!CJQ9"K[<-EA@'<,'C]<_A3Z**`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`I&)"DA2Q`Z#J:6B@`HH
MHH`S?$9C7P]J)E8*HMWP3V;'&/?.,>^*YR&\@MH(I]">&6YCLV:XBB&X8"9!
M;GKOQWSUZUV;A2A5P"K<$'H<]J:DD3.RHZ%P?F`(S^/Z4`<?HNMW,E_;I_:*
MW2R@EHGFC9CA?X0J@AN!@'CKGD\-TC7)'U".&XU-Q!+&^XRRQL48!2O(4!3R
M3@YZ8(X-=J`!G`Z]:6@#C]!U&4)H\\^JO/\`;#)&Z2,-J[02,<`YZ#GKGZ5V
M%(````,`=`*6@#SJU>W8:+O%A]D^UG`1</D@D[LGG_EF3\O]WFKEKK>I&_A-
MS<I'=-/LDMI'("IG[H3RR1P,ALGCZX':QO%(6\ID8HQ5MI!VGJ0?0T\G`)]/
M2@#EX=1TQ?&)DB>-?,M_(W*",R^:<KC'7W]J>-0T]/&3.DJ#;;-#)MC/$GF+
MP3CDUTNT9S@9]<?Y]:6@#B+C5]334)6:Y\ETF8QQG)1XLC;\HC8D$=PW<\BI
MY+J.3Q//91ZW=0PL$VHHR1*&*;`2IXX!/KZUV%(0#C(Z=*`&Q*R1(K.795`+
M'JQ]:?5*_P!7T_365;V[CA9AD*QY(]<>GO5J&6.>&.:)@\<BAE8="",@T`/H
MJO<W]G:$"ZNX(">GF2!<_G4@FB,WDB1#+MW[-PW;>F<>GO0!)114;3QK<)`6
M`D=2RJ>X&,X_,4`24444`%%%%`!1110`4444`%-21)`2C!@"5..Q'44ZHK==
MJN-K+\['GODYR/SH`EHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`&--&F_?(B[%WOE@-J\\GT'!_(TGG1;-_F)LS
MC=N&*YR]T+4KA;J19H?/O!)')ECM2,XV`''.,>G\3>Q"6^@WT+,SQV<_S3%4
MD8A%W!,=%Z_*0>!Q]3D`Z:21(D+R.J*.K,<`4(ZN@9#E3T-8%KX<DMY;?;-&
M(T&Z08+9<*RH.>JA7[G^`<<FI-&TFYL].F@G2#S&C"QE6)QA2!GY1CKVSU/U
M(!JW[11V,\D^3$D99]HR<`9.!7$:1OMPS:;!!/=16<@22.W:.4'"G$BG(9C]
M3R>F#74Z!I]UIT$T5PT3*64IL`S]T`Y(`STP.,X'>M:@#BM%U6_EU2");MI-
M[?O8Y92Y.!R,")=A!Z\@=1R:DL[XO/8R/JU\;H,)+VV,1VH-K$C&!@`\=3P0
M>>*[&B@#CM$GDOI[B.WUB]F>UF<VZ/\`=F0!?OMMY!8X]NV*IZ=JNH_VA;B:
MZ=KDNGVB%GE;V8;!%A3SG`/IUYKO-H!)P,GO2T`<;8O!IVIWT4]SJ'VHW9:*
M!0[^8"B_.P4?-T.>>U1)JUS%XCB!GNEC-TT<L4C.VU3N`^79@#@$'.2/Q-=O
M10!QL$L5QKEY:+J^IQ0/Y8@`+_?RV>6!(`('4@'OFIIX+];W^QA=W1:6X6XA
MNO-)98=N'4GL<@@>NX=,''652CTJQBN_M4=N%GR3O!.<GKWH`MHNQ%7).T8R
MQR3]:Y._GNC=W7G2ZC%?I,?L4-NA\EUZ(3P5(.?FR?6NNHH`XEGM3XJD^U7-
M^K&*.)A$TC`R[B2@('W><XZ<GZ5VH````P!T`I:*`..U^+S-2U`)!([2(BE)
M+)IDFXZ*ZX*=1W_G4E_;1V^N)/='4HH)K4KNMY)6V-E?E`7)4=3CIQ76T4`<
M7KNH:C_:!ELX;R$K&CQHXF(?C<<*@*\9`.[T/M5G5X;=];L]1>74([:>V8"6
M#S<@G:5`"\KD9/3]>G5T4`<5J=UJ@U-I/])C@9(VME*S@C*C@B/(+!LY#9_E
M75:4T[:9;&Z8O/Y:[V9"A)QU(/(_3Z#I5NB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@#.U/4I[*6*.#3KB\,BLQ\K`VX(')/'.?TJE_
M;]\"1_PCVH<'GE/?WYZ5H:KJMII-L9KJ:-#@E4+89\8SM'4]?\<=:M03+<01
MS1YV2*'7<,'!&>1VH`Q&\07ZJ6_X1W4,#K@J3^6:8?$E]DC_`(1S4>,=AT/_
M`.L?KZ5IRZK;1:NFF.V+B2+S57U7YLX]3\O3_"H[+7M/NK&*Z-Q'&DI<*7.`
M=IP2,XX[_C0!3B\0W9DQ-X?U&./:&W*H8\]L9]OK4@\1,54C1M5)89`$`_GG
M%:4U_:02B*6XC1RP7:6[G.!]3@_E33J-J;.6Z2XB,460SEL*I]">W44`41KY
M(7&D:F=R@@B#COQU_P`YIS:Y(A^;1]2X./EB#?R-:RL'4,I#*1D$'@BF1S12
MO(D<BLT3;7`.2IQG!_`B@#'7Q(K(7_LK4]JE@V+?.-N<]#@\C'7K36\40HA9
MM.U$*,$EK5P,'OT^OY5;T_7;._L);V,R1V\1.YY$*C:/XAGJ.*GMM2M[G31J
M"%Q;LI<%E()`[XZ\XX]:`,A?&-FV,6=^,@8S;MU]..]+_P`)A9;<BTOR,X_X
M]FX'K^>!^(KH%=6C$@/RD;LGCBHKF[@M3")WVF>011_*3EB"0..G0T`95OXJ
MT^5`98KVW8C.V2UD)(]?E!XJ1?$VF,B-NN!N[?9920?3A>O^?2M&WN[>Z61H
M)0ZQR&-B.FX=1[U(\BIG)Y`SM'4T`97_``DVFX8@W!`..+:3UQZ<?C2GQ+IB
MAR[W"!.6+6DH`&/]VK]C>V^HVD=U:2>9!)G:V",X.#P>>HJ/5SC1[TY`_P!'
MDY/^Z:`*H\2::2`6N5)!ZVDHY]/N\GZ4U/$VEM_'<#W-K+Q_X[4^E2W$E@5\
MH1F,(D3/T<>6IW?F2/PJYY(\\R[WR0!MW?+QGM^/Z4`9Q\1Z?ZW)^EK*?QX7
MZ'\:;)XFTR/.Y[@'L#;2`GIT!&3UK8HH`PE\8:*2`;EUYVG="XP??CUX^M/C
M\5:0Y=?M#JR`$JT3#@]#TK89=V,,5P0>*%0*[,"WS8R"<@?3TH`R!XIT<KD7
M1/&0!$_(ZYZ>E)_PE.E;POFRY(R/W#G(]N*VJBMX?(1E\R20LQ8EV)/T]OPH
M`S3XETM1S+*.2`#"_/&?3VH7Q-I;.%,SIQDEXV4#KZCV_7BM>JZ6QC\D)/-B
M,\AFW;Q@C!)^N>/2@"F/$.DF-I!>*47'.UN<C/''/X=^.M/;7--3[UTHSTRI
MY[^E73&QE#^:X7CY!C!Z^V>X_(>^7X.X'<<`=.QH`S6\0:4BEFO8PH;:6.<9
MP6ZX]!FF-XFT906;4(0H.-V3C/I]:L'3Y#;>4+ZX5]B@R#:22,_-R#SDC_OD
M?C=(!!!&0>H-`&6/$FC%78:E;E4(#$-P,].:=+XATB#R_-U"%/,02(2?O+ZC
M\C4TNF02!50+'&F-L:Q)M!Y&<$=<$TU],BF@"RA/,,/E%E084_WE!'')-`%8
M^*=#4`G4H/FZ<GW_`,#1_P`)5H6"?[3@X]S5J;38I)HV`2.-%V[%B7GY@>I'
M3A@1_M'I2#38RS`I;JNX,IC@4,.<X.<CIQT_*@"K_P`)9H6`?[3AY`/?_"@>
M*]"89&IP_CD?TJXFGJO!,04'(V0*#G)]<]L#IGWJ5K2(!5CA@5<_,#$#D<\#
MT_6@"I'XAT>2+S!J=J%_VI0O<CH?H:E76M*?[NIV;?2=3_6K/V:#)/DQY/!^
M44U;2!6SY49```&P<=?\:`*QUW201G4[/D9'[Y>1DC/7V-!US20<?VI99SC_
M`%Z]?SJT;>((0D<:G.00@X/8_G2+:P!-K0Q$`\#8..>*`(/[:TO(7^TK,,1D
M`SJ#^6:3^V])SC^U++.<8^T)U_.I8+"W@>4QPPJLC!MJ1*HR!U.!R?>FQ:79
M11E!:VY7)('DJ`,C!X`[]Z`&+K>E,%(U&U^89&9E''YTIUK2AUU.S_[_`*_X
M^Q_*E.D:869CIUH2QR3Y"\G\O<TR71M/?:%TZQP2-^^W4Y7TH`7^V])SC^U+
M+.<8^T)U_.F_V]I&"1J5J0"!D2J1FB70M+D(/]FV0.023;(21Z=*>-%TL'(T
MVS'!7B!>AZCI[4`(=;TI2-VI6BY&[YIE''YTJ:UI<APFHVC'T692>N.F?<4U
MM#TIB#_9UJ"/2%1_3BG?V/I>"/[-L\'.1Y"_X4`21ZC92R^4EW`TF<;1(,YS
MC'YC%$NHV4,ZP2W4*2MC"%QDYZ<?A4?]C:7_`-`VS[?\L%[=.U+_`&/IFW;_
M`&=9[<8QY"XQ^5`#_P"T;(NB?:X-T@W)^\'S#D<>O0_E2C4+,Q^8+N#9QSY@
M[C(_.H1HNE#.--L^3G_4+[>WL*0:'I*N'&F688#`Q`O'Z4`71+&0I#J0V,'/
M7/2E5U<91@P]0<UGMH.E%T(TVQ"KG@6ZY_`]N]-/AS122?[+M.?^F0H`T@ZG
MHP/..O?TI<C.,\^E9:^'=)VGS-,L6))Y6W"C&<C\<8Y_ETH7PYHX&#IEH1DX
M'E#C_P"O0!JTA('4XK-'AW1@5(TNT!7I^Z'Z^O6H7\.:8MW$\>FV@C*LD@V'
MICC`''U)]J`-FD!!S@].M8J^%-&4%!8IY?!`WOG/USTZ8^E-OO"VF2VP2#3[
M7S-X;=)NZ9YR0<G@G`SCIZ4`;M(2!C)Z]*Y__A#]'G8M=:?#G:/]7+(.<G/?
MIT_7K4O_``B&A88?8!\PP?WK_P"/^<GU-`&Y16%_PA^@Y!^P#@Y'[U^/ISQ2
M?\(9X?X_XER\?]-'_P`:`-W<-N[(QC.:`00"#D'H16$G@_0MJEM/4/U_USG!
MZ\'/K3;?PEHWERJVF^4&<@JMPY#CL3SZ=NU`&^&!Q@@Y&1SU%(K!NGY$8-9"
M^%-%082S*C&,+,X&._\`%W_6H[CPSIZ02/!;S/,$;:!=.I8X.!G/N0,],T`;
MBL&4,IR",BEKG[KPW:H%$,5Y.&8*5-](HC7(R1SSC'2GQ>'H8PJ(;U%="TA%
M_(,OQP1GG([^W2@#=HK(_L:$PHY-]YNT#:;^4[<]>2V/_P!5/_L*V!^6>_&1
MRPOIL_\`H7U_.@#4HK+.A6A)!DON.0?MLO!]OF_SFA]`L2#S>98\XO9NOK]^
M@#4HK#&C6Z>2)&OV>>0AMU_)E!AFQ]X9X&WN<?B:F'AZS!7][>D`8(-Y+R/^
M^O6@#6HK(7P[:A\_:M1*@Y"?;9,#OCKG_P#547_",6WD^6;[4S@\,;Q\CZ=O
M?I0!N45A_P#"+VQSF_U0AL[@;QN<^OZ_G0/#$.TJ=3U4@YP/MC<?3\Z`-RBL
M/_A%[7O>ZD0.@-V^._\`C^GUI?\`A&8-P)U'5&XYS>/\W&.:`-NBL4^&X3C.
MHZI@8!'VQ_F`[&F_\(S%N!74]64CIB\;CVY_'\Z`-RBL9?#J(6*ZIJHW?]/9
M./SIZZ%M`"ZKJ?'3-QGM[CF@#5!!Z'-+6%H2R6VLZI9-=37$<*PLAFD+L"P;
M.3^`K=H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`*>J6"ZE8R6S.(]X
MVE]H8A<C<.?49'XU+'%,MU([7&Z`@!(=@&S\>I_^O4]%`'):IH>KW4MPWVB!
MGF96CF5F22$+_`GU!;TZDDU4ET'5[JQ:TGMK<!;>."-HY`KJ%W9/3^+@$9QS
M[5HZI?6MOXLMI[N298+:V;841W7S&8K@A0><`_7CTJMJ%_+_`&K=ZC;Q\Q&*
MSAE5&8C*EV9E`Z`MCZ_D0""ZT76YO/+6%LQN)DDF*S`;@@P$&1]S@>^-WJ,)
M/HFK27(G:Q5%,S3LJ7`;:Y7:NT;<<<'D'OVI#K5[+'I1N[PV<T9EDG<0LP.V
M0HJLJX)R1C''3UIMWJNK?88[M59)(+#(+#YM[N%S[D*`Q'/+?3`!?LK/5K33
M[C3TT>-;>82!F%V-_P`V0".,#CZ<G/'2H7T.^^T;H],B2,VK0LOGJ,DC&<!>
M2"`>?Y]*<]Q=P286]:$_:HM.#EBS&,<.[!F(QN'WL`_G6QI^J:G>W4EBTL,,
MMI)_I,Y0%64D%`@SU(XSSCZXH`+BTU-]%&F6NG):0F/RW9)UW'C'`VD<]">O
M-/N[74;O2(=/_LQ8H5V`@7*D@*1@?=QV'3_]47B&[@34U^VW]U;V:0H0MOY@
M$K,S`@E.^`,#/?H:JG7+NQ@BM8Y)1MMQ-$]XN^6X;=_JCCC=@^N>GO0`^?1+
MN=F>32HG8WGVIB\Z;G&<[,[#\O3CVH@T>]M+D3#2TD19Y9UC^TJ0K/M`P-F`
M%`XZ]_P+_7=52ZFDM9+988KN&V,,@#'>R_,-P/0$]<=O8BHV\17Z2"":]MX`
M;F>,W+0DJ(U*@-@'C#-M!/!QSF@!BZ!>QVNGP-I<<@M0P)^T@*VY@6R-OI^`
MYXQBG#1+VV20)IAE:2V,"*9TD\D*5`(+!1A@6.,9RHY`Z-E\4ZA';VP8K%/Y
M$DY:2'Y9D#?+QN!4D`G'HP-6[_7-46YNQ9BW(@GAA"-_&Y^\BGC/)'/Z4`2^
M';?4;;4C'+97-I9+!MCB>X22-"-HXVC.X_,2<]S6UJ__`""+WC/[B3C_`(":
MS(-6OI]7DTZ&.)FBDW/,ZMM$14,N..6.XC&>B'ZUJ:K_`,@F]_ZX/_Z":`,.
M]D>'0"R3,D3/#]L>(C=%&8T#8]\;3SSALCM27H@1]1CLY&B3^SQ*6CF*X(+'
M.<X^I].];.CK$+3,94LP0R8&,-Y:=?7C%6T@BCW!(T4-G<%&`?KZT`<D8B;"
M9)IPAELGDB6.9B6<%F+8S@$':1CIR/2K-]->K=0V5Y)(&2*8K)'E4N$V'!//
MWQ@$CU.01TKH8;*UMY&D@MH8G;[S)&%)^I'U/YU,5#=0#QCD=J`.):\GBTZ.
M87LIFEL8I6'G,3@JOFOC=U50".!]X]:U+VSM8[206%[="X:TE,:I.W[TX)W,
M?[V6Z\=?0<;L=I;Q2M+%!&DCDEG50"V?4CK1!:6ULS-!;Q1,WWBB!2?KB@##
ME=)I](A^US9,+F58YR&/[OJQSZYY]<<TOAW5;>/P_92W=V"\D99GDF:1BRAB
MV<DD8"D^GTK;AM+:`,(;>*,,,'8@&1^%-6QM$)*6L"DYR1&!GC'\J`,/3[ZX
M%[$-1A$$6I*S1KYF2CYX4$>J8/U';BLWP]J$XNM-^T22J'@<$O<O*+ALMD<\
M;P0./?CBNT,:$*"BD*<KQT/M2&&,@`QH0K;QE1PWK]:`,?4#.?$,,=LP\PVC
MLBR2,J$B1.H'L3618R/(R6SW$H@FO+B.4F5@P=6/EQEN<`@=L=/S[#:N\/M&
MX#&<<XIDEO#+&\;Q*4<Y88ZGU^O`Y]J`.6N6"V^H6T-]--!#>6\0)N"73,@W
M(&'/&<9))Z]Q6GK;Q2SVT:7$@<3)%*B2,H*2$J0<=_E..XQVK5AM8+>W6WAA
M1(5``0#BH(])TZ(`16%M&!(LH"Q*,..C#CJ*`.<N;RYM8=2AM-0DFMH4C87+
M/O*2%U&P-DYX'0\\\YSFK-Q<:C9RW,X%PUG:_N)59V9G3;N$J\=06.<'I_NB
MNA%K;B-8Q!$$5=@78,!<8QCTP`,4HMX1*THC7>R",G'51G`^G)_.@#F]*6>^
MF1-1NI_.@@@D$:RL@.5RS$CKR#[=NA%4S=WUWI5K>V]S.(X+;]]!Y_[YH\\2
MY&!NPI//H1SGGJY]-LK@1B:TA<1(40,@^52,$#T&.*;+I>GS%#+8V[F-=B;H
M@=HSG`].:`'V\L%U;F..;S,(`^'PXRN1G'()!SVK&\-7AGTF;[9=R>9)<R1"
M224;B<D`+Z<#@>N:VXK6.&ZN+A!AI]I?W(&,_EC\JABTG3H9'DBL;9)'!#.L
M0#$'KS[YH`S+"_N!X-%PMQYMXMLS!F^=BW..!U[?6K-M;0+<VEPFKW$H=I&C
M1Y@1+E>0!W`QG';FK<6E:?!-'-%96Z2Q+M1UC`*C!&`?H33XM/LX)5DAM8HW
M3=M*H!C<<M^>*`+-%%(5!()SP<C!H`6BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`:RJQ4LH)4Y4D=#C''X$TZJMW%YD]FVUSY<Q;*MC;\CC)]1SC''7\#:H`R_$
M=]/I^E&6VP)'D2,,?X-S`;L=SSQ_7I5">\U6RU2.U2YAU!F)<P[1&X38QP2`
M1U7CCKU.*VK^2TBM&-_Y?D$@$2+N!)(P,=^<52TBST>6T273XK>2$.Y5E^;!
M(VGKSTX^G'2@"LGB1I'1TL93:N@828.<E`^,8QC!'.?7C@U4D\17<=];K/$L
M:X8/%O#`M^[VL7`^48DS@CKQW%;$FG:6EW&?LUNMPZ!(U*9!"CLO3@'&>P..
ME.71=.$"PM:1R*O3S!N/;N?]U1]%`[4`5M2U.XL-44+&);40AI%W89<N%W+Q
MSUZ$@<56C\32+&TES9;8A'YRR*Q.8PX5F(*Y4@'=MY]"1Q6E<1:;>7<GFB)[
MBU4;]Q^X#R-PZ$<9Y]*C@T?2F(GAA5M^UP=Y((W;QC)X&X`X'&10!!=:G=?V
M=IUY&AC^TSQ_NOXMK*<*3@\DXR>,>M0V6KWRZ#I]S)$+VZNW/[M'5>-K-P>G
M`7_/6K]M!I4\*VMO'&T=G<?+&H.(Y%Y_3=].:2[T[3+?3(UFB,=M9#<C(6S&
M`,'D<],YH`N6-R+RR@N54H)4#[3U4D<@^XZ5/4%G#;V]I%%:*%@"_(%Z`'GB
MIZ`,7301XHUK..4MR,>FUNOOQ^6*VJR-/"?\)+JY#'>4@#`YX&&Q_7\JUZ`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`HSZ-IES(\D^GVLCN<L
MS1*2Q]2<>],.@Z.<?\2JQX_Z=T_PK1HH`SUT/20@4Z;9D`8Y@3GI[>PI3HFD
MDL3IEF2W7,"G^GM5^B@"C_8VEYS_`&;9Y_ZX+_A[G\Z/[%TK&/[,L\>GD+Z8
M]/2KU%`%$:/I8SC3;,9.XX@7KZ]/>E&D::I!73K0$9(Q"O?KV]ZNT4`4QI.F
MJ25T^T!/7$*\_I3/[&TW>SK8VZEE"MB,#<H.X#CW`/X5?HH`S/\`A']+\GRO
MLB@$DD@D$D]2<=<_T'I4?_",:.6W/9J_3AF)'"@=,XZ**UZ*`,RU\/Z39W$4
M]O91QRQ?=8$Y'&/7GCUJQJO_`"";W_K@_P#Z":MU4U7_`)!-[_UP?_T$T`)I
M:;;&([%7>B'(/+?(HR??C'T`JY5?3_\`D'6W_7)/Y"K%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110!#/OW0[)O+`D^88!WC!^7GISCIZ5-5:\@DF:V,8B(CF#MY
MBYXP?N^AY'/UJS0!F:[;37$$'DVXF,4Z2</M90,Y9>.H]._-8$.F:I_Q+A-!
M,%28OA&4$?.'S(5(&2,@D`]#P2<ULG6G31DOVB0[K@PXWX`!E*`\]>Q_.HYO
M$T"M&L5O*S22*H5E8%D(<AU"@E@2A'`SWZ8)`,R;P_>0:>GDJSRB.4S'S,N<
MNAVISW5<#]3V+4T_48KO37%O=R;=ARS@*@\UB0V#D$*PXY';J*TKOQ&4E_T4
M0/$T;E&D9E*D1LX+`@<?+@CJ.O'2K-OXBL98Y'D8PE7*JC#YG&\H"![LI&*`
M*LL=Q;>(;[RK*XFBU".(-,I"K&0&4\_3!_'\\D:)?+Y"RQ7&TLR,HE8JJBW&
M/NGC]X#^(%=)>ZE<1WCV]G9_:6BA\Z4F0+P2P"KU)8E6]!P.>>&KXAT_)221
MXY%#;U,;':50.RY`QN`ZCKQ0!S<6EZL@DD6W<7+?:`KD_=9HHOFX/?8R_4@]
MJ<=*OY=*FMS;W;(6D2V3<%\L%4PQ!;UW]R!S@&M]/$^E.&Q-(-F_=N@<8*+N
M89(QD#DCK[4YO$FEI&7::4*,YS;R9&%W9(VYQMYSC&*`+.EK=):HMSY84(@C
M"@A@,<AL]ZNUECQ#IA=E,[*%SEC&VT8&X\XP..?I5VVNH;KS?)D5_*<QOM.0
M&`!(_6@#.L`P\3:N2/E,=OM.WV?(S_GK6Q638KCQ%JK9;E(!C''`;O\`C_*M
M:@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"JFJ_\`()O?^N#_`/H)JW535?\`D$WO_7!__030`NFL
M380`K@"-`#ZC:.:M5E^'QBSD^649=?\`6'.?W:=/:M2@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`**@N(&FEMG60H(9=[`$_,-K#''N0?PJ>@#'&@(0R/?7<D1
MF$PB<J54B3?Q\N>N1U[_`$Q!_P`(I:1OYEM<7$,H(*NNSY2-V#]WYCESU]O2
MM^B@#$'ABT\I(S-.5$31O\P^?<I4G_QXGZU&-)MXM2L]LZB"S:1F#3?,TCL7
M"E1@<9)&?:M^N7MM%T_4-?UHWUJDQ2:,KN)XS&#_`%H`T;_3/[1E\^QU`VS.
MGE3/"`V],[L#G`/)YY^\?6J[>'!)?2G^TIQ`RNWDKC>K.NS=O.2<+P!CC`]*
MM+X;TA4"+9(%!S@,V,XQZ^E4;K3+2QU_1WM8C'YD\F\*Y^8^4V#@GZ_F?6@`
MO_#+3QW/D71#RRSRJL@)&9(O+()'H22#C@<4LWAE[BV"3WC22,V'W#"B/;@(
M%&!QQR1UR<5T5%`&*F@^7`$,HN`LWF[)!@.##Y94]>#R<X[XJWHMA_9NF16S
M$-(N2[`D[F)R3D]:OT4`95B?^*@U497[D''?HWZ?_7K5K+LO^1AU0?-_JX#@
M].C]/RZ_X5J4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!14-U<):6T
MD\N[9&,D*,D^P'<UFR^)=.B1RS2DIC<%C)P3VSTR.XSQCTH`V**R)/$FF(L;
MK,[I)*(PRQG`///3D<=1GJ.W-"^)=+9-RSL<*K,!&QV`GN<8X[\T`:]%9$?B
M;2I)S"+AMV2,^4^.!GKC'/;UIT?B/29`/]+5203M92#@?A0!JT5DQ^)-)D5"
M+Q077<%(.<=Z>/$.E'&+Q#DX'RGD_E0!IT5F'Q!I0_Y>UZ[?NMU].E(?$.E*
M&)O%`4X8[6POUXXH`U**RW\1:0GW[^%,?WCC^??VII\2Z,"<W\7!"G@]2,@=
M*`-:BLP>(M'(!&H0$,NX$-VPQ_\`9&_R10OB'1WDV+J-N6P#]\="<?UH`TZJ
M:K_R";W_`*X/_P"@FF+K.F-LQ?V_SC*DR``]/\15?4M3L)+"[@2]MVE,#X19
M`2>,8^N2*`)-"S]C;,#1#*X))/F?(OS#T';\*TJY[3-7TZWLL02VYD,D:R(L
MF#N*J,G/T[<<?6M"'7--N&7R;ZV96S@^<H)()!&.O8F@#1HJFVK:<I`:_M02
M=H_>KU].M-_MG3-^W^T;3)(`_?IR3VZ]:`+U%9$6NVH"B:>`EV4*4F0[LGJ.
M>@!7GWJU_:EEYLB&[M\(H8GSE)YSV[=/UH`NT56.H60QF[M^>G[Q?\::^I62
M!O\`2X"0I;;YJY/YF@"W16?;ZS831;S=0Q')^5Y5!P#@'KT/!'U%$FMZ>B,P
MNH7PVT;9D^;IR,GWH`T**RE\06+6AN0X"@)\IEC!RQ.!][`/!X)%(?$%H))5
M&UEC+*9!<0[20,XY?.3[CZXH`UJ*HG46\E)([.:0/T"/$2>,\?/SQSQV!_%\
M%\LR2,8GB"GY?,*C?U&1S['K0!;HJBFI!HV9H)$*F(%25R-^.>N,#//T.,U)
M/>I#/'$59O,C>0,,8`7;U^NX8H`M45034PPMP;:96G7<%)7(//!.<9X]:L1W
M4;QAG98R1DJSKD?7!Q0!/14#7ENDWE-(`V,\@XZXQGIGVJ&YU.WMCAM[_*6_
M=C=G`8]!_NX^I`[T`7:*JF_@%RL`W$G)W@?*,#)Y_+\Z(]0MI5F97XB8JV>,
MD'''KS0!:HJJVH6RRF,R#<O7L!P#G/I@CFI9YQ`%+)(V3CY$+?RH`EHJ-YDC
MECC;<#)G:=IQD=B>U(TZ*4'S-O;8"BE@#[XZ=,<T`2T4P2J93&`Q(&2<';UQ
MC/3/M3&N8Q*(ES(^X*P3YMA(R-WIQZT`344R21(DW2.%7U)J&WO[6Z,HMYA*
M8<;]H)QD9%`%FBH;6ZBNXO-@8M&<;7P0&!`((/<<_GD=J='-'*SK&X9HVVN!
MU4^]`$E%17%S%:Q^9.^Q,A=V"0">F?2FM=VZP/,TJB.,L&8GH5SD?H:`)Z*@
M-Y;J%+3(H9BH+'&2.O\`+-+)=P16TMS)*HAB#%W[#;D'\L&@":BJ9U2R!8?:
M%RN_(`)^X0&_(D4]+^V=G5)"S(P5@$)()<H.W3<I&>G![4`6:*9%(DT2R1MN
M1QE2.X]:AM]0L[D$P7,4F`"0K`E<@D9';H>OI0!9HJ""[AN;=9[=_,C9=RE?
MXA@'C\Q42:I9.L;+<*1*&*<'G:P5OR)`H`N456DOK:%-TLZ!>NX<@#(P2>WW
ME_//2FS:E9002SRW")%$Q5V/0'&<?E0!;HII=0A<L`@&2Q/&/6E#`D@$$CJ,
M]*`%HJ.6>*!=TLBH,$_,<<`9/Z4OFQ_O,L`(_OD\`<9Z_2@!]%-9U09=@H]2
M<5')=V\4<KR31JL(S(=WW![^E`$U%1O-$D9D>5%09RQ8`#'7G\#3PP;.T@X.
M#@]#0`M%1O-'&6#NJ[5WDL<`+ZYI%N(&&5FC(R!D,.IZ"@"6BHS/"JJQE0*S
M;%)88+9Q@>^:3[1#O5?-CRQP/G')]!^OY4`2T5`UY:KC=<PC/JXIPGBV!C+'
M@KNR&&,>OTH`<\B1E`[8+MM7W."?Z4^H)+J-)(4#QLTK8`W@<8//OT[5/0`4
M444`%8>C,6\1Z^!C8)8<<=_+&?Y5N5G7&AZ;<W,MS+;;II<;V#L-V!@=#V%`
M&C6+K:L=9T,A<XN7R?3]VU3_`-@:9S_HYYS_`,M7[_C3H-#TZWNX[J*WQ-&,
M*YD8XZ^I]S0!HT444`%%%%`&38N&\2:LH;.V.#(*D8X?\Q]/>M:L+2G9O%>O
M;B2$%LJ]>!L8X_7]:W:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HJ
MCJ]])IUG]H2%)%5OG+R;`BX/.<'/.!@#/-/TJ\DU#38+N6V>V>5=QB<Y*_YZ
M_C0!;HK!U;Q'_9VJ"Q%O&3Y:R>9--Y:G)(P/E//'?%-B\56'V>*1XKH3S*9&
MMUC9F0`[2Q]%XSVSZ9.*`.@HK&;Q-IPN%@C^T3N0I/DPL^T,H9<X]0>,4A\2
M6B7=Q$S*R12^0!&'>1I.X"A>>_0GI[T`;5%<];^++2::X'E3+%$Z1KE&WN[`
M_*$QG(P2:L#Q1I;K;F&22=KG=Y4<43.S;3SP.G^30!LT5BVWB?3[RYM(;47$
MQN5+JRQ'"`'!+?B,<9_+FK6JZM#I<<9>.6:65PD<42Y9C_(<`GD]C0!;EMH)
MU*RQ(X+!B".I'?\`I0+>$`@0Q@$Y("C_`#WK./B*P%C:W7[X_:D+PQ+&6D8#
MK@#/3O4*^*],EB\R`SS<L-D<1+87&6QU`YZG%`&F=/LCUM+<_P#;-?\`"@Z=
M9$@FSMR1T/E+Q^E4;SQ+IEHR*TSREH?/Q$A?$>,[CCH*>FNVC:T-)C69YM@;
M>JY0#;D$MGTH`LC3+`*JBQM@JG(`B7`[>E5M3T^R32[ITM+=66!]I$:@C"G&
M.*U*J:J0-)O23@>0^3_P$T`5;>PLO[,@F:PAF=8%;:(D+,0`0!GOD<<U*+*S
M&Q1I48$B_-B*/"^QY]STSWJ?3CG3;4XQ^Y3@_05C:WJ-Y::J5ANUBC6",K&\
M89'D:0J-QZ@=,G/&/P(!?MM.T^56#:-!!@+D-#'@^PQZ?ESQ2BRL/M@M_P"R
MH0-C$2>2FW'''J,[CU_NFH5UW;-';265S)/MC,I@CW(A8'J200`5(R0*JW/B
M""^TJ]%NLZ-]CED9QL)A(###8;[WRD@>WL:`+ATZSN9'@ET6%(L`&1D09R.@
MQSD<#TZ\U.=%TPMD6,"G:5^1-N`<YZ>NXY^M5KK7?*:XCBM)6>``G<5&<[<%
M1GYAR>1_=-*=<'FRHEE<.L3R(T@QMR@R!G/?H/UH`KP>']+618SH,:J692Y*
ML,`<'KD@_GQS3QX:T9;E8QH\!C*[O,QP"#T_'/Z4#Q&K/&B6%P[M&)&5&0E`
M6VC/S=>#^@ZFA-9GGUFS@C2-;69KB,ECEV,9QD8/`R#_`)(H`F'AG1`/^07;
M?]\>V*K/HVA+`9O[%5@8R^$@R2..`!WZ8'UQWJ37];.F20Q0KODQYLB["Q\L
M'D#'1CS@GC@YQP:-1\206)*K!+.WV<3@+QD%E&W_`'OF!Q0`Z#1M'E:6'^QX
MXU4J3OA`5CR!CL<<_G35T716CDD&B1#8QCP;<`M@XW`=QR>?3\*9<>)D@GN5
M-E.T,!D7S1C#LBEB!GC^%N_\)I\7B%GPC6$J2M-'$JEQ@AUW!L^G!]^E`"MH
M^E`.BZ+&5CG08\E=KD@#</4`,<_0^E2OHVDIY5N-(MVC=B21"NU2`>3^>*C\
M17MY86WGVQQ&I`D94#LH(;YBIQP#MZ')R?2HV\0"WAC+1F[2,0K<7$'W5+KG
M=CTZ'Z,*`!]%T9[5B=(!#,B'9!Y;M\P&<#!`S@GH.,]JGE\/Z1/L@EL%=(H]
MJ;LD*"2<#GCG/3V]J@M]<=?-BFC\V6-;F;(.WY(Y60#'K]W]?Q@N_$<DMC/+
M:1K%Y3Q*'=L[M[*0`,8.4.>#Q0!(/#.AR(8VTMMN\Q@%GZ#N.>![_P"-.;PA
MX?169M/3&.29'.`/QXI[^(HXY@DEG.JN9EB;*G>T1;?P#P/ER/7GVS#+XH6*
MUEE-F^^.=(2F_`PZ[E8MC`!R!STS0`L'A?P_(BD:5LWYP'#@X'&3SQGKS@_B
M*F'A+0@,#3H\>FYO\?\`/%;(.0#C'L:6@#%/A/0C@'38L*20,M_C0_A/0WC*
M-IZ;2`.'8'`[9SGM6U10!B#PKH;@,+(8QC[[CH",=?0D8I!X1T-3D6;#Z3R<
M#T^]T]JW**`,K_A'=,SDPRGD'FXDY(QS][K\HY]J8GA?2$SMMY02=V?M,N<^
MN=U;%%`&%+X>TM[CR4DO(I!'N"I<R`8)/(R<9Y/YT^;PS:2,=EUJ$*D$;([I
MPHXP#@D]/ZFMJB@#`;PI"Q.=4U8AAA@;KAOKQ4(\-0+<Q0OJVKF0(7!$[`$`
M@=<8'7^M=+10!@'PI!R!J>K*.V+L\>O^%(WAFU60(VJZF&DSM3[81G@9P/P!
MKH*2@#"_X16#>6.IZH<@C!N>/Y<8I/\`A$[7<"+_`%,>O^E-S[?Y]:WZ*`.?
M;PQ9QO&6U'4E);Y?]+;D]?Y9J%="TV*X@MSJ]_Y\N6B3[8<D@?,0/SKI2`>M
M```P.!0!S[^&+*W4RS:CJ(C0#.^[.T<]3_G'%(NB:?$3*NLWJ!5!+?;<8&>Y
M].W/%=%2$`]:`,-?#,&-R:EJ6XG<'^U$G.",Y[]3^9IS:3#%.D0UG4$D?&R,
MW.20.<`8]CS]?:MNB@##;1;=+F%9-7U`3LA2,-=89E!!;`[]LGZ5'_9UE.XC
M_MN[>1&W*HN067YMO3'3<,9KH**`,.'PX8XMK:OJ9<G+NL^W<>.>GM0-'C,A
MM8];U%7C7)C2=<A3D`XV].N/I6Y10!AS>'[B0N$UW4E1B?E+J<`]1G%5IM'F
M@9P?$4Z`8F962,G(!^9L`<?+QZ!<>F.EI,#.>]`'.3Z#.K*LFO29F4P@3Q1.
MSJ1RN2,G(`./8]<FB;P]=_/)-KKY?"N[6T7S#D`$XYX8CGU_"MZ:V@G_`-;$
MCG&,D<]<]?J*<T,3A`\:,$(9`5!VD="/2@#GAX>GE4`ZXTBR'S5!MHFW<[L]
M.?F;/X^]./A^[`9&U^8!\@CR(QN!))!XYR2WYFNAV)N5MJ[E&T''('''Z#\J
M8]O#(Q:2&-B<9+*#TSC^9_.@#G#H$TTDEHVORL1EVB\B/^(G)QCN?UYZTHT:
MYAF:&+Q'-'(V"X$,8ST'4#KR/?I738&<X&?6F/$'5@50DD,NY<@$="?7&*`,
M"7P[=LS33:],3Y91V>"/E>>#D=,$_K4<'AB>$@PZ[,A!Q^[BC7G;CL.N,_3/
MUKI719$9)%#HP(96&00>QJ*.SMH@1';0H"<D*@'/K^IH`Y\>%9QM(URX'S;E
MQ$G!SNR...1GCT'I4L/AR4;735F*F3S5*V\6!U/'''4X(Z9K;-G:D`&VA(&,
M?(.W3\J2.QM(BICM8$*\J5C`Q]*`,3_A&59I`^HAFD(W@VL/7KD#;P>I^O-2
M'1+DD*=8R?NX-I#RN#\OW>F&/YGUK9:U@:43&"(R@@[R@)XXZ_3-.2"%-NR*
M-=I)7"@8)ZXH`QH]&FC>,1:MM:/=Y8%K""F2<@?+QW_7\)O[-U%D8#7[@YX!
M\B+CGV7\*TFMH&9F:&,E^&)4?-QCG\.*6*&*$$11I&#V50*`,^.SO5:/_B=R
M.,$8:*/YSGKP*5;746E<'5DV@#Y4MU#+T[DGW[>GISH+#&C%DC16/4A0":2.
M&*(L8HT3<<MM4#)P!D_@`/P%`&5]FUH-M.L6H`4G+6N6^I^8#CUI%M-?8J1K
M%ILSNW"TSD>GWNG^<UJ+:VZ[ML$0W9!P@YSDG\\G\ZE50JA5`"@8`'04`8\E
MKKZIE=5L^^=UH1@9Z_?]*/L?B###^UK3.?E/V/MCK][N?K6P0&!!`(/!![T*
MH10J@*H&``.`*`,1K7Q(&&W4[%@!_%;$9/\`WU0+7Q("/^)G8D`]?LQ^;Z_-
M_+TK;````&`.U,\F/R#``1'MVX#$8'L>HH`Q?LGB7*YU*P.&SS;'C]??'X?6
ME^R>)<#_`(FECQP?]&/(]>O7VZ5JR65O)$T3Q[D9MQ!)ZU8H`YOP\MPGB771
M=RI+-MMMS1H57[C=`2?Y]<UTE8.DY_X2W7\XQMML8/\`L-UK>H`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`,W6-&AUA85GFG00MO41L`-W&"01SC''U
M-26&EQ6$\DJ3W$K21QQGS9-V`@(!^ISDU>HH`YN?2+J:2_6864@OF1I0TC@X
M`"@#'3I^O6H)/#]Q>*I,MN[)";9W\XR%DR"%;*X/.#T!^O6J^K@2>(7OH;Q7
MNK%HUMH7E2/SCD^;&#W."!['BLO3KR9M/0QR7,4MWY][.UH2Q9]Q"KP"1C@X
M)`P>30!O7GAR\O)=\QMW0.&6(R-L7@`A>,J/E'`/Y4I\.78F>:/[-'*9GN!(
MCN&5WQNP<="!C%9MS>:A+]BWWUW;P1Z<))W0[6EE(W%1GJ1C/`R`&^E%KJ.K
MV[^>MZMP\ECN*3L%C6;<0$7.,,,-D'Z=,8`+P\+7&Q5/V8[97G#EB6WN,,"=
MO(/Y\#TJ:UT/4+>YCE'V0&.!H5(=@0&.2PPHPW`&?3Z<UO#MU>I?*+J_D,#(
M'D6Z)R9&!X3<BX&0>!GM[U'JFMZG+=2G3?.AV2+&`RAD&XXWL=I&WT.X=/S`
M+MKHNHV5Y!<6R6<;P6_V9?WCE6C!)`(QD'.#GGH:;>Z+J%Y=O=W45I-)RJ$S
MR1B),X^7;W())SW/7'%5[G5M8?[3<VSS(JW@@AMQ;APR8!,A.,[2,G/N*@UK
M6;JX-]:)=21R?:%MEMHH5<&-L`.S8XW9/?T&.M`%U="U");$VK0I]A3;"PG.
MYP3D[ODP00!QQ]>U,M=`O88;80F"2:VB,)F,V[>"P?D%#C!P1R>.QS5OQ2T0
MT<6JS30V[8A:6`AO).1@OSG;PP-<W)J)MM`OY+9S;F=T5)[9)!&RD8SM?E<#
M@L,\[0,T`;7_``CEZ(;V)$A5;F&*W&)^8T08P/DY!SD].16GIVGW46N7-_-'
M%$MQ$J,D<F\`J<*0<#MGM6/;2ZE:27<-A="6STV)$1712]PP7<1N]BR@CWP,
M'FHT\2:A#I]Q=0W$>I)';(QVJ`4E.">%'W0NXG/(*'.!U`.UJAK3L-&U':!\
MMK(1SSG:W;_Z]<KJ.KZI%H5^T.II>,@C*W%O$.,E@X!4D#`"G/O[BNBN;?['
MX1FMMWF""Q:/<O&X!,4`6XTE;2H4MW1)/+0!N2`.,X_#-4I+W2IC?37`0&$B
MTN"YR-I;`!QQ@EO\:TK(%;&W!&"(U!`[<5S-SH%[$E]-&BR27-X79$<\Q$H1
MZ<JR_D3ZT`:<GANR\R&:,2[X00H:4D,,DJIR>0I/`]A5.V\.2P2;)F4P3*T<
MJ6VY0=R!6)!.,$(.@SDC!XYH)H.HF^N"MI%&K17$?F@\EG!VG>3N8<\Y"C).
M`>,6&\/R0W-TUM9J@%R@MW!`\N,Q@,1SP,]<<F@#;DT33YY9I'AW^:C1E2V5
M7/WBHZ`G`SCT%,@\/V5N[M&UP/,!\Q3,Q5R0`6(Z%CC.>YYJGX9TVZLOM2W$
M301ED\M`5`X'HI([X]\5T-`&6V@V3M;EC<$P1B(?OF^=/[K\_,/8TJ:'8QZB
ME^D<OGH[NH\UBJE^&(4G`SG)K3HH`K"Q@$US+@E[E0LA)S\H&`!Z#D_F:P-5
MT.1)(!9QSO"D201[+EU:,%\L3SR.5/)_@^E=110!DOX=T^0W#2)*SW.XR'S6
MQEEVL0,X!(S^!(Z<4-HUE+'Y_P!GG#L4D$8DPRLJ%`.N`0"1UK6HH`SFT^*]
M6*Y=9H)RBJ^6&XH,Y1NH/WFZ<\\&HTTBU:38$D2&$1Q&,D[)`@!0_0$D>AQR
M#@5JT4`8M[I$+P.L<5PA#O\`-$X+2*^6<9/13N/N#TIEQH5O=[8F%S&-JJ#O
M&Q?*8;3CU(]L8ST.*W:*`,C_`(1ZT$S,))1&1*4C!`$32`AF7CK@GKD#-0_\
M(]#BXA2YNU,HB)D.TCY4,?<8S@9/U%;M%`$<$*6\$<,8PD:A%!/8#`J2BB@`
MI,_,!@\C.>U+10`5''+OD==CKM[L,`]>GY5)10!'#*90^8W3:Y7YAC..X]J<
M&RS#!&/4=:=10`4444`%%%%`!1110`4444`%%%%`%>6]MXHI9'D^2'/F$`G;
M@9/`[X&<?3UJQ2$`@@C(/4&EH`****`(/M=OO"><F2Q4<]Q@$?7)`^M+)=P1
M.4DE56!48/4EL@8]<X/Y4]4"^YR>2!W.:<5!()`)4Y&1T-`#3(BRK&6^=@2!
MZ@8R?U'YTW[1$)I(BWSQ(LC#T4E@#_XZ:EHH`9%(DT2R1MN1QE2.X]:?110`
MR26.(H)&"[VVKGN?3]*?110`FX%BN1N`R1GD#_(-+3/*C\XS;%\TKMWXYQG.
M/UI]`",P12S$*H&22>`*6FR1I+&T<B*Z."K*PR&!Z@BG4`%%%%`!2$].,_TI
M:*`"HC<P*CL9DVHI9CN'`&<G]#^52U"UK`RLK0H5=2C+CY6!Z@CH>I_,^IH`
MFHHHH`C6:)Y#&LJ,XSE0PR,8SQ^(_,4\D`$DX`ZDT!0"2``6.3@=32T`-1U=
M=R,&![@YH61')"NK$=0#G')'\P?RI0`.@Q0JA1A0`,D\#N>M`$:7$+PB99%\
ML]&S@=<?SJ16#J&4AE(R"#P13!#$(O*$2"/^YM&/RJ2@!LDB11M)(ZHBC)9C
M@`?6E!!`(.0>A%#*&&&`(/8B@````8`Z`4`+3`Y,S)Y;!0H(?C!)SQ]1C]13
MZ9'&L481!A1T%`&+I0QXLU[@#*VWX_*U;M86EY_X2S7<J1E+;!/?Y6K=H`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#`\1:I_9Z2II]NDVI"/S
MMIBR!&IRQ8Y&,<XYSDC'6D35=+M[:T06DCR7,*S"**WWMM/4L!TP>M,ET.ZG
MNKB:1=.F>27<&E1V*#:0!UQP#T]\U77PU=&./RKBV4);FU#IN):+.=ISD=><
MC!XQTH`-+UJPN;.W>\T^,SW!8HD%OO\`W:M@.>.GX?0=J9INNV$\:R7&FJ9)
MI&-O';VVX^4#@.3VZ'TZ5970K]9(Y()K6`QP"`&#<ORALX_QI+30+RV`,)LB
M#;"VY,A`CY)`Y[DYS0!-#JV@2S16\4"$R>8(\6WRMMR6(.,$<9R*(M7T*2%[
MI;8+#&A<S&UPNT'C!Q[\#KD],YJK;>'KRW^2(V:!%:)&0$,BD#HWWMW/4^_K
MRZ/P_?HLX6:R5Y@/-$:%%?EOX1P,@X/KS0!;;4-$-M-/]D#)"ZQL!:'.7QC`
MQG!R*TUL;)D4BT@VXX!B`P#[8XZU@PZ#J]K"Z6MW;1E[DW+A-ZJY_NXS\JY'
M..O3@5TRDB-3)M#8&<'C/M0!`NGV28V6=NN#D8B4<_E3_LEM_P`^\7K]P5-1
M0!5;3K%OO65N?K$O^%++86<[EYK6&1B`I+Q@Y`S@<_4_G5FB@"M/86=R6,]K
M!*67:2\8)(],_B:@UA$B\/WR(%C1;60```!0$/;TK0JCK>1H>H8Z_9I.HS_"
M:`'P*T^E0J)#$SPK\R``C@=/2H+G5M.M[[['<R*DSE<!DX8D@+S]35NR)-C;
MD]?+7.#GM56_AEN=1LHC&&MD8SR,1T9?N@?B<_\``?R`&6NM:9J%P88Y0SQ;
MG_>(5^Z<%@2,8!SS4UI?6>HRAX#YFP;HY-ORL#U*GOZ'T_&N:FAO-1O+N.2Q
MGC,5M+%$K!0JAUP26SR2>0!T`]ZT]%:>)Y2([F*U=5$$-UN#!P3WY*J05!SW
MH`O:;J=A=SR1VSOYKYD*N#D@':2,]L\?KWR;,J6\$6Y\[8U8XW$D@]?J?\:Y
MK18[BUNFN(M/NA906[,L,BY=';:66+)Y!*]..G'7G7U2WFNCI^H1^:%M',TE
ML1DN"IXV]W';ZF@"?3=6M=01Q;K)&8B`\<B;&7).,@^N,_\`UZFCM[5(Y'53
ML<[F^<D'!)]?T]./:L74!/?VXG@TZ]@>9_*E4D*^`C;68`_,H)Z!AUJK;1ZH
MC:<7MKY(XK=4G1),9;8^2!NP221Q@$';SVH`Z2VE@U"SCEC#M"P!4N"I/'7G
MFIH84A@2%`=B+M`9BQQ[D\FN4>TU>72(`WVSSTMD929#O$GF<YYZ[">OZ]*L
MVBZH=1B;;>1R->2^<99"T)@!.T*.@_AQP"<$]*`-F:_LK%E@DE._&=BAI'QZ
MD#)_$TZ*:UU.V$D$OFPR+\LD9(!&<<$=\C\*S9RVGZU<W5Q%/+#<>5Y1BC,F
M&57&W`Z<X/3&3U],N:+48M2MELX+VV@!#Q1(H8'+9D$AW<<XZYXQC'-`'7)A
M8U&[('RY..3T[4P6R):?9HF>-`FQ2K?,O'4$YYKDO[/U.'P],)&NY6>UMF(=
MV=EDWDO@%LC`V\`CIQBI9I=4E:]<1WL,A+&/"G"+Y;,I'8G.U2,9[`D4`=3/
M/%:0&6XD"1KC<[=!DXR?3ZU6@U+3S;M+'>1O"`9#(7RH!8C.3VSD>V/:LZ>U
MDM_"5W&&O;J>Y@?B7,DF]UP!@#@`^W%4=3@N3;ZA-Y$TL4FF2(KM'AT;<?D(
MQDGG)/MGWH`ZEXTFC(+-M<#E'*\>Q!X_"JP2W=I;(7<C2Y$K*)CO0$Y'0Y`X
M_P`YK.N(]2AU%/),KVZQ"<J#@95"ICZ'[Q*'\&JEHDEQ%=->W$-Y*3IT?FO)
M"P<R*S;EZ#IGI[=Z`.GN(O/@>+S)(]XQOC.&'N#40LHQ'L$EQC=O!\]R0<8Z
MYR1['BEGOK6VN8+>>=(Y9R1$K'&\CL/T_.IP0<X/3K0!"ULK(Z^;,-T?EY$A
MR!SR/]KGKUI\,0A0J&=LG)+L6-8GB28M=6%JDV"2\S6XD:,SA5^Z&'?G.#P<
M5F:=>3V6D22VDLH"ZFL;1W!\S8K%!Y8;)R!GKGJ#0!V+#<I&2,C&1U%5C81%
M-OF7.-X?_CX?.?3.>GMTJC;WMS/=:M`MS!F`IY#[?E3<N0&YYYZ_TJ#PR)A9
MW\;/_I`NI0SOR&D!P6`SPO3Y?UYH`WZJR6C'[.$E<I$^YE9L[_JW7CK^G2N;
M\*/J;PM-+?VZV[7,JF-HSDODX`);IGG'X4@\1:@&-Q';.;9"R>08W?.UMI_>
MXQG@G!_$T`=:X+(P5BI(P&';WINQ_/\`,\UMFW;Y>!C.>N<9S^.*>H(4!CD@
M<GUK&\0&Q#VXNQ/-,VY8+6)V4S-QZ>GKG`!YH`OBVN!.[_;I=C2!PFQ,`<?+
MG'3K[\]:E6%P\;-.YV!@1@`-GU^G:N:F$ER^A:;=W&Z.6.227RI<^;M484,,
M$\'.1UQ^-6=*A6_T'9?7LLT5K</BX64J9%1C@LP/(_PH`UKJTN)V_=WTL*Y8
M_*BDC(P,$CH.O>I8(IHBHDG,JB-5.0!\PSEOQS^&/>LKPO;[;2:[#.([J0O"
MAD+!8^V,],\G\:W*`*_D2^>[_:Y=C+@)A<*?FYZ>X_[Y'O4R*5&"Q;DG)QZ]
M./3I3J*`$`()R<@GCVH`()R<@GCVI:*`*YMYC+(QNY-C%2$VKA0.H!QGGZ]N
M*C+/9Q1B65Y0J-NE(7MSDCC/&>G_`.JV,]ZHZFL9",\#2.JN48?=0[3][)`P
M>G/K0`UUDGM(K?[8C7$@+K)C!*@_>`'IN7\ZO(K*$#2%L+@D@98^O'^>:YNZ
M-M]H\,EI`I`)`#[/D$6<G!Z95>,X[<U)J6NR1WBO97$)MH1F563[Y\T1L-Q(
MQC=P0",CGT(!N>3)NC)N'*KG<I5</]>/Y>E$<$B7)E-S(Z%2/+8+@'<2#P.P
M./H!G)YK)T?4I;W4KVTN+A'*;@$C7`4!R`0X)[8R#@@CWK-NX[BVN[GP_`)E
M@OMIMY#\WEJ?]:<[L\<8!_E0!TZ02B1&:[E95'*;4PYYZ\9[CICH/?,A63ST
M8.!&%8,N.IR,'\.?SKFH]9OP\\T<ML\4331&UE8B0%`2O.,Y8`]>W<GBFR:U
MJH@^7R09)46)F7YFWQ&3&TD8QP,GKSQV(!T(AN@85-PKHJXD+1C<Y_D`?\^T
MV)?M!;<ODE,;<<AL]<_2N=M->N[V^L&50EO<"/<%4.%)0L5;D,IZ8;&*Z:@!
M%!`Y.3DTM%%`"-DJ=I`;'!(R`:@`N]GS&`MQR`<#YN>_]W'XU8HH`KP+=+/*
M9Y(GB.WRPBD$<<YY/4Y^E/Q-LC^>,,"/,.PD-ZXYX_6I:*`*Y2ZW2,KP<@A2
M8SGH,9Y]=Q^A'U+@MSYLI,D9C/\`JQL.5X'7GGG/I4U%`$(6X$9!DB+DG#>6
M0`,<<9YYQW'X5&ZWQ5_+DMPQ^[NC8@?=Z\\_Q?F/0YM44`5(Q>J9?/DM]HC&
MQU0@!\MDD9Z8V=_6IX&+P1NQ4EE!)3[IX[>U25S8UFX-[<VTF;9WGA$6[!P&
M6(.O?D&0?7/UP`=)17':/XBNYF2:ZNO.AR%E1;4Q^43&S`9/7)'KU([&I].U
MVY2:UM+A<R&`R2Y`W,[J\BX&>P0Y]R!CN`#JJJ75PR7,5O&ZK)-'(8]Z%AN&
M,9P1QR>._J*P9=<U&SL)XYVM9+T0Q20.?D5PX;.1GJ-C'CJ,5J-=K-)83-,4
M62"1_D`('R@YR>PY_$B@"VR7QD8K/;A,':#$<YYQD[O<?D?7AB)J7S[[BTYQ
ML"P-QZD_/S].*X_2Y+I;="LK[7MTN&)N,">(2_.QW-B-@#@@'')Y';2B>1M+
MTYWEDB0ZD/(4RD,8BYVJ3N.X8.!STQ0!T,J7S2RF&X@1"BB,/"6PV>2<,,C'
M3I_C&D6IC[]W;'YNBVY'&X?[9_AR/QK`BN)%UH3+/)+-+J4EJ\0D.%B"$_=S
MVP&S6E9WO]GV-W+*;J[$=TZ94>8^!T_PH`THDO`09IX2!GA(B,\#'.[ZD\=Q
MTQR^V2Y2,BZFCE?/!CC*#\BQKFA>R7FJ^=,Y,1NI;*$12$&W89`;:1@L<$\Y
MQE<=Z2W26PEU`6-Q?RQHT=OO9C<%7ZL^W!Z+M7`'8#CL`='"EXK1>=/"X`;S
M-L17=TVX^8XQSGKGVJ&2>XM[B!9;FV*NX0KL*L<J,$<GG*OQTP>O'/,H]S>^
M'[5H]1O8[Z1I!;QJVSSGWDEFR`2H!![``'@]*ZV2-)$M_-F965U965MN]L=/
M?//%`&9IHQXJUOD\I;'I_LL/Z5MUB:;G_A*M;!VXV6Y&.OW6ZUMT`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!12*P894@@]P:6@#C[F[U)K_43'));
MJMRJH5C=\A=N!PA&W!<GN<`9QFFVVI:G;9$DY;/"DV\Y/_+0@$>7C<<J"?13
MG/>:[OI;;7;E&U'$,4@=XVF4,J;%8X'4#Y2N._F9[9K*M;V]MH+6*+5E:*!H
MS)B9&`_U8*L3VR9<\_W?8$`OP3B/4;>>Z-\Q2WD@A"Q3G<Y<D9)4?,R@'.><
M9/:JBZCJUMI=E%;3F!4B`E$MNS%>S$\9`#!@<<CCZU:L]2FCN[8SZRLD:$&;
M#*0&?>7!"CHIV!<\<D@D<"O!JES-.1)?2Q65[.P$DI3]VA>3A"<Y!VXR1P/P
MR`:SZI=+KJ2M*(M/\SRQ"(7\V4M&I&5QE<-GG@^O`S63IS7MBNF2"Z=FEMTD
MB@9R=^]E,B@'@X5?E7(Y/X586^UQK(!VGYD5#(L*A\[)"2.<,N!'SGN:8^J:
MS);3O([@RN1"MN@W,GS8V-M/!RA##=DCJ,YH`L_VMJ!FF2:ZM9?ECVP13(A;
MA?,96W`\,&&"1P<]@#3EUR=WL#-=VDAB*2$K=(JY\M02V#R-[2<<?=%:BWEZ
MBZR7D9YX=P@#KL4YR`0".2,=>0>,'J!GS:EJUNMR5O'D55'ENB(Q^\PQM'KM
MST)&1TH`GD\13/;:>\5]8B9D*W+>>FR-R5QG)YXW=,]#CUJH^LW#1$I>+OFA
M='WSQ91AYF"`&Q@%@3C/`''IK6&JW<M]=M+<P&W@#HBEE`EDR"-IZX`R.O<5
MG:??7T*64*7(,$4J%Q*%#,I1-P)R.`S/VZ@=AF@!MMJU['!9V]M>VP1)!&@+
MHV]0Z(J9SS\A+D]<D#Z@\07:R6P.H`AG#2?+&,J`@;/]S!67UYXXX-=M2$`C
M!Y%`$=K/'=6T<\3AXY%#*PZ,#WJOK0SHE^/^G:3_`-!-7:I:R,Z-?#_IWD_]
M!-`"0VR76BPP.65'A091B"O`P0?45CZGJ\MMJQ5TA$5L0JJ;LI)(#L).WH><
M#!/?MFMW3\_V=:Y))\I,D]^!38+"&&ZN;@#<]PX<[@/EPH7`_+]:`,VQ\26M
MP&>59XBN\D&)MFU7*[@V,'MTIUQXATY+L*TD[-#+)&42'<`44;F/&0`&'/'\
MZ7^Q+2*-887+W$<4H59)!EU=B6#<'`)/4"HF\,B73K>UEOI0R1/',ZJ#YN\Y
M8G?NP3\W(YY_"@"2W\0P^<+:Z0B<SM#F%&9!\X4$D@8R2!]:1?$EO<6UPUG&
M[RPH'Q(I12,@$@GJ!G/_`.NECT)3-YT=W/&&=VD"';Y@:4R8SU')X(/3/K3(
MO#2K+.TEY,RR(R*%"J1N96)R`#U4#!SQ]:`'ZSK<MA=QVT$4!=XFE#3R^6&V
MGE5XY;TR0*'\36L*S-<PSPB*.)L,N69G5FVC'<!3WZ\>F9]4T?\`M*XCE-W-
M"%0H45496ST.&!&1Z]?I34T&%)K.7SYBUJ5(RWWBJLOX9W=!QQTH`E77=,,D
MR_;(QY*%W)R,`=>H[9&1U!XIAUVT^W6MJKJYN9'C1E8<%5SR#SSTXSV]:J-X
M5M7)#7-P8_GV)\GR;B6&#MW<%B1DGG%2VWA^VMYXY(9V$L$WFKM1`!D8*D`#
M@C/TSQ0!9O-5CM=0AM2C,'VAW'1"S;4S]3FH-0URVMK^"T_UFYRLSJQ`APA;
MG`Y.!TS4E[HD-^MX+B61C<A-K#&Z+;TVGMR2?Q-57\-1.2LEW.8-[NL2@`!G
M4J_(YP22>V.?P`'CQ#9S27*>;Y4,<B1"?^^7C+#;U.1[BK4>JZ>3/,+X,B8#
M9/RJ1G@<<GUZU7MM)E>Z2YN;XSO'.)"OE*HW*KIVSU#+UY^4?A!%X:,$!BBO
M.5^6)S!'N1<Y(;CYOIQ0!?CUJP:&*0W,7[TD)M);/S!?3U('XU?D4NA4.R9[
MKUK$'AS;&BK?S*54J",G:"V1M))(P..21T.,BMQ1M&,D\D\T`100&$DF>63K
MPY!QS]/PIAM2T10W$_,ADW!L'&<[?IVJS10!FG1;:34XK^<O/+#&4C$N"%R<
MD].O:KT4(B+D,[%R2=QSW_\`K_R]*DHH`I7FE6>H.QO84N$*!521<A.N2OH3
MD9(]!0=,MC8BQ\I/L>TJT.P8(/TZ<^E7:*`,D^'-,$2PQVR1P;/+>-!@2`=-
MQZGGG.<D]33M/\/:;IUV;JVMPEP007#$<'MC.*U**`,W^P=-^VI="V3>CF4#
MG`?CY@.@/'^<4V?P_IUQ>M<RVZMO.Z2,_<D88PS+T)`S_P!]&M2B@`JG=:59
M7ERMS<0!YD0HK[B"%/;@U<HH`HR:1921P1M$2D',0#L-I_O`YSGWHL--2SLG
MLRRO`<A8UC"*JD<@`>IR>3WJ]10!"(/*MXH+8B%(PJJ`N<*.,#\*FHHH`***
M*`&,K&1&$A55SN7`^:B97>,K')Y;'HV,X_"GT4`0NDQ5`DV"&RQ*@Y'/'\OP
MI8UE,:B=D+;2'"CY2?Q_SS4M%`&1<:EIEB&L;^X21@A#H("RJASPP4$`8'?M
M4T#:9?`6R)%,(D("-%PJ;BN!D=,IC_@(JM<6.HQW.H/9)9N+QE8/,S!HR$"]
M-I#=,CIU[UD7VDW5E#<W#*9',4CQF%6<K(L[RIP!T8/@^G/K0!T\=E#"^^S2
M*W+R;IC'&H\WKP?Q/6I98=Y#H=DH&%?`)`)!(_'`JKHUJ]IIR+-S<2$RS')/
MSL<D<\X'09[`5?H`I3Z;;W7VCSX829L*76,;BO'#$]>1],8JO::!96DRRA%E
M8'):6-2<C!4Y`'(.3GKR:U:*`*ZV-K'()8K6!)5&%<1C(_&ID#*BAFW,``6Q
MC)]:=10!$B3+(2TH>,Y."F".>.<]!SVHG,X,7D*A&\>9N_N\YQ[]*EHH`KL+
MO[2NPP?9\?-D'?G)Z=NF*9*E]@^5+!GRP!N0\O@Y/7@9V\<]"/>K=%`#4W8^
M?&<GIZ9X_2H8%NPTGGR0D$G9L0C`SQGGTZ^_I5BB@",K+E#O7@'<-N-Q_H/S
MJ&);[S(3,\&P1#S512,R=\$_P^G?ZU:HH`@47/VDEVB$'S84`[OX<<_]]_F/
M2G2"<RH8GC$>#O#*23R.G/IN'X@]L&6B@`K._L>UDD$UROFSB9;@.>-KA%7Y
M<=`0@XK1HH`SO[&M"DD4AFDMW"@0/(2B!<8VCMTI#H6GL9R\.YII/,+G[RG`
M&%(Y`^4<?7M6E10!FC0[+S(I)$:9H^1YIW;NN,YZXW-CTS48TF*PB@:TE,:V
MF\H)26558@L/7`&<#/I6M3)69(G:-/,<*2J`XW'TS0!D0WFCS*8UN]+F'E^4
MRQHI^4L%48R?ERV,=#D=*T9[<RP0CR[=I(G5AOCRJD=2H['&<5SJVNHRQS33
MZ;*MZ\\+*S-'L1%F1@B[6)QC))P,XY[5-X3AN%19_+E2WE@0$R2;O-DY)D`)
M.`01Z?3`!H`T+(+-?B61K!I]A=MD)67!X0G)R/EX(([U/9PWD+MYBV:1M*7(
MA0@D$9)/JV[OW%8-IIM_;:6+5;!S?QK<%+]WCR6._:<Y)R<KU_I3?LNK,$VQ
MZ@MN7C,BR3H)7;$@8J0Q"C)CZD=.,]P#833,7,EY'#9^>RAHV"G!<YW,1GN-
MO/7CJ:F@M;NV=U@^R)$QWMA&RSLY+GKZ$=SSZ"N?%CK%O<VP5[J-?*MXH]@#
MK&>K[P#C^$\X[CGGGL*`,2X\/6]Q:00RVUHY@V"/Y6"HN?G`&>XS^F>E7Y['
M>;)862..UD#;2I.0%*@#GCK5RB@#%TW_`)&K6O\`KG;?R>MJL;3@W_"3ZRQ^
M[Y=N!^3_`.-;-`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`8M]
MK,MM)/LL7N$CE6(>6"Q<X!Z@$##''KFJ\'B.XGR8M.9P_F-"BOEV5,ALC&`=
MP`_X$*TI=%T^:5Y9("7=Q(Q\QOO#H1SQ^%(^AZ>TJR"#:P&WY68<9S@8/'//
MX"@#%U'Q'=O9X@M_LLH(WB4ABPQDA1C!!R/F]QQS73PPQV\2Q0J$C0`*BC`4
M>@K,E\-Z:^YEA<2'D-YSY'3ISQ]T=/05H64)M[.*%CDHH'WMV/;/?ZT`2O&D
M@Q(BL/1AGMC^1--,,3,&,2$A=H)4<#T^G`_*I**`*[V-I(6,EK"Y8Y.Z,')Y
MY_4TQM,L&7:UE;E?3REP>"/3T)_.K=%`%,:5IRYQ86HSUQ"O/Z>Y_.DBTG3H
ME4)8VP(V\B%03CH>!Z\U=HH`****`"J6LX_L:^W=/L\F?^^35VJ6L\:+?]/^
M/>3J,C[IH`=9>8-+M-N"WEQYXXQ@9_3-.=K21Y#(4W0\.6X*Y![_`$)IMDKO
MI5J`YC;RHR2N#V&1R/PKF;W3[N6XOW72'(GD5E++&6'S`$_>PPX#8)'09R,Y
M`.L:>,1>;O7;C=G('\Z8DEHS2R))&<D)(0PP2!T/O@URO]DW<UJ0^FNHABO!
M&C%%^9V+)@*Q'(;'H"#3[[2[H32&"PD,8N(IW51&V]RC[W`8X8AF7@^GY`'6
M0I'%#''$`(T4*H'0`#BH7L+625I7A4NQ))]25"D_]\@"F:3:BRTNVME651'&
M%"RL&8>Q(X_*KE`"`8`'IZTC(K;LC[PVGW'^33J*`&"-`%`&%5=H4<#'TZ=J
M9;VL%JI6WA2('&=HQTZ5-10`5'-$D\+12#<CC##U%244`-6-$9V50"YW,1W.
M`,_D!2D`@@C(/4&EHH`:B+&BH@PJC``["DCC6-0JEB!_>8L?UI]%`$:0HDLD
MJ@[Y,;B6)Z#`X[?A20V\<"1I&&Q&NU<L6...I)YZ=34M%`$<4*0A@@/S,7.6
M)Y)R>O\`*GX&2>YXI:*`"FJI#LQ=B#C"G&%^G'\Z=10!#-;1SI(L@;$BE3AB
M.,$<>G4U-110!'/"EQ"\4@)1QA@&*DCZCFG(H1%09(48&XDG\2>33J*`"D(R
M",X]Q2T4`1K$1;B(RR,0FWS#C<>,9Z8S^%+$ACB1&<NRJ`6;JWN:?10`5''$
M8X$C\V1BH&7;!9L>O&.?8?3%244`%%%%`!1110`5"8I?M(D%PWE]XBJXZ'H<
M9[YYST[5-4<JR-CRY`G7.5SVX_6@!TBEXV0.R%@1N7J/<4FP%-KG>.^X#FFV
MT?E6T4?F>9L0+O/\6!UJ6@`HHHH`****`"BBB@!H#<9;H2>!C(YP/\^GX4ZB
MB@!CB0R1E'54!.\%<EN.,'/'/UI]%%`#&5S(C*^%&=RXSG\>U"*RLY9]P9LJ
M,8VC`&/?G)_&GT4`0R).;B-DF18A]]#'DM^.>/RITZRO"RP2+%(1P[)NQ^&1
M4E%`#1NP,D9[\=:=110`U\[&P<''!`SC\*B@F\Y)-CQL5(`(;/50?F'8\]/3
M![U*_P!QOFV<?>&./?FH[>+R_,;*,TC!BRK@L=H&3ZGC\L#M0`V/[7MB\TP!
M@Q\W:"05P<;?0YV]<]Z<%G2U"[TDG"XWD;06QUP/>IJ*`(V\XP';Y8EQQG)4
M'U_^M5#[=<>9]GQ%YS3M&C'.T`+O]MW'&1W^AK3JE;?9EN[O:=LKSC>&;J_E
MKC`_W1V]#0!/.+@LGD-&%R-X8')&1T/TS^G2D=9EAVVXA0@X4,#M"_A4]%`%
M;_3?.3_CW\O^/[V>_3]*:RWQ"J&MBNU@^Y2<GG'],U;HH`K+]MRH;[.1GYB-
MPXQV'US_`)YI%%]A-SVY.S#X4@;L#D<],YX_6K5%`$`6Y\E@73S"S8..%'.W
MZXXJ3+)&NX@MP">G-/JM=V[7#6Y1]GE3"0GO@`C`^N<?0F@"AIV/^$FUG!7.
MRWR!U'RMUK8K&T[GQ/K/S@X2W^7'(^5O\_YYV:`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HJ.>:.WB:69UCC7[S,<`52_MW2?-6/^T;4EEW`B9<=N
M^<9Y'%`&C16<-=TGS"G]I6?"AL^>N#^OM^HIYUK2E(!U.S&02,SKT'X^Q_*@
M"]15`ZWI(ZZG9#C/_'PG3UZT-K>DH</J=DI]#<(/ZT`7Z*S_`.W='_Z"MC_X
M$)_C1_;ND<_\36RX[_:$Q_/VH`T**H#6]).,:G9<]/\`2$Y_6E&M:6>FI69X
M)XG4\`9)Z^G/TH`O455.H68E,7VF$R=D5P6/7@#J3P>!Z4O]H66,_:X-NW=G
MS!C'KF@"S14/VNV`)^T18!P3O'!I/MEMN"_:(L\\;QVSG^1H`GJGK&3H]Z%Q
MDP..3@=#W[5))>VL7W[B(9[;AZ@9^G(JOJEQ"^DW866)B\#A1N!W?*>/>@"7
M22#I%D021Y"<G&?NCTJ.+[,+^[MENIFG=`[QF0GRU.0-O]W_`/556SU[2(K&
MV5]3M`1$H/[Y>"!R.O7VK(6VLF/VM-<M9;EII&E=95`*LI#@8/R_(JX)Z;<T
M`='#-:QN+!9Y'=HC,I9V8E">H?VR.^>E0G6-.-JI%SB)XV.]2?E56"$Y_P!X
MX'_UJP;71HGCC":I9,B6J01[/XPDBR!C\W0D-TXP:D?1;<01P?;;!66.1?*Z
M*-TXEP.<X`4C\*`.CLKNWN+<&&8.JL8\ELDE6*_CRI^M/B>%`P68-DECNDS[
M_E7/'1H_,6476GNV_>9)$W%<SM(-OS<9W`<]<"G3Z#$)%,<EIYY%UYC$8:02
M;BH/4D#)ZYZ4`;IO[5;F*W,P\V;=Y8P?FP,G!Z=*9!>6JM=PB8YLSF;S&)*A
MAOSD]L']/:L/3=)^R:E;DW5D%CF,@AB(!SY7ELH'KG!)X^@X`DN]+\[4[B9+
MR'RKR7RYT\T_-&$4,N/[V8SSV!;.>P!MK<P7-K$\<ZA;F/=$W0L",@@'ZBL[
M^T+'[2@_M*;+M&RKS@#)0#IW;).?3L*R)_#[$0Q&XL@1"D*$G[I4EMOJ206(
MQCOG(Q5B+1Y$F"M>6V5,+8)&6"&0Y_'S!S@=,>AH`Z+[7`89)4EC=8P2Q5QQ
M^.<#\:C)B>VN'CGE=9>2T;Y*94#Y?3C!^I)[US<NF+8:5;&VBCG\M;=9X[52
M_GO&X+$@#D`9Y/TZXJUI4$PT"\@B:*SFEN93AN!&C2<X';Y<X]\4`:C36FI:
M6S0:B\<*':UQ%(%*E3SDGI_]>E,]M':7,LFHN(BSY=F53%M)!"\#H0>N?QK+
MFT"41R"">"XM9)HYG@F`"-M!!&0#P0$['[G/4TR?P_//IS6RFU)9F=5+L5AW
M2.X*X&2<,!V!VT`;\;1VT8B:9I&15W%N6QC`)P.`<'G`'6I6D5"0QQA2WU`Z
M_P!/SKGIO#;/:R!%A,LES))(&/$B%W9025;IN!QCGD'K3CHEXMWI;+)')]D"
M*TLBJS;0!N'*YR<'!&.O/(R0#HJ100.3DY-87A?2[O35N/M0(\P)U96+,`=S
M$J!U)')R>.36]0`4T`AF)8D'H,=*=10`R16:-E1RC$<,`#C\Z2%'CC"R2F5A
M_$0`3Q[5)10!7\F?R%3[4?,&W,FP?-@#.1[\FIP,`#.?<TM%`#6!.W#;<')X
MZ^U.HHH`*1LX^7&?>EHH`C'F[TSLV[3O'.<\8Q[=?TJ2BB@`HHHH`****`"B
MBB@`HHHH`IW-Q]G-O#]I@263A5E;#2$8X`_+/7&:M1NLB!D=7![J<@US6I6J
M_;=3:XT6;4)92AMV`!4KL`"[L_+A@Q/US52X;4+"6XN'>>W"QR/&Y(\MBD\C
M;&!_O(PQTS^%`'8'=O&,;<'/KGM_6A=V6W8QGY<>F._XYJMI;W$MA')=C;*^
MY]IQE5))4''&0N`?<5;H`A_TG[6.8OLVSG@[]W\L=:FHHH`C<2DG8R*.,94G
MOSW';I_6I***`&_-N[;<?CFG444`-`;>22-F!@8Y!YSS^5.HHH`*0YXQ^-+1
M0!&@E\V3>4,?&P`'(XYSZ\TYRP`V+N)(!YQ@=S3J*`"JYEN!*JBW!4O@L).B
MXZ].N>W_`.JK%%`#)-^PA54DD#D]NY_GQ4%G;?9@0%`WA=VTDA<*J@#/TJU3
M7;8C-M+8&<+U/TH`$+%`77:W<9SBG5Y_:HS6UTEM->K-Y6Z6:**192-ZY#JV
M07&7^Z<G!'2K$6JZG)>7:22SA?*N1(DB8$6U?W9P%^4D#/4YYQ0!W%48+`?:
M9+B;E_M!FC7/W/D\OKWR.>>F<=JP=(O]2EUN*&6X/E#Y'A:,\H(\J^<<,3@D
M$_Q#TQ764`(&!)`()4X.#T-+7GT\L=P-1O;22_C5MT=M;E926<M@N"3@=6P.
MV2?:N@T;4KZYU)HI9//A9IR1Y)3R0LA51NZ-GIZ\>QR`=#41E(N1#Y4F"I;S
M,#:#Z=<Y_#%<TLD?]IRF>YU`Z@MYF.&%GVM'G`&#\FW&<GC'/-1P:UJY56<J
MY>)F=!`<V[^:BD'N<*QXQV/X`'4/,RVS3"WE9@,^4NW<?IDX_6GPN98E=HWC
M+#.Q\9'UP37&)JVI66^%+J$C?.WF3(QW[7`(4$Y'<]^Y'`KLH-Y@C\W'F;1N
MQTSCF@!RL69P490IP"<?-P#D8/OCG'2JUT7>X@BC$H*N)"RX"E1D$'\QQ[U;
MHH`R-/W?\)-JX(&WR[?!V^S]^]:]9&GA1XDU<A,,4@RW8\-^O_UJUZ`"BBB@
M`J*&$0AP/XW+G\:EHH`****`"BBB@`HHHH`****`"BBB@"EJTSP63.L$4ZK\
MTBR-@!!R3C!SCCBHM'FBU328+M[2.+ST#%.&'Y_B:GO=-M;Z2-[A'+1A@I61
MDP#C(^4C.=HI]M96]IM$"%`L:QJNXD!1TP,X_'J:`*%U-(-2^QVEA;R>5$LS
MO*=H`9F&!A2<\,>E95KXIL)X+>9K((DD3S2C8"0%^7C'7+#'-5]8LUM]0NFE
MNY7:4;FBCB;,FYE55/SJ&..`!V#]ZI73I]EWL[0L\9@95LPC6ZJ1C.)?E&2#
M@9)QT/2@#HVUS3ELFNI+*18HV"IE$.]BV-JX/)R3D?6E37].E1&6UG,DTAA2
M/RAN<J,G'."!TSGMZ<US\%O)(KV[3W-I$;L;Y39I&/,'.3B3'\//RX]1R#4"
M`6]K&L=R;/=*OV9FB\N3S)#\KGYBOED`YXQ\IP`<"@#HO^$CM)!8_9+0NU[(
MZO&^U&01@[B>O(P,"GC7M+N%BA^RR.)[)I@FQ>(L<H1GOCIT-<S86I-S90"6
M'<T,VQFMV.PEB'+DL>HCDP<__6TX='U![!;N*6T3S[,))+=ABZ1E%RO&%4`[
MCQ^/>@!]GK.G32K)<Z9!:Q7,)DE9X\-&H*H,G'(.[KP`*ECN_#;6]W>M9+:^
M2@\U9+55=T8@`@$9(/*\>ISVJ$Z3-<PB.2YTZ8&"+[LQ!5(VX(X(QDMSC'M3
MO[!O;I,M):7'F!09C+(Q(5@0N1C@>G<Y)H`T-)CT'4Q<+9Z="JP2C(,*J&.#
MAP/3DX/%9!N-*:&]O+7PY9W%A92&,RJB!F*@9.".1SG-;5O9:M;3W$L1L`UP
M^]R0YYQ@=^G`_6L^+PQ<I`876TDA9_,>!WD,>X]2!Q0!/,OA:UN7M)K.T23>
M(R&M<`-@$+NQCD8/7GFJL%SX5FAEF.FVJQ+*8$_T;+28`)(7&?7WP/PIZ>&;
MU=1-ZSVDLAE\W$N]@&QCZ\<8YXQQ1;^&M1MQ;*EW;`VK2>5*J'>J.<L.<@GK
MR<]:`+UK:^&KEH(X+"P=IHRZ#[,I)"X!SQP1D=:=JNAZ4FF74D>F6:LD+L-M
MN@.=I]O\XHT?3]1T^6.)A:BU5`A$9;G&X[L8X8DC/)X'TK0U7_D$WO\`UP?_
M`-!-`%6RT?3)+&!WTZS9GB4LQ@4DG;WXJ;^P])X_XE=EP,?\>Z=/RJ?3_P#D
M'6W_`%R3^0I;>[AN6F6%]Q@D,;CT;`./UH`K-H>DL03IEGD'(_<KUY]O<U')
MX;T610K:9:X&,8C`_E6A-/%`%,TBQAFV@L<`GTI?,3Y,-D.<`CD'J?Z4`9/_
M``BFA;BW]FP\]1SC\LX[TH\*Z&&+?V;"21CG)[8]:UA(AD:,,-Z@,5SR`<X/
MZ'\JC>Z@CN%MWE1967<$)Y(]:`,UO"NAN,-IT1&2>_4]>],/A+0BP;^SDW#N
M&;/7/KUK5>Z@2X6!Y565EW*K'&1G''KR1^8J:@##_P"$0T#`']FQ\?[3?XTX
M>$M!!)_LV+).>2?\:V0P.,$'(R.>HH)`QD]>E`&7'X;T>*.1([%$63&\*S#.
M/QI#X:T8EB;",ELYR2>O7O6M29&<9Y]*`,P>'=)6V>V6R1878,RJ2.0",\'K
M@FD/AS2C;F$6Q520V5D8,"-V.<Y_B;\ZNF^MA:/=&9?(0LK/V!5BI_4$5)//
M%;1>9,X1,A<GU)``_,B@#(;PKIC`A5G0%0&VSN-V"#D\]>.M.E\,:?-##%*;
MEA$A0$SL"P))P2#SC)Q]:UI)$BC:25U1%&69C@`>YHCECE!,;JX#%25.<$'!
M'U!H`Q?^$2TK=NQ=$],_:9.GY_C^%)_PA^D8`$=P,9QBYDXR<^OX?_7YK>HH
M`PO^$0TC_GG<==W_`!\R=<=>OXT@\':*#DV\IYR<W$G)[_Q?C6Z3BEH`P?\`
MA#M%!R()>_6=SU^IIR^$M(C*^7%.BJ055;F0`$9Z<Y'4_G6Y10!CCPUIJER%
MNL.<L/M<O/U^:D'AJR216CFOHP(_+*I=R`,,D\\YZDGKBM8RQB982Z^8RE@N
M>2!@$_J/SI]`&#'X6BCA:,:KJO)RI^UL-ISGH*8WA8D\:]K8Z?\`+W^?:NAI
M"P&<D#`R?:@#G?\`A$P-P&NZT`W;[5W]^*4^$QC`UW6^N?\`C[]\^E=%10!S
M?_"'Q8(_MK6>>3_I0YXQ_=]*/^$008VZWK(`S_R]?_6KHP0<X/3K2T`<X?"$
M9`!UK6B!ZW0_^)IS^$TDC6-];UDJH*@?:1T/_`>:WPZE`X8%",A@>,>M+GD#
MGGVH`PE\,%%55UW6@%Z?Z2/_`(FG_P#".MLVC6]6`SG(F0'\]F:VB0`23@#J
M303TXS_2@#&?0KEF5AKVI`H,#YDQCGJ-O/7O_P#J:/#TX0)_;NIE01@ED+8!
MSRVW)K;4DC)4J?0TM`&-+H=S*`K:[J04'<NUHU.?<A1D>U21Z1=1N2NN:AM)
M)(81-^64XZ#]?6M6HA$GVEI@S%]H0C=P,<].QY_E0!GII%PBA4UK4`HXP?*/
M&,?W*C?1+F2'R9-9NGCR,J\41X&<?P>N#GV_$;-%`&-_9&I>8<>(+ORB>5\F
M+=U)^]MX_+_"F?V/JRNQ7Q%<;21@-;QD@?E6Y10!AG1]6VG_`(J*XW#&T_9X
M\`]\C'--_L;6"NT^([C`'&+>,'/OZUO44`<Z^BZ]M8IXFDW9!&;5`.O^>*/[
M&U[C'B63`'3[*G)QCK7144`<\NBZ[\I;Q-)D8R!:)CI2#1-=&S/B:4E3G/V5
M/Y=ZZ*B@#G3H>N?]#/+G'_/JG7\Z%T/7`[?\5-*4;M]E3(Z>]=#SGVH+!<;B
M!DX&3U-`&`NBZTL83_A))N@RWV9"2?QZ5,-,UH,Q_M\G/;[(F!]*UI_.\L_9
M_+\S(_UF<8[]*<=VS@`/CUXS0!D/INM$-LU\J3G&;.,X]*=_9VL8.==.<<8M
M$Q6O39-_EMY>W?@[=W3/;-`&:MCJBA/^)P&VG/S6R\]>#@CCGZ\#GKD^PZL#
M(5U@'<3@/:J0G7I@@_F3TK3&<<]:23>4/EE0W8L,@4`9GV+6,$#5XN><FTR<
M_P#?72E%GJ^>=6CQW'V0?I\W^-:E%`&4+36-JYU:'(//^B=>>GWJ46>L#_F+
MQ'!SS:#D>GWJU*:N_<VXJ5[8&#0!F?8M6SG^UXQG_IU'_P`52+9ZUYF&U:#R
M\YR+3YC[?>Q6M10!C16>O#;YNJVY.X[L6W;C&.>O7]*@BL/$-O"J0ZA8`!C\
MOV<@<G.>O4DG-=!10!SK6GBE^'O=,==P.&A8XP00?KD406GBB+`^UZ7@L2^(
MFYR<Y^O6NBJ&W>X=IO/A2-5?$95]VY<=3QQWXH`QV@\3LR-]ITL%1C/E/U[F
MI=GB/>Q$^EXP`H,4GKUZ^G\AZUK9?S<;?DVYW9[^E/H`Q=OB;(S+I)XZ".0<
M^G6DV>)@#B;2SGU208X'3]?TK:&<#/![XI:`,#08KQ=<U>6^$`E<0+F'.TX5
MN>?J!^%;]8FER,WBC7$V,JJMN>?XB5;D?D!^%;=`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`8FIZ9/>WTDD+Q(X2(QL6R59#)@E=O(.\CKZU4
MM]!NH)=TL%M>!?F5KB<EP^YF+9\O');]!UQ3O$<>HM=_Z)'=,CQ=8'*\HDIP
M2#GEG0?@?3-4KD:P\LKHVH-E(0@550C&-Y/!P>&/7^+'3-`%E]"OWMX89A;O
M&L\L\I69E9V?=\PPF01N.!DU'?:'<RJ9;J.&ZR-B@RF,[=NU`"5^\&).3W;M
MCB$R:O%;2$)?RS"-7&^($EE$A.<'C)*@8'0+]:9-;WSWEL\D&I7*?(LWVB)&
MP-P=\`$#J@&>2,G':@"TF@7@2&7(,RH@1TE8!<(1@J<9SN?GKF0\=33I=,U2
M9#%<6T4S11A(I!(51UPHVF/<>>7^;(/''855V:[]CB+2:BC`?-N"E@64#L<$
M`Y;G&.F<G%+:R:E%<QW%Y8ZA.;>9G*XCPN8V`((/3#@;1G&,D]J`'3:)?7$)
MCEM7DQ"L.]I$5R`,9R#@`J6X(/7\1N:'%=6UO]GGM%A`+.7$@.YF8D\<X'/<
MDUI1OYD:OM9=P!VL,$>QIU`!1110`4444`%5-5_Y!-[_`-<'_P#035D<,WS$
MYYP>U5=7&='O1@'_`$>3@_[IH`DT_P#Y!UM_UR3^0K&,&HV<FJ00V;2)>/+,
MD\<P&PF,`#'!R2.WK[5LZ?\`\@ZV_P"N2?R%6*`./31M7C9MQW[9HI(\.6`/
M[Q2<,3T#*3].F:CL-+U)+&Z5X)Q*#%A22-[*^6;&_!SSGYE!P.!P3VE%`&!X
M>L;VT)>YB*R26D2DLY;#*TF`<G/W67\CR>M9L6CWL4<JI9R"Y6V$+3>;\LI#
M`G;\W"E1T^7ICC-=C10!R$5CK.P$0W*-MN8HRTRAHPWEL#D,>I1@.2`2.W-6
M=$T^]CT#4(@98_/5OLJ-*&"`IA=I5C@=,<]JZ:B@#DKNRNW6(SV<ZA?LUNL:
MRAC*$9F?H<`'CDGH,G%*NF:N(8V>.66XCC`MR\XVPDR-G/.2=FP9YZ'GFNLH
MH`P]-L;V'4H[J22X*2I*)DEE#!2'&P`?3<?S]:K7NFZP]THCE$D*2-Y;^859
M%DWY.?504Q^(KI:*`.0?2M3ATU%59WDE\XS6_F#;@L64``[1P:=/9:A<"[0I
M>NS7(,A=P$*+-N3R\Y(P/Y=ZZVB@#`-E=R^'M5LW,[L6E2`S.2[+CCG//.<5
M7;3M1BCBEM&F1Y7NE,1;Y,/YCQNP]<[1SZ@5T]%`&!X<BU%+6Y:\-P2ZJ42=
MCD-@[N2Q/7'H/05G16&I_9X`3JYCW(;D?:0KY"OG9\W`R5X!P<<"NPHH`Y6/
M3-4DW3RW&I1R!X(UC^U`@)\HD8XX)VEN?49%1&UU-+I((I[][B!3Y;-+E"/.
M<J9?F&047'0_3/!Z^DP,DX&3QF@#E4M=4DN]0S'>`2VTZ;GFX+D@(5'1>!Q@
M<=R<4RZFO[&1;""X96N7DM84EE&\@C*S`]>#NSW/N<5UU-9%;&Y0<>HH`P=;
ML[T&`6"S2M%9R1;QMW<O%GDX^8JK<U*(;V3P_+#)%+Y^\[5>3>Q&_(^;`.,>
MO/%;=%`'-Z?%JT>K6TK"Y\J4R_:UDV;%P6V;<<]<>O!JKJ^FZM=WMS*5FE13
M,D49*>64-NX7C@YW.0?J,]*ZZB@#DT&J"^U$0RW;%4=5`(VJ,$)M!7GH>0>H
M&1SRAN]86Q@,1O8T\N18CY*R/+(&^3=\@*J5'7:.ISVSUM%`'(:;%J\*S0PI
M-&UY=.[3%05B(D^;[W.TJ,#OD9XS5S0KG59;Z9+U;EXEC;<LD2A0^[HK;5R.
MH[]N1TKHZ*`.&NH+J:QWQ0M)=NUW]I:%"V'W!0F<\?+@8[@5LZV;O3;.VATM
M98T1&"^1"'RPQ@%0IXQO/&.0.16^%"YV@#)R<#J:6@#D+N75[V+4H&BF:#RY
M%4"(?/+Y>"G.3LSE@>Y(&>.8IKG5+FVU*#S+TF,M(A2$`1[)A@*=HR<`\9.0
M/PKM**`.4^V:PUUJ$(DN`V6\M1#]Q=P"LIV\DJ0>IZG@8IUY=ZE:"2&6\N0B
M7#*+@6RL[`1*ZC`&W!8L,\=,9KJ:*`.;TW4=4EUP17&\PMD/&82HC^0$,#M[
MD<Y8_>'%4]:FU"RN=2DLY;B'S9P5\N$R%L11#Y1C'<]Q]T^E=A10!CZT-0DN
M88K.XE@B,4CR-'&&)(V[0"<X/_U_PR#?:O<L\:W$R3RJ8O(6V("`Q;A('XPP
M/;/H,5U]%`'+W%Y?1Z%H?EW4D<UU+%"\LL>6.Z-LDCU!_D"2:K2ZYJ8CLBOF
M*@C5_--LQ%Q\Q7Y@`2H(`/'/S`]L5ULL$4SQ-(@8Q/O0G^%L$9_(FI*`..N-
M5U>*\2`W/$J2R1`6C.PV/A00O)R._3GZ58.J:M<ZA]EDA>U21%0A8')3?&&9
MMXXRK9';_#HOLD/VQ;K9^^6,Q!O]DD''Y@5/0!R-OJ.K6^F;2LSSBWM&C+QL
M2[,^),YSS@@54NM<U&ZBN(`Y;]\A$D",AC_>*IC)SG/?G!Y'J`.YHH`P]%N;
MC[;=6DTV^..XF\O>AWLHV'KTP"Y'OQTQ6Y4-M;0VL0B@3:@+$#)/).3R?4G-
M34`4Y':66[@=S%"L*_O5.TJ3NR0>Q`VG_/'/075S;1Z3#>7-PR,XFCN`Y'F1
M[&8K+ZE<#/8\'UKIKFW6>-HFC1HI@4F!X+*5(QQ^'X9J!=.A>TBM;B&,PPC;
M&J%AM`!4=_[I'X_A0!@"[N!HY@FNIEN=3E:1-REI+>%B%R=H&,9'H.?:N@T>
M]74-,@N%;+,H#CNK#J#[YJ465NMPEPD2B:.+RD;GY5],?@*KZ7:+8FXAC@BA
M0OY@\O=\Q/4DGJ>!TH`T***CD\W?'Y>S9GY]V<X]O\]_;!`)**KV_P!JRWVD
MPXR=OEYSCMG/>I#YOG+C9Y6T[LYW9XQCVZT`2456_P!-\W'^CF/=U^8';GT]
M<?K3C]J^T`*(?(SR23NQ@=NG7/?IB@">D!R`?7UJ&'[5O/G^24P<%,Y^\<<'
M_9Q^.:=#Y^U1/Y>['S%,X)SV!Z<4`2T5&/-VQ9*9_P"6F`>>.WISC\*DH`**
M**`"BBD8D*2HR0.!ZT`+13<L8\A0'QG:3W],TQFF$H"QH8\?>+X(//;'3IW[
M^U`$M5;&9IFN=SLWESL@!3;M``XZ\_7WJ6=YDA+0PK))@_(7V@G!P,X]<#\:
M6)'0R;Y3(&;*@@#:,#CCKW_.@#$TB1I/%WB`$_*@ME`QC'R$_P`R:WZY_10/
M^$J\0M\VXM`,$''">OX]*Z"@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`1AN4KDC(QD'!K-3157'_$PU$@$G!N6/6I]2U*WTR#S;@MS]U%&6;Z#\:FL
MYS<V<%P4,9EC5RA.2N1G%`%$:(@"C[?J)V^MTW/UJO'X;V8SK.K%>I'VG&3G
M)/`SS4E[K\5EJZ64D+"+:3)<DX2,[&;!]\+_`)Q4=AXEBN+6:XN[:6SCCD\O
MY@7);`)'R@XQD?KZ&@"5=!53DZEJ3$.&&;I\``_=QGD8&.<^M(F@!2N[5-48
M8&X?:F^8]SZC/MBIKO7]+LF1;B[56>,2J`K,60YP1@'TIDOB+3(;9;B2:01M
M&)0WDN05/?.,4`0+X<93D:UJYXQAKG/T[4#PZX.5US5\X`_UZX`&.VW';^?K
M5BY\0Z7:3M#<701UQGY&(&1D`D#@X_F*ECUK3I+TV:72-.&*;0#RPZ@'H30!
M731)1*9'UC47W(59=ZJ.5VY&U1@C@@^HH?19G?<-8OU.S9PR],Y'&W&??ODT
ML7B729A(4NU(12^=K?,!UV\?-CVR:EEUW2X4B=[V+$J"1=IW?)G&[CH,]S[^
ME`%>'1+B!5$>N:B=IR#(4<D>A)7Z5-_94^'']L7XW-NX,?R]>!E.G^%+<Z]I
MMI<O;W-TL3IC)8''.<<].QHFUVP@N+J&6;;]D5#,Y'RIN.`,^O(_.@!HTFXW
M*S:UJ+%<<?N@#_XY31HUQC!UO4NN>L7K_N5K44`8QT!B0?[8U/(8,#YB'D$X
M_@]S46H:3+'I]W(VKZA(/)<E':,J?E/&-G\JWJJ:K_R";W_K@_\`Z":`.?MM
M%U^2U@DC\2.@,8(4VZD`$=.O^?YS?V%KZE0/$\A`P#FV7/\`.MVPQ_9]MCIY
M2_R%6*`.9;0=?*-CQ-*&SQ_HZXQC'KQ_GZT^30]=DD<GQ+(%8C[MNH(`'L<#
M/^?2NCHH`P8]*UV/`_M\,%51EK526QGKSQUQZ\5.+#6-R[]90@*P.VU"G)!P
M>IZ$]/IGWUZ*`,<:?K0#9UN-MQZFS`P.>!AO?K["G1V.L*FUM9C;T/V09Q_W
MU6M10!D-9:T5PNLQ9SU^R#I_WU^'YU#]E\2@%1J5D0?XFMB"/I@]_?TK=HH`
MP(K?Q3Y166^T[>44!EB8X.X9/O\`+G\<=.M,%MXL\G!O].\S=U$38V_Y]JZ*
MB@#"6V\2K:3*=0L6G+#RV,)`"\YS[],=>_KPW['XEV29U.S\S<`C>0<!>^1G
M&3QZ]^E;]%`&&MIXD$;9U.S9R/E_T<@`_G]?T^E2-!X@\B)4O;$2A6$C&!B"
M><$#/TK8HH`P?LGB4(`-4LB<#DVQZCKW[_YQ2I9^)%:7=JMFP;[N;4_+],'^
M>>E;M%`&4L6O9CW76GX`^?$#_-_X]3]FM$G_`$BP52#C$+DJ<<?Q<\_2M*B@
M#,\O6\Y%Q8=_E,+X_P#0O\YI&770#METYB",`QN,C//\1QQ]:U**`,F4>(54
M>4VER,0<[ED0`Y'N<\9]*A+>)QN(BTHY;`!>3@>O3_.?PK<HH`P5D\59^:#2
M,<?\M).?TH9_%>0!#I!ZDG?)@]./\^E:&IZQ8:0J-?W`A$F=N5)SCKT'O5#_
M`(3'0#G_`(F2<?[#?X4`1[_%HY$.DG@G!=_?C^5'F^+2N1;:2#GH7>K%IXJT
M6]N([>VO?,EE;:JB)QDXSU(XK9H`Y_S?%G/^BZ5VP/,?_/\`^N@R>+./W&D9
M'!^>3D^H]JZ"B@#`23Q7N^:WTC'M)(/Z4"3Q80<P:0"1QEY./KZUOT4`8`?Q
M86(\K2`.0#ND.#Z_2I(W\1*"&M=-VY;[L[YY&1R5/?O^E;=%`&&9/$_D@"WT
MH2Y&6\V3:>>>-O\`6GJ_B,[2UOIN=IR//?&>/]CZ]ZV:*`,F.;7Q`1)9Z>9L
MC#+<.%QD=MN?4TJRZXJA6M+%CM`W?:&&6[G&SIG/YBM6B@#,,NM^;D6ECY6T
M_+]H8MN^NS&/\\4OGZQS_H-GGM_I3?\`Q'7_`#FM*B@#,$VMA0#96#,1R1=.
M`#_W[I3+K1Z65@/K=O\`_&_I_GII54.J:>I(:_M002IS,O!'4=:`*GGZZ%.;
M&Q).0,7+<<'&?EZ=.G//0=FR7^M1LP71DD&X*"+L#.2>?N].GO@U;_M;3<9_
MM"TQZ^<O^-3V]U;W2LUM/%,%.&,;AL'T.*`,>74]=65T70B0/NLMPA'7'?&?
M7'''I3FU/6XU4G02Y8XVI=)Q]3_GK6Y3-[>=LV';MSOSQG/2@##_`+9UK9N_
MX1N7'I]J3-*=8UH9'_"-S9'7_2H\5O44`8#:SK0)'_"-RD]1_I28QSGGUXZ?
M2D_MK6\8'AF7<>WVI,>W/^<5T%%`'/\`]M:V>GAF7'O=(/K_`)[THUG6R,_\
M(U+CG/\`I<>:WZ*`.?;6=>`S_P`(P_3_`)_(^OY4IU;7P<?\(R2?:^CQ_+Z?
MY%;]%`&`=5\08R/#1[<?;8_Y_P#UO_K']K>(/^A9/_@='6_10!A'5->+$+X=
M(!'!:\CX..^,]Z6/5-<,;&3PXRN.BB]C.?QK<HH`Q%U+6]S^9X?;:,[=MW&2
M>>,YQC]:=_:>L#=_Q3\AP.,7<?)_.MFB@#)&HZH21_84P'.#]HB_7G_'^M(-
M3U-E4IH4_/7?<1KC]:UZ*`,H:G?^:T9T2Z!S\I\V+!7=@G.[@XYQ^'O2#6+H
M;5DT/4!)C+!/+91_P+>`>O\`G!K6HH`R/[:F.`FBZF6/0%$`Z9Y)?_/Y5'_P
MD3;2W]B:Q@8'_'N.I]MV?Z5MT4`89\1D8SHFL<\_\>P/'_?7Z=:#XC91EM#U
MC''(MP>O_`LUN44`<^?%./\`F`ZY_P"`G_UZ/^$J_P"H#KG_`(!__7KH**`.
M;\,7(O-7UNX\B>W9Y(LQ3Q['4;,#(]ZZ2L/2&_XJ;7UST>`X_P"V0]_;T_/M
MN4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`&7K.@V6LQ_Z0K+,JE4FC
M;#(#UQ5RVMC;9196:$*H2-N=F.OS'DY]ZL44`<AJGA^>\U)[J:SAD070D0&[
M9=XV@`8$9QD@9SWSSSFH9_#U_>VXB\J%E\R>1G%X&RSMR.8OO`CMW!YK8U;[
M4^J(L,,K1LJ(TB@J5!+;MK=`>5_+%9K1ZRD\IC^U$3-D_*/N^9&HR<<'8KG&
M>-U`$W]DZJF^2&UMUE6R6SA8WA9HP,_-_JL$\C/TJC>^%K^\@C@>V@5%C2%6
M6[.8]H8;AE#A3G)7KTYZXDO;'59H9XKI[UDE\J.)\@J,!?F*J2RMG+=.3QZ9
MMWMSK(BLDB%R)53,TXB&PL%4G*]U.&XPISCD#J`5I]#UMKR01?95MI[H7,L+
MR;E<AE;&[RPPZ`=^]3V6BW]JZP"RL#;1W+72`S-GS,<'.SMGI@'CKBHO+UZ7
M38PTETN71V)P)`WS?(`!D+N$8).>"3TK8T^:2VM(C)!<KYMU(OEE.4!=L$^V
M>?\`@7I0!D6OA_4;"W@-O#;&>"WDA0F<GYW()EY3K_LD=._:D&@WT'FK#:Q-
M'%:"T3=)N:=`Q;_9VY[@DCGN*Z^B@#B[O2=4N+6[633!(-0<32JLT:-&$(V1
M>A^ZOS9]>`>LR6^JB>:9M&):>6.=QOB8@J`-G+8/W<[NOS'CFNNHH`:A+(I9
M=K$9*DYQ[4ZBB@`JIJO_`"";W_K@_P#Z":MU4U7_`)!-[_UP?_T$T`/T_P#Y
M!UM_UR3^0JC-=7LEU?+:SVL*VNU?](C8@L5W9R&&!R/7H:O:?_R#K;_KDG\A
M3+C3;*ZG2>XM89)4.0S*"?Q]?QH`SI_$7E&5TLGEM8Y&B^T+(N"Z@Y&.O48S
MCZ9%)!KSM<.)+&2/!@5_WRL!YF0I`';.!^/3@FM1["S=V=[2!G8[F8Q@DG&,
M_E2RV5M*I#0IDE6W!0#E3E3GV/-`&/%XE=H`\VG/$\B1O$GG(=X=MHYS@<XZ
M\\]*>/$3G!73Y"%AEFE/F`",(2,9Z')':K%KX?LH;!+:5#*P1%>3<RDLO\0P
M<J<\\'O5I=,LD\S;;1CS$9'`'WE8DD'\2?SH`IP:T;F_BLX;;,F9!<9<?N=C
M*/QSNR/PXJE?^(KE#J%O;V@2XMD9D+N"6PR@'8<'!W=1Q[UJ:?IOV2\O+N6;
MSI[IADB,(%49VC`ZXSU)YJ0:99"2:3[.A:8Y?=D@GU`/3\*`,N[\2O:P%I+-
M(YDE\N2.6X5`OR;Q\QZY'ZY%%EK5Q>ZS''"4%I(%=0R8;:8@X[]<FM.XTFQN
M9UGFMU:57\P."0P;`'4>P`I;?2[*VDCDAMU1HU"(03P`,#].,T`9@UZ2&_O5
MN(MUI#.8ED'RE<1JV,'KR3S[CM5K2-:34C+'LQ)&$?"\_*X)7/\`=;`Y';(Y
M-6_[/M#/+.8$,DOWV/?C']*;9Z79V*N+6'RPZA&PQZ#.`.>,;CT]:`,Q?$4P
MTN:ZDT^4&.+S0W`1USACUX(Y./0#UI)_%,$,MX@MV?[,C,NV12SX4DY4<J..
MI]>F*U_L%I]C^R?9X_(\ORMF.-OI4$FBZ;+)([VD;-*27Z_,2,'(^G]/2@"D
M_B+R;>X>>RE22)P`A9!E6!*,3NP`<8XSSV[4L?B2&5XWA@DDMW\I6<8!C:0K
MM!&><AP>,XP?POW&DV5R69X0KMC+QDJW`P.1[$CZ'%9LOAF*2Z#!T2!)(G14
M0JRA,?+E2,_=&"V2`3C'6@!;;Q98W8800SR2!498U,99PS*H_BXY89W8IXU2
MZ?1+N[,?ES0S.@CP&90'Q@X)!./2K::-8IYVR$KYK*Q`<X0J<C:,X7GGC'-.
M32K1-,;3]C-;MN+!G)8DG<26ZYR:`*I\16R2^7/!<0.OF>8L@4>657?@D''*
MY(()'!K3MI6GMXY7A>%G4$QOC<OL<5F3Z!&R6\5O)LB6Y6>;S`9&FQV))_#Z
M5L4`%%%%`!1110!@Z\"-5TZ1(S)+'%<LB@$Y/ECC`Z_F*XZW\2W5Q9&Q^P1O
MJ\DXC1C;JH3'&[&/OCIV``'O74^++YM.O=/NHU#S)'/Y:-G#-A>.._MWKD%2
M"$0ZM'X@A_MK?YCJRG8V>V<#''MCGZ&@#JDL9M.U#04FEBDG>5S(1$D:K^[8
M$+M`]?Q/TXTQKB1ZKJ-G<J(UM$$J/_ST79N8>F1]>AZ<9K"_MV#5]1T%7EA^
MU1W+B5(6W+D+C(]B>G\^*Z"[T*WNYI9))IQYLZ3LJD8.U0NTY'*G&2/6@!++
MQ!97`MDE?[/<SJI$+@Y!;HN<8SP:6#Q'I%Q'.\5]&R0+N<X(P/;(Y_#-5T\-
M)'>QRI=R>1&L8\HHI8E&#+\^,X^49'4GG/:A/#2#3HK1KR5A'"L.=JX(#;NA
MSUZ'VH`F/B728X8'N+Z&,SH77DD<'!YP.^1SCH:F;6[!+NYMI9Q');1B23<1
M@#Z^HXR/<5AZGX;O_LXM["\<I+%Y$Q;;\V7+$E2,`#<?N\\_C6A)X:C>2]/V
MCY+E)%53$I*%SDG=U/);'3AC]:`)AXCT_P#>2>9BU14)N,?*2_10.N<<]*MV
M^HPW%PD4>[][`)XF(X=<X./IE>O]X>]4KC1YKB>^7SEB@G9)8RJAB'V;&!!X
M*X"\>YZ<4[3],EL[V('Y[:VM_+A+.6;+-ENO0`!0/:@#7HHHH`IZGJ,.F6Z2
MS!W,D@BC2,99W/10/6LN;Q5%`L:/878NGD$?V8J`X+`E3UP0<'H>U:6JZ?\`
MVC#$JS&&6"4312!0VU@"!P>#UK,?PNL\_P!HN[HW4QE$C^:F58!2`@7.`H+$
MT`:FE:C'JEI]HB1D`=D*MC((..U7:HZ1IPTNT-LDIDC#LT8*@;%))QQUQFKU
M`"$9!&<>XKE/#>BZ9>V5Q)=6,,SB[E4.Z#=@.<9KK*Y;PCJ-I#I4WVBYBA9K
MN4[9'`(RQ/.3[&@#4'AO10P(TNUR/6(5G^#(UA76(T141-2E10JX``P`!6T-
M4T\YQ?VIP,G$R\?K6+X-99'UN1&#(^I2E2#D$<<@_C0!H?V_:C4[ZR97!LH?
M.=R5VD8!..>V1_G&76FO:?<QVY:=899U5EAD.&&XX`^N0156\\-I>7TMR]TZ
MEYTE&U1D`)M9/3!`'Y5#_P`(P3/$YN(PF$\T-;JS,R,6!4GIG..0>/T`-"+Q
M#I$UR+:._B:8L%"9.<GM^9Q]>*CT[Q'I]_;K)YPB<QO*8G^\$4D$_H:K/X8#
M6#VJWC+F)D#;.A:7S,XSZ\8H?PT9O,@GO6:RWRO%!'&J%#)O#?-@YP'.!Z]:
M`+_]NZ7LA<WT(69S'&2<;F&`1^&14]GJ-G?M(MI<)*8\;@IZ9Z?R-9UCH)MI
M[6:2=':`R'"1>6/G55P`#Q]W/U/;M+HNCR:9+,[W*2!U552.+RU`!)R1DY/S
M=?:@#6HHHH`*15"C"@`9)X'<]:6B@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`,+1"7\1:_)D%3+$N`Q(R(P*W:PM&4+XDU\+P/,A./K&*W:`"
MBBB@`IJ,'&1ZD?D<4ZFHI48+%N2<G'KTX].E`#J***`"BBB@`HHHH`****`"
MBBB@!KMM1F"EL#.!U-4?[3EWE3I=\"!D\)@>V=W/X9QWK0HH`S!J\AC1QI6H
M8?&,QKGD9Y&[(_&A=6D8X&DZAD9R"B#IWSNQ6G10!E+K3-M/]DZD`3C)A`Q_
MX]FG/JTJA\:3J!*@D?(G)]/O?3_(-:=%`&6NKS-@?V1J&=N3\J8'YL,T+K$S
M$C^QM2!`)Y6,?^SUJ44`93:S(-W_`!)]2./2-.?_`!ZA]9E0X.CZD><<(A_]
MGK5HH`QSKQ#!3I&J\KD'[."/IUX-+'KC2(&72-2SW4QJ&7KU!;VK7HH`R&UX
M1P/+)I6J(5Z1_9]S-R.FTD=^Y'0U&/$J,0$TK5GR`>+0C`/U(K;HH`R&\00"
M,N+2_90JM@6KY^8XQ@CKTX_$9J+5-8A?39T6WO"9(&S_`*._R9!'S<<8/7TK
M<K/UW"Z'J$FQ69+67&?]T\?H*`*MCKEHME;(([QR(5/R6<K`\=B%J23Q)I<1
MQ+-+&<`X>WD4X)QG!6K>GRJ+6UB(;<8%8'!QC`[_`(BK#%PWRH"..<_G0!DO
MXITE<8FE?_=@?IV/3IG`SZFD?Q7HR*S-=,$3&6\F3`S[[?I^8]:V2H)!(!(]
M11M'/`Y.>G>@#$_X2[1`RJ]VR,>S0OD?7CBEC\6Z+*P6.Z=BP)4>1)S@9_NU
MM,H888`CW%54FN_/9/L<:QAQAQ+U4ELG&.O`X]_;D`S3XPT/#%;J1BO4"WDS
M_P"@TK>+M%!/^E2''4B"3U_W>:VVSCY0"<CJ<<=Z6@##;Q?HJD_Z3+\HR?\`
M1I./_':0>+]&/(GFQZ_9Y,?^@_3\Q6[10!C1^)],ER4>=@%#$BWDQD]!TZ^U
M#>*-*"+(LLKQ,H82)`Y7G.!TZ\'BMFF@G!RO3ISUH`S8_$.F2(7$[#!PP:)P
M5/`P1CCDTA\1:;Y#S+-(Z1L%8K"YP3G`Z>U:)D;RE<1.2Q7Y>,C)&<_3.?PI
MHDF\V13`-@&8V#_>XZ$=OU_"@"C_`,)%I>UV^TG;'C>?*?"YQC/'N*:_B72(
MX8IGO`L<V?+)1OGP<'''/)J^&+6Y?[*RLY^:)MNX]N<$@\>]!'FM$9+8=<DM
M@E".A_GS_D`&7_PEV@A@IU&,'W5N/TXIH\8Z`>FI)^*,/Z5K&WB>1P]M&1UW
M%0=Q/!_&G?9H,D^3'D\'Y10!D-XPT!1DZE'TSPC'^E!\8:`&P=2CS[(Q_I6G
M:XD0,UF8&'9PN1SST)]!^E2B.,''E*!CK@8[\?J?SH`Q1XS\/E2?[17`_P"F
M;_X4I\8^'QC_`(F*<_[#_P"%;**&4EXE4[R<<'OP?Q'-'DQ%=IB3;Z;1C_/`
M_*@#&3QCH#RB,:DFXD`$HP'/N1@=>M*?%^@"0I_:4>1GD*V.,]\8[?YS6O\`
M9X?^>,?_`'R*7R8L`>6F!R/E%`&4WB?0O-(.H6Y*<;MP(SST/X=N.GJ*C_MS
MPW.XD>[L2[J"2^W..."3]!Q[5L^1#_SRC_[Y%'DQ8(\M,$Y/RCD^M`&,-;\.
MP2+LN;)6(!#)M'&3W_X#_*K#>)-%5PIU.V!_WQQ6B88CG,:')R<J.:C:&!AM
M:V5@6Q@H,?7Z4`4O^$DT;?L.HVX/J7P!SC^=2/KVDI(J'4;3);:?WR\<9YYJ
MW)!"5+-`CX4C&P$X]/TJ..&WBB94MMJQ$X79U[\>O7\Z`(1KND,2!JMD<?\`
M3PG^-*=;TD'!U.R!]/M"?XU):+;O:+Y-MLB51L4H!D8R,?G^>:(+>U,0A2T6
M*.(J53RPJC!##'T/ZB@!G]LZ7Q_Q,K/GI^_7G]:7^U],R!_:-ID\C]^O^-(F
MC:7&05T^U!`(SY2]^O:H(=*TJZ63=I,2*'#8E@`W':#G'MNQ]010!/\`VSI>
M"?[2L\`9SYZ]/SI?[8TSC_B8V?)Q_KUZ_G51]'T<,6_L6W;AB3]G7J&].^<D
MCU`H71-'>X:`Z)`N$#>88%VG/&`1W&.?K[T`6O[8TO\`Z"5GUQ_KU_QH.LZ6
M,YU*SXZ_OUX_6H&T+1O/2/\`L>U.0S[A;KM&".#]<\#V-/.@Z,!G^RK+CG_C
MW4_TH`?_`&WI7'_$SL^>F)U_Q]Q^=']MZ3D#^U++).!_I"=?SJC<:1HB0Q,^
MAH=[!ML=L"R$CH=O;]*=!H.BRLP_L:)`R(^7BQUSQ[$8Y'O0!;_MS2=N[^U+
M(+G&3.N#^M1+J6@@LRW>GY)+-ATSDGG/N3^-(OAS1<L/[*MASWB'/':HCX?T
M3[*TO]C1956_=^4-YQV'J>.#G\:`'M>>''==UQI9=3\H9X\@]./PJ6+5-#MD
MVP7VGQ(3G$<J`'@<\'TQ^%01Z'HT@DWZ+!&$DVC=`/FZ<C';G]#1%HVBS-L.
MB1)@XRUNH[>OY?GZYP`6QK>E$X&I6><E<><N<_G0-:TLA3_:-KAEW`^<N".>
M>O\`LG\JK/H6B"0J=(MR?EY6WXY)'ICC'/I2-H6B@.?[%A.U@,"%>0<<CVY^
MO'2@"U'K>E2-MCU.S9LXP)UY/YU(NIV#;=MY;DMT`D&3WZ50_L3106D_L6'Y
M6V?Z@<X[X[CMG^G-+;:#HDT(QI%N@5BN'A&>OKWH`N_VII^,_;;<].D@/7I3
MFU&R1BK7<`8=O,&>F?Y$&LQ-'T214<:)&-Q8@&W`QM/4^QQQZYI[Z+HB1>:V
MC0_,R+M$"Y&X@=/09Y],&@"]_:NG[BOVZWRO7]Z./\_XT]M0LE&3=0XSCAP>
M<$_T-4TT#16W(-+M3L.TEH@3T!Z_E39]#T:,QC^Q[=]\@'R6Z_+U.3Z#_P"L
M*`+?]J6!0O\`;8-H[^8,=_\``TXZC9!2S7<"J.I:0#L#W^H_.LR?1]%*2RR:
M(N(<_=MP3)CT"\G\>M2Q^&M#:-&&E6X!&0&CY]>:`-#[=9[MOVN#.2,>8.HZ
M_P`C0M]:,H9;J`@D`$2#DGH/T/Y51_X1C0\`?V7;<'/W*/\`A&=$P1_9=KSG
M_EF*`-&&X@G3?#-'(G]Y&!'IVH2XADSLFC;#;3M8'!]/K6>?#6B'/_$KM>1C
M_5B@>'-%[:7;#J/]4!GG-`%P7]F=^+N#Y"`_[P?*>F#SQ4D=S!*K-'/&ZJ<,
M5<$`^]95QHN@PM$KZ5;DLZH-D&>3G&<#IUY-.&AZ$R22?V7:A5+;OW&"".#Q
MCIQQCKU'7D`UBR@`E@`>^:02(1D.I&,]>U9H\.:(WS?V7;<CO'3$T/0F:1AI
MML2'V,6A_BXZ9'OVH`U3-&&VF1`V"<;AG`ZTOF)G&]<^F??'\ZR3HFA><D!T
MRWW#./\`1_EZ<Y.,9P>_/Y42Z%H4`C:33;4*'"K^ZR,L0!D?7'6@#6#J<X8<
M'!Y[^E`D0]'4]._KTK'AT;09X]J:;"X10"7@.[@D<DC).5/O^=1SZ-X<+1Q2
M6-L#/\B`+MST;CI@\CGJ>GM0!N*Z-]UE/T-`=#C#*=W3!ZUCW'AK0DB,DFG1
M!8SORBMD8)/&WG'/2JL^B>&8K-99[`)$W0%9,J20N,#D')`QZT`=%O7(&X9.
M<#/7'6E!!&1R*Q!X:T.1U5+4C";L)*Z@AN,G!ZG%(WA71-R)Y#HV#M5;B0$X
M[_>YQG]:`#1=I\1Z^RL#^]A'#9Z1C_/_`.JMVN9\*PK::QKUJHVK'.C*A))`
M*D@Y/7(KIJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#+UW5)-+M8Y(
M+9KB1Y43:%;`!R2<@'L#].*GT>ZDOM+@NI6B9I5W9B!"X]L\T:EID6I(BRS7
M$>PY'DS%,].N.#T[^II;#38-/9_L[2"-@JK$7RD8`QA1V]?J:`,_7?$`TC4+
M"W:,%)V)FD()V(.IX]R.?3](8_$QA%VU]:N4BN)HT>!<C9&3DMD\<>_-3ZOI
M%S>7XFA%H\30F&1+D.V58C.,'C[J_K6%-X99?LUG*]DKF/RT`9\D[BY/(/4Y
M[YQN'3-`&]>>)+2TU&2UD2<"%U25Q%N7<RY4#!SD^P/]:KR>,M-CBCE:.Y*/
MNW;8\F(*VTEQG@9(YYZU372KR)KB1;C3EEAN&NYB0YVR$9!/L%)P.G/UIH\+
M7D]K%',]DZ(%V!%95<!B_P`R^Y)Z$=:`-M=>MGU06$<-S(Q(!E2/=&"5##)'
M(X8<XQ4>N^(8M'*((7GD(,CJO&R,=6S^0`]ZH1>'KZ'48;Y6LS/`"(B2^%!!
M!&/0`X'I3KGP]<W9NGN8[&::Z4J9)"[&,<8"^@!!/U/Y@%K5_%%GI0D5EDDE
MC56*J#M&>@+#(!(S@=\>])-XF@CG%L+>0W.55E)`0'^,!NA*]\57FT&^GD=G
ME@"2&-GB#MM=DQ@G`!Z*!V_2D/AVY)#!H@4:1XD,S,D;/G+`$9S@GOC/.*`+
M+>+M)$<4F^<I*&*$0/\`,JXW-C&<`$Y/^RWI5LZ]IRWHM#.1)\HW;&V`L,J"
MV,`D$8YK)N?#UQ/<)(_V)=L2PA?F.4&..>ASCD>PYIR>'KQ=0CNQ-;JR1A`%
M7&#QR#CD#`P#D#:*`+L7BC3)+2:Y+RQQ1`$L\9&X%MH*_P!X9!''I2S>)M+A
M1':60[BX($3$ILQNW#&5QD=<5FV_AB\@1E\^V;,J2J`K*JLC9'RCCV)ZGK]6
MMX=U'<)5>W$L8=E8-\S.^22&VY4YQR/2@#JD=9$5T.589!'<51\0?\B]J?\`
MUZ2_^@&DTNWO8)KIKQT9)7#Q*KEO+&,;!P.!C(^OYOUIUCT2_=EW*MM(2OJ-
MIXH`SKJY>WTLLDYB*Z:SI@C[P7.['7C'TY[UDW>JW\FDS:=Y[+?VG_'Q*IVM
ML1@=PQGE@R=<?Q>AKHK:RAGT^VEEC9V^Q^25R`65@N1GL>.Q'\J<=,M;N)O.
MMC&LJ(&7>0S;<%=V.X(QG)^M`%*Y\0I9WTEAY)=HMRAFDR6*PB3)XZ=LYZU)
MI>KW5W<S)<VL<,,,$<CR;^C,N2`.X]^/QIUQH-K=S-)-#Y;&5I"\<I);*E><
MCN.W;M5NVTNUMKO[5&C>=L\O<78Y&<]#QGW_``H`YJZU&[MH;NT-Y<!&>06L
MY7#QO&P)1F/4'@*3USCGBKMEJAM;^;3E2[>='C@ACFE5@<0[LYQP,#)Y))(X
M&2*U9=+M)8IK9K8>5+)Y[-NY\S.<CT.1]*=-I-C<&4RVXW2N)&96*G<%V@Y!
M!!QZ4`9[^(98Y)_,LU2*S$?VLF8%HRW7``P0.N<_A45YK9GM[C9&ZB&Z2+=%
M-M./,*?,>P)'K]U@<]<6;K2X=V8M.9UCPNQ)]@F"@%=XS\P!R`&_E5IM)M1;
MR0^29%ED61@[DGAMP&?0'G'3D^M`$-GK)GU:6REB6,9<1'=DML;#9';J"/8_
MGK5F1Z-;6ET+NWC<SB220_O,`F0C=G\A@5H*SG;N3&5R>>AXX_G^5`#Z*B#R
M^26,7SC/R;NO/K^M2#..>M`"T44F3N(QQCK0`M%,C,A+^8BJ`V%(;.X8')XX
M[\>U..<<=:`%HIK,1MPI;)P<8X]Z25S&FX(S\@87KR<4`/HJ.20H\2B-F#MM
M)7HG!.3[<8^I%/8D*2%+$#H.IH`6BHW=EEC41EE8G<P/"\4T3.68?9Y/ED"`
MDKR,`[NO3G'KQTH`FHI,G<!M.".O84T.3M_=ORQ4].,9YZ]./U%`#Z*@AG>1
MPK6\D?!)+8QP<8X]>OTJ>@`HJ!YW6Z6'[-(R-C]Z,;1UXZY[?J*GH`**8')E
M9-C```[NQSGC]/U%5%OYF4D:?<DCJ/E'][U(ST'3^\/?`!>HJ))'::1&B*HA
M`5R1A^,\?RJ6@`HJ*.5GDD5H70(<!FQAOI@_Y_.I:`"BH8I9'E9'@=`!D,2"
M#R1_(`_C4U`!13`Y,K)L8!0"&.,'.>GTQ^M.8D*2%+$#H.IH`6BHC*RVQF>)
MPP3<8U^9NF<<=3]*0SXNUM_)E^:,OYH7Y!@@;2?7G./8T`345'+,D+1A]W[Q
M]BX4GG!//ITZU#/?1V[['CF),;2#;&3D#J/8].N.HH`M44@.1FFQ2"5-ZJZC
M)&'4J>#CH?I0`X@'K2T@.<^U0K=!KV2U$<@9$5RY7Y2"2``?7@T`3T5%+<)"
MX5P_*LV0A(`'7)`XZ_C4,>H0NTH$=P/+<HW[A^H],#D>_O0!;HJFNI0LTH$=
MS^[&2?LTF"/;CD]L=>.E(NI1NK,MO=$`QC/D,,[^XXY`SSZ4`7:*K+?0M'%)
MME"R`L/W3'`'K@<=>_\`0TD=_%))L"3@Y`RT+`<[L'D=/E//TH`M45"MPCS>
M4H?/S<["!QC//X_H?0TQ[V*-F#K*-L@BR(R<DJ&XQU'.,^O%`%FBH_.3]W@.
M?,&5PA_7CC\:KOJ=L@R1<'DCY;:1N?3A:`+E%0BZC/:3[I;'E-G&<>GZ4UKR
M-8X9&28"5P@_=-D$]-PQD#W/%`%BBD)P"?3TJK-J,,#A'CN"6.!M@<@_B!B@
M"W14$=TDD<CJDN$Z@QL">,\9'/X?3K3(=0@G:-8EF/F`,I,#J,$9SDC'_P!?
MB@"U159KV%'D1A(I3.=T;`'`R<$C!&.].MKN*ZW^6)1L.#OB9!^!(P?PS0!/
M14+7,:VYFQ(4!P0(VW9SCIC/6GK*K&0`-^[.#P?0'CUZT`/I"`1@\BHC<QBV
M2?#E'VXPA)^8@#CKW_"HVOX1(Z!)V9,YVPN1QGH<8/W2./;U%`%JJ\]L9;JV
MF$A`A9B5[-E2/TS_`#IT%PEQ#YJ+(%Z_/&RD\9Z$9[_TZU72:.]N(I+>(-Y#
ME7>6-T905/W,CG)QGM0!GZ)$(O$OB##%MTD)R3SRF<?KZ?B>V]6+H\977M=9
MSEVFBYQ@;?+&*VJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`Y
MCQ1JCVM];V_F7,<'EO*Y@C))<?=!/8'G\0,D#D96E7=J=<-]K'GO<P6D"QB2
M%\B1ER^!CKD\=.O%:_BW7Y-)^R+:RHKF3=,&P?W8P"/8_,#QSQ^=&'Q/J2W-
MW/);"2V8JMG'E8]P;<P9F/\`L*3^7KF@#`N8"UM=)#!<YOH_.G`MY,^8)3A<
M$8RH8$D?W2.]:O\`;FH0ZE-]FCO5@BBE$4,D+,K;0%CXV]SS_,]:T9_&A^R1
M7%I8&9?+:6<F4*(PK;2`>=QR1C'7/UPV[U_5+BW2."'['>27$21Q[D?<C@MG
M)&!PI_2@"C_:]_'!*(;R_EW0P)YDEJV`Q/[QEPO8<8ZY/MFHAK&L/8IO;4OM
M,5H2J16Y&9"[`%R5YPH4].>>:V+OQBMO;J%M=UTLCI-&\@15V8W88_>Y(`'4
MY[=*LMXF_?3O%:22V=N%:65<`J#'O``)^8YP,#IUH`PUU744N;EC<7Q0"184
M^RR,&_=@+SU!W')_^O4PO+AYHD>;4)=MOYB$VK-FX?Y6&"H!55;ITY/4UO:9
MJ]S?PV[BP/S.4ED2:-D3`SN!4G(/%;%`'$6NH2"\L#>7%W+);W4N]O(9@(_+
M(4C:.=W![]3Z4[5]?\^2>YL-1,:P>6L49;RPQR3)O5ADX`7MTZ9KM,#.>](5
M4G)4'\*`.1L?$FGVNH7<NHZTS%II$C@`+QJ@?"D;0><#U[UU%A>P:C9QW=JY
M>&0$JQ4KG!QT/TJ<`#I2T`%4->S_`&!J.,9^RR]1G^$U?JCK(!T74`[$*;>3
ME1D@;3^=`#'A>;PZT,0WN]IL4`XR2F!UK#2SUZW58T\SRX[>)4E+*[KAD+`K
MG!(&[G!X`QDFN@TP2)IMBH"8$"!NV/E'2GO+;I?QPO*WGR`NB;SC`&.G3N?\
MC@`P(;GQ#<B%59EPD99UC0!LR.#UR/\`5A6P.^/7!;I%UKCZG;+<P-$CPHSJ
M^?F!!+MPIP=QZ$KC&,'K70_VA9L\L8N8R8@-^&^[G@9-3":(PF82H8@"2^X;
M0!U.:`)**KO+;S1*OVA0LW"%),%O]T@^W:K%`!1110`44A(`R>!3)YHK>%YI
MY%CC099V.`!0!)15>VGAFDD,-VDX(5]JLIV`CCIV/7GU]*L4`%%-==PQN*\@
MY'L:BBMC'+YC7$TAP1AR,<MGH`.G3Z"@">BLLW%G<3EHM493*O"I*N!M95)`
M(.#G"_CZU>:6.V0?:)U&3PSD#.6`'ZD#\10!-1374LC*&*$C`9<9'N,\4)@(
MN&W#'!)SF@!U%0RW5O"Y26>*-@NXAG`./7Z<'\J?M"R-*7;&T#!/RC&><?YZ
M4`/HIJLLD:O&X96`8,IR"*3>@0DN,)]YB1QCKF@!]%1PSPSQ)+#*DB.`593D
M'C/\J=O7Y?F'S=.>M`#J*9YL><;USG&,]_2GT`%%,D5FC*HY1CT8#./SI]`!
M12'.#C@]LTBJ59R79@QR`<?+P!@8'MGG/6@!U%%,F5WA=8Y#$Y!"N`#M/K@T
M`/HJ.%)$5A)*9278@E0,`G@<>G2G.I8##LF"#E<<^W(H`=13%1A*S&1BI`PA
M`PO]:<03C#$8/;O0`M%%-?=L;9@/CY=W3/O0`ZBJOEWHG#?:(C'NPR>6?NX[
M<_>S^&.WJ\)=?:=QFC$`S\@C.X_5L_TH`GHJ*X6=H91`Z)(4(C++D*V#@GU'
M3BH;B"ZENHREQY<"E6*A>6()R,YZ$$?E0!;HJ*+S]\WG>7MW_NMF<[<#[V>^
M=W3MBGL&.-A`Y&<C/%`#J*BMQ,L>+AT=\GE%P,=OQI(/M.YS<&,KD[`BD$#<
M<9Y.>-OXYH`FHJIMU#:`9;8D#DB-AD[AVR<?+G\3[5;H`**BE68O"8G55#YD
M##.Y<'@>ASC\J2Y6=HL6TB))ZNNX?SH`FHJH%OGM!^_@2<J/F,!P#W^7?].]
M6$W^6-Y7?CD@<9H`?2#/.?PJI$NH@@22VS`*OS"-@2V1NXSTQG%31K-B;S)!
M\S9CPO*#`X//)SD_C0!-14>V7[/M\P";9C?MR-V.N/KVJ!4O\8>>VSM'(@;K
MSSC?T^[Q['UX`+=%4+R>YL;2^O)6CE2"`R1QJI7)526R<GJ0,>GO4MJURXG,
MKKQ(PC!A*D`'OS\W'<8H`M45!:I.D8^T3>8^T`G:`,@<GCU.3^5,D2\Q/Y4T
M664^5O3.TX&,X/(SG]*`+5%%5P\[7,8$>R':^_=@G(*[<8/^]^5`%BBBH]LO
MDJ!(GF#&6*<'UXS]>_'O0!)146)5M0I<&;9C?MXW8ZX^M0;+_(_?0#Y@2-A.
M%V<CKS\W/;B@"Y14#+<M:!1)&MQLP6VY&['4#Z\TJ"X\XES$(MHPJ@ELY.><
M],;>WK0!-14<(E$?[\H7R?N`@8SQU]L4V)9Q/,99$:)B#$H7!7CD$YYYYH`S
MM+Q_;VMXSGS8LY]?*6M>L?2L?V]KF/\`GK%G_OTM;%`!1110`4@.:6B@`HHH
MH`****`"BBB@`HHHH`****`"BBB@#F_$]NDMS%YDT2K-"\+J\1?"9#%B0XVC
M(49[$CN168Z1F06[ZK;.LPCN&:.U.'!81KM(?(^8`?+CBM[5=+N;C4HKNWE*
MX58F"G:P7=N)ST()"@C'(S]*S/[%GMKE4ME411$+O\T*`P=G7U//FD8QUP?3
M(!5%K:WML@;6+%H)@EN@,#$E48;$.7]PW/)X[9R6&G1ZQ;W-T;N#*SO+(LML
MV4<,0&.)/0'&#C'J14PT*Z6)76$%@/,(-USRJD@M@]#&@!`'`_&G#3]42UDC
M6W`-U"L;,MZJL@5B1CY,')<Y]<CI0!7G%O%:V,R:Q%+#D);K#;98YZ@_/DYP
M<Y[YYS36>*3=%_;$%RDC">280<,V'^8L'S\HB8X&```!Z&S;Z#?H26B4,7$C
MH)U)?+B0@G;\HW+TYR.](=#OA"(I+<2&6-DQYZH$)C9!T7^ZS]NI[]2`)I4%
MO;7T"Q7T-N1(&1?(VF;>J,P&'(.0RCG..V.#721:M830^='=1M'Y@C)ST8_P
MGT/UKFK?2;D32*]M'*Y/F&(W2XE`96`SLR.=O3C"@'.:1/#MZBQJ;51&$02_
MOP?,PI!^78?[S'@]S0!U=I>0WJRM`VY8I&B8XXW#KCUJQ61X?MK^RM4MKN*,
M*JEO,64L69CN.1@8Y)YYS6LS!1EB`!W)H`6BBB@`JCK>?[#U#`)/V:3@?[IJ
M]5'6QG0]0&TMFVDX'?Y30!+8D+86HZYC4`@''W?TKF98]374+P(SK<W<\L2(
MZ#'EB)O+=6]`>V>K-P#TZ>R.-/MRQ`Q$N2,8Z50M=3M)H;E3=E6MLLTTA&!D
M'D'H<<@XXRIH`YZTM;I=+CM;-6%I;M!/.I@\MPRL-ZG/WC\I8G_9`&<\;5O;
MS6^B:PLD/DQM).T,8`)"$>G3D[CCWJU%X@TR9)GCNHRL4PA#;AMD<KD!3W[C
M\#2V6J6*6$(DODW1P(\AFD&\#:#EO?!!_&@#G8K:]M;6U:PB>XC:&6>V&S_C
MWEV<KM(Z9/R_4CZV;.34A:^;'?3S;)HY'5HBN\8Q)$-^2<!2>",9KH1J-D6C
MQ>PMY[!8\2`AB0<8QZX--L;BUN)KGR+Q;EEE.Y-P)B(`7:!V'!_,T`<_+>:M
M:6,KS321I#+#"TDB%BS-)N9A@<@*RKT&>1U`I$N[N(0QW-[=K:2JYM+B*)GD
M8;D,9<8))P2.1R.HR:Z:]L;;4(!#=Q"1`P8#)&".A!'2I8XS'NR[ON8M\QZ>
MP]J`.4G&KW=G>M>RW$+PVJ-Y-N!M+,K;AT))''`/!_30UV%I[?3+DI)<VL$R
MS3JJ'<PVG#;1R>2"1C\.M;U%`'/7M^&;[1IRRQQ>7BYF$#AMNQBFT;3R"V>G
M:J$=YJKOOBDO',$<#,&BPKDMALC&?N$,0".>W6NKCC=6W/*7RBJ1C`R,Y/XY
M_2HTANEF#-=AX][,4,0!VGHN?;UH`Y:*;4+;2Q%%<WJ"/S"7:UY5Q(H5<!.0
M0Q)'?L0,UM:/+=7&HW\LS7"PD1>7')'M4'8-V,\YSD$`X^IK8ICJS8VR%",]
M`"#]:`.0CCSI.LP&RG-Q-<S?9P(&4KO("<GH,G/IQGTJS?/J3:=?7,A\YH9R
MB0>1N5OFC`(![#Y^??G.*Z25)6MRB3;),#$FT'GZ5"UO=%X2+X@(Q,BB)?W@
MSD#V]*`,>Y77(+R^,$[20Q1RSQ*4#;RRC9'Z\,&/_?([U%HFLI'B.2ZEN()Y
MQ%;22(?O;!A<@#TYX&"2.<9KHYXY)#&8IVBVN"P"@[QW!S_2DF@\QHF5MA20
M/G:#G@C'/3@]1S0!S>OSQC4K@I$+B41Q02V<RX%PI+$>6V>N6.?I^:S:K>3:
MFUJ)A$!<30.-@(5#$'5FY['/.?6NIIC*QD1@^%&<KC[U`''KJ5W;Q0;))D#V
M%NYCCBRL(\S$A"@<!5SU]N>*TE635O#$\+798?.GGM&R;PK9!R1R"!@L,_G6
M]"C1Q*KN9&`Y<C!;WI]`''+!YVIQZI/`RZ=-<F8H8B,$08W,"`0O#\XYXX.1
M5*WM?+M6BF4^=-;1&R5E..)#P!QAOF4_CGL<=Z<]J6@#A6M4_M.26*SADF.J
M%X]B%9FVNNX[CQMY;/:NZIDHD,3B$JLFT["XR`>V1QD4XYXVD#GG(SQ0`M%1
MS"4J/(=$;<,ET+`CN.".?>I*`"BHQYOGMDIY6T8&#NW9.>?3&/UJ2@`HJ-!,
M)Y"[QF(@>6H4A@>^3GGMV%24`%%%%`!13?GW_P`.S!^IZ8_K^E.H`*CGV^4=
MRHPR,AS@=:DJO=V<5W$Z2#[X"D]>,YH`YVYDNH_$6JW%L[2Q06\9EM5/^M4J
M^2O^T,#Z]*6QU>:"VLX8A#Y7DK*QN)-K%3N.023GY5SGFND'DI*[((_-<?-M
MQN;&<?7'-1?9+"X=9?L]M*R`*K[%8J!R`#VZY'UH`Q!XBNEFDM98(Q=AWA50
MK8\P@&+/^RWS\_[/IS4AUR[CG/F1V[1"\-L0I;<!N`S]<-GIT!-;GV:#S3+Y
M$?F$AB^P9)`P#GV!(_&L^ST6*RN)I@%N6FN#/F95S$6ZE2%SZ<>U`&:?$%['
M%"K+9O+=+')"VY@J!W`VMW[GGO@\<5>TG4+FYUG5+2X>,K:F(*%4CDKEN?3/
M^>E7+>P@A::-;2W2%BI&U?O$<\CV/(JPMO"L[3K#&)G&&D"C<1[GKV%`'%6L
MZVXLK@7-Q\NH/&TGVAY,IO*A2IR",;1UR,YQCFM0^)+I%G>2*U"H`47S3N^^
M!R!D]&4=!SZ<5M0V-M')\MC;1B-@(V51G;@<]..>,>P/M3;?3[<%S)IUG$6(
MSL4-NQGK\H]?UH`S;/7Y+J&`#[(DY5RZ/)@$K)M(&,GID]#U'6JFB:G<1#3[
M5I$=+N68>8Y+,K*[G;VXVC'L2.HK;%I$6VR:=:*(R3!T/S$DG^'Y>`ISSU]N
M94MMLT4@@A0[?F(8DH?11CH<G)X^GH`6Z*09P-V,]\4M`!13)3((G,(5I-IV
M!S@$]LGG`H4R;\,JA=HY#9.>XQCI[_I0`^BHW,P#;%C)W#:"Q'R\9SQUZ_I4
ME`!14433&242HBH&'EE6R6&.XQQSGUHN&G6/-NB.^>CM@8^O^?ZT`,O_`/D'
MW/[\6_[IOWS`$1\'YB#UQUK&\0SK<+I\<LDD>GR7)2ZE4E!@`@*2.0I;C/ZU
MN&,3PF.YB1E.0RD;@1GC@_G58VSPVKPQP0RK),S&-L[<.Q+$YSGDD_H,4`94
MWV#2&E&FLSS76R`6\,N?G)/S9)PIQN)/<CU-3^&;TFW?3+DR)>61VLDS`NR=
M5;C(/!`X)Y%:-O':R(?)C@+1N22B#"R8Y(]^:!"\<\4J6\#32`+<3*-IX'YG
MIC'T]*`+=4-1AGF)2VPDK6\JI*PR%8[<`_C@_P#`:O+G'S``Y/0YX[545KJ-
MTDNGA6)4E,I4X4#<-AY_V<Y[=:`.462U97DN)WALHX(Y+I?M(=9I1G`4ANI`
M'(/IWZ+<S!;*T6>YAF@LK5YF5ICLF<-C;N!Y*@'UY(KKMEHUK&@2%K=L>6H4
M%3GI@=*7[%:A(T^S0[8R2@\L84GKCTH`XZXU&XD_M"8REI2LT,*;OFAQ!OW!
M>V2""?<`8%:WA]8H-7N[6QN))[&.")@6E#A9&SG\2`"?K[BM-(G=1-/9P?:3
M$H=5(.[(&X9(SQ@CT(_1L*W5M$ZV^GVJ#S#A(Y-FY>0"?EX.`GKW]*`-&BFN
M7&W8JGGG+8P/RID#3,I\]$1@>-C;@1@>P[Y'X4`2U6<Q_P!I0`M)YAAD*J/N
M$93)/OTQ]32M)=><ZI!'Y:E=KF3[P/7C'&.?T]>%@$LFR:X3RI`&7RUDW+R1
MR>!D\?J:`,W27W:_K:AMVV2+TX_=CBMFL71XRFOZXS?>>6(_>R<;!CZ=ZVJ`
M"BBB@`JIIY8I/NSD3OC))XS5NJ6F,6%T"<E;EQ_G\Z`+M%%%`!1110`4444`
M%%%%`!1110`444A.,>]`&!KNG75[J(:.*22W-N8FV2!2"6R2,G&<+C_@0["L
MY]+O&$RBQN)S*8V9Y/)(=@7.6^<9^^J\#H@^@[&B@#B(-&O8KDH;*ZDM3_RS
M\Y`2N(P`1N&!\LF.X!]L5:FL+ZYTR'3WTV941&#/B#!)!((4/P0V#@8'%=;1
M0!R=E::A;W3W7]F2-O3R]I,6\?*H#%BW'`P0"0>>`<Y@&D:D`GEV4\7E(&C5
M;A`/,VE<GD]V8_ESUKLZ*`..BTK5!;26QLY`C2B57:6,$_,3A\E@<!C@8(^4
M'N12OH]ZTK!+698&2-6::<,Y"[5P-HR,!=V>02!P<FNPHH`Y#^Q]8<=$A=8U
M6.5=H.=H0@A>@W`OP?XO48I+[19Y!=PP6$T=L\:QIB5<#L[E026.U5P,>O<\
M]A10!%;2O-"'DA>%LD%'QD8)&>/7&?QJ6BB@`JEK6/[$O\]/LTF?^^35VJ6L
MY_L6_P`'!^SR<_\``30`MN-VCQ+YGE%H%`?^Z2O6LM?#</V&.&UNW11&4=F!
M<NV0<\GCY@21ZD],FM6U4MI<`C52?*0J'Y&0`1G_`!K)T[7Q)?1V2VL2*\\L
M2+$XRFPGYB/0X/3N*`(X=%!,UU%K$32O,P,@B4H&8*A7;G&<CZ\X]<V(_#T#
M),\-R#YODM&^T-M,:A0>O(^4'Z]ZM1ZII<<4\L$L(CC(:1H\8P6*[O<9!Y]C
M4+>)M'BA$BW494QB3:OW@"`1D=CCU]*`*UOX<@"6DMO<Y\O:6=$QYAWAB>O?
M'.<U?TW2387,TWV@OYF?W:H$51G(P!Z<_7-6;&[M[M)A;_\`+"9H77&-K*>?
MZ'\:HZ5KHU0H8K?"!-\S;\B,Y("].3QTXP"/I0!K/(D:AI'5`2%RQQR3@#\2
M0*-Z[]FX;\9VYYQZU0CUW3)H7EBNXY%158[><[N%`]22,8ZYXI%US2S;PW37
M42+,F5+\'&<'/I@\'T[T`:5%4?[8T\2QQ?:XO,E;8JYY)P#^'!'7U'J*O4`(
MS!1EB`!W)HR,XSSZ4CHKKM=0R^A&10L:*S,J*&<Y8@<L<8Y_"@!0P)(!!(ZC
M/2A6##*D$'N#2*BJ6*J`6.6('4XQD_@!^5*JA%"J`J@8``X`H`6FLZJ0&8`G
MH">M.IC0QM*DK1H9$!".5&5!ZX/;.!0`^F^8FP/O7:V,-G@YZ4ZHVAB:(1-&
MAC&,(5&!CIQ[8H`DHHHH`0$'.#TZTM(%`)(`!8Y.!U-+0`4444`%%%%`!2`@
M]#F@@$8/(IL<:1*5C7:"Q;'N22?U)H`?2!@3@$$\]Z6JR:?:1MNCMXT;9Y>5
M&/DSG;],GI0!8!!Z'-!&01Z^E1PV\4&_RUQO;<V23D_C3HHTAB2*-=J(H50.
MP'2@!RJ%4*,X`QR<G\Z6BB@`I`0<X/3K2U$EM#'(TB1J&=MQ/OC&:`):*AN+
M6"Z3;<1+(OHPS35LK=(!"(AY8SP23U.XY]<F@#GK>T$,J6\FE2S7R7K2_:BF
MQ6&XMOWC/\)QM]>.*S;47VEI<.B2H["WA\M^/,+0JORYZE6QV.`"*[=H4>59
M2/G560$$C`.,_P#H(H\B+$8,2'RON97[O&./3B@!MI$\%I##+*9I(XU5I6&"
MY`P2?KUJ:H;FUANXO+N(Q(F<X-(]G;R21.\2EXL;&[C'2@"8$'H<TM11V\42
MJL:!55BX`X`)SG^9ILEI;RQ2QO$I25MT@Q]X\=?R%`$]%0SVEO<6_P!GFA1X
M>/D(XXZ4KV\,DOF/&K/M*9(_A/44`2T4R.)(H5AC7;&BA5`/0`8J.WM+>VC2
M.")8T0DJ%'3/6@">D)`!).`.I-->))&5G7)0Y7GI40L;81M&(5VMNX_WB2<>
MGWCT]:`+%%-6-$C5%4!5``'ICI0Z+(C(ZAD8896&01Z&@!U%1I#''`L"+B-5
MV!1V&,8I4ACC8LD:*S``E5`)`Z?S/YT`/I`0<X/3K2.BR(R.,JPP0>XIB6\*
M6_V=(U6(+LV`8&W&,?EQ0!("#T.:IZQ";C2+N$1R2F2(KLC8*QSZ$\9JS'!%
M%;K!&@6)5VA1V%+'&D0(C0*#V`QV`_D!0!Q%O:W<$UO(MO=!8IX9'>*T,1;`
MDRK*."`-HR`?UX;&=3:TGC=-1(<17$H?<2C>8N\+\B\8W?*,CY>.*[O`SGO3
M9(TD1E=<AA@T`<]X>EU)M2E^TR3/#(A9_-B("R#`^4X``(/;.<9[FMZ\9%M)
MC)"TZ;#NB5-Q<=QCO]*6*WAA>1XHD1I2"Y5<%B!CG\*EH`XBWL6W03Q6,T%S
M->V[RQ+:%(XHU(.T'&..YXR>>PK6\,SW<I0S3W=Q#):QR;[B,*`^!D*<`L/?
MGZ\\[[HKC#J&&0<$9Y!R#^=1Q6T,)4QQA=B"-<?PKQP/R%`'+VD4]KIXV:?<
M-K$:SYG$.U6<AB&)Z,"<`#Z4"361L"3:D8%EC,DLENHE&58NH7'S+GRQD9YW
M<D5UU%`'&P/KD,MCY`NGB6.`;6&%<$C?N^0CH?[P(`Z5V5(JA5"CH!@4M`!1
M15>ZEDB,'E1N^Z4*VU<X4@\GD8%`&;I2K'XBUI%).3#(<D<$J1_0=:VJR-/8
M_P#"3:NN>!';D?B'_P`*UZ`"BBB@`JII[`K.HSE9W#9Z=<\?@1^.?K5NJE@6
M(N=QSB=P.>WT[?Y/>@"W1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!5+6O^0+?]/\`CWDZ_P"Z:NU3UC/]C7V.OV>3
M_P!!-`$FG_\`(.MO^N2?R%8]IX=GC,#SWY+Q7$MS^[C`)9^V[J1R<^N<5J6Y
MQHT1^?\`X]Q]P$M]WMCG-<C:ZKJ5I#IKW5R\D8ADN%<+Q)'Y!8!E&,E6'KZ?
M6@#4L_#EW;6S1^?$3Y7D_,"=X$I=6/N=S$_4>F38;3!I\&L331R7L5\0[00I
ME\D;6`YY'?V_"LN#Q1?2L(HI+:9GN8XEE"C`#JQZ!SDC'J.OX4)XDU'[.LT\
MELBW$$<B%0`(MY*_-N.#C:2.1R3F@#:TX1:1H<0N+FVCG(_>RRR`!I>C9/?!
M&/PQ67HNCSV$UI]EO;$?*?.CC)*SQDC#!<X#<-\W/0=LBMW29I;W2XI;R)`[
M9R``589.&&">HYZ]ZNA57H`/H*`.7M](F,<"6]];%K>VCCC*)G+I)]_D'C&,
MX_,#K')I.H6]];6\#1LQM)T,S1-L&^4'!P?0\9],_3K`JJ254`GK@?Y]33J`
M.0BLF34)K%)(H;-'M]QG#*SB(*/DSVRH!ZYW9SZ]?28&<]Z"`1@\B@!::)$,
MC1AU+J`Q7/(!S@X]\'\C2@`=*0*H8L%`8X!..30`ZFEU!P6`/'!/K3J;L7<6
MVC<0`3CDXZ?SH`56#J&4AE(R"#P102!U.*``HP``/04CHLB[74,N0<$9&1R*
M`&^=%M9O,3"G!.X<'.,?G2^='DCS$RI`(W#@DX'ZT"-!G"*-QW'CJ?6D$,0<
MN(TW'J=HSUS_`#YH`<\B)C>ZKGIDXIU-:-'*ET5BIRI(S@^U.H`****`$)`!
M).`.I-+110`444SRT\T2;1O`V[N^/2@!]%%%`!12``=*6@`HHHH`****`"BB
MB@`HHIDD:2KMD177T89%`#Z*:8T*;"BE.FTCBDDACE*F2-'*'*EE!P?44`/H
MJ-88EB,:QJJ$8*J,"F_9H.<0Q@G/(4`T`345&L,:S/*J`2.`&8=\=*22V@EC
M6.6"-T4Y"L@(!^E`$M%-V+OW[1OQC=CG'I2>3'YWG>6GFA=N_:-V/3/I0`^B
MBHI;>&;'FPQOAMPW*#@^OUH`EHHIDD4<I0R(K;&W+D9P?7]:`'T44Q8T5W=1
MAGP6/KVH`?1110`44U55!A%"C).`,<DY/ZTUX(I)$D>-6=/NDC..A_H*`)**
MK+90(9/+#Q^:2SA'*@D]3P>#SU'-2F&,@!EW84I\W/!QD'/7H*`)**KQV<$5
ML+>-"D8_NL0?SSGM4J1*CR.N[,ARV6)&<`<`].G:@!]%5I[&*:)8LO'&J;`L
M;%1MXXX^@J98T1MRJ`VT+G'.!T&?Q-`#Z**@>UADN/.D7>VT*`W(7!)R!Z_X
M"@">BF21K(!NSQDC#$8X([?4U733X4`57GVAE8+YS?P].^<>W?%`%NBF2QB6
M)XR64.I4E&*D9]".0?>FV\"6Z,J-(0S%OG<MC/89/`]NE`$M-9@I4'JQP./;
M/]*22-98RC9VGKM8@_F*?0!D6'_(RZOG'^KM^_/1JUZR+#/_``DNKD@@>7;@
M'/!X>M>@`HHHH`*I:;@?:\(%_P!(?H3STY.:NU1TW[UX-Q.+EN">G`./\^M`
M%ZBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"J>KX_L>^SC'V>3KT^Z:N53U@XT:^)./]'DY_X":`)-/_Y!UM_UR3^0
MJ8HI4*5&!T&*H`R#1+=HCAE2(\-MX!4GG![9X[]*A3Q!9F^N(GD$44.$WR*R
MEGVEB!D=E_'K0!JB-%)*HH).XX'4^M(2DC-&RDX`)W*<'/OT/2N?_P"$@=D:
MY4HH;8(+8H=SARNQRW3H3D#.,@9SQ5^WU.2:POI6$4<]HTB,N=P!7)!/3@C!
MH`MB]B(!Q+R[(`(F/*MM)X'3/>K-8%OXB,ZV3O&EJ96(N(9R5:)=CL'W'@KA
M#SC!]16A:ZO:W-N\ZF18E<(':-@K;CA2IQR#D=/6@!5U6`HSO%<Q*I`+2P,@
M&>_(]Q5Q&#C(SU(Y!'0X[U0DUS38K<SO<_N@N\L$8@#=L[#^]Q3%\0::[E%F
MD+KNW)Y$FX;0"21MR!@CGIS0!<N+H6\B)Y$\F_O&FX#YE')[?>S]`?2F&_07
M#0^3<EESEA`VW@9X;&#_`)'6JMUXCTRU#!IVD<1^9LBC9SCG'08!X/!(I=5U
M5K:S@:S5)+F[8+;QS;DW$C//&1@<X./SH`M?;1Y22&VN1N&=OE\CY@.?3KGZ
M9/:I9IC"`?*D=<$L4`.W`STZG/L#67)JTNF-(VM/;Q0*J%98U8!F)P1@YZ?_
M`%^*E7Q!ISF$+,Y\Y4<$1L0H<X4MQP">,F@"R^HP))<1L)-T&W=B,G=G&-N.
MO4"G65XE[$\B1RQA)&C(D7!RK$$CVR*J-X@L$@DFD:1%21X\>66+%6VDC&<C
M./S&<59MM2MKNX>"!F=D17)"G;A@".>G(/3KP:`)4N4:2*,K(KR1F0!E(P!C
M()Z`_,.*?-*D$,DTK;8XU+,<9P`,FLN34KU)=2D6WB>WLB%"[RKO\BNQZ$<!
MN/7VIUSKUJEI)-;L)@D7F;N0BC:&&XX^7*D$9Z].M`%HZC"$9V64(A(9C&<+
MT.?<'(Z9_0XLHP<97IDCICH<5374;&.:XA,B1/!DRAAM`PH;.>GW2/P^E/L=
M3M-0:5;697:)MKCN*`(SK%D)I(?,<R1R"-E$39#'..WL:NJZLS*IR4.&]CC/
M]:Q-<U2XL+M<V<36T:"0S3R[%8Y/RKVW\*03CO6H+ZU,A03H6$ODD`]'QG!]
M.*`(QJUD2@$Q.]2PPC=.>3QQ]UNOI4ZW43W'D*6\S9O'R'!&<9!QBJ$&NVC%
M5FD56:`W&5.]`F[;PV.>?;O5F?48(;*YNAETMBPD5>H(ZC'K0!-<7,5LN96(
M&TMPI/`Z]*9'?6TMW):I)F:/&Y"I&,C([>E99U^=;B*S>P47LKA403ADQMW9
M+`9`P&[=O>F_\)&[J3%9$_9X_,O`9/\`4X9E(&`=Q!5CSC@>_`!O$X!/IZ5`
MM[`T,,N\A)\;"R$9R,\Y'''K6##XJ<W[VDUFJLET+9@)LN2Q^4J-H!'KR/7F
MNFH`@DNXH[E;=M_F,NX!8V(QD#J!@<D4_P`Y/M'D?-OV;_NG&,XZ]/PJ2B@!
MAE14=V)54SN+`CI_.E1UD170Y5AD$=Q2D`@@C(/4&@````8`Z`4`+1110`44
M44`-WCS-G?&>E.HHH`0$,`000>01WIID02K$6&]E+!>Y`QD_J/SI],<':650
M7`.W-`"R2)%&TDCJB*,EF.`!]:%=&8JK*2`"0#TSTK-NM5@LQ!;ZH@5I82\C
M`!HUQC=GG.,GKC'O21Z[IX6=Y";<),8F9U'S,$W9^7/&T9SV'7%`%_[7;^7*
MXF0K"2)"ISM(Z@X[^W6GB6,RF(.ID4`E<\@'OBJ,>J:5)+]GCGA+.X&P#[S,
M-P_$CFF-XATE&BW7:*T\8D3*L"RDD#MZY&*`-2D9@HRQ`&0.3W/2J*ZSI[7,
MEN+J/S(PY=3D%=O7MVJ&PU31[Z4"SFBE>60N,*>6"C)Y'4`C\Z`-6BLRZUZP
MM)IXII&#6^SS<*?E##(/N..U2R:O81W!MWN4$P0OL/'`!)]N@)H`N.ZQ@%S@
M$A1]3TIU9RZ]I;61O!>Q_9U(4OS@$]`:0Z_I@F2$72-))LV*.2V_E?SXYZ<T
M`:5%%1^3%Y31>6IC?=N4C@Y))R/?)H`DHHID44<$8CB0(@).![G)_4T`(9HQ
M*(BZB0C(4GD]?\#4E-V+OW[1OQC=CG'I3J`"BFHBH,(H49)P!CDG)/YTZ@!I
M=5^\P'U/^?0U$]Y:I-Y+W,*R@9V%P&QC.<?3FA[2!G=_*3>X`+$>F<?^A'\Z
MHR^1HFGR7E_,98X$0!C&,K@*N!W))&>3WH`O+>6K!2MS"0P4@AQR&.%/XDC'
MK3EN8'D\M)XV?)7:'!.1U&/:J5EJ$TUP1<:9<6F8?,,K[2"!_#D$\\G@^].T
M_4+/59'>%3YELW&]<,`PX8`]F'3UH`MM<P)]Z>-?G$?+C[YZ+]>1Q[TU+RU=
MT1+F%GDY10X);@GCUX!/X&I2BLK*R@AOO`CK]:PP;2WU)B83$D-Y@,,*BXM<
M[N%'&W(Y)^O04`;7GP[MOFQ[N>-PSQU_+O4(U&T-RMNMQ$TI(&T2+GD%AQG/
M09_$&LZ#Q$)XRR:?=%G57@10"9D9B`W7`'&3D\`YHN/$EC#:07$B.)I(]Z1,
M,,ISM(8GA1GC<<#WH`VLC..]0Q7MK/M\FYADW$JNR0')`R0/PYK/D\06D<QC
M99!Y8D,Q('[O8,D>YQC@9."#TI^E:M;7D\EO';R6LFWSPDBA3(C'[X`]^ON?
M6@"_-<P0!C--&@4`MN8#`.<$_D?R-+%/#,,PRI(,9RC`TVXM8+E=L\*2#GAA
MGJ"I_1B/Q-+;VT%JA2WB2)6.XA!@9Z?T%`#A-&41Q(A1QE6W###&>/7CFG*P
M=0RD,I&00>"*C>W@DC5)(8W1/NJR@@<$<#Z$CZ$U&[1V2P110_(\FP*@^[G)
MSCTH`HV`/_"2ZL>,>7;^F>C_`(UKUCZ?SXEU9@CX,<`W$8'&_C_/M6Q0`444
M4`%5+`@FYPQ8"=ARV<=.!Z?2K=4=-;=)>\DXN",G'9%ST`[T`7J***`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*J:M_R
M"+WC/[A__035NJFJ_P#()O?^N#_^@F@!+50^E6ZE`^8D^4G'8<_UJ(Z39/?/
M<X));<\6[,9?;C<5Z;L$5-9L4TJ!E4N5@4A1W^7I7-VEEJMK;NL$/DR7JB9W
MA&#'^]W$$,,!MCE0,'[@Z8H`VTTG3G6158R>7']G_P!9GR5&&"CT(^4^O`JQ
M!IMO;V#6<>\(X.]BV68GJQ/J:Y.>UO[?36@$6HB.Z:Y5P0CO,Q"B/?CH"`PS
MZCWJ[?PZ]%%-<075PYDN9<Q(%8Q(-_E[1CH?E)[]/>@#<.G64-I!'+!YRVT7
MDH63>VTC:1P,G(ZTRVT>TCMWC#32Q2*H"RRE@J@Y``/3^=8<KZ^DMR[-=X$2
MC:J*>0B'Y1W.?,!VD\]L`5N:`;HZ8OVQI'<.X5Y!AG3<=I/3MCJ`?:@"OJFB
M1?V-J$&G0JD]S&`3N/)'3G_/4^M2P:39NR7$7GI,REVFWL'<-C@D\_PKQVP*
MU:*`,1M,T^#S66*[598_LKH@;!"@C<<>Q/S?UJS+;6M]9+;R"Y;RU\R.0[@Z
MGD!E8_Q=??IGK6E10!F?V1;;959KJ1B#L9Y69H\YR48G*GYL9SSC':JT&D:?
M=QR#9>`E8U,DK-N90PD7!/N<'OQBMRB@#(71[!I)$"W$4CF23(=EQN8[B".!
MDD''LOI5NPLK:UWO;I(FX",[RQ.$R!U_'GO5RB@#%33[3%T7%_)YP:696+@2
M`X&,#`)(3&.N#CC-7+C3K-K>ZC>([+HJ9=@.3@*HQCI@*.G3K5ZB@"@UC9W=
MY<320,SM%Y#[U(5EYSCUZD9JD^C3V[Q2Q:G?OBZ61E>5GRG39C/3Z_4]*W**
M`,2_TQ=0:0F>\$5[&OF0;%V[5Q_>'RL0<=<_EQ*NAV[WWVPO*,S)<+#A0JNJ
M;/3/3MFM:B@#&M=`MHK>!!-,1'`802`IP6#@XQP015N&W6QM7CFN;FX:5B6E
MD&\DD=@!@#T&,5>HH`RQH5J+>-%>19D?S/M`P9"V"N<D$=#@#&!QC&!4;^&[
M)HHXU:9%"A)<$$SJ&W8<D'.223C&<FMBB@#&/ARV:69C//LFNA=/$-H5F&.#
M\N<<>M;-%%`#7<1HSMG:H).`2?R%*K!AD9ZD<C%+10`R618D+L&(&/NJ6/Y#
MFG$A02>@YI:*`"BBB@!-PSCG/TI:**`"F/(L90-G+MM&%)YP3VZ=*?10`4C9
MVG;C=CC/3-+10!E?8EEO;!I)4WVUNRO`V&9PP49/)XX/KFJ<_AG887LY8F:-
MG79=1^8A1R"1C(.0`,'/8`^M2#4+Z>ZO)K>*S6*SG,#^:2&<!0<E^B`;B>AZ
M?G%;>(BQ9+F`.F0ID0?*"TKQJ".N,H`3Z_6@"&YT".2TMW@U)8Y3%'''*A5`
M\BDD,,#'1G``'0_DS4-"GO-4E@AC6&W>P2V,K`D!?,8G'JW"GD]^:W].NH[Z
MV:6.$I$)&5,CAPIQN'L2,BKE`','1[M]ULDD+VL4LQA?^+,@.0V.REW]"<`<
M5>L-+>WNK":*6/R[>T-LXV?,V-H'0G&-O/)Z5LT4`<[J>AW-U/?2+/:H+TQQ
M$2QEMJ*&&1T^?+#'TZ^C(]!N5NY)/M$(B=O/\^6(O.&*;=N6X`&,^W3`ZUTA
M`.,CITH(!!!&0>H-`'(VNAZK$8;N"2T,UNJ>4#DI)PZGG)P"&!!'TX&,6KG0
M;U[2^C^TIND6W:.1000R-EN%^G``]*Z0````8`Z`4M`"`@C(Y%+2``#`X%+0
M`4444`%137$,!02R*A<X4$]:EICQJY7>BMMY!(S@T`*C*Z*Z$%6&01W%-EGB
MA&99%08)Y.../\1^="0Q1LS1QHC-C<54`G`P,_A3F17^\H;MR,T`*2`"2<`=
M2:SM2MK36=+FMI79(RH82;2I3N&&?I_.M*FNH9""H;V;H:`,:ZL-5NK22WFU
M"&+S%:$>7&3E21\Q)/W@NX>G>IQID5IJ,=_!(D$<<3I,&'#*3N'.>-IZ>@XK
M+_X2X1Z?-.UG&LD$6]K83D.N&"X(*C`R>HSV_"Y<^)+='N$@1W>W61F#+@.4
M&2@[@^Y'0'TH`VHY%EC62-@R.`RD=P:PXY[234D>*X2;[3<JQ56#@'[.<8XX
MX&?S_&:R\165W>I90AQ*6*<CY0RC)7([@?YX-:@B1%_=Q("O*C&.<8_EQ]*`
M.<BTI[-)MMW;V=S+&8D`4;;>$;CPNX;N<MN)SSR!@BH+N.*.U*B]TMG6%K>0
M$[,1J20%7>1D%6R">>Y&#5R?6;J'[4+FQM9A:QN9Y8I6*Q@X(4Y3DD8)`/;W
M`JW9:E9WUX;<V<B2,KLKRP@+(%?!P>^#M/Y&@"I-H$*E;>6[1+9FWJI3:^XH
M(R-V>AR./?'IB?2+%H-0\Z\O+:6[6W^SI'""-L:MGG).3RN3@8I\6J7-U=3"
MWL89HH+DP%O/`?`QN8#&.-W3.>*9!X@L'\^812I&B;XI#"1YX)`)3U^8J,=<
MD4`:9O[,%@;N`%20P,@X(ZY^G>GQ7$,S%8IHY&7J%8$CDC^8/Y5BIXBLUBCG
MGM)48M*QVQ9,*JY3<_\`=SC^=;D7EE`\07:X!!`ZCM0`P75NTHB6>(R-NP@<
M9.WKQ[=ZD#J3@')R10$4-N"@'UQ2111PKMC4*OH/KG^M`&58$?\`"4:LN?\`
MEE`<8'HWXUL5DV,A/B/58\G`C@;&..0W^%:U`!1110`5GZ,NV*Z;+'?=S'YO
M]XC^E:%9NB`"*[QWO)N1C^^?2@#2HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`JIJO_()O?^N#_P#H)JW535?^03>_
M]<'_`/030`_3_P#D'6W_`%R3^0JQ5?3_`/D'6W_7)/Y"K%`"$9H``S@=>M+1
M0!%+$KJQQN8J5P7('./RZ"I%)*@E2I(Z'J*6B@"-VE#?*BLN.I;!SGTQTQ2Q
MF0H#*JJ_<*VX?G@4^B@"*9I51C#&LC8X!?;DY^AJ6BB@`HHHH`@$\AN)8A;O
MM1<JY(PY]!4]%%`!1110`4444`,=F5D"QE@S88@CY1@G)_$`<>M#.PE1!&Q#
M`DOQA<?XY_G3Z*`"BBB@"*25T=56"20'JRE<+]<D5+110`4444`(QVJ3@G`S
M@=30K!E##.",\C!_*EHH`9N?S@GE_)MR7SWSTQ2R%EC9D7>P!(7.,GTS3J*`
M"F2LR(62,R$8^4$`G\Z?10`4444`(201A2<GDCM2T44`,FD\J,OL=\?PH,DT
M%R#&`CL'/)'&T8SDY_+UY^N'T4`9%[I=A-<RRS6D[LQ#NJ$[)<8^\`<-TZ'T
MZ<C,=]X>M6L+M+=")98)(@3\PPSE^AZD,21Z>M;=)TZ4`4K%X[>P6**WF1+=
M4C"%.?NJ?Z\^X-3"Z4WIMO)GR%)\SRSLXQQNZ9Y_0^E6**`"JTMXL33+Y,[F
M&,N0L1.[`SA?[Q]A5FB@"`7&7*F&8?/L!*\'W^G'?^HIEQ>K;N5:"X<`*2T<
M1<<DCMUQC)QT%62`1@@'OS2T`-C<21JZY`8`C(P:=2``#`X%+0!'#+YT>_8Z
M?,1M<8/!(S]#C(]J=(XC0L0Q`[*,G\J=10!$TX698RDF68J#MXZ9SG]/K3$N
MP[.!!.-A`R8\`Y8CCU`QD^W-6**`"DR,XSSZ4M%`!5?[6HACE:&8!W";2ARI
M)QDCTSW_`!Z<U8HH`*9,0(9"R&10IR@&2PQTQWI]%`&"="M5M9X]]ZZ20.L:
M%B?)7(.U??/3.>F.E2Q>'+%`26G8O++("6((WJ5(R.>`3@GD9ZULT4`9%KH$
M5K>K<)=7!`._R\@*7(P6.`"<\G!XRQQC-:/GC[/),8Y`$W':5Y./3Z]JFHH`
MY[_A&(([5EAO=26*1&5X6G)5MX(8D8/)R3]>:6RLDM'BN+LWD[^6Q6#RRZ1[
MFR>B_>Y'7I@UT%%`&'=:+:+>"62:Z%O//YLEN&'DEPI.YN,[?EY&<$XXIZ^&
MK00R1--<,C0F%!N5?*4MN^7`'(.,$YZ?6MFB@#'?0;<1C_2IXG:-H97W*3*'
M;+`[@>I)QC'6M6)?+C5!N(0!06.2>.N>]/HH`AN+J"U56GE6,,P5=QZD]!3X
MG$B!PK+G/##!_*GT4`8]B[#Q1JL9!V^3`PY_WA_GZ5L5C6*C_A*]58-SY$`*
M_P#??^?\\[-`!1110`5G:-]R\^?=_I<O0GCGI6C6;HNW9>E>]Y+GGOG'^?\`
M)(!I4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`54U7_D$WO_7!_P#T$U;JIJO_`"";W_K@_P#Z":`%LB5TNW8`DB%3
M@=_EK,L_$]G>R6[1+(L,K/&S2#9Y;*N_YL]MH/.?_K:NG_\`(.MO^N2?R%8=
MUX758+3['/(DMK#)"I!Y(9'4'J.07SU]:`-%O$&EK$9#=H45E5L`Y&[IQUYQ
M2Q:_I4T<KQWL;+$`SD`\`G`[<Y)QQ6=:>&GB:.5[A%D$L<C*D?&%8MC)))Z@
M9)XYI$\+N+1(&ND8):)`/W7!97+9(]#P#W]^:`-^VN8;N!9[>19(W&0RU+5'
M2;%=-LEM@X=P2[D<9+$GIV%7J`"BD#`D@$$CJ,]*"0`23@#J30`M%(6`(!(!
M/09ZTM`!13$ECD+".1'*$!@I!VD@'G\"#^-.W`,%R-Q&0,\D?Y(H`6BD!!S@
M].M!(`))P!U)H`6BBB@`HJ.*:*;=Y4BOL;:VTYP>N/U%24`%%%%`"+G:-V,X
MYQ2T44`%)]*6B@!D1D,:^:%$F/F"G(S[4^BB@!F9/-QA?+V]<\Y^GI3Z*0$'
MH<T``S@9`![X-+110`@S@9`![X-+110`4444`%%%%`!34+'.Y0O)Q@YR/6G4
M4`-<L$)10S#H"<9I1G'S``^QS2TFX;MN1NQG&><4`-E9U4&-`YW`$$XXR,G\
M!D_A30\WF[?*41YQNW\XQUQCUXJ6D9@HRQ`'N:`$<L%&Q0QR."<<9Y/Y4QWF
M$@"Q*R$\MOP1^&*D!!&1R*6@`HHHH`*CF:1$!BC$C;@""VW@GD_AUJ2B@!KE
MAC:N[)`/.,#UINZ3]W^['/W\M]WC]:DHH`8Q<.`$!4XYW<CKGC\OSI<MNZ#;
MGKGG'Y4ZB@"(-,9<&)1'S\V_G\L4\EMZ@*"ISDYZ4ZB@!A+^8H"@H0=S9Z>G
M'>E4M_$`.O0Y^E.HH`@#W&8P8$&<[R)/N\\8XYS^%/W2^2"(T\SC*E^!Z\X_
MI4E%`#"SA<A`6VDXW=_2F6\DTB1M-!Y)9<LI<,5/IQQ^52JP894@C)'![CK2
MT`,#/YQ4Q_)C(?/4^F*1&=G8-'M4=#NSGD__`%OSJ2B@")6F-PZM$HA`&U]^
M2Q[\8X_.AWE5`5B#MO`P'_ASC/([#G%2T4`0QS.\I1H74`M\QZ'&,?GG]#4U
M%%`$0E?>BF%_FSD@C"X[]?\`.?KB6BB@"$RR!W46[D*5`((^8$\GKVYS].*<
MCR-YH,13:V$+,,.,#GC.!G(YYXJ2B@#'L"/^$IU8`'_4V^3V_C_S^%;%9%CG
M_A)]6RN/W-O@XZ_ZRM>@`HHHH`*S-$4#[>P<MNO)#R>F,#'MTK3K.T=@?MP!
MR5NY`?T/]:`-&BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"JFJ_P#()O?^N#_^@FK=5-5_Y!-Y_P!<'_\`030`ME@Z
M7;Y;:/)7)!QCY:DM&1[6-HY&E4K]]_O'Z^A]J;I__(.MO^N2?R%2PRQSQ++"
MZR1L,JRG((]0:`'T444`-V+OW[1N`QNQSCTIU-DD2*-I)'5$0%F9C@*!U)-.
MH`:L:*[.J*&?EB!RW;FE90ZE6`92,$$<$4M%`"8'Y4M%%`#555SM4#/)P.O;
M^E+@9)P,GC-+10`F!^=!`(P>12T4`%(0&!!`(/!![T$@8R>O2EH`:JJI)50-
MQR<#J:=2`@]#FEH`****`"FJJJ254#<<G`ZFG44`%%%%`!3=J[]^T;B,9QSB
MG44`%,CC2)`D2*B#HJC`%/HH`*CA@A@!$,4<8.!A%`Z#`Z>U244`,BBCAC$<
M4:QH.BJ,`?A3Z**`"BBB@`I"`PP0"/0TM%`"$`XR`<<T@10<XYYY)S3JKWI0
M0J9$1QYL8PYP,[UP>AY!P1[@=.M`#C';S2[RL;NGRYX)7D''Y@&G)!%&<I&J
MGD9`YY.3^M16:JOG[87B!E8_-_&?[P[X^O\`+!JS0`QXHW96=%9D.5)&2/I3
M3;0&02&",NK;@Q09!]<^M2T4`-1%C140!548`'84DD:31M'*BNC`AE89!!X(
M(I]%`#%BC4$*BJ"=QVC&3Z_I35MH$D:1((U=@06"`$@G)Y^O-2T4`1Q0QP[_
M`"T"[V+MCN3WJ2BB@!KHLB,DBAT8$,K#((/8TS[-!Y(A$2",$$(!@`@@CI[@
M5+10!7:R@:6*1@Y:+&S]XV!@$#C.">3R:6.TMXY)9%B4-+]\GG/&,>P]NG4]
MS4]%`$?DQ^;YNQ0_]X#GT_H*:UM$^W*D!5VA58J`,@]!QV%344`0I;1)(DBA
MMR1^6"7)^7CKSSTZGG\Z:]G#),96#[CC.)&`.`0.`<=_T'H,6**`('M(9/*W
MJ3Y/W/F/'!'///![_6J[6L+_`+DB:>*65Y"?,.$/0@D$<9)&.?I@<7ZQ;%T@
MOXX+>=VCDDNC(K(/O^8&QZ@#<V.QS[B@#2-E`005;E0OWST'X]??K3V@C>(1
ML#M`(^\<\C'7KGD\U+10!`;2'>S[6!8$'#L!R`#QG`^Z/U]3FG<6;(LD=BX$
MSH.'F?<.0`>O3`/UQUYK3K,UJ5XK:9]D;1I%O_>?*N0PZMD#'MQG\:`+*Z?;
M+%)$$;9(I5E,C$8/4#GCKVJ=8D6+RU'R\\9]:?10!`]K$]L+=@QC``^^<\>^
M<_XU((D$/E8)3&W!)/'UI]%`%8V,!"@JY"L6&9&/)Z]ZG5%5=JJ`O/'UIU%`
M#418T5%&%4`#G/%,NI)(;6:6*(S2(C,L8."Y`X&?>I:*`,BR!'B?5<@\P6^.
M?^NE:]95H?\`BI]2`93_`*/;Y'<<R?Y_$5JT`%%%%`!6?I'_`"^_]?<G]*T*
MS='&#?G)YO'/7V%`&E1110`4444`%%%%`!1110`4444`%%(<X.`">V360+[6
M@I+:3$-OF`[;G=N(7*D?*.IXYQ0!L45C2ZCK*P[DT/=(,%E^UI@\$G!QG@@#
MIU/IS2MJ.L+\IT,EN>4ND*]^YP>R]N_M0!L45CC4=7,TD8T0[02(Y3<IM/'4
MCKC/MTIIU35R&$>AF0Y*AENDVY'!ZX/4'M0!M45BIJ>LB4K+H#;.@:.ZC;)R
M?7'&.YP?:G'4M87(_L&1B,\K=1X/7'4_[N?Q]!D`V**QO[2U<1DMH+[\$@+=
M1D9]SU_(&E74=8*MOT)P<<8N8SW.,\_3-`&Q162NI:IC#:%-NR>?M$6W';^+
M/IVJ-]4UC<RIH,F1@C_2(\$;AGG/7&<4`;5%91U'4OG`T67<,%?WZ88<]\\'
MIQ[T#4-5+@'1'`.<M]ICXH`U:JZI_P`@J\Z?ZA^O^Z:I-J.K!,C0G+<<?:H\
M?G4>HWU^R7-M_93^4R;1-YRXP4R3CKP<C\*`-'3,_P!EVF[AO)3.?]T56@UF
MV;4+RT<B+[/\P=@0''&[&1R0Q`./45B6^N7TND16\>AZEM>W"+,C`-]W&X']
M<U")E6*.%O#.I1P(DBH(\,PW#!R>ISG/)/(SSQ0!O0^)-+EDN0+N$10&,&7>
M-C%\X`/KP:6W\0Z=-;I+)<)"S0^>4<\JG8GT_P#KCUK#\N.16\S1=;5O,60-
MYQ9\@D`!MV0,.W?UJ=1;II\L,6@:F%FA6%@,!L(/EY+>YY&>GO0!M/J^ERQH
MK74+QSDQJ.JN<@$>G5@/QJ:WU&SNKB6"WN$DEA)$BJ>5(."#^-<^D4*H\<VD
MZM<`R/&6D<DNC$$L?F_V5X]OK5RT=$OOM(L=5+G>`)57:F]P3CGUQ^`/X@&]
M16<NJNQ7_B67XW>L:C'7K\WM35U:4QACI5^"<978F1G_`(%VH`TZA2UMTB,2
MP1B,KL*[1@KZ'U%4_P"U9<'_`(E.H9!P1M3\_O8J";Q"L+['TO4]YQM46^=W
M`/!!QW]?;K0!JQ010Y\J)(\C!VKC_/4TLD:2J%D17`((##/(Z&L=/$L3YQIF
MJ`!"^6M2`?89/)Z_D:!XD3Y@VDZJI4`D-;8ZG'7.._\`.@#86*-'9U159SEB
M!@L<`9/X`#\!22PQ3`"6))`.FY0>X/\`,`_@*R1XB4QRO_96JCRX_,VM;8+#
M<`0,GD\YQZ`TQ?$\1ADE.EZHJQJ&.ZVP2,XXY].?H,T`;*00QD%(HU(Z;5`Q
M_G`_*I*PD\2JZEO[)U5%$?F;GM2!@=N,\^G;W'6E_P"$EC^QQW']FZC^\=HU
MC\@E\@`C(]\_H:`-E(TC+%$52QRV!C)]33ZPH/%-M*5#6&IQ[B!\UHQ_EFEB
M\46[E@VGZI&5Z[K-O4CMGV_,>^`#<HK#7Q-$7VG3=53[I):S?"YQG.,],\_I
MFIHO$%O).L/V/4%+D!2UHX!YP>W&,<YH`UJ*QK?Q':39#07L;`'K:R$$@9('
MR\\<T^3Q'IR$?-<,-X1B+:3"GW^7_/X&@#6HK(_X233`I8R3@`][67GG''R\
MU&?%NB*2&O2"#@@PR=?^^:`-NDP,D]SQ6'_PE^B<?Z6PSD\PN,#U/'%)_P`)
MAHF0#<R#/7,#Y'&>F,]Q^=`&]3(HDA3;&N!]<UB#QCHI`(N)#GTA<\=STZ>_
MO0?&&B_PSRMDX&V!_F/H..OM0!NA0"2!R3DTM83>,-$"AOM;E2NX$0OSSC'3
MK2?\)AHH(#7$B],YA?C.,#I[C\Z`-ZBL(^+]&!P)YC_V[R=,9S]WI1_PE^C=
M?/F`]3;R<\X]/\X-`&[16'_PEVC9(^T2$^@@<Y/IP*<OBO1SN_TIP%(!)A?J
M<^WM0!L.BNA5QE3U%.K(_P"$GT8'#7T:\L,MD#@X[]?;UIB>+-$=B!?(,9Y8
M$#CTSU['Z'-`&U16,WBG1%95_M")BP)&.<XQ_C_/TIW_``D^C9Q_:$7X9/?&
M/KDC\Z`)M7U"WM(3%+#/<22HQ6&!26(&,G(Z=1SD>U5;74M)9[>YC$B+-M2.
M5L^624)QG.,@)@^AX]:J7^K:+>W4,L6LM:SQ*P\V$#YE;&5.Y2#V/ZU#)-X?
M!MY(]9#R0R1RK^]#%V52!N.TGG)S[GL<4`="8+.Z@$(V2)M#`*_.TG(.0<X.
M/QQ3WLK>2Z6Y9,S*``VXC@9P,?B?\BN<T"^T?2X96GU*V6:XD8`>>6V1JQ"I
MST`Y_/BM.Y\4:+:VQF;4890N!B)@[$_04`7WL8'4*RO@($XD8<`Y'0^U/%K"
M$5!&`JG(&>AR&_F`:J#7M(/`U.T)YX$RYX]LT#7M'(!&JV6#_P!-U_QH`L6]
MC;VQ8Q(067:=SLV1^)I!80"1W.]BZ>60SDC;QQC/M^I]:@_M[1_^@I98SC/G
MKCU]:3_A(-'[:G:'Z3*:`)5TNT5RXC?)*L096(RO0XSCZ^O>IFM8RR''W"",
MD\`#@#GU`]>_K54Z_HZD@ZI9#`S_`*]?\:/[?T?C_B:V7)Q_KU_QH`L16-O$
MCHL?RR$%@S%LD<`\GKP.?85,\2/&T;+\C+M*YP,50'B#1B,C5;+KCF=1_6AO
M$&C*,G5;+\)U/]:`+26-M&DJ)$`)5"OR?F`&T?I44.EVT+R%0Y5Y%E",Q*JP
M``('X9^O-0GQ%HP&?[4M,<<B44A\1Z*#@ZI:?A*#0!HQQK$I5!@%BW7/)))_
M4U%<6<5PCK)O.6WJVXY1L8ROI^'?-53XAT8'']JV><@?Z]?\:!XAT8_\Q6S_
M`._Z_P"/O0!>AA2"/RX\A02>3GJ<_P!:AN;%+JWDAFEF*2-DX?;Q_=XQ\I''
MXU6'B+13_P`Q6SZX_P!<M)_PD>BXS_:EI_W]%`%^>#SL?O9$Q_<;'<'^GZFJ
MPTN`-"RO,K0O(X(?D[VW,#[9J(^(M%&?^)I9\''^N6D_X2/1=P']J6F2,_ZT
M4`02:A8+>&U^V77F96'Y6)569@5YZ9Y'X?C4\'V6]LX'@O[CRT7(D$I!89QE
ML_0]?Z<8D\VC2ZHEZ-?M]@D6?82A<$?PJ_4*><J?7MFLY[/2)5CC;Q';^2L1
MB^;:<8)VX!/N,Y!SS@_,:`.NM!!?6QDAN[AE;>G+8(*OSQC@@C&?3UZU=A@$
M=NL+,\P`Y:4[BWUKA[NWTBX@16UVRRK.C'@G;(^_CYNJDG!Y'MFNJ3Q#H\C[
M4U*V8X)XD%`#)]3L=)N'BN9;H;F#-(Z2.B;F.!NQ@#.0/R[5>L[B*>T2:-V*
M%=V7ZX]37):A=6=SJ[7T/BFVB&S$2M$LGE?*00,G'.?3/;TJ"*&Q>>Y_XG-H
MNG_Z/ND^4M)L?.W[V5'W><<\'UR`=;J>J6NG^6MS+*C.&=?*B+DA<%N@.!@\
MGWZBIHI()8"R76])S\K!Q_$,@*?IR/K6!>WMA=71N],UBUAG*,KLP5PV,8X)
M'([>O'7%5_L^FK+(8-?@,#F$S!]KR$P%<?,&!R=H['J3W%`'4I<Q&Y^RJ^Z5
M8Q(1G^$G`/XX/Y?2G"(&V\E9'QMV;]V6],Y]?>N.>RM9H#%)K>GOM1(8<L!M
M5,E0YW`L3QG`'3(]][1;FS@L1&^H64DQ+22&)E7D_,<C).<9)).>,T`:KH6B
M**[(<8##!(_//ZT^J:ZMIK?=U"T/7I,O;KWIZZA9M$)5NX&C+!-RR`C<2`!G
MUY'YT`4[4,OB;40V,-;0%?IF0?SK5K+LY$D\1:@4D5P+:W!VMG!W2\>W_P!>
MM2@`HHHH`*SM'^]?G+$F[?.2?0=/_K5HUF:+OW:CNZ?;'V_3"_US0!IT444`
M%%%%`!1110`4444`%%%%`&?J^KP:3'$94>229PD<:#ECWY/`X]34VGW9O;5)
MS;RP!QD++C/4CL3Z9^A%4];TE]1DM)HC#YELS,JS)N1LC!R/I^N*?I&GW6FJ
MELURLMG%"L<:E?FW#J2?Z4`))KEK'K+Z85<S)#YN1@@_[/7KCGZ4EGKEC<V]
MM<3D6LDZ@QI,0&PQX_/C]*P=1TJ]O_[046MU'-<7>^.X0(-J!?+`^^#RI.<C
MH3WIKZ;?/-&8K*]2VB6!$B<1[MJ$9`/F<9V+G/I^!`.F36M->Z^RI?6[3;BN
MP2`G(SD8]L4W^WM*%LMP;^`0NVQ7+\$XSBN<@TBZ1D^T:;-(OVE[FX&V(^>V
M&*`Y?L2><<Y'3%5&T&]3RA:VE[`Z"7S&(3#;SD@;9,CC"]_TS0!V4FK:?%+!
M$]Y"KW`S&I<988R#]*NUP_\`9FH/=1M9V5Q;1(L<;!?+8E%Q\AS,1C.?X2<'
MG/?934=:.F2>9I4HO75S'M*%4^]LSENO`S]>/0`%Q=:LY-<_LM"6G$;,6`^7
M(/*@^OK]/6I;C5K.W$>9ED+RK"!$0Q#$XY`KG;/1[FRU&TO!;WLK0/([AGC(
M=G0AFQD8RP![]JBMM'U(26QFMF'V<S-YB0QAW+H<DGS#R&8X'?`/?@`Z636;
M%;BW@CF69YVVCRF#;>"V6YX&`34[7]FOE[KN`>80$S(/FSTQSS7'G0M1FB16
MT_R'%B;1601GR_NY/^LRV1O'MGOG-37FCW4I;[-HY$1M&@\MY(T*OMX(VG#9
MX'L?88H`ZN6^M()5BFNH(Y&.%1Y`"3QP!^(_,4Y;NV>=H%N(FF4X:,."P.,\
MCKTKD6TN^CU1;H6KB$2Q<E?,DD"*0FY22,CCY\C&>G6JXTF\LYY3/%=F1X)X
MD%JAF52^3OW'!'WLXR<GN,8H`[./4+*2*26.[MWCC^^RR*0OU.>*BNYXKG1[
MF2&1)$,+\J0PZ'TKD7M'DLKBWDTV5A+Y">4L4H&Q,_Q;>.>AP>/4UL:+'-;^
M';^&82[E\Q]SP&,'<,X4'E@#QDCZ<8H`V=)(.D61'`,"?^@BK=4=(=5T>P#,
M`3;QX!/7Y15Z@`HIJ2)(I9&#`$KD>H."/S!I3GC'XT`+137)5&*KN8#(4'&?
M:G4`%%%%`!112,2%)"EB!T'4T`+13%<M#O\`+<'&=AQN^G7%/H`****`"BD/
M3IFEH`****`"BBHI9'22%5B+B1]K,#]P;2<G\0!^-`$M%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`"$9I%15+%5`+'+$#J<8R?P`_*A'#@D!A@D?,I'3Z
M_P`Z02`RF/#9"AL[3CG/?IGCI0`^BBHDN89+B6!'!EA"EU[J#T_D:`):BE>*
MWB>XF8*L:$O(>RCDU+65XGE$7AZ]!=$\R,Q`N<#YOE_K0`AU&T.B0:C<P(L;
M`20QX!))Y7;D#D]:KVNB)J#RWNM6ZR2S*42"3YO(CX^7.>3QG=UR31IR+J]Y
M%>-;E=/M!MLA(N"YX_>\]L?=^N?3&U/-';P/-,X2.-2S,>@`H`3[-!OW^1'O
MQC=L&:8MA9I&T:VL(1CDJ$&#QCI].*HZ/>:CJ#?:YHH8K&5285!/F8R-I;MR
M,GVSBK2:I9.]XGGJILB//W?+LR,YY[>_M0!(EC:1[=EK`NWIMC`Q3/[,T_.?
ML-MG.<^2O7UZ53\*K,/#EDUP<R2*9>#V9BP'Y$5:L-2AOY[R*$'_`$2;R6;L
M3@$X^AR/PH`!I&F#IIUH/^V"_P"%']D:9G/]G6F?7R%_PJ[6#X9O;B_N-4F=
MG-K]HQ;[ACY?;Z\''O[T`:/]D:;C'V"VX!`/E+D`]0.*4:3IP((T^U!'0^2O
M^%,&JPMK9TI$D:98?.=@/E49P`3Z\]JO%@"`2`3T'K0!4_LG300?[/M,@Y!\
ME>#^5']E:=@C[!:X/)_<K_A5RB@"F=*TXDDV%KD]3Y*\_I2-I&F,<MIUH3QR
M8%[=.U2WU[#86_GW!81[U3(4G!8@#I[FK%`')B2RB@BO;K1+#[!.Y3S8X5)B
M4L5!?(Z$!>1TZ>E;ZZ3IF0ZZ?:9X(80K^';WK.\*>;<:'_I.&A<E$C9`!M`V
MGZAB"?QJ?PZSPP3Z9*[/)82>4&8Y+1D90G\#C\*`);FST:T$9GL[-/-D6),P
M+RQZ#I4W]E:=@C[!:X/)_<K_`(51UMA/J>D6:HK,;GSSNS\H12<X[\D?C^FU
M0!4_LO3\D_8+7)ZGR5Y_2@Z7IY&#86I''_+%?\*R]"U:[U74IY&,:6)B!ABZ
MN"&*L21VW*V/4`=.:U["]AU"RBN[<L8I1E=PP<?2@!@TRP!!%C;`CH?*7C]*
M!I>GC&+"UXZ?N5X_2DBU!)=4N+!8WWP1J[/CY?FS@?7BJ-GKLM_?A;33Y9=/
M+;?MN\`$X[*>2,\9H`T?[.LL`?8[?`Z#RE_PI/[.L<$?8K?!&#^Z7I^5.OKV
MWT^TDNKN01PQC+,?Y>YI]M,;BVCF,3Q;U#;)!AESV(['VH`9]@L_^?2#_OV*
M0Z?9'&;2WXZ?NU_PK-T*ZEOKR\O7N?W,[;+>U)R8UC)4M]2Q/Z<GMM,P12S$
M*H&22>`*`*YT^R.,VEOQT_=K_A65J>GVU]?V^G11Q0A-MS,R(`Q0-PH],L.O
MM6Y'(DL:R1L&1P&5@<@@]#65HJ++J&K7OS[I;GR?FZ!8U"C`^I8_C0!!I&F6
MKQ7-K>VT%R]I/Y0EDB4LR[5=23CK\PJ\=#THDDZ;:$G&285YQ^%,T0;EOKC?
MO$]V[*W8A<(,>WR?UK3H`QK"U@LO$E[':PK"CVD+LJ``$[I!GZX%;-9D6/\`
MA*+K^]]BAQ]-\O\`]:M.@`HHHH`*S])X-\,$8NWZC'8&M"LW1OOZCRI_TQ^@
M]EZ_Y_QH`TJ***`"BBB@`HHHH`****`"BBB@`HHHH`Y;Q+JU];W3PZ;<L)$B
M#"-84;<Q;`')SZ]`:BFU75I+J>6&9UMHKB*V\KR`6+D@/S_=Z\COTXJSJD=A
M-K1M(M.:[OG432@7!C4+PN6YYZKQCI]`*H0)H.V3[1I$L4L5P;,)#(\NX@$\
M;3R,`YX_K0!#<7>IZNJP2Z@L*7-WY9MXX<-%&C9W%@<C[O?'?\-+Q6\D\ULE
MO<*OEHTGE2!O*G)X`+#C(P2`>M1S)X9CLGG>WG>W6<0;E:1@7Z<<]*9!#X7^
MT+:164BM<2,H4,V"5P2>&X`'.?2@"LES-;PV;PVMR%*S7IBN&<M%M&%16'5=
MW(R#PPJ5]5UN$WNV^BNQ;6ID)A@'RR,Q55QR>-K'MVS3H)O#%P8&-G*HN2X1
MIMVT^6H)/4^O##N#2(^BI;V7VW2)X+BZCW)#&[.0#D#)!'\()]N^*`)Y=3UF
M+[3#+(K3`11QM#;<)(_)!#-V49SD`;CG.!48OM9N;>QMI79'?4&ADF\K:S(O
M/(!PN<$<'D#J:<A\--J)LS9R)+YKCS'<X)C!R2V[H`#U]/:HS)X8%M%<?V?.
M87D'E,RL`Y(.2N3T&.>W(H`L6.O:C<1VO[I)"XDFE*HWR1*/ESQPS8/KWX[`
MAU/7REFLYL8I9X#<,7B8+&!@!6RP^8EA]/>KT&A:+?V,<GV$B*1,A6=@<'.>
MA[YZ]_RI[>&-'9I&-F-S_P`6]LKTZ'/'0'ZT`95SK6N!+0K!'$[6X>4"/SB9
M">,`,."`2-NXCN*U]>U"XLC9QV^V,7$P1[AUW)$/?H.>G)%,D\+:1)$8_LS*
MI_NRN#USUS44?@[1HI%=(9E93G(N'Z]CU_SB@#)EN;_6KW3+3S5,)EE,\L)=
M%FC3:0PP00#NP/?N1UZN_P#ETVYY&!"WWNG0]:S8?"FE0W45U''.)XBI5S.Y
M/R]!R>F`!CT`J[KG&A:@<X_T:3D_[IH`BT^W$NDZ2P\Q?)CC<!CM/W,8('UZ
M5D075]<:K<Z<U^\0BO"PD?:"8E13L7`Y/S<YZ#GDUT.G'.FVIQC]RG!^@K+>
MUT:\"B*1HWO;AI8WC)#&5!RRY&!PN?0]><T`.N?$`@DNT%G(PMTE._>NUBB[
ML'!)7([D4V/4[BWU._CF5YH$NH(5(V@1;T7GU(W,/7K4DOANTEF,KS7#.S2,
MQ+C!WIL88`Q[].OMQ4L.B6P6X6;?(9VB9V+$%O+"[3P>N5SD8_2@"E;:S+:V
MDQEBNKUX[J56V("ZH)'4$`=0`O7\/:IW\0*@D+6<^(U=F8+D80CS/RYP>Y!'
M7BGR>'[=HE1;BZ3+NTK+)S*&)+*W&,98]/?UIYT&U,TC^9.$8-MB#_(FX8;:
M,=QVZ#MB@"QIM^+^*5O*:%HI6B9'()!&.N.G!!KFH+W4+'18=::]DN(DF:.>
M"4;MR^<4&W'0@5T]G9+9R3LDLKB=]Y5R"%.`#CC/.,_6JL>AVRK'&SRO!'(9
M5AW83<9"X)QUP3TZ<#.:`+FH(9+&91))&=A(>-L,".>#6=IM_+;^$[:_O/,G
M<0+(^,;F!YSUQT/_`.JM!;-%AN(A)+MG9F/S9V;ASM]/7ZDUGC0(%BBMVGNY
M(4C,2#>H\M=H'7&>W;UH`<^OP*95^S70,:RL"8P%<1@'(.<$$,,'^51IXHL)
M&98UF8K`LQX48#)O"\D<XQ[98#.34C:!#)())KR\ED&X;VE`)5@`5P``!\HZ
M<U#)H-N(4LREY+`BA5/G`!05\LCJ#T&X\<GGDT`*=9EDNH,6EW"5$@>V=!OD
M(4'Y3G:0,^O?ZT^/Q%9W!MT3S%-Q$C`C&Y"[;0,'J0<YQD#'/;,D&B11-'.9
MKE[D,S-(\OS,6`!S@8P`HP,8_G3;30[:UEB$(GCA6#RR@E..&##)SGCD>A!Y
MH`D\.7D]_HT5Q=,&E9Y`2%P.)&`&/H!6G5+3[=;""&TBAE"?.Y8L"%);)R?<
ML<8':KM`!114:R,9GC,;`*`0YQALYX'?(Q^HH`DHICLRE=J%LG!P1Q[T[/S$
M8[=:`%HHHH`**CF>2-"T<1E(_A#`$_GQ4E`!1110`44C':I."<#.!U-+0`44
M44`%%%%`!1110`45"URBSK"%=F)P2JDA>,\GM_\`7%/CD\PN-CKL;;\PQGW'
MM0`^H4MHX[F6X7.^4*&YX^7./YU-10`5RVI3MJ?B6TT]D'V6*<B1)%W"4K'O
M/!Z`;D^NX>E:$NNO'?/:?8<RABJK]JA#.,C!VEL\@YZ5C2+JBZN^HV.FNBE&
MD`E:.09?:&88D&/EC7`S_>]J`.Q``&!P*P/$=SY]Q#I2E1$P%Q>,PX6!6Y_,
MC'>JTLOBF4\Q-$H&,6Z0@D^OSNWK^G:LXZ3?)J#>;;W4L,RJOE2R0O*\:XRF
M\OG:3@G`[CWH`Z+PFK+X=M2R;&;>Q7N,N3S[USOBBW%C/=".>=TNB'N,*&\M
M#A7+>@P$(.#R#^%Z./7[2-H;2WDB@:0LN_RF:,,Y8@'?@]<#(/7M3DL+E=.N
M[=]+OI)+U2)Y6N(2[9''.>W.!T&30!:T[71+##;6EK<W$D2I%+MAVB-L8))8
MCCCI6+9S+:I#K$+N+2&<279W\.\H/F$]`VTM&!]#WKI4OM01%0:-<G'&6GB/
M'/.=WL/SJM:W$\=J+*/P_<>1&HCVR/%A@./7!'\Z`+U]JUI;6SL+F-I2I\M$
M(=F.,@!1UJEX-L_LOA^!VD+R7(\Z0DY^8@#'X``8[8J*T46$\K6OAAXG9@S.
MK1\DGL<^_P!`,UGR*L$AB70=9CBD?+P0R`Q$]^`Q&#WZ4`7?#A:^UW5]3\MX
MX?,\B(LWW]N-V1[8&,>IZU-J<4ESXLTH*K%;97E)P"`"K`YYZY"`<=ZR6?4[
M?SUL+#5;2&4[O+18GV$@*2"23VSU]_K7EM9A=-NTG67BD"FY5F5C<;2Q7+`\
M=>0/0"@#8355.MWUYYYN(80EI;0PG/F2'!;'8D$J,]AGI5ZRU^Q:TC^V7D$%
MTB?OXI'"LC#[W&>F>GKVK'LK@6%U)+:^&=25B,(#MVQC"Y"C.`"0/\\5;EUR
M=MLDGAF^?&2"44L/7CKV_P`\4`.O;ZWU^:VLM.8SPB999[A%RD81L[<^I(P.
MO'/2M#Q#=36>B74MLH>?:$C7U+$#CWYJA'X@GB$<7_".ZFBX``CB4A1TQUP.
MA_3U%0W^JC4X%AET36T'F!HW2$*R,.^<\?6@"YX?UK3KNTMK6WEVS(@C\IQA
M@0H)_P`_6GV9_P"*KU,94_Z/!T.2.7X/I6'J266I3+<R^'=925,-OB0(Q;L3
MAN2/7K^526MQ_9]O*ECHVLPR22B625HED:0C&0<MT[?CGUH`UER?&TGR@@:<
MOS9Z9D;C\<?H*=XIU`:=H-W+G$C1E$YQR>.OKSG'7CVK+OKZ2ZGCO(M%U>WN
MX!A9EB7)4_PD9^8<Y]B*JD/<O<'4M(UB]:XC\O+QHH13S@`-@$;0<^OUH`FC
MLI-!\.?V3`5EU"YA=I6))6-,89LX)VKD8&.3G`YK=M[VTT[0[*6YE6&'RHT4
MGU*C`X_I638W@L3(4T#5Y9Y^6EF579LG@%BW`&>G:H+=K:"Y$L/AK4V((*"2
M($)Q]U03\H&:`-/PL[7,-[?2C]]/<L&]@GR@>W`Z>]0FUO=#AF.GW\$EK;1A
MA:70V[%R3PXQCC@%@>AYJOINJ7UB98O[%U!K8NSQJ(0&4L<GDOR-Q8_B*@"V
MIU"749?#NKSW$IRXE`95Q@C`+8(SC'TXH`MV]]%K.L6LDBS16MK:_:A%,@4%
MB2H;'/`&[Z'%2ZOKH:PODTY6G*1MNG(*Q1#:,G=CYCR.!GKSBF7$]M>M&;OP
MS>MY:[5W1(<*>,<-Z@<=NM3SZE'-8FWDT'47@E!0Q^0H&/\`OKCK0!2\.Q1V
M]S:2.P_TB-X8&!QYB1A,'_@6UW_X%6QXCG^SZ)<2995RBN5`)"%P&P#U.TFL
MV^N%N[>&W_L;5(!`0\,B1KF)E!`P`QSZ8[@_C5-A<3F5=336KN%L_N3;*JD'
M'93@X]#WYH`Z72(9+?1[*&90LL=O&CJ.Q"@$<5A6=Q+]DO\`3-.<_;VNYAN)
M+>4AD/SD]CMSC.3D>E03V]M($6]M/$-RN\2;7!8$X(&=IXX^GOWJ2SGBTJ^D
MEL-%U!()HE$D0ML'<,[2#GG()SD^GO0!TME:QV-E#:PY\N%`@)ZG`ZGWJ>LI
M-<1B0=.U),9QFU;G\JGLM26\F:-;6\AVKNWSP%%/L,]_\C-`$,7_`"--UQ_R
MY0_^ARUJ5EQ9_P"$HNO3[%#_`.ARUJ4`%%%%`!6=I`(?4,YYNW/(/]U:T:SM
M(^_J'!S]K?DGK\J__J_"@#1HHHH`****`"BBB@`HHHH`****`"BBB@##U?1$
MO+@W$VIR6^XJB8"+@Y&%#8W<D#C-5+'2(9;H2VFM2&>'<RXBA+*KGDGY<DG;
MRQYZ].:L^*8[R6.V6SA>4AG^Z"<.8W"$]L!L'GOMK)@C^S:?>6\=M?AYKA$#
M+`Y_=+L`4E1D?*#QVR0:`+T?A-A<[VO_`-VDOGQF.WC5Q)@88X&TX.3]W\:&
M\*R1.[V5^D+%F8%K96(W*`W_`'T023QV`P!68UM<E/*:"[9((T,JA)`EP4#A
MAN'3YG''4A<^E5EAO)(7CD74VD8.H8POAML>Q#TR,,-WY=Z`-:3P]<H5CN]6
MM]BQ&*',`39&1M*#GH00,YW<#GKETGA:\FF:26_MPVT*LBQ2Y'MM\W:!\J=N
M<=..:MXTD_V9ULM0+16ZP@R6KDDAU+Y'3E01GOGBHVM=7B>`YN-UK;%!)LD9
M\F(@CC(;Y^1W'R_@`:A\-7!\\BYLE:<.'(M'.-Q.=O[SY<Y'3TIEQX9NKC9N
MNK-`L8B"QV\B`(/X.)>1R>OKVJ%%O'LOL7E:D=MP\N?G7=&,[4+D@@GY<X]^
MG6H8;/4UBACWWIE,04OODPJM%+C(X.0VWDC<..G2@#J-,M&L-/BM6:-O*&`8
MT*#';@D_SJW61H#2Q6R6TT5T&;?*&EW$*I?A"6.<@''?.,@D5KT`%%%%`!5'
M7/\`D!:ASC_1I.?3Y35ZJ6M?\@2_Q_S[2?\`H)H`72)#+H]E(5VE[>-BI[94
M<5RXTN^MA:3QV;!@EPS1J0")MD@'?^($<CT'K71Z;&Y\/6<=K.%;[-&$E*[O
MX1SCO5MYD\X1+/&LBC>Z$@G;],\=N:`.2M;+47NH_P!S>1V[7,$FW+)A<2AL
MY8\_=#>O''-$&EZA;VEH?])WF.W>X5I&.YUD''7J`!QD<#J*Z\SPK(8S+&'&
M/E+#//3CWJ2@#-\.PW$&B6\=V)!-\S,)""W+$C./8BM*DR,D9&1SBD9U7&Y@
M,],G\/ZB@!U%1[UE0K%*NXKD%2#C/0U';0S1,YENGG#?=#(HV\GT`[8_*@"Q
M114!#Q3R327.(-@'EL``I!.6W>_'Y4`3T5!S-)OAN1M52I50"-QQ@GZ>GO4H
M=2Y0,"RXR,\C-`#J*1@2I`8J2.HZBF*C+*[&0E6QA<<+_P#KH`DHIKLJ(SNP
M55&22<`"A<?,0V<GUZ=J`'44G.X\C;C@8YS_`)Q2T`%%%%`!1110`4444`%%
M%%`!13)1(4`B95;<N2PSQD9'Y9I]`!1110`4444`%%%%`!1110`4444`<7<D
M'7IK4VTKS37*RO`]N&RHPHE1P1M'RYY;V[FHY[N=(%5KBZAE$<'DQ095,9^<
ML`..21^7UKK4:YN--5XY(X[AU!W;=R@]^`Q_F:BN-+BN/WS1Q&[``65ER,@Y
M&1_DCL>]`'-SW%U:6R3O?7A^TQ@L3+@1$3(JD?*<##'/!SWJC_:=[/;PS;9%
MNH_M5O;NH=LDK&R'+#/W,XSR<`^M=L4O1:'R_L_GD#:C9V1G`R,CDC(]NOX4
MV1+]8P8%MC*J$*&D<+]X<'K_``CKU!]B:`.<MM0O]1O[6.VO+A+>6ZE`E$>#
MY:Q(>C#^_D<@\G%3>%M0NKW4)5FNC.NQFD02%A$X8`+C8-O&>,MG&?>NC83^
M7`1'"TBD%P20%X(.TX]?TS45LNHB$_:&MS*9,X7)`3'3/&3G/X<>]`%VBH)%
MN3<0E)(UA4$R@J2S'C`'/`Z_I[U)+YGE/Y.TR;3LW],]L^U`#Z*KSM>#RO(B
M@;/^LWR$;>G3"G/?TZ>_#9C?"Y`@6W,!49+LP8'G/`&".GIWH`M45',91&WD
M!"^.-Y(&?PJ*?[:(/]'%N\V3_K"RKCG'3)]/UH`LT4@S@9X/?%10FXWMYZQ!
M?X2C$G\<B@":BFONV-LP7Q\N[IGWI&\S;\A0MM/!!`+=OH*`'T564WOFR;T@
M\K</+VL=Q&1G/'IFI9?.#)Y0C*Y._<2#C'&/QH`DHJ"+[5YS^<(?*R=NPG=C
M(QG]?R]^&S33%BMM&K,C`/O;'RXS\H[GH.<=^:`+-%,A:1H8VE01R%060-N"
MG'(SW^M..<'')[9H`6BHX?.V?O\`9OS_``9QC\:;-.L+Q*59FE?:`N...O)Z
M#VH`FHHI"0.IQ0`M%%%`!1110`4444`9D1_XJ:['_3G#_P"ARUIUF1?\C/=?
M]></;_;EK3H`****`"LW2!^_U,Y)S>'K_N)6E6;I(_TG5.>MX>G3_5I[?Y.:
M`-*BBB@`HHHH`****`"BBB@`HHHH`****`,CQ#?R6,5KY3[6DN%7:`=SC^ZI
MP0"3CK[BN?.LZF88Y!>222(/+*QP##D(Q9NG4$+[<UO>(KZ>UBAALY"MU.S!
M,;>R,PSD'@E<?B:YVXN)_P"T/M@NI6(D=BJ2@X?;LC4`CCJYQ@GVY&0![ZIJ
MTRMLG^5XL+^Y.QR50EU_=YX+=P>2/>J\U]?VBR/:W<OV@+(L,;6[!V4RYW8*
M[>0O''?MWN_;=2V&RG+7#0QB)HXD5E9U5R0Q(!).$`VD'([4ZSU*ZM-*CLTN
M09BT$<&U59MF(MS9&1R6.,_W@3QS0`G]KZF);N5=162!F'E".U8[(RZ+O^[V
M&XXZ9P1D<5V$:E(U0NSE0!N;J?<UPLE]J=Y%!YKRR2(T+>6L8PTR1N[9&."'
M1`5R`,'IGB$BZOA/<QW4CR-+(%F?:LB`ND>-N1L(192>!P1^`!Z%17%0ZE=V
MRR-!.JQ,LERP381^\9V7EN^2`!GL#@YQ3HM=OXV\HWT-P\=P%F=0O`VQ]NR[
MC)R!R%/(/-`'9T5Q8U.6PT?3;.QG+RO'+).T;(YCR"1D'_;=>A_A(I?[?U#R
M!)),@#20C^!2/OA]OS8<?*IY/\1].`#LZ*XH:[>3Q>9/J$4,1B1/W>U0)&6-
ME?/)Y9G!'3:IZ$<]A;W$-S'YEO*DJ9(W(V1F@"6J>L$+HU\6&0+>0D>ORFKE
M4]8_Y`U]U_X]Y.G7[IH`CT4.N@6``(<6L>`XQ@[1P<5DWBVC>*(519TG64/)
M*MN[F3*A1'O'`3!#'/'TK4T9S+X<L3`V"UJ@5F&<':!DC/./K187IGOKJU-P
MLCVY7<NP#`(QC(8\Y&>>@(&.]`%#7K!-0UBTA%K%*YMY0SRQ$J@.-IW8X(.<
M<_EG-9QU*XTS6!:?;;BZ^S2)"T3Y.Y3"6#,VT_,7;CGMC%=/#J%O<7#P0RJQ
M6-'W@@J=Q8``YY/R']*73[N._LH;J/\`Y:)GE=I'X<XY%`'*?:+N&UM[F34)
MI6DA437(QNM\E&90@')`#'&,@9K1\50_:UT:ZAC,JI?1$MLSA&(Z]P"=OZ5K
M^5,+=5>_S)R5EV*/X,9QTZ_-^G2K2RQNQ5'5B,Y`.<4`<BUL^A7F4E'F0Z?=
M3C8OR*-ZL%"Y^Z.G4?6@:U>?9(A%J">8LC*V\*V4*@AV;`&!O7H!NRH]:[!@
M2I"G!(X/I3(O-Y\TH>3C:#TR<?IC\<T`<O'K]Q%K,*SW+M:RGA&B53M\O<&&
M,Y!;C)(Q[]1>URZM+_P_'(EQL@N73RYMNY5.<C<,\C(P?_K5ND!@00"#P0>]
M5S'<)(4MS#'`%4*#'G!^;=T(_P!G]:`.3TV\FLIU\C[+;VT[S1RSA#Y3R+&"
ML@Z8'RXVCC[W/2F"_NC')//<^3=O96[^:("K(=PRIX&0<$_C@8[]@%NA<L?-
MC,!8$*5^8#:<C/UP>_?\'W`F:(BW=$D[%U+#^8H`QM*U&ZNM9N()[F/:ADQ$
M$*G`8!<9&"-H+$[C]_H,"DN#?/J\<T\#I;Y1(T2;A_FR3C(P3P<$$80CJPQM
MPB4(?.9&;/!12!C\2:B"WC0R!I8ED9,(5C(VMSR>3GC;Q['UX`.,@M@OVQM/
MF%XDL&]KD!HV6-I#N3&<$[0W8$;,8Z"NC\-E6AO9("#:/=NUO@8!7C)'MNW8
MK3\N1$(B,2_?(&S`W$Y!Z_7/KG/%+"C1[P3\N[*CG@>G)/OZ?2@"6BBJ4VK:
M?;W:VLUY#'.QP$9L'IG^5`%VBBB@`HIJA][%F!4XV@#&/\:CC6X2!5>5)9=W
M+%=H(W>@]N*`)J*0YXQ^-+0`4444`%%%%`!13%W[GW[=N?DQUQCO^.:?0`45
M'!YWEC[1Y?F9/,><$=NM24`%%%%`!1110`4TJ"X;G(!'4XY]OPIU%`&#KDLK
M2Z,5:X@:><(Z)(RC!4DAB.,@@?KCO54ZYJ46GV]_<PQ?99V96:`$M'QA.#ZM
MQ^(YK=N+,7!59H89T"[2THR2">>,8[*?PI#;,\#0RV]L\7#"/!"[@<C/'KST
MH`PY]3U"RF::6!//>.V+1&5MJEV*MA2<`Y&.,^O>FC7KFW$5K_HJSQ!O,,D@
M5)-K!?E/8MNSDYP!T/6MB73WF)+V]D2TJ.P*;L@;=QY'7(...PZ=JUOH:$JE
MYI^F-"':0A4)RY51G!XYP<_\![B@#5M9Q<VD-POW945Q]",U-5.,ZCN/F+:A
M=@P%9L[\<]NF?T'OP^V-X8<72P)+M/,;%ESDXX('&,=_7ZT`6:*:F[8N_`?'
MS;>F?:G4`%%(N<?-C.3T].U1VQG,"_:EC6;G<(F)7KQ@D`]*`):*AMS<$R?:
M%B`W?NS&Q.5QWR.#G-2)OQ\^W/\`L_3_`!S0`ZBBHX&E>%6F0(YY*YSM'8'W
MQU]Z`)****`"BBFL6&W:N<GGG&!0`ZL*_N1I^DZAJ6GQ-<W+HC,0""?E`#$8
M[`YP!T`Z5N$9!'KZ5GQ6DT",C117"M''$V]SN8`$-NR"#U_')H`K06S:=)%>
M3:M/.KAS+YC;D?C=E1T4``GCMZU7T._O!J+0:E&Z-?J;JWW,2$7@&/V(&#V^
M\:GATR*"*:--)_=.SPB+S\J(CR2%)PNX]ACMGI5F'S)A'-/I*Q3VT>8071BI
M.Y2JD=.`I^C#TH`TJJ?9/+OFN8PK-*1OWX&W`P"./<]?[QY[4ZVGN9&E\^T,
M(4+L/F!M^5!/3I@Y'OC-1S6[7R1>?&T303)*`=I#$`'W[DCL<C/O0!S-K=ZF
MDL<5Q>S03263RW9F4'[-M<_.`#@9&<#H./3%2RW>H_V5!9">9)&2642,H626
M!1@`;NC'<I]0`,\YK=L+&(VLRW%@D;3G]\LA$IDXZL>=W?&?R%13Z'8;8X8+
M%8HV?YV@?RF0;?\`9P2#@`@>N:`([:_E(L[K,GV22P:;R<AW./+(/3<6PS`\
MGM4.AZO<W^MW\%QF.-8XWAA:,J4&2#DE0<].#^'>M.XMD5[,0V:LL3;048)Y
M28[>HX7@>@]*E\B..^\Z.U3S)5Q).H`;CH#W/?\`*@"Q1137+`?*NXY'&<<9
MYH`=5+58Q+:(IW<7$#?*NX\2H>GIQR>PYJ[3)(UE4*^<!@W#$<@@CI[C\:`,
M^+_D9[KG_ERAX_X'+6G69%_R,UW_`-></?\`VY:TZ`"BBB@`K,TG;]LU?;T^
MV?KY,>:TZS-(9'O=7:-]R_;`O7."(HP?UX_"@#3HHHH`****`"BBB@`HHHH`
M****`$9@JECT`R:S!K<0;;)9Z@A.['^B2$$#D<@=QVZ^M6[^_@TZ`37+,L98
M+E4+8)Z9Q187]MJ-OY]G*)8\[=P'&?Z]:`*K:W"N<VM_@=3]DDP/?I33KL0D
M*_8M0("EBWV5^.>G([\_E],RZEK-EIC(ES(?-?!6-%+,1G&<#L*EM]2LKFW6
M>&ZB:-C@$MCG)&.?H?RH`K?VW"W'V'42".]G(,^W(]J:FL01H%CT[4%7H`MF
MP'3CMQQ_*M-IHUV[I$&[IEASP3_($_@:IVVL6%T\:P7`?S`S(P5MI"D@\XQU
M4_E0!7;5[6$;O[/O55L@L+-OUX_S^--.KV2':VG7J[OE'^@N=W&<<#TJU9ZS
M97TXBM)&FR"=ZH=G0'K^(_\`UU?H`Q5U>Q"%_P"SKQ0!R39,,<_3Z_K2-K%@
MD:NVGW@0\@_8FZ>N,9'_`->M1[NW26.)IXQ)(<(F[EOH*F#`XP0<C(YZB@#&
M_M:Q^7.FWP#YSFPDZ@9Y^6G'6--V[Y+>=`8PX+6C_,""<9QZ`UKY&<9Y]*K)
MJ%I)?O91S![F-=SHH)V#CJ>@Z]Z`*)UJQ4A?L5[A6`)^PR80D#K\O'7]/IF0
MZS80Y6..X)W<HEK)DYSSC;STZ_2M2B@#.36[)D#?Z2,J6VFUEW8'7C;46H:I
M:-931,)_WL1"[K:0!LC`&=N.]:U5M257TR[5^%:%P>,\;30!D:)JMG!H.FPN
M\P<V\:#;;NWS;!TPN*Q#_9D:R%M>,5Q<!UNE>)@&#Y#;5(SP5')SPO/6NLT%
MS+H&G.2"6MHR2/7:,U8O+NWL;9[BZE$<2=6/^'<^U`'!I/IK/--<:EI9??;M
MY45NPBP@9<$8Y'S_`*8J.ZO-.$T*F>V=FM$A,[Q;8E7<2QCPOS?>*D<=#GOC
MJH;>ZUIHY[N-[*R4@QVI!620#_GJ.@'<+^M)XABO8634;:55M[""1VA[2],@
MCIC:#CWH`Y/&E[5#:_:^8Q(#K;,%7(3#`=,C;SGKGGIBM'2-5TZ'Q)(W]IQ3
MQ,F%D,1WO(SD$9QZ!?8\5T-YK,:V$!L$,EU>1C[)&5ZY&03_`+*@Y/I5O3K$
MVL;M.R27$K;Y65<#=P``.P`"@?0=Z`*/_"7:#@$:@A!.T81N3^5#>+-$4`_;
M001D81N?T]NE;=%`&'_PEVB$D+>AN-P(0\C\OKQ[&A/%VB.P7[9M)..8VX/O
MQ6Y10!DQ>)=(F5REXOR(7<%6RH'7/%,7Q3H[;\78`1=S$JP`_3_.1ZUL````
M#`'0"LN^OC::YI]K\@BO%EWY7JPV;>?Q(H`%\2:._FXOH\1('<\X`W;?YD#\
M:/\`A)='*.XOXRJ*'8@'A2P4'ITRP_.M-XT<$.BL&&"",Y%026%G+N\VT@?>
MNQMT8.5SG!XZ9YH`HQ>)]$E;;'J,+'#''/1023T]`:7_`(271A;+<?VA%Y3-
ML#<_>X..GN*N)IMA&Y=+*V5BNTD1*"1C&.G2E_LZR%N+?[';^2#N$?E+M!]<
M8Q0!F3>+-'%O(]O?0RRA"8X\X+MC@<],FN2FU_3+33WEFBBU#4[YB]SG(,0/
M15;'&W`'!Z@$>W1^)+6P7[#8);6T1N92781+E8D!=\8YYQCCU-3:!IEK<VCZ
MA=65N7O',T:L@8)&?N`<<<<_4F@"'1_%6G"P1+[4HC,GREG)#,.Q(P,'&,^^
M:N#Q9H)D\L:E#GU.0/SQCO5:#3K2PUU[>6TADAO]\L3/&I"R<[D'I\N#^!K;
M6QM$<.MK`K#D$1@$4`9__"5:%_T$X/S-">*M"<D#4X./4D=\=ZOC3[(``6EN
M`.@$:_X4OV"S_P"?2#_OV*`,]?%.AM)L&IV^>>K8'&>_3M_G-.'B;1"A;^U+
M;`!/+C/'M5[[!9_\^D'_`'[%`L;0=+6`?]LQ0!3M_$>C7.?)U&!L$#!;!Y(`
MX/N12IX@T=]^S4K5MBECB0=!UJW]@L_^?2#_`+]B@V-H<9M8..G[L4`0+K6E
MN^Q=0MBVP/\`ZT?=/0T[^U]-WLO]H6NY,;AYR\9_'VJ7[#:8Q]E@QZ>6*0Z?
M9$$&TMR#U!C7_"@!IU33QG-_:\=?WR\?K2#5=./2_M3C_ILO^-1G0]):0R'3
M;3>>K"%0>_M[TB:!I$:NJ:;:@.<L!$.><_SH`E&JZ<VW;?VIW?=Q,O/TYH.K
M::%W'4+0#.,^<O7\ZK3^&]%N&C:33;?]W]T*FT=<]!P?QI@\+:&""-,M^"#R
MN>G^>E`%QM6TU3AM0M`0<<S+U_.C^U=.!(^WVN0`2/.7@?G5;_A&]%P@_LRV
MPAR!L'MU]>G>FGPOH9Q_Q++?@8^[0!<_M33R2/M]KD#)_?+P/S]C2?VKIQQB
M_M><X_?+VZ]ZJ?\`"+Z'D'^S+?CI\M`\+Z&/^89;]<_=H`N#4[`JS"^MB%^\
M1*O'UYI!JVG,VT7]J3_UU7_&JO\`PC&AY!_LNVX&/N4@\+Z&!C^S+?O_``T`
M8MVUBVHW[SK;WQN$W6\ANU41@`?)G=E?F'4=S3(Y9;1C<S7,:+Y$Q659E;YQ
M<%]G!Y9A@8SS@@YK>_X1G1/^@7;=_P"#UH_X1G1,Y_LNV_[X_P`^E`#-)U&"
M/3T>_P!0MQ/+F9D:8?NPP#!>3G`4C^?>M%;ZT:)I1<P^6N<OYBXX&3SGL.:H
M#PQH8;=_9EMG.?N4[_A&M$SG^R[7_OV*`+?]I6/DB8WEN(BQ0.9``3SQGUX/
MY&GB\MC(8Q<PEQU4.,C\/Q%4%\,Z(I4C2[;Y>F4S^?K^-*?#>BD8_LNU_P"_
M8H`NQWUI*C-'=0.JDABL@(!'4&G)=6\D8DCGB=#T97!!_&J(\-Z*`1_9=IR<
M_P"J%+_PCVC\_P#$NMO^^!QVX]#[T`7#=VXE$9GC#D[0"W4\\#U/!XJ9F"C+
M$`9`Y/<]*S3X>T<L&.FVV1T/EBD;P[I#%2UA#\HP..@_R!CTH`U**R4\-:,B
MD+I\6,YYR<?3GCH.E!\,Z*0`=.AX&!UR/H<T`:U%9+>&=%8DG3X>>O7W_P`3
M^=+_`,(WHV2?[/AR?8^W^`H`U:*R1X9T4$$:=",<#&1BC_A&M&X_XE\7'3KQ
M].>*`-:BLD>&M%!4C3;?*G.=O7Z^HYZ&HF\):&T0C-BO``#!F##&><YZ\_H/
M08`-ND8D*2HR0.!ZU@#P7H(4#[(YP01^_D[?\"IP\&Z!Y'E'3U8;M^XR-NS_
M`+V<X]NE`&/'9:G]GOTMH]0+SP2G]^Y4J^[*[6!`.?3`Z]>HJ^KZP=7B02W@
MMW?"[EC&%\H$DY'][Z]#UZ&R?!N@LN&LBWJ3-)EOK\W-(?!F@%2OV$X/'^OD
M]O\`:]A0!6LGUXZI;J[RBV41*ZO&#QY0+9/KNSS[BNGW#&<C&<=>]<^W@CP^
MRX^PMG`&[SI,_P`Z7_A"M`W$_8FY.3^_DYX_WJ`*'D37&I7<AM]1AWETMU\P
M[`Q!^=@7[DX"[1C(SUJWI4U^FJI%(]Y+`SR1DRJ@154#;CN3G()YSW]I/^$*
M\/CI88'<>=)@_P#CWO2KX+\/J<BP_P#(K_XT`5[J.0ZK=^?;7TP>1#;217!C
M1E*J,?*P'RL6.2"<5%)<ZO').\,MSY@,YVRJIC"ECY>WU;`!`)_^O<'@GP\,
MXT_KU_?R?_%5)_PB.B<8M'`!R`+B08/K][K0!D@:Q:PW#1R7A26YE*NXW.0%
M0(<=EX?T_ASQ756)?[%;B:0R2B-0[$8+,!R<?6LN7PEI,K`O'.0"&`-S(<,,
M\C)SGFD3PEIB8YNR!V-U)]3T/?`S]!0!N`@@$'(/0BEK#3PIIB][L^N;J3GZ
MX-*?"NF-C/VHX&!FZDXZ>_L*`+$1_P"*GNA_TY0_^ARUIUAZ=8P:?XAN(K<2
M;6M8V_>2,^/F88!8GCCI[UN4`%%%%`!69I.P7NKB,`#[8"<#`SY4>?US6G6/
MX?\`]=K'&#_:#YY_V$H`V****`"BBB@`HHHH`****`"BBB@"IJ=M/=V3V]O/
M]G:3"M(!RJY&['OC(_'/:DMX);6X2W@CA33TAPH`PROD8`]L9]\U<JO?W8L;
M*6Y,4DHC&=D>-Q^F:`.>U.\DAUBYEM;+SFE@^S-YUM*1D$\@JA#+\V",@G`Q
M63J$,]ZMNLR7LRB)UF7[')"7D9LEU`C*DC&><$X'.<U<AO\`5;75H+Z^\P17
M@D1(/.4PHQ`,:[@.,D%<^HS21:MJHMRTCOYAMV#120;523/"J2V6^7)SSTY/
MH`5A8QR#4)+FVNKB=HA':-+8SL$55*@$;?O$<Y]3UJO]B/\`9SP6UM<(7M4A
M^6VGVA\H7<_)U(52,=\YK3EU^]6!2EV1`UQ\UQ)"N]8@.H1<YR<C)'7H.>(V
MUO44N5B-W$A^S,Q:*WWDN6VQA^.#SG@?A@T`1H#'!<QVUG?)%]GCMH(UMIA\
MH.7+D)U.2./3Z4UX7^RM;VUCY,3S>8T*VMSA0!\O)C//7.5]/K5J2]U&1HO,
MEB)2Q1R@V^6;@OTR".00I(YZG@\9D@U[4S%Y)-O',]WY437"8_=#EF8;AP.@
M[GZ\T`9UK8B!]/W17D@M()B,VDV4D8\;05Z#/'N.U6?#R'3;M)9;*_C,=L(G
M*13.)VX.X@H/4C&>*FEU_4HR5FDMDC,LL2SQQAFXP(^"V`6(8\Y'2I)]9U)?
M*)>U@G^SAE62/.]R<E#A_E"@+D\G!SQ0!0FMI[FZ>8VUZDDEWYRW[02&2W3J
ML80J2>`1QQTSUQ6YX8L6MY-0GEA:*2>;<NY6!\O:-H)89)'?W)HUW6+BSN[2
M.WE@CMI&"S3LIE*$YV@*".I&,^XJI$=2U>^T_P"U7!M%6(S211Y&XESM!(;(
M.U3QSC!Z\X`.JHHHH`*AN_\`CTF_ZYM_*IJ@O2193D#<1&V!Z\4`4O#C-_PC
M.G,0S$6R8&W:3A>!S_/O69?WBW5OH>IWPC73V999(_O%964[#G'0'/IU_"MG
M1!G0M/!R0;:/[PP3\HZCM4B:?;)#:1!/DLR#""<X(4J/KP30!7;7]*58V-['
MMD!*GGD!MI/L,\9-0:CKFF_9KNW%TK3A7B$8!W,X&"JCN<\<5)+X?L)93)M<
M%F)D7.Y9`6+$$-D8RQZ8/.,XJ5M%L3\R0B.7S'E\U/O[FSNY[@[CP>/R%`'-
M^%-1M+>!);^<K<BVCC7<IPL2H6`7KS@9/3/Y9ZN&_M9Y?+BG1W\I9L`_P-T;
M/IQ7,^&;:UNYBLI_TFVVO-''/NC+[F497L1LX'^T,UMZ;#9V.H7-I&X-RX\]
ME*XPC,V`/8=,#C//>@!S:_IBB3_202F.`K9;.0-O'S9((&,Y/UI!K^F,]LJW
M.[[3Q&0C$$[MHSQQELCG'0UC7$>BZ5?1:?<3W0,BHHD8_+'@L4^88(.<X//?
MWJ_<Z9I^G6OV^XN;IH[9!(Q:<GS-KEUS_>.YCC\!0!9_X2'2Q%-(UT`L.-YV
M-CKMR./F&>,C(J2VUFSN[F*"!W9I5<@E",%<;@<\@_,.HK*L=*TC5=/,VF7,
MH@E.!M;'EX8$J`>1RH//H/:K5[:VFC6TFI.]PWDAV)5_GD9R`<GOR$`'L*`+
M4FMV,5VUL\I61=PP4;D@9(!QC.`>_P#.L/6=4M+B?3]4M9_-AMIEC<!#G#LI
MSCKT7CC!J_<Z58:A;7&H07$C">-V#9+IDQLF=GL"1C^M8.O6$D^G3K:6UTK!
M%9KB[E!D`C&X*`"3SO[@8P2:`.N76=.9T1;N,EXA,O/5"=H/Y_E446M0`M'>
M-'!,)60*'#94/M#9[=LYZ9^E8>C:.^K:0+F:YV)=VJH?*#!LY))8,2&Y)["M
M";PK!-'<1O?796XSOSY?&7#DC"\<Y_[Z-`$\7B;2G;#W(A!+A3*-H;:2#@_A
MT//3BIVUW2UM8[DWT'D22>4LF\;=WIGM^-95YI$NFBXO?M#7=L$E,L4HQ($?
M+2!2"%Y.#@KVZUHKI]CJ$`NK2:9%G?SQ+;RLI)(`/X$*,C^M`&'XHNHKO48[
M6.>,&6T$43DC'[Z5$)![_*K=,\9]ZWM.U+3SHL%Y'.D-H5X,C@!?;\/2LF/2
MH;G5-7@MR87@6U$;;B1YB+N1CZ_PC'M[U=T^VMK[2%T^4.DEFP5D,FYHF'*X
M/<#MGMC-`%?Q!JE@\.F7<-[$WEW<<JE&#%DR4;'MR?RK1U#5OL5Y%:QVKSR.
MADXD1,`$#^(C)R0/QKF_%FEMING6,6GAW$DHMV+G>[%F+`\]]Q8YJWXATQX%
M@N#>7%U=S31VT1EV*JAG!.0JC=D+@@^YH`V8==L&@@>>YAMY90/W3R`,"3C'
MOSGGOC-(==LG,`M9$N3+*D9$;C*;@<$^HX[5@WEAI]GKNDZ;"79)^7RVYMB;
MFC`)'0$8X/08/6MRS\/VMH#B2:0[E93(P8J%?<`./?&3S[T`/AU[3IGE*W<'
MD1QH[3&50HW$@`YZ'@?F*E?6-.C2%WO856?F,EOO>N/ICGTJH?#ELT!B>XNF
M"JJPL77,(7<`%('.`Q^]DU)!H%K`)-LDY,D4D3DL.=YR3C&,\4`7+&^@O[7[
M1"WR996SC*D'!!_*JEMKMC<6C74C&!(WV_O1CJ,J1Z@J<C'K2G0[4Z?+8EI?
M(DD9]NX?*&;<RCCH3GWP3S69KUI9V"Q/9$07A*K#%&/O-D[6VCJ1D\GC&X<T
M`;"ZSIC1P2"_M]MP-T1,@&X9QW]^/KQ44VOZ<D=RT5RD[VT;2.D1W'CC&>F<
MD#'O7-IH6JWD4;BRLH<H=WG2$MDNSE>`<8+L."I]^!C33PL[\7=_O4+,!Y4.
MPYE;<QY+?0?UH`TK[6K:SGM(B&D-SE@5'"1@9+D^@X_.G+KFEM:K<K?0F%FV
M!PW\6<8_7^M5Y/#\5PQ-W>W5S^X>`;_+&%<`'[JCGCO4MMHD$,T=Q+++<7"/
MYGF2;02=FP<``<#I0`MWKEG:7;6TKA9$V%RQ`"JV?F)]!CGZBI6U;3T-N&O(
M?](.(OF'S=?ZC'UXZU'=:/!=:@+QY)0P"`Q@C8VQB02"/]HCZ54G\+V4RNHF
MN(UD,GF*I0A@[%B,,IQC)QC!_'F@#3N[^UL@#=3I%GGYCV]?I[TV#4K2>62)
M9D$D;%2C,`QP`<XZXP:KZMHD&K,K332Q[4*80(00?]Y3@^XQ43^';621BTUP
M8FW'R25*@F,QDYV[NA/&<9/2@"_;W]I=*C6]S%,LAPI1PV?RHAU"SN"@AN8W
M+J&7#?>!)`(^N#^1K/?PW:R)())[AGD*'S,JK*%Z`848!!(/?''I3F\/69O5
MN%9D575Q"L<>P%<8QE<CIV-`&C]J@\XP^<@E!QL)P>F>G?K2)>VKNZ)<Q%D?
M8P#CAN!CZY('XBJL^B6<]X]W(K&9GB?=GH8SD8]O7U_`56/ABQ:17DDGD*L&
M&XJ>0P;GCGE1US0!H_;[3SVA%Q&9%7<RAL[1SR?0<&E>]MDB\UIXPN"0=P&<
M=<5GS^&M/GC9&5U#&4L4(!;S,Y!..@SP/85')X7M)(0AN+@-EB9%$8+;@H.1
MLQT4`$#/6@"Y-K%K%9V]R/,D2YC,D01>6`0OT/L#5A;ZU:+S#/&@`!8.P4KD
M9&0>G'/-5)]#M;BQMK21Y3';1M&AW#)4QF,YX]&_.H5\-6`D@D;S'>"5Y58D
M<EACD`8('&/I]<@%I=7M'OEM`S^8S[%.T[6.S><'Z59-W;!&<W$053M+%Q@'
MTK)'A>RVQ!I)\QKC*OMS^Z$7U^Z`>O6AO#-J0I65U=-@5@B<A0P&X8PW#'.?
M:@"Z^KVR::;\B3[.,Y(3)&&VGCZU+_:%N(5D=Q&6!*QR,JL<>Q-4'\,V#P>4
M6N`?*,0<3$$`]\=,YR<X[T7GARVNY(R9I4C5"I0'KR2"/0Y8_IZ`@`L+K5F]
ME+=*S,L3LC(`-^5;:>,^I'YBG+K-B4+F8J@(!9T*@$NR#J.[*WY>XJ@_A>W=
M94:XE97>5UR!E3(06YZGIWSU]A3W\-VYMW197#D@JSJ'"D2M(.#[L0>>10!K
M27$,1`>102I95SRP!`X'4\D#CU'K2-=VRF0-<1`Q8W@N/DR<#/IDUFZ'I+63
MW$]RL?G2.1$%);RHLY5,GW))_#L!5=/"T,8VK.#&C>9$'A4L&+;CN/&\9'0_
MF>,`&T]W;1LBO<1*TGW`7`+?3UI/MMKY(F^TP^4?X_,&WKCK]>/K6"W@ZWDW
M^;<%O,MGA;$87#,^_<N.@!S\O/!Z]<K/X79IF-O<1Q(SRN"80WE[T1-H&?12
M0>W'6@#H?,02>7O7>1G;GG'TI$GAD&4EC89`X8'D]*Q/^$5MQ>PSBYFV1+&J
MHP#'Y$*#D\8((R,<XJ"[\.-;63&Q59KA;2*VC7_5@.C9$I(/4=?P]Z`.E5@P
MRI!'J*.<^U4]/LC9(D4;@6ZQ!1%MZ/DEFW=\YY^GUJ[0`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`9<>?\`A*9^N/L4?T^^]:E9B?\`(S3?]><?;_;?
MO6G0`4444`%8OAP@RZS@Y_XF,G_H*5M5C>'L^=K&>/\`B8/T_P!Q*`-FBBB@
M`HHHH`****`"BBB@`HHHH`*BN8X)8&2Z2-X21E90"I.>.OOBI:HZU8-JFDW%
MDLGE&8`;L=!D$T`8EK=Z)=ZQ+9+I%GM`DQ,$C8-LP&XQG'^%+'J7AN1!,FFI
MM:%Y5<V6T,J#YL$CG`)]NU5_^$?N)6,"ZE9+<PAQ&\=L%:,,,$8!&<J3SZXH
M3P9<1V8@CO8!A2GS6^\*#C.W+97=R#ZC\Z`+T=_X>,<SM9Q0BW59#YMKL)#=
M"`1G)(P!U-5VU+1I+0R6NE1-,9HK<030!#N?E>Q`'S$TUO#EW#;LLNIVD:S2
M+YK/`6W[?N+EGR,9P,$=!CG.0>&+R&6%QJ=JLI?>&-NQ9I=IR^2_S-C/MQG`
MYH`F?5/#AD2-;6)FE8@-':@@LIYP<8/?_P#738-<T`VOVA]/\D[7<(;4%MBD
M#=@#@8QR>/RIEMX4O+<1$:C;R/"CI$SVQRF_[S9#\D^_KQ22>%[B)VG?4[9$
M\@6[[X7^:/=G!8R;N^.O0`<4`6UUCPX4N)"D""V4&0O!M(R,@#(Z\4T7/AM[
M`3I9Q%+DE51+0[W.S.``,_=[^A]ZA'ARX@A=[N_LY1NCD>26V*[3&H"D$.,8
MQU]S[5)%X:G_`'+O=6<TD2%5EDMI&8YZDD2C)/Z=!Q0!'&WAN2\M;2SL(9/M
MT!.^*+:/*.>6QSU&.>^*L/'X;T74/-^SQP7,2[R\<+D1@@CDJ"!D9ZTVR\.W
MEC/;S07ML)+>'[.#]G?#IU&1YF."<_6BY\.7%U=RW,US9M))M+8MY0K%1@$J
M)L'`]0:`-"SUA+W5KNQA@E*VO#SD?(6XRH/KS^E:=9VD:=)IXN/,DMW,\K3,
M8H3&2S$DDY9L]L=,8K1H`*AN_P#CTF_ZYM_*IJBNAFUF`Y.QOY4`4_#RA/#V
MFA3D?9HR.,=5%:-9WAU0OAW30H`'V6,\#N5&:T:`"BBB@#AO"<JVNOWV]CY-
MQ=3P1NS_`,2L&"XZ]&8__KK9UB86'B;2+D%!]I#VLFY@,KPR_D?YX[TZUT$/
MI,\%TJK/)=R7*.,$H^XE&SSDXQ^'%5;G0M6U%X'U"YMC)9`O:R0AAND!&TR9
MS_=Y`]3[4`4;BPANO'D\=[\\5Y:[=@8`QL5X'UVJQS_^JKOB"SDL/`TEM+<K
M*(%5&>0'YDWC`X/7&T9YZ=.:;=:/JEU'=:A(J+>F2WF@A\S(0Q#D9`Y)+/[<
MU-J5XOB&*+2K:"Y43,OVMGB9!`@&XJ21]X\8Q^=`#]4A322=:TXK&LK(+A<X
MC92RY?']['''7/K5GQ<@?PU>;MV%"-\HR3AU/]*Q1+J>H:0FA&SNTNXB$GN)
M$"Q>6I/?D,2`.!W.<\&KCSWFOQP:?-IT]N$E1KMY@%1@C9(7!.<D<4`6]%Q;
MZYK-D%V()$GC7)P0Z_,0/]X'/N:R_#^F0:W+J&KZC;@W3W+QQ[@1L4*%`P#^
M'//%;-_;W=OJT>HV4`FW0-#+&&P2>J'DXP#Q_P`"K,LUU3PY:21SPO?+*1*9
M+:,$K(QPRXSR,X;..Y&/0`=X0O?LT+:-,'+VTTL4,A_Y:JKG)_#(X]Q73@@@
M$'(/0BLBPT=&T"*TO5_>R*9)F4!6$C'<V".G)QGT%+';ZQ8C$=S'J$2J`JSC
M9)G(ZN.#QGMG@=>:`->L7PP%AM+JTC=7BM;IXHRO8$!L<<=6/T&!VIQNM9EC
M8"RM[;*']Z\X?RS\W8#G&%SSZU<TO3X],LEMHF9\$L[N>78G)8_4T`5("MMX
MHNXB,?:[=)E//)0E6'IT*]/_`*]:0MX1<FY$2"=E"&3;\Q7KC/I535M.:]6*
M:VE\B]MB6@EQD`D8*L.ZGO5/R_$=PTL,TVGV\+95984<R8SU`)P#CZ\B@"CX
MHE.I++!:NX6P5KAY4X`E4$JH..2,'..GUJ>YF&H:OX>N`FV%P\J$=23&"!SC
MC!8_A^%:(T:Q?2&TMD#0*"I"DAA[DYSG!_'/H<57O]`6XTRPMK>?RYM/:-H)
MF4-C8`.1TZ#\Z`,?RIKCQ,VH26LKR6\S;HT(9EC5=J`8P/F9V;GLI].=Q=9G
M;:?[%U$*<]5C!S]-]9VGW?V&2Y%NL^L7UQ/F6:*,*F`,#YON@`+C&<YSBKIF
M\1S0@Q6FGVSEB?WLS/A<\`A5Z_0_E0!=M=3MKJ?[.&:*Y""0P2KM<*>^#U_#
M.*NUS%]9Z])-;7$D^EK<0MF)@'3YB<%.2=P*Y]#G'I2_VYJEQI$M]!;V$")\
MI,T[%D8'!4J%^]G&!GN/6@#6U34OL:B&WC^T7LBEHH!GG'<GL!FFZ7I*6;&Y
MG<W%_(H$L[=3QT7T'M659V'B`2W-\TUA]NE5<>9$Y"KVCW9X'4G`ZGKZ6X?^
M$E28[WTFYC`PP!>-@V/7#>OIT]*`-RBL.>\\0(@,.FV5QEB#Y5T3MQZ[@O?/
M3Z<=:L/J.H+G&BW!`_Z;1?\`Q7^<4`:E%8!\27&#M\/ZJ3GC,0''YU(OB-$M
MVFNM,U&V1<;B\!.,G&>/P_.@#;HK*M?$6E76`MVD;,Q55E.PMCN`>U7XKJWG
M8K#/%(P&2$<$@4`34444`%%%%`!15:WO[2Z=T@N(Y'C;:Z!OF4^A'4&K-`!1
M110`4444`%%%%`!14<\H@@DE;[L:ECCV&:<C;XU;!&X`X(P10`ZBH_-'G&+#
M9"ALXXYSW_`_Y-$\ODQE_+DDY`VQC)H`DHJ)9]UN)A'(,C.PKAORJ'[>N]5^
MSW7S$`'R3CEB,GTZ9Y[$4`6Z*I'4H]S*D%S(5=4)6%L<@'(/0CFK:L&+`9^4
MX.01VSQZ]>U`#J*0'KQC^M,ED\O;B-W+$@!1[$\^G3'U(H`DHJ..42-(H5U\
MMMI+*0&X!R/4<]?4&I*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#,C
MY\3S\CBRCXS_`+;_`.%:=9T8'_"17![_`&2(=/\`;D[UHT`%%%%`!6-X?&)]
M8_["#\=ON(?ZULUB^'3^^UA3U&H/QWQM2@#:HHHH`****`"BBB@`HHHH`***
M*`"JNI2/#IUQ)%&LCJA*JQ`!/;)-6J*`//[&W6SALUEOB/*0,T@9,13L&*J<
M+N;.X]^H^E2_Z4JM&][<"[DAV&`2$^9(V"9$Y`&>?NXSN]<BNZ(!ZC-+0!P:
MSR@00W#B(1SF:42SLX5-F(R5=B5#._0Y[5`IDB,5^EV$FBMG83W-RC))=,"I
MVY)&,!L=N!7?^3'L*[<`J%R.#@=.>O%,6TME#*((]K=1M&/ICTY/YGUH`XJV
MEN)H)H/MMQ#'<30Q;Y+MC+&$W/(3DDH<`KCC)QP*A1ED.GQWM\SQ#4'E7-QD
MI#@;-V6]0.HR!Z=^\:TMG9F:WB9G&&)0'/UI!9VJE"+:$&/[A"#Y?IZ=!0!S
M.NWUOJ<D*)=Z;_9Z8D<W%QQ,?F4`*#T4D$YQDXYXK,BU&6'3-.6>\W+;6TGR
M6TW+R*VU#]X$J%&?3VY%=U]EMR<_9XL^NP?Y["FFRM&^]:PGG=S&.OK0!Q,L
METIMX$U0^:RPJ)#.<1L<%F8`C)R>C9&%_*:.ZDN=86ZEU%(4-](VTW"E$A1>
M,KNQR4Z_0C'?L39VI+$VT)+8W'8.<=,TOV6W_P"?>+G(^X._6@#DO";6L=K9
MPW%U)%=-,]PR^>#O<Y4*V>3E2N!Z@UV=1&W@+AS#'O#;@VT9STS]:EH`*BN?
M^/67C/R'CUXJ6HY]OD2;ON[3GG'&*`,FPM+>]\(6,%W$LL+6D)9&)`.%4]1S
MVK"TW3](D5Y;C20J>:CV[0EP3%*Q",V6R3R<^E=%HL"S^%;"!RP22SC5MK$'
M!09Y[4W_`(1O3D(-M&UMA-H\DX&=P=6P<Y(89';DT`8&HV>A6]X;2'2'DDCD
M,;G>^U24\P'ANG3/IU[5-;V>@?9?.DT:[A<"-MA#AF))V[?F_O9]#R#6POAZ
MW\R662XN9)99`[.S@$_)LQP,8QQTSS4MWHL5Q&JK/)&R)&J,`O!1@RMTR3D>
MN.>E`&#>QZ+#9S2Q:;=&X\F9V0O(0A"DD2$-@9*@>^15L0Z3!?\`ERZ=>)*%
M8FX9FVMM0$G);.,8`)&,@CK6A)H-N8;Y8WD$MY'*C.[;L;\YQ].!]%%,G\/1
M2WWGBXE$4BLD\+882*5VA03RH&3T]3TH`SA<:&T*2M:78F>5=L!=O,);H0-W
M3@]#CY3Z5)%9V\_AVYNXK3?<*)BB`N0SHS!?ESG^$<58M_#L*0DQS21SI*LD
M+[`@CV@[1M7`/#$'UR:T(]+B2P-H996!=Y/,W8<%V9CR/]XB@#F;26TN8RR&
MVG(ECW21&4`J6P5*$EE/?)R#SR,&K\4V@NS8M9P57S%#1R#S%W``J#][)8=/
M6KA\/I++++=7D]S(YCP7"C"(Q8+P.^3D]>>U5;+P]/NC6^EC,,,*11"(Y8;7
M1@,D#C*#@YZ]1SD`!/H<"/+;6LCS1)(?+V.I`5,G.[H"",$_WABF1OHQO)(F
MM0(0(!"X##>9L@=_]D<_UJW/X;@GU"6Z:=PLS,9(MBE6#!`1R/\`8Z]>:5O#
MJ?N_+NY8S'!#$N%7K$V5?IUY(],$T`4UA\/J]RZQS[MLWG'S),($/S]\#!P!
MC\*--T[0;]IX[9+E247<CSR@NA((89;.,C&?8UHP:%!$)Q)-+*)EE0AR,!9'
M+,/UJ32M*736E83-*9`JY:-%("YQ]T#)^8Y)H`PO+T%;:YGM(;MG2"5TW/.R
MRJ/E)4YY&2.1TR#Q1J%C;6>FZ='/;Q@2%WD62[G14;R]S'=DD#"G@CO]<ZD/
MAU(HO)>]N)85MGMHU<+F-&QW`R<`8&:T+VPAOFM_/&Y()#)L(!5CM9>?^^C0
M!@Z-IEE=PS22031/%*5:2.]F*2$$993NSC(Z^OKC)31K'3]2DN?,AN%\MPT3
M?;)3YD9/RO\`?/5D8CV`-:8T3R[>2VMKVX@MI=Y:)=K!=W4*2,J.OYTR/P];
MVTD,EA(;-XXVC9HQDL#CUST(R.O4T`07UAI.F10JZ7[;B5CCAN9F;A>P#=`!
MCVK*O;?3+FYTZWLKRY:&ZG4R$W4C*8]K$+RV!N*XYYX..AKI=2TU[R>WN()Q
M;W$&Y0Y3=E6&".H/H<@\8JE'X9@6"2(W4Y!6,H^?G1U9WWY[DLY/(H`R&LP(
M[F>RM9ET^UD*L3J$JED0'=L4'&`<@<]NU74MM&?4/LGF:BD@9H]S74P0N.V[
M=C<020/8U%-HVN6T<UO;7OF6;>8QC0(K/N&<<H=I))Z<9)/R]*C,MI9W"+=)
M>6;B]^VE?L^\#Y"FSY">,#K_`/7P`1ZM!'ILTZPI*\=M$LC*=4E623<7X49Z
M@*3COCC/>K'!976M0L3-]BF9L$R3J5<#]W(6)QNPN`"1Q@]^)M5FT_Q#?N+?
M5K>&T>W7[1(ZKN`4DA5W8(SN8G_=JYJVE^3Y^H6]ZLD<*).%*AI04"Y*OG@;
M0#CG[Q_O4`,LSH\NG0SM?WUO*Z(X`N9B8RW.!S@C^'IVZYIMV]A9V5S):W.H
MLL<6Y3]JF5O,4_=(/J"HZ=*OW>@AHH$%^(Q!;1PM(RYSL(^\-PR"#T_/-5$T
MBSAAO1_;%H/,!$N%C41L3&.QP!E,8([C\0">>PM[6RC-YJVHP3.BEU6ZDDVG
M&2<')QP>2,57M=--WK%Q:PZCJ:VT$2-YZWC$N648QQC!&>0>H'I6GJZQ7$T5
MQ:ZI:VMS`&0LX5\JPY7!([K^AIFD-I.F-*(=7MI(W2)5#3(2H1-HYSSG'IZT
M`85@WVC48+:34-25)7:.-QJ2NX903R@&1D`YR.K#V-7M1T^+2WMUDU/5Y%?B
M0B[.(DR`7(QTRP[^GID7K?2(K0VEQ;W,"W,#D2.J`"2-VR5(SU]_4>^*5O#L
M-Y(\NI3+=W1A6(MMV@8!R2H/<\_@*`&GPO`K)-+JFI$Q$MF2XW#'ON!XK#M]
M%M+Q;662ROX[>17*3>9"@9=I(+E%!P1G&?;U-=A96]W''+'>W2W(;&TB/9@;
M0".I[@G\:SDT*X\B&SFOQ)80[U$*Q%2R%2JHS;N0`<=LT`98CT=[>64>(-66
M%-A.9G4J&.``"N2#C_Z_-#PQ3S&2T\57D4<$6YU<;@`!AB"<>ON0:T_[`FD,
M375U'.Z+#&=L`162-]_(R<DX'L/2HM3T&<V)6S?=*JW)5=HPQE;/<]LG\J`,
MC,\<"7#:V7CC=E#M)('(W=TV9Z8)^F?>ED-[%*(QXA1'9(XEC&9-Q;&UF;;P
M/F^AQR>36W+H%Q+<M=/?)Y[RK(X6)UC("A0-HDSVSU(]J2U\._8[">`WV?,6
M%0YC`V>7CWSSVYXXH`R9-(>^N8$ENXY6N-SQ,96WX1N2#L!!Y7(R._U%B"QU
M"'4H;74]2NV$D9-N\$H.TJHW*<KD_7G/US3M-U"PL+J]N[Z[B@S)Y<-N\BL\
M*ELMG!).7)/M@=.@TX#)JU]:WAMY;>WM6=HS*-K2L05SM/(7!)YP3D<"@!XT
M5QC_`(F^IG`_YZKS_P".U<LK4VD)C:YGN"6+;YV!8>W`'%6:*`"L[4]1ELY[
M6"WMOM$URS!5W;1P,G+=N,]N:T:S-5T^>ZO+"[M9(UEM'=@L@X8,I4\CF@!]
MOK%E+:I-+/';%B5:.9PK*P)!!SZ$$?A26^M6,JS-)/%!Y4IA(ED4'<,`]_4X
M_+UK#U+PK=WD$@%W&'E5FDPI`\QB2<8QQT7!]2>N<SW7AF:=KG$L`CEDF<*H
M=,^8%R6(/)X(QTP?I@`W-226;3+A;7!F:,^4<C&[''X9Q52]U&6#Q!IM@H`B
MNEE+$CJ5&0!5EK>2#2/L]M@R10!(QU!('`Y/(X[G\:HWOV(W\>I.;A&TW*$"
M([6#C;QQSSCD>E`%:UU^99XYKP*MI=F?RP,`PB+.2Q/7<`3[8]^"'4M:B:QE
MO8+=8)WCAV9Q(S.JDL,9'RG?QQD`].*671;&6RAA:6Z%NY>14V'Y4=@[*2!D
M#@CDYPQ%-NHK:6[DU%K^_5%Z!+8XC7^(`[,@DGJ.>?2@">#6YGN]0DFA:*PM
M(/,61D(,@RWS`<G&%/UZ]ZCM=9U&/R'O[2,1R)N(B?=(,KNW8'`7/R\\Y&<U
M%+HFD->>8@DB\S9)L%L=I5#O(^[T.X`Y^G7BD::TFOWOY=2N)H9,P"WCM&8;
M<D;>%)P3G)[\>@P`(/$=[%"CS6\6;NU6YM1N(&XE1Y9/<_,#GWQ4LGB*YB6>
M!K>,WD-SY)"[V79M#;L`%NA(P`><5$--MKEIK0SW3K;Q)9PCR'7R5.TYSC#-
MD+D\8`_&DABM8F6Y@NKHW<D[3&8V,A5]WRD8"],#CGJ<]Z`-_3)FN-.MYFE6
M4R1A]ZC`.>:M5CZ9<V>GZ9!:Q^>5BAR#]F92X`))VXXSM/7OZYJ4:]8E68"Z
MVA#)DVDJ@@8Z97GJ*`-.F;_WI3:W3.[''T^M+&ZRQK(F2K`,,C'!]JIVEV+J
MZ#QQR^4]NDJ2,2%(8GC;V.,'UYH`O4444`%%%%`!1110`4444`%%%%`!1110
M`4444`9R?\C',<'_`(](\^GWWK1K.0#_`(2.4\Y^R(#S_MMV_.M&@`HHHH`*
MQO#X_P!(UD_]1!O_`$!*V:QO#X'VC63CG^T&Y_X`E`&S1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!377>C+QR".1D
M?E3J*`,&WTO6K2V@MK?5;<0Q1!%W6V6&!@#KR.E21VGB%)$9M5LY%_B5K0X_
M1@3^8K:HH`PTLO$2J`VL6K$+C)M.2?4_-2FR\0;,#6;8L&SDV?4>GWO\^M;=
M%`&+]AU_+#^V[?!Z'[$,C_QZ@V&O%U_XGD(48SBR'/))S\WI@?AZ]=JB@#(^
MQ:V)2PUF`IV5K(']0XI/LFO+,&&JVKK@@J;0@<]^'ZBMBB@#+,6N!?EO+!CG
M^*V?T'H_UH$6N][O3A]+5_\`XY6I10!FPQZT'/G7-@R8.`ENX.<<=7/?]*:(
M=<VG-[8$[<#_`$5^#G_KIZ5J44`9*1Z_OD\RYT\J8R$VPN,/G@D%CQCWIWDZ
MX`^+RR/R#9FW;[V1G/S=.HX]?:M2B@#'2/Q%O'F7&FE=K\+$X.<';W/&<9]J
M)H_$7V,^3/IINO-X)1U01X/N3G./UK8HH`P2OBLQJ1)H^_\`B4+)C\#_`/6I
MNSQ8"")M(..Q63GW-=!10!A!?%>3^\T;';Y)?\:;L\5MM_?:0H/4[),C]:WZ
M*`,%E\5?)MDTD'&&RLA!YZ_B.WZTYE\3A1M?2BW'42'M@^GU_P`:W**`.-M;
M'4=3:>Z$&EMND:(B5&;8R`IQVP67/'KCUIVKZ9-;:?>S/IFB1*T3*#%$S2$D
M8&/EZY_QK7\+LJ:=+9ELRVEQ+')T'5RP./<$4S5;C[?K%OHD0X`6ZN7W?=16
M&%QW+$#Z#UH`K#09D"!-,T0>6-H/EG)&.YV_C_GF0Z/<_P#0,T/Y6RH\LC\>
MG6NAHH`YMM$N=Q*Z7H748S&W3)R>GN:E_LJ\R6^P:)NVD?ZIOP[?45OT4`<W
M+HEPZN3I6A%L97$1!)[\XX^M9L'A*="D@TS3(I$W$$3S9![<@CW^E=M10!QT
MOA[4Y``(XXU^\2E]/DMGIR3G@"IX]*\36K0BUU&W$:Y4QR;I`1R026&?R]>^
M*ZJB@#$6+Q+&Y;[5ILX('RM&Z`>^1G_/I0C^)C*H:+2Q'N&Y@\F<'K@>HY[U
MMT4`<O=6WBJ:Z53=6ZVX8,3;?(V,_=^8'MSG^=9LNC>()O-%S9V]R9B&D,E[
M)ANAQM!"XX]*[JB@#DK6QUS3,"RT;1E^0*S1LP)QTR3@G_ZU6FNO%O\`#IVG
M#ZRD_P!:Z.B@#G3<^+-F5T_3@<]#,Q_SVI1=^*O+8-IE@7S\I$Y``]QW_.NA
MHH`YV.Z\5^;F33M/*8Z"8@YQZ\_RIRW7BD+\^FV#,6R-LQ&%ST^OO7044`8(
MO/$OEC.E61;&.+D]<=<8Z9SW_P`:>][X@ZIH]L!@<&[R<Y]=OT_6MNB@#"^W
M^(L`_P!B6_;(^V#)Z_[/^<TOVS7W0J^BP<@Y_P!+&.G`Z5N44`88O?$7.=(M
M>^/]*]N.WK4R7FL[VWZ3$$W$#%T,D<8/3Z_E6M10!D"]UKRCG1XS)OQ@70QM
MSUZ=<4Y;O5@ZYTI",88BY`_$#'K[UJT4`93WFL$+LTF,<C)-R#QD9[>F?QI?
MM>J[E)TI>X(^U+TXYZ=:U**`,O[;J_\`T"$_\"Q_\32B\U;)SI,>W/'^E#)'
MK]VM.B@#+^V:MR?[)B&`.#=C)/?^&E^UZMG!TJ+IU%V,?^@UIT4`9"WVMG<#
MHL0()`)O1@X[_=[_`$^N*5[[648`:-$X/4K>#CGW4?7\_P`=:B@#)^W:SY9S
MHR;]I(`NU(SV'0=:<]_J:32@:-))&H^1EN(P6/T)Z>^>_2M2B@#+;4-3##&B
MR%<<G[1'D=,=_KGZ=ZC_`+5U+*_\2"Y^8C'[Z/ISU^;CI^M;%%`&/_:NH[6;
M^P;G"MMP)8\GU(&>E1#6]2/_`#+UY_W]3V]_K_GINT4`8DNLZC&[*-`NGV]6
M65,'Z<\TG]M:GS_Q3UWGM^]CZ<^_7CI6Y10!B#6M19B%\/7GMF2,<_G2#6=3
MZGP]=XYZ2Q_XUN44`8G]LZGCCP]=\#G,T?\`C0=8U3`QX>NB?>>/I^?UK;HH
M`Q],EN[K5IKJ>PGM(S;HBB5E.XAF/0'CKW__`%[%%%`!1110`5C>'Q_I&LG/
M_,0;C_@"5LUC>'R?M.LC''V]N?\`@"4`;-%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110!FZ[J4VDV!NX[9;A$(#*9=AY(`QP<\GVJK<:Y<6U_#:SV
M7S&)II3%)OV(![J,G_#O6C?:?%?O;F=Y=L$@D"*^%9AR-P[X(S22Z=%+/=2L
M[AKF%86P>BC=T]/O&@#/D\36D?[YV1;46T<[,SXD7?\`=&W'/'/!_IG2L;Z*
M^C9HED0HVUED7:1Z'T((Y!'8U!_9$2EC!-+"6:/[I!`5%VA,$$;<9/.>3GTJ
M33=,ATVR-K`TFPG/+=#@`X].F<#UH`S;+Q3#=1)*;:1%F=A;H,F28#'(7'J<
M=<<=:LGQ%IYBA:)I9I)L[(8HRTAP0&&/49Y]@30V@6D?V9K,M:S6J[(I4^8A
M#G*G.<CD]>_-36>D6]DRF$N-L1B7)&5W,68YQG)./R%`$/\`PD>FGR]LKMYK
M.L>(R0Y0@'!Z=3UZ5:AU.TGTL:DLN+4QF0NPQ@#KD52M?#EM:VL$"2RX@MI+
M=3QQO(+...#Q5J72+:;14TJ0R-;)&D?7YB%QC)_`4`5'\4Z7'&SRO-'L56=6
MA;*JV,$@#@<U8FU[38!(6N0?*F2%PH)(9N@_SZ&H[OP_;7;71DDD"W3Q-(JX
M`(0#"].0?0^M1OX<MWNFE:>4H;P7@BPH7>`!Z9QQTSZ?B`3QZY9RWSVB>:[J
MY0NL3E`PSD%L8!R/Y4:?K4&H6=S=P1RB&$L%9T*^8`.2N>V<C\#45OX>MX;U
M[OSYFE??D[47[W4DA03QZDC@'&14]IH\-IHG]EQ33"+:R^9N&\;B2><>YH`A
MT[Q%97L<'F;[6:9-X252!C`;AR-IX(/!Z&K%CK-AJ,S16LQ=U7>08V7Y<XSR
M!FJR>&[(!0[22+'%Y4(;;^Z'EA"00.20HY.>G&*M66EP6<YG7#2E-F\HH.."
M>0,\D$^F30`2:O8Q7J6CRMYSOY:XC8J6_N[@-N>.F:B@U[3[BY2".5R9"X1S
M&P1]I.[#8P?NGOVIKZ#;->17)9F=)FF/F?-DG/&>P&3@=.:;;Z#'#;36IN9F
MM'B,,<.%Q&I]#C)/)ZD]:`)(_$&FR6\TPN"$AC65]Z,N%;[IY'.>V*(]?TYH
MYW>62$0;?,$T3(5W9QP1GG!IB:)NL)+6YO)9%?R\>6JQB/805VJ!@=!ZU$_A
MU9\FZOIY6>9))?E4*X0L53;C&W+9.<YQ0!*?$FE+)-&UPRO"P60-$XVDD`9R
M/4_C@TI\0Z<MXMJ9)-YF^S[O*;8),\(6QC)[5&_A^*25W>XE(DNOM,B\?.<8
M"GU48&!]?6J>F^%VCM;9;^Z=V2;[5)&F-K3>N<9(S@XZ4`:=OKMA<WOV6*5S
M)\^"8V"DH<,,D=J9%XATR<*T-QO5T9U;80&VXW`$]QD?G52/PNJG,FH74A$4
ML2NQ&\!\9);')Z\^]3R>'H',86>2..&S-K"JA?D!ZMDCD\+^7O0`MEXCL;B`
M/,X@D\OSFC)W%8^SG`X!!!YQU%&H^)+"R@E:*07,T:;O*B.23E0`3V)W"F-X
M7L5N9YH,Q">$0NFT%=H``QGIP,>]//AVT9[H,SFWNI!*\/;>"""">1TZ=.W2
M@":_U=+"WM9)8)!)<'`BXW+\I8YQGICG%2VFK65['');REDED,2$H5RX!)&"
M,\!32:AIPOI;67SGB>V<NA7U*D#\LYK+N?#DHTZVM+.\D5_M33SW#'YVW(ZN
M1@=3NX]*`->#4[.XLY;N*=6MXMV^3L,#)_*H!K^E&&64WL:+"0'W'!&>AQZ'
MJ#W'-/O=,$^FQV5M/)9K&%$;Q'YE"C@`FL.[\+`7*Q6SF.&XN_M,TA897:#L
MC5<8(!).#QA:`-K^W=,^RO<F[01(_EL2",-Z8QG-(VO:6L8<WL7S/Y849+%O
M3;UST[=Q5&;P_<O<1,E^<-<FZGD907WA0J!`00%`]>>E6+3P_%;ZE]ODN))Y
MB[R'>!C<<`$#MA1C\:`)1X@TLRI%]K4.[*H4JP.6^Z#QP3[_`%HC\0:5+,(H
M[Q6=I!$`%;ES_#G'7^54?^$8"22^7<YMWN1=>28EW%P<X+]P3[4S2O#TXL[0
MW\VR5;AKJ:*,##.6W*,^@/U],XH`@UJ30[UY)XVF>\C=(G6U<QR%B=BANG()
MZ=>/0&KNGW&A:==3VD5XK7?F,\S2N2Y8`D[F/7`S]*;:^%H(K;3XI9=YM91/
M)\O^MD`//YG/O2IX97[6MS+?W$LB+(JLV"WS[@22<\@%0,8^[[T`3P^)])ET
M^&]>Z6&&:0QIYG!)'7('3\?4>M6]0U2STZP^VW$RB`XVL.0V>F,=:RE\+>7%
M;B.^;S(;8VQ9D.UESP0`1AL<9SR*T[O2;:YTZ&PQLMXF0A5`Z*00/TH`KV7B
M*PN%M(YID@NKE598&8%N>G3(Y'(^HJ<:UIS79M8[N)[@?\LPX!ZD'KC.,$D=
M<#W&:,OAF%KB9XI0L<SEWC=6;GY<8PPP!L&/3)Q38/#/D>6L=W\D4KS1YC^8
M,P8#)SSC=GH"2.M`&M9ZC97S2+:74,[1G#B-P2OUJRK!AD9ZD<C%8>G:-<Z5
M%(8+E#N*A8Q&61%WDD@%LC(/0'''0UNT`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%5Y+VVCN?L[RA9<*0IZG<2!CUY!^G>@"Q13!-
M&0Q$B$*=K'<.#Z&HVO+=8C()5=00"4^?KC'3_>!^ASTH`GHJ">[@@M[B=Y!L
MME+2[>2F%W'('?!!Q[BD@O;>XSY;X(;;A@5).`>`?J*`+%%1/<P(@=IHPI;;
MG<.N<8_/B@W$`V9FC&_&W+#YLYQCUS@_E0!+13$ECD+A'5BC;7"G.TX!P?0X
M(_.HY+N".9(6D'F.VU5')SC.,?3GZ`F@">BJ(U>Q,S1"?+K(L3?(V`QX`)Q@
M<\?4@=2*MM+&CHC.JN^=JDX+8Y./6@!]%5KN^@LC&)RX,I(0+&SEB!G'R@\X
M!X[X-6:`"BF"6,NZ!UW1@%QG[N?6F+=0-,\*R`NB+(P_V3G!SZ<'\J`)J*K6
MM_:WAE%O+YGE'#84^_3CD<'D<<&HVU:Q6&&8SYCF5G0A&.5`R6X'`'KTY'J*
M`+M%49-7LXE=GD;",$;;&S8)VX'`/7</K^%.DU2QBMDN7NHQ"YPKYXSG'X<\
M>QXH`N453;5+!%+/=1*!(8SEL88%@1^:M^1J:&YAGEECB?<T1`?`.`2,]>_%
M`$U%%%`!1110`5B^'C_I6LCG_C_;Z?<2MJL?0U*7^LH0P_TS=S[QI[_YXH`V
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`QM3O]335$L=-@M9&:W,Q,[L,88#M]1^1IHD\3$-_HVE#!X_?2?\`
MQ-2LF?%L;\_+8L.G',B_X5K4`80E\4\9M=+.!SB5^?IQ3?-\58Q]FTG/7/F2
M8Z=.E;]<WXQO[BR.F?9[R2V$MSM=HH][$8_NXYZ]/7%`$S2^*B?EMM*4$Y&9
M9#@>AXZ^]`E\4][72N>/]:_!]>G2LC1M9N8-0OGDN;RYLHK3SR+J+9("&/"@
M=N>N/3H`*U$\3E1,US8/&D4+2[T?>K;>H!P.>>/7GI0!*)?$Y8$VFEA><KYS
MY/''./7^?;K0LGB@.=UOI13G@2R`]\<X^G^>D/\`PE<<5K-<W-H\4<40DX8D
MYR%VD$`@Y/T]Z5O$%T]K=+_9=Q!=1QL4!^9-P7)&[&,CGV.",T`61/XA4DM8
M:>XQD!;EACCIRGKG\P/>HOM/B8.H.GZ>06#$BX;A3G*].HP.>G(X/.+N@7D]
M_HEG=72;)I8PS#&,^A_$<_C6A0!D&[UT#/\`95HWS[=HO"/E]<[/Q]?;TLZ1
M>3WUK))<0I$Z32181BP.UBI()`[@]JO5D^'1BVO?EQF_N.<]?WAH`UJ***`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"J=YIT5W*LCEMP9#C<=ORDD<9QGD\
M_3T%7**`,F/0H`(O,;+12[U9%"EEV[=KYSN&!C)YX'I3$\/0I('6>3.T)T&<
M#:!SCJ`H&:V:*`,W^QX([6>*W>2.29-C2L[.W!8CJ><%CQW'!XJ*308))H92
MYS&Q=@PW*Q+(3@$_*/W8X'3-:]%`&6F@VGS&4R2L45-Q8@X4Y4^YZ9)ZXILO
MA^SEG>4EU#1B,(NT*F,@$#'8,1Z8]^:UJ*`,F'0H(+BUEBE=?(=W8=I"Q)^8
M#CC)YQFB'0HHKS[5YTAD$GF+C@#YY&Q[\2E?P%:U%`&6^B027,TS229DECE`
M`4;65E;KCG)4=<X&0,`U6?PQ;O;M$;B8%A_K%PK9*E2V0.ISS[<=*W:*`*,U
MM'#!;33SD)8DRER``1L93G'0`-G\!5)M!LIB\:7<WFH9"Y$@+AI%89/&<X?C
MV5?2M._MA>Z?<VA;8)XFC+8SC<",_K6>?#\7F2N+NY03#;($?&Y=N,>P[C&,
M9..*`'IH]M%-)=++L,@(.WA=I15Q],J"/<GUIHTI?M)>2]+$6YMV4#;B,DGC
M!RI`(&1Z4V/P_%C9-,\B`L`HX!7^$$=#M''3G`STIO\`PCY$C[;Z;RI)"\J.
M`PE#,=RL.,C:<#T_`"@":UM!)92*E]YPE0QHX11\HX)^7[W.3G_:[43:);O*
M[^9)&C)(I"N<@L8SN!)XYCS[Y.>^4_L4_8K>W6XV&`-M8)T)8'(YXQC'XU8T
MS3(].0[79Y&15=CWVYP?7OZ]OK0!3FBLE91]M"2W4T=TF55B^Q4&%&#GA1TY
MR:F6RA2**U%V2MJYFEC)#%D;?A6!R<<\9_N^O-1/HLDL$-O).GD06WEP@1_<
MEV[=_O@9P/<^V+$>DPI>22L`T9CC14/8IN&?KAOTH`HMIUB'0#4E$N[8F6!^
M\LFU<=S^])]\"KVG6RQ7-PZSB3&$`5NV2V2.F<N1QV'X"C'X;"V=M:-,#%#&
MT>X(-Q!"@<'(Z@G\<5I:=IZV'F!)"5<)\N,`$+@D#MG`H`NT444`%%%%`!6;
MIW_(4U;D9\]/KCRD_3K^OO6E6;8?\A?5,@_?CP3G&/+'`_7IZT`:5%%%`!11
M10`4444`%%%%`!1110`4444`%%(S!%+,0J@9))X`I:`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`P=4O[32_$-M<7LX@CEM7C5F!(R'0XX]C_GN^/Q=H,@8KJ4
M0V]=P9>^.XYZ_P!>E;=%`&5'XET65PJZG;`E`X+OM&#[GC/MUJB=1\.WALYF
MU13]E;S(]\Q!8D9R<\D#\AC!Z8KHZ*`,*6_\.RW<US+J%H[O#]FD!G!4IDG&
M,X/WNOX>M4+:U\)6Z3#^TK>4SKL=I;P,=IXP.>.GUYZUUE%`'+*_AJUL[CR[
MV"X;[-Y026[!8KU"J6/&3C\<4MH/"EE)+)%?0-(Z&(F2Y+LB=U&3D#'\JZ<@
M'&0#CF@@$8(![\T`8NG:IH-A9);6^J0F*,87S+C<<#L"3V'8=*M+KVD,VU=2
MM2P&2!*,BKYC1@`R*<<#(_SZ"D>*.10KQJP'0$9H`SQXAT9MH&J6A+#('FC_
M`#GVJ/PU(DVGSS1,CQR7EPZ,O\0,C8/O_ABM(P0LNTQ1D=<%13TC2,8C15'7
M"C%`#J***`"BBB@`HHHH`****`$`P,4M%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!69I^
M1K.JCG!>)N?^N8''Y5IUDZ7()-9U@@'Y)8TSZXC!_K0!K4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4G.[H-N.N><TM%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`444A&>^*`%HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"LO3D5-9U8J`"S1EOFSSL_3C%:E9UB?^)S
MJ?L8NW^S0!HT444`%%%%`!1110`4444`%%%(,XYZT`+1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!6=9#_`(G&I>_E?^@U
MHUGV?_(8U'_ME_Z#0!H4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4C,%&
M6(`]32TG7K0`M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%(0&!!`(/!![T`+1110`44
M44`%%%%`!6?9_P#(8U'_`+9?^@UH5GV9']L:B/XAY1//;;_^N@#0HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"H$@9;V6<R$J\:($[*5+$G\=P_*IZ*`"BBB@`HHHH`
M****`"BBB@!LC,J%E0N1_""`3^=1>?+G_CUEQC/WDZ^G7_.*GHH`@\Z3<!]F
ME`QG.5Z^G6A)Y2!NM9%)_P!I3C]:GHH`9&[.F6C:,_W6QG]":?110`4PL0X7
M8Q!_B&,#]<__`*Z?10!6\^XVJ?LC9(.1O7@\_P#UOSJ17E+X,.U<D9+#WYQ^
M7YU+10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!12
M<TM`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%("&`(Z'F@!
M:***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
AHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
